PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chuchana, P; Holzmuller, P; Vezilier, F; Berthier, D; Chantal, I; Severac, D; Lemesre, JL; Cuny, G; Nirde, P; Bucheton, B				Chuchana, Paul; Holzmuller, Philippe; Vezilier, Frederic; Berthier, David; Chantal, Isabelle; Severac, Dany; Lemesre, Jean Loup; Cuny, Gerard; Nirde, Philippe; Bucheton, Bruno			Intertwining Threshold Settings, Biological Data and Database Knowledge to Optimize the Selection of Differentially Expressed Genes from Microarray	PLOS ONE			English	Article							SAMPLE-SIZE; CELL DIFFERENTIATION; RECEPTOR; LIPOPOLYSACCHARIDE; CYTOKINE; METALLOTHIONEIN; INFLAMMATION; MACROPHAGES; ACTIVATION; INNATE	Background: Many tools used to analyze microarrays in different conditions have been described. However, the integration of deregulated genes within coherent metabolic pathways is lacking. Currently no objective selection criterion based on biological functions exists to determine a threshold demonstrating that a gene is indeed differentially expressed. Methodology/Principal Findings: To improve transcriptomic analysis of microarrays, we propose a new statistical approach that takes into account biological parameters. We present an iterative method to optimise the selection of differentially expressed genes in two experimental conditions. The stringency level of gene selection was associated simultaneously with the p-value of expression variation and the occurrence rate parameter associated with the percentage of donors whose transcriptomic profile is similar. Our method intertwines stringency level settings, biological data and a knowledge database to highlight molecular interactions using networks and pathways. Analysis performed during iterations helped us to select the optimal threshold required for the most pertinent selection of differentially expressed genes. Conclusions/Significance: We have applied this approach to the well documented mechanism of human macrophage response to lipopolysaccharide stimulation. We thus verified that our method was able to determine with the highest degree of accuracy the best threshold for selecting genes that are truly differentially expressed.	[Chuchana, Paul] INSERM, U844, Montpellier, France; [Chuchana, Paul; Holzmuller, Philippe; Vezilier, Frederic; Berthier, David; Chantal, Isabelle; Lemesre, Jean Loup; Cuny, Gerard; Bucheton, Bruno] Ctr CIRAD 177, UMR IRD, Montpellier, France; [Severac, Dany] Montpellier GenomiX, Inst Genom Fonct, Montpellier, France; [Nirde, Philippe] Univ Montpellier I, Inst Rech Cancerol Montpellier, INSERM, U896, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Chuchana, P (corresponding author), INSERM, U844, Montpellier, France.	paul.chuchana@inserm.fr	Holzmuller, Philippe/F-7231-2019	Holzmuller, Philippe/0000-0002-8919-9081; Isabelle, CHANTAL/0000-0002-3429-484X; David, BERTHIER/0000-0002-3283-6588	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD); Institut National de la Sante Et de la Recherche Medicale (INSERM); EU [223341]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement (IRD); Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD); Institut National de la Sante Et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); EU(European Commission)	This study was co-supported by the Centre National de la Recherche Scientifique (CNRS), Institut de Recherche pour le Developpement (IRD), Centre de cooperation internationale en recherche agronomique pour le developpement (CIRAD), Institut National de la Sante Et de la Recherche Medicale (INSERM) and by EU (RAPSODI project, FP7), grant N<SUP>o</SUP>223341. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Bin LH, 2003, J IMMUNOL, V171, P924, DOI 10.4049/jimmunol.171.2.924; Bock-Axelsen J, 2007, P NATL ACAD SCI USA, V104, P13122, DOI 10.1073/pnas.0705824104; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Chuchana P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm093; Davis KE, 2004, J BIOL CHEM, V279, P42453, DOI 10.1074/jbc.M402197200; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Febbo PG, 2006, CLIN CANCER RES, V12, P152, DOI 10.1158/1078-0432.CCR-05-1652; Fernandes AF, 2008, J BIOL CHEM, V283, P20745, DOI 10.1074/jbc.M800268200; Genolet Raphael, 2004, Current Drug Targets - Inflammation and Allergy, V3, P361, DOI 10.2174/1568010042634578; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Inoue K, 2005, FASEB J, V19, P533, DOI 10.1096/fj.05-3864fje; Inoue K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/215935; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Laukens D, 2009, CRIT REV EUKAR GENE, V19, P301, DOI 10.1615/CritRevEukarGeneExpr.v19.i4.40; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Luo YQ, 2006, STEM CELLS, V24, P865, DOI 10.1634/stemcells.2005-0392; Mayburd AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005921; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Muller P, 2004, J AM STAT ASSOC, V99, P990, DOI 10.1198/016214504000001646; Oehler VG, 2009, BLOOD, V114, P3292, DOI 10.1182/blood-2009-03-212969; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Pulai JI, 2005, J IMMUNOL, V174, P5781, DOI 10.4049/jimmunol.174.9.5781; Puskas LG, 2002, BIOTECHNIQUES, V32, P1330, DOI 10.2144/02326mt04; Rigamonti E, 2008, ARTERIOSCL THROM VAS, V28, P1050, DOI 10.1161/ATVBAHA.107.158998; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; SIEGENTHALER G, 1994, BIOCHEM J, V302, P363, DOI 10.1042/bj3020363; Stolovitzky GA, 2005, P NATL ACAD SCI USA, V102, P1402, DOI 10.1073/pnas.0406555102; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Tibshirani R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-106; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Tulic MK, 2007, J IMMUNOL, V179, P132, DOI 10.4049/jimmunol.179.1.132; Wang CC, 2008, P NATL ACAD SCI USA, V105, P11661, DOI 10.1073/pnas.0804923105; Warnes GR, 2006, SAMPLE SIZE ESTIMATI; Wei CM, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-87; Yoon YD, 2003, INT IMMUNOPHARMACOL, V3, P1873, DOI 10.1016/j.intimp.2003.09.005; Zapolska-Downar D, 2009, J PHYSIOL PHARMACOL, V60, P123; Zhu LX, 2007, ANTIMICROB AGENTS CH, V51, P3707, DOI 10.1128/AAC.01461-06	50	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13518	10.1371/journal.pone.0013518	http://dx.doi.org/10.1371/journal.pone.0013518			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976008	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400022
J	Yang, RJ; Chen, M; Lee, CH; Yoon, R; Lal, S; Mao, JJ				Yang, Rujing; Chen, Mo; Lee, Chang Hun; Yoon, Richard; Lal, Shan; Mao, Jeremy J.			Clones of Ectopic Stem Cells in the Regeneration of Muscle Defects In Vivo	PLOS ONE			English	Article							SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; TEETH; PAX3; SIZE	Little is known about whether clones of ectopic, non-muscle stem cells contribute to muscle regeneration. Stem/progenitor cells that are isolated for experimental research or therapeutics are typically heterogeneous. Non-myogenic lineages in a heterogeneous population conceptually may compromise tissue repair. In this study, we discovered that clones of mononucleated stem cells of human tooth pulp fused into multinucleated myotubes that robustly expressed myosin heavy chain in vitro with or without co-culture with mouse skeletal myoblasts (C2C12 cells). Cloned cells were sustainably Oct4+, Nanog+ and Stro1+. The fusion indices of myogenic clones were approximately 16-17 folds greater than their parent, heterogeneous stem cells. Upon infusion into cardio-toxin induced tibialis anterior muscle defects, undifferentiated clonal progenies not only engrafted and colonized host muscle, but also expressed human dystrophin and myosin heavy chain more efficaciously than their parent heterogeneous stem cell populations. Strikingly, clonal progenies yielded, 9 times more human myosin heavy chain mRNA in regenerating muscles than those infused with their parent, heterogeneous stem cells. The number of human dystrophin positive cells in regenerating muscles infused with clonal progenies was more than, 3 times greater than muscles infused with heterogeneous stem cells from which clonal progenies were derived. These findings suggest the therapeutic potential of ectopic myogenic clones in muscle regeneration.	[Yang, Rujing; Chen, Mo; Lee, Chang Hun; Yoon, Richard; Lal, Shan; Mao, Jeremy J.] Columbia Univ, Med Ctr, Dept Growth & Dev, TERML, New York, NY 10027 USA; [Lee, Chang Hun; Mao, Jeremy J.] Columbia Univ, Dept Biomed Engn, New York, NY USA	Columbia University; Columbia University	Yang, RJ (corresponding author), Columbia Univ, Med Ctr, Dept Growth & Dev, TERML, New York, NY 10027 USA.	jmao@columbia.edu			NIH [R01DE018248]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018248] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work is supported by NIH grant R01DE018248. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blau HM, 2008, NEW ENGL J MED, V359, P1403, DOI 10.1056/NEJMcibr0805708; Chan J, 2006, STEM CELLS, V24, P1879, DOI 10.1634/stemcells.2005-0564; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dezawa M, 2005, SCIENCE, V309, P314, DOI 10.1126/science.1110364; Gang EJ, 2008, EXP CELL RES, V314, P1721, DOI 10.1016/j.yexcr.2008.02.016; Goudenege S, 2009, MOL THER, V17, P1064, DOI 10.1038/mt.2009.67; Gutierrez J, 2010, MOL CELL BIOL, V30, P1634, DOI 10.1128/MCB.01164-09; Huard J., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P337; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Kerkis I, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-35; Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085; Moioli EK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003922; Rafii S, 2002, NAT REV CANCER, V2, P826, DOI 10.1038/nrc925; Rafii S, 2002, SEMIN CELL DEV BIOL, V13, P61, DOI 10.1006/scdb.2001.0285; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; Wilschut KJ, 2008, J CELL BIOCHEM, V105, P1228, DOI 10.1002/jcb.21921	22	39	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13547	10.1371/journal.pone.0013547	http://dx.doi.org/10.1371/journal.pone.0013547			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975999	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400030
J	Agrawal, S; Gupta, S; Agrawal, A				Agrawal, Sudhanshu; Gupta, Sudhir; Agrawal, Anshu			Human Dendritic Cells Activated via Dectin-1 Are Efficient at Priming Th17, Cytotoxic CD8 T and B Cell Responses	PLOS ONE			English	Article							PATHOGEN CANDIDA-ALBICANS; INNATE IMMUNE-SYSTEM; BETA-GLUCAN; NLRP3 INFLAMMASOME; HELPER-CELLS; RECOGNITION; RECEPTOR; INDUCTION; INTERLEUKIN-1-BETA; DIFFERENTIATION	Background: Dendritic cells capture antigens through PRRs and modulate adaptive immune responses. The type of adaptive immune T cell response generated is dependent upon the type of PRR activated by the microbes. Dectin-1 is a C-type lectin receptor present on dendritic cells. Methodology/Principal Findings: Here we show that selective dectin-1 agonist Curdlan can activate human DCs and induce the secretion of large amounts of IL-23, IL-1 beta, IL-6 and low levels of IL-12p70 as determined by ELISA. The Curdlan-stimulated DCs are efficient at priming naive CD4 cells to differentiate into Th17 and Th1 cells. Furthermore, these CD4 T cells induce differentiation of B cells to secrete IgG and IgA. In addition, Curdlan-stimulated DCs promote the expansion and differentiation of Granzyme and perforin expressing cytotoxic T lymphocyte that display high cytolytic activity against target tumor cells in vitro. Conclusions/Significance: These data demonstrate that DCs stimulated through Dectin-1 can generate efficient Th, CTL and B cell responses and can therefore be used as effective mucosal and systemic adjuvants in humans.	[Agrawal, Sudhanshu; Gupta, Sudhir; Agrawal, Anshu] Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA	University of California System; University of California Irvine	Agrawal, S (corresponding author), Univ Calif Irvine, Dept Med, Div Basic & Clin Immunol, Irvine, CA 92717 USA.	aagrawal@uci.edu	Agrawal, Anshu/AAU-6341-2021		Ellison Medical Foundation	Ellison Medical Foundation(Lawrence Ellison Foundation)	This study is supported by a New Scholar grant from the Ellison Medical Foundation (www.ellisonfoundation.org.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Baran J, 2007, FOLIA HISTOCHEM CYTO, V45, P107; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; Chan GCF, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-25; DEKONING HD, 2010, J INVEST DERMAT 0715; Dhodapkar KM, 2008, BLOOD, V112, P2878, DOI 10.1182/blood-2008-03-143222; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Ferwerda B, 2009, NEW ENGL J MED, V361, P1760, DOI 10.1056/NEJMoa0901053; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gow NAR, 2007, J INFECT DIS, V196, P1565, DOI 10.1086/523110; Harnack U, 2009, INT IMMUNOPHARMACOL, V9, P1298, DOI 10.1016/j.intimp.2009.07.013; Higashi Takehiro, 2010, Allergology International, V59, P161, DOI 10.2332/allergolint.09-OA-0103; Hise AG, 2009, CELL HOST MICROBE, V5, P487, DOI 10.1016/j.chom.2009.05.002; Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X; Lara-Tejero M, 2006, J EXP MED, V203, P1407, DOI 10.1084/jem.20060206; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; MORIKAWA K, 1985, CANCER RES, V45, P1496; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Osorio F, 2008, EUR J IMMUNOL, V38, P3274, DOI 10.1002/eji.200838950; Pulendran B, 2001, SCIENCE, V293, P253, DOI 10.1126/science.1062060; Ragupathi G, 2008, VACCINE, V26, P4860, DOI 10.1016/j.vaccine.2008.06.098; Raupach B, 2006, INFECT IMMUN, V74, P4922, DOI 10.1128/IAI.00417-06; Reid DM, 2009, CURR OPIN IMMUNOL, V21, P30, DOI 10.1016/j.coi.2009.01.003; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; SUZUKI I, 1989, INT J IMMUNOPHARMACO, V11, P761, DOI 10.1016/0192-0561(89)90130-6; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Weitberg AB, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-40; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yoshitomi H, 2005, J EXP MED, V201, P949, DOI 10.1084/jem.20041758; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	48	58	59	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13418	10.1371/journal.pone.0013418	http://dx.doi.org/10.1371/journal.pone.0013418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976143	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300011
J	Choi, H; Schmidbauer, N; Sundell, J; Hasselgren, M; Spengler, J; Bornehag, CG				Choi, Hyunok; Schmidbauer, Norbert; Sundell, Jan; Hasselgren, Mikael; Spengler, John; Bornehag, Carl-Gustaf			Common Household Chemicals and the Allergy Risks in Pre-School Age Children	PLOS ONE			English	Article							VOLATILE ORGANIC-COMPOUNDS; GLYCOL MONOMETHYL ETHER; WATER-BASED PAINTS; BUILDING CHARACTERISTICS; SURFACE MATERIALS; AIRWAY SYMPTOMS; YOUNG-CHILDREN; LUNG-FUNCTION; EXPOSURE; ASTHMA	Background: The risk of indoor exposure to volatile organic compounds (VOCs) on allergic airway diseases in children remains unknown. Objective: We examined the residential concentrations of VOCs, emitted from building materials, paints, furniture, and other lifestyle practices and the risks of multiple allergic diseases as well as the IgE-sensitization in pre-school age children in Sweden. Methods: In a case-control investigation (198 case children with asthma and allergy and 202 healthy controls), air samples were collected in the room where the child slept. The air samples were analyzed for the levels of eight classes of VOCs. Results: A natural-log unit of summed propylene glycol and glycol ethers (PGEs) in bedroom air (equal to interquartile range, or 3.43 -15.65 mu g/m(3)) was associated with 1.5-fold greater likelihood of being a case (95% CI, 1.1 - 2.1), 1.5-fold greater likelihood of asthma (95% CI, 1.0 - 2.3), 2.8-fold greater likelihood of rhinitis (95% CI, 1.6 - 4.7), and 1.6-fold greater likelihood of eczema (95% CI, 1.1 - 2.3), accounting for gender, secondhand smoke, allergies in both parents, wet cleaning with chemical agents, construction period of the building, limonene, cat and dog allergens, butyl benzyl phthalate (BBzP), and di(2-ethylhexyl) phthalate (DEHP). When the analysis was restricted to the cases, the same unit concentration was associated with 1.8-fold greater likelihood of IgE-sensitization (95% CI, 1.1 - 2.8) compared to the non-IgE sensitized cases. No similar associations were found for the other classes of VOCs. Conclusion: We propose a novel hypothesis that PGEs in indoor air exacerbate and/or induce the multiple allergic symptoms, asthma, rhinitis and eczema, as well as IgE sensitization respectively.	[Choi, Hyunok; Spengler, John] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Schmidbauer, Norbert] Norwegian Inst Air Res, Kjeller, Norway; [Sundell, Jan] Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China; [Hasselgren, Mikael] Cty Council Varmland, Primary Care Res Unit, Karlstad, Sweden; [Bornehag, Carl-Gustaf] Karlstad Univ, Karlstad, Sweden; [Bornehag, Carl-Gustaf] SP Tech Res Inst Sweden, Boras, Sweden	Harvard University; Harvard T.H. Chan School of Public Health; Norwegian Institute for Air Research; Tsinghua University; Karlstad University; SP Technical Research Institute of Sweden	Choi, H (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.	carl-gustaf.bornehag@kau.se	Sundell, Jan H/B-2857-2012	Bornehag, Carl-Gustaf/0000-0003-0417-1686	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Norwegian Research Council; U.S. National Research Service [T32 ES 07069]; County Council of Varmland, Sweden; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007069] Funding Source: NIH RePORTER	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Asthma and Allergy Association's Research Foundation; Swedish Foundation for Health Care Sciences and Allergy Research; Norwegian Research Council(Research Council of NorwayEuropean Commission); U.S. National Research Service; County Council of Varmland, Sweden; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study has been supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), Swedish Asthma and Allergy Association's Research Foundation, the Swedish Foundation for Health Care Sciences and Allergy Research, Norwegian Research Council, the U.S. National Research Service Award (T32 ES 07069), and County Council of Varmland, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYER CW, 1988, J CHROMATOGR SCI, V26, P168, DOI 10.1093/chromsci/26.4.168; Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x; Bornehag CG, 2006, SCAND J PUBLIC HEALT, V34, P534, DOI 10.1080/14034940600607467; Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x; Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809; Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187; Brieger J, 2008, TOXICOL LETT, V177, P138, DOI 10.1016/j.toxlet.2008.01.007; Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x; Engman LH, 2007, SCAND J PUBLIC HEALT, V35, P125, DOI 10.1080/14034940600975658; Ernstgard L, 2007, J OCCUP ENVIRON MED, V49, P880, DOI 10.1097/JOM.0b013e3181161ced; HEDEROS CA, 2007, COMP CLIN DIAGNOSED, P135; Helmig D, 1996, J CHROMATOGR A, V732, P414, DOI 10.1016/0021-9673(95)01376-8; Henderson J, 2008, EUR RESPIR J, V31, P547, DOI 10.1183/09031936.00086807; Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188; Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560; Jurvelin J, 2001, J ENVIRON MONITOR, V3, P159, DOI 10.1039/b007600g; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Kleno JG, 2002, ENVIRON SCI TECHNOL, V36, P4121, DOI 10.1021/es025680f; Korinth G, 2003, CONTACT DERMATITIS, V49, P248, DOI 10.1111/j.0105-1873.2003.0242.x; Korinth G, 2007, TOXICOL LETT, V170, P97, DOI 10.1016/j.toxlet.2007.01.013; Kuntasal OO, 2005, J CHROMATOGR A, V1099, P43, DOI 10.1016/j.chroma.2005.08.093; Lemazurier E, 2005, TOXICOL IND HEALTH, V21, P33, DOI 10.1191/0748233705th213oa; Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x; MILLER RR, 1984, TOXICOL APPL PHARM, V75, P521, DOI 10.1016/0041-008X(84)90188-1; Nielsen GD, 2007, INDOOR AIR, V17, P236, DOI 10.1111/j.1600-0668.2006.00468.x; Patel SP, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-57; Pearce N, 2006, INT J TUBERC LUNG D, V10, P125; Rumchev K, 2004, THORAX, V59, P746, DOI 10.1136/thx.2003.013680; Schenker MB, 1996, TUBERCLE LUNG DIS, V77, P4, DOI 10.1016/S0962-8479(96)90069-6; STEWART RD, 1970, ARCH ENVIRON HEALTH, V20, P218, DOI 10.1080/00039896.1970.10665577; Uhde E., 2009, Organic indoor air pollutants: occurrence, measurement, evaluation, P3; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052; Wieslander G, 2007, INDOOR AIR, V17, P19, DOI 10.1111/j.1600-0668.2006.00441.x; Wieslander G, 1997, INT ARCH OCC ENV HEA, V69, P115; Wieslander G, 1997, ANN OCCUP HYG, V41, P155, DOI 10.1016/S0003-4878(96)00039-7; WIESLANDER G, 1994, INT ARCH OCC ENV HEA, V66, P261, DOI 10.1007/BF00454365; Wieslander G, 2001, OCCUP ENVIRON MED, V58, P649, DOI 10.1136/oem.58.10.649; Wolkoff P, 1998, SCI TOTAL ENVIRON, V215, P135, DOI 10.1016/S0048-9697(98)00110-7; Wu CH, 2004, CHEMOSPHERE, V56, P71, DOI 10.1016/j.chemosphere.2004.02.003	40	108	117	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13423	10.1371/journal.pone.0013423	http://dx.doi.org/10.1371/journal.pone.0013423			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976153	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000283045300012
J	Weingartner, O; Pinsdorf, T; Rogacev, KS; Blomer, L; Grenner, Y; Graber, S; Ulrich, C; Girndt, M; Bohm, M; Fliser, D; Laufs, U; Lutjohann, D; Heine, GH				Weingaertner, Oliver; Pinsdorf, Tobias; Rogacev, Kyrill S.; Bloemer, Lutz; Grenner, Yvonne; Graeber, Stefan; Ulrich, Christof; Girndt, Matthias; Boehm, Michael; Fliser, Danilo; Laufs, Ulrich; Luetjohann, Dieter; Heine, Gunnar H.			The Relationships of Markers of Cholesterol Homeostasis with Carotid Intima-Media Thickness	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SERUM PLANT STEROLS; ARTERY-DISEASE; RISK-FACTOR; NONCHOLESTEROL STEROLS; DIETARY-CHOLESTEROL; CARDIOVASCULAR RISK; ABSORPTION; ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA	Background: The relationship of cholesterol homeostasis and carotid intima-media thickness (cIMT) is unknown. To address this, we assessed markers of cholesterol homeostasis (serum plant sterols and cholesterol precursor concentrations as surrogate measures of cholesterol absorption and synthesis, respectively) and cIMT in a middle-aged, statin-naive population. Methods: In this prospective study of primary prevention cIMT was measured by ultrasound in 583 hospital employees aged 25-60 years without prevalent cardiovascular disease or lipid-modifying medication. The serum concentrations of plant sterols (as markers of cholesterol absorption) were measured by gas-liquid chromatography. Lathosterol serum concentrations were quantitated to assess hepatic cholesterol synthesis. Results: cIMT correlated positively with serum cholesterol (r = 0.22, P<0.0005) and lathosterol-to-cholesterol (r = 0.18, P<0.001). In contrast, plant sterols, as markers of cholesterol absorption, showed a weak negative correlation to cIMT measurements (r = 20.18; P<0.001 for campesterol-to-cholesterol). Stratifying subjects by serum sterol levels, we found that cIMT increased continuously over quintiles of serum cholesterol (P<0.0005) and was positively associated to serum lathosterol-to-cholesterol levels (P = 0.007), on the other hand, plant sterol levels showed a weak negative association to cIMT (P<0.001 for campesterol-to-cholesterol). Conclusions: In this population without prevalent cardiovascular diseases or lipid-modifying medication, markers of increased endogenous cholesterol synthesis correlated positively with cIMT, while markers of cholesterol absorption showed a weakly negative correlation. These data suggest that not only total serum cholesterol levels but also differences in cholesterol homeostasis are associated with cIMT.	[Weingaertner, Oliver; Boehm, Michael; Laufs, Ulrich] Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany; [Pinsdorf, Tobias; Luetjohann, Dieter] Univ Klinikum Bonn, Inst Klin Chem & Klin Pharmakol, Bonn, Germany; [Graeber, Stefan] Univ Klinikum Saarlandes, Inst Med Biometrie Epidemiol & Informat, Homburg, Germany; [Grenner, Yvonne] Univ Klinikum Saarlandes, Klin Innere Med 2, Homburg, Germany; [Rogacev, Kyrill S.; Bloemer, Lutz; Ulrich, Christof; Girndt, Matthias; Fliser, Danilo; Heine, Gunnar H.] Univ Klinikum Saarlandes, Klin Innere Med Nephrol & Hochdruckkrankheiten 4, Homburg, Germany	Universitatsklinikum des Saarlandes; University of Bonn; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Weingartner, O (corresponding author), Univ Klinikum Saarlandes, Klin Innere Med Kardiol Angiol & Internist Intens, Homburg, Germany.	oweingartner@aol.com	Böhm, Michael/C-3638-2011; Girndt, Matthias/M-1436-2019	Girndt, Matthias/0000-0003-2823-0847; Weingartner, Oliver/0000-0002-0236-206X; Heine, Gunnar/0000-0001-8320-5260	University of the Saarland; Merck Sharp Dohme; Raisio Nutrition Ltd.	University of the Saarland; Merck Sharp Dohme(Merck & Company); Raisio Nutrition Ltd.	University of the Saarland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; O.W. has received minor unrestricted research grants from Merck Sharp & Dohme and Raisio Nutrition Ltd. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Assmann G, 2006, NUTR METAB CARDIOVAS, V16, P13, DOI 10.1016/j.numecd.2005.04.001; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; Center for Disease Control and Prevention, 2012, PREV INS PHYS ACT; Clarenbach JJ, 2006, J LIPID RES, V47, P2820, DOI 10.1194/jlr.P600009-JLR200; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; Fassbender K, 2008, ATHEROSCLEROSIS, V196, P283, DOI 10.1016/j.atherosclerosis.2006.10.032; Filippatos TD, 2009, CURR PHARM DESIGN, V15, P490, DOI 10.2174/138161209787315738; Fleg JL, 2008, J AM COLL CARDIOL, V52, P2198, DOI 10.1016/j.jacc.2008.10.031; GEROULAKOS G, 1994, EUR HEART J, V15, P781, DOI 10.1093/oxfordjournals.eurheartj.a060585; GLUECK CJ, 1991, METABOLISM, V40, P842, DOI 10.1016/0026-0495(91)90013-M; Insull W, 2006, SOUTH MED J, V99, P257, DOI 10.1097/01.smj.0000208120.73327.db; Jakulj L, 2010, J LIPID RES, V51, P755, DOI 10.1194/jlr.M001487; Kalantar-Zadeh K, 2007, CURR OPIN CLIN NUTR, V10, P433, DOI 10.1097/MCO.0b013e3281a30594; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kidambi S, 2008, J CLIN PATHOL, V61, P588, DOI 10.1136/jcp.2007.049775; Knoflach M, 2003, CIRCULATION, V108, P1064, DOI 10.1161/01.CIR.0000085996.95532.FF; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Matthan NR, 2009, J LIPID RES, V50, P1927, DOI 10.1194/jlr.P900039-JLR200; MIETTINEN T A, 1970, Annals of Clinical Research, V2, P300; Miettinen TA, 2005, J AM COLL CARDIOL, V45, P1794, DOI 10.1016/j.jacc.2005.02.063; MIETTINEN TA, 1969, LIFE SCI PT 1 PHYSI, V8, P713, DOI 10.1016/0024-3205(69)90007-1; MIETTINEN TA, 1990, AM J EPIDEMIOL, V131, P20, DOI 10.1093/oxfordjournals.aje.a115479; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Patel MD, 2006, ATHEROSCLEROSIS, V186, P12, DOI 10.1016/j.atherosclerosis.2005.10.026; PEDERSEN TR, 1994, LANCET, V344, P1383; Pinedo S, 2007, J LIPID RES, V48, P139, DOI 10.1194/jlr.M600371-JLR200; Rajaratnam RA, 2000, J AM COLL CARDIOL, V35, P1185, DOI 10.1016/S0735-1097(00)00527-1; Rogacev KS, 2010, EUR HEART J, V31, P369, DOI 10.1093/eurheartj/ehp308; Rosvall M, 2005, ATHEROSCLEROSIS, V179, P325, DOI 10.1016/j.atherosclerosis.2004.10.015; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Silbernagel G, 2009, J LIPID RES, V50, P334, DOI 10.1194/jlr.P800013-JLR200; Simonen P, 2000, AM J CLIN NUTR, V72, P82; Strandberg TE, 2006, J AM COLL CARDIOL, V48, P708, DOI 10.1016/j.jacc.2006.04.081; Strandberg TE, 2010, ATHEROSCLEROSIS, V210, P282, DOI 10.1016/j.atherosclerosis.2009.11.007; Sudhop T, 2002, METABOLISM, V51, P1519, DOI 10.1053/meta.2002.36298; Thelen KM, 2006, J PHARMACOL EXP THER, V316, P1146, DOI 10.1124/jpet.105.094136; TILVIS RS, 1986, AM J CLIN NUTR, V43, P92, DOI 10.1093/ajcn/43.1.92; Wald NJ, 1995, ATHEROSCLEROSIS, V118, pS1, DOI 10.1016/0021-9150(95)90067-5; Weingartner O, 2008, J AM COLL CARDIOL, V51, P1553, DOI 10.1016/j.jacc.2007.09.074; Weingartner O, 2009, EUR HEART J, V30, P404, DOI 10.1093/eurheartj/ehn580; Weingartner O, 2009, CORONARY ARTERY DIS, V20, P376, DOI 10.1097/MCA.0b013e32832fa947	43	37	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13467	10.1371/journal.pone.0013467	http://dx.doi.org/10.1371/journal.pone.0013467			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976107	gold, Green Published, Green Submitted			2022-12-27	WOS:000283045300035
J	Younger, J; Aron, A; Parke, S; Chatterjee, N; Mackey, S				Younger, Jarred; Aron, Arthur; Parke, Sara; Chatterjee, Neil; Mackey, Sean			Viewing Pictures of a Romantic Partner Reduces Experimental Pain: Involvement of Neural Reward Systems	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; ORBITOFRONTAL CORTEX; DECISION-MAKING; CINGULATE CORTEX; BRAIN MECHANISM; LOVE; ADDICTION; ANALGESIA; NUCLEUS; FMRI	The early stages of a new romantic relationship are characterized by intense feelings of euphoria, well-being, and preoccupation with the romantic partner. Neuroimaging research has linked those feelings to activation of reward systems in the human brain. The results of those studies may be relevant to pain management in humans, as basic animal research has shown that pharmacologic activation of reward systems can substantially reduce pain. Indeed, viewing pictures of a romantic partner was recently demonstrated to reduce experimental thermal pain. We hypothesized that pain relief evoked by viewing pictures of a romantic partner would be associated with neural activations in reward-processing centers. In this functional magnetic resonance imaging (fMRI) study, we examined fifteen individuals in the first nine months of a new, romantic relationship. Participants completed three tasks under periods of moderate and high thermal pain: 1) viewing pictures of their romantic partner, 2) viewing pictures of an equally attractive and familiar acquaintance, and 3) a word-association distraction task previously demonstrated to reduce pain. The partner and distraction tasks both significantly reduced self-reported pain, although only the partner task was associated with activation of reward systems. Greater analgesia while viewing pictures of a romantic partner was associated with increased activity in several reward-processing regions, including the caudate head, nucleus accumbens, lateral orbitofrontal cortex, amygdala, and dorsolateral prefrontal cortex - regions not associated with distraction-induced analgesia. The results suggest that the activation of neural reward systems via non-pharmacologic means can reduce the experience of pain.	[Younger, Jarred; Chatterjee, Neil; Mackey, Sean] Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA; [Aron, Arthur] SUNY Stony Brook, Dept Psychol, Stony Brook, NY 11794 USA; [Parke, Sara] Stanford Univ, Dept Human Biol, Stanford, CA 94305 USA	Stanford University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stanford University	Younger, J (corresponding author), Stanford Univ, Sch Med, Dept Anesthesia, Stanford, CA 94305 USA.	smackey@pain.stanford.edu	Mackey, Sean/AAF-3314-2019	Mackey, Sean/0000-0001-7744-5348	Arthritis Foundation; Stanford University; National Institutes of Health NINDS [NS053961]; John and Dodie Rosekranz Pain Research Endowment; Chris Redlich Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053961] Funding Source: NIH RePORTER	Arthritis Foundation; Stanford University(Stanford University); National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); John and Dodie Rosekranz Pain Research Endowment; Chris Redlich Pain Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Younger was supported by a postdoctoral fellowship from the Arthritis Foundation. Ms. Parke was supported by a HB-REX (Human Biology Research Exploration) grant from Stanford University. Dr. Mackey was supported by National Institutes of Health NINDS NS053961, the John and Dodie Rosekranz Pain Research Endowment and the Chris Redlich Pain Research Fund. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Altier N, 1998, J PHARMACOL EXP THER, V285, P208; Aron A, 2005, J NEUROPHYSIOL, V94, P327, DOI 10.1152/jn.00838.2004; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Baliki MN, 2010, NEURON, V66, P149, DOI 10.1016/j.neuron.2010.03.002; Bartels A, 2004, NEUROIMAGE, V21, P1155, DOI 10.1016/j.neuroimage.2003.11.003; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BASBAUM AI, 1984, ANNU REV NEUROSCI, V7, P309, DOI 10.1146/annurev.ne.07.030184.001521; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Casey KL, 1996, J NEUROPHYSIOL, V76, P571, DOI 10.1152/jn.1996.76.1.571; Cason AM, 2010, PHYSIOL BEHAV, V100, P419, DOI 10.1016/j.physbeh.2010.03.009; CHEN GB, 1982, ACUPUNCTURE ELECTRO, V7, P255, DOI 10.3727/036012982816952053; Cloutier J, 2008, J COGNITIVE NEUROSCI, V20, P941, DOI 10.1162/jocn.2008.20062; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; D'Ardenne K, 2008, SCIENCE, V319, P1264, DOI 10.1126/science.1150605; Davis KD, 1997, J NEUROPHYSIOL, V77, P3370, DOI 10.1152/jn.1997.77.6.3370; DICKINSON A, 1977, PSYCHOL BULL, V84, P690, DOI 10.1037/0033-2909.84.4.690; Diekhof EK, 2008, BRAIN RES REV, V59, P164, DOI 10.1016/j.brainresrev.2008.07.004; Ferry AT, 2000, J COMP NEUROL, V425, P447, DOI 10.1002/1096-9861(20000925)425:3<447::AID-CNE9>3.0.CO;2-V; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fisher H, 2005, J COMP NEUROL, V493, P58, DOI 10.1002/cne.20772; Fisher HE, 1998, HUM NATURE-INT BIOS, V9, P23, DOI 10.1007/s12110-998-1010-5; Fisher HE, 2010, J NEUROPHYSIOL, V104, P51, DOI 10.1152/jn.00784.2009; Frankenstein UN, 2001, NEUROIMAGE, V14, P827, DOI 10.1006/nimg.2001.0883; FRANKLIN KBJ, 1989, NEUROSCI BIOBEHAV R, V13, P149, DOI 10.1016/S0149-7634(89)80024-7; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; HATFIELD E, 1986, J ADOLESCENCE, V9, P383, DOI 10.1016/S0140-1971(86)80043-4; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; LEMAGNEN J, 1980, PHARMACOL BIOCHEM BE, V12, P729, DOI 10.1016/0091-3057(80)90157-4; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Lu HC, 2010, PAIN, V148, P75, DOI 10.1016/j.pain.2009.10.012; Mashek D., 2000, REPRESENTATIVE RES S, V24, P48; Master SL, 2009, PSYCHOL SCI, V20, P1316, DOI 10.1111/j.1467-9280.2009.02444.x; Mesulam MM, 2001, NEUROIMAGE, V13, P1065, DOI 10.1006/nimg.2001.0768; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; Ortigue S, 2007, J COGNITIVE NEUROSCI, V19, P1218, DOI 10.1162/jocn.2007.19.7.1218; Qiu YH, 2009, NEUROSCI BULL, V25, P277, DOI 10.1007/s12264-009-0907-2; REYNAUD M, 2010, AM J DRUG ALCOHOL AB; Rogers RD, 2004, BIOL PSYCHIAT, V55, P594, DOI 10.1016/j.biopsych.2003.11.012; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SELEMON LD, 1985, J NEUROSCI, V5, P776; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Tanaka SC, 2006, NEURAL NETWORKS, V19, P1233, DOI 10.1016/j.neunet.2006.05.039; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Taylor BK, 2003, BRAIN RES, V987, P135, DOI 10.1016/S0006-8993(03)03318-3; Tran TD, 2010, PAIN, V150, P93, DOI 10.1016/j.pain.2010.04.001; Wood PB, 2006, PAIN, V120, P230, DOI 10.1016/j.pain.2005.12.014; XU X, 2010, HUMAN BRAIN MAPPING; Zubieta JK, 2009, ANN NY ACAD SCI, V1156, P198, DOI 10.1111/j.1749-6632.2009.04424.x; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	58	164	169	14	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13309	10.1371/journal.pone.0013309	http://dx.doi.org/10.1371/journal.pone.0013309			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967200	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800015
J	Shefer, G; Rauner, G; Yablonka-Reuveni, Z; Benayahu, D				Shefer, Gabi; Rauner, Gat; Yablonka-Reuveni, Zipora; Benayahu, Dafna			Reduced Satellite Cell Numbers and Myogenic Capacity in Aging Can Be Alleviated by Endurance Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; STEM-CELL; TESTOSTERONE CONCENTRATION; ESTROGEN METABOLISM; PHYSICAL-ACTIVITY; OLDER MEN; AGE; HEALTHY; YOUNG; PROLIFERATION	Background: Muscle regeneration depends on satellite cells, myogenic stem cells that reside on the myofiber surface. Reduced numbers and/or decreased myogenic aptitude of these cells may impede proper maintenance and contribute to the age-associated decline in muscle mass and repair capacity. Endurance exercise was shown to improve muscle performance; however, the direct impact on satellite cells in aging was not yet thoroughly determined. Here, we focused on characterizing the effect of moderate-intensity endurance exercise on satellite cell, as possible means to attenuate adverse effects of aging. Young and old rats of both genders underwent 13 weeks of treadmill-running or remained sedentary. Methodology: Gastrocnemius muscles were assessed for the effect of age, gender and exercise on satellite-cell numbers and myogenic capacity. Satellite cells were identified in freshly isolated myofibers based on Pax7 immunostaining (i.e., ex-vivo). The capacity of individual myofiber-associated cells to produce myogenic progeny was determined in clonal assays (in-vitro). We show an age-associated decrease in satellite-cell numbers and in the percent of myogenic clones in old sedentary rats. Upon exercise, there was an increase in myofibers that contain higher numbers of satellite cells in both young and old rats, and an increase in the percent of myogenic clones derived from old rats. Changes at the satellite cell level in old rats were accompanied with positive effects on the lean-to-fat Gast muscle composition and on spontaneous locomotion levels. The significance of these data is that they suggest that the endurance exercise-mediated boost in both satellite numbers and myogenic properties may improve myofiber maintenance in aging.	[Shefer, Gabi; Rauner, Gat; Benayahu, Dafna] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Shefer, Gabi; Yablonka-Reuveni, Zipora] Univ Washington, Sch Med, Dept Biol Struct, Seattle, WA 98195 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Washington; University of Washington Seattle	Shefer, G (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel.	gabise@post.tau.ac.il			US-Israel Binational Science Foundation (BSF) [2005132]; Ministry of Health [3-00000-4398]; EU [214706]; National Institute on Aging [5RO1 AG021566]; NATIONAL INSTITUTE ON AGING [R01AG021566] Funding Source: NIH RePORTER	US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Ministry of Health; EU(European Commission); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the US-Israel Binational Science Foundation (BSF, grant number 2005132) to DB and ZYR, from the Ministry of Health (grant number3-00000-4398) and EU-FP7, Excell project 214706 to DB, and by a grant from the National Institute on Aging (5RO1 AG021566) to ZYR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Atkinson C, 2004, CANCER EPIDEM BIOMAR, V13, P868; Bakay M, 2006, BRAIN, V129, P996, DOI 10.1093/brain/awl023; Bigot A, 2008, BIOL CELL, V100, P189, DOI 10.1042/BC20070085; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Burger HG, 2002, RECENT PROG HORM RES, V57, P257, DOI 10.1210/rp.57.1.257; Burniston JG, 2008, BBA-PROTEINS PROTEOM, V1784, P1077, DOI 10.1016/j.bbapap.2008.04.007; Campbell KL, 2007, CANCER EPIDEM BIOMAR, V16, P731, DOI 10.1158/1055-9965.EPI-06-0784; CARLSON BM, 1989, AM J PHYSIOL, V256, pC1262; Chen Y, 2005, J ENDOCRINOL, V186, P21, DOI 10.1677/joe.1.05976; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Cotman CW, 2007, ALZHEIMERS DEMENT, V3, pS30, DOI 10.1016/j.jalz.2007.01.013; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; Day K, 2010, DEV BIOL, V340, P330, DOI 10.1016/j.ydbio.2010.01.006; Day K, 2009, DEV DYNAM, V238, P1001, DOI 10.1002/dvdy.21903; Deschenes MR, 2010, EXP GERONTOL, V45, P389, DOI 10.1016/j.exger.2010.03.007; Enns DL, 2008, ACTA PHYSIOL, V194, P81, DOI 10.1111/j.1748-1716.2008.01861.x; Enns DL, 2008, J APPL PHYSIOL, V104, P347, DOI 10.1152/japplphysiol.00128.2007; Fahrner CL, 1998, INT J SPORTS MED, V19, P12, DOI 10.1055/s-2007-971872; FISER WM, 2010, J GERONTOL A; FRIEDMAN WA, 1992, PHYSIOL BEHAV, V52, P97, DOI 10.1016/0031-9384(92)90438-8; Frumkin D, 2005, PLOS COMPUT BIOL, V1, P382, DOI 10.1371/journal.pcbi.0010050; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Grandys M, 2009, INT J SPORTS MED, V30, P489, DOI 10.1055/s-0029-1202340; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Haaland DA, 2008, CLIN J SPORT MED, V18, P539, DOI 10.1097/JSM.0b013e3181865eec; Hakkinen K, 1996, J GERONTOL A-BIOL, V51, pB21, DOI 10.1093/gerona/51A.1.B21; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Harman SM, 2001, J CLIN ENDOCR METAB, V86, P724, DOI 10.1210/jc.86.2.724; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayasaki Hana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL135; Hikida RS, 1998, BASIC APPL MYOL, V8, P419; Iannuzzi-Sucich M, 2002, J GERONTOL A-BIOL, V57, pM772, DOI 10.1093/gerona/57.12.M772; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kadi F, 2008, BRIT J PHARMACOL, V154, P522, DOI 10.1038/bjp.2008.118; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Kargotich S, 2007, INT J SPORTS MED, V28, P211, DOI 10.1055/s-2006-924218; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kirchengast S, 2009, ANTHROPOL ANZ, V67, P139, DOI 10.1127/0003-5548/2009/0018; KUIPERS H, 1989, INT J SPORTS MED, V10, pS156, DOI 10.1055/s-2007-1024965; Leifke E, 2000, CLIN ENDOCRINOL, V53, P689, DOI 10.1046/j.1365-2265.2000.01159.x; LEXELL J, 1991, ACTA NEUROPATHOL, V81, P377, DOI 10.1007/BF00293457; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Nair KS, 2005, AM J CLIN NUTR, V81, P953; Nakano J, 2009, EXP PHYSIOL, V94, P1005, DOI 10.1113/expphysiol.2009.047738; Nnodim JO, 2000, MECH AGEING DEV, V112, P99, DOI 10.1016/S0047-6374(99)00076-7; Olsen DB, 2005, NEUROLOGY, V64, P1064, DOI 10.1212/01.WNL.0000150584.45055.27; Orngreen MC, 2005, ANN NEUROL, V57, P754, DOI 10.1002/ana.20460; PASTORET C, 1995, J NEUROL SCI, V129, P97, DOI 10.1016/0022-510X(94)00276-T; Paturi S, 2010, MECH AGEING DEV, V131, P202, DOI 10.1016/j.mad.2010.01.008; Ravaglia G, 2001, MECH AGEING DEV, V122, P191, DOI 10.1016/S0047-6374(00)00234-7; Renault V, 2002, AGING CELL, V1, P132, DOI 10.1046/j.1474-9728.2002.00017.x; Rossi CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008523; Roth SM, 2000, ANAT REC, V260, P351, DOI 10.1002/1097-0185(200012)260:4<350::AID-AR30>3.0.CO;2-6; Roubenoff R, 2003, J GERONTOL A-BIOL, V58, P1012; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; SCHULTZ E, 1982, MECH AGEING DEV, V20, P377, DOI 10.1016/0047-6374(82)90105-1; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shefer G, 2008, J CELL PHYSIOL, V215, P265, DOI 10.1002/jcp.21306; Shefer G, 2004, J CELL SCI, V117, P5393, DOI 10.1242/jcs.01419; Shefer G, 2007, CRIT REV EUKAR GENE, V17, P13, DOI 10.1615/CritRevEukarGeneExpr.v17.i1.20; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer Gabi, 2005, Methods Mol Biol, V290, P281; Sinha-Hikim I, 2004, J CLIN ENDOCR METAB, V89, P5245, DOI 10.1210/jc.2004-0084; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Sinha-Hikim I, 2006, J CLIN ENDOCR METAB, V91, P3024, DOI 10.1210/jc.2006-0357; SJODIN B, 1992, EUR J APPL PHYSIOL, V65, P150, DOI 10.1007/BF00705073; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; SNOW MH, 1977, CELL TISSUE RES, V185, P399; Sousa N, 2006, GENES BRAIN BEHAV, V5, P5, DOI 10.1111/j.1601-183X.2006.00228.x; Sveen ML, 2008, BRAIN, V131, P2824, DOI 10.1093/brain/awn189; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; Thompson LV, 2009, EXP GERONTOL, V44, P106, DOI 10.1016/j.exger.2008.05.003; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; van Praag H, 2009, TRENDS NEUROSCI, V32, P283, DOI 10.1016/j.tins.2008.12.007; Vertino AM, 2005, MOL BIOL CELL, V16, P2039, DOI 10.1091/mbc.E04-08-0720; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Wasserstrom A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001939; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006	90	135	144	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13307	10.1371/journal.pone.0013307	http://dx.doi.org/10.1371/journal.pone.0013307			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967266	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300020
J	Dothager, RS; Goiffon, RJ; Jackson, E; Harpstrite, S; Piwnica-Worms, D				Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David			Cerenkov Radiation Energy Transfer (CRET) Imaging: A Novel Method for Optical Imaging of PET Isotopes in Biological Systems	PLOS ONE			English	Article							POSITRON-EMITTING RADIOTRACERS; IN-VIVO	Background: Positron emission tomography (PET) allows sensitive, non-invasive analysis of the distribution of radiopharmaceutical tracers labeled with positron (beta(+))-emitting radionuclides in small animals and humans. Upon beta(+) decay, the initial velocity of high-energy beta(+) particles can momentarily exceed the speed of light in tissue, producing Cerenkov radiation that is detectable by optical imaging, but is highly absorbed in living organisms. Principal Findings: To improve optical imaging of Cerenkov radiation in biological systems, we demonstrate that Cerenkov radiation from decay of the PET isotopes (64)Cu and (18)F can be spectrally coupled by energy transfer to high Stokes-shift quantum nanoparticles (Qtracker705) to produce highly red-shifted photonic emissions. Efficient energy transfer was not detected with (99m)Tc, a predominantly gamma-emitting isotope. Similar to bioluminescence resonance energy transfer (BRET) and fluorescence resonance energy transfer (FRET), herein we define the Cerenkov radiation energy transfer (CRET) ratio as the normalized quotient of light detected within a spectral window centered on the fluorophore emission divided by light detected within a spectral window of the Cerenkov radiation emission to quantify imaging signals. Optical images of solutions containing Qtracker705 nanoparticles and [(18)F]FDG showed CRET ratios in vitro as high as 8.8 +/- 1.1, while images of mice with subcutaneous pseudotumors impregnated with Qtracker705 following intravenous injection of [(18)F] FDG showed CRET ratios in vivo as high as 3.5 +/- 0.3. Conclusions: Quantitative CRET imaging may afford a variety of novel optical imaging applications and activation strategies for PET radiopharmaceuticals and other isotopes in biomaterials, tissues and live animals.	[Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA; [Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Mallinckrodt Inst Radiol, Mol Imaging Ctr, St Louis, MO USA; [Dothager, Robin S.; Goiffon, Reece J.; Jackson, Erin; Harpstrite, Scott; Piwnica-Worms, David] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Dothager, RS (corresponding author), Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63130 USA.	piwnica-wormsd@mir.wustl.edu	Goiffon, Reece J/C-9686-2013	Goiffon, Reece J/0000-0003-1622-7253	U.S. National Institutes of Health [P50 CA94056]; National Institutes of Health [5T90 DA022781]; American Cancer Society; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R41DA022781] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was funded by U.S. National Institutes of Health grant P50 CA94056. This work also was supported by a National Institutes of Health Imaging Sciences Pathway Award 5T90 DA022781 (RJG), and an American Cancer Society Post-doctoral Fellowship Award (RSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametamey SM, 2008, CHEM REV, V108, P1501, DOI 10.1021/cr0782426; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Cho JS, 2009, PHYS MED BIOL, V54, P6757, DOI 10.1088/0031-9155/54/22/001; Gammon ST, 2009, BIOTECHNOL PROGR, V25, P559, DOI 10.1002/btpr.144; Gammon STM, 2006, ANAL CHEM, V78, P1520, DOI 10.1021/ac051999h; Glantz SA., 1987, PRIMER BIOSTATISTICS; Gross S, 2009, NAT MED, V15, P455, DOI 10.1038/nm.1886; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; JELLEY JV, 1955, BRIT J APPL PHYS, V6, P227, DOI 10.1088/0508-3443/6/7/301; Lambert J, 2009, APPL OPTICS, V48, P3362, DOI 10.1364/AO.48.003362; Li CQ, 2010, OPT LETT, V35, P1109, DOI 10.1364/OL.35.001109; Liu HG, 2010, SMALL, V6, P1087, DOI 10.1002/smll.200902408; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; ROSS HH, 1969, ANAL CHEM, V41, P1260, DOI 10.1021/ac60279a011; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; Spinelli AE, 2010, PHYS MED BIOL, V55, P483, DOI 10.1088/0031-9155/55/2/010; Tai YC, 2005, ANNU REV BIOMED ENG, V7, P255, DOI 10.1146/annurev.bioeng.6.040803.140021; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151	18	139	148	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13300	10.1371/journal.pone.0013300	http://dx.doi.org/10.1371/journal.pone.0013300			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949021	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100026
J	Friberg, J; Tonnesen, MF; Heller, S; Pociot, F; Bodvarsdottir, TB; Karlsen, AE				Friberg, Josefine; Tonnesen, Morten F.; Heller, Schott; Pociot, Flemming; Bodvarsdottir, Thora B.; Karlsen, Allan E.			Inhibition of the Nuclear Factor-kappa B Pathway Prevents Beta Cell Failure and Diet Induced Diabetes in Psammomys obesus	PLOS ONE			English	Article							INDUCED INSULIN-RESISTANCE; ENZYME GENE-EXPRESSION; IKK-BETA; PANCREATIC-ISLETS; INFLAMMATION; OBESITY; MECHANISMS; APOPTOSIS; ACTIVATION; SALICYLATE	Background: High doses of anti-inflammatory drugs, such as aspirin and salicylates, improve glucose metabolism in insulin resistant and type 2 diabetic patients. It has also been shown that the glucose lowering effect is related to the unspecific ability of these drugs to inhibit inhibitor kinase beta (IKK beta). In this study we have investigated the effect of a selective IKK beta-inhibitor on beta cell survival and the prevention of diet induced type 2 diabetes in the gerbil Psammomys obesus (P. obesus). Methodology/Principal Findings: P. obesus were fed a diabetes inducing high energy diet for one month in the absence or presence of the IKK beta-inhibitor. Body mass, blood glucose, HbA(1C), insulin production and pancreatic insulin stores were measured. The effects on beta cell survival were also studied in INS-1 cells and primary islets. The cells were exposed to IL-1 beta and subsequently reactive oxygen species, insulin release and cell death were measured in the absence or presence of the IKKb-inhibitor. In primary islets and beta cells, IL-1 beta induced the production of reactive oxygen species, reduced insulin production and increased beta cell death, which were all reversed by pre-treatment with the IKKb-inhibitor. In P. obesus the IKKb-inhibitor prevented the development of hyperglycaemia and hyperinsulinaemia, and maintained pancreatic insulin stores with no effect on body weight. Conclusions/Significance: Inhibition of IKK beta activity prevents diet-induced diabetes in P. obesus and inhibits IL-1b induced reactive oxygen species, loss of insulin production and beta cell death in vitro.	[Friberg, Josefine; Tonnesen, Morten F.; Heller, Schott; Pociot, Flemming; Karlsen, Allan E.] Hagedorn Res Inst, Gentofte, Denmark; [Pociot, Flemming; Karlsen, Allan E.] Lund Univ, Dept Clin Sci, Univ Hosp MAS, CRC, Malmo, Sweden; [Bodvarsdottir, Thora B.] Diabet & Obes Pharmacol Novo Nordisk AS, Malov, Denmark	Novo Nordisk; Hagedorn Research Institute; Lund University; Skane University Hospital; Novo Nordisk	Friberg, J (corresponding author), Hagedorn Res Inst, Gentofte, Denmark.	frib@novonordisk.com		Pociot, Flemming/0000-0003-3274-5448	Danish Agency for Science, Technology and Innovation	Danish Agency for Science, Technology and Innovation	This work was supported by PhD grants from Novo Nordisk A/S and the Danish Agency for Science, Technology and Innovation under the Danish Ministry of Science, Technology and Innovation. The funders Danish Agency for Science, Technology and Innovation had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novo Nordisk A/S employed one co-author so had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*APPL BIOS, 1997, US B APPL BIOS, V2; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BRUNSTEDT J, 1980, DIABETES METAB, V6, P87; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Eizirik DL, 2001, DIABETES, V50, pS64, DOI 10.2337/diabetes.50.2007.S64; Engstrom G, 2003, DIABETES, V52, P2097, DOI 10.2337/diabetes.52.8.2097; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; GADOT M, 1994, ENDOCRINOLOGY, V135, P610, DOI 10.1210/en.135.2.610; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gundersen HJG, 2002, J MICROSC-OXFORD, V207, P191, DOI 10.1046/j.1365-2818.2002.01054.x; Gurgul E, 2004, DIABETES, V53, P2271, DOI 10.2337/diabetes.53.9.2271; Heimberg H, 2001, DIABETES, V50, P2219, DOI 10.2337/diabetes.50.10.2219; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Kaiser N, 2005, DIABETES, V54, pS137, DOI 10.2337/diabetes.54.suppl_2.S137; Kaiser N, 2005, DIABETES, V54, P138, DOI 10.2337/diabetes.54.1.138; KALDERON B, 1986, DIABETES, V35, P717, DOI 10.2337/diabetes.35.6.717; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lenzen S, 2008, BIOCHEM SOC T, V36, P343, DOI 10.1042/BST0360343; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	39	5	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13341	10.1371/journal.pone.0013341	http://dx.doi.org/10.1371/journal.pone.0013341			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948968	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100035
J	Bruneel, F; Tubach, F; Corne, P; Megarbane, B; Mira, JP; Peytel, E; Camus, C; Schortgen, F; Azoulay, E; Cohen, Y; Georges, H; Meybeck, A; Hyvernat, H; Trouillet, JL; Frenoy, E; Nicolet, L; Roy, C; Durand, R; Le Bras, J; Wolff, M				Bruneel, Fabrice; Tubach, Florence; Corne, Philippe; Megarbane, Bruno; Mira, Jean-Paul; Peytel, Eric; Camus, Christophe; Schortgen, Frederique; Azoulay, Elie; Cohen, Yves; Georges, Hugues; Meybeck, Agnes; Hyvernat, Herve; Trouillet, Jean-Louis; Frenoy, Eric; Nicolet, Laurent; Roy, Carine; Durand, Remy; Le Bras, Jacques; Wolff, Michel		SIMA Study Grp	Severe Imported Falciparum Malaria: A Cohort Study in 400 Critically Ill Adults	PLOS ONE			English	Article							SEVERE SEPSIS; RISK-FACTORS; SCORE; SURVEILLANCE; MANAGEMENT	Background: Large studies on severe imported malaria in non-endemic industrialized countries are lacking. We sought to describe the clinical spectrum of severe imported malaria in French adults and to identify risk factors for mortality at admission to the intensive care unit. Methodology and Principal Findings: Retrospective review of severe Plasmodium falciparum malaria episodes according to the 2000 World Health Organization definition and requiring admission to the intensive care unit. Data were collected from medical charts using standardised case-report forms, in 45 French intensive care units in 2000-2006. Risk factors for in-hospital mortality were identified by univariate and multivariate analyses. Data from 400 adults admitted to the intensive care unit were analysed, representing the largest series of severe imported malaria to date. Median age was 45 years; 60% of patients were white, 96% acquired the disease in sub-Saharan Africa, and 65% had not taken antimalarial chemoprophylaxis. Curative quinine treatment was used in 97% of patients. Intensive care unit mortality was 10.5% (42 deaths). By multivariate analysis, three variables at intensive care unit admission were independently associated with hospital death: older age (per 10-year increment, odds ratio [OR], 1.72; 95% confidence interval [95% CI], 1.28-2.32; P = 0.0004), Glasgow Coma Scale score (per 1-point decrease, OR, 1.32; 95% CI, 1.20-1.45; P<0.0001), and higher parasitemia (per 5% increment, OR, 1.41; 95% CI, 1.22-1.62; P<0.0001). Conclusions and Significance: In a large population of adults treated in a non-endemic industrialized country, severe malaria still carried a high mortality rate. Our data, including predictors of death, can probably be generalized to other non-endemic countries where high-quality healthcare is available.	[Bruneel, Fabrice] Ctr Hosp Versailles, Serv Reanimat, Le Chesnay, France; [Tubach, Florence; Roy, Carine] Hop Bichat Claude Bernard, AP HP, Dept Epidemiol Biostat & Rech Clin, F-75877 Paris 18, France; [Tubach, Florence; Roy, Carine] INSERM, CIE 801, Paris, France; [Corne, Philippe] Ctr Hosp Univ Gui de Chauillac, Serv Reanimat, Montpellier, France; [Megarbane, Bruno] Ctr Hosp Univ Lariboisiere, AP HP, Serv Reanimat Med & Toxicol, Paris, France; [Mira, Jean-Paul] Ctr Hosp Univ Cochin St Vincent de Paul, AP HP, Serv Reanimat, Paris, France; [Peytel, Eric] Hop Instruct Armees Laveran, Serv Reanimat, Marseille, France; [Camus, Christophe] Ctr Hosp Univ Pontchaillou, Serv Reanimat, Rennes, France; [Schortgen, Frederique] Ctr Hosp Univ Henri Mondor, AP HP, Serv Reanimat, Creteil, France; [Azoulay, Elie] Ctr Hosp Univ St Louis, AP HP, Serv Reanimat, Paris, France; [Cohen, Yves] Ctr Hosp Univ Avicenne, AP HP, Serv Reanimat, Bobigny, France; [Georges, Hugues] Ctr Hosp Tourcoing, Serv Reanimat, Tourcoing, France; [Meybeck, Agnes] Ctr Hosp Univ Louis Mourier, AP HP, Serv Reanimat, Colombes, France; [Hyvernat, Herve] Ctr Hosp Univ Nice, Serv Reanimat, Nice, France; [Trouillet, Jean-Louis] CHU Pitie Salpetriere, AP HP, Serv Reanimat, Paris, France; [Frenoy, Eric] CHU Angers, Serv Reanimat, Angers, France; [Nicolet, Laurent] CHU Nantes, Serv Reanimat, F-44035 Nantes 01, France; [Durand, Remy] Ctr Hosp Univ Avicenne, AP HP, Serv Parasitol, Bobigny, France; [Le Bras, Jacques] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Parasitol, Paris, France; [Wolff, Michel] Ctr Hosp Univ Bichat Claude Bernard, AP HP, Serv Reanimat, Paris, France	Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Rennes; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP	Bruneel, F (corresponding author), Ctr Hosp Versailles, Serv Reanimat, Le Chesnay, France.	fbruneel@ch-versailles.fr	BRETAGNE, Stephane/H-6655-2019; Guery, Benoit/D-8089-2017; Benoit-Vical, Francoise/E-3938-2016; Grenouillet, Frédéric/R-5176-2016; picot, stephane/F-5973-2014; sandrine, houze/M-3260-2017	BRETAGNE, Stephane/0000-0001-6870-3800; Guery, Benoit/0000-0002-6526-0714; Benoit-Vical, Francoise/0000-0002-9468-4823; Grenouillet, Frédéric/0000-0001-6001-3135; picot, stephane/0000-0002-5735-6759; Ajzenberg, Daniel/0000-0002-5357-3318; Thellier, Marc/0000-0003-4867-2423; Schortgen, Frederique/0000-0003-1756-7508; sandrine, houze/0000-0001-9016-3847; Megarbane, Bruno/0000-0002-2522-2764				Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bruneel F, 2003, AM J RESP CRIT CARE, V167, P684, DOI 10.1164/rccm.200206-631OC; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dondorp AM, 2005, PLOS MED, V2, P788, DOI 10.1371/journal.pmed.0020204; Dondorp AM, 2008, CLIN INFECT DIS, V47, P151, DOI 10.1086/589287; Faiz MA, 2005, LANCET, V366, P717; Hanson J, 2010, CLIN INFECT DIS, V50, P679, DOI 10.1086/649928; Heymans MW, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-33; Hien TT, 1996, NEW ENGL J MED, V335, P76, DOI 10.1056/NEJM199607113350202; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Legros F, 2007, EMERG INFECT DIS, V13, P883, DOI 10.3201/eid1305.060955; Mali Sonja, 2010, Morbidity and Mortality Weekly Report, V59, P1; Morch K, 2008, EMERG INFECT DIS, V14, P1816, DOI 10.3201/eid1411.080636; Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012; Phillips A, 2009, CLIN INFECT DIS, V48, P871, DOI 10.1086/597258; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Smith AD, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a120; Societe de Pathologie Infectieuse de Langue Francaise, 2008, Med Mal Infect, V38, P68, DOI 10.1016/j.medmal.2007.11.009; TEASDALE G, 1974, LANCET, V2, P81; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; White NJ, 2003, AM J RESP CRIT CARE, V167, P673, DOI 10.1164/rccm.2212001; WHO, 2006, GUID TREATM MAL; World Health Organization, 2006, MAL CONTR EL WHO EUR; [No title captured]; 1990, MED MAL INFECT S2, V29, pS115	26	106	108	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13236	10.1371/journal.pone.0013236	http://dx.doi.org/10.1371/journal.pone.0013236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949045	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700011
J	Larmarange, J; Wade, AS; Diop, AK; Diop, O; Gueye, K; Marra, A; du Lou, AD				Larmarange, Joseph; Wade, Abdoulaye S.; Diop, Abdou K.; Diop, Oulimata; Gueye, Khady; Marra, Adama; du Lou, Annabel Desgrees		ELIHoS Grp	Men Who Have Sex with Men (MSM) and Factors Associated with Not Using a Condom at Last Sexual Intercourse with a Man and with a Woman in Senegal	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HIV-INFECTION; RISK BEHAVIOR; PREVALENCE; HEALTH; GAY	Background: Men who have sex with other men (MSM) are a vulnerable population in Africa that has been insufficiently explored. Given the high rate of bisexuality among MSM (73% in the past year), it is important to understand their risktaking behaviors regarding both men and women. Methodology/Principal Findings: A socio-behavioral survey was carried out in 2007 among 501 MSM recruited using the snowball sampling method. We explore in this article why a condom was not used during last sexual intercourse with a man and with a woman, taking into account the respondent's characteristics, type of relationship and the context of the sexual act. In the survey, 489 men reported that they had had sexual intercourse at least once with another man during the previous year, and 358 with a man and with a woman. The main risk factors for not using a condom at last sexual intercourse with another man were having sex in a public place (aOR = 6.26 [95% CI: 2.71-14.46]), non-participation in an MSM prevention program (aOR = 3.47 [95% CI: 2.12-5.69]), a 19 years old or younger partner (aOR = 2.6 [95% CI: 1.23-4.53]), being 24 years or younger (aOR = 2.07 [95% CI: 1.20-3.58]) or being 35 years or over (aOR = 3.08 [95% CI: 1.11-8.53]) and being unemployed (aOR = 0.36 [95% CI: 0.10-1.25]). The last sexual intercourse with the respondent's wife was hardly ever protected (2%). With women, the other factors were a 15 years or younger partner (aOR = 6.45 [95% CI: 2.56-16.28]), being educated (primary: aOR = 0.45 [95% CI: 0.21-0.95], secondary or higher: aOR = 0.26 [95% CI: 0.11-0.62]), being a student (aOR = 2.20 [95% CI: 1.07-4.54]) or unemployed (aOR = 3.72 [95% CI: 1.31-10.61]) and having participated in a MSM prevention program (aOR = 0.57 [95% CI: 0.34-0.93]). Conclusion: Having participated in a prevention program specifically targeting MSM constitutes a major prevention factor. However, these programs targeting MSM must address their heterosexual practices and the specific risks involved.	[Larmarange, Joseph; du Lou, Annabel Desgrees] IRD, CEPED Ctr Populat & Dev Paris Descartes INED UMR, Paris, France; [Wade, Abdoulaye S.; Diop, Abdou K.; Diop, Oulimata; Gueye, Khady] Inst Hyg Sociale, Div SIDA IST, Dakar, Senegal; [Marra, Adama] IRD, US009, Dakar, Senegal; Hop Dantec, Virol Lab, Dakar, Senegal; [ELIHoS Grp] Univ Cheikh Anta Diop, Dakar, Senegal	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); Institut de Recherche pour le Developpement (IRD); University Cheikh Anta Diop Dakar	Larmarange, J (corresponding author), IRD, CEPED Ctr Populat & Dev Paris Descartes INED UMR, Paris, France.	joseph.larmarange@ceped.org	Larmarange, Joseph/I-5889-2015	Larmarange, Joseph/0000-0001-7097-700X; Desgrees du Lou, annabel/0000-0002-2223-5316	Agence Nationale de Recherche sur le SIDA [ANRS-12139]	Agence Nationale de Recherche sur le SIDA(ANRSFrench National Research Agency (ANR))	The study was funded by the Agence Nationale de Recherche sur le SIDA (ANRS-12139). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Baral S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004997; Beyrer C, 2010, SEX TRANSM INFECT, V86, P323, DOI 10.1136/sti.2009.040162; Blanc AK, 2001, STUD FAMILY PLANN, V32, P189, DOI 10.1111/j.1728-4465.2001.00189.x; BLOOR MJ, 1992, AIDS CARE, V4, P131, DOI 10.1080/09540129208253084; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burrell E, 2010, SEX HEALTH, V7, P149, DOI 10.1071/SH09090; Caceres CF, 2008, SEX TRANSM INFECT, V84, pI49, DOI 10.1136/sti.2008.030569; CHIN J, 1988, AIDS, V2, pS247, DOI 10.1097/00002030-198800001-00038; Crowder M., 1959, PAGANS POLITICIANS; EKSTRAND ML, 1992, AIDS, V6, P875, DOI 10.1097/00002030-199208000-00017; Enel C., 2009, AUTREPART, V49, P103; Henry E, 2010, SEX TRANSM INFECT, V86, P136, DOI 10.1136/sti.2009.036939; Kajubi P, 2008, AIDS BEHAV, V12, P492, DOI 10.1007/s10461-007-9323-7; LANE T, 2009, AIDS BEHAV, V15, P626, DOI DOI 10.1007/S10461-009-9598-Y]; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; Larmarange J, 2009, POPULATION, V64, P723, DOI 10.3917/popu.904.0723; Murray S. O., 1998, BOY WIVES FEMALE HUS; Ndiaye S, 2006, ENQUETE DEMOGRAPHIQU; Niang CI, 2003, CULT HEALTH SEX, V5, P499, DOI 10.1080/1369105031000152715; Ottosson Daniel, 2009, STATE SPONSORED HOMO; SAAVEDRA J, 2008, INT AIDS C MEX 2008; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; SAPPE R, 2003, SIDA RAPPORTS SEXUEL; Schiltz MA, 2000, SOC SCI MED, V50, P1571, DOI 10.1016/S0277-9536(99)00466-9; Teunis N., 1996, INT J SEXUALITY GEND, V1, P153; Teunis N., 2001, AIDS BEHAV, V5, P173, DOI DOI 10.1023/A:1011335129358; van Griensven F, 2007, AIDS, V21, P1361, DOI 10.1097/QAD.0b013e328017f868; Wade AS, 2010, AIDS CARE, V22, P409, DOI 10.1080/09540120903253973; Wade AS, 2005, AIDS, V19, P2133, DOI 10.1097/01.aids.0000194128.97640.07; Weiss E, 2000, SEX RELATIONSHIP THE, V153, P233, DOI DOI 10.1080/14681990050109836; WIGHT D, 1992, AIDS CARE, V4, P11, DOI 10.1080/09540129208251616	33	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13189	10.1371/journal.pone.0013189	http://dx.doi.org/10.1371/journal.pone.0013189			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	658RC	20957157	Green Published, gold, Green Submitted			2022-12-27	WOS:000282506100014
J	Li, JK; Wu, J; Rundassa, DB; Song, FF; Zheng, AJ; Fang, Y				Li, Jianke; Wu, Jing; Rundassa, Desalegn Begna; Song, Feifei; Zheng, Aijuan; Fang, Yu			Differential Protein Expression in Honeybee (Apis mellifera L.) Larvae: Underlying Caste Differentiation	PLOS ONE			English	Article							GENE-EXPRESSION; BEE; POLYMORPHISM; STORAGE; WORKERS; REPRODUCTION; EVOLUTION; QUEENS; ACTIN	Honeybee (Apis mellifera) exhibits divisions in both morphology and reproduction. The queen is larger in size and fully developed sexually, while the worker bees are smaller in size and nearly infertile. To better understand the specific time and underlying molecular mechanisms of caste differentiation, the proteomic profiles of larvae intended to grow into queen and worker castes were compared at 72 and 120 hours using two dimensional electrophoresis (2-DE), network, enrichment and quantitative PCR analysis. There were significant differences in protein expression between the two larvae castes at 72 and 120 hours, suggesting the queen and the worker larvae have already decided their fate before 72 hours. Specifically, at 72 hours, queen intended larvae over-expressed transketolase, aldehyde reductase, and enolase proteins which are involved in carbohydrate metabolism and energy production, imaginal disc growth factor 4 which is a developmental related protein, long-chain-fatty-acid CoA ligase and proteasome subunit alpha type 5 which metabolize fatty and amino acids, while worker intended larvae over-expressed ATP synthase beta subunit, aldehyde dehydrogenase, thioredoxin peroxidase 1 and peroxiredoxin 2540, lethal (2) 37 and 14-3-3 protein epsilon, fatty acid binding protein, and translational controlled tumor protein. This differential protein expression between the two caste intended larvae was more pronounced at 120 hours, with particular significant differences in proteins associated with carbohydrate metabolism and energy production. Functional enrichment analysis suggests that carbohydrate metabolism and energy production and anti-oxidation proteins play major roles in the formation of caste divergence. The constructed network and validated gene expression identified target proteins for further functional study. This new finding is in contrast to the existing notion that 72 hour old larvae has bipotential and can develop into either queen or worker based on epigenetics and can help us to gain new insight into the time of departure as well as caste trajectory influencing elements at the molecular level.	[Li, Jianke; Wu, Jing; Rundassa, Desalegn Begna; Song, Feifei; Zheng, Aijuan; Fang, Yu] Chinese Acad Agr Sci, Inst Apicultural Res, Dept Beekeeping & Biotechnol, Key Lab Pollinating Insect Biol,Minist Agr, Beijing, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Apicultural Research, CAAS; Ministry of Agriculture & Rural Affairs	Li, JK (corresponding author), Chinese Acad Agr Sci, Inst Apicultural Res, Dept Beekeeping & Biotechnol, Key Lab Pollinating Insect Biol,Minist Agr, Beijing, Peoples R China.	freky@163.com	Li, Jianke/K-8139-2013		technical production system of national beekeeping industry [NYCYTX-43]; National Natural Science Foundation of China [30972148]	technical production system of national beekeeping industry; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by a special fund of technical production system of the national beekeeping industry (NYCYTX-43); National Natural Science Foundation of China (No. 30972148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Amdam GV, 2005, AGEING RES REV, V4, P398, DOI 10.1016/j.arr.2005.03.007; Amdam GV, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-1; Baer B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r67; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Beye M, 2002, INSECT MOL BIOL, V11, P527, DOI 10.1046/j.1365-2583.2002.00361.x; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Capella ICS, 2002, CELL TISSUE RES, V307, P265, DOI 10.1007/s00441-001-0490-y; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Chan QWT, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r156; Corona M, 1999, J EXP BIOL, V202, P929; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Corona M, 2005, MECH AGEING DEV, V126, P1230, DOI 10.1016/j.mad.2005.07.004; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; Evans JD, 2001, GENOME BIOL, V2; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Evans JD, 2001, BIOESSAYS, V23, P62, DOI 10.1002/1521-1878(200101)23:1&lt;62::AID-BIES1008&gt;3.0.CO;2-7; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Gadagkar R, 1997, J GENET, V76, P167, DOI 10.1007/BF02932215; Groh C, 2008, ARTHROPOD STRUCT DEV, V37, P459, DOI 10.1016/j.asd.2008.04.001; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Hasegawa M, 2009, INSECT BIOCHEM MOLEC, V39, P661, DOI 10.1016/j.ibmb.2009.08.001; Haunerland NH, 1996, INSECT BIOCHEM MOLEC, V26, P755, DOI 10.1016/S0965-1748(96)00035-5; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; HEPPERLE C, 2000, DIFFERENTIAL DISPLAY; ISHAY J, 1976, STUDY HONEYBEE CASTE, P23; Jacinto A, 2002, CURR BIOL, V12, P1245, DOI 10.1016/S0960-9822(02)00955-7; Kucharski R, 1998, GENE, V211, P343, DOI 10.1016/S0378-1119(98)00114-0; Li J, 2009, INSECT MOL BIOL, V18, P1, DOI 10.1111/j.1365-2583.2008.00849.x; Li JK, 2008, J PROTEOME RES, V7, P3339, DOI 10.1021/pr8002276; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; OMHOLT SW, 2004, SCI AGING KNOWLEDGE, pPE28; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; Rueppell O, 2007, EXP GERONTOL, V42, P1020, DOI 10.1016/j.exger.2007.06.002; Scharlaken B, 2007, ARCH INSECT BIOCHEM, V65, P223, DOI 10.1002/arch.20179; Seehuus SC, 2006, P NATL ACAD SCI USA, V103, P962, DOI 10.1073/pnas.0502681103; Seehuus SC, 2006, EXP GERONTOL, V41, P1117, DOI 10.1016/j.exger.2006.08.004; SEVERSON DW, 1989, INSECT BIOCHEM, V19, P215, DOI 10.1016/0020-1790(89)90094-2; Sies H, 1997, EXP PHYSIOL, V82, P291, DOI 10.1113/expphysiol.1997.sp004024; SMITH DF, 1981, CELL, V23, P441, DOI 10.1016/0092-8674(81)90139-2; Strauss K, 2008, BEHAV ECOL SOCIOBIOL, V62, P1523, DOI 10.1007/s00265-008-0581-9; WINSTON ML, 1987, BIOL HONEY BEE, P316	47	40	43	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13455	10.1371/journal.pone.0013455	http://dx.doi.org/10.1371/journal.pone.0013455			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975997	Green Published, gold			2022-12-27	WOS:000283216400008
J	Classen, AT; Norby, RJ; Campany, CE; Sides, KE; Weltzin, JF				Classen, Aimee T.; Norby, Richard J.; Campany, Courtney E.; Sides, Katherine E.; Weltzin, Jake F.			Climate Change Alters Seedling Emergence and Establishment in an Old-Field Ecosystem	PLOS ONE			English	Article							ELEVATED CO2; TREE ESTABLISHMENT; ATMOSPHERIC CO2; PLANT COMMUNITY; SOIL-MOISTURE; FOREST; RESPONSES; REGENERATION; TEMPERATURE; GROWTH	Background: Ecological succession drives large-scale changes in ecosystem composition over time, but the mechanisms whereby climatic change might alter succession remain unresolved. Here, we asked if the effects of atmospheric and climatic change would alter tree seedling emergence and establishment in an old-field ecosystem, recognizing that small shifts in rates of seedling emergence and establishment of different species may have long-term repercussions on the transition of fields to forests in the future. Methodology/Principal Findings: We introduced seeds from three early successional tree species into constructed old-field plant communities that had been subjected for 4 years to altered temperature, precipitation, and atmospheric CO2 regimes in an experimental facility. Our experiment revealed that different combinations of atmospheric CO2 concentration, air temperature, and soil moisture altered seedling emergence and establishment. Treatments directly and indirectly affected soil moisture, which was the best predictor of seedling establishment, though treatment effects differed among species. Conclusions: The observed impacts, coupled with variations in the timing of seed arrival, are demonstrated as predictors of seedling emergence and establishment in ecosystems under global change.	[Classen, Aimee T.; Campany, Courtney E.; Weltzin, Jake F.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Classen, Aimee T.; Norby, Richard J.; Sides, Katherine E.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Weltzin, Jake F.] USA Natl Phenol Network, Tucson, AZ USA	University of Tennessee System; University of Tennessee Knoxville; United States Department of Energy (DOE); Oak Ridge National Laboratory	Classen, AT (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	aclassen@utk.edu	Classen, Aimee/AAM-5671-2021; Classen, Aimee T/C-4035-2008; Norby, Richard J/C-1773-2012; Classen, Aimee/X-2984-2019	Classen, Aimee T/0000-0002-6741-3470; Norby, Richard J/0000-0002-0238-9828; Whitacre, Katherine/0000-0002-7573-6448; Campany, Courtney/0000-0003-2986-434X	US Department of Energy, Office of Science, Biological and Environmental [DE-FG02-02ER63366]; U. S. Department of Energy [DE-AC05-00OR22725]	US Department of Energy, Office of Science, Biological and Environmental(United States Department of Energy (DOE)); U. S. Department of Energy(United States Department of Energy (DOE))	Research was sponsored by the US Department of Energy, Office of Science, Biological and Environmental Research Program, Grant No. DE-FG02-02ER63366. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank SK Chapman, GM Crutsinger, W Godsoe, PJ Hanson, CM Iversen, JA Langley, and NJ Sanders, and two reviewers for very helpful comments on the manuscript. Work was conducted at Oak Ridge National Laboratory, which is managed by UT Battelle, LLC, for the U. S. Department of Energy under Contract DE-AC05-00OR22725.	Abe M, 2008, ECOL RES, V23, P681, DOI 10.1007/s11284-007-0428-2; Albani M, 2006, GLOBAL CHANGE BIOL, V12, P2370, DOI 10.1111/j.1365-2486.2006.01254.x; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; BROSI GB, NEW PHYTOLO IN PRESS; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; *CCSP, 2007, 1 STAT CARB CYCL REP, P242; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Christie DA, 2003, J ECOL, V91, P776, DOI 10.1046/j.1365-2745.2003.00813.x; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Cuesta B, 2010, J ECOL, V98, P687, DOI 10.1111/j.1365-2745.2010.01655.x; Davis MA, 2007, GLOBAL CHANGE BIOL, V13, P2308, DOI 10.1111/j.1365-2486.2007.01444.x; DEDEY, 2008, ECOL LETT, V11, P516; Dermody O, 2007, PLANT SOIL, V301, P255, DOI 10.1007/s11104-007-9443-x; DESTEVEN D, 1991, ECOLOGY, V72, P1066, DOI 10.2307/1940606; Dickie IA, 2007, J ECOL, V95, P309, DOI 10.1111/j.1365-2745.2006.01202.x; Engel EC, 2009, J PLANT ECOL, V2, P1, DOI 10.1093/jpe/rtn026; Engelkes T, 2008, NATURE, V456, P946, DOI 10.1038/nature07474; Fukami T, 2005, ECOL LETT, V8, P1283, DOI 10.1111/j.1461-0248.2005.00829.x; Garten CT, 2008, ECOSYSTEMS, V11, P125, DOI 10.1007/s10021-007-9112-1; Garten CT, 2009, PLANT SOIL, V319, P85, DOI 10.1007/s11104-008-9851-6; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harper J. L., 1977, Population biology of plants.; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Hovenden MJ, 2008, NEW PHYTOL, V180, P143, DOI 10.1111/j.1469-8137.2008.02563.x; Hurtt GC, 1998, GLOBAL CHANGE BIOL, V4, P581, DOI 10.1046/j.1365-2486.1998.t01-1-00203.x; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Kardol P, 2010, GLOBAL CHANGE BIOL, V16, P2676, DOI 10.1111/j.1365-2486.2010.02162.x; Kardol P, 2010, ECOLOGY, V91, P767, DOI 10.1890/09-0135.1; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Knapp AK, 2001, SCIENCE, V291, P481, DOI 10.1126/science.291.5503.481; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Langley JA, 2010, NATURE, V466, P96, DOI 10.1038/nature09176; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Liang SY, 2002, ECOLOGY, V83, P212, DOI 10.1890/0012-9658(2002)083[0212:BAMEOR]2.0.CO;2; MALLOWS CL, 1973, TECHNOMETRICS, V15, P661, DOI 10.2307/1267380; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Nepstad DC, 1996, OIKOS, V76, P25, DOI 10.2307/3545745; Norby RJ, 2004, P NATL ACAD SCI USA, V101, P9689, DOI 10.1073/pnas.0403491101; Norby RJ, 2001, OECOLOGIA, V127, P153, DOI 10.1007/s004420000615; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Reich PB, 2008, ECOL LETT, V11, P588, DOI 10.1111/j.1461-0248.2008.01172.x; Rudgers JA, 2007, ECOLOGY, V88, P18, DOI 10.1890/0012-9658(2007)88[18:FSSBAI]2.0.CO;2; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Seiwa K, 1998, J ECOL, V86, P219, DOI 10.1046/j.1365-2745.1998.00245.x; Sherry RA, 2007, P NATL ACAD SCI USA, V104, P198, DOI 10.1073/pnas.0605642104; Suding KN, 2008, GLOBAL CHANGE BIOL, V14, P1125, DOI 10.1111/j.1365-2486.2008.01557.x; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; van der Waal C, 2009, J ECOL, V97, P430, DOI 10.1111/j.1365-2745.2009.01498.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan SQ, 2004, NEW PHYTOL, V162, P437, DOI 10.1111/j.1469-8137.2004.01034.x	54	35	36	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13476	10.1371/journal.pone.0013476	http://dx.doi.org/10.1371/journal.pone.0013476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976104	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300038
J	Lee, JK; Lu, SY; Madhukar, A				Lee, Jae Kyoo; Lu, Siyuan; Madhukar, Anupam			Real-Time Dynamics of Ca2+, Caspase-3/7, and Morphological Changes in Retinal Ganglion Cell Apoptosis under Elevated Pressure	PLOS ONE			English	Article							DIFFERENTIATED RGC-5 CELLS; HYDROSTATIC-PRESSURE; CYTOCHROME-C; INTRACELLULAR CA2+; DEATH; CALCIUM; LINE; OSCILLATIONS; GLAUCOMA; MODEL	Quantitative information on the dynamics of multiple molecular processes in individual live cells under controlled stress is central to the understanding of the cell behavior of interest and the establishment of reliable models. Here, the dynamics of the apoptosis regulator intracellular Ca2+, apoptosis effector caspase-3/7, and morphological changes, as well as temporal correlation between them at the single cell level, are examined in retinal gangling cell line (differentiated RGC-5 cells) undergoing apoptosis at elevated hydrostatic pressure using a custom-designed imaging platform that allows long-term real-time simultaneous imaging of morphological and molecular-level physiological changes in large numbers of live cells (beyond the field-of-view of typical microscopy) under controlled hydrostatic pressure. This examination revealed intracellular Ca2+ elevation with transient single or multiple peaks of less than 0.5 hour duration appearing at the early stages (typically less than 5 hours after the onset of 100 mmHg pressure) followed by gradual caspase-3/7 activation at late stages (typically later than 5 hours). The data reveal a strong temporal correlation between the Ca2+ peak occurrence and morphological changes of neurite retraction and cell body shrinkage. This suggests that Ca2+ elevation, through its impact on ion channel activity and water efflux, is likely responsible for the onset of apoptotic morphological changes. Moreover, the data show a significant cell-to-cell variation in the onset of caspase-3/7 activation, an inevitable consequence of the stochastic nature of the underlying biochemical reactions not captured by conventional assays based on population-averaged cellular responses. This real-time imaging study provides, for the first time, statistically significant data on simultaneous multiple molecular level changes to enable refinements and testing of models of the dynamics of mitochondria-mediated apoptosis. Further, the platform developed and the approach has direct significance to the study of a variety of signaling pathway phenomena.	[Lee, Jae Kyoo; Madhukar, Anupam] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Lu, Siyuan; Madhukar, Anupam] Univ So Calif, Dept Phys, Los Angeles, CA USA; [Lu, Siyuan] Univ So Calif, Dept Ophthalmol, Los Angeles, CA USA; [Madhukar, Anupam] Univ So Calif, Dept Mat Sci, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lee, JK (corresponding author), Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA.	madhukar@usc.edu	Lee, Jae Kyoo/AAL-6850-2021	Lee, Jae Kyoo/0000-0002-1257-8737	Defense Advanced Research Projects Agency (DARPA) [F49620-01-1-0474]; Air Force Office of Scientific Research (AFOSR) [F49620-01-1-0474]; Kenneth Norris Chair Endowment; National Science Foundation (NSF) [NSF EEC-0310723]; Whittier Foundation	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Kenneth Norris Chair Endowment; National Science Foundation (NSF)(National Science Foundation (NSF)); Whittier Foundation	This research has benefited from the Defense Advanced Research Projects Agency (DARPA, http://www.darpa.mil)/Air Force Office of Scientific Research (AFOSR, http://www.wpafb.af.mil) funded Defense University Research Initiative in Nanotechnology (DURINT) program grant no. F49620-01-1-0474, the Kenneth Norris Chair Endowment, the National Science Foundation (NSF, http://www.nsf.gov) sponsored Biomimetics Microelectronics Systems ( BMES) Engineering Research Center at the University of Southern California grant no. NSF EEC-0310723, and the Whittier Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar A, 2006, BRAIN RES, V1086, P191, DOI 10.1016/j.brainres.2006.02.061; Assefa Z, 2004, J BIOL CHEM, V279, P43227, DOI 10.1074/jbc.M403872200; Bentele M, 2004, J CELL BIOL, V166, P839, DOI 10.1083/jcb.200404158; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Campbell A.K, 1983, INTRACELLULAR CALCIU; Cellerino A, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-16-j0002.2000; Das A, 2006, BRAIN RES, V1084, P146, DOI 10.1016/j.brainres.2006.02.051; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falcke M, 2004, ADV PHYS, V53, P255, DOI 10.1080/00018730410001703159; Florea AM, 2005, CELL CALCIUM, V37, P251, DOI 10.1016/j.ceca.2004.10.005; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; FRIEL DD, 1995, BIOPHYS J, V68, P1752, DOI 10.1016/S0006-3495(95)80352-8; Fussenegger M, 2000, NAT BIOTECHNOL, V18, P768, DOI 10.1038/77589; Gerasimenko JV, 2002, J CELL SCI, V115, P485; Gross Ronald L, 2003, Trans Am Ophthalmol Soc, V101, P163; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; IGLEWICZ B, 1993, DETECT HANDLE OUTLIE, P32; Ju WK, 2007, INVEST OPHTH VIS SCI, V48, P2145, DOI 10.1167/iovs.06-0573; Ju WK, 2009, MOL VIS, V15, P120; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Krick S, 2001, AM J PHYSIOL-CELL PH, V280, pC970, DOI 10.1152/ajpcell.2001.280.4.C970; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Lee DA, 2005, AM J HEALTH-SYST PH, V62, P691, DOI 10.1093/ajhp/62.7.691; LI YX, 1995, AM J PHYSIOL-CELL PH, V269, pC1079, DOI 10.1152/ajpcell.1995.269.5.C1079; Liu Q, 2007, INVEST OPHTH VIS SCI, V48, P4580, DOI 10.1167/iovs.07-0170; Maeno E, 2000, P NATL ACAD SCI USA, V97, P9487, DOI 10.1073/pnas.140216197; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Moorhouse AJ, 2004, BRAIN RES, V1003, P205, DOI 10.1016/j.brainres.2004.01.027; Nietsch HH, 2000, J BIOL CHEM, V275, P20556, DOI 10.1074/jbc.M002535200; NIITTYKOSKI M, 2010, INVEST OPHTHALMOL VI; Oshimi S, 1996, J PHYSIOL-LONDON, V495, P319, DOI 10.1113/jphysiol.1996.sp021596; Paulsson JF, 2008, EXP DIABETES RES, DOI 10.1155/2008/865850; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Raychaudhuri S, 2008, BIOPHYS J, V95, P3559, DOI 10.1529/biophysj.108.135483; ROSNER B, 2006, FUNDAMENTALS BIOSTAT, P328; Sappington RM, 2009, INVEST OPHTH VIS SCI, V50, P717, DOI 10.1167/iovs.08-2321; SHEN P, 1995, CELL CALCIUM, V17, P225, DOI 10.1016/0143-4160(95)90037-3; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Zhou LL, 2005, APOPTOSIS, V10, P289, DOI 10.1007/s10495-005-0803-9	43	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13437	10.1371/journal.pone.0013437	http://dx.doi.org/10.1371/journal.pone.0013437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976135	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300018
J	Dominguez, F; Simon, C; Quinonero, A; Ramirez, MA; Gonzalez-Munoz, E; Burghardt, H; Cervero, A; Martinez, S; Pellicer, A; Palacin, M; Sanchez-Madrid, F; Yanez-Mo, M				Dominguez, Francisco; Simon, Carlos; Quinonero, Alicia; Angel Ramirez, Miguel; Gonzalez-Munoz, Elena; Burghardt, Hans; Cervero, Ana; Martinez, Sebastian; Pellicer, Antonio; Palacin, Manuel; Sanchez-Madrid, Francisco; Yanez-Mo, Maria			Human Endometrial CD98 Is Essential for Blastocyst Adhesion	PLOS ONE			English	Article							AMINO-ACID TRANSPORTERS; INTEGRIN ALPHA-6-BETA-1; EMBRYO IMPLANTATION; EPITHELIAL-CELLS; GENE-EXPRESSION; MENSTRUAL-CYCLE; MICE LACKING; IN-VITRO; ASSOCIATION; FERTILIZATION	Background: Understanding the molecular basis of embryonic implantation is of great clinical and biological relevance. Little is currently known about the adhesion receptors that determine endometrial receptivity for embryonic implantation in humans. Methods and Principal Findings: Using two human endometrial cell lines characterized by low and high receptivity, we identified the membrane receptor CD98 as a novel molecule selectively and significantly associated with the receptive phenotype. In human endometrial samples, CD98 was the only molecule studied whose expression was restricted to the implantation window in human endometrial tissue. CD98 expression was restricted to the apical surface and included in tetraspanin-enriched microdomains of primary endometrial epithelial cells, as demonstrated by the biochemical association between CD98 and tetraspanin CD9. CD98 expression was induced in vitro by treatment of primary endometrial epithelial cells with human chorionic gonadotropin, 17-beta-estradiol, LIF or EGF. Endometrial overexpression of CD98 or tetraspanin CD9 greatly enhanced mouse blastocyst adhesion, while their siRNA-mediated depletion reduced the blastocyst adhesion rate. Conclusions: These results indicate that CD98, a component of tetraspanin-enriched microdomains, appears to be an important determinant of human endometrial receptivity during the implantation window.	[Dominguez, Francisco; Simon, Carlos; Quinonero, Alicia; Cervero, Ana; Martinez, Sebastian; Pellicer, Antonio] Univ Valencia, Inst Univ IVI, Fdn IVI, Valencia, Spain; [Simon, Carlos] Ctr Invest Principe Felipe, Valencia, Spain; [Angel Ramirez, Miguel] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Anim Reprod, Madrid, Spain; [Gonzalez-Munoz, Elena; Burghardt, Hans; Palacin, Manuel] Univ Barcelona, Fac Biol, Inst Res Biomed, CIBER Enfermedades Raras, Barcelona, Spain; [Gonzalez-Munoz, Elena; Burghardt, Hans; Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Barcelona, Spain; [Sanchez-Madrid, Francisco; Yanez-Mo, Maria] Hosp Princesa, Inst Invest Sanitaria Princesa IP, Serv Inmunol, Madrid, Spain; [Sanchez-Madrid, Francisco; Yanez-Mo, Maria] Ctr Nacl Invest Cardiovasc, Madrid, Spain	University of Valencia; Prince Felipe Research Center; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Barcelona; University of Barcelona; Hospital de La Princesa; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	Dominguez, F (corresponding author), Univ Valencia, Inst Univ IVI, Fdn IVI, Valencia, Spain.	myanez.hlpr@salud.madrid.org	Pellicer, Antonio/AAA-6005-2020; Yáñez-Mó, María/K-8577-2014; YÃÃez-MÃ, Maria/AAI-4544-2020; Dominguez, Francisco/AAA-7260-2020; Gonzalez-Munoz, Elena/AAY-4658-2020; Ramirez de Paz, Miguel Angel/H-3171-2015; Sanchez-Madrid, Francisco/M-7889-2016	Pellicer, Antonio/0000-0002-8254-863X; Yáñez-Mó, María/0000-0001-7484-2866; YÃÃez-MÃ, Maria/0000-0001-7484-2866; Dominguez, Francisco/0000-0002-7620-8081; Gonzalez-Munoz, Elena/0000-0001-8291-1518; Ramirez de Paz, Miguel Angel/0000-0002-5868-2134; Palacin, Manuel/0000-0002-8670-293X; Sanchez-Madrid, Francisco/0000-0001-5303-0762	Instituto de Salud Carlos III [Contrato-Investigador FIS 0019, PI080794]; Comunidad de Madrid [SAF2008-02635, INSINET-0159/2006]; Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares [RD06/0014-0030]; Genoma Espana; Generalitat Valenciana [GV05/178, BFU2006-14600]; La Marata -TV3;  [SAF 2004-0024];  [SAF 2008-0248];  [PROMETEO/2008/163]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Comunidad de Madrid(Comunidad de Madrid); Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares; Genoma Espana; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); La Marata -TV3; ; ; 	This work was supported by grants Contrato-Investigador FIS 0019 and PI080794 from Instituto de Salud Carlos III to M.Y.-M.; SAF2008-02635, INSINET-0159/2006 from Comunidad de Madrid, RD06/0014-0030 from Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares, and Genoma Espana to F. S. M.; Generalitat Valenciana GV05/178 to F. D.; BFU2006-14600 and La Marata -TV3 to M. P.; SAF 2004-0024, SAF 2008-0248 and PROMETEO/2008/163 to C. S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreiro O, 2005, BLOOD, V105, P2852, DOI 10.1182/blood-2004-09-3606; Bentin-Ley U, 2000, HUM REPROD, V15, P67; BENTINLEY U, 1994, J REPROD FERTIL, V101, P327; Borthwick JM, 2003, MOL HUM REPROD, V9, P19, DOI 10.1093/molehr/gag004; BULLETTI C, 1988, FERTIL STERIL, V49, P991; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Chen MS, 1999, P NATL ACAD SCI USA, V96, P11830, DOI 10.1073/pnas.96.21.11830; Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995, DOI 10.1152/ajprenal.2001.281.6.F995; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp; Dong S, 1996, FEBS LETT, V395, P165, DOI 10.1016/0014-5793(96)01031-9; Fenczik CA, 1997, NATURE, V390, P81, DOI 10.1038/36349; Feral CC, 2007, J CELL BIOL, V178, P701, DOI 10.1083/jcb.200705090; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; Guzelogiu-Kayisli Z, 2009, SEMIN REPROD MED, V27, P62, DOI 10.1055/s-0028-1108011; Horcajadas JA, 2007, HUM REPROD UPDATE, V13, P77, DOI 10.1093/humupd/dml046; HUSSA RO, 1975, J CLIN ENDOCR METAB, V40, P401, DOI 10.1210/jcem-40-3-401; JOHN NJ, 1993, IN VITRO CELL DEV-AN, V29A, P461, DOI 10.1007/BF02639380; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Landgren BM, 1996, FERTIL STERIL, V65, P1067, DOI 10.1016/S0015-0282(16)58291-0; Le Naour F, 2000, SCIENCE, V287, P319, DOI 10.1126/science.287.5451.319; LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; LINDENBERG S, 1991, DAN MED BULL, V38, P371; LINDENBERG S, 1989, HUM REPROD, V4, P446, DOI 10.1093/oxfordjournals.humrep.a136925; Liu WM, 2007, FERTIL STERIL, V87, P664, DOI 10.1016/j.fertnstert.2006.07.1525; Liu WM, 2006, J MOL ENDOCRINOL, V36, P121, DOI 10.1677/jme.1.01910; Liu X, 2003, J BIOL CHEM, V278, P23672, DOI 10.1074/jbc.M302777200; Martin JC, 2000, BIOL REPROD, V63, P1370, DOI 10.1095/biolreprod63.5.1370; Mercader A, 2006, METHOD ENZYMOL, V420, P3, DOI 10.1016/S0076-6879(06)20001-6; Miller BJ, 2000, J CELL BIOL, V149, P1289, DOI 10.1083/jcb.149.6.1289; Miyado K, 2000, SCIENCE, V287, P321, DOI 10.1126/science.287.5451.321; Miyamoto YJ, 2003, MOL IMMUNOL, V39, P739, DOI 10.1016/S0161-5890(02)00255-9; Murphy CR, 2000, J REPROD FERTIL, P23; NAVOT D, 1991, J CLIN ENDOCR METAB, V72, P408, DOI 10.1210/jcem-72-2-408; Nguyen HTT, 2010, J BIOL CHEM, V285, P1479, DOI 10.1074/jbc.M109.057141; Nguyen HTT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003895; Noguchi Y, 2003, J CLIN ENDOCR METAB, V88, P6063, DOI 10.1210/jc.2003-030457; Noyes R W, 1975, Am J Obstet Gynecol, V122, P262; Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Park KR, 2000, MOL HUM REPROD, V6, P252, DOI 10.1093/molehr/6.3.252; Riesewijk A, 2003, MOL HUM REPROD, V9, P253, DOI 10.1093/molehr/gag037; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Rubinstein E, 2006, DEV BIOL, V290, P351, DOI 10.1016/j.ydbio.2005.11.031; Sala-Valdes M, 2006, J BIOL CHEM, V281, P19665, DOI 10.1074/jbc.M602116200; Schatz F, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-2; Simon C, 1999, J CLIN ENDOCR METAB, V84, P2638, DOI 10.1210/jc.84.8.2638; THIE M, 1995, EUR J CELL BIOL, V66, P180; Tinel H, 2000, MOL HUM REPROD, V6, P1119, DOI 10.1093/molehr/6.12.1119; Tsumura H, 2003, BIOCHEM BIOPH RES CO, V308, P847, DOI 10.1016/S0006-291X(03)01473-6; Tsurudome M, 2000, CRIT REV IMMUNOL, V20, P167; Wakabayashi T, 2009, NAT CELL BIOL, V11, P1340, DOI 10.1038/ncb1978; WAY DL, 1983, IN VITRO CELL DEV B, V19, P147; Xiao LJ, 2002, REPRODUCTION, V124, P219, DOI 10.1530/rep.0.1240219; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yanez-Mo M, 1998, J CELL BIOL, V141, P791, DOI 10.1083/jcb.141.3.791; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004	58	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13380	10.1371/journal.pone.0013380	http://dx.doi.org/10.1371/journal.pone.0013380			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976164	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700004
J	Longrich, NR; Horner, JR; Erickson, GM; Currie, PJ				Longrich, Nicholas R.; Horner, John R.; Erickson, Gregory M.; Currie, Philip J.			Cannibalism in Tyrannosaurus rex	PLOS ONE			English	Article							DINOSAUR BONE; TOOTH MARKS; BITE MARKS; THEROPOD; PREDATION; BEHAVIOR; BEARS	Background: Tyrannosaurus rex was one of the largest terrestrial carnivores of all time, and consequently its ecology and diet have been the focus of much discussion. However, there is little direct evidence of diet or feeding habits in this species. Methodology/Principal Findings: Examination of museum collections has revealed four specimens of Tyrannosaurus rex that bear tooth marks made by large, carnivorous dinosaurs. Because Tyrannosaurus is the only large carnivore known from the Late Maastrichtian of western North America, we infer that Tyrannosaurus made these tooth marks. Conclusions/Significance: The marks are interpreted as feeding traces and these fossils therefore record instances of cannibalism. Given that this behavior has a low preservation potential, cannibalism seems to have been a surprisingly common behavior in Tyrannosaurus, and this behavior may have been relatively common in carnivorous dinosaurs.	[Longrich, Nicholas R.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA; [Horner, John R.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Erickson, Gregory M.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA; [Currie, Philip J.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada	Yale University; Montana State University System; Montana State University Bozeman; State University System of Florida; Florida State University; University of Alberta	Longrich, NR (corresponding author), Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA.	nicholas.longrich@yale.edu	Currie, Philip J/A-2628-2014	Currie, Philip J/0000-0001-6857-3161; Longrich, Nicholas/0000-0002-9586-8907	Alberta Ingenuity; Yale Institute for Biospheric Studies; Natural Sciences and Engineering Research Council Canada	Alberta Ingenuity; Yale Institute for Biospheric Studies; Natural Sciences and Engineering Research Council Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	NRL was supported by an Alberta Ingenuity Graduate Research Fellowship, and a Yale Institute for Biospheric Studies Donnelley Fellowship. PJC was supported by the Natural Sciences and Engineering Research Council Canada, and N. Myrvold supported fieldwork by JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstrup SC, 2006, POLAR BIOL, V29, P997, DOI 10.1007/s00300-006-0142-5; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Bakker R.T., 1988, HUNTERIA, V1, P1, DOI DOI 10.5281/ZEN0D0.1037529; Britt BB, 2008, ICHNOS, V15, P59, DOI 10.1080/10420940701193284; Brochu CA, 2002, SOC VERTEBRATE PALEO, V7, P1, DOI DOI 10.2307/3889334; Carpenter Kenneth, 2000, Gaia (Lisboa), V15, P135; Carr TD, 2004, ZOOL J LINN SOC-LOND, V142, P479, DOI 10.1111/j.1096-3642.2004.00130.x; Carr TD, 1999, J VERTEBR PALEONTOL, V19, P497, DOI 10.1080/02724634.1999.10011161; Chin K, 1998, NATURE, V393, P680, DOI 10.1038/31461; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; Eloff F.C., 1984, Koedoe, V27, P249; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Estes R., 1964, University of California Publications in Geological Sciences, V49, P1; Farlow James O., 1994, Paleontological Society Special Publication, V7, P165; FOX LR, 1975, ANNU REV ECOL SYST, V6, P87, DOI 10.1146/annurev.es.06.110175.000511; Gignac PM, 2010, J VERTEBR PALEONTOL, V30, P1169, DOI 10.1080/02724634.2010.483535; Godfrey SJ, 2005, LIFE O PAST, P292; Happ John, 2008, P354; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Holtz Thomas R. Jr, 2008, P370; Horner J.R, 1993, COMPLETE T REX; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; Kruuk H., 1972, SPOTTED HYENA STUDY; Lambe LM., 1917, GEOL SURV, V83, P1, DOI [10.4095/101672, DOI 10.4095/101672]; Lesowski J., 1963, Journal of Mammalogy, V44, P586, DOI 10.2307/1377154; Longrich NR, 2010, PALAEONTOLOGY, V53, P703, DOI 10.1111/j.1475-4983.2010.00957.x; LONGRICH NR, 2008, UNIQUE ROLE VERTEBRA, P135; MATTSON DJ, 1992, J MAMMAL, V73, P422, DOI 10.2307/1382078; Nesbitt SJ, 2006, BIOL LETT-UK, V2, P611, DOI 10.1098/rsbl.2006.0524; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; Nowak RM, 1991, WALKERS MAMMALS WORL; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; Paul G., 1988, PREDATORY DINOSAURS; Paul G. S., 2008, TYRANNOSAURUS REX TY, P354; Pooley A.C., 1989, P92; Roberts EM, 2007, J PALEONTOL, V81, P201, DOI 10.1666/0022-3360(2007)81[201:CIBIDB]2.0.CO;2; Rogers RR, 2003, NATURE, V422, P515, DOI 10.1038/nature01532; ROOTES WL, 1993, HERPETOLOGICA, V49, P99; Schubert BW, 2005, ACTA PALAEONTOL POL, V50, P93; SHIPMAN P, 1986, AM ANTHROPOL, V88, P27, DOI 10.1525/aa.1986.88.1.02a00020; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; THENIUS VE, 1979, ANN NATURHISTORISCHE, V82, P177; Therrien F, 2007, J VERTEBR PALEONTOL, V27, P108, DOI 10.1671/0272-4634(2007)27[108:MTIBTY]2.0.CO;2; TIETJE WD, 1986, J MAMMAL, V67, P762, DOI 10.2307/1381144	46	27	28	3	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13419	10.1371/journal.pone.0013419	http://dx.doi.org/10.1371/journal.pone.0013419			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976177	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700017
J	Nakou, M; Bertsias, G; Stagakis, I; Centola, M; Tassiulas, I; Hatziapostolou, M; Kritikos, I; Goulielmos, G; Boumpas, DT; Iliopoulos, D				Nakou, Magdalene; Bertsias, George; Stagakis, Ilias; Centola, Michael; Tassiulas, Ioannis; Hatziapostolou, Maria; Kritikos, Iraklis; Goulielmos, George; Boumpas, Dimitrios T.; Iliopoulos, Dimitrios			Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus	PLOS ONE			English	Article							NF-KAPPA-B; GRANULOPOIESIS SIGNATURES; T-CELLS; EXPRESSION; INTERFERON; DISEASE; CANCER; BLOOD; ADENOCARCINOMA; INFLAMMATION	Background: Gene profiling studies provide important information for key molecules relevant to a disease but are less informative of protein-protein interactions, post-translational modifications and regulation by targeted subcellular localization. Integration of genomic data and construction of functional gene networks may provide additional insights into complex diseases such as systemic lupus erythematosus (SLE). Methodology/Principal Findings: We analyzed gene expression microarray data of bone marrow mononuclear cells (BMMCs) from 20 SLE patients (11 with active disease) and 10 controls. Gene networks were constructed using the bioinformatic tool Ingenuity Gene Network Analysis. In SLE patients, comparative analysis of BMMCs genes revealed a network with 19 central nodes as major gene regulators including ERK, JNK, and p38 MAP kinases, insulin, Ca(2+) and STAT3. Comparison between active versus inactive SLE identified 30 central nodes associated with immune response, protein synthesis, and post-transcriptional modification. A high degree of identity between networks in active SLE and non-Hodgkin's lymphoma (NHL) patients was found, with overlapping central nodes including kinases (MAPK, ERK, JNK, PKC), transcription factors (NF-kappaB, STAT3), and insulin. In validation studies, western blot analysis in splenic B cells from 5-month-old NZB/NZW F1 lupus mice showed activation of STAT3, ITGB2, HSPB1, ERK, JNK, p38, and p32 kinases, and downregulation of FOXO3 and VDR compared to normal C57Bl/6 mice. Conclusions/Significance: Gene network analysis of lupus BMMCs identified central gene regulators implicated in disease pathogenesis which could represent targets of novel therapies in human SLE. The high similarity between active SLE and NHL networks provides a molecular basis for the reported association of the former with lymphoid malignancies.	[Nakou, Magdalene; Bertsias, George; Stagakis, Ilias; Tassiulas, Ioannis; Kritikos, Iraklis; Goulielmos, George; Boumpas, Dimitrios T.] Univ Crete, Div Rheumatol Clin Immunol & Allergy, Sch Med, Iraklion, Greece; [Bertsias, George; Stagakis, Ilias; Tassiulas, Ioannis; Boumpas, Dimitrios T.] Fdn Res & Technol, Inst Mol Biol & Biotechnol, Iraklion, Greece; [Centola, Michael] Oklahoma Med Res Fdn, Microarray Res Facil, Oklahoma City, OK 73104 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Hatziapostolou, Maria; Iliopoulos, Dimitrios] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Crete; Oklahoma Medical Research Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Nakou, M (corresponding author), Univ Crete, Div Rheumatol Clin Immunol & Allergy, Sch Med, Iraklion, Greece.	dimitrios_iliopoulos@dfci.harvard.edu	Hatziapostolou, Maria/N-1820-2015; Bertsias, George/AAA-8400-2020; Iliopoulos, Dimitrios/AAE-9106-2019	Hatziapostolou, Maria/0000-0003-2493-7028; Bertsias, George/0000-0001-5299-1406; 	Hellenic Rheumatology Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053483] Funding Source: NIH RePORTER	Hellenic Rheumatology Society; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work has been supported by Hellenic Rheumatology Society grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barber DF, 2005, NAT MED, V11, P933, DOI 10.1038/nm1291; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bernatsky S, 2005, ANN RHEUM DIS, V64, P1507, DOI 10.1136/ard.2004.034504; Bernatsky S, 2005, ARTHRITIS RHEUM-US, V52, P1481, DOI 10.1002/art.21029; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Courtney PA, 1999, ANN RHEUM DIS, V58, P309, DOI 10.1136/ard.58.5.309; Delys L, 2007, ONCOGENE, V26, P7894, DOI 10.1038/sj.onc.1210588; Doshi BM, 2010, ANN NY ACAD SCI, V1197, P76, DOI 10.1111/j.1749-6632.2010.05191.x; Ellmark P, 2006, MOL CELL PROTEOMICS, V5, P1638, DOI 10.1074/mcp.M600170-MCP200; EMLEN W, 1994, J IMMUNOL, V152, P3685; Glawe JD, 2009, DIABETES, V58, P1292, DOI 10.2337/db08-0804; Goertsches RH, 2008, J NEUROL, V255, P48, DOI 10.1007/s00415-008-6010-1; Hale MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006756; Harada T, 2007, AUTOIMMUNITY, V40, P1, DOI 10.1080/08916930601095148; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jarvis JN, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2048; Krishnan S, 2008, J IMMUNOL, V181, P8145, DOI 10.4049/jimmunol.181.11.8145; Lerebours F, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-41; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Logsdon CD, 2003, CANCER RES, V63, P2649; Molad Y, 2010, ANN RHEUM DIS, V69, P175, DOI 10.1136/ard.2008.102780; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; Nakou M, 2008, ARTHRITIS RHEUM, V58, P3541, DOI 10.1002/art.23961; Niewold TB, 2008, ARTHRITIS RHEUM, V58, P2481, DOI 10.1002/art.23613; Reddy PS, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2541; Sela U, 2006, EUR J IMMUNOL, V36, P2971, DOI 10.1002/eji.200636137; Sluimer JC, 2007, PHYSIOL GENOMICS, V30, P335, DOI 10.1152/physiolgenomics.00076.2007; STYLIANOU K, 2010, NEPHROL DIAL TRANSPL, P11601; Taher TE, 2010, ARTHRITIS RHEUM-US, V62, P2412, DOI 10.1002/art.27505; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Wang L, 2008, NAT IMMUNOL, V9, P186, DOI 10.1038/ni1548; Wong CK, 2009, J CLIN IMMUNOL, V29, P738, DOI 10.1007/s10875-009-9318-4; Wu TF, 2007, J CLIN INVEST, V117, P2186, DOI 10.1172/JCI30398	37	28	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13351	10.1371/journal.pone.0013351	http://dx.doi.org/10.1371/journal.pone.0013351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976278	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000006
J	Smith, ND				Smith, Nathan D.			Phylogenetic Analysis of Pelecaniformes (Aves) Based on Osteological Data: Implications for Waterbird Phylogeny and Fossil Calibration Studies	PLOS ONE			English	Article							SISTER GROUP RELATIONSHIP; HIGHER-LEVEL PHYLOGENY; LENGTH DIFFERENCE TEST; TOOTHED BIRDS AVES; MIDDLE EOCENE; SEQUENCE DATA; PHALACROCORACOIDEA CORMORANTS; MOLECULAR CLOCK; EARLIEST RECORD; EARLY OLIGOCENE	Background: Debate regarding the monophyly and relationships of the avian order Pelecaniformes represents a classic example of discord between morphological and molecular estimates of phylogeny. This lack of consensus hampers interpretation of the group's fossil record, which has major implications for understanding patterns of character evolution (e. g., the evolution of wing-propelled diving) and temporal diversification (e. g., the origins of modern families). Relationships of the Pelecaniformes were inferred through parsimony analyses of an osteological dataset encompassing 59 taxa and 464 characters. The relationships of the Plotopteridae, an extinct family of wing-propelled divers, and several other fossil pelecaniforms (Limnofregata, Prophaethon, Lithoptila, ?Borvocarbo stoeffelensis) were also assessed. The antiquity of these taxa and their purported status as stem members of extant families makes them valuable for studies of higher-level avian diversification. Methodology/Principal Findings: Pelecaniform monophyly is not recovered, with Phaethontidae recovered as distantly related to all other pelecaniforms, which are supported as a monophyletic Steganopodes. Some anatomical partitions of the dataset possess different phylogenetic signals, and partitioned analyses reveal that these discrepancies are localized outside of Steganopodes, and primarily due to a few labile taxa. The Plotopteridae are recovered as the sister taxon to Phalacrocoracoidea, and the relationships of other fossil pelecaniforms representing key calibration points are well supported, including Limnofregata (sister taxon to Fregatidae), Prophaethon and Lithoptila (successive sister taxa to Phaethontidae), and ? Borvocarbo stoeffelensis (sister taxon to Phalacrocoracidae). These relationships are invariant when 'backbone' constraints based on recent avian phylogenies are imposed. Conclusions/Significance: Relationships of extant pelecaniforms inferred from morphology are more congruent with molecular phylogenies than previously assumed, though notable conflicts remain. The phylogenetic position of the Plotopteridae implies that wing-propelled diving evolved independently in plotopterids and penguins, representing a remarkable case of convergent evolution. Despite robust support for the placement of fossil taxa representing key calibration points, the successive outgroup relationships of several "stem fossil + crown family'' clades are variable and poorly supported across recent studies of avian phylogeny. Thus, the impact these fossils have on inferred patterns of temporal diversification depends heavily on the resolution of deep nodes in avian phylogeny.	[Smith, Nathan D.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Smith, Nathan D.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA	University of Chicago; Field Museum of Natural History (Chicago)	Smith, ND (corresponding author), Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA.	smithnd@uchicago.edu			Field Museum of Natural History; National Science Foundation (NSF) [ANT-0838925, DEB-0808250, EAR-0938199, EAR-0719758, DEB-0949897, EAR-0719943, DEB-0949899]; American Museum of Natural History; University of Chicago; University of Chicago, Biological Sciences Division; Division Of Environmental Biology [0808250] Funding Source: National Science Foundation; Office of Polar Programs (OPP) [0838925] Funding Source: National Science Foundation	Field Museum of Natural History; National Science Foundation (NSF)(National Science Foundation (NSF)); American Museum of Natural History; University of Chicago(University of Chicago); University of Chicago, Biological Sciences Division(University of Chicago); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Polar Programs (OPP)(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Nathan Smith is supported by the Field Museum of Natural History Brown Family Graduate Fellowship, National Science Foundation (NSF) ANT-0838925, NSF DEB-0808250, American Museum of Natural History Frank M. Chapman Memorial Fund, University of Chicago Hinds Fund, and University of Chicago, Biological Sciences Division Travel Fund. Funding and support for this project were also provided by NSF EAR-0938199, EAR-0719758 and DEB-0949897 to Julia Clarke, NSF EAR-0719943 to Lance Grande, and NSF DEB-0949899 to Dan Ksepka. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumel J.J., 1979, P53; BECKER JJ, 1986, AUK, V103, P804, DOI 10.1093/auk/103.4.804; BERGGREN WA, 1985, GEOL SOC AM BULL, V96, P1407, DOI 10.1130/0016-7606(1985)96<1407:CG>2.0.CO;2; Bertelli S, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3525[1:RAPPOT]2.0.CO;2; Bourdon E, 2005, NATURWISSENSCHAFTEN, V92, P586, DOI 10.1007/s00114-005-0047-0; Bourdon E, 2005, J VERTEBR PALEONTOL, V25, P157, DOI 10.1671/0272-4634(2005)025[0157:EANBAN]2.0.CO;2; Bourdon E, 2008, J VERTEBR PALEONTOL, V28, P751, DOI 10.1671/0272-4634(2008)28[751:NSOLAA]2.0.CO;2; Brewer ML, 2007, J MORPHOL, V268, P866, DOI 10.1002/jmor.10555; Brown JW, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-6; Buckley TR, 2002, SYST BIOL, V51, P509, DOI 10.1080/10635150290069922; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Chandler A. C., 1916, U CALIFORNIA PUBLICA, V13, P243; Chatterjee Sankar, 2002, P125; Clarke JA, 2007, P NATL ACAD SCI USA, V104, P11545, DOI 10.1073/pnas.0611099104; CODDINGTON J, 1994, CLADISTICS, V10, P415; Cooper A, 1997, SCIENCE, V275, P1109, DOI 10.1126/science.275.5303.1109; Cottam PA, 1957, B BRIT MUS NAT HIST, V5, P51; Cracraft J, 2004, ASSEMBLING THE TREE OF LIFE, P468; CRACRAFT J, 1985, AUK, V102, P834; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Darlu P, 2002, MOL BIOL EVOL, V19, P432, DOI 10.1093/oxfordjournals.molbev.a004098; De Pietri VL, 2010, ACTA PALAEONTOL POL, V55, P23, DOI 10.4202/app.2009.0069; DEQUEIROZ A, 1995, ANNU REV ECOL SYST, V26, P657, DOI 10.1146/annurev.es.26.110195.003301; DEQUEIROZ K, 1992, BIOL J LINN SOC, V45, P333, DOI 10.1111/j.1095-8312.1992.tb00648.x; Dolphin K, 2000, MOL PHYLOGENET EVOL, V17, P401, DOI 10.1006/mpev.2000.0845; Dowton M, 2002, SYST BIOL, V51, P19, DOI 10.1080/106351502753475853; Dyke GJ, 2004, ZOOL J LINN SOC-LOND, V141, P153, DOI 10.1111/j.1096-3642.2004.00118.x; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Fain MG, 2004, EVOLUTION, V58, P2558; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FEDUCCIA A, 1993, P BIOL SOC WASH, V106, P749; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Felsenstein J., 2004, INFERRING PHYLOGENIE; Friesen VL, 1997, MOL PHYLOGENET EVOL, V7, P252, DOI 10.1006/mpev.1996.0397; Fuarbringer M., 1888, UNTERSUCHUNGEN MORPH, V15; Gatesy J, 1999, CLADISTICS, V15, P271, DOI 10.1111/j.1096-0031.1999.tb00268.x; GAUTHIER J, 1988, CLADISTICS, V4, P105, DOI 10.1111/j.1096-0031.1988.tb00514.x; GOEDERT J L, 1988, Proceedings of the California Academy of Sciences, V45, P97; Goldman N, 2000, SYST BIOL, V49, P652, DOI 10.1080/106351500750049752; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; HARRIS AH, 1977, NATIONAL PARK SERVIC, V3, P1; HARRISON CJO, 1976, ZOOL J LINN SOC-LOND, V59, P323, DOI 10.1111/j.1096-3642.1976.tb01017.x; HARRISON CJO, 1976, B BRIT MUS NAT HIST, V27, P1; Harvey P.H., 1991, COMP METHOD EVOLUTIO; HEDGES SB, 1994, P NATL ACAD SCI USA, V91, P9861, DOI 10.1073/pnas.91.21.9861; Hillis David M., 2000, P1; Hinic-Frlog S, 2010, J EVOLUTION BIOL, V23, P372, DOI 10.1111/j.1420-9101.2009.01909.x; Holland BR, 2010, SYST BIOL, V59, P433, DOI 10.1093/sysbio/syq023; HOWARD H, 1969, CONDOR, V71, P68, DOI 10.2307/1366050; HOWARD HILDEGARDE, 1929, UNIV CALIFORNIA PUBL ZOOL, V32, P301; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Jadwiszczak Piotr, 2006, Polish Polar Research, V27, P3; Kennedy M, 2005, SYST BIOL, V54, P620, DOI 10.1080/106351591007462; Kennedy M, 2004, MOL PHYLOGENET EVOL, V31, P31, DOI 10.1016/j.ympev.2003.07.007; Kennedy M, 1996, ANIM BEHAV, V51, P273, DOI 10.1006/anbe.1996.0028; Kennedy M, 2000, MOL PHYLOGENET EVOL, V17, P345, DOI 10.1006/mpev.2000.0840; Kennedy M, 2009, MOL PHYLOGENET EVOL, V53, P94, DOI 10.1016/j.ympev.2009.06.002; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Ksepka DT, 2006, CLADISTICS, V22, P412, DOI 10.1111/j.1096-0031.2006.00116.x; Lambrecht, 1933, HDB PALAEORNITHOLOGI; Lambrecht K., 1931, Wetenschappelijke Mededeelingen Batavia, Vno. 17, P15; Lambrecht K., 1929, 10 C INT ZOOL STEPH, P1262; Lee MSY, 2001, MOL BIOL EVOL, V18, P676, DOI 10.1093/oxfordjournals.molbev.a003848; Livezey BC, 2007, ZOOL J LINN SOC-LOND, V149, P1, DOI 10.1111/j.1096-3642.2006.00293.x; Louchart A, 2011, J ORNITHOL, V152, P15, DOI 10.1007/s10336-010-0537-5; Lydekker R., 1891, CATALOGUE FOSSIL BIR; Manegold A, 2006, ACTA ORNITHOL, V41, P79, DOI 10.3161/068.041.0113; Mayr G, 2005, BIOL REV, V80, P515, DOI 10.1017/S1464793105006779; Mayr G, 2003, CLADISTICS, V19, P527, DOI [10.1016/j.cladistics.2003.10.003, 10.1111/j.1096-0031.2003.tb00387.x]; Mayr G, 2008, J ZOOL SYST EVOL RES, V46, P63, DOI 10.1111/j.1439-0469.2007.00433.x; Mayr G, 2004, J ORNITHOL, V145, P281, DOI 10.1007/s10336-004-0050-9; Mayr G, 2004, ZOOL J LINN SOC-LOND, V140, P157, DOI 10.1111/j.1096-3642.2003.00094.x; Mayr G, 2003, J ZOOL SYST EVOL RES, V41, P233, DOI 10.1046/j.1439-0469.2003.00230.x; Mayr G, 2003, J ORNITHOL, V144, P157, DOI 10.1007/BF02465644; Mayr G, 2002, ACTA PALAEONTOL POL, V47, P507; Mayr G, 2002, J VERTEBR PALEONTOL, V22, P667, DOI 10.1671/0272-4634(2002)022[0667:PLBWAP]2.0.CO;2; Mayr G, 2008, PALAEONTOLOGY, V51, P1107, DOI 10.1111/j.1475-4983.2008.00798.x; Mayr G, 2007, J ORNITHOL, V148, pS455, DOI 10.1007/s10336-007-0159-8; Mayr G, 2007, CONDOR, V109, P929, DOI 10.1650/0010-5422(2007)109[929:ASROTP]2.0.CO;2; Mayr Gerald, 2008, Oryctos, V7, P67; Mayr Gerald, 2001, Senckenbergiana Lethaea, V81, P329; Mayr G, 2010, PALAEONTOLOGY, V53, P365, DOI 10.1111/j.1475-4983.2009.00930.x; Mayr G, 2009, WATERBIRDS, V32, P468, DOI 10.1675/063.032.0315; Mayr G, 2009, PALAEONTOL Z, V83, P247, DOI 10.1007/s12542-009-0019-3; Mayr G, 2009, IBIS, V151, P392, DOI 10.1111/j.1474-919X.2009.00920.x; Mayr Gerald, 2008, Senckenbergiana Lethaea, V88, P195; McCracken KG, 1999, SYST BIOL, V48, P683, DOI 10.1080/106351599259979; Mertz DF, 2007, INT J EARTH SCI, V96, P353, DOI 10.1007/s00531-006-0094-6; Milne-Edwards A., 1867, RECHERCHES ANATOMIQU; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Mlikovsky Jiri, 2007, Annalen des Naturhistorischen Museums in Wien A Mineralogie Petrologie Geologie Palaeontologie Archaeozoologie Anthropologie Praehistorie, V109A, P19; Muller J, 2005, BIOESSAYS, V27, P1069, DOI 10.1002/bies.20286; Myrcha Andrzej, 2002, Polish Polar Research, V23, P5; NELSON J.B., 1978, SULIDAE GANNETS BOOB; Nunn GB, 1998, MOL BIOL EVOL, V15, P1360, DOI 10.1093/oxfordjournals.molbev.a025864; Olson S.L., 1985, Avian Biology, V8, P79; Olson S.L., 1977, Smithsonian Contr. Paleobiol., VNo. 35, P1; Olson S.L., 1992, Journal of Vertebrate Paleontology, V12, P122; Olson S. L., 1987, SMITHSONIAN CONTRIBU, V63, P1, DOI DOI 10.5479/SI.00810266.63.1; Olson SL, 2005, ZOOTAXA, P1; Olson SL, 1996, J VERTEBR PALEONTOL, V16, P742, DOI 10.1080/02724634.1996.10011362; OLSON SL, 1984, P BIOL SOC WASH, V97, P736; OLSON SL, 1979, SCIENCE, V206, P688, DOI 10.1126/science.206.4419.688; Olson SL, 1980, CONTRIBUTIONS SCI NA, V330, P51; OMLAND KE, 1994, SYST BIOL, V43, P369, DOI 10.2307/2413674; Owre O. T., 1967, ORNITHOL MONOGR, V6, P1, DOI [DOI 10.2307/40166666, 10.2307/40166666]; Panteleyev A.V., 1993, Trudy Zoologicheskogo Instituta, V252, P95; Parham JF, 2008, AM NAT, V171, P132, DOI 10.1086/524198; PRAGER EM, 1988, J MOL EVOL, V27, P326, DOI 10.1007/BF02101195; Prothero DR, 2000, J GEOPHYS RES-SOL EA, V105, P16473, DOI 10.1029/2000JB900063; Rasmussen D.T., 1987, SMITHSON CONTRIB PAL, P1, DOI DOI 10.5479/SI.00810266.62.1; Sadleir RW, 2008, J EVOLUTION BIOL, V21, P1578, DOI 10.1111/j.1420-9101.2008.01602.x; SAIFF E, 1988, J MORPHOL, V196, P107, DOI 10.1002/jmor.1051960108; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; SIEGELCAUSEY D, 1988, CONDOR, V90, P885, DOI 10.2307/1368846; Simons AL, 2009, J CANCER RES THER, V5, P2, DOI 10.4103/0973-1482.55133; Slack KE, 2006, MOL BIOL EVOL, V23, P1144, DOI 10.1093/molbev/msj124; Smith AB, 1998, MOL PHYLOGENET EVOL, V9, P437, DOI 10.1006/mpev.1998.0488; Smith AB, 2006, MOL BIOL EVOL, V23, P1832, DOI 10.1093/molbev/msl039; Smith ME, 2010, GEOLOGY, V38, P527, DOI 10.1130/G30630.1; Smith ND, 2005, SYST BIOL, V54, P166, DOI 10.1080/10635150590906000; SORENSON MD, 1999, TREEROT VERSION 2; Stidham Thomas A., 2005, Contributions from the Museum of Paleontology University of Michigan, V31, P179; STORER ROBERT W., 1956, CONDOR, V58, P413, DOI 10.2307/1365096; SWOFFORD DL, 1996, MOL SYSTEMATICS, V2, P407; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TAMBUSSI C, 1998, JORN ARG PAL VERT NO, P34; Tambussi CP, 2005, GEOBIOS-LYON, V38, P667, DOI 10.1016/j.geobios.2004.02.003; TEMPLETON AR, 1983, EVOLUTION, V37, P221, DOI 10.1111/j.1558-5646.1983.tb05533.x; TEMPLETON AR, 1983, STATISTICAL ANAL DNA, P151; van Tets G. F., 1965, Ornithological Monographs, VNo. 2, P1; van Tets G.F., 1988, Notornis, V35, P35; VANTETS GF, 1976, P INT ORNITHOL C, V16, P121; VANTUINEN M, 2001, P ROY SOC LOND B BIO, V268, P1; VANTUINEN M, 2006, HIST BIOL, V18, P205; Warheit K.I., 2001, BIOL MARINE BIRDS, P17, DOI [DOI 10.1201/9781420036305.CH2, 10.1201/9781420036305, DOI 10.1201/9781420036305]; Warheit K. I., 1990, THESIS U CALIFORNIA; WARHEIT KI, 1992, PALEOBIOLOGY, V18, P401, DOI 10.1017/S0094837300010976; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	152	61	64	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13354	10.1371/journal.pone.0013354	http://dx.doi.org/10.1371/journal.pone.0013354			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976229	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000007
J	Zou, CG; Xu, YF; Liu, WJ; Zhou, W; Tao, N; Tu, HH; Huang, XW; Yang, JK; Zhang, KQ				Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin			Expression of a Serine Protease Gene prC Is Up-Regulated by Oxidative Stress in the Fungus Clonostachys rosea: Implications for Fungal Survival	PLOS ONE			English	Article							NEMATODE-TRAPPING FUNGUS; TRICHODERMA-ATROVIRIDE; CANDIDA-ALBICANS; TRANSCRIPTION; PURIFICATION; INFECTION; PATTERNS; BINDING; CUTICLE; FAMILY	Background: Soil fungi face a variety of environmental stresses such as UV light, high temperature, and heavy metals. Adaptation of gene expression through transcriptional regulation is a key mechanism in fungal response to environmental stress. In Saccharomyces cerevisiae, the transcription factors Msn2/4 induce stress-mediated gene expression by binding to the stress response element. Previous studies have demonstrated that the expression of extracellular proteases is up-regulated in response to heat shock in fungi. However, the physiological significance of regulation of these extracellular proteases by heat shock remains unclear. The nematophagous fungus Clonostachys rosea can secret an extracellular serine protease PrC during the infection of nematodes. Since the promoter of prC has three copies of the stress response element, we investigated the effect of environmental stress on the expression of prC. Methodology/Principal Findings: Our results demonstrated that the expression of prC was up-regulated by oxidants (H2O2 or menadione) and heat shock, most likely through the stress response element. After oxidant treatment or heat shock, the germination of conidia in the wild type strain was significantly higher than that in the prC mutant strain in the presence of nematode cuticle. Interestingly, the addition of nematode cuticle significantly attenuated the production of reactive oxygen species (ROS) induced by oxidants and heat shock in the wild type strain, but not in prC mutant strain. Moreover, low molecule weight (<3 kD) degradation products of nematode cuticle suppressed the inhibitory effect of conidial germination induced by oxidants and heat shock. Conclusions/Significance: These results indicate that PrC plays a protective role in oxidative stress in C. rosea. PrC degrades the nematode cuticle to produce degradation products, which in turn offer a protective effect against oxidative stress by scavenging ROS. Our study reveals a novel strategy for fungi to adapt to environmental stress.	[Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China; [Zou, Cheng-Gang; Xu, Yong-Fang; Liu, Wen-Jing; Zhou, Wei; Tao, Nan; Tu, Hui-Hui; Huang, Xiao-Wei; Yang, Jin-Kui; Zhang, Ke-Qin] Yunnan Univ, Key Lab Microbial Resources, Minist Educ, Kunming 650091, Yunnan, Peoples R China; [Xu, Yong-Fang] First Peoples Hosp Yunnan Prov, Ctr Human Reprod, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University	Zou, CG (corresponding author), Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming 650091, Yunnan, Peoples R China.	kqzhang111@yahoo.com.cn	Liu, Wenjing/ACS-5787-2022; zhang, ke/AAH-8217-2019	Yang, Jinkui/0000-0002-3106-2189	National Basic Research Program of China (973 Program) [2007CB411600, 2010CB134503]; National Natural Science Foundation of China [30630003, 30760053]; Department of Science and Technology of Yunnan Province [2007C007Z, 2009CI045]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported in part by a grant (2007CB411600 and 2010CB134503) from National Basic Research Program of China (973 Program), the grants (30630003 and 30760053) from the National Natural Science Foundation of China, and the grants (2007C007Z and 2009CI045) from the Department of Science and Technology of Yunnan Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrashev RI, 2008, CAN J MICROBIOL, V54, P977, DOI 10.1139/W08-091; Ahman J, 2002, APPL ENVIRON MICROB, V68, P3408, DOI 10.1128/AEM.68.7.3408-3415.2002; Ahman J, 1996, MICROBIOL-SGM, V142, P1605, DOI 10.1099/13500872-142-7-1605; Ahren D, 2005, MICROBIOL-SGM, V151, P789, DOI 10.1099/mic.0.27485-0; Bose S, 2005, GENETICS, V169, P1215, DOI 10.1534/genetics.104.034603; COX GN, 1981, J CELL BIOL, V90, P7, DOI 10.1083/jcb.90.1.7; Fekete C, 2008, ENVIRON MICROBIOL, V10, P364, DOI 10.1111/j.1462-2920.2007.01457.x; Freimoser FM, 2005, MICROBIOL-SGM, V151, P361, DOI 10.1099/mic.0.27560-0; Freitas FZ, 2004, MOL GENET GENOMICS, V272, P550, DOI 10.1007/s00438-004-1086-5; Galhaup C, 2002, MICROBIOL-SGM, V148, P2159, DOI 10.1099/00221287-148-7-2159; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; LERNER CG, 1993, J GEN MICROBIOL, V139, P1643, DOI 10.1099/00221287-139-7-1643; Li J, 2006, PROCESS BIOCHEM, V41, P925, DOI 10.1016/j.procbio.2005.10.006; Lorito M, 1996, P NATL ACAD SCI USA, V93, P14868, DOI 10.1073/pnas.93.25.14868; Mach RL, 1999, APPL ENVIRON MICROB, V65, P1858; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Nevarez L, 2008, MICROBIOL-SGM, V154, P3752, DOI 10.1099/mic.0.2008/021386-0; Ramesh G, 2009, APPL ENVIRON MICROB, V75, P2266, DOI 10.1128/AEM.02142-08; Reuss O, 2006, MOL MICROBIOL, V60, P795, DOI 10.1111/j.1365-2958.2006.05136.x; Roetzer A, 2008, MOL MICROBIOL, V69, P603, DOI 10.1111/j.1365-2958.2008.06301.x; Seidl V, 2004, FUNGAL GENET BIOL, V41, P1132, DOI 10.1016/j.fgb.2004.09.002; Steen BR, 2002, GENOME RES, V12, P1386, DOI 10.1101/gr.80202; Sugiyama K, 2000, J BIOL CHEM, V275, P15535, DOI 10.1074/jbc.275.20.15535; Yang HL, 2009, MOL CELL PROTEOMICS, V8, P571, DOI 10.1074/mcp.M800297-MCP200; Yang JK, 2007, APPL MICROBIOL BIOT, V75, P557, DOI 10.1007/s00253-007-0839-6; Zou CG, 2003, J BIOL CHEM, V278, P16802, DOI 10.1074/jbc.M212376200; Zou CG, 2010, ENVIRON MICROBIOL, V12, P3243, DOI 10.1111/j.1462-2920.2010.02296.x; Zou CG, 2010, ENVIRON MICROBIOL, V12, P1868, DOI 10.1111/j.1462-2920.2010.02191.x	29	17	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13386	10.1371/journal.pone.0013386	http://dx.doi.org/10.1371/journal.pone.0013386			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976223	gold, Green Submitted, Green Published			2022-12-27	WOS:000282941000017
J	Gotoh, K; Kodama, T; Hiyoshi, H; Izutsu, K; Park, KS; Dryselius, R; Akeda, Y; Honda, T; Iida, T				Gotoh, Kazuyoshi; Kodama, Toshio; Hiyoshi, Hirotaka; Izutsu, Kaori; Park, Kwon-Sam; Dryselius, Rikard; Akeda, Yukihiro; Honda, Takeshi; Iida, Tetsuya			Bile Acid-Induced Virulence Gene Expression of Vibrio parahaemolyticus Reveals a Novel Therapeutic Potential for Bile Acid Sequestrants	PLOS ONE			English	Article							THERMOSTABLE DIRECT HEMOLYSIN; III SECRETION SYSTEM; IN-VITRO; PATHOGENICITY ISLAND; CHOLERAE; ENTEROTOXICITY; RESISTANCE; BACTERIA; TOXIN; IDENTIFICATION	Vibrio parahaemolyticus, a bacterial pathogen, causes human gastroenteritis. A type III secretion system (T3SS2) encoded in pathogenicity island (Vp-PAI) is the main contributor to enterotoxicity and expression of Vp-PAI encoded genes is regulated by two transcriptional regulators, VtrA and VtrB. However, a host-derived inducer for the Vp-PAI genes has not been identified. Here, we demonstrate that bile induces production of T3SS2-related proteins under osmotic conditions equivalent to those in the intestinal lumen. We also show that bile induces vtrA-mediated vtrB transcription. Transcriptome analysis of bile-responsive genes revealed that bile strongly induces expression of Vp-PAI genes in a vtrA-dependent manner. The inducing activity of bile was diminished by treatment with bile acid sequestrant cholestyramine. Finally, we demonstrate an in vivo protective effect of cholestyramine on enterotoxicity and show that similar protection is observed in infection with a different type of V. parahaemolyticus or with non-O1/non-O139 V. cholerae strains of vibrios carrying the same kind of T3SS. In summary, these results provide an insight into how bacteria, through the ingenious action of Vp-PAI genes, can take advantage of an otherwise hostile host environment. The results also reveal a new therapeutic potential for widely used bile acid sequestrants in enteric bacterial infections.	[Gotoh, Kazuyoshi; Hiyoshi, Hirotaka; Izutsu, Kaori; Dryselius, Rikard; Iida, Tetsuya] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Genom Res Pathogenic Bacteria, Osaka, Japan; [Kodama, Toshio; Park, Kwon-Sam; Akeda, Yukihiro; Honda, Takeshi] Osaka Univ, Microbial Dis Res Inst, Dept Bacterial Infect, Osaka, Japan; [Park, Kwon-Sam] Kunsan Natl Univ, Coll Ocean Sci & Technol, Dept Food Sci & Bio Technol, Kunsan, South Korea; [Dryselius, Rikard] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Akeda, Yukihiro] Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Clin Res Infect Dis, Osaka, Japan	Osaka University; Osaka University; Kunsan National University; Karolinska Institutet; Osaka University	Gotoh, K (corresponding author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Genom Res Pathogenic Bacteria, Osaka, Japan.	kodama@biken.osaka-u.ac.jp		Hiyoshi, Hirotaka/0000-0003-3709-2386; Kodama, Toshio/0000-0002-6511-7301	Ministry of Education, Culture, Sports, Science and Technology of Japan [21790419, 18073003, 20390128, 17019058]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Young Scientists (21790419, http://kaken.nii.ac.jp/ja/p/21790419) and Scientific Research on Priority Areas, Matrix of Infection Phenomena (18073003, http://kaken.nii.ac.jp/ja/p/18073003), a Grant-in-Aid for Scientific Research (B) (20390128, http://kaken.nii.ac.jp/ja/p/20390128) and Special Coordination Funds for Promoting Science and Technology (17019058, http://kaken.nii.ac.jp/ja/p/17019058) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker-Austin C, 2008, J FOOD PROTECT, V71, P2552, DOI 10.4315/0362-028X-71.12.2552; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BERGEN SS, 1959, P SOC EXP BIOL MED, V102, P676, DOI 10.3181/00379727-102-25358; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Charlton-Menys V, 2008, EXP PHYSIOL, V93, P27, DOI 10.1113/expphysiol.2007.035147; Childers BM, 2007, FUTURE MICROBIOL, V2, P335, DOI 10.2217/17460913.2.3.335; Chowdhury R, 1996, J BIOSCIENCES, V21, P149, DOI 10.1007/BF02703105; Daramola BA, 2009, INT J ANTIMICROB AG, V34, P499, DOI 10.1016/j.ijantimicag.2009.06.015; Dziejman M, 2005, P NATL ACAD SCI USA, V102, P3465, DOI 10.1073/pnas.0409918102; Edwards AD, 2009, VACCINE, V27, P3897, DOI 10.1016/j.vaccine.2009.04.006; Escaich S, 2008, CURR OPIN CHEM BIOL, V12, P400, DOI 10.1016/j.cbpa.2008.06.022; Fabbri A, 1999, INFECT IMMUN, V67, P1139, DOI 10.1128/IAI.67.3.1139-1148.1999; Gonzalez-Escalona N, 2008, J BACTERIOL, V190, P2831, DOI 10.1128/JB.01808-07; GOSHIMA K, 1977, J MOL CELL CARDIOL, V9, P191, DOI 10.1016/0022-2828(77)90029-3; Gunn JS, 2000, MICROBES INFECT, V2, P907, DOI 10.1016/S1286-4579(00)00392-0; Gupta S, 1997, INFECT IMMUN, V65, P1131, DOI 10.1128/IAI.65.3.1131-1134.1997; Han F, 2007, APPL ENVIRON MICROB, V73, P7096, DOI 10.1128/AEM.01116-07; Hiyoshi H, 2010, INFECT IMMUN, V78, P1772, DOI 10.1128/IAI.01051-09; HONDA T, 1976, INFECT IMMUN, V13, P163, DOI 10.1128/IAI.13.1.163-171.1976; Honda T., 1993, REV MED MICROBIOL, V4, P106, DOI DOI 10.1097/00013542-199304000-00006; HONDA T, 1976, J JPN ASS INFECT DIS, V50, P216; Hung DT, 2005, P NATL ACAD SCI USA, V102, P3028, DOI 10.1073/pnas.0409559102; Izutsu K, 2008, INFECT IMMUN, V76, P1016, DOI 10.1128/IAI.01535-07; Kodama T, 2002, CELL MICROBIOL, V4, P213, DOI 10.1046/j.1462-5822.2002.00176.x; Kodama T, 2007, CELL MICROBIOL, V9, P2598, DOI 10.1111/j.1462-5822.2007.00980.x; Kodama T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008678; LIN Z, 1993, J BACTERIOL, V175, P3844, DOI 10.1128/JB.175.12.3844-3855.1993; Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1; Matsushita Shigeru, 2003, Kansenshogaku Zasshi, V77, P195; Miller JH., 1972, EXPT MOL GENETICS; MIYAMOTO Y, 1969, J BACTERIOL, V100, P1147, DOI 10.1128/JB.100.2.1147-1149.1969; MORRIS JG, 1985, NEW ENGL J MED, V312, P343, DOI 10.1056/NEJM198502073120604; Naim R, 2001, FEMS MICROBIOL LETT, V195, P237, DOI 10.1016/S0378-1097(01)00015-5; Nair GB, 2007, CLIN MICROBIOL REV, V20, P39, DOI 10.1128/CMR.00025-06; Nakano M, 2007, J INFECT DIS, V195, P1353, DOI 10.1086/513275; Neela FA, 2007, J MICROBIOL, V45, P64; NISHIBUCHI M, 1995, INFECT IMMUN, V63, P2093, DOI 10.1128/IAI.63.6.2093-2099.1995; Okada N, 2009, INFECT IMMUN, V77, P904, DOI 10.1128/IAI.01184-08; Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06; Osawa R, 1996, APPL ENVIRON MICROB, V62, P3023, DOI 10.1128/AEM.62.8.3023-3025.1996; Osawa R, 2002, CURR MICROBIOL, V44, P302, DOI 10.1007/s00284-001-0051-3; Pace JL, 1997, APPL ENVIRON MICROB, V63, P2372, DOI 10.1128/AEM.63.6.2372-2377.1997; PARALES RE, 1993, GENE, V133, P23, DOI 10.1016/0378-1119(93)90220-W; Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004; Prouty AM, 2000, INFECT IMMUN, V68, P6763, DOI 10.1128/IAI.68.12.6763-6769.2000; Raimondi F, 2000, INFECT IMMUN, V68, P3180, DOI 10.1128/IAI.68.6.3180-3185.2000; SAKURAI J, 1976, INFECT IMMUN, V13, P876, DOI 10.1128/IAI.13.3.876-883.1976; Schuhmacher DA, 1999, J BACTERIOL, V181, P1508, DOI 10.1128/JB.181.5.1508-1514.1999; Sperandio V, 2003, P NATL ACAD SCI USA, V100, P8951, DOI 10.1073/pnas.1537100100; Sugiyama T, 2008, J BACTERIOL, V190, P1835, DOI 10.1128/JB.01293-07; Takahashi A, 2001, J MED MICROBIOL, V50, P870, DOI 10.1099/0022-1317-50-10-870; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; TANG GQ, 1995, FEMS MICROBIOL LETT, V134, P233, DOI 10.1016/0378-1097(95)00411-3; Tang GQ, 1997, FEMS MICROBIOL LETT, V150, P289, DOI 10.1016/S0378-1097(97)00133-X; Waldor MK, 2006, NEW ENGL J MED, V354, P296, DOI 10.1056/NEJMcibr054591; XU M, 1994, INFECT IMMUN, V62, P166, DOI 10.1128/IAI.62.1.166-171.1994	56	90	95	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13365	10.1371/journal.pone.0013365	http://dx.doi.org/10.1371/journal.pone.0013365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967223	gold, Green Submitted, Green Published			2022-12-27	WOS:000282869800042
J	Mandel, AL; des Gachons, CP; Plank, KL; Alarcon, S; Breslin, PAS				Mandel, Abigail L.; des Gachons, Catherine Peyrot; Plank, Kimberly L.; Alarcon, Suzanne; Breslin, Paul A. S.			Individual Differences in AMY1 Gene Copy Number, Salivary alpha-Amylase Levels, and the Perception of Oral Starch	PLOS ONE			English	Article							SENSORY PROPERTIES; MILK-FAT; VISCOSITY; TEXTURE; FLAVOR	Background: The digestion of dietary starch in humans is initiated by salivary alpha-amylase, an endo-enzyme that hydrolyzes starch into maltose, maltotriose and larger oligosaccharides. Salivary amylase accounts for 40 to 50% of protein in human saliva and rapidly alters the physical properties of starch. Importantly, the quantity and enzymatic activity of salivary amylase show significant individual variation. However, linking variation in salivary amylase levels with the oral perception of starch has proven difficult. Furthermore, the relationship between copy number variations (CNVs) in the AMY1 gene, which influence salivary amylase levels, and starch viscosity perception has not been explored. Principal Findings: Here we demonstrate that saliva containing high levels of amylase has sufficient activity to rapidly hydrolyze a viscous starch solution in vitro. Furthermore, we show with time-intensity ratings, which track the digestion of starch during oral manipulation, that individuals with high amylase levels report faster and more significant decreases in perceived starch viscosity than people with low salivary amylase levels. Finally, we demonstrate that AMY1 CNVs predict an individual's amount and activity of salivary amylase and thereby, ultimately determine their perceived rate of oral starch viscosity thinning. Conclusions: By linking genetic variation and its consequent salivary enzymatic differences to the perceptual sequellae of these variations, we show that AMY1 copy number relates to salivary amylase concentration and enzymatic activity level, which, in turn, account for individual variation in the oral perception of starch viscosity. The profound individual differences in salivary amylase levels and salivary activity may contribute significantly to individual differences in dietary starch intake and, consequently, to overall nutritional status.	[Mandel, Abigail L.; des Gachons, Catherine Peyrot; Plank, Kimberly L.; Alarcon, Suzanne; Breslin, Paul A. S.] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Alarcon, Suzanne; Breslin, Paul A. S.] Rutgers State Univ, Dept Nutr Sci, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Monell Chemical Senses Center; Rutgers State University New Brunswick	Mandel, AL (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	breslin@aesop.rutgers.edu		Breslin, Paul/0000-0001-5988-8401	National Starch Co.; National Institutes of Health [R01 DC 02995]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002995] Funding Source: NIH RePORTER	National Starch Co.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This study was funded by National Starch Co. (http://www. foodinnovation. com/FoodInnovation/en-US/) and a grant by the National Institutes of Health (R01 DC 02995) to PASB. National Starch contributed to the design of the microviscoamylograph and perceptual studies. The company conducted the perceptual testing for eight of the 73 subjects included in this manuscript. National Starch had no role in analysis, decision to publish, or preparation of the manuscript.	BANK RA, 1992, HUM GENET, V89, P213; Chatterton RT, 1996, CLIN PHYSIOL, V16, P433, DOI 10.1111/j.1475-097X.1996.tb00731.x; de Wijk RA, 2004, PHYSIOL BEHAV, V83, P81, DOI 10.1016/j.physbeh.2004.07.014; Engelen L, 2007, ARCH ORAL BIOL, V52, P518, DOI 10.1016/j.archoralbio.2006.11.007; EVANS ID, 1986, J SCI FOOD AGR, V37, P573, DOI 10.1002/jsfa.2740370611; Ferry AL, 2004, J TEXTURE STUD, V35, P511, DOI 10.1111/j.1745-4603.2004.35503.x; FOGEL MR, 1973, J APPL PHYSIOL, V35, P263, DOI 10.1152/jappl.1973.35.2.263; Granger DA, 2007, ANN NY ACAD SCI, V1098, P122, DOI 10.1196/annals.1384.008; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Hoebler C, 1998, BRIT J NUTR, V80, P429, DOI 10.1017/S0007114598001494; Iontcheva I, 1997, J DENT RES, V76, P734, DOI 10.1177/00220345970760030501; MACKIE DA, 1990, PHYSIOL BEHAV, V47, P593, DOI 10.1016/0031-9384(90)90131-M; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Navazesh M, 2008, J AM DENT ASSOC, V139, p35S, DOI 10.14219/jada.archive.2008.0353; Noble R E, 2000, J Oral Sci, V42, P83; Oppenheim FG, 2007, ANN NY ACAD SCI, V1098, P22, DOI 10.1196/annals.1384.030; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Prindiville EA, 1999, J DAIRY SCI, V82, P1425, DOI 10.3168/jds.S0022-0302(99)75369-5; Prindiville EA, 2000, J DAIRY SCI, V83, P2216, DOI 10.3168/jds.S0022-0302(00)75105-8; SQUIRES BT, 1953, J PHYSIOL-LONDON, V119, P153, DOI 10.1113/jphysiol.1953.sp004835; STANLEY NL, 1993, ACTA PSYCHOL, V84, P79, DOI 10.1016/0001-6918(93)90074-2	21	156	160	6	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13352	10.1371/journal.pone.0013352	http://dx.doi.org/10.1371/journal.pone.0013352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967220	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800036
J	Robin, VV; Sinha, A; Ramakrishnan, U				Robin, V. V.; Sinha, Anindya; Ramakrishnan, Uma			Ancient Geographical Gaps and Paleo-Climate Shape the Phylogeography of an Endemic Bird in the Sky Islands of Southern India	PLOS ONE			English	Article							EASTERN ARC MOUNTAINS; WESTERN-GHATS; GENETIC DIVERSITY; POPULATIONS; MODELS; ORIGIN; DIFFERENTIATION; BIOGEOGRAPHY; DIVERGENCE; DISPERSAL	Background: Sky islands, formed by the highest reaches of mountain tracts physically isolated from one another, represent one of the biodiversity-rich regions of the world. Comparative studies of geographically isolated populations on such islands can provide valuable insights into the biogeography and evolution of species on these islands. The Western Ghats mountains of southern India form a sky island system, where the relationship between the island structure and the evolution of its species remains virtually unknown despite a few population genetic studies. Methods and Principal Findings: We investigated how ancient geographic gaps and glacial cycles have partitioned genetic variation in modern populations of a threatened endemic bird, the White-bellied Shortwing Brachypteryx major, across the montane Shola forests on these islands and also inferred its evolutionary history. We used Bayesian and maximum likelihood-based phylogenetic and population-genetic analyses on data from three mitochondrial markers and one nuclear marker (totally 2594 bp) obtained from 33 White-bellied Shortwing individuals across five islands. Genetic differentiation between populations of the species correlated with the locations of deep valleys in the Western Ghats but not with geographical distance between these populations. All populations revealed demographic histories consistent with population founding and expansion during the Last Glacial Maximum. Given the level of genetic differentiation north and south of the Palghat Gap, we suggest that these populations be considered two different taxonomic species. Conclusions and Significance: Our results show that the physiography and paleo-climate of this region historically resulted in multiple glacial refugia that may have subsequently driven the evolutionary history and current population structure of this bird. The first avian genetic study from this biodiversity hotspot, our results provide insights into processes that may have impacted the speciation and evolution of the endemic fauna of this region.	[Robin, V. V.; Sinha, Anindya] Natl Inst Adv Studies, Bangalore, Karnataka, India; [Robin, V. V.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore, Karnataka, India; [Sinha, Anindya] Nat Conservat Fdn, Mysore, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Robin, VV (corresponding author), Natl Inst Adv Studies, Indian Inst Sci Campus, Bangalore, Karnataka, India.	robinvijayan@gmail.com	Robin, V.V./H-7299-2019	Robin, V.V./0000-0003-3109-5498; Ramakrishnan, Uma/0000-0002-5370-5966	Ministry of Environment and Forests, Government of India; Council of Scientific and Industrial Research, Government of India; National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India; Fulbright Fellowship	Ministry of Environment and Forests, Government of India(Ministry of Environment, Forest and Climate Change (MoEFCC), Government of India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India; Fulbright Fellowship	A part of the fellowship for VVR and a part of the fieldwork were supported by a grant from the Eastern Ghats - Western Ghats Programme of the Ministry of Environment and Forests, Government of India to VVR and AS. A part of VVR's fellowship, all laboratory work and a part of the fieldwork were supported by the Council of Scientific and Industrial Research, Government of India and the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India and a start up grant to UR from the National Centre for Biological Sciences, Tata Institute of Fundamental Research, Bangalore, India. V. V. Robin was also supported by a Fulbright Fellowship while writing a part of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyar A, 2000, Methods Mol Biol, V132, P221; Assefa A, 2007, HEREDITY, V99, P133, DOI 10.1038/sj.hdy.6800974; Bahulikar RA, 2004, CURR SCI INDIA, V86, P824; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beresford P, 2004, AUK, V121, P23, DOI 10.1642/0004-8038(2004)121[0023:ANSOAS]2.0.CO;2; BirdLife International, 2001, THREAT BIRDS AS BIRD; Bohonak AJ, 2002, J HERED, V93, P153, DOI 10.1093/jhered/93.2.153; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bowie RCK, 2004, AUK, V121, P660, DOI 10.1642/0004-8038(2004)121[0660:SABODS]2.0.CO;2; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; DANIELS RJR, 1992, J BIOGEOGR, V19, P521, DOI 10.2307/2845771; DeChaine EG, 2005, J BIOGEOGR, V32, P1943, DOI 10.1111/j.1365-2699.2005.01356.x; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DeChaine EG, 2004, EVOLUTION, V58, P113, DOI 10.1111/j.0014-3820.2004.tb01578.x; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Deshpande AU, 2001, MOL ECOL, V10, P2397, DOI 10.1046/j.0962-1083.2001.01379.x; Drummond AJ, 2007, ROUGH GUIDE BEAST 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Edwards SV, 2002, TRENDS ECOL EVOL, V17, P347, DOI 10.1016/S0169-5347(02)02543-0; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Excoffier L, 2006, ARLEQUIN VER 3 01 IN; Field JS, 2007, J ANTHROPOL ARCHAEOL, V26, P88, DOI 10.1016/j.jaa.2006.06.001; Fjeldsa J, 2003, P ROY SOC B-BIOL SCI, V270, pS238, DOI 10.1098/rsbl.2003.0075; Fjeldsa J, 2008, AFR J ECOL, V46, P235, DOI 10.1111/j.1365-2028.2008.00992.x; Gower DJ, 2007, J ZOOL, V272, P266, DOI 10.1111/j.1469-7998.2006.00266.x; Grimmett R., 1999, POCKET GUIDE BIRDS I; Gunnell Y, 2003, EARTH PLANET SC LETT, V215, P187, DOI 10.1016/S0012-821X(03)00380-7; Harshman J., 1996, THESIS U CHICAGO; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Islam M.Z., 2004, IMPORTANT BIRD AREAS, V2nd; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Knowles LL, 2001, MOL ECOL, V10, P691, DOI 10.1046/j.1365-294x.2001.01206.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; LANYON SM, 1994, EVOLUTION, V48, P679, DOI 10.1111/j.1558-5646.1994.tb01353.x; Manly BFJ, 1997, RANDOMIZATION BOOTST; MANTEL N, 1967, CANCER RES, V27, P209; Marchant R, 2007, AFR J ECOL, V45, P4, DOI 10.1111/j.1365-2028.2006.00707.x; MAYR E, 1976, P NATL ACAD SCI USA, V73, P1765, DOI 10.1073/pnas.73.5.1765; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Omland KE, 2000, P ROY SOC B-BIOL SCI, V267, P2475, DOI 10.1098/rspb.2000.1308; PETERSON A, 1993, CONSERVATION PRIORIT, P33; Petraglia M, 2009, P NATL ACAD SCI USA, V106, P12261, DOI 10.1073/pnas.0810842106; POSADA D, 2003, USING MODELTEST PAUP; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; Prabhu CN, 2004, PALAEOGEOGR PALAEOCL, V214, P309, DOI 10.1016/j.palaeo.2004.07.027; RAMESH B, 1997, EN MAPS GEOG, V6; Rasmussen P. C., 2005, Zoologische Mededelingen (Leiden), V79, P137; Rasmussen P.C., 2005, BIRDS S ASIA; Ripley D, 1987, HDB BIRDS INDIA PAKI; Robin VV, 2002, BIRD CONSERV INT, V12, P335, DOI 10.1017/S0959270902002216; Robinson F, 2006, J ROY ASIATIC SOC, V16, P345, DOI 10.1017/S1356186306006419; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; RONQUIST F, 2005, BAYESIAN ANAL MOL EV, P183; Santosh M., 1992, B INDIAN GEOLOGICAL, V25, P1; SLATKIN M, 1991, GENETICS, V129, P555; Smith CI, 2005, MOL ECOL, V14, P3049, DOI 10.1111/j.1365-294X.2005.02647.x; SOMAN K, 1990, J GEOL SOC INDIA, V35, P82; Stanley WT, 2005, J ZOOL, V266, P341, DOI 10.1017/S0952836905007016; STOREY BC, 1995, NATURE, V377, P301, DOI 10.1038/377301a0; Sutherland W. J., 2004, BIRD ECOLOGY CONSERV; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Vidya TNC, 2005, HEREDITY, V94, P71, DOI 10.1038/sj.hdy.6800568; Warshall P., 1994, BIODIVERSITY MANAGEM, P6; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2006, EVOLUTION, V60, P842; WIKRAMANAYAKE E, 2001, TERRESTRIAL ECOREGIO; Wright S, 1943, GENETICS, V28, P114; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x; Zink RM, 2003, MOL ECOL, V12, P3069, DOI 10.1046/j.1365-294X.2003.01981.x	78	70	79	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13321	10.1371/journal.pone.0013321	http://dx.doi.org/10.1371/journal.pone.0013321			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967202	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800023
J	Romer, H; Lang, A; Hartbauer, M				Roemer, Heiner; Lang, Alexander; Hartbauer, Manfred			The Signaller's Dilemma: A Cost-Benefit Analysis of Public and Private Communication	PLOS ONE			English	Article							PREDATION RISK; RUSTLING SOUNDS; SENSORY ECOLOGY; COLOR PATTERNS; FEMALE CHOICE; BAT PREDATION; BEHAVIOR; EVOLUTION; TRANSMISSION; ORTHOPTERA	Background: Understanding the diversity of animal signals requires knowledge of factors which may influence the different stages of communication, from the production of a signal by the sender up to the detection, identification and final decision-making in the receiver. Yet, many studies on signalling systems focus exclusively on the sender, and often ignore the receiver side and the ecological conditions under which signals evolve. Methodology/Principal Findings: We study a neotropical katydid which uses airborne sound for long distance communication, but also an alternative form of private signalling through substrate vibration. We quantified the strength of predation by bats which eavesdrop on the airborne sound signal, by analysing insect remains at roosts of a bat family. Males do not arbitrarily use one or the other channel for communication, but spend more time with private signalling under full moon conditions, when the nocturnal rainforest favours predation by visually hunting predators. Measurements of metabolic CO2-production rate indicate that the energy necessary for signalling increases 3-fold in full moon nights when private signalling is favoured. The background noise level for the airborne sound channel can amount to 70 dB SPL, whereas it is low in the vibration channel in the low frequency range of the vibration signal. The active space of the airborne sound signal varies between 22 and 35 meters, contrasting with about 4 meters with the vibration signal transmitted on the insect's favourite roost plant. Signal perception was studied using neurophysiological methods under outdoor conditions, which is more reliable for the private mode of communication. Conclusions/Significance: Our results demonstrate the complex effects of ecological conditions, such as predation, nocturnal ambient light levels, and masking noise levels on the performance of receivers in detecting mating signals, and that the net advantage or disadvantage of a mode of communication strongly depends on these conditions.	[Roemer, Heiner; Lang, Alexander; Hartbauer, Manfred] Karl Franzens Univ Graz, Graz, Austria	University of Graz	Romer, H (corresponding author), Karl Franzens Univ Graz, Graz, Austria.	heinrich.roemer@uni-graz.at			Austrian Academy for Sciences; Karl-Franzens-University of Graz; Austrian Science Fund [FWF-P14257, P17986-B06]	Austrian Academy for Sciences; Karl-Franzens-University of Graz; Austrian Science Fund(Austrian Science Fund (FWF))	The project was supported by the Austrian Academy for Sciences and the Karl-Franzens-University of Graz to ABL, and the Austrian Science Fund (FWF-P14257 and P17986-B06) to HR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Malte, 1994; Bailey WJ, 1998, J ZOOL, V244, P505, DOI 10.1111/j.1469-7998.1998.tb00056.x; Barth FG, 2002, ZOOLOGY, V105, P271, DOI 10.1078/0944-2006-00082; Barth FG, 1997, EXS, V84, P247; BARTH FG, 1979, J ARACHNOL, V7, P255; BELL PD, 1980, J NEW YORK ENTOMOL S, V88, P210; BELWOOD JJ, 1987, SCIENCE, V238, P64, DOI 10.1126/science.238.4823.64; BELWOOD JJ, THESIS U FLORIDA GAI; BELWOOD JJ, 1990, TETTIGONIIDAE BEHAV, P6; Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Bristowe W., 1971, WORLD SPIDERS; Brumm H, 2005, ADV STUD BEHAV, V35, P151, DOI 10.1016/S0065-3454(05)35004-2; CADE W, 1975, SCIENCE, V190, P1312, DOI 10.1126/science.190.4221.1312; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Crnokrak P, 2002, J EVOLUTION BIOL, V15, P388, DOI 10.1046/j.1420-9101.2002.00401.x; Cummings ME, 2003, P ROY SOC B-BIOL SCI, V270, P897, DOI 10.1098/rspb.2003.2334; DALY M, 1992, ANIM BEHAV, V44, P1, DOI 10.1016/S0003-3472(05)80748-1; Dechmann DKN, 2004, EVOL ECOL RES, V6, P1037; ENDLER JA, 1991, VISION RES, V31, P587, DOI 10.1016/0042-6989(91)90109-I; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1980, EVOLUTION, V34, P76, DOI 10.1111/j.1558-5646.1980.tb04790.x; ENDLER JA, 1987, ANIM BEHAV, V35, P1376, DOI 10.1016/S0003-3472(87)80010-6; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; GERHARDT HC, 1982, AM ZOOL, V22, P581; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Goerlitz HR, 2007, FUNCT ECOL, V21, P143, DOI 10.1111/j.1365-2435.2006.01212.x; Goerlitz HR, 2008, J EXP BIOL, V211, P2799, DOI 10.1242/jeb.019596; Greenfield MD, 2002, SIGNALERS RECEIVERS; GUILFORD T, 1991, ANIM BEHAV, V42, P1, DOI 10.1016/S0003-3472(05)80600-1; Hartbauer M, 2006, J INSECT PHYSIOL, V52, P221, DOI 10.1016/j.jinsphys.2005.10.006; Haynes KF, 1999, ANN ENTOMOL SOC AM, V92, P960, DOI 10.1093/aesa/92.6.960; JOHNSTONE RA, 1994, P ROY SOC B-BIOL SCI, V256, P169, DOI 10.1098/rspb.1994.0066; Johnstone RA, 1998, EVOLUTION, V52, P1554, DOI 10.1111/j.1558-5646.1998.tb02236.x; Johnstone RA, 1999, BEHAV ECOL SOCIOBIOL, V45, P277, DOI 10.1007/s002650050562; Juliano SA, 2002, BEHAV ECOL, V13, P301, DOI 10.1093/beheco/13.3.301; Kalko EKV, 1999, BIOTROPICA, V31, P344, DOI 10.1111/j.1744-7429.1999.tb00146.x; Klump Georg M., 1996, P321; Lang AB, 2006, OECOLOGIA, V146, P659, DOI 10.1007/s00442-005-0131-3; Lang AB, 2008, BIOTROPICA, V40, P183, DOI 10.1111/j.1744-7429.2007.00360.x; Lang Alexander B., 2006, P152; Laumann RA, 2007, ANIM BEHAV, V73, P637, DOI 10.1016/j.anbehav.2006.09.011; Lehmann GUC, 2001, ENTOMOL GEN, V25, P135; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOCKARD RB, 1978, J MAMMAL, V59, P563, DOI 10.2307/1380233; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marquez R, 1997, BEHAV ECOL, V8, P588, DOI 10.1093/beheco/8.6.588; MARTEN K, 1977, BEHAV ECOL SOCIOBIOL, V2, P271, DOI 10.1007/BF00299740; MICHELSEN A, 1982, BEHAV ECOL SOCIOBIOL, V11, P269, DOI 10.1007/BF00299304; MORRIS GK, 1980, ANIM BEHAV, V28, P42, DOI 10.1016/S0003-3472(80)80006-6; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; Naskrecki P, 2000, KATYDIDS COSTA RICA; Nickle David A., 1992, P142; PAUL RC, 1979, J COMP PHYSIOL, V132, P217, DOI 10.1007/BF00614493; PFEIFFER M, PLOS COMP SCI UNPUB; PRESTWICH KN, 1994, AM ZOOL, V34, P625, DOI 10.1093/icb/34.6.625; Rand AS, 1997, COPEIA, P447, DOI 10.2307/1447770; RHEINLAENDER J, 1986, J COMP PHYSIOL A, V158, P647, DOI 10.1007/BF00603821; Romer H., 1992, BEHAV ECOL SOCIOBIOL, V157, P631; Schwabe Josef, 1906, Zoologica Stuttgart H, V50, pUnpaginated; SWETS JA, 1978, PERCEPT PSYCHOPHYS, V23, P275, DOI 10.3758/BF03199711; TELFORD S R, 1989, Bioacoustics, V2, P47; TUTTLE MD, 1981, SCIENCE, V214, P677, DOI 10.1126/science.214.4521.677; TUTTLE MD, 1982, BEHAV ECOL SOCIOBIOL, V11, P125, DOI 10.1007/BF00300101; Wiley R., 1982, ACOUSTIC COMMUNICATI; Wiley R. Haven, 1994, P157; WILEY RH, 2000, VERTEBRATE MATING SY, P8; Zuk M, 1998, Q REV BIOL, V73, P415, DOI 10.1086/420412	68	47	47	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13325	10.1371/journal.pone.0013325	http://dx.doi.org/10.1371/journal.pone.0013325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967210	gold, Green Published			2022-12-27	WOS:000282869800025
J	Chen, SCC; Yeh, JJ; Chang, MH; Liao, YK; Hsiao, LC; Neoh, CA; Tok, TS; Wang, JD				Chen, Solomon Chih-Cheng; Yeh, Jun-Jun; Chang, Mei-Hwei; Liao, Yu-Kuei; Hsiao, Li-Chen; Neoh, Choo-Aun; Tok, Teck-Siang; Wang, Jung-Der			Gender Difference of Alanine Aminotransferase Elevation May Be Associated with Higher Hemoglobin Levels among Male Adolescents	PLOS ONE			English	Article							FATTY LIVER-DISEASE; CHRONIC HEPATITIS-C; INSULIN-RESISTANCE; IRON DEPLETION; CONTROLLED-TRIAL; B-VACCINE; PHLEBOTOMY; CHILDREN; RISK; DETERMINANTS	Background: To explore the gender difference of ALT elevation and its association with high hemoglobin levels. Methods: A cross-sectional study of 3547 adolescents (2005 females, mean age of 16.5?.3 years) who were negative for hepatitis B surface antigen received health checkups in 2006. Body mass index (BMI), levels of hemoglobin, ALT and cholesterol were measured. ALT >42 U/L was defined as elevated ALT. Elevated ALT levels were detected in 112 of the 3547 participants (3.3%), more prevalent in males than in females (5.4% vs. 1.4%, p<0.001). Hemoglobin levels had a significant linear correlation with ALT levels in both genders. Abnormal ALT started to occur if hemoglobin >11 g/dl in females or >13.5 g/dl in males, but the cumulative cases of elevated ALT increased more quickly in males. Proportion of elevated ALT increased as either the BMI or hemoglobin level rise, more apparent in male adolescents. Logistic regression modeling showed odds ratio (95% confidence interval) were 24.7 (15.0-40.6) for BMI >= 27 kg/m(2); 5.5 (2.9-10.4) for BMI 24-27 kg/m(2); 2.7 (1.3-5.5) for Q5 (top 20th percentile) hemoglobin level; and 2.6 (1.6-4.1) for male gender. Further separately fitting the logistic models for two genders, the significance of Q5 hemoglobin level only appeared in the males. Conclusions: High hemoglobin level is a significant risk factor of ALT elevation after control hepatitis B, obesity and gender. Males have greater risk of abnormal liver function which may be associated with higher hemoglobin levels.	[Chen, Solomon Chih-Cheng; Tok, Teck-Siang] Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan; [Yeh, Jun-Jun] Pingtung Christian Hosp, Dept Internal Med, Pingtung, Taiwan; [Chang, Mei-Hwei] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Liao, Yu-Kuei; Hsiao, Li-Chen; Neoh, Choo-Aun] Pingtung Christian Hosp, Dept Community Hlth, Pingtung, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ, Coll Med, Dept Publ Hlth, Tainan 70101, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Cheng Kung Univ Hosp, Dept Environm & Occupat Med, Tainan 70428, Taiwan; [Wang, Jung-Der] Natl Taiwan Univ, Inst Occupat Med & Ind Hyg, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Cheng Kung University Hospital; National Taiwan University	Chen, SCC (corresponding author), Pingtung Christian Hosp, Dept Pediat, Pingtung, Taiwan.	jdwang121@gmail.com		Chen, Solomon/0000-0003-0031-6147; Chang, Mei Hwei/0000-0002-3648-9261; Yeh, Jun-Jun/0000-0002-4368-7880	National Science Council, Taiwan [NSC99-2314-B-475-001]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was funded by a grant (NSC99-2314-B-475-001) from the National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedogni G, 2004, ANN HUM BIOL, V31, P570, DOI 10.1080/03014460400001230; Carlo C, 2003, HEPATO-GASTROENTEROL, V50, P1467; Chang JG, 1997, BLOOD, V89, P3492, DOI 10.1182/blood.V89.9.3492; *DEP HLTH, SMOK RAT SEN HIGH SC; Di Bonito P, 2009, METABOLISM, V58, P368, DOI 10.1016/j.metabol.2008.10.010; Eaton JW, 2002, FREE RADICAL BIO MED, V32, P833, DOI 10.1016/S0891-5849(02)00772-4; Franchini M, 2008, HEPATOL INT, V2, P335, DOI 10.1007/s12072-008-9076-z; Fraser A, 2007, GASTROENTEROLOGY, V133, P1814, DOI 10.1053/j.gastro.2007.08.077; Fu CC, 2009, ANN ACAD MED SINGAP, V38, P15; Hsiao TJ, 2004, INT J OBESITY, V28, P167, DOI 10.1038/sj.ijo.0802519; Lai CL, 2007, J VIRAL HEPATITIS, V14, P6, DOI 10.1111/j.1365-2893.2007.00909.x; Li TC, 2004, J GASTROENTEROL, V39, P1170, DOI 10.1007/s00535-004-1467-x; Lin TJ, 2005, WORLD J GASTROENTERO, V11, P3905; Liu CM, 2005, WORLD J GASTROENTERO, V11, P7159, DOI 10.3748/wjg.v11.i45.7159; Lu CY, 2008, J INFECT DIS, V197, P1419, DOI 10.1086/587695; Lu CY, 2004, HEPATOLOGY, V40, P1415, DOI 10.1002/hep.20490; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Park HS, 2005, AM J CLIN NUTR, V82, P1046, DOI 10.1093/ajcn/82.5.1046; Price L, 2009, CAN J GASTROENTEROL, V23, P822, DOI 10.1155/2009/290383; Riquelme A, 2004, DIGEST DIS SCI, V49, P1012, DOI 10.1023/B:DDAS.0000034564.68307.39; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P1821, DOI 10.1016/S0016-5085(03)00395-0; Ruhl CE, 2003, GASTROENTEROLOGY, V124, P71, DOI 10.1053/gast.2003.50004; Sagi R, 2007, ACTA PAEDIATR, V96, P1209, DOI 10.1111/j.1651-2227.2007.00399.x; Sakugawa H, 2004, EUR J CLIN NUTR, V58, P1248, DOI 10.1038/sj.ejcn.1601956; Salazar LIF, 2004, REV ESP ENFERM DIG, V96, P818; Sartori M, 2010, WORLD J GASTROENTERO, V16, P596, DOI 10.3748/wjg.v16.i5.596; Schwimmer JB, 2005, PEDIATRICS, V115, pE561, DOI 10.1542/peds.2004-1832; Shakya R, 2004, ANN PHARMACOTHER, V38, P1074, DOI 10.1345/aph.1D525; Sikorska Katarzyna, 2003, Med Sci Monit, V9 Suppl 3, P64; Sumida Y, 2007, INTERNAL MED, V46, P637, DOI 10.2169/internalmedicine.46.6085; Tsai Ming-Han, 2005, Journal of Microbiology Immunology and Infection, V38, P255; Valenti L, 2007, AM J GASTROENTEROL, V102, P1251, DOI 10.1111/j.1572-0241.2007.01192.x; Yano M, 2004, J GASTROENTEROL, V39, P570, DOI 10.1007/s00535-003-1344-z; YEH PS, 2009, OBES SURG; Yen SL, 2008, INT J OBESITY, V32, P474, DOI 10.1038/sj.ijo.0803753	35	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13269	10.1371/journal.pone.0013269	http://dx.doi.org/10.1371/journal.pone.0013269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967274	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300011
J	Mencarelli, A; Cipriani, S; Renga, B; Francisci, D; Palladino, G; Distrutti, E; Baldelli, F; Fiorucci, S				Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Francisci, Daniela; Palladino, Giuseppe; Distrutti, Eleonora; Baldelli, Franco; Fiorucci, Stefano			The Bile Acid Sensor FXR Protects against Dyslipidemia and Aortic Plaques Development Induced by the HIV Protease Inhibitor Ritonavir in Mice	PLOS ONE			English	Article							FARNESOID-X-RECEPTOR; ATHEROSCLEROTIC LESION FORMATION; ELEMENT-BINDING PROTEINS; NUCLEAR RECEPTOR; CHENODEOXYCHOLIC ACID; SCAVENGER RECEPTORS; OXIDIZED LDL; FATTY-ACID; ACTIVATION; HYPERLIPIDEMIA	Background: Although human immunodeficiency virus (HIV)-related morbidity and mortality rates in patients treated with a combination of high active antiretroviral therapy (HAART) have declined, significant metabolic/vascular adverse effects associated with the long term use of HIV protease inhibitors (PIs) have emerged as a significant side effect. Here we illustrate that targeting the bile acid sensor farnesoid X receptor (FXR) protects against dyslipidemia and vascular injury induced HIV-PIs in rodents. Methodology/Principal Findings: Administration of the HIV PI ritonavir to wild type mice increased plasma triacylglycerols and cholesterol levels and this effect was exacerbated by dosing ritonavir to mice harbouring a disrupted FXR. Dyslipidemia induced by ritonavir associated with a shift in the liver expression of signature genes, Sterol Regulatory Element-Binding Protein (SREBP)1 and fatty acid synthase. Treating wild type mice with the FXR agonist (chenodeoxycholic acid, CDCA) protected against development of dyslipidemia induced by ritonavir. Administration of ritonavir to ApoE(-/-) mice, a strain that develop spontaneously atherosclerosis, increased the extent of aortic plaques without worsening the dyslipidemia. Treating these mice with CDCA reduced the extent of aortic plaques by 70% without changing plasma lipoproteins or the liver expression of signature genes. A beneficial effect on aortic plaques was also obtained by treating ApoE(-/-) mice with gemfibrozil, a PPAR alpha agonist. FXR activation counter-regulated induction of expression/activity of CD36 caused by HIV-PIs in circulating monocytes and aortic plaques. In macrophages cell lines, CDCA attenuated CD36 induction and uptake of acetylated LDL caused by ritonavir. Natural and synthetic FXR ligands reduced the nuclear translocation of SREBP1c caused by ritonavir. Conclusions/Significance: Activation of the bile acid sensor FXR protects against dyslipidemia and atherosclerotic caused by ritonavir, a widely used HIV PI. From a mechanistic stand point it appears that besides reducing the liver expression of genes involved in fatty acid synthesis, FXR activation counter-regulates the expression/activity of CD36 on monocytes. FXR ligands might hold promise in the treatment dyslipidemia induced by ritonavir.	[Mencarelli, Andrea; Cipriani, Sabrina; Renga, Barbara; Palladino, Giuseppe; Fiorucci, Stefano] Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy; [Francisci, Daniela; Baldelli, Franco] Univ Perugia, Fac Med & Chirurg, Dipartimento Med Sperimentale & Sci Biochim, I-06100 Perugia, Italy; [Distrutti, Eleonora] Osped S Maria Misericordia, Azienda Osped Perugia, Perugia, Italy	University of Perugia; University of Perugia; Hospital Santa Maria della Misericordia; University of Perugia; Azienda Ospedaliera di Perugia	Mencarelli, A (corresponding author), Univ Perugia, Fac Med & Chirurg, Dipartimento Med Clin & Sperimentale, I-06100 Perugia, Italy.	fiorucci@unipg.it	Fiorucci, Stefano/I-1251-2012					Barbaro G., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P337, DOI 10.2174/1568006054553444; BATESON MC, 1978, BRIT J CLIN PHARMACO, V5, P249, DOI 10.1111/j.1365-2125.1978.tb01632.x; Binder CJ, 2002, NAT MED, V8, P1218, DOI 10.1038/nm1102-1218; Bishop-Bailey D, 2004, P NATL ACAD SCI USA, V101, P3668, DOI 10.1073/pnas.0400046101; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Boullier A, 2001, ANN NY ACAD SCI, V947, P214; Calkin AC, 2006, DIABETOLOGIA, V49, P766, DOI 10.1007/s00125-005-0102-6; Calkin AC, 2007, ATHEROSCLEROSIS, V195, P17, DOI 10.1016/j.atherosclerosis.2006.11.021; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; Delerive P, 1999, J BIOL CHEM, V274, P32048, DOI 10.1074/jbc.274.45.32048; Distler O, 2001, CURR OPIN CLIN NUTR, V4, P99, DOI 10.1097/00075197-200103000-00003; Dressman J, 2003, J CLIN INVEST, V111, P389, DOI 10.1172/JCI200316261; Fiorucci S, 2010, PROG LIPID RES, V49, P171, DOI 10.1016/j.plipres.2009.11.001; Flexner C, 1998, NEW ENGL J MED, V338, P1281, DOI 10.1056/NEJM199804303381808; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Graham NM, 2000, J ACQ IMMUN DEF SYND, V25, pS4, DOI 10.1097/00126334-200010001-00002; Hanniman EA, 2005, J LIPID RES, V46, P2595, DOI 10.1194/jlr.M500390-JLR200; Hartman HB, 2009, J LIPID RES, V50, P1090, DOI 10.1194/jlr.M800619-JLR200; Huang XP, 2007, APPL OPTICS, V46, P147, DOI 10.1364/AO.46.000147; Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200; Lee JY, 2005, CURR OPIN LIPIDOL, V16, P19, DOI 10.1097/00041433-200502000-00005; Lenhard JM, 2000, ARTERIOSCL THROM VAS, V20, P2625, DOI 10.1161/01.ATV.20.12.2625; Li YTY, 2007, ARTERIOSCL THROM VAS, V27, P2606, DOI 10.1161/ATVBAHA.107.152694; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Linton MF, 2001, CURR OPIN LIPIDOL, V12, P489, DOI 10.1097/00041433-200110000-00003; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Mencarelli A, 2009, AM J PHYSIOL-HEART C, V296, pH272, DOI 10.1152/ajpheart.01075.2008; MILLER NE, 1974, LANCET, V2, P929; Mooser V, 2003, AIDS, V17, pS65, DOI 10.1097/00002030-200304001-00009; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Riddle TM, 2001, J BIOL CHEM, V276, P37514, DOI 10.1074/jbc.M104557200; Sato O, 2002, J BIOL CHEM, V277, P15703, DOI 10.1074/jbc.M110158200; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Stein JH, 2007, NEW ENGL J MED, V356, P1773, DOI 10.1056/NEJMe078037; Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yeni P, 2006, J HEPATOL, V44, pS100, DOI 10.1016/j.jhep.2005.11.021; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhou HP, 2005, MOL PHARMACOL, V68, P690, DOI 10.1124/mol.105.012898; Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200	45	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13238	10.1371/journal.pone.0013238	http://dx.doi.org/10.1371/journal.pone.0013238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949026	gold, Green Submitted, Green Published			2022-12-27	WOS:000282676700012
J	Du, QS; Wang, CH; Liao, SM; Huang, RB				Du, Qi-Shi; Wang, Cheng-Hua; Liao, Si-Ming; Huang, Ri-Bo			Correlation Analysis for Protein Evolutionary Family Based on Amino Acid Position Mutations and Application in PDZ Domain	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; STRESS-RESPONSE; INFORMATION; DETERMINANTS; RECOGNITION; ACTIVATION; CATALYSIS; PATHWAYS; RESIDUES; RECEPTOR	Background: It has been widely recognized that the mutations at specific directions are caused by the functional constraints in protein family and the directional mutations at certain positions control the evolutionary direction of the protein family. The mutations at different positions, even distantly separated, are mutually coupled and form an evolutionary network. Finding the controlling mutative positions and the mutative network among residues are firstly important for protein rational design and enzyme engineering. Methodology: A computational approach, namely amino acid position conservation-mutation correlation analysis (CMCA), is developed to predict mutually mutative positions and find the evolutionary network in protein family. The amino acid position mutative function, which is the foundational equation of CMCA measuring the mutation of a residue at a position, is derived from the MSA (multiple structure alignment) database of protein evolutionary family. Then the position conservation correlation matrix and position mutation correlation matrix is constructed from the amino acid position mutative equation. Unlike traditional SCA (statistical coupling analysis) approach, which is based on the statistical analysis of position conservations, the CMCA focuses on the correlation analysis of position mutations. Conclusions: As an example the CMCA approach is used to study the PDZ domain of protein family, and the results well illustrate the distantly allosteric mechanism in PDZ protein family, and find the functional mutative network among residues. We expect that the CMCA approach may find applications in protein engineering study, and suggest new strategy to improve bioactivities and physicochemical properties of enzymes.	[Du, Qi-Shi; Wang, Cheng-Hua; Liao, Si-Ming; Huang, Ri-Bo] Guangxi Acad Sci, State Key Lab Bioenergy Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China; [Du, Qi-Shi; Liao, Si-Ming; Huang, Ri-Bo] Guangxi Univ, Life Sci & Biotechnol Coll, Nanning 530004, Guangxi, Peoples R China; [Wang, Cheng-Hua; Huang, Ri-Bo] Nanjing Univ Technol, Nanjing 210009, Jiangsu, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, San Diego, CA USA	Guangxi University; Nanjing Tech University	Du, QS (corresponding author), Guangxi Acad Sci, State Key Lab Bioenergy Enzyme Technol, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Guangxi, Peoples R China.	qishi_du@yahoo.com.cn			National Program on Key Basic Research Project (973 Program) of China [2009CB724703]; Guangxi key laboratory of Biorefinery [07-109-001A]; National Science Foundation of China (NSFC) [30970562]	National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China); Guangxi key laboratory of Biorefinery; National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Program on Key Basic Research Project (973 Program) of China under the project 2009CB724703, by the Guangxi key laboratory of Biorefinery under the project 07-109-001A, and by the National Science Foundation of China (NSFC) under the project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood SX, 2007, J CELL SCI, V120, P3200, DOI 10.1242/jcs.014902; Bauler TJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004014; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Boxus M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-76; Cabral JHM, 1996, NATURE, V382, P649, DOI 10.1038/382649a0; Carmena A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000066; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Coleman SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008715; Daniels DL, 1998, NAT STRUCT BIOL, V5, P317, DOI 10.1038/nsb0498-317; Di Cera E, 2004, CR BIOL, V327, P1065, DOI 10.1016/j.crvi.2004.07.011; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Dutheil J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-242; Galtier N., 2007, V3, P1, DOI 10.1159/000107599; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Hatley ME, 2003, P NATL ACAD SCI USA, V100, P14445, DOI 10.1073/pnas.1835919100; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; Kaczanowski S, 2010, THEOR CHEM ACC, V125, P643, DOI 10.1007/s00214-009-0656-3; Kurakin A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000953; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Mishra P, 2007, CELL, V131, P80, DOI 10.1016/j.cell.2007.07.037; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ozkan E, 2005, P NATL ACAD SCI USA, V102, P18890, DOI 10.1073/pnas.0509418102; Peterson FC, 2004, MOL CELL, V13, P665, DOI 10.1016/S1097-2765(04)00086-3; Ponting CP, 1997, PROTEIN SCI, V6, P464; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Schlieker C, 2004, CELL, V117, P417, DOI 10.1016/S0092-8674(04)00453-2; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Thomas MC, 2006, ELEMENTS INFORM THEO; Velthuis AJWT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000189; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4	46	7	7	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13207	10.1371/journal.pone.0013207	http://dx.doi.org/10.1371/journal.pone.0013207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949088	gold, Green Submitted, Green Published			2022-12-27	WOS:000282568400016
J	Marques, RB; Thabet, MM; White, SJ; Houwing-Duistermaat, JJ; Bakker, AM; Hendriks, GJ; Zhernakova, A; Huizinga, TW; van der Helm-van Mil, AH; Toes, RE				Marques, Rute B.; Thabet, Mohamed M.; White, Stefan J.; Houwing-Duistermaat, Jeanine J.; Bakker, Aleida M.; Hendriks, Gert-Jan; Zhernakova, Alexandra; Huizinga, Tom W.; van der Helm-van Mil, Annette H.; Toes, Rene E.			Genetic Variation of the Fc Gamma Receptor 3B Gene and Association with Rheumatoid Arthritis	PLOS ONE			English	Article							COPY-NUMBER VARIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; DEPENDENT PROBE AMPLIFICATION; HUMAN GENOME; SEGMENTAL DUPLICATIONS; DISEASE SUSCEPTIBILITY; STRUCTURAL VARIATION; POLYMORPHISMS; REARRANGEMENTS; FCGR3B	Background: Fc gamma receptors (Fc gamma Rs) play a crucial role in immunity by linking IgG antibody-mediated responses with cellular effector and regulatory functions. Genetic variants in these receptors have been previously identified as risk factors for several chronic inflammatory conditions. The present study aimed to investigate the presence of copy number variations (CNVs) in the FCGR3B gene and its potential association with the autoimmune disease rheumatoid arthritis (RA). Methodology/Principal Findings: CNV of the FCGR3B gene was studied using Multiplex Ligation Dependent Probe Amplification (MLPA) in 518 Dutch RA patients and 304 healthy controls. Surprisingly, three independent MLPA probes targeting the FCGR3B promoter measured different CNV frequencies, with probe#1 and #2 measuring 0 to 5 gene copies and probe#3 showing little evidence of CNV. Quantitative-PCR correlated with the copy number results from MLPA probe#2, which detected low copy number (1 copy) in 6.7% and high copy number (>= 3 copies) in 9.4% of the control population. No significant difference was observed between RA patients and the healthy controls, neither in the low copy nor the high copy number groups (p-values = 0.36 and 0.71, respectively). Sequencing of the FCGR3B promoter region revealed an insertion/deletion (indel) that explained the disparate CNV results of MLPA probe#1. Finally, a non-significant trend was found between the novel -256A>TG indel and RA (40.7% in healthy controls versus 35.9% in RA patients; P = 0.08). Conclusions/Significance: The current study highlights the complexity and poor characterization of the FCGR3B gene sequence, indicating that the design and interpretation of genotyping assays based on specific probe sequences must be performed with caution. Nonetheless, we confirmed the presence of CNV and identified novel polymorphisms in the FCGR3B gene in the Dutch population. Although no association was found between RA and FCGR3B CNV, the possible protective effect of the -256A>TG indel polymorphism must be addressed in larger studies.	[Marques, Rute B.; Thabet, Mohamed M.; Bakker, Aleida M.; Hendriks, Gert-Jan; Zhernakova, Alexandra; Huizinga, Tom W.; van der Helm-van Mil, Annette H.; Toes, Rene E.] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Thabet, Mohamed M.] Assiut Univ Hosp, Dept Internal Med, Assiut, Egypt; [White, Stefan J.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Houwing-Duistermaat, Jeanine J.] Leiden Univ, Med Ctr, Dept Med Stat, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Egyptian Knowledge Bank (EKB); Assiut University; Murdoch Children's Research Institute; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Marques, RB (corresponding author), Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands.	r.b.marques@lumc.nl	Houwing-Duistermaat, Jeanne/V-9048-2018; Zhernakova, Alexandra/ABA-9372-2020	Hendriks, Gert-Jan/0000-0001-8798-1443; van der Helm - van Mil, Annette/0000-0001-8572-1437; Toes, Rene/0000-0002-9618-6414; Houwing-Duistermaat, Jeanine/0000-0002-4505-7137; Zhernakova, Alexandra/0000-0002-4574-0841	Dutch Organisation for Scientific Research; Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (NGI); Dutch Arthritis Association; European Union-funded FP7-integrated project Masterswitch [223404]	Dutch Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Centre for Medical Systems Biology (CMSB); Netherlands Genomics Initiative (NGI); Dutch Arthritis Association; European Union-funded FP7-integrated project Masterswitch	The work published in this manuscript was supported through the Dutch Organisation for Scientific Research (VICI grant), the Centre for Medical Systems Biology (CMSB) within the framework of the Netherlands Genomics Initiative (NGI), the Dutch Arthritis Association (Reumafonds grant) and the European Union-funded FP7-integrated project Masterswitch no. 223404. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Aten E, 2008, CYTOGENET GENOME RES, V123, P313, DOI 10.1159/000184723; Bournazos S, 2009, CLIN EXP IMMUNOL, V157, P244, DOI 10.1111/j.1365-2249.2009.03980.x; Brinkman BMN, 1997, BRIT J RHEUMATOL, V36, P516; Carcao MD, 2003, BRIT J HAEMATOL, V120, P135, DOI 10.1046/j.1365-2141.2003.04033.x; Chu ZT, 2004, TISSUE ANTIGENS, V63, P21, DOI 10.1111/j.1399-0039.2004.00142.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Daeron M, 1997, ANNU REV IMMUNOL, V15, P203, DOI 10.1146/annurev.immunol.15.1.203; de Jong BA, 2002, HUM IMMUNOL, V63, P281, DOI 10.1016/S0198-8859(02)00369-5; Fanciulli M, 2008, CYTOGENET GENOME RES, V123, P161, DOI 10.1159/000184704; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Janssen B, 2005, NEUROGENETICS, V6, P29, DOI 10.1007/s10048-004-0204-1; Kyogoku C, 2002, ARTHRITIS RHEUM, V46, P1242, DOI 10.1002/art.10257; Kyogoku C, 2002, GENES IMMUN, V3, P488, DOI 10.1038/sj.gene.6363921; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee YH, 2008, J RHEUMATOL, V35, P2129, DOI 10.3899/jrheum.080186; Li LH, 2010, SCAND J RHEUMATOL, V39, P148, DOI 10.3109/03009740903292304; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Mamtani M, 2010, GENES IMMUN, V11, P155, DOI 10.1038/gene.2009.71; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McKinney C, 2008, ANN RHEUM DIS, V67, P409, DOI 10.1136/ard.2007.075028; MCKINNEY C, 2010, ANN RHEUM D IN PRESS; Morgan AW, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1847; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; QIU WQ, 1990, SCIENCE, V248, P732, DOI 10.1126/science.2139735; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rooms L, 2004, HUM MUTAT, V23, P17, DOI 10.1002/humu.10300; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su K, 2002, GENES IMMUN, V3, pS51, DOI 10.1038/sj.gene.6363879; Thabet MM, 2009, ANN RHEUM DIS, V68, P1775, DOI 10.1136/ard.2008.099309; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Aken J, 2003, CLIN EXP RHEUMATOL, V21, pS100; van Sorge NM, 2003, TISSUE ANTIGENS, V61, P189, DOI 10.1034/j.1399-0039.2003.00037.x; White SJ, 2007, CYTOGENET GENOME RES, V118, P19, DOI 10.1159/000106437; White SJ, 2006, CYTOGENET GENOME RES, V115, P240, DOI 10.1159/000095920; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Williams RG, 1998, PEDIATRICS, V101, P779; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Wu YL, 2008, CYTOGENET GENOME RES, V123, P131, DOI 10.1159/000184700; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Yuan H, 2009, MOL BIOL REP, V36, P1053, DOI 10.1007/s11033-008-9280-x	57	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13173	10.1371/journal.pone.0013173	http://dx.doi.org/10.1371/journal.pone.0013173			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957197	Green Submitted, gold, Green Published			2022-12-27	WOS:000282506100011
J	Yazdanpanah, Y; Sloan, CE; Charlois-Ou, C; Le Vu, S; Semaille, C; Costagliola, D; Pillonel, J; Poullie, AI; Scemama, O; Deuffic-Burban, S; Losina, E; Walensky, RP; Freedberg, KA; Paltiel, AD				Yazdanpanah, Yazdan; Sloan, Caroline E.; Charlois-Ou, Cecile; Le Vu, Stephane; Semaille, Caroline; Costagliola, Dominique; Pillonel, Josiane; Poullie, Anne-Isabelle; Scemama, Olivier; Deuffic-Burban, Sylvie; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.; Paltiel, A. David			Routine HIV Screening in France: Clinical Impact and Cost-Effectiveness	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; UNITED-STATES; OPPORTUNISTIC INFECTIONS; LATE DIAGNOSIS; LIFETIME COST; CONSEQUENCES; TRANSMISSION; CARE; ERA	Background: In France, roughly 40,000 HIV-infected persons are unaware of their HIV infection. Although previous studies have evaluated the cost-effectiveness of routine HIV screening in the United States, differences in both the epidemiology of infection and HIV testing behaviors warrant a setting-specific analysis for France. Methods/Principal Findings: We estimated the life expectancy (LE), cost and cost-effectiveness of alternative HIV screening strategies in the French general population and high-risk sub-populations using a computer model of HIV detection and treatment, coupled with French national clinical and economic data. We compared risk-factor-based HIV testing ("current practice'') to universal routine, voluntary HIV screening in adults aged 18-69. Screening frequencies ranged from once to annually. Input data included mean age (42 years), undiagnosed HIV prevalence (0.10%), annual HIV incidence (0.01%), test acceptance (79%), linkage to care (75%) and cost/test ((sic)43). We performed sensitivity analyses on HIV prevalence and incidence, cost estimates, and the transmission benefits of ART. "Current practice'' produced LEs of 242.82 quality-adjusted life months (QALM) among HIV-infected persons and 268.77 QALM in the general population. Adding a one-time HIV screen increased LE by 0.01 QALM in the general population and increased costs by (sic)50/person, for a cost-effectiveness ratio (CER) of (sic)57,400 per quality-adjusted life year (QALY). More frequent screening in the general population increased survival, costs and CERs. Among injection drug users (prevalence 6.17%; incidence 0.17%/year) and in French Guyana (prevalence 0.41%; incidence 0.35%/year), annual screening compared to every five years produced CERs of (sic)51,200 and (sic)46,500/QALY. Conclusions/Significance: One-time routine HIV screening in France improves survival compared to "current practice'' and compares favorably to other screening interventions recommended in Western Europe. In higher-risk groups, more frequent screening is economically justifiable.	[Yazdanpanah, Yazdan] Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Yazdanpanah, Yazdan] INSERM, U995, Avenir Act Themat & Incitat Programme, F-59045 Lille, France; [Yazdanpanah, Yazdan; Semaille, Caroline] Fac Med Lille, EA 2694, F-59045 Lille, France; [Sloan, Caroline E.; Losina, Elena; Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Charlois-Ou, Cecile] Ctr Natl Rech Sci, CRESGE LEM, UMR8179, Lille, France; [Le Vu, Stephane; Semaille, Caroline; Pillonel, Josiane] Inst Veille Sanitaire, Dept Infect Dis, HIV AIDS STI HCV Unit, St Maurice, France; [Costagliola, Dominique] INSERM, U943, Paris, France; [Costagliola, Dominique] INSERM, UMR S 943, Paris, France; [Costagliola, Dominique] Univ Paris 06, Paris, France; [Costagliola, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Malad Infect & Trop, F-75634 Paris, France; [Poullie, Anne-Isabelle; Scemama, Olivier] Haute Autorite Sante, Econ & Publ Hlth Assessment Dept, St Denis, France; [Deuffic-Burban, Sylvie] INSERM, U995, Fac Med Lille, F-59045 Lille, France; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Losina, Elena; Freedberg, Kenneth A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Losina, Elena] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Walensky, Rochelle P.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Walensky, Rochelle P.; Freedberg, Kenneth A.] Harvard Univ, Sch Med, Ctr AIDS Res, Boston, MA USA; [Paltiel, A. David] Yale Univ, Sch Med, New Haven, CT USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Centre National de la Recherche Scientifique (CNRS); Institute of Public Health Surveillance; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Yale University	Yazdanpanah, Y (corresponding author), Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France.	yyazdan@yahoo.com	Costagliola, Dominique/H-5849-2011; Deuffic-Burban, Sylvie/O-3293-2017	Costagliola, Dominique/0000-0003-0765-0869; Deuffic-Burban, Sylvie/0000-0003-3241-7647; Le Vu, Stephane/0000-0002-1303-8281; Walensky, Rochelle P./0000-0002-8795-379X; Sloan, Caroline/0000-0003-1611-3846; Losina, ELENA/0000-0002-3424-0892; Paltiel, A. David/0000-0002-4861-3290	Haute Autorite de Sante; Institut de Veille Sanitaire, Sidaction; Agence Nationale de Recherches sur le SIDA et les hepatites virales; National Institute of Allergy and Infectious Diseases [R01 AI042006, K24 AI062476, P30 AI42851]; National Institute of Mental Health [R01 MH65869]; National Institute on Drug Abuse [R01 DA015612]; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck-Sharp Dohme-Chibret; Pfizer; Roche; Schering Plough; Tibotec; Abbott; Janssen-Cilag; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042006, K24AI062476, P30AI042851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Haute Autorite de Sante; Institut de Veille Sanitaire, Sidaction; Agence Nationale de Recherches sur le SIDA et les hepatites virales(ANRSFrench National Research Agency (ANR)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck-Sharp Dohme-Chibret(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); Tibotec; Abbott(Abbott Laboratories); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the Haute Autorite de Sante, the Institut de Veille Sanitaire, Sidaction, the Agence Nationale de Recherches sur le SIDA et les hepatites virales, the National Institute of Allergy and Infectious Diseases (R01 AI042006, K24 AI062476, P30 AI42851), the National Institute of Mental Health (R01 MH65869), and the National Institute on Drug Abuse (R01 DA015612). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With the exception of Yazdan Yazdanpanah and Dominique Costagliola, none of the authors report any association that might pose a conflict of interest (e. g. pharmaceutical stock ownership, consultancy, advisory board membership, relevant patents, or research funding). Dr. Yazdanpanah has received travel grants, consultancy fees and honoraria for presentation at workshops from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck-Sharp & Dohme-Chibret, Pfizer, Roche, Schering Plough and Tibotec. Dominique Costagliola has received travel grants, consultancy fees, honoraria and study grants from various pharmaceutical companies including Abbott, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead Sciences, Glaxo-SmithKline, Janssen-Cilag, Merck-Sharp & Dohme-Chibret and Roche.	Adams EJ, 2007, SEX TRANSM INFECT, V83, DOI 10.1136/sti.2006.024364; [Anonymous], 1992, FRENCH HOSP DATABASE; [Anonymous], 2009, GUID US ANT AG HIV 1; Arveux P, 2003, EUR J CANCER CARE, V12, P143, DOI 10.1046/j.1365-2354.2003.00373.x; Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bartlett JG, 2008, JAMA-J AM MED ASSOC, V300, P945, DOI 10.1001/jama.300.8.945; Borghi V, 2008, JAIDS-J ACQ IMM DEF, V49, P282, DOI 10.1097/QAI.0b013e318186eabc; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; *CAISS NAT ASS MAL, 2008, NOM GEN ACT BIOL MED; Castilla J, 2002, AIDS, V16, P1945, DOI 10.1097/00002030-200209270-00012; CAZEIN F, 2008, B EPIDEMIOL HEBD, V45, P434; CAZEIN F, 2009, B EPIDEMIOLOGIQUE HE; Coco A, 2005, ANN FAM MED, V3, P391, DOI 10.1370/afm.375; Cole SR, 2003, AM J EPIDEMIOL, V158, P687, DOI 10.1093/aje/kwg206; Conseil national du sida, 2006, RAPP EV DISP DEP INF; Conseil National du Sida, 2008, EP INF VIH GUYAN PRO; DESENCLOS JC, 2005, BEH, V11, P41; Deuffic-Burban S, 2006, EUR J EPIDEMIOL, V21, P389, DOI 10.1007/s10654-006-9003-3; Dybul M, 2002, J INFECT DIS, V185, P1818, DOI 10.1086/340650; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Girardi E, 2004, JAIDS-J ACQ IMM DEF, V36, P951, DOI 10.1097/00126334-200408010-00009; Girardi E, 2007, JAIDS-J ACQ IMM DEF, V46, pS3, DOI 10.1097/01.qai.0000286597.57066.2b; Gold R, 1996, COST EFFECTIVENESS H; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Hamers FF, 2008, HIV MED, V9, P6, DOI 10.1111/j.1468-1293.2008.00584.x; *I NAT STAT ET EC, 2006, TABL 6 POP TOT SEX A; *I NAT STAT ET EC, 2008, EFF PROF SANT; *I RECH DOC EC SAN, 2007, DEP SANT; *I VEILL SAN, 2007, B EPIDEMIOLOGIQUE HE, P46; *I VEILL SANT, 2006, SURV HIV AIDS INF FR; Jauffret Roustide M, 2006, B EPIDEMIOLOGIQUE HE, V33, P244; Johnson M, 2005, AIDS, V19, P685, DOI 10.1097/01.aids.0000166091.39317.99; Kim JJ, 2005, JNCI-J NATL CANCER I, V97, P888, DOI 10.1093/jnci/dji162; Lanoy E, 2007, ANTIVIR THER, V12, P89; Lejeune C, 2004, INT J TECHNOL ASSESS, V20, P434, DOI 10.1017/S0266462304001321; LEVU S, 2003, 2010 POPULATION BASE; Lewden C, 2006, EPIDEMIOL INFECT, V134, P1345, DOI 10.1017/S095026880600639X; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; MORTIER E, 2002, B EPIDEMIOLOGIQUE HE, V1, P2; Mounier-Jack S, 2008, HIV MED, V9, P13, DOI 10.1111/j.1468-1293.2008.00585.x; NDAWINZ J, 2009, ESTIMATION INC UNPUB; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 1998, MED DECIS MAKING, V18, pS93, DOI 10.1177/0272989X9801800211; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; RICHETMASTAIN L, I NATL STAT ETUDES E; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schackman BR, 2002, MED DECIS MAKING, V22, P27, DOI 10.1177/02729890222062892; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Siegel JE, 1996, JAMA-J AM MED ASSOC, V276, P1339, DOI 10.1001/jama.276.16.1339; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P797, DOI 10.1111/j.1365-2893.2008.01008.x; UNAIDS, UNAIDS REP GLOB AIDS; Weill A, 2006, PRAT ORG SOINS, V37, P173; Weinstein MC, 2001, ANN INTERN MED, V134, P440, DOI 10.7326/0003-4819-134-6-200103200-00008; *WHO, 2005, LIF TABL WHO MEMB ST; World Health Organization, 2001, MACR HLTH INV HLTH E; Yazdanpanah Y, 2002, ANTIVIR THER, V7, P257; Yazdanpanah Y, 2003, CLIN INFECT DIS, V36, P86, DOI 10.1086/344902; Yazdanpanah Y, 2001, INT J EPIDEMIOL, V30, P864, DOI 10.1093/ije/30.4.864; Yeni P, 2008, PRISE CHARGE MED PER; ASSURANCE MALADIE LI	62	83	85	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13132	10.1371/journal.pone.0013132	http://dx.doi.org/10.1371/journal.pone.0013132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20976112	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300023
J	Sharp, TM; Guix, S; Katayama, K; Crawford, SE; Estes, MK				Sharp, Tyler M.; Guix, Susana; Katayama, Kazuhiko; Crawford, Sue E.; Estes, Mary K.			Inhibition of Cellular Protein Secretion by Norwalk Virus Nonstructural Protein p22 Requires a Mimic of an Endoplasmic Reticulum Export Signal	PLOS ONE			English	Article							POLIOVIRUS 3A; TRANSPORT; COPII; REPLICATION; NOROVIRUS; ER; COMPLEX; RNA; GASTROENTERITIS; TRAFFICKING	Protein trafficking between the endoplasmic reticulum ( ER) and Golgi apparatus is central to cellular homeostasis. ER export signals are utilized by a subset of proteins to rapidly exit the ER by direct uptake into COPII vesicles for transport to the Golgi. Norwalk virus nonstructural protein p22 contains a YX Phi ESDG motif that mimics a di-acidic ER export signal in both sequence and function. However, unlike normal ER export signals, the ER export signal mimic of p22 is necessary for apparent inhibition of normal COPII vesicle trafficking, which leads to Golgi disassembly and antagonism of Golgi-dependent cellular protein secretion. This is the first reported function for p22. Disassembly of the Golgi apparatus was also observed in cells replicating Norwalk virus, which may contribute to pathogenesis by interfering with cellular processes that are dependent on an intact secretory pathway. These results indicate that the ER export signal mimic is critical to the antagonistic function of p22, shown herein to be a novel antagonist of ER/Golgi trafficking. This unique and well-conserved human norovirus motif is therefore an appealing target for antiviral drug development.	[Sharp, Tyler M.; Guix, Susana; Katayama, Kazuhiko; Crawford, Sue E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Katayama, Kazuhiko] Natl Inst Infect Dis, Tokyo, Japan	Baylor College of Medicine; National Institute of Infectious Diseases (NIID)	Sharp, TM (corresponding author), Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA 30333 USA.	mestes@bcm.edu	Guix, Susana/D-4318-2014	Guix, Susana/0000-0002-1588-3198; Katayama, Kazuhiko/0000-0002-7692-1151	National Institutes of Health (NIH) [P01 AI057788, T32 AI04741, S10RR024574, AI036211]; National Science Foundation [7316]; John S. Dunn Gulf Coast Consortium for Chemical Genomics; SCCPR [U54 HD-007495, P30 DK-56338, P30 CA-125123]; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI057788, P30AI036211] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); John S. Dunn Gulf Coast Consortium for Chemical Genomics; SCCPR; Dan L. Duncan Cancer Center of Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Public Health Service grants from the National Institutes of Health (NIH) P01 AI057788 (MKE) and T32 AI04741 (TMS), and by the East Asia and Pacific Summer Institute grant 7316 (TMS) from the National Science Foundation. Microscopy equipment support was from the John S. Dunn Gulf Coast Consortium for Chemical Genomics (MA Mancini). Additional funding for imaging was provided by SCCPR U54 HD-007495 (BW O'Malley), P30 DK-56338 (MKE), P30 CA-125123 (CK Osborne), and the Dan L. Duncan Cancer Center of Baylor College of Medicine. This project was supported by the BCM Cytometry and Cell Sorting Core with funding from the NIH (National Center for Research Resources grant S10RR024574 and National Institute of Allergy and Infectious Diseases AI036211). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Bailey D, 2010, J GEN VIROL, V91, P739, DOI 10.1099/vir.0.016279-0; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; BERG L, 1988, CHEM ENG COMMUN, V66, P1, DOI 10.1080/00986448808940257; Beske O, 2007, J CELL SCI, V120, P3207, DOI 10.1242/jcs.03483; Blanton LH, 2006, J INFECT DIS, V193, P413, DOI 10.1086/499315; Budnik A, 2009, FEBS LETT, V583, P3796, DOI 10.1016/j.febslet.2009.10.038; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Chang KO, 2006, VIROLOGY, V353, P463, DOI 10.1016/j.virol.2006.06.006; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Choe SS, 2005, VIROLOGY, V337, P18, DOI 10.1016/j.virol.2005.03.036; Cornell CT, 2006, J VIROL, V80, P6637, DOI 10.1128/JVI.02572-05; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; Doedens JR, 1997, J VIROL, V71, P9054, DOI 10.1128/JVI.71.12.9054-9064.1997; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; Estes MK, 2006, CURR OPIN INFECT DIS, V19, P467, DOI 10.1097/01.qco.0000244053.69253.3d; Ettayebi K, 2003, J VIROL, V77, P11790, DOI 10.1128/JVI.77.21.11790-11797.2003; Fernandez-Vega V, 2004, J VIROL, V78, P4827, DOI 10.1128/JVI.78.9.4827-4837.2004; Fujita K, 2007, BIOCHEMISTRY-US, V46, P5185, DOI 10.1021/bi6024758; Gilpatrick SG, 2000, J VIROL METHODS, V90, P69, DOI 10.1016/S0166-0934(00)00220-2; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; GLASS RI, 2009, NEW ENGL J MED, V361, P50; Green K, 2007, FIELDS VIROLOGY, P949; Green KY, 2002, J VIROL, V76, P8582, DOI 10.1128/JVI.76.17.8582-8595.2002; Guix S, 2009, CELLULAR SIGNALING AND INNATE IMMUNE RESPONSES TO RNA VIRUS INFECTIONS, P389; Guix S, 2007, J VIROL, V81, P12238, DOI 10.1128/JVI.01489-07; Hardy ME, 2005, FEMS MICROBIOL LETT, V253, P1, DOI 10.1016/j.femsle.2005.08.031; Hyde JL, 2009, J VIROL, V83, P9709, DOI 10.1128/JVI.00600-09; Kim J, 2007, CELL HOST MICROBE, V2, P160, DOI 10.1016/j.chom.2007.07.010; Konan KV, 2003, J VIROL, V77, P7843, DOI 10.1128/JVI.77.14.7843-7855.2003; Lev S, 2008, TRENDS CELL BIOL, V18, P282, DOI 10.1016/j.tcb.2008.03.006; MATSUI SM, 1991, J CLIN INVEST, V87, P1456, DOI 10.1172/JCI115152; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Nakamura N, 1998, MOL BIOL CELL, V9, P3493, DOI 10.1091/mbc.9.12.3493; Neznanov N, 2001, J VIROL, V75, P10409, DOI 10.1128/JVI.75.21.10409-10420.2001; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; Paulhe F, 2004, J BIOL CHEM, V279, P55545, DOI 10.1074/jbc.M407813200; Persico A, 2009, FEBS LETT, V583, P3857, DOI 10.1016/j.febslet.2009.10.077; Polishchuk RS, 2009, FEBS LETT, V583, P3847, DOI 10.1016/j.febslet.2009.10.031; Rismanchi N, 2009, TRAFFIC, V10, P201, DOI 10.1111/j.1600-0854.2008.00856.x; Rost B, 1996, PROTEIN SCI, V5, P1704, DOI 10.1002/pro.5560050824; Saraste J, 2009, FEBS LETT, V583, P3804, DOI 10.1016/j.febslet.2009.10.084; Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7; SCHEKMAN R, 1994, FASEB J, V8, pA1379; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Siebenga JJ, 2007, EMERG INFECT DIS, V13, P144; Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233; Tang BL, 2005, BBA-MOL CELL RES, V1744, P293, DOI 10.1016/j.bbamcr.2005.02.007; Teterina NL, 1997, VIROLOGY, V237, P66, DOI 10.1006/viro.1997.8775; TISDALE EJ, 1992, J CELL BIOL, V119, P749, DOI 10.1083/jcb.119.4.749; Wessels E, 2007, J VIROL, V81, P5238, DOI 10.1128/JVI.02680-06; Wessels E, 2006, J VIROL, V80, P11852, DOI 10.1128/JVI.01225-06; Wessels E, 2006, DEV CELL, V11, P191, DOI 10.1016/j.devcel.2006.06.005; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432; Zaal KJM, 1999, CELL, V99, P589, DOI 10.1016/S0092-8674(00)81548-2; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	60	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13130	10.1371/journal.pone.0013130	http://dx.doi.org/10.1371/journal.pone.0013130			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976190	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300003
J	Sotnikova, TD; Beaulieu, JM; Espinoza, S; Masri, B; Zhang, XD; Salahpour, A; Barak, LS; Caron, MG; Gainetdinov, RR				Sotnikova, Tatyana D.; Beaulieu, Jean-Martin; Espinoza, Stefano; Masri, Bernard; Zhang, Xiaodong; Salahpour, Ali; Barak, Larry S.; Caron, Marc G.; Gainetdinov, Raul R.			The Dopamine Metabolite 3-Methoxytyramine Is a Neuromodulator	PLOS ONE			English	Article							CATECHOL-O-METHYLTRANSFERASE; MONOAMINE-OXIDASE; PARKINSONS-DISEASE; IN-VIVO; PHARMACOLOGICAL CHARACTERIZATION; TRACE AMINES; RAT-BRAIN; AMPHETAMINE; RELEASE; RECEPTORS	Dopamine (3-hydroxytyramine) is a well-known catecholamine neurotransmitter involved in multiple physiological functions including movement control. Here we report that the major extracellular metabolite of dopamine, 3-methoxytyramine (3-MT), can induce behavioral effects in a dopamine-independent manner and these effects are partially mediated by the trace amine associated receptor 1 (TAAR1). Unbiased in vivo screening of putative trace amine receptor ligands for potential effects on the movement control revealed that 3-MT infused in the brain is able to induce a complex set of abnormal involuntary movements in mice acutely depleted of dopamine. In normal mice, the central administration of 3-MT caused a temporary mild hyperactivity with a concomitant set of abnormal movements. Furthermore, 3-MT induced significant ERK and CREB phosphorylation in the mouse striatum, signaling events generally related to PKA-mediated cAMP accumulation. In mice lacking TAAR1, both behavioral and signaling effects of 3-MT were partially attenuated, consistent with the ability of 3-MT to activate TAAR1 receptors and cause cAMP accumulation as well as ERK and CREB phosphorylation in cellular assays. Thus, 3-MT is not just an inactive metabolite of DA, but a novel neuromodulator that in certain situations may be involved in movement control. Further characterization of the physiological functions mediated by 3-MT may advance understanding of the pathophysiology and pharmacology of brain disorders involving abnormal dopaminergic transmission, such as Parkinson's disease, dyskinesia and schizophrenia.	[Sotnikova, Tatyana D.; Espinoza, Stefano; Gainetdinov, Raul R.] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Sotnikova, Tatyana D.; Masri, Bernard; Salahpour, Ali; Barak, Larry S.; Caron, Marc G.; Gainetdinov, Raul R.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Beaulieu, Jean-Martin] CRULRG Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada; [Masri, Bernard] Fac Med Toulouse, INSERM, I2MR U858, F-31073 Toulouse, France; [Zhang, Xiaodong] Duke Natl Univ Singapore, Grad Sch Med, Neurosci & Behav Disorders Program, Singapore, Singapore; [Salahpour, Ali] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	Istituto Italiano di Tecnologia - IIT; Duke University; Laval University; Institut National de la Sante et de la Recherche Medicale (Inserm); National University of Singapore; University of Toronto	Sotnikova, TD (corresponding author), Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy.	raul.gainetdinov@iit.it	Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011; Beaulieu, Jean-Martin/A-7598-2008; Masri, Bernard/N-9856-2018	Gainetdinov, Raul R/0000-0003-2951-6038; Beaulieu, Jean-Martin/0000-0002-0446-7447; Masri, Bernard/0000-0002-4027-2604; Espinoza, Stefano/0000-0002-3048-4822	National Institutes of Health [NS-19576, 1UO1-DA022950]; Michael J. Fox Foundation for Parkinson's Research; Natural Sciences and Engineering Research Council of Canada (NSERC); NARSAD; Singapore Ministry of Education [T208A3126]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA022950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation for Parkinson's Research; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NARSAD(NARSAD); Singapore Ministry of Education(Ministry of Education, Singapore); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported in part by National Institutes of Health grants NS-19576 and 1UO1-DA022950 to Marc G. Caron and research grants from the Michael J. Fox Foundation for Parkinson's Research to Raul R. Gainetdinov. Jean-Martin Beaulieu is supported by a discovery grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) and he is NARSAD Vital Projects Fund, Inc. Investigator and holds a Canada research Chair in Molecular Psychiatry. Xiaodong Zhang is supported by NARSAD Young Investigator Award and Singapore Ministry of Education T208A3126 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alachkar A, 2010, NEUROSCI RES, V67, P245, DOI 10.1016/j.neures.2010.03.008; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Antkiewicz-Michaluk L, 2008, EUR J PHARMACOL, V599, P32, DOI 10.1016/j.ejphar.2008.09.033; Apud JA, 2007, CNS DRUGS, V21, P535, DOI 10.2165/00023210-200721070-00002; BAKER WW, 1976, ARCH INT PHARMACOD T, V223, P271; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2006, J BIOL CHEM, V281, P32072, DOI 10.1074/jbc.M606062200; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787; Borowsky B, 2001, P NATL ACAD SCI USA, V98, P8966, DOI 10.1073/pnas.151105198; BROWN EE, 1991, J NEUROCHEM, V57, P701, DOI 10.1111/j.1471-4159.1991.tb03802.x; Bunzow JR, 2001, MOL PHARMACOL, V60, P1181, DOI 10.1124/mol.60.6.1181; CARLSSON A, 1958, SCIENCE, V127, P471, DOI 10.1126/science.127.3296.471; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Charlton CG, 2000, LIFE SCI, V66, P2159, DOI 10.1016/S0024-3205(00)00543-9; D'Souza UM, 2008, PROG BRAIN RES, V172, P73, DOI 10.1016/S0079-6123(08)00904-7; Diatchenko L, 2006, PAIN, V125, P216, DOI 10.1016/j.pain.2006.05.024; DILL RE, 1973, RES COMMUN CHEM PATH, V6, P975; Elverfors A, 1997, J NEUROCHEM, V69, P1684; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GARRIS PA, 1995, SYNAPSE, V20, P269, DOI 10.1002/syn.890200311; Girault JA, 2007, CURR OPIN PHARMACOL, V7, P77, DOI 10.1016/j.coph.2006.08.012; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Gizer IR, 2009, HUM GENET, V126, P51, DOI 10.1007/s00439-009-0694-x; Grandy DK, 2007, PHARMACOL THERAPEUT, V116, P355, DOI 10.1016/j.pharmthera.2007.06.007; Haavik J, 2008, HUM MUTAT, V29, P891, DOI 10.1002/humu.20700; Hu LYA, 2009, BIOCHEM J, V424, P39, DOI 10.1042/BJ20090998; JONAS W, 1969, ARCH INT PHARMACOD T, V177, P379; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; KATO T, 1986, J NEUROCHEM, V46, P1277, DOI 10.1111/j.1471-4159.1986.tb00650.x; KEHR W, 1981, J NEURAL TRANSM, V50, P165, DOI 10.1007/BF01249138; Lenders JWM, 1996, J CLIN INVEST, V97, P1010, DOI 10.1172/JCI118492; Lindemann L, 2005, TRENDS PHARMACOL SCI, V26, P274, DOI 10.1016/j.tips.2005.03.007; Mannisto PT, 1999, PHARMACOL REV, V51, P593; MANNISTO PT, 1992, BRIT J PHARMACOL, V105, P569; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Mori S, 2003, J CEREBR BLOOD F MET, V23, P432, DOI 10.1097/01.WCB.0000050062.57184.75; MUSKIET FAJ, 1979, CLIN CHEM, V25, P453; Nakazato T, 2002, EUR J PHARMACOL, V442, P73, DOI 10.1016/S0014-2999(02)01495-4; Nakazato T, 2002, BRAIN RES, V930, P134, DOI 10.1016/S0006-8993(02)02238-2; NAPOLITANO A, 1995, EUR J PHARMACOL, V273, P215, DOI 10.1016/0014-2999(94)00682-W; Osborne RH, 1996, PHARMACOL THERAPEUT, V69, P117, DOI 10.1016/0163-7258(95)02054-3; Rajput AH, 2004, PARKINSONISM RELAT D, V10, P221, DOI 10.1016/j.parkreldis.2004.01.004; Roeder T, 2005, ANNU REV ENTOMOL, V50, P447, DOI 10.1146/annurev.ento.50.071803.130404; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Shih JC, 1999, AM J HUM GENET, V65, P593, DOI 10.1086/302562; SIIRTOLA T, 1975, CLIN NEUROL NEUROSUR, V78, P77, DOI 10.1016/S0303-8467(75)80014-X; Sotnikova TD, 2006, NEUROLOGY, V67, pS12, DOI 10.1212/WNL.67.7_suppl_2.S12; Sotnikova TD, 2009, MOL PHARMACOL, V76, P229, DOI 10.1124/mol.109.055970; Sotnikova Tatyana D, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS99, DOI 10.1016/j.parkreldis.2008.04.006; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; VULTO AG, 1986, J NEUROCHEM, V47, P1387, DOI 10.1111/j.1471-4159.1986.tb00769.x; Wainscott DB, 2007, J PHARMACOL EXP THER, V320, P475, DOI 10.1124/jpet.106.112532; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; WESTERINK BHC, 1982, J NEUROCHEM, V38, P342, DOI 10.1111/j.1471-4159.1982.tb08634.x; WESTERINK BHC, 1982, J NEUROCHEM, V38, P680, DOI 10.1111/j.1471-4159.1982.tb08685.x; WOLINSKY TD, 2006, GENES BRAIN BEHAV; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	64	64	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13452	10.1371/journal.pone.0013452	http://dx.doi.org/10.1371/journal.pone.0013452			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976142	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300024
J	Bandaranayake, D; Huang, QS; Bissielo, A; Wood, T; Mackereth, G; Baker, MG; Beasley, R; Reid, S; Roberts, S; Hope, V				Bandaranayake, Don; Huang, Q. Sue; Bissielo, Ange; Wood, Tim; Mackereth, Graham; Baker, Michael G.; Beasley, Richard; Reid, Stewart; Roberts, Sally; Hope, Virginia		2009 H1N1 Serosurvey Invest Team	Risk Factors and Immunity in a Nationally Representative Population following the 2009 Influenza A(H1N1) Pandemic	PLOS ONE			English	Article							A H1N1; ANTIBODY; VIRUS; INFECTION; VACCINE; VOLUNTEERS; PROTECTION; CHALLENGE; SERUM	Background: Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling. Methods and Findings: We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand. Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region. Baseline immunity was measured from 521 sera collected during 2004 to April-2009. Haemagglutination inhibition (HI) antibody titres of >= 1:40 against 2009 H1N1 were considered seroprotective as well as seropositive. The overall community seroprevalence was 26.7% (CI: 22.6-29.4). The seroprevalence varied across age and ethnicity. Children aged 5-19 years had the highest seroprevalence (46.7%; CI: 38.3-55.0), a significant increase from the baseline (14%; CI: 7.2-20.8). Older adults aged >= 60 had no significant difference in seroprevalence between the serosurvey (24.8%; CI: 18.7-30.9) and baseline (22.6%; CI: 15.3-30.0). Pacific peoples had the highest seroprevalence (49.5%; CI: 35.1-64.0). There was no significant difference in seroprevalence between both primary (29.6%; CI: 22.6-36.5) and secondary healthcare workers (25.3%; CI: 20.8-29.8) and community participants. No significant regional variation was observed. Multivariate analysis indicated age as the most important risk factor followed by ethnicity. Previous seasonal influenza vaccination was associated with higher HI titres. Approximately 45.2% of seropositive individuals reported no symptoms. Conclusions: Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1. Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three. Older people were protected due to pre-existing immunity. Age was the most important factor associated with infection followed by ethnicity. Healthcare workers did not appear to have an increased risk of infection compared with the general population.	[Bandaranayake, Don; Huang, Q. Sue; Bissielo, Ange; Wood, Tim; Hope, Virginia] Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand; [Mackereth, Graham] Minist Hlth, Wellington, New Zealand; [Baker, Michael G.] Univ Otago, Wellington Sch Med, Wellington, New Zealand; [Beasley, Richard] Wellington Hosp, Med Res Inst New Zealand, Wellington, New Zealand; [Reid, Stewart] Ropata Med Ctr, Lower Hutt, New Zealand; [Roberts, Sally] Auckland Dist Hlth Board, Dept Microbiol, Auckland, New Zealand	Institute of Environmental Science & Research (ESR) - New Zealand; University of Otago; Medical Research Institute Of New Zealand; Auckland District Health Board	Bandaranayake, D (corresponding author), Natl Ctr Biosecur & Infect Dis, Inst Environm Sci & Res, Upper Hutt, New Zealand.	sue.huang@esr.cri.nz	Beasley, Richard/AAH-3908-2019	Beasley, Richard/0000-0003-0337-406X; Best, Emma/0000-0002-2667-5458; Huang, Q. Sue/0000-0002-3923-5195; Barr, Ian/0000-0002-7351-418X; Peacey, Matthew/0000-0002-4312-8085	New Zealand Ministry of Health	New Zealand Ministry of Health	This study was funded by the New Zealand Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker J, 2009, WIRES NANOMED NANOBI, V1, P1, DOI 10.1002/wnan.32; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P435; CHAN M, 2009, SWINE INFLUENZA STAT; Chan YJ, 2010, J CHIN MED ASSOC, V73, P62, DOI 10.1016/S1726-4901(10)70003-4; Chen MIC, 2010, JAMA-J AM MED ASSOC, V303, P1383, DOI 10.1001/jama.2010.404; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Gargiullo P., 2009, Morbidity and Mortality Weekly Report, V58, P1241; GREENBERG SB, 1974, AM J EPIDEMIOL, V100, P209, DOI 10.1093/oxfordjournals.aje.a112029; Grills N, 2010, AUST NZ J PUBL HEAL, V34, P228, DOI 10.1111/j.1753-6405.2010.00518.x; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Huang Q. S., 2009, Morbidity and Mortality Weekly Report, V58, P918; Iuliano AD, 2009, CLIN INFECT DIS, V49, P1811, DOI 10.1086/649555; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; Kendal AP, 1982, CONCEPTS PROCEDURES; La Ruche G, 2009, EURO SURVEILL, V14; LARSON HE, 1978, J HYG-CAMBRIDGE, V80, P243, DOI 10.1017/S0022172400053596; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; LOPEZ L, INFL NZ 2009; MILLER E, 2010, LANCET, P62126, DOI DOI 10.1016/S0140-6736(09); Paine S, 2010, EURO SURVEILL, V15; PEREIRA MS, 1972, BMJ-BRIT MED J, V4, P701, DOI 10.1136/bmj.4.5842.701; POTTER CW, 1977, J INFECT DIS, V135, P423, DOI 10.1093/infdis/135.3.423; POTTER CW, 1977, J HYG-CAMBRIDGE, V79, P321, DOI 10.1017/S0022172400053158; POTTER CW, 1979, BRIT MED BULL, V35, P69, DOI 10.1093/oxfordjournals.bmb.a071545; ROSS T, 2010, PLOS CURR INFLUENZA; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; *WHO, WHO SWIN INFL UPD 3; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	31	82	82	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13211	10.1371/journal.pone.0013211	http://dx.doi.org/10.1371/journal.pone.0013211			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976224	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000001
J	Williams, R; Khan, IM; Richardson, K; Nelson, L; McCarthy, HE; Analbelsi, T; Singhrao, SK; Dowthwaite, GP; Jones, RE; Baird, DM; Lewis, H; Roberts, S; Shaw, HM; Dudhia, J; Fairclough, J; Briggs, T; Archer, CW				Williams, Rebecca; Khan, Ilyas M.; Richardson, Kirsty; Nelson, Larissa; McCarthy, Helen E.; Analbelsi, Talal; Singhrao, Sim K.; Dowthwaite, Gary P.; Jones, Rhiannon E.; Baird, Duncan M.; Lewis, Holly; Roberts, Selwyn; Shaw, Hannah M.; Dudhia, Jayesh; Fairclough, John; Briggs, Timothy; Archer, Charles W.			Identification and Clonal Characterisation of a Progenitor Cell Sub-Population in Normal Human Articular Cartilage	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; IN-VITRO CHONDROGENESIS; HUMAN BONE-MARROW; STROMAL CELLS; MONOLAYER-CULTURE; TELOMERE LENGTH; SURFACE-MARKERS; GENE-EXPRESSION; TISSUE	Background: Articular cartilage displays a poor repair capacity. The aim of cell-based therapies for cartilage defects is to repair damaged joint surfaces with a functional replacement tissue. Currently, chondrocytes removed from a healthy region of the cartilage are used but they are unable to retain their phenotype in expanded culture. The resulting repair tissue is fibrocartilaginous rather than hyaline, potentially compromising long-term repair. Mesenchymal stem cells, particularly bone marrow stromal cells (BMSC), are of interest for cartilage repair due to their inherent replicative potential. However, chondrocyte differentiated BMSCs display an endochondral phenotype, that is, can terminally differentiate and form a calcified matrix, leading to failure in long-term defect repair. Here, we investigate the isolation and characterisation of a human cartilage progenitor population that is resident within permanent adult articular cartilage. Methods and Findings: Human articular cartilage samples were digested and clonal populations isolated using a differential adhesion assay to fibronectin. Clonal cell lines were expanded in growth media to high population doublings and karyotype analysis performed. We present data to show that this cell population demonstrates a restricted differential potential during chondrogenic induction in a 3D pellet culture system. Furthermore, evidence of high telomerase activity and maintenance of telomere length, characteristic of a mesenchymal stem cell population, were observed in this clonal cell population. Lastly, as proof of principle, we carried out a pilot repair study in a goat in vivo model demonstrating the ability of goat cartilage progenitors to form a cartilage-like repair tissue in a chondral defect. Conclusions: In conclusion, we propose that we have identified and characterised a novel cartilage progenitor population resident in human articular cartilage which will greatly benefit future cell-based cartilage repair therapies due to its ability to maintain chondrogenicity upon extensive expansion unlike full-depth chondrocytes that lose this ability at only seven population doublings.	[Williams, Rebecca; Khan, Ilyas M.; Richardson, Kirsty; Nelson, Larissa; McCarthy, Helen E.; Analbelsi, Talal; Singhrao, Sim K.; Dowthwaite, Gary P.; Shaw, Hannah M.; Archer, Charles W.] Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales; [Lewis, Holly; Roberts, Selwyn] Univ Wales Hosp, Dept Cytogenet, Cardiff CF4 4XW, S Glam, Wales; [Jones, Rhiannon E.; Baird, Duncan M.] Cardiff Univ, Dept Pathol, Cardiff, S Glam, Wales; [Dudhia, Jayesh] Royal Vet Coll, Dept Vet Clin Sci, N Mymms, England; [Fairclough, John] Univ Wales Hosp, Dept Orthopaed, Cardiff CF4 4XW, S Glam, Wales; [Briggs, Timothy] Royal Natl Orthopaed Hosp, Stanmore HA7 4LP, Middx, England	Cardiff University; Cardiff University; Cardiff University; University of London; University of London Royal Veterinary College; Cardiff University; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Williams, R (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Cardiff, S Glam, Wales.	archer@cf.ac.uk	Baird, Duncan M/C-9671-2011; Williams, Richard/B-8344-2011	Baird, Duncan M/0000-0001-8408-5467; Williams, Richard/0000-0001-8847-3213; Dudhia, Jayesh/0000-0002-2503-697X; Williams, Rebecca/0000-0003-2168-7369; Khan, Ilyas/0000-0002-3886-1987	Arthritis Research Council [17642]; AO Foundation, Davos, Switzerland	Arthritis Research Council; AO Foundation, Davos, Switzerland	The grant was funded by the Arthritis Research Council (www.arc.org.uk) Project Grant 17642. The caprine in vitro studies were funded by the AO Foundation, Davos, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ND, 2009, BBA-MOL BASIS DIS, V1792, P324, DOI 10.1016/j.bbadis.2009.02.004; Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; ARCHER CW, 1994, J ANAT, V184, P447; ARCHER CW, 1982, CELL DIFFER DEV, V11, P245, DOI 10.1016/0045-6039(82)90072-0; Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; BOYLE T, 2001, HUMAN CYTOGENETICS C, P55; Brittberg M., 1998, ICRS NEWSLETTER, V1; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Connelly JT, 2008, OSTEOARTHR CARTILAGE, V16, P1092, DOI 10.1016/j.joca.2008.01.004; Cournil-Henrionnet C, 2008, BIORHEOLOGY, V45, P513, DOI 10.3233/BIR-2008-0487; CRAIG FM, 1987, DEVELOPMENT, V99, P383; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; de la Fuente R, 2004, EXP CELL RES, V297, P313, DOI 10.1016/j.yexcr.2004.02.026; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; Diaz-Romero J, 2008, J CELL PHYSIOL, V214, P75, DOI 10.1002/jcp.21161; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Grogan SP, 2007, ARTHRITIS RHEUM-US, V56, P586, DOI 10.1002/art.22408; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hayes AJ, 2001, ANAT EMBRYOL, V203, P469, DOI 10.1007/s004290100178; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6; Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Karlsson C, 2008, CELLS TISSUES ORGANS, V187, P275, DOI 10.1159/000113409; Khan IM, 2007, CURR TOP DEV BIOL, V79, P1, DOI 10.1016/S0070-2153(06)79001-9; Khan IM, 2009, OSTEOARTHR CARTILAGE, V17, P518, DOI 10.1016/j.joca.2008.08.002; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; KOLETTAS E, 1995, J CELL SCI, V108, P1991; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Li Y, 2004, TISSUE ENG, V10, P575, DOI 10.1089/107632704323061933; Mareddy S, 2007, TISSUE ENG, V13, P819, DOI 10.1089/ten.2006.0180; Martin JA, 2002, J GERONTOL A-BIOL, V57, pB48, DOI 10.1093/gerona/57.2.B48; Martin JA, 2001, J GERONTOL A-BIOL, V56, pB172, DOI 10.1093/gerona/56.4.B172; Montesinos JJ, 2009, CYTOTHERAPY, V11, P163, DOI 10.1080/14653240802582075; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Peterson L, 2000, CLIN ORTHOP RELAT R, P212, DOI 10.1097/00003086-200005000-00020; RADA T, 2009, TISSUE ENG B; Roberts S, 2003, ARTHRITIS RES THER, V5, pR60, DOI 10.1186/ar613; ROONEY G, 2009, TISSUE ENG A    0331; Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482; SEABRIGHT M, 1972, CHROMOSOMA, V36, P204; SINGHRAO S, 2009, IMMUNOFLUORESCENCE M; TIGLI RS, 2009, J TISSUE ENG REGEN M; Tuan RS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2310; Tuli R, 2003, ARTHRITIS RES THER, V5, P235, DOI 10.1186/ar991; Vidal MA, 2008, VET SURG, V37, P713, DOI 10.1111/j.1532-950X.2008.00462.x; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447; WATT FM, 1988, DIFFERENTIATION, V38, P140, DOI 10.1111/j.1432-0436.1988.tb00208.x; Wolf F, 2008, EUR CELLS MATER, V16, P92, DOI 10.22203/eCM.v016a10; Yang R, 2003, Eur Cell Mater, V6, P57; Yang XC, 2007, J TISSUE ENG REGEN M, V1, P128, DOI 10.1002/term.13	61	191	200	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13246	10.1371/journal.pone.0013246	http://dx.doi.org/10.1371/journal.pone.0013246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976230	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000282941000003
J	Hu, LJ; Lind, T; Sundqvist, A; Jacobson, A; Melhus, K				Hu, Lijuan; Lind, Thomas; Sundqvist, Anders; Jacobson, Annica; Melhus, Hakan			Retinoic Acid Increases Proliferation of Human Osteoclast Progenitors and Inhibits RANKL-Stimulated Osteoclast Differentiation by Suppressing RANK	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; BONE-MINERAL DENSITY; KAPPA-B LIGAND; VITAMIN-A; ALL-TRANS; RECEPTOR ACTIVATOR; IN-VITRO; REGULATES RANKL; PRECURSOR CELLS; RESORPTION	It has been shown that high vitamin A intake is associated with bone fragility and fractures in both animals and humans. However, the mechanism by which vitamin A affects bones is unclear. In the present study, the direct effects of retinoic acid (RA) on human and murine osteoclastogenesis were evaluated using cultured peripheral blood CD14(+) monocytes and RAW264.7 cells. Both the activity of the osteoclast marker tartrate resistant acid phosphatase (TRAP) in culture supernatant and the expression of the genes involved in osteoclast differentiation together with bone resorption were measured. To our knowledge, this is the first time that the effects of RA on human osteoclast progenitors and mature osteoclasts have been studied in vitro. RA stimulated proliferation of osteoclast progenitors both from humans and mice. In contrast, RA inhibited differentiation of the receptor activator of nuclear factor kappa B ligand (RANKL)-induced osteoclastogenesis of human and murine osteoclast progenitors via retinoic acid receptors (RARs). We also show that the mRNA levels of receptor activator of nuclear factor kappa B (RANK), the key initiating factor and osteoclast associated receptor for RANKL, were potently suppressed by RA in osteoclast progenitors. More importantly, RA abolished the RANK protein in osteoclast progenitors. This inhibition could be partially reversed by a RAR pan-antagonist. Furthermore, RA treatment suppressed the expression of the transcription factor nuclear factor of activated T-cells cytoplasmic 1 (NFATc1) and increased the expression of interferon regulatory factor-8 (IRF-8) in osteoclast progenitors via RARs. Also, RA demonstrated differential effects depending on the material supporting the cell culture. RA did not affect TRAP activity in the culture supernatant in the bone slice culture system, but inhibited the release of TRAP activity if cells were cultured on plastic. In conclusion, our results suggest that retinoic acid increases proliferation of human osteoclast progenitors and that it inhibits RANK-stimulated osteoclast differentiation by suppressing RANK.	[Hu, Lijuan; Lind, Thomas; Sundqvist, Anders; Jacobson, Annica; Melhus, Hakan] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University	Hu, LJ (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.			Rasmusson, Annica/0000-0002-7228-7755; Lind, Thomas/0000-0003-2791-688X	Swedish Research Council; Swedish Society of Medicine	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine	This work was supported by The Swedish Research Council (HM and GA) and The Swedish Society of Medicine (TL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Barnicot N, 1956, BIOCHEMISTRY PHYSIOL, P507; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Colucci S, 1996, BIOCHEM BIOPH RES CO, V227, P47, DOI 10.1006/bbrc.1996.1465; Conaway HH, 2009, FASEB J, V23, P3526, DOI 10.1096/fj.09-132548; Conaway HH, 1997, J ENDOCRINOL, V155, P513, DOI 10.1677/joe.0.1550513; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Day CJ, 2004, J CELL BIOCHEM, V91, P303, DOI 10.1002/jcb.10780; DELVA L, 1993, BLOOD, V82, P2175; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Fuller K, 2006, ENDOCRINOLOGY, V147, P1979, DOI 10.1210/en.2005-1340; Ishimi Y, 1999, J CLIN BIOCHEM NUTR, V27, P113; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; Ji JD, 2009, J IMMUNOL, V183, P7223, DOI 10.4049/jimmunol.0900072; KAJI H, 1995, LIFE SCI, V56, P1903, DOI 10.1016/0024-3205(95)00165-3; Karsdal MA, 2003, J BIOL CHEM, V278, P44975, DOI 10.1074/jbc.M303905200; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; Kirstein B, 2006, J CELL BIOCHEM, V98, P1085, DOI 10.1002/jcb.20835; Kneissel M, 2005, BONE, V36, P202, DOI 10.1016/j.bone.2004.11.006; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lerner UH, 2004, CRIT REV ORAL BIOL M, V15, P64, DOI 10.1177/154411130401500202; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Melhus H, 2003, NUTR ASPECTS BONE HL, P369; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; MUINDI J, 1992, BLOOD, V79, P299; NAKAJIMA H, 1994, BLOOD, V84, P4107, DOI 10.1182/blood.V84.12.4107.bloodjournal84124107; Nakashima T, 2008, ARCH BIOCHEM BIOPHYS, V473, P166, DOI 10.1016/j.abb.2008.04.004; ONEILL RPJ, 1992, BONE, V13, P23, DOI 10.1016/8756-3282(92)90357-3; OREFFO ROC, 1988, J BONE MINER RES, V3, P203; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; Ross FP, 2005, IMMUNOL REV, V208, P88, DOI 10.1111/j.0105-2896.2005.00331.x; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; Sorensen MG, 2007, J BONE MINER METAB, V25, P36, DOI 10.1007/s00774-006-0725-9; SPORN MB, 1975, NATURE, V253, P47, DOI 10.1038/253047a0; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; WALSH CA, 1991, J BONE MINER RES, V6, P661; Wang XX, 2002, J BONE MINER RES, V17, P91, DOI 10.1359/jbmr.2002.17.1.91; WOODS C, 1995, ENDOCRINOLOGY, V136, P85, DOI 10.1210/en.136.1.85; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yonezawa T, 2007, BIOCHEM BIOPH RES CO, V355, P10, DOI 10.1016/j.bbrc.2006.12.237; Zhao BH, 2009, NAT MED, V15, P1066, DOI 10.1038/nm.2007; Zhou DC, 2002, BLOOD, V99, P1356, DOI 10.1182/blood.V99.4.1356	50	43	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13305	10.1371/journal.pone.0013305	http://dx.doi.org/10.1371/journal.pone.0013305			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949013	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100029
J	Jain, A; Fuller, S; Backus, BT				Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.			Absence of Cue-Recruitment for Extrinsic Signals: Sounds, Spots, and Swirling Dots Fail to Influence Perceived 3D Rotation Direction after Training	PLOS ONE			English	Article							MOTION; INTEGRATION; PERCEPTION; STIMULI; DRIVEN; FIELD; AREA	The visual system can learn to use information in new ways to construct appearance. Thus, signals such as the location or translation direction of an ambiguously rotating wire frame cube, which are normally uninformative, can be learned as cues to determine the rotation direction [1]. This perceptual learning occurs when the formerly uninformative signal is statistically associated with long-trusted visual cues (such as binocular disparity) that disambiguate appearance during training. In previous demonstrations, the newly learned cue was intrinsic to the perceived object, in that the signal was conveyed by the same image elements as the object itself. Here we used extrinsic new signals and observed no learning. We correlated three new signals with long-trusted cues in the rotating cube paradigm: one crossmodal (an auditory signal) and two within modality (visual). Cue recruitment did not occur in any of these conditions, either in single sessions or in ten sessions across as many days. These results suggest that the intrinsic/extrinsic distinction is important for the perceptual system in determining whether it can learn and use new information from the environment to construct appearance. Extrinsic cues do have perceptual effects (e.g. the "bounce-pass'' illusion [2] and McGurk effect [3]), so we speculate that extrinsic signals must be recruited for perception, but only if certain conditions are met. These conditions might specify the age of the observer, the strength of the long-trusted cues, or the amount of exposure to the correlation.	[Jain, Anshul; Fuller, Stuart; Backus, Benjamin T.] SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA	State University of New York (SUNY) System; SUNY Optometry	Jain, A (corresponding author), SUNY Coll Optometry, Grad Ctr Vis Res, New York, NY 10010 USA.	ajain@sunyopt.edu			Human Frontier Science Program [RPG 2006/3]; National Science Foundation [BCS-0617422]; National Institutes of Health [EY-013988]; NATIONAL EYE INSTITUTE [R01EY013988] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Human Frontier Science Program grant RPG 2006/3, National Science Foundation grant BCS-0617422 and National Institutes of Health grant EY-013988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backus BT, 2007, VISION RES, V47, P919, DOI 10.1016/j.visres.2006.12.008; Backus BT, 2009, J VISION, V9, DOI 10.1167/9.1.6; BRUNSWIK E, 1956, PERCEPTION REPRESENT, P92; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; EBY DW, 1989, PERCEPTION, V18, P427, DOI 10.1068/p180427; Ernst MO, 2007, J VISION, V7, DOI 10.1167/7.5.7; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; Freeman ED, 2006, VISION RES, V46, P4007, DOI 10.1016/j.visres.2006.07.008; Garcia J, 1966, PSYCHON SCI, V4, P123, DOI [10.3758/BF03342209, DOI 10.3758/BF03342209]; Geisler WS, 2002, PHILOS T R SOC B, V357, P419, DOI 10.1098/rstb.2001.1055; Georgeson MA, 2009, VISION RES, V49, P84, DOI 10.1016/j.visres.2008.09.030; Gilroy LA, 2004, NAT NEUROSCI, V7, P921, DOI 10.1038/nn1297; Harrison S, 2010, J ADVENTURE EDUC OUT, V10, P3, DOI 10.1080/14729671003669321; HARRISON SJ, 2010, VISION RES; Hebb Donald O., 1949, ORG BEHAV; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; Klink PC, 2008, J VISION, V8, DOI 10.1167/8.5.16; Klink PC, 2009, J VISION, V9, DOI 10.1167/9.10.20; Leopold DA, 2002, NAT NEUROSCI, V5, P605, DOI 10.1038/nn0602-851; Long GM, 2007, PERCEPTION, V36, P431, DOI 10.1068/p5630; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; Meyer GF, 2005, EXP BRAIN RES, V166, P538, DOI 10.1007/s00221-005-2394-7; Michel MM, 2007, J VISION, V7, DOI 10.1167/7.1.4; Noest AJ, 2007, J VISION, V7, DOI 10.1167/7.8.10; Pastukhov A, 2008, J VISION, V8, DOI 10.1167/8.13.7; Pavlov I. P., 1928, LECT CONDITIONED REF; PICK HL, 1969, PERCEPT PSYCHOPHYS, V6, P203, DOI 10.3758/BF03207017; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; SAITO H, 1986, J NEUROSCI, V6, P145; SCHOUPS AA, 1995, J PHYSIOL-LONDON, V483, P797, DOI 10.1113/jphysiol.1995.sp020623; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Sinha P, 1996, NATURE, V384, P460, DOI 10.1038/384460a0; Spillmann L, 1996, TRENDS NEUROSCI, V19, P428; Sundareswara R, 2008, J VISION, V8, DOI 10.1167/8.5.12; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; van der Burg E, 2008, J VISION, V8, DOI 10.1167/8.5.2; VONHELMHOLTZ H, 1910, TREATISE PHYSIOLOGIC, V3; WATANABE T, 1995, VISION RES, V35, P2853, DOI 10.1016/0042-6989(95)00064-7	43	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13295	10.1371/journal.pone.0013295	http://dx.doi.org/10.1371/journal.pone.0013295			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949047	Green Submitted, gold, Green Published			2022-12-27	WOS:000282676700022
J	Konar, B; Iken, K; Cruz-Motta, JJ; Benedetti-Cecchi, L; Knowlton, A; Pohle, G; Miloslavich, P; Edwards, M; Trott, T; Kimani, E; Riosmena-Rodriguez, R; Wong, M; Jenkins, S; Silva, A; Pinto, IS; Shirayama, Y				Konar, Brenda; Iken, Katrin; Cruz-Motta, Juan Jose; Benedetti-Cecchi, Lisandro; Knowlton, Ann; Pohle, Gerhard; Miloslavich, Patricia; Edwards, Matt; Trott, Thomas; Kimani, Edward; Riosmena-Rodriguez, Rafael; Wong, Melisa; Jenkins, Stuart; Silva, Angelica; Pinto, Isabel Sousa; Shirayama, Yoshihisa			Current Patterns of Macroalgal Diversity and Biomass in Northern Hemisphere Rocky Shores	PLOS ONE			English	Article							SPECIES-DIVERSITY; ZONATION PATTERNS; PHYTOGEOGRAPHIC CHARACTERIZATION; LATITUDINAL GRADIENT; MARINE; RICHNESS; BIODIVERSITY; COMMUNITIES; ASSEMBLAGES; VARIABILITY	Latitudinal gradients in species abundance and diversity have been postulated for nearshore taxa but few analyses have been done over sufficiently broad geographic scales incorporating various nearshore depth strata to empirically test these gradients. Typically, gradients are based on literature reviews and species lists and have focused on alpha diversity across the entire nearshore zone. No studies have used a standardized protocol in the field to examine species density among sites across a large spatial scale while also focusing on particular depth strata. The present research used field collected samples in the northern hemisphere to explore the relationships between macroalgal species density and biomass along intertidal heights and subtidal depths and latitude. Results indicated no overall correlations between either estimates of species density or biomass with latitude, although the highest numbers of both were found at mid-latitudes. However, when strata were examined separately, significant positive correlations were found for both species numbers and biomass at particular strata, namely the intertidal ones. While the data presented in this paper have some limitations, we show that latitudinal macroalgal trends in species density and biomass do exist for some strata in the northern hemisphere with more taxa and biomass at higher latitudes.	[Konar, Brenda; Iken, Katrin; Knowlton, Ann] Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA; [Cruz-Motta, Juan Jose] Univ Simon Bolivar, Ctr Biodiversidad Marina, Dept Estudios Ambientales, Caracas, Venezuela; [Benedetti-Cecchi, Lisandro; Miloslavich, Patricia] Univ Pisa, Dept Biol, CoNISMa, Pisa, Italy; [Pohle, Gerhard] Huntsman Marine Sci Ctr, Atlantic Reference Ctr, St Andrews, NB, Canada; [Edwards, Matt] San Diego State Univ, Coll Sci, Dept Biol, San Diego, CA 92182 USA; [Trott, Thomas] Suffolk Univ, Dept Biol, Boston, MA 02114 USA; [Kimani, Edward] Kenya Marine & Fisheries Res Inst, Mombasa, Kenya; [Riosmena-Rodriguez, Rafael] Univ Autonoma Baja California Sur, Dept Biol Marina, Programa Invest Bot Marina, La Paz, Baja California, Mexico; [Wong, Melisa; Silva, Angelica] Fisheries & Oceans Canada, Bedford Inst Oceanog, Dartmouth, NS B2Y 4A2, Canada; [Jenkins, Stuart] Bangor Univ, Sch Ocean Sci, Anglesey, Wales; [Pinto, Isabel Sousa] Univ Porto, Ctr Marine & Environm Res, CIIMAR CIMAR, P-4100 Oporto, Portugal; [Shirayama, Yoshihisa] Kyoto Univ, Seto Marine Biol Lab, Wakayama, Japan	University of Alaska System; University of Alaska Fairbanks; Simon Bolivar University; CoNISMa; University of Pisa; California State University System; San Diego State University; Suffolk University; Universidad Autonoma de Baja California; Bedford Institute of Oceanography; Fisheries & Oceans Canada; Bangor University; Universidade do Porto; Kyoto University	Konar, B (corresponding author), Univ Alaska Fairbanks, Sch Fisheries & Ocean Sci, Fairbanks, AK 99775 USA.	bkonar@guru.uaf.edu	Pinto, Isabel Sousa/W-1591-2019; Trott, Thomas J/N-4660-2018; Benedetti-Cecchi, Lisandro/J-8225-2019; Silva, Angelica J/GRO-4906-2022; Jenkins, Stuart/D-2032-2010	Pinto, Isabel Sousa/0000-0002-9231-0553; Trott, Thomas J/0000-0002-1851-5243; Benedetti-Cecchi, Lisandro/0000-0001-5244-5202; Miloslavich, Patricia/0000-0001-5409-1401; Jenkins, Stuart/0000-0002-2299-6318; Cruz Motta, Juan Jose/0000-0001-6117-9014	Alfred P. Sloan Foundation; Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program; Alaska Sea Grant; South African Environmental Observation Network (SAEON); University of Pisa; Italian Ministry of Education and Research; History of Marine Populations (HMAP); Nippon Foundation; Marine Biodiversity and Ecosystem Functioning Program (MarBEF); Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Department of Fisheries and Oceans Canada; Suffolk University; History of the Near Shore (HNS) program; Gulf of Maine (GoMA) project	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program(Exxon Mobil Corporation); Alaska Sea Grant; South African Environmental Observation Network (SAEON)(National Research Foundation - South Africa); University of Pisa; Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); History of Marine Populations (HMAP); Nippon Foundation(Nippon Foundation); Marine Biodiversity and Ecosystem Functioning Program (MarBEF); Coastal Biodiversity Lab (Cimar); West Indian Ocean Marine Science Association (WIOMSA); Department of Fisheries and Oceans Canada; Suffolk University; History of the Near Shore (HNS) program; Gulf of Maine (GoMA) project	Funding was provided by multiple sources, including the Alfred P. Sloan Foundation, the Exxon Valdez Oil Spill Gulf Ecosystem Monitoring Program, Alaska Sea Grant, the South African Environmental Observation Network (SAEON), the University of Pisa, the Italian Ministry of Education and Research, the History of Marine Populations (HMAP), the Nippon Foundation, the Marine Biodiversity and Ecosystem Functioning Program (MarBEF), the Coastal Biodiversity Lab (Cimar), the West Indian Ocean Marine Science Association (WIOMSA), the Department of Fisheries and Oceans Canada, Suffolk University, the History of the Near Shore (HNS) program, and the Gulf of Maine (GoMA) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEEM AA, 1973, BOT MAR, V16, P83, DOI 10.1515/botm.1973.16.2.83; [Anonymous], 2001, PLANT STRATEGIES VEG; Arenas F, 2009, MAR ECOL PROG SER, V381, P99, DOI 10.3354/meps07950; Blanchette CA, 2008, J BIOGEOGR, V35, P1593, DOI 10.1111/j.1365-2699.2008.01913.x; BOLTON JJ, 1994, BOT MAR, V37, P241, DOI 10.1515/botm.1994.37.3.241; Bustamante RH, 1997, S AFR J MARINE SCI, V18, P119; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Crain CM, 2006, BIOSCIENCE, V56, P211; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; GAINES SD, 1982, ANNU REV ECOL SYST, V13, P111, DOI 10.1146/annurev.es.13.110182.000551; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; GOUGH L, 1994, OIKOS, V70, P271, DOI 10.2307/3545638; Gray JS, 2000, J EXP MAR BIOL ECOL, V250, P23, DOI 10.1016/S0022-0981(00)00178-7; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; GRIME JP, 1973, J ENVIRON MANAGE, V1, P151; Hillebrand H, 2004, MAR ECOL PROG SER, V273, P251, DOI 10.3354/meps273251; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 2004, DIVERS DISTRIB, V10, P167, DOI 10.1111/j.1366-9516.2004.00083.x; Ingolfsson A, 2005, J BIOGEOGR, V32, P169, DOI 10.1111/j.1365-2699.2004.01150.x; Kerswell AP, 2006, ECOLOGY, V87, P2479, DOI 10.1890/0012-9658(2006)87[2479:GBPOBM]2.0.CO;2; Konar B, 2009, MAR ECOL-EVOL PERSP, V30, P63, DOI 10.1111/j.1439-0485.2008.00259.x; MARKAGER S, 1992, MAR ECOL PROG SER, V88, P83, DOI 10.3354/meps088083; Norton TA, 1996, PHYCOLOGIA, V35, P308, DOI 10.2216/i0031-8884-35-4-308.1; Okuda T, 2004, POPUL ECOL, V46, P159, DOI 10.1007/s10144-004-0185-9; PIANKA ER, 1966, AM NAT, V100, P33, DOI 10.1086/282398; PIELOU EC, 1977, J BIOGEOGR, V4, P299, DOI 10.2307/3038189; Price ARG, 2006, MAR ECOL PROG SER, V319, P85, DOI 10.3354/meps319085; RIGBY PR, 2007, SAMPLING DIVERSITY C; Rivadeneira MM, 2002, MAR ECOL PROG SER, V245, P123, DOI 10.3354/meps245123; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Roy K, 2000, P ROY SOC B-BIOL SCI, V267, P293, DOI 10.1098/rspb.2000.0999; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; SANDERS HL, 1968, AM NAT, V102, P243, DOI 10.1086/282541; Sanford Eric, 2009, P357; SANTELICES B, 1980, PHYCOLOGIA, V19, P1, DOI 10.2216/i0031-8884-19-1-1.1; Santelices B, 2000, REV CHIL HIST NAT, V73, P605; Santelices B, 2009, MARINE MACROECOLOGY, P153, DOI DOI 10.7208/CHICAGO/9780226904146.003.0006; SANTELICES B, 1991, ECOSYSTEMS WORLD, V24, P347; Santelices Bernabe, 1998, Diversity and Distributions, V4, P71, DOI 10.1046/j.1472-4642.1998.00005.x; Scrosati R, 2007, MAR ECOL PROG SER, V342, P1, DOI 10.3354/meps342001; Silva Paul C., 1992, Pacific Science, V46, P429; SOUSA WP, 1979, ECOLOGY, V60, P1225, DOI 10.2307/1936969; STEHLI FG, 1967, GEOL SOC AM BULL, V78, P455, DOI 10.1130/0016-7606(1967)78[455:TDORBA]2.0.CO;2; Thorson G., 1957, TREATISE MARINE ECOL, V67, P461, DOI DOI 10.1130/MEM67V1-P461; Valentine James W., 2009, P3; VANDENHOEK C, 1982, BIOL J LINN SOC, V18, P81; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; Witman JD, 2004, P NATL ACAD SCI USA, V101, P15664, DOI 10.1073/pnas.0404300101; Witman JD, MARINE MACROECOLOGY	52	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13195	10.1371/journal.pone.0013195	http://dx.doi.org/10.1371/journal.pone.0013195			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949030	Green Published, gold			2022-12-27	WOS:000208952200004
J	Yu, H; Liu, FF; Ramesh, BP				Yu, Hong; Liu, Feifan; Ramesh, Balaji Polepalli			Automatic Figure Ranking and User Interfacing for Intelligent Figure Search	PLOS ONE			English	Article							MASS-SPECTROMETRY; RERANKING; EXPRESSION; MODELS; ENGINE	Background: Figures are important experimental results that are typically reported in full-text bioscience articles. Bioscience researchers need to access figures to validate research facts and to formulate or to test novel research hypotheses. On the other hand, the sheer volume of bioscience literature has made it difficult to access figures. Therefore, we are developing an intelligent figure search engine (http://figuresearch.askhermes.org). Existing research in figure search treats each figure equally, but we introduce a novel concept of "figure ranking'': figures appearing in a full-text biomedical article can be ranked by their contribution to the knowledge discovery. Methodology/Findings: We empirically validated the hypothesis of figure ranking with over 100 bioscience researchers, and then developed unsupervised natural language processing (NLP) approaches to automatically rank figures. Evaluating on a collection of 202 full-text articles in which authors have ranked the figures based on importance, our best system achieved a weighted error rate of 0.2, which is significantly better than several other baseline systems we explored. We further explored a user interfacing application in which we built novel user interfaces (UIs) incorporating figure ranking, allowing bioscience researchers to efficiently access important figures. Our evaluation results show that 92% of the bioscience researchers prefer as the top two choices the user interfaces in which the most important figures are enlarged. With our automatic figure ranking NLP system, bioscience researchers preferred the UIs in which the most important figures were predicted by our NLP system than the UIs in which the most important figures were randomly assigned. In addition, our results show that there was no statistical difference in bioscience researchers' preference in the UIs generated by automatic figure ranking and UIs by human ranking annotation. Conclusion/Significance: The evaluation results conclude that automatic figure ranking and user interfacing as we reported in this study can be fully implemented in online publishing. The novel user interface integrated with the automatic figure ranking system provides a more efficient and robust way to access scientific information in the biomedical domain, which will further enhance our existing figure search engine to better facilitate accessing figures of interest for bioscientists.	[Yu, Hong] Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA; [Yu, Hong; Liu, Feifan; Ramesh, Balaji Polepalli] Univ Wisconsin, Dept Elect Engn & Comp Sci, Milwaukee, WI 53201 USA	University of Wisconsin System; University of Wisconsin Milwaukee; University of Wisconsin System; University of Wisconsin Milwaukee	Yu, H (corresponding author), Univ Wisconsin, Dept Hlth Sci, Milwaukee, WI 53201 USA.	hongyu@uwm.edu	PADAMATI, RameshBabu/AAI-4589-2020; Liu, Feifan/D-2478-2012	PADAMATI, RameshBabu/0000-0003-0102-0049; Liu, Feifan/0000-0003-0881-6365	National Institutes of Health [5R01LM009836, 5R21RR024933]; University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024933] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009836] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Milwaukee; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funding for this study was provided by the National Institutes of Health (http://www.nih.gov/) grant 5R01LM009836 and 5R21RR024933 and the Research Growth Initiative (RGI) from University of Wisconsin-Milwaukee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 2009, AMIA ANN S P; Agarwal Shashank, 2009, BIOINFORMATICS; BARZILAY R, 1999, 37 ASS COMPUTATIONAL; Bengoechea TG, 2009, P NATL ACAD SCI USA, V106, P7870, DOI 10.1073/pnas.0901533106; Braschler M, 2004, INFORM RETRIEVAL, V7, P7, DOI 10.1023/B:INRT.0000009438.69013.fa; Charniak E., 2005, P 43 ANN M ASS COMP; Chu W, 2005, J MACH LEARN RES, V6, P1019; Chu W, 2007, NEURAL COMPUT, V19, P792, DOI 10.1162/neco.2007.19.3.792; Collins M, 2005, COMPUT LINGUIST, V31, P25, DOI 10.1162/0891201053630273; COLLINS M, 2002, P 40 ANN M ASS COMP; Collobert R, 2001, J MACH LEARN RES, V1, P143, DOI 10.1162/15324430152733142; CRAMMER K, 2001, P C NEUR INF PROC SY; DEMNERFUSHMAN D, 2009, INT J MED INFORM; Erkan G, 2004, J ARTIF INTELL RES, V22, P457, DOI 10.1613/jair.1523; Ge Y, 2009, P NATL ACAD SCI USA, V106, P12658, DOI 10.1073/pnas.0813369106; HARPELED S, 2003, ADV NEURAL INFORM PR, V15, P785; Hearst MA, 2007, BIOINFORMATICS, V23, P2196, DOI 10.1093/bioinformatics/btm301; HUANG L, 2008, P ACL; Kahn CE, 2007, AM J ROENTGENOL, V188, P1475, DOI 10.2214/AJR.06.1740; Kou ZZ, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P257; Lane AL, 2009, P NATL ACAD SCI USA, V106, P7314, DOI 10.1073/pnas.0812020106; Lane MC, 2006, J BIOL CHEM, V281, P508, DOI 10.1074/jbc.M507238200; LI L, 2007, ADV NEURAL INFORM PR, V19, P865; LI Z, 2009, FOREST RERANKING MAC; LIU F, 2010, IEEE T AUDIO SPEECH; Liu Q, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-433; LIU Y, 2008, P ICASSP, V8; MCCULLAGH P, 1980, J ROY STAT SOC B MET, V42, P109; Murphy RF, 2001, 2ND ANNUAL IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, PROCEEDINGS, P119, DOI 10.1109/BIBE.2001.974420; Papanayotou C, 2008, PLOS BIOL, V6, P109, DOI 10.1371/journal.pbio.0060002; RADEV D, 2002, P 11 INT C WORLD WID; RAFKIND B, 2006, HLT NAACL BIONLP; Rajaram S, 2003, LECT NOTES ARTIF INT, V2837, P301; ROBERTSON S, 2004, ACM CIKM; Rosset S, 2007, KNOWL INF SYST, V12, P331, DOI 10.1007/s10115-006-0037-3; SALTON G, 1975, COMMUN ACM, V18, P613, DOI 10.1145/361219.361220; SHASHUA A, 2003, ADV NEURAL INFORM PR; Shatkay H, 2006, BIOINFORMATICS, V22, pE446, DOI 10.1093/bioinformatics/btl235; SHEN L, 2004, P JOINT HLT NAACL C; Shen LB, 2005, MACH LEARN, V60, P73, DOI 10.1007/s10994-005-0918-9; Shen Libin, 2003, P CONLL 2003, P9; Xu JX, 2000, ACM T INFORM SYST, V18, P79, DOI 10.1145/333135.333138; Xu SH, 2008, BIOINFORMATICS, V24, P1968, DOI 10.1093/bioinformatics/btn340; Yan D, 2008, J BIOL CHEM, V283, P332, DOI 10.1074/jbc.M705313200; Yates R. B., 1999, MODERN INFORM RETRIE; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; YU H, 2006, HLT NAACL; Yu Hong, 2006, AMIA Annu Symp Proc, P834; Yu H, 2006, BIOINFORMATICS, V22, pE547, DOI 10.1093/bioinformatics/btl261; Yu Hong, 2009, J Biomed Discov Collab, V4, P1, DOI 10.1186/1747-5333-4-1; Zhou JX, 2009, P NATL ACAD SCI USA, V106, P7840, DOI 10.1073/pnas.0901854106; ZHOU Z, 2006, P ICASSP, V1	52	13	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e12983	10.1371/journal.pone.0012983	http://dx.doi.org/10.1371/journal.pone.0012983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949102	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700002
J	Chuck, CP; Chong, LT; Chen, C; Chow, HF; Wan, DCC; Wong, KB				Chuck, Chi-Pang; Chong, Lin-Tat; Chen, Chao; Chow, Hak-Fun; Wan, David Chi-Cheong; Wong, Kam-Bo			Profiling of Substrate Specificity of SARS-CoV 3CL(pro)	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; CORONAVIRUS 3C-LIKE PROTEASE; MAIN PROTEASE; 3CL PROTEASE; IDENTIFICATION; INHIBITORS; PROTEINASE; SEQUENCE; MECHANISM; BINDING	Background: The 3C-like protease (3CL(pro)) of severe acute respiratory syndrome-coronavirus is required for autoprocessing of the polyprotein, and is a potential target for treating coronaviral infection. Methodology/Principal Findings: To obtain a thorough understanding of substrate specificity of the protease, a substrate library of 19 x 8 variants was created by performing saturation mutagenesis on the autocleavage sequence at P5 to P3' positions. The substrate sequences were inserted between cyan and yellow fluorescent proteins so that the cleavage rates were monitored by in vitro fluorescence resonance energy transfer. The relative cleavage rate for different substrate sequences was correlated with various structural properties. P5 and P3 positions prefer residues with high beta-sheet propensity; P4 prefers small hydrophobic residues; P2 prefers hydrophobic residues without beta-branch. Gln is the best residue at P1 position, but observable cleavage can be detected with His and Met substitutions. P1' position prefers small residues, while P2' and P3' positions have no strong preference on residue substitutions. Noteworthy, solvent exposed sites such as P5, P3 and P3' positions favour positively charged residues over negatively charged one, suggesting that electrostatic interactions may play a role in catalysis. A super-active substrate, which combined the preferred residues at P5 to P1 positions, was found to have 2.8 fold higher activity than the wild-type sequence. Conclusions/Significance: Our results demonstrated a strong structure-activity relationship between the 3CL(pro) pro and its substrate. The substrate specificity profiled in this study may provide insights into a rational design of peptidomimetic inhibitors.	[Chuck, Chi-Pang; Wan, David Chi-Cheong] Chinese Univ Hong Kong, Sch Biochem Sci, Sha Tin, Hong Kong, Peoples R China; [Chong, Lin-Tat; Wong, Kam-Bo] Chinese Univ Hong Kong, Dept Biochem, Sha Tin, Hong Kong, Peoples R China; [Chong, Lin-Tat; Wong, Kam-Bo] Chinese Univ Hong Kong, Mol Biotechnol Programme, Sha Tin, Hong Kong, Peoples R China; [Chen, Chao; Chow, Hak-Fun] Chinese Univ Hong Kong, Dept Chem, Sha Tin, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong	Chuck, CP (corresponding author), Chinese Univ Hong Kong, Sch Biochem Sci, Sha Tin, Hong Kong, Peoples R China.	kbwong@cuhk.edu.hk	Wong, Kam-Bo/G-4258-2013; Chow, Hak-Fun/A-9925-2008; Wong, Kam-Bo/AAU-9364-2021; Wan, David C/H-3335-2014	Wong, Kam-Bo/0000-0002-6984-5373; Chow, Hak-Fun/0000-0002-7621-0851; Wong, Kam-Bo/0000-0002-6984-5373; 	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government [06060432]	Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government	This work was supported by the Research Fund for the Control of Infectious Diseases, Hong Kong SAR Government (project number: 06060432) (http://www.fhb.gov.hk/grants/english/funds/funds_rfcid/funds_rfcid_abt/funds_rfcid_abt.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaji K, 2008, BIOORGAN MED CHEM, V16, P9400, DOI 10.1016/j.bmc.2008.09.057; Bacha U, 2004, BIOCHEMISTRY-US, V43, P4906, DOI 10.1021/bi0361766; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; Chen S, 2005, ACTA PHARMACOL SIN, V26, P99, DOI 10.1111/j.1745-7254.2005.00010.x; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; Chu LHM, 2006, PROTEIN SCI, V15, P699, DOI 10.1110/ps.052007306; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Fan KQ, 2005, BIOCHEM BIOPH RES CO, V329, P934, DOI 10.1016/j.bbrc.2005.02.061; Goetz DH, 2007, BIOCHEMISTRY-US, V46, P8744, DOI 10.1021/bi0621415; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hegyi A, 2002, J GEN VIROL, V83, P595, DOI 10.1099/0022-1317-83-3-595; Hsu MF, 2005, J BIOL CHEM, V280, P31257, DOI 10.1074/jbc.M502577200; Kao RY, 2004, FEBS LETT, V576, P325, DOI 10.1016/j.febslet.2004.09.026; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee S, 2008, BIOPHYS CHEM, V134, P185, DOI 10.1016/j.bpc.2008.02.009; Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Peiris JSM, 2003, LANCET, V361, P1319, DOI 10.1016/S0140-6736(03)13077-2; Phakthanakanok K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S48; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tsui SKW, 2003, NEW ENGL J MED, V349, P187, DOI 10.1056/NEJM200307103490216; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100	26	51	51	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13197	10.1371/journal.pone.0013197	http://dx.doi.org/10.1371/journal.pone.0013197			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949131	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400012
J	Proctor, CJ; Tangeman, PJ; Ardley, HC				Proctor, Carole J.; Tangeman, Paul J.; Ardley, Helen C.			Modelling the Role of UCH-L1 on Protein Aggregation in Age-Related Neurodegeneration	PLOS ONE			English	Article							TERMINAL HYDROLASE L1; UBIQUITIN-PROTEASOME SYSTEM; MUTANT ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DEGRADATION; BRAIN; IMPAIRMENT; BIOLOGY; SBML	Overexpression of the de-ubiquitinating enzyme UCH-L1 leads to inclusion formation in response to proteasome impairment. These inclusions contain components of the ubiquitin-proteasome system and alpha-synuclein confirming that the ubiquitin-proteasome system plays an important role in protein aggregation. The processes involved are very complex and so we have chosen to take a systems biology approach to examine the system whereby we combine mathematical modelling with experiments in an iterative process. The experiments show that cells are very heterogeneous with respect to inclusion formation and so we use stochastic simulation. The model shows that the variability is partly due to stochastic effects but also depends on protein expression levels of UCH-L1 within cells. The model also indicates that the aggregation process can start even before any proteasome inhibition is present, but that proteasome inhibition greatly accelerates aggregation progression. This leads to less efficient protein degradation and hence more aggregation suggesting that there is a vicious cycle. However, proteasome inhibition may not necessarily be the initiating event. Our combined modelling and experimental approach show that stochastic effects play an important role in the aggregation process and could explain the variability in the age of disease onset. Furthermore, our model provides a valuable tool, as it can be easily modified and extended to incorporate new experimental data, test hypotheses and make testable predictions.	[Proctor, Carole J.] Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Tangeman, Paul J.; Ardley, Helen C.] St James Univ Hosp, Sect Ophthalmol & Neurosci, Leeds Inst Mol Med, Leeds, W Yorkshire, England	Newcastle University - UK; Saint James's University Hospital; University of Leeds	Proctor, CJ (corresponding author), Newcastle Univ, Ctr Integrated Syst Biol Ageing & Nutr, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	c.j.proctor@ncl.ac.uk		Proctor, Carole/0000-0002-1366-1399	Alzheimer Scotland; Alzheimer's Research Trust (UK) [ART/RF2008/3]; Research Councils (UK); Alzheimers Research UK [ART-RF2008-3] Funding Source: researchfish	Alzheimer Scotland; Alzheimer's Research Trust (UK); Research Councils (UK)(UK Research & Innovation (UKRI)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	CJP is currently funded by a Research Fellowship from Alzheimer Scotland (http://www.alzscot.org/) and the Alzheimer's Research Trust (UK) (http://www.alzheimers-research.org.uk/) (Grant Ref: ART/RF2008/3). HCA is currently funded by a Research Councils (UK) Academic Fellowship (http://www.rcuk.ac.uk/acfellow/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], BIOMODELS; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Ardley HC, 2005, FEBS LETT, V579, P571, DOI 10.1016/j.febslet.2004.12.058; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Cuervo AM, 2000, EXP GERONTOL, V35, P119, DOI 10.1016/S0531-5565(00)00075-9; DAY INM, 2001, PROGR NEURO IN PRESS; ERIKO OT, 2006, INT J CANCER, V119, P1338; Galvin JE, 2006, ACTA NEUROPATHOL, V112, P115, DOI 10.1007/s00401-006-0096-2; Gillespie CS, 2006, BIOINFORMATICS, V22, P628, DOI 10.1093/bioinformatics/btk042; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Hibi K, 1999, AM J PATHOL, V155, P711, DOI 10.1016/S0002-9440(10)65169-3; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, HUM MOL GENET, V17, P1482, DOI 10.1093/hmg/ddn037; Keller JN, 2002, AGEING RES REV, V1, P279, DOI 10.1016/S1568-1637(01)00006-X; Kirkwood TBL, 2003, NAT REV MOL CELL BIO, V4, P243, DOI 10.1038/nrm1051; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Liu C, 2007, J BIOL CHEM, V282, P14558, DOI 10.1074/jbc.M700422200; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; LOWE J, 1990, J PATHOL, V161, P153, DOI 10.1002/path.1711610210; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McNaught KS, 2003, EXP NEUROL, V179, P38, DOI 10.1006/exnr.2002.8050; Moore DJ, 2006, BIOCHEM SOC T, V34, P749, DOI 10.1042/BST0340749; Morris AM, 2009, BBA-PROTEINS PROTEOM, V1794, P375, DOI 10.1016/j.bbapap.2008.10.016; Mukaetova-Ladinska EB, 2006, MECH AGEING DEV, V127, P188, DOI 10.1016/j.mad.2005.09.014; Nishikawa K, 2003, BIOCHEM BIOPH RES CO, V304, P176, DOI 10.1016/S0006-291X(03)00555-2; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Petrucelli L, 2002, NEURON, V36, P1007, DOI 10.1016/S0896-6273(02)01125-X; Proctor CJ, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-17; Ragland M, 2009, AM J EPIDEMIOL, V170, P1344, DOI 10.1093/aje/kwp288; Setsuie R, 2007, NEUROCHEM INT, V51, P105, DOI 10.1016/j.neuint.2007.05.007; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Shoghi-Jadid K, 2005, NUCL MED BIOL, V32, P337, DOI 10.1016/j.nucmedbio.2005.02.003; Sitte N, 2000, FASEB J, V14, P1490, DOI 10.1096/fj.14.11.1490; Tan EK, 2007, HUM MUTAT, V28, P641, DOI 10.1002/humu.20507; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x; Tofaris GK, 2001, FEBS LETT, V509, P22, DOI 10.1016/S0014-5793(01)03115-5; Tseng BP, 2008, NEUROBIOL AGING, V29, P1607, DOI 10.1016/j.neurobiolaging.2007.04.014; Van Laar VS, 2009, EXP NEUROL, V218, P247, DOI 10.1016/j.expneurol.2009.03.019; Wikstrom JD, 2009, INT J BIOCHEM CELL B, V41, P1914, DOI 10.1016/j.biocel.2009.06.006; Wilkinso D.J., 2006, STOCHASTIC MODELLING; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	52	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13175	10.1371/journal.pone.0013175	http://dx.doi.org/10.1371/journal.pone.0013175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949132	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400007
J	Fasseu, M; Treton, X; Guichard, C; Pedruzzi, E; Cazals-Hatem, D; Richard, C; Aparicio, T; Daniel, F; Soule, JC; Moreau, R; Bouhnik, Y; Laburthe, M; Groyer, A; Ogier-Denis, E				Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric			Identification of Restricted Subsets of Mature microRNA Abnormally Expressed in Inactive Colonic Mucosa of Patients with Inflammatory Bowel Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; REAL-TIME PCR; ULCERATIVE-COLITIS; GENE-EXPRESSION; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; SEQUENCE VARIANTS; CANCER; PROFILES; ONSET	Background: Ulcerative Colitis (UC) and Crohn's Disease (CD) are two chronic Inflammatory Bowel Diseases (IBD) affecting the intestinal mucosa. Current understanding of IBD pathogenesis points out the interplay of genetic events and environmental cues in the dysregulated immune response. We hypothesized that dysregulated microRNA (miRNA) expression may contribute to IBD pathogenesis. miRNAs are small, non-coding RNAs which prevent protein synthesis through translational suppression or mRNAs degradation, and regulate several physiological processes. Methodology/Findings: Expression of mature miRNAs was studied by Q-PCR in inactive colonic mucosa of patients with UC (8), CD (8) and expressed relative to that observed in healthy controls (10). Only miRNAs with highly altered expression (. 5 or,0.2 -fold relative to control) were considered when Q-PCR data were analyzed. Two subsets of 14 (UC) and 23 (CD) miRNAs with highly altered expression (5.2->100 -fold and 0.05-0.19 -fold for over-and under-expression, respectively; 0.001<p<0.05) were identified in quiescent colonic mucosa, 8 being commonly dysregulated in non-inflamed UC and CD (mir-26a,-29a,-29b,-30c,-126*,-127-3p,-196a,-324-3p). Several miRNA genes with dysregulated expression co-localize with acknowledged IBD-susceptibility loci while others, (eg. clustered on 14q32.31), map on chromosomal regions not previously recognized as IBD-susceptibility loci. In addition, in silico clustering analysis identified 5 miRNAs (mir-26a,-29b,-126*,-127-3p,- 324-3p) that share coordinated dysregulation of expression both in quiescent and in inflamed colonic mucosa of IBD patients. Six miRNAs displayed significantly distinct alteration of expression in non-inflamed colonic biopsies of UC and CD patients (mir-196b,-199a-3p,-199b-5p,-320a,-150,-223). Conclusions/Significance: Our study supports miRNAs as crucial players in the onset and/or relapse of inflammation from quiescent mucosal tissues in IBD patients. It allows speculating a role for miRNAs as contributors to IBD susceptibility and suggests that some of the miRNA with altered expression in the quiescent mucosa of IBD patients may define miRNA signatures for UC and CD and help develop new diagnostic biomarkers.	[Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric] Ctr Rech Biomed Bichat Beaujon, INSERM U773, Paris, France; [Fasseu, Magali; Treton, Xavier; Guichard, Cecile; Pedruzzi, Eric; Cazals-Hatem, Dominique; Richard, Christophe; Aparicio, Thomas; Daniel, Fanny; Soule, Jean-Claude; Moreau, Richard; Bouhnik, Yoram; Laburthe, Marc; Groyer, Andre; Ogier-Denis, Eric] Univ Paris 07, Paris, France; [Treton, Xavier; Bouhnik, Yoram] Hop Beaujon, Serv Gastroenterol & Assistance Nutr, Clichy, France; [Cazals-Hatem, Dominique] Hop Beaujon, Serv Anat Pathol, Clichy, France; [Aparicio, Thomas; Soule, Jean-Claude] Hopital Xavier Bichat, Serv Gastroenterol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Fasseu, M (corresponding author), Ctr Rech Biomed Bichat Beaujon, INSERM U773, Paris, France.	andre.groyer@inserm.fr	Moreau, Richard/N-2197-2017; Ogier-Denis, Eric/E-5030-2016; LABURTHE, Marc/C-1875-2012; Moreau, Richard/S-1300-2019; pedruzzi, eric/B-6050-2017	Moreau, Richard/0000-0003-0862-403X; Moreau, Richard/0000-0003-0862-403X; Ogier-Denis, Eric/0000-0002-0057-7593; treton, xavier/0000-0001-8123-9213	Institut National de la Sante et de la Recherche Medicale (Inserm); Association Francois Aupetit AFA; Assistance Publique-Hopitaux de Paris; Ferring Laboratories; Ipsen Laboratories; Societe Nationale Francaise de Gastro-enterologie (SNFGE); Association Francaise pour l'etude du foie (AFEF); Programme National de Recherche en Hepato-Gastroenterologie	Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Francois Aupetit AFA; Assistance Publique-Hopitaux de Paris; Ferring Laboratories(Ferring Pharmaceuticals); Ipsen Laboratories(Ipsen); Societe Nationale Francaise de Gastro-enterologie (SNFGE); Association Francaise pour l'etude du foie (AFEF); Programme National de Recherche en Hepato-Gastroenterologie	Institut National de la Sante et de la Recherche Medicale (Inserm) and in parts by grants from Association Francois Aupetit AFA, Assistance Publique-Hopitaux de Paris, Ferring Laboratories, Ipsen Laboratories, Societe Nationale Francaise de Gastro-enterologie (SNFGE), Association Francaise pour l'etude du foie (AFEF), and Programme National de Recherche en Hepato-Gastroenterologie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding by Ipsen Laboratories was only a small part of the doctoral fellowships dedicated to Xavier Treton. It did not interfere with the study reported in the manuscript and does not alter the authors' adherence to all the PLoS ONE policies.	Ahn SH, 2008, INFLAMM BOWEL DIS, V14, P908, DOI 10.1002/ibd.20413; Allez M, 2007, GASTROENTEROLOGY, V132, P2346, DOI 10.1053/j.gastro.2007.03.025; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Broeckel U, 2006, PEDIATR CLIN N AM, V53, P807, DOI 10.1016/j.pcl.2006.08.007; Burns M, 2008, EUR FOOD RES TECHNOL, V226, P1513, DOI 10.1007/s00217-007-0683-z; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho JH, 2007, GASTROENTEROLOGY, V133, P1327, DOI 10.1053/j.gastro.2007.08.032; Costello CM, 2005, PLOS MED, V2, P771, DOI 10.1371/journal.pmed.0020199; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dieckgraefe BK, 2000, PHYSIOL GENOMICS, V4, P1; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Dooley TP, 2004, INFLAMM BOWEL DIS, V10, P1, DOI 10.1097/00054725-200401000-00001; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FARMER RG, 1993, DIGEST DIS SCI, V38, P1137, DOI 10.1007/BF01295733; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Flavin R, 2009, INT J GYNECOL CANCER, V19, P641, DOI 10.1111/IGC.0b013e3181a48cf9; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Franke A, 2008, NAT GENET, V40, P1319, DOI 10.1038/ng.221; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; GOMES P, 1986, GUT, V27, P92, DOI 10.1136/gut.27.1.92; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; HARVEY RF, 1980, LANCET, V1, P514; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kota J, 2009, CELL, V137, P1005, DOI 10.1016/j.cell.2009.04.021; Kugathasan S, 2008, NAT GENET, V40, P1211, DOI 10.1038/ng.203; Lawrance IC, 2001, HUM MOL GENET, V10, P445, DOI 10.1093/hmg/10.5.445; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Li ZJ, 2008, P NATL ACAD SCI USA, V105, P15535, DOI 10.1073/pnas.0808266105; Liu L, 2008, CURR ISSUES MOL BIOL, V10, P25, DOI 10.21775/cimb.010.025; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Miska EA, 2005, CURR OPIN GENET DEV, V15, P563, DOI 10.1016/j.gde.2005.08.005; Moschos SA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-240; Musiyenko A, 2008, J MOL MED, V86, P313, DOI 10.1007/s00109-007-0296-9; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Olsen J, 2009, INFLAMM BOWEL DIS, V15, P1032, DOI 10.1002/ibd.20879; Paavola-Sakki P, 2003, EUR J HUM GENET, V11, P112, DOI 10.1038/sj.ejhg.5200936; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; RUTGEERTS P, 1990, GASTROENTEROLOGY, V99, P956, DOI 10.1016/0016-5085(90)90613-6; Sander S, 2009, CELL CYCLE, V8, P556, DOI 10.4161/cc.8.4.7599; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Sonkoly E, 2008, CLIN EXP DERMATOL, V33, P312, DOI 10.1111/j.1365-2230.2008.02804.x; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; TUKEY JW, 1977, BOX AND WHISKER PLOT, P39; Van Limbergen J, 2007, AM J GASTROENTEROL, V102, P2820, DOI 10.1111/j.1572-0241.2007.01527.x; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Von Stein P, 2008, GASTROENTEROLOGY, V134, P1869, DOI 10.1053/j.gastro.2008.02.083; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Xiao Li Feng, 2002, Curr Gastroenterol Rep, V4, P490, DOI 10.1007/s11894-002-0025-z; Xu H, 2009, CANCER RES, V69, P6275, DOI 10.1158/0008-5472.CAN-08-4517; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Zhou QQ, 2010, GUT, V59, P775, DOI 10.1136/gut.2009.181834	78	174	184	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13160	10.1371/journal.pone.0013160	http://dx.doi.org/10.1371/journal.pone.0013160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957151	gold, Green Published			2022-12-27	WOS:000282506100006
J	Bachetti, T; Di Paolo, D; Di Lascio, S; Mirisola, V; Brignole, C; Bellotti, M; Caffa, I; Ferraris, C; Fiore, M; Fornasari, D; Chiarle, R; Borghini, S; Pfeffer, U; Ponzoni, M; Ceccherini, I; Perri, P				Bachetti, Tiziana; Di Paolo, Daniela; Di Lascio, Simona; Mirisola, Valentina; Brignole, Chiara; Bellotti, Marta; Caffa, Irene; Ferraris, Chiara; Fiore, Michele; Fornasari, Diego; Chiarle, Roberto; Borghini, Silvia; Pfeffer, Ulrich; Ponzoni, Mirco; Ceccherini, Isabella; Perri, Patrizia			PHOX2B-Mediated Regulation of ALK Expression: In Vitro Identification of a Functional Relationship between Two Genes Involved in Neuroblastoma	PLOS ONE			English	Article							ANAPLASTIC LYMPHOMA KINASE; CENTRAL HYPOVENTILATION SYNDROME; N-MYC AMPLIFICATION; NEURO-BLASTOMA; HOMEOBOX GENE; CELL-LINES; FAMILIAL NEUROBLASTOMA; ACTIVATING MUTATIONS; TRANSCRIPTION FACTOR; GERMLINE MUTATIONS	Background: Neuroblastoma (NB) is a severe pediatric tumor originating from neural crest derivatives and accounting for 15% of childhood cancer mortality. The heterogeneous and complex genetic etiology has been confirmed with the identification of mutations in two genes, encoding for the receptor tyrosine kinase Anaplastic Lymphoma Kinase (ALK) and the transcription factor Paired-like Homeobox 2B (PHOX2B), in a limited proportion of NB patients. Interestingly, these two genes are overexpressed in the great majority of primary NB samples and cell lines. These observations led us to test the hypothesis of a regulatory or functional relationship between ALK and PHOX2B underlying NB pathogenesis. Methodology/Principal Findings: Following this possibility, we first confirmed a striking correlation between the transcription levels of ALK, PHOX2B and its direct target PHOX2A in a panel of NB cell lines. Then, we manipulated their expression in NB cell lines by siRNA-mediated knock-down and forced over-expression of each gene under analysis. Surprisingly, PHOX2B- and PHOX2A-directed siRNAs efficiently downregulated each other as well as ALK gene and, consistently, the enhanced expression of PHOX2B in NB cells yielded an increment of ALK protein. We finally demonstrated that PHOX2B drives ALK gene transcription by directly binding its promoter, which therefore represents a novel PHOX2B target. Conclusions/Significance: These findings provide a compelling explanation of the concurrent involvement of these two genes in NB pathogenesis and are going to foster a better understanding of molecular interactions at the base of the disease. Moreover, this work opens new perspectives for NBs refractory to conventional therapies that may benefit from the design of novel therapeutic RNAi-based approaches for multiple gene targets.	[Bachetti, Tiziana; Brignole, Chiara; Bellotti, Marta; Borghini, Silvia; Ceccherini, Isabella] G Gaslini Childrens Hosp, Mol Genet Lab, Genoa, Italy; [Di Paolo, Daniela; Brignole, Chiara; Caffa, Irene; Ponzoni, Mirco; Perri, Patrizia] G Gaslini Childrens Hosp, Lab Oncol, Expt Therapy Unit, Genoa, Italy; [Chiarle, Roberto] Univ Turin, Dept Biomed Sci & Human Oncol, I-10124 Turin, Italy; [Mirisola, Valentina; Bellotti, Marta; Pfeffer, Ulrich] Natl Inst Canc Res, Genoa, Italy; [Di Lascio, Simona; Fornasari, Diego] Univ Milan, Sch Med, Dept Pharmacol, I-20122 Milan, Italy; [Di Lascio, Simona; Fornasari, Diego] CNR, Inst Neurosci, I-20133 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Genoa; IRCCS Istituto Giannina Gaslini; University of Turin; University of Genoa; IRCCS AOU San Martino IST; University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Bachetti, T (corresponding author), G Gaslini Childrens Hosp, Mol Genet Lab, Genoa, Italy.	isa.c@unige.it	Perri, Patrizia/AFV-5794-2022; borghini, silvia/C-8335-2012; Ponzoni, Mirco/J-7713-2016; Bachetti, Tiziana/AAB-4516-2021; Di Paolo, Daniela/J-7681-2016; Brignole, Chiara/H-9986-2018; Ceccherini, Isabella/P-8195-2014; Caffa, Irene/J-9835-2016; Bachetti, Tiziana/K-6405-2016; Pfeffer, Ulrich/J-7064-2016; Fiore, Michele/ABE-1026-2020; Perri, Patrizia/I-8124-2018	Perri, Patrizia/0000-0003-2538-8278; Ponzoni, Mirco/0000-0002-6164-4286; Di Paolo, Daniela/0000-0001-7264-6888; Brignole, Chiara/0000-0002-2563-6991; Ceccherini, Isabella/0000-0001-8732-1955; Caffa, Irene/0000-0003-1111-9915; Bachetti, Tiziana/0000-0002-9456-8945; Pfeffer, Ulrich/0000-0003-0872-4671; Fiore, Michele/0000-0002-6489-2648; Perri, Patrizia/0000-0003-2538-8278; Fornasari, Diego/0000-0002-9668-3103; DI LASCIO, SIMONA/0000-0002-5971-1515; CHIARLE, Roberto/0000-0003-1564-8531	Fondazione Pierfranco e Luisa Mariani; Fondazione Italiana Ricerca Cancro (FIRC); Associazione Italiana Ricerca Cancro (AIRC); Fondazione Mariani [08/69]; Ministry of Health	Fondazione Pierfranco e Luisa Mariani; Fondazione Italiana Ricerca Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana Ricerca Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Fondazione Mariani; Ministry of Health	T. Bachetti has been supported by Fondazione Pierfranco e Luisa Mariani. D. Di Paolo is a recipient of a Fondazione Italiana Ricerca Cancro (FIRC) fellowship. The financial support of Associazione Italiana Ricerca Cancro (AIRC) (to M. P.), Fondazione Mariani (grant# 08/69 to I. Ceccherini) and of Ministry of Health (Progetti Finalizzato 2006 and Strategico 2009 to I. Ceccherini and Finalizzato 2007 to M. P.) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi M, 2000, DNA CELL BIOL, V19, P539, DOI 10.1089/104454900439773; Alam G, 2009, AM J PATHOL, V175, P856, DOI 10.2353/ajpath.2009.090019; Bachetti T, 2005, GENE EXPRESSION, V12, P137, DOI 10.3727/000000005783992106; Bachetti T, 2005, HUM MOL GENET, V14, P1815, DOI 10.1093/hmg/ddi188; BARNES EN, 1981, IN VITRO CELL DEV B, V17, P619, DOI 10.1007/BF02618461; Benfante R, 2007, J BIOL CHEM, V282, P13290, DOI 10.1074/jbc.M608616200; BIEDLER JL, 1973, CANCER RES, V33, P2643; BIEDLER JL, 1978, CANCER RES, V38, P3751; Bogenmann E, 1996, INT J CANCER, V67, P379, DOI 10.1002/(SICI)1097-0215(19960729)67:3<379::AID-IJC12>3.0.CO;2-3; Borghini S, 2006, BIOCHEM J, V395, P355, DOI 10.1042/BJ20051386; Bourdeaut F, 2005, CANCER LETT, V228, P51, DOI 10.1016/j.canlet.2005.01.055; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Caren H, 2008, BIOCHEM J, V416, P153, DOI 10.1042/BJ20081834; Cargnin F, 2005, J BIOL CHEM, V280, P37439, DOI 10.1074/jbc.M508368200; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Cheung IY, 2008, CLIN CANCER RES, V14, P7020, DOI 10.1158/1078-0432.CCR-08-0541; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; CORNAGLIAFERRARIS P, 1990, INT J CANCER, V45, P578, DOI 10.1002/ijc.2910450334; Flora A, 2001, J NEUROSCI, V21, P7037, DOI 10.1523/JNEUROSCI.21-18-07037.2001; George RE, 2008, NATURE, V455, P975, DOI 10.1038/nature07397; GROSS N, 1992, INT J CANCER, V52, P85, DOI 10.1002/ijc.2910520116; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Longo L, 2008, INT J ONCOL, V33, P985, DOI 10.3892/ijo_00000086; LONGO L, 1988, J CANCER RES CLIN, V114, P636, DOI 10.1007/BF00398190; Longo L, 2007, HUM HERED, V63, P205, DOI 10.1159/000099997; McConville C, 2006, AM J MED GENET A, V140A, P1297, DOI 10.1002/ajmg.a.31278; Mosse YP, 2008, NATURE, V455, P930, DOI 10.1038/nature07261; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Mosse YP, 2004, AM J HUM GENET, V75, P727, DOI 10.1086/424530; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Pagnan G, 2000, J NATL CANCER I, V92, P253, DOI 10.1093/jnci/92.3.253; Pagnan G, 2009, CLIN CANCER RES, V15, P1199, DOI 10.1158/1078-0432.CCR-08-2477; Palmer RH, 2009, BIOCHEM J, V420, P345, DOI 10.1042/BJ20090387; Passoni L, 2009, CANCER RES, V69, P7338, DOI 10.1158/0008-5472.CAN-08-4419; Pastorino F, 2008, CLIN CANCER RES, V14, P7320, DOI 10.1158/1078-0432.CCR-08-0804; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Perez-Pinera P, 2007, J BIOL CHEM, V282, P28683, DOI 10.1074/jbc.M704505200; Perri P, 2005, ONCOGENE, V24, P3050, DOI 10.1038/sj.onc.1208532; Raabe EH, 2008, ONCOGENE, V27, P469, DOI 10.1038/sj.onc.1210659; Reiff T, 2010, J NEUROSCI, V30, P905, DOI 10.1523/JNEUROSCI.5368-09.2010; Revet I, 2008, EXP CELL RES, V314, P707, DOI 10.1016/j.yexcr.2007.12.008; Rozen S, 2000, Methods Mol Biol, V132, P365; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; SEEGER RC, 1977, CANCER RES, V37, P1364; SEEGER RC, 1982, ANN INTERN MED, V97, P873, DOI 10.7326/0003-4819-97-6-873; Stutterheim J, 2008, J CLIN ONCOL, V26, P5443, DOI 10.1200/JCO.2007.13.6531; Trochet D, 2005, AM J HUM GENET, V76, P421, DOI 10.1086/428366; Trochet D, 2004, AM J HUM GENET, V74, P761, DOI 10.1086/383253; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; van Limpt V, 2004, ONCOGENE, V23, P9280, DOI 10.1038/sj.onc.1208157; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Webb TR, 2009, EXPERT REV ANTICANC, V9, P331, DOI 10.1586/14737140.9.3.331; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520	54	32	33	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13108	10.1371/journal.pone.0013108	http://dx.doi.org/10.1371/journal.pone.0013108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957039	Green Published, gold			2022-12-27	WOS:000282359300012
J	Yang, SH; Peng, QA; Zhang, Q; Zou, LF; Li, Y; Robert, C; Pritchard, L; Liu, H; Hovey, R; Wang, Q; Birch, P; Toth, IK; Yang, CH				Yang, Shihui; Peng, Quan; Zhang, Qiu; Zou, Lifang; Li, Yan; Robert, Christelle; Pritchard, Leighton; Liu, Hui; Hovey, Raymond; Wang, Qi; Birch, Paul; Toth, Ian K.; Yang, Ching-Hong			Genome-Wide Identification of HrpL-Regulated Genes in the Necrotrophic Phytopathogen Dickeya dadantii 3937	PLOS ONE			English	Article							III SECRETION SYSTEM; EFFECTOR PROTEINS; ADENYLATE-CYCLASE; ERWINIA-AMYLOVORA; TRANSLOCATION; VIRULENCE; EXPRESSION; ERWINIA-CHRYSANTHEMI-3937; PATHOGENICITY; PECTINOLYSIS	Background: Dickeya dadantii is a necrotrophic pathogen causing disease in many plants. Previous studies have demonstrated that the type III secretion system (T3SS) of D. dadantii is required for full virulence. HrpL is an alternative sigma factor that binds to the hrp box promoter sequence of T3SS genes to up-regulate their expression. Methodology/Principal Findings: To explore the inventory of HrpL-regulated genes of D. dadantii 3937 (3937), transcriptome profiles of wild-type 3937 and a hrpL mutant grown in a T3SS-inducing medium were examined. Using a cutoff value of 1.5, significant differential expression was observed in sixty-three genes, which are involved in various cellular functions such as type III secretion, chemotaxis, metabolism, regulation, and stress response. A hidden Markov model (HMM) was used to predict candidate hrp box binding sites in the intergenic regions of 3937, including the promoter regions of HrpL-regulated genes identified in the microarray assay. In contrast to biotrophic phytopathgens such as Pseudomonas syringae, among the HrpL up-regulated genes in 3937 only those within the T3SS were found to contain a hrp box sequence. Moreover, direct binding of purified HrpL protein to the hrp box was demonstrated for hrp box-containing DNA fragments of hrpA and hrpN using the electrophoretic mobility shift assay (EMSA). In this study, a putative T3SS effector DspA/E was also identified as a HrpL-upregulated gene, and shown to be translocated into plant cells in a T3SS-dependent manner. Conclusion/Significances: We provide the genome-wide study of HrpL-regulated genes in a necrotrophic phytopathogen (D. dadantii 3937) through a combination of transcriptomics and bioinformatics, which led to identification of several effectors. Our study indicates the extent of differences for T3SS effector protein inventory requirements between necrotrophic and biotrophic pathogens, and may allow the development of different strategies for disease control for these different groups of pathogens.	[Yang, Shihui; Peng, Quan; Zhang, Qiu; Zou, Lifang; Li, Yan; Hovey, Raymond; Yang, Ching-Hong] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Li, Yan; Wang, Qi] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Robert, Christelle; Pritchard, Leighton; Liu, Hui; Birch, Paul; Toth, Ian K.] Scottish Crop Res Inst, Dundee DD2 5DA, Scotland	University of Wisconsin System; University of Wisconsin Milwaukee; China Agricultural University; James Hutton Institute	Yang, SH (corresponding author), Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN USA.	Ian.Toth@scri.ac.uk; chyang@uwm.edu	Pritchard, Leighton/A-7331-2008; YANG, SHIHUI/A-6526-2008; Yang, Shihui/AAE-4100-2020; Birch, Paul/F-7681-2012	Pritchard, Leighton/0000-0002-8392-2822; YANG, SHIHUI/0000-0002-9394-9148; Yang, Shihui/0000-0002-9394-9148; Birch, Paul/0000-0002-6559-3746	National Science Foundation [EF-0332163]; Research Growth Initiative of the University of Wisconsin-Milwaukee; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); China Scholarship Council	National Science Foundation(National Science Foundation (NSF)); Research Growth Initiative of the University of Wisconsin-Milwaukee; Scottish Government Rural and Environment Research and Analysis Directorate (RERAD); China Scholarship Council(China Scholarship Council)	This project is supported by grants from the National Science Foundation (award no. EF-0332163), the Research Growth Initiative of the University of Wisconsin-Milwaukee, the Scottish Government Rural and Environment Research and Analysis Directorate (RERAD), and the State Scholarship Fund of the China Scholarship Council awarded to Yan Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; BAUER DW, 1994, MOL PLANT MICROBE IN, V7, P573, DOI 10.1094/MPMI-7-0573; BAUER DW, 1995, MOL PLANT MICROBE IN, V8, P484, DOI 10.1094/MPMI-8-0484; Bocsanczy AM, 2008, MOL PLANT PATHOL, V9, P425, DOI 10.1111/J.1364-3703.2008.00471.X; Bogdanove AJ, 1998, P NATL ACAD SCI USA, V95, P1325, DOI 10.1073/pnas.95.3.1325; Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Buttner D, 2006, CURR OPIN MICROBIOL, V9, P193, DOI 10.1016/j.mib.2006.02.006; Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x; Casper-Lindley C, 2002, P NATL ACAD SCI USA, V99, P8336, DOI 10.1073/pnas.122220299; Chatterjee A, 2002, MOL PLANT MICROBE IN, V15, P971, DOI 10.1094/MPMI.2002.15.9.971; Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Fouts DE, 2002, P NATL ACAD SCI USA, V99, P2275, DOI 10.1073/pnas.032514099; Francis MS, 2002, CURR OPIN MICROBIOL, V5, P166, DOI 10.1016/S1369-5274(02)00301-6; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; Franza T, 2002, MOL PLANT MICROBE IN, V15, P1181, DOI 10.1094/MPMI.2002.15.11.1181; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011; Holeva MC, 2004, MOL PLANT MICROBE IN, V17, P943, DOI 10.1094/MPMI.2004.17.9.943; Hovey R, 2005, MOL GENET GENOMICS, V273, P225, DOI 10.1007/s00438-005-1126-9; HugouvieuxCottePattat N, 1996, ANNU REV MICROBIOL, V50, P213, DOI 10.1146/annurev.micro.50.1.213; Jafra S, 1999, MOL PLANT MICROBE IN, V12, P845, DOI 10.1094/MPMI.1999.12.10.845; Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7; Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x; Lindeberg M, 2006, MOL PLANT MICROBE IN, V19, P1151, DOI 10.1094/MPMI-19-1151; Liu H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000093; Login FH, 2006, J BIOL CHEM, V281, P33152, DOI 10.1074/jbc.M606245200; Lopez-Solanilla E, 2001, MOL PLANT MICROBE IN, V14, P386, DOI 10.1094/MPMI.2001.14.3.386; Mota LJ, 2005, FEMS MICROBIOL LETT, V252, P1, DOI 10.1016/j.femsle.2005.08.036; Peng Q, 2006, MOL PLANT MICROBE IN, V19, P451, DOI 10.1094/MPMI-19-0451; Schechter LM, 2006, MOL PLANT MICROBE IN, V19, P1180, DOI 10.1094/MPMI-19-1180; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x; Tang XY, 2006, MOL PLANT MICROBE IN, V19, P1159, DOI 10.1094/MPMI-19-1159; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Toth IK, 2003, MOL PLANT PATHOL, V4, P17, DOI 10.1046/j.1364-3703.2003.00149.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venkatesh B, 2006, J BACTERIOL, V188, P3088, DOI 10.1128/JB.188.8.3088-3098.2006; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weber E, 2005, J BACTERIOL, V187, P6175, DOI 10.1128/JB.187.17.6175-6186.2005; Yang CH, 2002, MOL PLANT MICROBE IN, V15, P472, DOI 10.1094/MPMI.2002.15.5.472; Yang SH, 2004, MOL PLANT MICROBE IN, V17, P999, DOI 10.1094/MPMI.2004.17.9.999; Yang SH, 2008, MOL PLANT MICROBE IN, V21, P133, DOI 10.1094/MPMI-21-1-0133; Yang SH, 2007, APPL ENVIRON MICROB, V73, P1079, DOI 10.1128/AEM.01770-06; Yang SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002973; Yap MN, 2005, J BACTERIOL, V187, P639, DOI 10.1128/JB.187.2.639-648.2005	49	23	23	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13472	10.1371/journal.pone.0013472	http://dx.doi.org/10.1371/journal.pone.0013472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976052	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000283114700009
J	Ji, W; Zhang, W; Xiao, WH				Ji, Wei; Zhang, Wei; Xiao, Wuhan			E2F-1 Directly Regulates Thrombospondin 1 Expression	PLOS ONE			English	Article							RB/E2F PATHWAY; MLL; LEUKEMIA; GENE; ANGIOGENESIS; ACTIVATION; MECHANISMS; APOPTOSIS; BINDING; CD36	Thrombospondin 1 (TSP1) has been shown to play a critical role in inhibiting angiogenesis, resulting in inhibition of tumor growth and metastases. To figure out TSP1's regulators will lead to reveal its biological function mechanistically. In this study, we show that E2F-1 could activate the transcription of TSP1 by both promoter assays and Northern blot. Analysis of various TSP1 promoter mutant constructs showed that a sequence located -144/-137 up-stream of the transcriptional initiation site, related to the consensus E2F-responsive sequence, is necessary for the activation. In consistence with up-regulation of TSP-1 activity by over-expression of E2F-1, the knockdown of endogenous E2F-1 inhibited TSP-1 promoter activity significantly, implying that E2F-1 mediated regulation of TSP-1 is relevant in vivo. In addition, E2F-1 could also directly bind to the TSP1 promoter region covering -144/-137 region as revealed by ChIP assays. Furthermore, the E2F-1-induced activation of TSP1 gene transcription is suppressed by pRB1 in a dose-dependent manner. Taken together, the results demonstrate that TSP1 is a novel target for E2F1, which might imply that E2F-1 can affect angiogenesis by modulating TSP1 expression.	[Ji, Wei; Zhang, Wei; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Ji, W (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	Zhang, Wei/I-1481-2017; Xiao, Wuhan/GLU-7352-2022		"973'' grant [2010CB126306, 2007CB815705, 2006CB504102]; Natural Science Foundation of China (NSFC) [31071211, 30971667, 30890113]; National Transgene Project [2009ZX08010-021B]	"973'' grant(National Basic Research Program of China); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Transgene Project	W.X. is supported by "973'' grant 2010CB126306, 2007CB815705, 2006CB504102, Natural Science Foundation of China (NSFC) grant 31071211, 30971667, 30890113 and National Transgene Project 2009ZX08010-021B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Armstrong SA, 2002, NAT GENET, V30, P41, DOI 10.1038/ng765; Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Bruel A, 2005, ANTICANCER RES, V25, P757; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; DAMERON KM, 1994, SCIENCE, V265, P1582, DOI 10.1126/science.7521539; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; DiMartino JF, 2000, BLOOD, V96, P3887, DOI 10.1182/blood.V96.12.3887.h8003887_3887_3893; DiPietro LA, 1996, AM J PATHOL, V148, P1851; Eguchi M, 2005, INT J HEMATOL, V82, P9, DOI 10.1532/IJH97.05042; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; HELIN K, 1993, GENE DEV, V7, P1850, DOI 10.1101/gad.7.10.1850; Isenberg JS, 2007, J BIOL CHEM, V282, P15404, DOI 10.1074/jbc.M701638200; Isenberg JS, 2006, J BIOL CHEM, V281, P26069, DOI 10.1074/jbc.M605040200; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Lawler J, 2001, AM J PATHOL, V159, P1949, DOI 10.1016/S0002-9440(10)63042-8; Li K, 2003, INT J MOL MED, V12, P995; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Liu H, 2008, CELL CYCLE, V7, P428, DOI 10.4161/cc.7.4.5426; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu P, 2003, LEUKEMIA RES, V27, P701, DOI 10.1016/S0145-2126(02)00346-6; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Oganesian A, 2008, MOL BIOL CELL, V19, P563, DOI 10.1091/mbc.E07-07-0649; Pallero MA, 2008, FASEB J, V22, P3968, DOI 10.1096/fj.07-104802; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; Sheibani N, 1996, CANCER LETT, V107, P45, DOI 10.1016/0304-3835(96)04341-8; Streit M, 2000, EMBO J, V19, P3272, DOI 10.1093/emboj/19.13.3272; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Watnick RS, 2003, CANCER CELL, V3, P219, DOI 10.1016/S1535-6108(03)00030-8; Wen SH, 2001, P NATL ACAD SCI USA, V98, P4622, DOI 10.1073/pnas.081063798; XU J, NAT NEUROSCI, V13, P22; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	47	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13442	10.1371/journal.pone.0013442	http://dx.doi.org/10.1371/journal.pone.0013442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976175	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700027
J	Urao, N; Razvi, M; Oshikawa, J; McKinney, RD; Chavda, R; Bahou, WF; Fukai, T; Ushio-Fukai, M				Urao, Norifumi; Razvi, Masooma; Oshikawa, Jin; McKinney, Ronald D.; Chavda, Rupal; Bahou, Wadie F.; Fukai, Tohru; Ushio-Fukai, Masuko			IQGAP1 Is Involved in Post-Ischemic Neovascularization by Regulating Angiogenesis and Macrophage Infiltration	PLOS ONE			English	Article							SKELETAL-MUSCLE REGENERATION; HINDLIMB ISCHEMIA; NADPH OXIDASE; ENDOTHELIAL-CELLS; PROTEIN-KINASE; LIMB ISCHEMIA; MICE LACKING; BONE-MARROW; MOUSE MODEL; MIGRATION	Background: Neovascularization is an important repair mechanism in response to ischemic injury and is dependent on inflammation, angiogenesis and reactive oxygen species (ROS). IQGAP1, an actin-binding scaffold protein, is a key regulator for actin cytoskeleton and motility. We previously demonstrated that IQGAP1 mediates vascular endothelial growth factor (VEGF)-induced ROS production and migration of cultured endothelial cells (ECs); however, its role in post-ischemic neovascularization is unknown. Methodology/Principal Findings: Ischemia was induced by left femoral artery ligation, which resulted in increased IQGAP1 expression in Mac3(+) macrophages and CD31(+) capillary-like ECs in ischemic legs. Mice lacking IQGAP1 exhibited a significant reduction in the post-ischemic neovascularization as evaluated by laser Doppler blood flow, capillary density and a-actin positive arterioles. Furthermore, IQGAP1(-/-) mice showed a decrease in macrophage infiltration and ROS production in ischemic muscles, leading to impaired muscle regeneration and increased necrosis and fibrosis. The numbers of bone marrow (BM)-derived cells in the peripheral blood were not affected in these knockout mice. BM transplantation revealed that IQGAP1 expressed in both BM-derived cells and tissue resident cells, such as ECs, is required for post-ischemic neovascularization. Moreover, thioglycollate-induced peritoneal macrophage recruitment and ROS production were inhibited in IQGAP1(-/-) mice. In vitro, IQGAP1(-/-) BM-derived macrophages showed inhibition of migration and adhesion capacity, which may explain the defective macrophage recruitment into the ischemic tissue in IQGAP1(-/-) mice. Conclusions/Significance: IQGAP1 plays a key role in post-ischemic neovascularization by regulating, not only, ECs-mediated angiogenesis but also macrophage infiltration as well as ROS production. Thus, IQGAP1 is a potential therapeutic target for inflammation-and angiogenesis-dependent ischemic cardiovascular diseases.	[Urao, Norifumi; Razvi, Masooma; Oshikawa, Jin; McKinney, Ronald D.; Chavda, Rupal; Ushio-Fukai, Masuko] Univ Illinois, Cardiovasc Res Ctr, Ctr Lung & Vasc Biol, Dept Pharmacol, Chicago, IL 60680 USA; [Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Med, Chicago, IL USA; [Fukai, Tohru] Univ Illinois, Cardiovasc Res Ctr, Dept Pharmacol, Chicago, IL USA; [Bahou, Wadie F.] SUNY Stony Brook, Dept Med, New York, NY USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Urao, N (corresponding author), Univ Illinois, Cardiovasc Res Ctr, Ctr Lung & Vasc Biol, Dept Pharmacol, Chicago, IL 60680 USA.	mfukai@uic.edu	Urao, Norifumi/O-7313-2015	Urao, Norifumi/0000-0001-9750-8406	National Institutes of Health (NIH) [077524, HL077524-S1, HL070187]; American Heart Association (AHA) [0755805Z, 0970336N, 09POST2250151]; Uehara Memorial Foundation; Naito Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070187, R01HL077524] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) R01 Heart and Lung (HL) 077524 and HL077524-S1 (to M.U.-F.), HL070187 (to T. F.), American Heart Association (AHA) Grant-In-Aid 0755805Z (to M.U.-F.) and AHA National Center Research Program (NCRP) Innovative Research Grant 0970336N (to M.U.-F), AHA Post-doctoral Fellowship 09POST2250151 (to N.U.), Uehara Memorial Foundation and Naito Foundation (to J.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Bensenor LB, 2007, J CELL SCI, V120, P658, DOI 10.1242/jcs.03376; Bogatkevich GS, 2008, AM J PHYSIOL-LUNG C, V295, pL603, DOI 10.1152/ajplung.00530.2007; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Brechot N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003950; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Fan J, 2002, J BIOL CHEM, V277, P3404, DOI 10.1074/jbc.M110054200; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Heil M, 2006, J CELL MOL MED, V10, P45, DOI 10.1111/j.1582-4934.2006.tb00290.x; Heil M, 2004, CIRC RES, V95, P449, DOI 10.1161/01.RES.0000141145.78900.44; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Le Clainche C, 2007, J BIOL CHEM, V282, P426, DOI 10.1074/jbc.M607711200; Li SH, 2000, MOL CELL BIOL, V20, P697, DOI 10.1128/MCB.20.2.697-701.2000; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Mateer SC, 2003, CELL MOTIL CYTOSKEL, V55, P147, DOI 10.1002/cm.10118; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Munugalavadla V, 2005, BLOOD, V106, P103, DOI 10.1182/blood-2004-10-4041; Nakhaei-Nejad M, 2010, EUR J IMMUNOL, V40, P204, DOI 10.1002/eji.200839214; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Segal BH, 2002, J LEUKOCYTE BIOL, V71, P410; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shireman PK, 2007, J VASC SURG, V45, p48A, DOI 10.1016/j.jvs.2007.02.030; Shireman PK, 2005, J SURG RES, V129, P242, DOI 10.1016/j.jss.2005.06.013; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Silvestre JS, 2008, CARDIOVASC RES, V78, P242, DOI 10.1093/cvr/cvn027; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Takahashi K, 2006, J CELL PHYSIOL, V208, P213, DOI 10.1002/jcp.20657; Tojo T, 2005, CIRCULATION, V111, P2347, DOI 10.1161/01.CIR.0000164261.62586.14; Urao N, 2008, CIRC RES, V103, P212, DOI 10.1161/CIRCRESAHA.108.176230; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; White CD, 2009, FEBS LETT, V583, P1817, DOI 10.1016/j.febslet.2009.05.007; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7	41	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13440	10.1371/journal.pone.0013440	http://dx.doi.org/10.1371/journal.pone.0013440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976168	Green Submitted, Green Published, gold			2022-12-27	WOS:000283043700025
J	DeLisle, S; South, B; Anthony, JA; Kalp, E; Gundlapallli, A; Curriero, FC; Glass, GE; Samore, M; Perl, TM				DeLisle, Sylvain; South, Brett; Anthony, Jill A.; Kalp, Ericka; Gundlapallli, Adi; Curriero, Frank C.; Glass, Greg E.; Samore, Matthew; Perl, Trish M.			Combining Free Text and Structured Electronic Medical Record Entries to Detect Acute Respiratory Infections	PLOS ONE			English	Article							PUBLIC-HEALTH SURVEILLANCE; INFLUENZA-LIKE ILLNESS; SYNDROMIC SURVEILLANCE; INTERNATIONAL-CLASSIFICATION; DISCHARGE SUMMARIES; DISEASES; SYSTEM; CATEGORIES; DATABASES; HUMANS	Background: The electronic medical record (EMR) contains a rich source of information that could be harnessed for epidemic surveillance. We asked if structured EMR data could be coupled with computerized processing of free-text clinical entries to enhance detection of acute respiratory infections (ARI). Methodology: A manual review of EMR records related to 15,377 outpatient visits uncovered 280 reference cases of ARI. We used logistic regression with backward elimination to determine which among candidate structured EMR parameters (diagnostic codes, vital signs and orders for tests, imaging and medications) contributed to the detection of those reference cases. We also developed a computerized free-text search to identify clinical notes documenting at least two non-negated ARI symptoms. We then used heuristics to build case-detection algorithms that best combined the retained structured EMR parameters with the results of the text analysis. Principal Findings: An adjusted grouping of diagnostic codes identified reference ARI patients with a sensitivity of 79%, a specificity of 96% and a positive predictive value (PPV) of 32%. Of the 21 additional structured clinical parameters considered, two contributed significantly to ARI detection: new prescriptions for cough remedies and elevations in body temperature to at least 38 degrees C. Together with the diagnostic codes, these parameters increased detection sensitivity to 87%, but specificity and PPV declined to 95% and 25%, respectively. Adding text analysis increased sensitivity to 99%, but PPV dropped further to 14%. Algorithms that required satisfying both a query of structured EMR parameters as well as text analysis disclosed PPVs of 52-68% and retained sensitivities of 69-73%. Conclusion: Structured EMR parameters and free-text analyses can be combined into algorithms that can detect ARI cases with new levels of sensitivity or precision. These results highlight potential paths by which repurposed EMR information could facilitate the discovery of epidemics before they cause mass casualties.	[DeLisle, Sylvain] Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA; [DeLisle, Sylvain] Univ Maryland, Baltimore, MD 21201 USA; [South, Brett; Gundlapallli, Adi; Samore, Matthew] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [South, Brett; Gundlapallli, Adi; Samore, Matthew] Univ Utah, Salt Lake City, UT USA; [Anthony, Jill A.; Curriero, Frank C.; Glass, Greg E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kalp, Ericka; Perl, Trish M.] Johns Hopkins Med Inst, Baltimore, MD 21205 USA	University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	DeLisle, S (corresponding author), Vet Affairs Maryland Hlth Care Syst, Baltimore, MD USA.	sdelisle@umaryland.edu			Centers for Disease Control and Prevention [R01 CI000098, RFA HK000013, 1 P01HK000069-01]; Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs [IIR 06-119-1]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000098] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported in part by grants R01 CI000098, RFA HK000013 and 1 P01HK000069-01 from the Centers for Disease Control and Prevention, and by grant IIR 06-119-1 from the Office of Research and Development, Health Services Research and Development Service, Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Aguilera JF, 2003, EUR J EPIDEMIOL, V18, P751, DOI 10.1023/A:1025337616327; Aronson AR, 2001, J AM MED INFORM ASSN, P17; Babcock HM, 2006, INFECT CONT HOSP EP, V27, P266, DOI 10.1086/501539; Beitel AJ, 2004, PEDIATR EMERG CARE, V20, P355, DOI 10.1097/01.pec.0000133608.96957.b9; Bourgeois FT, 2006, ANN EMERG MED, V47, P265, DOI 10.1016/j.annemergmed.2005.11.022; Bradley Colleen A, 2005, MMWR Suppl, V54, P11; Burkom Howard S, 2005, MMWR Suppl, V54, P55; Chapman WW, 2005, J AM MED INFORM ASSN, V12, P618, DOI 10.1197/jamia.M1841; Chapman WW, 2004, STUD HEALTH TECHNOL, V107, P487; Chapman WW, 2004, J BIOMED INFORM, V37, P120, DOI 10.1016/j.jbi.2004.03.002; Chapman WW, 2001, J BIOMED INFORM, V34, P301, DOI 10.1006/jbin.2001.1029; Chen Jian-Hua, 2005, MMWR Suppl, V54, P31; DARA J, 2007, J BIOMED INFORM; Davison A. C., 1998, BOOTSTRAP METHODS TH; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Day FC, 2004, ANN EMERG MED, V43, P401, DOI 10.1016/S0196-0644(03)00748-0; Espino JU, 2001, J AM MED INFORM ASSN, P164; ESPINO JU, 2004, RODS OPEN SOURCE PRO, P1192; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Friedlin Jeff, 2008, AMIA Annu Symp Proc, P207; Friedman C, 2001, J AM MED INFORM ASSN, P189; Friedman C, 2004, J AM MED INFORM ASSN, V11, P392, DOI 10.1197/jamia.M1552; Gonzales R, 2001, ANN INTERN MED, V134, P479, DOI 10.7326/0003-4819-134-6-200103200-00013; Gundlapalli AV, 2007, AM J INFECT CONTROL, V35, P163, DOI 10.1016/j.ajic.2006.08.003; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Henning Kelly J, 2004, MMWR Suppl, V53, P5; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hripcsak G, 2009, J AM MED INFORM ASSN, V16, P354, DOI 10.1197/jamia.M2922; Hurt-Mullen Kathy J, 2005, MMWR Suppl, V54, P141; Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029; Lazarus R, 2009, J AM MED INFORM ASSN, V16, P18, DOI 10.1197/jamia.M2848; Leng QB, 2003, NEW ENGL J MED, V349, P709, DOI 10.1056/NEJMc031427; Li Ran, 2005, AMIA Annu Symp Proc, P450; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lombardo J, 2003, J URBAN HEALTH, V80, pI32; Lombardo Joseph S, 2004, MMWR Suppl, V53, P159; Ma Haobo, 2005, MMWR Suppl, V54, P27; Magruder Steven F, 2004, MMWR Suppl, V53, P117; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Melton CB, 2005, J AM MED INFORM ASSN, V12, P448, DOI 10.1197/jamia.M1794; Mikosz Christina A, 2004, MMWR Suppl, V53, P101; Nadkarni P, 2001, J AM MED INFORM ASSN, V8, P80, DOI 10.1136/jamia.2001.0080080; Nguyen Trang Quyen, 2007, Am J Public Health, V97 Suppl 1, pS142, DOI 10.2105/AJPH.2006.098996; Ohkusa Yasushi, 2005, MMWR Suppl, V54, P47; Overhage JM, 2008, AM J PUBLIC HEALTH, V98, P344, DOI 10.2105/AJPH.2006.092700; Reingold AL, 1998, EMERG INFECT DIS, V4, P21, DOI 10.3201/eid0401.980104; Smith G, 2007, J PUBLIC HEALTH, V29, P75, DOI 10.1093/pubmed/fdl078; Sokolow Leslie Z, 2005, MMWR Suppl, V54, P133; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Vergu E, 2006, EMERG INFECT DIS, V12, P416, DOI 10.3201/eid1203.050573; Wagner MM, 2003, J AM MED INFORM ASSN, V10, P409, DOI 10.1197/jamia.M1357; Wallstrom GL, 2007, J BIOMED INFORM, V40, P642, DOI 10.1016/j.jbi.2007.03.008; Yih W Katherine, 2004, MMWR Suppl, V53, P43; Zou Qinghua, 2003, AMIA Annu Symp Proc, P763	55	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13377	10.1371/journal.pone.0013377	http://dx.doi.org/10.1371/journal.pone.0013377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976281	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000014
J	Arkun, Y; Erman, B				Arkun, Yaman; Erman, Burak			Prediction of Optimal Folding Routes of Proteins That Satisfy the Principle of Lowest Entropy Loss: Dynamic Contact Maps and Optimal Control	PLOS ONE			English	Article							CHYMOTRYPSIN INHIBITOR-2; 2-STATE PROTEINS; TRANSITION-STATE; PATHWAYS; MECHANISM; RATES; MODEL	An optimization model is introduced in which proteins try to evade high energy regions of the folding landscape, and prefer low entropy loss routes during folding. We make use of the framework of optimal control whose convenient solution provides practical and useful insight into the sequence of events during folding. We assume that the native state is available. As the protein folds, it makes different set of contacts at different folding steps. The dynamic contact map is constructed from these contacts. The topology of the dynamic contact map changes during the course of folding and this information is utilized in the dynamic optimization model. The solution is obtained using the optimal control theory. We show that the optimal solution can be cast into the form of a Gaussian Network that governs the optimal folding dynamics. Simulation results on three examples (CI2, Sso7d and Villin) show that folding starts by the formation of local clusters. Non-local clusters generally require the formation of several local clusters. Non-local clusters form cooperatively and not sequentially. We also observe that the optimal controller prefers "zipping" or small loop closure steps during folding. The folding routes predicted by the proposed method bear strong resemblance to the results in the literature.	[Arkun, Yaman; Erman, Burak] Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey	Koc University	Arkun, Y (corresponding author), Koc Univ, Dept Chem & Biol Engn, Istanbul, Turkey.	yarkun@ku.edu.tr; berman@ku.edu.tr	erman, burak/F-5900-2015	erman, burak/0000-0002-2496-6059				Alm E, 1999, CURR OPIN STRUC BIOL, V9, P189, DOI 10.1016/S0959-440X(99)80027-X; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; Baker D, 2000, NATURE, V405, P39, DOI 10.1038/35011000; Callen H.B., 1985, THERMODYNAMICS INTRO; Dill KA, 2005, BIOPHYS J, V88, p355A; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Doob Michael, 1998, SPECTRA GRAPHS THEOR; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Guner U, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2181976; ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616; Ivarsson Y, 2008, EUR BIOPHYS J BIOPHY, V37, P721, DOI 10.1007/s00249-007-0256-x; JACKSON SE, 1993, BIOCHEMISTRY-US, V32, P11270, DOI 10.1021/bi00093a002; Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398; Kmiecik S, 2006, ACTA BIOCHIM POL, V53, P131; Kwakernaak H., 1972, LINEAR OPTIMAL CONTR; Ladurner AG, 1999, NAT STRUCT BIOL, V6, P28; MERRIS R, 1994, LIN ALGEBRA APPL, V143, P197; Pan YP, 2001, BIOCHEMISTRY-US, V40, P2723, DOI 10.1021/bi0022036; SHAW GL, 1995, BIOCHEMISTRY-US, V34, P2225, DOI 10.1021/bi00007a017; Weikl TR, 2003, J MOL BIOL, V332, P953, DOI 10.1016/S0022-2836(03)00884-2; Weikl TR, 2003, J MOL BIOL, V329, P585, DOI 10.1016/S0022-2836(03)00436-4; Weikl TR, 2002, BIOPHYS J, V82, p302A; WEISSTEIN EW, LAPLACIAN MATRIX MAT	26	5	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13275	10.1371/journal.pone.0013275	http://dx.doi.org/10.1371/journal.pone.0013275			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967269	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300014
J	Deyde, VM; Sampath, R; Garten, RJ; Blair, PJ; Myers, CA; Massire, C; Matthews, H; Svoboda, P; Reed, MS; Pohl, J; Klimov, AI; Gubareva, LV				Deyde, Varough M.; Sampath, Rangarajan; Garten, Rebecca J.; Blair, Patrick J.; Myers, Christopher A.; Massire, Christian; Matthews, Heather; Svoboda, Pavel; Reed, Matthew S.; Pohl, Jan; Klimov, Alexander I.; Gubareva, Larisa V.			Genomic Signature-Based Identification of Influenza A Viruses Using RT-PCR/Electro-Spray Ionization Mass Spectrometry (ESI-MS) Technology	PLOS ONE			English	Article							AMANTADINE-RESISTANT; NUCLEIC-ACIDS; H1N1 VIRUS; PCR; REASSORTMENT; EVOLUTION; DIAGNOSIS; INFECTION; HUMANS	Background: The emergence and rapid spread of the 2009 H1N1 pandemic influenza A virus (H1N1pdm) in humans highlights the importance of enhancing the capability of existing influenza surveillance systems with tools for rapid identification of emerging and re-emerging viruses. One of the new approaches is the RT-PCR electrospray ionization mass spectrometry (RT-PCR/ESI-MS) technology, which is based on analysis of base composition (BC) of RT-PCR amplicons from influenza "core" genes. Combination of the BC signatures represents a "genomic print" of an influenza A virus. Methodology/Principal Findings: Here, 757 samples collected between 2006 and 2009 were tested, including 302 seasonal H1N1, 171 H3N2, 7 swine triple reassortants, and 277 H1N1pdm viruses. Of the 277 H1N1pdm samples, 209 were clinical specimens (throat, nasal and nasopharyngeal swabs, nasal washes, blood and sputum). BC signatures for the clinical specimen from one of the first cases of the 2009 pandemic, A/California/04/2009, confirmed it as an unusual, previously unrecognized influenza A virus, with "core" genes related to viruses of avian, human and swine origins. Subsequent analysis of additional 276 H1N1pdm samples revealed that they shared the genomic print of A/California/04/2009, which differed from those of North American swine triple reassortant viruses, seasonal H1N1 and H3N2 and other viruses tested. Moreover, this assay allowed distinction between "core" genes of co-circulating groups of seasonal H1N1, such as clades 2B, 2C, and their reassortants with dual antiviral resistance to adamantanes and oseltamivir. Conclusions/Significance: The RT-PCR/ESI-MS assay is a broad range influenza identification tool that can be used directly on clinical specimens for rapid and accurate detection of influenza virus genes. The assay differentiates the H1N1pdm from seasonal and other nonhuman hosts viruses. Although not a diagnostic tool, this assay demonstrates its usefulness and robustness in influenza virus surveillance and detection of novel and unusual viruses with previously unseen genomic prints.	[Deyde, Varough M.; Garten, Rebecca J.; Klimov, Alexander I.; Gubareva, Larisa V.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA; [Blair, Patrick J.; Myers, Christopher A.] USN, Hlth Res Ctr, Naval Resp Dis Lab, San Diego, CA 92152 USA; [Svoboda, Pavel; Reed, Matthew S.; Pohl, Jan] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Sci Resources, Atlanta, GA USA; [Sampath, Rangarajan; Massire, Christian; Matthews, Heather] Ibis Biosci, Genom & Computat Biol, Carlsbad, CA USA	Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); Centers for Disease Control & Prevention - USA	Deyde, VM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Influenza Div, Atlanta, GA 30333 USA.	lqg3@cdc.gov			Centers for Disease Control and Prevention	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded by the Centers for Disease Control and Prevention. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. However, the manuscript was cleared for submission to the journal following CDC's standard operating procedures. RS, CM and HM were involved in data analysis and interpretation. RS was also involved in assay design and preparation of manuscript. All three are full time employees of Abbott Molecular Inc. Abbott Molecular Inc. who funds RS, CM, and HM has therefore a role in the study design, data collection and analysis, and manuscript preparation.	Brownstein MJ, 1996, BIOTECHNIQUES, V20, P1004, DOI 10.2144/96206st01; Buggs RJA, 2010, MOL ECOL, V19, P132, DOI 10.1111/j.1365-294X.2009.04469.x; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chen ZY, 2010, J VIROL, V84, P44, DOI 10.1128/JVI.02106-09; Cheng PKC, 2010, EMERG INFECT DIS, V16, P155, DOI 10.3201/eid1601.091304; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Das K, 2010, NAT STRUCT MOL BIOL, V17, P530, DOI 10.1038/nsmb.1779; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deyde V, 2009, INFLUENZA OTHER RESP, V3, P297, DOI 10.1111/j.1750-2659.2009.00103.x; Ecker DJ, 2009, METHODS MOL BIOL, V551, P71, DOI 10.1007/978-1-60327-999-4_7; Ellegren H, 2008, MOL ECOL, V17, P1629, DOI 10.1111/j.1365-294X.2008.03699.x; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Furuse Y, 2009, J CLIN MICROBIOL, V47, P841, DOI 10.1128/JCM.01622-08; Gabriel S, 2009, CURRENT PROTOCOLS HU; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Hofstadler SA, 2005, INT J MASS SPECTROM, V242, P23, DOI 10.1016/j.ijms.2004.09.014; Hofstadler SA, 2005, MASS SPECTROM REV, V24, P265, DOI 10.1002/mas.20016; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Hudson ME, 2008, MOL ECOL RESOUR, V8, P3, DOI 10.1111/j.1471-8286.2007.02019.x; Jiang Y, 2003, ANAL BIOCHEM, V316, P50, DOI 10.1016/S0003-2697(03)00024-1; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; KHIABANIAN H, 2009, PLOS ONE, V4; Maynard A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4888; Muddiman DC, 1997, ANAL CHEM, V69, P1543, DOI 10.1021/ac961134r; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000012; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Nelson MI, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000133; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sampath R, 2007, ANN NY ACAD SCI, V1102, P109, DOI 10.1196/annals.1408.008; Schweiger B, 2000, J CLIN MICROBIOL, V38, P1552, DOI 10.1128/JCM.38.4.1552-1558.2000; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; SHEU TG, 2010, J INFEC DIS IN PRESS; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Simonsen L, 2007, MOL BIOL EVOL, V24, P1811, DOI 10.1093/molbev/msm103; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Stupar RM, 2006, GENETICS, V173, P2199, DOI 10.1534/genetics.106.060699; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; van Elden LJR, 2001, BRIT J GEN PRACT, V51, P630; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; World Health Organization, 2002, WHO MAN AN INFL DIAG; WRIGHT KE, 1995, J CLIN MICROBIOL, V33, P1180, DOI 10.1128/JCM.33.5.1180-1184.1995	45	32	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13293	10.1371/journal.pone.0013293	http://dx.doi.org/10.1371/journal.pone.0013293			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967258	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300018
J	Rzehak, P; Thijs, C; Standl, M; Mommers, M; Glaser, C; Jansen, E; Klopp, N; Koppelman, GH; Singmann, P; Postma, DS; Sausenthaler, S; Dagnelie, PC; van den Brandt, PA; Koletzko, B; Heinrich, J				Rzehak, Peter; Thijs, Carel; Standl, Marie; Mommers, Monique; Glaser, Claudia; Jansen, Eugene; Klopp, Norman; Koppelman, Gerard H.; Singmann, Paula; Postma, Dirkje S.; Sausenthaler, Stefanie; Dagnelie, Pieter C.; van den Brandt, Piet A.; Koletzko, Berthold; Heinrich, Joachim		KOALA & LISA Study Grp	Variants of the FADS1 FADS2 Gene Cluster, Blood Levels of Polyunsaturated Fatty Acids and Eczema in Children within the First 2 Years of Life	PLOS ONE			English	Article							TOTAL IMMUNOGLOBULIN-E; KOALA BIRTH COHORT; FADS2; PHOSPHOLIPIDS; ASSOCIATION; DISEASES; MILK; IGE; INFLAMMATION; INFECTIONS	Background: Association of genetic-variants in the FADS1-FADS2-gene-cluster with fatty-acid-composition in blood of adult-populations is well established. We analyze this genetic-association in two children-cohort-studies. In addition, the association between variants in the FADS-gene-cluster and blood-fatty-acid-composition with eczema was studied. Methods and Principal Findings: Data of two population-based-birth-cohorts in the Netherlands and Germany (KOALA, LISA) were pooled (n = 879) and analyzed by (logistic) regression regarding the mutual influence of single-nucleotide-polymorphisms (SNPs) in the FADS-gene-cluster (rs174545, rs174546, rs174556, rs174561, rs3834458), on polyunsaturated fatty acids (PUFA) in blood and parent-reported eczema until the age of 2 years. All SNPs were highly significantly associated with all PUFAs except for alpha-linolenic-acid and eicosapentaenoic-acid, also after correction for multiple-testing. All tested SNPs showed associations with eczema in the LISA-study, but not in the KOALA-study. None of the PUFAs was significantly associated with eczema neither in the pooled nor in the analyses stratified by study-cohort. Conclusions and Significance: PUFA-composition in young children's blood is under strong control of the FADS-gene-cluster. Inconsistent results were found for a link between these genetic-variants with eczema. PUFA in blood was not associated with eczema. Thus the hypothesis of an inflammatory-link between PUFA and eczema by the metabolic-pathway of LC-PUFAs as precursors for inflammatory prostaglandins and leukotrienes could not be confirmed by these data.	[Rzehak, Peter; Standl, Marie; Klopp, Norman; Singmann, Paula; Sausenthaler, Stefanie; Heinrich, Joachim] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Rzehak, Peter] Univ Munich, Chair Epidemiol, Inst Med Informat Biometr & Epidemiol, Oberschleissheim, Germany; [Thijs, Carel; Mommers, Monique; Dagnelie, Pieter C.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, Maastricht, Netherlands; [Glaser, Claudia; Koletzko, Berthold] Univ Munich, Dr von Hauner Childrens Hosp, Div Metab Dis & Nutr Med, Munich, Germany; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Lab Hlth Protect Res, NL-3720 BA Bilthoven, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, Groningen, Netherlands; [van den Brandt, Piet A.] Maastricht Univ, GROW Sch Oncol & Dev Biol, Dept Epidemiol, Maastricht, Netherlands	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Maastricht University; University of Munich; Netherlands National Institute for Public Health & the Environment; University of Groningen; University of Groningen; Maastricht University	Rzehak, P (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany.	peter.rzehak@helmholtz-muenchen.de	Koppelman, Gerard/AAG-9187-2020; Singmann, Paula/B-3624-2014; Heinrich, Joachim/N-1720-2013; Sack, Ulrich/J-6301-2015; Thijs, Carel/H-8340-2019	Heinrich, Joachim/0000-0002-9620-1629; Sack, Ulrich/0000-0002-7813-0492; Thijs, Carel/0000-0001-6646-5458; Koppelman, Gerard/0000-0001-8567-3252; Standl, Marie/0000-0002-5345-2049; Singmann, Paula/0000-0003-2109-9970; van den Brandt, Piet/0000-0001-8781-8099	Netherlands Organisation for Health Research and Development [2100.0090, 912-03-031]; Netherlands Asthma Foundation [3.2.03.48]; Royal Friesland Foods, Triodos Foundation; Phoenix Foundation; Raphae Foundation; Iona Foundation; Foundation for the Advancement of Heilpedagogie; Netherlands Ministry of Public Health, Welfare and Sport; Netherlands and the Netherlands Organisation for Scientific Research; Federal Ministry for Education, Science, Research and Technology [01 EG 9705/2, 01EG9732]; Federal Ministry of Education and Research [01GI0826, 01GI0823, 01GS0820]; Munich Center of Health Sciences (MCHEALTH), Ludwig-Maximilians University Munich LMU; Netherlands Organisation for Scientific Research; Bristol-Myers-Squibb Foundation, New York, NY, USA	Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Asthma Foundation; Royal Friesland Foods, Triodos Foundation; Phoenix Foundation; Raphae Foundation; Iona Foundation; Foundation for the Advancement of Heilpedagogie; Netherlands Ministry of Public Health, Welfare and Sport; Netherlands and the Netherlands Organisation for Scientific Research; Federal Ministry for Education, Science, Research and Technology; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Munich Center of Health Sciences (MCHEALTH), Ludwig-Maximilians University Munich LMU; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Bristol-Myers-Squibb Foundation, New York, NY, USA(Bristol-Myers Squibb)	KOALA study with follow-up until age 2 years was co-sponsored by the Netherlands Organisation for Health Research and Development (ZonMW grants no. 2100.0090 and 912-03-031), the Netherlands Asthma Foundation (grant no. 3.2.03.48), Royal Friesland Foods, Triodos Foundation, Phoenix Foundation, Raphae Foundation, Iona Foundation, Foundation for the Advancement of Heilpedagogie, and the Netherlands Ministry of Public Health, Welfare and Sport, the Netherlands and the Netherlands Organisation for Scientific Research (NWO Spinoza award of Prof. D.S. Postma). The LISA study was funded by grants of the Federal Ministry for Education, Science, Research and Technology (Grant No. 01 EG 9705/2 and 01EG9732). This work was partly supported by the "Kompetenznetz Adipositas (Competence Network Obesity)" and NGFNplus funded by the Federal Ministry of Education and Research (FKZ: 01GI0826, 01GI0823, 01GS0820). Personal and financial support by the Munich Center of Health Sciences (MCHEALTH) as part of the Ludwig-Maximilians University Munich LMU innovative is gratefully acknowledged. Dirkje S. Postma received the NWO Spinoza award from the Netherlands Organisation for Scientific Research. Berthold Koletzko is the recipient of a Freedom to Discover Award of the Bristol-Myers-Squibb Foundation, New York, NY, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALBERSE RC, 1981, J ALLERGY CLIN IMMUN, V68, P356, DOI 10.1016/0091-6749(81)90133-0; AGREN JJ, 1992, J LIPID RES, V33, P1871; Akkerdaas JH, 2005, INT ARCH ALLERGY IMM, V138, P203, DOI 10.1159/000088720; Bottema RWB, 2008, EUR RESPIR J, V32, P593, DOI 10.1183/09031936.00162407; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Calder PC, 2005, BIOCHEM SOC T, V33, P423, DOI 10.1042/BST0330423; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chen CM, 2010, CLIN EXP DERMATOL, V35, P238, DOI 10.1111/j.1365-2230.2009.03460.x; Chen CM, 2007, J ALLERGY CLIN IMMUN, V119, P1148, DOI 10.1016/j.jaci.2007.02.017; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Duchen K, 2001, LIPIDS, V36, P1033, DOI 10.1007/s11745-001-0814-5; Filipiak B, 2007, J PEDIATR-US, V151, P352, DOI 10.1016/j.jpeds.2007.05.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Glaser C, 2010, METABOLISM, V59, P993, DOI 10.1016/j.metabol.2009.10.022; Glaser C, 2010, J LIPID RES, V51, P216, DOI 10.1194/jlr.D000547; Heinrich J, 2002, EUR RESPIR J, V20, P617, DOI 10.1183/09031936.02.02322001; Institute Inc SAS, 2005, SAS GEN 9 1 3 US GUI; Kompauer I, 2005, BRIT J NUTR, V93, P529, DOI 10.1079/BJN20041387; Kummeling I, 2005, PEDIATR ALLERGY IMMU, V16, P679, DOI 10.1111/j.1399-3038.2005.00333.x; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lattka E, 2009, J NUTRIGENET NUTRIGE, V2, P119, DOI 10.1159/000235559; Malerba G, 2008, LIPIDS, V43, P289, DOI 10.1007/s11745-008-3158-5; Molto-Puigmarti C, 2010, AM J CLIN NUTR, V91, P1368, DOI 10.3945/ajcn.2009.28789; Nwankwo JO, 2003, J LIPID RES, V44, P2311, DOI 10.1194/jlr.M300273-JLR200; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Reimerink J, 2009, CLIN EXP ALLERGY, V39, P254, DOI 10.1111/j.1365-2222.2008.03128.x; Rzehak P, 2009, BRIT J NUTR, V101, P20, DOI 10.1017/S0007114508992564; SAS Institute, 2008, SAS STAT US GUID; Sausenthaler S, 2007, AM J CLIN NUTR, V85, P530; Sausenthaler S, 2006, CURR NUTR FOOD SCI, V2, P351, DOI 10.2174/157340106778699395; Schaeffer L, 2006, HUM MOL GENET, V15, P1745, DOI 10.1093/hmg/ddl117; Snijders BEP, 2008, PEDIATRICS, V122, pE115, DOI 10.1542/peds.2007-1651; STALLMAN PJ, 1977, INT ARCH ALLER A IMM, V54, P9, DOI 10.1159/000231803; Stapel SO, 2004, PEDIATR ALLERGY IMMU, V15, P230, DOI 10.1111/j.1399-3038.2004.00142.x; Tanaka T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000338; Xie L, 2008, J NUTR, V138, P2222, DOI 10.3945/jn.108.096156	40	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13261	10.1371/journal.pone.0013261	http://dx.doi.org/10.1371/journal.pone.0013261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948998	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100011
J	Cui, QH				Cui, Qinghua			A Network of Cancer Genes with Co-Occurring and Anti-Co-Occurring Mutations	PLOS ONE			English	Article							COLORECTAL CANCERS; HUMAN BREAST; SIMILARITY; PATTERNS	Certain cancer genes contribute to tumorigenesis in a manner of either co-occurring or mutually exclusive (anti-co-occurring) mutations; however, the global picture of when, where and how these functional interactions occur remains unclear. This study presents a systems biology approach for this purpose. After applying this method to cancer gene mutation data generated from large-scale and whole genome sequencing of cancer samples, a network of cancer genes with co-occurring and anti-co-occurring mutations was constructed. Analysis of this network revealed that genes with co-occurring mutations prefer direct signaling transductions and that the interaction relations among cancer genes in the network are related with their functional similarity. It was also revealed that genes with co-occurring mutations tend to have similar mutation frequencies, whereas genes with anti-co-occurring mutations tend to have different mutation frequencies. Moreover, genes with more exons tend to have more co-occurring mutations with other genes, and genes having lower local coherent network structures tend to have higher mutation frequency. The network showed two complementary modules that have distinct functions and have different roles in tumorigenesis. This study presented a framework for the analysis of cancer genome sequencing outputs. The presented data and uncovered patterns are helpful for understanding the contribution of gene mutations to tumorigenesis and valuable in the identification of key biomarkers and drug targets for cancer.	Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China	Peking University	Cui, QH (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biomed Informat, Beijing 100871, Peoples R China.	cuiqinghua@hsc.pku.edu.cn						Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Chng WJ, 2007, SCIENCE, V315, P762; Cui QH, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100200; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du ZD, 2009, NUCLEIC ACIDS RES, V37, pW345, DOI 10.1093/nar/gkp463; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hernandez P, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-13; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Lin J, 2007, GENOME RES, V17, P1304, DOI 10.1101/gr.6431107; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; PLEASANCE ED, 2009, NATURE; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Torkamani A, 2009, GENOME RES, V19, P1570, DOI 10.1101/gr.092833.109; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	26	28	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13180	10.1371/journal.pone.0013180	http://dx.doi.org/10.1371/journal.pone.0013180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957180	Green Submitted, Green Published, gold			2022-12-27	WOS:000282423300016
J	Elson-Schwab, I; Lorentzen, A; Marshall, CJ				Elson-Schwab, Ilan; Lorentzen, Anna; Marshall, Christopher J.			MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion	PLOS ONE			English	Article							MIR-200 FAMILY; E-CADHERIN; BREAST-CANCER; MESENCHYMAL TRANSITION; MALIGNANT-MELANOMA; REPRESSORS ZEB1; EXPRESSION; TARGETS; MARCKS; PROTEIN	Background: A functional role of microRNAs (miRNAs or miRs) in neoplasia and metastasis is becoming clear, and the miR-200 family has received much attention for potentially regulating tumor progression. The miRNAs of this family have been shown to suppress epithelial-mesenchymal transition, and their down-regulation in some tumors promotes invasion and metastasis. Interestingly, while miR-200 is down-regulated in some cancers, it is up-regulated in others. Principal Findings: We show that levels of miR-200 are increased in melanoma cell lines compared to normal melanocytes and that miR-200 family members play a role in determining modes of tumor cell migration. Individual tumor cells can invade in either elongated, "mesenchymal-type'' or rounded, "amoeboid-like'' modes and these two modes of invasion are inter-convertible [1]. In melanoma cell lines, expression of miR-200 members does not suppress invasion but rather leads to a switch between modes of invasion. MicroRNA-200c results in a higher proportion of cells adopting the rounded, amoeboid-like mode of invasion, while miR-200a results in a protrusion-associated elongated mode of invasion. Functional target identification studies suggest that the morphological effects of miR-200c may be mediated by reduced expression of MARCKS, which has been linked to formation of cell protrusions. In contrast miR-200a reduces actomyosin contractility, a feature of rounded morphology. Significance: Overall our findings call into question the general role of miR-200 in suppressing invasion and metastasis, and highlight novel distinguishing characteristics of individual miR-200 family members.	[Elson-Schwab, Ilan; Lorentzen, Anna; Marshall, Christopher J.] Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Elson-Schwab, I (corresponding author), Inst Canc Res, Canc Res UK Ctr Cell & Mol Biol, London SW3 6JB, England.	chris.marshall@icr.ac.uk	Xie, Huangming/B-2260-2012	Lorentzen, Anna/0000-0002-4405-935X	Cancer Research UK	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK. C.J.M. is a Cancer Research UK Gibb Life Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; COCHRANE DR, 2009, MOL CANC THER; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Estrada-Bernal A, 2009, J CELL SCI, V122, P2300, DOI 10.1242/jcs.047860; Fidler IJ, 1999, CANCER CHEMOTH PHARM, V43, pS3, DOI 10.1007/s002800051091; Gadea G, 2008, CURR BIOL, V18, P1456, DOI 10.1016/j.cub.2008.08.053; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Hurteau GJ, 2006, CELL CYCLE, V5, P1951, DOI 10.4161/cc.5.17.3133; Hurteau GJ, 2009, CELL CYCLE, V8, P2064, DOI 10.4161/cc.8.13.8883; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; JOSEPH CK, 1992, J BIOL CHEM, V267, P1327; Kent OA, 2009, CANCER BIOL THER, V8, P2013, DOI 10.4161/cbt.8.21.9685; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lee JW, 2008, CLIN CANCER RES, V14, P2535, DOI 10.1158/1078-0432.CCR-07-1231; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Manenti S, 1998, CANCER RES, V58, P1429; Mees ST, 2010, INT J CANCER, V126, P114, DOI 10.1002/ijc.24695; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Michel S, 2010, MOL CARCINOGEN, V49, P175, DOI 10.1002/mc.20587; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pinner S, 2008, NAT CELL BIOL, V10, P127, DOI 10.1038/ncb1675; Pogribny IR, 2009, TOXICOL APPL PHARM, V235, P305, DOI 10.1016/j.taap.2008.12.021; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Smith HW, 2008, J CELL BIOL, V182, P777, DOI 10.1083/jcb.200712050; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Wilkinson S, 2005, NAT CELL BIOL, V7, P255, DOI 10.1038/ncb1230; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; ZHANG L, 2010, CARCINOGENESIS	44	108	119	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13176	10.1371/journal.pone.0013176	http://dx.doi.org/10.1371/journal.pone.0013176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957176	Green Published, Green Submitted, gold			2022-12-27	WOS:000282423300013
J	Murayama, Y; Yoshioka, M; Masujin, K; Okada, H; Iwamaru, Y; Imamura, M; Matsuura, Y; Fukuda, S; Onoe, S; Yokoyama, T; Mohri, S				Murayama, Yuichi; Yoshioka, Miyako; Masujin, Kentaro; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Fukuda, Shigeo; Onoe, Sadao; Yokoyama, Takashi; Mohri, Shirou			Sulfated Dextrans Enhance In Vitro Amplification of Bovine Spongiform Encephalopathy PrPSc and Enable Ultrasensitive Detection of Bovine PrPSc	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; CREUTZFELDT-JAKOB-DISEASE; RESISTANT PRION PROTEIN; CHRONIC WASTING DISEASE; TRANSGENIC MICE; PENTOSAN POLYSULFATE; INFECTIOUS PRIONS; CULTURED-CELLS; VARIANT CJD; SCRAPIE	Background: Prions, infectious agents associated with prion diseases such as Creutzfeldt-Jakob disease in humans, bovine spongiform encephalopathy (BSE) in cattle, and scrapie in sheep and goats, are primarily comprised of PrPSc, a protease-resistant misfolded isoform of the cellular prion protein PrPC. Protein misfolding cyclic amplification (PMCA) is a highly sensitive technique used to detect minute amounts of scrapie PrPSc. However, the current PMCA technique has been unsuccessful in achieving good amplification in cattle. The detailed distribution of PrPSc in BSE-affected cattle therefore remains unknown. Methodology/Principal Findings: We report here that PrPSc derived from BSE-affected cattle can be amplified ultraefficiently by PMCA in the presence of sulfated dextran compounds. This method is capable of amplifying very small amounts of PrPSc from the saliva, palatine tonsils, lymph nodes, ileocecal region, and muscular tissues of BSE-affected cattle. Individual differences in the distribution of PrPSc in spleen and cerebrospinal fluid samples were observed in terminal-stage animals. However, the presence of PrPSc in blood was not substantiated in the BSE-affected cattle examined. Conclusions/Significance: The distribution of PrPSc is not restricted to the nervous system and can spread to peripheral tissues in the terminal disease stage. The finding that PrPSc could be amplified in the saliva of an asymptomatic animal suggests a potential usefulness of this technique for BSE diagnosis. This highly sensitive method also has other practical applications, including safety evaluation or safety assurance of products and byproducts manufactured from bovine source materials.	[Murayama, Yuichi; Yoshioka, Miyako; Masujin, Kentaro; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Yokoyama, Takashi; Mohri, Shirou] Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Safety Res Team, Tsukuba, Ibaraki 305, Japan; [Fukuda, Shigeo; Onoe, Sadao] Hokkaido Anim Res Ctr, Shintoku, Hokkaido 0810038, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Matsuura, Yuichi/AAF-3170-2021; Mohri, Shirou/AAK-1281-2020	Matsuura, Yuichi/0000-0003-3383-7918; Fukuda, Shigeo/0000-0001-5964-815X	Ministry of Agriculture, Forestry and Fisheries of Japan	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This study was supported by a grant-in-aid from the BSE Control Project of the Ministry of Agriculture, Forestry and Fisheries of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2010, BIOCHEMISTRY-US, V49, P3928, DOI 10.1021/bi100370b; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; FARQUHAR CF, 1986, J GEN VIROL, V67, P463, DOI 10.1099/0022-1317-67-3-463; Fujihara A, 2009, FEBS J, V276, P2841, DOI 10.1111/j.1742-4658.2009.07007.x; Gough KC, 2009, PRION, V3, P236, DOI 10.4161/pri.3.4.10425; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Houston F, 2008, BLOOD, V112, P4739, DOI 10.1182/blood-2008-04-152520; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Maddison BC, 2010, J INFECT DIS, V201, P1672, DOI 10.1086/652457; Mathiason CK, 2006, SCIENCE, V314, P133, DOI 10.1126/science.1132661; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Terada T, 2010, ACTA NEUROL SCAND, V121, P127, DOI 10.1111/j.1600-0404.2009.01272.x; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Todd NV, 2005, J INFECTION, V50, P394, DOI 10.1016/j.jinf.2004.07.015; Vascellari M, 2007, J VIROL, V81, P4872, DOI 10.1128/JVI.02148-06; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401; WELLS GAH, 1996, 6 INT WORKSH BOV SPO, P28; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; WILESMITH JW, 1988, VET REC, V123, P638; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377; Yokoyama T, 2007, JPN J INFECT DIS, V60, P317	39	45	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13152	10.1371/journal.pone.0013152	http://dx.doi.org/10.1371/journal.pone.0013152			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957174	Green Published, Green Submitted, gold			2022-12-27	WOS:000282423300007
J	Chu, HY; Gu, QH; Jin, GZ; Hu, GY; Zhen, XC				Chu, Hong-Yuan; Gu, Qinhua; Jin, Guo-Zhang; Hu, Guo-Yuan; Zhen, Xuechu			Electrophysiological Effects of SKF83959 on Hippocampal CA1 Pyramidal Neurons: Potential Mechanisms for the Drug's Neuroprotective Effects	PLOS ONE			English	Article							OUTWARD POTASSIUM CURRENT; D-1 DOPAMINE AGONISTS; PARKINSONS-DISEASE; VARYING EFFICACIES; STRIATAL NEURONS; CHANNELS; RAT; RECEPTOR; EXCITABILITY; PHARMACOLOGY	Although the potent anti-parkinsonian action of the atypical D(1)-like receptor agonist SKF83959 has been attributed to the selective activation of phosphoinositol(PI)-linked D(1) receptor, whereas the mechanism underlying its potent neuroprotective effect is not fully understood. In the present study, the actions of SKF83959 on neuronal membrane potential and neuronal excitability were investigated in CA1 pyramidal neurons of rat hippocampal slices. SKF83959 (10100 mu M) caused a concentration-dependent depolarization, associated with a reduction of input resistance in CA1 pyramidal neurons. The depolarization was blocked neither by antagonists for D(1), D(2), 5-HT(2A/2C) receptors and alpha(1)-adrenoceptor, nor by intracellular dialysis of GDP-beta-S. However, the specific HCN channel blocker ZD7288 (10 mu M) antagonized both the depolarization and reduction of input resistance caused by SKF83959. In voltage-clamp experiments, SKF83959 (10-100 mu M) caused a concentration-dependent increase of Ih current in CA1 pyramidal neurons, which was independent of D(1) receptor activation. Moreover, SKF83959 (50 mu M) caused a 6 mV positive shift in the activation curve of Ih and significantly accelerated the activation of Ih current. In addition, SKF83959 also reduced the neuronal excitability of CA1 pyramidal neurons, which was manifested by the decrease in the number and amplitude of action potentials evoked by depolarizing currents, and by the increase of firing threshold and rhoebase current. The above results suggest that SKF83959 increased Ih current through a D(1) receptor-independent mechanism, which led to the depolarization of hippocampal CA1 pyramidal neurons. These findings provide a novel mechanism for the drug's neuroprotective effects, which may contributes to its therapeutic benefits in Parkinson's disease.	[Chu, Hong-Yuan] Chinese Acad Sci, State Key Lab Drug Res, Shanghai, Peoples R China; Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol 2, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chu, HY (corresponding author), Chinese Acad Sci, State Key Lab Drug Res, Shanghai, Peoples R China.	xczhen@mail.shcnc.ac.cn	Chu, Hong-yuan/G-2380-2014	Chu, Hong-yuan/0000-0003-0923-683X; zhen, xuechu/0000-0001-7458-2566	Ministry of Science and Technology of China [2007AA02z163, 2009CB522000]; Natural Science Foundation of China [20872153, 30825042]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from National 863 and 973 research projects of the Ministry of Science and Technology of China (2007AA02z163, 2009CB522000), grants from Natural Science Foundation of China (20872153, 30825042). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Andringa G, 1999, PSYCHOPHARMACOLOGY, V146, P328, DOI 10.1007/s002130051124; ARNT J, 1992, EUR J PHARMACOL, V213, P259, DOI 10.1016/0014-2999(92)90690-6; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; CALABRESI P, 1993, BRAIN, V116, P433; Chen MT, 2001, EXP NEUROL, V171, P72, DOI 10.1006/exnr.2001.7730; Chen XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005811; Clifford JJ, 1999, NEUROSCIENCE, V93, P1483, DOI 10.1016/S0306-4522(99)00297-3; Cools AR, 2002, NEUROPHARMACOLOGY, V42, P237, DOI 10.1016/S0028-3908(01)00169-1; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P287, DOI 10.1007/BF02246103; GNANALINGHAM KK, 1995, PSYCHOPHARMACOLOGY, V117, P275, DOI 10.1007/BF02246102; Jin LQ, 2003, J NEUROCHEM, V85, P378, DOI 10.1046/j.1471-4159.2003.01698.x; Kish LJ, 1999, BRAIN RES, V833, P58, DOI 10.1016/S0006-8993(99)01496-1; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Magee JC, 1998, J NEUROSCI, V18, P7613; Neumeyer JL, 2003, EUR J PHARMACOL, V474, P137, DOI 10.1016/S0014-2999(03)02008-9; Pal S, 2003, J NEUROSCI, V23, P4798; Panchalingam S, 2001, NEUROPHARMACOLOGY, V40, P826, DOI 10.1016/S0028-3908(01)00011-9; Poolos NP, 2002, NAT NEUROSCI, V5, P767, DOI 10.1038/nn891; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SCHULTZ W, 1978, EXP BRAIN RES, V33, P159; Wahl-Schott C, 2009, CELL MOL LIFE SCI, V66, P470, DOI 10.1007/s00018-008-8525-0; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 1998, NEUROBIOL DIS, V5, P81, DOI 10.1006/nbdi.1998.0186; Yu Y, 2008, J NEUROCHEM, V104, P946, DOI 10.1111/j.1471-4159.2007.05062.x; Yu Y, 2007, ACTA PHARMACOL SIN, V28, P1891, DOI 10.1111/j.1745-7254.2007.00730.x; Zhang H, 2007, NEUROPHARMACOLOGY, V53, P125, DOI 10.1016/j.neuropharm.2007.04.004; Zhen XC, 2005, PHARMACOL BIOCHEM BE, V80, P597, DOI 10.1016/j.pbb.2005.01.016	30	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13118	10.1371/journal.pone.0013118	http://dx.doi.org/10.1371/journal.pone.0013118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957037	Green Submitted, Green Published, gold			2022-12-27	WOS:000282359300016
J	Skrzypczak, M; Goryca, K; Rubel, T; Paziewska, A; Mikula, M; Jarosz, D; Pachlewski, J; Oledzki, J; Ostrowsk, J				Skrzypczak, Magdalena; Goryca, Krzysztof; Rubel, Tymon; Paziewska, Agnieszka; Mikula, Michal; Jarosz, Dorota; Pachlewski, Jacek; Oledzki, Janusz; Ostrowsk, Jerzy			Modeling Oncogenic Signaling in Colon Tumors by Multidirectional Analyses of Microarray Data Directed for Maximization of Analytical Reliability	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; GENE-EXPRESSION; COLORECTAL-CANCER; OLIGONUCLEOTIDE ARRAYS; BIOPSY SPECIMEN; PATTERNS; ADENOMA; NORMALIZATION; PROFILES; CDNA	Background: Clinical progression of colorectal cancers (CRC) may occur in parallel with distinctive signaling alterations. We designed multidirectional analyses integrating microarray-based data with biostatistics and bioinformatics to elucidate the signaling and metabolic alterations underlying CRC development in the adenoma-carcinoma sequence. Methodology/Principal Findings: Studies were performed on normal mucosa, adenoma, and carcinoma samples obtained during surgery or colonoscopy. Collections of cryostat sections prepared from the tissue samples were evaluated by a pathologist to control the relative cell type content. The measurements were done using Affymetrix GeneChip HG-U133plus2, and probe set data was generated using two normalization algorithms: MAS5.0 and GCRMA with least-variant set (LVS). The data was evaluated using pair-wise comparisons and data decomposition into singular value decomposition (SVD) modes. The method selected for the functional analysis used the Kolmogorov-Smirnov test. Expressional profiles obtained in 105 samples of whole tissue sections were used to establish oncogenic signaling alterations in progression of CRC, while those representing 40 microdissected specimens were used to select differences in KEGG pathways between epithelium and mucosa. Based on a consensus of the results obtained by two normalization algorithms, and two probe set sorting criteria, we identified 14 and 17 KEGG signaling and metabolic pathways that are significantly altered between normal and tumor samples and between benign and malignant tumors, respectively. Several of them were also selected from the raw microarray data of 2 recently published studies (GSE4183 and GSE8671). Conclusion/Significance: Although the proposed strategy is computationally complex and labor-intensive, it may reduce the number of false results.	[Skrzypczak, Magdalena; Goryca, Krzysztof; Paziewska, Agnieszka; Jarosz, Dorota; Pachlewski, Jacek; Ostrowsk, Jerzy] Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland; [Rubel, Tymon] Maria Sklodowska Curie Mem Canc Ctr, Lab Bioinformat & Syst Biol, Warsaw, Poland; [Rubel, Tymon; Mikula, Michal; Oledzki, Janusz; Ostrowsk, Jerzy] Inst Oncol, Warsaw, Poland; [Mikula, Michal; Ostrowsk, Jerzy] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, Warsaw, Poland; [Oledzki, Janusz] Maria Sklodowska Curie Mem Canc Ctr, Dept Colorectal Canc, Warsaw, Poland	Centre of Postgraduate Medical Education - Poland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Skrzypczak, M (corresponding author), Med Ctr Postgrad Educ, Dept Gastroenterol & Hepatol, Warsaw, Poland.	jostrow@warman.com.pl	Rubel, Tymon/L-6861-2017; Skrzypczak, Magdalena/F-2575-2016; Mikula, Michal/G-8276-2011	Rubel, Tymon/0000-0002-1342-414X; Mikula, Michal/0000-0003-3447-7328; Oledzki, Jacek/0000-0002-8622-3218; Skrzypczak, Magdalena/0000-0002-3336-0403; Ostrowski, Jerzy/0000-0003-1363-3766	Polish Ministry of Science and Higher Education [PBZ-MNiI-2/1/2005]; Masovian PhD scholarship	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Masovian PhD scholarship	This work was supported by the Polish Ministry of Science and Higher Education grant PBZ-MNiI-2/1/2005. KG and MS were supported by "Masovian PhD scholarship". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affymetrix, 2001, STAT ALG REF GUID; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson JR, 2008, SURG CLIN N AM, V88, P681, DOI 10.1016/j.suc.2008.04.011; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calza S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-140; Cardoso J, 2007, BBA-REV CANCER, V1775, P103, DOI 10.1016/j.bbcan.2006.08.004; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Cope LM, 2004, BIOINFORMATICS, V20, P323, DOI 10.1093/bioinformatics/btg410; Friederichs J, 2005, INT J COLORECTAL DIS, V20, P391, DOI 10.1007/s00384-004-0722-1; Fritzmann J, 2009, GASTROENTEROLOGY, V137, P165, DOI 10.1053/j.gastro.2009.03.041; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Galamb O, 2006, WORLD J GASTROENTERO, V12, P6998, DOI 10.3748/wjg.v12.i43.6998; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Groene J, 2006, INT J CANCER, V119, P1829, DOI 10.1002/ijc.22027; Ilyas M, 1999, EUR J CANCER, V35, P335, DOI 10.1016/S0959-8049(98)00431-6; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jarzab B, 2005, CANCER RES, V65, P1587, DOI 10.1158/0008-5472.CAN-04-3078; Kitahara O, 2001, CANCER RES, V61, P3544; Kong W, 2008, BIOTECHNIQUES, V45, P501, DOI 10.2144/000112950; Lechner S, 2003, GUT, V52, P1148, DOI 10.1136/gut.52.8.1148; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lutter D, 2009, J BIOMED INFORM, V42, P605, DOI 10.1016/j.jbi.2009.01.002; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Notterman DA, 2001, CANCER RES, V61, P3124; Ostrowski J, 2007, J MOL MED, V85, P733, DOI 10.1007/s00109-007-0176-3; Ostrowski J, 2006, J MOL MED, V84, P872, DOI 10.1007/s00109-006-0083-z; Ostrowski J, 2009, EXPERT REV MOL DIAGN, V9, P623, DOI 10.1586/ERM.09.41; Peano C, 2006, EXPERT REV MOL DIAGN, V6, P465, DOI 10.1586/14737159.6.3.465; Pearson RD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-164; Ploner A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-80; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shih W, 2005, ONCOL REP, V13, P517; Shlomi T, 2008, NAT BIOTECHNOL, V26, P1003, DOI 10.1038/nbt.1487; Staub E, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-79; Sugiyama Y, 2005, GASTROENTEROLOGY, V128, P480, DOI 10.1053/j.gastro.2004.11.010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wiese AH, 2007, CANCER DETECT PREV, V31, P282, DOI 10.1016/j.cdp.2007.07.003; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanagawa R, 2001, NEOPLASIA, V3, P395, DOI 10.1038/sj.neo.7900185; Zhu JS, 2008, WORLD J GASTROENTERO, V14, P5887, DOI 10.3748/wjg.14.5887	49	283	288	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13091	10.1371/journal.pone.0013091	http://dx.doi.org/10.1371/journal.pone.0013091			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957034	Green Submitted, Green Published, gold			2022-12-27	WOS:000282359300004
J	Covey, TM; Edes, K; Coombs, GS; Virshup, DM; Fitzpatrick, FA				Covey, Tracy M.; Edes, Kornelia; Coombs, Gary S.; Virshup, David M.; Fitzpatrick, Frank A.			Alkylation of the Tumor Suppressor PTEN Activates Akt and beta-Catenin Signaling: A Mechanism Linking Inflammation and Oxidative Stress with Cancer	PLOS ONE			English	Article							CYCLOPENTENONE PROSTAGLANDINS; COLORECTAL-CANCER; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); COVALENT MODIFICATION; LIPID-PEROXIDATION; CELL; INACTIVATION; RESOLUTION; PROTEIN; GROWTH	PTEN, a phosphoinositide-3-phosphatase, serves dual roles as a tumor suppressor and regulator of cellular anabolic/catabolic metabolism. Adaptation of a redox-sensitive cysteinyl thiol in PTEN for signal transduction by hydrogen peroxide may have superimposed a vulnerability to other mediators of oxidative stress and inflammation, especially reactive carbonyl species, which are commonly occurring by-products of arachidonic acid peroxidation. Using MCF7 and HEK-293 cells, we report that several reactive aldehydes and ketones, e.g. electrophilic alpha,beta-enals (acrolein, 4-hydroxy-2-nonenal) and alpha,beta-enones (prostaglandin A(2), Delta 12-prostaglandin J(2) and 15-deoxy-Delta-12,14-prostaglandin J(2)) covalently modify and inactivate cellular PTEN, with ensuing activation of PKB/Akt kinase; phosphorylation of Akt substrates; increased cell proliferation; and increased nuclear beta-catenin signaling. Alkylation of PTEN by alpha,beta-enals/enones and interference with its restraint of cellular PKB/Akt signaling may accentuate hyperplastic and neoplastic disorders associated with chronic inflammation, oxidative stress, or aging.	[Covey, Tracy M.; Edes, Kornelia; Coombs, Gary S.; Virshup, David M.; Fitzpatrick, Frank A.] Univ Utah, Dept Med Chem, Hlth Sci Ctr, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Covey, TM (corresponding author), Duke Natl Univ Singapore Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.	FFitzpatrick@kcumb.edu	Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Coombs, Gary/0000-0002-0711-185X	National Institutes of Health Research [R01 AI 26730, PO1 CA73992, R03 MH082387-01]; NATIONAL CANCER INSTITUTE [P01CA073992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH082387] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by the National Institutes of Health Research Project Grant R01 AI 26730 (Frank A. Fitzpatrick), Research Program Projects PO1 CA73992 Project 4 (David M. Virshup) and Project 5 (Frank A. Fitzpatrick), and Small Grant Program R03 MH082387-01 (Gary S. Coombs, David M. Virshup and Frank A. Fitzpatrick). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Carothers AM, 2006, CANCER RES, V66, P6432, DOI 10.1158/0008-5472.CAN-06-0992; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Chen Y, 1999, J BIOL CHEM, V274, P10863, DOI 10.1074/jbc.274.16.10863; Chinery R, 1999, CANCER RES, V59, P2739; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Covey TM, 2007, ONCOGENE, V26, P5784, DOI 10.1038/sj.onc.1210391; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; ESTERBAUER H, 1990, MUTAT RES, V238, P223, DOI 10.1016/0165-1110(90)90014-3; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FITZPATRICK FA, 1983, J BIOL CHEM, V258, P1713; Gayarre J, 2005, FEBS LETT, V579, P5803, DOI 10.1016/j.febslet.2005.09.069; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gilroy DW, 2003, FASEB J, V17, P2269, DOI 10.1096/fj.02-1162fje; Grimsrud PA, 2008, J BIOL CHEM, V283, P21837, DOI 10.1074/jbc.R700019200; Hays E, 2009, IN VITRO CELL DEV-AN, V45, P361, DOI 10.1007/s11626-009-9189-2; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Landar A, 2006, BIOCHEM J, V394, P185, DOI 10.1042/BJ20051259; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; NARUMIYA S, 1986, J PHARMACOL EXP THER, V239, P500; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Peek RM, 2005, CANCER RES, V65, P8583, DOI 10.1158/0008-5472.CAN-05-1777; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piazza GA, 1997, CANCER RES, V57, P2909; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rajakariar R, 2007, P NATL ACAD SCI USA, V104, P20979, DOI 10.1073/pnas.0707394104; Roncucci L, 2008, CANCER EPIDEM BIOMAR, V17, P2291, DOI 10.1158/1055-9965.EPI-08-0224; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Rostom A, 2007, ANN INTERN MED, V146, P376, DOI 10.7326/0003-4819-146-5-200703060-00010; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; SHAHABI NA, 1987, EXP CELL BIOL, V55, P18; Sheehan KM, 1999, JAMA-J AM MED ASSOC, V282, P1254, DOI 10.1001/jama.282.13.1254; Shibata T, 2002, J BIOL CHEM, V277, P10459, DOI 10.1074/jbc.M110314200; Shin SY, 2006, CELL SIGNAL, V18, P601, DOI 10.1016/j.cellsig.2005.06.001; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; West JD, 2006, CHEM RES TOXICOL, V19, P173, DOI 10.1021/tx050321u; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	59	62	64	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13545	10.1371/journal.pone.0013545	http://dx.doi.org/10.1371/journal.pone.0013545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975834	Green Submitted, Green Published, gold			2022-12-27	WOS:000283293800014
J	Widodo, N; Priyandoko, D; Shah, N; Wadhwa, R; Kaul, SC				Widodo, Nashi; Priyandoko, Didik; Shah, Navjot; Wadhwa, Renu; Kaul, Sunil C.			Selective Killing of Cancer Cells by Ashwagandha Leaf Extract and Its Component Withanone Involves ROS Signaling	PLOS ONE			English	Article							FUNCTION EVOLUTION DATA; MEDIATED MECHANISM; PANCREATIC-CANCER; RIBOZYME LIBRARY; PROTEIN-SEQUENCE; IN-VITRO; DIFFERENTIATION; IDENTIFICATION; SOMNIFERA; APOPTOSIS	Background and Purpose: Ashwagandha is a popular Ayurvedic herb used in Indian traditional home medicine. It has been assigned a variety of health-promoting effects of which the mechanisms remain unknown. We previously reported the selective killing of cancer cells by leaf extract of Ashwagandha (i-Extract) and its purified component Withanone. In the present study, we investigated its mechanism by loss-of-function screening (abrogation of i-Extract induced cancer cell killing) of the cellular targets and gene pathways. Methodology/Principal Findings: Randomized ribozyme library was introduced into cancer cells prior to the treatment with i-Extract. Ribozymes were recovered from cells that survived the i-Extract treatment. Gene targets of the selected ribozymes (as predicted by database search) were analyzed by bioinformatics and pathway analyses. The targets were validated for their role in i-Extract induced selective killing of cancer cells by biochemical and molecular assays. Fifteen gene-targets were identified and were investigated for their role in specific cancer cell killing activity of i-Extract and its two major components (Withaferin A and Withanone) by undertaking the shRNA-mediated gene silencing approach. Bioinformatics on the selected gene-targets revealed the involvement of p53, apoptosis and insulin/IGF signaling pathways linked to the ROS signaling. We examined the involvement of ROS-signaling components (ROS levels, DNA damage, mitochondrial structure and membrane potential) and demonstrate that the selective killing of cancer cells is mediated by induction of oxidative stress. Conclusion: Ashwagandha leaf extract and Withanone cause selective killing of cancer cells by induction of ROS-signaling and hence are potential reagents that could be recruited for ROS-mediated cancer chemotherapy.	[Widodo, Nashi; Priyandoko, Didik; Shah, Navjot; Wadhwa, Renu; Kaul, Sunil C.] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan; [Widodo, Nashi] Brawijaya Univ, Fac Math & Nat Sci, Dept Biol, Malang, Indonesia; [Priyandoko, Didik; Shah, Navjot] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Brawijaya University; University of Tsukuba	Widodo, N (corresponding author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan.	renu-wadhwa@aist.go.jp; s-kaul@aist.go.jp	widodo, nashi/X-4595-2019; Priyandoko, Didik/GNP-1593-2022; Kaul, Sunil C/L-8671-2018; Wadhwa, Renu/L-8898-2018	widodo, nashi/0000-0002-1126-498X; Priyandoko, Didik/0000-0001-8601-9818; Kaul, Sunil C/0000-0002-0046-3916; Wadhwa, Renu/0000-0001-8248-5192	New Energy and Industrial Technology Development Organization (Japan); MEXT, Japan	New Energy and Industrial Technology Development Organization (Japan)(New Energy and Industrial Technology Development Organization (NEDO)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants from the New Energy and Industrial Technology Development Organization (Japan). N. S. is a recipient of MEXT Scholarship, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby RA, 2009, J BIOL CHEM, V284, P33177, DOI 10.1074/jbc.M109.032722; Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r23; Deocaris CC, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-14; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; Ding HM, 2009, NUTR CANCER, V61, P348, DOI 10.1080/01635580802567158; Furukawa T, 2006, ONCOGENE, V25, P4831, DOI 10.1038/sj.onc.1209494; Ge Y, 2006, BLOOD, V108, P4126, DOI 10.1182/blood-2006-04-017046; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Kim Y, 2003, CANCER GENE THER, V10, P707, DOI 10.1038/sj.cgt.7700623; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Lebedeva IV, 2003, CANCER RES, V63, P8138; Lieber A, 1996, J VIROL, V70, P8782, DOI 10.1128/JVI.70.12.8782-8791.1996; Menendez C, 2009, CURR DRUG TARGETS, V10, P406, DOI 10.2174/138945009788185077; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Rajab A, 2008, HUM MOL GENET, V17, P2150, DOI 10.1093/hmg/ddn114; Scott WG, 2009, BBA-GENE REGUL MECH, V1789, P634, DOI 10.1016/j.bbagrm.2009.09.006; Shah N, 2009, CANCER SCI, V100, P1740, DOI 10.1111/j.1349-7006.2009.01236.x; Shah S, 2009, BIOCHEM CELL BIOL, V87, P117, DOI 10.1139/O08-107; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tohda C, 2008, YAKUGAKU ZASSHI, V128, P1159, DOI 10.1248/yakushi.128.1159; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Tuschl T, 1998, EMBO J, V17, P2637, DOI 10.1093/emboj/17.9.2637; Unwalla HJ, 2008, MOL THER, V16, P1113, DOI 10.1038/mt.2008.54; Usman N, 1996, CURR OPIN STRUC BIOL, V6, P527, DOI 10.1016/S0959-440X(96)80119-9; Vlassov AV, 2004, OLIGONUCLEOTIDES, V14, P210, DOI 10.1089/oli.2004.14.210; Wadhwa R, 2004, J BIOL CHEM, V279, P51622, DOI 10.1074/jbc.M407428200; Wadhwa R, 2000, CANCER RES, V60, P6818; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Welch PJ, 2000, GENOMICS, V66, P274, DOI 10.1006/geno.2000.6230; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2009, J GERONTOL A-BIOL, V64, P1031, DOI 10.1093/gerona/glp088; Winters M, 2006, ALTERN MED REV, V11, P269; Wu XJ, 2007, CANCER BIOL THER, V6, P646, DOI 10.4161/cbt.6.5.4092; Xu YM, 2009, BIOORGAN MED CHEM, V17, P2210, DOI 10.1016/j.bmc.2008.10.091; Yen Laising, 2009, V540, P335, DOI 10.1007/978-1-59745-558-9_24; Zhu Z, 2009, HEPATOLOGY, V49, P504, DOI 10.1002/hep.22675	43	101	101	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13536	10.1371/journal.pone.0013536	http://dx.doi.org/10.1371/journal.pone.0013536			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975835	Green Submitted, Green Published, gold			2022-12-27	WOS:000283293800010
J	Frommer, F; Waisman, A				Frommer, Friederike; Waisman, Ari			B Cells Participate in Thymic Negative Selection of Murine Auto-reactive CD4(+) T Cells	PLOS ONE			English	Article							DENDRITIC CELLS; POSITIVE SELECTION; SELF-TOLERANCE; RECEPTOR; MICE; RECOGNITION; EXPRESSION; APOPTOSIS; ANTIGENS; DELETION	It is well documented that thymic epithelial cells participate in the process of negative selection in the thymus. In recent years it was reported that also dendritic cells enter the thymus and contribute to this process, thus allowing for the depletion of thymocytes that are specific to peripherally expressed self-antigens. Here we report that also B cells may take part in the elimination of auto-reactive thymocytes. Using a unique mouse model we show that B cells induce negative selection of self-reactive thymocytes in a process that leads to the deletion of these cells whereas regulatory T cells are spared. These findings have direct implication in autoimmunity, as expression of a myelin antigen by B cells in the thymus renders the mice resistant to autoimmune inflammation of the CNS.	[Frommer, Friederike; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Frommer, F (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55131 Mainz, Germany.	waisman@uni-mainz.de	Waisman, Ari/C-7383-2015	Waisman, Ari/0000-0003-4304-8234	DFG [WA 1600/3-1, FOR1336, SFB/TR 52]; Immunology Center; German Ministry for Education and Research (BMBF)	DFG(German Research Foundation (DFG)); Immunology Center; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	AW is supported by the DFG grants WA 1600/3-1, FOR1336 and SFB/TR 52, by the Immunology Center of Excellence Mainz (FZI) and by the German Ministry for Education and Research (BMBF, Consortium UNDERSTANDMS, as part of the "German Competence Network of MS"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, J IMMUNOL, V164, P5221, DOI 10.4049/jimmunol.164.10.5221; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brocker T, 1997, J EXP MED, V185, P541, DOI 10.1084/jem.185.3.541; Bruno L, 1996, IMMUNITY, V5, P343, DOI 10.1016/S1074-7613(00)80260-5; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Doffinger R, 1997, MOL IMMUNOL, V34, P115, DOI 10.1016/S0161-5890(97)00014-X; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Frommer F, 2008, J IMMUNOL, V181, P5748, DOI 10.4049/jimmunol.181.8.5748; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hanahan D, 1998, CURR OPIN IMMUNOL, V10, P656, DOI 10.1016/S0952-7915(98)80085-X; Hare KJ, 2003, J IMMUNOL, V171, P2825, DOI 10.4049/jimmunol.171.6.2825; Hovelmeyer N, 2007, J EXP MED, V204, P2615, DOI 10.1084/jem.20070318; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; JENKINSON EJ, 1994, DEV IMMUNOL, V3, P265, DOI 10.1155/1994/75434; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Kleindienst P, 2000, BLOOD, V95, P2610; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Proietto AI, 2008, P NATL ACAD SCI USA, V105, P19869, DOI 10.1073/pnas.0810268105; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rolink A, 1996, IMMUNITY, V5, P319, DOI 10.1016/S1074-7613(00)80258-7; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Taylor SRJ, 2007, J IMMUNOL, V178, P3474, DOI 10.4049/jimmunol.178.6.3474; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Volkmann A, 1997, J IMMUNOL, V158, P693	37	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e15372	10.1371/journal.pone.0015372	http://dx.doi.org/10.1371/journal.pone.0015372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976010	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400031
J	Mills, RF; Valdes, B; Duke, M; Peaston, KA; Lahner, B; Salt, DE; Williams, LE				Mills, Rebecca F.; Valdes, Billy; Duke, Michael; Peaston, Kerry A.; Lahner, Brett; Salt, David E.; Williams, Lorraine E.			Functional Significance of AtHMA4 C-Terminal Domain In Planta	PLOS ONE			English	Article							METAL-BINDING DOMAIN; ARABIDOPSIS-THALIANA; THLASPI-CAERULESCENS; TRANSPORTING ATPASE; ZINC HOMEOSTASIS; P-1B-TYPE ATPASE; CADMIUM; EXPRESSION; HYPERACCUMULATION; BIOFORTIFICATION	Background: Enhancing the upward translocation of heavy metals such as Zn from root to shoot through genetic engineering has potential for biofortification and phytoremediation. This study examined the contribution of the heavy metal-transporting ATPase, AtHMA4, to the shoot ionomic profile of soil-grown plants, and investigated the importance of the C-terminal domain in the functioning of this transporter. Principal Findings: The Arabidopsis hma2 hma4 mutant has a stunted phenotype and a distinctive ionomic profile, with low shoot levels of Zn, Cd, Co, K and Rb, and high shoot Cu. Expression of AtHMA4 (AtHMA4-FL) under the CaMV-35S promoter partially rescued the stunted phenotype of hma2 hma4; rosette diameter returned to wild-type levels in the majority of lines and bolts were also produced, although the average bolt height was not restored completely. AtHMA4-FL expression rescued Co, K, Rb and Cu to wild-type levels, and partially returned Cd and Zn levels (83% and 28% of wild type respectively). In contrast, expression of AtHMA4-trunc (without the C-terminal region) in hma2 hma4 only partially restored the rosette diameter in two of five lines and bolt production was not rescued. There was no significant effect on the shoot ionomic profile, apart from Cd, which was increased to 41% of wild-type levels. When the AtHMA4 C-terminal domain (AtHMA4-C-term) was expressed in hma2 hma4 it had no marked effect. When expressed in yeast, AtHMA4-C-term and AtHMA4-trunc conferred greater Cd and Zn tolerance than AtHMA4-FL. Conclusion: The ionome of the hma2 hma4 mutant differs markedly from wt plants. The functional relevance of domains of AtHMA4 in planta can be explored by complementing this mutant. AtHMA4-FL is more effective in restoring shoot metal accumulation in this mutant than a C-terminally truncated version of the pump, indicating that the C-terminal domain is important in the functioning of AtHMA4 in planta.	[Mills, Rebecca F.; Valdes, Billy; Duke, Michael; Peaston, Kerry A.; Williams, Lorraine E.] Univ Southampton, Sch Biol Sci, Southampton, Hants, England; [Lahner, Brett; Salt, David E.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA	University of Southampton; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Mills, RF (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	lew@soton.ac.uk			European Union [FOOD-CT-2006- 016253]; US National Science Foundation [IBN-0419695, DBI- 0953433]; US National Institutes of Health [R01 GM078536]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078536] Funding Source: NIH RePORTER	European Union(European Commission); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the European Union Framework Programme 6 as part of the Integrated Project Public health impact of long-term, low-level mixed element exposure in susceptible population strata (PHIME) (contract no FOOD-CT-2006- 016253); it reflects only the authors' views. The Community is not liable for any use that may be made of the information contained therein. The authors also acknowledge funding to D. E. S. from the US National Science Foundation (IBN-0419695 & DBI- 0953433) and the US National Institutes of Health (R01 GM078536). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEKGAARD L, J BIOL CHEM IN PRESS; Bernard C, 2004, FEBS LETT, V569, P140, DOI 10.1016/j.febslet.2004.05.036; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Brown KH, 1998, BIBL NUTR DIET, P76; BROWN KH, 2009, PREVENTIVE ZINC SUPP; Caulfield LE, 2004, AM J CLIN NUTR, V80, P193; Clemens S, 2006, J PLANT PHYSIOL, V163, P319, DOI 10.1016/j.jplph.2005.11.010; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Genc Y, 2009, PLANT SOIL, V314, P49, DOI 10.1007/s11104-008-9704-3; Hanikenne M, 2008, NATURE, V453, P391, DOI 10.1038/nature06877; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Lahner B, 2003, NAT BIOTECHNOL, V21, P1215, DOI 10.1038/nbt865; Li ZS, 1996, J BIOL CHEM, V271, P6509, DOI 10.1074/jbc.271.11.6509; McCormac AC, 1997, MOL BIOTECHNOL, V8, P199, DOI 10.1007/BF02760773; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mills RF, 2005, FEBS LETT, V579, P783, DOI 10.1016/j.febslet.2004.12.040; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Ramesh SA, 2004, PLANT MOL BIOL, V54, P373, DOI 10.1023/B:PLAN.0000036370.70912.34; ROBINSON NJ, 1993, BIOCHEM J, V295, P1; SIEMIANOWSKI O, 2010, PLANT BIOTE IN PRESS; Sinclair SA, 2007, NEW PHYTOL, V174, P39, DOI 10.1111/j.1469-8137.2007.02030.x; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Verret F, 2004, FEBS LETT, V576, P306, DOI 10.1016/j.febslet.2004.09.023; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; White PJ, 2009, NEW PHYTOL, V182, P49, DOI 10.1111/j.1469-8137.2008.02738.x; Williams L, 2009, CURR OPIN PLANT BIOL, V12, P247, DOI 10.1016/j.pbi.2009.05.009; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x	32	46	49	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13388	10.1371/journal.pone.0013388	http://dx.doi.org/10.1371/journal.pone.0013388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975991	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283216400003
J	Tao, WJ; Zou, M; Wang, XZ; Gan, XN; Mayden, RL; He, SP				Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni; Mayden, Richard L.; He, Shunping			Phylogenomic Analysis Resolves the Formerly Intractable Adaptive Diversification of the Endemic Clade of East Asian Cyprinidae (Cypriniformes)	PLOS ONE			English	Article							ORDER CYPRINIFORMES; DIVERGENCE TIME; NUCLEAR GENE; MITOCHONDRIAL; EVOLUTIONARY; TELEOSTEI; MODEL; ACTINOPTERYGII; TREE; OSTARIOPHYSI	Despite their great diversity and biological importance, evolutionary relationships among the endemic clade of East Asian Cyprinidae remain ambiguous. Understanding the phylogenetic history of this group involves many challenges. For instance, ecomorphological convergence may confound morphology-based phylogenetic inferences, and previous molecular phylogenetic studies based on single genes have often yielded contradictory and poorly supported trees. We assembled a comprehensive data matrix of 100 nuclear gene segments (similar to 71132 base pairs) for representative species of the endemic East Asian cyprinid fauna and recovered a robust phylogeny from this genome-wide signal supported by multiple analytical methods, including maximum parsimony, maximum likelihood and Bayesian inference. Relaxed molecular clock analyses indicated species radiations of this clade concentrated at approximately 1.9-7.6 MYA. We provide evidence that the bursts of diversification in this fauna are directly linked to major paleoenvironmental events associated with monsoon evolution occurring from late Miocene to Pliocene. Ancestral state reconstruction reveals convergent morphological characters are hypothesized to be independent products of similar selective pressures in ecosystems. Our study is the first comprehensive phylogenetic study of the enigmatic East-Asian cyprinids. The explicit molecular phylogeny provides a valuable framework for future research in genome evolution, adaptation and speciation of cyprinids.	[Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni; He, Shunping] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China; [Tao, Wenjing; Zou, Ming; Wang, Xuzhen; Gan, Xiaoni] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Mayden, Richard L.] St Louis Univ, Dept Biol, Lab Integrated Genom Biodivers & Conservat, St Louis, MO 63103 USA	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Saint Louis University	Tao, WJ (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	clad@ihb.ac.cn	Wang, Xuzhen/L-7892-2019		Major State Basic Research Development Program of China (973 Program) [2007CB411601, 2004CB117400]; United States National Science Foundation (NSF) [EF-0431326]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); United States National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by the Major State Basic Research Development Program of China (973 Program), grants number 2007CB411601 and 2004CB117400) to SH and United States National Science Foundation (NSF) grant number EF-0431326 to RLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Angelini DR, 2008, MOL PHYLOGENET EVOL, V46, P127, DOI 10.1016/j.ympev.2007.08.017; Badyaev AV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-3; Baker RH, 1997, SYST BIOL, V46, P654, DOI 10.2307/2413499; Bapteste E, 2002, P NATL ACAD SCI USA, V99, P1414, DOI 10.1073/pnas.032662799; Barrier M, 2001, P NATL ACAD SCI USA, V98, P10208, DOI 10.1073/pnas.181257698; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Castresana J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-216; Chen WJ, 2008, GENE, V423, P125, DOI 10.1016/j.gene.2008.07.016; CHEN X, 1984, ACT ZOO SINICA, V9; CHEN YY, 1998, FAUNA SINICA OSTEI 2; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dettai A, 2005, CR BIOL, V328, P674, DOI 10.1016/j.crvi.2005.04.002; Franzosa EA, 2007, TREEROT VERSION 3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hackett JD, 2007, MOL BIOL EVOL, V24, P1702, DOI 10.1093/molbev/msm089; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; He SP, 2004, SCI CHINA SER C, V47, P130, DOI 10.1360/03yc0034; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hulsey CD, 2008, EVOLUTION, V62, P1587, DOI 10.1111/j.1558-5646.2008.00384.x; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kikugawa K, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-3; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Koblmuller S, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-49; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; *LAB ICHTH, 1976, FISH YANGTZ RIV; Lecointre G, 2005, ZOOL SCR, V34, P101, DOI 10.1111/j.1463-6409.2005.00168.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Li JB, 2008, MOL PHYLOGENET EVOL, V47, P472, DOI 10.1016/j.ympev.2007.09.012; Lienau EK, 2009, ACTA BIOTHEOR, V57, P187, DOI 10.1007/s10441-008-9066-5; LIU HSIEN-T'ING, 1962, VERTEBR PALASIAT, V6, P1; Liu HZ, 2003, CAN J ZOOL, V81, P1938, DOI [10.1139/z03-169, 10.1139/Z03-169]; Mayden RL, 2007, J EXP ZOOL PART B, V308B, P642, DOI 10.1002/jez.b.21175; MHAPAH M, 1993, OIKOS, V68, P549; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nabholz B, 2008, MOL BIOL EVOL, V25, P120, DOI 10.1093/molbev/msm248; NELSON J S, 1976, P416; Page RDM, 2000, MOL PHYLOGENET EVOL, V14, P89, DOI 10.1006/mpev.1999.0676; Peregrin-Alvarez Jose M., 2009, V533, P257, DOI 10.1007/978-1-60327-136-3_12; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qiu YL, 1999, NATURE, V402, P404, DOI 10.1038/46536; Rieppel O, 2003, SYST BIOL, V52, P259, DOI 10.1080/10635150390192762; ROBERT EK, 1995, AM STAT ASS, V90, P773; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Rutschmann F., 2005, BAYESIAN MOL DATING; Saitoh K, 2006, J MOL EVOL, V63, P826, DOI 10.1007/s00239-005-0293-y; SAMBROOK E, 1989, MOL CLONING LAB MANU; Savard J, 2006, GENOME RES, V16, P1334, DOI 10.1101/gr.5204306; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Sims GE, 2009, P NATL ACAD SCI USA, V106, P17077, DOI 10.1073/pnas.0909377106; Springer MS, 1999, SYST BIOL, V48, P65, DOI 10.1080/106351599260445; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Syring J, 2005, AM J BOT, V92, P2086, DOI 10.3732/ajb.92.12.2086; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Varona L, 2001, GENET SEL EVOL, V33, P133, DOI 10.1051/gse:2001113; Wang XZ, 2007, MOL PHYLOGENET EVOL, V42, P157, DOI 10.1016/j.ympev.2006.06.014; Wang XZ, 2004, PROG NAT SCI-MATER, V14, P132, DOI 10.1080/10020070412331343261; WILEY EO, 1981, PHYLOGENETICS THEORY; WINFIELD IJ, 1991, BIOL CYPRINIDS; Witek A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-345; Wood RM, 2002, REV FISH BIOL FISHER, V12, P253, DOI 10.1023/A:1025018118339; Zou XH, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r49	67	25	27	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13508	10.1371/journal.pone.0013508	http://dx.doi.org/10.1371/journal.pone.0013508			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976012	gold, Green Published, Green Submitted			2022-12-27	WOS:000283216400015
J	Machida, K; Eschrich, S; Li, J; Bai, Y; Koomen, J; Mayer, BJ; Haura, EB				Machida, Kazuya; Eschrich, Steven; Li, Jiannong; Bai, Yun; Koomen, John; Mayer, Bruce J.; Haura, Eric B.			Characterizing Tyrosine Phosphorylation Signaling in Lung Cancer Using SH2 Profiling	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; C-MET; RECEPTOR GENE; CELL-LINES; IN-VITRO; KINASE; GEFITINIB; SENSITIVITY; EGFR; MUTATIONS	Background: Tyrosine kinases drive the proliferation and survival of many human cancers. Thus profiling the global state of tyrosine phosphorylation of a tumor is likely to provide a wealth of information that can be used to classify tumors for prognosis and prediction. However, the comprehensive analysis of tyrosine phosphorylation of large numbers of human cancer specimens is technically challenging using current methods. Methodology/Principal Findings: We used a phosphoproteomic method termed SH2 profiling to characterize the global state of phosphotyrosine (pTyr) signaling in human lung cancer cell lines. This method quantifies the phosphorylated binding sites for SH2 domains, which are used by cells to respond to changes in pTyr during signaling. Cells could be grouped based on SH2 binding patterns, with some clusters correlated with EGF receptor (EGFR) or K-RAS mutation status. Binding of specific SH2 domains, most prominently RAS pathway activators Grb2 and ShcA, correlated with EGFR mutation and sensitivity to the EGFR inhibitor erlotinib. SH2 binding patterns also reflected MET activation and could identify cells driven by multiple kinases. The pTyr responses of cells treated with kinase inhibitors provided evidence of distinct mechanisms of inhibition. Conclusions/Significance: This study illustrates the potential of modular protein domains and their proteomic binding profiles as powerful molecular diagnostic tools for tumor classification and biomarker identification.	[Machida, Kazuya; Mayer, Bruce J.] Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT USA; [Eschrich, Steven] H Lee Moffitt Canc Ctr & Res Inst, Dept Bioinformat, Tampa, FL USA; [Li, Jiannong; Bai, Yun; Haura, Eric B.] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol, Tampa, FL USA; [Koomen, John] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	University of Connecticut; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Machida, K (corresponding author), Univ Connecticut, Ctr Hlth, Raymond & Beverly Sackler Lab Genet & Mol Med, Dept Genet & Dev Biol, Farmington, CT USA.	bmayer@neuron.uchc.edu; Eric.haura@moffitt.org	Eschrich, Steven/K-6848-2013; Koomen, John/D-1844-2013	Eschrich, Steven/0000-0002-9833-2788; 	National Functional Genomics Center [E395859332944CBF8AFBDED2CE39B74A, W81XWH-08-2-0101]; National Institutes of Health [P50-CA119997, R33-CA107785, RC1-CA146843, P30CA076292]; CT Breast Health Initiative, Inc.; NATIONAL CANCER INSTITUTE [P50CA119997, P30CA076292, RC1CA146843, R33CA107785] Funding Source: NIH RePORTER	National Functional Genomics Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CT Breast Health Initiative, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was partially funded by grants from the National Functional Genomics Center (http://nfgc.moffitt.org/nfgc_Site.aspx?spid = E395859332944CBF8AFBDED2CE39B74A) (W81XWH-08-2-0101), the National Institutes of Health (http://grants.nih.gov/grants/oer.htm) (P50-CA119997, R33-CA107785, and RC1-CA146843) and the CT Breast Health Initiative, Inc. (http://ctbhi.org/). This work has been supported in part by a grant from the National Institutes of Health (P30CA076292) to the Molecular Biology Core and Bioinformatics Core Facilities at the H. Lee Moffitt Cancer Center & Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoku S, 2009, J CELL SCI, V122, P4228, DOI 10.1242/jcs.054627; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brannan JM, 2009, CLIN CANCER RES, V15, P4423, DOI 10.1158/1078-0432.CCR-09-0473; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Christensen JG, 2003, CANCER RES, V63, P7345; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dierck K, 2006, NAT METHODS, V3, P737, DOI 10.1038/nmeth917; Dierck Kevin, 2009, V527, P131, DOI 10.1007/978-1-60327-834-8_11; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fischer H, 2008, MOL CANCER THER, V7, P3408, DOI 10.1158/1535-7163.MCT-08-0444; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson FM, 2005, CLIN CANCER RES, V11, P6924, DOI 10.1158/1078-0432.CCR-05-0757; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kikuchi T, 2007, RESPIROLOGY, V12, P22, DOI 10.1111/j.1440-1843.2006.00957.x; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Machida K, 2005, BBA-PROTEINS PROTEOM, V1747, P1, DOI 10.1016/j.bbapap.2004.10.005; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Machida K, 2009, METHODS MOL BIOL, V536, P313, DOI 10.1007/978-1-59745-542-8_34; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Nakamura Y, 2008, CANCER SCI, V99, P14, DOI 10.1111/j.1349-7006.2007.00640.x; Nollau P, 2001, P NATL ACAD SCI USA, V98, P13531, DOI 10.1073/pnas.241215998; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Ptacek J, 2006, TRENDS GENET, V22, P545, DOI 10.1016/j.tig.2006.08.005; Puri N, 2007, CANCER RES, V67, P3529, DOI 10.1158/0008-5472.CAN-06-4416; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Schmezle K, 2006, CURR OPIN BIOTECH, V17, P406, DOI 10.1016/j.copbio.2006.06.004; Sequist LV, 2008, J CLIN ONCOL, V26, P2442, DOI 10.1200/JCO.2007.14.8494; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Song LX, 2006, CANCER RES, V66, P5542, DOI 10.1158/0008-5472.CAN-05-4620; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957	52	29	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13470	10.1371/journal.pone.0013470	http://dx.doi.org/10.1371/journal.pone.0013470			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976048	Green Published, Green Submitted, gold			2022-12-27	WOS:000283114700008
J	Martignani, E; Eirew, P; Accornero, P; Eaves, CJ; Baratta, M				Martignani, Eugenio; Eirew, Peter; Accornero, Paolo; Eaves, Connie J.; Baratta, Mario			Human Milk Protein Production in Xenografts of Genetically Engineered Bovine Mammary Epithelial Stem Cells	PLOS ONE			English	Article							TEMPLATE DNA STRANDS; ALDEHYDE DEHYDROGENASE; GLAND; MARKER; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; PROLIFERATION; PROGENITORS; POPULATION	Background: In the bovine species milk production is well known to correlate with mammary tissue mass. However, most advances in optimizing milk production relied on improvements of breeding and husbandry practices. A better understanding of the cells that generate bovine mammary tissue could facilitate important advances in milk production and have global economic impact. With this possibility in mind, we show that a mammary stem cell population can be functionally identified and isolated from the bovine mammary gland. We also demonstrate that this stem cell population may be a promising target for manipulating the composition of cow's milk using gene transfer. Methods and Findings: We show that the in vitro colony-forming cell assay for detecting normal primitive bipotent and lineage-restricted human mammary clonogenic progenitors are applicable to bovine mammary cells. Similarly, the ability of normal human mammary stem cells to regenerate functional bilayered structures in collagen gels placed under the kidney capsule of immunodeficient mice is shared by a subset of bovine mammary cells that lack aldehyde dehydrogenase activity. We also find that this activity is a distinguishing feature of luminal-restricted bovine progenitors. The regenerated structures recapitulate the organization of bovine mammary tissue, and milk could be readily detected in these structures when they were assessed by immunohistochemical analysis. Transplantation of the bovine cells transduced with a lentivirus encoding human beta-CASEIN led to expression of the transgene and secretion of the product by their progeny regenerated in vivo. Conclusions: These findings point to a common developmental hierarchy shared by human and bovine mammary glands, providing strong evidence of common mechanisms regulating the maintenance and differentiation of mammary stem cells from both species. These results highlight the potential of novel engineering and transplant strategies for a variety of commercial applications including the production of modified milk components for human consumption.	[Martignani, Eugenio; Eirew, Peter; Accornero, Paolo; Baratta, Mario] Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy; [Martignani, Eugenio; Eirew, Peter; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	University of Turin; British Columbia Cancer Agency	Baratta, M (corresponding author), Univ Turin, Dept Vet Morphophysiol, Grugliasco, Italy.	mario.baratta@unito.it	Baratta, Mario/ABA-7749-2021; Baratta, Mario/AAP-8882-2021	Baratta, Mario/0000-0003-2537-6429; Eaves, Connie/0000-0002-3452-1926	Canadian Cancer Society; Canadian Bank of Commerce, Regione Piemonte; CRC Foundation; British Columbia Cancer Foundation; University of Turin; United States Department of Defense	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Bank of Commerce, Regione Piemonte(Regione Piemonte); CRC Foundation; British Columbia Cancer Foundation; University of Turin; United States Department of Defense(United States Department of Defense)	This work was supported by grants from the Canadian Cancer Society, the Canadian Bank of Commerce, Regione Piemonte, and the CRC Foundation with core support provided by the British Columbia Cancer Foundation and the University of Turin. Peter Eirew held a United States Department of Defense Breast Cancer Research Program Studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Burger PE, 2009, STEM CELLS, V27, P2220, DOI 10.1002/stem.135; Capuco AV, 2007, EXP BIOL MED, V232, P1381, DOI 10.3181/0703-RM-58; Capuco AV, 2002, TISSUE CELL, V34, P143, DOI 10.1016/S0040-8166(02)00024-1; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Ellis S, 2002, TISSUE CELL, V34, P155, DOI 10.1016/S0040-8166(02)00025-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hanker L, 2010, BREAST CANCER RES TR, V122, P765, DOI 10.1007/s10549-009-0608-6; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; JEAN E, 2009, J CELL MOL MED; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; RICHARDS SR, 1983, AM J OBSTET GYNECOL, V146, P1; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Smith GH, 2005, DEVELOPMENT, V132, P681, DOI 10.1242/dev.01609; SMITH GH, 1988, J CELL SCI, V90, P173; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Stingl J, 2009, J PATHOL, V217, P229, DOI 10.1002/path.2457; Stingl J, 2006, CELL CYCLE, V5, P1519, DOI 10.4161/cc.5.14.2983; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Tiede BJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008035	31	37	37	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13372	10.1371/journal.pone.0013372	http://dx.doi.org/10.1371/journal.pone.0013372			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976049	Green Published, Green Submitted, gold			2022-12-27	WOS:000283114700003
J	Andersson, T; Rahman, S; Sansom, SN; Alsio, JM; Kaneda, M; Smith, J; O'Carroll, D; Tarakhovsky, A; Livesey, FJ				Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Kaneda, Masahiro; Smith, James; O'Carroll, Donal; Tarakhovsky, Alexander; Livesey, Frederick J.			Reversible Block of Mouse Neural Stem Cell Differentiation in the Absence of Dicer and MicroRNAs	PLOS ONE			English	Article							MICROARRAY ANALYSIS; GENE-EXPRESSION; SELF-RENEWAL; BRAIN; MORPHOGENESIS; NEUROGENESIS; TRANSITION; SURVIVAL; NEURONS; MURINE	Background: To investigate the functions of Dicer and microRNAs in neural stem (NS) cell self-renewal and neurogenesis, we established neural stem cell lines from the embryonic mouse Dicer-null cerebral cortex, producing neural stem cell lines that lacked all microRNAs. Principal Findings: Dicer-null NS cells underwent normal self-renewal and could be maintained in vitro indefinitely, but had subtly altered cell cycle kinetics and abnormal heterochromatin organisation. In the absence of all microRNAs, Dicer-null NS cells were incapable of generating either glial or neuronal progeny and exhibited a marked dependency on exogenous EGF for survival. Dicer-null NS cells assumed complex differences in mRNA and protein expression under self-renewing conditions, upregulating transcripts indicative of self-renewing NS cells and expressing genes characteristic of differentiating neurons and glia. Underlining the growth-factor dependency of Dicer-null NS cells, many regulators of apoptosis were enriched in expression in these cells. Dicer-null NS cells initiate some of the same gene expression changes as wild-type cells under astrocyte differentiating conditions, but also show aberrant expression of large sets of genes and ultimately fail to complete the differentiation programme. Acute replacement of Dicer restored their ability to differentiate to both neurons and glia. Conclusions: The block in differentiation due to loss of Dicer and microRNAs is reversible and the significantly altered phenotype of Dicer-null NS cells does not constitute a permanent transformation. We conclude that Dicer and microRNAs function in this system to maintain the neural stem cell phenotype and to facilitate the completion of differentiation.	[Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Kaneda, Masahiro; Smith, James; Livesey, Frederick J.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Andersson, Therese; Rahman, Sabhi; Sansom, Stephen N.; Alsioe, Jessica M.; Smith, James; Livesey, Frederick J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [O'Carroll, Donal; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signalling, New York, NY 10021 USA	University of Cambridge; University of Cambridge; Rockefeller University	Andersson, T (corresponding author), Univ Cambridge, Gurdon Inst, Cambridge, England.	rick@gurdon.cam.ac.uk	Kaneda, Masahiro/E-3117-2010; Vasilica, Andrei V/F-2185-2010	Kaneda, Masahiro/0000-0003-0660-7156; O'Carroll, Donal/0000-0002-8626-2217; Smith, James/0000-0001-9131-5849; Livesey, Rick/0000-0001-6128-3372	Wellcome Trust; Wenner-Gren Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Wenner-Gren Foundation	This work was supported by grants from the Wellcome Trust (FJL) and the Wenner-Gren Foundation (TA) and by core support to the Gurdon Institute from Cancer Research UK and the Wellcome Trust (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KM, 1999, EPILEPSY RES, V36, P143, DOI 10.1016/S0920-1211(99)00048-0; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Ferland RJ, 2003, J COMP NEUROL, V460, P266, DOI 10.1002/cne.10654; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Giles KE, 2010, NAT CELL BIOL, V12, P94, DOI 10.1038/ncb2010; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris KS, 2006, P NATL ACAD SCI USA, V103, P2208, DOI 10.1073/pnas.0510839103; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawase-Koga Y, 2010, J CELL SCI, V123, P586, DOI 10.1242/jcs.059659; Kawase-Koga Y, 2009, DEV DYNAM, V238, P2800, DOI 10.1002/dvdy.22109; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Martin D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r101; Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stadler BM, 2008, CELL, V132, P563, DOI 10.1016/j.cell.2008.02.005; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Young ARJ, 2007, GENE DEV, V21, P1005, DOI 10.1101/gad.1554707	49	55	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13453	10.1371/journal.pone.0013453	http://dx.doi.org/10.1371/journal.pone.0013453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976144	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300025
J	Baek, RC; Broekman, MLD; Leroy, SG; Tierney, LA; Sandberg, MA; d'Azzo, A; Seyfried, TN; Sena-Esteves, M				Baek, Rena C.; Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sandberg, Michael A.; d'Azzo, Alessandra; Seyfried, Thomas N.; Sena-Esteves, Miguel			AAV-Mediated Gene Delivery in Adult GM1-Gangliosidosis Mice Corrects Lysosomal Storage in CNS and Improves Survival	PLOS ONE			English	Article							ACID BETA-GALACTOSIDASE; SANDHOFF-DISEASE MICE; GM1 GANGLIOSIDOSIS; MOUSE MODEL; ANIMAL-MODEL; NIEMANN-PICK; GENERALIZED GANGLIOSIDOSIS; BRAIN GANGLIOSIDE; RAT-BRAIN; THERAPY	Background: GM1-gangliosidosis is a glycosphingolipid (GSL) lysosomal storage disease caused by a genetic deficiency of acid beta-galactosidase (beta gal), which results in the accumulation of GM1-ganglioside and its asialo-form (GA1) primarily in the CNS. Age of onset ranges from infancy to adulthood, and excessive ganglioside accumulation produces progressive neurodegeneration and psychomotor retardation in humans. Currently, there are no effective therapies for the treatment of GM1-gangliosidosis. Methodology/Principal Findings: In this study we examined the effect of thalamic infusion of AAV2/1-beta gal vector in adult GM1 mice on enzyme distribution, activity, and GSL content in the CNS, motor behavior, and survival. Six to eight week-old GM1 mice received bilateral injections of AAV vector in the thalamus, or thalamus and deep cerebellar nuclei (DCN) with pre-determined endpoints at 1 and 4 months post-injection, and the humane endpoint, or 52 weeks of age. Enzyme activity was elevated throughout the CNS of AAV-treated GM1 mice and GSL storage nearly normalized in most structures analyzed, except in the spinal cord which showed similar to 50% reduction compared to age-matched untreated GM1 mice spinal cord. Survival was significantly longer in AAV-treated GM1 mice (52 wks) than in untreated mice. However the motor performance of AAV-treated GM1 mice declined over time at a rate similar to that observed in untreated GM1 mice. Conclusions/Significance: Our studies show that the AAV-modified thalamus can be used as a 'built-in' central node network for widespread distribution of lysosomal enzymes in the mouse cerebrum. In addition, this study indicates that thalamic delivery of AAV vectors should be combined with additional targets to supply the cerebellum and spinal cord with therapeutic levels of enzyme necessary to achieve complete correction of the neurological phenotype in GM1 mice.	[Baek, Rena C.; Seyfried, Thomas N.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sena-Esteves, Miguel] Massachusetts Gen Hosp, Dept Neurol, Program Neurosci, Charlestown, MA USA; [Broekman, Marike L. D.; Leroy, Stanley G.; Tierney, Laryssa A.; Sena-Esteves, Miguel] Harvard Univ, Sch Med, Charlestown, MA USA; [Broekman, Marike L. D.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, Utrecht, Netherlands; [Sandberg, Michael A.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA USA; [d'Azzo, Alessandra] St Jude Childrens Hosp, Dept Genet, Memphis, TN 38105 USA	Boston College; Harvard University; Massachusetts General Hospital; Harvard University; Utrecht University; Utrecht University Medical Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; St Jude Children's Research Hospital	Baek, RC (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	Miguel.Esteves@umassmed.edu		Seyfried, Thomas/0000-0003-1491-3989	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R21NS053993]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Institute of Neurological Disorders and Stroke grant R21NS053993 (MSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek RC, 2008, NEUROCHEM INT, V52, P1125, DOI 10.1016/j.neuint.2007.12.001; BIEBER FR, 1986, ARCH NEUROL-CHICAGO, V43, P736, DOI 10.1001/archneur.1986.00520070090027; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; Broekman MLD, 2007, MOL THER, V15, P30, DOI 10.1038/sj.mt.6300004; Broekman MLD, 2009, GENE THER, V16, P303, DOI 10.1038/gt.2008.149; Broekman MLD, 2006, NEUROSCIENCE, V138, P501, DOI 10.1016/j.neuroscience.2005.11.057; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Cachon-Gonzalez MB, 2006, P NATL ACAD SCI USA, V103, P10373, DOI 10.1073/pnas.0603765103; Cearley CN, 2007, J NEUROSCI, V27, P9928, DOI 10.1523/JNEUROSCI.2185-07.2007; Chang M, 2008, MOL THER; Denny CA, 2006, J NEUROSCI RES, V83, P1028, DOI 10.1002/jnr.20798; Denny CA, 2007, J NEUROCHEM, V101, P1294, DOI 10.1111/j.1471-4159.2007.04525.x; Dickson P, 2007, MOL GENET METAB, V91, P61, DOI 10.1016/j.ymgme.2006.12.012; Dodge JC, 2009, EXP NEUROL, V215, P349, DOI 10.1016/j.expneurol.2008.10.021; Dodge JC, 2005, P NATL ACAD SCI USA, V102, P17822, DOI 10.1073/pnas.0509062102; DODGE JC, 2008, MOL THER; Elliot-Smith E, 2008, MOL GENET METAB, V94, P204, DOI 10.1016/j.ymgme.2008.02.005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Folkerth RD, 2000, PEDIATR DEVEL PATHOL, V3, P73, DOI 10.1007/s100240050010; GOLDSTEIN G, 1984, PLANT CELL ENVIRON, V7, P179; Hahn CN, 1997, HUM MOL GENET, V6, P205, DOI 10.1093/hmg/6.2.205; Hauser EC, 2004, BIOCHEM GENET, V42, P241, DOI 10.1023/B:BIGI.0000034429.55418.71; Hennig AK, 2003, J NEUROSCI, V23, P3302; Husain T, 2009, GENE THER, V16, P927, DOI 10.1038/gt.2009.52; Jeyakumar M, 2003, BRAIN, V126, P974, DOI 10.1093/brain/awg089; Jurevics H, 2002, J NEUROCHEM, V82, P126, DOI 10.1046/j.1471-4159.2002.00954.x; KASAMA T, 1986, JPN J EXP MED, V56, P1; Kasperzyk JL, 2004, J NEUROCHEM, V89, P645, DOI 10.1046/j.1471-4159.2004.02381.x; KASPERZYK JL, 2005, J LIPID RES; KAYE EM, 1992, PEDIATR NEUROL, V8, P255, DOI 10.1016/0887-8994(92)90361-2; Kells AP, 2009, P NATL ACAD SCI USA, V106, P2407, DOI 10.1073/pnas.0810682106; Klein RL, 2008, MOL THER, V16, P89, DOI 10.1038/sj.mt.6300331; KUDOH T, 1978, HUM GENET, V44, P287, DOI 10.1007/BF00394293; LATTANZI A, HUM MOL GENET, V19, P2208; Liu GM, 2005, J NEUROSCI, V25, P9321, DOI 10.1523/JNEUROSCI.2936-05.2005; Luca T, 2005, MOL THER, V12, P669, DOI 10.1016/j.ymthe.2005.06.438; Matsuda J, 1997, GLYCOCONJUGATE J, V14, P729, DOI 10.1023/A:1018573518127; MATTHIEU JM, 1973, BRAIN RES, V55, P391, DOI 10.1016/0006-8993(73)90304-1; Morell P., 1999, BASIC NEUROCHEMISTRY, V6th ed.; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; OBRIEN JS, 1965, AM J DIS CHILD, V109, P338, DOI 10.1001/archpedi.1965.02090020340014; OKADA S, 1968, SCIENCE, V160, P1002, DOI 10.1126/science.160.3831.1002; Passini MA, 2002, J NEUROSCI, V22, P6437; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Sands MS, 2006, MOL THER, V13, P839, DOI 10.1016/j.ymthe.2006.01.006; Sano R, 2005, BLOOD, V106, P2259, DOI 10.1182/blood-2005-03-1189; Sano R, 2009, MOL CELL, V36, P500, DOI 10.1016/j.molcel.2009.10.021; Schuettrumpf J, 2005, BLOOD, V105, P2316, DOI 10.1182/blood-2004-08-2990; SEYFRIED TN, 1982, J NEUROCHEM, V39, P277, DOI 10.1111/j.1471-4159.1982.tb04735.x; SEYFRIED TN, 1984, EXP NEUROL, V84, P590, DOI 10.1016/0014-4886(84)90206-1; SEYFRIED TN, 1980, BIOCHEM GENET, V18, P1229, DOI 10.1007/BF00484350; SUZUKI Y, 2001, ONLINE METABOLIC MOL, P3775; SVENNERHOLM L, 1957, BIOCHIM BIOPHYS ACTA, V24, P604, DOI 10.1016/0006-3002(57)90254-8; Tessitore A, 2004, MOL CELL, V15, P753, DOI 10.1016/j.molcel.2004.08.029; Vite CH, 2005, ANN NEUROL, V57, P355, DOI 10.1002/ana.20392; Watson G, 2006, GENE THER, V13, P917, DOI 10.1038/sj.gt.3302735; WILLIAMS MA, 1980, J NEUROCHEM, V35, P266, DOI 10.1111/j.1471-4159.1980.tb12515.x	57	54	69	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13468	10.1371/journal.pone.0013468	http://dx.doi.org/10.1371/journal.pone.0013468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976108	gold, Green Published, Green Submitted			2022-12-27	WOS:000283045300036
J	Greninger, AL; Chen, EC; Sittler, T; Scheinerman, A; Roubinian, N; Yu, GX; Kim, E; Pillai, DR; Guyard, C; Mazzulli, T; Isa, P; Arias, CF; Hackett, J; Schochetman, G; Miller, S; Tang, P; Chiu, CY				Greninger, Alexander L.; Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Roubinian, Nareg; Yu, Guixia; Kim, Edward; Pillai, Dylan R.; Guyard, Cyril; Mazzulli, Tony; Isa, Pavel; Arias, Carlos F.; Hackett, John, Jr.; Schochetman, Gerald; Miller, Steve; Tang, Patrick; Chiu, Charles Y.			A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America	PLOS ONE			English	Article							FLUCHIP DIAGNOSTIC MICROARRAY; RESPIRATORY-TRACT INFECTIONS; VIRUS; IDENTIFICATION; CORONAVIRUS; HUMANS	Although metagenomics has been previously employed for pathogen discovery, its cost and complexity have prevented its use as a practical front-line diagnostic for unknown infectious diseases. Here we demonstrate the utility of two metagenomics-based strategies, a pan-viral microarray (Virochip) and deep sequencing, for the identification and characterization of 2009 pandemic H1N1 influenza A virus. Using nasopharyngeal swabs collected during the earliest stages of the pandemic in Mexico, Canada, and the United States (n = 17), the Virochip was able to detect a novel virus most closely related to swine influenza viruses without a priori information. Deep sequencing yielded reads corresponding to 2009 H1N1 influenza in each sample ( percentage of aligned sequences corresponding to 2009 H1N1 ranging from 0.0011% to 10.9%), with up to 97% coverage of the influenza genome in one sample. Detection of 2009 H1N1 by deep sequencing was possible even at titers near the limits of detection for specific RT-PCR, and the percentage of sequence reads was linearly correlated with virus titer. Deep sequencing also provided insights into the upper respiratory microbiota and host gene expression in response to 2009 H1N1 infection. An unbiased analysis combining sequence data from all 17 outbreak samples revealed that 90% of the 2009 H1N1 genome could be assembled de novo without the use of any reference sequence, including assembly of several near full-length genomic segments. These results indicate that a streamlined metagenomics detection strategy can potentially replace the multiple conventional diagnostic tests required to investigate an outbreak of a novel pathogen, and provide a blueprint for comprehensive diagnosis of unexplained acute illnesses or outbreaks in clinical and public health settings.	[Greninger, Alexander L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Yu, Guixia; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Chen, Eunice C.; Sittler, Taylor; Scheinerman, Alex; Yu, Guixia; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA; [Roubinian, Nareg; Chiu, Charles Y.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kim, Edward; Tang, Patrick] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Kim, Edward; Tang, Patrick] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Pillai, Dylan R.; Guyard, Cyril; Mazzulli, Tony] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Pillai, Dylan R.; Guyard, Cyril] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Mazzulli, Tony] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Isa, Pavel; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotechnol, Cuernavaca, Morelos, Mexico; [Hackett, John, Jr.; Schochetman, Gerald] Abbott Diagnost, Abbott Pk, IL USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of British Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Universidad Nacional Autonoma de Mexico	Greninger, AL (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu	Isa, Pavel/GVU-8303-2022; Arias, Carlos/O-4036-2019	Arias, Carlos/0000-0003-3130-4501; Tang, Patrick/0000-0003-1583-5484; Sittler, Taylor/0000-0001-7495-4147; , cyril/0000-0002-2721-0097; Tripp, Ralph/0000-0002-2924-9956; Greninger, Alexander/0000-0002-7443-0527; Chiu, Charles/0000-0003-2915-2094	National Institutes of Health (NIH) [AI074913]; Kleine-Levin Syndrome Foundation; Abbott Diagnostics, Inc.; Amazon, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI074913] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kleine-Levin Syndrome Foundation; Abbott Diagnostics, Inc.(Abbott Laboratories); Amazon, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.Y.C. is supported by National Institutes of Health (NIH) K08 grant AI074913, a grant from the Kleine-Levin Syndrome Foundation, and a viral discovery award from Abbott Diagnostics, Inc. The authors also acknowledge an Amazon Web Services (AWS) grant to T. S., A. G., and C.Y.C. from Amazon, Inc., for high-performance computation on the Elastic Compute Cloud (EC2) platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnulf I, 2008, ANN NEUROL, V63, P482, DOI 10.1002/ana.21333; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2008, J PEDIATR-US, V153, P76, DOI 10.1016/j.jpeds.2007.12.035; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DEYDE VM, 2009, ANTIMICROB AGENTS CH; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; DRUMMOND AJ, 2009, GENEIOUS V4 7; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Fischer N, 2010, EMERG INFECT DIS, V16, P1000, DOI 10.3201/eid1606.100066; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Ganev PN, 2010, LITHOSPHERE-US, V2, P33, DOI 10.1130/L51.1; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; *GROUP NHW, 2009, GENOME RES, V19, P2317; HALE BG, 2010, J VIROL; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kuroda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010256; Lee CWH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq089; LI L, 2010, J VIROL; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lin BC, 2006, GENOME RES, V16, P527, DOI 10.1101/gr.4337206; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Lu Q, 2009, J CLIN MICROBIOL, V47, P3060, DOI 10.1128/JCM.01243-09; Martinez DA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000906; Mehlmann M, 2006, J CLIN MICROBIOL, V44, P2857, DOI 10.1128/JCM.00135-06; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Palacios G, 2007, EMERG INFECT DIS, V13, P73, DOI 10.3201/eid1301.060837; Palacios G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008540; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Sorber K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003495; Stewart FJ, 2010, ISME J, V4, P896, DOI 10.1038/ismej.2010.18; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Thompson B, 2002, PORTAL-LIBR ACAD, V2, P3, DOI 10.1353/pla.2002.0022; Townsend MB, 2006, J CLIN MICROBIOL, V44, P2863, DOI 10.1128/JCM.00134-06; Treanor J, 2004, NEW ENGL J MED, V350, P218, DOI 10.1056/NEJMp038238; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Wang Z, 2006, EMERG INFECT DIS, V12, P638, DOI 10.3201/eid1204.051441; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Zhang HW, 2006, INT J MULTISCALE COM, V4, P3, DOI 10.1615/IntJMultCompEng.v4.i1.20	55	133	150	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13381	10.1371/journal.pone.0013381	http://dx.doi.org/10.1371/journal.pone.0013381			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976137	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300008
J	Meenderink, LM; Ryzhova, LM; Donato, DM; Gochberg, DF; Kaverina, I; Hanks, SK				Meenderink, Leslie M.; Ryzhova, Larisa M.; Donato, Dominique M.; Gochberg, Daniel F.; Kaverina, Irina; Hanks, Steven K.			P130Cas Src-Binding and Substrate Domains Have Distinct Roles in Sustaining Focal Adhesion Disassembly and Promoting Cell Migration	PLOS ONE			English	Article							CRK-ASSOCIATED SUBSTRATE; TYROSINE PHOSPHORYLATION SITES; ADAPTER PROTEIN CAS; TRANSFORMED CELLS; CAS/CRK SCAFFOLD; ACTIN; P130(CAS); PAXILLIN; KINASE; LOCALIZATION	The docking protein p130Cas is a prominent Src substrate found in focal adhesions (FAs) and is implicated in regulating critical aspects of cell motility including FA disassembly and protrusion of the leading edge plasma membrane. To better understand how p130Cas acts to promote these events we examined requirements for established p130Cas signaling motifs including the SH3-binding site of the Src binding domain (SBD) and the tyrosine phosphorylation sites within the substrate domain (SD). Expression of wild type p130Cas in Cas -/- mouse embryo fibroblasts resulted in enhanced cell migration associated with increased leading-edge actin flux, increased rates of FA assembly/disassembly, and uninterrupted FA turnover. Variants lacking either the SD phosphorylation sites or the SBD SH3-binding motif were able to partially restore the migration response, while only a variant lacking both signaling functions was fully defective. Notably, the migration defects associated with p130Cas signaling-deficient variants correlated with longer FA lifetimes resulting from aborted FA disassembly attempts. However the SD mutational variant was fully defective in increasing actin assembly at the protruding leading edge and FA assembly/disassembly rates, indicating that SD phosphorylation is the sole p130Cas signaling function in regulating these processes. Our results provide the first quantitative evidence supporting roles for p130Cas SD tyrosine phosphorylation in promoting both leading edge actin flux and FA turnover during cell migration, while further revealing that the p130Cas SBD has a function in cell migration and sustained FA disassembly that is distinct from its known role of promoting SD tyrosine phosphorylation.	[Meenderink, Leslie M.; Ryzhova, Larisa M.; Donato, Dominique M.; Kaverina, Irina; Hanks, Steven K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Sch Med, Dept Radiol & Radiol Sci, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37212 USA; [Gochberg, Daniel F.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Meenderink, LM (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA.	steve.hanks@vanderbilt.edu	Donato, Dominique/C-1058-2012	Donato, Dominique/0000-0002-0495-4376; Meenderink, Leslie/0000-0003-3943-4079	National Institutes of Health [R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, P30-DK058404]; American Heart Association [0815136E]; NATIONAL CANCER INSTITUTE [T32CA009592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347, R01GM078373, R01GM049882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-GM049882, R01-GM78373, T32-CA09592, T32-GM07347, and P30-DK058404, and by a predoctoral fellowship 0815136E from the American Heart Association (to L.M.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestrem C, 2006, J CELL SCI, V119, P866, DOI 10.1242/jcs.02794; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burnham MR, 2000, MOL CELL BIOL, V20, P5865, DOI 10.1128/MCB.20.16.5865-5878.2000; Cho SY, 2002, J CELL BIOL, V156, P725, DOI 10.1083/jcb.200111032; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Cunningham-Edmondson AC, 2009, BREAST CANCER-TARGET, V1, P39; Defilippi P, 2006, TRENDS CELL BIOL, V16, P257, DOI 10.1016/j.tcb.2006.03.003; Donaldson JC, 2000, EXP CELL RES, V256, P168, DOI 10.1006/excr.2000.4822; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Efimov A, 2008, J CELL SCI, V121, P196, DOI 10.1242/jcs.012666; Etienne-Manneville S, 2004, TRAFFIC, V5, P470, DOI 10.1111/j.1600-0854.2004.00196.x; Fonseca PM, 2004, CELL SIGNAL, V16, P621, DOI 10.1016/j.cellsig.2003.10.004; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Huang JH, 2002, J BIOL CHEM, V277, P27265, DOI 10.1074/jbc.M203063200; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kruchten AE, 2008, AM J PHYSIOL-CELL PH, V295, pC1113, DOI 10.1152/ajpcell.00238.2008; Lai FP, 2008, EMBO J, V27, P982, DOI 10.1038/emboj.2008.34; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; O'Neill GM, 2000, TRENDS CELL BIOL, V10, P111, DOI 10.1016/S0962-8924(99)01714-6; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivera GM, 2006, P NATL ACAD SCI USA, V103, P9536, DOI 10.1073/pnas.0603786103; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Siesser PMF, 2008, CELL MOTIL CYTOSKEL, V65, P25, DOI 10.1002/cm.20241; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Wang Yu-li, 2007, Sci STKE, V2007, ppe10; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314	40	40	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13412	10.1371/journal.pone.0013412	http://dx.doi.org/10.1371/journal.pone.0013412			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976150	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300010
J	Reich, HN; Tritchler, D; Cattran, DC; Herzenberg, AM; Eichinger, F; Boucherot, A; Henger, A; Berthier, CC; Nair, V; Cohen, CD; Scholey, JW; Kretzler, M				Reich, Heather N.; Tritchler, David; Cattran, Daniel C.; Herzenberg, Andrew M.; Eichinger, Felix; Boucherot, Anissa; Henger, Anna; Berthier, Celine C.; Nair, Viji; Cohen, Clemens D.; Scholey, James W.; Kretzler, Matthias			A Molecular Signature of Proteinuria in Glomerulonephritis	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; TUBULAR EPITHELIAL-CELLS; GENE-EXPRESSION ANALYSIS; GROWTH-FACTOR-BETA; IGA NEPHROPATHY; RENAL-DISEASE; NATURAL-HISTORY; KIDNEY-DISEASE; TUBULOINTERSTITIAL CHANGES; PROGNOSTIC-SIGNIFICANCE	Proteinuria is the most important predictor of outcome in glomerulonephritis and experimental data suggest that the tubular cell response to proteinuria is an important determinant of progressive fibrosis in the kidney. However, it is unclear whether proteinuria is a marker of disease severity or has a direct effect on tubular cells in the kidneys of patients with glomerulonephritis. Accordingly we studied an in vitro model of proteinuria, and identified 231 "albumin-regulated genes" differentially expressed by primary human kidney tubular epithelial cells exposed to albumin. We translated these findings to human disease by studying mRNA levels of these genes in the tubulo-interstitial compartment of kidney biopsies from patients with IgA nephropathy using microarrays. Biopsies from patients with IgAN (n = 25) could be distinguished from those of control subjects ( n = 6) based solely upon the expression of these 231 "albumin-regulated genes." The expression of an 11-transcript subset related to the degree of proteinuria, and this 11-mRNA subset was also sufficient to distinguish biopsies of subjects with IgAN from control biopsies. We tested if these findings could be extrapolated to other proteinuric diseases beyond IgAN and found that all forms of primary glomerulonephritis ( n = 33) can be distinguished from controls ( n = 21) based solely on the expression levels of these 11 genes derived from our in vitro proteinuria model. Pathway analysis suggests common regulatory elements shared by these 11 transcripts. In conclusion, we have identified an albumin-regulated 11-gene signature shared between all forms of primary glomerulonephritis. Our findings support the hypothesis that albuminuria may directly promote injury in the tubulo-interstitial compartment of the kidney in patients with glomerulonephritis.	[Reich, Heather N.; Cattran, Daniel C.; Scholey, James W.] Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Reich, Heather N.; Cattran, Daniel C.; Scholey, James W.] Toronto Glomerulonephritis Registry, Toronto, ON, Canada; [Tritchler, David] Ontario Canc Inst, Div Epidemiol & Stat, Toronto, ON M4X 1K9, Canada; [Tritchler, David] Univ Toronto, Univ Hlth Network, Dept Lab Med & Pathol, Toronto, ON, Canada; [Eichinger, Felix; Boucherot, Anissa; Henger, Anna; Berthier, Celine C.; Nair, Viji; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Cohen, Clemens D.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Cohen, Clemens D.] Univ Zurich Hosp, Inst Physiol, CH-8091 Zurich, Switzerland	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Michigan System; University of Michigan; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Reich, HN (corresponding author), Univ Toronto, Univ Hlth Network, Div Nephrol, Toronto, ON, Canada.	hreich@uhnresearch.on.ca			KRESCENT; Physicians Services Inc. Foundation; KFOC; CIHR; Swiss National Science Foundation [32-122439/1]; Else Kroener-Fresenius Foundation [A62/04]; Mathematics of Information Technology and Complex Systems (MITACS); Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079912] Funding Source: NIH RePORTER	KRESCENT; Physicians Services Inc. Foundation; KFOC; CIHR(Canadian Institutes of Health Research (CIHR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Else Kroener-Fresenius Foundation; Mathematics of Information Technology and Complex Systems (MITACS); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Heather Reich is the recipient of a KRESCENT new investigator award and her work is supported by the Physicians Services Inc. Foundation, with gratitude to the physicians of Ontario. Dr. James Scholey holds the Amgen-CIHR Research Chair at University Health Network/University of Toronto. Funding for this study was also supported by operating grants from the KFOC and CIHR, in addition to the CIHR Genes, Gender, and Glomerulonephritis New Emerging Team grant. Dr. David Tritchler was supported by funding from the Mathematics of Information Technology and Complex Systems (MITACS) and the Natural Sciences and Engineering Research Council of Canada (NSERC). The work was supported by the Swiss National Science Foundation (32-122439/1) and the Else Kroener-Fresenius Foundation (A62/04) to CDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2002, KIDNEY INT, V61, P2066, DOI 10.1046/j.1523-1755.2002.00380.x; Bartosik LP, 2001, AM J KIDNEY DIS, V38, P728, DOI 10.1053/ajkd.2001.27689; BOHLE A, 1987, AM J NEPHROL, V7, P421, DOI 10.1159/000167514; Brown NJ, 2000, KIDNEY INT, V58, P1219, DOI 10.1046/j.1523-1755.2000.00277.x; CAMERON JS, 1990, AM J NEPHROL, V10, P81; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Christensen PK, 1999, DIABETIC MED, V16, P388, DOI 10.1046/j.1464-5491.1999.00063.x; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; DAMICO G, 1987, Q J MED, V64, P709; Diwakar R, 2007, AM J PHYSIOL-RENAL, V292, pF1464, DOI 10.1152/ajprenal.00069.2006; Donadelli R, 2000, AM J KIDNEY DIS, V36, P1226, DOI 10.1053/ajkd.2000.19838; Donadio JV, 2002, NEPHROL DIAL TRANSPL, V17, P1197, DOI 10.1093/ndt/17.7.1197; Drummond K, 2002, DIABETES, V51, P1580, DOI 10.2337/diabetes.51.5.1580; Eddy AA, 2004, NEPHROL DIAL TRANSPL, V19, P277, DOI 10.1093/ndt/gfg533; EDDY AA, 1995, KIDNEY INT, V47, P1546, DOI 10.1038/ki.1995.218; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Erkan E, 2005, J AM SOC NEPHROL, V16, P398, DOI 10.1681/ASN.2003100861; Erkan E, 2001, AM J PHYSIOL-RENAL, V280, pF1107, DOI 10.1152/ajprenal.2001.280.6.F1107; GALL MA, 1993, DIABETOLOGIA, V36, P1071, DOI 10.1007/BF02374501; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; GENTLEMAN R, 2003, BIOCONDUCTOR FAQ; GENTLEMAN R, 2007, USING GO STAT ANAL; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Grandaliano G, 2000, AM J KIDNEY DIS, V35, P726, DOI 10.1016/S0272-6386(00)70022-9; Hamano K, 2002, AM J KIDNEY DIS, V39, P695, DOI 10.1053/ajkd.2002.31986; Henger A, 2004, KIDNEY INT, V65, P904, DOI 10.1111/j.1523-1755.2004.00499.x; Heymann F, 2009, J CLIN INVEST, V119, P1286, DOI 10.1172/JCI38399; IBELS LS, 1994, MEDICINE, V73, P79, DOI 10.1097/00005792-199403000-00002; Iglesias J, 2001, NEPHROL DIAL TRANSPL, V16, P215, DOI 10.1093/ndt/16.2.215; Irizarry R. A., 2003, ANAL GENE EXPRESSION, P102; Ju WJ, 2009, AM J PATHOL, V174, P2073, DOI 10.2353/ajpath.2009.080888; Kamijo A, 2002, KIDNEY INT, V62, P1628, DOI 10.1046/j.1523-1755.2002.00618.x; Katz A, 2002, KIDNEY INT, V61, P2058, DOI 10.1046/j.1523-1755.2002.00370.x; KEESFOLTS D, 1994, KIDNEY INT, V45, P1697, DOI 10.1038/ki.1994.222; KOBAYASHI Y, 1983, NEPHRON, V34, P146, DOI 10.1159/000183000; Kretzler M, 2002, J AM SOC NEPHROL, V13, P1961, DOI 10.1097/01.ASN.0000020390.29418.70; Kriz W, 2001, J AM SOC NEPHROL, V12, P496, DOI 10.1681/ASN.V123496; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li PKT, 2002, NEPHROL DIAL TRANSPL, V17, P64, DOI 10.1093/ndt/17.1.64; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Meyer TW, 2003, KIDNEY INT, V63, P774, DOI 10.1046/j.1523-1755.2003.00795.x; MOGENSEN CE, 1976, SCAND J CLIN LAB INV, V36, P383, DOI 10.3109/00365517609055274; MYERS BD, 1995, KIDNEY INT, V47, P1781, DOI 10.1038/ki.1995.246; Nakamura H, 2002, GENE THER, V9, P495, DOI 10.1038/sj.gt.3301681; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Nikolic-Paterson DJ, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_5.3; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Peterson KS, 2004, J CLIN INVEST, V113, P1722, DOI 10.1172/JCI200419139; Philibert D, 2008, NAT CLIN PRACT NEPHR, V4, P550, DOI 10.1038/ncpneph0915; Porubsky S, 2004, AM J PATHOL, V164, P2175, DOI 10.1016/S0002-9440(10)63775-3; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Reich H, 2005, J AM SOC NEPHROL, V16, P1266, DOI 10.1681/ASN.2004030222; Reich HN, 2007, J AM SOC NEPHROL, V18, P3177, DOI 10.1681/ASN.2007050526; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; Row P G, 1975, Ateneo Parmense Acta Biomed, V46, P433; Rudnicki M, 2007, KIDNEY INT, V71, P325, DOI 10.1038/sj.ki.5002043; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Schmid H, 2004, NEPHROL DIAL TRANSPL, V19, P1347, DOI 10.1093/ndt/gfh181; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Sitailo LA, 2006, J BIOL CHEM, V281, P29703, DOI 10.1074/jbc.M607351200; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Striker LJ, 2003, J AM SOC NEPHROL, V14, P1096, DOI 10.1097/01.ASN.0000060865.30249.40; Stuart JR, 2005, ONCOGENE, V24, P8085, DOI 10.1038/sj.onc.1208953; Tang S, 2003, J CLIN INVEST, V111, P515, DOI [10.1172/JCI16079, 10.1172/JCI200316079]; Tarshish P, 1997, J AM SOC NEPHROL, V8, P769; Theilig F, 2007, J AM SOC NEPHROL, V18, P1824, DOI 10.1681/ASN.2006111266; Thomas ME, 2002, AM J PHYSIOL-RENAL, V283, pF640, DOI 10.1152/ajprenal.00001.2002; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Tritchler D, 2005, COMPUT STAT DATA AN, V49, P63, DOI 10.1016/j.csda.2004.04.010; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Timmeren MM, 2005, NEPHROL DIAL TRANSPL, V20, P2349, DOI 10.1093/ndt/gfh964; Waga I, 2003, KIDNEY INT, V64, P1253, DOI 10.1046/j.1523-1755.2003.00220.x; Wang SN, 2000, KIDNEY INT, V57, P1002, DOI 10.1046/j.1523-1755.2000.00928.x; WETTENHALL J, GENE ONTOLOGIES GENE; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Yamamoto T, 1996, KIDNEY INT, V49, P461, DOI 10.1038/ki.1996.65; Yang-Yen HF, 2006, J BIOMED SCI, V13, P201, DOI 10.1007/s11373-005-9064-4; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zoja C, 2004, CURR OPIN NEPHROL HY, V13, P31, DOI 10.1097/00041552-200401000-00005; Zoja C, 1998, KIDNEY INT, V53, P1608, DOI 10.1046/j.1523-1755.1998.00905.x; Zoja C, 1995, AM J KIDNEY DIS, V26, P934, DOI 10.1016/0272-6386(95)90058-6	86	52	52	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13451	10.1371/journal.pone.0013451	http://dx.doi.org/10.1371/journal.pone.0013451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976140	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300023
J	Huber, G; Heynen, S; Imsand, C; vom Hagen, F; Muehlfriedel, R; Tanimoto, N; Feng, Y; Hammes, HP; Grimm, C; Peichl, L; Seeliger, MW; Beck, SC				Huber, Gesine; Heynen, Severin; Imsand, Coni; vom Hagen, Franziska; Muehlfriedel, Regine; Tanimoto, Naoyuki; Feng, Yuxi; Hammes, Hans-Peter; Grimm, Christian; Peichl, Leo; Seeliger, Mathias W.; Beck, Susanne C.			Novel Rodent Models for Macular Research	PLOS ONE			English	Article							RETINAL DEGENERATION; GANGLION-CELLS; ANIMAL-MODELS; MOUSE MODELS; PHOTORECEPTORS; COEXPRESSION; PATHOGENESIS; ARRANGEMENT; PREVALENCE; PHENOTYPE	Background: Many disabling human retinal disorders involve the central retina, particularly the macula. However, the commonly used rodent models in research, mouse and rat, do not possess a macula. The purpose of this study was to identify small laboratory rodents with a significant central region as potential new models for macular research. Methodology/Principal Findings: Gerbillus perpallidus, Meriones unguiculatus and Phodopus campbelli, laboratory rodents less commonly used in retinal research, were subjected to confocal scanning laser ophthalmoscopy (cSLO), fluorescein and indocyanine green angiography, and spectral-domain optical coherence tomography (SD-OCT) using standard equipment (Heidelberg Engineering HRA1 and Spectralis (TM)) adapted to small rodent eyes. The existence of a visual streak-like pattern was assessed on the basis of vascular topography, retinal thickness, and the topography of retinal ganglion cells and cone photoreceptors. All three species examined showed evidence of a significant horizontal streak-like specialization. cSLO angiography and retinal wholemounts revealed that superficial retinal blood vessels typically ramify and narrow into a sparse capillary net at the border of the respective area located dorsal to the optic nerve. Similar to the macular region, there was an absence of larger blood vessels in the streak region. Furthermore, the thickness of the photoreceptor layer and the population density of neurons in the ganglion cell layer were markedly increased in the visual streak region. Conclusions/Significance: The retinal specializations of Gerbillus perpallidus, Meriones unguiculatus and Phodopus campbelli resemble features of the primate macula. Hence, the rodents reported here may serve to study aspects of macular development and diseases like age-related macular degeneration and diabetic macular edema, and the preclinical assessment of therapeutic strategies.	[Huber, Gesine; Muehlfriedel, Regine; Tanimoto, Naoyuki; Seeliger, Mathias W.; Beck, Susanne C.] Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany; [Heynen, Severin; Imsand, Coni; Grimm, Christian] Univ Zurich, Dept Ophthalmol, Lab Retinal Cell Biol, Zurich, Switzerland; [vom Hagen, Franziska; Feng, Yuxi; Hammes, Hans-Peter] Heidelberg Univ, Univ Med Mannheim, Dept Med 5, D-6800 Mannheim, Germany; [Peichl, Leo] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Zurich; Ruprecht Karls University Heidelberg; Max Planck Society	Huber, G (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany.	Susanne.Beck@med.uni-tuebingen.de		Grimm, Christian/0000-0001-9318-4352; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft (DFG) [Se837/5-2, Se837/6-1, Se837/7-1]; German Ministry of Education and Research (BMBF) [0314106]; European Union [EU HEALTH-F2-2008-200234, EU MEST-CT-2005-020235]; Kerstan Foundation; Swiss National Science Foundation [3100A0-117760, GRK880, Ha 1755/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Kerstan Foundation(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (DFG, grants Se837/5-2, Se837/6-1, Se837/7-1), the German Ministry of Education and Research (BMBF, grant 0314106), and the European Union grants EU HEALTH-F2-2008-200234, EU MEST-CT-2005-020235, Kerstan Foundation, Swiss National Science Foundation Grant 3100A0-117760, GRK880, Ha 1755/8-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the mansucript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; Bobu C, 2008, VISION RES, V48, P424, DOI 10.1016/j.visres.2007.08.011; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; DESCHAEPDRIJVER L, 1989, RES VET SCI, V47, P34; Eppens MC, 2006, DIABETES CARE, V29, P1300, DOI 10.2337/dc05-2470; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Gaillard F, 2009, INVEST OPHTH VIS SCI, V50, P5426, DOI 10.1167/iovs.09-3896; Glosmann M, 2002, BRAIN RES, V929, P139, DOI 10.1016/S0006-8993(02)02267-9; Hahn P, 2004, P NATL ACAD SCI USA, V101, P13850, DOI 10.1073/pnas.0405146101; HENKIND P, 1966, EXP EYE RES, V5, P10, DOI 10.1016/S0014-4835(66)80015-5; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hughes A., 1985, PROGR RETINAL RES, V4, P243; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; LONG KO, 1983, J COMP NEUROL, V221, P329, DOI 10.1002/cne.902210308; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Lukats A, 2002, INVEST OPHTH VIS SCI, V43, P2468; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; Musser G G, 1993, MAMMAL SPECIES WORLD; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; PEICHL L, 1992, J COMP NEUROL, V324, P603, DOI 10.1002/cne.903240412; Rakoczy PE, 2006, EXP EYE RES, V82, P741, DOI 10.1016/j.exer.2005.10.012; Rakoczy PE, 2002, AM J PATHOL, V161, P1515, DOI 10.1016/S0002-9440(10)64427-6; Ramkumar HL, 2010, PROG RETIN EYE RES, V29, P169, DOI 10.1016/j.preteyeres.2010.02.002; RODIECK RW, 1973, VERTEBRATE RETINA PR; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Singh Ajay, 2009, Int Ophthalmol Clin, V49, P1, DOI 10.1097/IIO.0b013e31819fd164; WASSLE H, 1975, J COMP NEUROL, V159, P419, DOI 10.1002/cne.901590308; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; WOLFENSBERGER TJ, 1998, RETINAL PIGMENT EPIT, P621; Yoshida T, 2005, J CLIN INVEST, V115, P2793, DOI 10.1172/JCI24635; Zeiss CJ, 2010, VET PATHOL, V47, P396, DOI 10.1177/0300985809359598	36	37	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13403	10.1371/journal.pone.0013403	http://dx.doi.org/10.1371/journal.pone.0013403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976212	gold, Green Published			2022-12-27	WOS:000283043700008
J	Grigoryev, YA; Kurian, SM; Avnur, Z; Borie, D; Deng, J; Campbell, D; Sung, J; Nikolcheva, T; Quinn, A; Schulman, H; Peng, SL; Schaffer, R; Fisher, J; Mondala, T; Head, S; Flechner, SM; Kantor, AB; Marsh, C; Salomon, DR				Grigoryev, Yevgeniy A.; Kurian, Sunil M.; Avnur, Zafi; Borie, Dominic; Deng, Jun; Campbell, Daniel; Sung, Joanna; Nikolcheva, Tania; Quinn, Anthony; Schulman, Howard; Peng, Stanford L.; Schaffer, Randolph; Fisher, Jonathan; Mondala, Tony; Head, Steven; Flechner, Stuart M.; Kantor, Aaron B.; Marsh, Christopher; Salomon, Daniel R.			Deconvoluting Post-Transplant Immunity: Cell Subset-Specific Mapping Reveals Pathways for Activation and Expansion of Memory T, Monocytes and B Cells	PLOS ONE			English	Article							ANTITHYMOCYTE GLOBULIN THYMOGLOBULIN(R); RENAL-ALLOGRAFT REJECTION; LONG-TERM; PERIPHERAL-BLOOD; ISCHEMIA/REPERFUSION INJURY; KIDNEY-TRANSPLANTATION; LIVER-TRANSPLANTATION; DE-NOVO; INDUCTION; EXPRESSION	A major challenge for the field of transplantation is the lack of understanding of genomic and molecular drivers of early post-transplant immunity. The early immune response creates a complex milieu that determines the course of ensuing immune events and the ultimate outcome of the transplant. The objective of the current study was to mechanistically deconvolute the early immune response by purifying and profiling the constituent cell subsets of the peripheral blood. We employed genome-wide profiling of whole blood and purified CD4, CD8, B cells and monocytes in tandem with high-throughput laser-scanning cytometry in 10 kidney transplants sampled serially pre-transplant, 1, 2, 4, 8 and 12 weeks. Cytometry confirmed early cell subset depletion by antibody induction and immunosuppression. Multiple markers revealed the activation and proliferative expansion of CD45RO(+)CD62L(-) effector memory CD4/CD8 T cells as well as progressive activation of monocytes and B cells. Next, we mechanistically deconvoluted early post-transplant immunity by serial monitoring of whole blood using DNA microarrays. Parallel analysis of cell subset-specific gene expression revealed a unique spectrum of time-dependent changes and functional pathways. Gene expression profiling results were validated with 157 different probesets matching all 65 antigens detected by cytometry. Thus, serial blood cell monitoring reflects the profound changes in blood cell composition and immune activation early post-transplant. Each cell subset reveals distinct pathways and functional programs. These changes illuminate a complex, early phase of immunity and inflammation that includes activation and proliferative expansion of the memory effector and regulatory cells that may determine the phenotype and outcome of the kidney transplant.	[Grigoryev, Yevgeniy A.; Campbell, Daniel; Mondala, Tony; Head, Steven] Scripps Res Inst, DNA Microarray Core Facil, La Jolla, CA 92037 USA; [Deng, Jun; Schulman, Howard; Kantor, Aaron B.] Pharmaceut Product Dev PPD, Biomarker Discovery Sci, Menlo Pk, CA USA; [Sung, Joanna; Schaffer, Randolph; Fisher, Jonathan; Marsh, Christopher; Salomon, Daniel R.] Scripps Ctr Organ & Cell Transplantat, La Jolla, CA USA; [Avnur, Zafi; Borie, Dominic; Nikolcheva, Tania; Quinn, Anthony; Peng, Stanford L.] Roche, Palo Alto, CA USA; [Flechner, Stuart M.] Cleveland Clin, Glickman Urol Inst, Cleveland, OH 44106 USA	Scripps Research Institute; Scripps Research Institute; Roche Holding; Cleveland Clinic Foundation	Grigoryev, YA (corresponding author), Scripps Res Inst, DNA Microarray Core Facil, La Jolla, CA 92037 USA.	dsalomon@scripps.edu	Peng, Stanford/S-6723-2019; Schaffer, Randolph/S-7432-2019; Salomon, Daniel/E-9380-2012; Kurian, Sunil/C-4493-2008	Kurian, Sunil/0000-0002-7782-7263; Marsh, Christopher/0000-0002-6517-076X	NIH [U19 AI063603]; Molly Baber Research Fund; Verna Harrah Research Fund; Roche Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI063603] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molly Baber Research Fund; Verna Harrah Research Fund; Roche Pharmaceuticals(Roche Holding); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH U19 AI063603, Molly Baber Research Fund, Verna Harrah Research Fund, service work for high throughput flow cytometry and data analysis by Pharmaceutical Product Development Inc. (PPD) and an unrestricted research grant from Roche Pharmaceuticals. Roche and PPD were involved in the study design as a scientific collaboration and involved in the first half of the data collection and analysis that was performed during the period covered by their unrestricted educational grant. Roche and PPD were not involved in the next stage, where the second half of the samples were analyzed and in all the subsequent data analysis, genomic pathway mapping, final decision to publish, and preparation of the manuscript. The Roche and PPD authors as listed, however, were treated as scientific collaborators and were provided a full copy of the submitted manuscript for their review and approval prior to submission.	Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bloom DD, 2008, AM J TRANSPLANT, V8, P793, DOI 10.1111/j.1600-6143.2007.02134.x; Boros P, 2006, AM J TRANSPLANT, V6, P652, DOI 10.1111/j.1600-6143.2005.01228.x; Chapman JR, 2010, TRANSPLANTATION, V89, P644, DOI 10.1097/TP.0b013e3181d62f1b; Cockayne DA, 1998, BLOOD, V92, P1324, DOI 10.1182/blood.V92.4.1324.416k26_1324_1333; Deeks ED, 2009, DRUGS, V69, P1483, DOI 10.2165/00003495-200969110-00007; Dietz LJ, 1996, CYTOMETRY, V23, P177; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esposito L, 2005, TRANSPL P, V37, P785, DOI 10.1016/j.transproceed.2004.12.200; Flechner SM, 2004, AM J TRANSPLANT, V4, P1475, DOI 10.1111/j.1600-6143.2004.00526.x; Flechner SM, 2004, AM J TRANSPLANT, V4, P1776, DOI 10.1111/j.1600-6143.2004.00627.x; Fox DA, 2001, IMMUNOL INVEST, V30, P67, DOI 10.1081/IMM-100104017; Gaber AO, 2010, DRUGS, V70, P691, DOI 10.2165/11315940-000000000-00000; Gould SJ, 2004, Q REV BIOL, V79, P359, DOI 10.1086/426088; Grigoryev DN, 2006, TRANSPLANT P, V38, P3333, DOI 10.1016/j.transproceed.2006.10.129; Gunther OP, 2009, TRANSPLANTATION, V88, P942, DOI 10.1097/TP.0b013e3181b7ccc6; Hale DA, 2004, CURR OPIN IMMUNOL, V16, P565, DOI 10.1016/j.coi.2004.07.005; Heidenhain C, 2009, ANN TRANSPL, V14, P36; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Kamoun M, 2006, THER DRUG MONIT, V28, P14, DOI 10.1097/01.ftd.0000194499.32398.32; Kantor AB, 2007, J NEUROIMMUNOL, V188, P103, DOI 10.1016/j.jneuroim.2007.05.009; Kantor AB, 2004, BIOTECHNIQUES, V36, P520, DOI 10.2144/04363PF01; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Kurian SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006212; LANIER LL, 1995, J IMMUNOL, V154, P97; Lopez M, 2006, J AM SOC NEPHROL, V17, P2844, DOI 10.1681/ASN.2006050422; Louis S, 2007, TRANSPLANTATION, V83, P712, DOI 10.1097/01.tp.0000255683.66156.d3; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P378, DOI 10.1111/j.1600-6143.2004.00332.x; Mollen KP, 2006, SHOCK, V26, P430, DOI 10.1097/01.shk.0000228797.41044.08; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Neujahr DC, 2006, J IMMUNOL, V176, P4632, DOI 10.4049/jimmunol.176.8.4632; Noris M, 2009, J IMMUNOL, V183, P4249, DOI 10.4049/jimmunol.0803549; Oertel M, 2002, TRANSPL INT, V15, P463, DOI 10.1111/j.1432-2277.2002.tb00201.x; Perco P, 2007, TRANSPL INT, V20, P2, DOI 10.1111/j.1432-2277.2006.00376.x; Ramsey C, 2008, J IMMUNOL, V180, P5320, DOI 10.4049/jimmunol.180.8.5320; Rush D, 1998, J AM SOC NEPHROL, V9, P2129; Serban G, 2009, HUM IMMUNOL, V70, P882, DOI 10.1016/j.humimm.2009.07.027; Shigeoka AA, 2007, J IMMUNOL, V178, P6252, DOI 10.4049/jimmunol.178.10.6252; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Trieb K, 1998, PATHOL RES PRACT, V194, P679, DOI 10.1016/S0344-0338(98)80126-X; Trivedi HL, 2007, TRANSPL P, V39, P647, DOI 10.1016/j.transproceed.2007.01.047; Woodroffe R, 2005, HEALTH TECHNOL ASSES, V9, P1	42	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13358	10.1371/journal.pone.0013358	http://dx.doi.org/10.1371/journal.pone.0013358			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976225	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000009
J	Zhang, WQ; Wu, WW; Lin, WC; Zhou, PF; Dai, L; Zhang, Y; Huang, JF; Zhang, DL				Zhang, Wenqian; Wu, Wenwu; Lin, Wenchao; Zhou, Pengfang; Dai, Li; Zhang, Yang; Huang, Jingfei; Zhang, Deli			Deciphering Heterogeneity in Pig Genome Assembly Sscrofa9 by Isochore and Isochore-Like Region Analyses	PLOS ONE			English	Article							BIASED GENE CONVERSION; GC-CONTENT EVOLUTION; EUKARYOTIC GENOMES; VERTEBRATE GENOMES; DNA-SEQUENCES; ARABIDOPSIS-THALIANA; MAMMALIAN GENOMES; CHROMOSOME MAPS; TRANSCRIPTION; RECOMBINATION	Background: The isochore, a large DNA sequence with relatively small GC variance, is one of the most important structures in eukaryotic genomes. Although the isochore has been widely studied in humans and other species, little is known about its distribution in pigs. Principal Findings: In this paper, we construct a map of long homogeneous genome regions (LHGRs), i.e., isochores and isochore-like regions, in pigs to provide an intuitive version of GC heterogeneity in each chromosome. The LHGR pattern study not only quantifies heterogeneities, but also reveals some primary characteristics of the chromatin organization, including the followings: (1) the majority of LHGRs belong to GC-poor families and are in long length; (2) a high gene density tends to occur with the appearance of GC-rich LHGRs; and (3) the density of LINE repeats decreases with an increase in the GC content of LHGRs. Furthermore, a portion of LHGRs with particular GC ranges (50%-51% and 54%-55%) tend to have abnormally high gene densities, suggesting that biased gene conversion (BGC), as well as time-and energy-saving principles, could be of importance to the formation of genome organization. Conclusion: This study significantly improves our knowledge of chromatin organization in the pig genome. Correlations between the different biological features (e.g., gene density and repeat density) and GC content of LHGRs provide a unique glimpse of in silico gene and repeats prediction.	[Zhang, Wenqian; Lin, Wenchao; Zhou, Pengfang; Dai, Li] NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Xianyang, Shaanxi, Peoples R China; [Zhang, Yang; Zhang, Deli] NW A&F Univ, Coll Vet Med, Invest Grp Mol Virol Immunol Oncol & Syst Biol, Xianyang, Shaanxi, Peoples R China; [Zhang, Yang; Zhang, Deli] NW A&F Univ, Coll Vet Med, Bioinformat Ctr, Xianyang, Shaanxi, Peoples R China; [Huang, Jingfei] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Yunnan, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China; Chinese Academy of Sciences; Kunming Institute of Zoology	Zhang, WQ (corresponding author), NW A&F Univ, Bioinformat Ctr, Coll Life Sci, Xianyang, Shaanxi, Peoples R China.	huangjf@mail.kiz.ac.cn; zhangdeli@tsinghua.org.cn	Wu, Wenwu/AAP-1966-2021; Wu, Wenwu/HDO-7873-2022	Wu, Wenwu/0000-0003-2996-8675; Wu, Wenwu/0000-0003-2996-8675	Open Foundation of the State Key Laboratory of Genetic Resources; Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences [GREKF09-05]	Open Foundation of the State Key Laboratory of Genetic Resources; Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Open Foundation of the State Key Laboratory of Genetic Resources and Evolution of Kunming Institute of Zoology, Chinese Academy of Sciences (grant GREKF09-05 to J.H. and D.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benecke A, 2006, EUR PHYS J E, V19, P353, DOI 10.1140/epje/i2005-10068-8; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; Bernardi G., 2004, STRUCTURAL EVOLUTION; BROWN TC, 1988, CELL, V54, P705, DOI 10.1016/S0092-8674(88)80015-1; Carpena P, 2002, GENE, V300, P97, DOI 10.1016/S0378-1119(02)01041-7; Chen LL, 2005, FEBS J, V272, P3328, DOI 10.1111/j.1742-4658.2005.04748.x; Chojnowski JL, 2008, INTEGR COMP BIOL, V48, P454, DOI 10.1093/icb/icn062; Costantini M, 2006, GENOME RES, V16, P536, DOI 10.1101/gr.4910606; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Costantini M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-146; Duret L, 2006, GENE, V385, P71, DOI 10.1016/j.gene.2006.04.030; Elhaik E, 2009, MOL BIOL EVOL, V26, P1829, DOI 10.1093/molbev/msp100; Eyre-Walker A, 2001, NAT REV GENET, V2, P549, DOI 10.1038/35080577; Fearnhead P, 2009, J AM STAT ASSOC, V104, P132, DOI 10.1198/jasa.2009.0009; Federico C, 2004, GENE, V343, P245, DOI 10.1016/j.gene.2004.09.011; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2001, GENETICS, V159, P907; Gao F, 2006, NUCLEIC ACIDS RES, V34, pW686, DOI 10.1093/nar/gkl040; Gautier C, 2000, CURR OPIN GENET DEV, V10, P656, DOI 10.1016/S0959-437X(00)00144-1; Gonzalez-Barrera S, 2002, GENETICS, V162, P603; Gottipati P, 2009, MUTAGENESIS, V24, P203, DOI 10.1093/mutage/gen072; Guo FB, 2003, NUCLEIC ACIDS RES, V31, P1780, DOI 10.1093/nar/gkg254; Haiminen N, 2007, GENE, V394, P53, DOI 10.1016/j.gene.2007.01.028; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Lercher MJ, 2003, HUM MOL GENET, V12, P2411, DOI 10.1093/hmg/ddg251; Li WT, 2002, COMPUT CHEM, V26, P491, DOI 10.1016/S0097-8485(02)00010-4; Marais G, 2003, TRENDS GENET, V19, P330, DOI 10.1016/S0168-9525(03)00116-1; Melodelima C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-632; Nekrutenko A, 2000, GENOME RES, V10, P1986, DOI 10.1101/gr.10.12.1986; NICKOLOFF JA, 1992, MOL CELL BIOL, V12, P5311, DOI 10.1128/MCB.12.12.5311; Oliver JL, 2002, GENE, V300, P117, DOI 10.1016/S0378-1119(02)01034-X; Oliver JL, 2001, GENE, V276, P47, DOI 10.1016/S0378-1119(01)00641-2; Ou HY, 2004, INT J BIOCHEM CELL B, V36, P535, DOI 10.1016/j.biocel.2003.08.013; SABEUR G, 1993, J MOL EVOL, V37, P93, DOI 10.1007/BF02407344; Schmidt T, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r104; Semon M, 2005, HUM MOL GENET, V14, P421, DOI 10.1093/hmg/ddi038; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sofronov GY, 2009, ENVIRON MODEL ASSESS, V14, P577, DOI 10.1007/s10666-008-9160-8; SORIANO P, 1983, P NATL ACAD SCI-BIOL, V80, P1816, DOI 10.1073/pnas.80.7.1816; THIERY JP, 1976, J MOL BIOL, V108, P219, DOI 10.1016/S0022-2836(76)80104-0; Versteeg R, 2003, GENOME RES, V13, P1998, DOI 10.1101/gr.1649303; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; YUNIS JJ, 1977, MOL STRUCTURE HUMAN, P20; ZHANG CT, 1991, NUCLEIC ACIDS RES, V19, P6313, DOI 10.1093/nar/19.22.6313; Zhang CT, 2001, J BIOMOL STRUCT DYN, V19, P333, DOI 10.1080/07391102.2001.10506743; ZHANG R, 1994, J BIOMOL STRUCT DYN, V11, P767, DOI 10.1080/07391102.1994.10508031; Zhang R, 2004, J MOL EVOL, V59, P227, DOI 10.1007/s00239-004-2617-8	49	1	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13303	10.1371/journal.pone.0013303	http://dx.doi.org/10.1371/journal.pone.0013303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948965	gold, Green Published, Green Submitted			2022-12-27	WOS:000282748100028
J	Ghanta, S; Mitchell, ME; Ames, M; Hidestrand, M; Simpson, P; Goetsch, M; Thilly, WG; Struble, CA; Tomita-Mitchell, A				Ghanta, Sujana; Mitchell, Michael E.; Ames, Mary; Hidestrand, Mats; Simpson, Pippa; Goetsch, Mary; Thilly, William G.; Struble, Craig A.; Tomita-Mitchell, Aoy			Non-Invasive Prenatal Detection of Trisomy 21 Using Tandem Single Nucleotide Polymorphisms	PLOS ONE			English	Article							TEMPERATURE CAPILLARY-ELECTROPHORESIS; WHOLE GENOME AMPLIFICATION; POLYMERASE-CHAIN-REACTION; MATERNAL BLOOD; LARGE POPULATIONS; FETAL DNA; ANEUPLOIDY; DIAGNOSIS; IDENTIFICATION; PLASMA	Background: Screening tests for Trisomy 21 (T21), also known as Down syndrome, are routinely performed for the majority of pregnant women. However, current tests rely on either evaluating non-specific markers, which lead to false negative and false positive results, or on invasive tests, which while highly accurate, are expensive and carry a risk of fetal loss. We outline a novel, rapid, highly sensitive, and targeted approach to non-invasively detect fetal T21 using maternal plasma DNA. Methods and Findings: Highly heterozygous tandem Single Nucleotide Polymorphism (SNP) sequences on chromosome 21 were analyzed using High-Fidelity PCR and Cycling Temperature Capillary Electrophoresis (CTCE). This approach was used to blindly analyze plasma DNA obtained from peripheral blood from 40 high risk pregnant women, in adherence to a Medical College of Wisconsin Institutional Review Board approved protocol. Tandem SNP sequences were informative when the mother was heterozygous and a third paternal haplotype was present, permitting a quantitative comparison between the maternally inherited haplotype and the paternally inherited haplotype to infer fetal chromosomal dosage by calculating a Haplotype Ratio (HR). 27 subjects were assessable; 13 subjects were not informative due to either low DNA yield or were not informative at the tandem SNP sequences examined. All results were confirmed by a procedure (amniocentesis/CVS) or at postnatal follow-up. Twenty subjects were identified as carrying a disomy 21 fetus (with two copies of chromosome 21) and seven subjects were identified as carrying a T21 fetus. The sensitivity and the specificity of the assay was 100% when HR values lying between 3/5 and 5/3 were used as a threshold for normal subjects. Conclusions: In summary, a targeted approach, based on calculation of Haplotype Ratios from tandem SNP sequences combined with a sensitive and quantitative DNA measurement technology can be used to accurately detect fetal T21 in maternal plasma when sufficient fetal DNA is present in maternal plasma.	[Ghanta, Sujana; Mitchell, Michael E.; Hidestrand, Mats; Goetsch, Mary; Tomita-Mitchell, Aoy] Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, Milwaukee, WI 53226 USA; [Ghanta, Sujana] Univ Louisville, Dept Comp Sci & Engn, Louisville, KY 40292 USA; [Ames, Mary] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA; [Simpson, Pippa] Med Coll Wisconsin, Dept Pediat, Div Quantitat Hlth Sci, Milwaukee, WI 53226 USA; [Thilly, William G.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Struble, Craig A.] Marquette Univ, Dept Math Stat & Comp Sci, Milwaukee, WI 53233 USA	Medical College of Wisconsin; University of Louisville; Medical College of Wisconsin; Medical College of Wisconsin; Massachusetts Institute of Technology (MIT); Marquette University	Ghanta, S (corresponding author), Med Coll Wisconsin, Dept Surg, Div Cardiothorac Surg, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	amitchell@mcw.edu	simpson, pippa/AAI-8172-2020	simpson, pippa/0000-0003-1458-3748	Wallace Coulter Foundation; Medical College of Wisconsin Biotechnology and Bioengineering Center; Medical College of Wisconsin Department of Surgery; National Science Foundation PFI [0438604]; Tandem Diagnostics	Wallace Coulter Foundation; Medical College of Wisconsin Biotechnology and Bioengineering Center; Medical College of Wisconsin Department of Surgery; National Science Foundation PFI; Tandem Diagnostics	This work was supported in part by the Wallace Coulter Foundation (ATM and MEM), the Medical College of Wisconsin Biotechnology and Bioengineering Center Inducement Grant Fund, the Medical College of Wisconsin Department of Surgery, and through the National Science Foundation PFI grant NSF#0438604 (SG). The Reconstruction experiments described in Supporting Information were funded in part by Tandem Diagnostics. The funders had no role in study design, data collection and analysis, decision to publish, or scientific preparation of the manuscript.	[Anonymous], 2003, NATURE, V426, P789; Birch L, 2005, CLIN CHEM, V51, P312, DOI 10.1373/clinchem.2004.042713; Bjorheim J, 2005, ELECTROPHORESIS, V26, P2520, DOI 10.1002/elps.200410403; Bjorheim J, 2003, ELECTROPHORESIS, V24, P63, DOI 10.1002/elps.200390032; Boys C, 2008, LANCET, V372, P1789, DOI 10.1016/S0140-6736(08)61742-0; Chiu RWK, 2008, P NATL ACAD SCI USA, V105, P20458, DOI 10.1073/pnas.0810641105; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dhallan R, 2007, LANCET, V369, P474, DOI 10.1016/S0140-6736(07)60115-9; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Ekstrom PO, 2006, ELECTROPHORESIS, V27, P1878, DOI 10.1002/elps.200500642; Evans MI, 2008, CURR OPIN OBSTET GYN, V20, P164, DOI 10.1097/GCO.0b013e3282f7321f; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Fan HC, 2007, ANAL CHEM, V79, P7576, DOI 10.1021/ac0709394; Granelli AD, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3037; Hinselwood DC, 2005, ELECTROPHORESIS, V26, P2553, DOI 10.1002/elps.200410427; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li-Sucholeiki XC, 2005, ELECTROPHORESIS, V26, P2531, DOI 10.1002/elps.200410431; Li-Sucholeiki XC, 2005, MUTAT RES-FUND MOL M, V570, P267, DOI 10.1016/j.mrfmmm.2004.11.004; Lim EL, 2001, APPL ENVIRON MICROB, V67, P3897, DOI 10.1128/AEM.67.9.3897-3903.2001; Liu CJ, 2004, GLOBAL ECOL BIOGEOGR, V13, P105, DOI 10.1111/j.1466-882X.2004.00072.x; Lo YMD, 2007, NAT MED, V13, P218, DOI 10.1038/nm1530; Marshall AC, 2008, PRENATAL DIAG, V28, P1023, DOI 10.1002/pd.2114; Simpson JL, 2004, JAMA-J AM MED ASSOC, V291, P1135, DOI 10.1001/jama.291.9.1135; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; Wang VW, 2001, CANCER RES, V61, P4169	25	17	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13184	10.1371/journal.pone.0013184	http://dx.doi.org/10.1371/journal.pone.0013184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949031	gold, Green Published, Green Submitted			2022-12-27	WOS:000282676700004
J	Muller-Anstett, MA; Muller, P; Albrecht, T; Nega, M; Wagener, J; Gao, Q; Kaesler, S; Schaller, M; Biedermann, T; Gotz, F				Mueller-Anstett, Maria Anna; Mueller, Patrick; Albrecht, Till; Nega, Mulugeta; Wagener, Jeanette; Gao, Qiang; Kaesler, Susanne; Schaller, Martin; Biedermann, Tilo; Goetz, Friedrich			Staphylococcal Peptidoglycan Co-Localizes with Nod2 and TLR2 and Activates Innate Immune Response via Both Receptors in Primary Murine Keratinocytes	PLOS ONE			English	Article								In mammalian host cells staphylococcal peptidoglycan (PGN) is recognized by Nod2. Whether PGN is also recognized by TLR2 is disputed. Here we carried out PGN co-localization and stimulation studies with TLR2 and Nod2 in wild type and mutant host cells. To exclude contamination with lipoproteins, polymeric staphylococcal PGN (PGN(pol)) was isolated from Staphylococcus aureus Delta lgt (lacking lipidated prelipoproteins). PGN(pol) was biotinylated (PGN-Bio) for fluorescence monitoring with specific antibodies. Keratinocytes from murine oral epithelium (MK) readily internalized PGN-Bio in an endocytosis-like process. In wt MK, PGN(pol) induced intracellular accumulation of Nod2 and TLR2 and co-localized with Nod2 and TLR2, but not with TLR4. In TLR2-deficient MK Nod2 and in Nod2-deficient MK TLR2 was induced, indicating that PGN(pol) recognition by Nod2 is independent of TLR2 and vice versa. In both mutants IL-6 and IL-1B release was decreased by approximately 50% compared to wt MK, suggesting that the immune responses induced by Nod2 and TLR2 are comparable and that the two receptors act additively in MK. In TLR2-tranfected HEK293 cells PGN(pol) induced NFkB-promoter fused luciferase expression. To support the data, co-localization and signaling studies were carried out with SHL-PGN, a lipase protein covalently tethered to PGN-fragments of varying sizes at its C-terminus. SHL-PGN also co-localized with Nod2 or TLR2 and induced their accumulation, while SHL without PGN did not. The results show that staphylococcal PGN not only co-localizes with Nod2 but also with TLR2. PGN is able to stimulate the immune system via both receptors.	[Mueller-Anstett, Maria Anna; Mueller, Patrick; Albrecht, Till; Nega, Mulugeta; Gao, Qiang; Goetz, Friedrich] Univ Tubingen, Tubingen, Germany; [Wagener, Jeanette; Kaesler, Susanne; Schaller, Martin; Biedermann, Tilo] Univ Tubingen, Dept Dermatol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gotz, F (corresponding author), Univ Tubingen, Tubingen, Germany.	friedrich.goetz@uni-tuebingen.de		Biedermann, Tilo/0000-0002-5352-5105; Wagener, Jeanette/0000-0002-7227-4348	DFG [SFB 766]; Graduate College "Infection biology'' [GKI 685]	DFG(German Research Foundation (DFG)); Graduate College "Infection biology''	This work was supported by the DFG: SFB 766 and Graduate College "Infection biology'' (GKI 685). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuwon KM, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-8; Ali RS, 2001, J INVEST DERMATOL, V117, P106; Asong J, 2009, J BIOL CHEM, V284, P8634, DOI 10.1074/jbc.M806633200; AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V; Begon E, 2007, EUR J DERMATOL, V17, P497; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Buwitt-Beckmann U, 2006, J BIOL CHEM, V281, P9049, DOI 10.1074/jbc.M512525200; Buwitt-Beckmann U, 2005, FEBS J, V272, P6354, DOI 10.1111/j.1742-4658.2005.05029.x; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Dorschner RA, 2001, J INVEST DERMATOL, V117, P91, DOI 10.1046/j.1523-1747.2001.01340.x; Dziarski R, 2005, INFECT IMMUN, V73, P5212, DOI 10.1128/IAI.73.8.5212-5216.2005; Dziarski R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-232; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2004, EUR J IMMUNOL, V34, P1777, DOI 10.1002/eji.200425095; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; GOTZ F, 1990, J APPL BACTERIOL, V69, pS49, DOI 10.1111/j.1365-2672.1990.tb01797.x; Guan RJ, 2007, TRENDS MICROBIOL, V15, P127, DOI 10.1016/j.tim.2007.01.006; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Hashimoto M, 1997, J BIOCHEM-TOKYO, V121, P779; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; HAYASHI K, 1975, ANAL BIOCHEM, V67, P503, DOI 10.1016/0003-2697(75)90324-3; Herbert S, 2010, INFECT IMMUN; Hermanson GT, 1996, BIOCONJUGATE TECHNIQ, P116; HUSSAIN M, 1982, J BIOL CHEM, V257, P5177; Hussain T, 2008, AM J PHYSIOL-LUNG C, V295, pL461, DOI 10.1152/ajplung.00276.2007; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Ip WKE, 2008, J EXP MED, V205, P169, DOI 10.1084/jem.20071164; Iwaki D, 2002, J BIOL CHEM, V277, P24315, DOI 10.1074/jbc.M107057200; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kobayashi M, 2009, BRIT J DERMATOL, V160, P297, DOI 10.1111/j.1365-2133.2008.08897.x; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krismer BA, STAPHYLOCOCCUS CARNO, VVI; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lee J, 2009, J BIOL CHEM, V284, P23818, DOI 10.1074/jbc.M109.033670; Lu XF, 2006, J BIOL CHEM, V281, P5895, DOI 10.1074/jbc.M511631200; Mempel M, 2002, BRIT J DERMATOL, V146, P943, DOI 10.1046/j.1365-2133.2002.04752.x; Natsuka M, 2008, INNATE IMMUN-LONDON, V14, P298, DOI 10.1177/1753425908096518; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Peschel A, 1996, FEMS MICROBIOL LETT, V137, P279; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schmaler M, 2009, J IMMUNOL, V182, P7110, DOI 10.4049/jimmunol.0804292; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Sieradzki K, 1997, J BACTERIOL, V179, P2557, DOI 10.1128/jb.179.8.2557-2566.1997; Stoll H, 2005, INFECT IMMUN, V73, P2411, DOI 10.1128/IAI.73.4.2411-2423.2005; Strauss A, 1996, MOL MICROBIOL, V21, P491, DOI 10.1111/j.1365-2958.1996.tb02558.x; Sugita K, 2007, CLIN EXP IMMUNOL, V147, P176, DOI 10.1111/j.1365-2249.2006.03258.x; Takeda K, 2003, CELL MICROBIOL, V5, P143, DOI 10.1046/j.1462-5822.2003.00264.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Uehara A, 2006, J IMMUNOL, V177, P1796, DOI 10.4049/jimmunol.177.3.1796; Underhill DM, 1999, NATURE, V402, P39, DOI DOI 10.1038/35005543; Wang MH, 2007, J IMMUNOL, V178, P3116, DOI 10.4049/jimmunol.178.5.3116; Watanabe T, 2008, J CLIN INVEST, V118, P545, DOI [10.1172/JC133145, 10.1172/JCI33145]; WONG W, 1974, J BACTERIOL, V120, P837, DOI 10.1128/JB.120.2.837-843.1974; Xuan N, 2009, CELL PHYSIOL BIOCHEM, V24, P167, DOI 10.1159/000233243; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	66	67	69	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13153	10.1371/journal.pone.0013153	http://dx.doi.org/10.1371/journal.pone.0013153			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949035	Green Submitted, Green Published, gold			2022-12-27	WOS:000208952200002
J	Bromenshenk, JJ; Henderson, CB; Wick, CH; Stanford, MF; Zulich, AW; Jabbour, RE; Deshpande, SV; McCubbin, PE; Seccomb, RA; Welch, PM; Williams, T; Firth, DR; Skowronski, E; Lehmann, MM; Bilimoria, SL; Gress, J; Wanner, KW; Cramer, RA				Bromenshenk, Jerry J.; Henderson, Colin B.; Wick, Charles H.; Stanford, Michael F.; Zulich, Alan W.; Jabbour, Rabih E.; Deshpande, Samir V.; McCubbin, Patrick E.; Seccomb, Robert A.; Welch, Phillip M.; Williams, Trevor; Firth, David R.; Skowronski, Evan; Lehmann, Margaret M.; Bilimoria, Shan L.; Gress, Joanna; Wanner, Kevin W.; Cramer, Robert A., Jr.			Iridovirus and Microsporidian Linked to Honey Bee Colony Decline	PLOS ONE			English	Article							CHILO IRIDESCENT VIRUS; APIS-MELLIFERA L.; COLLAPSE DISORDER; NOSEMA-CERANAE; KAKUGO-VIRUS; TRANSMISSION; INDUCTION; INFECTION; APOPTOSIS; DISEASE	Background: In 2010 Colony Collapse Disorder (CCD), again devastated honey bee colonies in the USA, indicating that the problem is neither diminishing nor has it been resolved. Many CCD investigations, using sensitive genome-based methods, have found small RNA bee viruses and the microsporidia, Nosema apis and N. ceranae in healthy and collapsing colonies alike with no single pathogen firmly linked to honey bee losses. Methodology/Principal Findings: We used Mass spectrometry-based proteomics (MSP) to identify and quantify thousands of proteins from healthy and collapsing bee colonies. MSP revealed two unreported RNA viruses in North American honey bees, Varroa destructor-1 virus and Kakugo virus, and identified an invertebrate iridescent virus (IIV) (Iridoviridae) associated with CCD colonies. Prevalence of IIV significantly discriminated among strong, failing, and collapsed colonies. In addition, bees in failing colonies contained not only IIV, but also Nosema. Co-occurrence of these microbes consistently marked CCD in (1) bees from commercial apiaries sampled across the U. S. in 2006-2007, (2) bees sequentially sampled as the disorder progressed in an observation hive colony in 2008, and (3) bees from a recurrence of CCD in Florida in 2009. The pathogen pairing was not observed in samples from colonies with no history of CCD, namely bees from Australia and a large, non-migratory beekeeping business in Montana. Laboratory cage trials with a strain of IIV type 6 and Nosema ceranae confirmed that co-infection with these two pathogens was more lethal to bees than either pathogen alone. Conclusions/Significance: These findings implicate co-infection by IIV and Nosema with honey bee colony decline, giving credence to older research pointing to IIV, interacting with Nosema and mites, as probable cause of bee losses in the USA, Europe, and Asia. We next need to characterize the IIV and Nosema that we detected and develop management practices to reduce honey bee losses.	[Bromenshenk, Jerry J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Henderson, Colin B.] Univ Montana, Coll Technol, Missoula, MT USA; [Wick, Charles H.; Stanford, Michael F.; Zulich, Alan W.; Skowronski, Evan] USA, Edgewood Chem Biol Ctr, Edgewood Area, MD USA; [Jabbour, Rabih E.] Sci Applicat Int Corp, Abingdon, MD USA; [Deshpande, Samir V.] Sci Technol Corp, Edgewood, MD USA; [McCubbin, Patrick E.] OptiMetrics Inc, Abingdon, MD USA; [Bromenshenk, Jerry J.; Henderson, Colin B.; Seccomb, Robert A.; Welch, Phillip M.] Bee Alert Technol Inc, Missoula, MT USA; [Williams, Trevor] Inst Ecol AC, Xalapa, Veracruz, Mexico; [Firth, David R.] Univ Montana, Dept Informat Syst & Technol, Missoula, MT 59812 USA; [Lehmann, Margaret M.; Cramer, Robert A., Jr.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Bilimoria, Shan L.] Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA; [Gress, Joanna; Wanner, Kevin W.] Montana State Univ, Dept Plant Sci & Plant Pathol, Bozeman, MT 59717 USA; [Deshpande, Samir V.] Towson Univ, Dept Comp & Informat Sci, Towson, MD USA; [Bilimoria, Shan L.] Texas Tech Univ, Ctr Biotechnol & Genom, Lubbock, TX 79409 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); Science Applications International Corporation (SAIC); Instituto de Ecologia - Mexico; University of Montana System; University of Montana; Montana State University System; Montana State University Bozeman; Texas Tech University System; Texas Tech University; Montana State University System; Montana State University Bozeman; University System of Maryland; Towson University; Texas Tech University System; Texas Tech University	Bromenshenk, JJ (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.	beeresearch@aol.com	Williams, Trevor/F-1447-2011; Williams, Trevor/J-4239-2013; Williams, Trevor/ABG-3961-2020	Williams, Trevor/0000-0003-3414-3440; Williams, Trevor/0000-0003-3414-3440; 	Point Detection Branch of ECBC, Defense Threat Reduction Agency (DTRA); National Honey Board, California Almond Board [06-POLL8-Bromenshenk, 09-POLL10-Bromenshenk]; Foundation for the Preservation of the Honey Bee; US Army Medical Research and Material Command [W81XWH-04-C-0013]; California Beekeepers Association; Montana Agricultural Experiment Station in the laboratory of RAC	Point Detection Branch of ECBC, Defense Threat Reduction Agency (DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Honey Board, California Almond Board; Foundation for the Preservation of the Honey Bee; US Army Medical Research and Material Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); California Beekeepers Association; Montana Agricultural Experiment Station in the laboratory of RAC	Proteomics analysis was provided by the Point Detection Branch of ECBC under the auspices of the basic science program of the Defense Threat Reduction Agency (DTRA). Sampling and analysis was supported by the National Honey Board, California Almond Board (06-POLL8-Bromenshenk, 09-POLL10-Bromenshenk), The Foundation for the Preservation of the Honey Bee, and the US Army Medical Research and Material Command (W81XWH-04-C-0013), with data processing and statistical analysis by the US Army Night Vision Laboratory (W909MY-06-C-0037). Project Apis m. is funding confirmatory inoculation studies. Work related to these studies was supported by the California Beekeepers Association and the Montana Agricultural Experiment Station in the laboratory of RAC. These companies and the other listed funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Anderson D, 2008, SCIENCE, V319, P724, DOI 10.1126/science.319.5864.724c; BAILEY L, 1976, J GEN VIROL, V31, P459, DOI 10.1099/0022-1317-31-3-459; BAILEY L, 1978, J INVERTEBR PATHOL, V31, P368, DOI 10.1016/0022-2011(78)90231-8; Baker AC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-10; Becnel JJ, 2007, J AM MOSQUITO CONTR, V23, P36, DOI 10.2987/8756-971X(2007)23[36:MPVLY]2.0.CO;2; Bilimoria SL, 2001, US patent, Patent No. 6200561; BROMENSHENK JJ, 2010, BEE CULTURE, V138, P51; BRUCE WA, 1995, AM BEE J, V135, P352; Camazine S, 1998, J INVERTEBR PATHOL, V71, P177, DOI 10.1006/jipa.1997.4713; *CCD WORK GROUP, 2006, COL COLL DIS CCD; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chitnis NS, 2008, VIROLOGY, V370, P333, DOI 10.1016/j.virol.2007.09.010; COLE A, 1980, INTERVIROLOGY, V14, P21, DOI 10.1159/000149158; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; D'Costa SM, 2004, ARCH VIROL, V149, P723, DOI 10.1007/s00705-003-0232-4; DE MIRANDA, 2004, J GEN VIROL 8, V85, P2263; Debnam S WD, 2008, BEE CULTURE, V137, P30; Delhon G, 2006, J VIROL, V80, P8439, DOI 10.1128/JVI.00464-06; Dworzanski JP, 2006, J PROTEOME RES, V5, P76, DOI 10.1021/pr050294t; *EDG CHEM BIOL CTR, 2007, SCI ID PATH THAT MAY; Fries I, 1996, EUR J PROTISTOL, V32, P356, DOI 10.1016/S0932-4739(96)80059-9; Fujiyuki T, 2006, J VIROL, V80, P11528, DOI 10.1128/JVI.00754-06; Henderson CW, 2001, ARCH VIROL, V146, P767, DOI 10.1007/s007050170145; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; HUKUHARA T, 1964, J INSECT PATHOL, V6, P246; Jabbour RE, 2010, APPL ENVIRON MICROB, V76, P3637, DOI 10.1128/AEM.00055-10; Jakob NJ, 2001, VIROLOGY, V286, P182, DOI 10.1006/viro.2001.0963; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; Lopez M, 2002, J INVERTEBR PATHOL, V80, P160, DOI 10.1016/S0022-2011(02)00106-4; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Marina CF, 2005, ECOL ENTOMOL, V30, P376, DOI 10.1111/j.0307-6946.2005.00711.x; Marina CF, 2003, ENTOMOL EXP APPL, V106, P53, DOI 10.1046/j.1570-7458.2003.00010.x; Marina CF, 1999, OECOLOGIA, V119, P383, DOI 10.1007/s004420050799; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Ongus JR, 2006, J GEN VIROL, V87, P3397, DOI 10.1099/vir.0.82122-0; Paul ER, 2007, ARCH VIROL, V152, P1353, DOI 10.1007/s00705-007-0945-x; Suter II G.W., 2007, ECOLOGICAL RISK ASSE; Terio V, 2008, NEW MICROBIOL, V31, P439; TINSLEY T W, 1970, Journal of Invertebrate Pathology, V16, P470, DOI 10.1016/0022-2011(70)90170-9; Tonka T, 2000, J INVERTEBR PATHOL, V76, P229, DOI 10.1006/jipa.2000.4971; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Verma S., 1983, Indian Bee Journal, V44, P36; Webby R, 1998, ARCH VIROL, V143, P1949, DOI 10.1007/s007050050432; WICK CH, 2010, TR814 EDG CHEM BIOL; Williams T, 1998, VIRUSES, P31; WILLIAMS T, 1994, J GEN VIROL, V75, P1291, DOI 10.1099/0022-1317-75-6-1291; Williams T, 2008, NEOTROP ENTOMOL, V37, P615, DOI 10.1590/S1519-566X2008000600001; WILSON WT, 1979, AM BEE J, V119, P184; 2000, ANAL INFORM LAB ANAL	54	158	173	0	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13181	10.1371/journal.pone.0013181	http://dx.doi.org/10.1371/journal.pone.0013181			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949138	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400008
J	Josset, L; Textoris, J; Loriod, B; Ferraris, O; Moules, V; Lina, B; N'Guyen, C; Diaz, JJ; Rosa-Calatrava, M				Josset, Laurence; Textoris, Julien; Loriod, Beatrice; Ferraris, Olivier; Moules, Vincent; Lina, Bruno; N'Guyen, Catherine; Diaz, Jean-Jacques; Rosa-Calatrava, Manuel			Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; IN-VITRO; SIGNALING PATHWAYS; VIRUS-REPLICATION; EPITHELIAL-CELLS; CONNECTIVITY MAP; HOST IMMUNE; NEUTRAL RED; H1N1 VIRUS; MICROARRAYS	Classical antiviral therapies target viral proteins and are consequently subject to resistance. To counteract this limitation, alternative strategies have been developed that target cellular factors. We hypothesized that such an approach could also be useful to identify broad-spectrum antivirals. The influenza A virus was used as a model for its viral diversity and because of the need to develop therapies against unpredictable viruses as recently underlined by the H1N1 pandemic. We proposed to identify a gene-expression signature associated with infection by different influenza A virus subtypes which would allow the identification of potential antiviral drugs with a broad anti-influenza spectrum of activity. We analyzed the cellular gene expression response to infection with five different human and avian influenza A virus strains and identified 300 genes as differentially expressed between infected and non-infected samples. The most 20 dysregulated genes were used to screen the connectivity map, a database of drug-associated gene expression profiles. Candidate antivirals were then identified by their inverse correlation to the query signature. We hypothesized that such molecules would induce an unfavorable cellular environment for influenza virus replication. Eight potential antivirals including ribavirin were identified and their effects were tested in vitro on five influenza A strains. Six of the molecules inhibited influenza viral growth. The new pandemic H1N1 virus, which was not used to define the gene expression signature of infection, was inhibited by five out of the eight identified molecules, demonstrating that this strategy could contribute to identifying new broad anti-influenza agents acting on cellular gene expression. The identified infection signature genes, the expression of which are modified upon infection, could encode cellular proteins involved in the viral life cycle. This is the first study showing that gene expression-based screening can be used to identify antivirals. Such an approach could accelerate drug discovery and be extended to other pathogens.	[Josset, Laurence; Ferraris, Olivier; Moules, Vincent; Lina, Bruno; Rosa-Calatrava, Manuel] Univ Lyon 1, CNRS, FRE Virol & Pathol Humaine 3011, F-69365 Lyon, France; [Josset, Laurence; Lina, Bruno] Hosp Civils Lyon, Virol Lab, Ctr Biol & Pathol Est, Lyon, France; [Textoris, Julien; Loriod, Beatrice; N'Guyen, Catherine] Univ Mediterranee, INSERM, Technol Avancees Genome & Clin U928, Marseille, France; [Textoris, Julien; Diaz, Jean-Jacques] Univ Lyon 1, CNRS, UMR 5534, Ctr Leon Berard,Ctr Genet Mol & Cellulaire, F-69365 Lyon, France; [Textoris, Julien] Hop Nord Marseille, Assistance Publ Hop Marseille, Serv Anesthesie & Reanimat, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Josset, L (corresponding author), Univ Lyon 1, CNRS, FRE Virol & Pathol Humaine 3011, F-69365 Lyon, France.	laurence.josset@chu-lyon.fr; manuel.rosa-calatrava@univ-lyon1.fr	Rosa-calatrava, Manuel/M-7263-2014; Nguyen, Catherine/M-4119-2016; lina, bruno/N-3663-2019; DIAZ, Jean-Jacques/AAT-3846-2021; Textoris, Julien/H-3317-2019; loriod, beatrice bl/L-2948-2016; Josset, Laurence/A-7960-2015; MOULES, Vincent/M-8084-2014; DIAZ, Jean-Jacques/H-3018-2014; LINA, bruno/M-4572-2014	Nguyen, Catherine/0000-0001-9376-6360; lina, bruno/0000-0002-8959-2123; DIAZ, Jean-Jacques/0000-0002-7914-4319; Textoris, Julien/0000-0002-3821-9337; loriod, beatrice bl/0000-0001-5801-2264; Josset, Laurence/0000-0002-7158-1186; DIAZ, Jean-Jacques/0000-0002-7914-4319; Rosa-calatrava, Manuel/0000-0002-7559-9527	CNRS (Centre National de la Recherche Scientifique); Hospices Civils de Lyon; European Vigilance Network for the Management of Antiviral Drug Resistance (VIRGIL); Institut de Microbiologie et Maladies Infectieuses (INSERM)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Hospices Civils de Lyon; European Vigilance Network for the Management of Antiviral Drug Resistance (VIRGIL); Institut de Microbiologie et Maladies Infectieuses (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by CNRS (Centre National de la Recherche Scientifique), the Hospices Civils de Lyon, the European Vigilance Network for the Management of Antiviral Drug Resistance (VIRGIL), and by a grant of the "Programme de Recherche A(H1N1)" co-ordinated by the Institut de Microbiologie et Maladies Infectieuses (INSERM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2009, ANTI-CANCER DRUG, V20, P373, DOI 10.1097/CAD.0b013e32832a2dd9; Baas T, 2006, J VIROL, V80, P10813, DOI 10.1128/JVI.00851-06; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORNSON AB, 1991, AM REV RESPIR DIS, V143, P1062, DOI 10.1164/ajrccm/143.5_Pt_1.1062; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Chan RWY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008713; Chan-Tack KM, 2009, NEW ENGL J MED, V361, P1713, DOI 10.1056/NEJMc0905290; Cruz D N, 2000, Expert Opin Pharmacother, V1, P835, DOI 10.1517/14656566.1.4.835; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Eichelberger MC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-109; El Kasmi KC, 2007, J IMMUNOL, V179, P7215, DOI 10.4049/jimmunol.179.11.7215; FAUTZ R, 1991, MUTAT RES, V253, P173, DOI 10.1016/0165-1161(91)90130-Z; Feld JJ, 2007, HEPATOLOGY, V46, P1548, DOI 10.1002/hep.21853; Feld JJ, 2010, GASTROENTEROLOGY, V139, P154, DOI 10.1053/j.gastro.2010.03.037; Fotakis G, 2006, TOXICOL LETT, V160, P171, DOI 10.1016/j.toxlet.2005.07.001; Geiss GK, 2001, J VIROL, V75, P4321, DOI 10.1128/JVI.75.9.4321-4331.2001; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gonzalez-Cabrera PJ, 2004, ENDOCRINOLOGY, V145, P5157, DOI 10.1210/en.2004-0728; Gonzalez-Cabrera PJ, 2003, MOL PHARMACOL, V63, P1104, DOI 10.1124/mol.63.5.1104; Greco A, 2005, FASEB J, V19, P1128, DOI 10.1096/fj.04-2108fje; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; Guo Y, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-39; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hayden FG, 2006, ANTIVIR RES, V71, P372, DOI 10.1016/j.antiviral.2006.05.016; Herraiz T, 2010, FOOD CHEM TOXICOL, V48, P839, DOI 10.1016/j.fct.2009.12.019; Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008; Im JH, 2009, VASC PHARMACOL, V50, P147, DOI 10.1016/j.vph.2008.11.008; Jonges M, 2010, J CLIN MICROBIOL, V48, P928, DOI 10.1128/JCM.02045-09; KANAI Y, 2010, VIRUS RES IN PRESS; Karlas A, 2010, NATURE, V463, P818, DOI 10.1038/nature08760; Kash JC, 2004, J VIROL, V78, P9499, DOI 10.1128/JVI.78.17.9499-9511.2004; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kash JC, 2009, ANTIVIR RES, V83, P10, DOI 10.1016/j.antiviral.2009.04.004; KATZE MG, 1984, MOL CELL BIOL, V4, P2198, DOI 10.1128/MCB.4.10.2198; KLEIN M, 1948, J IMMUNOL, V59, P135; Konig R, 2010, NATURE, V463, P813, DOI 10.1038/nature08699; Kurokawa M, 1999, INT J MOL MED, V3, P527; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lee DCW, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-71; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez F, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-38; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Ludwig S, 2009, J ANTIMICROB CHEMOTH, V64, P1, DOI 10.1093/jac/dkp161; Marjuki H, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-134; Michaelis M, 2009, INFECTION, V37, P381, DOI 10.1007/s15010-009-9181-5; Moules V, 2010, VIROLOGY, V404, P215, DOI 10.1016/j.virol.2010.04.030; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Ning S, 2003, J VIROL, V77, P9359, DOI 10.1128/JVI.77.17.9359-9368.2003; Puthier D, 2004, J IMMUNOL, V173, P6109, DOI 10.4049/jimmunol.173.10.6109; Reeves JD, 2005, DRUGS, V65, P1747, DOI 10.2165/00003495-200565130-00002; RITZ C, 2005, J STAT SOFTWARE, V12; Root CN, 2000, J GEN VIROL, V81, P2697, DOI 10.1099/0022-1317-81-11-2697; Schmolke M, 2009, J IMMUNOL, V183, P5180, DOI 10.4049/jimmunol.0804198; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Scull MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000424; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shi T, 2006, MOL PHARMACOL, V70, P129, DOI 10.1124/mol.105.020735; Sidwell RW, 2005, ANTIVIR RES, V68, P10, DOI 10.1016/j.antiviral.2005.06.003; Smee DF, 2002, J VIROL METHODS, V106, P71, DOI 10.1016/S0166-0934(02)00137-4; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Tong HH, 2004, MICROB PATHOGENESIS, V37, P193, DOI 10.1016/j.micpath.2004.06.012; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; *WHO, 2009, WHO INFL SEAS; Zhang H, 2006, MICROBES INFECT, V8, P2172, DOI 10.1016/j.micinf.2006.04.018; Zhang YH, 2003, J VIROL, V77, P5933, DOI 10.1128/JVI.77.10.5933-5947.2003	73	51	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13169	10.1371/journal.pone.0013169	http://dx.doi.org/10.1371/journal.pone.0013169			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957181	Green Published, gold, Green Submitted			2022-12-27	WOS:000282423300011
J	Gnidehou, S; Jessen, L; Gangnard, S; Ermont, C; Triqui, C; Quiviger, M; Guitard, J; Lund, O; Deloron, P; Ndam, NT				Gnidehou, Sedami; Jessen, Leon; Gangnard, Stephane; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Lund, Ole; Deloron, Philippe; Ndam, Nicaise Tuikue			Insight into Antigenic Diversity of VAR2CSA-DBL5 epsilon Domain from Multiple Plasmodium falciparum Placental Isolates	PLOS ONE			English	Article							PREGNANCY-ASSOCIATED MALARIA; CHONDROITIN SULFATE-A; CSA-BINDING PARASITES; INFECTED ERYTHROCYTES; VAR GENE; VAR2CSA; ADHESION; ANTIBODIES; PFEMP1; WOMEN	Background: Protection against pregnancy associated malaria (PAM) is associated with high levels of anti-VAR2CSA antibodies. This protection is obtained by the parity dependent acquisition of anti-VAR2CSA antibodies. Distinct parity-associated molecular signatures have been identified in VAR2CSA domains. These two observations combined point to the importance of identifying VAR2CSA sequence variation, which facilitate parasitic evasion or subversion of host immune response. Highly conserved domains of VAR2CSA such as DBL5e are likely to contain conserved epitopes, and therefore do constitute attractive targets for vaccine development. Methodology/Principal Findings: VAR2CSA DBL5e-domain sequences obtained from cDNA of 40 placental isolates were analysed by a combination of experimental and in silico methods. Competition ELISA assays on two DBL5e variants, using plasma samples from women from two different areas and specific mice hyperimmune plasma, indicated that DBL5e possess conserved and cross-reactive B cell epitopes. Peptide ELISA identified conserved areas that are recognised by naturally acquired antibodies. Specific antibodies against these peptides labelled the native proteins on the surface of placental parasites. Despite high DBL5e sequence homology among parasite isolates, sequence analyses identified motifs in DBL5e that discriminate parasites according to donor's parity. Moreover, recombinant proteins of two VAR2CSA DBL5e variants displayed diverse recognition patterns by plasma from malaria-exposed women, and diverse proteoglycan binding abilities. Conclusions/Significance: This study provides insights into conserved and exposed B cell epitopes in DBL5e that might be a focus for cross reactivity. The importance of sequence variation in VAR2CSA as a critical challenge for vaccine development is highlighted. VAR2CSA conformation seems to be essential to its functionality. Therefore, identification of sequence variation sites in distinct locations within VAR2CSA, affecting antigenicity and/or binding properties, is critical to the effort of developing an efficient VAR2CSA-based vaccine. Motifs associated with parasite segregation according to parity constitute one such site.	[Gnidehou, Sedami; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Deloron, Philippe; Ndam, Nicaise Tuikue] Inst Rech Dev, IRD UMR 216, Paris, France; [Jessen, Leon; Lund, Ole] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Gnidehou, Sedami; Ermont, Caroline; Triqui, Choukri; Quiviger, Mickael; Guitard, Juliette; Deloron, Philippe] Univ Paris 05, Paris, France; [Gangnard, Stephane] Inst Pasteur, CNRS, URA2185, Unite Immunol Struct, Paris, France; [Ndam, Nicaise Tuikue] Inst Sci Biomed & Appl, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; Technical University of Denmark; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Gnidehou, S (corresponding author), Inst Rech Dev, IRD UMR 216, Paris, France.	gcarine@yahoo.com; nicaise.ndam@ird.fr	Lund, Ole/F-4437-2014; Deloron, Philippe/G-6305-2010; Guitard, Juliette/AAE-6344-2019; Jessen, Leon/L-7156-2018	Lund, Ole/0000-0003-1108-0491; Deloron, Philippe/0000-0003-4705-2484; Guitard, Juliette/0000-0002-9782-3577; Jessen, Leon Eyrich/0000-0003-2879-2559; Tuikue Ndam, Nicaise/0000-0003-2646-2513	French National Agency of Research [ANR-05-MIME-009-01]; European Commission [200889]; Copenhagen University	French National Agency of Research(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Copenhagen University	This work was supported by grants from the French National Agency of Research (grant # ANR-05-MIME-009-01), the European Commission, FP7 work program (Grant # 200889), and the Copenhagen University Programme of Excellence. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akogbeto M., 1992, Parassitologia (Rome), V34, P147; Andersen P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040042; Avril M, 2006, MICROBES INFECT, V8, P2863, DOI 10.1016/j.micinf.2006.09.005; Barfod L, 2007, MOL MICROBIOL, V63, P335, DOI 10.1111/j.1365-2958.2006.05503.x; Beeson JG, 2000, NAT MED, V6, P86, DOI 10.1038/71582; Bengtsson D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-101; Briand V, 2009, J INFECT DIS, V200, P991, DOI 10.1086/605474; Dahlback M, 2006, PLOS PATHOG, V2, P1069, DOI 10.1371/journal.ppat.0020124; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duffy PE, 2003, INFECT IMMUN, V71, P6620, DOI 10.1128/IAI.71.11.6620-6623.2003; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Gamain B, 2005, J INFECT DIS, V191, P1010, DOI 10.1086/428137; GANGNARD S, 2010, MOL BIOCH PARASITOL; Guitard J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-165; Higgins MK, 2008, J BIOL CHEM, V283, P21842, DOI 10.1074/jbc.C800086200; HOOF I, 2009, THESIS TU DENMARK; Juillerat A, 2010, MOL BIOCHEM PARASIT, V170, P84, DOI 10.1016/j.molbiopara.2009.12.008; Khunrae P, 2009, J MOL BIOL, V393, P202, DOI 10.1016/j.jmb.2009.08.027; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leblond J, 2007, BIOCONJUGATE CHEM, V18, P484, DOI 10.1021/bc060141b; Magistrado P, 2008, J INFECT DIS, V198, P1071, DOI 10.1086/591502; Ndam NGT, 2006, J INFECT DIS, V193, P713, DOI 10.1086/500146; Ndam NGT, 2004, J INFECT DIS, V190, P2001, DOI 10.1086/425521; Nielsen MA, 2007, EXP PARASITOL, V117, P1, DOI 10.1016/j.exppara.2007.03.002; Resende M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-104; Resende M, 2009, INT J PARASITOL, V39, P1195, DOI 10.1016/j.ijpara.2009.02.022; Salanti A, 2004, J EXP MED, V200, P1197, DOI 10.1084/jem.20041579; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sander AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006667; Shannon C. E., 1949, MATH THEORY COMMUNIC; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEKETEE RW, 1988, ANN TROP MED PARASIT, V82, P113, DOI 10.1080/00034983.1988.11812217; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; Viebig NK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000910; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; H2PDB SERVER	41	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13105	10.1371/journal.pone.0013105	http://dx.doi.org/10.1371/journal.pone.0013105			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957045	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300011
J	Kuriwada, T; Hosokawa, T; Kumano, N; Shiromoto, K; Haraguchi, D; Fukatsu, T				Kuriwada, Takashi; Hosokawa, Takahiro; Kumano, Norikuni; Shiromoto, Keiko; Haraguchi, Dai; Fukatsu, Takema			Biological Role of Nardonella Endosymbiont in Its Weevil Host	PLOS ONE			English	Article							SWEET-POTATO WEEVIL; DRYOPHTHORIDAE WEEVILS; GENOME SEQUENCE; EVOLUTIONARY RELATIONSHIPS; BACTERIAL ENDOSYMBIONTS; ARTIFICIAL DIET; COLEOPTERA; SYMBIONT; COSPECIATION; SURVIVAL	Weevils constitute the most species-rich animal group with over 60,000 described species, many of which possess specialized symbiotic organs and harbor bacterial endosymbionts. Among the diverse microbial associates of weevils, Nardonella spp. represent the most ancient and widespread endosymbiont lineage, having co-speciated with the host weevils for over 125 million years. Thus far, however, no empirical work on the role of Nardonella for weevil biology has been reported. Here we investigated the biological role of the Nardonella endosymbiont for the West Indian sweet potato weevil, Euscepes postfasciatus. This insect is an experimentally tractable pest insect that can easily be reared on a natural diet of sweet potato root as well as on an agar-based artificial diet. By larval feeding on an antibiotic-containing artificial diet, Nardonella infection was effectively eliminated from the treated insects. The antibiotic-treated insects exhibited significantly lighter body weight and lower growth rate than the control insects. Then, the antibiotic-treated insects and the control insects were respectively allowed to mate and oviposit on fresh sweet potatoes without the antibiotic. The offspring of the antibiotic-treated insects, which were all Nardonella-negative, exhibited significantly lighter body weight, smaller body size, lower growth rate and paler body color in comparison with the offspring of the control insects, which were all Nardonella-positive. In conclusion, the Nardonella endosymbiont is involved in normal growth and development of the host weevil. The biological role of the endosymbiont probably underlies the long-lasting host-symbiont co-speciation in the evolutionary course of weevils.	[Kuriwada, Takashi; Kumano, Norikuni; Shiromoto, Keiko; Haraguchi, Dai] Okinawa Prefectural Plant Protect Ctr, Naha, Japan; [Hosokawa, Takahiro; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Kuriwada, T (corresponding author), Okinawa Prefectural Plant Protect Ctr, Naha, Japan.	t-fukatsu@aist.go.jp		Hosokawa, Takahiro/0000-0001-7618-1774; Kumano, Norikuni/0000-0003-2803-8660	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan	Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan	This research was supported by a funding from the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN), Japan, to T. F. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman L, 2002, NAT GENET, V32, P402, DOI 10.1038/ng986; Allen JM, 2007, APPL ENVIRON MICROB, V73, P1659, DOI 10.1128/AEM.01877-06; Baumann P, 1997, ANTON LEEUW INT J G, V72, P39, DOI 10.1023/A:1000239108771; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOURTZIS K, 2008, INSECT SYMBIOSIS, V3, P384; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Buchner P, 1965, ENDOSYMBIONTS ANIMAL; Chen XA, 1999, J MOL EVOL, V48, P49, DOI 10.1007/PL00006444; Clark MA, 2000, EVOLUTION, V54, P517, DOI 10.1111/j.0014-3820.2000.tb00054.x; COCHRAN DG, 1985, ANNU REV ENTOMOL, V30, P29, DOI 10.1146/annurev.en.30.010185.000333; Conord C, 2008, MOL BIOL EVOL, V25, P859, DOI 10.1093/molbev/msn027; Costa HS, 1997, J ECON ENTOMOL, V90, P333, DOI 10.1093/jee/90.2.333; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Feldhaar H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-48; Fukatsu T, 2007, APPL ENVIRON MICROB, V73, P6660, DOI 10.1128/AEM.01131-07; Gil R, 2003, P NATL ACAD SCI USA, V100, P9388, DOI 10.1073/pnas.1533499100; Heddi A, 2005, SYMBIOSIS, V39, P1; Hosokawa T, 2010, APPL ENTOMOL ZOOL, V45, P115, DOI 10.1303/aez.2010.115; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; HOUK EJ, 1980, ANNU REV ENTOMOL, V25, P161, DOI 10.1146/annurev.en.25.010180.001113; Jansson RK, 1991, SWEET POTATO PEST MA, P1; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Koga R, 2007, FEMS MICROBIOL ECOL, V60, P229, DOI 10.1111/j.1574-6941.2007.00284.x; Kono M, 2008, APPL ENVIRON MICROB, V74, P4175, DOI 10.1128/AEM.00250-08; Kuba H., 2000, PLANT PROT Q, V54, P483; Kuriwada T, 2009, FLA ENTOMOL, V92, P221, DOI 10.1653/024.092.0205; Lefevre C, 2004, MOL BIOL EVOL, V21, P965, DOI 10.1093/molbev/msh063; McCutcheon JP, 2007, P NATL ACAD SCI USA, V104, P19392, DOI 10.1073/pnas.0708855104; McCutcheon JP, 2009, P NATL ACAD SCI USA, V106, P15394, DOI 10.1073/pnas.0906424106; McKenna DD, 2009, P NATL ACAD SCI USA, V106, P7083, DOI 10.1073/pnas.0810618106; Moran NA, 2005, APPL ENVIRON MICROB, V71, P8802, DOI 10.1128/AEM.71.12.8802-8810.2005; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Nardon P, 2002, SYMBIOSIS, V33, P227; NOGGE G, 1981, PARASITOLOGY, V82, P101; Oberprieler Rolf G., 2007, Zootaxa, V1668, P491; Ohno S, 2009, APPL ENTOMOL ZOOL, V44, P13, DOI 10.1303/aez.2009.13; Pontes MH, 2006, TRENDS MICROBIOL, V14, P406, DOI 10.1016/j.tim.2006.07.004; Puchta O., 1955, Zeitschrift fuer Parasitenkunde, V17, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Raman K.V., 1991, P263; Sabree ZL, 2009, P NATL ACAD SCI USA, V106, P19521, DOI 10.1073/pnas.0907504106; Sauer C, 2000, INT J SYST EVOL MICR, V50, P1877, DOI 10.1099/00207713-50-5-1877; Shigenobu S, 2000, NATURE, V407, P81, DOI 10.1038/35024074; Shimoji Y, 1996, APPL ENTOMOL ZOOL, V31, P152, DOI 10.1303/aez.31.152; Takiya DM, 2006, MOL ECOL, V15, P4175, DOI 10.1111/j.1365-294X.2006.03071.x; Thao ML, 2000, APPL ENVIRON MICROB, V66, P2898, DOI 10.1128/AEM.66.7.2898-2905.2000; Thao ML, 2004, APPL ENVIRON MICROB, V70, P3401, DOI 10.1128/AEM.70.6.3401-3406.2004; Toju H, 2010, APPL ENVIRON MICROB, V76, P275, DOI 10.1128/AEM.02154-09; Urasaki K, 2009, JPN J APPL ENTOMOL Z, V53, P1, DOI 10.1303/jjaez.2009.1; Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969; WICKER C, 1983, COMP BIOCHEM PHYS A, V76, P177, DOI 10.1016/0300-9629(83)90311-0; Woolfe JA., 2008, SWEETPOTATO UNTAPPED; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188	55	44	45	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13101	10.1371/journal.pone.0013101	http://dx.doi.org/10.1371/journal.pone.0013101			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957033	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300008
J	Liu, XA; Qin, SZ; Rijpkema, M; Luo, J; Fernandez, G				Liu, Xiao; Qin, Shaozheng; Rijpkema, Mark; Luo, Jing; Fernandez, Guillen			Intermediate Levels of Hippocampal Activity Appear Optimal for Associative Memory Formation	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; PATTERN SEPARATION; DENTATE GYRUS; ITEM; RECOGNITION; CA3; MECHANISMS; STRENGTH; DORSAL; CORTEX	Background: It is well established that hippocampal activity is positively related to effective associative memory formation. However, in biological systems often optimal levels of activity are contrasted by both sub-and supra-optimal levels. Suboptimal levels of hippocampal activity are commonly attributed to unsuccessful memory formation, whereas the supraoptimal levels of hippocampal activity related to unsuccessful memory formation have been rarely studied. It is still unclear under what circumstances such supra-optimal levels of hippocampal activity occur. To clarify this issue, we aimed at creating a condition, in which supra-optimal hippocampal activity is associated with encoding failure. We assumed that such supra-optimal activity occurs when task-relevant information is embedded in task-irrelevant, distracting information, which can be considered as noise. Methodology/Principal Findings: In the present fMRI study, we probed neural correlates of associative memory formation in a full-factorial design with associative memory (subsequently remembered versus forgotten) and noise (induced by high versus low distraction) as factors. Results showed that encoding failure was associated with supra-optimal activity in the high-distraction condition and with sub-optimal activity in the low distraction condition. Thus, we revealed evidence for a bell-shape function relating hippocampal activity with associative encoding success. Conclusions/Significance: Our findings indicate that intermediate levels of hippocampal activity are optimal while both too low and too high levels appear detrimental for associative memory formation. Supra-optimal levels of hippocampal activity seem to occur when task-irrelevant information is added to task-relevant signal. If such task-irrelevant noise is reduced adequately, hippocampal activity is lower and thus optimal for associative memory formation.	[Liu, Xiao; Qin, Shaozheng; Rijpkema, Mark; Fernandez, Guillen] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Liu, Xiao; Luo, Jing] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Liu, Xiao] Chinese Acad Sci, Grad Sch, Beijing 100101, Peoples R China; [Qin, Shaozheng] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Fernandez, Guillen] Radboud Univ Nijmegen, Dept Cognit Neurosci, Donders Inst Brain Cognit & Behav, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Radboud University Nijmegen; Radboud University Nijmegen	Liu, XA (corresponding author), Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	luoj@psych.ac.cn; guillen.fernandez@donders.ru.nl	Rijpkema, Mark/D-1974-2010; Qin, Shaozheng/AAD-2107-2019; Fernandez, Guillen/B-3771-2009	Rijpkema, Mark/0000-0002-8495-4703; Qin, Shaozheng/0000-0002-1859-2150; Fernandez, Guillen/0000-0002-5522-0604	Netherlands Organization for Scientific Research (NWO) [918.66.613]; Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Royal Netherlands Academy of Arts and Sciences (KNAW); Chinese Academy of Sciences (CAS)(Chinese Academy of Sciences)	This work is supported by Netherlands Organization for Scientific Research (NWO), grant number: 918.66.613, Royal Netherlands Academy of Arts and Sciences (KNAW) and the Chinese Academy of Sciences (CAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Baldi Elisabetta, 2005, Nonlinearity in Biology Toxicology and Medicine, V3, P9, DOI 10.2201/nonlin.003.01.002; Caplan JB, 2007, CEREB CORTEX, V17, P1650, DOI 10.1093/cercor/bhl076; Cheng DT, 2008, P NATL ACAD SCI USA, V105, P8108, DOI 10.1073/pnas.0800374105; Clark RE, 1998, SCIENCE, V280, P77, DOI 10.1126/science.280.5360.77; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Forster S, 2009, COGNITION, V111, P345, DOI 10.1016/j.cognition.2009.02.006; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gerwig M, 2007, CEREBELLUM, V6, P38, DOI 10.1080/14734220701225904; Henckens MJAG, 2009, J NEUROSCI, V29, P10111, DOI 10.1523/JNEUROSCI.1184-09.2009; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 1999, J NEUROSCI, V19, P3962; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P955, DOI 10.1002/hipo.20455; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Kirwan CB, 2004, HIPPOCAMPUS, V14, P919, DOI 10.1002/hipo.20014; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Luo J, 2005, HIPPOCAMPUS, V15, P141, DOI 10.1002/hipo.20054; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; MCNAUGHTON BL, 1989, NEUROSCIENCE CONNECT, P1; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Piekema C, 2009, LEARN MEMORY, V16, P231, DOI 10.1101/lm.1283109; Qin SZ, 2007, NEUROIMAGE, V38, P212, DOI 10.1016/j.neuroimage.2007.07.020; Qin SZ, 2009, NEUROIMAGE, V46, P874, DOI 10.1016/j.neuroimage.2009.02.039; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ranganath C, 2001, NEURON, V31, P865, DOI 10.1016/S0896-6273(01)00411-1; Rolls ET, 2007, LEARN MEMORY, V14, P714, DOI 10.1101/lm.631207; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Shrager Y, 2008, NEURON, V59, P547, DOI 10.1016/j.neuron.2008.07.022; Tseng W, 2004, HIPPOCAMPUS, V14, P58, DOI 10.1002/hipo.10157; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Wagner AD, 2001, CURR BIOL, V11, pR964, DOI 10.1016/S0960-9822(01)00575-9; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Weible AP, 2006, NEUROSCIENCE, V141, P1123, DOI 10.1016/j.neuroscience.2006.04.065; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Yerkes RM, 1908, J COMP NEUROL PSYCHO, V18, P459, DOI 10.1002/cne.920180503	42	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13147	10.1371/journal.pone.0013147	http://dx.doi.org/10.1371/journal.pone.0013147			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957209	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300031
J	Siepmann, M; Kumar, S; Mayer, G; Walter, J				Siepmann, Martin; Kumar, Sathish; Mayer, Guenter; Walter, Jochen			Casein Kinase 2 Dependent Phosphorylation of Neprilysin Regulates Receptor Tyrosine Kinase Signaling to Akt	PLOS ONE			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; SURFACE-PLASMON RESONANCE; TUMOR-SUPPRESSOR GENE; NEUTRAL ENDOPEPTIDASE-24.11; PROSTATE-CANCER; CD10/NEUTRAL ENDOPEPTIDASE-24.11; MEMBRANE ASSOCIATION; CYTOPLASMIC DOMAIN; CELL CARCINOMAS; HUMAN BRAIN	Neprilysin (NEP) is a type II membrane metalloproteinase that cleaves physiologically active peptides at the cell surface thus regulating the local concentration of these peptides available for receptor binding and signal transduction. In addition, the cytoplasmic N-terminal domain of NEP interacts with the phosphatase and tensin homologue deleted on chromosome 10 (PTEN) thereby regulating intracellular signaling via Akt. Thus, NEP serves dual functions in extracellular and intracellular signal transduction. Here, we show that NEP undergoes phosphorylation at serine residue 6 within the N-terminal cytoplasmic domain. In vitro and cell culture experiments demonstrate that Ser 6 is efficiently phosphorylated by protein kinase CK2. The phosphorylation of the cytoplasmic domain of NEP inhibits its interaction with PTEN. Interestingly, expression of a pseudophosphorylated NEP variant (Ser6Asp) abrogates the inhibitory effect of NEP on insulin/insulin-like growth factor-1 (IGF-1) stimulated activation of Akt. Thus, our data demonstrate a regulatory role of CK2 in the interaction of NEP with PTEN and insulin/IGF-1 signaling.	[Siepmann, Martin; Kumar, Sathish; Walter, Jochen] Univ Bonn, Dept Neurol, D-5300 Bonn, Germany; [Mayer, Guenter] Univ Bonn, Chem Biol CO Kekule Inst Organ Chem & Biochem, Limes Inst, D-5300 Bonn, Germany	University of Bonn; University of Bonn	Siepmann, M (corresponding author), Univ Bonn, Dept Neurol, D-5300 Bonn, Germany.	Jochen.Walter@ukb.uni-bonn.de	Wang, Caihong/T-5837-2019; Walter, Jochen/B-3677-2014; Kumar, Sathish/L-1367-2019	Wang, Caihong/0000-0002-6808-3709; Walter, Jochen/0000-0002-4678-2912; Kumar, Sathish/0000-0002-2792-7047	Deutsche Forschungsgemeinschaft [SFB645, KFo177]; Hans und Ilse Breuer Stiftung; Bundesministerium fur Bildung und Forschung [01GI0708]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hans und Ilse Breuer Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Deutsche Forschungsgemeinschaft (SFB645, KFo177), the Hans und Ilse Breuer Stiftung, and the Bundesministerium fur Bildung und Forschung (01GI0708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura Y, 2004, J BIOL CHEM, V279, P11408, DOI 10.1074/jbc.M309063200; Blanco-Aparicio C, 2007, CARCINOGENESIS, V28, P1379, DOI 10.1093/carcin/bgm052; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; DAYAMAKIN M, 1994, CANCER RES, V54, P2262; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Ganju RK, 1996, BLOOD, V88, P4159; Guerra B, 1999, PHARMACOL THERAPEUT, V82, P303, DOI 10.1016/S0163-7258(98)00064-3; Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Iwase A, 2004, J BIOL CHEM, V279, P11898, DOI 10.1074/jbc.M212737200; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; KENNY J, 1993, BIOCHEM SOC T, V21, P663, DOI 10.1042/bst0210663; Kim SO, 1998, J CELL BIOCHEM, V71, P328, DOI 10.1002/(SICI)1097-4644(19981201)71:3<328::AID-JCB2>3.0.CO;2-U; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; LAFRANCE MH, 1994, BIOCHEM J, V302, P451, DOI 10.1042/bj3020451; Landesman-Bollag E, 2001, ONCOGENE, V20, P3247, DOI 10.1038/sj.onc.1204411; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MARIN O, 1994, BIOCHEM BIOPH RES CO, V198, P898, DOI 10.1006/bbrc.1994.1128; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McKendrick L, 1999, MOL CELL BIOCHEM, V191, P187, DOI 10.1023/A:1006854109926; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Nelson JB, 2000, CANCER INVEST, V18, P87, DOI 10.3109/07357900009023066; OSHANNESSY DJ, 1993, ANAL BIOCHEM, V212, P457, DOI 10.1006/abio.1993.1355; Papandreou CN, 1998, NAT MED, V4, P50, DOI 10.1038/nm0198-050; Piazza FA, 2006, BLOOD, V108, P1698, DOI 10.1182/blood-2005-11-013672; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Rentmeister A, 2006, RNA, V12, P1650, DOI 10.1261/rna.126306; Roher N, 1998, FEBS LETT, V437, P211, DOI 10.1016/S0014-5793(98)01230-7; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; SELDIN DC, 1995, SCIENCE, V267, P894, DOI 10.1126/science.7846532; SHIPP MA, 1991, P NATL ACAD SCI USA, V88, P10662, DOI 10.1073/pnas.88.23.10662; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; STEWART JR, 1984, BIOCHEM J, V224, P549, DOI 10.1042/bj2240549; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Tamboli IY, 2008, J NEUROSCI, V28, P12097, DOI 10.1523/JNEUROSCI.2635-08.2008; Terawaki S, 2007, J BIOL CHEM, V282, P19854, DOI 10.1074/jbc.M609232200; Torres J, 2001, J BIOL CHEM, V276, P993, DOI 10.1074/jbc.M009134200; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Vazquez F, 2006, CELL CYCLE, V5, P1523, DOI 10.4161/cc.5.14.3005; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wahle T, 2006, J NEUROSCI, V26, P12838, DOI 10.1523/JNEUROSCI.1982-06.2006; Walter J, 1998, BIOCHEMISTRY-US, V37, P5961, DOI 10.1021/bi971763a; Weng LP, 2001, HUM MOL GENET, V10, P605, DOI 10.1093/hmg/10.6.605; Xu Z, 2002, CELL GROWTH DIFFER, V13, P285; Yonemura S, 1998, J CELL BIOL, V140, P885, DOI 10.1083/jcb.140.4.885	56	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13134	10.1371/journal.pone.0013134	http://dx.doi.org/10.1371/journal.pone.0013134			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957047	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300024
J	Sousa, JF; Torrieri, R; Silva, RR; Pereira, CG; Valente, V; Torrieri, E; Peronni, KC; Martins, W; Muto, N; Francisco, G; Brohem, CA; Carlotti, CG; Maria-Engler, SS; Chammas, R; Espreafico, EM				Sousa, Josane F.; Torrieri, Raul; Silva, Rodrigo R.; Pereira, Cristiano G.; Valente, Valeria; Torrieri, Erico; Peronni, Kamila C.; Martins, Waleska; Muto, Nair; Francisco, Guilherme; Brohem, Carla Abdo; Carlotti, Carlos G., Jr.; Maria-Engler, Silvya S.; Chammas, Roger; Espreafico, Enilza M.			Novel Primate-Specific Genes, RMEL 1, 2 and 3, with Highly Restricted Expression in Melanoma, Assessed by New Data Mining Tool	PLOS ONE			English	Article							NONCODING RNAS; PROSTATE; APOPTOSIS; PCA3; HYBRIDIZATION; SENESCENCE; PREDICTION; DIAGNOSIS; PATHWAYS; REVEAL	Melanoma is a highly aggressive and therapy resistant tumor for which the identification of specific markers and therapeutic targets is highly desirable. We describe here the development and use of a bioinformatic pipeline tool, made publicly available under the name of EST2TSE, for the in silico detection of candidate genes with tissue-specific expression. Using this tool we mined the human EST (Expressed Sequence Tag) database for sequences derived exclusively from melanoma. We found 29 UniGene clusters of multiple ESTs with the potential to predict novel genes with melanoma-specific expression. Using a diverse panel of human tissues and cell lines, we validated the expression of a subset of three previously uncharacterized genes (clusters Hs.295012, Hs.518391, and Hs.559350) to be highly restricted to melanoma/melanocytes and named them RMEL1, 2 and 3, respectively. Expression analysis in nevi, primary melanomas, and metastatic melanomas revealed RMEL1 as a novel melanocytic lineage-specific gene up-regulated during melanoma development. RMEL2 expression was restricted to melanoma tissues and glioblastoma. RMEL3 showed strong up-regulation in nevi and was lost in metastatic tumors. Interestingly, we found correlations of RMEL2 and RMEL3 expression with improved patient outcome, suggesting tumor and/or metastasis suppressor functions for these genes. The three genes are composed of multiple exons and map to 2q12.2, 1q25.3, and 5q11.2, respectively. They are well conserved throughout primates, but not other genomes, and were predicted as having no coding potential, although primate-conserved and human-specific short ORFs could be found. Hairpin RNA secondary structures were also predicted. Concluding, this work offers new melanoma-specific genes for future validation as prognostic markers or as targets for the development of therapeutic strategies to treat melanoma.	[Sousa, Josane F.; Torrieri, Raul; Silva, Rodrigo R.; Pereira, Cristiano G.; Torrieri, Erico; Peronni, Kamila C.; Espreafico, Enilza M.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil; [Valente, Valeria; Carlotti, Carlos G., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Cirurgia & Anat, Sao Paulo, Brazil; [Martins, Waleska; Muto, Nair] AC Camargo Hosp Melanoma Grp, Div Pathol, Mol Biol Grp, Sao Paulo, Brazil; [Francisco, Guilherme; Chammas, Roger] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [Francisco, Guilherme; Chammas, Roger] Univ Sao Paulo, Fac Med, Inst Canc Estado Sao Paulo, Sao Paulo, Brazil; [Brohem, Carla Abdo; Maria-Engler, Silvya S.] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin & Toxicol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Sousa, JF (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Sao Paulo, Brazil.	emesprea@fmrp.usp.br	Carlotti, Carlos G/C-1608-2012; Martins, Waleska Kerllen/L-5187-2018; Valente, Valeria/F-1301-2014; Pereira, Cristiano G/M-9963-2014; Engler, Silvya Stuchi Maria/K-5936-2016; de Freitas Sousa, Josane/C-8644-2015; Maria-Engler, Silvya/ABC-2016-2020; Chammas, Roger/A-8004-2011; Espreafico, Enilza/O-3053-2016; Muto, Nair/P-8363-2017; Espreafico, Enilza/AAW-4658-2021	Carlotti, Carlos G/0000-0002-7055-0564; Martins, Waleska Kerllen/0000-0003-1502-4606; Valente, Valeria/0000-0002-3942-7744; Pereira, Cristiano G/0000-0003-0364-7793; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; de Freitas Sousa, Josane/0000-0001-7932-9818; Maria-Engler, Silvya/0000-0003-4771-6041; Chammas, Roger/0000-0003-0342-8726; Espreafico, Enilza/0000-0002-7552-4234; Espreafico, Enilza/0000-0002-7552-4234	Departamento de Ciencia e Tecnologia (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [401322/2005-0, 481759/2004-2, 308715/2005-5, 305029/2008-8]; Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC/CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/60328-6, 2007/50604-9, 2008/56521-0, 2007/57307-0, 2005/60026-7]	Departamento de Ciencia e Tecnologia (DECIT); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC/CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Departamento de Ciencia e Tecnologia (DECIT) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) - grant 401322/2005-0 (EME); CNPq grant 481759/2004-2 (EME); CNPq research fellowships 308715/2005-5 and 305029/2008-8 (EME), fellowships from Programa Institucional de Bolsas de Iniciacao Cientifica (PIBIC/CNPq) to RT and ET; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant 2006/60328- 6 (JFS), and FAPESP fellowships: post-doctorate, 2007/50604-9 (JFS); master, 2008/56521-0 (CGP) and 2007/57307-0 (RRS); doctorate, 2005/60026-7 (KCP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aouacheria A, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-94; Beddingfield FC, 2003, ONCOLOGIST, V8, P459, DOI 10.1634/theoncologist.8-5-459; Bussemakers MJG, 1999, CANCER RES, V59, P5975; Clarke RA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004995; Dynek JN, 2008, CANCER RES, V68, P3124, DOI 10.1158/0008-5472.CAN-07-6622; Fernandez Y, 2005, CANCER RES, V65, P6294, DOI 10.1158/0008-5472.CAN-05-0686; Galindo MI, 2007, PLOS BIOL, V5, P1052, DOI 10.1371/journal.pbio.0050106; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gomes LI, 2003, ANAL BIOCHEM, V321, P244, DOI 10.1016/S0003-2697(03)00466-4; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Gruber AR, 2007, NUCLEIC ACIDS RES, V35, pW335, DOI 10.1093/nar/gkm222; Ha LN, 2008, CELL CYCLE, V7, P1944, DOI 10.4161/cc.7.13.6230; Hessels D, 2009, NAT REV UROL, V6, P255, DOI 10.1038/nrurol.2009.40; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Hurst DR, 2009, CANCER RES, V69, P7495, DOI 10.1158/0008-5472.CAN-09-2111; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KIKUCHI K, 2009, NUCL ACIDS RES; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Mueller DW, 2009, BRIT J CANCER, V101, P551, DOI 10.1038/sj.bjc.6605204; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pollock PM, 2003, NAT GENET, V33, P19, DOI 10.1038/ng1054; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Sinibaldi-Vallebona P, 2006, GENE CHROMOSOME CANC, V45, P1, DOI 10.1002/gcc.20266; Smalley KSM, 2005, ANN NY ACAD SCI, V1059, P16, DOI 10.1196/annals.1339.005; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Sousa JF, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-19; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Vasmatzis G, 1998, P NATL ACAD SCI USA, V95, P300, DOI 10.1073/pnas.95.1.300; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wegrzyn JL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-232; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595	38	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13510	10.1371/journal.pone.0013510	http://dx.doi.org/10.1371/journal.pone.0013510			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975957	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400016
J	Lemus, JA; Fargallo, JA; Vergara, P; Parejo, D; Banda, E				Lemus, Jesus A.; Fargallo, Juan A.; Vergara, Pablo; Parejo, Deseada; Banda, Eva			Natural Cross Chlamydial Infection between Livestock and Free-Living Bird Species	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; PROTEIN ELECTROPHORESIS; KESTRELS; DIVERSITY; LESSER; VIRUS; DISEASES; RAPTORS; POULTRY; GERMANY	The study of cross-species pathogen transmission is essential to understanding the epizootiology and epidemiology of infectious diseases. Avian chlamydiosis is a zoonotic disease whose effects have been mainly investigated in humans, poultry and pet birds. It has been suggested that wild bird species play an important role as reservoirs for this disease. During a comparative health status survey in common (Falco tinnunculus) and lesser (Falco naumanni) kestrel populations in Spain, acute gammapathies were detected. We investigated whether gammapathies were associated with Chlamydiaceae infections. We recorded the prevalence of different Chlamydiaceae species in nestlings of both kestrel species in three different study areas. Chlamydophila psittaci serovar I (or Chlamydophila abortus), an ovine pathogen causing late-term abortions, was isolated from all the nestlings of both kestrel species in one of the three studied areas, a location with extensive ovine livestock enzootic of this atypical bacteria and where gammapathies were recorded. Serovar and genetic cluster analysis of the kestrel isolates from this area showed serovars A and C and the genetic cluster 1 and were different than those isolated from the other two areas. The serovar I in this area was also isolated from sheep abortions, sheep faeces, sheep stable dust, nest dust of both kestrel species, carrion beetles (Silphidae) and Orthoptera. This fact was not observed in other areas. In addition, we found kestrels to be infected by Chlamydia suis and Chlamydia muridarum, the first time these have been detected in birds. Our study evidences a pathogen transmission from ruminants to birds, highlighting the importance of this potential and unexplored mechanism of infection in an ecological context. On the other hand, it is reported a pathogen transmission from livestock to wildlife, revealing new and scarcely investigated anthropogenic threats for wild and endangered species.	[Lemus, Jesus A.; Fargallo, Juan A.] Museo Nacl Ciencias Nat CSIC, Dept Ecol Evolut, Madrid, Spain; [Vergara, Pablo] Univ Aberdeen, Sch Biol Sci, ACES, Aberdeen, Scotland; [Parejo, Deseada] Estac Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Almeria, Spain; [Banda, Eva] Minist Medio Ambiente & Medio Rural & Marino, Oficina Especies Migratorias, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); University of Aberdeen; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA)	Lemus, JA (corresponding author), Museo Nacl Ciencias Nat CSIC, Dept Ecol Evolut, Madrid, Spain.	jlemus@ebd.csic.es	Vergara, Pablo/G-1860-2010; Fargallo, Juan A/I-5585-2015; Deseada, Parejo/L-3953-2014	Fargallo, Juan A/0000-0003-4090-9000; Deseada, Parejo/0000-0002-7368-2378; Banda, Eva/0000-0003-4653-1408	Spanish Ministerio de Ciencia e Innovacion [CGL2007-61395/BOS]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The Spanish Ministerio de Ciencia e Innovacion (Project CGL2007-61395/BOS) financed the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, MOL ECOL, V19, P691, DOI 10.1111/j.1365-294X.2009.04507.x; Andersen AA, 2000, REV SCI TECH OIE, V19, P396, DOI 10.20506/rst.19.2.1223; Andersen Arthur A., 2007, P303, DOI 10.1002/9780470344668.ch15; Aparicio JM, 2000, ORNIS FENNICA, V77, P169; ATIENZA JC, 2004, LIBRO ROJO AVES ESPA, P161; BRAND CJ, 1989, J AM VET MED ASSOC, V195, P1531; Burkhart R. L., 1971, Infectious and parasitic diseases of wild birds, P118; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; Chahota R, 2006, MICROBIOL IMMUNOL, V50, P663, DOI 10.1111/j.1348-0421.2006.tb03839.x; Cramp S., 1992, BIRDS W PALEARCTIC, VVI; Cray C, 1998, J AVIAN MED SURG, V12, P4; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson I, 2008, VIRUS GENES, V36, P1, DOI 10.1007/s11262-007-0165-1; DROOGENBROECK C, 2009, VET MICROBIOL, V135, P78; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Everett KDE, 1997, INT J SYST BACTERIOL, V47, P461, DOI 10.1099/00207713-47-2-461; Forbes NA, 1997, J AVIAN MED SURG, V11, P110; FRANSON JC, 1995, J WILDLIFE DIS, V31, P424, DOI 10.7589/0090-3558-31.3.424; FROLICH K, 2002, ANN NY ACAD SCI, V9489, P4; Gerlach Helga, 1994, P984; GRIMES JE, 1994, HDB ZOONOSES, P389; Hernandez-Divers SM, 2008, AVIAN DIS, V52, P558, DOI 10.1637/8298-032808-Reg.1; Herrmann B, 2006, EMERG INFECT DIS, V12, P330, DOI 10.3201/eid1202.050404; Hewinson RG, 1997, VET MICROBIOL, V54, P155, DOI 10.1016/S0378-1135(96)01268-0; Kaleta EF, 2003, AVIAN PATHOL, V32, P435, DOI 10.1080/03079450310001593613; Laroucau K, 2001, VET MICROBIOL, V82, P155, DOI 10.1016/S0378-1135(01)00381-9; Lumeij J. T., 1996, Journal of Avian Medicine and Surgery, V10, P150; MARTIN WB, 1991, DIS SHEEP; *OIE, 2000, MAN STAND DIAGN TEST; Pantchev A, 2010, COMP IMMUNOL MICROB, V33, P473, DOI 10.1016/j.cimid.2009.08.002; Pennycott TW, 2009, VET REC, V164, P157, DOI 10.1136/vr.164.5.157-b; ROBERTSON T, 2009, J APPL MICROBIOL; Rodriguez C, 2006, J APPL ECOL, V43, P587, DOI 10.1111/j.1365-2664.2006.01152.x; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; SACK RB, 1986, MANUAL CLIN LAB INMU; Schettler E, 2003, J WILDLIFE DIS, V39, P57, DOI 10.7589/0090-3558-39.1.57; Schettler E, 2001, J WILDLIFE DIS, V37, P145, DOI 10.7589/0090-3558-37.1.145; Schiller I, 2004, VET J, V168, P74, DOI 10.1016/S1090-0233(03)00039-X; Smith KA, 2005, JAVMA-J AM VET MED A, V226, P532, DOI 10.2460/javma.2005.226.532; SPALATIN J, 1966, CAN J COMP MED VET S, V30, P260; Sudler C, 2004, VET MICROBIOL, V98, P235, DOI 10.1016/j.vetmic.2003.07.008; Taft SC, 2005, VECTOR-BORNE ZOONOT, V5, P383, DOI 10.1089/vbz.2005.5.383; Tanaka C, 2005, J VET MED SCI, V67, P951, DOI 10.1292/jvms.67.951; Tatum LM, 2000, J ZOO WILDLIFE MED, V31, P497, DOI 10.1638/1042-7260(2000)031[0497:PEAADA]2.0.CO;2; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Tucker G. M., 1994, BIRDLIFE CONSERVATIO, V3; VANROMPAY D, 1993, J CLIN MICROBIOL, V31, P134, DOI 10.1128/JCM.31.1.134-137.1993; Vergara P, 2008, BIOL CONSERV, V141, P499, DOI 10.1016/j.biocon.2007.11.004; Verminnen K, 2009, DRUG TODAY, V45, P147; Verminnen K, 2008, J CLIN MICROBIOL, V46, P281, DOI 10.1128/JCM.01153-07; Weiss RA, 2003, CURR TOP MICROBIOL, V278, P47; ZWART P, 2000, AVIAN MED, P252; Zweifel D, 2009, EUR J WILDLIFE RES, V55, P575, DOI 10.1007/s10344-009-0275-2; 2004, MANUAL OIE ANIMALES, P683	55	13	13	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13512	10.1371/journal.pone.0013512	http://dx.doi.org/10.1371/journal.pone.0013512			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976071	gold, Green Published, Green Submitted			2022-12-27	WOS:000283114700025
J	Gkrania-Klotsas, E; Ye, Z; Cooper, AJ; Sharp, SJ; Luben, R; Biggs, ML; Chen, LK; Gokulakrishnan, K; Hanefeld, M; Ingelsson, E; Lai, WA; Lin, SY; Lind, L; Lohsoonthorn, V; Mohan, V; Muscari, A; Nilsson, G; Ohrvik, J; Qiang, JC; Jenny, NS; Tamakoshi, K; Temelkova-Kurktschiev, T; Wang, YY; Yajnik, CS; Zoli, M; Khaw, KT; Forouhi, NG; Wareham, NJ; Langenberg, C				Gkrania-Klotsas, Effrossyni; Ye, Zheng; Cooper, Andrew J.; Sharp, Stephen J.; Luben, Robert; Biggs, Mary L.; Chen, Liang-Kung; Gokulakrishnan, Kuppan; Hanefeld, Markolf; Ingelsson, Erik; Lai, Wen-An; Lin, Shih-Yi; Lind, Lars; Lohsoonthorn, Vitool; Mohan, Viswanathan; Muscari, Antonio; Nilsson, Goran; Ohrvik, John; Qiang, Jiang Chao; Jenny, Nancy Swords; Tamakoshi, Koji; Temelkova-Kurktschiev, Theodora; Wang, Ya-Yu; Yajnik, Chittaranjan Sakerlal; Zoli, Marco; Khaw, Kay-Tee; Forouhi, Nita G.; Wareham, Nicholas J.; Langenberg, Claudia			Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; METABOLIC SYNDROME; INSULIN-RESISTANCE; LEUKOCYTE COUNT; EPIC-NORFOLK; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR-DISEASE; INFLAMMATORY MARKERS; ATHEROSCLEROSIS RISK	Objective: Biological evidence suggests that inflammation might induce type 2 diabetes (T2D), and epidemiological studies have shown an association between higher white blood cell count (WBC) and T2D. However, the association has not been systematically investigated. Research Design and Methods: Studies were identified through computer-based and manual searches. Previously unreported studies were sought through correspondence. 20 studies were identified (8,647 T2D cases and 85,040 non-cases). Estimates of the association of WBC with T2D were combined using random effects meta-analysis; sources of heterogeneity as well as presence of publication bias were explored. Results: The combined relative risk (RR) comparing the top to bottom tertile of the WBC count was 1.61 (95% CI: 1.45; 1.79, p = 1.5*10(-18)). Substantial heterogeneity was present (I-2 = 83%). For granulocytes the RR was 1.38 (95% CI: 1.17; 1.64, p = 1.5*10(-4)), for lymphocytes 1.26 (95% CI: 1.02; 1.56, p = 0.029), and for monocytes 0.93 (95% CI: 0.68; 1.28, p = 0.67) comparing top to bottom tertile. In cross-sectional studies, RR was 1.74 (95% CI: 1.49; 2.02, p = 7.7*10(-13)), while in cohort studies it was 1.48 (95% CI: 1.22; 1.79, p = 7.7*10(-5)). We assessed the impact of confounding in EPIC-Norfolk study and found that the age and sex adjusted HR of 2.19 (95% CI: 1.74; 2.75) was attenuated to 1.82 (95% CI: 1.45; 2.29) after further accounting for smoking, T2D family history, physical activity, education, BMI and waist circumference. Conclusions: A raised WBC is associated with higher risk of T2D. The presence of publication bias and failure to control for all potential confounders in all studies means the observed association is likely an overestimate.	[Gkrania-Klotsas, Effrossyni; Ye, Zheng; Cooper, Andrew J.; Sharp, Stephen J.; Forouhi, Nita G.; Wareham, Nicholas J.; Langenberg, Claudia] Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England; [Luben, Robert; Khaw, Kay-Tee] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Biggs, Mary L.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA; [Chen, Liang-Kung] Natl Yang Ming Univ, Sch Med, Taipei Vet Gen Hosp, Dept Family Med, Taipei 112, Taiwan; [Gokulakrishnan, Kuppan; Mohan, Viswanathan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Gokulakrishnan, Kuppan; Mohan, Viswanathan] Dr Mohans Diabet Special Ctr, Madras, Tamil Nadu, India; [Hanefeld, Markolf; Temelkova-Kurktschiev, Theodora] Tech Univ Dresden GmBH, Ctr Clin Study Gesell Wissens & Technol Transfer, Dresden, Germany; [Ingelsson, Erik] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Lai, Wen-An; Wang, Ya-Yu] Kuang Tien Gen Hosp, Dept Family Med, Taichung, Taiwan; [Lin, Shih-Yi] Taichung Vet Gen Hosp, Div Endrocrinol & Metab, Taichung, Taiwan; [Lind, Lars] Univ Uppsala Hosp, Dept Med Sci, Uppsala, Sweden; [Lohsoonthorn, Vitool] Chulalongkorn Univ, Fac Med, Dept Prevent & Social Med, Bangkok 10330, Thailand; [Muscari, Antonio; Zoli, Marco] Univ Bologna, Dept Internal Med Aging & Nephrol Dis, Bologna, Italy; [Nilsson, Goran] Uppsala Univ, Clin Res Ctr, Vasteras, Sweden; [Ohrvik, John] Karolinska Inst, Dept Med, Stockholm, Sweden; [Qiang, Jiang Chao] Guangzhou 12 Hosp, Guangzhou, Guangdong, Peoples R China; [Jenny, Nancy Swords] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Tamakoshi, Koji] Nagoya Univ, Sch Hlth Sci, Dept Nursing, Nagoya, Aichi 4648601, Japan; [Temelkova-Kurktschiev, Theodora] Natl Sports Acad, Int Sci Inst, Medicobiol Unit, Sofia, Bulgaria; [Temelkova-Kurktschiev, Theodora] Robert Koch German Med Ctr, Sofia, Bulgaria; [Yajnik, Chittaranjan Sakerlal] King Edward Mem Hosp, Pune, Maharashtra, India	University of Cambridge; University of Cambridge; University of Washington; University of Washington Seattle; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Madras Diabetes Research Foundation; Technische Universitat Dresden; Karolinska Institutet; Taichung Veterans General Hospital; Uppsala University; Uppsala University Hospital; Chulalongkorn University; University of Bologna; Uppsala University; Karolinska Institutet; University of Vermont; Nagoya University; National Sports Academy - Bulgaria	Gkrania-Klotsas, E (corresponding author), Inst Metab Sci, MRC Epidemiol Unit, Cambridge, England.	eg318@cam.ac.uk	Luben, Robert N/H-5519-2015; Langenberg, Claudia/ABG-9067-2021; Khaw, Kay-Tee/AAZ-3209-2021; GOKULAKRISHNAN, KUPPAN/AAT-3244-2020; Gkrania-Klotsas, Effrossyni/AAT-8424-2021	Luben, Robert N/0000-0002-5088-6343; Langenberg, Claudia/0000-0002-5017-7344; Gkrania-Klotsas, Effrossyni/0000-0002-0930-8330; GOKULAKRISHNAN, KUPPAN/0000-0003-3167-8239; Forouhi, Nita/0000-0002-5041-248X; Cooper, Andrew/0000-0003-1025-0268	Medical Research Council; Cambridge BRC-NIHR; Cancer Research United Kingdom; Faculty of Medicine, Chulalongkorn University, Thailand; National Institutes of Health [T37-TW00049, T37-MD-100449]; Swedish Research Council; Swedish Foundation for Strategic Research; Royal Swedish Academy of Science; Uppsala University Hospital; AstraZeneca RD, Moelndal; National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366, R01 HL-094555]; National Institute on Aging [R01 AG-023629, R01 AG-15928, R01 AG-20098, AG-027058]; University of Pittsburgh Claude; Medical Research Council [MC_UP_A100_1003, G0401527, MC_U106179471, G0701652] Funding Source: researchfish; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC045133, N01HC035129, N01HC015103] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [T37TW000049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094555, U01HL080295, R01HL075366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023629, R01AG027058, R01AG020098, P30AG024827, R01AG015928] Funding Source: NIH RePORTER; MRC [MC_UP_A100_1003, G0701652] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge BRC-NIHR; Cancer Research United Kingdom(Cancer Research UK); Faculty of Medicine, Chulalongkorn University, Thailand(Chulalongkorn University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Royal Swedish Academy of Science; Uppsala University Hospital; AstraZeneca RD, Moelndal(AstraZeneca); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	EGK is supported by the Medical Research Council through a Clinical Research Training Fellowship and the Cambridge BRC-NIHR. EPIC-Norfolk is supported by grant funding from the Medical Research Council and Cancer Research United Kingdom with additional support from the Stroke Association, British Heart Foundation, Research Into Ageing, and the Academy of Medical Science. The sponsors had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data, and preparation, review, or approval of the manuscript. VL is supported by the Rachadapiseksompoj Faculty of Medicine Research Fund Chulalongkorn University, Thailand, and by the National Institutes of Health ( grants T37-TW00049 and T37-MD-100449). PIVUS work was supported by the Swedish Research Council, the Swedish Foundation for Strategic Research, the Royal Swedish Academy of Science, Uppsala University Hospital and AstraZeneca R&D, Moelndal. The sponsors had no role in the PIVUS study design, analyses, writing or decision to publish the manuscript. The Cardiovascular Health Study research was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295, R01 HL-075366 and R01 HL-094555 from the National Heart, Lung, and Blood Institute; R01 AG-023629, R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center P30-AG-024827, with additional contribution from the National Institute of Neurological Disorders and Stroke. A full list of principal CHS investigators and institutions can be found at http://www.chs-nhlbi.org/pi.htm. JO and GN's work was supported by grants from Vastmanland's research foundation against cardiovascular disease and SparbanksstiftelsenNya. GN had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Barzilay JI, 2001, DIABETES, V50, P2384, DOI 10.2337/diabetes.50.10.2384; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Chen Liang-Kung, 2006, J Chin Med Assoc, V69, P248; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chuo SK, 2005, ENDOCR RES, V31, P39, DOI 10.1080/07435800500229151; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P3257, DOI 10.1210/jc.86.7.3257; Dandona P, 2004, REV ENDOCR METAB DIS, V5, P189, DOI 10.1023/B:REMD.0000032407.88070.0a; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Day N, 1999, BRIT J CANCER, V80, P95; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; Duncan BB, 2000, OBES RES, V8, P279, DOI 10.1038/oby.2000.33; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford ES, 2002, AM J EPIDEMIOL, V155, P57, DOI 10.1093/aje/155.1.57; Gokulakrishnan K, 2009, METAB SYNDR RELAT D, V7, P205, DOI 10.1089/met.2008.0024; Haffner SM, 2002, CIRCULATION, V106, P679, DOI 10.1161/01.CIR.0000025403.20953.23; Hak AE, 1999, ARTERIOSCL THROM VAS, V19, P1986, DOI 10.1161/01.ATV.19.8.1986; Hanefeld M, 2009, HORM METAB RES, V41, P132, DOI 10.1055/s-0028-1119407; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ingelsson E, 2008, EUR J CLIN INVEST, V38, P502, DOI 10.1111/j.1365-2362.2008.01962.x; Ishizaka N, 2007, INTERNAL MED, V46, P1167, DOI 10.2169/internalmedicine.46.0136; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kim DJ, 2008, J KOREAN MED SCI, V23, P193, DOI 10.3346/jkms.2008.23.2.193; Kim JA, 2006, ENDOCR J, V53, P133, DOI 10.1507/endocrj.53.133; Kim JA, 2008, METABOLISM, V57, P1375, DOI 10.1016/j.metabol.2008.05.005; Lao XQ, 2008, ATHEROSCLEROSIS, V201, P418, DOI 10.1016/j.atherosclerosis.2007.12.053; Lohsoonthorn V, 2006, AM J HYPERTENS, V19, P339, DOI 10.1016/j.amjhyper.2005.10.008; Lundgren CH, 1996, CIRCULATION, V93, P106, DOI 10.1161/01.CIR.93.1.106; Marques-Vidal P, 2002, DIABETES CARE, V25, P1371, DOI 10.2337/diacare.25.8.1371; MCCARTHY DA, 1988, SPORTS MED, V6, P333, DOI 10.2165/00007256-198806060-00002; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Muntner P, 2004, ANN EPIDEMIOL, V14, P686, DOI 10.1016/j.annepidem.2004.01.002; Muscari A, 2007, DIABETES CARE, V30, P2362, DOI 10.2337/dc07-0637; Nagasawa N, 2004, CIRC J, V68, P892, DOI 10.1253/circj.68.892; Nakanishi N, 2002, IND HEALTH, V40, P273, DOI 10.2486/indhealth.40.273; Natale Valéria Maria, 2003, Sao Paulo Med. J., V121, P09; Nilsson G., 2007, Metabolic Syndrome and Related Disorders, V5, P359, DOI 10.1089/met.2007.0012; Pannacciulli N, 2003, OBES RES, V11, P1232, DOI 10.1038/oby.2003.169; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Schmidt MI, 1999, LANCET, V353, P1649, DOI 10.1016/S0140-6736(99)01046-6; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; SHIZAKA N, 2006, DIABETES CARE, V29, P741; Smith MR, 2003, ATHEROSCLEROSIS, V169, P331, DOI 10.1016/S0021-9150(03)00200-4; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59; Temelkova-Kurktschiev T, 2002, METABOLISM, V51, P743, DOI 10.1053/meta.2002.32804; Tian JY, 2008, DIABETES RES CLIN PR, V82, P132, DOI 10.1016/j.diabres.2008.05.014; Van Wijk JPH, 2006, ATHEROSCLEROSIS, V186, P152, DOI 10.1016/j.atherosclerosis.2005.07.001; VANFURTH R, 1973, J EXP MED, V138, P1314, DOI 10.1084/jem.138.6.1314; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wang YY, 2004, J DIABETES COMPLICAT, V18, P322, DOI 10.1016/S1056-8727(04)00003-0; Wannamethee SG, 2005, ATHEROSCLEROSIS, V181, P101, DOI 10.1016/j.atherosclerosis.2004.12.031; WHITEHEAD A, 1991, STAT MED, V10, P1665, DOI 10.1002/sim.4780101105; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Yajnik CS, 2008, DIABETOLOGIA, V51, P39, DOI 10.1007/s00125-007-0847-1; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	60	93	94	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13405	10.1371/journal.pone.0013405	http://dx.doi.org/10.1371/journal.pone.0013405			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976133	gold, Green Published			2022-12-27	WOS:000283045300009
J	Irie, T; Bessho, K; Findlay, HS; Calosi, P				Irie, Takahiro; Bessho, Kazuhiro; Findlay, Helen S.; Calosi, Piero			Increasing Costs Due to Ocean Acidification Drives Phytoplankton to Be More Heavily Calcified: Optimal Growth Strategy of Coccolithophores	PLOS ONE			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; CARBON-DIOXIDE; BODY-SIZE; CALCIFICATION; CO2; SEAWATER; MODEL; CONSEQUENCES; DIVERSITY; CLIMATE	Ocean acidification is potentially one of the greatest threats to marine ecosystems and global carbon cycling. Amongst calcifying organisms, coccolithophores have received special attention because their calcite precipitation plays a significant role in alkalinity flux to the deep ocean (i.e., inorganic carbon pump). Currently, empirical effort is devoted to evaluating the plastic responses to acidification, but evolutionary considerations are missing from this approach. We thus constructed an optimality model to evaluate the evolutionary response of coccolithophorid life history, assuming that their exoskeleton (coccolith) serves to reduce the instantaneous mortality rates. Our model predicted that natural selection favors constructing more heavily calcified exoskeleton in response to increased acidification-driven costs. This counter-intuitive response occurs because the fitness benefit of choosing a better-defended, slower growth strategy in more acidic conditions, outweighs that of accelerating the cell cycle, as this occurs by producing less calcified exoskeleton. Contrary to the widely held belief, the evolutionarily optimized population can precipitate larger amounts of CaCO3 during the bloom in more acidified seawater, depending on parameter values. These findings suggest that ocean acidification may enhance the calcification rates of marine organisms as an adaptive response, possibly accompanied by higher carbon fixation ability. Our theory also provides a compelling explanation for the multispecific fossil time-series record from similar to 200 years ago to present, in which mean coccolith size has increased along with rising atmospheric CO2 concentration.	[Irie, Takahiro] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Bessho, Kazuhiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Findlay, Helen S.] Plymouth Marine Lab, Plymouth, Devon, England; [Calosi, Piero] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England	University of Amsterdam; Kyushu University; Plymouth Marine Laboratory; University of Plymouth	Irie, T (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	irie@bio-math10.biology.kyushu-u.ac.jp	Irie, Takahiro/A-3621-2012; Irie, Takahiro/AAG-4293-2020	Irie, Takahiro/0000-0001-7730-5556; Calosi, Piero/0000-0003-3378-2603	Japan Society for the Promotion of Science; Plymouth Marine Laboratory; University of Plymouth; NERC [pml010004] Funding Source: UKRI; Natural Environment Research Council [pml010004] Funding Source: researchfish	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Plymouth Marine Laboratory(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Plymouth; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Japan Society for the Promotion of Science to T. I. and K. B. This work was also undertaken while H. S. F. was in receipt of the Lord Kingsland Fellowship at the Plymouth Marine Laboratory and P. C. of a RCUK Fellowship to investigate ocean acidification at the University of Plymouth. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Balch WM, 1996, LIMNOL OCEANOGR, V41, P1669, DOI 10.4319/lo.1996.41.8.1669; Bibby R, 2007, BIOLOGY LETT, V3, P699, DOI 10.1098/rsbl.2007.0457; Brand Larry E., 1994, P39; Buitenhuis ET, 1999, J PHYCOL, V35, P949, DOI 10.1046/j.1529-8817.1999.3550949.x; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Day T, 1997, AM NAT, V149, P381, DOI 10.1086/285995; Day T, 2005, ECOLOGICAL PARADIGMS, P273, DOI DOI 10.1016/B978-012088459-9/50015-7; Delille B, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002318; DEVRINDDEJONG EW, 1994, HAPTOPHYTE ALGAE, P149; Ellis RP, 2009, AQUAT BIOL, V5, P41, DOI 10.3354/ab00118; Engel A, 2005, LIMNOL OCEANOGR, V50, P493, DOI 10.4319/lo.2005.50.2.0493; Erez J, 2003, REV MINERAL GEOCHEM, V54, P115, DOI 10.2113/0540115; Fine M, 2007, SCIENCE, V315, P1811, DOI 10.1126/science.1137094; Gibbs SJ, 2006, SCIENCE, V314, P1770, DOI 10.1126/science.1133902; Grelaud M, 2009, BIOGEOSCIENCES, V6, P2025, DOI 10.5194/bg-6-2025-2009; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Halloran PR, 2008, BIOGEOSCIENCES, V5, P1651, DOI 10.5194/bg-5-1651-2008; Havenhand JN, 2008, CURR BIOL, V18, pR651, DOI 10.1016/j.cub.2008.06.015; Heinze C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020613; Houdan A, 2006, AQUAT MICROB ECOL, V44, P291, DOI 10.3354/ame044291; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Iglesias-Rodriguez MD, 2006, J PHYCOL, V42, P526; Irie T, 2005, AM NAT, V165, P238, DOI 10.1086/427157; Irie T, 2003, EVOL ECOL RES, V5, P1133; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; KLEYPAS JA, 2006, WORKSH NSF NOAA US G; KOZLOWSKI J, 1992, TRENDS ECOL EVOL, V7, P15, DOI 10.1016/0169-5347(92)90192-E; Kozlowski J, 1997, AM NAT, V149, P352; Kurihara H, 2008, MAR ECOL PROG SER, V373, P275, DOI 10.3354/meps07802; Kuroyanagi A, 2009, MAR MICROPALEONTOL, V73, P190, DOI 10.1016/j.marmicro.2009.09.003; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Langer G, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001227; Lika K, 2000, J MATH BIOL, V41, P361, DOI 10.1007/s002850000049; MALONE TC, 1980, PHYSL ECOLOGY PHYTOP, P433; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; Merico A, 2006, J MARINE SYST, V59, P120, DOI 10.1016/j.jmarsys.2005.11.004; METZ JAJ, 1996, WP9604 IIASA; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Przeslawski R, 2008, GLOBAL CHANGE BIOL, V14, P2773, DOI 10.1111/j.1365-2486.2008.01693.x; Ridgwell A, 2005, MAR GEOL, V217, P339, DOI 10.1016/j.margeo.2004.10.036; Ridgwell A, 2009, BIOGEOSCIENCES, V6, P2611, DOI 10.5194/bg-6-2611-2009; Ridgwell A, 2010, NAT GEOSCI, V3, P196, DOI 10.1038/NGEO755; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Roff Derek, 2002, pi; Schmidt DN, 2006, EARTH-SCI REV, V78, P239, DOI 10.1016/j.earscirev.2006.05.004; Sciandra A, 2003, MAR ECOL PROG SER, V261, P111, DOI 10.3354/meps261111; SIKES CS, 1994, PHOTOSYNTHETIC CARBO, P217; Stearns S.C., 1992, pi; The Royal Society, 2005, 1205 ROYAL SOC; Triantaphyllou M, 2010, GEOBIOS-LYON, V43, P99, DOI 10.1016/j.geobios.2009.09.002; Twitchett R.J., 2009, BIOGEOSCIENCES DISCU, V6, P2267, DOI [DOI 10.5194/BGD-6-2267-2009, 10.5194/bgd-6-2267-2009]; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Voss KJ, 1998, LIMNOL OCEANOGR, V43, P870, DOI 10.4319/lo.1998.43.5.0870; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Young Jeremy R., 1994, P63; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zondervan I, 2001, GLOBAL BIOGEOCHEM CY, V15, P507, DOI 10.1029/2000GB001321; Zondervan I, 2007, DEEP-SEA RES PT II, V54, P521, DOI 10.1016/j.dsr2.2006.12.004	64	24	25	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13436	10.1371/journal.pone.0013436	http://dx.doi.org/10.1371/journal.pone.0013436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976167	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700023
J	Grigg, O; Grady, CL				Grigg, Omer; Grady, Cheryl L.			Task-Related Effects on the Temporal and Spatial Dynamics of Resting-State Functional Connectivity in the Default Network	PLOS ONE			English	Article							BOLD SIGNAL FLUCTUATIONS; PARTIAL LEAST-SQUARES; HUMAN BRAIN; MODE NETWORK; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; GLOBAL SIGNAL; BASE-LINE; FMRI; HYPOTHESIS	Recent evidence points to two potentially fundamental aspects of the default network (DN), which have been relatively understudied. One is the temporal nature of the functional interactions among nodes of the network in the resting-state, usually assumed to be static. The second is possible influences of previous brain states on the spatial patterns (i.e., the brain regions involved) of functional connectivity (FC) in the DN at rest. The goal of the current study was to investigate modulations in both the spatial and temporal domains. We compared the resting-state FC of the DN in two runs that were separated by a 45 minute interval containing cognitive task execution. We used partial least squares (PLS), which allowed us to identify FC spatiotemporal patterns in the two runs and to determine differences between them. Our results revealed two primary modes of FC, assessed using a posterior cingulate seed - a robust correlation among DN regions that is stable both spatially and temporally, and a second pattern that is reduced in spatial extent and more variable temporally after cognitive tasks, showing switching between connectivity with certain DN regions and connectivity with other areas, including some task-related regions. Therefore, the DN seems to exhibit two simultaneous FC dynamics at rest. The first is spatially invariant and insensitive to previous brain states, suggesting that the DN maintains some temporally stable functional connections. The second dynamic is more variable and is seen more strongly when the resting-state follows a period of task execution, suggesting an after-effect of the cognitive activity engaged during task that carries over into resting-state periods.	[Grigg, Omer; Grady, Cheryl L.] Rotman Res Inst Baycrest, Toronto, ON, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Grady, Cheryl L.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; University of Toronto	Grigg, O (corresponding author), Rotman Res Inst Baycrest, Toronto, ON, Canada.	OGrigg@Rotman-Baycrest.on.ca		Orringer, Daniel/0000-0001-6427-8376	Canadian Institutes of Health Research [MOP14036]; Canada Research Chairs; Ontario Research Fund; Canadian Foundation for Innovation; Heart and Stroke Foundation Centre for Stroke Recovery	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Ontario Research Fund; Canadian Foundation for Innovation(Canada Foundation for Innovation); Heart and Stroke Foundation Centre for Stroke Recovery(Heart & Stroke Foundation of Canada)	This work was supported by the Canadian Institutes of Health Research (MOP14036 to CLG), the Canada Research Chairs program, the Ontario Research Fund, the Canadian Foundation for Innovation, and the Heart and Stroke Foundation Centre for Stroke Recovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006626; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Chang C, 2010, NEUROIMAGE, V50, P81, DOI 10.1016/j.neuroimage.2009.12.011; Chang C, 2009, NEUROIMAGE, V47, P1448, DOI 10.1016/j.neuroimage.2009.05.012; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Duff EP, 2008, HUM BRAIN MAPP, V29, P778, DOI 10.1002/hbm.20601; Efron B., 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Esposito F, 2006, BRAIN RES BULL, V70, P263, DOI 10.1016/j.brainresbull.2006.06.012; Farb NAS, 2007, SOC COGN AFFECT NEUR, V2, P313, DOI 10.1093/scan/nsm030; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Fransson P, 2006, NEUROPSYCHOLOGIA, V44, P2836, DOI 10.1016/j.neuropsychologia.2006.06.017; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; GRIGG O, 2010, NEUROPSYCHO IN PRESS; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Harrison BJ, 2008, P NATL ACAD SCI USA, V105, P9781, DOI 10.1073/pnas.0711791105; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lin FH, 2003, NEUROIMAGE, V20, P625, DOI 10.1016/S1053-8119(03)00333-1; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Mai JK, 2004, ATLAS HUMAN BRAIN; Martuzzi R, 2010, NEUROIMAGE, V49, P823, DOI 10.1016/j.neuroimage.2009.07.028; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; McIntosh AR, 1999, MEMORY, V7, P523, DOI 10.1080/096582199387733; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; McIntosh AR, 2004, NEUROINFORMATICS, V2, P175, DOI 10.1385/NI:2:2:175; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Stevens WD, 2010, CEREB CORTEX, V20, P1997, DOI 10.1093/cercor/bhp270; STEVENS WD, 2009, CEREB CORTEX; Toro R, 2008, CEREB CORTEX, V18, P2553, DOI 10.1093/cercor/bhn014; Waites AB, 2005, HUM BRAIN MAPP, V24, P59, DOI 10.1002/hbm.20069; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	50	92	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13311	10.1371/journal.pone.0013311	http://dx.doi.org/10.1371/journal.pone.0013311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967203	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800016
J	Huang, QX; Cheng, XY; Mao, ZC; Wang, YS; Zhao, LL; Yan, X; Ferris, VR; Xu, RM; Xie, BY				Huang, Qi-Xing; Cheng, Xin-Yue; Mao, Zhen-Chuan; Wang, Yun-Sheng; Zhao, Li-Lin; Yan, Xia; Ferris, Virginia R.; Xu, Ru-Mei; Xie, Bing-Yan			MicroRNA Discovery and Analysis of Pinewood Nematode Bursaphelenchus xylophilus by Deep Sequencing	PLOS ONE			English	Article							MONOCHAMUS-CAROLINENSIS; ANIMAL DEVELOPMENT; C-ELEGANS; EXPRESSION; EVOLUTION; PATHWAYS; 21U-RNAS; ENCODES; COMPLEX; SPREAD	Background: MicroRNAs (miRNAs) are considered to be very important in regulating the growth, development, behavior and stress response in animals and plants in post-transcriptional gene regulation. Pinewood nematode, Bursaphelenchus xylophilus, is an important invasive plant parasitic nematode in Asia. To have a comprehensive knowledge about miRNAs of the nematode is necessary for further in-depth study on roles of miRNAs in the ecological adaptation of the invasive species. Methods and Findings: Five small RNA libraries were constructed and sequenced by Illumina/Solexa deep-sequencing technology. A total of 810 miRNA candidates (49 conserved and 761 novel) were predicted by a computational pipeline, of which 57 miRNAs (20 conserved and 37 novel) encoded by 53 miRNA precursors were identified by experimental methods. Ten novel miRNAs were considered to be species-specific miRNAs of B. xylophilus. Comparison of expression profiles of miRNAs in the five small RNA libraries showed that many miRNAs exhibited obviously different expression levels in the third-stage dispersal juvenile and at a cold-stressed status. Most of the miRNAs exhibited obviously down-regulated expression in the dispersal stage. But differences among the three geographic libraries were not prominent. A total of 979 genes were predicted to be targets of these authentic miRNAs. Among them, seven heat shock protein genes were targeted by 14 miRNAs, and six FMRFamide-like neuropeptides genes were targeted by 17 miRNAs. A real-time quantitative polymerase chain reaction was used to quantify the mRNA expression levels of target genes. Conclusions: Basing on the fact that a negative correlation existed between the expression profiles of miRNAs and the mRNA expression profiles of their target genes (hsp, flp) by comparing those of the nematodes at a cold stressed status and a normal status, we suggested that miRNAs might participate in ecological adaptation and behavior regulation of the nematode. This is the first description of miRNAs in plant parasitic nematodes. The results provide a useful resource for further in-depth study on molecular regulation and evolution of miRNAs in plant parasitic nematodes.	[Huang, Qi-Xing; Cheng, Xin-Yue; Yan, Xia; Xu, Ru-Mei] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Huang, Qi-Xing; Mao, Zhen-Chuan; Wang, Yun-Sheng; Xie, Bing-Yan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing, Peoples R China; [Wang, Yun-Sheng] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zhao, Li-Lin] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Ferris, Virginia R.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA	Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Hunan Agricultural University; Chinese Academy of Sciences; Institute of Zoology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Huang, QX (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China.	xiebingyan2003@yahoo.com.cn		Wang, Yunsheng/0000-0001-5003-4434	National Basic Research and Development Program [2009CB119200]; National Natural Science Foundation of China [30570288]	National Basic Research and Development Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Basic Research and Development Program (No. 2009CB119200), the National Natural Science Foundation of China (No. 30570288). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; BOLLA RI, 1993, J NEMATOL, V25, P227; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cheng XY, 2008, HEREDITY, V100, P356, DOI 10.1038/sj.hdy.6801082; de Wit E, 2009, GENOME RES, V19, P2064, DOI 10.1101/gr.093781.109; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Ibanez-Ventoso C, 2006, AGING CELL, V5, P235, DOI 10.1111/j.1474-9726.2006.00210.x; Ibanez-Ventoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002818; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kang JS, 2009, GENOMICS, V94, P70, DOI 10.1016/j.ygeno.2009.03.001; Kato M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r54; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kimber MJ, 2007, FASEB J, V21, P1233, DOI 10.1096/fj.06-7343com; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; LI HM, 2008, THESIS GHENT U GHENT; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Liu TW, 2007, J NEUROSCI, V27, P7174, DOI 10.1523/JNEUROSCI.1405-07.2007; Necibi S, 1998, J NEMATOL, V30, P246; Parkinson J, 2004, NUCLEIC ACIDS RES, V32, pD427, DOI 10.1093/nar/gkh018; Pasiecznik N. M., 2005, Bulletin OEPP, V35, P1, DOI 10.1111/j.1365-2338.2005.00815.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poole CB, 2010, MOL BIOCHEM PARASIT, V169, P87, DOI 10.1016/j.molbiopara.2009.10.004; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ren XP, 2009, CIRCULATION, V119, P2357, DOI 10.1161/CIRCULATIONAHA.108.814145; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; *SPSS INC, 2003, SPSS WIND; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; VIGLIERCHIO DR, 1983, J NEMATOL, V15, P438; WARREN JE, 1993, J NEMATOL, V25, P703; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; WINGFIELD MJ, 1983, EUR J FOREST PATHOL, V13, P360; Xie BY, 2009, SCI CHINA SER C, V52, P587, DOI 10.1007/s11427-009-0071-y; Yang, 2003, PINE WILT DIS; Zhao BG., 2008, PINE WILT DIS; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	59	29	33	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13271	10.1371/journal.pone.0013271	http://dx.doi.org/10.1371/journal.pone.0013271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967259	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300013
J	Shen, H; Harris, G; Chen, WX; Sjostedt, A; Ryden, P; Conlan, W				Shen, Hua; Harris, Gregory; Chen, Wangxue; Sjostedt, Anders; Ryden, Patrik; Conlan, Wayne			Molecular Immune Responses to Aerosol Challenge with Francisella tularensis in Mice Inoculated with Live Vaccine Candidates of Varying Efficacy	PLOS ONE			English	Article							DELTA-T-CELLS; INTERFERON-GAMMA; PROTECTIVE IMMUNITY; TULAREMIA VACCINE; RESPIRATORY CHALLENGE; NATURAL INFECTION; IL-17 PRODUCTION; STRAIN; PATHOGEN; IMMUNIZATION	Background: Francisella tularensis is a facultative intracellular bacterial pathogen and the etiological agent of tularemia. The subspecies F. tularensis tularensis is especially virulent for humans when inhaled and respiratory tularemia is associated with high mortality if not promptly treated. A live vaccine strain (LVS) derived from the less virulent holarctica subspecies confers incomplete protection against aerosol challenge with subsp. tularensis. Moreover, correlates of protection have not been established for LVS. Methodology/Principal Findings: In the present study we compare molecular immune responses elicited by LVS and two defined deletion mutants of clinical subsp. tularensis strain, SCHU S4, that confer enhanced protection in a mouse model. BALB/c mice were immunized intradermally then challenged with an aerosol of SCHU S4 six weeks later. Changes in the levels of a selected panel of cytokines and chemokines were examined in the lungs, spleens, and sera of vaccinated and challenged mice. Mostly, increased cytokine and chemokine levels correlated with increased bacterial burden. However, after adjusting for this variable, immunization with either of the two Schu S4 mutants resulted in higher levels of several pulmonary cytokines, versus those resulting after LVS immunization, including IL-17. Moreover, treatment of mice immunized with Delta clpB with anti-IL-17 antibodies post-challenge enhanced lung infection. Conclusions/Significance: This is the first report characterizing local and systemic cytokine and chemokine responses in mice immunized with vaccines with different efficacies against aerosol challenge with virulent F. tularensis subsp. tularensis. It shows that increases in the levels of most of these immunomodulators, including those known to be critical for protective immunity, do not superficially correlate with protection unless adjusted for the effects of bacterial burden. Additionally, several cytokines were selectively suppressed in the lungs of naive mice, suggesting that one mechanism of vaccine action is to overcome this pathogen-induced immunosuppression.	[Shen, Hua; Harris, Gregory; Chen, Wangxue; Conlan, Wayne] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Ryden, Patrik] Umea Univ, Dept Stat, Computat Life Sci Cluster, Dept Math & Math Stat,Dept Stat, Umea, Sweden	National Research Council Canada; Umea University; Umea University	Shen, H (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	wayne.conlan@nrc-cnrc.gc.ca	Rydén, Patrik/I-4201-2016; Sjöstedt, Anders/AAC-6575-2020	Rydén, Patrik/0000-0002-0577-123X; Sjöstedt, Anders/0000-0002-0768-8405	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [AI60689]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060689] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project has been funded with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services under grant No. AI60689. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Chen WX, 2004, MICROB PATHOGENESIS, V36, P311, DOI 10.1016/j.micpath.2004.02.003; Chen WX, 2003, VACCINE, V21, P3690, DOI 10.1016/S0264-410X(03)00386-4; Conlan JW, 2008, MOL IMMUNOL, V45, P2962, DOI 10.1016/j.molimm.2008.01.022; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Conlan JW, 2005, VACCINE, V23, P2477, DOI 10.1016/j.vaccine.2004.10.034; Cowley SC, 2010, J IMMUNOL, V184, P5791, DOI 10.4049/jimmunol.1000362; Elkins KL, 2007, ANN NY ACAD SCI, V1105, P284, DOI 10.1196/annals.1409.014; ERICSSON M, 1994, J INFECT DIS, V170, P110, DOI 10.1093/infdis/170.1.110; Fuller CL, 2006, J ALLERGY CLIN IMMUN, V117, P1186, DOI 10.1016/j.jaci.2006.01.044; Fuller CL, 2007, MOL IMMUNOL, V44, P3173, DOI 10.1016/j.molimm.2007.01.037; Green M, 2005, VACCINE, V23, P2680, DOI 10.1016/j.vaccine.2004.03.071; Higgins SC, 2006, J IMMUNOL, V177, P7980, DOI 10.4049/jimmunol.177.11.7980; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; KARTTUNEN R, 1987, J CLIN MICROBIOL, V25, P1074, DOI 10.1128/JCM.25.6.1074-1078.1987; Kelchtermans H, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2787; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Lin YY, 2009, IMMUNITY, V31, P799, DOI 10.1016/j.immuni.2009.08.025; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Markel G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011176; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; McMurry JA, 2007, VACCINE, V25, P3179, DOI 10.1016/j.vaccine.2007.01.039; Paranavitana C, 2010, J INTERF CYTOK RES, V30, P471, DOI 10.1089/jir.2009.0108; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Salerno-Goncalves R, 2009, VACCINE, V28, P195, DOI 10.1016/j.vaccine.2009.09.100; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; SJOSTEDT A, 1992, IMMUNOLOGY, V76, P584; Sjostedt A, 1996, MICROBIOL-UK, V142, P1369, DOI 10.1099/13500872-142-6-1369; SJOSTEDT A, 1994, INFECT IMMUN, V62, P2779; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Velin D, 2009, GASTROENTEROLOGY, V136, P2237, DOI 10.1053/j.gastro.2009.02.077; Woolard MD, 2008, INFECT IMMUN, V76, P2651, DOI 10.1128/IAI.01412-07; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060; Wu TH, 2005, INFECT IMMUN, V73, P2644, DOI 10.1128/IAI.73.5.2644-2654.2005; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075	40	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13349	10.1371/journal.pone.0013349	http://dx.doi.org/10.1371/journal.pone.0013349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967278	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300027
J	Zhou, ZK; Sheng, XH; Zhang, ZW; Zhao, KY; Zhu, L; Guo, G; Friedenberg, SG; Hunter, LS; Vandenberg-Foels, WS; Hornbuckle, WE; Krotscheck, U; Corey, E; Moise, NS; Dykes, NL; Li, JY; Xu, SZ; Du, LX; Wang, YC; Sandler, J; Acland, GM; Lust, G; Todhunter, RJ				Zhou, Zhengkui; Sheng, Xihui; Zhang, Zhiwu; Zhao, Keyan; Zhu, Lan; Guo, Gang; Friedenberg, Steve G.; Hunter, Linda S.; Vandenberg-Foels, Wendy S.; Hornbuckle, William E.; Krotscheck, Ursula; Corey, Elizabeth; Moise, Nancy S.; Dykes, Nathan L.; Li, Junya; Xu, Shangzhong; Du, Lixin; Wang, Yachun; Sandler, Jody; Acland, Gregory M.; Lust, George; Todhunter, Rory J.			Differential Genetic Regulation of Canine Hip Dysplasia and Osteoarthritis	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; LIMITED FOOD-CONSUMPTION; GERMAN-SHEPHERD DOGS; LABRADOR-RETRIEVERS; DOMESTIC DOGS; COAT COLOR; CANDIDATE GENES; PROTEIN; JOINT	Background: Canine hip dysplasia (HD) is a common polygenic trait characterized by hip malformation that results in osteoarthritis (OA). The condition in dogs is very similar to developmental dysplasia of the human hip which also leads to OA. Methodology/Principal Findings: A total of 721 dogs, including both an association and linkage population, were genotyped. The association population included 8 pure breeds (Labrador retriever, Greyhounds, German Shepherd, Newfoundland, Golden retriever, Rottweiler, Border Collie and Bernese Mountain Dog). The linkage population included Labrador retrievers, Greyhounds, and their crosses. Of these, 366 dogs were genotyped at similar to 22,000 single nucleotide polymorphism (SNP) loci and a targeted screen across 8 chromosomes with similar to 3,300 SNPs was performed on 551 dogs (196 dogs were common to both sets). A mixed linear model approach was used to perform an association study on this combined association and linkage population. The study identified 4 susceptibility SNPs associated with HD and 2 SNPs associated with hip OA. Conclusion/Significance: The identified SNPs included those near known genes (PTPRD, PARD3B, and COL15A1) reported to be associated with, or expressed in, OA in humans. This suggested that the canine model could provide a unique opportunity to identify genes underlying natural HD and hip OA, which are common and debilitating conditions in both dogs and humans.	[Zhou, Zhengkui] NW A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China; [Zhou, Zhengkui; Sheng, Xihui; Li, Junya; Xu, Shangzhong; Du, Lixin] Chinese Acad Agr Sci, Inst Anim Sci, Beijing, Peoples R China; [Zhou, Zhengkui; Sheng, Xihui; Friedenberg, Steve G.; Hunter, Linda S.; Vandenberg-Foels, Wendy S.; Hornbuckle, William E.; Krotscheck, Ursula; Corey, Elizabeth; Moise, Nancy S.; Dykes, Nathan L.; Todhunter, Rory J.] Cornell Univ, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Sheng, Xihui] Beijing Agr Univ, Dept Anim Sci & Technol, Beijing 100094, Peoples R China; [Zhang, Zhiwu] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Zhao, Keyan] Cornell Univ, Dept Computat Biol & Stat, Ithaca, NY USA; [Zhu, Lan] Oklahoma State Univ, Dept Stat, Stillwater, OK 74078 USA; [Guo, Gang; Wang, Yachun] China Agr Univ, Dept Anim Sci, Beijing 100094, Peoples R China; [Sandler, Jody] Guiding Eyes Blind, Yorktown Hts, NY USA; [Acland, Gregory M.; Lust, George] Cornell Univ, James A Baker Inst Anim Hlth, Ithaca, NY USA	Northwest A&F University - China; Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Cornell University; Beijing University of Agriculture; Cornell University; Cornell University; Oklahoma State University System; Oklahoma State University - Stillwater; China Agricultural University; Cornell University	Zhou, ZK (corresponding author), NW A&F Univ, Coll Anim Sci & Technol, Yangling, Peoples R China.	zz19@cornell.edu	Friedenberg, Steven/L-2681-2019; Zhang, Zhiwu/P-6156-2016; Zhang, zs/GXN-3521-2022	Friedenberg, Steven/0000-0002-7510-2322; Zhang, Zhiwu/0000-0002-5784-9684; Zhou, Zhengkui/0000-0002-5192-2465; Vanden Berg-Foels, Wendy/0000-0002-1557-3317	National Institutes of Health [1R21AR055228-01A1]; National Science Foundation [0606461]; Chinese National Key Technologies RD Program [2006BAD04A01, 2006BAD01A10, 2008BADB2B03, 2008AA101010]; National Department Public Benefit Research Foundation of China [nyhyzx07-035]; National Natural Science Foundation of China [30871774]; Waltham Center for Pet Nutrition; Cornell Advanced Technology in Biotechnology; Department of Clinical Sciences; Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR055228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Chinese National Key Technologies RD Program(National Key Technology R&D Program); National Department Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Waltham Center for Pet Nutrition; Cornell Advanced Technology in Biotechnology; Department of Clinical Sciences; Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The study was supported by National Institutes of Health (1R21AR055228-01A1), National Science Foundation (#0606461), Chinese National Key Technologies R&D Program (No. 2006BAD04A01, No. 2006BAD01A10, No. 2008BADB2B03, No. 2008AA101010), National Department Public Benefit Research Foundation of China (No. nyhyzx07-035), National Natural Science Foundation of China (No. 30871774), Waltham Center for Pet Nutrition, Cornell Advanced Technology in Biotechnology, and the Collaborative Research Grant Program, Department of Clinical Sciences, and the Baker Institute for Animal Health in the College of Veterinary Medicine, Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bliss S, 2002, AM J VET RES, V63, P1029, DOI 10.2460/ajvr.2002.63.1029; BOYKO AR, PLOS BIOL, V8; Breur G. J., 2001, The genetics of the dog, P267, DOI 10.1079/9780851995205.0267; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Candille SI, 2007, SCIENCE, V318, P1418, DOI 10.1126/science.1147880; Chase K, 2005, AM J MED GENET A, V135A, P334, DOI 10.1002/ajmg.a.30719; Chase K, 2004, AM J MED GENET A, V124A, P239, DOI 10.1002/ajmg.a.20363; Choi B, 2007, EXP MOL MED, V39, P796, DOI 10.1038/emm.2007.86; CILLIERS HJ, 1990, AM J MED GENET, V36, P386, DOI 10.1002/ajmg.1320360403; Clements DN, 2006, AM J VET RES, V67, P909, DOI 10.2460/ajvr.67.5.909; Feldman G, 2010, CLIN ORTHOP RELAT R, V468, P337, DOI 10.1007/s11999-009-1073-6; FRIEDENBERG SG, 2010, AM J VET RE IN PRESS; FUERST PA, 1977, GENETICS, V86, P455; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Higashino A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-24; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jacobsen S, 2005, RHEUMATOLOGY, V44, P211, DOI 10.1093/rheumtology/keh436; Jacobsen S, 2006, ACTA ORTHOP, V77, P8; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Karlsson EK, 2008, NAT REV GENET, V9, P713, DOI 10.1038/nrg2382; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; KEALY RD, 1993, AM J VET RES, V54, P555; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 1997, J AM VET MED ASSOC, V210, P222; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Lark KG, 2006, TRENDS GENET, V22, P537, DOI 10.1016/j.tig.2006.08.009; Lee JW, 2000, J ANIM SCI, V78, P2108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Liu WG, 1997, HUM GENET, V99, P578, DOI 10.1007/s004390050409; Lou XY, 2003, MAMM GENOME, V14, P555, DOI 10.1007/s00335-003-2272-1; Lust G, 1997, J AM VET MED ASSOC, V210, P1443; Lust G, 2001, J AM VET MED ASSOC, V219, P1242, DOI 10.2460/javma.2001.219.1242; Lust G, 2001, AM J VET RES, V62, P1711, DOI 10.2460/ajvr.2001.62.1711; MADSEN JS, 1994, ACTA VET SCAND, V35, P115; MAFFIA M, 1996, AM J PHYSIOL-REG I, V271, pR1576; Makarieva AM, 2001, HEREDITY, V87, P41, DOI 10.1046/j.1365-2540.2001.00899.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Marschall Y, 2007, MAMM GENOME, V18, P861, DOI 10.1007/s00335-007-9071-z; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Meulenbelt I, 2006, EUR J HUM GENET, V14, P1280, DOI 10.1038/sj.ejhg.5201704; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; NAKAMURA S, 1989, CLIN ORTHOP RELAT R, P190; Ortiz EM, 1998, GASTROENTEROLOGY, V114, P808, DOI 10.1016/S0016-5085(98)70595-5; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Parentin F, 2001, GRAEF ARCH CLIN EXP, V239, P316, DOI 10.1007/s004170100286; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Phavaphutanon J, 2009, AM J VET RES, V70, P1094, DOI 10.2460/ajvr.70.9.1094; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Rogers J, 2006, GENOMICS, V87, P30, DOI 10.1016/j.ygeno.2005.10.004; Schmutz SM, 2002, MAMM GENOME, V13, P380, DOI 10.1007/s00335-001-2147-2; Schormair B, 2008, NAT GENET, V40, P946, DOI 10.1038/ng.190; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Stevenson DA, 2009, J PEDIATR ORTHOPED, V29, P463, DOI 10.1097/BPO.0b013e3181aa586b; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Todhunter RJ, 1997, J AM VET MED ASSOC, V210, P1458; Todhunter RJ, 2005, MAMM GENOME, V16, P720, DOI 10.1007/s00335-005-0004-4; Todhunter RJ, 2003, AM J VET RES, V64, P1472, DOI 10.2460/ajvr.2003.64.1472; Tompson SWJ, 2007, HUM GENET, V120, P663, DOI 10.1007/s00439-006-0237-7; Tsuritani K, 2010, CALCIFIED TISSUE INT, V86, P47, DOI 10.1007/s00223-009-9311-1; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Valdes AM, 2008, AM J HUM GENET, V82, P1231, DOI 10.1016/j.ajhg.2008.04.006; WEINSTEIN SL, 1987, CLIN ORTHOP RELAT R, P62; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; YEH H, 1994, GENOMICS, V23, P443, DOI 10.1006/geno.1994.1521; Yoshimura N, 1998, BRIT J RHEUMATOL, V37, P1193; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhu L, 2008, ANIM GENET, V39, P141, DOI 10.1111/j.1365-2052.2007.01691.x	72	41	41	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13219	10.1371/journal.pone.0013219	http://dx.doi.org/10.1371/journal.pone.0013219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949002	Green Submitted, Green Published, gold			2022-12-27	WOS:000282748100003
J	Blasco, H; Corcia, P; Moreau, C; Veau, S; Fournier, C; Vourc'h, P; Emond, P; Gordon, P; Pradat, PF; Praline, J; Devos, D; Nadal-Desbarats, L; Andres, CR				Blasco, Helene; Corcia, Philippe; Moreau, Caroline; Veau, Segolene; Fournier, Clementine; Vourc'h, Patrick; Emond, Patrick; Gordon, Paul; Pradat, Pierre-Francois; Praline, Julien; Devos, David; Nadal-Desbarats, Lydie; Andres, Christian R.			H-1-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOTOR-NEURON DISEASE; CEREBROSPINAL-FLUID; ASCORBIC-ACID; BRAIN GLUCOSE; BIOMARKERS; TRANSPORT; ALS; NEURODEGENERATION; ASTROCYTES; DIAGNOSIS	Background: Pathophysiological mechanisms involved in amyotrophic lateral sclerosis (ALS) are complex and none has identified reliable markers useful in routine patient evaluation. The aim of this study was to analyze the CSF of patients with ALS by H-1 NMR (Nuclear Magnetic Resonance) spectroscopy in order to identify biomarkers in the early stages of the disease, and to evaluate the biochemical factors involved in ALS. Methodology: CSF samples were collected from patients with ALS at the time of diagnosis and from patients without neurodegenerative diseases. One and two-dimensional H-1 NMR analyses were performed and metabolites were quantified by the ERETIC method. We compared the concentrations of CSF metabolites between both groups. Finally, we performed principal component (PCA) and discriminant analyses. Principal Findings: Fifty CSF samples from ALS patients and 44 from controls were analyzed. We quantified 17 metabolites including amino-acids, organic acids, and ketone bodies. Quantitative analysis revealed significantly lower acetate concentrations (p = 0.0002) in ALS patients compared to controls. Concentration of acetone trended higher (p = 0.015), and those of pyruvate (p = 0.002) and ascorbate (p = 0.003) were higher in the ALS group. PCA demonstrated that the pattern of analyzed metabolites discriminated between groups. Discriminant analysis using an algorithm of 17 metabolites revealed that patients were accurately classified 81.6% of the time. Conclusion/Significance: CSF screening by NMR spectroscopy could be a useful, simple and low cost tool to improve the early diagnosis of ALS. The results indicate a perturbation of glucose metabolism, and the need to further explore cerebral energetic metabolism.	[Blasco, Helene; Corcia, Philippe; Vourc'h, Patrick; Emond, Patrick; Praline, Julien; Nadal-Desbarats, Lydie; Andres, Christian R.] CNRS 2448, INSERM, U930, Tours, France; [Vourc'h, Patrick; Emond, Patrick; Nadal-Desbarats, Lydie] Univ Tours, Lab RMN PPF Anal Syst Biol, Tours, France; [Blasco, Helene; Veau, Segolene; Fournier, Clementine; Vourc'h, Patrick; Emond, Patrick; Andres, Christian R.] CHRU Tours, Lab Biochim & Biol Mol, Tours, France; [Corcia, Philippe; Praline, Julien] CHRU Tours, Serv Neurol, Tours, France; [Moreau, Caroline; Devos, David] CHRU Lille, Serv Neurol, Lille, France; [Gordon, Paul] No Navajo Med Ctr, Shiprock, NM USA; [Pradat, Pierre-Francois] Hop La Pitie Salpetriere, APHP, Ctr Referent Malad Rare SLA, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; CHU Tours; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Blasco, H (corresponding author), CNRS 2448, INSERM, U930, Tours, France.	helene.blasco@univ-tours.fr	Devos, David/E-4059-2013; Emond, Patrick/P-6994-2016	Devos, David/0000-0002-2417-799X; Emond, Patrick/0000-0002-5324-2164; blasco, helene/0000-0001-6107-0035; Andres, Christian/0000-0002-5062-3156; Gordon, Paul/0000-0001-5714-9875				Ala-Korpela M, 2007, EXPERT REV MOL DIAGN, V7, P761, DOI 10.1586/14737159.7.6.761; Barantin L, 1997, MAGN RESON MED, V38, P179, DOI 10.1002/mrm.1910380203; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Castro MA, 2007, J NEUROCHEM, V102, P773, DOI 10.1111/j.1471-4159.2007.04631.x; Castro MA, 2009, J NEUROCHEM, V110, P423, DOI 10.1111/j.1471-4159.2009.06151.x; Deelchand DK, 2009, J NEUROCHEM, V109, P46, DOI 10.1111/j.1471-4159.2009.05895.x; Desport JC, 2005, NEURODEGENER DIS, V2, P202, DOI 10.1159/000089626; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Fiszman ML, 2010, ACTA NEUROL SCAND, V121, P120, DOI 10.1111/j.1600-0404.2009.01200.x; Ihara Y, 2005, NEUROL RES, V27, P105, DOI 10.1179/016164105X18430; Kalapos MP, 2003, BBA-GEN SUBJECTS, V1621, P122, DOI 10.1016/S0304-4165(03)00051-5; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kraemer M, 2010, CLIN NEUROL NEUROSUR, V112, P103, DOI 10.1016/j.clineuro.2009.10.014; Kumar A, 2010, CLIN CHIM ACTA; Lavi R, 2010, EUR NEUROL, V64, P108, DOI 10.1159/000316774; Maillet S, 1998, BRAIN RES PROTOC, V3, P123, DOI 10.1016/S1385-299X(98)00033-6; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Paraskevas GP, 1997, ACTA NEUROL SCAND, V96, P88; Pawlosky RJ, 2010, ALCOHOL CLIN EXP RES, V34, P375, DOI 10.1111/j.1530-0277.2009.01099.x; Pradat PF, 2009, MOL DIAGN THER, V13, P115, DOI 10.2165/01250444-200913020-00005; Quinones MP, 2009, NEUROBIOL DIS, V35, P165, DOI 10.1016/j.nbd.2009.02.019; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SPENCER PS, 1987, CAN J NEUROL SCI, V14, P347, DOI 10.1017/S0317167100037732; Sussmuth SD, 2008, CURR MED CHEM, V15, P1788, DOI 10.2174/092986708785133031; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Tumani H, 2008, EXPERT REV MOL DIAGN, V8, P479, DOI 10.1586/14737159.8.4.479; Wilson JX, 2000, BRAIN RES, V858, P61, DOI 10.1016/S0006-8993(99)02433-6; Wishart DS, 2008, J CHROMATOGR B, V871, P164, DOI 10.1016/j.jchromb.2008.05.001; Wuolikainen A, 2009, AMYOTROPH LATERAL SC, V10, P229, DOI 10.1080/17482960902871009	32	95	96	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13223	10.1371/journal.pone.0013223	http://dx.doi.org/10.1371/journal.pone.0013223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949041	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700010
J	Wang, YP; Robbins, KR; Rekaya, R				Wang, Yupeng; Robbins, Kelly R.; Rekaya, Romdhane			Comparison of Computational Models for Assessing Conservation of Gene Expression across Species	PLOS ONE			English	Article							MOUSE ORTHOLOGOUS GENES; SEQUENCE DIVERGENCE; EVOLUTION; PROFILES; TRANSCRIPTOMES; COEXPRESSION; DROSOPHILA; PATTERNS; REPEATS; HUMANS	Assessing conservation/divergence of gene expression across species is important for the understanding of gene regulation evolution. Although advances in microarray technology have provided massive high-dimensional gene expression data, the analysis of such data is still challenging. To date, assessing cross-species conservation of gene expression using microarray data has been mainly based on comparison of expression patterns across corresponding tissues, or comparison of co-expression of a gene with a reference set of genes. Because direct and reliable high-throughput experimental data on conservation of gene expression are often unavailable, the assessment of these two computational models is very challenging and has not been reported yet. In this study, we compared one corresponding tissue based method and three co-expression based methods for assessing conservation of gene expression, in terms of their pair-wise agreements, using a frequently used human-mouse tissue expression dataset. We find that 1) the co-expression based methods are only moderately correlated with the corresponding tissue based methods, 2) the reliability of co-expression based methods is affected by the size of the reference ortholog set, and 3) the corresponding tissue based methods may lose some information for assessing conservation of gene expression. We suggest that the use of either of these two computational models to study the evolution of a gene's expression may be subject to great uncertainty, and the investigation of changes in both gene expression patterns over corresponding tissues and co-expression of the gene with other genes is necessary.	[Wang, Yupeng; Robbins, Kelly R.; Rekaya, Romdhane] Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA; [Wang, Yupeng; Rekaya, Romdhane] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Rekaya, Romdhane] Univ Georgia, Dept Stat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Wang, YP (corresponding author), Univ Georgia, Dept Anim & Dairy Sci, Athens, GA 30602 USA.	wyp1125@uga.edu	Wang, Yupeng/B-7986-2009; Robbins, Kelly R/ABU-9024-2022	Wang, Yupeng/0000-0002-3002-8069; Robbins, Kelly/0000-0001-9522-9585	University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer	University of Georgia Research Computing Center; Office of the Vice President for Research; Office of the Chief Information Officer	This study was supported in part by resources and technical expertise from the University of Georgia Research Computing Center, a partnership between the Office of the Vice President for Research and the Office of the Chief Information Officer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-110; Dutilh BE, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-10; Elbez Y, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-136; Essien K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003122; Gilad Y, 2005, GENOME RES, V15, P674, DOI 10.1101/gr.3335705; Gu X, 2007, P NATL ACAD SCI USA, V104, P2779, DOI 10.1073/pnas.0610797104; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Jordan IK, 2005, GENE, V345, P119, DOI 10.1016/j.gene.2004.11.034; Jordan IK, 2004, MOL BIOL EVOL, V21, P2058, DOI 10.1093/molbev/msh222; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2004, PLOS BIOL, V2, P682, DOI 10.1371/journal.pbio.0020132; Kim RS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-44; Lemos B, 2005, MOL BIOL EVOL, V22, P1345, DOI 10.1093/molbev/msi122; Liao BY, 2008, P NATL ACAD SCI USA, V105, P6987, DOI [10.1073/pnas.0800387105, 10.1073/pnas.0806419105]; Liao BY, 2006, MOL BIOL EVOL, V23, P1119, DOI 10.1093/molbev/msj119; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Liao BY, 2006, MOL BIOL EVOL, V23, P530, DOI 10.1093/molbev/msj054; Nuzhdin SV, 2004, MOL BIOL EVOL, V21, P1308, DOI 10.1093/molbev/msh128; Park SG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-241; Pereira V, 2009, GENETICS, V183, P1597, DOI 10.1534/genetics.109.110247; Sartor MA, 2006, NUCLEIC ACIDS RES, V34, P185, DOI 10.1093/nar/gkj413; Semon M, 2006, MOL BIOL EVOL, V23, P1715, DOI 10.1093/molbev/msl034; Singh LN, 2010, NUCLEIC ACIDS RES, V38, P738, DOI 10.1093/nar/gkp989; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tirosh I, 2008, TRENDS GENET, V24, P109, DOI 10.1016/j.tig.2007.12.004; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Urrutia AO, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r25; Wagner A, 2000, P NATL ACAD SCI USA, V97, P6579, DOI 10.1073/pnas.110147097; Wang YP, 2009, EVOL BIOINFORM, V5, P81; Yanai I, 2006, TRENDS GENET, V22, P132, DOI 10.1016/j.tig.2006.01.006; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Yang J, 2005, MOL BIOL EVOL, V22, P2113, DOI 10.1093/molbev/msi206	33	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13239	10.1371/journal.pone.0013239	http://dx.doi.org/10.1371/journal.pone.0013239			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949029	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700013
J	Liu, JY; Hutchison, K; Perrone-Bizzozero, N; Morgan, M; Sui, J; Calhoun, V				Liu, Jingyu; Hutchison, Kent; Perrone-Bizzozero, Nora; Morgan, Marilee; Sui, Jing; Calhoun, Vince			Identification of Genetic and Epigenetic Marks Involved in Population Structure	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ALPHA-N-CATENIN; DNA METHYLATION; EYE COLOR; HERC2; PHENOTYPE; HUMANS; WOMEN; OCA2	Population structure is well known as a prevalent and important factor in genetic studies, but its relevance in epigenetics is unclear. Very little is known about the affected epigenetic markers and their connections with genetics. In this study we assessed the impact of population diversity on genome wide single nucleotide polymorphisms (SNPs) and DNA methylation levels in 196 participants from five ethnic groups, using principle and independent component analyses. Three population stratification factors (PSFs) were identified in the genomic SNP dataset, accounting for a relatively large portion of total variance (6%). In contrast, only one PSF was identified in genomic methylation dataset accounting for 0.2% of total variance. This methylation PSF, however, was significantly correlated with the largest SNP PSF (r = 0.72, p<1E-23). We then investigated the top contributing markers in these two linked PSFs. The SNP PSF predominantly consists of 8 SNPs from three genes, SLC45A2, HERC2 and CTNNA2, known to encode skin/hair/eye color. The methylation PSF includes 48 methylated sites in 44 genes coding for basic molecular functions, including transcription regulation, DNA binding, cytokine, and transferase activity. Among them, 8 sites are either hypo- or hyper-methylated correlating to minor alleles of SNPs in the SNP PSF. We found that the genes in SNP and methylation PSFs share common biological processes including sexual/multicellular organism reproduction, cell-cell signaling and cytoskeleton organization. We further investigated the transcription regulatory network operating at these genes and identified that most of genes closely interact with ID2, which encodes for a helix-loop-helix inhibitor of DNA binding. Overall, our results show a significant correlation between genetic and epigenetic population stratification, and suggest that the interrelationship between genetic and epigenetic population structure is mediated via complex multiple gene interactions in shared biological processes, through possibly, SNP-dependent modulation and ID2 repressor function.	[Liu, Jingyu; Hutchison, Kent; Morgan, Marilee; Sui, Jing; Calhoun, Vince] Mind Res Network, Albuquerque, NM USA; [Liu, Jingyu; Calhoun, Vince] Univ New Mexico, Dept Elect & Comp Engn, Albuquerque, NM 87131 USA; [Hutchison, Kent] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Perrone-Bizzozero, Nora; Calhoun, Vince] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	Lovelace Respiratory Research Institute; University of New Mexico; University of New Mexico; University of New Mexico	Liu, JY (corresponding author), Mind Res Network, Albuquerque, NM USA.	jliu@mrn.org	Sui, Jing/B-3455-2018; Calhoun, Vince D./ACN-9399-2022	Sui, Jing/0000-0001-6837-5966; Calhoun, Vince D./0000-0001-9058-0747; Liu, Jingyu/0000-0002-1724-7523	National Institutes of Health [NIH R01EB005846, NIH R01AA012238, NIH R21DA027626]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005846] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA027626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institutes of Health (NIH R01EB005846 to V. Calhoun and NIH R01AA012238 to K. Hutchison, NIH R21DA027626 to J. Liu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Babor TF, 2006, AUDIT ALCOHOL USE DI; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BRAIT M, 2009, CANC EPIDEMIOL BIOMA; Branicki W, 2009, ANN HUM GENET, V73, P160, DOI 10.1111/j.1469-1809.2009.00504.x; Branicki W, 2008, J HUM GENET, V53, P966, DOI 10.1007/s10038-008-0338-3; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardoso JF, 1997, IEEE SIGNAL PROC LET, V4, P112, DOI 10.1109/97.566704; Chandler VL, 2007, CELL, V128, P641, DOI 10.1016/j.cell.2007.02.007; Chang HSW, 2004, CANCER-AM CANCER SOC, V101, P125, DOI 10.1002/cncr.20323; Das PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-28; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edenberg HJ, 2006, ADDICT BIOL, V11, P386, DOI 10.1111/j.1369-1600.2006.00035.x; Eiberg H, 2008, HUM GENET, V123, P177, DOI 10.1007/s00439-007-0460-x; Han JL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000074; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jacob RA, 1998, J NUTR, V128, P1204, DOI 10.1093/jn/128.7.1204; Kaati G, 2007, EUR J HUM GENET, V15, P784, DOI 10.1038/sj.ejhg.5201832; Kayser M, 2008, AM J HUM GENET, V82, P411, DOI 10.1016/j.ajhg.2007.10.003; LIU J, 2010, PLOS ONE IN PRESS; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; NIELSEN DA, HUM GENET; Park C, 2002, NAT GENET, V31, P279, DOI 10.1038/ng908; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Sturm RA, 2008, AM J HUM GENET, V82, P424, DOI 10.1016/j.ajhg.2007.11.005; Sutherland JE, 2003, ANN NY ACAD SCI, V983, P151, DOI 10.1111/j.1749-6632.2003.tb05970.x; Terry MB, 2008, CANCER EPIDEM BIOMAR, V17, P2306, DOI 10.1158/1055-9965.EPI-08-0312; Tost J, 2008, DNA METHYLATION METH, P3; WANG K, 2009, GENET EPIDEMIOL; Wang K, 2010, HUM MOL GENET, V19, P2059, DOI 10.1093/hmg/ddq078; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551	36	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13209	10.1371/journal.pone.0013209	http://dx.doi.org/10.1371/journal.pone.0013209			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949057	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700010
J	Funderburg, N; Kalinowska, M; Eason, J; Goodrich, J; Heera, J; Mayer, H; Rajicic, N; Valdez, H; Lederman, MM				Funderburg, Nicholas; Kalinowska, Magdalena; Eason, James; Goodrich, James; Heera, Jayvant; Mayer, Howard; Rajicic, Natasa; Valdez, Hernan; Lederman, Michael M.			Effects of Maraviroc and Efavirenz on Markers of Immune Activation and Inflammation and Associations with CD4(+) Cell Rises in HIV-Infected Patients	PLOS ONE			English	Article							C-REACTIVE PROTEIN; T-LYMPHOCYTE ACTIVATION; DISEASE; WOMEN; MEN; ATHEROSCLEROSIS; PATHOGENESIS; MORTALITY; BURDEN; CCR5	Background: Maraviroc treatment for HIV-1 infected patients results in larger CD4(+) T cell rises than are attributable to its antiviral activity alone. We investigated whether this is due to modulation of T cell activation and inflammation. Methods and Findings: Thirty maraviroc-treated patients from the Maraviroc versus Efavirenz Regimens as Initial Therapy (MERIT) study were randomly selected from among those who had CCR5-tropic (R5) HIV on screening and achieved undetectable HIV RNA (<50 copies/mL) by Week 48. Efavirenz-treated controls were matched for baseline characteristics to the maraviroc-treated patients selected for this substudy. Changes in immune activation and inflammation markers were examined for associations with CD4(+) T cell changes. Maraviroc treatment tended to result in more rapid decreases in CD38 expression on CD4(+) T cells and in plasma D-dimer concentrations than did treatment with efavirenz. The proportion of patients with high-sensitivity C-reactive protein >2 mg/mL increased from 45% to 66% in the efavirenz arm, but remained constant in the maraviroc arm (P = 0.033). Decreases in CD38 expression on CD8(+) T cells were correlated with CD4(+) T cell rises for maraviroc treatment (r = 20.4, P = 0.048), but not for treatment with efavirenz. Conclusions: Maraviroc-treated patients had earlier, modest decreases in certain markers of immune activation and inflammation, although in this small study, many of the differences were not statistically significant. Levels of high-sensitivity C-reactive protein remained constant in the maraviroc arm and increased in the efavirenz arm. Decreases in immune activation correlated with increased CD4(+) T cell gains.	[Funderburg, Nicholas; Kalinowska, Magdalena; Eason, James; Lederman, Michael M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Goodrich, James] ViiV Healthcare, Res Triangle Pk, NC USA; [Heera, Jayvant] Pfizer Global Res & Dev, New London, CT USA; [Mayer, Howard] EMD Serono, Rockland, MA USA; [Rajicic, Natasa; Valdez, Hernan] Pfizer Inc, New York, NY USA	Case Western Reserve University; GlaxoSmithKline; Pfizer; Pfizer	Funderburg, N (corresponding author), Case Western Reserve Univ, Cleveland, OH 44106 USA.	hernan.valdez@pfizer.com	Funderburg, Nicholas/L-8022-2013	Funderburg, Nicholas/0000-0003-3113-1217	Pfizer, Inc.	Pfizer, Inc.(Pfizer)	The study was sponsored by Pfizer Global Research and Development and was funded by Pfizer, Inc. Pfizer had a role in the study as employer of authors H. V., J.H. and N.R, who reviewed the data and wrote/contributed to the final manuscript. Editorial assistance was provided by Jennifer Tobin of Health Interactions, with funding by Pfizer, Inc.; Authors H. Valdez, J. Goodrich, J. Heera, and N. Rajicic are all Pfizer and or ViiV Healthcare employees. Author M. Letterman is the recipient of research grant support and has also served as a consultant to Pfizer. Authors N. Case, M. Kalinowska, J. Eason, and H. Mayer have no competing interest. Maraviroc is a product of Pfizer. The responsibilities preformed do not alter the authors' adherence to the PLoS ONE policies on sharing data and materials and has not influenced the final manuscript in any way.	Asmuth DM, 2010, JAIDS-J ACQ IMM DEF, V54, P394, DOI 10.1097/QAI.0b013e3181c5c83b; Ballantyne CM, 2004, CIRCULATION, V109, P837, DOI 10.1161/01.CIR.0000116763.91992.F1; Boekholdt SM, 2006, ATHEROSCLEROSIS, V187, P415, DOI 10.1016/j.atherosclerosis.2005.09.023; Braunersreuther V, 2007, ARTERIOSCL THROM VAS, V27, P373, DOI 10.1161/01.ATV.0000253886.44609.ae; Cooper DA, 2010, J INFECT DIS, V201, P803, DOI 10.1086/650697; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Derdeyn CA, 2005, CURR OPIN IMMUNOL, V17, P366, DOI 10.1016/j.coi.2005.06.001; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; HSUE P, 2010, 17 C RETR OPP INF SA; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; KULLER L, 2008, 15 C RETR OPP INF BO; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lau B, 2006, ARCH INTERN MED, V166, P64, DOI 10.1001/archinte.166.1.64; Liu Z, 1998, J ACQ IMMUN DEF SYND, V18, P332, DOI 10.1097/00042560-199808010-00004; Muntinghe FLH, 2009, J AM SOC NEPHROL, V20, P1641, DOI 10.1681/ASN.2008040432; Neuhuaus J, 2009, 16 C RETR OPP INF MO; PETERS L, 2010, 17 C RETR OPP INF SA; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2002, NEW ENGL J MED, V347, P1557, DOI 10.1056/NEJMoa021993; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Ross AC, 2009, CLIN INFECT DIS, V49, P1119, DOI 10.1086/605578; Triant VA, 2009, JAIDS-J ACQ IMM DEF, V51, P268, DOI 10.1097/QAI.0b013e3181a9992c	24	72	72	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13188	10.1371/journal.pone.0013188	http://dx.doi.org/10.1371/journal.pone.0013188			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949133	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400009
J	Groussard, M; La Joie, R; Rauchs, G; Landeau, B; Chetelat, G; Viader, F; Desgranges, B; Eustache, F; Platel, H				Groussard, Mathilde; La Joie, Renaud; Rauchs, Geraldine; Landeau, Brigitte; Chetelat, Gael; Viader, Fausto; Desgranges, Beatrice; Eustache, Francis; Platel, Herve			When Music and Long-Term Memory Interact: Effects of Musical Expertise on Functional and Structural Plasticity in the Hippocampus	PLOS ONE			English	Article							EPISODIC MEMORY; SEMANTIC MEMORY; GREY-MATTER; BRAIN; ACTIVATION; FMRI; PERFORMANCE; FAMILIARITY; RETRIEVAL; IMAGERY		[Groussard, Mathilde; La Joie, Renaud; Rauchs, Geraldine; Landeau, Brigitte; Chetelat, Gael; Viader, Fausto; Desgranges, Beatrice; Eustache, Francis; Platel, Herve] Univ Caen Basse Normandie, CHU Cote Nacre, GIP Cyceron, U923,EPHE,Inserm, Caen, France; [Viader, Fausto] CHU Cote Nacre, Dept Neurol, Caen, France	CHU de Caen NORMANDIE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie	Groussard, M (corresponding author), Univ Caen Basse Normandie, CHU Cote Nacre, GIP Cyceron, U923,EPHE,Inserm, Caen, France.	herve.platel@unicaen.fr	Chetelat, Gael/G-2316-2015; Desgranges, Béatrice/L-7739-2015; RAUCHS, Géraldine/L-7921-2015; Eustache, Francis/J-9465-2015; DESGRANGES, BEATRICE/AAK-4756-2021; Platel, Herve/L-8468-2015; La Joie, Renaud/AAC-8569-2021; Groussard, Mathilde/L-7923-2015	RAUCHS, Géraldine/0000-0001-7128-2189; Eustache, Francis/0000-0003-4460-8686; DESGRANGES, BEATRICE/0000-0002-3657-9996; Platel, Herve/0000-0003-1576-0398; La Joie, Renaud/0000-0003-2581-8100; Gael, Chetelat/0000-0002-4889-7932; GROUSSARD, Mathilde/0000-0002-6749-8611				Altenmueller E, 2008, CLIN MED, V8, P410, DOI 10.7861/clinmedicine.8-4-410; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; BAILEY DL, 1991, EUR J NUCL MED, V18, P374, DOI 10.1007/BF02258426; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Burianova H, 2010, NEUROIMAGE, V49, P865, DOI 10.1016/j.neuroimage.2009.08.066; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Cohen J.E., 1988, STAT POWER ANAL BEHA; Daselaar SM, 2006, J NEUROPHYSIOL, V96, P1902, DOI 10.1152/jn.01029.2005; Draganski B, 2008, BEHAV BRAIN RES, V192, P137, DOI 10.1016/j.bbr.2008.02.015; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eustache F, 2008, NEUROPSYCHOL REV, V18, P53, DOI 10.1007/s11065-008-9052-3; Gaser C, 2003, J NEUROSCI, V23, P9240; Gilboa A, 2004, NEUROPSYCHOLOGIA, V42, P1336, DOI 10.1016/j.neuropsychologia.2004.02.014; Groussard M, 2010, NEUROIMAGE, V49, P2764, DOI 10.1016/j.neuroimage.2009.10.039; Hackert VH, 2002, NEUROIMAGE, V17, P1365, DOI 10.1006/nimg.2002.1248; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Herdener M, 2010, J NEUROSCI, V30, P1377, DOI 10.1523/JNEUROSCI.4513-09.2010; Herholz SC, 2008, EUR J NEUROSCI, V28, P2352, DOI 10.1111/j.1460-9568.2008.06515.x; Hyde KL, 2009, J NEUROSCI, V29, P3019, DOI 10.1523/JNEUROSCI.5118-08.2009; Imfeld A, 2009, NEUROIMAGE, V46, P600, DOI 10.1016/j.neuroimage.2009.02.025; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Janata P, 2009, CEREB CORTEX, V19, P2579, DOI 10.1093/cercor/bhp008; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Luders E, 2004, NEUROIMAGE, V22, P656, DOI 10.1016/j.neuroimage.2004.01.032; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Meister IG, 2004, COGNITIVE BRAIN RES, V19, P219, DOI 10.1016/j.cogbrainres.2003.12.005; MILNER B, 1962, INTERHEMISPHER RELAT, P177; Munte TF, 2002, NAT REV NEUROSCI, V3, P473, DOI 10.1038/nrn843; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Peretz I, 2009, ANN NY ACAD SCI, V1169, P256, DOI 10.1111/j.1749-6632.2009.04557.x; Piolino P, 2009, NEUROPSYCHOLOGIA, V47, P2314, DOI 10.1016/j.neuropsychologia.2009.01.020; Plailly J, 2007, CEREB CORTEX, V17, P2650, DOI 10.1093/cercor/bhl173; Platel H, 2003, NEUROIMAGE, V20, P244, DOI 10.1016/S1053-8119(03)00287-8; POLINE JB, 1995, J COMPUT ASSIST TOMO, V19, P788, DOI 10.1097/00004728-199509000-00017; Richardson MP, 1997, BRAIN, V120, P1961, DOI 10.1093/brain/120.11.1961; Ryan L, 2008, NEUROPSYCHOLOGIA, V46, P2109, DOI 10.1016/j.neuropsychologia.2008.02.030; Satoh M, 2006, AM J NEURORADIOL, V27, P1101; SCHLAUG G, 1995, NEUROPSYCHOLOGIA, V33, P1047, DOI 10.1016/0028-3932(95)00045-5; SCHLAUG G, 1995, SCIENCE, V267, P699, DOI 10.1126/science.7839149; Schmidt-Wilcke T, 2009, NEUROIMAGE, V47, P1914, DOI 10.1016/j.neuroimage.2009.04.092; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; SCHOENFELD AH, 1982, J EXP PSYCHOL LEARN, V8, P484, DOI 10.1037/0278-7393.8.5.484; Seung Y, 2005, NEUROSCI RES, V52, P323, DOI 10.1016/j.neures.2005.04.011; Skinner EI, 2007, NEUROPSYCHOLOGIA, V45, P2163, DOI 10.1016/j.neuropsychologia.2007.03.007; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Tervaniemi M, 2009, ANN NY ACAD SCI, V1169, P151, DOI 10.1111/j.1749-6632.2009.04591.x; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; Van Laere KJ, 2001, RADIOLOGY, V221, P810, DOI 10.1148/radiol.2213010295; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; VILLAIN V, 2010, J NEUROIMAGING, DOI DOI 10.1111/J.1552-6569.2010.00470.X; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Westmacott R, 2004, NEUROPSYCHOLOGIA, V42, P25, DOI 10.1016/S0028-3932(03)00147-7; Whitwell JL, 2009, J NEUROSCI, V29, P9661, DOI 10.1523/JNEUROSCI.2160-09.2009; Wiltgen BJ, 2004, NEURON, V44, P101, DOI 10.1016/j.neuron.2004.09.015; Zatorre RJ, 1998, P NATL ACAD SCI USA, V95, P3172, DOI 10.1073/pnas.95.6.3172	61	83	87	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13225	10.1371/journal.pone.0013225	http://dx.doi.org/10.1371/journal.pone.0013225			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	658RC	20957158	Green Submitted, Green Published, gold			2022-12-27	WOS:000282506100017
J	Arankalle, VA; Lole, KS; Arya, RP; Tripathy, AS; Ramdasi, AY; Chadha, MS; Sangle, SA; Kadam, DB				Arankalle, Vidya A.; Lole, Kavita S.; Arya, Ravi P.; Tripathy, Anuradha S.; Ramdasi, Ashwini Y.; Chadha, Mandeep S.; Sangle, Shashi A.; Kadam, Deelip B.			Role of Host Immune Response and Viral Load in the Differential Outcome of Pandemic H1N1 (2009) Influenza Virus Infection in Indian Patients	PLOS ONE			English	Article							EXPRESSION; INNATE; IL-10	Background: An unusually high number of severe pneumonia cases with considerable mortality is being observed with the pandemic H1N1 2009 virus infections globally. In India, all mild as well as critically ill cases were admitted and treated in the government hospitals during the initial phase of the pandemic. The present study was undertaken during this early phase of the pandemic. Methodology: The role of viral load and host factors in the pathogenesis were assessed by examining 26 mild (MP), 15 critically ill patients (CIP) and 20 healthy controls from Pune, India. Sequential blood and lung aspirate samples were collected from CIP. Viral load and cytokines/chemokine levels were determined from the plasma and lung aspirates of the patients. TLR levels were determined by staining and FACS analysis. Gene profiling was done for both cells in the lung aspirates and PBMCs using TaqMan Low Density arrays. Antibody titres and isotyping was done using HA protein based ELISAs. Principal Findings: 13/15 critically ill patients expired. All plasma samples were negative for the virus irrespective of the patient's category. Sequential lung samples from CIP showed lower viral loads questioning association of viral replication with the severity. Anti-rpH1N1-09-HA-IgG titres were significantly higher in critically ill patients and both categories circulated exclusively IgG1 isotype. Critically ill patients exhibited increase in TLR-3, 4, 7 and decrease in TLR-2 expressions. The disease severity correlated with increased plasma levels of IL1RA, IL2, IL6, CCL3, CCL4 and IL10. Majority of the immune-function genes were down-regulated in the PBMCs and up-regulated in the cells from lung aspirates of critically ill patients. No distinct pattern differentiating fatal and surviving patients was observed when sequential samples were examined for various parameters. Conclusions: Disease severity was associated with pronounced impairment of host immune response.	[Arankalle, Vidya A.; Lole, Kavita S.; Arya, Ravi P.; Tripathy, Anuradha S.; Ramdasi, Ashwini Y.; Chadha, Mandeep S.] Natl Inst Virol, Pune, Maharashtra, India; [Sangle, Shashi A.; Kadam, Deelip B.] Sassoon Gen Hosp, Pune, Maharashtra, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Virology (NIV)	Arankalle, VA (corresponding author), Natl Inst Virol, Pune, Maharashtra, India.	varankalle@yahoo.com	ARYA, RAVI/F-7684-2015; ARYA, RAVI/AAF-4108-2020	ARYA, RAVI/0000-0001-9255-610X; ARYA, RAVI/0000-0001-9255-610X; Arankalle, Vidya/0000-0002-9940-3437	Indian Council of Medical Research	Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by the Indian Council of Medical Research, www.icmr.org.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARANKALLE VA, 2010, CLIN VACCINE IM 0714; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Bermejo-Martin JF, 2009, CRIT CARE, V13, DOI 10.1186/cc8208; Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07; Centers for Disease Control and Prevention, 2009, MMWR-MORBID MORTAL W, V58, P431; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Deng R, 2008, J PATHOL, V216, P328, DOI 10.1002/path.2417; Deshmukh TM, 2007, VACCINE, V25, P4350, DOI 10.1016/j.vaccine.2007.03.040; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; KATZE MG, 1984, MOL CELL BIOL, V4, P2198, DOI 10.1128/MCB.4.10.2198; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2007, NATURE, V445, P319, DOI 10.1038/nature05495; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Osterlund P, 2010, J VIROL, V84, P1414, DOI 10.1128/JVI.01619-09; Potdar VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009693; QIU Y, 1994, J VIROL, V68, P2425, DOI 10.1128/JVI.68.4.2425-2432.1994; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Steensberg A, 2003, AM J PHYSIOL-ENDOC M, V285, pE433, DOI 10.1152/ajpendo.00074.2003; To KKW, 2010, CLIN INFECT DIS, V50, P850, DOI 10.1086/650581; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; Woo PCY, 2010, J INFECT DIS, V201, P346, DOI 10.1086/649785	27	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13099	10.1371/journal.pone.0013099	http://dx.doi.org/10.1371/journal.pone.0013099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957032	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300007
J	Burke, SP; Smith, JB				Burke, Stephen P.; Smith, Jeffrey B.			Monomerization of Cytosolic Mature Smac Attenuates Interaction with IAPs and Potentiation of Caspase Activation	PLOS ONE			English	Article							X-LINKED INHIBITOR; UBIQUITIN-PROTEIN LIGASE; STRUCTURAL BASIS; APOPTOSIS; SMAC/DIABLO; DEGRADATION; PROMOTES; BINDING; XIAP; REAPER	The four residues at the amino-terminus of mature Smac/DIABLO are an IAP binding motif (IBM). Upon exit from mitochondria, mature Smac interacts with inhibitor of apoptosis proteins (IAPs), abrogating caspase inhibition. We used the ubiquitin fusion model to express mature Smac in the cytosol. Transiently expressed mature Smac56-239 (called Smac56) and Smac60-239 (called Smac60), which lacks the IBM, interacted with X-linked inhibitor of apoptosis protein (XIAP). However, stable expression produced wild type Smac56 that failed to homodimerize, interact with XIAP, and potentiate caspase activation. Cytosolic Smac60 retained these functions. Cytosolic Smac56 apparently becomes posttranslationally modified at the dimer interface region, which obliterated the epitope for a monoclonal antibody. Cytosolic Smac delta, which has the IBM but lacks amino acids 62-105, homodimerized and weakly interacted with XIAP, but failed to potentiate apoptosis. These findings suggest that the IBM of Smac is a recognition point for a posttranslational modification(s) that blocks homodimerization and IAP interaction, and that amino acids 62-105 are required for the proapoptotic function of Smac.	[Burke, Stephen P.; Smith, Jeffrey B.] Univ Alabama Birmingham, Sch Med & Dent, Dept Pharmacol & Toxicol, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham	Burke, SP (corresponding author), Univ Alabama Birmingham, Sch Med & Dent, Dept Pharmacol & Toxicol, Birmingham, AL USA.	jeff.smith@ccc.uab.edu		Burke, Stephen/0000-0002-8489-6953	National Institutes of Health [GM60383]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060383] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant GM60383 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Burke SP, 2010, J BIOL CHEM, V285, P30061, DOI 10.1074/jbc.M110.125955; Burri L, 2005, MOL BIOL CELL, V16, P2926, DOI 10.1091/mbc.E04-12-1086; Chai JJ, 2000, NATURE, V406, P855, DOI 10.1038/35022514; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Claveria C, 2002, EMBO J, V21, P3327, DOI 10.1093/emboj/cdf354; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Eckelman BP, 2008, CELL DEATH DIFFER, V15, P920, DOI 10.1038/cdd.2008.6; Fallaux FJ, 1996, HUM GENE THER, V7, P215, DOI 10.1089/hum.1996.7.2-215; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Goncalves RB, 2008, BIOCHEMISTRY-US, V47, P3832, DOI 10.1021/bi702248n; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Holley CL, 2002, NAT CELL BIOL, V4, P439, DOI 10.1038/ncb798; Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200; Huang HK, 2000, J BIOL CHEM, V275, P26661; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Hunter AM, 2003, J BIOL CHEM, V278, P7494, DOI 10.1074/jbc.C200695200; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Liu ZH, 2000, NATURE, V408, P1004, DOI 10.1038/35050006; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Olson MR, 2003, J BIOL CHEM, V278, P44758, DOI 10.1074/jbc.M308055200; Park BD, 2007, BIOCHEM BIOPH RES CO, V361, P994, DOI 10.1016/j.bbrc.2007.07.121; Pop C, 2009, J BIOL CHEM, V284, P21777, DOI 10.1074/jbc.R800084200; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Roberts DL, 2001, J CELL BIOL, V153, P221, DOI 10.1083/jcb.153.1.221; Sambrook J., 2001, MOL CLONING LAB MANU; Shin H, 2003, BIOCHEM J, V373, P965, DOI 10.1042/BJ20030583; Silke J, 2004, J BIOL CHEM, V279, P4313, DOI 10.1074/jbc.M305661200; Srinivasula SM, 2000, J BIOL CHEM, V275, P36152, DOI 10.1074/jbc.C000533200; Srinivasula SM, 2001, NATURE, V410, P112, DOI 10.1038/35065125; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012; Yang QH, 2004, J BIOL CHEM, V279, P16963, DOI 10.1074/jbc.M401253200; Yang Y, 2000, SCIENCE, V288, P874, DOI 10.1126/science.288.5467.874	44	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13094	10.1371/journal.pone.0013094	http://dx.doi.org/10.1371/journal.pone.0013094			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957035	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300005
J	Sinnett, S; Kingstone, A				Sinnett, Scott; Kingstone, Alan			A Preliminary Investigation Regarding the Effect of Tennis Grunting: Does White Noise During a Tennis Shot Have a Negative Impact on Shot Perception?	PLOS ONE			English	Article							ATTENTION; ENHANCEMENT; INTENSITY; BRAIN	Background: There is a growing chorus of critics who complain that many of the top-ranked professional tennis players who grunt when they hit the ball gain an unfair advantage because the sound of the grunt interferes with their opponent's game. However, there is no scientific evidence to support this claim. Methodology/Principal Findings: We explored this potential detrimental effect of grunting by presenting videos of a tennis player hitting a ball to either side of a tennis court; the shot either did, or did not, contain a brief sound that occurred at the same time as contact. The participants' task was to respond as quickly as possible, indicating whether the ball was being hit to the left-or right-side of the court. The results were unequivocal: The presence of an extraneous sound interfered with a participants' performance, making their responses both slower and less accurate. Conclusions/Significance: Our data suggest that a grunting player has a competitive edge on the professional tennis tour. The mechanism that underlies this effect is a topic for future investigation. Viable alternatives are discussed. For example, the possibility that the interfering auditory stimulus masks the sound of the ball being struck by the racket or it distracts an opponent's attention away from the sound of the ball.	[Sinnett, Scott] Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA; [Kingstone, Alan] Univ British Columbia, Dept Psychol, Vancouver, BC V5Z 1M9, Canada	University of Hawaii System; University of Hawaii Manoa; University of British Columbia	Sinnett, S (corresponding author), Univ Hawaii Manoa, Dept Psychol, Honolulu, HI 96822 USA.	ssinnett@hawaii.edu			Natural Sciences and Engineering Research Council of Canada (NSERC) [12R80338]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grant (12R80338) to AK's lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belopolsky AV, 2009, PSYCHOL SCI, V20, P1340, DOI 10.1111/j.1467-9280.2009.02445.x; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Calvert GA, 2004, J PHYSIOL-PARIS, V98, P191, DOI 10.1016/j.jphysparis.2004.03.018; DONALDSON RH, 2009, GRUNTING CRITICS GRO; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; EMBERSON LL, 2010, PSYCHOL SCI IN PRESS; Fernandez J, 2006, BRIT J SPORT MED, V40, P387, DOI 10.1136/bjsm.2005.023168; FLATMAN B, 2009, ONE MORE GRUNT YOURE; *ITF, INT TENN FED ITF RUL; Magnus J. R., 1999, STATISTICIAN, V58, P247; Miller S, 2006, BRIT J SPORT MED, V40, P401, DOI 10.1136/bjsm.2005.023283; NAVRATILOVA M, 2009, M NAVRATILOVA GRUNTI; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Sekuler R, 1997, NATURE, V385, P308, DOI 10.1038/385308a0; Shelton JT, 2009, J ENVIRON PSYCHOL, V29, P513, DOI 10.1016/j.jenvp.2009.03.001; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Strayer DL, 2003, J EXP PSYCHOL-APPL, V9, P23, DOI 10.1037/1076-898X.9.1.23	17	17	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13148	10.1371/journal.pone.0013148	http://dx.doi.org/10.1371/journal.pone.0013148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656TI	20957210	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300032
J	Smejkalova, H; Erb, TJ; Fuchs, G				Smejkalova, Hana; Erb, Tobias J.; Fuchs, Georg			Methanol Assimilation in Methylobacterium extorquens AM1: Demonstration of All Enzymes and Their Regulation	PLOS ONE			English	Article							MALYL-COENZYME-A; BETA-HYDROXYBUTYRATE BIOSYNTHESIS; METABOLIC-CONTROL ANALYSIS; ETHYLMALONYL-COA PATHWAY; MALATE SYNTHASE ACTIVITY; PSEUDOMONAS AM1; C1 COMPOUNDS; MICROBIAL-METABOLISM; METHYLOTROPHIC METABOLISM; RHODOBACTER-SPHAEROIDES	Background: Methylobacterium extorquens AM1 is an aerobic facultative methylotrophic alpha-proteobacterium that can use reduced one-carbon compounds such as methanol, but also multi-carbon substrates like acetate (C(2)) or succinate (C(4)) as sole carbon and energy source. The organism has gained interest as future biotechnological production platform based on methanol as feedstock. Methodology/Principal Findings: We present a comprehensive study of all postulated enzymes for the assimilation of methanol and their regulation in response to the carbon source. Formaldehyde, which is derived from methanol oxidation, is assimilated via the serine cycle, which starts with glyoxylate and forms acetyl-CoA. Acetyl-CoA is assimilated via the proposed ethylmalonyl-CoA pathway, which thereby regenerates glyoxylate. To further the understanding of the central carbon metabolism we identified and quantified all enzymes of the pathways involved in methanol assimilation. We observed a strict differential regulation of their activity level depending on whether C(1), C(2) or C(4) compounds are used. The enzymes, which are specifically required for the utilization of the individual substrates, were several-fold up-regulated and those not required were down-regulated. The enzymes of the ethylmalonyl-CoA pathway showed specific activities, which were higher than the calculated minimal values that can account for the observed growth rate. Yet, some enzymes of the serine cycle, notably its first and last enzymes serine hydroxymethyl transferase and malate thiokinase, exhibit much lower values and probably are rate limiting during methylotrophic growth. We identified the natural C(1) carrying coenzyme as tetrahydropteroyl-tetraglutamate rather than tetrahydrofolate. Conclusion/Significance: This study provides the first complete picture of the enzymes required for methanol assimilation, the regulation of their activity levels in response to the growth substrate, and the identification of potential growth limiting steps.	[Smejkalova, Hana; Erb, Tobias J.; Fuchs, Georg] Univ Freiburg, Fak Biol, Freiburg, Germany	University of Freiburg	Smejkalova, H (corresponding author), Univ Freiburg, Fak Biol, Freiburg, Germany.	georg.fuchs@biologie.uni-freiburg.de	Erb, Tobias/J-5214-2013	Erb, Tobias/0000-0003-3685-0894	Evonik-Degussa GmbH	Evonik-Degussa GmbH	This work was supported by Evonik-Degussa GmbH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abanda-Nkpwatt D, 2006, J EXP BOT, V57, P4025, DOI 10.1093/jxb/erl173; Alber BE, 2006, MOL MICROBIOL, V61, P297, DOI 10.1111/j.1365-2958.2006.05238.x; ANTHONY C, 1964, BIOCHEM J, V92, P614, DOI 10.1042/bj0920614; Anthony C., 1982, BIOCH METHYLOTROPHS; ARPS PJ, 1993, J BACTERIOL, V175, P3776, DOI 10.1128/JB.175.12.3776-3783.1993; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cascante M, 2002, NAT BIOTECHNOL, V20, P243, DOI 10.1038/nbt0302-243; Chistoserdova L, 2009, ANNU REV MICROBIOL, V63, P477, DOI 10.1146/annurev.micro.091208.073600; CHISTOSERDOVA LV, 1991, J BACTERIOL, V173, P7228, DOI 10.1128/jb.173.22.7228-7232.1991; CHISTOSERDOVA LV, 1994, J BACTERIOL, V176, P6759, DOI 10.1128/JB.176.21.6759-6762.1994; Chou HH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000652; COX RB, 1976, J GEN MICROBIOL, V95, P121, DOI 10.1099/00221287-95-1-121; Crosby HA, 2010, MOL MICROBIOL, V76, P874, DOI 10.1111/j.1365-2958.2010.07127.x; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; Dawson R. M. C., 1986, DATA BIOCH RES, V3rd; Delmotte N, 2009, P NATL ACAD SCI USA, V106, P16428, DOI 10.1073/pnas.0905240106; DUNSTAN PM, 1973, BIOCHEM J, V132, P797, DOI 10.1042/bj1320797; DUNSTAN PM, 1972, BIOCHEM J, V128, P99, DOI 10.1042/bj1280099; DUNSTAN PM, 1972, BIOCHEM J, V128, P107, DOI 10.1042/bj1280107; Erb TJ, 2009, THESIS A LUDWIGS U F; Erb TJ, 2008, J BIOL CHEM, V283, P32283, DOI 10.1074/jbc.M805527200; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; ESCALANTESEMERENA JC, 1984, J BIOL CHEM, V259, P9447; Garratt LC, 2005, RAPID COMMUN MASS SP, V19, P2390, DOI 10.1002/rcm.2074; Glykys DJ, 2009, BIOTECHNOL BIOENG, V102, P1624, DOI 10.1002/bit.22199; GOODWIN PM, 1990, METHOD ENZYMOL, V188, P361; Gourion B, 2006, P NATL ACAD SCI USA, V103, P13186, DOI 10.1073/pnas.0603530103; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; HACKING AJ, 1990, METHOD ENZYMOL, V188, P379; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; Hatzimanikatis V, 1996, J THEOR BIOL, V182, P233, DOI 10.1006/jtbi.1996.0160; HEPTINST.J, 1970, BIOCHEM J, V117, P563, DOI 10.1042/bj1170563; HILL B, 1974, J GEN MICROBIOL, V83, P187, DOI 10.1099/00221287-83-1-187; HUENNEKENS FM, 1963, METHOD ENZYMOL, V6, P802, DOI 10.1016/0076-6879(63)06253-4; Kiefer P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007831; Kirstine WV, 2004, J AIR WASTE MANAGE, V54, P1299, DOI 10.1080/10473289.2004.10470990; KISLIUK RL, 1981, MOL CELL BIOCHEM, V39, P331, DOI 10.1007/BF00232583; Korotkova N, 2004, J BIOL CHEM, V279, P13652, DOI 10.1074/jbc.M312852200; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Korotkova N, 2001, J BACTERIOL, V183, P1038, DOI 10.1128/JB.183.3.1038-1046.2001; KREMA C, 1990, METHOD ENZYMOL, V188, P373; LARGE PJ, 1963, BIOCHEM J, V87, P386, DOI 10.1042/bj0870386; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Lee MC, 2009, EVOLUTION, V63, P2816, DOI 10.1111/j.1558-5646.2009.00757.x; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Lengeler J. W., 1999, BIOL PROKARYOTES; Madhaiyan M, 2004, BOT BULL ACAD SINICA, V45, P315; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; MCGUIRE JJ, 1981, MOL CELL BIOCHEM, V38, P19, DOI 10.1007/BF00235686; MCNERNEY T, 1980, APPL ENVIRON MICROB, V40, P370, DOI 10.1128/AEM.40.2.370-375.1980; Moreno-Sanchez R, 2008, J BIOMED BIOTECHNOL, DOI 10.1155/2008/597913; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Okubo Y, 2010, J BACTERIOL, V192, P1813, DOI 10.1128/JB.01166-09; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Sage RF, 2002, J EXP BOT, V53, P609, DOI 10.1093/jexbot/53.369.609; SALEM AR, 1973, BIOCHEM J, V136, P89, DOI 10.1042/bj1360089; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Schuster S, 1999, METAB ENG, V1, P232, DOI 10.1006/mben.1999.0119; SIMON EJ, 1953, J AM CHEM SOC, V75, P2520, DOI 10.1021/ja01106a522; Smith LM, 1996, MICROBIOL-UK, V142, P675, DOI 10.1099/13500872-142-3-675; STADTMAN ER, 1957, METHOD ENZYMOL, V3, P931, DOI 10.1016/S0076-6879(57)03481-3; Sy A, 2005, APPL ENVIRON MICROB, V71, P7245, DOI 10.1128/AEM.71.11.7245-7252.2005; TAYLOR IJ, 1976, J GEN MICROBIOL, V95, P134, DOI 10.1099/00221287-95-1-134; Thomas AH, 2000, J PHOTOCH PHOTOBIO A, V135, P147, DOI 10.1016/S1010-6030(00)00304-X; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vorholt JA, 2002, ARCH MICROBIOL, V178, P239, DOI 10.1007/s00203-002-0450-2; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Williams P, 2006, J MOL BIOL, V357, P151, DOI 10.1016/j.jmb.2005.12.055; WILLIBALD B, 1995, ANAL BIOCHEM, V227, P363, DOI 10.1006/abio.1995.1292; Zarzycki J, 2008, J BACTERIOL, V190, P1366, DOI 10.1128/JB.01621-07	77	81	86	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13001	10.1371/journal.pone.0013001	http://dx.doi.org/10.1371/journal.pone.0013001			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957036	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300002
J	Yu, XB; Hartmann, M; Wang, QA; Poetz, O; Schneiderhan-Marra, N; Stoll, D; Kazmaier, C; Joos, TO				Yu, Xiaobo; Hartmann, Michael; Wang, Quan; Poetz, Oliver; Schneiderhan-Marra, Nicole; Stoll, Dieter; Kazmaier, Cornelia; Joos, Thomas O.			mu FBI: A Microfluidic Bead-Based Immunoassay for Multiplexed Detection of Proteins from a mu L Sample Volume	PLOS ONE			English	Article							BREAST-CANCER; MICROARRAY ANALYSIS; IMMUNOAFFINITY CE; PHOSPHORYLATION; BIOPSIES; ARRAYS; CELLS; TECHNOLOGY; ACTIVATION; PREDICTION	Background: Over the last ten years, miniaturized multiplexed immunoassays have become robust, reliable research tools that enable researchers to simultaneously determine a multitude of parameters. Among the numerous analytical protein arrays available, bead-based assay systems have evolved into a key technology that enables the quantitative protein profiling of biological samples whilst requiring only a minimal amount of sample material. Methodology/Principal Findings: A microfluidic bead-based immunoassay, mu FBI, was developed to perform bead-based multiplexed sandwich immunoassays in a capillary. This setup allows the simultaneous detection of several parameters and only requires 200 ng of tissue lysate in a 1 mu L assay volume. In addition, only 1 mu L of detection antibodies and 1 mu L of the reporter molecule Streptavidin-Phycoerythrin were required. The mu FBI was used to compare the expression of seven receptor tyrosine kinases and their degree of tyrosine phosphorylation in breast cancer tissue and in normal tissue lysates. The total amount of HER-2, as well the degree of tyrosine phosphorylation was much higher in breast cancer tissue than in normal tissue. mu FBI and a standard bead-based assay led to identical protein expression data. Moreover, it was possible to reduce the quantity of sample material required by a factor of 100 and the quantity of reagents by a factor of 30. Conclusions/Significance: The mu FBI, microfluidic bead-based immunoassay, allows the analysis of multiple parameters from a very small amount of sample material, such as tumor biopsies or tissue sections.	[Yu, Xiaobo; Hartmann, Michael; Wang, Quan; Poetz, Oliver; Schneiderhan-Marra, Nicole; Stoll, Dieter; Kazmaier, Cornelia; Joos, Thomas O.] Univ Tubingen, Nat & Med Sci Inst NMI, Reutlingen, Germany; [Hartmann, Michael] Royal Inst Technol, Dept Analyt Chem, Sch Chem Sci & Engn, S-10044 Stockholm, Sweden; [Stoll, Dieter] Hsch Albstadt Sigmaringen, Sigmaringen, Germany; [Joos, Thomas O.] Expt & Diagnost Immunol EDI GmbH, Reutlingen, Germany	Eberhard Karls University of Tubingen; Royal Institute of Technology	Yu, XB (corresponding author), Univ Tubingen, Nat & Med Sci Inst NMI, Reutlingen, Germany.	joos@nmi.de	Yu, Xiaobo/F-5997-2015		Alexander von Humboldt Foundation, Germany [1126997]	Alexander von Humboldt Foundation, Germany(Alexander von Humboldt Foundation)	XY is supported by a Humboldt research fellowship (Alexander von Humboldt Foundation, Germany, fellowship ID: 1126997). No additional current external funding sources were used for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2009, GENOME MED, V1, DOI 10.1186/gm68; Bainer R, 2003, J MICROBIOL METH, V55, P315, DOI 10.1016/S0167-7012(03)00112-X; Baselga J, 2009, NAT REV CANCER, V9, P463, DOI 10.1038/nrc2656; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903; Frogne T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2230; Hsu HY, 2008, MED ENG PHYS, V30, P976, DOI 10.1016/j.medengphy.2008.01.003; Hu LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-16; Huang RP, 2007, EXPERT REV PROTEOMIC, V4, P299, DOI 10.1586/14789450.4.2.299; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joos Thomas O, 2007, Expert Rev Proteomics, V4, P347, DOI 10.1586/14789450.4.3.347; Kim JS, 2009, ANAL CHEM, V81, P5426, DOI 10.1021/ac9005827; Knickerbocker T, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100167; Korf U, 2009, PROTEOM CLIN APPL, V3, P1140, DOI 10.1002/prca.200780035; Kricka LJ, 2006, ANN CLIN BIOCHEM, V43, P457, DOI 10.1258/000456306778904731; KULASINGAM V, 2007, NATURE CLIN PRACTICE, P588; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Paczesny S, 2009, BLOOD, V113, P273, DOI 10.1182/blood-2008-07-167098; Pantel K, 2008, NAT REV CANCER, V8, P329, DOI 10.1038/nrc2375; Phillips TM, 2007, ELECTROPHORESIS, V28, P3041, DOI 10.1002/elps.200700193; Phillips TM, 2009, ELECTROPHORESIS, V30, P2307, DOI 10.1002/elps.200900095; Phillips TM, 2004, ELECTROPHORESIS, V25, P1652, DOI 10.1002/elps.200305873; Qiu J, 2009, CLIN LAB MED, V29, P31, DOI 10.1016/j.cll.2009.01.002; Ramachandran N, 2008, NAT METHODS, V5, P535, DOI 10.1038/NMETH.1210; Sauer G, 2008, CLIN CANCER RES, V14, P3345, DOI 10.1158/1078-0432.CCR-07-4802; Schwenk JM, 2007, MOL CELL PROTEOMICS, V6, P125, DOI 10.1074/mcp.T600035-MCP200; Templin MF, 2004, COMB CHEM HIGH T SCR, V7, P223; Thor AD, 2000, J CLIN ONCOL, V18, P3230, DOI 10.1200/JCO.2000.18.18.3230; VanMeter AJ, 2008, MOL CELL PROTEOMICS, V7, P1902, DOI 10.1074/mcp.M800204-MCP200; Wingren C, 2008, CURR OPIN BIOTECH, V19, P55, DOI 10.1016/j.copbio.2007.11.010; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127; Yu XB, 2010, CLIN CHEM, V56, P376, DOI 10.1373/clinchem.2009.137158; Yu XB, 2009, METHODS MOL BIOL, V577, P199, DOI 10.1007/978-1-60761-232-2_15; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	35	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13125	10.1371/journal.pone.0013125	http://dx.doi.org/10.1371/journal.pone.0013125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957050	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300019
J	Reiner, CL; McCullar, JS; Kow, RL; Le, JH; Goodlett, DR; Nathanson, NM				Reiner, Cindy L.; McCullar, Jennifer S.; Kow, Rebecca L.; Le, Joshua H.; Goodlett, David R.; Nathanson, Neil M.			RACK1 Associates with Muscarinic Receptors and Regulates M-2 Receptor Trafficking	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ACETYLCHOLINE-RECEPTOR; MASS-SPECTROMETRY; BETA-ARRESTIN; CELL-SURFACE; LIPID RAFTS; INTERNALIZATION; ENDOCYTOSIS; KINASE; SEQUESTRATION	Receptor internalization from the cell surface occurs through several mechanisms. Some of these mechanisms, such as clathrin coated pits, are well understood. The M-2 muscarinic acetylcholine receptor undergoes internalization via a poorly-defined clathrin-independent mechanism. We used isotope coded affinity tagging and mass spectrometry to identify the scaffolding protein, receptor for activated C kinase (RACK1) as a protein enriched in M-2-immunoprecipitates from M-2-expressing cells over those of non-M-2 expressing cells. Treatment of cells with the agonist carbachol disrupted the interaction of RACK1 with M-2. We further found that RACK1 overexpression inhibits the internalization and subsequent down regulation of the M-2 receptor in a receptor subtype-specific manner. Decreased RACK1 expression increases the rate of agonist internalization of the M-2 receptor, but decreases the extent of subsequent down-regulation. These results suggest that RACK1 may both interfere with agonist-induced sequestration and be required for subsequent targeting of internalized M-2 receptors to the degradative pathway.	[Reiner, Cindy L.; McCullar, Jennifer S.; Kow, Rebecca L.; Le, Joshua H.; Nathanson, Neil M.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Goodlett, David R.] Inst Syst Biol, Seattle, WA USA	University of Washington; University of Washington Seattle; Institute for Systems Biology (ISB)	Reiner, CL (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	nathanso@u.washington.edu		Nathanson, Neil/0000-0002-9216-121X	American Heart Association; National Institutes of Health [P01-HL44948, T32 GM 07727, R01-ES015594]; National Heart, Lung, and Blood Institute Seattle Proteome Center [N01-HV-8179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015594] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute Seattle Proteome Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a Grant-in-Aid from the American Heart Association, and by the National Institutes of Health, under grants P01-HL44948, T32 GM 07727 and R01-ES015594, and in part with Federal funds from the National Heart, Lung, and Blood Institute Seattle Proteome Center (contract No. N01-HV-8179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Claing A, 2002, PROG NEUROBIOL, V66, P61, DOI 10.1016/S0301-0082(01)00023-5; Delaney KA, 2002, J BIOL CHEM, V277, P33439, DOI 10.1074/jbc.M205293200; Dell EJ, 2002, J BIOL CHEM, V277, P49888, DOI 10.1074/jbc.M202755200; GOLDMAN PS, 1994, J BIOL CHEM, V269, P15640; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Jones Kymry T, 2006, J Mol Signal, V1, P7, DOI 10.1186/1750-2187-1-7; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Min L, 2002, J BIOL CHEM, V277, P702, DOI 10.1074/jbc.M106082200; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nikolov EN, 2004, J BIOL CHEM, V279, P23630, DOI 10.1074/jbc.M312861200; PalsRylaarsdam R, 1997, J BIOL CHEM, V272, P14152, DOI 10.1074/jbc.272.22.14152; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Reiner C, 2008, LIFE SCI, V82, P718, DOI 10.1016/j.lfs.2008.01.013; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Roseberry AG, 2001, MOL PHARMACOL, V59, P1256, DOI 10.1124/mol.59.5.1256; Roseberry AG, 2001, J CELL SCI, V114, P739; Sambrook J., 2002, MOL CLONING LAB MANU; Schlador ML, 2000, J BIOL CHEM, V275, P23295, DOI 10.1074/jbc.M002380200; Schlador ML, 1997, J BIOL CHEM, V272, P18882, DOI 10.1074/jbc.272.30.18882; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; van Koppen CJ, 2001, BIOCHEM SOC T, V29, P505, DOI 10.1042/BST0290505; Vogler O, 1998, J BIOL CHEM, V273, P12155, DOI 10.1074/jbc.273.20.12155; von Zastrow M, 2003, LIFE SCI, V74, P217, DOI 10.1016/j.lfs.2003.09.008; Wang W, 2002, INT J BIOCHEM CELL B, V34, P93, DOI 10.1016/S1357-2725(01)00094-2; Yaka R, 2003, J NEUROSCI, V23, P3623; Yaka R, 2002, P NATL ACAD SCI USA, V99, P5710, DOI 10.1073/pnas.062046299; Yi EC, 2003, RAPID COMMUN MASS SP, V17, P2093, DOI 10.1002/rcm.1150; Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512	34	10	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13517	10.1371/journal.pone.0013517	http://dx.doi.org/10.1371/journal.pone.0013517			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976005	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400021
J	Abu-Khudir, R; Paquette, J; Lefort, A; Libert, F; Chanoine, JP; Vassart, G; Deladoey, J				Abu-Khudir, Rasha; Paquette, Jean; Lefort, Anne; Libert, Frederick; Chanoine, Jean-Pierre; Vassart, Gilbert; Deladoey, Johnny			Transcriptome, Methylome and Genomic Variations Analysis of Ectopic Thyroid Glands	PLOS ONE			English	Article							CONGENITAL HYPOTHYROIDISM; GENE-EXPRESSION; MOLECULAR-MECHANISMS; DYSGENESIS; CATENIN; REGULATORS; DYSPHAGIA; DISEASE; CELLS	Background: Congenital hypothyroidism from thyroid dysgenesis (CHTD) is predominantly a sporadic disease characterized by defects in the differentiation, migration or growth of thyroid tissue. Of these defects, incomplete migration resulting in ectopic thyroid tissue is the most common (up to 80%). Germinal mutations in the thyroid-related transcription factors NKX2.1, FOXE1, PAX-8, and NKX2.5 have been identified in only 3% of patients with sporadic CHTD. Moreover, a survey of monozygotic twins yielded a discordance rate of 92%, suggesting that somatic events, genetic or epigenetic, probably play an important role in the etiology of CHTD. Methodology/Principal Findings: To assess the role of somatic genetic or epigenetic processes in CHTD, we analyzed gene expression, genome-wide methylation, and structural genome variations in normal versus ectopic thyroid tissue. In total, 1011 genes were more than two-fold induced or repressed. Expression array was validated by quantitative real-time RT-PCR for 100 genes. After correction for differences in thyroid activation state, 19 genes were exclusively associated with thyroid ectopy, among which genes involved in embryonic development (e. g. TXNIP) and in the Wnt pathway (e. g. SFRP2 and FRZB) were observed. None of the thyroid related transcription factors (FOXE1, HHEX, NKX2.1, NKX2.5) showed decreased expression, whereas PAX8 expression was associated with thyroid activation state. Finally, the expression profile was independent of promoter and CpG island methylation and of structural genome variations. Conclusions/Significance: This is the first integrative molecular analysis of ectopic thyroid tissue. Ectopic thyroids show a differential gene expression compared to that of normal thyroids, although molecular basis could not be defined. Replication of this pilot study on a larger cohort could lead to unraveling the elusive cause of defective thyroid migration during embryogenesis.	[Abu-Khudir, Rasha; Paquette, Jean; Deladoey, Johnny] Univ Montreal, Dept Pediat, CHU St Justine, Serv Endocrinol, Montreal, PQ H3C 3J7, Canada; [Abu-Khudir, Rasha; Paquette, Jean; Deladoey, Johnny] Univ Montreal, Res Ctr, CHU St Justine, Montreal, PQ, Canada; [Abu-Khudir, Rasha; Deladoey, Johnny] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Lefort, Anne; Libert, Frederick; Vassart, Gilbert] Free Univ Brussels ULB, IRIBHM, Brussels, Belgium; [Chanoine, Jean-Pierre] Univ British Columbia, Dept Pediat, BC Childrens Hosp, Endocrinol & Diabet Unit, Vancouver, BC V6T 1W5, Canada	Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Universite Libre de Bruxelles; BC Childrens Hospital; University of British Columbia	Abu-Khudir, R (corresponding author), Univ Montreal, Dept Pediat, CHU St Justine, Serv Endocrinol, Montreal, PQ H3C 3J7, Canada.	johnny.deladoey@umontreal.ca	Deladoey, Johnny/S-4006-2019; Deladoey, Johnny/F-1438-2011; Abu Khudir, Rasha/GQZ-3359-2022; Abu-Khudir, Rasha/GQZ-3415-2022	Deladoey, Johnny/0000-0002-2060-1730; Deladoey, Johnny/0000-0002-2060-1730; Abu-Khudir, Rasha/0000-0002-1300-3150; Chanoine, Jean-Pierre/0000-0002-5167-2064	Egyptian Ministry of Higher Education; University of Montreal; Fonds de Recherche en Sante du Quebec (FRSQ); Canadian Child Health Clinician Scientist Program (CCHCSP); Belgian Fonds de la Recherche Scientifique Medicale (FRSM); Fonds ERASME	Egyptian Ministry of Higher Education(Science and Technology Development Fund (STDF)); University of Montreal; Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Child Health Clinician Scientist Program (CCHCSP); Belgian Fonds de la Recherche Scientifique Medicale (FRSM)(Fonds de la Recherche Scientifique - FNRS); Fonds ERASME	This work was supported by a joint scholarship from the Egyptian Ministry of Higher Education and University of Montreal (to R. A. K.); by a research junior 1 scholarship of the Fonds de Recherche en Sante du Quebec (FRSQ) and by a fellowship from the Canadian Child Health Clinician Scientist Program (CCHCSP) (to J.D.); by the Belgian Fonds de la Recherche Scientifique Medicale (FRSM) and Fonds ERASME (to F. L. and G. V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AS, 2006, NAT GENET, V38, P421, DOI 10.1038/ng1752; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bruno R, 2005, J CLIN ENDOCR METAB, V90, P5692, DOI 10.1210/jc.2005-0800; Castanet M, 2005, EUR J HUM GENET, V13, P232, DOI 10.1038/sj.ejhg.5201321; Castanet M, 2001, J CLIN ENDOCR METAB, V86, P2009, DOI 10.1210/jc.86.5.2009; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; Deladoey J, 2007, J CLIN ENDOCR METAB, V92, P3158, DOI 10.1210/jc.2007-0527; Deladoey Johnny, 2007, V10, P29, DOI 10.1159/000106818; Devos H, 1999, J CLIN ENDOCR METAB, V84, P2502, DOI 10.1210/jc.84.7.2502; Dumont J E, 1971, Vitam Horm, V29, P287; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; Fagman H, 2003, ENDOCRINOLOGY, V144, P3618, DOI 10.1210/en.2003-0393; Gallo A, 2001, DYSPHAGIA, V16, P220, DOI 10.1007/s00455-001-0067-7; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Hebrant A, 2009, J CLIN ENDOCR METAB, V94, P2602, DOI 10.1210/jc.2008-2191; KONGKHAM PN, ONCOGENE, V29, P3017; Kremenevskaja N, 2005, ONCOGENE, V24, P2144, DOI 10.1038/sj.onc.1208370; LEGER J, 1988, PEDIATR RES, V23, P266, DOI 10.1203/00006450-198803000-00007; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Perry R, 2002, J CLIN ENDOCR METAB, V87, P4072, DOI 10.1210/jc.2001-011995; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Roth W, 2000, ONCOGENE, V19, P4210, DOI 10.1038/sj.onc.1203783; Sadikovic B, 2009, HUM MOL GENET, V18, P1962, DOI 10.1093/hmg/ddp117; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Schoen EJ, 2004, PEDIATRICS, V114, pE683, DOI 10.1542/peds.2004-0803; STOPPAVAUCHER S, 2010, J CLIN ENDO IN PRESS; TEAM RDC, 2006, R LANGUAGE ENV STAT; Toso A, 2009, ACTA OTORHINOLARYNGO, V29, P213; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	32	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13420	10.1371/journal.pone.0013420	http://dx.doi.org/10.1371/journal.pone.0013420			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976176	Green Submitted, gold, Green Published			2022-12-27	WOS:000283043700018
J	Boulanger, J; Gidon, A; Kervran, C; Salamero, J				Boulanger, Jerome; Gidon, Alexandre; Kervran, Charles; Salamero, Jean			A Patch-Based Method for Repetitive and Transient Event Detection in Fluorescence Imaging	PLOS ONE			English	Article							LANGERHANS CELLS; TRACKING	Automatic detection and characterization of molecular behavior in large data sets obtained by fast imaging in advanced light microscopy become key issues to decipher the dynamic architectures and their coordination in the living cell. Automatic quantification of the number of sudden and transient events observed in fluorescence microscopy is discussed in this paper. We propose a calibrated method based on the comparison of image patches expected to distinguish sudden appearing/vanishing fluorescent spots from other motion behaviors such as lateral movements. We analyze the performances of two statistical control procedures and compare the proposed approach to a frame difference approach using the same controls on a benchmark of synthetic image sequences. We have then selected a molecular model related to membrane trafficking and considered real image sequences obtained in cells stably expressing an endocytic-recycling transmembrane protein, the Langerin-YFP, for validation. With this model, we targeted the efficient detection of fast and transient local fluorescence concentration arising in image sequences from a data base provided by two different microscopy modalities, wide field (WF) video microscopy using maximum intensity projection along the axial direction and total internal reflection fluorescence microscopy. Finally, the proposed detection method is briefly used to statistically explore the effect of several perturbations on the rate of transient events detected on the pilot biological model.	[Boulanger, Jerome] Radon Inst Computat & Appl Math, Linz, Austria; [Boulanger, Jerome; Salamero, Jean] Inst Curie, CNRS, Cell & Tissue Imaging Core Facil, F-75231 Paris, France; [Boulanger, Jerome; Salamero, Jean] Inst Curie, CNRS, Nikon Imaging Ctr, F-75231 Paris, France; [Kervran, Charles] Inst Natl Rech Informat & Automat, Ctr Rennes Bretagne Atlantique, F-35042 Rennes, France; [Kervran, Charles] Inst Natl Rech Agronom, Unite Rech Math & Informat Appl 341, Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; INRAE	Boulanger, J (corresponding author), Radon Inst Computat & Appl Math, Linz, Austria.	jerome.boulanger@oeaw.ac.at	Gidon, Alexandre/ABC-1477-2020	salamero, jean/0000-0002-2610-5826; Boulanger, Jerome/0000-0003-0237-3743; Gidon, Alexandre/0000-0001-9722-1253	Canceropole de la region ile de France; Fondation pour la Recherche Medicale [DGE20061007766]; French Ministry of Research and Higher Education	Canceropole de la region ile de France(Region Ile-de-France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research and Higher Education	The authors greatly acknowledge the Nikon imaging Centre@Institut Curie-Centre National de la Recherche Scientifique (CNRS) for providing them with up to date microscopy systems (nimce.curie.fr). This work was partly funded by the "Canceropole de la region ile de France" (www.canceropole-idf.fr). J. B. was supported by grant DGE20061007766 from the "Fondation pour la Recherche Medicale" (www.frm.org). A. G. was supported by a PhD Grant from the French Ministry of Research and Higher Education (www.enseignementsup-recherche.gouv.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich F, 2006, ANN STAT, V34, P584, DOI 10.1214/009053606000000074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERMAN SM, 1964, ANN MATH STAT, V35, P502, DOI 10.1214/aoms/1177703551; Boulanger J, 2010, IEEE T MED IMAGING, V29, P442, DOI 10.1109/TMI.2009.2033991; Bruzzone L, 2000, IEEE T GEOSCI REMOTE, V38, P1171, DOI 10.1109/36.843009; Criminisi A., 2006, IEEE C COMP VIS PATT, P53, DOI DOI 10.1109/CVPR.2006.69; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Diaz E, 2010, IEEE ACM T COMPUT BI, V7, P2, DOI 10.1109/TCBB.2008.30; Embrechts P., 1997, MODELLING EXTREMAL E, DOI 10.1007/978-3-642-33483-2; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Genovesio A, 2006, IEEE T IMAGE PROCESS, V15, P1062, DOI 10.1109/TIP.2006.872323; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Laptev I, 2005, INT J COMPUT VISION, V64, P107, DOI 10.1007/s11263-005-1838-7; Lisani JL, 2003, IEEE IMAGE PROC, P941; Mc Dermott R, 2002, MOL BIOL CELL, V13, P317, DOI 10.1091/mbc.01-06-0300; McDermott R, 2004, J INVEST DERMATOL, V123, P72, DOI 10.1111/j.0022-202X.2004.22728.x; McHugh JM, 2008, IEEE IMAGE PROC, P873, DOI 10.1109/ICIP.2008.4711894; Mittal A, 2004, PROC CVPR IEEE, P302; Morrison JE, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000502; MURTAGH F, 1995, ASTRON ASTROPHYS SUP, V112, P179; Paragios N, 2000, IEEE T PATTERN ANAL, V22, P266, DOI 10.1109/34.841758; PECOT T, 2008, P 8 INT C MED IM COM, V2, P95; Racine V, 2006, I S BIOMED IMAGING, P1020; Rosin PL, 2002, COMPUT VIS IMAGE UND, V86, P79, DOI 10.1006/cviu.2002.0960; Sebastian R, 2006, IEEE ACM T COMPUT BI, V3, P17, DOI 10.1109/TCBB.2006.11; SHI JB, 1994, 1994 IEEE COMPUTER SOCIETY CONFERENCE ON COMPUTER VISION AND PATTERN RECOGNITION, PROCEEDINGS, P593, DOI 10.1109/CVPR.1994.323794; SIDAK Z, 1967, J AM STAT ASSOC, V62, P626, DOI 10.2307/2283989; Smal I, 2008, MED IMAGE ANAL, V12, P764, DOI 10.1016/j.media.2008.03.004; Smal I, 2010, IEEE T MED IMAGING, V29, P282, DOI 10.1109/TMI.2009.2025127; Stauffer C, 2000, IEEE T PATTERN ANAL, V22, P747, DOI 10.1109/34.868677; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Uzan-Gafsou S, 2007, MOL BIOL CELL, V18, P3169, DOI 10.1091/mbc.E06-09-0779; Valladeau J, 2000, IMMUNITY, V12, P71, DOI 10.1016/S1074-7613(00)80160-0; Veit T, 2006, INT J COMPUT VISION, V68, P163, DOI 10.1007/s11263-006-6661-2	34	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13190	10.1371/journal.pone.0013190	http://dx.doi.org/10.1371/journal.pone.0013190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976222	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700001
J	Tjomsland, V; Spangeus, A; Sandstrom, P; Borch, K; Messmer, D; Larsson, M				Tjomsland, Vegard; Spangeus, Anna; Sandstrom, Per; Borch, Kurt; Messmer, Davorka; Larsson, Marie			Semi Mature Blood Dendritic Cells Exist in Patients with Ductal Pancreatic Adenocarcinoma Owing to Inflammatory Factors Released from the Tumor	PLOS ONE			English	Article							EXPRESSION; SUBSETS; MATURATION; ACTIVATION; INDUCTION; CANCER; ABNORMALITIES; DEFICIENCIES; PHENOTYPE; MONOCYTES	Background: Much evidence exists regarding the fact that blood DCs, both myeloid DCs (MDCs) and plasmacytoid DCs (PDCs), are negatively affected in different types of cancer, with both reduced numbers and impaired functionality. Functional impairment of DCs in patients with pancreatic ductal adenocarcinoma (PDAC), may contribute to the poor clinical outcome. The aim of this study was to examine the effects PDAC had on blood DCs and elucidate the underlying mechanism responsible for the DC impairment. Methodology/Principal Findings: We examined the systemic influence PDAC exerted on blood DCs by ex vivo measuring numerous activation and maturation markers expressed on these cells. Furthermore, the effect patient plasma and the inflammatory factors CXCL8 and PGE(2) had on purified MDCs and PDCs from healthy donors was assessed and compared to the DCs existing in PDAC patients. We found a partial maturation of the blood MDCs and PDCs in PDAC patients with significantly enhanced expression of CD83, CD40, B7H3, PDL-1, CCR6, and CCR7 and decreased expression of ICOSL, and DCIR. These changes lead to impairment in their immunostimulatory function. Furthermore, chronic pancreatitis gave rise to DCs with similar semi-mature phenotype as seen in PDAC. Low expression of ICOSL was associated with poor prognosis. We found that the mechanism underlying this semi-maturation of DCs was inflammatory factors existing in the PDAC patients' plasma. Of note, PGE2, which is elevated PDAC patient plasma, was one contributing factor to the changes seen in MDCs and PDCs phenotype. Conclusion/Significance: Our findings point to a role for the systemic inflammation in transforming blood MDCs and PDCs into semi-mature cells in PDAC patients and we show a correlation between maturation status and clinical outcome. Thus, means to preserve a functional blood DC compartment in PDAC patients by diminishing the inflammation could facilitate their ability to control the disease and improve survival.	[Tjomsland, Vegard] Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden; [Spangeus, Anna] Linkoping Univ, Dept Endocrinol, Div Internal Med, Linkoping, Sweden; [Spangeus, Anna] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Sandstrom, Per; Borch, Kurt] Linkoping Univ, Div Surg, Linkoping, Sweden; [Messmer, Davorka; Larsson, Marie] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Linkoping University; Linkoping University; Linkoping University; Linkoping University; University of California System; University of California San Diego	Tjomsland, V (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Div Mol Virol, Linkoping, Sweden.	marie.larsson@liu.se	SandstrÃm, Per/AAF-1841-2019	Larsson, Marie/0000-0002-4524-0177	Swedish Research Council [AI52731]; Swedish International Development Cooperation Agency (SIDA); Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER); Medical Research Council of Southeast Sweden; Swedish Society of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI052731, R01AI052731] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish International Development Cooperation Agency (SIDA); Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER)(Vinnova); Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by grants from: ML: The Swedish Research Council AI52731, The Swedish International Development Cooperation Agency (SIDA), The Swedish Governmental Agency for Innovation Systems (VINNOVA:VINNMER), Medical Research Council of Southeast Sweden, and Swedish Society of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam JP, 2008, J ALLERGY CLIN IMMUN, V121, P368, DOI 10.1016/j.jaci.2007.09.045; Almeida M, 2005, AIDS, V19, P261; Bachmann J, 2008, J GASTROINTEST SURG, V12, P1193, DOI 10.1007/s11605-008-0505-z; Barron MA, 2003, J INFECT DIS, V187, P26, DOI 10.1086/345957; Beckebaum S, 2004, CLIN CANCER RES, V10, P7260, DOI 10.1158/1078-0432.CCR-04-0872; Braun D, 2005, BLOOD, V106, P2375, DOI 10.1182/blood-2005-03-0979; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Brittingham KC, 2005, J IMMUNOL, V174, P5545, DOI 10.4049/jimmunol.174.9.5545; Cao W, 2007, CURR OPIN IMMUNOL, V19, P24, DOI 10.1016/j.coi.2006.11.004; Charles J, 2010, J INVEST DERMATOL, V130, P1646, DOI 10.1038/jid.2010.24; Chen YW, 2007, EUR J IMMUNOL, V37, P167, DOI 10.1002/eji.200636285; Coates PTH, 2004, KIDNEY INT, V66, P1907, DOI 10.1111/j.1523-1755.2004.00965.x; Della Bella S, 2003, BRIT J CANCER, V89, P1463, DOI 10.1038/sj.bjc.6601243; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Dieu-Nosjean MC, 1999, J LEUKOCYTE BIOL, V66, P252, DOI 10.1002/jlb.66.2.252; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Farrow B, 2004, ANN SURG, V239, P763, DOI 10.1097/01.sla.0000128681.76786.07; Ferlay J, 2007, ANN ONCOL, V18, P581, DOI 10.1093/annonc/mdl498; Forster R, 2008, NAT REV IMMUNOL, V8, P362, DOI 10.1038/nri2297; Frick VO, 2008, PANCREATOLOGY, V8, P488, DOI 10.1159/000151776; Fung E, 2010, NAT PROTOC, V5, P357, DOI 10.1038/nprot.2009.246; Hashizume H, 2005, J IMMUNOL, V174, P2396, DOI 10.4049/jimmunol.174.4.2396; Hoffmann TK, 2002, CLIN CANCER RES, V8, P1787; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jongbloed SL, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1864; Kunitani H, 2002, J HEPATOL, V36, P734, DOI 10.1016/S0168-8278(02)00062-4; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; Li M, 2008, CANCER SCI, V99, P733, DOI 10.1111/j.1349-7006.2008.00740.x; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Maecker B, 2006, LEUKEMIA, V20, P645, DOI 10.1038/sj.leu.2404146; Mahnke K, 2007, EUR J IMMUNOL, V37, P2117, DOI 10.1002/eji.200636841; Matsubayashi H, 2007, CANCER BIOL THER, V6, P1569, DOI 10.4161/cbt.6.10.4711; Meier A, 2008, AIDS, V22, P655, DOI 10.1097/QAD.0b013e3282f4de23; Mengshol JA, 2009, GUT, V58, P964, DOI 10.1136/gut.2008.168948; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Mohty M, 2001, BLOOD, V98, P3750, DOI 10.1182/blood.V98.13.3750; Pacanowski J, 2001, BLOOD, V98, P3016, DOI 10.1182/blood.V98.10.3016; Penna G, 2002, HUM IMMUNOL, V63, P1164, DOI 10.1016/S0198-8859(02)00755-3; Pinzon-Charry A, 2007, BRIT J CANCER, V97, P1251, DOI 10.1038/sj.bjc.6604018; Satthaporn S, 2004, CANCER IMMUNOL IMMUN, V53, P510, DOI 10.1007/s00262-003-0485-5; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Sciarra A, 2007, PROSTATE, V67, P1, DOI 10.1002/pros.20431; Selenko-Gebauer N, 2003, J IMMUNOL, V170, P3637, DOI 10.4049/jimmunol.170.7.3637; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Takahashi K, 2006, CANCER IMMUNOL IMMUN, V55, P775, DOI 10.1007/s00262-005-0079-5; TJOMSLAND V, 2010, ROLE IL 1ALPHA UNPUB; Tjomsland V, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-87; Verslype C, 2007, ANN ONCOL, V18, pVII1, DOI 10.1093/annonc/mdm210; Wigmore SJ, 2002, INT J ONCOL, V21, P881; Yanagimoto H, 2005, CLIN IMMUNOL, V114, P52, DOI 10.1016/j.clim.2004.09.007	55	52	55	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13441	10.1371/journal.pone.0013441	http://dx.doi.org/10.1371/journal.pone.0013441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976171	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700026
J	Forero-Medina, G; Joppa, L				Forero-Medina, German; Joppa, Lucas			Representation of Global and National Conservation Priorities by Colombia's Protected Area Network	PLOS ONE			English	Article							DEFORESTATION; PATTERNS; RESERVES	Background: How do national-level actions overlap with global priorities for conservation? Answering this question is especially important in countries with high and unique biological diversity like Colombia. Global biodiversity schemes provide conservation guidance at a large scale, while national governments gazette land for protection based on a combination of criteria at regional or local scales. Information on how a protected area network represents global and national conservation priorities is crucial for finding gaps in coverage and for future expansion of the system. Methodology/Principal Findings: We evaluated the agreement of Colombia's protected area network with global conservation priorities, and the extent to which the network reflects the country's biomes, species richness, and common environmental and physical conditions. We used this information to identify priority biomes for conservation. We find the dominant strategy in Colombia has been a proactive one, allocating the highest proportion of protected land on intact, difficult to access and species rich areas like the Amazon. Threatened and unique areas are disproportionately absent from Colombia's protected lands. We highlight six biomes in Colombia as conservation priorities that should be considered in any future expansion of Colombia's protected area network. Two of these biomes have less than 3% of their area protected and more than 70% of their area transformed for human use. One has less than 3% protected and high numbers of threatened vertebrates. Three biomes fall in both categories. Conclusions: Expansion of Colombia's Protected Area Network should consider the current representativeness of the network. We indicate six priority biomes that can contribute to improving the representation of threatened species and biomes in Colombia.	[Forero-Medina, German] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Joppa, Lucas] Microsoft Res, Cambridge, England	Duke University; Microsoft	Forero-Medina, G (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	forecroc@yahoo.com			Fulbright-Colciencias-DNP; Duke University Graduate School; Microsoft Research	Fulbright-Colciencias-DNP; Duke University Graduate School; Microsoft Research(Microsoft)	G. Forero-Medina is sponsored by a Fulbright-Colciencias-DNP grant and Duke University Graduate School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Microsoft Research funded Lucas Joppa, who did have a role in data analysis and manuscript preparation.	Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; Andam KS, 2008, P NATL ACAD SCI USA, V105, P16089, DOI 10.1073/pnas.0800437105; *ANH, 2010, MAP TIERR; [Anonymous], [No title captured]; Armenteras D, 2003, BIOL CONSERV, V113, P245, DOI 10.1016/S0006-3207(02)00359-2; *BIRDL INT, 2009, SPEC FACTSH ER MIR; BORRERO JOSE IGNACIO, 1952, LOZANIA [ACTA ZOOL COLOMBIANA], V1, P7; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bryant D., 1997, LAST FRONTIER FOREST; Chaves ME, 1998, INFORM NACL ESTADO B; CIESIN, 2004, GLOB RUR URB MAPP PR; *CONCIVILES, 2010, EST DIS CONSTR PAV C; Etter A, 2006, J ENVIRON MANAGE, V79, P74, DOI 10.1016/j.jenvman.2005.05.017; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Etter A, 2000, AMBIO, V29, P432, DOI 10.1639/0044-7447(2000)029[0432:POLTIC]2.0.CO;2; ETTER A, 1998, INFORM NACL ESTADO B; ETTER A, 1993, NUESTRA DIVERSIDAD B; Fischer Gunther, 2001, GLOBAL AGRO ECOLOGIC; HERNANDEZCAMACH.J, 1992, ACTA ZOOLOGICA MEXIC; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Humphreys D, 2008, INT FOREST REV, V10, P433, DOI 10.1505/ifor.10.3.433; HUNTER ML, 1993, CONSERV BIOL, V7, P420, DOI 10.1046/j.1523-1739.1993.07020420.x; *IAV, 1998, BOSQ SEC TROP COL; IUCN, 1994, GUID PROT AR MAN CAT; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004279; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Leuteritz T.E., 2008, IUCN RED LIST THREAT; Mittermeier RA, 2003, P NATL ACAD SCI USA, V100, P10309, DOI 10.1073/pnas.1732458100; MONSALVE LM, 2008, CONSULTA PREVIA PROY; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEPSTAD D, 2006, INHIBITION AMAZON DE, P65; Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x; Olson DM, 2002, ANN MO BOT GARD, V89, P199, DOI 10.2307/3298564; Pimm SL, 2005, SCI AM, V293, P66, DOI 10.1038/scientificamerican0905-66; Pimm SL, 2001, SCIENCE, V293, P2207, DOI 10.1126/science.1061626; Redford KH, 2003, CONSERV BIOL, V17, P116, DOI 10.1046/j.1523-1739.2003.01467.x; *REP VDL, 2010, TIT COL ADJ COM NEGR; Ricketts TH, 2005, P NATL ACAD SCI USA, V102, P18497, DOI 10.1073/pnas.0509060102; Ridgely R. S, 2007, DIGITAL DISTRIBUTION; ROLDAN R, 2005, FUTUROS, V3, P1; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Scott JM, 2001, ECOL APPL, V11, P999, DOI 10.1890/1051-0761(2001)011[0999:NRDTCT]2.0.CO;2; SINCHI I, 2007, ECOSISTEMAS CONTINEN; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; USGS, 2004, SHUTTL RAD TOP MISS; Vasquez V., 2009, AREAS NATURALES PROT; WIJNINGA V M, 1989, Caldasia, V16, P23; *WWF, 1994, CTR PLANT DIV; Zimmerman B, 2001, ENVIRON CONSERV, V28, P10, DOI 10.1017/S0376892901000029	51	52	60	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13210	10.1371/journal.pone.0013210	http://dx.doi.org/10.1371/journal.pone.0013210			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967270	Green Published, Green Submitted, gold			2022-12-27	WOS:000282807300004
J	Carroll, RW; Wainwright, MS; Kim, KY; Kidambi, T; Gomez, ND; Taylor, T; Haldar, K				Carroll, Ryan W.; Wainwright, Mark S.; Kim, Kwang-Youn; Kidambi, Trilokesh; Gomez, Noe D.; Taylor, Terrie; Haldar, Kasturi			A Rapid Murine Coma and Behavior Scale for Quantitative Assessment of Murine Cerebral Malaria	PLOS ONE			English	Article							FALCIPARUM-MALARIA; PARASITE SEQUESTRATION; PLASMODIUM-FALCIPARUM; SUSCEPTIBLE MICE; RESISTANT MICE; BURDEN; SHIRPA; BRAIN; PATHOGENESIS; PATHOLOGY	Background: Cerebral malaria (CM) is a neurological syndrome that includes coma and seizures following malaria parasite infection. The pathophysiology is not fully understood and cannot be accounted for by infection alone: patients still succumb to CM, even if the underlying parasite infection has resolved. To that effect, there is no known adjuvant therapy for CM. Current murine CM (MCM) models do not allow for rapid clinical identification of affected animals following infection. An animal model that more closely mimics the clinical features of human CM would be helpful in elucidating potential mechanisms of disease pathogenesis and evaluating new adjuvant therapies. Methodology/Principal Findings: A quantitative, rapid murine coma and behavior scale (RMCBS) comprised of 10 parameters was developed to assess MCM manifested in C57BL/6 mice infected with Plasmodium berghei ANKA (PbA). Using this method a single mouse can be completely assessed within 3 minutes. The RMCBS enables the operator to follow the evolution of the clinical syndrome, validated here by correlations with intracerebral hemorrhages. It provides a tool by which subjects can be identified as symptomatic prior to the initiation of trial treatment. Conclusions/Significance: Since the RMCBS enables an operator to rapidly follow the course of disease, label a subject as affected or not, and correlate the level of illness with neuropathologic injury, it can ultimately be used to guide the initiation of treatment after the onset of cerebral disease (thus emulating the situation in the field). The RMCBS is a tool by which an adjuvant therapy can be objectively assessed.	[Carroll, Ryan W.; Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Kim, Kwang-Youn] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Carroll, Ryan W.; Kidambi, Trilokesh; Gomez, Noe D.; Haldar, Kasturi] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gomez, Noe D.; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, South Bend, IN USA; [Taylor, Terrie] Michigan State Univ, Coll Osteopath Med, Dept Internal Med, E Lansing, MI 48824 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; University of Notre Dame; Michigan State University; Michigan State University College of Osteopathic Medicine	Carroll, RW (corresponding author), Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA.	rcarroll1@childrensmemorial.org; khaldar@nd.edu	Haldar, Kasturi/C-6685-2014	Kim, Kwang-Youn/0000-0002-4168-757X	American Society of Tropical Medicine; Hygiene-Burroughs Wellcome Fund [F31 HL09277, R01HL69630, P01HL078826]; NCI [CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826, R01HL069630] Funding Source: NIH RePORTER	American Society of Tropical Medicine; Hygiene-Burroughs Wellcome Fund; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by an American Society of Tropical Medicine and Hygiene-Burroughs Wellcome Fund research career award grant (to RC) (http://www.astmh.org/AM/Template.cfm?Section = ASTMH_Sponsored_Fellowships&Template = /CM/ContentDisplay.cfm&ContentID = 2138); F31 HL09277 (to NG); R01HL69630 and P01HL078826 (to KH) (http://www.nih.gov/). Imaging work was performed at the Northwestern University Cell Imaging Facility, generously supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center (http://report.nih.gov/rcdc/categories/ProjectSearch.aspx? FY = 2009&ARRA = N&DCat = HIV/AIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amani V, 1998, INFECT IMMUN, V66, P4093; [Anonymous], 2000, T R SOC TROP MED S1, V94, pS1; Blanco YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003126; Breman JG, 2001, AM J TROP MED HYG, V64, P1; CARVALHO LJ, 2010, TRENDS PARASITOL; de Sousa JRM, 2009, P ASME 2009 28 INT C, P1, DOI [10.1115/OMAE2009-80014, DOI 10.1115/OMAE2009-80014]; Delahaye NF, 2006, J INFECT DIS, V193, P312, DOI 10.1086/498579; Delahaye NF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-452; Evans KJ, 2006, BLOOD, V107, P1192, DOI 10.1182/blood-2005-08-3460; Franke-Fayard B, 2005, P NATL ACAD SCI USA, V102, P11468, DOI 10.1073/pnas.0503386102; Hatcher JP, 2001, BEHAV BRAIN RES, V125, P43, DOI 10.1016/S0166-4328(01)00275-3; Hatcher JP, 2002, BEHAV BRAIN RES, V131, P139, DOI 10.1016/S0166-4328(01)00377-1; Hearn J, 2000, INFECT IMMUN, V68, P5364, DOI 10.1128/IAI.68.9.5364-5376.2000; Helmers AJ, 2008, AM J TROP MED HYG, V79, P823, DOI 10.4269/ajtmh.2008.79.823; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; HUNT NH, 2010, TRENDS PARASITOL; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kihara M, 2006, TROP MED INT HEALTH, V11, P386, DOI 10.1111/j.1365-3156.2006.01579.x; Lackner P, 2006, NEUROPATH APPL NEURO, V32, P177, DOI 10.1111/j.1365-2990.2006.00706.x; Lackner P, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-207; Lackner P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-36; Mackintosh CL, 2004, TRENDS PARASITOL, V20, P597, DOI 10.1016/j.pt.2004.09.006; Martins YC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-85; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mohanty S, 2006, INDIAN J MED RES, V124, P245; Mturi N, 2003, CNS DRUGS, V17, P153, DOI 10.2165/00023210-200317030-00002; Newton CRJC, 1998, ANN NEUROL, V43, P695, DOI 10.1002/ana.410430603; Newton CRJC, 1997, T ROY SOC TROP MED H, V91, P161, DOI 10.1016/S0035-9203(97)90207-8; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Patel SN, 2008, J EXP MED, V205, P1133, DOI 10.1084/jem.20072248; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; Reis PA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000963; REST JR, 1982, T ROY SOC TROP MED H, V76, P410, DOI 10.1016/0035-9203(82)90203-6; Rogers DC, 2001, NEUROSCI LETT, V306, P89, DOI 10.1016/S0304-3940(01)01885-7; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Shukla M, 2006, NEUROCHEM INT, V48, P108, DOI 10.1016/j.neuint.2005.09.001; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; STEVENSON MM, 2010, TRENDS PARASITOL; Taylor TE, 2004, NAT MED, V10, P143, DOI 10.1038/nm986; Vigario AM, 2007, J IMMUNOL, V178, P6416, DOI 10.4049/jimmunol.178.10.6416; White NJ, 2010, TRENDS PARASITOL, V26, P11, DOI 10.1016/j.pt.2009.10.007; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3	42	90	91	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13124	10.1371/journal.pone.0013124	http://dx.doi.org/10.1371/journal.pone.0013124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957049	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300018
J	Guo, JB; Zheng, XD; Xu, LP; Liu, ZY; Xu, KH; Li, ST; Wen, TY; Liu, SG; Pang, H				Guo, Jiubiao; Zheng, Xiangdong; Xu, Lipeng; Liu, Zhongyuan; Xu, Kehui; Li, Shentao; Wen, Tingyi; Liu, Siguo; Pang, Hai			Characterization of a Novel Esterase Rv0045c from Mycobacterium tuberculosis	PLOS ONE			English	Article							ALPHA/BETA-HYDROLASE FOLD; GENOME SEQUENCE; PROTEIN; EXPRESSION; SURVIVAL; ENZYMES; FAMILY; LIPASE	Background: It was proposed that there are at least 250 enzymes in M. tuberculosis involved in lipid metabolism. Rv0045c was predicted to be a hydrolase by amino acid sequence similarity, although its precise biochemical characterization and function remained to be defined. Methodology/Principal Findings: We expressed the Rv0045c protein to high levels in E. coli and purified the protein to high purity. We confirmed that the prepared protein was the Rv0045c protein by mass spectrometry analysis. Circular dichroism spectroscopy analysis showed that the protein possessed abundant beta-sheet secondary structure, and confirmed that its conformation was stable in the range pH 6.0-10.0 and at temperatures <= 40 degrees C. Enzyme activity analysis indicated that the Rv0045c protein could efficiently hydrolyze short chain p-nitrophenyl esters (C-2-C-8), and its suitable substrate was p-nitrophenyl caproate (C-6) with optimal catalytic conditions of 39 degrees C and pH 8.0. Conclusions/Significance: Our results demonstrated that the Rv0045c protein is a novel esterase. These experiments will be helpful in understanding ester/lipid metabolism related to M. tuberculosis.	[Guo, Jiubiao; Zheng, Xiangdong; Xu, Lipeng; Liu, Zhongyuan; Xu, Kehui; Pang, Hai] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Guo, Jiubiao; Liu, Siguo] Chinese Acad Agr, Harbin Vet Res Inst, Harbin, Peoples R China; [Li, Shentao] Capital Med Univ, Dept Immunol, Sch Basic Med Sci, Beijing, Peoples R China; [Wen, Tingyi] Chinese Acad Sci, Dept Ind Microbiol & Biotechnol, Inst Microbiol, Beijing, Peoples R China	Tsinghua University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Capital Medical University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Guo, JB (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.	siguo_liu@yahoo.com.cn; pangh@xtal.tsinghua.edu.cn	Zheng, Xiangdong/AAL-4774-2021; Wen, Tingyi/M-6095-2014	Wen, Tingyi/0000-0003-2583-7088; Guo, Jiubiao/0000-0003-2716-1712	Foundation of State Key Laboratory of Veterinary Biotechnology [SKLVBF2009]; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program [2008ZX09401-05]; National Natural Science Foundation of China [30770439]; Project 973 of the Major State Basic Research Development Program of China [2006CB504400]	Foundation of State Key Laboratory of Veterinary Biotechnology; Harbin Veterinary Research Institute (HVRI); National Drug Discovery Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project 973 of the Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was financially supported by the Foundation of State Key Laboratory of Veterinary Biotechnology (SKLVBF2009), Harbin Veterinary Research Institute (HVRI), the National Drug Discovery Program (Grant 2008ZX09401-05), the National Natural Science Foundation of China (No. 30770439) and Project 973 of the Major State Basic Research Development Program of China (No. 2006CB504400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1882, BERLINER KLIN WOCHEN, V19, P221; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Canaan S, 2004, EUR J BIOCHEM, V271, P3953, DOI 10.1111/j.1432-1033.2004.04335.x; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Iijima N, 1998, FISH PHYSIOL BIOCHEM, V18, P59, DOI 10.1023/A:1007725513389; KIRSTY M, 2009, BIOCHEMISTRY-US, V48, P863; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Levisson M, 2009, EXTREMOPHILES, V13, P567, DOI 10.1007/s00792-009-0260-4; Lopez-Lopez S, 2003, COMP BIOCHEM PHYS B, V135, P337, DOI 10.1016/S1096-4959(03)00087-3; Lun SC, 2007, J BIOL CHEM, V282, P18348, DOI 10.1074/jbc.M700035200; Nardini M, 1999, CURR OPIN STRUC BIOL, V9, P732, DOI 10.1016/S0959-440X(99)00037-8; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Park SY, 2007, APPL MICROBIOL BIOT, V77, P107, DOI 10.1007/s00253-007-1134-2; Park SY, 2008, J MOL BIOL, V376, P1426, DOI 10.1016/j.jmb.2007.12.062; Petersen MTN, 2001, J BIOTECHNOL, V85, P115, DOI 10.1016/S0168-1656(00)00360-6; Ryan KJ., 2004, SHERRIS MED MICROBIO; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; SCHARA JD, 1997, METHOD ENZYMOL, V284, P85; Sorrentino N, 2003, ACTA CRYSTALLOGR D, V59, P1846, DOI 10.1107/S0907444903017864; VAUGHAN A, 1995, J BIOL CHEM, V270, P17044, DOI 10.1074/jbc.270.28.17044; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang M, 2005, PROTEIN EXPRES PURIF, V42, P59, DOI 10.1016/j.pep.2005.03.022	25	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13143	10.1371/journal.pone.0013143	http://dx.doi.org/10.1371/journal.pone.0013143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957207	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300029
J	Schutz, P; Karlberg, T; van den Berg, S; Collins, R; Lehtio, L; Hogbom, M; Holmberg-Schiavone, L; Tempel, W; Park, HW; Hammarstrom, M; Moche, M; Thorsell, AG; Schuler, H				Schutz, Patrick; Karlberg, Tobias; van den Berg, Susanne; Collins, Ruairi; Lehtio, Lari; Hogbom, Martin; Holmberg-Schiavone, Lovisa; Tempel, Wolfram; Park, Hee-Won; Hammarstrom, Martin; Moche, Martin; Thorsell, Ann-Gerd; Schuler, Herwig			Comparative Structural Analysis of Human DEAD-Box RNA Helicases	PLOS ONE			English	Article							INITIATION-FACTOR EIF-4A; EXON JUNCTION COMPLEX; CRYSTAL-STRUCTURE; TRANSLATION INITIATION; DIFFRACTION DATA; CHROMOSOME-TRANSLOCATION; MAMMALIAN TRANSLATION; COOPERATIVE BINDING; MESSENGER-RNA; PROTEIN	DEAD-box RNA helicases play various, often critical, roles in all processes where RNAs are involved. Members of this family of proteins are linked to human disease, including cancer and viral infections. DEAD-box proteins contain two conserved domains that both contribute to RNA and ATP binding. Despite recent advances the molecular details of how these enzymes convert chemical energy into RNA remodeling is unknown. We present crystal structures of the isolated DEAD-domains of human DDX2A/eIF4A1, DDX2B/eIF4A2, DDX5, DDX10/DBP4, DDX18/myc-regulated DEAD-box protein, DDX20, DDX47, DDX52/ROK1, and DDX53/CAGE, and of the helicase domains of DDX25 and DDX41. Together with prior knowledge this enables a family-wide comparative structural analysis. We propose a general mechanism for opening of the RNA binding site. This analysis also provides insights into the diversity of DExD/H- proteins, with implications for understanding the functions of individual family members.	[Schutz, Patrick; Karlberg, Tobias; van den Berg, Susanne; Collins, Ruairi; Lehtio, Lari; Hogbom, Martin; Holmberg-Schiavone, Lovisa; Hammarstrom, Martin; Moche, Martin; Thorsell, Ann-Gerd; Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden; [Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Tempel, Wolfram; Park, Hee-Won] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada	Karolinska Institutet; University of Toronto; Structural Genomics Consortium; University of Toronto	Schutz, P (corresponding author), Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501; Moche, Martin/0000-0002-4834-7076; Lehtio, Lari/0000-0001-7250-832X; Hogbom, Martin/0000-0001-5574-9383	Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2004, BBA-REV CANCER, V1704, P37, DOI 10.1016/j.bbcan.2004.05.001; Almstead LL, 2007, GENE DEV, V21, P1086, DOI 10.1101/gad.1535607; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Arai Y, 1997, BLOOD, V89, P3936, DOI 10.1182/blood.V89.11.3936; ARNDT UW, 1968, J PHYS E SCI INSTRUM, V1, P510, DOI 10.1088/0022-3735/1/5/303; Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07; Bohnsack MT, 2008, EMBO REP, V9, P1230, DOI 10.1038/embor.2008.184; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Cauchi RJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000265; Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223; Cho BS, 2003, BIOCHEM BIOPH RES CO, V307, P52, DOI 10.1016/S0006-291X(03)01121-5; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Crumpacker CS, 2002, NAT MED, V8, P327, DOI 10.1038/nm0402-327; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dubaele S, 2007, ONCOL RES, V16, P549, DOI 10.3727/000000007783630015; Dufau ML, 2007, TRENDS ENDOCRIN MET, V18, P314, DOI 10.1016/j.tem.2007.09.001; Elles LM, 2008, NUCLEIC ACIDS RES, V36, P41, DOI 10.1093/nar/gkm926; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Frick DN, 2003, DRUG NEWS PERSPECT, V16, P355, DOI 10.1358/dnp.2003.16.6.829307; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Grandori C, 1996, EMBO J, V15, P4344, DOI 10.1002/j.1460-2075.1996.tb00808.x; GRIFO JA, 1984, J BIOL CHEM, V259, P8648; Gu MG, 2010, P NATL ACAD SCI USA, V107, P521, DOI 10.1073/pnas.0913380107; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050; Jackson RN, 2010, EMBO J, V29, P2205, DOI 10.1038/emboj.2010.107; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kwong AD, 2005, NAT REV DRUG DISCOV, V4, P845, DOI 10.1038/nrd1853; Le Hir H, 2008, CURR OPIN STRUC BIOL, V18, P112, DOI 10.1016/j.sbi.2007.11.002; Leslie AGW, 1992, RECENT CHANGES MOSFL; Linder P, 2001, TRENDS BIOCHEM SCI, V26, P339, DOI 10.1016/S0968-0004(01)01870-9; Lindqvist L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001583; Manfroni G, 2009, J MED CHEM, V52, P3354, DOI 10.1021/jm801608u; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakamura T, 1999, BLOOD, V94, P741, DOI 10.1182/blood.V94.2.741.414k04_741_747; Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x; Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Schroder M, 2010, BIOCHEM PHARMACOL, V79, P297, DOI 10.1016/j.bcp.2009.08.032; Schutz P, 2010, J MOL BIOL, V400, P768, DOI 10.1016/j.jmb.2010.05.046; Schwer B, 2001, NAT STRUCT BIOL, V8, P113, DOI 10.1038/84091; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Sekito A, 2005, INT J ONCOL, V26, P685; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Talavera MA, 2005, BIOCHEMISTRY-US, V44, P959, DOI 10.1021/bi048253i; Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105; Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; WEISS M, 1997, J APPL CRYSTALLOGR, P203; Wortham NC, 2009, ONCOGENE, V28, P4053, DOI 10.1038/onc.2009.261; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910	74	76	87	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12791	10.1371/journal.pone.0012791	http://dx.doi.org/10.1371/journal.pone.0012791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941364	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600004
J	Callenberg, KM; Choudhary, OP; de Forest, GL; Gohara, DW; Baker, NA; Grabe, M				Callenberg, Keith M.; Choudhary, Om P.; de Forest, Gabriel L.; Gohara, David W.; Baker, Nathan A.; Grabe, Michael			APBSmem: A Graphical Interface for Electrostatic Calculations at the Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GENERALIZED BORN THEORY; ION CHANNELS; K+ CHANNEL; DIELECTRIC ENVIRONMENTS; POTASSIUM CHANNELS; FREE-ENERGIES; PROTEIN; ASSOCIATION; MODEL	Electrostatic forces are one of the primary determinants of molecular interactions. They help guide the folding of proteins, increase the binding of one protein to another and facilitate protein-DNA and protein-ligand binding. A popular method for computing the electrostatic properties of biological systems is to numerically solve the Poisson-Boltzmann (PB) equation, and there are several easy-to-use software packages available that solve the PB equation for soluble proteins. Here we present a freely available program, called APBSmem, for carrying out these calculations in the presence of a membrane. The Adaptive Poisson-Boltzmann Solver (APBS) is used as a back-end for solving the PB equation, and a Java-based graphical user interface (GUI) coordinates a set of routines that introduce the influence of the membrane, determine its placement relative to the protein, and set the membrane potential. The software Jmol is embedded in the GUI to visualize the protein inserted in the membrane before the calculation and the electrostatic potential after completing the computation. We expect that the ease with which the GUI allows one to carry out these calculations will make this software a useful resource for experimenters and computational researchers alike. Three examples of membrane protein electrostatic calculations are carried out to illustrate how to use APBSmem and to highlight the different quantities of interest that can be calculated.	[Callenberg, Keith M.; Choudhary, Om P.] Univ Pittsburgh, Carnegie Mellon Univ Pittsburgh Program Computat, Pittsburgh, PA 15260 USA; [de Forest, Gabriel L.; Grabe, Michael] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Gohara, David W.] St Louis Univ, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO USA; [Baker, Nathan A.] Pacific NW Natl Lab, Richland, WA 99352 USA; [Grabe, Michael] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Pittsburgh, PA 15260 USA	Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Saint Louis University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Callenberg, KM (corresponding author), Univ Pittsburgh, Carnegie Mellon Univ Pittsburgh Program Computat, Pittsburgh, PA 15260 USA.	mdgrabe@pitt.edu	Callenberg, Keith/C-4838-2011; Baker, Nathan A/A-8605-2010	Baker, Nathan A/0000-0002-5892-6506; Gohara, David/0000-0001-8799-9125	National Science Foundation [MCB0845286]; Direct For Biological Sciences [0845286] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069702] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation CAREER Grant MCB0845286. M. G. is a Research Fellow of the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TW, 1999, BIOPHYS J, V77, P2502, DOI 10.1016/S0006-3495(99)77086-4; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beckstein O, 2004, J AM CHEM SOC, V126, P14694, DOI 10.1021/ja045271e; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Bond PJ, 2006, P NATL ACAD SCI USA, V103, P9518, DOI 10.1073/pnas.0600398103; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Choe S, 2008, J GEN PHYSIOL, V131, P563, DOI 10.1085/jgp.200809959; Choudhary OP, 2010, J MOL BIOL, V396, P580, DOI 10.1016/j.jmb.2009.12.006; Cohen BE, 2002, SCIENCE, V296, P1700, DOI 10.1126/science.1069346; Denning EJ, 2008, BIOPHYS J, V95, P3161, DOI 10.1529/biophysj.108.134049; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Faraldo-Gomez JD, 2004, J MOL BIOL, V339, P981, DOI 10.1016/j.jmb.2004.04.023; Feig M, 2004, J CHEM PHYS, V120, P903, DOI 10.1063/1.1631258; Feig M, 2010, ANN REP COMP CHEM, V4, P107, DOI 10.1016/S1574-1400(08)00006-6; GILSON MK, 1988, J COMPUT CHEM, V9, P327, DOI 10.1002/jcc.540090407; Grabe M, 2004, P NATL ACAD SCI USA, V101, P17640, DOI 10.1073/pnas.0408116101; Grant JA, 2001, J COMPUT CHEM, V22, P608, DOI 10.1002/jcc.1032; Green DF, 2003, J PHYS CHEM B, V107, P10261, DOI 10.1021/jp0350971; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; HILLE B, 1984, IONIC CHANNELS EXCIT, V174, P289; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2; Jackson J., 1975, CLASSICAL ELECTRODYN; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jmol, JMOL OP SOURC JAV VI; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; Khelashvili G, 2008, BIOPHYS J, V94, P2580, DOI 10.1529/biophysj.107.120667; Khelashvili G, 2009, BIOPHYS J, V97, P1626, DOI 10.1016/j.bpj.2009.07.006; KLAPPER I, 1986, Proteins Structure Function and Genetics, V1, P47, DOI 10.1002/prot.340010109; Krepkiy D, 2009, NATURE, V462, P473, DOI 10.1038/nature08542; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; MacCallum JL, 2007, P NATL ACAD SCI USA, V104, P6206, DOI 10.1073/pnas.0605859104; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1; Murray D, 1998, BIOCHEMISTRY-US, V37, P2145, DOI 10.1021/bi972012b; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; Nina M, 2000, EUR BIOPHYS J BIOPHY, V29, P439, DOI 10.1007/PL00006649; PARSEGIAN A, 1969, NATURE, V221, P844, DOI 10.1038/221844a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Petrache HI, 2002, LANGMUIR, V18, P1340, DOI 10.1021/la011338p; Philippsen A, 2002, BIOPHYS J, V82, P1667, DOI 10.1016/S0006-3495(02)75517-3; Robertson JL, 2008, J GEN PHYSIOL, V132, P613, DOI 10.1085/jgp.200810068; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; Roux B, 1997, BIOPHYS J, V73, P2980, DOI 10.1016/S0006-3495(97)78327-9; Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v; Schutz CN, 2001, PROTEINS, V44, P400, DOI 10.1002/prot.1106; Silva JR, 2009, P NATL ACAD SCI USA, V106, P11102, DOI 10.1073/pnas.0904505106; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Swanson JMJ, 2007, J CHEM THEORY COMPUT, V3, P170, DOI 10.1021/ct600216k; Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778; Tanizaki S, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1865992; Tanizaki S, 2006, J PHYS CHEM B, V110, P548, DOI 10.1021/jp054694f; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Ulmschneider MB, 2007, BIOPHYS J, V92, P2338, DOI 10.1529/biophysj.106.081810; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; WARWICKER J, 1986, J THEOR BIOL, V121, P199, DOI 10.1016/S0022-5193(86)80093-5; ZAUHAR RJ, 1985, J MOL BIOL, V186, P815, DOI 10.1016/0022-2836(85)90399-7; Zhang JM, 2006, BIOPHYS J, V91, P1710, DOI 10.1529/biophysj.106.081224; Zhou YC, 2008, J COMPUT CHEM, V29, P87, DOI 10.1002/jcc.20769	63	72	72	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2010	5	9							e12722	10.1371/journal.pone.0012722	http://dx.doi.org/10.1371/journal.pone.0012722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	655SI	20949122	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000282269400001
J	Issaeva, I; Cohen, AA; Eden, E; Cohen-Saidon, C; Danon, T; Cohen, L; Alon, U				Issaeva, Irina; Cohen, Ariel A.; Eden, Eran; Cohen-Saidon, Cellina; Danon, Tamar; Cohen, Lydia; Alon, Uri			Generation of Double-Labeled Reporter Cell Lines for Studying Co-Dynamics of Endogenous Proteins in Individual Human Cells	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; NF-KAPPA-B; THIOREDOXIN REDUCTASE; GENE-EXPRESSION; ADENOASSOCIATED VIRUS; TRANSCRIPTION FACTOR; REDOX REGULATION; SINGLE CELLS; LIVING CELLS; NUCLEAR THIOREDOXIN-1	Understanding the dynamic relationship between components of a system or pathway at the individual cell level is a current challenge. To address this, we developed an approach that allows simultaneous tracking of several endogenous proteins of choice within individual living human cells. The approach is based on fluorescent tagging of proteins at their native locus by directed gene targeting. A fluorescent tag-encoding DNA is introduced as a new exon into the intronic region of the gene of interest, resulting in expression of a full-length fluorescently tagged protein. We used this approach to establish human cell lines simultaneously expressing two components of a major antioxidant defense system, thioredoxin 1 (Trx) and thioredoxin reductase 1 (TrxR1), labeled with CFP and YFP, respectively. We find that the distributions of both proteins between nuclear and cytoplasmic compartments were highly variable between cells. However, the two proteins did not vary independently of each other: protein levels of Trx and TrxR1 in both the whole cell and the nucleus were substantially correlated. We further find that in response to a stress-inducing drug (CPT), both Trx and TrxR1 accumulated in the nuclei in a manner that was highly temporally correlated. This accumulation considerably reduced cell-to-cell variability in nuclear content of both proteins, suggesting a uniform response of the thioredoxin system to stress. These results indicate that Trx and TrxR1 act in concert in response to stress in regard to both time course and variability. Thus, our approach provides an efficient tool for studying dynamic relationship between components of systems of interest at a single-cell level.	[Issaeva, Irina; Cohen, Ariel A.; Eden, Eran; Cohen-Saidon, Cellina; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Issaeva, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	irina.issaeva@weizmann.ac.il; urialon@weizmann.ac.il			Kahn Family Foundation; European Research Council; Israel Science Foundation	Kahn Family Foundation; European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation)	The authors received funding from the Kahn Family Foundation, the European Research Council and the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bai J, 2003, J NEUROSCI, V23, P503, DOI 10.1523/JNEUROSCI.23-02-00503.2003; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Bunz F, 2002, CURR OPIN ONCOL, V14, P73, DOI 10.1097/00001622-200201000-00013; Byrne RH, 2005, MAR CHEM, V97, P1, DOI 10.1016/j.marchem.2005.09.002; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; Clyne PJ, 2003, GENETICS, V165, P1433; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cohen AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004901; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Day RN, 2005, MOL CELL ENDOCRINOL, V230, P1, DOI 10.1016/j.mce.2004.10.011; Day RN, 2005, MOL ENDOCRINOL, V19, P1675, DOI 10.1210/me.2005-0028; Dong JY, 1996, HUM GENE THER, V7, P2101, DOI 10.1089/hum.1996.7.17-2101; Dunlop MJ, 2008, NAT GENET, V40, P1493, DOI 10.1038/ng.281; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Fernandez SL, 2007, BIOL PROCED ONLINE, V9, P84, DOI 10.1251/bpo136; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Go YM, 2007, FREE RADICAL BIO MED, V42, P363, DOI 10.1016/j.freeradbiomed.2006.11.005; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hansen JM, 2004, TOXICOL SCI, V82, P308, DOI 10.1093/toxsci/kfh231; Hirata R, 2002, NAT BIOTECHNOL, V20, P735, DOI 10.1038/nbt0702-735; Hirata RK, 2000, J VIROL, V74, P4612, DOI 10.1128/JVI.74.10.4612-4620.2000; Hirota K, 1999, Tanpakushitsu Kakusan Koso, V44, P2414; Hirota K, 1999, J BIOL CHEM, V274, P27891, DOI 10.1074/jbc.274.39.27891; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Holmgren A, 2010, BIOCHEM BIOPH RES CO, V396, P120, DOI 10.1016/j.bbrc.2010.03.083; Jarvik JW, 1996, BIOTECHNIQUES, V20, P896; Jarvik JW, 2002, BIOTECHNIQUES, V33, P852, DOI 10.2144/02334rr02; Jarvik JW, 1998, ANNU REV GENET, V32, P601, DOI 10.1146/annurev.genet.32.1.601; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Karimpour S, 2002, ONCOGENE, V21, P6317, DOI 10.1038/sj.onc.1205749; Kim JS, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn566; Kohli M, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh009; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lalonde S, 2008, PLANT J, V53, P610, DOI 10.1111/j.1365-313X.2007.03332.x; Li XQ, 1999, J BIOL CHEM, V274, P21244, DOI 10.1074/jbc.274.30.21244; Locke JCW, 2009, NAT REV MICROBIOL, V7, P383, DOI 10.1038/nrmicro2056; Makino Y, 1999, J BIOL CHEM, V274, P3182, DOI 10.1074/jbc.274.5.3182; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MELAN MA, 1992, J CELL SCI, V101, P731; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Muzzey D, 2009, ANNU REV CELL DEV BI, V25, P301, DOI 10.1146/annurev.cellbio.042308.113408; Nelson DE, 2004, BIOCHEM SOC T, V32, P1090; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rago C, 2007, NAT PROTOC, V2, P2734, DOI 10.1038/nprot.2007.408; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Russell DW, 1998, NAT GENET, V18, P325, DOI 10.1038/ng0498-325; Schroeder P, 2007, ARTERIOSCL THROM VAS, V27, P2325, DOI 10.1161/ATVBAHA.107.149419; Sedivy JM, 1999, TRENDS GENET, V15, P88, DOI 10.1016/S0168-9525(98)01689-8; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Simizu S, 1998, J BIOL CHEM, V273, P26900, DOI 10.1074/jbc.273.41.26900; Smith DJ, 1997, BIOTECHNIQUES, V23, P116, DOI 10.2144/97231st01; Soini Y, 2001, CLIN CANCER RES, V7, P1750; SPITZ DR, 1987, J CELL PHYSIOL, V131, P364, DOI 10.1002/jcp.1041310308; Topaloglu O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni160; Ueno M, 1999, J BIOL CHEM, V274, P35809, DOI 10.1074/jbc.274.50.35809; Wang ZH, 2009, METHODS MOL BIOL, V567, P87, DOI 10.1007/978-1-60327-414-2_6; Watson WH, 2008, BIOCHEM BIOPH RES CO, V368, P832, DOI 10.1016/j.bbrc.2008.02.006; Wei SJ, 2000, CANCER RES, V60, P6688; Welsh SJ, 2002, CANCER RES, V62, P5089; Wiesel P, 2000, J BIOL CHEM, V275, P24840, DOI 10.1074/jbc.M000835200; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Zhang XD, 2008, NAT METHODS, V5, P163, DOI [10.1038/nmeth1170, 10.1038/NMETH1170]	73	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13524	10.1371/journal.pone.0013524	http://dx.doi.org/10.1371/journal.pone.0013524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975952	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800006
J	Alkhalaf, A; Zurbig, P; Bakker, SJL; Bilo, HJG; Cerna, M; Fischer, C; Fuchs, S; Janssen, B; Medek, K; Mischak, H; Roob, JM; Rossing, K; Rossing, P; Rychlik, I; Sourij, H; Tiran, B; Winklhofer-Roob, BM; Navis, GJ				Alkhalaf, Alaa; Zurbig, Petra; Bakker, Stephan J. L.; Bilo, Henk J. G.; Cerna, Marie; Fischer, Christine; Fuchs, Sebastian; Janssen, Bart; Medek, Karel; Mischak, Harald; Roob, Johannes M.; Rossing, Kasper; Rossing, Peter; Rychlik, Ivan; Sourij, Harald; Tiran, Beate; Winklhofer-Roob, Brigitte M.; Navis, Gerjan J.		PREDICTIONS Grp	Multicentric Validation of Proteomic Biomarkers in Urine Specific for Diabetic Nephropathy	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ENHANCED LASER-DESORPTION/IONIZATION; SUPPORT VECTOR MACHINES; MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; DISCOVERY; PROTEINS; PATTERNS; SURFACE; SERUM	Background: Urine proteome analysis is rapidly emerging as a tool for diagnosis and prognosis in disease states. For diagnosis of diabetic nephropathy (DN), urinary proteome analysis was successfully applied in a pilot study. The validity of the previously established proteomic biomarkers with respect to the diagnostic and prognostic potential was assessed on a separate set of patients recruited at three different European centers. In this case-control study of 148 Caucasian patients with diabetes mellitus type 2 and duration >= 5 years, cases of DN were defined as albuminuria >300 mg/d and diabetic retinopathy (n = 66). Controls were matched for gender and diabetes duration (n = 82). Methodology/Principal Findings: Proteome analysis was performed blinded using high-resolution capillary electrophoresis coupled with mass spectrometry (CE-MS). Data were evaluated employing the previously developed model for DN. Upon unblinding, the model for DN showed 93.8% sensitivity and 91.4% specificity, with an AUC of 0.948 (95% CI 0.898-0.978). Of 65 previously identified peptides, 60 were significantly different between cases and controls of this study. In <10% of cases and controls classification by proteome analysis not entirely resulted in the expected clinical outcome. Analysis of patient's subsequent clinical course revealed later progression to DN in some of the false positive classified DN control patients. Conclusions: These data provide the first independent confirmation that profiling of the urinary proteome by CE-MS can adequately identify subjects with DN, supporting the generalizability of this approach. The data further establish urinary collagen fragments as biomarkers for diabetes-induced renal damage that may serve as earlier and more specific biomarkers than the currently used urinary albumin.	[Alkhalaf, Alaa; Bakker, Stephan J. L.; Bilo, Henk J. G.; Navis, Gerjan J.] Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands; [Alkhalaf, Alaa; Bilo, Henk J. G.] Ctr Diabet, Isala Clin, Zwolle, Netherlands; [Zurbig, Petra; Mischak, Harald] Mosaiques Diagnost GmbH, Hannover, Germany; [Cerna, Marie; Medek, Karel] Charles Univ Prague, Dept Gen Biol & Genet, Fac Med 3, Prague, Czech Republic; [Fischer, Christine; Janssen, Bart] Univ Heidelberg, Inst Human Genet, Med Fac Heidelberg, Heidelberg, Germany; [Fuchs, Sebastian; Winklhofer-Roob, Brigitte M.] Karl Franzens Univ Graz, Inst Mol Biosci, Human Nutr & Metab Res & Training Ctr, Graz, Austria; [Mischak, Harald] Univ Glasgow, Fac Med, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland; [Roob, Johannes M.] Med Univ Graz, Dept Internal Med, Clin Div Nephrol & Hemodialysis, Graz, Austria; [Rossing, Kasper; Rossing, Peter] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Rychlik, Ivan] Charles Univ Prague, Dept Internal Med 2, Fac Med 3, Prague, Czech Republic; [Sourij, Harald] Med Univ Graz, Dept Internal Med, Div Endocrinol & Nucl Med, Graz, Austria; [Tiran, Beate] Med Univ Graz, Clin Inst Med & Chem Lab Diagnost, Graz, Austria	University of Groningen; Isala Clinics; Mosaiques Diagnostics GmbH (MOS); Charles University Prague; Ruprecht Karls University Heidelberg; University of Graz; University of Glasgow; Medical University of Graz; Steno Diabetes Center; Charles University Prague; Medical University of Graz; Medical University of Graz	Alkhalaf, A (corresponding author), Univ Groningen, Dept Internal Med, Univ Med Ctr Groningen, Groningen, Netherlands.	zuerbig@mosaiques-diagnostics.com	rossing, peter/AAZ-3415-2021; Bakker, Stephan J. L./J-4023-2015; Sourij, Harald/V-3370-2019; Winklhofer-Roob, Brigitte M/L-7899-2015; Mischak, Harald/E-8685-2011; rossing, peter/AAH-7879-2021; Černá, Marie/G-8372-2016	rossing, peter/0000-0002-1531-4294; Bakker, Stephan J. L./0000-0003-3356-6791; Winklhofer-Roob, Brigitte M/0000-0002-2021-2137; Černá, Marie/0000-0002-1208-5588; Mischak, Harald/0000-0003-0323-0306; Rychlik, Ivan/0000-0002-4245-5949; Medek, Karel/0000-0003-4350-8659; Zurbig, Petra/0000-0003-3465-2173; Sourij, Harald/0000-0003-3510-9594	Commission of the European Communities [LSHM-CT-2005-018733]; European Community [HEALTH-F2-2009-241544]; mosaiques diagnostics GmbH (MoD); Czech grant [VZ MSM 0021620814]	Commission of the European Communities(European Commission); European Community(European Commission); mosaiques diagnostics GmbH (MoD); Czech grant	This work was supported by the Commission of the European Communities, 6th Framework Programme Priority 1, Life Sciences, Genomics and Biotechnology for Health, LSHM-CT-2005-018733, acronym PREDICTIONS (PREvention of DIabetic ComplicaTIONS) and was partially supported by the European Community's 7th Framework Programme to the SysKID consortium, (HEALTH-F2-2009-241544). HM and PZ were partially supported by mosaiques diagnostics GmbH (MoD) (www.mosaiques-diagnostics.com). Furthermore, the Czech participants were supported in part also by a Czech grant VZ MSM 0021620814. Investigators from the co-sponsoring institution (MoD) were involved in study design, data production and analysis, and interpretation of the results. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; BENJAMINI Y, 1995, J R STAT SOC B, V57, P125; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; DeLeo J. M., 1993, RECEIVER OPERATING C, P318; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Girolami M, 2007, DRUG DISCOV TODAY TE, V3, P12; Good DM, 2007, J PROTEOME RES, V6, P4549, DOI 10.1021/pr070529w; Good DM, 2010, PROTEOMICS, V10, P164, DOI 10.1002/pmic.200900570; Good DM, 2009, J AM SOC MASS SPECTR, V20, P1435, DOI 10.1016/j.jasms.2009.03.006; GOOD DM, 2010, MOL CELL PR IN PRESS; Goodsaid F, 2007, PROTEOM CLIN APPL, V1, P1526, DOI 10.1002/prca.200700575; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Huang F, 2007, CLIN NEPHROL, V67, P293; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Julian BA, 2007, ELECTROPHORESIS, V28, P4469, DOI 10.1002/elps.200700237; Julian BA, 2009, PROTEOM CLIN APPL, V3, P1029, DOI 10.1002/prca.200800243; Knepper MA, 2009, J AM SOC NEPHROL, V20, P1175, DOI 10.1681/ASN.2009030321; Kottgen A, 2009, NAT GENET, V41, P712, DOI 10.1038/ng.377; Lescuyer P, 2007, J PROTEOME RES, V6, P3371, DOI 10.1021/pr0702060; Levey AS, 2009, AM J KIDNEY DIS, V54, P205, DOI 10.1053/j.ajkd.2009.04.029; McLerran D, 2008, CLIN CHEM, V54, P53, DOI 10.1373/clinchem.2007.091496; Mischak H, 2007, PROTEOM CLIN APPL, V1, P792, DOI 10.1002/prca.200700043; Neuhoff NV, 2004, RAPID COMMUN MASS SP, V18, P149, DOI 10.1002/rcm.1294; PARVING HH, 1992, KIDNEY INT, V41, P758, DOI 10.1038/ki.1992.118; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Rossing K, 2005, KIDNEY INT, V68, P193, DOI 10.1111/j.1523-1755.2005.00394.x; Rossing K, 2008, PROTEOM CLIN APPL, V2, P997, DOI 10.1002/prca.200780166; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Schaub S, 2004, KIDNEY INT, V65, P323, DOI 10.1111/j.1523-1755.2004.00352.x; Smulders YM, 1998, J LAB CLIN MED, V132, P39, DOI 10.1016/S0022-2143(98)90023-3; Snell-Bergeon JK, 2009, DIABETES TECHNOL THE, V11, P1, DOI 10.1089/dia.2008.0040; Soylemezoglu O, 1997, NEPHROL DIAL TRANSPL, V12, P1883, DOI 10.1093/ndt/12.9.1883; Stehouwer CDA, 1998, NEPHROL DIAL TRANSPL, V13, P2751, DOI 10.1093/ndt/13.11.2751; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Varghese SA, 2007, J AM SOC NEPHROL, V18, P913, DOI 10.1681/ASN.2006070767; Weissinger EM, 2004, KIDNEY INT, V65, P2426, DOI 10.1111/j.1523-1755.2004.00659.x; Williams BJ, 2007, ANAL CHEM, V79, P3850, DOI 10.1021/ac062395w; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Wong TYH, 2002, DIABETES CARE, V25, P900, DOI 10.2337/diacare.25.5.900; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Yang ZR, 2004, BIOINFORMATICS, V20, P735, DOI 10.1093/bioinformatics/btg477; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827; Zurbig P, 2009, PROTEOMICS, V9, P2108, DOI 10.1002/pmic.200800560	43	104	108	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13421	10.1371/journal.pone.0013421	http://dx.doi.org/10.1371/journal.pone.0013421			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975990	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000283216400005
J	Anastos, K; Hoover, DR; Burk, RD; Cajigas, A; Shi, QH; Singh, DK; Cohen, MH; Mutimura, E; Sturgis, C; Banzhaf, WC; Castle, PE				Anastos, Kathryn; Hoover, Donald R.; Burk, Robert D.; Cajigas, Antonio; Shi, Qiuhu; Singh, Diljeet K.; Cohen, Mardge H.; Mutimura, Eugene; Sturgis, Charles; Banzhaf, William C.; Castle, Philip E.			Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; NATURAL-HISTORY; NEOPLASIA; POPULATION; DIAGNOSIS; DNA; BIOPSY	Background: Although cervical cancer is an AIDS-defining condition, infection with human immunodeficiency virus (HIV) may only modestly increase the risk of cervical cancer. There is a paucity of information regarding factors that influence the natural history of human papillomavirus (HPV) in HIV-infected women. We examined factors associated with cervical intraepithelial neoplasia grade 3 or cancer (CIN3+) in Rwandan women infected with both HIV and HPV (HIV+/HPV+). Methods: In 2005, 710 HIV+ Rwandan women >= 25 years enrolled in an observational cohort study; 476 (67%) tested HPV+. Each woman provided sociodemographic data, CD4 count, a cervical cytology specimen and cervicovaginal lavage (CVL), which was tested for >40 HPV genotypes by MY09/MY11 PCR assay. Logistic regression models calculated odds ratios (OR) and 95% confidence intervals (CI) of associations of potential risk factors for CIN3+ among HIV+/HPV+ women. Results: Of the 476 HIV+/HPV+ women 42 (8.8%) were diagnosed with CIN3+. Factors associated with CIN3+ included >= 7 (vs. 0-2) pregnancies, malarial infection in the previous six months (vs. never), and >= 7 (vs. 0-2) lifetime sexual partners. Compared to women infected by non-HPV16 carcinogenic HPV genotypes, HPV16 infection was positively associated and non-carcinogenic HPV infection was inversely associated with CIN3+. CD4 count was significantly associated with CIN3+ only in analyses of women with non-HPV16 carcinogenic HPV (OR = 0.62 per 100 cells/mm(3), CI = 0.40-0.97). Conclusions: In this HIV+/HPV+ population, lower CD4 was significantly associated with CIN3+ only in women infected with carcinogenic non-HPV16. We found a trend for higher risk of CIN3+ in HIV+ women reporting recent malarial infection; this association should be investigated in a larger group of HIV+/HPV+ women.	[Anastos, Kathryn] Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Hoover, Donald R.] Rutgers State Univ, Dept Stat, Piscataway, NJ USA; [Hoover, Donald R.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, Piscataway, NJ USA; [Burk, Robert D.] Albert Einstein Coll Med, Dept Pediat, Div Genet, Bronx, NY 10467 USA; [Cajigas, Antonio] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA; [Shi, Qiuhu] New York Med Coll, Dept Epidemiol & Community Hlth, Valhalla, NY 10595 USA; [Singh, Diljeet K.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Cohen, Mardge H.] John Stroger Hosp, Chicago, IL USA; [Cohen, Mardge H.] Rush Univ, Chicago, IL 60612 USA; [Mutimura, Eugene] Womens Equ Access Care & Treatment, Kigali, Rwanda; [Sturgis, Charles] Providence Reg Med Ctr, Everett, WA USA; [Banzhaf, William C.] Univ Chicago, Pritzker Sch Med, Evanston, IL USA; [Castle, Philip E.] NCI, NIH, US Dept HHS, Bethesda, MD 20892 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; New York Medical College; Northwestern University; Feinberg School of Medicine; John H Stroger Junior Hospital Cook County; Rush University; University of Chicago; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anastos, K (corresponding author), Montefiore Med Ctr, Dept Med, Bronx, NY 10467 USA.	kanastos@verizon.net	Castle, Philip/AAP-6395-2020; Banzhaf, Wolfgang/A-7992-2008	Castle, Philip/0000-0003-1082-6554; Banzhaf, Wolfgang/0000-0002-6382-3245; Sturgis, Charles/0000-0003-0153-498X	National Institute of Allergy and Infectious Diseases [UO1-AI-35004]; AIDS International Training and Research Program (Fogarty International Center) [NIH D43-TW001403]; National Institutes of Health (NIH) [AI-51519]; National Institute of Diabetes and Digestive and Kidney Disease [DK54615]; NIH, National Cancer Institute; FOGARTY INTERNATIONAL CENTER [D43TW001403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035004, P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054615] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS International Training and Research Program (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases and the National Cancer Institute to the Bronx/Manhattan Women's Interagency HIV Study (WIHS) funded by the National Institute of Allergy and Infectious Diseases (UO1-AI-35004). This work was also supported in part by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403) and the Center for AIDS Research at the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the National Institute of Diabetes and Digestive and Kidney Disease (DK54615). Dr. Castle was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Castellsague Xavier, 2003, J Natl Cancer Inst Monogr, P20; Castle PE, 2006, CANCER RES, V66, P1218, DOI 10.1158/0008-5472.CAN-05-3066; Castle PE, 2004, J INFECT DIS, V190, P458, DOI 10.1086/421916; Castle PE, 2002, J MED VIROL, V68, P417, DOI 10.1002/jmv.10220; Castle PE, 2008, OBSTET GYNECOL, V111, P847, DOI 10.1097/AOG.0b013e318168460b; Castle PE, 2007, AM J CLIN PATHOL, V127, P805, DOI 10.1309/PT3PNC1QL2F4D2VL; Castle PE, 2009, OBSTET GYNECOL, V113, P18, DOI 10.1097/AOG.0b013e31818f5008; Clifford GM, 2009, FUTURE ONCOL, V5, P669, DOI [10.2217/fon.09.28, 10.2217/FON.09.28]; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; KOSHIOL J, 2008, AM J EPIDEMIOL; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Pretorius RG, 2004, AM J OBSTET GYNECOL, V191, P430, DOI 10.1016/j.ajog.2004.02.065; Rodriguez AC, 2008, JNCI-J NATL CANCER I, V100, P513, DOI 10.1093/jnci/djn044; Singh DK, 2009, J INFECT DIS, V199, P1851, DOI 10.1086/599123; Stoler MH, 2001, JAMA-J AM MED ASSOC, V285, P1500, DOI 10.1001/jama.285.11.1500; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wright TC, 2003, NEW ENGL J MED, V348, P489, DOI 10.1056/NEJMp020178	26	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13525	10.1371/journal.pone.0013525	http://dx.doi.org/10.1371/journal.pone.0013525			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976000	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400027
J	Farzaneh-Far, R; Desir, GV; Na, B; Schiller, NB; Whooley, MA				Farzaneh-Far, Ramin; Desir, Gary V.; Na, Beeya; Schiller, Nelson B.; Whooley, Mary A.			A Functional Polymorphism in Renalase (Glu37Asp) Is Associated with Cardiac Hypertrophy, Dysfunction, and Ischemia: Data from the Heart and Soul Study	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; PROGNOSTIC IMPLICATIONS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; STABLE ANGINA; BETA-BLOCKERS; ECHOCARDIOGRAPHY; HYPERTENSION	Background: Renalase is a soluble enzyme that metabolizes circulating catecholamines. A common missense polymorphism in the flavin-adenine dinucleotide-binding domain of human renalase (Glu37Asp) has recently been described. The association of this polymorphism with cardiac structure, function, and ischemia has not previously been reported. Methods: We genotyped the rs2296545 single-nucleotide polymorphism (Glu37Asp) in 590 Caucasian individuals and performed resting and stress echocardiography. Logistic regression was used to examine the associations of the Glu37Asp polymorphism (C allele) with cardiac hypertrophy (LV mass>100 g/m(2)), systolic dysfunction (LVEF<50%), diastolic dysfunction, poor treadmill exercise capacity (METS<5) and inducible ischemia. Results: Compared with the 406 participants who had GG or CG genotypes, the 184 participants with the CC genotype had increased odds of left ventricular hypertrophy (OR = 1.43; 95% CI 0.99-2.06), systolic dysfunction (OR = 1.72; 95% CI 1.01-2.94), diastolic dysfunction (OR = 1.75; 95% CI 1.05-2.93), poor exercise capacity (OR = 1.61; 95% CI 1.05-2.47), and inducible ischemia (OR = 1.49, 95% CI 0.99-2.24). The Glu37Asp (CC genotype) caused a 24-fold decrease in affinity for NADH and a 2.3-fold reduction in maximal renalase enzymatic activity. Conclusions: A functional missense polymorphism in renalase (Glu37Asp) is associated with cardiac hypertrophy, ventricular dysfunction, poor exercise capacity, and inducible ischemia in persons with stable coronary artery disease. Further studies investigating the therapeutic implications of this polymorphism should be considered.	[Farzaneh-Far, Ramin] San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Schiller, Nelson B.; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Desir, Gary V.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Na, Beeya; Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Farzaneh-Far, R (corresponding author), San Francisco Gen Hosp, Div Cardiol, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu			American Heart Association; Department of Veterans Affairs; National Heart, Lung and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award. The Heart and Soul study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program), the National Heart, Lung and Blood Institute (R01 HL079235), the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), the Ischemia Research and Education Foundation, and the Nancy Kirwan Heart Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2005, NEW ENGL J MED, V352, P2524, DOI 10.1056/NEJMcp042317; Abrams J, 2005, CIRCULATION, V112, pE255, DOI 10.1161/CIRCULATIONAHA.104.526699; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Coats AJS, 2009, INT J CARDIOL, V131, P149, DOI 10.1016/j.ijcard.2008.11.048; Culleton BF, 2007, JAMA-J AM MED ASSOC, V298, P1291, DOI 10.1001/jama.298.11.1291; Desir GV, 2008, CURR OPIN NEPHROL HY, V17, P181, DOI 10.1097/MNH.0b013e3282f521ba; Desir GV, 2009, KIDNEY INT, V76, P366, DOI 10.1038/ki.2009.169; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; FOLEY RN, 1995, KIDNEY INT, V47, P186, DOI 10.1038/ki.1995.22; Fonarow GC, 2006, REV CARDIOVASC MED, V7, P1; GHOSH SS, 2008, PEDIAT NEPHROL; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Joles JA, 2004, HYPERTENSION, V43, P699, DOI 10.1161/01.HYP.0000121881.77212.b1; Kopecky SL, 2006, AM J CARDIOL, V98, P1115, DOI 10.1016/j.amjcard.2006.05.039; LEVEY AS, 1990, KIDNEY INT, V38, P167, DOI 10.1038/ki.1990.182; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Li G, 2008, CIRCULATION, V117, P1277, DOI 10.1161/CIRCULATIONAHA.107.732032; Lunetta KL, 2008, CIRCULATION, V118, P96, DOI 10.1161/CIRCULATIONAHA.107.700401; MORRIS CK, 1991, AM HEART J, V122, P1423, DOI 10.1016/0002-8703(91)90586-7; Neumann J, 2004, KIDNEY INT, V65, P1568, DOI 10.1111/j.1523-1755.2004.00552.x; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; PEART WS, 1977, LANCET, V2, P543; Remme WJ, 1998, EUR HEART J, V19, pF62; Ren XS, 2007, AM J CARDIOL, V99, P1643, DOI 10.1016/j.amjcard.2007.01.041; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SCHILLER NB, 1983, CIRCULATION, V68, P210, DOI 10.1161/01.CIR.68.1.210; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Turakhia MP, 2008, AM J CARDIOL, V102, P1131, DOI 10.1016/j.amjcard.2008.06.036; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Xu JC, 2005, J CLIN INVEST, V115, P1275, DOI 10.1172/JCI200524066; Xu JC, 2007, CURR OPIN NEPHROL HY, V16, P373, DOI 10.1097/MNH.0b013e3281bd8877; Zhao Q, 2007, J MOL MED, V85, P877, DOI 10.1007/s00109-006-0151-4	36	55	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13496	10.1371/journal.pone.0013496	http://dx.doi.org/10.1371/journal.pone.0013496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975995	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400011
J	Klein, MI; Debaz, L; Agidi, S; Lee, H; Xie, G; Lin, AHM; Hamaker, BR; Lemos, JA; Koo, H				Klein, Marlise I.; DeBaz, Lena; Agidi, Senyo; Lee, Herbert; Xie, Gary; Lin, Amy H. -M.; Hamaker, Bruce R.; Lemos, Jose A.; Koo, Hyun			Dynamics of Streptococcus mutans Transcriptome in Response to Starch and Sucrose during Biofilm Development	PLOS ONE			English	Article							DENTAL-CARIES; POLYSACCHARIDE PRODUCTION; GENE-EXPRESSION; DNA RELEASE; TT-FARNESOL; METABOLISM; APIGENIN; PH; GLUCOSYLTRANSFERASES; HYDROXYAPATITE	The combination of sucrose and starch in the presence of surface-adsorbed salivary a-amylase and bacterial glucosyltransferases increase the formation of a structurally and metabolically distinctive biofilm by Streptococcus mutans. This host-pathogen-diet interaction may modulate the formation of pathogenic biofilms related to dental caries disease. We conducted a comprehensive study to further investigate the influence of the dietary carbohydrates on S. mutans-transcriptome at distinct stages of biofilm development using whole genomic profiling with a new computational tool (MDV) for data mining. S. mutans UA159 biofilms were formed on amylase-active saliva coated hydroxyapatite discs in the presence of various concentrations of sucrose alone (ranging from 0.25 to 5% w/v) or in combination with starch (0.5 to 1% w/v). Overall, the presence of sucrose and starch (suc+st) influenced the dynamics of S. mutans transcriptome (vs. sucrose alone), which may be associated with gradual digestion of starch by surface-adsorbed amylase. At 21 h of biofilm formation, most of the differentially expressed genes were related to sugar metabolism, such as upregulation of genes involved in maltose/maltotriose uptake and glycogen synthesis. In addition, the groEL/groES chaperones were induced in the suc+st-biofilm, indicating that presence of starch hydrolysates may cause environmental stress. In contrast, at 30 h of biofilm development, multiple genes associated with sugar uptake/transport (e. g. maltose), two-component systems, fermentation/glycolysis and iron transport were differentially expressed in suc+st-biofilms (vs. sucrose-biofilms). Interestingly, lytT (bacteria autolysis) was upregulated, which was correlated with presence of extracellular DNA in the matrix of suc+st-biofilms. Specific genes related to carbohydrate uptake and glycogen metabolism were detected in suc+st-biofilms in more than one time point, indicating an association between presence of starch hydrolysates and intracellular polysaccharide storage. Our data show complex remodeling of S. mutans-transcriptome in response to changing environmental conditions in situ, which could modulate the dynamics of biofilm development and pathogenicity.	[Klein, Marlise I.; DeBaz, Lena; Agidi, Senyo; Lemos, Jose A.; Koo, Hyun] Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA; [Klein, Marlise I.; DeBaz, Lena; Agidi, Senyo; Lemos, Jose A.; Koo, Hyun] Univ Rochester, Med Ctr, Eastman Dept Dent, Rochester, NY 14642 USA; [Lemos, Jose A.; Koo, Hyun] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Lee, Herbert; Xie, Gary] Los Alamos Natl Lab, Los Alamos, NM USA; [Lin, Amy H. -M.; Hamaker, Bruce R.] Purdue Univ, Dept Food Sci, Whistler Ctr Carbohydrate Res, W Lafayette, IN 47907 USA	University of Rochester; University of Rochester; University of Rochester; United States Department of Energy (DOE); Los Alamos National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Klein, MI (corresponding author), Univ Rochester, Med Ctr, Ctr Oral Biol, Rochester, NY 14642 USA.	Hyun_Koo@urmc.rochester.edu	Klein, Marlise Inêz/A-2550-2014	Klein, Marlise Inêz/0000-0002-7916-1557; Lemos, Jose/0000-0003-0791-5863; xie, gary/0000-0002-9176-924X	National Institutes of Health (NIH) [Y1-DE-6006-02]; University of California Office of President-UCOP	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Office of President-UCOP	This research was partially supported by grants from the National Institutes of Health (NIH Y1-DE-6006-02) and the University of California Office of President-UCOP 2009 Lab Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2006, FEMS MICROBIOL LETT, V255, P240, DOI 10.1111/j.1574-6968.2005.00076.x; Abranches J, 2006, J BACTERIOL, V188, P3748, DOI 10.1128/JB.00169-06; Ahn SJ, 2007, J BACTERIOL, V189, P8519, DOI 10.1128/JB.01180-07; AHN SJ, 2010, MICROBIOLOGY    0729; Ahn SJ, 2009, APPL ENVIRON MICROB, V75, P2517, DOI 10.1128/AEM.02367-08; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Ao ZH, 2007, J AGR FOOD CHEM, V55, P4540, DOI 10.1021/jf063123x; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; BOWEN WH, 1980, J AM DENT ASSOC, V100, P677, DOI 10.14219/jada.archive.1980.0211; Bowen WH, 2002, J AM DENT ASSOC, V133, P1405, DOI 10.14219/jada.archive.2002.0057; Campain AC, 2003, EUR J ORAL SCI, V111, P316, DOI 10.1034/j.1600-0722.2003.00056.x; CLARKSON BH, 1987, J DENT RES, V66, P795, DOI 10.1177/00220345870660031801; Cury JA, 2007, ANAL BIOCHEM, V365, P208, DOI 10.1016/j.ab.2007.03.021; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; DIBDIN GH, 1988, J DENT RES, V67, P890, DOI 10.1177/00220345880670060101; DIPERSIO JR, 1974, INFECT IMMUN, V10, P597, DOI 10.1128/IAI.10.3.597-604.1974; Duarte S, 2008, ORAL MICROBIOL IMMUN, V23, P206, DOI 10.1111/j.1399-302X.2007.00412.x; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; FIRESTONE AR, 1982, ARCH ORAL BIOL, V27, P759, DOI 10.1016/0003-9969(82)90026-7; FU DT, 1991, CARBOHYD RES, V217, P201, DOI 10.1016/0008-6215(91)84130-7; Galperin MY, 2008, STRUCTURE, V16, P657, DOI 10.1016/j.str.2008.04.003; Hunter RC, 2005, APPL ENVIRON MICROB, V71, P2501, DOI 10.1128/AEM.71.5.2501-2510.2005; Klein MI, 2009, APPL ENVIRON MICROB, V75, P837, DOI 10.1128/AEM.01299-08; KLEINBERG I, 1970, INT DENT J, V20, P451; Koo H, 2006, ANTIMICROB AGENTS CH, V50, P542, DOI 10.1128/AAC.50.2.542-546.2006; Koo H, 2005, J DENT RES, V84, P1016, DOI 10.1177/154405910508401109; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Koo H, 2010, J BACTERIOL, V192, P3024, DOI 10.1128/JB.01649-09; Koo H, 2008, Adv Dent Res, V20, P17; Korithoski B, 2008, FEMS MICROBIOL LETT, V289, P13, DOI 10.1111/j.1574-6968.2008.01351.x; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1967, ARCH ORAL BIOL, V12, P189, DOI 10.1016/0003-9969(67)90037-4; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Quivey RG, 2000, ADV MICROB PHYSIOL, V42, P239, DOI 10.1016/S0065-2911(00)42004-7; Ribeiro CCC, 2005, BRIT J NUTR, V94, P44, DOI 10.1079/BJN20051452; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; RUSSELL RRB, 1992, J BIOL CHEM, V267, P4631; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Smith AMV, 2007, CARIES RES, V41, P445, DOI 10.1159/000107930; SPATAFORA G, 1995, INFECT IMMUN, V63, P2556, DOI 10.1128/IAI.63.7.2556-2563.1995; Tanzer JM, 1976, P MICR ASP DENT CAR, P596; VaccaSmith AM, 1996, ARCH ORAL BIOL, V41, P291, DOI 10.1016/0003-9969(95)00129-8; Venkitaraman AR, 1995, J DENT RES, V74, P1695, DOI 10.1177/00220345950740101101; Vroom JM, 1999, APPL ENVIRON MICROB, V65, P3502; Webb AJ, 2008, J BACTERIOL, V190, P168, DOI 10.1128/JB.01509-07; Webb AJ, 2007, J BACTERIOL, V189, P3322, DOI 10.1128/JB.01633-06; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Xiao J, 2010, J APPL MICROBIOL, V108, P2103, DOI 10.1111/j.1365-2672.2009.04616.x; YAMASHITA Y, 1993, INFECT IMMUN, V61, P3811, DOI 10.1128/IAI.61.9.3811-3817.1993	52	93	96	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13478	10.1371/journal.pone.0013478	http://dx.doi.org/10.1371/journal.pone.0013478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976057	gold, Green Published, Green Submitted			2022-12-27	WOS:000283114700011
J	Metzger, M; Bernstein, C; Hoffmeister, TS; Desouhant, E				Metzger, Marie; Bernstein, Carlos; Hoffmeister, Thomas S.; Desouhant, Emmanuel			Does Kin Recognition and Sib-Mating Avoidance Limit the Risk of Genetic Incompatibility in a Parasitic Wasp?	PLOS ONE			English	Article							COMPLEMENTARY SEX DETERMINATION; MATE CHOICE; INBREEDING DEPRESSION; VENTURIA-CANESCENS; INCEST AVOIDANCE; SOLITARY WASP; DIPLOID MALES; EVOLUTION; INSECT; RELATEDNESS	Background: When some combinations of maternal and paternal alleles have a detrimental effect on offspring fitness, females should be able to choose mates on the basis of their genetic compatibility. In numerous Hymenoptera, the sex of an individual depends of the allelic combination at a specific locus (single-locus Complementary Sex Determination), and in most of these species individuals that are homozygous at this sexual locus develop into diploid males with zero fitness. Methods and Findings: In this paper, we tested the hypothesis of genetic incompatibility avoidance by investigating sib-mating avoidance in the solitary wasp parasitoid, Venturia canescens. In the context of mate choice we show, for the first time in a non-social hymenopteran species, that females can avoid mating with their brothers through kin recognition. In "no-choice'' tests, the probability a female will mate with an unrelated male is twice as high as the chance of her mating with her brothers. In contrast, in choice tests in small test arenas, no kin discrimination effect was observed. Further experiments with male extracts demonstrate that chemical cues emanating from related males influence the acceptance rate of unrelated males. Conclusions: Our results are compatible with the genetic incompatibility hypothesis. They suggest that the female wasps recognize sibs on the basis of a chemical signature carried or emitted by males possibly using a "self-referent phenotype matching'' mechanism.	[Metzger, Marie; Bernstein, Carlos; Desouhant, Emmanuel] Univ Lyon 1, CNRS, Labe Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France; [Metzger, Marie; Hoffmeister, Thomas S.] Univ Bremen, Inst Oekol, Bremen, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; VetAgro Sup; University of Bremen	Metzger, M (corresponding author), Univ Lyon 1, CNRS, Labe Biometrie & Biol Evolut, UMR 5558, Villeurbanne, France.	emmanuel.desouhant@univ-lyon1.fr	Hoffmeister, Thomas S./AAH-7796-2020; Hoffmeister, Thomas S/E-2804-2013; DESOUHANT, Emmanuel/A-9537-2013; Metzger, Marie/K-9772-2018	Hoffmeister, Thomas S./0000-0003-2840-7278; Hoffmeister, Thomas S/0000-0003-2840-7278; DESOUHANT, Emmanuel/0000-0003-0317-4463; Metzger, Marie/0000-0003-3597-5409	French Ministry for Research; BEPAR (Behavioural Ecology of Insect Parasitoids; ESF); 'Fondation pour la Recherche sur la Biodiversite', FRB	French Ministry for Research(Ministry of Research, France); BEPAR (Behavioural Ecology of Insect Parasitoids; ESF); 'Fondation pour la Recherche sur la Biodiversite', FRB	This work was funded by a Ph.D. grant from the French Ministry for Research to M.M., and a BEPAR (Behavioural Ecology of Insect Parasitoids; ESF program) visiting grant to M.M. to conduct work at the University of Bremen (Experiment 3). The project was partially financed by 'Fondation pour la Recherche sur la Biodiversite', FRB (Project: 'Vortex'). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; AMAT I, 2004, COEXISTENCE REPROD S, P226; Andersson Malte, 1994; [Anonymous], 2014, PHEROMONES ANIMAL BE; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; Beukeboom LW, 2001, NETH J ZOOL, V51, P1, DOI 10.1163/156854201750210805; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Bonduriansky R, 2001, BIOL REV, V76, P305, DOI 10.1017/S1464793101005693; Bourdais D, 2009, BEHAV PROCESS, V81, P92, DOI 10.1016/j.beproc.2009.02.015; Brown JL, 1997, BEHAV ECOL, V8, P60, DOI 10.1093/beheco/8.1.60; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; COOK JM, 1995, TRENDS ECOL EVOL, V10, P281, DOI 10.1016/0169-5347(95)90011-X; Cowan DP, 2004, P NATL ACAD SCI USA, V101, P10374, DOI 10.1073/pnas.0402481101; de Boer JG, 2007, HEREDITY, V99, P288, DOI 10.1038/sj.hdy.6800995; DUCHATEAU MJ, 1995, INSECT SOC, V42, P255, DOI 10.1007/BF01240420; Enigl M, 2004, ENTOMOL EXP APPL, V112, P21, DOI 10.1111/j.0013-8703.2004.00175.x; Facon B, 2006, EVOL ECOL, V20, P395, DOI 10.1007/s10682-006-0009-9; Fellowes MDE, 1998, ECOL ENTOMOL, V23, P223, DOI 10.1046/j.1365-2311.1998.00128.x; Hauber ME, 2000, TRENDS ECOL EVOL, V15, P349, DOI 10.1016/S0169-5347(00)01923-6; Hedrick PW, 2006, TRENDS ECOL EVOL, V21, P55, DOI 10.1016/j.tree.2005.11.014; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Hein S, 2009, ECOL MODEL, V220, P1663, DOI 10.1016/j.ecolmodel.2009.04.001; Henter HJ, 2003, EVOLUTION, V57, P1793, DOI 10.1111/j.0014-3820.2003.tb00587.x; Holmes WG, 2004, ANN ZOOL FENN, V41, P691; HOLMES WG, 1982, AM ZOOL, V22, P491; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; Hunt J, 2004, TRENDS ECOL EVOL, V19, P329, DOI 10.1016/j.tree.2004.03.035; Ivy TM, 2005, P ROY SOC B-BIOL SCI, V272, P2475, DOI 10.1098/rspb.2005.3222; KELLER L, 1993, BEHAV ECOL SOCIOBIOL, V33, P191, DOI 10.1007/BF00216600; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kokko H, 2003, P ROY SOC B-BIOL SCI, V270, P653, DOI 10.1098/rspb.2002.2235; Kokko H, 2006, ANNU REV ECOL EVOL S, V37, P43, DOI 10.1146/annurev.ecolsys.37.091305.110259; LaSalle J., 1993, HYMENOPTERA BIODIVER; Lihoreau M, 2009, BEHAV ECOL, V20, P46, DOI 10.1093/beheco/arn113; Lihoreau M, 2007, BEHAV ECOL, V18, P880, DOI 10.1093/beheco/arm046; Lize A, 2010, BEHAV ECOL, V21, P633, DOI 10.1093/beheco/arq034; Lize A, 2010, ANIM COGN, V13, P189, DOI 10.1007/s10071-009-0247-7; Marris GC, 1996, ENTOMOL EXP APPL, V78, P167, DOI 10.1007/BF00187513; Mateo JM, 2000, P ROY SOC B-BIOL SCI, V267, P695, DOI 10.1098/rspb.2000.1058; Mays HL, 2004, TRENDS ECOL EVOL, V19, P554, DOI 10.1016/j.tree.2004.07.018; METZGER M, 2008, THESIS U LYON 1, P213; Metzger M, 2010, ANIM BEHAV, V79, P1307, DOI 10.1016/j.anbehav.2010.03.003; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Murray TJ, 2010, BIOL CONTROL, V52, P153, DOI 10.1016/j.biocontrol.2009.10.003; Neff BD, 2005, MOL ECOL, V14, P19, DOI 10.1111/j.1365-294X.2004.02395.x; ODE PJ, 1995, ANIM BEHAV, V49, P1239, DOI 10.1006/anbe.1995.0156; Petrie M, 1999, NATURE, V401, P155, DOI 10.1038/43651; PFENNIG DW, 1989, ETHOLOGY, V80, P1; PFENNIG DW, 1993, EVOLUTION, V47, P700, DOI [10.2307/2410085, 10.1111/j.1558-5646.1993.tb02127.x]; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; R Core Team, 2020, R LANG ENV STAT COMP; RIDLEY M, 1993, AM NAT, V142, P893, DOI 10.1086/285579; SALT G, 1976, ECOL ENTOMOL, V1, P63, DOI 10.1111/j.1365-2311.1976.tb01205.x; Shellman-Reeve JS, 2001, ANIM BEHAV, V61, P869, DOI 10.1006/anbe.2000.1674; Sherman Paul W., 1997, P69; SIMMONS LW, 1991, ANIM BEHAV, V41, P493, DOI 10.1016/S0003-3472(05)80852-8; SIMMONS LW, 1989, ANIM BEHAV, V38, P68, DOI 10.1016/S0003-3472(89)80066-1; SMITH BH, 1987, BEHAV ECOL SOCIOBIOL, V20, P313, DOI 10.1007/BF00300676; Tang-Martinez Z, 2001, BEHAV PROCESS, V53, P21, DOI 10.1016/S0376-6357(00)00148-0; Thurin N, 2009, J EVOLUTION BIOL, V22, P2481, DOI 10.1111/j.1420-9101.2009.01864.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; van Santen Marlies C.P., 2002, Proceedings of the Section Experimental and Applied Entomology of the Netherlands Entomological Society (N.E.V.), V13, P87; VANWILGENBURG E, 2006, FRONTIERS ZOOLOGY, V3; Villavicencio CP, 2009, ANIM BEHAV, V78, P377, DOI 10.1016/j.anbehav.2009.04.026; WALDMAN B, 1988, ANNU REV ECOL SYST, V19, P543; Whitehorn PR, 2009, APIDOLOGIE, V40, P627, DOI 10.1051/apido/2009050; Whitehorn PR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-152; Whiting PW, 1943, GENETICS, V28, P365; Zayed A, 2005, P NATL ACAD SCI USA, V102, P10742, DOI 10.1073/pnas.0502271102; Zeh JA, 1996, P ROY SOC B-BIOL SCI, V263, P1711, DOI 10.1098/rspb.1996.0250	73	31	31	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13505	10.1371/journal.pone.0013505	http://dx.doi.org/10.1371/journal.pone.0013505			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976063	gold, Green Submitted, Green Published			2022-12-27	WOS:000283114700024
J	van Mansfeld, R; Jongerden, I; Bootsma, M; Buiting, A; Bonten, M; Willems, R				van Mansfeld, Rosa; Jongerden, Irene; Bootsma, Martin; Buiting, Anton; Bonten, Marc; Willems, Rob			The Population Genetics of Pseudomonas aeruginosa Isolates from Different Patient Populations Exhibits High-Level Host Specificity	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CYSTIC-FIBROSIS PATIENTS; TANDEM-REPEAT ANALYSIS; TYPING METHODS; STRAIN; INFECTION; DIVERSITY; PATTERNS	Objective: To determine whether highly prevalent P. aeruginosa sequence types (ST) in Dutch cystic fibrosis (CF) patients are specifically linked to CF patients we investigated the population structure of P. aeruginosa from different clinical backgrounds. We first selected the optimal genotyping method by comparing pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST) and multilocus variable number tandem-repeat analysis (MLVA). Methods: Selected P. aeruginosa isolates (n = 60) were genotyped with PFGE, MLST and MLVA to determine the diversity index (DI) and congruence (adjusted Rand and Wallace coefficients). Subsequently, isolates from patients admitted to two different ICUs (n = 205), from CF patients (n = 100) and from non-ICU, non-CF patients (n = 58, of which 19 were community acquired) were genotyped with MLVA to determine distribution of genotypes and genetic diversity. Results: Congruence between the typing methods was >79% and DIs were similar and all >0.963. Based on costs, ease, speed and possibilities to compare results between labs an adapted MLVA scheme called MLVA9-Utrecht was selected as the preferred typing method. In 363 clinical isolates 252 different MLVA types (MTs) were identified, indicating a highly diverse population (DI = 0.995; CI = 0.993-0.997). DI levels were similarly high in the diverse clinical sources (all >0.981) and only eight genotypes were shared. MTs were highly specific (>80%) for the different patient populations, even for similar patient groups (ICU patients) in two distinct geographic regions, with only three of 142 ICU genotypes detected in both ICUs. The two major CF clones were unique to CF patients. Conclusion: The population structure of P. aeruginosa isolates is highly diverse and population specific without evidence for a core lineage in which major CF, hospital or community clones co-cluster. The two genotypes highly prevalent among Dutch CF patients appeared unique to CF patients, suggesting specific adaptation of these clones to the CF lung.	[van Mansfeld, Rosa; Bonten, Marc; Willems, Rob] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Jongerden, Irene] Univ Med Ctr Utrecht, Dept Intens Care Med, Utrecht, Netherlands; [Bootsma, Martin] Univ Med Ctr Utrecht, Julius Ctr Hlth Res & Primary Care, Utrecht, Netherlands; [Bootsma, Martin] Univ Utrecht, Fac Sci, Dept Math, Utrecht, Netherlands; [Buiting, Anton] St Elizabeth Hosp, Dept Med Microbiol & Immunol, Tilburg, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Elisabeth-TweeSteden Ziekenhuis (ETZ)	van Mansfeld, R (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	r.vanmansfeld@umcutrecht.nl	Willems, Rob JL/E-3681-2010	Willems, Rob JL/0000-0002-7370-0812; Jongerden, Irene/0000-0002-6637-7631	Netherlands Organization for Scientific Research (VICI NWO) [918.76.611]	Netherlands Organization for Scientific Research (VICI NWO)(Netherlands Organization for Scientific Research (NWO))	M.J.M.B. is supported by the Netherlands Organization for Scientific Research (VICI NWO Grant 918.76.611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Aloul M, 2004, THORAX, V59, P334, DOI 10.1136/thx.2003.014258; Alonso A, 1999, ENVIRON MICROBIOL, V1, P421, DOI 10.1046/j.1462-2920.1999.00052.x; [Anonymous], PSEUDOMONAS AERUGINO; Armstrong D, 2003, J CLIN MICROBIOL, V41, P2266, DOI 10.1128/JCM.41.5.2266-2267.2003; Armstrong DS, 2002, AM J RESP CRIT CARE, V166, P983, DOI 10.1164/rccm.200204-269OC; Bradbury RS, 2009, J HOSP INFECT, V73, P151, DOI 10.1016/j.jhin.2009.05.021; Carrico JA, 2006, J CLIN MICROBIOL, V44, P2524, DOI 10.1128/JCM.02536-05; Curran B, 2004, J CLIN MICROBIOL, V42, P5644, DOI 10.1128/JCM.42.12.5644-5649.2004; DENAMUR E, 1993, FEMS MICROBIOL LETT, V110, P275, DOI 10.1111/j.1574-6968.1993.tb06334.x; Doring G, 2000, EUR RESPIR J, V16, P749, DOI 10.1034/j.1399-3003.2000.16d30.x; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Griffiths AL, 2005, AM J RESP CRIT CARE, V171, P1020, DOI 10.1164/rccm.200409-1194OC; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Johnson JK, 2007, J CLIN MICROBIOL, V45, P3707, DOI 10.1128/JCM.00560-07; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; Jones AM, 2002, LANCET, V359, P527, DOI 10.1016/S0140-6736(02)07648-1; Jones AM, 2002, THORAX, V57, P924, DOI 10.1136/thorax.57.11.924; Lanotte P, 2004, J MED MICROBIOL, V53, P73, DOI 10.1099/jmm.0.05324-0; PICARD B, 1994, J MED MICROBIOL, V40, P313, DOI 10.1099/00222615-40-5-313; Pirnay JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007740; Pirnay JP, 2005, ENVIRON MICROBIOL, V7, P969, DOI 10.1111/j.1462-2920.2005.00776.x; Pirnay JP, 2002, ENVIRON MICROBIOL, V4, P898, DOI 10.1046/j.1462-2920.2002.00321.x; Schouls LM, 2004, J BACTERIOL, V186, P5496, DOI 10.1128/JB.186.16.5496-5505.2004; Scott FW, 2004, J MED MICROBIOL, V53, P609, DOI 10.1099/jmm.0.45620-0; Speijer H, 1999, J CLIN MICROBIOL, V37, P3654, DOI 10.1128/JCM.37.11.3654-3661.1999; Talon D, 1996, J HOSP INFECT, V32, P135, DOI 10.1016/S0195-6701(96)90055-9; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Van Mansfeld R, 2009, J CLIN MICROBIOL, V47, P4096, DOI 10.1128/JCM.01462-09; Vu-Thien H, 2007, J CLIN MICROBIOL, V45, P3175, DOI 10.1128/JCM.00702-07; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104	31	40	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13482	10.1371/journal.pone.0013482	http://dx.doi.org/10.1371/journal.pone.0013482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976062	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700013
J	Sneppen, K; Trusina, A; Jensen, MH; Bornholdt, S				Sneppen, Kim; Trusina, Ala; Jensen, Mogens H.; Bornholdt, Stefan			A Minimal Model for Multiple Epidemics and Immunity Spreading	PLOS ONE			English	Article							INFECTIOUS-DISEASES; VIRUSES; ABUNDANCE; INFLUENZA; BACTERIAL; BACTERIOPHAGES; POPULATIONS; RESISTANCE; DIVERSITY; EVOLUTION	Pathogens and parasites are ubiquitous in the living world, being limited only by availability of suitable hosts. The ability to transmit a particular disease depends on competing infections as well as on the status of host immunity. Multiple diseases compete for the same resource and their fate is coupled to each other. Such couplings have many facets, for example cross-immunization between related influenza strains, mutual inhibition by killing the host, or possible even a mutual catalytic effect if host immunity is impaired. We here introduce a minimal model for an unlimited number of unrelated pathogens whose interaction is simplified to simple mutual exclusion. The model incorporates an ongoing development of host immunity to past diseases, while leaving the system open for emergence of new diseases. The model exhibits a rich dynamical behavior with interacting infection waves, leaving broad trails of immunization in the host population. This obtained immunization pattern depends only on the system size and on the mutation rate that initiates new diseases.	[Sneppen, Kim; Trusina, Ala; Jensen, Mogens H.] Niels Bohr Inst CMOL, Copenhagen, Denmark; [Bornholdt, Stefan] Univ Bremen, Inst Theoret Phys, Bremen, Germany	University of Copenhagen; Niels Bohr Institute; University of Bremen	Sneppen, K (corresponding author), Niels Bohr Inst CMOL, Copenhagen, Denmark.	sneppen@nbi.dk	trusina, ala/H-7312-2012; Trusina, Ala/L-6069-2013; Jensen, Mogens H./U-5510-2017; Trusina, Ala/N-5030-2019	Trusina, Ala/0000-0003-1945-454X; Jensen, Mogens H./0000-0001-8104-4299; Trusina, Ala/0000-0003-1945-454X; Sneppen, Kim/0000-0001-9820-3567	Danish Research council	Danish Research council(Det Frie Forskningsrad (DFF))	The research was funded by Danish Research council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Ashelford KE, 2003, APPL ENVIRON MICROB, V69, P285, DOI 10.1128/AEM.69.1.285-289.2003; BARKSDALE L, 1974, ANNU REV MICROBIOL, V28, P265, DOI 10.1146/annurev.mi.28.100174.001405; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Burdon JJ., 1987, DIS PLANT POPULATION; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P3677, DOI 10.1128/JB.186.12.3677-3686.2004; CHRISTIE GE, 1990, ANNU REV GENET, V24, P465, DOI 10.1146/annurev.ge.24.120190.002341; Comeau AM, 2005, CURR OPIN MICROBIOL, V8, P488, DOI 10.1016/j.mib.2005.06.004; DEBOER J, 1994, PHYS REV LETT, V73, P906, DOI 10.1103/PhysRevLett.73.906; Djordjevic GM, 1997, J BACTERIOL, V179, P6741, DOI 10.1128/jb.179.21.6741-6748.1997; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gupta S, 1996, NAT MED, V2, P437, DOI 10.1038/nm0496-437; Heilmann S, 2010, J VIROL, V84, P3016, DOI 10.1128/JVI.02326-09; KENDALL DG, 1948, BIOMETRIKA, V35, P6, DOI 10.2307/2332624; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Levin SA, 2004, MATH BIOSCI, V188, P17, DOI 10.1016/j.mbs.2003.08.010; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Luria SE, 1943, GENETICS, V28, P491; MOLLISON D, 1977, J ROY STAT SOC B MET, V39, P283; Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759; MORSE SS, 1995, EMERG INFECT DIS, V1, P7, DOI 10.3201/eid0101.950102; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; Rohani P, 2003, NATURE, V422, P885, DOI 10.1038/nature01542; Rosvall M, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066105; Shapiro OH, 2010, ISME J, V4, P327, DOI 10.1038/ismej.2009.118; SHAW MW, 1994, ANNU REV PHYTOPATHOL, V32, P523, DOI 10.1146/annurev.py.32.090194.002515; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Vos M, 2009, SCIENCE, V325, P833, DOI 10.1126/science.1174173; Williamson KE, 2005, APPL ENVIRON MICROB, V71, P3119, DOI 10.1128/AEM.71.6.3119-3125.2005; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000	37	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13326	10.1371/journal.pone.0013326	http://dx.doi.org/10.1371/journal.pone.0013326			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976185	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300007
J	Yu, DD; Jia, XY; Zhang, AM; Li, SQ; Zou, Y; Zhang, QJ; Yao, YG				Yu, Dandan; Jia, Xiaoyun; Zhang, A-Mei; Li, Shiqiang; Zou, Yang; Zhang, Qingjiong; Yao, Yong-Gang			Mitochondrial DNA Sequence Variation and Haplogroup Distribution in Chinese Patients with LHON and m.14484T > C	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; MTDNA MUTATIONS; DISEASE; FAMILIES; G11778A; IDENTIFICATION; POLYMORPHISMS; DYSFUNCTION; PENETRANCE	Background: Leber hereditary optic neuropathy (LHON, MIM 535000) is one of the most common mitochondrial genetic disorders caused by three primary mtDNA mutations (m. 3460G>A, m. 11778G>A and m. 14484T>C). The clinical expression of LHON is affected by many additional factors, e. g. mtDNA background, nuclear genes, and environmental factors. Hitherto, there is no comprehensive study of Chinese LHON patients with m. 14484T>C. Methodology/Principal Findings: In this study, we analyzed the mtDNA sequence variations and haplogroup distribution pattern of the largest number of Chinese LHON patients with m. 14484T>C to date. We first determined the complete mtDNA sequences in eleven LHON probands with m. 14484T>C, to discern the potentially pathogenic mutations that co-segregate with m. 14484T>C. We then dissected the matrilineal structure of 52 patients with m. 14484T>C (including 14 from unrelated families and 38 sporadic cases) and compared it with the reported Han Chinese from general populations. Complete mtDNA sequencing showed that the eleven matrilines belonged to nine haplogroups including Y2, C4a, M8a, M10a1a, G1a1, G2a1, G2b2, D5a2a1, and D5c. We did not identify putatively pathogenic mutation that was co-segregated with m. 14484T>C in these lineages based on the evolutionary analysis. Compared with the reported Han Chinese from general populations, the LHON patients with m. 14484T>C had significantly higher frequency of haplogroups C, G, M10, and Y, but a lower frequency of haplogroup F. Intriguingly, we also observed a lower prevalence of F lineages in LHON subjects with m. 11778G>A in our previous study, suggesting that this haplogroup may enact similar role during the onset of LHON in the presence of m. 14484T>C or m. 11778G>A. Conclusions/Significance: Our current study provided a comprehensive profile regarding the mtDNA variation and background of Chinese patients with LHON and m. 14484T>C. Matrilineal background might affect the expression of LHON in Chinese patients with m. 14484T>C.	[Yu, Dandan; Zhang, A-Mei; Zou, Yang; Yao, Yong-Gang] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China; [Jia, Xiaoyun; Li, Shiqiang; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, A-Mei; Zou, Yang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yu, DD (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming, Peoples R China.	qingjiongzhang@yahoo.com; ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Zhang, Qingjiong/AAR-6331-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Qingjiong/0000-0001-7508-848X	Yunnan Province [2009CI119]; Guangdong Province [2009B091300150]; Chinese Academy of Sciences; National Natural Science Foundation of China [30925021]	Yunnan Province; Guangdong Province; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Yunnan Province (2009CI119), Guangdong Province (2009B091300150), Chinese Academy of Sciences, and the National Natural Science Foundation of China (30925021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bi R, 2010, CLIN CHIM ACTA, V411, P1671, DOI 10.1016/j.cca.2010.06.026; Brown MD, 2001, HUM GENET, V109, P33, DOI 10.1007/s004390100538; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; HOWELL N, 1991, AM J HUM GENET, V49, P939; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; HUOPONEN K, 1991, AM J HUM GENET, V48, P1147; Jacobi FK, 2001, INVEST OPHTH VIS SCI, V42, P1208; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; JOHNS DR, 1993, BIOCHEM BIOPH RES CO, V196, P810, DOI 10.1006/bbrc.1993.2321; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V174, P1324, DOI 10.1016/0006-291X(91)91567-V; JOHNS DR, 1991, BIOCHEM BIOPH RES CO, V181, P1358, DOI 10.1016/0006-291X(91)92088-2; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Kirkman MA, 2009, BRAIN, V132, P2317, DOI 10.1093/brain/awp158; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; MACKEY D, 1992, AM J HUM GENET, V51, P1218; Man PYW, 2002, J MED GENET, V39, P162, DOI 10.1136/jmg.39.3.162; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Tharaphan P, 2006, J NEURO-OPHTHALMOL, V26, P264, DOI 10.1097/01.wno.0000249318.88991.c4; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Wei YL, 2009, CLIN EXP PHARMACOL P, V36, P933, DOI 10.1111/j.1440-1681.2009.05183.x; Yang JH, 2009, BIOCHEM BIOPH RES CO, V386, P50, DOI 10.1016/j.bbrc.2009.05.127; Yang JH, 2009, MITOCHONDRION, V9, P273, DOI 10.1016/j.mito.2009.04.003; Yao YG, 2008, J MED GENET, V45, P769, DOI 10.1136/jmg.2008.059782; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Yao YG, 2003, MOL BIOL EVOL, V20, P214, DOI 10.1093/molbev/msg026; Yao YG, 2007, BLOOD, V109, P756, DOI 10.1182/blood-2006-01-011007; Yao YG, 2009, AM J HUM GENET, V85, P929, DOI 10.1016/j.ajhg.2009.10.023; Yen MY, 2006, PROG RETIN EYE RES, V25, P381, DOI 10.1016/j.preteyeres.2006.05.002; Yu DD, 2010, NEUROGENETICS, V11, P349, DOI 10.1007/s10048-010-0236-7; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang AM, 2008, BIOCHEM BIOPH RES CO, V376, P221, DOI 10.1016/j.bbrc.2008.08.128; Zhang AM, 2009, BIOCHEM BIOPH RES CO, V386, P392, DOI 10.1016/j.bbrc.2009.06.051; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	42	20	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13426	10.1371/journal.pone.0013426	http://dx.doi.org/10.1371/journal.pone.0013426			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976138	gold, Green Published, Green Submitted			2022-12-27	WOS:000283045300013
J	Kim, ML; Jeong, HG; Kasper, CA; Arrieumerlou, C				Kim, Man Lyang; Jeong, Hyun Gyeong; Kasper, Christoph Alexander; Arrieumerlou, Cecile			IKK alpha Contributes to Canonical NF-kappa B Activation Downstream of Nod1-Mediated Peptidoglycan Recognition	PLOS ONE			English	Article							SHIGELLA-FLEXNERI; SIGNALING PATHWAY; ESCHERICHIA-COLI; INNATE IMMUNITY; REGULATOR; NOD1; PATHOGENESIS; INFLAMMATION; EXPRESSION; INHIBITOR	Background: During pathogen infection, innate immunity is initiated via the recognition of microbial products by pattern recognition receptors and the subsequent activation of transcription factors that upregulate proinflammatory genes. By controlling the expression of cytokines, chemokines, anti-bacterial peptides and adhesion molecules, the transcription factor nuclear factor-kappa B (NF-kappa B) has a central function in this process. In a typical model of NF-kappa B activation, the recognition of pathogen associated molecules triggers the canonical NF-kappa B pathway that depends on the phosphorylation of Inhibitor of NF-kappa B (I kappa B) by the catalytic subunit IkB kinase beta (IKK beta), its degradation and the nuclear translocation of NF-kappa B dimers. Methodology: Here, we performed an RNA interference (RNAi) screen on Shigella flexneri-induced NF-kappa B activation to identify new factors involved in the regulation of NF-kappa B following infection of epithelial cells by invasive bacteria. By targeting a subset of the human signaling proteome, we found that the catalytic subunit IKK alpha is also required for complete NF-kappa B activation during infection. Depletion of IKK alpha by RNAi strongly reduces the nuclear translocation of NF-kappa B p65 during S. flexneri infection as well as the expression of the proinflammatory chemokine interleukin-8. Similar to IKK beta, IKK alpha contributes to the phosphorylation of IkBa on serines 32 and 36, and to its degradation. Experiments performed with the synthetic Nod1 ligand L-Ala-D-gamma-Glu-meso-diaminopimelic acid confirmed that IKK alpha is involved in NF-kappa B activation triggered downstream of Nod1-mediated peptidoglycan recognition. Conclusions: Taken together, these results demonstrate the unexpected role of IKK alpha in the canonical NF-kappa B pathway triggered by peptidoglycan recognition during bacterial infection. In addition, they suggest that IKK alpha may be an important drug target for the development of treatments that aim at limiting inflammation in bacterial infection.	[Kim, Man Lyang; Jeong, Hyun Gyeong; Kasper, Christoph Alexander; Arrieumerlou, Cecile] Univ Basel, Biozentrum, Basel, Switzerland	University of Basel	Kim, ML (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	cecile.arrieumerlou@unibas.ch			Swiss National Science Foundation [3100A0-113561]; University of Basel; Werner-Siemens Foundation; SystemsX.ch	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Basel; Werner-Siemens Foundation; SystemsX.ch	This work was supported by Swiss National Science Foundation (grant 3100A0-113561, www.snf.ch), the University of Basel (www.unibas.ch) and the InfectX grant from SystemsX.ch (www.systemsx.ch). C. Kasper was supported by the Werner-Siemens Foundation (www.wernersiemens-stiftung.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLI M, PLOS ONE, V5, pE9428; Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; BLASIUS AL, IMMUNITY, V32, P305; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEHIO C, 1995, EMBO J, V14, P2471, DOI 10.1002/j.1460-2075.1995.tb07244.x; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Girardin SE, 2001, EMBO REP, V2, P736, DOI 10.1093/embo-reports/kve155; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Inohara N, 2000, J BIOL CHEM, V275, P27823; Islam D, 1997, INFECT IMMUN, V65, P739, DOI 10.1128/IAI.65.2.739-749.1997; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Le Bourhis L, 2007, BIOCHEM SOC T, V35, P1479, DOI 10.1042/BST0351479; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Murphy KC, 2003, BMC MOL BIOL, V4, DOI 10.1186/1471-2199-4-11; OGAWA H, CLIN EXP ALLERGY; Ogawa M, 2008, NAT REV MICROBIOL, V6, P11, DOI 10.1038/nrmicro1814; Pedron T, 2003, J BIOL CHEM, V278, P33878, DOI 10.1074/jbc.M303749200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Rasmussen SB, 2009, APMIS, V117, P323, DOI 10.1111/j.1600-0463.2009.02456.x; REIJMERINK NE, ALLERGY, V65, P199; Sansonetti PJ, 1999, INFECT IMMUN, V67, P1471, DOI 10.1128/IAI.67.3.1471-1480.1999; Schroeder GN, 2008, CLIN MICROBIOL REV, V21, P134, DOI 10.1128/CMR.00032-07; Solt LA, 2007, J BIOL CHEM, V282, P8724, DOI 10.1074/jbc.M609613200; Solt LA, 2008, IMMUNOL RES, V42, P3, DOI 10.1007/s12026-008-8025-1; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Weidinger S, 2005, J ALLERGY CLIN IMMUN, V116, P177, DOI 10.1016/j.jaci.2005.02.034; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Ziegelbauer K, 2005, BRIT J PHARMACOL, V145, P178, DOI 10.1038/sj.bjp.0706176	38	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15371	10.1371/journal.pone.0015371	http://dx.doi.org/10.1371/journal.pone.0015371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976174	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700033
J	Conceicao, IC; Aguade, M				Conceicao, Ines C.; Aguade, Montserrat			Odorant Receptor (Or) Genes: Polymorphism and Divergence in the D. melanogaster and D. pseudoobscura Lineages	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SEQUENCE EVOLUTION; POSITIVE SELECTION; DNA; POPULATION; PATTERNS; HITCHHIKING; SIGNATURE; PROTEINS; AFRICAN	Background: In insects, like in most invertebrates, olfaction is the principal sensory modality, which provides animals with essential information for survival and reproduction. Odorant receptors are involved in this response, mediating interactions between an individual and its environment, as well as between individuals of the same or different species. The adaptive importance of odorant receptors renders them good candidates for having their variation shaped by natural selection. Methodology/Principal Findings: We analyzed nucleotide variation in a subset of eight Or genes located on the 3L chromosomal arm of Drosophila melanogaster in a derived population of this species and also in a population of Drosophila pseudoobscura. Some heterogeneity in the silent polymorphism to divergence ratio was detected in the D. melanogaster/D. simulans comparison, with a single gene (Or67b) contributing similar to 37% to the test statistic. However, no other signals of a very recent selective event were detected at this gene. In contrast, at the speciation timescale, the MK test uncovered the footprint of positive selection driving the evolution of two of the encoded proteins in both D. melanogaster -OR65c and OR67a -and D. pseudoobscura -OR65b1 and OR67c. Conclusions: The powerful polymorphism/divergence approach provided evidence for adaptive evolution at a rather high proportion of the Or genes studied after relatively recent speciation events. It did not provide, however, clear evidence for very recent selective events in either D. melanogaster or D. pseudoobscura.	[Conceicao, Ines C.; Aguade, Montserrat] Univ Barcelona, Dept Genet, Fac Biol, Barcelona, Spain; [Aguade, Montserrat] Univ Barcelona, Inst Recerca Biodiversitat, Barcelona, Spain	University of Barcelona; University of Barcelona	Conceicao, IC (corresponding author), Univ Barcelona, Dept Genet, Fac Biol, Barcelona, Spain.	maguade@ub.edu	Conceiçao, Ines/ABC-6167-2021	Aguade, Montserrat/0000-0002-3884-7800; Conceicao, Ines/0000-0002-1246-3761	Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BD/11107/2002]; Comision Interdepartamental de Ciencia y Tecnologia, Spain [BFU2004-02253, BFU2007-63229]; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain [2005SGR-00166]	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Comision Interdepartamental de Ciencia y Tecnologia, Spain; Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain(Generalitat de Catalunya)	I.C.C. was supported by predoctoral fellowship SFRH/BD/11107/2002 from Fundacao para a Ciencia e a Tecnologia, Portugal. This work was supported by grants BFU2004-02253 and BFU2007-63229 from Comision Interdepartamental de Ciencia y Tecnologia, Spain, and 2005SGR-00166 from Comissio Interdepartamental de Recerca i Innovacio Tecnologica, Generalitat de Catalunya, Spain, to M. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 1989, DROSOPHILA LAB HDB; Begun DJ, 2007, PLOS BIOL, V5, P2534, DOI 10.1371/journal.pbio.0050310; Burland T G, 2000, Methods Mol Biol, V132, P71; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; CONCEICAO IC, 2008, J MOL EVOL; Dean MD, 2003, GENETICS, V165, P1959; DOBZHANSKY T, 1970, GENETICS EVOLUTIONAR, pR9; Fay JC, 2000, GENETICS, V155, P1405; Gallach M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-408; Glinka S, 2003, GENETICS, V165, P1269; Haddrill PR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r67; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204; Hamblin MT, 1999, GENETICS, V153, P859; HOLM S, 1979, SCAND J STAT, V6, P65; HUDSON RR, 1987, GENETICS, V116, P153; HUDSON RR, 1985, GENETICS, V111, P147; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kelly JK, 1997, GENETICS, V146, P1197; Kim Y, 2002, GENETICS, V160, P765; Kovacevic M, 2000, GENETICS, V156, P155; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Machado CA, 2002, MOL BIOL EVOL, V19, P472, DOI 10.1093/oxfordjournals.molbev.a004103; MADDISON W. P., 2000, MACCLADE 4 ANAL PHYL; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Nei M., 1987, MOL EVOLUTIONARY GEN; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Pascual M, 2004, J ZOOL SYST EVOL RES, V42, P33, DOI 10.1046/j.0947-5745.2003.00237.x; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozas J, 2001, GENETICS, V158, P1147; Shapiro JA, 2007, P NATL ACAD SCI USA, V104, P2271, DOI 10.1073/pnas.0610385104; TAJIMA F, 1989, GENETICS, V123, P585; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Zeng K, 2006, GENETICS, V174, P1431, DOI 10.1534/genetics.106.061432; Zhou JJ, 2010, INSECT MOL BIOL, V19, P113, DOI 10.1111/j.1365-2583.2009.00919.x; Zhou SS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000681	44	3	3	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13389	10.1371/journal.pone.0013389	http://dx.doi.org/10.1371/journal.pone.0013389			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967126	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800049
J	Kandadi, MR; Hua, YN; Ma, H; Li, Q; Kuo, SR; Frankel, AE; Ren, J				Kandadi, Machender R.; Hua, Yinan; Ma, Heng; Li, Qun; Kuo, Shu-ru; Frankel, Arthur E.; Ren, Jun			Anthrax Lethal Toxin Suppresses Murine Cardiomyocyte Contractile Function and Intracellular Ca2+ Handling via a NADPH Oxidase-Dependent Mechanism	PLOS ONE			English	Article							PROTECTIVE ANTIGEN; EDEMA TOXIN; RAT MODEL; MICE; SHOCK; DYSFUNCTION; INFECTION; GROWTH; TOXICITY; SURVIVAL	Objectives: Anthrax infection is associated with devastating cardiovascular sequelae, suggesting unfavorable cardiovascular effects of toxins originated from Bacillus anthracis namely lethal and edema toxins. This study was designed to examine the direct effect of lethal toxins on cardiomyocyte contractile and intracellular Ca2+ properties. Methods: Murine cardiomyocyte contractile function and intracellular Ca2+ handling were evaluated including peak shortening (PS), maximal velocity of shortening/relengthening (+/- dL/dt), time-to-PS (TPS), time-to-90% relengthening (TR90), intracellular Ca2+ rise measured as fura-2 fluorescent intensity (Delta FFI), and intracellular Ca2+ decay rate. Stress signaling and Ca2+ regulatory proteins were assessed using Western blot analysis. Results: In vitro exposure to a lethal toxin (0.05-50 nM) elicited a concentration-dependent depression on cardiomyocyte contractile and intracellular Ca2+ properties (PS, +/- dL/dt, Delta FFI), along with prolonged duration of contraction and intracellular Ca2+ decay, the effects of which were nullified by the NADPH oxidase inhibitor apocynin. The lethal toxin significantly enhanced superoxide production and cell death, which were reversed by apocynin. In vivo lethal toxin exposure exerted similar time-dependent cardiomyocyte mechanical and intracellular Ca2+ responses. Stress signaling cascades including MEK1/2, p38, ERK and JNK were unaffected by in vitro lethal toxins whereas they were significantly altered by in vivo lethal toxins. Ca2+ regulatory proteins SERCA2a and phospholamban were also differentially regulated by in vitro and in vivo lethal toxins. Autophagy was drastically triggered although ER stress was minimally affected following lethal toxin exposure. Conclusions: Our findings indicate that lethal toxins directly compromised murine cardiomyocyte contractile function and intracellular Ca2+ through a NADPH oxidase-dependent mechanism.	[Kandadi, Machender R.; Hua, Yinan; Ma, Heng; Li, Qun; Ren, Jun] Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA; [Kuo, Shu-ru; Frankel, Arthur E.] Scott & White Mem Hosp & Clin, Canc Res Inst, Temple, TX 76508 USA	University of Wyoming; Scott & White Medical Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Kandadi, MR (corresponding author), Univ Wyoming, Coll Hlth Sci, Ctr Cardiovasc Res & Alternat Med, Laramie, WY 82071 USA.	jren@uwyo.edu	Ren, Jun/ACG-5366-2022	Ren, Jun/0000-0002-0275-0783				Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Behe P, 2007, BIOCHEM SOC T, V35, P1100, DOI 10.1042/BST0351100; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bleeke T, 2004, CIRC RES, V94, P37, DOI 10.1161/01.RES.0000109412.80157.7D; Borio L, 2001, JAMA-J AM MED ASSOC, V286, P2554, DOI 10.1001/jama.286.20.2554; Cai H, 2003, TRENDS PHARMACOL SCI, V24, P471, DOI 10.1016/S0165-6147(03)00233-5; Cone LA, 2005, J HEART VALVE DIS, V14, P37; Cui XZ, 2007, J INFECT DIS, V195, P572, DOI 10.1086/510856; Cui XZ, 2005, J INFECT DIS, V191, P422, DOI 10.1086/427189; Cui XZ, 2004, AM J PHYSIOL-REG I, V286, pR699, DOI 10.1152/ajpregu.00593.2003; Culley NC, 2005, INFECT IMMUN, V73, P7006, DOI 10.1128/IAI.73.10.7006-7010.2005; Dong F, 2006, HYPERTENSION, V47, P222, DOI 10.1161/01.HYP.0000198555.51645.f1; Edick MJ, 2007, MOL BIOL CELL, V18, P2481, DOI 10.1091/mbc.E06-04-0261; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; Firoved AM, 2007, INFECT IMMUN, V75, P2120, DOI 10.1128/IAI.01781-06; Firoved AM, 2005, AM J PATHOL, V167, P1309, DOI 10.1016/S0002-9440(10)61218-7; Frankel AE, 2009, FRONT BIOSCI, V14, P4516, DOI 10.2741/3544; Hougee S, 2006, EUR J PHARMACOL, V531, P264, DOI 10.1016/j.ejphar.2005.11.061; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; KLEIN F, 1968, J INFECT DIS, V118, P97, DOI 10.1093/infdis/118.1.97; Kuo SR, 2008, MICROB PATHOGENESIS, V44, P467, DOI 10.1016/j.micpath.2007.12.001; Li Q, 2007, REJUV RES, V10, P501, DOI 10.1089/rej.2007.0552; Marcus H, 2004, INFECT IMMUN, V72, P3471, DOI 10.1128/IAI.72.6.3471-3477.2004; MILLER DJ, 1995, J HUM HYPERTENS, V9, P465; Moayeri M, 2004, CURR OPIN MICROBIOL, V7, P19, DOI 10.1016/j.mib.2003.12.001; Moayeri M, 2003, J CLIN INVEST, V112, P670, DOI [10.1172/JCI200317991, 10.1172/JCI17991]; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Noh KM, 2000, J NEUROSCI, V20; Privratsky JR, 2003, HYPERTENSION, V42, P206, DOI 10.1161/01.HYP.0000082814.62655.85; Rossi CA, 2008, INFECT IMMUN, V76, P5790, DOI 10.1128/IAI.00520-08; Sapra R, 2006, MICROB PATHOGENESIS, V41, P157, DOI 10.1016/j.micpath.2006.07.002; Watson LE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000466; Watson LE, 2007, FRONT BIOSCI-LANDMRK, V12, P4670, DOI 10.2741/2416	33	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13335	10.1371/journal.pone.0013335	http://dx.doi.org/10.1371/journal.pone.0013335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967205	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800030
J	Nettle, D				Nettle, Daniel			Why Are There Social Gradients in Preventative Health Behavior? A Perspective from Behavioral Ecology	PLOS ONE			English	Article							SOCIOECONOMIC INEQUALITIES; TIME PERSPECTIVE; LIFE EXPECTANCY; ADULT HEALTH; MORTALITY; DISEASE; SMOKING; MODELS; EPIDEMIOLOGY; DISADVANTAGE	Background: Within affluent populations, there are marked socioeconomic gradients in health behavior, with people of lower socioeconomic position smoking more, exercising less, having poorer diets, complying less well with therapy, using medical services less, ignoring health and safety advice more, and being less health-conscious overall, than their more affluent peers. Whilst the proximate mechanisms underlying these behavioral differences have been investigated, the ultimate causes have not. Methodology/Principal Findings: This paper presents a theoretical model of why socioeconomic gradients in health behavior might be found. I conjecture that lower socioeconomic position is associated with greater exposure to extrinsic mortality risks (that is, risks that cannot be mitigated through behavior), and that health behavior competes for people's time and energy against other activities which contribute to their fitness. Under these two assumptions, the model shows that the optimal amount of health behavior to perform is indeed less for people of lower socioeconomic position. Conclusions/Significance: The model predicts an exacerbatory dynamic of poverty, whereby the greater exposure of poor people to unavoidable harms engenders a disinvestment in health behavior, resulting in a final inequality in health outcomes which is greater than the initial inequality in material conditions. I discuss the assumptions of the model, and its implications for strategies for the reduction of health inequalities.	Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK	Nettle, D (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne, Tyne & Wear, England.	daniel.nettle@ncl.ac.uk	Nettle, Daniel/B-2259-2008	Nettle, Daniel/0000-0001-9089-2599				Abrams PA, 1995, EVOLUTION, V49, P1055, DOI 10.1111/j.1558-5646.1995.tb04433.x; Adams J, 2009, J HEALTH PSYCHOL, V14, P794, DOI 10.1177/1359105309338979; Adams J, 2009, HEALTH PSYCHOL, V28, P83, DOI 10.1037/0278-6133.28.1.83; ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Auld MC, 2003, J HEALTH ECON, V22, P361, DOI 10.1016/S0167-6296(02)00103-0; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Barr RG, 2002, ARCH INTERN MED, V162, P1761, DOI 10.1001/archinte.162.15.1761; Bolte G, 2010, EUR J PUBLIC HEALTH, V20, P14, DOI 10.1093/eurpub/ckp213; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Cichon M, 1997, P ROY SOC B-BIOL SCI, V264, P1383, DOI 10.1098/rspb.1997.0192; Colgan F, 2004, J EPIDEMIOL COMMUN H, V58, P929, DOI 10.1136/jech.2003.016972; Cristia JP, 2009, J HEALTH ECON, V28, P984, DOI 10.1016/j.jhealeco.2009.06.003; Crouse DL, 2009, SOC SCI MED, V69, P971, DOI 10.1016/j.socscimed.2009.07.010; Cubbin C, 2000, J EPIDEMIOL COMMUN H, V54, P517, DOI 10.1136/jech.54.7.517; Frank SA, 1996, Q REV BIOL, V71, P37, DOI 10.1086/419267; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Guthrie LC, 2009, SOC SCI MED, V68, P2145, DOI 10.1016/j.socscimed.2009.04.004; Heinrich J, 2007, INT J HYG ENVIR HEAL, V210, P617, DOI 10.1016/j.ijheh.2007.07.012; Jerrett M, 2009, ENVIRON HEALTH PERSP, V117, P772, DOI 10.1289/ehp.11533; Kirkwood TBL, 1997, PHILOS T R SOC B, V352, P1765, DOI 10.1098/rstb.1997.0160; Kremer M, 1996, Q J ECON, V111, P549, DOI 10.2307/2946687; KRIEGER N, 1994, SOC SCI MED, V39, P887, DOI 10.1016/0277-9536(94)90202-X; Lahelma E, 2010, HEALTH PLACE, V16, P61, DOI 10.1016/j.healthplace.2009.08.004; Lantz PM, 1998, JAMA-J AM MED ASSOC, V279, P1703, DOI 10.1001/jama.279.21.1703; Lawlor DA, 2003, AM J PUBLIC HEALTH, V93, P266, DOI 10.2105/AJPH.93.2.266; Lowry R, 1996, JAMA-J AM MED ASSOC, V276, P792, DOI 10.1001/jama.276.10.792; Lynch JW, 2000, BMJ-BRIT MED J, V320, P1200, DOI 10.1136/bmj.320.7243.1200; Lynch JW, 1997, SOC SCI MED, V44, P809, DOI 10.1016/S0277-9536(96)00191-8; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; MARMOT MG, 1987, ANNU REV PUBL HEALTH, V8, P111, DOI 10.1146/annurev.pu.08.050187.000551; McNamara JM, 1996, NATURE, V380, P215, DOI 10.1038/380215a0; Mechanic D, 2002, HEALTH AFFAIR, V21, P48, DOI 10.1377/hlthaff.21.2.48; Nettle D, 2010, BEHAV ECOL, V21, P387, DOI 10.1093/beheco/arp202; Nettle D, 2009, PSYCHOLOGIST, V22, P934; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; PILL R, 1995, J EPIDEMIOL COMMUN H, V49, P28, DOI 10.1136/jech.49.1.28; Poulton R, 2002, LANCET, V360, P1640, DOI 10.1016/S0140-6736(02)11602-3; Power C, 1997, LANCET, V350, P1584, DOI 10.1016/S0140-6736(97)07474-6; Qi V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-275; QUINLAN RJ, HUMAN NATUREAN INTER, V21, P124; Quinlan RJ, 2007, P ROY SOC B-BIOL SCI, V274, P121, DOI 10.1098/rspb.2006.3690; Relton CL, 2005, PUBLIC HEALTH NUTR, V8, P338, DOI 10.1079/PHN2004690; Robb KA, 2009, INT J BEHAV MED, V16, P331, DOI 10.1007/s12529-008-9018-0; Scheper-Hughes Nancy., 1992, DEATH WEEPING VIOLEN; Singh GK, 2006, INT J EPIDEMIOL, V35, P969, DOI 10.1093/ije/dyl083; SMITH GD, 1993, BRIT MED J, V307, P1085, DOI 10.1136/bmj.307.6912.1085; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Soskolne V, 2010, HEALTH PLACE, V16, P242, DOI 10.1016/j.healthplace.2009.10.005; Stearns S.C., 1992, pi; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; Virtanen P, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-123; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; White M, 2009, SOCIAL INEQUALITY AND PUBLIC HEALTH, P65; Wilson M, 1997, BRIT MED J, V314, P1271, DOI 10.1136/bmj.314.7089.1271; Zweig Ferdinand, 1948, MEN PITS	58	53	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13371	10.1371/journal.pone.0013371	http://dx.doi.org/10.1371/journal.pone.0013371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967214	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800044
J	Proulx, R; Wirth, C; Voigt, W; Weigelt, A; Roscher, C; Attinger, S; Baade, J; Barnard, RL; Buchmann, N; Buscot, F; Eisenhauer, N; Fischer, M; Gleixner, G; Halle, S; Hildebrandt, A; Kowalski, E; Kuu, A; Lange, M; Milcu, A; Niklaus, PA; Oelmann, Y; Rosenkranz, S; Sabais, A; Scherber, C; Scherer-Lorenzen, M; Scheu, S; Schulze, ED; Schumacher, J; Schwichtenberg, G; Soussana, JF; Temperton, VM; Weisser, WW; Wilcke, W; Schmid, B				Proulx, Raphael; Wirth, Christian; Voigt, Winfried; Weigelt, Alexandra; Roscher, Christiane; Attinger, Sabine; Baade, Jussi; Barnard, Romain L.; Buchmann, Nina; Buscot, Francois; Eisenhauer, Nico; Fischer, Markus; Gleixner, Gerd; Halle, Stefan; Hildebrandt, Anke; Kowalski, Esther; Kuu, Annely; Lange, Markus; Milcu, Alex; Niklaus, Pascal A.; Oelmann, Yvonne; Rosenkranz, Stephan; Sabais, Alexander; Scherber, Christoph; Scherer-Lorenzen, Michael; Scheu, Stefan; Schulze, Ernst-Detlef; Schumacher, Jens; Schwichtenberg, Guido; Soussana, Jean-Francois; Temperton, Vicky M.; Weisser, Wolfgang W.; Wilcke, Wolfgang; Schmid, Bernhard			Diversity Promotes Temporal Stability across Levels of Ecosystem Organization in Experimental Grasslands	PLOS ONE			English	Article							PLANT DIVERSITY; COMPETITIVE COMMUNITIES; COMPENSATORY DYNAMICS; BIODIVERSITY; VARIABILITY; SOIL; PRODUCTIVITY; HYPOTHESIS; POOLS	The diversity-stability hypothesis states that current losses of biodiversity can impair the ability of an ecosystem to dampen the effect of environmental perturbations on its functioning. Using data from a long-term and comprehensive biodiversity experiment, we quantified the temporal stability of 42 variables characterizing twelve ecological functions in managed grassland plots varying in plant species richness. We demonstrate that diversity increases stability i) across trophic levels (producer, consumer), ii) at both the system (community, ecosystem) and the component levels (population, functional group, phylogenetic clade), and iii) primarily for aboveground rather than belowground processes. Temporal synchronization across studied variables was mostly unaffected with increasing species richness. This study provides the strongest empirical support so far that diversity promotes stability across different ecological functions and levels of ecosystem organization in grasslands.	[Proulx, Raphael; Wirth, Christian; Roscher, Christiane; Gleixner, Gerd; Schulze, Ernst-Detlef; Temperton, Vicky M.] Max Planck Inst Biogeochem, Hans Knoll Str, Jena, Germany; [Wirth, Christian; Weigelt, Alexandra] Univ Leipzig, Dept Special Bot & Funct Biodivers Res, Leipzig, Germany; [Voigt, Winfried; Weigelt, Alexandra; Halle, Stefan; Kowalski, Esther; Kuu, Annely; Lange, Markus; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Jena, Germany; [Attinger, Sabine; Hildebrandt, Anke; Schwichtenberg, Guido] UFZ Helmholtz Ctr Environm Res, Leipzig, Germany; [Baade, Jussi] Univ Jena, Inst Geog, Jena, Germany; [Barnard, Romain L.; Buchmann, Nina; Niklaus, Pascal A.; Scherer-Lorenzen, Michael] ETH, Inst Plant Anim & Agroecosyst Sci, Zurich, Switzerland; [Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Halle, Germany; [Eisenhauer, Nico; Sabais, Alexander] Tech Univ Darmstadt, Inst Zool, Darmstadt, Germany; [Eisenhauer, Nico; Scheu, Stefan] Univ Gottingen, JF Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Fischer, Markus] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Kuu, Annely] Tallinn Univ Technol, Tartu Coll, Tartu, Estonia; [Milcu, Alex] Univ London Imperial Coll Sci Technol & Med, Ctr Populat Biol, Silwood Pk, England; [Niklaus, Pascal A.; Schmid, Bernhard] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Oelmann, Yvonne; Rosenkranz, Stephan] Johannes Gutenberg Univ Mainz, Inst Geog, Mainz, Germany; [Scherber, Christoph] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Scherer-Lorenzen, Michael] Univ Freiburg, Fac Biol, Freiburg, Germany; [Soussana, Jean-Francois] INRA, Grassland Ecosystem Res, Clermont Ferrand, France; [Temperton, Vicky M.] Forschungszentrum Julich, Phytosphere Inst ICG 3, D-52425 Julich, Germany; [Wilcke, Wolfgang] Univ Bern, Inst Geog, Bern, Switzerland; [Schumacher, Jens] Univ Jena, Inst Stochast, Jena, Germany	Max Planck Society; Leipzig University; Friedrich Schiller University of Jena; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Friedrich Schiller University of Jena; Swiss Federal Institutes of Technology Domain; ETH Zurich; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Technical University of Darmstadt; University of Gottingen; University of Bern; University of Potsdam; Tallinn University of Technology; Imperial College London; University of Zurich; Johannes Gutenberg University of Mainz; University of Gottingen; University of Freiburg; INRAE; Helmholtz Association; Research Center Julich; University of Bern; Friedrich Schiller University of Jena	Proulx, R (corresponding author), Max Planck Inst Biogeochem, Hans Knoll Str, Jena, Germany.	rproulx@bgc-jena.mpg.de	Baade, Jussi/D-4281-2013; Scherber, Christoph/B-6611-2009; Scherer-Lorenzen, Michael/AGB-4140-2022; Schulze, Ernst-Detlef/K-9627-2014; Weisser, Wolfgang W/B-9718-2014; Soussana, Jean-Francois/E-2543-2012; Scheu, Stefan/H-7049-2015; Schmid, Bernhard/C-8625-2009; Soussana, Jean-Francois/P-2094-2016; Soussana, Jean-Francois/M-2814-2017; Wilcke, Wolfgang/P-4620-2016; Niklaus, Pascal A/G-5786-2010; Kuu, Annely/AAL-4740-2020; Wirth, Christian/A-4446-2016; Buchmann, Nina/E-6095-2011; Barnard, Romain L./G-8190-2011; Fischer, Markus/C-6411-2008; Oelmann, Yvonne/J-8730-2016; Buscot, Francois/A-4125-2016; Hildebrandt, Anke/J-7062-2012; Gleixner, Gerd/M-8519-2017; Eisenhauer, Nico/I-3191-2019; Eisenhauer, Nico/I-5932-2012; Gleixner, Gerd/O-4215-2019; Milcu, Alexandru/X-6267-2018	Baade, Jussi/0000-0001-9878-7232; Scherber, Christoph/0000-0001-7924-8911; Scherer-Lorenzen, Michael/0000-0001-9566-590X; Weisser, Wolfgang W/0000-0002-2757-8959; Schmid, Bernhard/0000-0002-8430-3214; Soussana, Jean-Francois/0000-0002-1932-6583; Wilcke, Wolfgang/0000-0002-6031-4613; Niklaus, Pascal A/0000-0002-2360-1357; Buchmann, Nina/0000-0003-0826-2980; Barnard, Romain L./0000-0002-6440-1159; Fischer, Markus/0000-0002-5589-5900; Oelmann, Yvonne/0000-0003-3513-6568; Buscot, Francois/0000-0002-2364-0006; Hildebrandt, Anke/0000-0001-8643-1634; Gleixner, Gerd/0000-0002-4616-0953; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Gleixner, Gerd/0000-0002-4616-0953; Proulx, Raphael/0000-0002-9188-9225; Kuu, Annely/0000-0002-0335-6243; Milcu, Alexandru/0000-0002-2889-1234; Temperton, Vicky/0000-0003-0543-4521	German Science Foundation [FOR 456]; Natural Environment Research Council [cpb010001] Funding Source: researchfish; NERC [cpb010001] Funding Source: UKRI	German Science Foundation(German Research Foundation (DFG)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The Jena Experiment is funded by the German Science Foundation (FOR 456) with additional support from the Max Planck Society and the Friedrich Schiller University Jena. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai YF, 2004, NATURE, V431, P181, DOI 10.1038/nature02850; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Caldeira MC, 2005, OIKOS, V110, P115, DOI 10.1111/j.0030-1299.2005.13873.x; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Christianou M, 2008, J THEOR BIOL, V253, P162, DOI 10.1016/j.jtbi.2008.03.001; Delta-T Devices, 1999, THET PROB SOIL MOIST; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Eisenhauer N, 2010, ECOLOGY, V91, P485, DOI 10.1890/08-2338.1; Eisenhauer N, 2009, OECOLOGIA, V161, P291, DOI 10.1007/s00442-009-1374-1; Flynn DFB, 2008, J PLANT ECOL, V1, P59, DOI 10.1093/jpe/rtm004; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jiang L, 2009, AM NAT, V174, P651, DOI 10.1086/605961; Kolasa J, 2003, P ROY SOC B-BIOL SCI, V270, pS198, DOI 10.1098/rsbl.2003.0059; Legendre P., 2012, NUMERICAL ECOLOGY; Lehman CL, 2000, AM NAT, V156, P534, DOI 10.1086/303402; Loreau M, 2008, AM NAT, V172, pE48, DOI 10.1086/589746; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Ranta E, 2008, OIKOS, V117, P1907, DOI 10.1111/j.1600-0706.2008.16614.x; Romanuk TN, 2004, ECOSCIENCE, V11, P455, DOI 10.1080/11956860.2004.11682855; Roscher C, 2004, BASIC APPL ECOL, V5, P107, DOI 10.1078/1439-1791-00216; Roscher C, 2009, J ECOL, V97, P32, DOI 10.1111/j.1365-2745.2008.01451.x; Roscher C, 2009, ACTA OECOL, V35, P206, DOI 10.1016/j.actao.2008.10.003; Schmid Bernhard, 2009, P14; Siemann E, 1998, AM NAT, V152, P738, DOI 10.1086/286204; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Steinbeiss S, 2008, GLOBAL CHANGE BIOL, V14, P2937, DOI 10.1111/j.1365-2486.2008.01697.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TOKESHI M, 1995, RES POPUL ECOL, V37, P43, DOI 10.1007/BF02515760; Weigelt A., 2010, ECOLOGY, V91, P930, DOI DOI 10.1890/09-0863.1; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	37	74	76	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13382	10.1371/journal.pone.0013382	http://dx.doi.org/10.1371/journal.pone.0013382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967213	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800046
J	Jaeger, S; Ertaylan, G; van Dijk, D; Leser, U; Sloot, P				Jaeger, Samira; Ertaylan, Gokhan; van Dijk, David; Leser, Ulf; Sloot, Peter			Inference of Surface Membrane Factors of HIV-1 Infection through Functional Interaction Networks	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; DUFFY ANTIGEN RECEPTOR; LYMPHOTOXIN-BETA RECEPTOR; LEUKEMIA INHIBITOR FACTOR; RED-BLOOD-CELLS; INTERACTION DATABASE; TRANS-INFECTION; LYMPHOID-TISSUE; GENE ONTOLOGY; IG PRODUCTION	Background: HIV infection affects the populations of T helper cells, dendritic cells and macrophages. Moreover, it has a serious impact on the central nervous system. It is yet not clear whether this list is complete and why specifically those cell types are affected. To address this question, we have developed a method to identify cellular surface proteins that permit, mediate or enhance HIV infection in different cell/tissue types in HIV-infected individuals. Receptors associated with HIV infection share common functions and domains and are involved in similar cellular processes. These properties are exploited by bioinformatics techniques to predict novel cell surface proteins that potentially interact with HIV. Methodology/Principal Findings: We compiled a set of surface membrane proteins (SMP) that are known to interact with HIV. This set is extended by proteins that have direct interaction and share functional similarity. This resulted in a comprehensive network around the initial SMP set. Using network centrality analysis we predict novel surface membrane factors from the annotated network. We identify 21 surface membrane factors, among which three have confirmed functions in HIV infection, seven have been identified by at least two other studies, and eleven are novel predictions and thus excellent targets for experimental investigation. Conclusions: Determining to what extent HIV can interact with human SMPs is an important step towards understanding patient specific disease progression. Using various bioinformatics techniques, we generate a set of surface membrane factors that constitutes a well-founded starting point for experimental testing of cell/tissue susceptibility of different HIV strains as well as for cohort studies evaluating patient specific disease progression.	[Jaeger, Samira; Leser, Ulf] Humboldt Univ, Berlin, Germany; [Jaeger, Samira] Cent Wiskunde & Informat, Amsterdam, Netherlands; [Ertaylan, Gokhan; van Dijk, David; Sloot, Peter] Univ Amsterdam, Amsterdam, Netherlands	Humboldt University of Berlin; University of Amsterdam	Jaeger, S (corresponding author), Humboldt Univ, Berlin, Germany.	sjaeger@informatik.hu-berlin.de; g.ertaylan@uva.nl	Sloot, Peter/B-3078-2014	Sloot, Peter/0000-0002-3848-5395; van Dijk, David/0000-0003-3911-9925; Ertaylan, Gokhan/0000-0001-5602-6435	European Union [IST-027446, FET-233847]; European Molecular Biology Organization (EMBO); NaFoeG	European Union(European Commission); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NaFoeG	This work is supported by European Union projects Virolab (IST-027446) and Dynanets (FET-233847), a European Molecular Biology Organization (EMBO) short-term fellowship and a NaFoeG scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baillou C, 2003, AIDS, V17, P563, DOI 10.1097/00002030-200303070-00012; Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664; Becker Y, 2006, VIRUS GENES, V33, P235, DOI 10.1007/s11262-006-0064-x; Beel K, 2009, HAEMATOL-HEMATOL J, V94, P1449, DOI 10.3324/haematol.2009.009001; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; BRESSLER P, 1991, J IMMUNOL, V147, P2290; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Broder CC, 1997, J LEUKOCYTE BIOL, V62, P20, DOI 10.1002/jlb.62.1.20; Chaipan C, 2006, J VIROL, V80, P8951, DOI 10.1128/JVI.00136-06; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Chen J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-73; Chu PG, 2001, APPL IMMUNOHISTO M M, V9, P97, DOI 10.1097/00022744-200106000-00001; Coleman CM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-51; Cook JA, 2002, J IMMUNOL, V169, P254, DOI 10.4049/jimmunol.169.1.254; Couto FM, 2007, DATA KNOWL ENG, V61, P137, DOI 10.1016/j.datak.2006.05.003; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dobbs AK, 2007, J IMMUNOL, V179, P2055, DOI 10.4049/jimmunol.179.4.2055; Dong CS, 2007, J VIROL, V81, P11352, DOI 10.1128/JVI.01081-07; Dunn SJ, 2004, VIROLOGY, V321, P260, DOI 10.1016/j.virol.2004.01.010; Edwards CTT, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-28; Fang CT, 2007, QJM-INT J MED, V100, P97, DOI 10.1093/qjmed/hcl141; Fasnacht N, 2008, SEMIN CELL DEV BIOL, V19, P379, DOI 10.1016/j.semcdb.2008.07.001; Favre D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000295; Filonzi M, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-29; FOY TM, 1993, J EXP MED, V178, P1567, DOI 10.1084/jem.178.5.1567; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Ghosn J, 2004, AIDS, V18, P447, DOI 10.1097/00002030-200402200-00011; Gianesello L, 2009, ANN NY ACAD SCI, V1160, P192, DOI 10.1111/j.1749-6632.2008.03789.x; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gorry PR, 2007, VIROLOGY, V362, P163, DOI 10.1016/j.virol.2006.11.025; Hadjkacem B, 2009, ANN HEMATOL, V88, P465, DOI 10.1007/s00277-008-0611-8; He WJ, 2008, CELL HOST MICROBE, V4, P52, DOI 10.1016/j.chom.2008.06.002; Horne KC, 2009, CELL HOST MICROBE, V5, P415, DOI 10.1016/j.chom.2009.04.013; JAEGER S, 2007, LNI, V115, P146; Julg B, 2009, CELL HOST MICROBE, V5, P413, DOI 10.1016/j.chom.2009.04.009; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kawamura T, 2003, P NATL ACAD SCI USA, V100, P8401, DOI 10.1073/pnas.1432450100; Kern A, 2009, ANN NY ACAD SCI, V1160, P60, DOI 10.1111/j.1749-6632.2008.03826.x; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Kop EN, 2009, IMMUNOL LETT, V123, P160, DOI 10.1016/j.imlet.2009.03.009; Koschutzki D, 2008, GENE REGUL SYST BIO, V2, P193, DOI 10.4137/GRSB.S702; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liu Y, 2004, J VIROL, V78, P4120, DOI 10.1128/JVI.78.8.4120-4133.2004; Macal M, 2008, MUCOSAL IMMUNOL, V1, P475, DOI 10.1038/mi.2008.35; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Maho A, 1999, CYTOGENET CELL GENET, V87, P265, DOI 10.1159/000015443; Marshall WL, 1999, J IMMUNOL, V162, P6016; Martin G, 2007, J VIROL, V81, P5872, DOI 10.1128/JVI.02542-06; Morikawa K, 2002, BRIT J HAEMATOL, V118, P296, DOI 10.1046/j.1365-2141.2002.03574.x; Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106; Nance CL, 2002, CLIN IMMUNOL, V105, P208, DOI 10.1006/clim.2002.5284; Neil SJD, 2005, J VIROL, V79, P9618, DOI 10.1128/JVI.79.15.9618-9624.2005; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Pagel P, 2005, BIOINFORMATICS, V21, P832, DOI 10.1093/bioinformatics/bti115; Passam AM, 2007, AIDS RES HUM RETROV, V23, P1026, DOI 10.1089/aid.2006.0248; Patke CL, 2000, J ALLERGY CLIN IMMUN, V105, P975, DOI 10.1067/mai.2000.105315; Patterson BK, 2001, J CLIN INVEST, V107, P287, DOI 10.1172/JCI11481; Piguet V, 1999, REV MED VIROL, V9, P111, DOI 10.1002/(SICI)1099-1654(199904/06)9:2&lt;111::AID-RMV245&gt;3.0.CO;2-P; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; RAPAPORT R, 2004, C RETR OPP INF 11 20; Reich D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000360; Romanowicz L, 2010, INT J EXP PATHOL, V91, P1, DOI 10.1111/j.1365-2613.2009.00675.x; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Shen AD, 2007, J VIROL, V81, P1660, DOI 10.1128/JVI.01396-06; Shimizu N, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-52; Shimizu N, 2009, AIDS, V23, P761, DOI 10.1097/QAD.0b013e328326cc0d; Singh P, 2008, VACCINE, V26, P2966, DOI 10.1016/j.vaccine.2008.01.012; Sloot PMA, 2009, PHILOS T R SOC A, V367, P2691, DOI 10.1098/rsta.2009.0043; Tjernlund A, 2006, AIDS, V20, P11, DOI 10.1097/01.aids.0000198082.16960.94; Tjernlund A, 2003, AIDS, V17, P1303, DOI 10.1097/00002030-200306130-00004; Utaipat U, 2002, AIDS RES HUM RETROV, V18, P1, DOI 10.1089/088922202753394664; van Dijk D, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-96; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Vanham G, 1999, CLIN EXP IMMUNOL, V117, P335; Walley NM, 2009, CELL HOST MICROBE, V5, P408, DOI 10.1016/j.chom.2009.04.011; Walton RT, 2008, CELL HOST MICROBE, V4, P3, DOI 10.1016/j.chom.2008.06.006; Winkler CA, 2009, CELL HOST MICROBE, V5, P411, DOI 10.1016/j.chom.2009.04.010; Wu JQ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-24; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Zhang S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-395; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	87	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13139	10.1371/journal.pone.0013139	http://dx.doi.org/10.1371/journal.pone.0013139			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967291	Green Published, Green Submitted, gold			2022-12-27	WOS:000282807300003
J	Peterson, JE; Lenczewski, ME; Scherer, RP				Peterson, Joseph E.; Lenczewski, Melissa E.; Scherer, Reed P.			Influence of Microbial Biofilms on the Preservation of Primary Soft Tissue in Fossil and Extant Archosaurs	PLOS ONE			English	Article							CELLULAR PRESERVATION; BACTERIAL BIOFILMS; TYRANNOSAURUS-REX; PROTEIN SEQUENCES; BONE; MINERALIZATION; FOSSILIZATION; DECAY; ENVIRONMENT; SURVIVAL	Background: Mineralized and permineralized bone is the most common form of fossilization in the vertebrate record. Preservation of gross soft tissues is extremely rare, but recent studies have suggested that primary soft tissues and biomolecules are more commonly preserved within preserved bones than had been presumed. Some of these claims have been challenged, with presentation of evidence suggesting that some of the structures are microbial artifacts, not primary soft tissues. The identification of biomolecules in fossil vertebrate extracts from a specimen of Brachylophosaurus canadensis has shown the interpretation of preserved organic remains as microbial biofilm to be highly unlikely. These discussions also propose a variety of potential mechanisms that would permit the preservation of soft-tissues in vertebrate fossils over geologic time. Methodology/Principal Findings: This study experimentally examines the role of microbial biofilms in soft-tissue preservation in vertebrate fossils by quantitatively establishing the growth and morphology of biofilms on extant archosaur bone. These results are microscopically and morphologically compared with soft-tissue extracts from vertebrate fossils from the Hell Creek Formation of southeastern Montana (Latest Maastrichtian) in order to investigate the potential role of microbial biofilms on the preservation of fossil bone and bound organic matter in a variety of taphonomic settings. Based on these analyses, we highlight a mechanism whereby this bound organic matter may be preserved. Conclusions/Significance: Results of the study indicate that the crystallization of microbial biofilms on decomposing organic matter within vertebrate bone in early taphonomic stages may contribute to the preservation of primary soft tissues deeper in the bone structure.	[Peterson, Joseph E.] Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA; [Lenczewski, Melissa E.; Scherer, Reed P.] No Illinois Univ, Dept Geol & Environm Geosci, De Kalb, IL 60115 USA	University of Wisconsin System; Northern Illinois University	Peterson, JE (corresponding author), Univ Wisconsin, Dept Geol, Oshkosh, WI 54901 USA.	jpeterson0204@gmail.com			Northern Illinois University Department of Geology and Environmental Geosciences; American Association for Microbiology	Northern Illinois University Department of Geology and Environmental Geosciences; American Association for Microbiology	Funding was provided by Goldich Fund, Northern Illinois University Department of Geology and Environmental Geosciences; Student Travel Fund, American Association for Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P.A., 1991, FOSSILIZATION PROCES, P120; ALLISON PA, 1988, PALEOBIOLOGY, V14, P139, DOI 10.1017/S009483730001188X; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Behrensmeyer A.K., 1991, TAPHONOMY RELEASING, P291, DOI [DOI 10.1007/978-1-4899-5034-5, 10.1007/978-1-4899-5034-5_6, DOI 10.1007/978-1-4899-5034-5_6]; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Blob RW, 1997, PALAIOS, V12, P151, DOI 10.2307/3515304; BOAZ NT, 1976, AM J PHYS ANTHROPOL, V45, P53, DOI 10.1002/ajpa.1330450107; Briggs DEG, 1997, J GEOL SOC LONDON, V154, P587, DOI 10.1144/gsjgs.154.4.0587; BRIGGS DEG, 1993, J GEOL SOC LONDON, V150, P1035, DOI 10.1144/gsjgs.150.6.1035; Carpenter K, 2005, NEUES JAHRB GEOL P-M, P83; CHILD AM, 1995, J ARCHAEOL SCI, V22, P165, DOI 10.1006/jasc.1995.0018; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Davis J, 1986, STAT DATA ANAL GEOLO; DAVIS PG, 1995, GEOLOGY, V23, P783, DOI 10.1130/0091-7613(1995)023<0783:FOF>2.3.CO;2; Dodson P., 1973, U WYOMING CONTRIB GE, V12, P15; EBDON D, 1991, STATITICS GEOGRAPHY; Hof CHJ, 1997, PALAIOS, V12, P420, DOI 10.2307/3515381; Hollocher TC, 2001, PALAIOS, V16, P547, DOI 10.2307/3515628; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; McNamara ME, 2009, PALAIOS, V24, P104, DOI 10.2110/palo.2008.p08-017r; Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159; PERRY E, 1995, GEOLOGY, V23, P17, DOI 10.1130/0091-7613(1995)023<0017:ROCSNY>2.3.CO;2; Perry E, 2009, J HYDROL, V367, P27, DOI 10.1016/j.jhydrol.2008.12.026; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WOLFF RG, 1973, PALAEOGEOGR PALAEOCL, V13, P91, DOI 10.1016/0031-0182(73)90038-2; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0	32	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13334	10.1371/journal.pone.0013334	http://dx.doi.org/10.1371/journal.pone.0013334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967227	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300025
J	Raistrick, CA; Day, INM; Gaunt, TR				Raistrick, Christopher A.; Day, Ian N. M.; Gaunt, Tom R.			Genome-Wide Data-Mining of Candidate Human Splice Translational Efficiency Polymorphisms (STEPs) and an Online Database	PLOS ONE			English	Article							PRE-MESSENGER-RNA; HUMAN-DISEASE GENES; NUCLEOTIDE STRUCTURE; COMPUTATIONAL TOOLS; ALZHEIMERS-DISEASE; MUTATION PATTERN; 5'-SPLICE SITES; INSULIN GENE; ASSOCIATION; INTRON	Background: Variation in pre-mRNA splicing is common and in some cases caused by genetic variants in intronic splicing motifs. Recent studies into the insulin gene (INS) discovered a polymorphism in a 59 non-coding intron that influences the likelihood of intron retention in the final mRNA, extending the 59 untranslated region andmaintaining protein quality. Retention was also associated with increased insulin levels, suggesting that such variants-splice translational efficiency polymorphisms (STEPs)-may relate to disease phenotypes through differential protein expression. We set out to explore the prevalence of STEPs in the human genome and validate this new category of protein quantitative trait loci (pQTL) using publicly available data. Methodology/Principal Findings: Gene transcript and variant data were collected and mined for candidate STEPs in motif regions. Sequences from transcripts containing potential STEPs were analysed for evidence of splice site recognition and an effect in expressed sequence tags (ESTs). 16 publicly released genome-wide association data sets of common diseases were searched for association to candidate polymorphisms with HapMap frequency data. Our study found 3324 candidate STEPs lying in motif sequences of 59 non-coding introns and further mining revealed 170 with transcript evidence of intron retention. 21 potential STEPs had EST evidence of intron retention or exon extension, as well as population frequency data for comparison. Conclusions/Significance: Results suggest that the insulin STEP was not a unique example and that many STEPs may occur genome-wide with potentially causal effects in complex disease. An online database of STEPs is freely accessible at http://dbstep. genes.org.uk/.	[Raistrick, Christopher A.; Day, Ian N. M.; Gaunt, Tom R.] Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England; [Day, Ian N. M.; Gaunt, Tom R.] Univ Bristol, Sch Social & Community Med, MRC Ctr Causal Anal Translat Epidemiol CAiTE, Bristol, Avon, England	University of Bristol; University of Bristol	Raistrick, CA (corresponding author), Univ Bristol, Bristol Genet Epidemiol Labs, Sch Social & Community Med, Bristol, Avon, England.	ian.day@bristol.ac.uk	Gaunt, Tom R/O-3918-2014	Gaunt, Tom R/0000-0003-0924-3247	UK Medical Research Council; MRC; MRC [G0600705] Funding Source: UKRI; Medical Research Council [G0600705] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the UK Medical Research Council (MRC Capacity Building Studentship in Bioinformatics to author CR). CR is a member of the MRC funded Bristol Centre for Systems Biomedicine (BCSBmed) doctoral training centre (director INMD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMARA SG, 1982, NATURE, V298, P240, DOI 10.1038/298240a0; BERNARDI G, 1988, J MOL EVOL, V28, P7, DOI 10.1007/BF02143493; Bian L, 2005, BIOL PSYCHIAT, V58, P731, DOI 10.1016/j.biopsych.2005.05.013; Birzele F, 2008, NUCLEIC ACIDS RES, V36, pD63, DOI 10.1093/nar/gkm793; BODMER WF, 1995, CANCER SURV, V22, P5; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bonnal S, 2003, NUCLEIC ACIDS RES, V31, P427, DOI 10.1093/nar/gkg003; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Buratti E, 2007, NUCLEIC ACIDS RES, V35, P4250, DOI 10.1093/nar/gkm402; Day INM, 2006, PHYSIOL GENOMICS, V28, P113, DOI 10.1152/physiolgenomics.00126.2006; DESMET F, 2009, NUCLEIC ACIDS RES; Dodel RC, 2000, NEUROLOGY, V54, P438, DOI 10.1212/WNL.54.2.438; Eden E, 2004, NUCLEIC ACIDS RES, V32, P1131, DOI 10.1093/nar/gkh273; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Fernandez-Capetillo O, 2010, EMBO REP, V11, P32, DOI 10.1038/embor.2009.262; Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gao KP, 2008, NUCLEIC ACIDS RES, V36, P2257, DOI 10.1093/nar/gkn073; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; HAWKINS JD, 1988, NUCLEIC ACIDS RES, V16, P9893, DOI 10.1093/nar/16.21.9893; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Jones MH, 1997, GENOMICS, V45, P529, DOI 10.1006/geno.1997.5000; Kogan S, 2005, GENE, V352, P57, DOI 10.1016/j.gene.2005.03.004; Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79; Kralovicova J, 2006, DIABETES, V55, P260, DOI 10.2337/diabetes.55.01.06.db05-0773; Lin CL, 2004, BIOCHEM BIOPH RES CO, V321, P638, DOI 10.1016/j.bbrc.2004.07.013; Liu G, 2006, BIOCHEM BIOPH RES CO, V349, P360, DOI 10.1016/j.bbrc.2006.08.049; Marchand L, 2007, DIABETES, V56, P709, DOI 10.2337/db06-0402; Mauger DM, 2008, MOL CELL BIOL, V28, P5403, DOI 10.1128/MCB.00739-08; McClelland S, 2009, PPAR RES, V2009, DOI 10.1155/2009/193413; McCullough AJ, 2000, MOL CELL BIOL, V20, P9225, DOI 10.1128/MCB.20.24.9225-9235.2000; Mignone F, 2005, NUCLEIC ACIDS RES, V33, pD141, DOI 10.1093/nar/gki021; Mount SM, 2000, AM J HUM GENET, V67, P788, DOI 10.1086/303098; Myllykangas L, 1999, ANN NEUROL, V46, P382; Nestel FP, 1996, GENE, V180, P151, DOI 10.1016/S0378-1119(96)00436-2; Rao KS, 2007, NAT CLIN PRACT NEURO, V3, P162, DOI 10.1038/ncpneuro0448; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; RODRIGUEZ S, 2007, DIABETES, V56, pE17; Rodriguez Santiago, 2007, Diabetes, V56, pe17, DOI 10.2337/db07-0805; Sakashita E, 2004, MOL CELL BIOL, V24, P1174, DOI 10.1128/MCB.24.3.1174-1187.2004; SEDMAN SA, 1990, J VIROL, V64, P453, DOI 10.1128/JVI.64.1.453-457.1990; Sharma S, 2008, NAT STRUCT MOL BIOL, V15, P183, DOI 10.1038/nsmb.1375; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Thanaraj TA, 2001, NUCLEIC ACIDS RES, V29, P2581, DOI 10.1093/nar/29.12.2581; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Vorechovsky I, 2007, DIABETES, V56, P709; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Zappia M, 2004, ARCH NEUROL-CHICAGO, V61, P341, DOI 10.1001/archneur.61.3.341; ZHANG J, 1995, GENOMICS, V29, P179, DOI 10.1006/geno.1995.1229; Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919	55	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13340	10.1371/journal.pone.0013340	http://dx.doi.org/10.1371/journal.pone.0013340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948966	Green Submitted, gold, Green Published			2022-12-27	WOS:000282748100034
J	Warrilow, D; Warren, K; Harrich, D				Warrilow, David; Warren, Kylie; Harrich, David			Strand Transfer and Elongation of HIV-1 Reverse Transcription Is Facilitated by Cell Factors In Vitro	PLOS ONE			English	Article							AVIAN RETROVIRUS PARTICLES; PREINTEGRATION COMPLEXES; VIRUS; DNA; REPLICATION; CDNA; INTEGRASE; INFECTION; PROTEINS; IDENTIFICATION	Recent work suggests a role for multiple host factors in facilitating HIV-1 reverse transcription. Previously, we identified a cellular activity which increases the efficiency of HIV-1 reverse transcription in vitro. Here, we describe aspects of the activity which shed light on its function. The cellular factor did not affect synthesis of strong-stop DNA but did improve downstream DNA synthesis. The stimulatory activity was isolated by gel filtration in a single fraction of the exclusion volume. Velocity-gradient purified HIV-1, which was free of detectable RNase activity, showed poor reverse transcription efficiency but was strongly stimulated by partially purified cell proteins. Hence, the cell factor(s) did not inactivate an RNase activity that might degrade the viral genomic RNA and block completion of reverse transcription. Instead, the cell factor(s) enhanced first strand transfer and synthesis of late reverse transcription suggesting it stabilized the reverse transcription complex. The factor did not affect lysis of HIV-1 by Triton X-100 in the endogenous reverse transcription (ERT) system, and ERT reactions with HIV-1 containing capsid mutations, which varied the biochemical stability of viral core structures and impeded reverse transcription in cells, showed no difference in the ability to be stimulated by the cell factor(s) suggesting a lack of involvement of the capsid in the in vitro assay. In addition, reverse transcription products were found to be resistant to exogenous DNase I activity when the active fraction was present in the ERT assay. These results indicate that the cell factor(s) may improve reverse transcription by facilitating DNA strand transfer and DNA synthesis. It also had a protective function for the reverse transcription products, but it is unclear if this is related to improved DNA synthesis.	[Warrilow, David; Warren, Kylie; Harrich, David] Queensland Inst Med Res, Div Immunol & Infect Dis, Brisbane, Qld 4006, Australia; [Warrilow, David; Harrich, David] Griffith Med Res Coll, Herston, Qld, Australia; [Warren, Kylie] Univ Western Sydney, Sch Nat Sci, Hawkesbury, Australia	QIMR Berghofer Medical Research Institute; Griffith University; Western Sydney University	Warrilow, D (corresponding author), Queensland Inst Med Res, Div Immunol & Infect Dis, Brisbane, Qld 4006, Australia.	David.Harrich@qimr.edu.au	Harrich, David/H-6668-2016	Harrich, David/0000-0003-3690-0150	Australian National Health and Medical Research Council [496663]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the Australian National Health and Medical Research Council project grant number 496663. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; BOONE LR, 1981, J VIROL, V37, P109, DOI 10.1128/JVI.37.1.109-116.1981; BOONE LR, 1980, P NATL ACAD SCI-BIOL, V77, P847, DOI 10.1073/pnas.77.2.847; BORROTOESODA K, 1994, ANTIVIR RES, V23, P235, DOI 10.1016/0166-3542(94)90021-3; BORROTOESODA K, 1991, J VIROL, V65, P1952, DOI 10.1128/JVI.65.4.1952-1959.1991; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Choi SJ, 2000, ANAL BIOCHEM, V281, P95, DOI 10.1006/abio.2000.4529; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Fassati A, 1999, J VIROL, V73, P8919, DOI 10.1128/JVI.73.11.8919-8925.1999; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Hamamoto S, 2006, J VIROL, V80, P5670, DOI 10.1128/JVI.02471-05; Iordanskiy S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-4; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Khiytani DK, 2002, J GEN VIROL, V83, P2523, DOI 10.1099/0022-1317-83-10-2523; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lemay J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-47; Lemay J, 2008, J MOL BIOL, V383, P783, DOI 10.1016/j.jmb.2008.08.055; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Lin CW, 2003, J VIROL, V77, P5030, DOI 10.1128/JVI.77.8.5030-5036.2003; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Narayan S, 2004, P NATL ACAD SCI USA, V101, P7721, DOI 10.1073/pnas.0401312101; Nermut MV, 2003, J VIROL, V77, P8196, DOI 10.1128/JVI.77.15.8196-8206.2003; Sambook J, 1989, MOL CLONING LAB MANU; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Warren K, 2009, VIRUSES-BASEL, V1, P873, DOI 10.3390/v1030873; Warrilow D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-77; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; Warrilow D, 2009, REV MED VIROL, V19, P324, DOI 10.1002/rmv.627; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Ye Y, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-63; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; YONG WH, 1990, AIDS, V4, P199, DOI 10.1097/00002030-199003000-00004; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	35	19	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13229	10.1371/journal.pone.0013229	http://dx.doi.org/10.1371/journal.pone.0013229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949087	Green Published, gold			2022-12-27	WOS:000282568400018
J	Loeuillet, C; Lemaire-Vieille, C; Naquet, P; Cesbron-Delauw, MF; Gagnon, J; Cesbron, JY				Loeuillet, Corinne; Lemaire-Vieille, Catherine; Naquet, Philippe; Cesbron-Delauw, Marie-France; Gagnon, Jean; Cesbron, Jean-Yves			Prion Replication in the Hematopoietic Compartment Is Not Required for Neuroinvasion in Scrapie Mouse Model	PLOS ONE			English	Article							FOLLICULAR DENDRITIC CELLS; IMMUNE-SYSTEM; BLOOD-TRANSFUSION; PRP EXPRESSION; MICE; PROTEIN; DISEASES; SPLEEN; TRANSMISSION; LYMPHOCYTES	Fatal neurodegenerative prion diseases are caused by the transmissible PrP(Sc) prion agent whose initial replication after peripheral inoculation takes place in follicular dendritic cells present in germinal centers of lymphoid organs. However, prion replication also occurs in lymphoid cells. To assess the role of the hematopoietic compartment in neuroinvasion and prion replication, we generated chimeric mice, on a uniform congenic C57/BL6J background, by bone marrow replacement with hematopoietic cells expressing different levels of PrP protein. Nine different types of chimeric mice were inoculated intraperitoneally either with the lymphotropic Rocky Mountain Laboratory (RML) strain or the non lymphotropic ME-7 scrapie strain, at different doses. Here, we clearly demonstrate that overexpression of PrP by the hematopoietic system, or the lack of PrP expression by the bone marrow derived cells, does not change the incubation time period of the disease, even when the mice are infected at limiting doses. We conclude that the hematopoietic compartment is more or less permissive to prion replication, both for RML and ME-7, but does not play a role in neuroinvasion.	[Loeuillet, Corinne; Lemaire-Vieille, Catherine; Cesbron-Delauw, Marie-France; Gagnon, Jean; Cesbron, Jean-Yves] Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Grenoble, France; [Naquet, Philippe] Univ Aix Marseille 2, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Loeuillet, C (corresponding author), Univ Grenoble 1, CNRS, UMR 5163, Lab Adaptat & Pathogenie Microorganismes, Grenoble, France.	jean-yves.cesbron@ujf-grenoble.fr	cesbron delauw, marie france/M-6076-2014; Lemaire-Vieille, Catherine/C-1495-2009; loeuillet, corinne/M-6504-2014; Gagnon, Jean/C-3136-2008	loeuillet, corinne/0000-0001-6474-4453; Gagnon, Jean/0000-0002-0177-824X	Centre National de la Recherche Scientifique	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	CL was supported by a non-permanent research position at the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Aucouturier P, 2002, J LEUKOCYTE BIOL, V72, P1075; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI200113155; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Follet J, 2002, J VIROL, V76, P2434, DOI 10.1128/JVI.76.5.2434-2439.2002; Fraser H, 1996, J GEN VIROL, V77, P1935, DOI 10.1099/0022-1317-77-8-1935; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Heikenwalder M, 2005, SCIENCE, V307, P1107, DOI 10.1126/science.1106460; Hunter N, 2002, J GEN VIROL, V83, P2897, DOI 10.1099/0022-1317-83-11-2897; Jouvin-Marche E, 2006, J IMMUNOL, V176, P3490, DOI 10.4049/jimmunol.176.6.3490; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Lasmezas CI, 1996, J VIROL, V70, P1292; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Mabbott NA, 2000, J VIROL, V74, P3338, DOI 10.1128/JVI.74.7.3338-3344.2000; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; Raeber AJ, 1999, EMBO J, V18, P2702, DOI 10.1093/emboj/18.10.2702; Raymond CR, 2007, J NEUROIMMUNOL, V187, P114, DOI 10.1016/j.jneuroim.2007.05.006; Thielen C, 2001, Dev Immunol, V8, P259, DOI 10.1155/2001/45454; van Nierop K, 2002, SEMIN IMMUNOL, V14, P251, DOI 10.1016/S1044-5323(02)00057-X; Visscher PM, 1999, GENET RES, V74, P81, DOI 10.1017/S0016672399003857; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zabel M, 2009, IMMUNOLOGY, V127, P226, DOI 10.1111/j.1365-2567.2008.02944.x; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13166	10.1371/journal.pone.0013166	http://dx.doi.org/10.1371/journal.pone.0013166			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957200	Green Published, gold, Green Submitted			2022-12-27	WOS:000282506100009
J	Kam, JH; Lenassi, E; Jeffery, G				Kam, Jaimie Hoh; Lenassi, Eva; Jeffery, Glen			Viewing Ageing Eyes: Diverse Sites of Amyloid Beta Accumulation in the Ageing Mouse Retina and the Up-Regulation of Macrophages	PLOS ONE			English	Article							AGE-RELATED MACULOPATHY; COMPLEMENT ACTIVATION; SUBRETINAL MICROGLIA; COGNITIVE IMPAIRMENT; ELECTRON-MICROSCOPE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; PERIPHERAL-NERVE; A-BETA; DRUSEN	Background: Amyloid beta (A beta) accumulates in the ageing central nervous system and is associated with a number of age-related diseases, including age-related macular degeneration (AMD) in the eye. AMD is characterised by accumulation of extracellular deposits called drusen in which A beta is a key constituent. A beta activates the complement cascade and its deposition is associated with activated macrophages. So far, little is known about the quantitative measurements of A beta accumulation and definitions of its relative sites of ocular deposition in the normal ageing mouse. Methodology/Principal Findings: We have traced A beta accumulation quantitatively in the ageing mouse retina using immunohistochemistry and Western blot analysis. We reveal that it is not only deposited at Bruch's membrane and along blood vessels, but unexpectedly, it also coats photoreceptor outer segments. While A beta is present at all sites of deposition from 3 months of age, it increases markedly from 6 months onward. Progressive accumulation of deposits on outer segments was confirmed with scanning electron microscopy, revealing age-related changes in their morphology. Such progress of accumulation of A beta on photoreceptor outer segments with age was also confirmed in human retinae using immunohistochemistry. We also chart the macrophage response to increases in A beta showing up-regulation in their numbers using both confocal laser imaging of the eye in vivo followed by in vitro immunostaining. With age macrophages become bloated with cellular debris including A beta, however, their increasing numbers fail to stop A beta accumulation. Conclusions: Increasing A beta deposition in blood vessels and Bruch's membrane will impact upon retinal perfusion and clearance of cellular waste products from the outer retina, a region of very high metabolic activity. This accumulation of A beta may contribute to the 30% reduction of photoreceptors found throughout life and the shortening of those that remain. The coating of A beta on outer segments may also have an impact upon visual function with age.	[Kam, Jaimie Hoh; Lenassi, Eva; Jeffery, Glen] UCL, Inst Ophthalmol, London, England; [Lenassi, Eva] Univ Med Ctr, Hosp Eye, Ljubljana, Slovenia	University of London; University College London; University Medical Centre Ljubljana	Kam, JH (corresponding author), UCL, Inst Ophthalmol, London, England.	g.jeffery@ucl.ac.uk			Rosetrees Trust	Rosetrees Trust(Rosetrees Trust)	Funding was received from Rosetrees Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DH, 2004, EXP EYE RES, V78, P243, DOI 10.1016/j.exer.2003.10.011; Anderson DH, 2002, AM J OPHTHALMOL, V134, P411, DOI 10.1016/S0002-9394(02)01624-0; Baker D R, 1997, J Am Optom Assoc, V68, P483; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; Boissonneault V, 2009, BRAIN, V132, P1078, DOI 10.1093/brain/awn331; BRESSLER SB, 1990, ARCH OPHTHALMOL-CHIC, V108, P1442, DOI 10.1001/archopht.1990.01070120090035; Bruban J, 2009, AGING CELL, V8, P162, DOI 10.1111/j.1474-9726.2009.00456.x; COIMBRA A, 1971, BRAIN, V94, P199, DOI 10.1093/brain/94.2.199; COIMBRA A, 1971, BRAIN, V94, P207, DOI 10.1093/brain/94.2.207; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Cunea A, 2007, VISUAL NEUROSCI, V24, P151, DOI 10.1017/S0952523807070204; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; D'Andrea MR, 2004, NEUROBIOL AGING, V25, P675, DOI 10.1016/j.neurobiolaging.2003.12.026; DAVIS JB, 1992, BIOCHEM BIOPH RES CO, V189, P1096, DOI 10.1016/0006-291X(92)92317-Q; Dentchev T, 2003, MOL VIS, V9, P184; Dutescu RM, 2009, GRAEF ARCH CLIN EXP, V247, P1213, DOI 10.1007/s00417-009-1060-3; FEENEYBURNS L, 1984, INVEST OPHTH VIS SCI, V25, P195; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; GRAYMORE CN, 1969, EYE, P601; Green W R, 1999, Mol Vis, V5, P27; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Hageman GS, 2001, PROG RETIN EYE RES, V20, P705, DOI 10.1016/S1350-9462(01)00010-6; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Isas JM, 2010, INVEST OPHTH VIS SCI, V51, P1304, DOI 10.1167/iovs.09-4207; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Jackson GR, 2006, VISION RES, V46, P1422, DOI 10.1016/j.visres.2005.09.003; Jackson GR, 2004, INVEST OPHTH VIS SCI, V45, P3271, DOI 10.1167/iovs.04-0019; Johnson LV, 2002, P NATL ACAD SCI USA, V99, P11830, DOI 10.1073/pnas.192203399; KATZ B, 1989, SURV OPHTHALMOL, V34, P31, DOI 10.1016/0039-6257(89)90127-6; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein R, 1997, OPHTHALMOLOGY, V104, P7, DOI 10.1016/S0161-6420(97)30368-6; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEWIS H, 1986, OPHTHALMOLOGY, V93, P1098; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; MEDA L, 1995, J NEUROIMMUNOL, V59, P29, DOI 10.1016/0165-5728(95)00021-S; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; PAULEIKHOFF D, 1990, AM J OPHTHALMOL, V109, P38, DOI 10.1016/S0002-9394(14)75576-X; Perez SE, 2009, INVEST OPHTH VIS SCI, V50, P793, DOI 10.1167/iovs.08-2384; Raoul W, 2008, OPHTHAL RES, V40, P115, DOI 10.1159/000119860; ROGERS J, 1992, P NATL ACAD SCI USA, V89, P10016, DOI 10.1073/pnas.89.21.10016; SADUN AA, 1987, AM J OPHTHALMOL, V104, P113, DOI 10.1016/0002-9394(87)90001-8; SARKS SH, 1980, AUST J OPHTHALMOL, V8, P117, DOI 10.1111/j.1442-9071.1980.tb01670.x; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; SHIRAHAMA T, 1990, LAB INVEST, V62, P61; Takechi R, 2009, HISTOCHEM CELL BIOL, V131, P661, DOI 10.1007/s00418-009-0567-3; Terman A, 1998, APMIS, V106, P265, DOI 10.1111/j.1699-0463.1998.tb01346.x; WRIGHT CE, 1985, DOC OPHTHALMOL, V59, P385, DOI 10.1007/BF00159172; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Xu HP, 2008, AGING CELL, V7, P58, DOI 10.1111/j.1474-9726.2007.00351.x; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303	59	94	94	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13127	10.1371/journal.pone.0013127	http://dx.doi.org/10.1371/journal.pone.0013127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957206	gold, Green Submitted, Green Published			2022-12-27	WOS:000282359300021
J	Blum, R; Gupta, R; Burger, PE; Ontiveros, CS; Salm, SN; Xiong, XZ; Kamb, A; Wesche, H; Marshall, L; Cutler, G; Wang, XY; Zavadil, J; Moscatelli, D; Wilson, EL				Blum, Roy; Gupta, Rashmi; Burger, Patricia E.; Ontiveros, Christopher S.; Salm, Sarah N.; Xiong, Xiaozhong; Kamb, Alexander; Wesche, Holger; Marshall, Lisa; Cutler, Gene; Wang, Xiangyun; Zavadil, Jiri; Moscatelli, David; Wilson, E. Lynette			Molecular Signatures of the Primitive Prostate Stem Cell Niche Reveal Novel Mesenchymal-Epithelial Signaling Pathways	PLOS ONE			English	Article							HUMAN EMBRYONIC STEM; DIFFERENTIAL GENE-EXPRESSION; ELEMENT-BINDING PROTEINS; CANCER CELLS; SELF-RENEWAL; PROXIMAL REGION; IN-VIVO; TFII-I; TRANSCRIPTION FACTORS; ANDROGEN RECEPTOR	Background: Signals between stem cells and stroma are important in establishing the stem cell niche. However, very little is known about the regulation of any mammalian stem cell niche as pure isolates of stem cells and their adjacent mesenchyme are not readily available. The prostate offers a unique model to study signals between stem cells and their adjacent stroma as in the embryonic prostate stem cell niche, the urogenital sinus mesenchyme is easily separated from the epithelial stem cells. Here we investigate the distinctive molecular signals of these two stem cell compartments in a mammalian system. Methodology/Principal Findings: We isolated fetal murine urogenital sinus epithelium and urogenital sinus mesenchyme and determined their differentially expressed genes. To distinguish transcripts that are shared by other developing epithelial/mesenchymal compartments from those that pertain to the prostate stem cell niche, we also determined the global gene expression of epidermis and dermis of the same embryos. Our analysis indicates that several of the key transcriptional components that are predicted to be active in the embryonic prostate stem cell niche regulate processes such as self-renewal (e.g., E2f and Ap2), lipid metabolism (e.g., Srebp1) and cell migration (e.g., Areb6 and Rreb1). Several of the enriched promoter binding motifs are shared between the prostate epithelial/mesenchymal compartments and their epidermis/dermis counterparts, indicating their likely relevance in epithelial/mesenchymal signaling in primitive cellular compartments. Based on differential gene expression we also defined ligand-receptor interactions that may be part of the molecular interplay of the embryonic prostate stem cell niche. Conclusions/Significance: We provide a comprehensive description of the transcriptional program of the major regulators that are likely to control the cellular interactions in the embryonic prostatic stem cell niche, many of which may be common to mammalian niches in general. This study provides a comprehensive source for further studies of mesenchymal/epithelial interactions in the prostate stem cell niche. The elucidation of pathways in the normal primitive niche may provide greater insight into mechanisms subverted during abnormal proliferative and oncogenic processes. Understanding these events may result in the development of specific targeted therapies for prostatic diseases such as benign prostatic hypertrophy and carcinomas.	[Blum, Roy; Gupta, Rashmi; Ontiveros, Christopher S.; Salm, Sarah N.; Xiong, Xiaozhong; Moscatelli, David; Wilson, E. Lynette] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Blum, Roy; Zavadil, Jiri] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Burger, Patricia E.; Wilson, E. Lynette] Univ Cape Town, Div Immunol, ZA-7925 Cape Town, South Africa; [Salm, Sarah N.] CUNY, Borough Manhattan Community Coll, Dept Sci, New York, NY USA; [Wilson, E. Lynette] NYU, Sch Med, Dept Urol, New York, NY 10016 USA; [Kamb, Alexander; Wesche, Holger; Marshall, Lisa; Cutler, Gene] Amgen Inc, San Francisco, CA USA; [Wang, Xiangyun] Pfizer Inc, Groton, CT 06340 USA; [Zavadil, Jiri; Moscatelli, David; Wilson, E. Lynette] NYU, Sch Med, NYU Canc Inst, New York, NY 10016 USA; [Zavadil, Jiri] NYU, Med Ctr, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA	New York University; New York University; University of Cape Town; City University of New York (CUNY) System; New York University; Amgen; Pfizer; New York University; New York University	Blum, R (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.	Elaine.Wilson@nyumc.org	Zavadil, Jiri/ABG-1780-2020	Zavadil, Jiri/0000-0003-0640-5562; Blum, Roy/0000-0002-3987-7198; Moscatelli, David/0000-0002-4627-4213	National Institutes of Health [CA132641, CA 90593]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [5F32DK071468]; Amgen Inc.; Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine; NATIONAL CANCER INSTITUTE [R01CA132641, R01CA090593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK071468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Amgen Inc.(Amgen); Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health, CA132641 (ELW) CA 90593 (DM), National Research Service Award (NRSA) from the National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 5F32DK071468 (CSO), Amgen Inc. and the Helen L and Martin S Kimmel Center for Stem Cell Biology at NYU School of Medicine. Amgen scientists had a role in this study by participating in the analysis of data and in the preparation of the RNA used in the microarray experiments. No other funders had a role in this study.	Abate-Shen C, 2007, CANCER CELL, V12, P495, DOI 10.1016/j.ccr.2007.11.021; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Annes JP, 2002, FEBS LETT, V511, P65, DOI 10.1016/S0014-5793(01)03280-X; Aparicio LMA, 2007, CLIN TRANSL ONCOL, V9, P66, DOI 10.1007/s12094-007-0015-6; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blum R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005722; BREUSS JM, 1995, J CELL SCI, V108, P2241; Brusselmans K, 2003, INT J CANCER, V106, P856, DOI 10.1002/ijc.11317; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Caine GJ, 2003, EUR J CLIN INVEST, V33, P883, DOI 10.1046/j.1365-2362.2003.01243.x; Charpentier E, 2000, J CELL BIOL, V149, P503, DOI 10.1083/jcb.149.2.503; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Crusselle-Davis VJ, 2006, MOL CELL BIOL, V26, P6832, DOI 10.1128/MCB.01770-05; Cunha G R, 1987, Prog Clin Biol Res, V239, P273; D'Souza SJA, 2002, J BIOL CHEM, V277, P10626, DOI 10.1074/jbc.M111956200; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; Gipp J, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-19; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Graham TR, 2008, CANCER RES, V68, P2479, DOI 10.1158/0008-5472.CAN-07-2559; Gratzinger D, 2009, AM J CLIN PATHOL, V131, P264, DOI 10.1309/AJCP5FP3NAXAXRJE; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hoei-Hansen CE, 2006, J PATHOL, V209, P25, DOI 10.1002/path.1948; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hughes-Fulford M, 2001, CARCINOGENESIS, V22, P701, DOI 10.1093/carcin/22.5.701; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kaneko KJ, 2004, MOL CELL BIOL, V24, P1968, DOI 10.1128/MCB.24.5.1968-1982.2004; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Kidder BL, 2010, GENOME RES, V20, P458, DOI 10.1101/gr.101469.109; Kong DJ, 2008, STEM CELLS, V26, P1425, DOI 10.1634/stemcells.2007-1076; Ku MC, 2005, MOL CELL BIOL, V25, P7144, DOI 10.1128/MCB.25.16.7144-7157.2005; Kubo M, 2007, ACTA ORTHOP, V78, P845, DOI 10.1080/17453670710014653; Kurata S, 2004, J BIOL CHEM, V279, P50069, DOI 10.1074/jbc.M406322200; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li JX, 2008, CELL RES, V18, P360, DOI 10.1038/cr.2007.103; Lickliter JD, 1996, P NATL ACAD SCI USA, V93, P145, DOI 10.1073/pnas.93.1.145; Lin YS, 2007, DEVELOPMENT, V134, P723, DOI 10.1242/dev.02765; Lind AJ, 2005, PROSTATE, V62, P394, DOI 10.1002/pros.20163; Lorz C, 2010, STEM CELL REV REP, V6, P162, DOI 10.1007/s12015-010-9139-0; Ma JJ, 2009, J BIOL CHEM, V284, P34600, DOI 10.1074/jbc.M109.016246; Ma S, 2007, J PATHOL, V211, P278, DOI 10.1002/path.2109; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Manton KJ, 2007, STEM CELLS, V25, P2845, DOI 10.1634/stemcells.2007-0065; Melani M, 2008, CURR BIOL, V18, P532, DOI 10.1016/j.cub.2008.03.024; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Miura Y, 2006, STEM CELLS, V24, P2428, DOI 10.1634/stemcells.2006-0089; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Mukhopadhyay NK, 2007, MOL ENDOCRINOL, V21, P2056, DOI 10.1210/me.2006-0503; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Parra E, 2009, ONCOL REP, V22, P1513, DOI 10.3892/or_00000595; Pinto L, 2009, NAT NEUROSCI, V12, P1229, DOI 10.1038/nn.2399; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Risbridger GP, 2008, ENDOCRINOLOGY, V149, P4303, DOI 10.1210/en.2008-0465; Salah Z, 2007, CANCER RES, V67, P9835, DOI 10.1158/0008-5472.CAN-07-1886; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Schmid T, 2007, J NEUROCHEM, V102, P2061, DOI 10.1111/j.1471-4159.2007.04694.x; Seo J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-395; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Shetty RS, 2005, MOL CELL NEUROSCI, V30, P583, DOI 10.1016/j.mcn.2005.06.003; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Sperandio S, 2009, MOL CARCINOGEN, V48, P38, DOI 10.1002/mc.20454; Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x; Stasyk T, 2005, MOL BIOL CELL, V16, P4765, DOI 10.1091/mbc.E05-03-0257; Swinnen JV, 1997, P NATL ACAD SCI USA, V94, P12975, DOI 10.1073/pnas.94.24.12975; Titus MA, 2005, CLIN CANCER RES, V11, P4653, DOI 10.1158/1078-0432.CCR-05-0525; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; WANG SP, 2008, CLIN EXP PHARM PHYSL; Wang XD, 2006, DEV BIOL, V290, P66, DOI 10.1016/j.ydbio.2005.11.009; Wang XD, 2004, J BIOL CHEM, V279, P24733, DOI 10.1074/jbc.M401602200; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Weissman AM, 2008, CANCER CELL, V13, P381, DOI 10.1016/j.ccr.2008.04.011; Wenzel PL, 2007, GENE DEV, V21, P85, DOI 10.1101/gad.1485307; Wildwater M, 2005, CELL, V123, P1337, DOI 10.1016/j.cell.2005.09.042; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WOLOSIN JM, 1995, INVEST OPHTH VIS SCI, V36, pS217; Yamashita YM, 2005, J CELL SCI, V118, P665, DOI 10.1242/jcs.01680; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yang SZ, 2006, J CELL BIOCHEM, V97, P1292, DOI 10.1002/jcb.20736; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zheng CG, 2009, CANCER RES, V69, P2324, DOI 10.1158/0008-5472.CAN-08-4113; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768	100	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13024	10.1371/journal.pone.0013024	http://dx.doi.org/10.1371/journal.pone.0013024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941365	Green Published, gold			2022-12-27	WOS:000282312600011
J	Emmert-Streib, F; Dehmer, M				Emmert-Streib, Frank; Dehmer, Matthias			Influence of the Time Scale on the Construction of Financial Networks	PLOS ONE			English	Article							INFORMATION; DYNAMICS	Background: In this paper we investigate the definition and formation of financial networks. Specifically, we study the influence of the time scale on their construction. Methodology/Principal Findings: For our analysis we use correlation-based networks obtained from the daily closing prices of stock market data. More precisely, we use the 30 stocks that currently comprise the Dow Jones Industrial Average (DJIA) and estimate financial networks where nodes correspond to stocks and edges correspond to none vanishing correlation coefficients. That means only if a correlation coefficient is statistically significant different from zero, we include an edge in the network. This construction procedure results in unweighted, undirected networks. By separating the time series of stock prices in non-overlapping intervals, we obtain one network per interval. The length of these intervals corresponds to the time scale of the data, whose influence on the construction of the networks will be studied in this paper. Conclusions/Significance: Numerical analysis of four different measures in dependence on the time scale for the construction of networks allows us to gain insights about the intrinsic time scale of the stock market with respect to a meaningful graph-theoretical analysis.	[Emmert-Streib, Frank] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Dehmer, Matthias] Hlth & Life Sci Univ UMIT, Inst Bioinformat & Translat Res, Hall In Tirol, Austria	Queens University Belfast	Emmert-Streib, F (corresponding author), Queens Univ Belfast, Ctr Canc Res & Cell Biol, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.	v@bio-complexity.com	Emmert-Streib, Frank/G-8099-2011; Emmert-Streib, Frank/AAF-2878-2020	Emmert-Streib, Frank/0000-0003-0745-5641; Emmert-Streib, Frank/0000-0003-0745-5641				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], MINING GRAPH DATA; [Anonymous], HDB GRAPHS NETWORKS; Bar-yam Y., 2019, DYNAMICS COMPLEX SYS; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boginski V, 2005, COMPUT STAT DATA AN, V48, P431, DOI 10.1016/j.csda.2004.02.004; Bunke H, 2000, INT C PATT RECOG, P117, DOI 10.1109/ICPR.2000.906030; BUNKE H, 2000, P VIS INT 2000 MONTR, P82; BUNKE H, 1983, B EATCS, V20, P35; DING M, HDB TIME SERIES ANAL, P437; Drozdz S, 2000, PHYSICA A, V287, P440, DOI 10.1016/S0378-4371(00)00383-6; DURRET R, 2006, RANDOM GRAPH DYNAMIC; Emmert-Streib F, MED BIOSTATISTICS CO; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; EMMERTSTREIB F, ANAL MICROARRAY DATA; EMMERTSTREIB F, 2010, COMPLEXITY IN PRESS; EPPS TW, 1979, J AM STAT ASSOC, V74, P291, DOI 10.2307/2286325; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Kullback S., 1968, INFORM THEORY STAT; Kullmann L, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.026125; Kwapien J, 2004, PHYSICA A, V337, P231, DOI 10.1016/j.physa.2004.01.050; Mantegna RN, 1999, EUR PHYS J B, V11, P193, DOI 10.1007/s100510050929; MANTEGNA RN, 2000, INTRO ECONOPHYSICS C; McCauley J., 2004, DYNAMICS MARKETS ECO; Nagurney A., 1997, FINANCIAL NETWORKS S; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Onnela JP, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.056110; Onnela JP, 2004, EUR PHYS J B, V38, P353, DOI 10.1140/epjb/e2004-00128-7; R Core Team, 2021, R LANGUAGE ENV STAT; Rencher AC, 2002, METHODS MULTIVARIATE; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Schuster H, 2002, COMPLEX ADAPTIVE SYS; Sheskin D., 2011, HDB PARAMETRIC NONPA, V5th; SIMON HA, 1955, BIOMETRIKA, V42, P425; SORNETTE D, 2003, STOCK MARKETS CRASH; Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899; Toth B, 2007, PHYSICA A, V383, P54, DOI 10.1016/j.physa.2007.04.111; Tsay R., 2005, ANAL FINANCIAL TIME, DOI DOI 10.1002/0471746193; Watts D. J, 1999, SMALL WORLDS DYNAMIC; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	42	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12884	10.1371/journal.pone.0012884	http://dx.doi.org/10.1371/journal.pone.0012884			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20949124	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600007
J	Zaslavsky, E; Bradley, P; Yanover, C				Zaslavsky, Elena; Bradley, Philip; Yanover, Chen			Inferring PDZ Domain Multi-Mutant Binding Preferences from Single-Mutant Data	PLOS ONE			English	Article							PEPTIDE INTERACTIONS	Many important cellular protein interactions are mediated by peptide recognition domains. The ability to predict a domain's binding specificity directly from its primary sequence is essential to understanding the complexity of protein-protein interaction networks. One such recognition domain is the PDZ domain, functioning in scaffold proteins that facilitate formation of signaling networks. Predicting the PDZ domain's binding specificity was a part of the DREAM4 Peptide Recognition Domain challenge, the goal of which was to describe, as position weight matrices, the specificity profiles of five multi-mutant ERBB2IP-1 domains. We developed a method that derives multi-mutant binding preferences by generalizing the effects of single point mutations on the wild type domain's binding specificities. Our approach, trained on publicly available ERBB2IP-1 single-mutant phage display data, combined linear regression-based prediction for ligand positions whose specificity is determined by few PDZ positions, and single-mutant position weight matrix averaging for all other ligand columns. The success of our method as the winning entry of the DREAM4 competition, as well as its superior performance over a general PDZ-ligand binding model, demonstrates the advantages of training a model on a well-selected domain-specific data set.	[Zaslavsky, Elena] Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA; [Zaslavsky, Elena] Mt Sinai Sch Med, Dept Neurol, New York, NY USA; [Bradley, Philip; Yanover, Chen] Fred Hutchinson Canc Res Ctr, Program Computat Biol, Seattle, WA 98104 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Fred Hutchinson Cancer Center	Zaslavsky, E (corresponding author), Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY USA.	cyanover@fhcrc.org	Yanover, Chen/A-3754-2012	Yanover, Chen/0000-0003-3663-4286; Zaslavsky, Elena/0000-0002-4828-7771	Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200500021C]	Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been funded in part by institutional support from the Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America. E.Z. was supported by National Institutes of Health, National Institute of Allergy and Infectious Diseases Contract No. HHSN266200500021C (http://www3.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Beltrao P, 2007, PLOS COMPUT BIOL, V3, P258, DOI 10.1371/journal.pcbi.0030025; Beuming T, 2005, BIOINFORMATICS, V21, P827, DOI 10.1093/bioinformatics/bti098; Ceol A, 2007, NUCLEIC ACIDS RES, V35, pD557, DOI 10.1093/nar/gkl961; Chen JR, 2008, NAT BIOTECHNOL, V26, P1041, DOI 10.1038/nbt.1489; Ernst A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000416; Habib N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000010; Harris BZ, 2001, J CELL SCI, V114, P3219; Hertz T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S3; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Nourry Claire, 2003, Sci STKE, V2003, pRE7; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Venkatarajan MS, 2001, J MOL MODEL, V7, P445, DOI 10.1007/s00894-001-0058-5; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048	17	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12787	10.1371/journal.pone.0012787	http://dx.doi.org/10.1371/journal.pone.0012787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20976110	Green Published, Green Submitted, gold			2022-12-27	WOS:000282312600003
J	Nyman, T; Tresaugues, L; Welin, M; Lehtio, L; Flodin, S; Persson, C; Johansson, I; Hammarstrom, M; Nordlund, P				Nyman, Tomas; Tresaugues, Lionel; Welin, Martin; Lehtio, Lari; Flodin, Susanne; Persson, Camilla; Johansson, Ida; Hammarstrom, Martin; Nordlund, Par			The Crystal Structure of the Dachshund Domain of Human SnoN Reveals Flexibility in the Putative Protein Interaction Surface	PLOS ONE			English	Article							SKI ONCOPROTEIN INTERACTS; SMAD PROTEINS; TRANSCRIPTIONAL REPRESSION; STRUCTURE PREDICTION; CDNA-CLONES; SEQUENCE; HOMOLOG; RECEPTOR; CELLS; TRANSFORMATION	The human SnoN is an oncoprotein that interacts with several transcription-regulatory proteins such as the histone-deacetylase, N-CoR containing co-repressor complex and Smad proteins. This study presents the crystal structure of the Dachshund homology domain of human SnoN. The structure reveals a groove composed of conserved residues with characteristic properties of a protein-interaction surface. A comparison of the 12 monomers in the asymmetric unit reveals the presence of two major conformations: an open conformation with a well accessible groove and a tight conformation with a less accessible groove. The variability in the backbone between the open and the tight conformations matches the differences seen in previously determined structures of individual Dachshund homology domains, suggesting a general plasticity within this fold family. The flexibility observed in the putative protein binding groove may enable SnoN to recognize multiple interaction partners.	[Nyman, Tomas; Tresaugues, Lionel; Welin, Martin; Flodin, Susanne; Persson, Camilla; Johansson, Ida; Hammarstrom, Martin; Nordlund, Par] Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden; [Nordlund, Par] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Lehtio, Lari] Abo Akad Univ, Dept Biosci, Turku, Finland	Karolinska Institutet; Karolinska Institutet; Abo Akademi University	Nyman, T (corresponding author), Karolinska Inst, Struct Genom Consortium, Stockholm, Sweden.	tomas.nyman@ki.se; par.nordlund@ki.se		Lehtio, Lari/0000-0001-7250-832X	Canadian Institutes for Health Research [1097737]; Canada Foundation for Innovation, Genome Canada; Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet(GlaxoSmithKline); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation, Merck Co., Inc.(Ministry of Research and Innovation, OntarioMerck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Arndt S, 2005, LAB INVEST, V85, P1330, DOI 10.1038/labinvest.3700344; Arndt S, 2007, MOL CELL NEUROSCI, V34, P603, DOI 10.1016/j.mcn.2007.01.002; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; BOYER PL, 1993, ONCOGENE, V8, P457; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Cohen SB, 1999, NUCLEIC ACIDS RES, V27, P1006, DOI 10.1093/nar/27.4.1006; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FUMAGALLI S, 1993, MELANOMA RES, V3, P23, DOI 10.1097/00008390-199304000-00004; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; HEYMAN HC, 1994, J BIOL CHEM, V269, P26996; Hwang H, 2008, PROTEINS, V73, P705, DOI 10.1002/prot.22106; Ikeda K, 2002, MOL CELL BIOL, V22, P6759, DOI 10.1128/MCB.22.19.6759-6766.2002; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim SS, 2002, STRUCTURE, V10, P787, DOI 10.1016/S0969-2126(02)00769-4; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; PEARSONWHITE S, 1993, NUCLEIC ACIDS RES, V21, P4632, DOI 10.1093/nar/21.19.4632; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; STAVNEZER E, 1981, J VIROL, V39, P920, DOI 10.1128/JVI.39.3.920-934.1981; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Tokitou F, 1999, J BIOL CHEM, V274, P4485, DOI 10.1074/jbc.274.8.4485; Wilson JJ, 2004, STRUCTURE, V12, P785, DOI 10.1016/S0969-2126(04)00118-2; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205	41	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12907	10.1371/journal.pone.0012907	http://dx.doi.org/10.1371/journal.pone.0012907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20957027	gold, Green Submitted, Green Published			2022-12-27	WOS:000282091100015
J	Ikonen, N; Haanpaa, M; Ronkko, E; Lyytikainen, O; Kuusi, M; Ruutu, P; Kallio-Kokko, H; Mannonen, L; Lappalainen, M; Ziegler, T; Julkunen, I				Ikonen, Niina; Haanpaa, Minna; Ronkko, Esa; Lyytikainen, Outi; Kuusi, Markku; Ruutu, Petri; Kallio-Kokko, Hannimari; Mannonen, Laura; Lappalainen, Maija; Ziegler, Thedi; Julkunen, Ilkka			Genetic Diversity of the 2009 Pandemic Influenza A(H1N1) Viruses in Finland	PLOS ONE			English	Article							A H1N1; HEMAGGLUTININ; SUBSTITUTION; ASSOCIATION; DISEASE	Background: In Finland, the first infections caused by the 2009 pandemic influenza A(H1N1) virus were identified on May 10. During the next three months almost all infections were found from patients who had recently traveled abroad. In September 2009 the pandemic virus started to spread in the general population, leading to localized outbreaks and peak epidemic activity was reached during weeks 43-48. Methods/Results: The nucleotide sequences of the hemagglutinin (HA) and neuraminidase (NA) genes from viruses collected from 138 patients were determined. The analyzed viruses represented mild and severe infections and different geographic regions and time periods. Based on HA and NA gene sequences, the Finnish pandemic viruses clustered in four groups. Finnish epidemic viruses and A/California/07/2009 vaccine virus strain varied from 2-8 and 0-5 amino acids in HA and NA molecules, respectively, giving a respective maximal evolution speed of 1.4% and 1.1%. Most amino acid changes in HA and NA molecules accumulated on the surface of the molecule and were partly located in antigenic sites. Three severe infections were detected with a mutation at HA residue 222, in two viruses with a change D222G, and in one virus D222Y. Also viruses with change D222E were identified. All Finnish pandemic viruses were sensitive to oseltamivir having the amino acid histidine at residue 275 of the neuraminidase molecule. Conclusions: The Finnish pandemic viruses were quite closely related to A/California/07/2009 vaccine virus. Neither in the HA nor in the NA were changes identified that may lead to the selection of a virus with increased epidemic potential or exceptionally high virulence. Continued laboratory-based surveillance of the 2009 pandemic influenza A(H1N1) is important in order to rapidly identify drug resistant viruses and/or virus variants with potential ability to cause severe forms of infection and an ability to circumvent vaccine-induced immunity.	[Ikonen, Niina; Haanpaa, Minna; Ronkko, Esa; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland; [Lyytikainen, Outi; Kuusi, Markku; Ruutu, Petri] Natl Inst Hlth & Welf THL, Dept Infect Dis Surveillance & Control, Helsinki, Finland; [Kallio-Kokko, Hannimari; Mannonen, Laura; Lappalainen, Maija] Helsinki Univ Hosp, Lab Serv HUSLAB, Dept Virol, Helsinki, Finland	Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Helsinki; Helsinki University Central Hospital	Ikonen, N (corresponding author), Natl Inst Hlth & Welf THL, Dept Vaccinat & Immune Protect, Viral Infect Unit, Helsinki, Finland.	niina.ikonen@thl.fi		Ikonen, Niina/0000-0003-0724-8888; Lappalainen, Maija/0000-0001-5400-1250	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health (Finland); European Commission DG Research [201169]	National Institute for Health and Welfare (THL); Ministry of Social Affairs and Health (Finland); European Commission DG Research(European CommissionEuropean Commission Joint Research Centre)	The study was supported by the funds of the National Institute for Health and Welfare (THL), the Ministry of Social Affairs and Health (Finland) and the Identification of Mechanisms Correlating with Susceptibility for Avian Influenza (IMECS) project (grant no 201169) supported by the European Commission DG Research and the participating member states. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P21; Brownlee GG, 2001, PHILOS T ROY SOC B, V356, P1871, DOI 10.1098/rstb.2001.1001; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Chen HL, 2010, J INFECT DIS, V201, P1517, DOI 10.1086/652661; COLMAN PM, 1983, NATURE, V303, P41, DOI 10.1038/303041a0; Glinsky GV, 2010, CELL CYCLE, V9, P958, DOI 10.4161/cc.9.5.10913; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; IKONEN N, 2010, EUROSURVEILL, V15; KILANDER A, 2010, EUROSURVEILL, V15; LIU Y, 2010, J VIROL, DOI DOI 10.1128/JVL.01639-10; Mak GC, 2010, EUROSURVEILLANCE, V15, P15; MAURERSTROH S, 2010, PLOS CURR INFLUENZA, pN1162; Melidou A, 2010, VIRUS RES, V151, P192, DOI 10.1016/j.virusres.2010.05.005; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	19	41	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13329	10.1371/journal.pone.0013329	http://dx.doi.org/10.1371/journal.pone.0013329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975994	Green Submitted, Green Published, gold			2022-12-27	WOS:000283216400001
J	Ma, XM; Jiang, Y; Wu, AM; Chen, XH; Pi, RB; Liu, M; Liu, YY				Ma, Xiaomeng; Jiang, Ying; Wu, Aimin; Chen, Xiaohong; Pi, Rongbiao; Liu, Mei; Liu, Yingying			Berberine Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MATRIX-METALLOPROTEINASE EXPRESSION; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; PLASMINOGEN-ACTIVATOR; TISSUE INHIBITORS; SPINAL-CORD; IN-VITRO; CELLS	Background: Berberine, an isoquinoline derivative alkaloid, has a wide range of pharmacological properties and is considered to have anti-inflammatory and neuroprotective effects. However, there are no reports about the effects and mechanisms of berberine in experimental autoimmune encephalomyelitis (EAE), an established model of multiple sclerosis (MS). Methodology/Principal Findings: Female C57BL/6 mice immunized with myelin oligodendrocyte glycoprotein 35-55 amino acid peptide were treated with berberine at the day of disease onset and medication was administered daily until mice were sacrificed. Blood-brain barrier (BBB) permeability and the alteration of matrix metalloproteinase-2 (MMP-2, 72 kDa) and matrix metalloproteinase-9 (MMP-9, 92 kDa) in the brain and cerebrospinal fluid (CSF) of EAE mice were detected by quantitative measurement for Evan's blue (EB) content, Western blot and gelatin zymography respectively. The results showed that berberine attenuated clinical and pathological parameters of EAE, reduced the permeability of BBB, inhibited the activity and expression of MMP-9 but not MMP-2 in the CSF and brain of EAE mice. Conclusions/Significance: These findings suggest that berberine is effective to attenuate the clinical severity of EAE in C57 BL/6 mice by reducing the permeability of BBB, decreasing the expression and activity of MMP-9, and decreasing the inflammatory infiltration. We think that berberine might be a potential therapeutic agent for MS.	[Ma, Xiaomeng; Jiang, Ying; Wu, Aimin; Chen, Xiaohong; Liu, Mei; Liu, Yingying] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou, Peoples R China; [Pi, Rongbiao] Sun Yat Sen Univ, Dept Pharmacol & Toxicol, Sch Pharmaceut Sci, Guangzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Ma, XM (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou, Peoples R China.	xiaohongchenzssy@yahoo.com.cn			National Natural Science Foundation of China [81071068, 30870849]; Planned Science and Technology Project of Guangdong Province, China [2009B030801101]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Planned Science and Technology Project of Guangdong Province, China	This work was supported by grants (to X Chen) from the National Natural Science Foundation of China (81071068 and 30870849) and from the Planned Science and Technology Project of Guangdong Province, China (2009B030801101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony DC, 1998, J NEUROIMMUNOL, V87, P62, DOI 10.1016/S0165-5728(98)00046-0; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Brown KA, 2001, INT IMMUNOPHARMACOL, V1, P2043; Chen FL, 2008, ENDOCRINE, V33, P331, DOI 10.1007/s12020-008-9089-3; Chen XH, 2009, J NEUROIMMUNOL, V210, P22, DOI 10.1016/j.jneuroim.2009.02.016; Conant K, 1999, ANN NEUROL, V46, P391, DOI 10.1002/1531-8249(199909)46:3<391::AID-ANA15>3.0.CO;2-0; Cossins JA, 1997, ACTA NEUROPATHOL, V94, P590, DOI 10.1007/s004010050754; Cuzner ML, 1996, J NEUROPATH EXP NEUR, V55, P1194, DOI 10.1097/00005072-199612000-00002; DANIEL PM, 1983, J NEUROL SCI, V60, P367, DOI 10.1016/0022-510X(83)90147-8; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dubois B, 1999, J CLIN INVEST, V104, P1507, DOI 10.1172/JCI6886; Engelhardt B, 1997, BLOOD, V90, P4459, DOI 10.1182/blood.V90.11.4459.4459_4459_4472; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fabis MJ, 2007, P NATL ACAD SCI USA, V104, P5656, DOI 10.1073/pnas.0701252104; Guo M, 2008, NEUROSCIENCE, V151, P340, DOI 10.1016/j.neuroscience.2007.10.006; Hartung HP, 2000, J NEUROIMMUNOL, V107, P140, DOI 10.1016/S0165-5728(00)00225-3; Ho YT, 2009, CANCER LETT, V279, P155, DOI 10.1016/j.canlet.2009.01.033; HUANG Z, 2009, INT J CARDIOL; HUHTALA P, 1990, J BIOL CHEM, V265, P11077; Hwang JM, 2006, ARCH TOXICOL, V80, P62, DOI 10.1007/s00204-005-0014-8; IKRAM M, 1975, PLANTA MED, V28, P353, DOI 10.1055/s-0028-1097869; Kean RB, 2000, J IMMUNOL, V165, P6511, DOI 10.4049/jimmunol.165.11.6511; Keegan BM, 2002, ANNU REV MED, V53, P285, DOI 10.1146/annurev.med.53.082901.103909; Kim S, 2008, PHYTOMEDICINE, V15, P340, DOI 10.1016/j.phymed.2007.09.011; Kolb SA, 1998, J NEUROIMMUNOL, V84, P143, DOI 10.1016/S0165-5728(97)00247-6; Kozler P, 2003, PHYSIOL RES, V52, P607; Kuerten S, 2007, J NEUROIMMUNOL, V189, P31, DOI 10.1016/j.jneuroim.2007.06.016; Kuo CL, 2004, CANCER LETT, V203, P127, DOI 10.1016/j.canlet.2003.09.002; LASSMANN H, 1983, PROG BRAIN RES, V59, P305; Leib SL, 2000, INFECT IMMUN, V68, P615, DOI 10.1128/IAI.68.2.615-620.2000; Li HY, 2003, BIOL PHARM BULL, V26, P110, DOI 10.1248/bpb.26.110; Liu XJ, 2008, BRAIN RES, V1207, P237, DOI 10.1016/j.brainres.2008.01.106; Mandler RN, 2001, BRAIN, V124, P493, DOI 10.1093/brain/124.3.493; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; Mirowska D, 2004, J NEUROIMMUNOL, V146, P171, DOI 10.1016/j.jneuroim.2003.10.046; Mitani N, 2001, CANCER LETT, V165, P35, DOI 10.1016/S0304-3835(00)00710-2; Mun-Bryce S, 1998, AM J PHYSIOL-REG I, V274, pR1203, DOI 10.1152/ajpregu.1998.274.5.R1203; Nagase H, 1997, BIOL CHEM, V378, P151; NISHINO H, 1986, ONCOLOGY, V43, P131, DOI 10.1159/000226349; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; O'Neill EJ, 2006, J NEUROIMMUNOL, V178, P1, DOI 10.1016/j.jneuroim.2006.05.030; Pan LR, 2005, ACTA PHARMACOL SIN, V26, P1334, DOI 10.1111/j.1745-7254.2005.00186.x; Peng PL, 2006, TOXICOL APPL PHARM, V214, P8, DOI 10.1016/j.taap.2005.11.010; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; RACKE MK, 1994, J IMMUNOL, V152, P2051; ROMANIC AM, 1994, J CELL BIOL, V125, P1165, DOI 10.1083/jcb.125.5.1165; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Xu LH, 2005, CELL MOL IMMUNOL, V2, P295; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou XQ, 2008, NEUROSCI LETT, V447, P31, DOI 10.1016/j.neulet.2008.09.064	55	78	84	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13489	10.1371/journal.pone.0013489	http://dx.doi.org/10.1371/journal.pone.0013489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976070	Green Published, Green Submitted, gold			2022-12-27	WOS:000283114700017
J	Li, RW; MacKeben, M; Chat, SW; Kumar, M; Ngo, C; Levi, DM				Li, Roger W.; MacKeben, Manfred; Chat, Sandy W.; Kumar, Maya; Ngo, Charlie; Levi, Dennis M.			Aging and Visual Counting	PLOS ONE			English	Article							POSITION DISCRIMINATION; CONTRAST SENSITIVITY; SELECTIVE ATTENTION; SPATIAL ENUMERATION; ALZHEIMERS-DISEASE; EYE-MOVEMENTS; LIFE-SPAN; AGE; NUMBER; MEMORY	Background: Much previous work on how normal aging affects visual enumeration has been focused on the response time required to enumerate, with unlimited stimulus duration. There is a fundamental question, not yet addressed, of how many visual items the aging visual system can enumerate in a "single glance", without the confounding influence of eye movements. Methodology/Principal Findings: We recruited 104 observers with normal vision across the age span ( age 21-85). They were briefly ( 200 ms) presented with a number of well- separated black dots against a gray background on a monitor screen, and were asked to judge the number of dots. By limiting the stimulus presentation time, we can determine the maximum number of visual items an observer can correctly enumerate at a criterion level of performance ( counting threshold, defined as the number of visual items at which approximate to 63% correct rate on a psychometric curve), without confounding by eye movements. Our findings reveal a 30% decrease in the mean counting threshold of the oldest group ( age 61-85: similar to 5 dots) when compared with the youngest groups ( age 21-40: 7 dots). Surprisingly, despite decreased counting threshold, on average counting accuracy function ( defined as the mean number of dots reported for each number tested) is largely unaffected by age, reflecting that the threshold loss can be primarily attributed to increased random errors. We further expanded this interesting finding to show that both young and old adults tend to over-count small numbers, but older observers over-count more. Conclusion/Significance: Here we show that age reduces the ability to correctly enumerate in a glance, but the accuracy (veridicality), on average, remains unchanged with advancing age. Control experiments indicate that the degraded performance cannot be explained by optical, retinal or other perceptual factors, but is cortical in origin.	[Li, Roger W.; Chat, Sandy W.; Kumar, Maya; Ngo, Charlie; Levi, Dennis M.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Li, Roger W.; Levi, Dennis M.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [MacKeben, Manfred] Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; The Smith-Kettlewell Eye Research Institute	Li, RW (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	oroger@berkeley.edu	Kumar, Maya/HDM-9018-2022; Levi, Dennis/J-7836-2019	Levi, Dennis/0000-0002-5350-8639; Li, Roger/0000-0002-1666-0543	National Eye Institute [R01EY01728]; NATIONAL EYE INSTITUTE [R01EY001728] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute grant R01EY01728. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak C, 2003, PSYCHOL AGING, V18, P240, DOI 10.1037/0882-7974.18.2.240; Bennett PJ, 2007, VISION RES, V47, P799, DOI 10.1016/j.visres.2007.01.001; Boone KB, 2002, ARCH CLIN NEUROPSYCH, V17, P625, DOI 10.1016/S0887-6177(01)00166-4; Burr D, 2008, CURR BIOL, V18, P425, DOI 10.1016/j.cub.2008.02.052; CURCIO CA, 1993, ANN NEUROL, V33, P248, DOI 10.1002/ana.410330305; CURCIO CA, 1993, INVEST OPHTH VIS SCI, V34, P3278; Del Viva MM, 2007, INVEST OPHTH VIS SCI, V48, P2940, DOI 10.1167/iovs.06-0729; ELLIOTT D, 1990, VISION RES, V30, P541, DOI 10.1016/0042-6989(90)90066-T; ELLIOTT DB, 1995, OPTOMETRY VISION SCI, V72, P186, DOI 10.1097/00006324-199503000-00006; Fahle M, 2005, CURR OPIN NEUROBIOL, V15, P154, DOI 10.1016/j.conb.2005.03.010; Garcia-Suarez L, 2004, VISION RES, V44, P1039, DOI 10.1016/j.visres.2003.11.018; Geary DC, 1998, EXP AGING RES, V24, P101; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Hennelly ML, 1998, OPHTHAL PHYSL OPT, V18, P197, DOI 10.1016/S0275-5408(97)00077-X; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; KOTARY L, 1995, EXP AGING RES, V21, P159, DOI 10.1080/03610739508254275; LACHENMAYR BJ, 1994, INVEST OPHTH VIS SCI, V35, P2741; Lemaire P, 2007, J GERONTOL B-PSYCHOL, V62, pP305, DOI 10.1093/geronb/62.6.P305; Li RW, 2004, J VISION, V4, P476, DOI 10.1167/4.6.7; Li RW, 2004, NAT NEUROSCI, V7, P178, DOI 10.1038/nn1183; Li RWH, 2000, VISION RES, V40, P3775, DOI 10.1016/S0042-6989(00)00212-1; Lott LA, 2005, OPTOMETRY VISION SCI, V82, P874, DOI 10.1097/01.opx.0000180764.68737.91; Maylor EA, 2008, NEUROPSYCHOLOGIA, V46, P2696, DOI 10.1016/j.neuropsychologia.2008.05.002; McIntosh AR, 1999, CURR BIOL, V9, P1275, DOI 10.1016/S0960-9822(99)80512-0; Nan Y, 2006, NEUROPSYCHOLOGIA, V44, P1103, DOI 10.1016/j.neuropsychologia.2005.10.020; Narasimhan S, 2009, VISION RES, V49, P10, DOI 10.1016/j.visres.2008.09.023; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Nieder A, 2009, ANNU REV NEUROSCI, V32, P185, DOI 10.1146/annurev.neuro.051508.135550; OWSLEY C, 1983, VISION RES, V23, P689, DOI 10.1016/0042-6989(83)90210-9; Pearson PM, 2006, OPTOMETRY VISION SCI, V83, P444, DOI 10.1097/01.opx.0000218432.52508.10; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; PILZ KS, VISION RES, V50, P211; PYLYSHYN Z, 1994, COGNITION, V50, P363, DOI 10.1016/0010-0277(94)90036-1; RABBITT P, 1993, Q J EXP PSYCHOL-A, V46, P385, DOI 10.1080/14640749308401055; Railo H, 2008, COGNITION, V107, P82, DOI 10.1016/j.cognition.2007.08.004; Ross J, 2010, J VISION, V10, DOI 10.1167/10.2.10; Sekuler R, 2005, EXP AGING RES, V31, P1, DOI 10.1080/03610730590882800; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; Sliwinski M, 1997, PSYCHOL AGING, V12, P38, DOI 10.1037/0882-7974.12.1.38; Spry PGD, 2001, OPTOMETRY VISION SCI, V78, P436, DOI 10.1097/00006324-200106000-00017; Trick LM, 2005, PSYCHON B REV, V12, P675, DOI 10.3758/BF03196757; Trick LM, 1996, DEV PSYCHOL, V32, P925, DOI 10.1037/0012-1649.32.5.925; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P1389, DOI 10.1037/0096-1523.33.6.1389; Watson DG, 2007, J EXP PSYCHOL HUMAN, V33, P549, DOI 10.1037/0096-1523.33.3.549; Watson DG, 2005, Q J EXP PSYCHOL-A, V58, P1119, DOI 10.1080/02724980443000511; Watson DG, 2005, PSYCHOL AGING, V20, P226, DOI 10.1037/0882-7974.20.2.226; Watson DG, 2002, PSYCHOL AGING, V17, P496, DOI 10.1037//0882-7974.17.3.496; WEALE RA, 1961, T ILLUMINATING ENG S, V26, P95, DOI DOI 10.1177/147715356102600204; WHITAKER D, 1992, OPHTHAL PHYSL OPT, V12, P29, DOI 10.1111/j.1475-1313.1992.tb00250.x; WHITAKER D, 1992, DOC OPHTHALMOL, V82, P307, DOI 10.1007/BF00161018; Yang Q, 2002, INVEST OPHTH VIS SCI, V43, P2939; Zaroff CM, 2003, INVEST OPHTH VIS SCI, V44, P891, DOI 10.1167/iovs.02-0361	55	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13434	10.1371/journal.pone.0013434	http://dx.doi.org/10.1371/journal.pone.0013434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	665ON	20976149	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300016
J	Avargues-Weber, A; de Brito Sanchez, MG; Giurfa, M; Dyer, AG				Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin; Dyer, Adrian G.			Aversive Reinforcement Improves Visual Discrimination Learning in Free-Flying Honeybees	PLOS ONE			English	Article							APIS-MELLIFERA L; COLOR DISCRIMINATION; CONDITIONING PROCEDURE; PATTERN-RECOGNITION; FORAGING SPEED; TRADE-OFF; TASTE; INSECT; DROSOPHILA; RESPONSES	Background: Learning and perception of visual stimuli by free-flying honeybees has been shown to vary dramatically depending on the way insects are trained. Fine color discrimination is achieved when both a target and a distractor are present during training (differential conditioning), whilst if the same target is learnt in isolation (absolute conditioning), discrimination is coarse and limited to perceptually dissimilar alternatives. Another way to potentially enhance discrimination is to increase the penalty associated with the distractor. Here we studied whether coupling the distractor with a highly concentrated quinine solution improves color discrimination of both similar and dissimilar colors by free-flying honeybees. As we assumed that quinine acts as an aversive stimulus, we analyzed whether aversion, if any, is based on an aversive sensory input at the gustatory level or on a post-ingestional malaise following quinine feeding. Methodology/Principal Findings: We show that the presence of a highly concentrated quinine solution (60 mM) acts as an aversive reinforcer promoting rejection of the target associated with it, and improving discrimination of perceptually similar stimuli but not of dissimilar stimuli. Free-flying bees did not use remote cues to detect the presence of quinine solution; the aversive effect exerted by this substance was mediated via a gustatory input, i.e. via a distasteful sensory experience, rather than via a post-ingestional malaise. Conclusion: The present study supports the hypothesis that aversion conditioning is important for understanding how and what animals perceive and learn. By using this form of conditioning coupled with appetitive conditioning in the framework of a differential conditioning procedure, it is possible to uncover discrimination capabilities that may remain otherwise unsuspected. We show, therefore, that visual discrimination is not an absolute phenomenon but can be modulated by experience.	[Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin] Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France; [Avargues-Weber, Aurore; de Brito Sanchez, Maria G.; Giurfa, Martin] CNRS, Ctr Rech Cognit Anim, Toulouse, France; [Avargues-Weber, Aurore; Dyer, Adrian G.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Monash University	Avargues-Weber, A (corresponding author), Univ Toulouse, Ctr Rech Cognit Anim, UPS, Toulouse, France.	adrian.dyer@monash.edu	Avargues-Weber, Aurore/V-5795-2019; Giurfa, Martin MG/A-7322-2008; Giurfa, Martin/H-5140-2016; Giurfa, Martin/AAS-4945-2020	Giurfa, Martin/0000-0001-7173-769X; Giurfa, Martin/0000-0001-7173-769X; de Brito Sanchez, Maria Gabriela/0000-0001-6940-8088	French Research Council (CNRS); University Paul Sabatier; Company of Biologists; Alexander von Humboldt Foundation [ARC DP0987989, ARC DP0878968]; National Research Agency (ANR)	French Research Council (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paul Sabatier; Company of Biologists; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); National Research Agency (ANR)(French National Research Agency (ANR))	A.A.-W, M. G. de B. S and M. G. thank the National Research Agency (ANR) (Project INSAVEL), the French Research Council (CNRS) and the University Paul Sabatier for support. A.A.-W. was supported by a Travelling Fellowship from The Company of Biologists and by the University Paul Sabatier (ATUPS fellowship). A. G. D. acknowledges the Alexander von Humboldt Foundation, ARC DP0987989 and ARC DP0878968 for support. http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avargues-Weber A, 2010, J EXP BIOL, V213, P593, DOI 10.1242/jeb.039263; AVARGUESWEBER A, 2010, ANN REV ENT IN PRESS; AYESTARAN A, 2010, PLOS ONE UNPUB; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Benard J, 2006, ANIM COGN, V9, P257, DOI 10.1007/s10071-006-0032-9; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Camlitepe Y, 2010, J EXP BIOL, V213, P72, DOI 10.1242/jeb.037853; Chittka L, 2003, NATURE, V424, P388, DOI 10.1038/424388a; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P533; Chittka L, 2009, TRENDS ECOL EVOL, V24, P400, DOI 10.1016/j.tree.2009.02.010; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; de Brito Sanchez M. G., 2008, J COMP PHYSIOL A, V194, P861, DOI DOI 10.1007/S00359-008-0357-8; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2008, J EXP BIOL, V211, P1180, DOI 10.1242/jeb.016683; Dyer AG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004086; Dyer AG, 2005, J EXP BIOL, V208, P4709, DOI 10.1242/jeb.01929; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Gegear RJ, 2007, ECOL LETT, V10, P375, DOI 10.1111/j.1461-0248.2007.01027.x; Giurfa M, 1999, ANIM BEHAV, V57, P315, DOI 10.1006/anbe.1998.0957; Giurfa M, 2001, NATURE, V410, P930, DOI 10.1038/35073582; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 1996, NATURE, V382, P458, DOI 10.1038/382458a0; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Hori S, 2007, J COMP PHYSIOL A, V193, P825, DOI 10.1007/s00359-007-0234-x; Hori S, 2006, J COMP PHYSIOL A, V192, P691, DOI 10.1007/s00359-005-0091-4; Horridge A, 2009, J EXP BIOL, V212, P2721, DOI 10.1242/jeb.030916; Horridge A, 2009, J INSECT PHYSIOL, V55, P499, DOI 10.1016/j.jinsphys.2009.03.006; Johnson SD, 2006, ECOLOGY, V87, P2709, DOI 10.1890/0012-9658(2006)87[2709:DBNFAA]2.0.CO;2; JUDD DB, 1964, J OPT SOC AM, V54, P1031, DOI 10.1364/JOSA.54.001031; Liu FL, 2006, BEHAV ECOL SOCIOBIOL, V59, P582, DOI 10.1007/s00265-005-0084-x; Marella S, 2006, NEURON, V49, P285, DOI 10.1016/j.neuron.2005.11.037; MENZEL R, 1985, CENTRAL PERIPHERAL M, P211; Moon SJ, 2006, CURR BIOL, V16, P1812, DOI 10.1016/j.cub.2006.07.024; Niggebrugge C, 2009, J EXP BIOL, V212, P1344, DOI 10.1242/jeb.021881; NUNEZ JA, 1966, Z VERGL PHYSIOL, V53, P142; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rival C, 2003, NEUROSCI LETT, V336, P65, DOI 10.1016/S0304-3940(02)01246-6; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; SANCHEZ GD, 2007, ARTHROPOD-PLANT INTE, V1, P69; Scott K, 2005, NEURON, V48, P455, DOI 10.1016/j.neuron.2005.10.015; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; VANHATEREN JH, 1990, J COMP PHYSIOL A, V167, P649, DOI 10.1007/BF00192658; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Zhang Shaowu, 2004, P41; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069; ZHANG SW, 1994, NATURE, V368, P330, DOI 10.1038/368330a0	57	104	105	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15370	10.1371/journal.pone.0015370	http://dx.doi.org/10.1371/journal.pone.0015370			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976170	gold, Green Submitted, Green Published			2022-12-27	WOS:000283043700032
J	Hopkins, WD; Taglialatela, JP; Russell, JL; Nir, TM; Schaeffer, J				Hopkins, William D.; Taglialatela, Jared P.; Russell, Jamie L.; Nir, Talia M.; Schaeffer, Jennifer			Cortical Representation of Lateralized Grasping in Chimpanzees (Pan troglodytes): A Combined MRI and PET Study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; HAND AREA; PRECENTRAL GYRUS; LEFT-HEMISPHERE; HANDEDNESS; ASYMMETRIES; LOCALIZATION; BRAIN; PREFERENCE; MATTER	Functional imaging studies in humans have localized the motor-hand region to a neuroanatomical landmark call the KNOB within the precentral gyrus. It has also been reported that the KNOB is larger in the hemisphere contralateral to an individual's preferred hand, and therefore may represent the neural substrate for handedness. The KNOB has also been neuronatomically described in chimpanzees and other great apes and is similarly associated with handedness. However, whether the chimpanzee KNOB represents the hand region is unclear from the extant literature. Here, we used PET to quantify neural metabolic activity in chimpanzees when engaged in unilateral reach-and-grasping responses and found significantly lateralized activation of the KNOB region in the hemisphere contralateral to the hand used by the chimpanzees. We subsequently constructed a probabilistic map of the KNOB region in chimpanzees in order to assess the overlap in consistency in the anatomical landmarks of the KNOB with the functional maps generated from the PET analysis. We found significant overlap in the anatomical and functional voxels comprising the KNOB region, suggesting that the KNOB does correspond to the hand region in chimpanzees. Lastly, from the probabilistic maps, we compared right-and left-handed chimpanzees on lateralization in grey and white matter within the KNOB region and found that asymmetries in white matter of the KNOB region were larger in the hemisphere contralateral to the preferred hand. These results suggest that neuroanatomical asymmetries in the KNOB likely reflect changes in connectivity in primary motor cortex that are experience dependent in chimpanzees and possibly humans.	[Hopkins, William D.; Taglialatela, Jared P.; Russell, Jamie L.; Nir, Talia M.; Schaeffer, Jennifer] Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA; [Hopkins, William D.] Agnes Scott Coll, Dept Psychol, Decatur, GA 30030 USA; [Taglialatela, Jared P.] Kennesaw State Univ, Dept Biol & Phys, Kennesaw, GA USA	University System of Georgia; Kennesaw State University	Hopkins, WD (corresponding author), Yerkes Natl Primate Res Ctr, Div Dev & Cognit Neurosci, Atlanta, GA USA.	whopkin@emory.edu			National Institutes of Health [NS-42867, NS-36605, HD-38051, HD-56232]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD038051, R01HD056232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042867, R01NS036605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by National Institutes of Health grants NS-42867, NS-36605, HD-38051 and HD-56232. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKADHI H, 2004, AM J NEURORADIOLOGY, V25; Amunts K, 1996, NEUROIMAGE, V4, P216, DOI 10.1006/nimg.1996.0073; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Annett M, 2002, HANDEDNESS BRAIN ASY; Bailey P, 1950, ISOCORTEX CHIMPANZEE; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Boling W, 1999, J NEUROSURG, V91, P903, DOI 10.3171/jns.1999.91.6.0903; Boroojerdi B, 1999, CLIN NEUROPHYSIOL, V110, P699, DOI 10.1016/S1388-2457(98)00027-3; Brown SG, 2004, BRAIN COGNITION, V55, P283, DOI 10.1016/j.bandc.2004.02.010; Buchel C, 2004, CEREB CORTEX, V14, P945, DOI 10.1093/cercor/bhh055; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Catani M, 2005, BRAIN, V128, P2224, DOI 10.1093/brain/awh622; Caulo M, 2007, AM J NEURORADIOL, V28, P1480, DOI 10.3174/ajnr.A0597; CHRISTEL MI, 1994, CURRENT PRIMATOLOGY, V3, P37; Connolly K. J., 1998, PSYCHOBIOLOGY HAND; Corballis MC, 2002, HAND MOUTH ORIGINS L; Corey DM, 2001, NEUROPSY NEUROPSY BE, V14, P144; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Dadda M, 2006, NEUROPSYCHOLOGIA, V44, P2582, DOI 10.1016/j.neuropsychologia.2006.03.037; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2001, J NEUROPHYSIOL, V85, P2613, DOI 10.1152/jn.2001.85.6.2613; ETTLINGER G, 1988, CORTEX, V24, P389, DOI 10.1016/S0010-9452(88)80002-9; Fragaszy DM, 1998, CLIN DEV MED, P77; Frey SH, 2005, COGNITIVE BRAIN RES, V23, P397, DOI 10.1016/j.cogbrainres.2004.11.010; Gaser C, 2003, J NEUROSCI, V23, P9240; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Hammond G, 2002, NEUROSCI BIOBEHAV R, V26, P285, DOI 10.1016/S0149-7634(02)00003-9; HATTA T, 2006, MAGN RESON MED SCI, V6, P99; HEALEY JM, 1986, CORTEX, V22, P33, DOI 10.1016/S0010-9452(86)80031-4; Hopkins WD, 2004, BEHAV NEUROSCI, V118, P1176, DOI 10.1037/0735-7044.118.6.1176; Hopkins WD, 2004, NEUROPSYCHOLOGIA, V42, P990, DOI 10.1016/j.neuropsychologia.2003.11.017; Hopkins WD, 2002, J EXP PSYCHOL GEN, V131, P412, DOI 10.1037//0096-3445.131.3.412; Hopkins WD, 2001, BEHAV NEUROSCI, V115, P1159, DOI 10.1037//0735-7044.115.5.1159; Hopkins WD, 1998, NEUROREPORT, V9, P2913, DOI 10.1097/00001756-199808240-00043; HOPKINS WD, 2007, EVOLUTION HEMISPHERI, P112; Hopkins WD, 2007, CEREB CORTEX, V17, P1750, DOI 10.1093/cercor/bhl085; Hopkins WD, 2007, CEREB CORTEX, V17, P1757, DOI 10.1093/cercor/bhl086; Hopkins WD, 2007, EUR J NEUROSCI, V25, P2565, DOI 10.1111/j.1460-9568.2007.05502.x; JEANNEROD M, 1998, NEURAL BEHAV ORG GOA; Kaufman JA, 2003, AM J PHYS ANTHROPOL, V121, P369, DOI 10.1002/ajpa.10181; Lacreuse A, 2005, NEUROBIOL AGING, V26, P543, DOI 10.1016/j.neurobiolaging.2004.05.007; LI S, CEREBRAL CO IN PRESS; Lu LH, 2007, CEREB CORTEX, V17, P1092, DOI 10.1093/cercor/bhl019; Marzke MW, 1997, AM J PHYS ANTHROPOL, V102, P91; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Napier J.R., 1980, HANDS; NUDO RJ, 1992, J NEUROSCI, V12, P2918, DOI 10.1523/JNEUROSCI.12-08-02918.1992; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048; Phillips KA, 2005, BEHAV NEUROSCI, V119, P1701, DOI 10.1037/0735-7044.119.6.1701; Phillips KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000792; Phillips KA, 2007, NEUROPSYCHOLOGIA, V45, P2333, DOI 10.1016/j.neuropsychologia.2007.02.010; Pizzella V, 1999, NEUROREPORT, V10, P3809, DOI 10.1097/00001756-199912160-00016; Porac C, 1981, LATERAL PREFERENCES; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Rilling JK, 1999, J HUM EVOL, V37, P191, DOI 10.1006/jhev.1999.0313; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Sastre-Janer FA, 1998, CEREB CORTEX, V8, P641, DOI 10.1093/cercor/8.7.641; Sherwood CC, 2007, J COMP NEUROL, V503, P525, DOI 10.1002/cne.21399; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Taglialatela JP, 2006, NEUROREPORT, V17, P923, DOI 10.1097/01.wnr.0000221835.26093.5e; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; TORIGOE T, 1985, Primates, V26, P182, DOI 10.1007/BF02382017; Vilensky JA, 2002, INT J PRIMATOL, V23, P1319, DOI 10.1023/A:1021135122571; WHITE LE, 1994, NATURE, V368, P197, DOI 10.1038/368197a0; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	68	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13383	10.1371/journal.pone.0013383	http://dx.doi.org/10.1371/journal.pone.0013383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967216	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800047
J	Mrkonjic, M; Roslin, NM; Greenwood, CM; Raptis, S; Pollett, A; Laird, PW; Pethe, VV; Chiang, T; Daftary, D; Dicks, E; Thibodeau, SN; Gallinger, S; Parfrey, PS; Younghusband, HB; Potter, JD; Hudson, TJ; McLaughlin, JR; Green, RC; Zanke, BW; Newcomb, PA; Paterson, AD; Bapat, B				Mrkonjic, Miralem; Roslin, Nicole M.; Greenwood, Celia M.; Raptis, Stavroula; Pollett, Aaron; Laird, Peter W.; Pethe, Vaijayanti V.; Chiang, Theodore; Daftary, Darshana; Dicks, Elizabeth; Thibodeau, Stephen N.; Gallinger, Steven; Parfrey, Patrick S.; Younghusband, H. Banfield; Potter, John D.; Hudson, Thomas J.; McLaughlin, John R.; Green, Roger C.; Zanke, Brent W.; Newcomb, Polly A.; Paterson, Andrew D.; Bapat, Bharati			Specific Variants in the MLH1 Gene Region May Drive DNA Methylation, Loss of Protein Expression, and MSI-H Colorectal Cancer	PLOS ONE			English	Article							MLH1-93G-GREATER-THAN-A PROMOTER POLYMORPHISM; MICROSATELLITE-INSTABILITY; COLON-CANCER; RISK; CHEMOTHERAPY; IMMUNOHISTOCHEMISTRY; PREDISPOSITION; 5-FLUOROURACIL; INACTIVATION; GUIDELINES	Background: We previously identified an association between a mismatch repair gene, MLH1, promoter SNP (rs1800734) and microsatellite unstable (MSI-H) colorectal cancers (CRCs) in two samples. The current study expanded on this finding as we explored the genetic basis of DNA methylation in this region of chromosome 3. We hypothesized that specific polymorphisms in the MLH1 gene region predispose it to DNA methylation, resulting in the loss of MLH1 gene expression, mismatch-repair function, and consequently to genome-wide microsatellite instability. Methodology/Principal Findings: We first tested our hypothesis in one sample from Ontario (901 cases, 1,097 controls) and replicated major findings in two additional samples from Newfoundland and Labrador (479 cases, 336 controls) and from Seattle (591 cases, 629 controls). Logistic regression was used to test for association between SNPs in the region of MLH1 and CRC, MSI-H CRC, MLH1 gene expression in CRC, and DNA methylation in CRC. The association between rs1800734 and MSI-H CRCs, previously reported in Ontario and Newfoundland, was replicated in the Seattle sample. Two additional SNPs, in strong linkage disequilibrium with rs1800734, showed strong associations with MLH1 promoter methylation, loss of MLH1 protein, and MSI-H CRC in all three samples. The logistic regression model of MSI-H CRC that included MLH1-promoter-methylation status and MLH1 immunohisotchemistry status fit most parsimoniously in all three samples combined. When rs1800734 was added to this model, its effect was not statistically significant (P-value = 0.72 vs. 2.3x10(-4) when the SNP was examined alone). Conclusions/Significance: The observed association of rs1800734 with MSI-H CRC occurs through its effect on the MLH1 promoter methylation, MLH1 IHC deficiency, or both.	[Mrkonjic, Miralem; Raptis, Stavroula; Gallinger, Steven; Bapat, Bharati] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mrkonjic, Miralem; Raptis, Stavroula; Pethe, Vaijayanti V.; Gallinger, Steven; McLaughlin, John R.; Bapat, Bharati] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Mrkonjic, Miralem; Raptis, Stavroula; Pollett, Aaron; Bapat, Bharati] Mt Sinai Hosp, Dept Pathol & Lab Med, Toronto, ON M5G 1X5, Canada; [Roslin, Nicole M.; Greenwood, Celia M.; Chiang, Theodore; Paterson, Andrew D.] Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Greenwood, Celia M.; McLaughlin, John R.; Paterson, Andrew D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Laird, Peter W.] Univ So Calif, Univ So Calif Epigenome Ctr, Los Angeles, CA USA; [Daftary, Darshana; Gallinger, Steven; McLaughlin, John R.; Zanke, Brent W.] Canc Care Ontario, Ontario Familial Colorectal Canc Registry, Toronto, ON, Canada; [Dicks, Elizabeth; Parfrey, Patrick S.] Mem Univ Newfoundland, Clin Epidemiol Unit, St John, NF, Canada; [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Gallinger, Steven] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Younghusband, H. Banfield; Green, Roger C.] Mem Univ Newfoundland, Discipline Genet, St John, NF, Canada; [Potter, John D.; Newcomb, Polly A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Hudson, Thomas J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Zanke, Brent W.] Ottawa Hosp Res Inst, Ottawa, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Southern California; Cancer Care Ontario; Memorial University Newfoundland; Mayo Clinic; University of Toronto; Memorial University Newfoundland; Fred Hutchinson Cancer Center; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Mrkonjic, M (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	bapat@lunenfeld.ca	Gallinger, Steven/E-4575-2013; Bapat, Bharati/B-5839-2014; Pollett, Aaron/AAQ-2540-2021; Laird, Peter W/G-8683-2012; Paterson, Andrew D/A-4088-2011; Pollett, Aaron/J-2308-2016; McLaughlin, John R/E-4577-2013; Paterson, Andrew/AAQ-7511-2020	Pollett, Aaron/0000-0001-5121-8788; Laird, Peter W/0000-0001-9117-3641; Paterson, Andrew D/0000-0002-9169-118X; Pollett, Aaron/0000-0001-5121-8788; Paterson, Andrew/0000-0002-9169-118X; Potter, John/0000-0001-5439-1500; Greenwood, Celia/0000-0002-2427-5696; Roslin, Nicole/0000-0002-4609-8299	Canadian Institutes of Health Research (CIHR) [CRT-43821]; National Cancer Institute, National Institutes of Health [CA-95-011, U01 CA074783, U24 CA074794]; Genome Canada; Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation; American Institute for Cancer Research [99B055]; National Cancer Institute of Canada [018668]; Samuel Lunenfeld Research Institute; Team in Interdisciplinary Research on Colorectal Cancer; NATIONAL CANCER INSTITUTE [U24CA074794, U01CA074783, U24CA074783, K22CA095011, U01CA074794, R01CA118699] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genome Canada(Genome Canada); Ontario Institute for Cancer Research; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); American Institute for Cancer Research; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Samuel Lunenfeld Research Institute; Team in Interdisciplinary Research on Colorectal Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Team Grant from the Canadian Institutes of Health Research (CIHR grant CRT-43821 to J.M., B. B., J.K., S. G., R. G., P. P. and B.Y.). In addition, this work was supported by the National Cancer Institute, National Institutes of Health under Request For Applications CA-95-011 and through cooperative agreements with members of the colon family registry and Principal Investigators (U01 CA074783 awarded to Ontario Registry for Studies of Familial Colorectal Cancer, and U24 CA074794 awarded to Seattle Colorectal Cancer Family Registry). A. D. P. and N.R. are supported by Genome Canada. A. D. P. holds Canada Research Chair in Genetics of Complex Diseases. B.W.Z. and T.J.H. are recipients of Senior Investigator Awards from the Ontario Institute for Cancer Research, through generous support from the Ontario Ministry of Research and Innovation. In addition, this work was supported in part by the American Institute for Cancer Research grant 99B055 (B. B. and J.K.). M. M. is a Research Student of the Canadian Cancer Society through an award from the National Cancer Institute of Canada (018668). M. M. was also supported by graduate studentship from the Team in Interdisciplinary Research on Colorectal Cancer with funding from the Canadian Institutes of Health Research (CIHR) and from the Samuel Lunenfeld Research Institute. All authors had full responsibility for the design of the study, the collection of data, the analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Allan JM, 2008, INT J CANCER, V123, P2456, DOI 10.1002/ijc.23770; Beiner ME, 2006, CANCER EPIDEM BIOMAR, V15, P1636, DOI 10.1158/1055-9965.EPI-06-0257; Boland CR, 1998, CANCER RES, V58, P5248; CAMPBELL PT, 2008, GUT; Cappel WHDN, 2004, INT J CANCER, V109, P468, DOI 10.1002/ijc.11712; Carethers JM, 1999, GASTROENTEROLOGY, V117, P123, DOI 10.1016/S0016-5085(99)70558-5; Carethers JM, 2004, GASTROENTEROLOGY, V126, P394, DOI 10.1053/j.gastro.2003.12.023; Chen HP, 2007, INT J CANCER, V120, P1684, DOI 10.1002/ijc.22406; Cotterchio M, 2000, Chronic Dis Can, V21, P81; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Greene FL, 2002, AJCC CANC STAGING MA; Hampel H, 2006, CANCER RES, V66, P7810, DOI 10.1158/0008-5472.CAN-06-1114; Harley I, 2008, GYNECOL ONCOL, V109, P384, DOI 10.1016/j.ygyno.2007.11.046; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Hitchins MP, 2007, CANCER RES, V67, P9107, DOI 10.1158/0008-5472.CAN-07-0869; Ilyas M, 1999, EUR J CANCER, V35, P1986, DOI 10.1016/S0959-8049(99)00298-1; Jenkins MA, 2007, GASTROENTEROLOGY, V133, P48, DOI 10.1053/j.gastro.2007.04.044; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Liu J, 2005, P NATL ACAD SCI USA, V102, P1927, DOI 10.1073/pnas.0409472102; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Mrkonjic M, 2007, CARCINOGENESIS, V28, P2575, DOI 10.1093/carcin/bgm229; Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Raptis S, 2007, JNCI-J NATL CANCER I, V99, P463, DOI 10.1093/jnci/djk095; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Samowitz WS, 2008, GENE CHROMOSOME CANC, V47, P835, DOI 10.1002/gcc.20584; Thorsen K, 2008, MOL CELL PROTEOMICS, V7, P1214, DOI 10.1074/mcp.M700590-MCP200; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Wang WS, 2006, CELL MOL LIFE SCI, V63, P663, DOI 10.1007/s00018-005-5425-4; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Woods MO, 2005, CLIN CANCER RES, V11, P6853, DOI 10.1158/1078-0432.CCR-05-0726; Worrillow LJ, 2008, J MED GENET, V45, P142, DOI 10.1136/jmg.2007.053850; Yu JH, 2006, AM J GASTROENTEROL, V101, P1313, DOI 10.1111/j.1572-0241.2006.00551.x; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	41	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13314	10.1371/journal.pone.0013314	http://dx.doi.org/10.1371/journal.pone.0013314			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967208	gold, Green Published, Green Accepted			2022-12-27	WOS:000282869800019
J	Prakash, T; Sharma, VK; Adati, N; Ozawa, R; Kumar, N; Nishida, Y; Fujikake, T; Takeda, T; Taylor, TD				Prakash, Tulika; Sharma, Vineet K.; Adati, Naoki; Ozawa, Ritsuko; Kumar, Naveen; Nishida, Yuichiro; Fujikake, Takayoshi; Takeda, Tadayuki; Taylor, Todd D.			Expression of Conjoined Genes: Another Mechanism for Gene Regulation in Eukaryotes	PLOS ONE			English	Article							MESSENGER-RNA; ALTERNATIVE POLYADENYLATION; HUMAN GENOME; FUSION PROTEIN; IDENTIFICATION; TRANSCRIPTS; COMPLEXITY; CANCER; TUMORS	From the ENCODE project, it is realized that almost every base of the entire human genome is transcribed. One class of transcripts resulting from this arises from the conjoined gene, which is formed by combining the exons of two or more distinct (parent) genes lying on the same strand of a chromosome. Only a very limited number of such genes are known, and the definition and terminologies used for them are highly variable in the public databases. In this work, we have computationally identified and manually curated 751 conjoined genes (CGs) in the human genome that are supported by at least one mRNA or EST sequence available in the NCBI database. 353 representative CGs, of which 291 (82%) could be confirmed, were subjected to experimental validation using RT-PCR and sequencing methods. We speculate that these genes are arising out of novel functional requirements and are not merely artifacts of transcription, since more than 70% of them are conserved in other vertebrate genomes. The unique splicing patterns exhibited by CGs reveal their possible roles in protein evolution or gene regulation. Novel CGs, for which no transcript is available, could be identified in 80% of randomly selected potential CG forming regions, indicating that their formation is a routine process. Formation of CGs is not only limited to human, as we have also identified 270 CGs in mouse and 227 in drosophila using our approach. Additionally, we propose a novel mechanism for the formation of CGs. Finally, we developed a database, ConjoinG, which contains detailed information about all the CGs (800 in total) identified in the human genome. In summary, our findings reveal new insights about the functionality of CGs in terms of another possible mechanism for gene regulation and genomic evolution and the mechanism leading to their formation.	[Prakash, Tulika; Sharma, Vineet K.; Adati, Naoki; Ozawa, Ritsuko; Kumar, Naveen; Nishida, Yuichiro; Fujikake, Takayoshi; Takeda, Tadayuki; Taylor, Todd D.] RIKEN Adv Sci Inst, MetaSyst Res Team, Adv Computat Sci Dept, Computat Syst Biol Res Grp, Yokohama, Kanagawa, Japan	RIKEN	Prakash, T (corresponding author), RIKEN Adv Sci Inst, MetaSyst Res Team, Adv Computat Sci Dept, Computat Syst Biol Res Grp, Yokohama, Kanagawa, Japan.	taylor@riken.jp	sharma, Vijay K/A-6733-2009; Taylor, Todd/A-7121-2009; Srivastava, Tulika/A-7207-2009	sharma, Vijay K/0000-0002-8976-5696; Taylor, Todd/0000-0003-4247-6253; Kumar, Naveen/0000-0001-7364-6601; K. Sharma, Vineet/0000-0002-2958-6215	RIKEN	RIKEN	Funding support from operational expenditure fund of RIKEN is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Denoeud F, 2007, GENOME RES, V17, P746, DOI 10.1101/gr.5660607; FRIEDMAN DI, 1995, MOL MICROBIOL, V18, P191, DOI 10.1111/j.1365-2958.1995.mmi_18020191.x; Gingeras TR, 2009, NATURE, V461, P206, DOI 10.1038/nature08452; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Kato M, 2003, J BIOL CHEM, V278, P34035, DOI 10.1074/jbc.M303112200; Kaye FJ, 2009, MOL CANCER THER, V8, P1399, DOI 10.1158/1535-7163.MCT-09-0135; Kim N, 2006, NUCLEIC ACIDS RES, V34, pD21, DOI 10.1093/nar/gkj019; Kowalski PE, 1999, GENOMICS, V57, P371, DOI 10.1006/geno.1999.5787; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; Li X, 2009, J MOL EVOL, V68, P56, DOI 10.1007/s00239-008-9187-0; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Licatalosi DD, 2010, NAT REV GENET, V11, P75, DOI 10.1038/nrg2673; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Parra G, 2006, GENOME RES, V16, P37, DOI 10.1101/gr.4145906; Pearson H, 2006, NATURE, V441, P398, DOI 10.1038/441398a; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Pradet-Balade B, 2002, EMBO J, V21, P5711, DOI 10.1093/emboj/cdf565; Qureshi IA, 2009, NEUROSCI LETT, V466, P73, DOI 10.1016/j.neulet.2009.07.093; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Taylor TD, 2006, NATURE, V440, P497, DOI 10.1038/nature04632; Thomson TM, 2000, GENOME RES, V10, P1743, DOI 10.1101/gr.GR-1405R; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-348; Xing AQ, 2010, PLANT BIOTECHNOL J, V8, P772, DOI 10.1111/j.1467-7652.2010.00504.x; Yada T, 2003, Pac Symp Biocomput, P375; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	36	72	77	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13284	10.1371/journal.pone.0013284	http://dx.doi.org/10.1371/journal.pone.0013284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967262	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300016
J	Zepeda-Lopez, HM; Perea-Araujo, L; Miliar-Garcia, A; Dominguez-Lopez, A; Xoconostle-Cazarez, B; Lara-Padilla, E; Hernandez, JAR; Sevilla-Reyes, E; Orozco, ME; Ahued-Ortega, A; Villasenor-Ruiz, I; Garcia-Cavazos, RJ; Teran, LM				Zepeda-Lopez, Hector M.; Perea-Araujo, Lizbeth; Miliar-Garcia, Angel; Dominguez-Lopez, Aaron; Xoconostle-Cazarez, Beatriz; Lara-Padilla, Eleazar; Ramirez Hernandez, Jorge A.; Sevilla-Reyes, Edgar; Esther Orozco, Maria; Ahued-Ortega, Armando; Villasenor-Ruiz, Ignacio; Garcia-Cavazos, Ricardo J.; Teran, Luis M.			Inside the Outbreak of the 2009 Influenza A (H1N1) v Virus in Mexico	PLOS ONE			English	Article							TRANSMISSION; A(H1N1)	Background: Influenza viruses pose a threat to human health because of their potential to cause global disease. Between mid March and mid April a pandemic influenza A virus emerged in Mexico. This report details 202 cases of infection of humans with the 2009 influenza A virus (H1N1) v which occurred in Mexico City as well as the spread of the virus throughout the entire country. Methodology and Findings: From May 1st to May 5th nasopharyngeal swabs, derived from 751 patients, were collected at 220 outpatient clinics and 28 hospitals distributed throughout Mexico City. Analysis of samples using real time RT-PCR revealed that 202 patients out of the 751 subjects (26.9%) were confirmed to be infected with the new virus. All confirmed cases of human infection with the strain influenza (H1N1) v suffered respiratory symptoms. The greatest number of confirmed cases during the outbreak of the 2009 influenza A (H1N1) v were seen in neighbourhoods on the northeast side of Mexico City including Iztapalapa, Gustavo A. Madero, Iztacalco, and Tlahuac which are the most populated areas in Mexico City. Using these data, together with data reported by the Mexican Secretariat of Health (MSH) to date, we plot the course of influenza (H1N1) v activity throughout Mexico. Conclusions: Our data, which is backed up by MSH data, show that the greatest numbers of the 2009 influenza A (H1N1) cases were seen in the most populated areas. We speculate on conditions in Mexico which may have sparked this flu pandemic, the first in 41 years. We accept the hypothesis that high population density and a mass gathering which took in Iztapalapa contributed to the rapid spread of the disease which developed in three peaks of activity throughout the Country.	[Zepeda-Lopez, Hector M.; Perea-Araujo, Lizbeth; Miliar-Garcia, Angel; Dominguez-Lopez, Aaron; Lara-Padilla, Eleazar; Garcia-Cavazos, Ricardo J.] Inst Politecn Nacl, Escuela Super Med, Lab Med Conservac, Mexico City 07738, DF, Mexico; [Xoconostle-Cazarez, Beatriz] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biotecnol & Bioingn, Mexico City 07738, DF, Mexico; [Ramirez Hernandez, Jorge A.; Sevilla-Reyes, Edgar; Teran, Luis M.] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Esther Orozco, Maria] Inst Ciencia & Tecnol, Direcc Gen, Mexico City, DF, Mexico; [Ahued-Ortega, Armando] Secretaria Salud Mexico, Direcc Gen, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Zepeda-Lopez, HM (corresponding author), Inst Politecn Nacl, Escuela Super Med, Lab Med Conservac, Mexico City 07738, DF, Mexico.	lmteran@iner.gob.mx	Sevilla, Edgar/AAS-3300-2021; Teran, Luis/AAI-9815-2021	Sevilla, Edgar/0000-0002-7047-0222; Teran, Luis Manuel/0000-0003-1806-1779	Federal District government	Federal District government	The Federal District government provided a grant to support the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bi YH, 2010, EMERG INFECT DIS, V16, P1162, DOI 10.3201/eid1607.091881; Caley P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000143; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; *DEIS, 2009, GOOD FRID IZT MEX; DELACRUZ JPL, 2009, B TUR CANCUN, V2, P9; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Ebrahim SH, 2009, SCIENCE, V326, P938, DOI 10.1126/science.1183210; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Haworth E, 2010, J ROY SOC MED, V103, P79, DOI 10.1258/jrsm.2010.090463; *INEGI, 2009, 12 CENS POBL VIV 200; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; KINGSFORD C, 2009, PLOS            0728, DOI DOI 10.1371/JOURNAL.PONE.0006402; Lipsitch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006895; Memish ZA, 2009, LANCET, V374, P1786, DOI 10.1016/S0140-6736(09)61927-9; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Mubareka S, 2009, J INFECT DIS, V199, P858, DOI 10.1086/597073; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; *SECR SAL, 2009, INFL MEX TEMP OT INV; *SECR SAL, 2009, SIT ACT PAND; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Tsouros AD, 2004, MASS GATHERINGS PUBL; van Hal SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006620; Vijaykrishna D, 2010, SCIENCE, V328, P1529, DOI 10.1126/science.1189132; Ward HH, 2004, GENOMICS, V84, P991, DOI 10.1016/j.ygeno.2004.08.002; World Health Organization, 2009, PAND H1N1 2009 UPD 8	29	30	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13256	10.1371/journal.pone.0013256	http://dx.doi.org/10.1371/journal.pone.0013256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949040	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700019
J	Hamano, T; Fujisawa, Y; Ishida, Y; Subramanian, SV; Kawachi, I; Shiwaku, K				Hamano, Tsuyoshi; Fujisawa, Yoshikazu; Ishida, Yu; Subramanian, S. V.; Kawachi, Ichiro; Shiwaku, Kuninori			Social Capital and Mental Health in Japan: A Multilevel Analysis	PLOS ONE			English	Article							NEIGHBORHOOD	Background: A national cross-sectional survey was conducted in Japan. This is because the growing recognition of the social determinants of health has stimulated research on social capital and mental health. In recent years, systematic reviews have found that social capital may be a useful factor in the prevention of mental illness. Despite these studies, evidence on the association between social capital and mental health is limited as there have been few empirical discussions that adopt a multilevel framework to assess whether social capital at the ecological level is associated with individual mental health. The aim of this study was to use the multilevel approach to investigate the association between neighborhood social capital and mental health after taking into account potential individual confounders. Methodology/Principal Findings: We conducted a multilevel analysis on 5,956 individuals nested within 199 neighborhoods. The outcome variable of self-reported mental health was measured by the one dimension of SF-36 and was summed to calculate a score ranging from 0 to 100. This study showed that high levels of cognitive social capital, measured by trust (regression coefficient = 9.56), and high levels of structural social capital, measured by membership in sports, recreation, hobby, or cultural groups (regression coefficient = 8.72), were associated with better mental health after adjusting for age, sex, household income, and educational attainment. Furthermore, after adjusting for social capital perceptions at the individual level, we found that the association between social capital and mental health also remained. Conclusions/Significance: Our findings suggest that both cognitive and structural social capital at the ecological level may influence mental health, even after adjusting for individual potential confounders including social capital perceptions. Promoting social capital may contribute to enhancing the mental health of the Japanese.	[Hamano, Tsuyoshi] Shimane Univ, Org Promot Project Res, Matsue, Shimane, Japan; [Hamano, Tsuyoshi; Shiwaku, Kuninori] Shimane Univ, Dept Environm & Prevent Med, Sch Med, Izumo, Shimane, Japan; [Fujisawa, Yoshikazu] Univ Shizuoka, Sch Adm & Informat, Div Publ Policy, Shizuoka 4228526, Japan; [Ishida, Yu] Akashi Natl Coll Technol, Dept Gen Studies, Akashi, Hyogo, Japan; [Subramanian, S. V.; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Shimane University; Shimane University; University of Shizuoka; Harvard University; Harvard T.H. Chan School of Public Health	Hamano, T (corresponding author), Shimane Univ, Org Promot Project Res, Matsue, Shimane, Japan.	thamano@med.shimane-u.ac.jp	Ishida, Yu/AAL-9889-2021	Ishida, Yu/0000-0003-1100-7403; Hamano, Tsuyoshi/0000-0002-6755-9138	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [18683004]; Japan Society for the Promotion of Science (JSPS) [21650064]; National Institutes of Health (NHLBI) [1 K25 HL081275]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT: http://www.mext.go.jp/english/),Grant-in-Aid for Young Scientists (A) (#18683004; Principle Investigator, Yoshikazu Fujisawa) and by Japan Society for the Promotion of Science (JSPS: http://www.jsps.go.jp/english/index.html), Grant-in-Aid for Challenging Exploratory Research (#21650064; Principle Investigator, Tsuyoshi Hamano). SVS is supported by the National Institutes of Health Career Development Award (NHLBI 1 K25 HL081275). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas J, 2009, Public Health, V123, pe35, DOI 10.1016/j.puhe.2008.10.007; Aveyard P, 2000, J PUBLIC HEALTH MED, V22, P317, DOI 10.1093/pubmed/22.3.317; De Silva M.J., 2006, SOCIAL CAPITAL MENTA, P39; De Silva MJ, 2005, J EPIDEMIOL COMMUN H, V59, P619, DOI 10.1136/jech.2004.029678; Fujisawa Y, 2009, SOC SCI MED, V69, P500, DOI 10.1016/j.socscimed.2009.05.046; Fujiwara T, 2008, J EPIDEMIOL COMMUN H, V62, P627, DOI 10.1136/jech.2007.064261; Fukuhara S, 2004, MANUAL SF 36 V2 JAPA; Harpham T., 2008, SOCIAL CAPITAL HLTH, P51; Kawachi I, 2008, SOCIAL CAPITAL HLTH, DOI [10.1007/978-0-387-71311-3_1, DOI 10.1007/978-0-387-71311-3_1]; Kondo N, 2007, SOC SCI MED, V64, P2311, DOI 10.1016/j.socscimed.2007.02.009; Lindstrom M, 2003, SOC SCI MED, V56, P1111, DOI 10.1016/S0277-9536(02)00114-4; Lochner KA, 2003, SOC SCI MED, V56, P1797, DOI 10.1016/S0277-9536(02)00177-6; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mohan J, 2005, SOC SCI MED, V60, P1267, DOI 10.1016/j.socscimed.2004.06.050; Nakata K, 2003, INT SER PROG WAT RES, V9, P23; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; READING R, 1994, J EPIDEMIOL COMMUN H, V48, P192, DOI 10.1136/jech.48.2.192; Shatalova N.A, 2003, INF PORTAL; Stafford M, 2008, HEALTH PLACE, V14, P394, DOI 10.1016/j.healthplace.2007.08.006; Subramanian SV, 2002, J URBAN HEALTH, V79, pS21, DOI 10.1093/jurban/79.suppl_1.S21; Veenstra G, 2005, SOC SCI MED, V60, P2059, DOI 10.1016/j.socscimed.2004.08.064; Ware J., 1993, SF 36 HLTH SURVEY MA; Yip W, 2007, SOC SCI MED, V64, P35, DOI 10.1016/j.socscimed.2006.08.027	23	96	98	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13214	10.1371/journal.pone.0013214	http://dx.doi.org/10.1371/journal.pone.0013214			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659LQ	20949091	Green Published, gold			2022-12-27	WOS:000282568400017
J	Badadani, M; Nalbandian, A; Watts, GD; Vesa, J; Kitazawa, M; Su, HL; Tanaja, J; Dec, E; Wallace, DC; Mukherjee, J; Caiozzo, V; Warman, M; Kimonis, VE				Badadani, Mallikarjun; Nalbandian, Angele; Watts, Giles D.; Vesa, Jouni; Kitazawa, Masashi; Su, Hailing; Tanaja, Jasmin; Dec, Eric; Wallace, Douglas C.; Mukherjee, Jogeshwar; Caiozzo, Vincent; Warman, Matthew; Kimonis, Virginia E.			VCP Associated Inclusion Body Myopathy and Paget Disease of Bone Knock-In Mouse Model Exhibits Tissue Pathology Typical of Human Disease	PLOS ONE			English	Article							VALOSIN-CONTAINING PROTEIN; AAA-ATPASE; ENDOPLASMIC-RETICULUM; FRONTOTEMPORAL DEMENTIA; AUTOPHAGIC VACUOLES; CELL-DEATH; UBIQUITIN; P97; EXPRESSION; VCP/P97	Dominant mutations in the valosin containing protein (VCP) gene cause inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBMPFD). We have generated a knock-in mouse model with the common R155H mutation. Mice demonstrate progressive muscle weakness starting approximately at the age of 6 months. Histology of mutant muscle showed progressive vacuolization of myofibrils and centrally located nuclei, and immunostaining shows progressive cytoplasmic accumulation of TDP-43 and ubiquitin-positive inclusion bodies in quadriceps myofibrils and brain. Increased LC3-II staining of muscle sections representing increased number of autophagosomes suggested impaired autophagy. Increased apoptosis was demonstrated by elevated caspase-3 activity and increased TUNEL-positive nuclei. Xray microtomography (uCT) images show radiolucency of distal femurs and proximal tibiae in knock-in mice and uCT morphometrics shows decreased trabecular pattern and increased cortical wall thickness. Bone histology and bone marrow derived macrophage cultures in these mice revealed increased osteoclastogenesis observed by TRAP staining suggestive of Paget bone disease. The VCP R155H/+ knock-in mice replicate the muscle, bone and brain pathology of inclusion body myopathy, thus representing a useful model for preclinical studies.	[Badadani, Mallikarjun; Nalbandian, Angele; Vesa, Jouni; Su, Hailing; Tanaja, Jasmin; Dec, Eric; Wallace, Douglas C.; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA; [Watts, Giles D.] Harvard Univ, Sch Med, Dept Orthoped Surg, Childrens Hosp Boston, Boston, MA 02115 USA; [Kitazawa, Masashi] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Ecol, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Evolutionary Biol, Irvine, CA USA; [Wallace, Douglas C.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA; [Mukherjee, Jogeshwar] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Caiozzo, Vincent] Univ Calif Irvine, Dept Orthoped, Irvine, CA USA; [Warman, Matthew] Harvard Univ, Sch Med, Dept Genet, Childrens Hosp Boston, Boston, MA USA; [Watts, Giles D.] Univ E Anglia, Sch Med Hlth Policy & Practice, Dept Cell Biol & Biochem, Norwich NR4 7TJ, Norfolk, England	University of California System; University of California Irvine; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Harvard University; Boston Children's Hospital; Harvard Medical School; University of East Anglia	Badadani, M (corresponding author), Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA.	vkimonis@uci.edu	Kitazawa, Masashi/AAI-1721-2021; Mukherjee, Jogeshwar/O-1320-2013	Kitazawa, Masashi/0000-0003-2165-8197; Mukherjee, Jogeshwar/0000-0003-1009-877X	National Institutes of Health [R01 AR050236, 1K01AR056002-01A2]; MicroCT [S10 RR024546]; Muscular Dystrophy Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR056002, R01AR050236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MicroCT; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health [R01 AR050236 to VEK], [S10 RR024546 for MicroCT to JM] and the Muscular Dystrophy Association [Development grant to JV] and NIH 1K01AR056002-01A2 [GW]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2000, BRIT J RADIOL, V73, P1078, DOI 10.1259/bjr.73.874.11271900; Arnold SE, 2000, NEUROBIOL AGING, V21, P913, DOI 10.1016/S0197-4580(00)00173-1; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bernardi P, 1999, ITAL J NEUROL SCI, V20, P395; Boya P, 2002, CELL DEATH DIFFER, V9, P465, DOI 10.1038/sj.cdd.4401006; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; CONFALONIERI F, 1995, BIOESSAYS, V17, P639, DOI 10.1002/bies.950170710; Custer SK, 2010, HUM MOL GENET, V19, P1741, DOI 10.1093/hmg/ddq050; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Eskelinen EL, 2005, AUTOPHAGY, V1, P1, DOI 10.4161/auto.1.1.1270; FARBER JL, 1994, ENVIRON HEALTH PERSP, V102, P17, DOI 10.2307/3432207; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Galluzzi L, 2008, CURR MOL MED, V8, P78; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x; JU JS, HUM MOL GENET; Kimonis V., 2007, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, BIOCH BIOPHYS ACTA; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Muller JMM, 1999, J BIOL CHEM, V274, P10154, DOI 10.1074/jbc.274.15.10154; Mumby DG, 2002, BEHAV BRAIN RES, V132, P215, DOI 10.1016/S0166-4328(01)00444-2; Neumann M, 2007, J NEUROPATH EXP NEUR, V66, P152, DOI 10.1097/nen.0b013e31803020b9; Nishino Ichizo, 2003, Curr Neurol Neurosci Rep, V3, P64, DOI 10.1007/s11910-003-0040-y; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Okere CO, 2000, BRAIN RES, V877, P85, DOI 10.1016/S0006-8993(00)02656-1; Patel S, 1998, TRENDS CELL BIOL, V8, P65, DOI 10.1016/S0962-8924(97)01212-9; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; SCHNEIDER R, 1979, ORTHOPADE, V8, P79; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4; Stypmann J, 2006, BASIC RES CARDIOL, V101, P281, DOI 10.1007/s00395-006-0591-6; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Turner RS, 1996, ANN NEUROL, V39, P166, DOI 10.1002/ana.410390205; VANSWIETEN JC, 2007, GENEREVIEWS; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Weihl CC, 2008, J NEUROL NEUROSUR PS, V79, P1186, DOI 10.1136/jnnp.2007.131334; Weihl CC, 2007, HUM MOL GENET, V16, P919, DOI 10.1093/hmg/ddm037; Weihl CC, 2009, NEUROMUSCULAR DISORD, V19, P308, DOI 10.1016/j.nmd.2009.01.009; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Zhukareva V, 2001, ANN NEUROL, V49, P165, DOI 10.1002/1531-8249(20010201)49:2<165::AID-ANA36>3.0.CO;2-3; Zwickl P, 1999, NAT CELL BIOL, V1, pE97, DOI 10.1038/12097	64	87	90	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13183	10.1371/journal.pone.0013183	http://dx.doi.org/10.1371/journal.pone.0013183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957154	Green Published, gold, Green Submitted			2022-12-27	WOS:000282506100013
J	Brown, K; Doss, MX; Legros, S; Artus, J; Hadjantonakis, AK; Foley, AC				Brown, Kemar; Doss, Michael Xavier; Legros, Stephanie; Artus, Jerome; Hadjantonakis, Anna-Katerina; Foley, Ann C.			eXtraembryonic ENdoderm (XEN) Stem Cells Produce Factors that Activate Heart Formation	PLOS ONE			English	Article							AVIAN PREGASTRULA EPIBLAST; ACID-METABOLIZING ENZYME; RETINOIC-ACID; CARDIOMYOCYTE DIFFERENTIATION; CARDIAC DIFFERENTIATION; EMBRYONIC HEART; OPPOSING FGF; INDUCTION; EXPRESSION; MOUSE	Background: Initial specification of cardiomyocytes in the mouse results from interactions between the extraembryonic anterior visceral endoderm (AVE) and the nascent mesoderm. However the mechanism by which AVE activates cardiogenesis is not well understood, and the identity of specific cardiogenic factors in the endoderm remains elusive. Most mammalian studies of the cardiogenic potential of the endoderm have relied on the use of cell lines that are similar to the heart-inducing AVE. These include the embryonal-carcinoma-derived cell lines, END2 and PYS2. The recent development of protocols to isolate eXtraembryonic ENdoderm (XEN) stem cells, representing the extraembryonic endoderm lineage, from blastocyst stage mouse embryos offers new tools for the genetic dissection of cardiogenesis. Methodology/Principal Findings: Here, we demonstrate that XEN cell-conditioned media (CM) enhances cardiogenesis during Embryoid Body (EB) differentiation of mouse embryonic stem (ES) cells in a manner comparable to PYS2-CM and END2-CM. Addition of CM from each of these three cell lines enhanced the percentage of EBs that formed beating areas, but ultimately, only XEN-CM and PYS2-CM increased the total number of cardiomyocytes that formed. Furthermore, our observations revealed that both contact-independent and contact-dependent factors are required to mediate the full cardiogenic potential of the endoderm. Finally, we used gene array comparison to identify factors in these cell lines that could mediate their cardiogenic potential. Conclusions/Significance: These studies represent the first step in the use of XEN cells as a molecular genetic tool to study cardiomyocyte differentiation. Not only are XEN cells functionally similar to the heart-inducing AVE, but also can be used for the genetic dissection of the cardiogenic potential of AVE, since they can be isolated from both wild type and mutant blastocysts. These studies further demonstrate the importance of both contact-dependent and contact-independent factors in cardiogenesis and identify potential heart-inducing proteins in the endoderm.	[Brown, Kemar; Doss, Michael Xavier; Legros, Stephanie; Foley, Ann C.] Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY 10065 USA; [Artus, Jerome; Hadjantonakis, Anna-Katerina] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	Cornell University; Memorial Sloan Kettering Cancer Center	Brown, K (corresponding author), Weill Cornell Med Coll, Greenberg Div Cardiol, New York, NY 10065 USA.	acf2002@med.cornell.edu	; Jesudoss, Michael Xavier Doss/D-1983-2015	Artus, Jerome/0000-0003-3423-8634; Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	American Heart Association [0930056N]; Raymond and Beverly Sackler; National Institutes of Health [RO1-HD052115, RO1-DK084391]; New York Stem Cell Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052115] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084391] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Raymond and Beverly Sackler; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Work in Ann Foley's laboratory is supported by the American Heart Association (0930056N) and funding from Raymond and Beverly Sackler. Anna-Katerina Hadjantonakis's laboratory is supported by the National Institutes of Health (RO1-HD052115 and RO1-DK084391) and New York Stem Cell Science. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Abu-Abed SS, 1998, J BIOL CHEM, V273, P2409, DOI 10.1074/jbc.273.4.2409; AbuAbed M, 1997, BIOCHEMISTRY-US, V36, P14012, DOI 10.1021/bi971407s; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Artus J, 2010, DEVELOPMENT, V137, P3361, DOI 10.1242/dev.050864; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Brown K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012016; Bruneau BG, 1999, DEV BIOL, V211, P100, DOI 10.1006/dbio.1999.9298; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diez del Corral R, 2003, NEURON, V40, P65; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Drysdale TA, 1997, DEV BIOL, V188, P205, DOI 10.1006/dbio.1997.8623; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Espinoza-Lewis RA, 2009, DEV BIOL, V327, P376, DOI 10.1016/j.ydbio.2008.12.028; Foley AC, 2000, DEVELOPMENT, V127, P3839; Foley AC, 2005, GENE DEV, V19, P387, DOI 10.1101/gad.1279405; Foley AC, 2001, J ANAT, V199, P35; Foley AC, 2006, ANN NY ACAD SCI, V1080, P85, DOI 10.1196/annals.1380.008; Foley AC, 2007, DEV BIOL, V303, P57, DOI 10.1016/j.ydbio.2006.10.033; Franco D, 1998, CARDIOVASC RES, V38, P25, DOI 10.1016/S0008-6363(97)00321-0; FULLILOVE SL, 1970, J EXP ZOOL, V175, P323, DOI 10.1002/jez.1401750306; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; GANNON M, 1995, DEVELOPMENT, V121, P2439; GISSEL C, SACHINIDIS METHODS M; Goldbeter A, 2007, DEV DYNAM, V236, P1495, DOI 10.1002/dvdy.21193; GOURDIE RG, 1993, J CELL SCI, V105, P985; Holtzinger A, 2010, DEV BIOL, V337, P63, DOI 10.1016/j.ydbio.2009.10.003; Honda M, 2005, BIOCHEM BIOPH RES CO, V333, P1334, DOI 10.1016/j.bbrc.2005.05.202; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; JACOBSON AG, 1968, J EXP ZOOL, V167, P79, DOI 10.1002/jez.1401670106; JACOBSON AG, 1960, DEV BIOL, V2, P138, DOI 10.1016/0012-1606(60)90003-8; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kwon GS, 2006, DEV DYNAM, V235, P2549, DOI 10.1002/dvdy.20843; LEHMAN JM, 1974, J CELL PHYSIOL, V84, P13, DOI 10.1002/jcp.1040840103; Liberatore CM, 2000, DEV BIOL, V223, P169, DOI 10.1006/dbio.2000.9748; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Matsui H, 2005, DEV DYNAM, V233, P1419, DOI 10.1002/dvdy.20477; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Mummery C, 2002, J ANAT, V200, P233, DOI 10.1046/j.1469-7580.2002.00031.x; MUMMERY CL, 1991, DIFFERENTIATION, V46, P51, DOI 10.1111/j.1432-0436.1991.tb00865.x; MUMMERY CL, 1985, DEV BIOL, V109, P402, DOI 10.1016/0012-1606(85)90466-X; Nagy A., 2003, MANIPULATING MOUSE E; NASCONE N, 1995, DEVELOPMENT, V121, P515; Nijmeijer RM, 2009, STEM CELL RES, V3, P170, DOI 10.1016/j.scr.2009.06.003; Pal R, 2009, EXP BIOL MED, V234, P1230, DOI 10.3181/0901-RM-38; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Passier R, 2005, STEM CELLS, V23, P772, DOI 10.1634/stemcells.2004-0184; Saga Y, 1999, DEVELOPMENT, V126, P3437; SATER AK, 1990, DEVELOPMENT, V108, P461; SATER AK, 1989, DEVELOPMENT, V105, P821; Schneider VA, 1999, CURR BIOL, V9, P800, DOI 10.1016/S0960-9822(99)80363-7; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; Stary M, 2005, EXP CELL RES, V310, P331, DOI 10.1016/j.yexcr.2005.07.013; Takahashi T, 2003, CIRCULATION, V107, P1912, DOI 10.1161/01.CIR.0000064899.53876.A3; Tam PPL, 1997, DEVELOPMENT, V124, P1631; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomas T, 1998, DEV BIOL, V196, P228, DOI 10.1006/dbio.1998.8849; Wei H, 2005, J CELL MOL MED, V9, P804, DOI 10.1111/j.1582-4934.2005.tb00381.x; White JA, 1997, J BIOL CHEM, V272, P18538, DOI 10.1074/jbc.272.30.18538; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Wobus AM, 1997, J MOL CELL CARDIOL, V29, P1525, DOI 10.1006/jmcc.1997.0433; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561	73	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13446	10.1371/journal.pone.0013446	http://dx.doi.org/10.1371/journal.pone.0013446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975998	Green Submitted, Green Published, gold			2022-12-27	WOS:000283216400006
J	Keil, JM; Shen, ZX; Briggs, SP; Patrick, GN				Keil, Jeffrey M.; Shen, Zhouxin; Briggs, Steven P.; Patrick, Gentry N.			Regulation of STIM1 and SOCE by the Ubiquitin-Proteasome System (UPS)	PLOS ONE			English	Article							STROMAL INTERACTION MOLECULE-1; CAPACITATIVE CA2+ ENTRY; PLASMA-MEMBRANE; PROTEIN-DEGRADATION; STORE DEPLETION; LIGASE POSH; CHANNELS; PLASTICITY; NEURONS; BRAIN	The ubiquitin proteasome system (UPS) mediates the majority of protein degradation in eukaryotic cells. The UPS has recently emerged as a key degradation pathway involved in synapse development and function. In order to better understand the function of the UPS at synapses we utilized a genetic and proteomic approach to isolate and identify novel candidate UPS substrates from biochemically purified synaptic membrane preparations. Using these methods, we have identified Stromal interacting molecule 1 (STIM1). STIM1 is as an endoplasmic reticulum (ER) calcium sensor that has been shown to regulate store-operated Ca(2+) entry (SOCE). We have characterized STIM1 in neurons, finding STIM1 is expressed throughout development with stable, high expression in mature neurons. As in non-excitable cells, STIM1 is distributed in a membranous and punctate fashion in hippocampal neurons. In addition, a population of STIM1 was found to exist at synapses. Furthermore, using surface biotinylation and live-cell labeling methods, we detect a subpopulation of STIM1 on the surface of hippocampal neurons. The role of STIM1 as a regulator of SOCE has typically been examined in non-excitable cell types. Therefore, we examined the role of the UPS in STIM1 and SOCE function in HEK293 cells. While we find that STIM1 is ubiquitinated, its stability is not altered by proteasome inhibitors in cells under basal conditions or conditions that activate SOCE. However, we find that surface STIM1 levels and thapsigargin (TG)-induced SOCE are significantly increased in cells treated with proteasome inhibitors. Additionally, we find that the overexpression of POSH (Plenty of SH3's), an E3 ubiquitin ligase recently shown to be involved in the regulation of Ca(2+) homeostasis, leads to decreased STIM1 surface levels. Together, these results provide evidence for previously undescribed roles of the UPS in the regulation of STIM1 and SOCE function.	[Keil, Jeffrey M.; Patrick, Gentry N.] Univ Calif San Diego, Dept Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Dept Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Keil, JM (corresponding author), Univ Calif San Diego, Dept Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.	gpatrick@ucsd.edu			University of California San Diego (UCSD); Ray Thomas Edward Career Award; UCSD; National Institutes of Health [NS054732]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847, R21NS054732] Funding Source: NIH RePORTER	University of California San Diego (UCSD); Ray Thomas Edward Career Award; UCSD; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by University of California San Diego (UCSD) Biology departmental funds to J.M.K.; Ray Thomas Edward Career Award, UCSD Startup Funds, and National Institutes of Health funding (NS054732) to G.N.P. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Baba A, 2003, J NEUROSCI, V23, P7737; Bardo S, 2006, TRENDS PHARMACOL SCI, V27, P78, DOI 10.1016/j.tips.2005.12.008; Berna-Erro A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000522; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Dziadek MA, 2007, CELL CALCIUM, V42, P123, DOI 10.1016/j.ceca.2007.02.006; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gasperini R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-29; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hewavitharana T, 2008, J BIOL CHEM, V283, P26252, DOI 10.1074/jbc.M802239200; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; JOHNSTONE LS, J CELL MOL MED; Klejman ME, 2009, NEUROCHEM INT, V54, P49, DOI 10.1016/j.neuint.2008.10.005; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; Oritani K, 1996, J CELL BIOL, V134, P771, DOI 10.1083/jcb.134.3.771; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Skibinska-Kijek A, 2009, ACTA NEUROBIOL EXP, V69, P413; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tang FJ, 2005, J NEUROSCI, V25, P6702, DOI 10.1523/JNEUROSCI.0871-05.2005; Tsirigotis M, 2001, BIOTECHNIQUES, V31, P120, DOI 10.2144/01311rr03; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	41	33	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13465	10.1371/journal.pone.0013465	http://dx.doi.org/10.1371/journal.pone.0013465			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976103	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300034
J	Shibata, T; Ariki, S; Shinzawa, N; Miyaji, R; Suyama, H; Sako, M; Inomata, N; Koshiba, T; Kanuka, H; Kawabata, S				Shibata, Toshio; Ariki, Shigeru; Shinzawa, Naoaki; Miyaji, Ryuta; Suyama, Haruka; Sako, Miyuki; Inomata, Nobuyuki; Koshiba, Takumi; Kanuka, Hirotaka; Kawabata, Shun-ichiro			Protein Crosslinking by Transglutaminase Controls Cuticle Morphogenesis in Drosophila	PLOS ONE			English	Article							FRESH-WATER CRAYFISH; CUTICULAR PROTEINS; HORSESHOE-CRAB; PACIFASTACUS-LENIUSCULUS; TISSUE TRANSGLUTAMINASE; HEMOLYMPH-PROTEINS; CLOTTABLE PROTEIN; CLOTTING PROTEIN; ACTIVATION; GENE	Transglutaminase (TG) plays important and diverse roles in mammals, such as blood coagulation and formation of the skin barrier, by catalyzing protein crosslinking. In invertebrates, TG is known to be involved in immobilization of invading pathogens at sites of injury. Here we demonstrate that Drosophila TG is an important enzyme for cuticle morphogenesis. Although TG activity was undetectable before the second instar larval stage, it dramatically increased in the third instar larval stage. RNA interference (RNAi) of the TG gene caused a pupal semi-lethal phenotype and abnormal morphology. Furthermore, TG-RNAi flies showed a significantly shorter life span than their counterparts, and approximately 90% of flies died within 30 days after eclosion. Stage-specific TG-RNAi before the third instar larval stage resulted in cuticle abnormality, but the TG-RNAi after the late pupal stage did not, indicating that TG plays a key role at or before the early pupal stage. Immediately following eclosion, acid-extractable protein from wild-type wings was nearly all converted to non-extractable protein due to wing maturation, whereas several proteins remained acid-extractable in the mature wings of TG-RNAi flies. We identified four proteins-two cuticular chitin-binding proteins, larval serum protein 2, and a putative C-type lectin-as TG substrates. RNAi of their corresponding genes caused a lethal phenotype or cuticle abnormality. Our results indicate that TG-dependent protein crosslinking in Drosophila plays a key role in cuticle morphogenesis and sclerotization.	[Shibata, Toshio; Miyaji, Ryuta; Inomata, Nobuyuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan; [Ariki, Shigeru; Suyama, Haruka; Sako, Miyuki; Inomata, Nobuyuki; Koshiba, Takumi; Kawabata, Shun-ichiro] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan; [Shinzawa, Naoaki; Kanuka, Hirotaka] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan	Kyushu University; Kyushu University; Obihiro University of Agriculture & Veterinary Medicine	Shibata, T (corresponding author), Kyushu Univ, Grad Sch Syst Life Sci, Fukuoka 812, Japan.	skawascb@kyudai.jp	Ariki, Shigeru/E-3861-2014; Koshiba, Takumi/A-3996-2013; Shibata, Toshio/AAE-1694-2020	Ariki, Shigeru/0000-0001-5838-499X; Shibata, Toshio/0000-0003-0211-5525; Koshiba, Takumi/0000-0001-8535-5043	Kyushu University [21415]; Japan Foundation for Applied Enzymology; Takeda Science Foundation	Kyushu University; Japan Foundation for Applied Enzymology; Takeda Science Foundation(Takeda Science Foundation (TSF))	This study was supported by the Kyushu University Interdisciplinary Program in Education and Project in Research Development (type E-2 No. 21415 to S. K.), by Grants-in-Aid for graduate students in Kyushu University (to T. S.), by the Japan Foundation for Applied Enzymology (http://www.mt-pharma.co.jp/jfae/index.html) (to S. K.), and by Takeda Science Foundation (http://www.takeda-sci.or.jp/) (to S. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAM ME, 1978, CELL, V13, P215, DOI 10.1016/0092-8674(78)90190-3; AKAM ME, 1978, BIOCHEM GENET, V16, P101, DOI 10.1007/BF00484387; Andersen SO, 1996, COMP BIOCHEM PHYS B, V113, P689, DOI 10.1016/0305-0491(95)02089-6; Baker JD, 2002, J EXP BIOL, V205, P2555; Butler MJ, 2003, DEVELOPMENT, V130, P659, DOI 10.1242/dev.00293; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; FESUS L, 1987, FEBS LETT, V224, P104, DOI 10.1016/0014-5793(87)80430-1; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Iijima M, 2005, FEBS J, V272, P4774, DOI 10.1111/j.1742-4658.2005.04891.x; Kalinin A, 2001, J CELL SCI, V114, P3069; Karlsson C, 2004, J BIOL CHEM, V279, P52033, DOI 10.1074/jbc.M408220200; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kawasaki H, 2000, J BIOL CHEM, V275, P35297, DOI 10.1074/jbc.M006856200; Kiger JA, 2007, DEV BIOL, V301, P178, DOI 10.1016/j.ydbio.2006.08.011; Kimura KI, 2004, DEVELOPMENT, V131, P1597, DOI 10.1242/dev.01049; KONIG M, 1986, ROUX ARCH DEV BIOL, V195, P296, DOI 10.1007/BF00376062; KOPACEK P, 1993, EUR J BIOCHEM, V213, P591, DOI 10.1111/j.1432-1033.1993.tb17798.x; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; LEVENBOOK L, 1984, INSECT BIOCHEM, V14, P77, DOI 10.1016/0020-1790(84)90086-6; Lin XH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-58; Lorand L, 2001, ANN NY ACAD SCI, V936, P291; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LUSTIGMAN S, 1995, ANTIMICROB AGENTS CH, V39, P1913, DOI 10.1128/AAC.39.9.1913; Mace KA, 2005, SCIENCE, V308, P381, DOI 10.1126/science.1107573; Matsuda Y, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705854200; Matsuda Y, 2007, J BIOL CHEM, V282, P37316, DOI 10.1074/jbc.M705731200; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; MousseronGrall S, 1997, EUR J BIOCHEM, V245, P191, DOI 10.1111/j.1432-1033.1997.00191.x; Osaki T, 2004, CELL MOL LIFE SCI, V61, P1257, DOI 10.1007/s00018-004-3396-5; Osaki T, 2002, J BIOL CHEM, V277, P40084, DOI 10.1074/jbc.M206773200; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; ROBERTS DB, 1977, J INSECT PHYSIOL, V23, P871, DOI 10.1016/0022-1910(77)90013-0; Scherfer C, 2004, CURR BIOL, V14, P625, DOI 10.1016/j.cub.2004.03.030; Sugumaran M, 1998, ADV INSECT PHYSIOL, V27, P229, DOI 10.1016/S0065-2806(08)60014-4; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Ting SB, 2005, SCIENCE, V308, P411, DOI 10.1126/science.1107511; Ueda Y, 2009, J IMMUNOL, V183, P3810, DOI 10.4049/jimmunol.0900430; Wang R, 2001, FISH SHELLFISH IMMUN, V11, P623, DOI 10.1006/fsim.2001.0341; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Willis JH, 1999, AM ZOOL, V39, P600	43	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13477	10.1371/journal.pone.0013477	http://dx.doi.org/10.1371/journal.pone.0013477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976106	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300039
J	Frentiu, FD; Robinson, J; Young, PR; McGraw, EA; O'Neill, SL				Frentiu, Francesca D.; Robinson, Jodie; Young, Paul R.; McGraw, Elizabeth A.; O'Neill, Scott L.			Wolbachia-Mediated Resistance to Dengue Virus Infection and Death at the Cellular Level	PLOS ONE			English	Article							LIFE-SHORTENING WOLBACHIA; AEDES-AEGYPTI; MOSQUITO; DROSOPHILA; STRAIN; TEMPERATURE; PIPIENTIS; VIRULENT; SYMBIONT; DENSITY	Background: Dengue is currently the most important arthropod-borne viral disease of humans. Recent work has shown dengue virus displays limited replication in its primary vector, the mosquito Aedes aegypti, when the insect harbors the endosymbiotic bacterium Wolbachia pipientis. Wolbachia-mediated inhibition of virus replication may lead to novel methods of arboviral control, yet the functional and cellular mechanisms that underpin it are unknown. Methodology/Principal Findings: Using paired Wolbachia-infected and uninfected Aedes-derived cell lines and dengue virus, we confirm the phenomenon of viral inhibition at the cellular level. Although Wolbachia imposes a fitness cost to cells via reduced proliferation, it also provides a significant degree of protection from virus-induced mortality. The extent of viral inhibition is related to the density of Wolbachia per cell, with highly infected cell lines showing almost complete protection from dengue infection and dramatically reduced virus titers compared to lines not infected with the bacteria. Conclusions/Significance: We have shown that cells infected with Wolbachia display inhibition of dengue virus replication, that the extent of inhibition is related to bacterial density and that Wolbachia infection, although costly, will provide a fitness benefit in some circumstances. Our results parallel findings in mosquitoes and flies, indicating that cell line models will provide useful and experimentally tractable models to study the mechanisms underlying Wolbachia-mediated protection from viruses.	[Frentiu, Francesca D.; McGraw, Elizabeth A.; O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Robinson, Jodie; Young, Paul R.] Univ Queensland, Sch Chem & Mol Biosci, Ctr Infect Dis Res, Brisbane, Qld, Australia	University of Queensland; University of Queensland	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	scott.oneill@uq.edu.au	Frentiu, Francesca D/K-4561-2012; Young, Paul R/A-6176-2010; O'Neill, Scott/R-9560-2019; McGraw, Elizabeth/GRF-0434-2022; O'Neill, Scott L/B-3568-2009; McGraw, Elizabeth A/A-6658-2012	Young, Paul R/0000-0002-2040-5190; O'Neill, Scott/0000-0002-4131-3615; O'Neill, Scott L/0000-0002-4131-3615; McGraw, Elizabeth A/0000-0001-7973-088X; Frentiu, Francesca/0000-0001-8628-4216	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council of Australia	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by grants from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation and the National Health and Medical Research Council of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; BROWNSTEIN JS, 1998, J INVERTEBR PATHOL, V84, P24; Clancy DJ, 1998, ENTOMOL EXP APPL, V86, P13, DOI 10.1023/A:1003043814761; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Halstead SB, 2008, ANNU REV ENTOMOL, V53, P273, DOI 10.1146/annurev.ento.53.103106.093326; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; IGARASHI A, 1978, J GEN VIROL, V66, P2773; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Kroeger A, 2006, LANCET, V368, P2193, DOI 10.1016/S0140-6736(06)69873-5; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499; McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Moreira LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000568; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Mouton L, 2006, PARASITOLOGY, V132, P49, DOI 10.1017/S0031182005008723; ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; R Core Team, 2018, R LANG ENV STAT COMP; Reynolds KT, 2003, GENETICS, V164, P1027; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Texeira L., 2008, PLOS BIOL, V6; Tsai KH, 2006, J MED ENTOMOL, V43, P752, DOI 10.1603/0022-2585(2006)43[752:PIOJEV]2.0.CO;2; Turley AP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000516; Voronin D, 2010, J APPL MICROBIOL, V108, P2133, DOI 10.1111/j.1365-2672.2009.04621.x; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1	38	147	151	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13398	10.1371/journal.pone.0013398	http://dx.doi.org/10.1371/journal.pone.0013398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976219	gold, Green Published			2022-12-27	WOS:000283043700006
J	Toh, ML; Gonzales, G; Koenders, MI; Tournadre, A; Boyle, D; Lubberts, E; Zhou, YA; Firestein, GS; van den Berg, WB; Miossec, P				Toh, Myew-Ling; Gonzales, Gaelle; Koenders, Marije I.; Tournadre, Anne; Boyle, David; Lubberts, Erik; Zhou, Yuan; Firestein, Gary S.; van den Berg, Wim B.; Miossec, Pierre			Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression	PLOS ONE			English	Article							OXIDE-INDUCED APOPTOSIS; NECROSIS FACTOR THERAPY; E3 UBIQUITIN LIGASE; RHEUMATOID-ARTHRITIS; NITRIC-OXIDE; CUTTING EDGE; HUMAN HRD1; CELLS; PROTEIN; GENE	Background: The use of TNF inhibitors has been a major progress in the treatment of chronic inflammation. However, not all patients respond. In addition, response will be often lost when treatment is stopped. These clinical aspects indicate that other cytokines might be involved and we focus here on the role of IL-17. In addition, the chronic nature of joint inflammation may contribute to reduced response and enhanced chronicity. Therefore we studied the capacity of IL-17 to regulate synoviolin, an E3 ubiquitin ligase implicated in synovial hyperplasia in human rheumatoid arthritis (RA) FLS and in chronic reactivated streptococcal cell wall (SCW)-induced arthritis. Methodology/Principal Findings: Chronic reactivated SCW-induced arthritis was examined in IL-17R deficient and wild-type mice. Synoviolin expression was analysed by real-time RT-PCR, Western Blot or immunostaining in RA FLS and tissue, and p53 assessed by Western Blot. Apoptosis was detected by annexin V/propidium iodide staining, SS DNA apoptosis ELISA kit or TUNEL staining and proliferation by PCNA staining. IL-17 receptor A (IL-17RA), IL-17 receptor C (IL-17-RC) or synoviolin inhibition were achieved by small interfering RNA (siRNA) or neutralizing antibodies. IL-17 induced sustained synoviolin expression in RA FLS. Sodium nitroprusside (SNP)-induced RA FLS apoptosis was associated with reduced synoviolin expression and was rescued by IL-17 treatment with a corresponding increase in synoviolin expression. IL-17RC or IL-17RA RNA interference increased SNP-induced apoptosis, and decreased IL-17-induced synoviolin. IL-17 rescued RA FLS from apoptosis induced by synoviolin knockdown. IL-17 and TNF had additive effects on synoviolin expression and protection against apoptosis induced by synoviolin knowndown. In IL-17R deficient mice, a decrease in arthritis severity was characterized by increased synovial apoptosis, reduced proliferation and a marked reduction in synoviolin expression. A distinct absence of synoviolin expressing germinal centres in IL-17R deficient mice contrasted with synoviolin positive B cells and Th17 cells in synovial germinal centre-like structures. Conclusion/Significance: IL-17 induction of synoviolin may contribute at least in part to RA chronicity by prolonging the survival of RA FLS and immune cells in germinal centre reactions. These results extend the role of IL-17 to synovial hyperplasia.	[Toh, Myew-Ling; Gonzales, Gaelle; Tournadre, Anne; Zhou, Yuan; Miossec, Pierre] Univ Lyon, Hosp Edouard Herriot, EA 4130, Res Unit Immunogenom & Inflammat, Lyon, France; [Koenders, Marije I.; Lubberts, Erik; van den Berg, Wim B.] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands; [Boyle, David; Firestein, Gary S.] Univ Calif San Diego, Dept Med, Div Rheumatol Allergy & Immunol, La Jolla, CA 92093 USA	bioMerieux; CHU Lyon; Radboud University Nijmegen; University of California System; University of California San Diego	Toh, ML (corresponding author), Univ Lyon, Hosp Edouard Herriot, EA 4130, Res Unit Immunogenom & Inflammat, Lyon, France.	pierre.miossec@univ-lyon1.fr	Koenders, Marije I/A-1341-2012; Lubberts, Erik/AAI-4657-2020; van den Berg, W.B./H-8010-2014; Zhou, Yuan/B-1375-2013	Koenders, Marije I/0000-0001-5845-8362; 	Hospices Civils de Lyon; Region Rhone-Alpes; Merieux Institute	Hospices Civils de Lyon; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes); Merieux Institute	This work has been supported by research grants from the Hospices Civils de Lyon and the Region Rhone-Alpes and in part by the Merieux Institute. Ling Toh and Yuan Zhou were supported by a post-doctoral fellowship of the Region Rhone-Alpes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Aupperle KR, 1998, AM J PATHOL, V152, P1091; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Borderie D, 1999, OSTEOARTHR CARTILAGE, V7, P203, DOI 10.1053/joca.1998.0209; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Chen QQ, 2006, J RHEUMATOL, V33, P1061; Cohen SB, 2006, ARTHRITIS RHEUM-US, V54, P2793, DOI 10.1002/art.22025; Dufour JM, 2004, GENE THER, V11, P694, DOI 10.1038/sj.gt.3302218; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gao BX, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2081; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Hwang SY, 2005, MOL CELLS, V19, P180; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Lacey D, 2003, ARTHRITIS RHEUM, V48, P103, DOI 10.1002/art.10733; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Leech M, 2003, ARTHRITIS RHEUM, V48, P1881, DOI 10.1002/art.11165; Lubberts E, 2005, J IMMUNOL, V175, P3360, DOI 10.4049/jimmunol.175.5.3360; Maitra A, 2007, P NATL ACAD SCI USA, V104, P7506, DOI 10.1073/pnas.0611589104; Miossec P, 2007, ARTHRITIS RHEUM-US, V56, P2111, DOI 10.1002/art.22733; Nadav E, 2003, BIOCHEM BIOPH RES CO, V303, P91, DOI 10.1016/S0006-291X(03)00279-1; Nakamura H, 2004, CLIN EXP RHEUMATOL, V22, P151; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Page G, 2004, J PATHOL, V204, P28, DOI 10.1002/path.1607; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; TOH M, 1994, ARTHRITIS RHEUM; Toh ML, 2005, J IMMUNOL, V175, P7687, DOI 10.4049/jimmunol.175.11.7687; Toh ML, 2004, ARTHRITIS RHEUM-US, V50, P3118, DOI 10.1002/art.20580; Toh ML, 2006, ARTHRITIS RHEUM-US, V54, P2109, DOI 10.1002/art.21926; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Yagishita N, 2005, J BIOL CHEM, V280, P7909, DOI 10.1074/jbc.M410863200; Yamasaki S, 2007, EMBO J, V26, P113, DOI 10.1038/sj.emboj.7601490; You ZB, 2006, CANCER RES, V66, P175, DOI 10.1158/0008-5472.CAN-05-1130; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	44	66	70	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13416	10.1371/journal.pone.0013416	http://dx.doi.org/10.1371/journal.pone.0013416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976214	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700015
J	Cisneros, JC; Cabral, UG; de Beer, F; Damiani, R; Fortier, DC				Cisneros, Juan Carlos; Cabral, Uiara Gomes; de Beer, Frikkie; Damiani, Ross; Fortier, Daniel Costa			Spondarthritis in the Triassic	PLOS ONE			English	Article							OSSEOUS PATHOLOGY; BEAUFORT GROUP; SOUTH-AFRICA; SPONDYLOARTHROPATHY; KAROO	Background: The evidence of several forms of arthritis has been well documented in the fossil record. However, for pre-Cenozoic vertebrates, especially regarding reptiles, this record is rather scarce. In this work we present a case report of spondarthritis found in a vertebral series that belonged to a carnivorous archosaurian reptile from the Lower Triassic (similar to 245 million years old) of the South African Karoo. Methodology/Principal Findings: Neutron tomography confirmed macroscopic data, revealing the ossification of the entire intervertebral disc space (both annulus fibrosus and nucleus pulposus), which supports the diagnosis of spondarthritis. Conclusions/Significance: The presence of spondarthritis in the new specimen represents by far the earliest evidence of any form of arthritis in the fossil record. The present find is nearly 100 million years older than the previous oldest report of this pathology, based on a Late Jurassic dinosaur. Spondarthritis may have indirectly contributed to the death of the animal under study.	[Cisneros, Juan Carlos] Univ Fed Piaui, Ctr Ciencias Nat, Teresina, Brazil; [Cabral, Uiara Gomes] Univ Fed Rio de Janeiro, Dept Geol & Paleontol, Museu Nacl, Rio De Janeiro, Brazil; [de Beer, Frikkie] S African Nucl Energy Corp, Nucl Technol Div, Pretoria, South Africa; [Damiani, Ross] Staatliches Museum Nat Kunde Stuttgart, Stuttgart, Germany; [Fortier, Daniel Costa] Univ Fed Rio Grande do Sul, Dept Paleontol & Estrati, Porto Alegre, RS, Brazil	Universidade Federal do Piaui; Universidade Federal do Rio de Janeiro; The South African Nuclear Energy Corporation SOC Limited (Necsa); Universidade Federal do Rio Grande do Sul	Cisneros, JC (corresponding author), Univ Fed Piaui, Ctr Ciencias Nat, Teresina, Brazil.	juan.cisneros@ufpi.edu.br	De Beer, Frederik/AAA-1724-2020; Fortier, Daniel/R-2895-2017	De Beer, Frederik/0000-0001-9810-6038; Cisneros, Juan Carlos/0000-0001-6159-1981				Belanger T A, 2001, J Am Acad Orthop Surg, V9, P258; Campillo D., 2001, INTRO PALEOPATOLOGIA; de Beer FC, 2005, NUCL INSTRUM METH A, V542, P1, DOI 10.1016/j.nima.2005.01.003; DEBEER FC, 2001, NONDESTRUCT TEST EVA, V16, P163; Ehrenfeld M, 2008, DIAGNOSTIC CRITERIA IN AUTOIMMUNE DISEASES, P195, DOI 10.1007/978-1-60327-285-8_38; FRANCOIS RJ, 1995, ANN RHEUM DIS, V54, P615, DOI 10.1136/ard.54.8.615; GOLDING DN, 1985, J ROY SOC MED, V78, P706, DOI 10.1177/014107688507800902; HANCOX PJ, 1995, S AFR J SCI, V91, P143; Kitching J.W., 1977, Memoirs Bernard Price Inst palaeont Res, VNo. 1, P1; Kompanje E.J.O., 1999, Zoologische Mededelingen (Leiden), V73, P99; Mader R, 2009, RHEUMATOLOGY, V48, P1478, DOI 10.1093/rheumatology/kep308; Neveling J., 2005, Palaeontologia Africana, V41, P81; Ortner D. J., 2003, IDENTIFICATION PATHO, DOI DOI 10.1016/B978-012528628-2/50057-0; Resnick D., 1988, DIAGNOSIS BONE JOINT; RIVERS ML, 2001, GSECARS TOMOGRAPHY P; Rothschild B, 2002, LANCET, V360, P1454, DOI 10.1016/S0140-6736(02)11471-1; Rothschild B.M., 2006, SKELETAL IMPACT DIS; Rothschild BM, 1999, LANCET, V354, P398, DOI 10.1016/S0140-6736(99)01019-3; ROTHSCHILD BM, 1994, J ZOO WILDLIFE MED, V25, P360; Rothschild B, 2010, J HERPETOL, V44, P13, DOI 10.1670/08-243.1; Rothschild B, 2009, APPL HERPETOL, V6, P47, DOI 10.1163/157075409X413842; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Zochling J, 2005, RHEUMATOLOGY, V44, P1483, DOI 10.1093/rheumatology/kei047	23	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13425	10.1371/journal.pone.0013425	http://dx.doi.org/10.1371/journal.pone.0013425			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976231	Green Submitted, Green Published, gold			2022-12-27	WOS:000282941000027
J	Mfonkeu, JBP; Gouado, I; Kuate, HF; Zambou, O; Zollo, PHA; Grau, GER; Combes, V				Mfonkeu, Joel Bertrand Pankoui; Gouado, Inocent; Kuate, Honore Fotso; Zambou, Odile; Zollo, Paul Henri Amvam; Grau, Georges Emile Raymond; Combes, Valery			Elevated Cell-Specific Microparticles Are a Biological Marker for Cerebral Dysfunctions in Human Severe Malaria	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; COMATOSE MALAWIAN CHILDREN; BLOOD-BRAIN-BARRIER; ENDOTHELIAL MICROPARTICLES; COMPLICATED MALARIA; CLINICAL-FEATURES; PATHOGENESIS; PANTETHINE; PLATELETS; NEUROPATHOLOGY	Cerebral malaria (CM) and severe anemia (SA) are the most severe complications of Plasmodium falciparum infections. Although increased release of endothelial microparticles (MP) correlates with malaria severity, the full extent of vascular cell vesiculation remains unknown. Here, we characterize the pattern of cell-specific MP in patients with severe malaria. We tested the hypothesis that systemic vascular activation contributes to CM by examining origins and levels of plasma MP in relation to clinical syndromes, disease severity and outcome. Patients recruited in Douala, Cameroon, were assigned to clinical groups following WHO criteria. MP quantitation and phenotyping were carried out using cell-specific markers by flow cytometry using antibodies recognizing cell-specific surface markers. Platelet, erythrocytic, endothelial and leukocytic MP levels were elevated in patients with cerebral dysfunctions and returned to normal by discharge. In CM patients, platelet MP were the most abundant and their levels significantly correlated with coma depth and thrombocytopenia. This study shows for the first time a widespread enhancement of vesiculation in the vascular compartment appears to be a feature of CM but not of SA. Our data underpin the role of MP as a biomarker of neurological involvement in severe malaria. Therefore, intervention to block MP production in severe malaria may provide a new therapeutic pathway.	[Mfonkeu, Joel Bertrand Pankoui; Gouado, Inocent; Zollo, Paul Henri Amvam] Univ Douala, Dept Biochem, Fac Sci, Douala, Cameroon; [Kuate, Honore Fotso] Laquintinie Hosp, Lab Serv, Douala, Cameroon; [Zambou, Odile] Deido Dist Hosp, Serv Pediat, Douala, Cameroon; [Grau, Georges Emile Raymond; Combes, Valery] Univ Sydney, Dept Pathol, Sydney, NSW 2006, Australia	University of Sydney	Mfonkeu, JBP (corresponding author), Univ Douala, Dept Biochem, Fac Sci, Douala, Cameroon.	valery.combes@sydney.edu.au	Grau, Georges/AGR-7139-2022	Grau, Georges/0000-0002-0442-0462; Combes, Valery/0000-0003-2178-3596	Europena Union [LSHP-CT-2006-037749]; National Health Medical Research Council - European Union [512101]; AL Kerr Bequest, Sydney Medical School	Europena Union; National Health Medical Research Council - European Union; AL Kerr Bequest, Sydney Medical School	This study was supported by the Europena Union-Framework Program 6, #LSHP-CT-2006-037749 and National Health Medical Research Council - European Union collaborative grant/Australia #512101. The support of the AL Kerr Bequest, Sydney Medical School, is also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEBAWY M, 2009, LEUKEMIA; Biemba G, 1998, TROP MED INT HEALTH, V3, P60, DOI 10.1046/j.1365-3156.1998.00168.x; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; Coltel N, 2006, MICROBES INFECT, V8, P2305, DOI 10.1016/j.micinf.2006.04.006; Combes V, 1999, J CLIN INVEST, V104, P93, DOI 10.1172/JCI4985; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; CORONEL F, 1991, AM J NEPHROL, V11, P32, DOI 10.1159/000168269; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Gilstad CW, 2003, CURR OPIN HEMATOL, V10, P419, DOI 10.1097/00062752-200311000-00004; Grau GE, 2003, J INFECT DIS, V187, P461, DOI 10.1086/367960; GRAU GE, 1993, EUR CYTOKINE NETW, V4, P415; Guiducci S, 2008, ARTHRITIS RHEUM-US, V58, P2845, DOI 10.1002/art.23735; Ho M, 1999, AM J PHYSIOL-CELL PH, V276, pC1231, DOI 10.1152/ajpcell.1999.276.6.C1231; Horvath Z, 2009, IDEGGYOGY SZEMLE, V62, P220; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Lackner P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-116; Lou J, 2001, CLIN MICROBIOL REV, V14, P810, DOI 10.1128/CMR.14.4.810-820.2001; Medana IM, 2007, J INFECT DIS, V195, P921, DOI 10.1086/512089; Mfonkeu J B Pankoui, 2008, Pak J Biol Sci, V11, P2401, DOI 10.3923/pjbs.2008.2401.2406; Mishra SK, 2006, J POSTGRAD MED, V52, P281; Mockenhaupt FP, 2004, AM J TROP MED HYG, V71, P167, DOI 10.4269/ajtmh.2004.71.167; MOLYNEUX ME, 1989, Q J MED, V71, P441; Nieuwland R, 1997, CIRCULATION, V96, P3534; Penet MF, 2008, P NATL ACAD SCI USA, V105, P1321, DOI 10.1073/pnas.0706867105; PICCIN A, 2006, CIRCULATING MICROPAR, P11601; Piguet PF, 2002, APOPTOSIS, V7, P91, DOI 10.1023/A:1014341611412; POLDER TW, 1991, J NEUROL SCI, V101, P24, DOI 10.1016/0022-510X(91)90015-Y; PRISCO D, 1987, ANGIOLOGY, V38, P241, DOI 10.1177/000331978703800307; Schellenberg D, 2003, B WORLD HEALTH ORGAN, V81, P581; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Seydel KB, 2006, J INFECT DIS, V194, P208, DOI 10.1086/505078; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Xiao HY, 2000, TRANSFUSION, V40, P420, DOI 10.1046/j.1537-2995.2000.40040420.x	37	96	98	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13415	10.1371/journal.pone.0013415	http://dx.doi.org/10.1371/journal.pone.0013415			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976232	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000026
J	Rose, G; Romeo, G; Dato, S; Crocco, P; Bruni, AC; Hervonen, A; Majamaa, K; Sevini, F; Franceschi, C; Passarino, G				Rose, Giuseppina; Romeo, Giuseppe; Dato, Serena; Crocco, Paolina; Bruni, Amalia C.; Hervonen, Antti; Majamaa, Kari; Sevini, Federica; Franceschi, Claudio; Passarino, Giuseppe		GEHA Project Consortium	Somatic Point Mutations in mtDNA Control Region Are Influenced by Genetic Background and Associated with Healthy Aging: A GEHA Study	PLOS ONE			English	Article							DNA HAPLOGROUP-J; MITOCHONDRIAL-DNA; REPLICATION ORIGIN; CENTENARIANS; CELLS; ACCUMULATION; DYSFUNCTION; LEUKOCYTES; MORTALITY; APOPTOSIS	Tissue specific somatic mutations occurring in the mtDNA control region have been proposed to provide a survival advantage. Data on twins and on relatives of long-lived subjects suggested that the occurrence/accumulation of these mutations may be genetically influenced. To further investigate control region somatic heteroplasmy in the elderly, we analyzed the segment surrounding the nt 150 position (previously reported as specific of Leukocytes) in various types of leukocytes obtained from 195 ultra-nonagenarians sib-pairs of Italian or Finnish origin collected in the frame of the GEHA Project. We found a significant correlation of the mtDNA control region heteroplasmy between sibs, confirming a genetic influence on this phenomenon. Furthermore, many subjects showed heteroplasmy due to mutations different from the C150T transition. In these cases heteroplasmy was correlated within sibpairs in Finnish and northern Italian samples, but not in southern Italians. This suggested that the genetic contribution to control region mutations may be population specific. Finally, we observed a possible correlation between heteroplasmy and Hand Grip strength, one of the best markers of physical performance and of mortality risk in the elderly. Our study provides new evidence on the relevance of mtDNA somatic mutations in aging and longevity and confirms that the occurrence of specific point mutations in the mtDNA control region may represent a strategy for the age-related remodelling of organismal functions.	[Rose, Giuseppina; Romeo, Giuseppe; Dato, Serena; Crocco, Paolina; Passarino, Giuseppe] Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy; [Bruni, Amalia C.] Reg Ctr NeuroGenet, Lamezia Terme, Italy; [Hervonen, Antti] Tampere Sch Publ Hlth, Gerontol Lab, Tampere, Finland; [Majamaa, Kari] Univ Oulu, Dept Neurol, Oulu, Finland; [Sevini, Federica; Franceschi, Claudio] Univ Bologna, Interdept Ctr Luigi Galvani CIG, Bologna, Italy	University of Calabria; Tampere University; University of Oulu; University of Bologna	Rose, G (corresponding author), Univ Calabria, Dept Cell Biol, I-87036 Arcavacata Di Rende, Italy.	g.passarino@unical.it	Robine, Jean-Marie/F-5439-2011; Crocco, Paolina/AAX-2695-2020; Slagboom, P. Eline/R-4790-2016; Majamaa, Kari/A-1344-2012; Dato, Serena/AAC-4072-2020; Kristensen, Peter/T-6684-2018; Franceschi, Claudio/L-4484-2017; Bruni, Amalia/K-5038-2016	Robine, Jean-Marie/0000-0002-4111-6195; Slagboom, P. Eline/0000-0002-2875-4723; Dato, Serena/0000-0003-2589-7929; Kristensen, Peter/0000-0001-7205-6853; Franceschi, Claudio/0000-0001-9841-6386; Bruni, Amalia/0000-0003-3471-3343; Rose, Giuseppina/0000-0002-4264-4184; Majamaa, Kari/0000-0002-9070-3791; crocco, paolina/0000-0001-7803-5340; Sikora, Ewa/0000-0002-1111-1748	GEHA (GEnetics of Healthy Ageing) Project; European Union [LSHM-CT-2004-503270]; National Institute for Health Research [NF-SI-0508-10260] Funding Source: researchfish	GEHA (GEnetics of Healthy Ageing) Project; European Union(European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was supported by the GEHA (GEnetics of Healthy Ageing) Project. This project is supported through Priority 1 (Life Sciences, Genomics and Biotechnology for Health) of European Union's FP6, Project Number LSHM-CT-2004-503270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Bossy-Wetzel E, 2003, CURR OPIN CELL BIOL, V15, P706, DOI 10.1016/j.ceb.2003.10.015; Cesari M, 2009, J GERONTOL A-BIOL, V64, P377, DOI 10.1093/gerona/gln031; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Dato S, 2004, EUR J HUM GENET, V12, P1080, DOI 10.1038/sj.ejhg.5201278; Fish J, 2004, SCIENCE, V306, P2098, DOI 10.1126/science.1102077; Franceschi C, 2007, ANN NY ACAD SCI, V1100, P21, DOI 10.1196/annals.1395.003; Gale CR, 2007, INT J EPIDEMIOL, V36, P228, DOI 10.1093/ije/dyl224; Ghelli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007922; HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x; Iwata N, 2007, MITOCHONDRION, V7, P267, DOI 10.1016/j.mito.2007.03.001; Jeune B, 2006, J GERONTOL A-BIOL, V61, P707, DOI 10.1093/gerona/61.7.707; Krishnan KJ, 2007, NUCLEIC ACIDS RES, V35, P7399, DOI 10.1093/nar/gkm635; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Ono T, 2001, NAT GENET, V28, P272, DOI 10.1038/90116; Park MK, 2001, EMBO J, V20, P1863, DOI 10.1093/emboj/20.8.1863; Procaccio V, 2006, MOL DIAGN THER, V10, P381, DOI 10.1007/BF03256215; Rose G, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-293; Shlush LI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003425; Solvioli Stefano, 2008, Biotechnology Journal, V3, P740, DOI 10.1002/biot.200800046; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Wallace DC, 2007, ANNU REV BIOCHEM, V76, P781, DOI 10.1146/annurev.biochem.76.081205.150955; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; Yao YG, 2007, HUM MOL GENET, V16, P286, DOI 10.1093/hmg/ddl457; Zhang J, 2003, P NATL ACAD SCI USA, V100, P1116, DOI 10.1073/pnas.242719399	28	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13395	10.1371/journal.pone.0013395	http://dx.doi.org/10.1371/journal.pone.0013395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976236	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000020
J	Shrestha, S; Wiener, HW; Aissani, B; Song, W; Shendre, A; Wilson, CM; Kaslow, RA; Tang, JM				Shrestha, Sadeep; Wiener, Howard W.; Aissani, Brahim; Song, Wei; Shendre, Aditi; Wilson, Craig M.; Kaslow, Richard A.; Tang, Jianming			Interleukin-10 (IL-10) Pathway: Genetic Variants and Outcomes of HIV-1 Infection in African American Adolescents	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; LOAD SET-POINT; DISEASE PROGRESSION; HUMAN MONOCYTES; T-CELLS; CYTOKINE PRODUCTION; HUMAN MACROPHAGES; IL10 HAPLOTYPES; BLOOD MONOCYTES; TAT PROTEIN	Background: Immunological and clinical outcomes can vary considerably at the individual and population levels during both treated and untreated HIV-1 infection. Cytokines encoded by the interleukin-10 gene (IL10) family have broad immunomodulatory function in viral persistence, and several SNPs in the IL10 promoter sequence have been reported to influence pathogenesis or acquisition of HIV-1 infection. Methodology/Principal Findings: We examined 104 informative SNPs in IL10, IL19, IL20, IL24, IL10RA and IL10RB among 250 HIV-1 seropositive and 106 high-risk seronegative African American adolescents in the REACH cohort. In subsequent evaluation of five different immunological and virological outcomes related to HIV-1 infection, 25 SNPs were associated with a single outcome and three were associated with two different outcomes. One SNP, rs2243191 in the IL19 open reading frame (Ser to Phe substitution) was associated with CD4(+)T-cell increase during treatment. Another SNP rs2244305 in IL10RB (in strong linkage disequilibrium with rs443498) was associated with an initial decrease in CD4(+)T-cell by 23 +/- 69% and 29 +/- 69% every 3 months (for AA and AG genotypes, respectively, compared with GG) during ART-free period. These associations were reversed during treatment, as CD4(+)T-cell increased by 31 +/- 60.9% and 17 +/- 68% every 3 months for AA and AG genotype, respectively. Conclusions/Significance: In African Americans, variants in IL10 and related genes might influence multiple outcomes of HIV-1 infection, especially immunological response to HAART. Fine mapping coupled with analysis of gene expression and function should help reveal the immunological importance of the IL10 gene family to HIV-1/AIDS.	[Shrestha, Sadeep; Wiener, Howard W.; Aissani, Brahim; Song, Wei; Shendre, Aditi; Wilson, Craig M.; Kaslow, Richard A.] Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA; [Wilson, Craig M.; Kaslow, Richard A.; Tang, Jianming] Univ Alabama, Dept Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Shrestha, S (corresponding author), Univ Alabama, Dept Epidemiol, Birmingham, AL 35294 USA.	sshresth@uab.edu; jtang@uab.edu	Tang, Jianming "James"/O-4980-2019	Tang, Jianming "James"/0000-0003-0137-7486; Wilson, Craig/0000-0001-6869-1053; Shendre, Aditi/0000-0003-4123-7613	National Institute of Child Health and Human Development [U01-HD32830]; UAB Center for AIDS Research [5P30 AI27767-20]; National Institute of Allergy and Infectious Diseases [AI051173, AI076123]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD032830] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027767, K02AI076123, R01AI051173] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UAB Center for AIDS Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The REACH study was supported by grant U01-HD32830 from the National Institute of Child Health and Human Development. This work was supported in part by a developmental award from the UAB Center for AIDS Research (5P30 AI27767-20) and two grants (AI051173 and AI076123) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKRIDGE RE, 1994, J IMMUNOL, V153, P5782; Badou A, 2000, J VIROL, V74, P10551, DOI 10.1128/JVI.74.22.10551-10562.2000; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMIN D, 1992, BLOOD, V80, P1289; BERKMAN N, 1995, J IMMUNOL, V155, P4412; Bettaccini AA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-20; Blackburn SD, 2007, TRENDS MICROBIOL, V15, P143, DOI 10.1016/j.tim.2007.02.006; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chatterjee A, 2009, J CLIN IMMUNOL, V29, P71, DOI 10.1007/s10875-008-9220-5; Commins S, 2008, J ALLERGY CLIN IMMUN, V121, P1108, DOI 10.1016/j.jaci.2008.02.026; DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Elrefaei M, 2006, J IMMUNOL, V176, P1274, DOI 10.4049/jimmunol.176.2.1274; Erikstrup C, 2007, AIDS, V21, P2283, DOI 10.1097/QAD.0b013e3282f153ed; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fickenscher H, 2002, TRENDS IMMUNOL, V23, P89, DOI 10.1016/S1471-4906(01)02149-4; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gallagher G, 2004, INT IMMUNOPHARMACOL, V4, P615, DOI 10.1016/j.intimp.2004.01.005; GRAZIOSI C, 1994, SCIENCE, V265, P248, DOI 10.1126/science.8023143; Houle M, 1999, INFLAMMATION, V23, P241; Jordan WJ, 2005, EUR J IMMUNOL, V35, P1576, DOI 10.1002/eji.200425317; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; MarfaingKoka A, 1996, INT IMMUNOL, V8, P1587, DOI 10.1093/intimm/8.10.1587; Mei Y, 2008, STAT MED, V27, P121, DOI 10.1002/sim.3038; MONTANER LJ, 1994, J GEN VIROL, V75, P3393, DOI 10.1099/0022-1317-75-12-3393; MOSMANN TR, 1994, ADV IMMUNOL, V56, P1, DOI 10.1016/S0065-2776(08)60449-6; Murphy DA, 2001, AIDS CARE, V13, P27, DOI 10.1080/09540120020018161; Naicker DD, 2009, J INFECT DIS, V200, P448, DOI 10.1086/600072; Oleksyk TK, 2009, GENES IMMUN, V10, P309, DOI 10.1038/gene.2009.9; Ostrowski MA, 2001, J INFECT DIS, V184, P1268, DOI 10.1086/324005; Rogers AS, 1998, J ADOLESCENT HEALTH, V22, P300, DOI 10.1016/S1054-139X(97)00279-6; Shin HD, 2000, P NATL ACAD SCI USA, V97, P14467, DOI 10.1073/pnas.97.26.14467; Shrestha S, 2009, AIDS, V23, P673, DOI 10.1097/QAD.0b013e328325d414; Sozzani S, 1998, J EXP MED, V187, P439, DOI 10.1084/jem.187.3.439; TAGA K, 1993, INT IMMUNOL, V5, P1599, DOI 10.1093/intimm/5.12.1599; Tang J, 1999, GENES IMMUN, V1, P20, DOI 10.1038/sj.gene.6363640; Tang JM, 2002, AIDS, V16, P2275, DOI 10.1097/00002030-200211220-00007; Vasilescu A, 2003, GENES IMMUN, V4, P441, DOI 10.1038/sj.gene.6363983; Wilson CM, 2001, J ADOLESCENT HEALTH, V29, P8, DOI 10.1016/S1054-139X(01)00291-9; Wilson JN, 2006, GENES IMMUN, V7, P680, DOI 10.1038/sj.gene.6364336; Zanussi S, 1996, CLIN EXP IMMUNOL, V105, P220, DOI 10.1046/j.1365-2249.1996.d01-746.x	42	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13384	10.1371/journal.pone.0013384	http://dx.doi.org/10.1371/journal.pone.0013384			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976276	gold, Green Published, Green Submitted			2022-12-27	WOS:000282941000015
J	Barraud, Q; Obeid, I; Aubert, I; Barriere, G; Contamin, H; McGuire, S; Ravenscroft, P; Porras, G; Tison, F; Bezard, E; Ghorayeb, I				Barraud, Quentin; Obeid, Ibrahim; Aubert, Incarnation; Barriere, Gregory; Contamin, Hugues; McGuire, Steve; Ravenscroft, Paula; Porras, Gregory; Tison, Francois; Bezard, Erwan; Ghorayeb, Imad			Neuroanatomical Study of the A11 Diencephalospinal Pathway in the Non-Human Primate	PLOS ONE			English	Article							RESTLESS LEGS SYNDROME; RAT SPINAL-CORD; AMINO-ACID DECARBOXYLASE; MONOAMINERGIC DESCENDING PATHWAYS; MIDBRAIN DOPAMINERGIC-NEURONS; LEVODOPA-INDUCED DYSKINESIA; IN-SITU HYBRIDIZATION; PARKINSONS-DISEASE; L-DOPA; TYROSINE-HYDROXYLASE	Background: The A11 diencephalospinal pathway is crucial for sensorimotor integration and pain control at the spinal cord level. When disrupted, it is thought to be involved in numerous painful conditions such as restless legs syndrome and migraine. Its anatomical organization, however, remains largely unknown in the non-human primate (NHP). We therefore characterized the anatomy of this pathway in the NHP. Methods and Findings: In situ hybridization of spinal dopamine receptors showed that D1 receptor mRNA is absent while D2 and D5 receptor mRNAs are mainly expressed in the dorsal horn and D3 receptor mRNA in both the dorsal and ventral horns. Unilateral injections of the retrograde tracer Fluoro-Gold (FG) into the cervical spinal enlargement labeled A11 hypothalamic neurons quasi-exclusively among dopamine areas. Detailed immunohistochemical analysis suggested that these FG-labeled A11 neurons are tyrosine hydroxylase-positive but dopa-decarboxylase and dopamine transporter-negative, suggestive of a L-DOPAergic nucleus. Stereological cell count of A11 neurons revealed that this group is composed by 4002 +/- 501 neurons per side. A 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) intoxication with subsequent development of a parkinsonian syndrome produced a 50% neuronal cell loss in the A11 group. Conclusion: The diencephalic A11 area could be the major source of L-DOPA in the NHP spinal cord, where it may play a role in the modulation of sensorimotor integration through D2 and D3 receptors either directly or indirectly via dopamine formation in spinal dopa-decarboxylase-positives cells.	[Barraud, Quentin; Aubert, Incarnation; Barriere, Gregory; Porras, Gregory; Tison, Francois; Bezard, Erwan; Ghorayeb, Imad] Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France; [Obeid, Ibrahim; Tison, Francois; Ghorayeb, Imad] Ctr Hosp, Bordeaux, France; [Obeid, Ibrahim; Tison, Francois; Ghorayeb, Imad] Univ Bordeaux, Bordeaux, France; [Contamin, Hugues] Cynbiose, Marcy Letoile, France; [McGuire, Steve; Ravenscroft, Paula] Motac Neurosci Ltd, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Barraud, Q (corresponding author), Univ Bordeaux 2, CNRS, Bordeaux Inst Neurosci, UMR 5227, F-33076 Bordeaux, France.	imad.ghorayeb@u-bordeaux2.fr	Ghorayeb, Imad/B-3473-2012; Bezard, Erwan/A-8173-2008; Ghorayeb, Imad/D-5073-2017; Bezard, Erwan/ABD-5153-2021	Ghorayeb, Imad/0000-0003-1996-8049; Barraud, Quentin/0000-0003-0894-1959; Barriere, Gregory/0000-0002-0704-508X; Bezard, Erwan/0000-0002-0410-4638	Agence Nationale de la Recherche [ANR-08-MNP-018]; GlaxoSmithKline laboratory	Agence Nationale de la Recherche(French National Research Agency (ANR)); GlaxoSmithKline laboratory(GlaxoSmithKline)	IG and QB received research donations from the French Association of Patients with Restless Legs Syndrome and from GlaxoSmithKline Laboratory. This study was also supported by the Agence Nationale de la Recherche, ANR-08-MNP-018, (MCHPRIMAPARK). HC is salaried of Cynbiose. SMC and PR are salaried employees of Motac Neuroscience Ltd. Cynbiose and Motac Neuroscience Ltd had a role in data collection. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.; HC is salaried of Cynbiose. SMC and PR are salaried employees of Motac Neuroscience Ltd. IG received research donation from GlaxoSmithKline laboratory. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Accili D, 1996, P NATL ACAD SCI USA, V93, P1945, DOI 10.1073/pnas.93.5.1945; Akhavan M, 2006, J NEUROSCI METH, V152, P156, DOI 10.1016/j.jneumeth.2005.09.010; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Aubert I, 2005, ANN NEUROL, V57, P17, DOI 10.1002/ana.20296; Aubert I, 2000, J COMP NEUROL, V418, P22; BAKER LL, 1984, EXP NEUROL, V86, P515, DOI 10.1016/0014-4886(84)90086-4; Bara-Jimenez W, 2000, NEUROLOGY, V54, P1609, DOI 10.1212/WNL.54.8.1609; BARASI S, 1987, BRIT J PHARMACOL, V90, P15, DOI 10.1111/j.1476-5381.1987.tb16820.x; Barraud Q, 2009, EXP NEUROL, V219, P574, DOI 10.1016/j.expneurol.2009.07.019; Barriere G, 2004, EUR J NEUROSCI, V19, P1325, DOI 10.1111/j.1460-9568.2004.03210.x; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; Bezard E, 1998, PROG NEUROBIOL, V55, P93, DOI 10.1016/S0301-0082(98)00006-9; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 1998, REV NEUROSCIENCE, V9, P71; Bezard E, 1999, EXP NEUROL, V155, P268, DOI 10.1006/exnr.1998.6995; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; BJORKLUND A, 1979, BRAIN RES, V177, P170, DOI 10.1016/0006-8993(79)90927-2; BJORKLUND A, 1973, BRAIN RES, V51, P193, DOI 10.1016/0006-8993(73)90372-7; Bjorklund A, 2007, TRENDS NEUROSCI, V30, P194, DOI 10.1016/j.tins.2007.03.006; BLESSING WW, 1979, NEUROSCI LETT, V11, P35, DOI 10.1016/0304-3940(79)90052-1; BOURGOIN S, 1993, NEUROPHARMACOLOGY, V32, P633, DOI 10.1016/0028-3908(93)90076-F; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; CARP JS, 1982, BRAIN RES, V242, P247, DOI 10.1016/0006-8993(82)90307-9; Charbit AR, 2009, J NEUROSCI, V29, P12532, DOI 10.1523/JNEUROSCI.2887-09.2009; CHEN PK, J NEUROL NEUROSURG P, V81, P524; Ciliax BJ, 1999, J COMP NEUROL, V409, P38, DOI 10.1002/(SICI)1096-9861(19990621)409:1<38::AID-CNE4>3.0.CO;2-1; Clemens S, 2004, J NEUROSCI, V24, P11337, DOI 10.1523/JNEUROSCI.3698-04.2004; Clemens S, 2006, NEUROLOGY, V67, P125, DOI 10.1212/01.wnl.0000223316.53428.c9; COTZIAS GC, 1969, NEW ENGL J MED, V280, P337, DOI 10.1056/NEJM196902132800701; Cuenca N, 2005, J COMP NEUROL, V493, P261, DOI 10.1002/cne.20761; d'Onofrio F, 2008, NEUROL SCI, V29, pS169, DOI 10.1007/s10072-008-0916-3; Damier P, 1999, BRAIN, V122, P1421, DOI 10.1093/brain/122.8.1421; DEARRY A, 1990, NATURE, V347, P72, DOI 10.1038/347072a0; DUBOIS A, 1986, NEUROSCIENCE, V19, P125, DOI 10.1016/0306-4522(86)90010-2; Emborg ME, 2006, NEUROBIOL DIS, V23, P281, DOI 10.1016/j.nbd.2006.03.010; Ershov PV, 2002, J COMP NEUROL, V446, P114, DOI 10.1002/cne.10173; FLEETWOODWALKER SM, 1988, J PHYSIOL-LONDON, V399, P335; FUXE K, 1965, ACTA PHYSL SCAND S, V247; Gao X, 2001, BRAIN RES BULL, V54, P391, DOI 10.1016/S0361-9230(00)00460-3; Garraway SM, 2001, J NEUROPHYSIOL, V86, P2183, DOI 10.1152/jn.2001.86.5.2183; Gerin C, 1998, BRAIN RES, V794, P169, DOI 10.1016/S0006-8993(98)00278-9; Gerin C, 1995, BRAIN RES, V704, P191, DOI 10.1016/0006-8993(95)01111-0; GIROS B, 1992, MOL PHARMACOL, V42, P383; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; Guigoni C, 2005, EUR J NEUROSCI, V22, P283, DOI 10.1111/j.1460-9568.2005.04196.x; HABER SN, 1995, J COMP NEUROL, V362, P400, DOI 10.1002/cne.903620308; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Hening W, 1999, SLEEP, V22, P970; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Holstege JC, 1996, J COMP NEUROL, V376, P631, DOI 10.1002/(SICI)1096-9861(19961223)376:4<631::AID-CNE10>3.0.CO;2-P; JAVITCH JA, 1985, P NATL ACAD SCI USA, V82, P2173, DOI 10.1073/pnas.82.7.2173; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Karasawa N, 1995, NEUROSCI RES, V24, P67, DOI 10.1016/0168-0102(95)00976-0; Karasawa N, 2007, ACTA HISTOCHEM CYTOC, V40, P83, DOI 10.1267/ahc.06019; Kiehn O, 1996, J NEUROPHYSIOL, V75, P1472, DOI 10.1152/jn.1996.75.4.1472; Kitahama K, 1998, J CHEM NEUROANAT, V16, P43, DOI 10.1016/S0891-0618(98)00060-X; Lapointe NP, 2008, J NEUROPHYSIOL, V100, P160, DOI 10.1152/jn.90339.2008; Lapointe NP, 2009, J PHYSIOL-LONDON, V587, P1499, DOI 10.1113/jphysiol.2008.166314; Levant B, 2001, NEUROSCI LETT, V303, P9, DOI 10.1016/S0304-3940(01)01692-5; Liang CL, 1996, NEURODEGENERATION, V5, P313, DOI 10.1006/neur.1996.0042; LORANG D, 1994, J NEUROSCI, V14, P4903; MARKEY SP, 1984, NATURE, V311, P464, DOI 10.1038/311464a0; McEwen ML, 1997, BEHAV NEUROSCI, V111, P825, DOI 10.1037/0735-7044.111.4.825; Meister B, 1988, J Chem Neuroanat, V1, P59; MEN DS, 1994, BRAIN RES BULL, V33, P625, DOI 10.1016/0361-9230(94)90225-9; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MONS N, 1989, SYNAPSE, V4, P99, DOI 10.1002/syn.890040203; Moreau MS, 2002, BRAIN, V125, P2125, DOI 10.1093/brain/awf201; Okura M, 2004, NEUROBIOL DIS, V16, P274, DOI 10.1016/j.nbd.2004.02.008; ONALI P, 1985, MOL PHARMACOL, V28, P138; Ondo WG, 2000, MOVEMENT DISORD, V15, P154, DOI 10.1002/1531-8257(200001)15:1<154::AID-MDS1025>3.0.CO;2-Q; PIFL C, 1991, NEUROSCIENCE, V44, P591, DOI 10.1016/0306-4522(91)90080-8; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; Rhode AM, 2007, CEPHALALGIA, V27, P1255, DOI 10.1111/j.1468-2982.2007.01453.x; RIDET JL, 1992, BRAIN RES, V598, P233, DOI 10.1016/0006-8993(92)90188-F; SCHILLING C, MOV DISORD, V25, P1047; Scholz B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001589; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; SKAGERBERG G, 1982, BRAIN RES BULL, V9, P237, DOI 10.1016/0361-9230(82)90136-8; SOKOLOFF P, 1990, NATURE, V347, P146, DOI 10.1038/347146a0; Spiga S, 2008, ANN NY ACAD SCI, V1139, P299, DOI 10.1196/annals.1432.008; Stiasny-Kolster K, 2004, BRAIN, V127, P773, DOI 10.1093/brain/awh079; SUNAHARA RK, 1991, NATURE, V350, P614, DOI 10.1038/350614a0; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; TISON F, 1991, J NEURAL TRANSM-PARK, V3, P27, DOI 10.1007/BF02251134; TISON F, 1990, HISTOCHEMISTRY, V93, P655, DOI 10.1007/BF00272209; Ugrumov MV, 2009, J CHEM NEUROANAT, V38, P241, DOI 10.1016/j.jchemneu.2009.08.004; van Os J, 2009, LANCET, V374, P635, DOI [10.1016/S0140-6736(09)60995-8, 10.1016/S0140-6736(15)01121-6]; vanDijken H, 1996, EUR J NEUROSCI, V8, P621; Weihe E, 2006, CELL MOL NEUROBIOL, V26, P659, DOI 10.1007/s10571-006-9053-9; WEILFUGAZZA J, 1993, BRAIN RES BULL, V30, P319, DOI 10.1016/0361-9230(93)90259-E; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WESTLUND KN, 1980, BRAIN RES REV, V2, P235, DOI 10.1016/0165-0173(80)90009-0; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Yang HW, 2005, J NEUROPHYSIOL, V94, P961, DOI 10.1152/jn.01324.2004; YOKOYAMA C, 1994, J COMP NEUROL, V344, P121, DOI 10.1002/cne.903440109; Zhao HR, 2007, J NEUROSCI RES, V85, P1065, DOI 10.1002/jnr.21207; Zhu H, 2007, NEUROSCIENCE, V149, P885, DOI 10.1016/j.neuroscience.2007.07.052	98	69	70	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13306	10.1371/journal.pone.0013306	http://dx.doi.org/10.1371/journal.pone.0013306			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967255	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800014
J	Rapp, JB; Noguchi, C; Das, MM; Wong, LK; Ansbach, AB; Holmes, AM; Arcangioli, B; Noguchi, E				Rapp, Jordan B.; Noguchi, Chiaki; Das, Mukund M.; Wong, Lisa K.; Ansbach, Alison B.; Holmes, Allyson M.; Arcangioli, Benoit; Noguchi, Eishi			Checkpoint-Dependent and -Independent Roles of Swi3 in Replication Fork Recovery and Sister Chromatid Cohesion in Fission Yeast	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; DNA-DAMAGE CHECKPOINT; SCHIZOSACCHAROMYCES-POMBE; S-PHASE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; INTERACTING PROTEIN; PROTECTION COMPLEX; RESPONSE PATHWAY; EUKARYOTIC DNA	Multiple genome maintenance processes are coordinated at the replication fork to preserve genomic integrity. How eukaryotic cells accomplish such a coordination is unknown. Swi1 and Swi3 form the replication fork protection complex and are involved in various processes including stabilization of replication forks, activation of the Cds1 checkpoint kinase and establishment of sister chromatid cohesion in fission yeast. However, the mechanisms by which the Swi1-Swi3 complex achieves and coordinates these tasks are not well understood. Here, we describe the identification of separation-of-function mutants of Swi3, aimed at dissecting the molecular pathways that require Swi1-Swi3. Unlike swi3 deletion mutants, the separation-of-function mutants were not sensitive to agents that stall replication forks. However, they were highly sensitive to camptothecin that induces replication fork breakage. In addition, these mutants were defective in replication fork regeneration and sister chromatid cohesion. Interestingly, unlike swi3-deleted cell, the separation-of-functions mutants were proficient in the activation of the replication checkpoint, but their fork regeneration defects were more severe than those of checkpoint mutants including cds1 Delta, chk1 Delta and rad3 Delta. These results suggest that, while Swi3 mediates full activation of the replication checkpoint in response to stalled replication forks, Swi3 activates a checkpoint-independent pathway to facilitate recovery of collapsed replication forks and the establishment of sister chromatid cohesion. Thus, our separation-of-function alleles provide new insight into understanding the multiple roles of Swi1-Swi3 in fork protection during DNA replication, and into understanding how replication forks are maintained in response to different genotoxic agents.	[Rapp, Jordan B.; Noguchi, Chiaki; Das, Mukund M.; Wong, Lisa K.; Ansbach, Alison B.; Noguchi, Eishi] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Holmes, Allyson M.; Arcangioli, Benoit] Inst Pasteur, Unite Dynam Genome, CNRS, URA 1644,Dept Struct & Dynam Genomes, Paris, France	Drexel University; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Rapp, JB (corresponding author), Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA.	enoguchi@drexelmed.edu	Noguchi, Eishi/E-7283-2013; Noguchi, Eishi/AAF-3986-2021	Noguchi, Eishi/0000-0001-5470-5127; Lee, Lisa/0000-0001-5857-9260	Leukemia Research Foundation; National Institutes of Health [GM077604]; American Recovery and Reinvestment Act of 2009 [R01GM077604-S1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077604] Funding Source: NIH RePORTER	Leukemia Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act of 2009; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from Leukemia Research Foundation (to E.N.) and National Institutes of Health (GM077604, to E.N.). This work was also supported by The American Recovery and Reinvestment Act of 2009 (R01GM077604-S1, to E.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Alfa C., 1993, EXPT FISSION YEAST; ALKHODAIRY F, 1994, MOL BIOL CELL, V5, P147, DOI 10.1091/mbc.5.2.147; Ansbach AB, 2008, MOL BIOL CELL, V19, P595, DOI 10.1091/mbc.E07-06-0618; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2007, DNA REPAIR, V6, P994, DOI 10.1016/j.dnarep.2007.02.018; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Carr AM, 2002, DNA REPAIR, V1, P983, DOI 10.1016/S1568-7864(02)00165-9; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Dalgaard JZ, 2000, CELL, V102, P745, DOI 10.1016/S0092-8674(00)00063-5; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Du LL, 2003, MOL CELL BIOL, V23, P6150, DOI 10.1128/MCB.23.17.6150-6158.2003; Edwards RJ, 1999, NAT CELL BIOL, V1, P393, DOI 10.1038/15623; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2007, J MOL BIOL, V366, P36, DOI 10.1016/j.jmb.2006.10.097; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; ICHIHARA Y, 1993, GENE, V130, P153, DOI 10.1016/0378-1119(93)90361-6; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kaykov A, 2004, EMBO J, V23, P930, DOI 10.1038/sj.emboj.7600099; KEENEY JB, 1994, GENETICS, V136, P849; Krings G, 2004, P NATL ACAD SCI USA, V101, P14085, DOI 10.1073/pnas.0406037101; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; Lambert S, 2007, DNA REPAIR, V6, P1042, DOI 10.1016/j.dnarep.2007.02.024; Lee BS, 2004, MOL CELL BIOL, V24, P9813, DOI 10.1128/MCB.24.22.9813-9822.2004; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lisby M, 2003, NAT CELL BIOL, V5, P572, DOI 10.1038/ncb997; Lisby M, 2001, P NATL ACAD SCI USA, V98, P8276, DOI 10.1073/pnas.121006298; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Noguchi E, 2003, MOL CELL BIOL, V23, P7861, DOI 10.1128/MCB.23.21.7861-7874.2003; Noguchi Eishi, 2009, V521, P493, DOI [10.1007/978-1-60327-817-5_28, 10.1007/978-1-60327-815-7_28]; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Paciotti V, 2001, MOL CELL BIOL, V21, P3913, DOI 10.1128/MCB.21.12.3913-3925.2001; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pryce DW, 2009, P NATL ACAD SCI USA, V106, P4770, DOI 10.1073/pnas.0807739106; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Shimmoto M, 2009, GENES CELLS, V14, P669, DOI 10.1111/j.1365-2443.2009.01300.x; Silverstein RA, 2003, CURR BIOL, V13, P68, DOI 10.1016/S0960-9822(02)01401-X; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Tatebayashi K, 1998, GENETICS, V148, P49; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; UNSALKACMAZ K, 2007, MOL CELL BIOL; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Wang SW, 2002, J CELL SCI, V115, P587; Warren CD, 2004, MOL BIOL CELL, V15, P1724, DOI 10.1091/mbc.E03-09-0637; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wolkow TD, 2002, MOL BIOL CELL, V13, P480, DOI 10.1091/mbc.01-03-0104; WOODS A, 1989, J CELL SCI, V93, P491; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	66	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13379	10.1371/journal.pone.0013379	http://dx.doi.org/10.1371/journal.pone.0013379			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967229	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300033
J	Pessa, HKJ; Greco, D; Kvist, J; Wahlstrom, G; Heino, TI; Auvinen, P; Frilander, MJ				Pessa, Heli K. J.; Greco, Dario; Kvist, Jouni; Wahlstrom, Gudrun; Heino, Tapio I.; Auvinen, Petri; Frilander, Mikko J.			Gene Expression Profiling of U12-Type Spliceosome Mutant Drosophila Reveals Widespread Changes in Metabolic Pathways	PLOS ONE			English	Article							U12-DEPENDENT INTRONS; MINOR-CLASS; PROHIBITIN FAMILY; IN-VIVO; U11; PROTEIN; SITE; U6ATAC; SNRNPS; ACTIVATION	Background: The U12-type spliceosome is responsible for the removal of a subset of introns from eukaryotic mRNAs. U12-type introns are spliced less efficiently than normal U2-type introns, which suggests a rate-limiting role in gene expression. The Drosophila genome contains about 20 U12-type introns, many of them in essential genes, and the U12-type spliceosome has previously been shown to be essential in the fly. Methodology/Principal Findings: We have used a Drosophila line with a P-element insertion in U6atac snRNA, an essential component of the U12-type spliceosome, to investigate the impact of U12-type introns on gene expression at the organismal level during fly development. This line exhibits progressive accumulation of unspliced U12-type introns during larval development and the death of larvae at the third instar stage. Surprisingly, microarray and RT-PCR analyses revealed that most genes containing U12-type introns showed only mild perturbations in the splicing of U12-type introns. In contrast, we detected widespread downstream effects on genes that do not contain U12-type introns, with genes related to various metabolic pathways constituting the largest group. Conclusions/Significance: U12-type intron-containing genes exhibited variable gene-specific responses to the splicing defect, with some genes showing up-or downregulation, while most did not change significantly. The observed residual U12-type splicing activity could be explained with the mutant U6atac allele having a low level of catalytic activity. Detailed analysis of all genes suggested that a defect in the splicing of the U12-type intron of the mitochondrial prohibitin gene may be the primary cause of the various downstream effects detected in the microarray analysis.	[Pessa, Heli K. J.; Greco, Dario; Kvist, Jouni; Wahlstrom, Gudrun; Auvinen, Petri; Frilander, Mikko J.] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Wahlstrom, Gudrun; Heino, Tapio I.] Univ Helsinki, Dept Biosci, Helsinki, Finland	University of Helsinki; University of Helsinki	Pessa, HKJ (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	Mikko.Frilander@Helsinki.fi	Frilander, Mikko J/B-6660-2009; Auvinen, Petri/AAP-8117-2021; Greco, Dario/T-7113-2019; Auvinen, Petri/D-5044-2009	Frilander, Mikko J/0000-0002-1732-4808; Greco, Dario/0000-0001-9195-9003; Auvinen, Petri/0000-0002-3947-4778; Wahlstrom, Gudrun/0000-0003-1177-1137; Kvist, Jouni/0000-0002-4089-8877	Academy of Finland [110245, 117968]; Viikki Graduate School in Biosciences; Alfred Kordelin Foundation	Academy of Finland(Academy of Finland); Viikki Graduate School in Biosciences; Alfred Kordelin Foundation	This work was supported by the Academy of Finland (Grant 110245 to MJF and Grant 117968 to PA; www.aka.fi), Viikki Graduate School in Biosciences (HP; www.biocenter.helsinki.fi/viikkigs), and Alfred Kordelin Foundation (HP; www.kordelin.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2007, NUCLEIC ACIDS RES, V35, pD110, DOI 10.1093/nar/gkl796; Artal-Sanz M, 2009, TRENDS ENDOCRIN MET, V20, P394, DOI 10.1016/j.tem.2009.04.004; Basu MK, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-19; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Burge CB, 1998, MOL CELL, V2, P773, DOI 10.1016/S1097-2765(00)80292-0; Clark TA, 2002, SCIENCE, V296, P907, DOI 10.1126/science.1069415; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169; Fernandez-Ayala DJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008549; Friend K, 2008, RNA, V14, P1459, DOI 10.1261/rna.1119708; Frilander MJ, 1999, GENE DEV, V13, P851, DOI 10.1101/gad.13.7.851; Frilander MJ, 2001, MOL CELL, V7, P217, DOI 10.1016/S1097-2765(01)00169-1; Haider S, 2009, NUCLEIC ACIDS RES, V37, pW23, DOI 10.1093/nar/gkp265; Hall SL, 1996, SCIENCE, V271, P1716, DOI 10.1126/science.271.5256.1716; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Incorvaia R, 1998, RNA, V4, P709, DOI 10.1017/S1355838298980207; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Konig H, 2007, CELL, V131, P718, DOI 10.1016/j.cell.2007.09.043; Kolossova I, 1997, RNA, V3, P227; Levine A, 2001, NUCLEIC ACIDS RES, V29, P4006, DOI 10.1093/nar/29.19.4006; Lin CF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-47; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nilsen TW, 2003, BIOESSAYS, V25, P1147, DOI 10.1002/bies.10394; Otake LR, 2002, MOL CELL, V9, P439, DOI 10.1016/S1097-2765(02)00441-0; Patel AA, 2003, NAT REV MOL CELL BIO, V4, P960, DOI 10.1038/nrm1259; Patel AA, 2002, EMBO J, V21, P3804, DOI 10.1093/emboj/cdf297; Pessa HKJ, 2008, P NATL ACAD SCI USA, V105, P8655, DOI 10.1073/pnas.0803646105; Pessa HKJ, 2006, RNA, V12, P1883, DOI 10.1261/rna.213906; Pleiss JA, 2007, PLOS BIOL, V5, P745, DOI 10.1371/journal.pbio.0050090; Russell AG, 2006, NATURE, V443, P863, DOI 10.1038/nature05228; Schneider C, 2004, P NATL ACAD SCI USA, V101, P9584, DOI 10.1073/pnas.0403400101; Schneider C, 2002, MOL CELL BIOL, V22, P3219, DOI 10.1128/MCB.22.10.3219-3229.2002; Sheth N, 2006, NUCLEIC ACIDS RES, V34, P3955, DOI 10.1093/nar/gkl556; Shukla GC, 1999, RNA, V5, P525, DOI 10.1017/S1355838299982213; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spradling AC, 1999, GENETICS, V153, P135; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Tarn WY, 1996, SCIENCE, V273, P1824, DOI 10.1126/science.273.5283.1824; Tarn WY, 1996, CELL, V84, P801, DOI 10.1016/S0092-8674(00)81057-0; Turunen JJ, 2008, MOL CELL BIOL, V28, P3548, DOI 10.1128/MCB.01928-07; Valadkhan S, 2005, CURR OPIN CHEM BIOL, V9, P603, DOI 10.1016/j.cbpa.2005.10.008; Valadkhan S, 2001, NATURE, V413, P701, DOI 10.1038/35099500; Van Aken O, 2007, PLANT J, V52, P850, DOI 10.1111/j.1365-313X.2007.03276.x; Verbeeren J, 2010, MOL CELL, V37, P821, DOI 10.1016/j.molcel.2010.02.014; Will CL, 2004, RNA, V10, P929, DOI 10.1261/rna.7320604; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yu YT, 1997, P NATL ACAD SCI USA, V94, P6030, DOI 10.1073/pnas.94.12.6030; Zahurak M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-142	54	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13215	10.1371/journal.pone.0013215	http://dx.doi.org/10.1371/journal.pone.0013215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949011	Green Published, gold, Green Submitted			2022-12-27	WOS:000282748100002
J	Neumann, N; Lundin, D; Poole, AM				Neumann, Nadja; Lundin, Daniel; Poole, Anthony M.			Comparative Genomic Evidence for a Complete Nuclear Pore Complex in the Last Eukaryotic Common Ancestor	PLOS ONE			English	Article							WD-REPEAT; PHYLOGENETIC ANALYSIS; NUCLEOMORPH GENOME; ADAPTER COMPLEX; CLOSED MITOSIS; CELL-DIVISION; COAT PROTEINS; EVOLUTION; ORIGIN; ARCHITECTURE	Background: The Nuclear Pore Complex (NPC) facilitates molecular trafficking between nucleus and cytoplasm and is an integral feature of the eukaryote cell. It exhibits eight-fold rotational symmetry and is comprised of approximately 30 nucleoporins (Nups) in different stoichiometries. Nups are broadly conserved between yeast, vertebrates and plants, but few have been identified among other major eukaryotic groups. Methodology/Principal Findings: We screened for Nups across 60 eukaryote genomes and report that 19 Nups (spanning all major protein subcomplexes) are found in all eukaryote supergroups represented in our study (Opisthokonts, Amoebozoa, Viridiplantae, Chromalveolates and Excavates). Based on parsimony, between 23 and 26 of 31 Nups can be placed in LECA. Notably, they include central components of the anchoring system (Ndc1 and Gp210) indicating that the anchoring system did not evolve by convergence, as has previously been suggested. These results significantly extend earlier results and, importantly, unambiguously place a fully-fledged NPC in LECA. We also test the proposal that transmembrane Pom proteins in vertebrates and yeasts may account for their variant forms of mitosis (open mitoses in vertebrates, closed among yeasts). The distribution of homologues of vertebrate Pom121 and yeast Pom152 is not consistent with this suggestion, but the distribution of fungal Pom34 fits a scenario wherein it was integral to the evolution of closed mitosis in ascomycetes. We also report an updated screen for vesicle coating complexes, which share a common evolutionary origin with Nups, and can be traced back to LECA. Surprisingly, we find only three supergroup-level differences (one gain and two losses) between the constituents of COPI, COPII and Clathrin complexes. Conclusions/Significance: Our results indicate that all major protein subcomplexes in the Nuclear Pore Complex are traceable to the Last Eukaryotic Common Ancestor (LECA). In contrast to previous screens, we demonstrate that our conclusions hold regardless of the position of the root of the eukaryote tree.	[Neumann, Nadja; Lundin, Daniel; Poole, Anthony M.] Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden; [Poole, Anthony M.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Poole, Anthony M.] Univ Canterbury, Biomol Interact Ctr, Christchurch 1, New Zealand	Stockholm University; University of Canterbury; University of Canterbury	Neumann, N (corresponding author), Stockholm Univ, Dept Mol Biol & Funct Genom, S-10691 Stockholm, Sweden.	anthony.poole@canterbury.ac.nz		Lundin, Daniel/0000-0002-8779-6464; Neumann, Nadja/0000-0002-7178-1823; Poole, Anthony/0000-0001-9940-2824	Carl Tryggers Foundation [CTS04:329]; Knut and Alice Wallenberg Foundation	Carl Tryggers Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Financial support from the Carl Tryggers Foundation (CTS04:329 www.carltryggersstiftelse.se) to AMP is gratefully acknowledged. AMP is a Royal Swedish Academy of Sciences (www.kva.se) Research Fellow supported by a grant from the Knut and Alice Wallenberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Benchimol M, 2004, PARASITOL RES, V94, P254, DOI 10.1007/s00436-004-1211-8; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Cavalier-Smith T, 2002, HEREDITY, V88, P125, DOI 10.1038/sj.hdy.6800034; Collins L, 2005, MOL BIOL EVOL, V22, P1053, DOI 10.1093/molbev/msi091; Collins Lesley J, 2003, Appl Bioinformatics, V2, pS85; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; Dacks J, 1999, J MOL EVOL, V48, P779, DOI 10.1007/PL00013156; Dacks JB, 2004, SYST ASSOC SPEC VOL, P309; Dacks JB, 2008, P NATL ACAD SCI USA, V105, P588, DOI 10.1073/pnas.0707318105; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; Dacks JB, 2009, INT J BIOCHEM CELL B, V41, P330, DOI 10.1016/j.biocel.2008.08.041; De Souza CPC, 2007, EUKARYOT CELL, V6, P1521, DOI 10.1128/EC.00178-07; De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DESMOND E, 2009, GENOME BIOL EVOL; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103; Dill KA, 2007, CURR OPIN STRUC BIOL, V17, P342, DOI 10.1016/j.sbi.2007.06.001; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; EGEL R, 2008, ORIGIN MEIOSIS EUKAR; Eme L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005021; Esser C, 2004, MOL BIOL EVOL, V21, P1643, DOI 10.1093/molbev/msh160; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Field MC, 2009, CURR OPIN CELL BIOL, V21, P4, DOI 10.1016/j.ceb.2008.12.004; FIELD MC, 2006, EVOLUTION EUKARYOTIC; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fitzpatrick DA, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-99; Fuerst JA, 2005, ANNU REV MICROBIOL, V59, P299, DOI 10.1146/annurev.micro.59.030804.121258; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; HAMPL V, 2009, P NATL ACAD SCI US; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.e04-10-0857; Hawryluk-Gara LA, 2008, MOL BIOL CELL, V19, P1753, DOI 10.1091/mbc.E07-08-0820; HEATH IB, 1980, INT REV CYTOL, V64, P1, DOI 10.1016/S0074-7696(08)60235-1; Hisbergues M, 2001, PROTEIN SCI, V10, P293, DOI 10.1110/ps.22701; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jekely G, 2005, CELL CYCLE, V4, P297; Jekely G, 2003, BIOESSAYS, V25, P1129, DOI 10.1002/bies.10353; Jekely G, 2007, ADV EXP MED BIOL, V607, P38; Jekely G, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-31; KARPOV SA, 1993, EUR J PROTISTOL, V29, P19, DOI 10.1016/S0932-4739(11)80292-0; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2002, ANNU REV MICROBIOL, V56, P93, DOI 10.1146/annurev.micro.56.012302.160854; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kloepper TH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-22; Lane CE, 2007, P NATL ACAD SCI USA, V104, P19908, DOI 10.1073/pnas.0707419104; Lane CE, 2006, J EUKARYOT MICROBIOL, V53, P515, DOI 10.1111/j.1550-7408.2006.00135.x; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1; Liu HL, 2009, MOL BIOL CELL, V20, P616, DOI 10.1091/mbc.E08-06-0628; Lonhienne TGA, 2010, P NATL ACAD SCI USA, V107, P12883, DOI 10.1073/pnas.1001085107; Mans BJ, 2004, CELL CYCLE, V3, P1612; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Miao M, 2006, GENETICS, V172, P1441, DOI 10.1534/genetics.105.052068; Minge MA, 2009, P ROY SOC B-BIOL SCI, V276, P597, DOI 10.1098/rspb.2008.1358; MOCHIZUKI T, 1987, J MED VET MYCOL, V25, P223; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Neumann N, 2006, EVOL BIOINFORM, V2, P23; Osmani AH, 2006, MOL BIOL CELL, V17, P4946, DOI 10.1091/mbc.E06-07-0657; Panek HR, 1997, EMBO J, V16, P4194, DOI 10.1093/emboj/16.14.4194; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Ribeiro KC, 2002, BIOL CELL, V94, P157, DOI 10.1016/S0248-4900(02)01191-7; Ritchie DW, 2008, CURR PROTEIN PEPT SC, V9, P1, DOI 10.2174/138920308783565741; Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Rout MP, 2000, ESSAYS BIOCHEM, V36, P75, DOI 10.1042/bse0360075; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Santarella-Mellwig R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000281; Sazer S, 2005, CURR BIOL, V15, pR23, DOI 10.1016/j.cub.2004.12.015; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; STEPP JD, 1995, MOL BIOL CELL, V6, P41, DOI 10.1091/mbc.6.1.41; Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X; TAYLOR FJR, 1999, ULTRASTRUCTURE CONTR; Theisen U, 2008, MOL BIOL CELL, V19, P1230, DOI 10.1091/mbc.E07-02-0130; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; van der Giezen M, 2005, EMBO REP, V6, P525, DOI 10.1038/sj.embor.7400440; White DJ, 2000, MOL MICROBIOL, V36, P662, DOI 10.1046/j.1365-2958.2000.01887.x; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643	100	103	106	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13241	10.1371/journal.pone.0013241	http://dx.doi.org/10.1371/journal.pone.0013241			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949036	Green Published, Green Submitted, gold			2022-12-27	WOS:000282676700015
J	Pongratz, C; Yazdanpanah, B; Kashkar, H; Lehmann, MJ; Krausslich, HG; Kronke, M				Pongratz, Carola; Yazdanpanah, Benjamin; Kashkar, Hamid; Lehmann, Maik J.; Kraeusslich, Hans-Georg; Kroenke, Martin			Selection of Potent Non-Toxic Inhibitory Sequences from a Randomized HIV-1 Specific Lentiviral Short Hairpin RNA Library	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SMALL INTERFERING RNAS; MAMMALIAN-CELLS; PHAGE POLYMERASE; GENE-THERAPY; SIRNA; EXPRESSION; INFECTION; SHRNA; ESCAPE	RNA interference (RNAi) has been considered as an efficient therapeutic approach against the human immunodeficiency virus type 1 (HIV-1). However, to establish a durable inhibition of HIV-1, multiple effective short hairpin RNAs (shRNAs) need to be stably expressed to prevent the emergence of viral escape variants. In this study, we engineered a randomized lentiviral H1-promoter driven shRNA-library against the viral genome. Potent HIV-1 specific shRNAs were selected by ganciclovir treatment of cell lines stably expressing the cDNA of Herpes Simplex Virus thymidine kinase (HSV-TK) fused to HIV-1 nucleotide sequences. More than 50% of 200 selected shRNAs inhibited an HIV-1 based luciferase reporter assay by more than 70%. Stable expression of some of those shRNAs in an HIV-1 permissive HeLa cell line inhibited infection of wildtype HIV-1 by more than 90%. The combination of a randomized shRNA-library directed against HIV-1 with a live cell selection procedure yielded non-toxic and highly efficient HIV-1 specific inhibitory sequences that could serve as valuable candidates for gene therapy studies.	[Pongratz, Carola; Yazdanpanah, Benjamin; Kashkar, Hamid; Kroenke, Martin] Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [Pongratz, Carola; Kashkar, Hamid; Kroenke, Martin] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Yazdanpanah, Benjamin; Kashkar, Hamid; Kroenke, Martin] Univ Cologne, Ctr Mol Med, Cologne, Germany; [Lehmann, Maik J.; Kraeusslich, Hans-Georg] Univ Heidelberg Hosp, Dept Virol, Heidelberg, Germany	University of Cologne; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg	Pongratz, C (corresponding author), Univ Hosp Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany.	benjamin.yazdanpanah@uk-koeln.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas-Terki T, 2002, HUM GENE THER, V13, P2197, DOI 10.1089/104303402320987888; ANDERSON S, 1981, NUCLEIC ACIDS RES, V9, P3015, DOI 10.1093/nar/9.13.3015; Berkhout B, 2004, CURR OPIN MOL THER, V6, P141; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164; Boden D, 2003, J VIROL, V77, P11531, DOI 10.1128/JVI.77.21.11531-11535.2003; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chang LJ, 2005, GENE THER, V12, P1133, DOI 10.1038/sj.gt.3302509; CLAVEL F, 1994, J VIROL, V68, P1179, DOI 10.1128/JVI.68.2.1179-1185.1994; Coburn GA, 2002, J VIROL, V76, P9225, DOI 10.1128/JVI.76.18.9225-9231.2002; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; EHRLICH SD, 1973, EUR J BIOCHEM, V40, P143, DOI 10.1111/j.1432-1033.1973.tb03178.x; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fuchs U, 2007, ADV CANCER RES, V96, P75, DOI 10.1016/S0065-230X(06)96004-7; Gondai T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1043; Gragoudas ES, 2004, NEW ENGL J MED, V351, P2805, DOI 10.1056/NEJMoa042760; Ill CR, 2005, GENE THER, V12, P795, DOI 10.1038/sj.gt.3302524; Jabs DA, 2002, AM J OPHTHALMOL, V133, P552, DOI 10.1016/S0002-9394(02)01325-9; Jacque JM, 2002, NATURE, V418, P435, DOI 10.1038/nature00896; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jakobsen MR, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh064; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kaiser J, 2003, SCIENCE, V299, P495, DOI 10.1126/science.299.5606.495; Kasim Vivi, 2003, Nucleic Acids Res Suppl, P255; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kittler R, 2005, CELL CYCLE, V4, P564; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Lee NS, 2002, NAT BIOTECHNOL, V20, P500, DOI 10.1038/nbt0502-500; Li MJ, 2005, MOL THER, V12, P900, DOI 10.1016/j.ymthe.2005.07.524; Li W, 2007, CELL MOL LIFE SCI, V64, P1785, DOI 10.1007/s00018-007-7057-3; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Luo B, 2004, P NATL ACAD SCI USA, V101, P5494, DOI 10.1073/pnas.0400551101; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Patzel V, 2005, NAT BIOTECHNOL, V23, P1440, DOI 10.1038/nbt1151; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Scherer LJ, 2004, MOL THER, V10, P597, DOI 10.1016/j.ymthe.2004.05.003; Sen G, 2004, NAT GENET, V36, P183, DOI 10.1038/ng1288; Shirane D, 2004, NAT GENET, V36, P190, DOI 10.1038/ng1290; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; ter Brake O, 2008, MOL THER, V16, P557, DOI 10.1038/sj.mt.6300382; ter Brake O, 2006, MOL THER, V14, P883, DOI 10.1016/j.ymthe.2006.07.007; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Van Rij RP, 2006, TRENDS BIOTECHNOL, V24, P186, DOI 10.1016/j.tibtech.2006.02.006; Voinnet O, 2001, TRENDS GENET, V17, P449, DOI 10.1016/S0168-9525(01)02367-8; von Eije KJ, 2008, J VIROL, V82, P2895, DOI 10.1128/JVI.02035-07; Westerhout EM, 2005, NUCLEIC ACIDS RES, V33, P796, DOI 10.1093/nar/gki220; Wu RH, 2007, J GENE MED, V9, P620, DOI 10.1002/jgm.1048; Yazdanpanah B, 2009, NATURE, V460, P1159, DOI 10.1038/nature08206; Zhao HF, 2005, NAT METHODS, V2, P967, DOI 10.1038/NMETH812; Zheng LX, 2004, P NATL ACAD SCI USA, V101, P135, DOI 10.1073/pnas.2136685100; Zhou DM, 2008, CHEMBIOCHEM, V9, P1365, DOI 10.1002/cbic.200800049; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	55	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13172	10.1371/journal.pone.0013172	http://dx.doi.org/10.1371/journal.pone.0013172			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949027	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700003
J	Thorner, AR; Parker, JS; Hoadley, KA; Perou, CM				Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.			Potential Tumor Suppressor Role for the c-Myb Oncogene in Luminal Breast Cancer	PLOS ONE			English	Article							ANTISENSE OLIGODEOXYNUCLEOTIDES; PREOPERATIVE CHEMOTHERAPY; EXPRESSION SIGNATURE; MOLECULAR PORTRAITS; CELL-LINES; IN-VITRO; B-MYB; GENE; LEUKEMIA; SENSITIVITY	Background: The transcription factor c-Myb has been well characterized as an oncogene in several human tumor types, and its expression in the hematopoietic stem/progenitor cell population is essential for proper hematopoiesis. However, the role of c-Myb in mammopoeisis and breast tumorigenesis is poorly understood, despite its high expression in the majority of breast cancer cases (60-80%). Methodology/Principal Findings: We find that c-Myb high expression in human breast tumors correlates with the luminal/ER+ phenotype and a good prognosis. Stable RNAi knock-down of endogenous c-Myb in the MCF7 luminal breast tumor cell line increased tumorigenesis both in vitro and in vivo, suggesting a possible tumor suppressor role in luminal breast cancer. We created a mammary-derived c-Myb expression signature, comprised of both direct and indirect c-Myb target genes, and found it to be highly correlated with a published mature luminal mammary cell signature and least correlated with a mammary stem/progenitor lineage gene signature. Conclusions/Significance: These data describe, for the first time, a possible tumor suppressor role for the c-Myb protooncogene in breast cancer that has implications for the understanding of luminal tumorigenesis and for guiding treatment.	[Thorner, Aaron R.; Parker, Joel S.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA; [Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Thorner, Aaron R.; Parker, Joel S.; Hoadley, Katherine A.; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Perou, Charles M.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Thorner, AR (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	cperou@med.unc.edu	Perou, Charles M/H-9934-2014; Parker, Joel/AAG-1108-2019	Perou, Charles M/0000-0001-9827-2247; Hoadley, Katherine/0000-0002-1216-477X	National Cancer Institute (NCI) [P50-CA58223-09A1, RO1-CA138255]; Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA138255, P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	5This work was supported by funds from the National Cancer Institute (NCI) Breast SPORE program to University of North Carolina-Chapel Hill (UNC-CH) (P50-CA58223-09A1), by the NCI (RO1-CA138255), the Breast Cancer Research Foundation, and by the V Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFOSSI G, 1989, P NATL ACAD SCI USA, V86, P3379, DOI 10.1073/pnas.86.9.3379; Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; Biroccio A, 2001, AM J PATHOL, V158, P1289, DOI 10.1016/S0002-9440(10)64080-1; CALABRETTA B, 1991, P NATL ACAD SCI USA, V88, P2351, DOI 10.1073/pnas.88.6.2351; DEISENROTH C, 2010, MOL CELL BIOL; Drabsch Y, 2007, P NATL ACAD SCI USA, V104, P13762, DOI 10.1073/pnas.0700104104; Ess KC, 1999, ONCOGENE, V18, P1103, DOI 10.1038/sj.onc.1202387; Fu SL, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-54; GUDAS JM, 1995, CLIN CANCER RES, V1, P235; GUERIN M, 1990, ONCOGENE, V5, P131; Harrell JC, 2006, CANCER RES, V66, P9308, DOI 10.1158/0008-5472.CAN-06-1769; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hogg A, 1997, ONCOGENE, V15, P2885, DOI 10.1038/sj.onc.1201472; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Kauraniemi P, 2000, CANCER RES, V60, P5323; KLEMPNAUER KH, 1982, CELL, V31, P453, DOI 10.1016/0092-8674(82)90138-6; Kopecki Z, 2007, J PATHOL, V211, P351, DOI 10.1002/path.2113; Lei WL, 2004, J BIOL CHEM, V279, P29519, DOI 10.1074/jbc.M403133200; LEPRINCE D, 1983, NATURE, V306, P395, DOI 10.1038/306395a0; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Malaterre J, 2008, STEM CELLS, V26, P173, DOI 10.1634/stemcells.2007-0293; Malaterre J, 2007, P NATL ACAD SCI USA, V104, P3829, DOI 10.1073/pnas.0610055104; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; RATAJCZAK MZ, 1992, P NATL ACAD SCI USA, V89, P11823, DOI 10.1073/pnas.89.24.11823; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Rushton JJ, 2003, ONCOGENE, V22, P308, DOI 10.1038/sj.onc.1206131; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Troester MA, 2004, CANCER RES, V64, P4218, DOI 10.1158/0008-5472.CAN-04-0107; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Usary J, 2004, ONCOGENE, V23, P7669, DOI 10.1038/sj.onc.1207966; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967	42	34	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13073	10.1371/journal.pone.0013073	http://dx.doi.org/10.1371/journal.pone.0013073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949095	Green Published, Green Submitted, gold			2022-12-27	WOS:000282633700003
J	Guo, ZW; Zhang, L; Li, YM				Guo, Zhongwei; Zhang, Lin; Li, Yiming			Increased Dependence of Humans on Ecosystem Services and Biodiversity	PLOS ONE			English	Article							ENVIRONMENTAL-CHANGE; FOREST CONSERVATION; ECONOMIC INCENTIVES; DIVERSITY; PROSPECTS; IMPACTS; ECOLOGY; SUPPORT	Humans have altered ecosystems more rapidly and extensively than ever, largely to meet rapidly growing demands for resources along with economic development. These demands have been considered important drivers of ecosystem degradation and biodiversity loss. Are humans becoming less dependent on ecosystem services and biodiversity following economic development? Here, we used roundwood production, hydroelectricity generation and tourism investment in 92 biodiversity hotspot and 60 non-hotspot countries as cases to seek the answer. In 1980-2005, annual growth rates of roundwood production, hydroelectricity generation and tourism investment were higher in hotspot countries (5.2, 9.1 and 7.5%) than in non-hotspot countries (3.4, 5.9 and 5.6%), when GDP grew more rapidly in hotspot countries than non-hotspot countries. Annual growth rates of per capita hydropower and per capita tourism investment were higher in hotspot countries (5.3% and 6.1%) than in non-hotspot countries (3.5% and 4.3%); however, the annual growth rate of per capita roundwood production in hotspot countries (1%) was lower than in non-hotspot countries (1.4%). The dependence of humans on cultural services has increased more rapidly than on regulating services, while the dependence on provisioning services has reduced. This pattern is projected to continue during 2005-2020. Our preliminary results show that economic growth has actually made humans more dependent upon ecosystem services and biodiversity. As a consequence, the policies and implementations of both economic development and ecosystems/biodiversity conservation should be formulated and carried out in the context of the increased dependence of humans on ecosystem services along with economic development.	[Guo, Zhongwei; Zhang, Lin; Li, Yiming] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Guo, ZW (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	guozw@ioz.ac.cn			National Natural Science Fund of China [30670369]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The project was supported by programs of National Natural Science Fund of China (#30670369). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya G, 2000, ECOL ECON, V35, P63, DOI 10.1016/S0921-8009(00)00168-3; Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; [Anonymous], 2005, EC HUM WELL BEING SY; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Balvanera P, 2001, SCIENCE, V291, P2047, DOI 10.1126/science.291.5511.2047; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Brown C., 2000, GLOBAL OUTLOOK FUTUR; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Costanza R, 2007, ECOL ECON, V61, P478, DOI 10.1016/j.ecolecon.2006.03.021; Cowling RM, 2008, P NATL ACAD SCI USA, V105, P9483, DOI 10.1073/pnas.0706559105; Daily G. C., 2002, NEW EC NATURE QUEST; Daily G C, 1997, NATURES SERVICES SOC, P365; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; Guo ZW, 2007, ECOL APPL, V17, P1557, DOI 10.1890/06-0840.1; Heal G.M., 2000, NATURE MARKETPLACE C; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Janzen D, 1998, SCIENCE, V279, P1312, DOI 10.1126/science.279.5355.1312; Jenkins M, 2003, SCIENCE, V302, P1175, DOI 10.1126/science.1088666; Kremen C, 2000, SCIENCE, V288, P1828, DOI 10.1126/science.288.5472.1828; Maeler KG, 2008, P NATL ACAD SCI USA, V105, P9501, DOI 10.1073/pnas.0708856105; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; Milton SJ, 2003, FRONT ECOL ENVIRON, V1, P247, DOI 10.1890/1540-9295(2003)001[0247:EIFRNC]2.0.CO;2; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Nilsson C, 2005, SCIENCE, V308, P405, DOI 10.1126/science.1107887; Ricketts TH, 2004, P NATL ACAD SCI USA, V101, P12579, DOI 10.1073/pnas.0405147101; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 2001, P NATL ACAD SCI USA, V98, P5433, DOI 10.1073/pnas.091093198; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	33	126	138	7	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13113	10.1371/journal.pone.0013113	http://dx.doi.org/10.1371/journal.pone.0013113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957042	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300015
J	Robinson, E; Kur, LW; Ndyaba, A; Lado, M; Shafi, J; Kabare, E; McClelland, RS; Kolaczinski, JH				Robinson, Emily; Kur, Lucia W.; Ndyaba, Aggrey; Lado, Mounir; Shafi, Juma; Kabare, Emmanuel; McClelland, R. Scott; Kolaczinski, Jan H.			Trachoma Rapid Assessments in Unity and Northern Bahr-el-Ghazal States, Southern Sudan	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; PREVALENCE; DIAGNOSIS; AZITHROMYCIN; INFECTION; SEVERITY	Background: Trachoma is thought to be endemic over large parts of Southern Sudan, but empirical evidence is limited. While some areas east of the Nile have been identified as highly endemic, few trachoma surveys have been conducted in the remainder of the country. This study aimed to determine whether trachoma constitutes a problem to public health in Northern Bahr-el-Ghazal and Unity State, both located west of the Nile. Methods and Principal Findings: Trachoma rapid assessments (TRA) were conducted between July and September 2009. Seven villages in Northern Bahr-el-Ghazal State and 13 villages in Unity State were surveyed; an average of 50 children (age 1-9 years) and 44 women (age 15 years and above) were examined per village. Samples for analysis using the APTIMA Combo-2 nucleic acid amplification test (NAAT) were collected from participants with active trachoma in eight villages in Unity State. In Northern Bahr-el-Ghazal State, only three children with active trachoma (trachomatous inflammation follicular (TF) and/or trachomatous inflammation intense (TI)) and two women with trichiasis (TT) were found, in two of the seven villages surveyed. In Unity State, trachoma was endemic in all thirteen villages surveyed; the proportion of children with active trachoma ranged from 33% to 75% between villages, while TF in children ranged from 16% to 44%. Between 4% to 51% of examined women showed signs of TT. Samples from active trachoma cases tested using the NAAT were positive for Chlamydia trachomatis infection for 46.6% of children and 19.0% of women. Conclusions: Trachoma presents a major problem to public health Unity State, while the disease is of low priority in Northern-Bahr-el-Ghazal State. Implementation of a population-based prevalence survey is now required in Unity State to generate baseline prevalence data so that trachoma interventions can be initiated and monitored over time.	[Robinson, Emily; Ndyaba, Aggrey; Kolaczinski, Jan H.] Malaria Consortium, Africa Reg Off, Kampala, Uganda; [Kur, Lucia W.; Lado, Mounir] Govt So Sudan, Minist Hlth, Juba, Sudan; [Shafi, Juma; Kabare, Emmanuel] Univ Nairobi, Inst Trop & Infect Dis, Nairobi, Kenya; [McClelland, R. Scott] Univ Washington, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Kolaczinski, Jan H.] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England	University of Nairobi; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine	Kolaczinski, JH (corresponding author), Malaria Consortium, Africa Reg Off, Kampala, Uganda.	j.kolaczinski@malariaconsortium.org			UK Department for International Development (DFID)	UK Department for International Development (DFID)	The work presented here was funded by the UK Department for International Development (DFID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khatib T. K., 2006, Eastern Mediterranean Health Journal, V12, P566; Assefa T, 2001, TROP DOCT, V31, P202, DOI 10.1177/004947550103100406; Baral K, 1999, B WORLD HEALTH ORGAN, V77, P461; BOBO L, 1991, LANCET, V338, P847, DOI 10.1016/0140-6736(91)91502-L; Brooker S, 2009, PARASITOLOGY, V136, P1707, DOI 10.1017/S0031182009005940; Burton MJ, 2007, BRIT MED BULL, V84, P99, DOI 10.1093/bmb/ldm034; Clements ACA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000799; DESOLE G, 1987, BRIT J OPHTHALMOL, V71, P873, DOI 10.1136/bjo.71.11.873; Diamant J, 2001, Ophthalmic Epidemiol, V8, P109, DOI 10.1076/opep.8.2.109.4156; *GEN PROB INC, 2009, APTIMA COMBO 2 ASSAY; Khanduja S, 2009, OPHTHAL EPIDEMIOL, V16, P206, DOI [10.1080/09286580902999389, 10.3109/09286580902999389]; King JD, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000299; Kur LW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000492; Lansingh VC, 2007, SURV OPHTHALMOL, V52, P535, DOI 10.1016/j.survophthal.2007.06.007; Limburg H, 2001, Ophthalmic Epidemiol, V8, P73, DOI 10.1076/opep.8.2.73.4157; Liu HS, 2002, OPHTHALMIC EPIDEMIOL, V9, P97, DOI 10.1076/opep.9.2.97.1521; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Mathew AA, 2009, BRIT J OPHTHALMOL, V93, P866, DOI 10.1136/bjo.2008.151720; Mathew AA, 2009, DRUGS, V69, P953, DOI 10.2165/00003495-200969080-00002; Negrel A D, 1999, Community Eye Health, V12, P51; NEGREL AD, 2001, GUID RAP ASS BLIND T; Ngondi J, 2006, PLOS MED, V3, P2424, DOI 10.1371/journal.pmed.0030478; Ngondi J, 2007, AM J TROP MED HYG, V77, P126, DOI 10.4269/ajtmh.2007.77.126; Ngondi J, 2009, B WORLD HEALTH ORGAN, V87, P143, DOI 10.2471/BLT.07.046326; Paxton A, 2001, Ophthalmic Epidemiol, V8, P87; Polack S, 2005, B WORLD HEALTH ORGAN, V83, P913; Rabiu M M, 2001, Ophthalmic Epidemiol, V8, P263; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rumunu J, 2009, TRENDS PARASITOL, V25, P301, DOI 10.1016/j.pt.2009.03.011; Schachter J, 1999, LANCET, V354, P630, DOI 10.1016/S0140-6736(98)12387-5; SCHACHTER J, 2010, 110 GEN M AM SOC MIC; Solomon AW, 2008, NEW ENGL J MED, V358, P1870, DOI 10.1056/NEJMc0706263; Solomon AW, 2004, CLIN MICROBIOL REV, V17, P982, DOI 10.1128/CMR.17.4.982-1011.2004; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; VICKERY L, 2006, 106 GEN M AM SOC MIC; WHO, 1993, PRIM HLTH CAR LEV MA PRIM HLTH CAR LEV MA; World Health Organization London School of Hygiene and Tropical Medicine International Trachoma Inititative, 2006, TRACH GUID PROGR MAN; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Wright HR, 2005, BRIT J OPHTHALMOL, V89, P526, DOI 10.1136/bjo.2005.066183; Yang JL, 2007, BRIT J OPHTHALMOL, V91, P293, DOI 10.1136/bjo.2006.099150; Yang JL, 2009, INVEST OPHTH VIS SCI, V50, P90, DOI 10.1167/iovs.08-2247	41	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13138	10.1371/journal.pone.0013138	http://dx.doi.org/10.1371/journal.pone.0013138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957205	gold, Green Published			2022-12-27	WOS:000282359300027
J	Welzel, O; Tischbirek, CH; Jung, J; Kohler, EM; Svetlitchny, A; Henkel, AW; Kornhuber, J; Groemer, TW				Welzel, Oliver; Tischbirek, Carsten H.; Jung, Jasmin; Kohler, Eva M.; Svetlitchny, Alexei; Henkel, Andreas W.; Kornhuber, Johannes; Groemer, Teja W.			Synapse Clusters Are Preferentially Formed by Synapses with Large Recycling Pool Sizes	PLOS ONE			English	Article							NEUROTRANSMITTER RELEASE; NEURONAL NETWORKS; VESICLES; PROBABILITY; INCREASES; DYNAMICS; VISUALIZATION; INFORMATION; PROPAGATION; ENDOCYTOSIS	Synapses are distributed heterogeneously in neural networks. The relationship between the spatial arrangement of synapses and an individual synapse's structural and functional features remains to be elucidated. Here, we examined the influence of the number of adjacent synapses on individual synaptic recycling pool sizes. When measuring the discharge of the styryl dye FM1-43 from electrically stimulated synapses in rat hippocampal tissue cultures, a strong positive correlation between the number of neighbouring synapses and recycling vesicle pool sizes was observed. Accordingly, vesicle-rich synapses were found to preferentially reside next to neighbours with large recycling pool sizes. Although these synapses with large recycling pool sizes were rare, they were densely arranged and thus exhibited a high amount of release per volume. To consolidate these findings, functional terminals were marked by live-cell antibody staining with anti-synaptotagmin-1-cypHer or overexpression of synaptopHluorin. Analysis of synapse distributions in these systems confirmed the results obtained with FM 1-43. Our findings support the idea that clustering of synapses with large recycling pool sizes is a distinct developmental feature of newly formed neural networks and may contribute to functional plasticity.	[Welzel, Oliver; Tischbirek, Carsten H.; Jung, Jasmin; Kohler, Eva M.; Svetlitchny, Alexei; Henkel, Andreas W.; Kornhuber, Johannes; Groemer, Teja W.] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Erlangen Nuremberg	Welzel, O (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Erlangen, Germany.	teja.groemer@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014; Henkel, Andreas/E-9522-2011	Kornhuber, Johannes/0000-0002-8096-3987; Henkel, Andreas/0000-0002-2627-0215; Groemer, Teja/0000-0003-3854-716X; Wenzel, Eva Maria/0000-0002-5561-3344	Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN [PS-08.09.22.2]; Interdisciplinary Center of Clinical Research (IZKF) in Erlangen [J5]	Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN; Interdisciplinary Center of Clinical Research (IZKF) in Erlangen	This work was supported by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung ELAN Grant, PS-08.09.22.2, and by the Interdisciplinary Center of Clinical Research (IZKF) in Erlangen (Project J5), both to Teja W. Groemer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie EJ, 2002, BIOTECHNIQUES, V33, P1152, DOI 10.2144/02335dd10; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; Ahmadi S, 2003, SCIENCE, V300, P2094, DOI 10.1126/science.1083970; Aradi I, 2004, J NEUROSCI, V24, P9681, DOI 10.1523/JNEUROSCI.2800-04.2004; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Axmacher N, 2004, NEUROIMAGE, V22, P1014, DOI 10.1016/j.neuroimage.2004.02.009; Bak P, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.031912; Balaji J, 2007, P NATL ACAD SCI USA, V104, P20576, DOI 10.1073/pnas.0707574105; Beggs JM, 2003, J NEUROSCI, V23, P11167; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Branco T, 2008, NEURON, V59, P475, DOI 10.1016/j.neuron.2008.07.006; Branco T, 2009, NAT REV NEUROSCI, V10, P373, DOI 10.1038/nrn2634; Brewer GJ, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/1/014001; Chen X, 2008, J NEUROSCI, V28, P1894, DOI 10.1523/JNEUROSCI.4518-07.2008; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Cohen J.E., 1988, STAT POWER ANAL BEHA; Colicos MA, 2004, DEV NEUROSCI-BASEL, V26, P406, DOI 10.1159/000082283; Colicos MA, 2006, J EXP BIOL, V209, P2312, DOI 10.1242/jeb.02163; Darcy KJ, 2006, NAT NEUROSCI, V9, P315, DOI 10.1038/nn1640; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GRAY EG, 1959, J ANAT, V93, P420; Groemer TW, 2007, NAT NEUROSCI, V10, P145, DOI 10.1038/nn1831; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Kaiser M, 2004, NEUROCOMPUTING, V58, P297, DOI 10.1016/j.neucom.2004.01.059; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; Martens H, 2008, J NEUROSCI, V28, P13125, DOI 10.1523/JNEUROSCI.3887-08.2008; Masuda N, 2004, BIOL CYBERN, V90, P302, DOI 10.1007/s00422-004-0471-9; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Minerbi A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000136; Miralles F, 1996, J PHYSIOL-LONDON, V495, P717, DOI 10.1113/jphysiol.1996.sp021628; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Netoff TI, 2005, J NEUROPHYSIOL, V93, P1197, DOI 10.1152/jn.00982.2004; Prange O, 1999, J NEUROSCI, V19, P6427; Pyle JL, 1999, NEURON, V24, P803, DOI 10.1016/S0896-6273(00)81028-4; Reyes AD, 2003, NAT NEUROSCI, V6, P593, DOI 10.1038/nn1056; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Schikorski T, 1997, J NEUROSCI, V17, P5858; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Staras K, 2010, NEURON, V66, P37, DOI 10.1016/j.neuron.2010.03.020; STROEBEL A, 2010, MICROSCOPY RES TECHN; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498	66	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13514	10.1371/journal.pone.0013514	http://dx.doi.org/10.1371/journal.pone.0013514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976002	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400019
J	Zhao, JM; Li, CH; Chen, AQ; Li, LY; Su, XR; Li, TW				Zhao, Jianmin; Li, Chenghua; Chen, Aiqin; Li, Lingyun; Su, Xiurong; Li, Taiwu			Molecular Characterization of a Novel Big Defensin from Clam Venerupis philippinarum	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; GENE; EXPRESSION; FAMILY; PENAEIDINS; PROTEINS; MUSSELS; CRAB	Antimicrobial peptides (AMPs) are important mediators of the primary defense mechanism against microbial invasion. In the present study, a big defensin was identified from Venerupis philippinarum haemocytes (denoted as VpBD) by RACE and EST approaches. The VpBD cDNA contained an open reading frame (ORF) of 285 bp encoding a polypeptide of 94 amino acids. The deduce amino acid sequence of VpBD shared the common features of big defensin including disulfide array organization and helix structure, indicating that VpBD should be a new member of the big defensin family. The mRNA transcript of VpBD was up-regulated significantly during the first 24 hr after Vibrio anguillarum challenge, which was 7.4-fold increase compared to that of the control group. Then the expression decreased gradually from 24 hr to 96 hr, and the lowest expression level was detected at 96 hr post-infection, which was still 3.9-fold higher than that of control. The mature peptide of VpBD was recombined in Escherichia coli and purified for minimum inhibitory concentration (MIC) determination. The rVpBD displayed broad-spectrum inhibitory activity towards all tested bacteria with the highest activity against Staphyloccocus aureus and Pseudomonas putida. These results indicated that VpBD was involved in the host immune response against bacterial infection and might contribute to the clearance of invading bacteria.	[Zhao, Jianmin; Li, Chenghua; Chen, Aiqin] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China; [Li, Chenghua; Su, Xiurong; Li, Taiwu] Ningbo Univ, Fac Life Sci & Biotechnol, Ningbo, Peoples R China; [Li, Lingyun] NE Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China	Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Ningbo University; Northeast Agricultural University - China	Zhao, JM (corresponding author), Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Peoples R China.	chli@yic.ac.cn	Li, Chenghua/L-9825-2019	Li, Chenghua/0000-0003-2978-8762	Chinese Academy of Sciences [kzcx2-yw-225]; NSFC [30901115]	Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC))	The project was supported by Chinese Academy of Sciences Innovation Program (kzcx2-yw-225) and NSFC grant (No. 30901115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachere E, 2004, IMMUNOL REV, V198, P149, DOI 10.1111/j.0105-2896.2004.00115.x; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; De Zoysa M, 2010, FISH SHELLFISH IMMUN, V28, P261, DOI 10.1016/j.fsi.2009.11.005; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 1997, J BIOL CHEM, V272, P28398, DOI 10.1074/jbc.272.45.28398; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; HANDCOCK REW, 1999, ANTIMICROBIAL AGENTS, V43, P1317; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CH, 2009, MOLLUSCAN RES, V29, P17; Liu HP, 2006, J VIROL, V80, P10365, DOI 10.1128/JVI.01101-06; Mitta G, 2000, DEV COMP IMMUNOL, V24, P381, DOI 10.1016/S0145-305X(99)00084-1; Mitta G, 2000, FEBS LETT, V486, P185, DOI 10.1016/S0014-5793(00)02192-X; MOR A, 1994, EUR J BIOCHEM, V219, P145, DOI 10.1111/j.1432-1033.1994.tb19924.x; Mu CK, 2010, DEV COMP IMMUNOL, V34, P734, DOI 10.1016/j.dci.2010.02.001; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; SAITO T, 1995, J BIOCHEM-TOKYO, V117, P1131, DOI 10.1093/oxfordjournals.jbchem.a124818; Sitaram N, 2002, CURR PHARM DESIGN, V8, P727, DOI 10.2174/1381612023395358; Storici P, 1996, EUR J BIOCHEM, V238, P769, DOI 10.1111/j.1432-1033.1996.0769w.x; Supungul P, 2004, DIS AQUAT ORGAN, V61, P123, DOI 10.3354/dao061123; TERRAS FRG, 1993, FEBS LETT, V316, P233, DOI 10.1016/0014-5793(93)81299-F; Yu Y, 2009, FISH SHELLFISH IMMUN, V26, P492, DOI 10.1016/j.fsi.2009.02.005; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang G, 1999, CHINA FISH, V9, P34; Zhao JM, 2007, MOL IMMUNOL, V44, P360, DOI 10.1016/j.molimm.2006.02.025	27	63	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13480	10.1371/journal.pone.0013480	http://dx.doi.org/10.1371/journal.pone.0013480			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975988	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400009
J	Floyd, S; Molesworth, A; Dube, A; Banda, E; Jahn, A; Mwafulirwa, C; Ngwira, B; Branson, K; Crampin, AC; Zaba, B; Glynn, JR; French, N				Floyd, Sian; Molesworth, Anna; Dube, Albert; Banda, Emmanuel; Jahn, Andreas; Mwafulirwa, Charles; Ngwira, Bagrey; Branson, Keith; Crampin, Amelia C.; Zaba, Basia; Glynn, Judith R.; French, Neil			Population-Level Reduction in Adult Mortality after Extension of Free Anti-Retroviral Therapy Provision into Rural Areas in Northern Malawi	PLOS ONE			English	Article							RAPID SCALE-UP; SOUTH-AFRICA; FOLLOW-UP; TREATMENT PROGRAM; HIV; OUTCOMES; SERVICE; INDIVIDUALS; COMMUNITY	Background: Four studies from sub-Saharan Africa have found a substantial population-level effect of ART provision on adult mortality. It is important to see if the impact changes with time since the start of treatment scale-up, and as treatment moves to smaller clinics. Methods and Findings: During 2002-4 a demographic surveillance site (DSS) was established in Karonga district, northern Malawi. Information on births and deaths is collected monthly, with verbal autopsies conducted for all deaths; migrations are updated annually. We analysed mortality trends by comparing three time periods: pre-ART roll-out in the district (August 2002-June 2005), ART period 1 (July 2005-September 2006) when ART was available only in a town 70 km away, and ART period 2 (October 2006-September 2008), when ART was available at a clinic within the DSS area. HIV prevalence and ART uptake were estimated from a sero-survey conducted in 2007/2008. The all-cause mortality rate among 15-59 year olds was 10.2 per 1000 person-years in the pre-ART period (288 deaths/28285 person-years). It fell by 16% in ART period 1 and by 32% in ART period 2 (95% CI 18%-43%), compared with the pre-ART period. The AIDS mortality rate fell from 6.4 to 4.6 to 2.7 per 1000 person-years in the pre-ART period, period 1 and period 2 respectively (rate ratio for period 2 = 0.43, 95% CI 0.33-0.56). There was little change in non-AIDS mortality. Treatment coverage among individuals eligible to start ART was around 70% in 2008. Conclusions: ART can have a dramatic effect on mortality in a resource-constrained setting in Africa, at least in the early years of treatment provision. Our findings support the decentralised delivery of ART from peripheral health centres with unsophisticated facilities. Continued funding to maintain and further scale-up treatment provision will bring large benefits in terms of saving lives.	[Floyd, Sian; Molesworth, Anna; Jahn, Andreas; Ngwira, Bagrey; Branson, Keith; Crampin, Amelia C.; Zaba, Basia; Glynn, Judith R.; French, Neil] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Molesworth, Anna; Dube, Albert; Banda, Emmanuel; Mwafulirwa, Charles; Ngwira, Bagrey; Crampin, Amelia C.; French, Neil] Karonga Prevent Study, Chilumba, Karonga, Malawi	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit	Floyd, S (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England.	sian.floyd@lshtm.ac.uk	Jahn, Andreas/ABB-7796-2020; French, Neil/A-2994-2012	Jahn, Andreas/0000-0003-4645-1600; Crampin, Amelia/0000-0002-1513-4330; French, Neil/0000-0003-4814-8293; Dube, Albert/0000-0002-6392-0475	Wellcome Trust [079828/Z/06/Z]; Government of the Republic of Malawi	Wellcome Trust(Wellcome TrustEuropean Commission); Government of the Republic of Malawi	The study was funded by a Wellcome Trust Programme grant (number 079828/Z/06/Z), URL http://www.wellcome.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Government of the Republic of Malawi for their interest in and support of the Project and the National Health Sciences Research Committee of Malawi for permission to publish the paper.	Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Bassett IV, 2010, AIDS, V24, pS37, DOI 10.1097/01.aids.0000366081.91192.1c; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Crampin AC, 2003, AIDS, V17, P1817, DOI 10.1097/00002030-200308150-00011; Crampin AC, 2002, AIDS, V16, P1545, DOI 10.1097/00002030-200207260-00012; Fairall LR, 2008, ARCH INTERN MED, V168, P86, DOI 10.1001/archinternmed.2007.10; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Global Fund, 2010, GLOB FUND 2010 INN I; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; *INDEPTH NETW, 2003, INDEPTH STAND VERB A; Isingo R, 2007, AIDS, V21, pS5, DOI 10.1097/01.aids.0000299405.06658.a8; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; KAPLAN R, 2009, 5 INT AIDS SOC IAS C; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lowrance DW, 2008, JAIDS-J ACQ IMM DEF, V49, P287, DOI 10.1097/QAI.0b013e3181893ef0; Lowrance DW, 2009, JAIDS-J ACQ IMM DEF, V52, P49, DOI 10.1097/QAI.0b013e3181b03316; Massaquoi M, 2009, T ROY SOC TROP MED H, V103, P594, DOI 10.1016/j.trstmh.2009.02.012; McGrath N, 2007, AIDS, V21, pS105, DOI 10.1097/01.aids.0000299417.69432.65; *MIN HLTH ROM, 2006, GUID US ANT THER MAL; Mwagomba B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010452; *PEPFAR, 2010, MAK DIFF FUND; Reniers G, 2009, AIDS, V23, P511, DOI 10.1097/QAD.0b013e32832403d0; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; TENTHANI L, 2009, 5 INT AIDS SOC IAS C; UNAIDS/WHO, AIDS EP UPD; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, RAP ADV ANT THER HIV; Zaba B, 2007, AIDS, V21, pS87, DOI 10.1097/01.aids.0000299415.67646.26; Zachariah R, 2009, T ROY SOC TROP MED H, V103, P549, DOI 10.1016/j.trstmh.2008.09.019; Zwahlen M, 2008, SEX TRANSM INFECT, V84, pI31, DOI 10.1136/sti.2008.029793	36	53	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13499	10.1371/journal.pone.0013499	http://dx.doi.org/10.1371/journal.pone.0013499			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976068	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000283114700019
J	Massey, AJ; Borgognoni, J; Bentley, C; Foloppe, N; Fiumana, A; Walmsley, L				Massey, Andrew J.; Borgognoni, Jenifer; Bentley, Carol; Foloppe, Nicolas; Fiumana, Andrea; Walmsley, Lee			Context-Dependent Cell Cycle Checkpoint Abrogation by a Novel Kinase Inhibitor	PLOS ONE			English	Article							DNA-DAMAGE CHECKPOINT; AURORA KINASES; CANCER; CHK1; PF-00477736; THERAPIES; TARGETS	Background: Checkpoint kinase 1 and 2 (Chk1/Chk2), and the Aurora kinases play a critical role in the activation of the DNA damage response and mitotic spindle checkpoints. We have identified a novel inhibitor of these kinases and utilized this molecule to probe the functional interplay between these two checkpoints. Principal Findings: Fragment screening, structure guided design, and kinase cross screening resulted in the identification of a novel, potent small molecule kinase inhibitor (VER-150548) of Chk1 and Chk2 kinases with IC(50)s of 35 and 34 nM as well as the Aurora A and Aurora B kinases with IC(50)s of 101 and 38 nM. The structural rationale for this kinase specificity could be clearly elucidated through the X-ray crystal structure. In human carcinoma cells, VER-150548 induced reduplication and the accumulation of cells with >4N DNA content, inhibited histone H3 phosphorylation and ultimately gave way to cell death after 120 hour exposure; a phenotype consistent with cellular Aurora inhibition. In the presence of DNA damage induced by cytotoxic chemotherapeutic drugs, VER-150548 abrogated DNA damage induced cell cycle checkpoints. Abrogation of these checkpoints correlated with increased DNA damage and rapid cell death in p53 defective HT29 cells. In the presence of DNA damage, reduplication could not be observed. These observations are consistent with the Chk1 and Chk2 inhibitory activity of this molecule. Conclusions: In the presence of DNA damage, we suggest that VER-150548 abrogates the DNA damage induced checkpoints forcing cells to undergo a lethal mitosis. The timing of this premature cell death induced by Chk1 inhibition negates Aurora inhibition thereby preventing re-entry into the cell cycle and subsequent DNA reduplication. This novel kinase inhibitor therefore serves as a useful chemical probe to further understand the temporal relationship between cell cycle checkpoint pathways, chemotherapeutic agent induced DNA damage and cell death.	[Massey, Andrew J.; Borgognoni, Jenifer; Bentley, Carol; Foloppe, Nicolas; Fiumana, Andrea; Walmsley, Lee] Vernalis R&D Ltd, Cambridge, England	Vernalis	Massey, AJ (corresponding author), Vernalis R&D Ltd, Granta Pk, Cambridge, England.	a.massey@vernalis.com	Massey, Andrew J./H-6954-2019	Massey, Andrew J./0000-0002-0276-2573; Walmsley, Lee/0000-0001-8471-5895				Ashwell S, 2008, EXPERT OPIN INV DRUG, V17, P1331, DOI [10.1517/13543784.17.9.1331, 10.1517/13543784.17.9.1331 ]; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bebbington D, 2009, BIOORG MED CHEM LETT, V19, P3586, DOI 10.1016/j.bmcl.2009.04.136; Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Blasina A, 2008, MOL CANCER THER, V7, P2394, DOI 10.1158/1535-7163.MCT-07-2391; Bucher N, 2008, BRIT J CANCER, V98, P523, DOI 10.1038/sj.bjc.6604208; Carvajal RD, 2006, CLIN CANCER RES, V12, P6869, DOI 10.1158/1078-0432.CCR-06-1405; Cheung CHA, 2009, EXPERT OPIN INV DRUG, V18, P379, DOI [10.1517/13543780902806392 , 10.1517/13543780902806392]; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Foloppe N, 2005, J MED CHEM, V48, P4332, DOI 10.1021/jm049022c; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Liu QH, 2000, GENE DEV, V14, P1448; Marumoto T, 2005, NAT REV CANCER, V5, P42, DOI 10.1038/nrc1526; Marumoto T, 2003, J BIOL CHEM, V278, P51786, DOI 10.1074/jbc.M306275200; Matthews DJ, 2007, CELL CYCLE, V6, P104, DOI 10.4161/cc.6.1.3699; O'Connor MJ, 2007, ONCOGENE, V26, P7816, DOI 10.1038/sj.onc.1210879; Pascreau Gaetan, 2003, Prog Cell Cycle Res, V5, P369; Scharer CD, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-79; Vader G, 2008, BBA-REV CANCER, V1786, P60, DOI 10.1016/j.bbcan.2008.07.003; VanderPorten EC, 2009, MOL CANCER THER, V8, P930, DOI 10.1158/1535-7163.MCT-08-0754; Zabludoff SD, 2008, MOL CANCER THER, V7, P2955, DOI 10.1158/1535-7163.MCT-08-0492; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; Zhang C, 2009, CLIN CANCER RES, V15, P4630, DOI 10.1158/1078-0432.CCR-08-3272; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	27	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13123	10.1371/journal.pone.0013123	http://dx.doi.org/10.1371/journal.pone.0013123			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976184	gold, Green Published, Green Submitted			2022-12-27	WOS:000283045300002
J	Yang, YJ; Yao, HH; Lu, YM; Wang, C; Buch, S				Yang, Yanjing; Yao, Honghong; Lu, Yaman; Wang, Chao; Buch, Shilpa			Cocaine Potentiates Astrocyte Toxicity Mediated by Human Immunodeficiency Virus (HIV-1) Protein gp120	PLOS ONE			English	Article							OXIDATIVE STRESS; CYTOCHROME-C; IN-VITRO; INFECTION; APOPTOSIS; BRAIN; ACTIVATION; DEGENERATION; MITOCHONDRIA; CULTURES	It is becoming widely accepted that psychoactive drugs, often abused by HIV-I infected individuals, can significantly alter the progression of neuropathological changes observed in HIV-associated neurodegenerative diseases (HAND). The underlying mechanisms mediating these effects however, remain poorly understood. In the current study, we explored whether the psychostimulant drug cocaine could exacerbate toxicity mediated by gp120 in rat primary astrocytes. Exposure to both cocaine and gp120 resulted in increased cell toxicity compared to cells treated with either factor alone. The combinatorial toxicity of cocaine and gp120 was accompanied by an increase in caspase-3 activation. In addition, increased apoptosis of astrocytes in the presence of both the agents was associated with a concomitant increase in the production of intracellular reactive oxygen species and loss of mitochondrial membrane potential. Signaling pathways including c-jun N-teminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear factor (NF-kappa B) were identified to be major players in cocaine and gp120-mediated apoptosis of astrocytes. Our results demonstrated that cocaine-mediated potentiation of gp120 toxicity involved regulation of oxidative stress, mitochondrial membrane potential and MAPK signaling pathways.	[Yang, Yanjing; Yao, Honghong; Lu, Yaman; Wang, Chao; Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Yang, YJ (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.	sbuch@unmc.edu		Buch, Shilpa/0000-0002-3103-6685	National Institutes of Health [MH-068212, DA020392, DA024442]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261, R01MH068212] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020392, R01DA024442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants MH-068212, DA020392 and DA024442 from the National Institutes of Health (SB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksenov MY, 2006, NEUROTOXICOLOGY, V27, P217, DOI 10.1016/j.neuro.2005.10.003; Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Andersson S, 2000, SOIL BIOL BIOCHEM, V32, P1, DOI 10.1016/S0038-0717(99)00103-0; Barbin G, 2001, NEUROCHEM RES, V26, P107, DOI 10.1023/A:1011086426652; Benjelloun N, 1998, CELL MOL BIOL, V44, P579; Bodner A, 2004, EXP NEUROL, V188, P246, DOI 10.1016/j.expneurol.2004.04.009; BRENNEMAN DE, 1988, NATURE, V335, P639, DOI 10.1038/335639a0; Busciglio J, 2002, NEURON, V33, P677, DOI 10.1016/S0896-6273(02)00604-9; Chen YM, 2001, J NEUROCHEM, V77, P1601, DOI 10.1046/j.1471-4159.2001.00374.x; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Cysique LA, 2009, NEUROPSYCHOL REV, V19, P169, DOI 10.1007/s11065-009-9092-3; Dent P, 2003, RADIAT RES, V159, P283, DOI 10.1667/0033-7587(2003)159[0283:SARIAO]2.0.CO;2; Franz G, 2002, J CEREBR BLOOD F MET, V22, P951, DOI 10.1097/00004647-200208000-00006; Gray F, 2001, CLIN NEUROPATHOL, V20, P146; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gurwell JA, 2001, NEUROSCIENCE, V102, P555, DOI 10.1016/S0306-4522(00)00461-9; HAMPRECHT B, 1985, METHOD ENZYMOL, V109, P341; Jiao HY, 2007, J NEUROCHEM, V103, P840, DOI 10.1111/j.1471-4159.2007.04840.x; Kalasinsky KS, 2000, J FORENSIC SCI, V45, P1041; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; LEE SC, 1993, ANN NY ACAD SCI, V693, P314, DOI 10.1111/j.1749-6632.1993.tb26295.x; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Mazzanti M, 2001, NEUROSCIENTIST, V7, P396, DOI 10.1177/107385840100700509; Peng FW, 2008, EUR J NEUROSCI, V28, P1255, DOI 10.1111/j.1460-9568.2008.06444.x; Peng FW, 2008, J NEUROVIROL, V14, P62, DOI 10.1080/13550280701809084; PETITO CK, 1995, AM J PATHOL, V146, P1121; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; RYCHERT J, 2010, AIDS RES HUM RETROVI; Sabri F, 2003, BRAIN PATHOL, V13, P84, DOI 10.1111/j.1750-3639.2003.tb00009.x; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Simard M, 2004, NEUROSCIENCE, V129, P877, DOI 10.1016/j.neuroscience.2004.09.053; Stephens BG, 2004, AM J FOREN MED PATH, V25, P1, DOI 10.1097/01.paf.0000118960.58334.a9; Stewart VC, 1998, J NEUROCHEM, V70, P432; Subramaniam S, 2004, J CELL BIOL, V165, P357, DOI 10.1083/jcb.200403028; Szydlowska K, 2006, J NEUROCHEM, V99, P965, DOI 10.1111/j.1471-4159.2006.04136.x; Takahashi K, 1996, ANN NEUROL, V39, P705, DOI 10.1002/ana.410390606; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thompson KA, 2001, ANN NEUROL, V49, P745, DOI 10.1002/ana.1011; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; Turchan J, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-3; VANDYKE C, 1976, SCIENCE, V191, P859, DOI 10.1126/science.56036; Visalli V, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-106; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375	50	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13427	10.1371/journal.pone.0013427	http://dx.doi.org/10.1371/journal.pone.0013427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976166	gold, Green Submitted, Green Published			2022-12-27	WOS:000283043700019
J	Teng, HJ; Cai, WS; Zhou, LL; Zhang, J; Liu, Q; Wang, YQ; Dai, W; Zhao, M; Sun, ZS				Teng, Huajing; Cai, Wanshi; Zhou, LingLin; Zhang, Jing; Liu, Qi; Wang, Yongqing; Dai, Wei; Zhao, Mei; Sun, Zhongsheng			Evolutionary Mode and Functional Divergence of Vertebrate NMDA Receptor Subunit 2 Genes	PLOS ONE			English	Article							WHOLE-GENOME DUPLICATION; EVENTS; MEMORY; DISRUPTION; DIVERSITY; REVEALS; DOMAIN; BRAIN; SITE; LTD	Background: Ionotropic glutamate receptors in the central nervous system play a major role in numerous brain functions including learning and memory in many vertebrate species. NR2 subunits have been regarded as rate-limiting molecules in controlling the optimal N-methyl-D-aspartate (NMDA) receptor's coincidence-detection property and subsequent learning and memory function across multi-species. However, its evolutionary mode among vertebrate species remains unclear. Results: With extensive analysis of phylogeny, exon structure, protein domain, paralogon and synteny, we demonstrated that two-round genome duplication generated quartet GRIN2 genes and the third-round fish-specific genome duplication generated extra copies of fish GRIN2 genes. In addition, in-depth investigation has enabled the identification of three novel genes, GRIN2C_Gg, GRIN2D-1_Ol and GRIN2D-2_Tr in the chicken, medaka and fugu genome, respectively. Furthermore, we showed functional divergence of NR2 genes mostly occurred at the first-round duplication, amino acid residues located at the N-terminal Lig_chan domain were responsible for type I functional divergence between these GRIN2 subfamilies and purifying selection has been the prominent natural pressure operating on these diversified GRIN2 genes. Conclusion and Significance: These findings provide intriguing subjects for testing the 2R and 3R hypothesis and we expect it could provide new insights into the underlying evolution mechanisms of cognition in vertebrate.	[Teng, Huajing; Zhang, Jing; Wang, Yongqing; Dai, Wei; Zhao, Mei; Sun, Zhongsheng] Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China; [Cai, Wanshi; Zhou, LingLin; Liu, Qi] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Wenzhou Medical University	Teng, HJ (corresponding author), Chinese Acad Sci, Inst Psychol, Behav Genet Ctr, Beijing 100101, Peoples R China.	sunzs@psych.ac.cn	Sun, Zhongsheng/AAS-4883-2020; Huajing, Teng/AAF-4040-2020	Sun, Zhongsheng/0000-0002-7640-5026; Huajing, Teng/0000-0001-9952-3618	Chinese Academy of Sciences [KSCX2-YW-R-38]; Major State Basic Research Development Program of China [2007CB512302]; National High Technology Research and Development Program of China [2006AA02A304]; National Natural Science Foundation of China [30770786]	Chinese Academy of Sciences(Chinese Academy of Sciences); Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the Knowledge Innovation Project of The Chinese Academy of Sciences (KSCX2-YW-R-38), Major State Basic Research Development Program of China (2007CB512302), National High Technology Research and Development Program of China (2006AA02A304) and National Natural Science Foundation of China (30770786). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burrell BD, 2001, CURR OPIN NEUROBIOL, V11, P757, DOI 10.1016/S0959-4388(01)00281-1; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Ebralidze AK, 1996, J NEUROSCI, V16, P5014; FALLS WA, 1992, J NEUROSCI, V12, P854; Finn RN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000169; Frazer KA, 2003, GENOME RES, V13, P1, DOI 10.1101/gr.222003; Friedman R, 2003, MOL BIOL EVOL, V20, P154, DOI 10.1093/molbev/msg017; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; HALDANE J. B. S., 1932; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holland PWH, 1999, SEMIN CELL DEV BIOL, V10, P541, DOI 10.1006/scdb.1999.0335; Ito H, 2007, BRAIN BEHAV EVOLUT, V69, P76, DOI 10.1159/000095196; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niethammer M, 1996, J NEUROSCI, V16, P2157; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; OHNO S., 1970, Evolution by gene duplication.; Ohno S, 1999, SEMIN CELL DEV BIOL, V10, P517, DOI 10.1006/scdb.1999.0332; OHTA T, 1989, GENOME, V31, P304, DOI 10.1139/g89-048; Olinski RP, 2006, MOL BIOL EVOL, V23, P10, DOI 10.1093/molbev/msj002; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Ryan TJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-6; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; STERN P, 1992, P ROY SOC B-BIOL SCI, V250, P271, DOI 10.1098/rspb.1992.0159; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; von Schantz M, 2006, J MOL EVOL, V62, P701, DOI 10.1007/s00239-005-0185-1; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2008, GENOME, V51, P222, DOI 10.1139/G07-098; Wang W, 2007, MOL BIOL EVOL, V24, P784, DOI 10.1093/molbev/msl205; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305; Yang ZH, 2002, MOL BIOL EVOL, V19, P49, DOI 10.1093/oxfordjournals.molbev.a003981	53	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13342	10.1371/journal.pone.0013342	http://dx.doi.org/10.1371/journal.pone.0013342			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976280	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000004
J	Lehner, F; Kulik, U; Klempnauer, J; Borlak, J				Lehner, Frank; Kulik, Ulf; Klempnauer, Juergen; Borlak, Juergen			Inhibition of the Liver Enriched Protein FOXA2 Recovers HNF6 Activity in Human Colon Carcinoma and Liver Hepatoma Cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; C/EBP-ALPHA; HEPATOCELLULAR-CARCINOMA; EXPRESSION; COACTIVATOR; BINDING; HEPG2	Recently, we demonstrated that the transcription factors HNF6 and FOXA2 function as key regulators in human colorectal liver metastases. To better understand their proposed inhibitory crosstalk, the consequences of functional knockdown of FOXA2 on HNF6 and C/EBP alpha activity were investigated in the human colon Caco-2 and HepG2 carcinoma cell lines. Specifically, siRNA-mediated gene silencing of FOXA2 repressed transcript expression by >80%. This resulted in a statistically significant 6-, 3-, 4-, and 8-fold increase in mRNA expression of HNF6 and of genes targeted by this transcription factor, e.g., HSP105B, CYP51, and C/EBP alpha, as determined by qRT-PCR. Thus, functional knockdown of FOXA2 recovered HNF6 activity. Furthermore, with nuclear extracts of Caco-2 cells no HNF6 DNA binding was observed, but expression of HNF1 alpha, FOXA2, FOXA3, and HNF4 alpha protein was abundant. We therefore transfected a plasmid encoding HNF6 into Caco-2 cells but also employed a retroviral vector to transfect HNF6 into HepG2 cells. This resulted in HNF6 protein expression with DNA binding activity being recovered as determined by EMSA band shift assays. Furthermore, by flow cytometry the consequences of HNF6 expression on cell cycle regulation in transfected cells was studied. Essentially, HNF6 inhibited cell cycle progression in the G2/M and G1 phase in Caco-2 and HepG2 cell lines, respectively. Here, proliferation was reduced by 80% and 50% in Caco-2 and HepG2 cells, respectively, as determined by the BrdU labeling assay. Therefore functional knockdown of FOXA2 recovered HNF6 activity and inhibited growth of tumor-cells and may possibly represent a novel therapeutic target in primary and secondary liver malignancies.	[Lehner, Frank; Kulik, Ulf; Klempnauer, Juergen] Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, D-3000 Hannover, Germany; [Borlak, Juergen] Fraunhofer Inst Toxicol & Expt Med, Hannover, Germany; [Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, D-3000 Hannover, Germany	Hannover Medical School; Fraunhofer Gesellschaft; Hannover Medical School	Lehner, F (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplantat Surg, D-3000 Hannover, Germany.	juergen.borlak@item.fraunhofer.de			Ministry of Science and Culture, Lower Saxony, Germany [25A.5-76251-99-3/00]	Ministry of Science and Culture, Lower Saxony, Germany	The work was funded by Ministry of Science and Culture, Lower Saxony, Germany; Grant number: 25A.5-76251-99-3/00 to Juergen Borlak. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berrino F, 2007, LANCET ONCOL, V8, P773, DOI 10.1016/S1470-2045(07)70245-0; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kishimoto T, 1998, CELL GROWTH DIFFER, V9, P337; Lampen A, 1998, XENOBIOTICA, V28, P429, DOI 10.1080/004982598239362; Lehner F, 2007, FASEB J, V21, P1445, DOI 10.1096/fj.06-6575com; Lehner F, 2010, WORLD J GASTROENTERO, V16, P3919, DOI 10.3748/wjg.v16.i31.3919; Niehof M, 2001, J BIOL CHEM, V276, P9016, DOI 10.1074/jbc.M009284200; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Poll AV, 2006, DIABETES, V55, P61; Rausa FM, 2004, J BIOL CHEM, V279, P43070, DOI 10.1074/jbc.M407472200; Rausa FM, 2003, MOL CELL BIOL, V23, P437, DOI 10.1128/MCB.23.2.437-449.2003; Rubins NE, 2005, MOL CELL BIOL, V25, P7069, DOI 10.1128/MCB.25.16.7069-7077.2005; Slomiany BA, 2000, MOL CELL BIOL, V20, P5986, DOI 10.1128/MCB.20.16.5986-5997.2000; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wilkening S, 2003, DRUG METAB DISPOS, V31, P1035, DOI 10.1124/dmd.31.8.1035; Xu L, 2001, CANCER RES, V61, P3176; Yoshida Y, 2006, HEPATOLOGY, V43, P276, DOI 10.1002/hep.21044	22	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13344	10.1371/journal.pone.0013344	http://dx.doi.org/10.1371/journal.pone.0013344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967225	Green Published, gold			2022-12-27	WOS:000282869800034
J	Park, HK; Wang, H; Zhang, J; Datta, S; Fei, PW				Park, Hwan Ki; Wang, Hong; Zhang, Jun; Datta, Suvamoy; Fei, Peiwen			Convergence of Rad6/Rad18 and Fanconi Anemia Tumor Suppressor Pathways upon DNA Damage	PLOS ONE			English	Article							HUMAN-CELLS; XERODERMA-PIGMENTOSUM; TRANSLESION SYNTHESIS; RESPONSE NETWORK; UBIQUITIN LIGASE; POLYMERASE ETA; BRCA PROTEINS; REPAIR; RAD6; SPECIFICITY	Extremely high cancer incidence associated with patients with Fanconi anemia (FA) suggests the importance of the FA signaling pathway in the suppression of non-FA human tumor development. Indeed, we found that an impaired FA signaling pathway substantially contributes to the development of non-FA human tumors. However, the mechanisms underlying the function of the FA pathway remain less understood. Using RNA interfering approach in combining with cell proliferation and reporter assays, we showed that the function of FA signaling pathway is at least partly mediated through coupling with hRad6/hRad18 signaling (HHR6 pathway). We previously reported that FANCD2 monoubiquitination, a hallmark of the FA pathway activation, can be regulated by HHR6. Here we found that hRad18 can also regulate activation of the FA pathway. More importantly, we found that FANCD2 is capable of modulating activity of DNA translesion synthesis polymerase eta, an effector of HHR6 pathway. These results provide novel insights into how the FA pathway is intertwined with HHR6 pathway to maintain chromosomal stability and suppress the development of human cancer, representing an important conceptual advance in the field of FA cancer research.	[Park, Hwan Ki; Datta, Suvamoy; Fei, Peiwen] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Wang, Hong; Zhang, Jun] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA	University of Minnesota System; Mayo Clinic	Park, HK (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	pfei@hi.umn.edu			National Institutes of Health [CA136532]; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Hormel Institute, University of Minnesota, Austin, Minnesota; NATIONAL CANCER INSTITUTE [R01CA136532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota; Hormel Institute, University of Minnesota, Austin, Minnesota(University of Minnesota System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study is partly supported by National Institutes of Health grant CA136532 to PF, and is also partly supported by the Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, and the Hormel Institute, University of Minnesota, Austin, Minnesota. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avkin S, 2004, J BIOL CHEM, V279, P53298, DOI 10.1074/jbc.M409155200; Avkin S, 2002, MUTAT RES-FUND MOL M, V510, P81, DOI 10.1016/S0027-5107(02)00254-3; Bagby GC, 2003, CURR OPIN HEMATOL, V10, P68, DOI 10.1097/00062752-200301000-00011; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Bilsland E, 2005, MUTAGENESIS, V20, P153, DOI 10.1093/mutage/gei031; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fei PW, 2005, CELL CYCLE, V4, P80, DOI 10.4161/cc.4.1.1358; Garg P, 2005, P NATL ACAD SCI USA, V102, P18361, DOI 10.1073/pnas.0505949102; HEJNA J, CELL BIOL INT; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Karras G.I., CELL, V141, P255; Kee Y, GENES DEV, V24, P1680; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; MEINDL A, NAT GENET, V42, P410; PACE P, SCIENCE; Plosky BS, 2004, CURR OPIN GENET DEV, V14, P113, DOI 10.1016/j.gde.2004.02.002; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; SWIFT M, 1971, NATURE, V230, P370, DOI 10.1038/230370a0; Taniguchi T, 2002, CELL, V109, P459, DOI 10.1016/S0092-8674(02)00747-X; Ulrich HD, 2001, NUCLEIC ACIDS RES, V29, P3487, DOI 10.1093/nar/29.17.3487; VAZ F, NAT GENET, V42, P406; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhang J, 2008, CELL CYCLE, V7, P407, DOI 10.4161/cc.7.3.5156; Zhang J, 2006, CANCER BIOL THER, V5, P1632, DOI 10.4161/cbt.5.12.3351; Zhang J, 2010, J CLIN INVEST, V120, P1524, DOI 10.1172/JCI40908	35	31	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13313	10.1371/journal.pone.0013313	http://dx.doi.org/10.1371/journal.pone.0013313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967207	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800018
J	Regueiro, BJ; Varela-Ledo, E; Martinez-Lamas, L; Rodriguez-Calvino, J; Aguilera, A; Santos, A; Gomez-Tato, A; Alvarez-Escudero, J				Regueiro, Benito J.; Varela-Ledo, Eduardo; Martinez-Lamas, Lucia; Rodriguez-Calvino, Javier; Aguilera, Antonio; Santos, Antonio; Gomez-Tato, Antonio; Alvarez-Escudero, Julian			Automated Extraction Improves Multiplex Molecular Detection of Infection in Septic Patients	PLOS ONE			English	Article							INADEQUATE ANTIMICROBIAL TREATMENT; POLYMERASE-CHAIN-REACTION; PCR ASSAY; SEPSIS; DIAGNOSIS; THERAPY; PNEUMONIA; MORTALITY; ICU	Sepsis is one of the leading causes of morbidity and mortality in hospitalized patients worldwide. Molecular technologies for rapid detection of microorganisms in patients with sepsis have only recently become available. LightCycler SeptiFast test M-grade (Roche Diagnostics GmbH) is a multiplex PCR analysis able to detect DNA of the 25 most frequent pathogens in bloodstream infections. The time and labor saved while avoiding excessive laboratory manipulation is the rationale for selecting the automated MagNA Pure compact nucleic acid isolation kit-I (Roche Applied Science, GmbH) as an alternative to conventional SeptiFast extraction. For the purposes of this study, we evaluate extraction in order to demonstrate the feasibility of automation. Finally, a prospective observational study was done using 106 clinical samples obtained from 76 patients in our ICU. Both extraction methods were used in parallel to test the samples. When molecular detection test results using both manual and automated extraction were compared with the data from blood cultures obtained at the same time, the results show that SeptiFast with the alternative MagNA Pure compact extraction not only shortens the complete workflow to 3.57 hrs., but also increases sensitivity of the molecular assay for detecting infection as defined by positive blood culture confirmation.	[Regueiro, Benito J.; Varela-Ledo, Eduardo; Martinez-Lamas, Lucia; Rodriguez-Calvino, Javier; Aguilera, Antonio] Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain; [Santos, Antonio] Complejo Hosp Univ Santiago, Dept Intens Care, Hosp Conxo, Santiago De Compostela, Spain; [Gomez-Tato, Antonio] Univ Santiago, Sch Math, Santiago De Compostela, Spain; [Alvarez-Escudero, Julian] Complejo Hosp Univ Santiago, Dept Anesthesiol, Santiago De Compostela, Spain	Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Regueiro, BJ (corresponding author), Complejo Hosp Univ Santiago, Dept Clin Microbiol, Santiago De Compostela, Spain.	benito.regueiro@usc.es	Regueiro, Benito/H-4264-2014; Tato, Antonio Gómez/N-3202-2013; Julian, Alvarez/D-5716-2011; Aguilera, Antonio/L-6586-2018	Regueiro, Benito/0000-0002-4009-7922; Tato, Antonio Gómez/0000-0003-2465-3500; Julian, Alvarez/0000-0001-6806-6944; Aguilera, Antonio/0000-0001-6940-241X; Rodriguez Calvino, Jose Javier/0000-0003-2358-7468; Alvarez, Julian/0000-0002-2518-0891	Spanish Ministerio de Ciencia e Innovacion [MAT2008-06503]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was partially supported by the Spanish Ministerio de Ciencia e Innovacion (MAT2008-06503) which supported Javier Rodriguez Calvino's fellowship.	Abe Al-Soud W, 2000, J CLIN MICROBIOL, V38, P4463; Abu Al-Soud W, 2000, J CLIN MICROBIOL, V38, P345; Abu al-Soud W, 2001, J CLIN MICROBIOL, V39, P485, DOI 10.1128/JCM.39.2.485-493.2001; ALVAREZ M, 2008, 18 ECCMID 26 ICC 200, pS578; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Baron RM, 2006, AM J RESP CELL MOL, V34, P129, DOI 10.1165/rcmb.F308; CASALTA JP, 2008, EUR J CLIN MICROBIOL; Celard M., 2008, Annales de Cardiologie et d'Angeiologie, V57, P78, DOI 10.1016/j.ancard.2008.02.007; Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jahan Ali, 2006, Cleve Clin J Med, V73 Suppl 1, pS67; Kollef MH, 2006, NEW ENGL J MED, V355, P2691, DOI 10.1056/NEJMe068231; Kollef MH, 2006, AM J RESP CRIT CARE, V173, P1182, DOI 10.1164/rccm.2603004; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Kumar S, 2008, J CLIN MICROBIOL, V46, P3063, DOI 10.1128/JCM.00625-08; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Lehmann LE, 2009, CRIT CARE MED, V37, P3085, DOI 10.1097/CCM.0b013e3181b033d7; Louie RF, 2008, CRIT CARE MED, V36, P1487, DOI 10.1097/CCM.0b013e31816f487c; Mancini N, 2008, J MED MICROBIOL, V57, P601, DOI 10.1099/jmm.0.47732-0; Miller DN, 1999, APPL ENVIRON MICROB, V65, P4715; Morata P, 1998, J CLIN MICROBIOL, V36, P2443, DOI 10.1128/JCM.36.9.2443-2446.1998; Mussap M, 2007, J Chemother, V19 Suppl 2, P31; REGUEIRO B, 2008, SEPS 2008 GRAN CR S5, V12, pS5; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schrenzel J, 2007, INT J ANTIMICROB AG, V30, pS2, DOI 10.1016/j.ijantimicag.2007.06.030; Stormer M, 2007, CLIN CHEM, V53, P104, DOI 10.1373/clinchem.2006.070987; Uhl JR, 2003, J CLIN MICROBIOL, V41, P242, DOI 10.1128/JCM.41.1.242-249.2003; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0	30	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13387	10.1371/journal.pone.0013387	http://dx.doi.org/10.1371/journal.pone.0013387			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967222	Green Submitted, gold, Green Published			2022-12-27	WOS:000282869800048
J	Sommerlad, S; Mcrae, AF; McDonald, B; Johnstone, I; Cuttell, L; Seddon, JM; O'Leary, CA				Sommerlad, Susan; McRae, Allan F.; McDonald, Brenda; Johnstone, Isobel; Cuttell, Leigh; Seddon, Jennifer M.; O'Leary, Caroline A.			Congenital Sensorineural Deafness in Australian Stumpy-Tail Cattle Dogs Is an Autosomal Recessive Trait That Maps to CFA10	PLOS ONE			English	Article							AUDITORY-EVOKED RESPONSE; CLINICALLY NORMAL DOG; SEGREGATION ANALYSIS; TRANSCRIPTION-FACTOR; BILATERAL DEAFNESS; MODEL ANALYSIS; COAT COLOR; PIGMENTATION; LINKAGE; ASSOCIATIONS	Background: Congenital sensorineural deafness is an inherited condition found in many dog breeds, including Australian Stumpy-tail Cattle Dogs (ASCD). This deafness is evident in young pups and may affect one ear (unilateral) or both ears (bilateral). The genetic locus/loci involved is unknown for all dog breeds. The aims of this study were to determine incidence, inheritance mechanism, and possible association of congenital sensorineural deafness with coat colour in ASCD and to identify the genetic locus underpinning this disease. Methodology/Principal Findings: A total of 315 ASCD were tested for sensorineural deafness using the brain stem auditory evoked response (BAER) test. Disease penetrance was estimated directly, using the ratio of unilaterally to bilaterally deaf dogs, and segregation analysis was performed using Mendel. A complete genome screen was undertaken using 325 microsatellites spread throughout the genome, on a pedigree of 50 BAER tested ASCD in which deafness was segregating. Fifty-six dogs (17.8%) were deaf, with 17 bilaterally and 39 unilaterally deaf. Unilaterally deaf dogs showed no significant left/right bias (p = 0.19) and no significant difference was observed in frequencies between the sexes (p = 0.18). Penetrance of deafness was estimated as 0.72. Testing the association of red/blue coat colour and deafness without accounting for pedigree structure showed that red dogs were 1.8 times more likely to be deaf (p = 0.045). The within family association between red/blue coat colour and deafness was strongly significant (p = 0.00036), with red coat colour segregating more frequently with deafness (COR = 0.48). The relationship between deafness and coat speckling approached significance (p = 0.07), with the lack of statistical significance possibly due to only four families co-segregating for both deafness and speckling. The deafness phenotype was mapped to CFA10 (maximum linkage peak on CFA10 -log 10 p-value = 3.64), as was both coat colour and speckling. Fine mapping was then performed on 45 of these 50 dogs and a further 48 dogs (n = 93). Sequencing candidate gene Sox10 in 6 hearing ASCD, 2 unilaterally deaf ASCD and 2 bilaterally deaf ASCD did not reveal any disease-associated mutations. Conclusions: Deafness in ASCD is an incompletely penetrant autosomal recessive inherited disease that maps to CFA10.	[Sommerlad, Susan; McDonald, Brenda; Johnstone, Isobel; Cuttell, Leigh; Seddon, Jennifer M.] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia; [O'Leary, Caroline A.] Univ Queensland, Ctr Compan Anim Hlth, Brisbane, Qld, Australia; [McRae, Allan F.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia	University of Queensland; University of Queensland; QIMR Berghofer Medical Research Institute	Sommerlad, S (corresponding author), Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.	c.oleary@uq.edu.au	McRae, Allan F/J-2644-2014; Cuttell, Leigh/F-9281-2011; Seddon, Jennifer/A-1402-2010; Seddon, Jennifer/AAM-3827-2021	McRae, Allan F/0000-0001-5286-5485; Seddon, Jennifer/0000-0003-3789-6878; Seddon, Jennifer/0000-0003-3789-6878	Canine Control Council of Queensland	Canine Control Council of Queensland	Funding was provided by The Canine Control Council of Queensland, 7026001 03 475 21 XXXXXX 001748, 429 7155 CCC (http://www.cccq.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Cargill EJ, 2004, GENETICS, V166, P1385, DOI 10.1534/genetics.166.3.1385; Clark NE., 2003, DOG CALLED BLUE, P22; Clark NE., 2003, DOG CALLED BLUE, P5; Coppens AG, 2003, J COMP PATHOL, V128, P67, DOI 10.1053/jcpa.2002.0596; Coppens AG, 2000, J COMP PATHOL, V122, P223, DOI 10.1053/jcpa.1999.0360; Coppens AG, 2001, HEARING RES, V161, P65, DOI 10.1016/S0378-5955(01)00354-9; Famula TR, 2000, AM J VET RES, V61, P550, DOI 10.2460/ajvr.2000.61.550; Famula TR, 1996, MAMM GENOME, V7, P650, DOI 10.1007/s003359900199; Finsterer J, 2005, INT J PEDIATR OTORHI, V69, P621, DOI 10.1016/j.ijporl.2004.12.002; FORGE A, 2000, BRIT MED B, V63, P5; GREIBROKK T, 1994, J AM ANIM HOSP ASSOC, V30, P170; Guyon R, 2003, P NATL ACAD SCI USA, V100, P5296, DOI 10.1073/pnas.0831002100; HIRAIDE F, 1988, Auris Nasus Larynx, V15, P97; Juraschko K, 2003, MAMM GENOME, V14, P547, DOI 10.1007/s00335-002-3033-2; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerns JA, 2007, GENETICS, V176, P1679, DOI 10.1534/genetics.107.074237; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Lange K, 2001, AM J HUM GENET, V69, P504; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; Muhle AC, 2002, VET J, V163, P311, DOI 10.1053/tvjl.2001.0661; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Petersen MB, 2006, CLIN GENET, V69, P371, DOI 10.1111/j.1399-0004.2006.00613.x; Platt S, 2006, J VET INTERN MED, V20, P1355, DOI 10.1892/0891-6640(2006)20[1355:POUABD]2.0.CO;2; Potterf SB, 2000, HUM GENET, V107, P1, DOI 10.1007/s004390050001; PUTSCH C, 1998, HUM GENET, V103, P115; Rak SG, 2005, VET J, V169, P188, DOI 10.1016/j.tvjl.2004.01.015; Sanderson A., 1981, COMPLETE BOOK AUSTR, P45; Schmutz SM, 2007, ANIM GENET, V38, P539, DOI 10.1111/j.1365-2052.2007.01664.x; Schmutz SM, 2009, J HERED, V100, pS66, DOI 10.1093/jhered/esp029; SIMS MH, 1984, AM J VET RES, V45, P2019; SIMS MH, 1984, AM J VET RES, V45, P2028; STEEL KP, 1989, DEVELOPMENT, V107, P453; Steel KP, 2002, P NATL ACAD SCI USA, V99, P14613, DOI 10.1073/pnas.232585699; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Strain GM, 1999, VET CLIN N AM-SMALL, V29, P895, DOI 10.1016/S0195-5616(99)50079-X; STRAIN GM, 1992, J VET INTERN MED, V6, P175, DOI 10.1111/j.1939-1676.1992.tb00333.x; STRAIN GM, 2005, GENETICS DEAFNESS DO; Stritzel S, 2009, J ANIM BREED GENET, V126, P59, DOI 10.1111/j.1439-0388.2008.00761.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yoshida H, 1996, DEVELOPMENT, V122, P1207	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13364	10.1371/journal.pone.0013364	http://dx.doi.org/10.1371/journal.pone.0013364			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967282	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300029
J	Laeyendecker, O; Church, JD; Oliver, AE; Mwatha, A; Owen, SM; Donnell, D; Brookmeyer, R; Musoke, P; Jackson, JB; Guay, L; Nakabiito, C; Quinn, TC; Eshleman, SH				Laeyendecker, Oliver; Church, Jessica D.; Oliver, Amy E.; Mwatha, Anthony; Owen, S. Michele; Donnell, Deborah; Brookmeyer, Ron; Musoke, Philippa; Jackson, J. Brooks; Guay, Laura; Nakabiito, Clemesia; Quinn, Thomas C.; Eshleman, Susan H.			Pregnancy Does Not Affect HIV Incidence Test Results Obtained Using the BED Capture Enzyme Immunoassay or an Antibody Avidity Assay	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; UNITED-STATES; WOMEN; SEROCONVERSION; INFECTIONS; ALGORITHM	Background: Accurate incidence estimates are needed for surveillance of the HIV epidemic. HIV surveillance occurs at maternal-child health clinics, but it is not known if pregnancy affects HIV incidence testing. Methods: We used the BED capture immunoassay (BED) and an antibody avidity assay to test longitudinal samples from 51 HIV-infected Ugandan women infected with subtype A, C, D and intersubtype recombinant HIV who were enrolled in the HIVNET 012 trial (37 baseline samples collected near the time of delivery and 135 follow-up samples collected 3, 4 or 5 years later). Nineteen of 51 women were also pregnant at the time of one or more of the follow-up visits. The BED assay was performed according to the manufacturer's instructions. The avidity assay was performed using a Genetic Systems HIV-1/HIV-2 + O EIA using 0.1M diethylamine as the chaotropic agent. Results: During the HIVNET 012 follow-up study, there was no difference in normalized optical density values (OD-n) obtained with the BED assay or in the avidity test results (%) when women were pregnant (n = 20 results) compared to those obtained when women were not pregnant (n = 115; for BED: p = 0.9, generalized estimating equations model; for avidity: p = 0.7, Wilcoxon rank sum). In addition, BED and avidity results were almost exactly the same in longitudinal samples from the 18 women who were pregnant at only one study visit during the follow-up study (p = 0.6, paired t-test). Conclusions: These results from 51 Ugandan women suggest that any changes in the antibody response to HIV infection that occur during pregnancy are not sufficient to alter results obtained with the BED and avidity assays. Confirmation with larger studies and with other HIV subtypes is needed.	[Laeyendecker, Oliver; Church, Jessica D.; Oliver, Amy E.; Jackson, J. Brooks; Guay, Laura; Quinn, Thomas C.; Eshleman, Susan H.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Mwatha, Anthony; Donnell, Deborah] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA; [Owen, S. Michele] Ctr Dis Control & Prevent, Atlanta, GA USA; [Brookmeyer, Ron] Univ Calif Los Angeles, Los Angeles, CA USA; [Musoke, Philippa; Nakabiito, Clemesia] MUJHU Res Collaborat, Kampala, Uganda; [Musoke, Philippa; Nakabiito, Clemesia] Makerere Univ, Sch Med, Kampala, Uganda; [Laeyendecker, Oliver; Quinn, Thomas C.] NIAID, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Fred Hutchinson Cancer Center; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; Makerere University; Makerere University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Laeyendecker, O (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.	olaeyen1@jhmi.edu	Laeyendecker, Oliver B/B-9331-2009	Laeyendecker, Oliver/0000-0002-6429-4760; Donnell, Deborah/0000-0002-0587-7480; jackson, brooks/0000-0001-9458-135X	U.S. National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Dept. of Health and Human Services (DHHS) through Family Health International [N01-AI-35173]; Fred Hutchinson Cancer Research Center [N01-AI-45200]; Johns Hopkins Univ. [NOI-AI-35173-417]; NIAID; National Institutes of Child Health and Human Development (NICH/HD); National Institute on Drug Abuse; National Institute of Mental Health; Office of AIDS Research of NIH, DHHS [U01-AI-46745, U01-AI-48054, U01-AI-068613]; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory [U01 AI068632]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068613, N01AI045200, ZIAAI001040, U01AI048054, N01AI035173, ZIAAI000361, U01AI046745, U01AI068632] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Health and Human Services (DHHS) through Family Health International; Fred Hutchinson Cancer Research Center; Johns Hopkins Univ.; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Child Health and Human Development (NICH/HD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research of NIH, DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by (1) the HIV Network for Prevention Trials (HIVNET) and sponsored by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS), through contracts with Family Health International (N01-AI-35173), Fred Hutchinson Cancer Research Center (N01-AI-45200), and Johns Hopkins Univ. (NOI-AI-35173-417), (2) the HIV Prevention Trials Network (HPTN) sponsored by the NIAID, National Institutes of Child Health and Human Development (NICH/HD), National Institute on Drug Abuse, National Institute of Mental Health, and Office of AIDS Research, of the NIH, DHHS (U01-AI-46745, U01-AI-48054, and U01-AI-068613), and (3) the International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) Group Network Laboratory (U01 AI068632). Additional support was provided by the Division of Intramural Research, NIAID, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2010, EPIDEMIOL REV, V32, P26, DOI 10.1093/epirev/mxq002; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Eshleman SH, 2004, JAIDS-J ACQ IMM DEF, V35, P126, DOI 10.1097/00126334-200402010-00004; Flys TS, 2007, AIDS, V21, P2077, DOI 10.1097/QAD.0b013e3282703847; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hallett TB, 2008, PLOS MED, V5, P611, DOI 10.1371/journal.pmed.0050080; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Karon JM, 2008, STAT MED, V27, P4617, DOI 10.1002/sim.3144; LAEYENDECKER O, 2009, DECREASING HIV INCID; LAEYENDECKER O, 2009, 2 GLOB HIV ADIS SURV; Laeyendecker O., 2009, 16 C RETR OPP INF MO; Laeyendecker O, 2008, JAIDS-J ACQ IMM DEF, V48, P211, DOI 10.1097/QAI.0b013e3181743980; MARINDA ET, 2004, J ACQ IMMUN DEF SYND, V53, P496; Martro E, 2005, J CLIN MICROBIOL, V43, P6197, DOI 10.1128/JCM.43.12.6197-6199.2005; Masciotra S, 2010, 17 C RETR OPP INF SA; Murphy G, 2008, EURO SURVEILL, V13; Patel D, 2009, INT J INFECT DIS, V13, P266, DOI 10.1016/j.ijid.2008.07.004; Piccinni MP, 2010, J REPROD IMMUNOL, V85, P71, DOI 10.1016/j.jri.2010.01.006; Robertson SA, 2010, J REPROD IMMUNOL, V85, P51, DOI 10.1016/j.jri.2010.01.008; *UNAIDS, 2006, WKLY EPIDEMIOL REC, V81, P40; WELTE A, EURO SURVEILL, V15; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13259	10.1371/journal.pone.0013259	http://dx.doi.org/10.1371/journal.pone.0013259			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949006	Green Submitted, gold, Green Published			2022-12-27	WOS:000282748100009
J	Kalpouzos, G; Eriksson, J; Sjolie, D; Molin, J; Nyberg, L				Kalpouzos, Gregoria; Eriksson, Johan; Sjolie, Daniel; Molin, Jonas; Nyberg, Lars			Neurocognitive Systems Related to Real-World Prospective Memory	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; EPISODIC MEMORY; PARIETAL CORTEX; WORKING-MEMORY; BRAIN; RETRIEVAL; ATTENTION; DISTINCTIVENESS; HIPPOCAMPUS; COMPONENTS	Background: Prospective memory (PM) denotes the ability to remember to perform actions in the future. It has been argued that standard laboratory paradigms fail to capture core aspects of PM. Methodology/Principal Findings: We combined functional MRI, virtual reality, eye-tracking and verbal reports to explore the dynamic allocation of neurocognitive processes during a naturalistic PM task where individuals performed errands in a realistic model of their residential town. Based on eye movement data and verbal reports, we modeled PM as an iterative loop of five sustained and transient phases: intention maintenance before target detection (TD), TD, intention maintenance after TD, action, and switching, the latter representing the activation of a new intention in mind. The fMRI analyses revealed continuous engagement of a top-down fronto-parietal network throughout the entire task, likely subserving goal maintenance in mind. In addition, a shift was observed from a perceptual (occipital) system while searching for places to go, to a mnemonic (temporo-parietal, fronto-hippocampal) system for remembering what actions to perform after TD. Updating of the top-down fronto-parietal network occurred at both TD and switching, the latter likely also being characterized by frontopolar activity. Conclusion/Significance: Taken together, these findings show how brain systems complementary interact during real-world PM, and support a more complete model of PM that can be applied to naturalistic PM tasks and that we named PROspective MEmory DYnamic (PROMEDY) model because of its dynamics on both multi-phase iteration and the interactions of distinct neurocognitive networks.	[Kalpouzos, Gregoria; Eriksson, Johan; Nyberg, Lars] Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden; [Kalpouzos, Gregoria; Eriksson, Johan; Molin, Jonas; Nyberg, Lars] Umea Ctr Funct Brain Imaging, Umea, Sweden; [Sjolie, Daniel] Umea Univ, Dept Comp Sci, Umea, Sweden; [Nyberg, Lars] Umea Univ, Dept Radiat Sci, Umea, Sweden	Umea University; Umea University; Umea University	Kalpouzos, G (corresponding author), Umea Univ, Dept Integrat Med Biol, Physiol Sect, Umea, Sweden.	gregoria.kalpouzos@ki.se	Nyberg, Lars/M-5986-2019; Nyberg, Lars/C-2514-2009	Nyberg, Lars/0000-0002-3367-1746; Nyberg, Lars/0000-0002-3367-1746	Goran Gustafsson Award in Medicine; Swedish Research Council [20061661]; Swedish Brain Power	Goran Gustafsson Award in Medicine; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Brain Power	This work was funded by the 2007 Goran Gustafsson Award in Medicine and a grant from the Swedish Research Council to LN [grant number 20061661]. DS is supported by Swedish Brain Power. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman Anders, 2005, EUROGRAPHICS WORKSH, P225; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; BRANDIMONTE MA, 1994, Q J EXP PSYCHOL-A, V47, P565, DOI 10.1080/14640749408401128; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2005, MEASURING MIND SPEED, P217, DOI DOI 10.1093/ACPR0F:0S0/9780198566427.003.0009; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Ciaramelli E, 2008, NEUROPSYCHOLOGIA, V46, P1828, DOI 10.1016/j.neuropsychologia.2008.03.022; Cohen AL, 2003, CAN J EXP PSYCHOL, V57, P274, DOI 10.1037/h0087431; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Einstein G. O., 1996, PROSPECTIVE MEMORY T, P115; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Ellis J, 2000, APPL COGNITIVE PSYCH, V14, pS1, DOI 10.1002/acp.767; ERICSSON KA, 1980, PSYCHOL REV, V87, P215, DOI 10.1037/0033-295X.87.3.215; Gilbert SJ, 2009, J EXP PSYCHOL LEARN, V35, P905, DOI 10.1037/a0015535; Kalpouzos G, 2010, 2 HALVES BRAIN INFOR, P499; Knight R.G., 1998, MEMORY NEURODEGENERA, P172; Knight RG, 2008, INT PSYCHOGERIATR, V20, P124, DOI 10.1017/S1041610207005923; Koechlin E, 2007, TRENDS COGN SCI, V11, P229, DOI 10.1016/j.tics.2007.04.005; Morris R., 2007, HIPPOCAMPUS BOOK, P581; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; O'Keefe J, 2007, HIPPOCAMPUS BOOK, P475, DOI DOI 10.1093/ACPROF:OSO/9780195100273.003.0011; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Spiers HJ, 2007, TRENDS COGN SCI, V11, P356, DOI 10.1016/j.tics.2007.06.002; Spiers HJ, 2006, NEUROIMAGE, V31, P1826, DOI 10.1016/j.neuroimage.2006.01.037; Vilberg KL, 2008, NEUROPSYCHOLOGIA, V46, P1787, DOI 10.1016/j.neuropsychologia.2008.01.004; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; West R, 2007, INT J PSYCHOPHYSIOL, V64, P269, DOI 10.1016/j.ijpsycho.2006.09.006; Yamadori A, 1997, BRAIN COGNITION, V35, P366	39	38	39	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13304	10.1371/journal.pone.0013304	http://dx.doi.org/10.1371/journal.pone.0013304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660WH	20949046	Green Published, Green Submitted, gold			2022-12-27	WOS:000282676700024
J	Shanab, SMM; Shalaby, EA; Lightfoot, DA; El-Shemy, HA				Shanab, Sanaa M. M.; Shalaby, Emad A.; Lightfoot, David A.; El-Shemy, Hany A.			Allelopathic Effects of Water Hyacinth [Eichhornia crassipes]	PLOS ONE			English	Article							BLUE-GREEN-ALGAE; DIBUTYL PHTHALATE; GROWTH; SUBSTANCES; MACROPHYTE; COMPOUND; PLANTS	Eichhornia crassipes (Mart) Solms is an invasive weed known to out-compete native plants and negatively affect microbes including phytoplankton. The spread and population density of E. crassipes will be favored by global warming. The aim here was to identify compounds that underlie the effects on microbes. The entire plant of E. crassipes was collected from El Zomor canal, River Nile (Egypt), washed clean, then air dried. Plant tissue was extracted three times with methanol and fractionated by thin layer chromatography (TLC). The crude methanolic extract and five fractions from TLC (A-E) were tested for antimicrobial (bacteria and fungal) and anti-algal activities (green microalgae and cyanobacteria) using paper disc diffusion bioassay. The crude extract as well as all five TLC fractions exhibited antibacterial activities against both the Gram positive bacteria; Bacillus subtilis and Streptococcus faecalis; and the Gram negative bacteria; Escherichia coli and Staphylococcus aureus. Growth of Aspergillus flavus and Aspergillus niger were not inhibited by either E. crassipes crude extract nor its five fractions. In contrast, Candida albicans (yeast) was inhibited by all. Some antialgal activity of the crude extract and its fractions was manifest against the green microalgae; Chlorella vulgaris and Dictyochloropsis splendida as well as the cyanobacteria; Spirulina platensis and Nostoc piscinale. High antialgal activity was only recorded against Chlorella vulgaris. Identifications of the active antimicrobial and antialgal compounds of the crude extract as well as the five TLC fractions were carried out using gas chromatography combined with mass spectroscopy. The analyses showed the presence of an alkaloid (fraction A) and four phthalate derivatives (Fractions B-E) that exhibited the antimicrobial and antialgal activities.	[Shanab, Sanaa M. M.] Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt; [Shalaby, Emad A.; El-Shemy, Hany A.] Cairo Univ, Fac Agr, Dept Biochem, Giza, Egypt; [Lightfoot, David A.] So Illinois Univ Carbondale, Genom Core Facil, Carbondale, IL USA	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University; Southern Illinois University System; Southern Illinois University	Shanab, SMM (corresponding author), Cairo Univ, Fac Sci, Dept Bot, Giza, Egypt.	helshemy@hotmail.com	Shanab, Sanaa/AAR-2613-2020; Shalaby, Emad A./AAB-6935-2021; El-Shemy, Hany A./A-6367-2008	Shanab, Sanaa/0000-0002-3254-9618; Lightfoot, David/0000-0002-5725-4381; Shalaby, Emad/0000-0003-2900-4833				Alim Al-Bari M. A., 2006, RES J MED SCI, V1, P77; ALLER RTV, 1985, CHEM ALLELOPATHY BIO, P387; ALLIOTTA G, 1991, J CHEM ECOL, V17, P2223; ALLIOTTA G, 1990, J CHEM ECOL, V16, P2637; Awad HEA, 2008, THESIS CAIRO U; BOURRELLY P, 1970, INITIATION SYSTEMATI, V3; BOURRELLY P., 1972, INITIATION SYSTEMATI, VI; Chattopadhyay D, 1998, FITOTERAPIA, V69, P365; Dandelot S, 2008, AQUAT BOT, V88, P311, DOI 10.1016/j.aquabot.2007.12.004; DELLAGRECA M, 1989, PHYTOCHEMISTRY, V28, P2319; El-Mehalawy A. A., 2008, Journal of Applied Sciences Research, P425; ElNaggar MYM, 1997, BIOMED LETT, V55, P125; ELSHOUBARY MEE, 2010, THESIS TANTA U TANTA; GAOLEI, 2004, ACTA PHYTOECOLOGICA, V28, P735; GONZALEZ S, 2004, J ATAWAPASKAT RES, V2, P7; GRAYER RJ, 1994, PHYTOCHEMISTRY, V37, P19, DOI 10.1016/0031-9422(94)85005-4; Gross E. M., 1994, Acta Horticulturae, P710; Gross EM, 2003, CRIT REV PLANT SCI, V22, P313, DOI 10.1080/713610859; HASLER AD, 1949, ECOLOGY, V30, P359, DOI 10.2307/1932616; Ignacimuthu S., 1997, Proceedings of the Indian National Science Academy Part B Biological Sciences, V63, P537; Jawetz E, 1974, REV MED MICROBIOLOGY, V11th; Jin ZH, 2003, B ENVIRON CONTAM TOX, V71, P1048, DOI 10.1007/s00128-003-0226-7; Khattab A.F., 1988, INT WORKSH WAT HYAC, P303; KHATTAB AF, 2007, THESIS CAIRO U EGYPT; Mahalwal V. S., 2001, Journal of Essential Oil-Bearing Plants, V4, P45; MOGESTU K, 1960, JAP J LIMNOL, V21, P124; Muanza D. N., 1994, International Journal of Pharmacognosy, V32, P337; Nakai S, 1996, WATER SCI TECHNOL, V34, P227, DOI 10.1016/S0273-1223(96)00749-4; Nakai S, 1999, WATER SCI TECHNOL, V39, P47, DOI 10.1016/S0273-1223(99)00185-7; Prescott GW., 1982, ALGAE W GREAT LAKES, P1; Prescott GW., 1978, KNOW FRESH WATER ALG, P12; Rice EL, 1974, ALLELOPATHY; RICE EL, 1979, BOT REV, P45; Rossenthaler L., 1930, CHEM INVESTIGATION P; Roy RN, 2006, MICROBIOL RES, V161, P121, DOI 10.1016/j.micres.2005.06.007; SAITO K, 1989, J NAT PROD, V52, P1221, DOI 10.1021/np50066a004; SASTRY VMVS, 1994, BOT MAR, V37, P357, DOI 10.1515/botm.1994.37.4.357; SASTRY VMVS, 1995, J APPL PHYCOL, V7, P185, DOI 10.1007/BF00693066; Sharma A, 1996, WATER RES, V30, P2281, DOI 10.1016/0043-1354(96)00113-3; SHARMA KP, 1985, AQUAT BOT, V22, P71, DOI 10.1016/0304-3770(85)90030-0; Subhasini Sharma, 2005, Aquatic weeds: problems, control and management, P95; SUN W-H, 1990, Acta Phytophysiologica Sinica, V16, P301; SWAIN T, 1977, ANNU REV PLANT PHYS, V28, P479, DOI 10.1146/annurev.pp.28.060177.002403; Yu S, 1991, BIOINDICATORS ENV MA, P255; ZHILAN C, 2005, ACTA HYDROBIOL, V29, P313	45	77	83	3	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13200	10.1371/journal.pone.0013200	http://dx.doi.org/10.1371/journal.pone.0013200			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949048	Green Published, Green Submitted, gold			2022-12-27	WOS:000282676700007
J	Sreekumar, PG; Kannan, R; Kitamura, M; Spee, C; Barron, E; Ryan, SJ; Hinton, DR				Sreekumar, Parameswaran G.; Kannan, Ram; Kitamura, Mizuki; Spee, Christine; Barron, Ernesto; Ryan, Stephen J.; Hinton, David R.			alpha B Crystallin Is Apically Secreted within Exosomes by Polarized Human Retinal Pigment Epithelium and Provides Neuroprotection to Adjacent Cells	PLOS ONE			English	Article							GROWTH-FACTOR; PROTEINS; HSP70; DEGENERATION; PATHOGENESIS; EXPRESSION; LOCALIZATION; TRAFFICKING; RELEVANCE; PROTEOME	alpha B Crystallin is a chaperone protein with anti-apoptotic and anti-inflammatory functions and has been identified as a biomarker in age-related macular degeneration. The purpose of this study was to determine whether alpha B crystallin is secreted from retinal pigment epithelial (RPE) cells, the mechanism of this secretory pathway and to determine whether extracellular alpha B crystallin can be taken up by adjacent retinal cells and provide protection from oxidant stress. We used human RPE cells to establish that alpha B crystallin is secreted by a non-classical pathway that involves exosomes. Evidence for the release of exosomes by RPE and localization of alpha B crystallin within the exosomes was achieved by immunoblot, immunofluorescence, and electron microscopic analyses. Inhibition of lipid rafts or exosomes significantly reduced alpha B crystallin secretion, while inhibitors of classic secretory pathways had no effect. In highly polarized RPE monolayers, alpha B crystallin was selectively secreted towards the apical, photoreceptor-facing side. In support, confocal microscopy established that alpha B crystallin was localized predominantly in the apical compartment of RPE monolayers, where it colocalized in part with exosomal marker CD63. Severe oxidative stress resulted in barrier breakdown and release of alpha B crystallin to the basolateral side. In normal mouse retinal sections, alpha B crystallin was identified in the interphotoreceptor matrix. An increased uptake of exogenous alpha B crystallin and protection from apoptosis by inhibition of caspase 3 and PARP activation were observed in stressed RPE cultures. alpha B Crystallin was taken up by photoreceptors in mouse retinal explants exposed to oxidative stress. These results demonstrate an important role for alpha B crystallin in maintaining and facilitating a neuroprotective outer retinal environment and may also explain the accumulation of alpha B crystallin in extracellular sub-RPE deposits in the stressed microenvironment in age-related macular degeneration. Thus evidence from our studies supports a neuroprotective role for alpha B crystallin in ocular diseases.	[Sreekumar, Parameswaran G.; Kannan, Ram; Kitamura, Mizuki; Spee, Christine; Barron, Ernesto; Ryan, Stephen J.; Hinton, David R.] Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Kannan, Ram; Ryan, Stephen J.; Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Hinton, David R.] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; University of Southern California	Sreekumar, PG (corresponding author), Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, 1355 San Pablo St, Los Angeles, CA 90033 USA.	dhinton@usc.edu	kannan, ram/ABB-7154-2020	kannan, ram/0000-0002-1583-3414; /0000-0002-9425-3986	Arnold and Mabel Beckman Foundation; National Institutes of Health [EY01545, EY03040]; Department of Ophthalmology by Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [P30EY003040, R01EY001545] Funding Source: NIH RePORTER	Arnold and Mabel Beckman Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology by Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The Arnold and Mabel Beckman Foundation, National Institutes of Health Grants (EY01545, EY03040), and a grant to the Department of Ophthalmology by Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER AJ, 1989, EXP EYE RES, V49, P1067, DOI 10.1016/S0014-4835(89)80027-2; Alcazar O, 2009, MOL CELL PROTEOMICS, V8, P2201, DOI 10.1074/mcp.M900203-MCP200; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Asea A, 2000, CELL STRESS CHAPERON, V5, P425, DOI 10.1379/1466-1268(2000)005<0425:HPBAPN>2.0.CO;2; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Bryantsev AL, 2007, EXP CELL RES, V313, P195, DOI 10.1016/j.yexcr.2006.10.004; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Danysh BP, 2010, MATRIX BIOL, V29, P228, DOI 10.1016/j.matbio.2009.12.004; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; De S, 2007, ARCH OPHTHALMOL-CHIC, V125, P641, DOI 10.1001/archopht.125.5.641; Ethen CM, 2006, INVEST OPHTH VIS SCI, V47, P2280, DOI 10.1167/iovs.05-1395; GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Hauck SM, 2005, PROTEOMICS, V5, P3623, DOI 10.1002/pmic.200401223; HIGHTOWER LE, 1989, J CELL PHYSIOL, V138, P257, DOI 10.1002/jcp.1041380206; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Jin JK, 2008, AM J PHYSIOL-HEART C, V294, pH337, DOI 10.1152/ajpheart.00881.2007; Johnson PT, 2005, INVEST OPHTH VIS SCI, V46, P4788, DOI 10.1167/iovs.05-0767; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Karakousis PC, 2001, MOL VIS, V7, P154; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; MIGNATTI P, 1992, J CELL PHYSIOL, V151, P81, DOI 10.1002/jcp.1041510113; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Nickel W, 2003, EUR J BIOCHEM, V270, P2109, DOI 10.1046/j.1432-1033.2003.03577.x; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; ROHLICH P, 1970, EXP EYE RES, V10, P80, DOI 10.1016/S0014-4835(70)80013-6; Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X; Schmitt E, 2007, J LEUKOCYTE BIOL, V81, P15, DOI 10.1189/jlb.0306167; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Sonoda S, 2010, AGING-US, V2, P28, DOI 10.18632/aging.100111; Sonoda S, 2009, NAT PROTOC, V4, P662, DOI 10.1038/nprot.2009.33; Sreekumar PG, 2008, INVEST OPHTH VIS SCI, V49, P1210, DOI 10.1167/iovs.07-0667; Steiner-Champliaud MF, 2006, MOL VIS, V12, P892; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; van Rijk AF, 2003, EUR J CELL BIOL, V82, P361, DOI 10.1078/0171-9335-00321; Wang AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004160; Whiston EA, 2008, INFECT IMMUN, V76, P1781, DOI 10.1128/IAI.01285-07; Yaung J, 2008, EXP EYE RES, V86, P355, DOI 10.1016/j.exer.2007.11.007; Yaung J, 2007, MOL VIS, V13, P566; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	45	146	152	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e12578	10.1371/journal.pone.0012578	http://dx.doi.org/10.1371/journal.pone.0012578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949024	Green Published, Green Submitted, gold			2022-12-27	WOS:000282676700001
J	Bartmeyer, B; Kuecherer, C; Houareau, C; Werning, J; Keeren, K; Somogyi, S; Kollan, C; Jessen, H; Dupke, S; Hamouda, O				Bartmeyer, Barbara; Kuecherer, Claudia; Houareau, Claudia; Werning, Johanna; Keeren, Kathrin; Somogyi, Sybille; Kollan, Christian; Jessen, Heiko; Dupke, Stephan; Hamouda, Osamah		German HIV-1 Seroconverter Study G	Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE INHIBITORS; ACTIVE ANTIRETROVIRAL THERAPY; GENOTYPIC RESISTANCE; INFECTED PATIENTS; MUTATIONS; TRANSMISSION; EPIDEMIOLOGY; SURVEILLANCE; DECLINE; INDIVIDUALS	Background: The aim of this study is to analyse the prevalence of transmitted drug resistance, TDR, and the impact of TDR on treatment success in the German HIV-1 Seroconverter Cohort. Methods: Genotypic resistance analysis was performed in treatment-naive study patients whose sample was available 1,312/1,564 (83.9% October 2008). A genotypic resistance result was obtained for 1,276/1,312 (97.3%). The resistance associated mutations were identified according to the surveillance drug resistance mutations list recommended for drug-naive patients. Treatment success was determined as viral suppression below 500 copies/ml. Results: Prevalence of TDR was stable at a high level between 1996 and 2007 in the German HIV-1 Seroconverter Cohort (N = 158/1,276; 12.4%; CI(wilson) 10.7-14.3; p (for trend) = 0.25). NRTI resistance was predominant (7.5%) but decreased significantly over time (CI(Wilson): 6.2-9.1, p (for trend) = 0.02). NNRTI resistance tended to increase over time (NNRTI: 3.5%; CI(Wilson): 2.6-4.6; p for trend = 0.07), whereas PI resistance remained stable (PI: 3.0%; CI(Wilson): 2.1-4.0; p (for trend) = 0.24). Resistance to all drug classes was frequently caused by singleton resistance mutations (NRTI 55.6%, PI 68.4%, NNRTI 99.1%). The majority of NRTI-resistant strains (79.8%) carried resistance-associated mutations selected by the thymidine analogues zidovudine and stavudine. Preferably 2NRTI/1PIr combinations were prescribed as first line regimen in patients with resistant HIV as well as in patients with susceptible strains (susceptible 45.3%; 173/382 vs. resistant 65.5%; 40/61). The majority of patients in both groups were treated successfully within the first year after ART-initiation (susceptible: 89.9%; 62/69; resistant: 7/9; 77.8%). Conclusion: Overall prevalence of TDR remained stable at a high level but trends of resistance against drug classes differed over time. The significant decrease of NRTI-resistance in patients newly infected with HIV might be related to the introduction of novel antiretroviral drugs and a wider use of genotypic resistance analysis prior to treatment initiation.	[Bartmeyer, Barbara; Houareau, Claudia; Werning, Johanna; Kollan, Christian; Hamouda, Osamah] Robert Koch Inst, HIV AIDS STD Unit, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany; [Kuecherer, Claudia; Keeren, Kathrin; Somogyi, Sybille] Robert Koch Inst, Project HIV Variabil & Mol Epidemiol, D-1000 Berlin, Germany	Robert Koch Institute; Robert Koch Institute	Bartmeyer, B (corresponding author), Robert Koch Inst, HIV AIDS STD Unit, Dept Infect Dis Epidemiol, D-1000 Berlin, Germany.	Gunsenheimer-BartmeyerB@rki.de	Jessen, Heiko/P-2192-2019	Keeren, Kathrin/0000-0001-5230-2199	German Ministry of Health	German Ministry of Health	The German HIV-1 Seroconerverter Study was funded by the German Ministry of Health (http://www.bmg.bund.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bezemer D, 2004, AIDS, V18, P1571, DOI 10.1097/01.aids.0000131357.52457.33; Bogart LM, 2000, J ACQ IMMUN DEF SYND, V23, P396; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Brenner BG, 2002, EXPERT OPIN BIOL TH, V2, P751, DOI 10.1517/14712598.2.7.751; CUEVAS MT, 2009, J ACQUIR IMMUNE DEFI; de Mendoza C, 2002, AIDS, V16, P1830, DOI 10.1097/00002030-200209060-00019; De Mendoza C, 2007, AIDS RES HUM RETROV, V23, P879, DOI 10.1089/aid.2005.0072; Duwe S, 2001, J ACQ IMMUN DEF SYND, V26, P266, DOI 10.1097/00126334-200103010-00010; FAUCI AS, 1995, NATURE, V378, P561, DOI 10.1038/378561a0; Garcia-Lerma JG, 2005, J ANTIMICROB CHEMOTH, V56, P265, DOI 10.1093/jac/dki194; Garcia-Lerma JG, 2004, J VIROL, V78, P7545, DOI 10.1128/JVI.78.14.7545-7552.2004; Geretti AM, 2007, CURR OPIN INFECT DIS, V20, P22, DOI 10.1097/QCO.0b013e328013caff; Geretti AM, 2006, AIDS REV, V8, P210; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Johnson Victoria A, 2007, Top HIV Med, V15, P119; Little SJ, 2005, CLIN INFECT DIS, V41, P233, DOI 10.1086/431215; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Neifer S, 2006, AIDS, V20, P2231, DOI 10.1097/QAD.0b013e328010ac6f; Oette M, 2007, DEUT MED WOCHENSCHR, V132, P977, DOI 10.1055/s-2007-979365; Oette M, 2006, JAIDS-J ACQ IMM DEF, V41, P573, DOI 10.1097/01.qai.0000214805.52723.c1; Pao D, 2004, JAIDS-J ACQ IMM DEF, V37, P1570, DOI 10.1097/00126334-200412150-00006; Parruti G, 2006, AIDS PATIENT CARE ST, V20, P48, DOI 10.1089/apc.2006.20.48; Poggensee G, 2007, HIV MED, V8, P511, DOI 10.1111/j.1468-1293.2007.00504.x; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sagir A, 2007, J ANTIMICROB CHEMOTH, V60, P843, DOI 10.1093/jac/dkm274; Shafer RW, 2008, AIDS REV, V10, P67; Shafer RW, 2008, ANTIVIR THER, V13, P59; Shafer RW, 2007, AIDS, V21, P215, DOI 10.1097/QAD.0b013e328011e691; Shet A, 2006, JAIDS-J ACQ IMM DEF, V41, P439, DOI 10.1097/01.qai.0000219290.49152.6a; Simon V, 2002, AIDS, V16, P1511, DOI 10.1097/00002030-200207260-00008; Tozzi V, 2008, AIDS RES HUM RETROV, V24, P787, DOI 10.1089/aid.2007.0236; Turner D, 2004, JAIDS-J ACQ IMM DEF, V37, P1627, DOI 10.1097/00126334-200412150-00017; VERCAUTEREN J, 2009, J INFECT DIS; Vercauteren J, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-12; Violin M, 2004, AIDS, V18, P227, DOI 10.1097/00002030-200401230-00012; Vo TTN, 2008, J INFECT DIS, V197, P1685, DOI 10.1086/588141; Waters L, 2007, INT J CLIN PRACT, V61, P105, DOI 10.1111/j.1742-1241.2006.01146.x; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wensing AMJ, 2008, AIDS, V22, P625, DOI 10.1097/QAD.0b013e3282f5e062; Yerly S, 2007, AIDS, V21, P2223, DOI 10.1097/QAD.0b013e3282f0b685; 2007, AIDS, V21, P1035	44	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e12718	10.1371/journal.pone.0012718	http://dx.doi.org/10.1371/journal.pone.0012718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949104	gold, Green Published			2022-12-27	WOS:000282633700001
J	Chen, B; Mi, SL; Wright, B; Connon, CJ				Chen, Bo; Mi, Shengli; Wright, Bernice; Connon, Che John			Investigation of K14/K5 as a Stem Cell Marker in the Limbal Region of the Bovine Cornea	PLOS ONE			English	Article							OCULAR SURFACE; EPITHELIAL-CELLS; AMNIOTIC MEMBRANE; DIFFERENTIATION; EXPRESSION; LOCATION; KERATINS; P63	Background: Identification of stem cells from a corneal epithelial cell population by specific molecular markers has been investigated previously. Expressions of P63, ABCG2 and K14/K5 have all been linked to mammalian corneal epithelial stem cells. Here we report on the limitations of K14/K5 as a limbal stem cell marker. Methodology/Principal Findings: K14/K5 expression was measured by immunohistochemistry, Western blotting and Real time PCR and compared between bovine epithelial cells in the limbus and central cornea. A functional study was also included to investigate changes in K5/14 expression within cultured limbal epithelial cells undergoing forced differentiation. K14 expression (or its partner K5) was detected in quiescent epithelial cells from both the limbal area and central cornea. K14 was localized predominantly to basal epithelial cells in the limbus and suprabasal epithelial cells in the central cornea. Western blotting revealed K14 expression in both limbus and central cornea (higher levels in the limbus). Similarly, quantitative real time PCR found K5, partner to K14, to be expressed in both the central cornea and limbus. Following forced differentiation in culture the limbal epithelial cells revealed an increase in K5/14 gene/protein expression levels in concert with a predictable rise in a known differentiation marker. Conclusions/Significance: K14 and its partner K5 are limited not only to the limbus but also to the central bovine cornea epithelial cells suggesting K14/K5 is not limbal specific in situ. Furthermore K14/K5 expression levels were not lowered (in fact they increased) within a limbal epithelial cell culture undergoing forced differentiation suggesting K14/K5 is an unreliable maker for undifferentiated cells ex vivo.	[Chen, Bo; Mi, Shengli; Wright, Bernice; Connon, Che John] Univ Reading, Sch Pharm, Reading, Berks, England	University of Reading	Chen, B (corresponding author), Univ Reading, Sch Pharm, Reading, Berks, England.	c.j.connon@reading.ac.uk	Connon, Che/B-3128-2012; Chen, Bo/A-3351-2015	Connon, Che/0000-0001-8264-6531; 	Biotechnology and Biological Sciences Research Council of United Kingdom [BB/F019742/1]; Cardiff University; University of Reading; Biotechnology and Biological Sciences Research Council [BB/F019742/1] Funding Source: researchfish; BBSRC [BB/F019742/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council of United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cardiff University; University of Reading; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was financially supported by the Biotechnology and Biological Sciences Research Council of United Kingdom (Grant Ref: BB/F019742/1), Cardiff University and University of Reading. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard Z, 2001, CLIN EXP OPHTHALMOL, V29, P138, DOI 10.1046/j.1442-9071.2001.00394.x; Bickenbach Jr, 2004, METH MOL B, V289, P97; CHALOINDUFAU C, 1990, CELL DIFFER DEV, V32, P97, DOI 10.1016/0922-3371(90)90103-4; Chen B, 2010, TISSUE ENG PT A, V16, P2721, DOI 10.1089/ten.tea.2009.0711; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; DAVANGER M, 1971, NATURE, V229, P560, DOI 10.1038/229560a0; Djalilian AR, 2008, MOL VIS, V14, P1041; Higa K, 2007, INVEST OPHTH VIS SCI, V48, P597, DOI 10.1167/iovs.06-0664; Hsueh YJ, 2004, J BIOMED SCI, V11, P641, DOI 10.1159/000079677; HUANG AJW, 1991, INVEST OPHTH VIS SCI, V32, P96; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; KURPAKUS MA, 1994, CURR EYE RES, V13, P805, DOI 10.3109/02713689409025135; KURPAKUS MA, 1990, INVEST OPHTH VIS SCI, V31, P448; Lavker RM, 2003, EYE, V17, P937, DOI 10.1038/sj.eye.6700575; LAVKER RM, 1991, INVEST OPHTH VIS SCI, V32, P1864; Lehrer MS, 1998, J CELL SCI, V111, P2867; Ma A, 2007, INVEST OPHTH VIS SCI, V48, P3576, DOI 10.1167/iovs.06-1373; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Matic M, 1997, DIFFERENTIATION, V61, P251, DOI 10.1046/j.1432-0436.1997.6140251.x; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Mi SL, 2010, TISSUE ENG PT A, V16, P2091, DOI 10.1089/ten.TEA.2009.0748; Mimura T, 2008, MOL VIS, V14, P1819; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; PRUNIERAS M, 1983, J INVEST DERMATOL, V81, pS28, DOI 10.1111/1523-1747.ep12540324; Romano AC, 2003, INVEST OPHTH VIS SCI, V44, P5125, DOI 10.1167/iovs.03-0628; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Secker GA, 2008, STEM CELL REV, V4, P159, DOI 10.1007/s12015-008-9029-x; Wang DY, 2003, INVEST OPHTH VIS SCI, V44, P4698, DOI 10.1167/iovs.03-0272; Watanabe K, 2004, FEBS LETT, V565, P6, DOI 10.1016/j.febslet.2004.03.064; WILLIAMS ML, 1988, J CELL PHYSIOL, V136, P103, DOI 10.1002/jcp.1041360113; Yoshida S, 2006, INVEST OPHTH VIS SCI, V47, P4780, DOI 10.1167/iovs.06-0574; Zhao B, 2008, INVEST OPHTH VIS SCI, V49, P3395, DOI 10.1167/iovs.07-1263	35	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13192	10.1371/journal.pone.0013192	http://dx.doi.org/10.1371/journal.pone.0013192			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949137	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000282568400010
J	Labriola, CA; Conte, IL; Medus, ML; Parodi, AJ; Caramelo, JJ				Labriola, Carlos A.; Conte, Ianina L.; Lopez Medus, Maximo; Parodi, Armando J.; Caramelo, Julio J.			Endoplasmic Reticulum Calcium Regulates the Retrotranslocation of Trypanosoma Cruzi Calreticulin to the Cytosol	PLOS ONE			English	Article							PROTEIN-KINASE-C; RECEPTOR MESSENGER-RNA; MAMMALIAN-CELLS; BINDING PROTEIN; NUCLEAR EXPORT; CHAPERONE; IDENTIFICATION; POLYPEPTIDE; 80K-H; ERP57	For most secretory pathway proteins, crossing the endoplasmic reticulum (ER) membrane is an irreversible process. However, in some cases this flow can be reversed. For instance, misfolded proteins retained in the ER are retrotranslocated to the cytosol to be degraded by the proteasome. This mechanism, known as ER associated degradation (ERAD), is exploited by several bacterial toxins to gain access to the cytosol. Interestingly, some ER resident proteins can also be detected in the cytosol or nucleus, calreticulin (CRT) being the most studied. Here we show that in Trypanosoma cruzi a minor fraction of CRT localized to the cytosol. ER calcium depletion, but not increasing cytosolic calcium, triggered the retrotranslocation of CRT in a relatively short period of time. Cytosolic CRT was subsequently degraded by the proteasome. Interestingly, the single disulfide bridge of CRT is reduced when the protein is located in the cytosol. The effect exerted by ER calcium was strictly dependent on the C-terminal domain (CRT-C), since a CRT lacking it was totally retained in the ER, whereas the localization of an unrelated protein fused to CRT-C mirrored that of endogenous CRT. This finding expands the regulatory mechanisms of protein sorting and may represent a new crossroad between diverse physiological processes.	[Labriola, Carlos A.; Conte, Ianina L.; Parodi, Armando J.] Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina; [Labriola, Carlos A.; Conte, Ianina L.; Lopez Medus, Maximo; Parodi, Armando J.; Caramelo, Julio J.] Consejo Nacl Invest Cient & Tecn, Inst Invest Bioquim Buenos Aires, RA-1405 Buenos Aires, DF, Argentina; [Lopez Medus, Maximo; Caramelo, Julio J.] Fdn Inst Leloir, Lab Struct Cell Biol, Buenos Aires, DF, Argentina; [Caramelo, Julio J.] Univ Buenos Aires, Sch Sci, Dept Biol Chem, Buenos Aires, DF, Argentina	Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires	Labriola, CA (corresponding author), Fdn Inst Leloir, Lab Glycobiol, Buenos Aires, DF, Argentina.	jcaramelo@leloir.org.ar		Conte, Ianina/0000-0003-0235-8682	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT); University of Buenos Aires; Howard Hughes Medical Institute; National Institutes of Health [GM-44500]	Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT)(ANPCyT); University of Buenos Aires(University of Buenos Aires); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work reported here was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCYT), the University of Buenos Aires, the Howard Hughes Medical Institute, and the National Institutes of Health (Grant GM-44500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; Andrin C, 1998, BIOCHEMISTRY-US, V37, P10386, DOI 10.1021/bi980595z; Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; CANNATA JJB, 1984, MOL BIOCHEM PARASIT, V11, P37, DOI 10.1016/0166-6851(84)90053-7; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CAZZULO JJ, 1985, MOL BIOCHEM PARASIT, V16, P329, DOI 10.1016/0166-6851(85)90074-X; Chichiarelli S, 2007, J CELL PHYSIOL, V210, P343, DOI 10.1002/jcp.20824; COE H, 2009, J BIOL CHEM; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Conte L, 2003, MOL BIOL CELL, V14, P3529, DOI 10.1091/mbc.E03-04-0228; Coppari S, 2002, J CELL BIOCHEM, V85, P325, DOI 10.1002/jcb.10137; Coppolino MG, 1997, NATURE, V386, P843, DOI 10.1038/386843a0; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Castaneda-Patlan MC, 2010, INT J BIOCHEM CELL B, V42, P120, DOI 10.1016/j.biocel.2009.09.019; Decca MB, 2007, J BIOL CHEM, V282, P8237, DOI 10.1074/jbc.M608559200; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Fraser SA, 2000, J IMMUNOL, V164, P4150, DOI 10.4049/jimmunol.164.8.4150; Furuya T, 2001, J BIOL CHEM, V276, P32437, DOI 10.1074/jbc.M104000200; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; GIRALDO AMV, 2009, J BIOL CHEM; Gkika D, 2004, J BIOL CHEM, V279, P26351, DOI 10.1074/jbc.M403801200; Gold LI, 2006, J INVEST DERM SYMP P, V11, P57, DOI 10.1038/sj.jidsymp.5650011; Grillo C, 2006, FREE RADICAL BIO MED, V41, P1113, DOI 10.1016/j.freeradbiomed.2006.06.016; Guo GG, 2002, J INTERF CYTOK RES, V22, P555, DOI 10.1089/10799900252982034; Ribeiro CH, 2009, MOL IMMUNOL, V46, P1092, DOI 10.1016/j.molimm.2008.10.034; HIRAI M, 1990, BIOCHEM J, V270, P583, DOI 10.1042/bj2700583; Hodgkinson CP, 2005, BIOCHEM J, V388, P785, DOI 10.1042/BJ20041845; Holaska JM, 2002, MOL CELL BIOL, V22, P6286, DOI 10.1128/MCB.22.17.6286-6297.2002; Holaska JM, 2001, J CELL BIOL, V152, P127, DOI 10.1083/jcb.152.1.127; Iakova P, 2004, EMBO J, V23, P406, DOI 10.1038/sj.emboj.7600052; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Kawaai K, 2009, J BIOL CHEM, V284, P372, DOI 10.1074/jbc.M805828200; Labriola C, 1999, MOL BIOL CELL, V10, P1381, DOI 10.1091/mbc.10.5.1381; LABRIOLA C, 1995, J CELL BIOL, V130, P771, DOI 10.1083/jcb.130.4.771; Lord JM, 2005, CURR TOP MICROBIOL, V300, P149; Massey S, 2009, J MOL BIOL, V393, P1083, DOI 10.1016/j.jmb.2009.09.013; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Mueller CFH, 2008, BIOCHEM BIOPH RES CO, V370, P669, DOI 10.1016/j.bbrc.2008.04.011; Nanney LB, 2008, AM J PATHOL, V173, P610, DOI 10.2353/ajpath.2008.071027; Nguyen MM, 2009, MOL CELL ENDOCRINOL, V302, P65, DOI 10.1016/j.mce.2008.12.010; Nickenig G, 2002, CIRC RES, V90, P53, DOI 10.1161/hh0102.102503; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; Rendon-Huerta E, 1999, BIOCHEM J, V344, P469, DOI 10.1042/0264-6021:3440469; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; ROJIANI MV, 1991, BIOCHEMISTRY-US, V30, P9859, DOI 10.1021/bi00105a008; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SINGH NK, 1994, P NATL ACAD SCI USA, V91, P12770, DOI 10.1073/pnas.91.26.12770; Souto-Padron T, 2004, HISTOCHEM CELL BIOL, V122, P563, DOI 10.1007/s00418-004-0724-7; Spooner RA, 2004, BIOCHEM J, V383, P285, DOI 10.1042/BJ20040742; Sprung R, 2005, J PROTEOME RES, V4, P950, DOI 10.1021/pr050033j; Tesniere A, 2008, CURR OPIN IMMUNOL, V20, P504, DOI 10.1016/j.coi.2008.05.007; Timchenko LT, 2002, MOL CELL BIOL, V22, P7242, DOI 10.1128/MCB.22.20.7242-7257.2002; Totary-Jain H, 2005, CIRC RES, V97, P1001, DOI 10.1161/01.RES.0000189260.46084.e5; Tsuji N, 1998, MOL BIOCHEM PARASIT, V97, P69, DOI 10.1016/S0166-6851(98)00131-5; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Yu R, 2000, J BIOL CHEM, V275, P23648, DOI 10.1074/jbc.M002684200	60	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13141	10.1371/journal.pone.0013141	http://dx.doi.org/10.1371/journal.pone.0013141			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957192	Green Published, Green Submitted, gold			2022-12-27	WOS:000282506100002
J	Taib, WRW; Smyth, DJ; Merriman, ME; Dalbeth, N; Gow, PJ; Harrison, AA; Highton, J; Jones, PBB; Stamp, L; Steer, S; Todd, JA; Merriman, TR				Taib, Wan R. Wan; Smyth, Deborah J.; Merriman, Marilyn E.; Dalbeth, Nicola; Gow, Peter J.; Harrison, Andrew A.; Highton, John; Jones, Peter B. B.; Stamp, Lisa; Steer, Sophia; Todd, John A.; Merriman, Tony R.			The PTPN22 Locus and Rheumatoid Arthritis: No Evidence for an Effect on Risk Independent of Arg620Trp	PLOS ONE			English	Article							LYMPHOID TYROSINE PHOSPHATASE; GENOME-WIDE ASSOCIATION; OF-FUNCTION VARIANT; PROMOTER POLYMORPHISM; GENETIC-VARIATION; DISEQUILIBRIUM; HAPLOTYPES; GENOTYPES; DISEASES	Objectives: The Trp(620) allotype of PTPN22 confers susceptibility to rheumatoid arthritis (RA) and certain other classical autoimmune diseases. There has been a report of other variants within the PTPN22 locus that alter risk of RA; protective haplotype '5', haplotype group '6-10' and susceptibility haplotype '4', suggesting the possibility of other PTPN22 variants involved in the pathogenesis of RA independent of R620W (rs2476601). Our aim was to further investigate this possibility. Methods: A total of 4,460 RA cases and 4,481 controls, all European, were analysed. Single nucleotide polymorphisms rs3789607, rs12144309, rs3811021 and rs12566340 were genotyped over New Zealand (NZ) and UK samples. Publically-available Wellcome Trust Case Control Consortium (WTCCC) genotype data were used. Results: The protective effect of haplotype 5 was confirmed (rs3789607; (OR = 0.91, P = 0.016), and a second protective effect (possibly of haplotype 6) was observed (rs12144309; OR = 0.90, P = 0.021). The previously reported susceptibility effect of haplotype 4 was not replicated; instead a protective effect was observed (rs3811021; OR = 0.85, P = 1.4 x 10(-5)). Haplotypes defined by rs3789607, rs12144309 and rs3811021 coalesced with the major allele of rs12566340 within the adjacent BFK (B-cell lymphoma 2 (BCL2) family kin) gene. We, therefore, tested rs12566340 for association with RA conditional on rs2476601; there was no evidence for an independent effect at rs12566340 (P = 0.76). Similarly, there was no evidence for an independent effect at rs12566340 in type 1 diabetes (P = 0.85). Conclusions: We have no evidence for a common variant additional to rs2476601 within the PTPN22 locus that influences the risk of RA. Arg620Trp is almost certainly the single common causal variant.	[Taib, Wan R. Wan; Merriman, Marilyn E.; Merriman, Tony R.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Smyth, Deborah J.; Todd, John A.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge, England; [Dalbeth, Nicola; Jones, Peter B. B.] Univ Auckland, Dept Med, Auckland, New Zealand; [Gow, Peter J.] Middlemore Hosp, Dept Rheumatol, Auckland 6, New Zealand; [Harrison, Andrew A.] Univ Otago, Dept Med, Wellington, New Zealand; [Highton, John] Univ Otago, Dept Med, Dunedin, New Zealand; [Stamp, Lisa] Univ Otago, Dept Med, Christchurch, New Zealand; [Steer, Sophia] Kings Coll London, Sch Med Guys, Dept Rheumatol, London WC2R 2LS, England	University of Otago; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Auckland; University of Otago; University of Otago; University of Otago; University of London; King's College London	Taib, WRW (corresponding author), Univ Otago, Dept Biochem, Dunedin, New Zealand.	tony.merriman@otago.ac.nz	Taib, Wan Rohani Wan/N-4183-2017; Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148; Merriman, Tony/0000-0003-0844-8726; smyth, deborah/0000-0002-6330-2669; Harrison, Andrew/0000-0003-4372-3252; Wan Taib, Wan Rohani/0000-0001-9455-5768	Health Research Council of New Zealand; Arthritis New Zealand; Juvenile Diabetes Research Foundation International; Wellcome Trust [079895, 068545/Z/02, 076113/C/04/Z]; National Institute for Health Research Cambridge Biomedical Centre; Medical Research Council [G0000934]; Wellcome Trust/Juvenile Diabetes Research Foundation [061858]; National Institute of Health Research of England; National Institute for Health Research [NF-SI-0508-10275] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Health Research Council of New Zealand(Health Research Council of New Zealand); Arthritis New Zealand; Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome Trust); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust/Juvenile Diabetes Research Foundation(Juvenile Diabetes Research FoundationWellcome Trust); National Institute of Health Research of England(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Health Research Council of New Zealand, Arthritis New Zealand, the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research is in receipt of a Wellcome Trust Strategic Award (079895). The authors acknowledge use of DNA from the 1958 British Birth Cohort collection, funded by the Medical Research Council (grant G0000934) and the Wellcome Trust (grant 068545/Z/02). The authors acknowledge use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust (grant 076113/C/04/Z), the Wellcome Trust/Juvenile Diabetes Research Foundation (grant 061858) and the National Institute of Health Research of England. The collection was established as part of the Wellcome Trust Case-Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechiga AF, 2009, J IMMUNOL, V182, P3343, DOI 10.4049/jimmunol.0713370; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carlton VEH, 2005, AM J HUM GENET, V77, P567, DOI 10.1086/468189; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Heward JM, 2007, J CLIN ENDOCR METAB, V92, P685, DOI 10.1210/jc.2006-2064; Hinks A, 2007, ANN RHEUM DIS, V66, P683, DOI 10.1136/ard.2006.060459; Kawasaki E, 2006, AM J MED GENET A, V140A, P586, DOI 10.1002/ajmg.a.31124; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Orru V, 2009, HUM MOL GENET, V18, P569, DOI 10.1093/hmg/ddn363; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; RODRIGEUZRODRIG.L, 2010, ARTHR RHEUM IN PRESS; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; STECK AK, GENES IMMUN S, V1, pS21; Steer S, 2007, GENES IMMUN, V8, P57, DOI 10.1038/sj.gene.6364359; Vang T, 2005, NAT GENET, V37, P1317, DOI 10.1038/ng1673; Viken MK, 2007, TISSUE ANTIGENS, V70, P190, DOI 10.1111/j.1399-0039.2007.00871.x; Wesoly J, 2007, RHEUMATOLOGY, V46, P617, DOI 10.1093/rheumatology/kel381; Wu JS, 2006, J BIOL CHEM, V281, P11002, DOI 10.1074/jbc.M600498200	21	13	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13544	10.1371/journal.pone.0013544	http://dx.doi.org/10.1371/journal.pone.0013544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975833	Green Submitted, gold, Green Published			2022-12-27	WOS:000283293800013
J	Fleissner, D; Hansen, W; Geffers, R; Buer, J; Westendorf, AM				Fleissner, Diana; Hansen, Wiebke; Geffers, Robert; Buer, Jan; Westendorf, Astrid M.			Local Induction of Immunosuppressive CD8(+) T Cells in the Gut-Associated Lymphoid Tissues	PLOS ONE			English	Article							DENDRITIC CELLS; REGULATORY PHENOTYPE; LAMINA PROPRIA; CUTTING EDGE; TOLERANCE; INFLAMMATION; SUPPRESSION; LUPUS	Background: In contrast to intestinal CD4(+) regulatory T cells (T-regs), the generation and function of immunomodulatory intestinal CD8(+) T cells is less well defined. To dissect the immunologic mechanisms of CD8(+) T cell function in the mucosa, reactivity against hemagglutinin (HA) expressed in intestinal epithelial cells of mice bearing a MHC class-I-restricted T-cell-receptor specific for HA was studied. Methodology and Principal Findings: HA-specific CD8(+) T cells were isolated from gut-associated tissues and phenotypically and functionally characterized for the expression of Foxp3(+) and their suppressive capacity. We demonstrate that intestinal HA expression led to peripheral induction of HA-specific CD8(+) Foxp3(+) T cells. Antigen-experienced CD8(+) T cells in this transgenic mouse model suppressed the proliferation of CD8(+) and CD4(+) T cells in vitro. Gene expression analysis of suppressive HA-specific CD8(+) T cells revealed a specific up-regulation of CD103, Nrp1, Tnfrsf9 and Pdcd1, molecules also expressed on CD4(+) T-reg subsets. Finally, gut-associated dendritic cells were able to induce HA-specific CD8+ Foxp3(+) T cells. Conclusion and Significance: We demonstrate that gut specific antigen presentation is sufficient to induce CD8(+) T-regs in vivo which may maintain intestinal homeostasis by down-modulating effector functions of T cells.	[Fleissner, Diana; Hansen, Wiebke; Buer, Jan; Westendorf, Astrid M.] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany	University of Duisburg Essen; Helmholtz Association; Helmholtz-Center for Infection Research	Fleissner, D (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.	astrid.westendorf@uk-essen.de	Westendorf, Astrid M./AAX-1937-2020	Buer, Jan/0000-0002-7602-1698; Hansen, Wiebke/0000-0002-6020-0886	German Research Foundation (DFG)	German Research Foundation (DFG)(German Research Foundation (DFG))	German Research Foundation (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allez M, 2002, GASTROENTEROLOGY, V123, P1516, DOI 10.1053/gast.2002.36588; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Brimnes J, 2005, J IMMUNOL, V174, P5814, DOI 10.4049/jimmunol.174.9.5814; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Fantini MC, 2004, J IMMUNOL, V172, P5149, DOI 10.4049/jimmunol.172.9.5149; Iwata M, 2004, IMMUNITY, V21, P527, DOI 10.1016/j.immuni.2004.08.011; Johansson-Lindbom B, 2005, J EXP MED, V202, P1063, DOI 10.1084/jem.20051100; Joosten SA, 2007, P NATL ACAD SCI USA, V104, P8029, DOI 10.1073/pnas.0702257104; Kang HK, 2005, J IMMUNOL, V174, P3247, DOI 10.4049/jimmunol.174.6.3247; KIRBERG J, 1994, J EXP MED, V180, P25, DOI 10.1084/jem.180.1.25; Menager-Marcq I, 2006, GASTROENTEROLOGY, V131, P1775, DOI 10.1053/j.gastro.2006.09.008; Morgan DJ, 1996, J IMMUNOL, V157, P978; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Reibke R, 2006, P NATL ACAD SCI USA, V103, P15142, DOI 10.1073/pnas.0602622103; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Singh RP, 2007, J IMMUNOL, V178, P7649, DOI 10.4049/jimmunol.178.12.7649; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; van Driel IR, 2008, J GASTROEN HEPATOL, V23, P171, DOI 10.1111/j.1440-1746.2007.05278.x; von Boehmer H, 2007, J EXP MED, V204, P1737, DOI 10.1084/jem.20071251; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Westendorf AM, 2009, GUT, V58, P211, DOI 10.1136/gut.2008.151720; Westendorf AM, 2005, GUT, V54, P60, DOI 10.1136/gut.2003.037663; Westendorf AM, 2006, ANN NY ACAD SCI, V1072, P401, DOI 10.1196/annals.1326.035; Westendorf AM, 2006, GASTROENTEROLOGY, V131, P510, DOI 10.1053/j.gastro.2006.05.015	29	19	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e15373	10.1371/journal.pone.0015373	http://dx.doi.org/10.1371/journal.pone.0015373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975955	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400032
J	Gravano, DM; McLelland, BT; Horiuchi, K; Manilay, JO				Gravano, David M.; McLelland, Bryce T.; Horiuchi, Keisuke; Manilay, Jennifer O.			ADAM17 Deletion in Thymic Epithelial Cells Alters Aire Expression without Affecting T Cell Developmental Progression	PLOS ONE			English	Article							ALPHA-CONVERTING-ENZYME; NECROSIS-FACTOR-ALPHA; AUTOIMMUNE REGULATOR; LINEAGE COMMITMENT; DEFICIENT MICE; CUTTING EDGE; THYMOCYTES; LIGAND; DIFFERENTIATION; INACTIVATION	Background: Cellular interactions between thymocytes and thymic stromal cells are critical for normal T cell development. Thymic epithelial cells (TECs) are important stromal niche cells that provide essential growth factors, cytokines, and present self-antigens to developing thymocytes. The identification of genes that mediate cellular crosstalk in the thymus is ongoing. One candidate gene, Adam17, encodes a metalloprotease that functions by cleaving the ectodomain of several transmembrane proteins and regulates various developmental processes. In conventional Adam17 knockout mice, a non-cell autonomous role for ADAM17 in adult T cell development was reported, which strongly suggested that expression of ADAM17 in TECs was required for normal T cell development. However, knockdown of Adam17 results in multisystem developmental defects and perinatal lethality, which has made study of the role of Adam17 in specific cell types difficult. Here, we examined T cell and thymic epithelial cell development using a conditional knockout approach. Methodology/Principal Findings: We generated an Adam17 conditional knockout mouse in which floxed Adam17 is deleted specifically in TECs by Cre recombinase under the control of the Foxn1 promoter. Normal T cell lineage choice and development through the canonical ab T cell stages was observed. Interestingly, Adam17 deficiency in TECs resulted in reduced expression of the transcription factor Aire. However, no alterations in the patterns of TEC phenotypic marker expression and thymus morphology were noted. Conclusions/Significance: In contrast to expectation, our data clearly shows that absence of Adam17 in TECs is dispensable for normal T cell development. Differentiation of TECs is also unaffected by loss of Adam17 based on phenotypic markers. Surprisingly, we have uncovered a novel genetic link between Adam17 and Aire expression in vivo. The cell type in which ADAM17 mediates its non-cell autonomous impact and the mechanisms by which it regulates intrathymic T cell development remain to be identified.	[Gravano, David M.; McLelland, Bryce T.; Manilay, Jennifer O.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan; [Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo, Japan	University of California System; University of California Merced; Keio University; Keio University	Gravano, DM (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	jmanilay@ucmerced.edu	Horiuchi, Keisuke/L-2277-2013	Horiuchi, Keisuke/0000-0001-7063-9609	University of California; California Institute for Regenerative Medicine [RN1-00054-1]	University of California(University of California System); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by the University of California through faculty start-up funds, a UC Merced faculty development award (www.ucmerced.edu) and California Institute for Regenerative Medicine New Faculty Award RN1-00054-1 to J.O.M. (www.cirm.ca.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Anderson G, 1997, EUR J IMMUNOL, V27, P1200, DOI 10.1002/eji.1830270522; Ashwell JD, 2000, ANNU REV IMMUNOL, V18, P309, DOI 10.1146/annurev.immunol.18.1.309; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Contin C, 2003, J BIOL CHEM, V278, P32801, DOI 10.1074/jbc.M209993200; Derbinski J, 2005, J EXP MED, V202, P33, DOI 10.1084/jem.20050471; Dooley J, 2008, J IMMUNOL, V181, P5225, DOI 10.4049/jimmunol.181.8.5225; Dyczynska E, 2007, J BIOL CHEM, V282, P436, DOI 10.1074/jbc.M605451200; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Gelling RW, 2008, ENDOCRINOLOGY, V149, P6053, DOI 10.1210/en.2008-0775; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Gordon J, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-69; GRAVANO DM, 2010, IMMUNOL CELL BIOL; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Gray DHD, 2007, J IMMUNOL, V178, P4956, DOI 10.4049/jimmunol.178.8.4956; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Hakozaki A, 2010, J IMMUNOL, V184, P2442, DOI 10.4049/jimmunol.0901188; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Hollander G, 2006, IMMUNOL REV, V209, P28, DOI 10.1111/j.0105-2896.2006.00357.x; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jiang WY, 2005, J EXP MED, V202, P805, DOI 10.1084/jem.20050693; Kawaguchi N, 2007, J CELL SCI, V120, P943, DOI 10.1242/jcs.03403; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kuroda N, 2005, J IMMUNOL, V174, P1862, DOI 10.4049/jimmunol.174.4.1862; Li NY, 2007, EMBO J, V26, P494, DOI 10.1038/sj.emboj.7601520; Li NY, 2007, J IMMUNOL, V178, P4214, DOI 10.4049/jimmunol.178.7.4214; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Murphy G, 2008, TRENDS IMMUNOL, V29, P75, DOI 10.1016/j.it.2007.10.009; Nishikawa Y, 2010, J EXP MED, V207, P963, DOI 10.1084/jem.20092144; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Ramsey C, 2002, HUM MOL GENET, V11, P397, DOI 10.1093/hmg/11.4.397; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; Ruan QG, 1999, J AUTOIMMUN, V13, P307, DOI 10.1006/jaut.1999.0326; Seach N, 2008, J IMMUNOL, V180, P5384, DOI 10.4049/jimmunol.180.8.5384; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Shinohara T, 1996, EUR J IMMUNOL, V26, P747, DOI 10.1002/eji.1830260404; Solomon KA, 1999, J IMMUNOL, V163, P4105; Sternlicht MD, 2005, DEVELOPMENT, V132, P3923, DOI 10.1242/dev.01966; Suniara RK, 2000, J EXP MED, V191, P1051, DOI 10.1084/jem.191.6.1051; Trotter-Mayo RN, 2008, ENDOCRINOLOGY, V149, P5209, DOI 10.1210/en.2008-0476; Varnum-Finney B, 2008, BLOOD, V111, P2615, DOI 10.1182/blood-2007-03-079855; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	59	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13528	10.1371/journal.pone.0013528	http://dx.doi.org/10.1371/journal.pone.0013528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976004	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400028
J	Nandakumar, KS; Jansson, A; Xu, BZ; Rydell, N; Blom, AM; Holmdahl, R				Nandakumar, Kutty Selva; Jansson, Asa; Xu, Bingze; Rydell, Niclas; Blom, Anna M.; Holmdahl, Rikard			A Recombinant Vaccine Effectively Induces C5a-Specific Neutralizing Antibodies and Prevents Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; INNATE IMMUNE-SYSTEM; SINGLE-CHAIN FV; C5A RECEPTOR; COMPLEMENT ACTIVATION; EFFECTOR PHASE; RHEUMATOID-ARTHRITIS; C4B-BINDING PROTEIN; JOINT DESTRUCTION; II COLLAGEN	Objectives: To develop and validate a recombinant vaccine to attenuate inflammation in arthritis by sustained neutralization of the anaphylatoxin C5a. Methods: We constructed and expressed fusion protein of C5a and maltose binding protein. Efficacy of specific C5a neutralization was tested using the fusion protein as vaccine in three different arthritis mouse models: collagen induced arthritis (CIA), chronic relapsing CIA and collagen antibody induced arthritis (CAIA). Levels of anti-C5a antibodies and anti-collagen type II were measured by ELISA. C5a neutralization assay was done using a rat basophilic leukemia cell-line transfected with the human C5aR. Complement activity was determined using a hemolytic assay and joint morphology was assessed by histology. Results: Vaccination of mice with MBP-C5a led to significant reduction of arthritis incidence and severity but not anti-collagen antibody synthesis. Histology of the MBP-C5a and control (MBP or PBS) vaccinated mice paws confirmed the vaccination effect. Sera from the vaccinated mice developed C5a-specific neutralizing antibodies, however C5 activation and formation of the membrane attack complex by C5b were not significantly altered. Conclusions: Exploitation of host immune response to generate sustained C5a neutralizing antibodies without significantly compromising C5/C5b activity is a useful strategy for developing an effective vaccine for antibody mediated and C5a dependent inflammatory diseases. Further developing of such a therapeutic vaccine would be more optimal and cost effective to attenuate inflammation without affecting host immunity.	[Nandakumar, Kutty Selva; Holmdahl, Rikard] Lund Univ, Dept Expt Med, Lund, Sweden; [Nandakumar, Kutty Selva; Holmdahl, Rikard] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Jansson, Asa; Xu, Bingze; Rydell, Niclas] Resistentia Pharmaceut AB, Uppsala, Sweden; [Blom, Anna M.] Lund Univ, Sect Med Prot Chem, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Karolinska Institutet; Lund University; Skane University Hospital	Nandakumar, KS (corresponding author), Lund Univ, Dept Expt Med, Lund, Sweden.	Nandakumar.kutty-selva@ki.se	Blom, Anna/B-9607-2009; Nandakumar, Kutty Selva/D-5438-2011; Blom, Anna/AFS-7369-2022; Holmdahl, Rikard/AAI-7682-2020	Blom, Anna/0000-0002-1348-1734; Nandakumar, Kutty Selva/0000-0001-7790-8197; , Bingze/0000-0002-5341-1722	Swedish Rheumatism Association; King Gustaf V:s 80-Years Foundation; KI Fund (Fobi); Swedish Research Council; Swedish Foundation for Strategic Research; EU [HEALTH-F2-2008-223404]	Swedish Rheumatism Association; King Gustaf V:s 80-Years Foundation; KI Fund (Fobi); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EU(European Commission)	This work was supported by Alex and Eva Wallstrom, Professor Nanna Svartz, Ake Wieberg, Anne Greta Holger Crafoord, Swedish Rheumatism Association and King Gustaf V:s 80-Years Foundation, KI Fund (Fobi), Swedish Research Council, Swedish Foundation for Strategic Research and the EU project Masterswitch HEALTH-F2-2008-223404. All the above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Resistentia Pharmaceuticals AB supported this study by employing three of the authors of this manuscript, who provided purified proteins and analyzed serum samples for anti-C5a levels and C5a neutralization in vitro in the study, but the company did not have any part in designing, executing and analysis of in vivo experiments in mice. In 2008, Resistentia Pharmaceuticals AB was closed down, and Medical Inflammation Research Division, Karolinska Institute has taken over the project completely, financed mainly by EU Masterswitch HEALTH-F2-2008-223404.	Allegretti M, 2005, CURR MED CHEM, V12, P217, DOI 10.2174/0929867053363379; Andersson U, 2004, J INTERN MED, V255, P344, DOI 10.1111/j.1365-2796.2003.01303.x; Banda NK, 2010, CLIN EXP IMMUNOL, V159, P100, DOI 10.1111/j.1365-2249.2009.04035.x; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Blom AM, 2009, ANN RHEUM DIS, V68, P136, DOI 10.1136/ard.2007.085753; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dzhambazov B, 2006, J IMMUNOL, V176, P1525, DOI 10.4049/jimmunol.176.3.1525; Fischetti F, 2007, ARTHRITIS RHEUM-US, V56, P1187, DOI 10.1002/art.22492; Gasque P, 2000, IMMUNOPHARMACOLOGY, V49, P171, DOI 10.1016/S0162-3109(00)80302-1; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hawlisch H, 2006, MOL IMMUNOL, V43, P13, DOI 10.1016/j.molimm.2005.06.028; Hawlisch H, 2005, IMMUNITY, V22, P415, DOI 10.1016/j.immuni.2005.02.006; Hietala MA, 2004, EUR J IMMUNOL, V34, P1208, DOI 10.1002/eji.200424895; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314; HOLMDAHL R, 1986, IMMUNOGENETICS, V24, P84, DOI 10.1007/BF00373114; Holmdahl R, 1998, HUMAN GENOME METHODS, P215; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Koehl J, 2006, CURR OPIN MOL THER, V8, P529; Kohl J, 2006, J CLIN INVEST, V116, P783, DOI 10.1172/JCI26582; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; Konrad S, 2007, J BIOL CHEM, V282, P37906, DOI 10.1074/jbc.M707937200; Konrad S, 2008, J BIOL CHEM, V283, P33296, DOI 10.1074/jbc.M804617200; Lee H, 2006, NAT BIOTECHNOL, V24, P1279, DOI 10.1038/nbt1248; Lindqvist AKB, 2006, J IMMUNOL, V177, P3952, DOI 10.4049/jimmunol.177.6.3952; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Monach PA, 2004, ADV IMMUNOL, V82, P217, DOI 10.1016/S0065-2776(04)82005-4; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nandakumar KS, 2008, TRENDS IMMUNOL, V29, P173, DOI 10.1016/j.it.2008.01.007; Nandakumar KS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2089; Nandakumar KS, 2010, CELL TISSUE RES, V339, P213, DOI 10.1007/s00441-009-0816-8; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Schulte S, 1998, J BIOL CHEM, V273, P1551, DOI 10.1074/jbc.273.3.1551; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Sprong T, 2003, BLOOD, V102, P3702, DOI 10.1182/blood-2003-03-0703; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Trouw LA, 2007, J BIOL CHEM, V282, P28540, DOI 10.1074/jbc.M704354200; Uysal H, 2009, J EXP MED, V206, P449, DOI 10.1084/jem.20081862; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wang Y, 2000, J IMMUNOL, V164, P4340, DOI 10.4049/jimmunol.164.8.4340; WARD PA, 1970, J IMMUNOL, V104, P535; WETSEL RA, 1983, J EXP MED, V157, P2029, DOI 10.1084/jem.157.6.2029; Woodruff TM, 2002, ARTHRITIS RHEUM-US, V46, P2476, DOI 10.1002/art.10449; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com	54	22	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13511	10.1371/journal.pone.0013511	http://dx.doi.org/10.1371/journal.pone.0013511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975959	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400017
J	Mediavilla, MG; Di Venanzio, GA; Guibert, EE; Tiribelli, C				Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.; Tiribelli, Claudio			Heterologous Ferredoxin Reductase and Flavodoxin Protect Cos-7 Cells from Oxidative Stress	PLOS ONE			English	Article							CYTOSOLIC DIHYDROFOLATE-REDUCTASE; IMPORTED MITOCHONDRIAL PROTEIN; COLD-INDUCED APOPTOSIS; 12 AMINO-ACIDS; ESCHERICHIA-COLI; RAT-LIVER; NADP+ OXIDOREDUCTASE; FREE MALONDIALDEHYDE; SOXRS RESPONSE; HYBRID SYSTEM	Background: Ferredoxin-NADP(H) reductase (FNR) from Pisum sativum and Flavodoxin (Fld) from Anabaena PCC 7119 have been reported to protect a variety of cells and organisms from oxidative insults. In this work, these two proteins were expressed in mitochondria of Cos-7 cells and tested for their efficacy to protect these cells from oxidative stress in vitro. Principal Findings: Cos-7/pFNR and Cos-7/pFld cell lines expressing FNR and Fld, respectively, showed a significantly higher resistance to 24 h exposure to 300-600 mu M hydrogen peroxide measured by LDH retention, MTT reduction, malondialdehyde (MDA) levels and lipid peroxide (LPO; FOX assay) levels. However, FNR and Fld did not exhibit any protection at shorter incubation times (2 h and 4 h) to 4 mM hydrogen peroxide or to a 48 h exposure to 300 mM methyl viologen. We found enhanced methyl viologen damage exerted by FNR that may be due to depletion of NADPH pools through NADPH-MV diaphorase activity as previously observed for other overexpressed enzymes. Significance: The results presented are a first report of antioxidant function of these heterologous enzymes of vegetal and cyanobacterial origin in mammalian cells.	[Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.] Ctr Binac Argentina Italia Invest Criobiol Clin &, Rosario, Argentina; [Mediavilla, Maria G.; Di Venanzio, Gisela A.; Guibert, Edgardo E.] Consejo Nacl Invest Cient & Tecn, Rosario, Argentina; [Guibert, Edgardo E.] Univ Nacl Rosario, Area Biol Mol, Fac Ciencias Bioquim & Farmaceut, RA-2000 Rosario, Argentina; [Tiribelli, Claudio] Ctr Studi Fegato, Basovizza, Italy; [Tiribelli, Claudio] Univ Trieste, Dept ACADEM, Trieste, Italy	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Trieste	Mediavilla, MG (corresponding author), Ctr Binac Argentina Italia Invest Criobiol Clin &, Rosario, Argentina.	mmediavi@fbioyf.unr.edu.ar	Di Venanzio, Gisela/GYV-3910-2022; Mediavilla, María Gabriela/L-5445-2016; Tiribelli, Claudio/A-4716-2014	Mediavilla, María Gabriela/0000-0002-1999-7707; Tiribelli, Claudio/0000-0001-6596-7595	StartUp; CONICET/Sistema Cientifico de Trieste; CONICET (National Scientific and Technology Council), Argentina; Italian Liver Foundation [legge26/00]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [703]	StartUp; CONICET/Sistema Cientifico de Trieste(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); CONICET (National Scientific and Technology Council), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Italian Liver Foundation; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	This work was supported by StartUp Grant AREA Science Park/Centro Studi Fegato to Dra. Mediavilla and a postdoctoral fellowship CONICET/Sistema Cientifico de Trieste to Dra. Mediavilla. Dra. Mediavilla and Dr. Guibert are members of CONICET (National Scientific and Technology Council), Argentina. Italian Liver Foundation (legge26/00) to Professor Tiribelli. Grant PICT N<SUP>o</SUP> 703 "Prestamo BID" from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Baudhuin P, 1974, Methods Enzymol, V31, P356; Bilzer M, 1999, AM J PHYSIOL-GASTR L, V276, pG1137, DOI 10.1152/ajpgi.1999.276.5.G1137; Carrillo N, 2003, EUR J BIOCHEM, V270, P1900, DOI 10.1046/j.1432-1033.2003.03566.x; CECCARELLI EA, 1991, J BIOL CHEM, V266, P14283; Cocheme HM, 2008, J BIOL CHEM, V283, P1786, DOI 10.1074/jbc.M708597200; Davies KJA, 2005, HANDB ENVIRON CHEM, V2, P63, DOI 10.1007/b10146; Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; Faro M, 2003, EUR J BIOCHEM, V270, P726, DOI 10.1046/j.1432-1033.2003.03433.x; FILLAT MF, 1991, BIOCHEM J, V280, P187, DOI 10.1042/bj2800187; Gaudu P, 2000, J BACTERIOL, V182, P1788, DOI 10.1128/JB.182.7.1788-1793.2000; Girardini JE, 2002, MOL BIOCHEM PARASIT, V124, P37, DOI 10.1016/S0166-6851(02)00158-5; Giro M, 2006, MICROBIOL-SGM, V152, P1119, DOI 10.1099/mic.0.28612-0; Griffiths HR, 2002, MOL ASPECTS MED, V23, P101, DOI 10.1016/S0098-2997(02)00017-1; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; HORWICH AL, 1985, EMBO J, V4, P1129, DOI 10.1002/j.1460-2075.1985.tb03750.x; HURT EC, 1985, EMBO J, V4, P3509, DOI 10.1002/j.1460-2075.1985.tb04110.x; HURT EC, 1985, EMBO J, V4, P2061, DOI 10.1002/j.1460-2075.1985.tb03892.x; HURT EC, 1984, FEBS LETT, V178, P306, DOI 10.1016/0014-5793(84)80622-5; ITOH S, 1995, BBA-GENE STRUCT EXPR, V1264, P159; Jenkins CM, 1998, BIOCHEMISTRY-US, V37, P6106, DOI 10.1021/bi973076p; Joseph B, 2002, GASTROENTEROLOGY, V123, P1677, DOI 10.1053/gast.2002.36592; Kang HJ, 2006, MOL CELLS, V22, P113; Karatas F, 2002, ANAL BIOCHEM, V311, P76, DOI 10.1016/S0003-2697(02)00387-1; Kerkweg U, 2002, HEPATOLOGY, V35, P560, DOI 10.1053/jhep.2002.31869; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Krapp AR, 1997, EUR J BIOCHEM, V249, P556, DOI 10.1111/j.1432-1033.1997.00556.x; Krapp AR, 2002, J BACTERIOL, V184, P1474, DOI 10.1128/JB.184.5.1474-1480.2002; KRAPP AR, 1995, ARCH BIOCHEM BIOPHYS, V317, P215, DOI 10.1006/abbi.1995.1156; LIOCHEV SI, 1994, P NATL ACAD SCI USA, V91, P1328, DOI 10.1073/pnas.91.4.1328; Mamprin ME, 2001, CRYOBIOLOGY, V43, P310, DOI 10.1006/cryo.2001.2364; Mamprin ME, 2000, CRYOBIOLOGY, V40, P270, DOI 10.1006/cryo.2000.2242; Mediavilla MG, 2006, J GENE MED, V8, P306, DOI 10.1002/jgm.847; Mockett RJ, 2003, FREE RADICAL BIO MED, V34, P207, DOI 10.1016/S0891-5849(02)01190-5; MOREL I, 1990, BIOCHEM PHARMACOL, V39, P1647, DOI 10.1016/0006-2952(90)90107-V; NEWMAN BJ, 1988, PLANT MOL BIOL, V10, P511, DOI 10.1007/BF00033606; Nguyen-nhu NT, 2003, FEBS LETT, V544, P148, DOI 10.1016/S0014-5793(03)00493-9; Palatnik JF, 2003, PLANT J, V35, P332, DOI 10.1046/j.1365-313X.2003.01809.x; Palatnik JF, 1997, PLANT PHYSIOL, V115, P1721, DOI 10.1104/pp.115.4.1721; Pomposiello PJ, 2000, J BACTERIOL, V182, P23, DOI 10.1128/JB.182.1.23-29.2000; PORTER TD, 1986, BIOCHEMISTRY-US, V25, P1682, DOI 10.1021/bi00355a036; Rauen U, 1999, FASEB J, V13, P155, DOI 10.1096/fasebj.13.1.155; RODRIGUEZ JV, 1995, CELL TRANSPLANT, V4, P245, DOI 10.1016/0963-6897(95)90036-5; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Rodriguez RE, 1998, MICROBIOL-UK, V144, P2375, DOI 10.1099/00221287-144-9-2375; SERRA EC, 1993, PROTEIN EXPRES PURIF, V4, P539, DOI 10.1006/prep.1993.1071; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Singh AK, 2004, PHYSIOL PLANTARUM, V120, P27, DOI 10.1111/j.0031-9317.2004.0232.x; Tognetti VB, 2006, PLANT CELL, V18, P2035, DOI 10.1105/tpc.106.042424; Trouet A, 1974, Methods Enzymol, V31, P323; VANLEEUWEN JW, 1983, EUR J BIOCHEM, V135, P601; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yousef N, 2003, ARCH MICROBIOL, V180, P471, DOI 10.1007/s00203-003-0618-4; Zheng M, 1999, J BACTERIOL, V181, P4639, DOI 10.1128/JB.181.15.4639-4643.1999; Zollner A, 2004, BIOELECTROCHEMISTRY, V63, P61, DOI 10.1016/j.bioelechem.2003.10.014; Zurbriggen MD, 2008, TRENDS BIOTECHNOL, V26, P531, DOI 10.1016/j.tibtech.2008.07.001	57	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13501	10.1371/journal.pone.0013501	http://dx.doi.org/10.1371/journal.pone.0013501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976072	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700021
J	Yuan, HY; Huang, CJ; Zhang, SL				Yuan, Hongyan; Huang, Changjin; Zhang, Sulin			Virus-Inspired Design Principles of Nanoparticle-Based Bioagents	PLOS ONE			English	Article							MEDIATED ENDOCYTOSIS; CELLULAR UPTAKE; QUANTUM DOTS; SIZE; CELLS; CLATHRIN; EXPRESSION; MECHANICS; VESICLES; ADHESION	The highly effectiveness and robustness of receptor-mediated viral invasion of living cells shed lights on the biomimetic design of nanoparticle(NP)-based therapeutics. Through thermodynamic analysis, we elucidate that the mechanisms governing both the endocytic time of a single NP and the cellular uptake can be unified into a general energy-balance framework of NP-membrane adhesion and membrane deformation. Yet the NP-membrane adhesion strength is a globally variable quantity that effectively regulates the NP uptake rate. Our analysis shows that the uptake rate interrelatedly depends on the particle size and ligand density, in contrast to the widely reported size effect. Our model predicts that the optimal radius of NPs for maximal uptake rate falls in the range of 25-30 nm, and optimally several tens of ligands should be coated onto NPs. These findings are supported by both recent experiments and typical viral structures, and serve as fundamental principles for the rational design of NP-based nanomedicine.	[Yuan, Hongyan; Huang, Changjin; Zhang, Sulin] Penn State Univ, Dept Engn Sci & Mech, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Yuan, HY (corresponding author), Penn State Univ, Dept Engn Sci & Mech, 227 Hammond Bldg, University Pk, PA 16802 USA.	suz10@psu.edu	Yuan, Hongyan/C-3816-2011; HUANG, CHANGJIN/G-6318-2011; Zhang, Sulin/X-3617-2019; Zhang, Sulin/E-6457-2010	Yuan, Hongyan/0000-0001-8225-0211; HUANG, CHANGJIN/0000-0002-1941-1200; 	National Science Foundation (NSF) [0754463]; Div Of Civil, Mechanical, & Manufact Inn [0754463] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	SLZ gratefully acknowledges the grant support from the National Science Foundation (NSF) grant under Award No. 0754463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 1999, NEW ENGL J MED, V341, P556, DOI 10.1056/NEJM199908193410802; Bao G, 2005, P NATL ACAD SCI USA, V102, P9997, DOI 10.1073/pnas.0504555102; Buehler MJ, 2006, NATURE, V439, P307, DOI 10.1038/nature04408; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Cevc G, 1999, ADV DRUG DELIVER REV, V38, P207, DOI 10.1016/S0169-409X(99)00030-7; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; Decuzzi P, 2007, BIOMATERIALS, V28, P2915, DOI 10.1016/j.biomaterials.2007.02.013; Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290; Deserno M, 2003, EUROPHYS LETT, V62, P767, DOI 10.1209/epl/i2003-00438-4; Elghanian R, 1997, SCIENCE, V277, P1078, DOI 10.1126/science.277.5329.1078; Freund LB, 2004, J MECH PHYS SOLIDS, V52, P2455, DOI 10.1016/j.jmps.2004.05.004; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; GAROFF H, 1974, P NATL ACAD SCI USA, V71, P3988, DOI 10.1073/pnas.71.10.3988; Garoff H, 1998, MICROBIOL MOL BIOL R, V62, P1171, DOI 10.1128/MMBR.62.4.1171-1190.1998; GOLDSTEIN JL, 1979, NATURE, V279, P679, DOI 10.1038/279679a0; Jaiswal JK, 2004, NAT METHODS, V1, P73, DOI 10.1038/nmeth1004-73; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Lamblet M, 2008, EUR PHYS J E, V26, P205, DOI 10.1140/epje/i2007-10317-x; LERNER DM, 1993, BIOPHYS J, V65, P73, DOI 10.1016/S0006-3495(93)81071-3; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Nakai T, 2003, J AM CHEM SOC, V125, P8465, DOI 10.1021/ja035636f; Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0; Qaddoumi MG, 2003, MOL VIS, V9, P559; Rejman J, 2004, BIOCHEM J, V377, P159, DOI 10.1042/BJ20031253; Shenoy VB, 2005, P NATL ACAD SCI USA, V102, P3213, DOI 10.1073/pnas.0500368102; Shi WD, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.061914; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; SILVERSTEIN SC, 1977, ANNU REV BIOCHEM, V46, P669, DOI 10.1146/annurev.bi.46.070177.003321; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Sun SX, 2006, BIOPHYS J, V90, pL10, DOI 10.1529/biophysj.105.074203; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Terdalkar SS, 2010, CHEM PHYS LETT, V494, P218, DOI 10.1016/j.cplett.2010.05.090; Tzlil S, 2004, BIOPHYS J, V86, P2037, DOI 10.1016/S0006-3495(04)74265-4; van Effenterre D, 2003, EUROPHYS LETT, V64, P543, DOI 10.1209/epl/i2003-00268-x; Xing XL, 2005, J NANOSCI NANOTECHNO, V5, P1688, DOI 10.1166/jnn.2005.199; Yuan HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.138101; Yuan HY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3293303; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393; Zhang SL, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.094114	43	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13495	10.1371/journal.pone.0013495	http://dx.doi.org/10.1371/journal.pone.0013495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976064	Green Published, Green Submitted, gold			2022-12-27	WOS:000283114700018
J	Gregory, KJ; Zhao, B; Bielenberg, DR; Dridi, S; Wu, J; Jiang, WH; Huang, B; Pirie-Shepherd, S; Fannon, M				Gregory, Kalvin J.; Zhao, Bing; Bielenberg, Diane R.; Dridi, Sami; Wu, Jason; Jiang, Weihua; Huang, Bin; Pirie-Shepherd, Steven; Fannon, Michael			Vitamin D Binding Protein-Macrophage Activating Factor Directly Inhibits Proliferation, Migration, and uPAR Expression of Prostate Cancer Cells	PLOS ONE			English	Article							N-ACETYLGALACTOSAMINIDASE ACTIVITY; SERUM VITAMIN-D-3-BINDING PROTEIN; FACTOR DBP-MAF; TUMOR-GROWTH; CARCINOMA CELLS; FACTOR GCMAF; MEDIATED MIGRATION; ENDOTHELIAL-CELLS; C-MET; IMMUNOTHERAPY	Background: Vitamin D binding protein-macrophage activating factor (DBP-maf) is a potent inhibitor of tumor growth. Its activity, however, has been attributed to indirect mechanisms such as boosting the immune response by activating macrophages and inhibiting the blood vessel growth necessary for the growth of tumors. Methods and Findings: In this study we show for the first time that DBP-maf exhibits a direct and potent effect on prostate tumor cells in the absence of macrophages. DBP-maf demonstrated inhibitory activity in proliferation studies of both LNCaP and PC3 prostate cancer cell lines as well as metastatic clones of these cells. Flow cytometry studies with annexin V and propidium iodide showed that this inhibitory activity is not due to apoptosis or cell death. DBP-maf also had the ability to inhibit migration of prostate cancer cells in vitro. Finally, DBP-maf was shown to cause a reduction in urokinase plasminogen activator receptor (uPAR) expression in prostate tumor cells. There is evidence that activation of this receptor correlates with tumor metastasis. Conclusions: These studies show strong inhibitory activity of DBP-maf on prostate tumor cells independent of its macrophage activation.	[Gregory, Kalvin J.; Zhao, Bing; Dridi, Sami; Wu, Jason; Jiang, Weihua; Fannon, Michael] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Bielenberg, Diane R.] Harvard Univ, Sch Med, Dept Surg, Vasc Biol Program,Childrens Hosp, Boston, MA 02115 USA; [Huang, Bin] Univ Kentucky, Markey Canc Ctr, Lexington, KY USA; [Pirie-Shepherd, Steven] CovX, San Diego, CA USA	University of Kentucky; Harvard University; Boston Children's Hospital; Harvard Medical School; University of Kentucky	Gregory, KJ (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	michael.fannon@uky.edu	Dridi, Sami/Q-8207-2019	Wu, Jason/0000-0002-9137-0351	Department of Defense (DOD) [PC030286]; Research to Prevent Blindness Challenge Grant	Department of Defense (DOD)(United States Department of Defense); Research to Prevent Blindness Challenge Grant(Research to Prevent Blindness (RPB))	This work was supported by Department of Defense (DOD) grant PC030286 and Research to Prevent Blindness Challenge Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ass K, 2008, CANCER TREAT REV, V34, P122, DOI 10.1016/j.ctrv.2007.10.005; Bajou K, 2001, J CELL BIOL, V152, P777, DOI 10.1083/jcb.152.4.777; Bajou K, 2004, ONCOGENE, V23, P6986, DOI 10.1038/sj.onc.1207859; Bauer TW, 2005, CANCER RES, V65, P7775, DOI 10.1158/0008-5472.CAN-05-0946; Bauer TW, 2005, ANN SURG, V241, P748, DOI 10.1097/01.sla.0000160699.59061.92; Besch R, 2007, CELL DEATH DIFFER, V14, P818, DOI 10.1038/sj.cdd.4402065; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Chang LK, 2004, P NATL ACAD SCI USA, V101, P11658, DOI 10.1073/pnas.0404272101; CONNOLLY DT, 1986, ANAL BIOCHEM, V152, P136, DOI 10.1016/0003-2697(86)90131-4; COOKE NE, 1985, J CLIN INVEST, V76, P2420, DOI 10.1172/JCI112256; Dass CR, 2005, CLIN EXP METASTAS, V22, P643, DOI 10.1007/s10585-006-9004-3; Dong Z, 2008, NEOPLASIA, V10, P439, DOI 10.1593/neo.08106; Fannon M, 2008, J CELL PHYSIOL, V215, P434, DOI 10.1002/jcp.21327; Greco M, 2009, CANCER LETT, V283, P222, DOI 10.1016/j.canlet.2009.04.001; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; HELBERT MR, 1993, IMMUNOL TODAY, V14, P340, DOI 10.1016/0167-5699(93)90232-A; Kanda S, 2002, JNCI-J NATL CANCER I, V94, P1311; KAWAKAMI M, 1981, J CLIN ENDOCR METAB, V53, P1110, DOI 10.1210/jcem-53-6-1110; Kisker O, 2003, NEOPLASIA, V5, P32, DOI 10.1016/S1476-5586(03)80015-5; Kisker O, 2001, CANCER RES, V61, P7669; Koga Y, 1999, P SOC EXP BIOL MED, V220, P20, DOI 10.1046/j.1525-1373.1999.d01-3.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohamad SB, 2002, COMP BIOCHEM PHYS A, V132, P1, DOI 10.1016/S1095-6433(01)00522-0; Pettaway CA, 1996, CLIN CANCER RES, V2, P1627; Schneider GB, 2003, CRIT REV EUKAR GENE, V13, P277; Serrati S, 2008, J PATHOL, V214, P545, DOI 10.1002/path.2309; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Trinh L, 2000, BIOSEPARATION, V9, P223, DOI 10.1023/A:1008133914854; Yamamoto N, 1996, CELL IMMUNOL, V170, P161, DOI 10.1006/cimm.1996.0148; Yamamoto N, 2006, AIDS RES HUM RETROV, V22, P262, DOI 10.1089/aid.2006.22.262; Yamamoto N, 1997, CLIN IMMUNOL IMMUNOP, V82, P290, DOI 10.1006/clin.1996.4320; Yamamoto N, 1996, MOL IMMUNOL, V33, P1157, DOI 10.1016/S0161-5890(96)00081-8; YAMAMOTO N, 1995, AIDS RES HUM RETROV, V11, P1373, DOI 10.1089/aid.1995.11.1373; Yamamoto N, 2009, J MED VIROL, V81, P16, DOI 10.1002/jmv.21376; Yamamoto N, 2008, CANCER IMMUNOL IMMUN, V57, P1007, DOI 10.1007/s00262-007-0431-z; Yamamoto N, 2008, INT J CANCER, V122, P461, DOI 10.1002/ijc.23107; Yamamoto N, 2008, TRANSL ONCOL, V1, P65, DOI 10.1593/tlo.08106	37	48	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13428	10.1371/journal.pone.0013428	http://dx.doi.org/10.1371/journal.pone.0013428			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976141	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300014
J	Shen, YF; Tolic, N; Liu, T; Zhao, R; Petritis, BO; Gritsenko, MA; Camp, DG; Moore, RJ; Purvine, SO; Esteva, FJ; Smith, RD				Shen, Yufeng; Tolic, Nikola; Liu, Tao; Zhao, Rui; Petritis, Brianne O.; Gritsenko, Marina A.; Camp, David G.; Moore, Ronald J.; Purvine, Samuel O.; Esteva, Francisco J.; Smith, Richard D.			Blood Peptidome-Degradome Profile of Breast Cancer	PLOS ONE			English	Article							HUMAN PLASMA PROTEOME; MASS-SPECTROMETRY; HEAVY-CHAINS; TUMOR-CELLS; PLASMINOGEN; INHIBITOR; PROTEINS; MARKERS; MICROENVIRONMENT; DEGRADATION	Background: Cancer invasion and metastasis are closely associated with activities within the degradome; however, little is known about whether these activities can be detected in the blood of cancer patients. Methodology and Principal Findings: The peptidome-degradome profiles of pooled blood plasma sampled from 15 breast cancer patients (BCP) and age, race, and menopausal status matched control healthy persons (HP) were globally characterized using advanced comprehensive separations combined with tandem Fourier transform mass spectrometry and new data analysis approaches that facilitated top-down peptidomic analysis. The BCP pool displayed 71 degradome protein substrates that encompassed 839 distinct peptidome peptides. In contrast, the HP 50 degradome substrates found encompassed 425 peptides. We find that the ratios of the peptidome peptide relative abundances can vary as much as >4000 fold between BCP and HP. The experimental results also show differential degradation of substrates in the BCP sample in their functional domains, including the proteolytic and inhibitory sites of the plasmin-antiplasmin and thrombin-antithrombin systems, the main chains of the extracellular matrix protection proteins, the excessive degradation of innate immune system key convertases and membrane attack complex components, as well as several other cancer suppressor proteins. Conclusions: Degradomics-peptidomics profiling of blood plasma is highly sensitive to changes not evidenced by conventional bottom-up proteomics and potentially provides unique signatures of possible diagnostic utility.	[Shen, Yufeng; Liu, Tao; Gritsenko, Marina A.; Camp, David G.; Moore, Ronald J.; Smith, Richard D.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [Tolic, Nikola; Zhao, Rui; Purvine, Samuel O.; Smith, Richard D.] Pacific NW Natl Lab, Environm Mol Sci Lab, Richland, WA 99352 USA; [Petritis, Brianne O.] Arizona State Univ, Biol Design Interdisciplinary Grad Degree Program, Tempe, AZ USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Esteva, Francisco J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Arizona State University; Arizona State University-Tempe; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Shen, YF (corresponding author), Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA.	Yufeng.shen@pnl.gov; rds@pnl.gov	Purvine, Samuel O/O-3358-2017; Liu, Tao/A-9020-2013; Smith, Richard D/J-3664-2012	Purvine, Samuel O/0000-0002-2257-2400; Liu, Tao/0000-0001-9529-6550; Smith, Richard D/0000-0002-2381-2349; Esteva, Francisco J./0000-0003-2437-3920	National Institutes of Health, National Center for Research Resources [RR18522]; DOE [DE-AC05-76RLO-1830]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by the National Institutes of Health, National Center for Research Resources (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work was performed in the Environmental Molecular Science Laboratory, a DOE/BER national scientific user facility located on the campus of Pacific Northwest National Laboratory (PNNL) in Richland, Washington. PNNL is a multi-program national laboratory operated by Battelle Memorial Institute for the DOE under contract DE-AC05-76RLO-1830.	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; Bost F, 1998, EUR J BIOCHEM, V252, P339, DOI 10.1046/j.1432-1327.1998.2520339.x; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; Dieplinger H, 2009, CANCER EPIDEM BIOMAR, V18, P1127, DOI 10.1158/1055-9965.EPI-08-0653; Dong Y, 2002, EXP CELL RES, V276, P328, DOI 10.1006/excr.2002.5534; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; He H, 2009, J BIOL CHEM, V284, P20136, DOI 10.1074/jbc.M109.021881; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Koblinski JE, 2000, CLIN CHIM ACTA, V291, P113, DOI 10.1016/S0009-8981(99)00224-7; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Lopez-Otin C, 2002, NAT REV MOL CELL BIO, V3, P509, DOI 10.1038/nrm858; Markiewski MM, 2009, TRENDS IMMUNOL, V30, P286, DOI 10.1016/j.it.2009.04.002; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; NICULESCU F, 1992, AM J PATHOL, V140, P1039; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN TE, 1990, J BIOL CHEM, V265, P6104; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; POTEMPA J, 1988, SCIENCE, V241, P699, DOI 10.1126/science.2456616; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Sanggaard KW, 2008, J BIOL CHEM, V283, P18530, DOI 10.1074/jbc.M800874200; SCHAPIRA DV, 1983, BREAST CANCER RES TR, V3, P221, DOI 10.1007/BF01803564; Shen YF, 2005, ANAL CHEM, V77, P7763, DOI 10.1021/ac051257o; Shen YF, 2004, ANAL CHEM, V76, P1134, DOI 10.1021/ac034869m; Shen YF, 2010, J PROTEOME RES, V9, P4053, DOI 10.1021/pr1002559; Shen YF, 2010, J PROTEOME RES, V9, P2339, DOI 10.1021/pr901083m; SHVYRKOVA IG, 2000, RUSS J BIOORG CHEM+, V26, P317; Smith RD, 2002, PROTEOMICS, V2, P513, DOI 10.1002/1615-9861(200205)2:5<513::AID-PROT513>3.0.CO;2-W; Sturgeon CM, 2008, CLIN CHEM, V54, pE11, DOI 10.1373/clinchem.2008.105601; Villanueva J, 2006, J CLIN INVEST, V116, P271, DOI 10.1172/JCI26022; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; WOJTUKIEWICZ MZ, 1993, INT J CANCER, V54, P793, DOI 10.1002/ijc.2910540514	43	40	41	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13133	10.1371/journal.pone.0013133	http://dx.doi.org/10.1371/journal.pone.0013133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976186	gold, Green Submitted, Green Published			2022-12-27	WOS:000283045300004
J	De Cesarei, A; Codispoti, M				De Cesarei, Andrea; Codispoti, Maurizio			Effects of Picture Size Reduction and Blurring on Emotional Engagement	PLOS ONE			English	Article							STARTLE REFLEX; MODULATION; ATTENTION; AROUSAL; PERCEPTION	The activity of basic motivational systems is reflected in emotional responses to arousing stimuli, such as natural pictures. The manipulation of picture properties such as size or detail allows for investigation into the extent to which separate emotional reactions are similarly modulated by perceptual changes, or, rather, may subserve different functions. Pursuing this line of research, the present study examined the effects of two types of perceptual degradation, namely picture size reduction and blurring, on emotional responses. Both manipulations reduced picture relevance and dampened affective modulation of skin conductance, possibly because of a reduced action preparation in response to degraded or remote pictures. However, the affective modulation of the startle reflex did not vary with picture degradation, suggesting that the identification of these degraded affective cues activated the neural circuits mediating appetitive or defensive motivation.	[De Cesarei, Andrea; Codispoti, Maurizio] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna	De Cesarei, A (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	andrea.decesarei@unibo.it	Codispoti, Maurizio/B-7672-2008	Codispoti, Maurizio/0000-0002-7285-4342; De Cesarei, Andrea/0000-0002-6624-5006	RFO (Ricerca Fondamentale Orientata) funds	RFO (Ricerca Fondamentale Orientata) funds	This study was funded by RFO (Ricerca Fondamentale Orientata) funds to the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, A5 U FLOR CTR RES PS; ANTHONY BJ, 1985, BIOL PSYCHOL, V21, P43, DOI 10.1016/0301-0511(85)90052-3; Balaban MT, 1986, PSYCHOPHYSIOLOGY, V23, P612; Blumenthal TD, 2005, PSYCHOPHYSIOLOGY, V42, P1, DOI 10.1111/j.1469-8986.2005.00271.x; BONNET M, 1995, PSYCHOPHYSIOLOGY, V32, P367, DOI 10.1111/j.1469-8986.1995.tb01219.x; Bradley M. M., 1999, STARTLE MODIFICATION, P157, DOI [10.1017/CBO9780511665523.010, DOI 10.1017/CBO9780511665523.010]; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; Bradley MM, 2001, EMOTION, V1, P276, DOI 10.1037//1528-3542.1.3.276; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Codispoti M, 2006, BRAIN RES, V1068, P213, DOI 10.1016/j.brainres.2005.11.009; Codispoti M, 2006, PROG BRAIN RES, V156, P53, DOI 10.1016/S0079-6123(06)56003-0; Codispoti M, 2009, PSYCHOPHYSIOLOGY, V46, P731, DOI 10.1111/j.1469-8986.2009.00804.x; Codispoti M, 2007, PSYCHOPHYSIOLOGY, V44, P680, DOI 10.1111/j.1469-8986.2007.00545.x; Cook E.W., 2001, VPM REFERENCE MANUAL; Cuthbert BN, 1996, PSYCHOPHYSIOLOGY, V33, P103, DOI 10.1111/j.1469-8986.1996.tb02114.x; De Cesarei A, 2008, EMOTION, V8, P352, DOI 10.1037/1528-3542.8.3.352; De Cesarei A, 2006, PSYCHOPHYSIOLOGY, V43, P207, DOI 10.1111/j.1469-8986.2006.00392.x; Detenber BH, 1996, J COMMUN, V46, P66, DOI 10.1111/j.1460-2466.1996.tb01489.x; EDELBERG R, 1972, HDB PSYCHOPHYSIOLOGY, P376; FERRARI V, 2011, PSYCHOPHYSI IN PRESS, P11601; Filion DL, 1998, BIOL PSYCHOL, V47, P1, DOI 10.1016/S0301-0511(97)00020-3; Greenwald M. K., 1989, J PSYCHOPHYSIOL, V3, P51; Lang PJ, 1997, ATTENTION AND ORIENTING: SENSORY AND MOTIVATIONAL PROCESSES, P97; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Low A, 2008, PSYCHOL SCI, V19, P865, DOI 10.1111/j.1467-9280.2008.02170.x; Loftus GR, 2005, PSYCHON B REV, V12, P43, DOI 10.3758/BF03196348; Loftus GR, 1996, CURR DIR PSYCHOL SCI, V5, P161, DOI 10.1111/1467-8721.ep11512376; Muhlberger A, 2008, EMOTION, V8, P192, DOI 10.1037/1528-3542.8.2.192; Schneider W., 2002, E PRIME USERS GUIDE; VENABLES PH, 1980, TECHNIQUES PSYCHOPHY, P2; VRANA SR, 1988, J ABNORM PSYCHOL, V97, P487, DOI 10.1037/0021-843X.97.4.487; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; WINTON WM, 1984, J EXP SOC PSYCHOL, V20, P195, DOI 10.1016/0022-1031(84)90047-7	33	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13399	10.1371/journal.pone.0013399	http://dx.doi.org/10.1371/journal.pone.0013399			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	664DX	20976237	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000021
J	Oathes, DJ; Squillante, CM; Ray, WJ; Nitschke, JB				Oathes, Desmond J.; Squillante, Christian M.; Ray, William J.; Nitschke, Jack B.			The Impact of Worry on Attention to Threat	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; CONFIDENCE-INTERVALS; SELECTIVE ATTENTION; ANTERIOR CINGULATE; VISUAL-ATTENTION; CLINICAL ANXIETY; SOCIAL PHOBIA; TIME-COURSE; BIAS; CHILDREN	Prior research has often linked anxiety to attentional vigilance for threat using the dot probe task, which presents probes in spatial locations that were or were not preceded by a putative threat stimulus. The present study investigated the impact of worry on threat vigilance by administering this task during a worry condition and during a mental arithmetic control condition to 56 undergraduate students scoring in the low normal range on a measure of chronic worry. The worry induction was associated with faster responses than arithmetic to probes in the attended location following threat words, indicating the combined influence of worry and threat in facilitating attention. Within the worry condition, responses to probes in the attended location were faster for trials containing threat words than for trials with only neutral words, whereas the converse pattern was observed for responses to probes in the unattended location. This connection between worry states and attentional capture by threat may be central to understanding the impact of hypervigilance on information processing in anxiety and its disorders.	[Oathes, Desmond J.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Oathes, Desmond J.; Nitschke, Jack B.] Univ Wisconsin, Dept Psychiat, Waisman Lab Brain Imaging & Behav, Madison, WI 53706 USA; [Oathes, Desmond J.; Nitschke, Jack B.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Squillante, Christian M.] Univ Penn Hlth Syst, Philadelphia, PA USA; [Ray, William J.] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA	Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Oathes, DJ (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	oathes@stanford.edu	Oathes, Desmond/X-4088-2019; Oathes, Desmond/AAW-3048-2021	Oathes, Desmond/0000-0001-7346-2669; 	National Institutes of Health/National Institute of Mental Health [5K02MH082130-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH082130] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work on this project was supported in part by National Institutes of Health/National Institute of Mental Health Grant# 5K02MH082130-02 to JBN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir N, 2003, BEHAV RES THER, V41, P1325, DOI 10.1016/S0005-7967(03)00039-1; Amir N, 2009, J ABNORM PSYCHOL, V118, P28, DOI 10.1037/a0012589; Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bar-Haim Y, 2010, AM J PSYCHIAT, V167, P694, DOI 10.1176/appi.ajp.2009.09070956; Barlow D. H., 2004, ANXIETY ITS DISORDER; BECK A T, 1976, P356; Beck A.T., 1988, ANXIETY RES, V1, P23, DOI [DOI 10.1080/10615808808248218, 10.1080/10615808808248218]; Beck A.T., 1979, COGNITIVE THERAPY EM; BORKOVEC TD, 1990, BEHAV RES THER, V28, P153, DOI 10.1016/0005-7967(90)90027-G; BORKOVEC TD, 2004, ADV RES PRACTICE, P77; Bradley BP, 1999, BRIT J CLIN PSYCHOL, V38, P267, DOI 10.1348/014466599162845; Carretie L, 2004, HUM BRAIN MAPP, V22, P290, DOI 10.1002/hbm.20037; Carter RM, 2001, DEPRESS ANXIETY, V13, P78, DOI 10.1002/da.1020; CLARK LA, 1991, J ABNORM PSYCHOL, V100, P316, DOI 10.1037/0021-843X.100.3.316; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cumming G, 2005, AM PSYCHOL, V60, P170, DOI 10.1037/0003-066X.60.2.170; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029; EYSENCK MW, 1988, ANXIETY COGNITIVE PE; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; GOTLIB IH, 1984, J PERS SOC PSYCHOL, V47, P427, DOI 10.1037/0022-3514.47.2.427; Hayes S, 2010, BEHAV RES THER, V48, P171, DOI 10.1016/j.brat.2009.10.006; Hayes S, 2010, J ABNORM PSYCHOL, V119, P235, DOI 10.1037/a0018264; Hazen RA, 2009, J PSYCHIATR RES, V43, P627, DOI 10.1016/j.jpsychires.2008.07.004; HAZLETT RL, 1994, PSYCHOPHYSIOLOGY, V31, P189, DOI 10.1111/j.1469-8986.1994.tb01039.x; Hirsch CR, 2009, J ABNORM PSYCHOL, V118, P44, DOI 10.1037/a0013473; Hoehn-Saric R, 2004, PSYCHIAT RES-NEUROIM, V131, P11, DOI 10.1016/j.pscychresns.2004.02.003; HOEHNSARIC R, 2005, PSYCHIAT RES, V30, P259; Koster EHW, 2005, BEHAV RES THER, V43, P1087, DOI 10.1016/j.brat.2004.08.004; Koster EHW, 2004, BEHAV RES THER, V42, P1183, DOI 10.1016/j.brat.2003.08.001; Koster EHW, 2010, EMOTION, V10, P230, DOI 10.1037/a0018424; Krebs G, 2010, BEHAV RES THER, V48, P251, DOI 10.1016/j.brat.2009.10.009; Lipp OV, 2005, EMOTION, V5, P365, DOI 10.1037/1528-3542.5.3.365; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; MACLEOD C, 1995, BEHAV RES THER, V33, P1, DOI 10.1016/0005-7967(94)E0004-3; MACLEOD C, 1988, Q J EXP PSYCHOL-A, V40, P653, DOI 10.1080/14640748808402292; MacLeod C, 2002, J ABNORM PSYCHOL, V111, P107, DOI 10.1037//0021-843X.111.1.107; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MATHEWS A, 1995, BEHAV RES THER, V33, P293, DOI 10.1016/0005-7967(94)E0022-B; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; McKay D, 2005, COGNITIVE THER RES, V29, P359, DOI 10.1007/s10608-005-4268-3; McLaughlin KA, 2007, BEHAV THER, V38, P23, DOI 10.1016/j.beth.2006.03.003; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mogg K, 1999, BEHAV RES THER, V37, P595, DOI 10.1016/S0005-7967(98)00158-2; Mogg K, 1997, BEHAV RES THER, V35, P297, DOI 10.1016/S0005-7967(96)00109-X; Mogg K, 2005, COGNITIVE THER RES, V29, P29, DOI 10.1007/s10608-005-1646-y; MOGG K, 1990, J PERS SOC PSYCHOL, V59, P1230, DOI 10.1037/0022-3514.59.6.1230; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; MOGG K, 1992, COGNITION EMOTION, V6, P149, DOI 10.1080/02699939208411064; Mogg K, 1998, BEHAV RES THER, V36, P809, DOI 10.1016/S0005-7967(98)00063-1; Molina S, 1998, COGNITIVE THER RES, V22, P109, DOI 10.1023/A:1018772104808; Monk CS, 2008, ARCH GEN PSYCHIAT, V65, P568, DOI 10.1001/archpsyc.65.5.568; Musa C, 2003, BEHAV RES THER, V41, P1043, DOI 10.1016/S0005-7967(02)00212-7; Neshat-Doost HT, 2000, J CHILD PSYCHOL PSYC, V41, P363, DOI 10.1111/1469-7610.00620; Nitschke JB, 2009, AM J PSYCHIAT, V166, P302, DOI 10.1176/appi.ajp.2008.07101682; Nitschke JB, 2005, INT REV NEUROBIOL, V67, P1, DOI 10.1016/S0074-7742(05)67001-8; Nitschke JB, 2001, COGNITIVE THER RES, V25, P1, DOI 10.1023/A:1026485530405; Oathes DJ, 2008, DEPRESS ANXIETY, V25, P969, DOI 10.1002/da.20445; Oathes DJ, 2008, BIOL PSYCHOL, V79, P165, DOI 10.1016/j.biopsycho.2008.04.005; Paulesu E, 2010, PSYCHOL MED, V40, P117, DOI 10.1017/S0033291709005649; Pine DS, 2005, AM J PSYCHIAT, V162, P291, DOI 10.1176/appi.ajp.162.2.291; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; Provencher MD, 2000, BEHAV COGN PSYCHOTH, V28, P211; Robinson MD, 2002, PSYCHOL BULL, V128, P934, DOI 10.1037//0033-2909.128.6.934; Schmukle SC, 2005, EUR J PERSONALITY, V19, P595, DOI 10.1002/per.554; Taghavi MR, 1999, J ABNORM CHILD PSYCH, V27, P215, DOI 10.1023/A:1021952407074; Thompson T, 2002, PERS INDIV DIFFER, V33, P837, DOI 10.1016/S0191-8869(01)00076-9; WEINSTEIN AM, 1995, BIOL PSYCHIAT, V37, P847, DOI 10.1016/0006-3223(94)00249-3; Wells A, 1998, BEHAV RES THER, V36, P899, DOI 10.1016/S0005-7967(98)00070-9; Whalen PJ, 1998, CURR DIR PSYCHOL SCI, V7, P177, DOI 10.1111/1467-8721.ep10836912; Yiend J, 2001, Q J EXP PSYCHOL-A, V54, P665, DOI 10.1080/02724980042000462; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	73	17	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13411	10.1371/journal.pone.0013411	http://dx.doi.org/10.1371/journal.pone.0013411			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	664DX	20976238	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000025
J	Bonomi, M; Barducci, A; Gervasio, FL; Parrinello, M				Bonomi, Massimiliano; Barducci, Alessandro; Gervasio, Francesco L.; Parrinello, Michele			Multiple Routes and Milestones in the Folding of HIV-1 Protease Monomer	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; ENERGY LANDSCAPES; DRUG-RESISTANCE; STABILITY; DIMERIZATION; SIMULATIONS; FLEXIBILITY; PROTEINS; INSIGHT; FUNNELS	Proteins fold on a time scale incompatible with a mechanism of random search in conformational space thus indicating that somehow they are guided to the native state through a funneled energetic landscape. At the same time the heterogeneous kinetics suggests the existence of several different folding routes. Here we propose a scenario for the folding mechanism of the monomer of HIV-1 protease in which multiple pathways and milestone events coexist. A variety of computational approaches supports this picture. These include very long all-atom molecular dynamics simulations in explicit solvent, an analysis of the network of clusters found in multiple high-temperature unfolding simulations and a complete characterization of free-energy surfaces carried out using a structure-based potential at atomistic resolution and a combination of metadynamics and parallel tempering. Our results confirm that the monomer in solution is stable toward unfolding and show that at least two unfolding pathways exist. In our scenario, the formation of a hydrophobic core is a milestone in the folding process which must occur along all the routes that lead this protein towards its native state. Furthermore, the ensemble of folding pathways proposed here substantiates a rational drug design strategy based on inhibiting the folding of HIV-1 protease.	[Bonomi, Massimiliano; Barducci, Alessandro; Parrinello, Michele] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Lugano, Switzerland; [Gervasio, Francesco L.] Spanish Natl Res Ctr, Computat Biophys Grp, Struct Biol & Biocomp Programme, Madrid, Spain		Bonomi, M (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Lugano, Switzerland.	mbonomi@ethz.ch	Barducci, Alessandro/K-3510-2013; Gervasio, Francesco Luigi/D-8154-2012; Bonomi, Massimiliano/G-2476-2010; Gervasio, Francesco/AAD-1036-2022; Barducci, Alessandro/AAF-9015-2019	Gervasio, Francesco Luigi/0000-0003-4831-5039; Gervasio, Francesco/0000-0003-4831-5039; Barducci, Alessandro/0000-0002-1911-8039; Bonomi, Massimiliano/0000-0002-7321-0004				Alm E, 1999, P NATL ACAD SCI USA, V96, P11305, DOI 10.1073/pnas.96.20.11305; Bahar I, 1998, PHYS REV LETT, V80, P2733, DOI 10.1103/PhysRevLett.80.2733; Bannwarth L, 2007, BIOCHEM SOC T, V35, P551, DOI 10.1042/BST0350551; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bonomi M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.190601; Bonomi M, 2009, J COMPUT CHEM, V30, P1615, DOI 10.1002/jcc.21305; Bonomi M, 2007, BIOPHYS J, V93, P2813, DOI 10.1529/biophysj.107.106369; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Bowman MJ, 2002, BIOPOLYMERS, V66, P126, DOI 10.1002/bip.10232; Brandes U, 2004, MATH VIS, P321; Brandes U, 2007, LECT NOTES COMPUT SC, V4372, P42; Broglia RA, 2008, CURR OPIN STRUC BIOL, V18, P60, DOI 10.1016/j.sbi.2007.10.004; Broglia RA, 2006, PROTEINS, V62, P928, DOI 10.1002/prot.20849; Broglia RA, 2005, PROTEIN SCI, V14, P2668, DOI 10.1110/ps.051670905; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Bussi G, 2006, J AM CHEM SOC, V128, P13435, DOI 10.1021/ja062463w; Cecconi F, 2001, PROTEINS, V43, P365, DOI 10.1002/prot.1049; Chipot C., 2007, SPRINGER SERIES CHEM; Clementi C, 2000, P NATL ACAD SCI USA, V97, P5871, DOI 10.1073/pnas.100547897; Daggett V, 2006, CHEM REV, V106, P1898, DOI 10.1021/cr0404242; Dellago C, 2009, ADV POLYM SCI, V221, P167, DOI 10.1007/12_2008_3; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Ding F, 2008, J AM CHEM SOC, V130, P7184, DOI 10.1021/ja800893d; Fersht AR, 2002, CELL, V108, P573, DOI 10.1016/S0092-8674(02)00620-7; Galiano L, 2007, J AM CHEM SOC, V129, P11004, DOI 10.1021/ja073684k; Galzitskaya OV, 1999, P NATL ACAD SCI USA, V96, P11299, DOI 10.1073/pnas.96.20.11299; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Hornak V, 2006, P NATL ACAD SCI USA, V103, P915, DOI 10.1073/pnas.0508452103; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Ishima R, 2003, J BIOL CHEM, V278, P43311, DOI 10.1074/jbc.M307549200; Ishima R, 2001, J BIOL CHEM, V276, P49110, DOI 10.1074/jbc.M108136200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Kogo H, 2009, BBA-PROTEINS PROTEOM, V1794, P70, DOI 10.1016/j.bbapap.2008.09.022; Laio A, 2002, P NATL ACAD SCI USA, V99, P12562, DOI 10.1073/pnas.202427399; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; Levy Y, 2004, J MOL BIOL, V340, P67, DOI 10.1016/j.jmb.2004.04.028; Levy Y, 2003, J PHYS CHEM B, V107, P3068, DOI 10.1021/jp0219956; LLOYD SP, 1982, IEEE T INFORM THEORY, V28, P129, DOI 10.1109/TIT.1982.1056489; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274; Noel AF, 2009, J MOL BIOL, V387, P1002, DOI 10.1016/j.jmb.2008.12.061; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piana S, 2002, J MOL BIOL, V319, P567, DOI 10.1016/S0022-2836(02)00301-7; Pietrucci F, 2009, J AM CHEM SOC, V131, P11811, DOI 10.1021/ja903045y; Rout MK, 2009, ARCH BIOCHEM BIOPHYS, V482, P33, DOI 10.1016/j.abb.2008.11.022; RUSCONI S, 2007, P INT SCH PHYS ENR F, V165, P293; Settanni G, 2008, BIOPHYS J, V94, P4444, DOI 10.1529/biophysj.107.122606; Shafer RW, 1999, J VIROL, V73, P6197, DOI 10.1128/JVI.73.7.6197-6202.1999; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; Sugita Y, 1999, CHEM PHYS LETT, V314, P141, DOI 10.1016/S0009-2614(99)01123-9; Tiana G, 2009, PROTEINS, V76, P895, DOI 10.1002/prot.22395; Tomasselli AG, 2000, BBA-PROTEIN STRUCT M, V1477, P189, DOI 10.1016/S0167-4838(99)00273-3; Vendruscolo M, 1999, PHYS REV LETT, V82, P656, DOI 10.1103/PhysRevLett.82.656; Wallqvist A, 1998, PROTEIN ENG, V11, P999, DOI 10.1093/protein/11.11.999; Weinkam P, 2005, P NATL ACAD SCI USA, V102, P12401, DOI 10.1073/pnas.0505274102; Whitford PC, 2009, PROTEINS, V75, P430, DOI 10.1002/prot.22253; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Xie D, 1999, PROTEIN SCI, V8, P1702, DOI 10.1110/ps.8.8.1702; Yan MC, 2008, PROTEINS, V70, P731, DOI 10.1002/prot.21539	62	13	13	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13208	10.1371/journal.pone.0013208	http://dx.doi.org/10.1371/journal.pone.0013208			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967249	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800005
J	Knox, SS; Guo, XX; Zhang, YQ; Weidner, G; Williams, S; Ellison, RC				Knox, Sarah S.; Guo, Xinxin; Zhang, Yuqing; Weidner, G.; Williams, Scott; Ellison, R. Curtis			AGT M235T Genotype/Anxiety Interaction and Gender in the HyperGEN Study	PLOS ONE			English	Article							LONGITUDINAL DATA-ANALYSIS; GENOME-WIDE ASSOCIATION; ESSENTIAL-HYPERTENSION; COMPLEX DISEASE; HEART-RATE; ANGIOTENSINOGEN; ENVIRONMENT; STRESS; GENES; RISK	Background: Both anxiety and elevated heart rate (HR) have been implicated in the development of hypertension. The HyperGen cohort, consisting of siblings with severe and mild hypertension, an age-matched random sample of persons from the same base populations, and unmedicated adult offspring of the hypertensive siblings (N = 1,002 men and 987 women), was analyzed for an association of the angiotenisinogen AGTM235T genotype (TT, MT, MM) with an endophenotype, heart rate (HR) in high and low anxious groups. Methodology: The interaction of AGTM genotype with anxiety, which has been independently associated with hypertension, was investigated adjusting for age, hypertension status, smoking, alcohol consumption, beta blocker medication, body mass index, physical activity and hours of television viewing (sedentary life style). Principal Findings: Although there was no main effect of genotype on HR in men or women, high anxious men with the TT genotype had high HR, whereas high anxious men with the MM genotype had low HR. In women, HR was inversely associated with anxiety but there was no interaction with genotype. Conclusion/Significance: The results suggest that high anxiety in men with the TT genotype may increase risk for hypertension whereas the MM genotype may be protective in high anxious men. This type of gene x environment interaction may be one reason why genome wide association studies sometimes fail to replicate. The locus may be important only in combination with certain environmental factors.	[Knox, Sarah S.] W Virginia Univ, Sch Med, Mary Babb Randolf Canc Ctr, Dept Community Med, Morgantown, WV 26506 USA; [Guo, Xinxin] Outcome Sci Inc, Cambridge, MA USA; [Zhang, Yuqing; Ellison, R. Curtis] Boston Univ, Sch Med, Evans Dept Med, Boston, MA 02118 USA; [Weidner, G.] San Francisco State Univ, Dept Biol, Tiburon, CA USA; [Williams, Scott] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN USA	West Virginia University; Boston University; California State University System; San Francisco State University; Vanderbilt University	Knox, SS (corresponding author), W Virginia Univ, Sch Med, Mary Babb Randolf Canc Ctr, Dept Community Med, Morgantown, WV 26506 USA.	sknox@hsc.wvu.edu	Williams, Scott/Q-4812-2019; Williams, Scott/B-9491-2012	Williams, Scott/0000-0002-4835-9544; Ellison, Robert Curtis/0000-0002-0582-7467; Knox, Sarah/0000-0002-6286-9997; Zhang, Yuqing/0000-0001-7954-1149	NHLBI [HL544471, HL54472, HL54473, HL54495, HL54496, HL54497, HL54509, HL54515]; National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL054472, U01HL054509, U10HL054496, U01HL054497, U10HL054515, U01HL054496, U10HL054473, U10HL054497, U10HL054495, U01HL054495, U01HL054473, U10HL054472, U10HL054509] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The HyperGEN network is funded by cooperative agreements (U10) with NHLBI: HL544471 (UT FC), HL54472 (MN Lab), HL54473 (DCC), HL54495 (AL FC), HL54496 (MN FC), HL54497 (MA), HL54509 (NJC), HL54515 (UT DNA Lab). The National Heart, Lung and Blood Institute (NHLBI) at the U.S. National Institutes of Health funded this work and NHLBI scientists were involved in its design together with university scientists. The design, implementation, and preparation of manuscripts from this study was the result of a collaborative effort of investigators from the NHLBI and all institutions involved. Although one of the co-authors, Xinxin Guo, is currently employed by a commercial company, Outcome Sciences, Inc., she was employed by Boston University at the time these analyses were performed. Outcome Sciences had no role in planning this study nor were they involved in any way in the analyses or interpretation of the data. They are completely independent.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DIMSDALE JE, 1990, NEUROPSYCHOPHARMACOL, V3, P237; Gardner M, 2008, AM J MED GENET B, V147B, P1070, DOI 10.1002/ajmg.b.30717; Harter MC, 2003, EUR ARCH PSY CLIN N, V253, P313, DOI 10.1007/s00406-003-0449-y; HOLLENBERG NK, 1981, HYPERTENSION, V3, P11, DOI 10.1161/01.HYP.3.1.11; Iacobas DA, 2010, BIOCHEM BIOPH RES CO, V391, P1769, DOI 10.1016/j.bbrc.2009.12.151; Imumorin IG, 2005, CARDIOVASC TOXICOL, V5, P109, DOI 10.1385/CT:5:2:109; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; Jonas BS, 1997, ARCH FAM MED, V6, P43, DOI 10.1001/archfami.6.1.43; Knox SS, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-11; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; Lanz JR, 2005, CLIN CHIM ACTA, V362, P176, DOI 10.1016/j.cccn.2005.06.004; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lin JL, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-9; MARKOVITZ JH, 1993, JAMA-J AM MED ASSOC, V270, P2439; MONDRY A, 2004, BMC NEPHROL, V6, P1; Moore JH, 2009, AM J HUM GENET, V85, P309, DOI 10.1016/j.ajhg.2009.08.006; Musani SK, 2007, HUM HERED, V63, P67, DOI 10.1159/000099179; Pan WH, 2006, GENET EPIDEMIOL, V30, P143, DOI 10.1002/gepi.20136; Sarzani R, 2001, J HYPERTENS, V19, P2171, DOI 10.1097/00004872-200112000-00009; Sethi AA, 2003, ARTERIOSCL THROM VAS, V23, P1269, DOI 10.1161/01.ATV.0000079007.40884.5C; Sing CF, 2003, ARTERIOSCL THROM VAS, V23, P1190, DOI 10.1161/01.ATV.0000075081.51227.86; SPENCE JD, 1990, AM J HYPERTENS, V3, P859, DOI 10.1093/ajh/3.11.859; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; TJUGEN TB, 2010, CURR HYPERTENS REP; Wilk JB, 2006, ANN HUM GENET, V70, P566, DOI 10.1111/j.1469-1809.2005.00258.x; Williams RR, 2000, ANN EPIDEMIOL, V10, P389, DOI 10.1016/S1047-2797(00)00063-6; Xing SQ, 2009, AM J PHYSIOL-HEART C, V296, pH1907, DOI 10.1152/ajpheart.00681.2008; Yang G, 1996, BIOL SIGNAL, V5, P1; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	31	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13353	10.1371/journal.pone.0013353	http://dx.doi.org/10.1371/journal.pone.0013353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967221	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800037
J	Satyanarayana, S; Shivashankar, R; Vashist, RP; Chauhan, LS; Chadha, SS; Dewan, PK; Wares, F; Sahu, S; Singh, V; Wilson, NC; Harries, AD				Satyanarayana, Srinath; Shivashankar, Roopa; Vashist, Ram Pal; Chauhan, Lakhbir Singh; Chadha, Sarabjit Singh; Dewan, Puneet Kumar; Wares, Fraser; Sahu, Suvanand; Singh, Varinder; Wilson, Nevin Charles; Harries, Anthony David			Characteristics and Programme-Defined Treatment Outcomes among Childhood Tuberculosis (TB) Patients under the National TB Programme in Delhi	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; RESPIRATORY TUBERCULOSIS; PEDIATRIC TUBERCULOSIS; CHILDREN; EPIDEMIOLOGY; TRANSMISSION; DIAGNOSIS	Background: Childhood tuberculosis (TB) patients under India's Revised National TB Control Programme (RNTCP) are managed using diagnostic algorithms and directly observed treatment with intermittent thrice-weekly short-course treatment regimens for 6-8 months. The assignment into pre-treatment weight bands leads to drug doses (milligram per kilogram) that are lower than current World Health Organization (WHO) guidelines for some patients. Objectives: The main aim of our study was to describe the baseline characteristics and treatment outcomes reported under RNTCP for registered childhood (age <15 years) TB patients in Delhi. Additionally, we compared the reported programmatic treatment completion rates between children treated as per WHO recommended anti-TB drug doses with those children treated with anti-TB drug doses below that recommended in WHO guidelines. Methods: For this cross-sectional retrospective study, we reviewed programme records of all 1089 TB patients aged <15 years registered for TB treatment from January to June, 2008 in 6 randomly selected districts of Delhi. WHO disease classification and treatment outcome definitions are used by RNTCP, and these were extracted as reported in programme records. Results and Conclusions: Among 1074 patients with records available, 651 (61%) were females, 122 (11%) were <5 years of age, 1000 (93%) were new cases, and 680 (63%) had extra-pulmonary TB (EP-TB)-most commonly peripheral lymph node disease [310 (46%)]. Among 394 pulmonary TB (PTB) cases, 165 (42%) were sputum smear-positive. The overall reported treatment completion rate was 95%. Similar reported treatment completion rates were found in all subgroups assessed, including those patients whose drug dosages were lower than that currently recommended by WHO. Further studies are needed to assess the reasons for the low proportion of under-5 years of age TB case notifications, address challenges in reaching all childhood TB patients by RNTCP, the accuracy of diagnosis, and the clinical validity of reported programme defined treatment completion.	[Satyanarayana, Srinath; Harries, Anthony David] Int Union TB & Lung Dis Union, Ctr Operat Res, Paris, France; [Satyanarayana, Srinath; Wilson, Nevin Charles] Int Union TB & Lung Dis Union, SE Asia Reg Off, New Delhi, India; [Shivashankar, Roopa] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Vashist, Ram Pal] Govt Delhi, State TB Off, Delhi, India; [Chauhan, Lakhbir Singh] Govt India, Minist Hlth & Family Welf, Directorate Gen Hlth Serv, Cent TB Div, New Delhi, India; [Chadha, Sarabjit Singh; Dewan, Puneet Kumar; Wares, Fraser; Sahu, Suvanand] WHO, Off World Hlth Org Representat India, New Delhi, India; [Singh, Varinder] Lady Hardinge Med Coll & Hosp, Dept Paediat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; World Health Organization; Lady Hardinge Medical College & Hospital	Satyanarayana, S (corresponding author), Int Union TB & Lung Dis Union, Ctr Operat Res, Paris, France.	ssrinath@theunion.org		Satyanarayana, Srinath/0000-0002-5420-2551; Wilson, Nevin/0000-0002-0191-8855	Centre for Operational Research; International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	Centre for Operational Research; International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, the International Union Against Tuberculosis and Lung Disease, and the Operational Research Unit, Medecins sans Frontieres, Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Cardona M, 1999, J PAEDIATR CHILD H, V35, P375, DOI 10.1046/j.1440-1754.1999.00385.x; *CENTR TUB DIV, 2006, GUID US PED PAT WIS; *CENTR TUB DIV, 2009, TUB IND 2009 ANN REP; *CENTR TUB DIV, 2005, REV NAT TUB CONTR PR; Central Tuberculosis Division, 2005, STRAT DOC SUP MON RE; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Chauhan L S, 2004, Indian Pediatr, V41, P901; Curtis AB, 1999, NEW ENGL J MED, V341, P1491, DOI 10.1056/NEJM199911113412002; Donabedian P., 2007, RENAISSANCE ARCHITEC, P124; GIE RP, 1995, S AFR MED J, V85, P658; *GOV IND MIN HLTH, 2008, HIV SENT SURV HIV ES; Graham SM, 2006, ANTIMICROB AGENTS CH, V50, P407, DOI 10.1128/AAC.50.2.407-413.2006; Indumathi CK, 2010, INDIAN PEDIATR, V47, P93, DOI 10.1007/s13312-010-0012-7; Kabra S K, 2004, Indian Pediatr, V41, P927; Lodha R, 2008, INDIAN PEDIATR, V45, P852; Marais BJ, 2008, PEDIATR PULM, V43, P322, DOI 10.1002/ppul.20787; Marais BJ, 2006, AM J RESP CRIT CARE, V173, P1078, DOI 10.1164/rccm.200511-1809SO; Marais BJ, 2005, INT J TUBERC LUNG D, V9, P1305; NANI N, 2007, RES PRIORITIES TB CO; Nelson LJ, 2004, INT J TUBERC LUNG D, V8, P636; RABALAIS G, 1991, LANCET, V338, P825, DOI 10.1016/0140-6736(91)90719-6; Schaaf HS, 2005, ARCH DIS CHILD, V90, P614, DOI 10.1136/adc.2004.052175; SCHAAF HS, 1995, PEDIATR INFECT DIS J, V14, P189, DOI 10.1097/00006454-199503000-00004; Sharma S, 2008, INT J TUBERC LUNG D, V12, P74; Sharma Sangeeta, 2010, Indian J Tuberc, V57, P4; Singh V, 2006, PAEDIATR RESPIR REV, V7, pS132, DOI 10.1016/j.prrv.2006.04.222; Starke JR, 2003, TUBERCULOSIS, V83, P208, DOI 10.1016/S1472-9792(02)00088-4; Stop TB Partnership, 2006, GLOB PLAN STOP TB 20; Swaminathan S, 2008, INDIAN PEDIATR, V45, P743; WHO, 2009, WHO REP GLOB TUB CON; *WHO, 2010, CHILDH TUB; WHO, 2009, DOS INSTR US CURR AV; *WHO, 2009, REP M TB MED CHILDR; World Health Organisation, 2006, GUID NAT TUB PROGR M; World Health Organization, 2003, TREATM TUB GUID NAT, DOI DOI 10.1016/S0035-9203(99)90185-2	36	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13338	10.1371/journal.pone.0013338	http://dx.doi.org/10.1371/journal.pone.0013338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967279	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300026
J	Ger, MF; Rendon, G; Tilson, JL; Jakobsson, E				Ger, Mao-Feng; Rendon, Gloria; Tilson, Jeffrey L.; Jakobsson, Eric			Domain-Based Identification and Analysis of Glutamate Receptor Ion Channels and Their Relatives in Prokaryotes	PLOS ONE			English	Article							PREDICTION; MECHANISMS	Voltage-gated and ligand-gated ion channels are used in eukaryotic organisms for the purpose of electrochemical signaling. There are prokaryotic homologues to major eukaryotic channels of these sorts, including voltage-gated sodium, potassium, and calcium channels, Ach-receptor and glutamate-receptor channels. The prokaryotic homologues have been less well characterized functionally than their eukaryotic counterparts. In this study we identify likely prokaryotic functional counterparts of eukaryotic glutamate receptor channels by comprehensive analysis of the prokaryotic sequences in the context of known functional domains present in the eukaryotic members of this family. In particular, we searched the nonredundant protein database for all proteins containing the following motif: the two sections of the extracellular glutamate binding domain flanking two transmembrane helices. We discovered 100 prokaryotic sequences containing this motif, with a wide variety of functional annotations. Two groups within this family have the same topology as eukaryotic glutamate receptor channels. Group 1 has a potassium-like selectivity filter. Group 2 is most closely related to eukaryotic glutamate receptor channels. We present analysis of the functional domain architecture for the group of 100, a putative phylogenetic tree, comparison of the protein phylogeny with the corresponding species phylogeny, consideration of the distribution of these proteins among classes of prokaryotes, and orthologous relationships between prokaryotic and human glutamate receptor channels. We introduce a construct called the Evolutionary Domain Network, which represents a putative pathway of domain rearrangements underlying the domain composition of present channels. We believe that scientists interested in ion channels in general, and ligand-gated ion channels in particular, will be interested in this work. The work should also be of interest to bioinformatics researchers who are interested in the use of functional domain-based analysis in evolutionary and functional discovery.	[Ger, Mao-Feng; Jakobsson, Eric] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Rendon, Gloria; Jakobsson, Eric] Univ Illinois, Natl Ctr Supercomp Applicat, Urbana, IL 61801 USA; [Tilson, Jeffrey L.] Renaissance Comp Inst, Raleigh, NC USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Ger, MF (corresponding author), Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA.	jake@illinois.edu			National Science Foundation (NSF) [0835718]	National Science Foundation (NSF)(National Science Foundation (NSF))	The authors gratefully acknowledge support from National Science Foundation (NSF) grant 0835718, "Hierarchical Modularity in Structure and Function'' to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashcroft FM, 2006, NATURE, V440, P440, DOI 10.1038/nature04707; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Booth IR, 2003, BIOCHEMISTRY-US, V42, P10045, DOI 10.1021/bi034953w; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FELSENSTEIN J, 1993, PHYIP PHYLOGENY INFE; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hu ZJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-1; Kalsbeek A, 2007, ENDOCRINOLOGY, V148, P5635, DOI 10.1210/en.2007-0776; Kuner T, 2003, TRENDS NEUROSCI, V26, P27, DOI 10.1016/S0166-2236(02)00010-3; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Pohorille A, 2005, ASTROBIOLOGY, V5, P1, DOI 10.1089/ast.2005.5.1; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tasneem A, 2005, GENOME BIOL, V6; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tilson JL, 2007, PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II, P620; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	25	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e12827	10.1371/journal.pone.0012827	http://dx.doi.org/10.1371/journal.pone.0012827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949136	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400001
J	Liu, XP; Tang, WH; Zhao, XM; Chen, LN				Liu, Xiaoping; Tang, Wei-Hua; Zhao, Xing-Ming; Chen, Luonan			A Network Approach to Predict Pathogenic Genes for Fusarium graminearum	PLOS ONE			English	Article							PROTEIN BETA-SUBUNIT; COMPLEX NETWORKS; CUTINASE GENE; NUCLEUS; KINASES; ROLES	Fusarium graminearum is the pathogenic agent of Fusarium head blight (FHB), which is a destructive disease on wheat and barley, thereby causing huge economic loss and health problems to human by contaminating foods. Identifying pathogenic genes can shed light on pathogenesis underlying the interaction between F. graminearum and its plant host. However, it is difficult to detect pathogenic genes for this destructive pathogen by time-consuming and expensive molecular biological experiments in lab. On the other hand, computational methods provide an alternative way to solve this problem. Since pathogenesis is a complicated procedure that involves complex regulations and interactions, the molecular interaction network of F. graminearum can give clues to potential pathogenic genes. Furthermore, the gene expression data of F. graminearum before and after its invasion into plant host can also provide useful information. In this paper, a novel systems biology approach is presented to predict pathogenic genes of F. graminearum based on molecular interaction network and gene expression data. With a small number of known pathogenic genes as seed genes, a subnetwork that consists of potential pathogenic genes is identified from the protein-protein interaction network (PPIN) of F. graminearum, where the genes in the subnetwork are further required to be differentially expressed before and after the invasion of the pathogenic fungus. Therefore, the candidate genes in the subnetwork are expected to be involved in the same biological processes as seed genes, which imply that they are potential pathogenic genes. The prediction results show that most of the pathogenic genes of F. graminearum are enriched in two important signal transduction pathways, including G protein coupled receptor pathway and MAPK signaling pathway, which are known related to pathogenesis in other fungi. In addition, several pathogenic genes predicted by our method are verified in other pathogenic fungi, which demonstrate the effectiveness of the proposed method. The results presented in this paper not only can provide guidelines for future experimental verification, but also shed light on the pathogenesis of the destructive fungus F. graminearum.	[Liu, Xiaoping; Zhao, Xing-Ming; Chen, Luonan] Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China; [Liu, Xiaoping] Shanghai Univ, Sch Commun & Informat Engn, Shanghai, Peoples R China; [Tang, Wei-Hua; Zhao, Xing-Ming] Chinese Acad Sci, Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Chen, Luonan] Chinese Acad Sci, Shanghai Inst Biol Sci, SIBS Novo Nordisk Translat Res Ctr PreDiabet, Key Lab Syst Biol, Shanghai, Peoples R China	Shanghai University; Shanghai University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Novo Nordisk	Liu, XP (corresponding author), Shanghai Univ, Inst Syst Biol, Shanghai, Peoples R China.	xm_zhao@shu.edu.cn; lnchen@sibs.ac.cn	Tang, Wei-Hua/C-9989-2011; liu, Xiaoping/B-5052-2016	Tang, Wei-Hua/0000-0002-6167-7870; liu, Xiaoping/0000-0002-3246-4227	Ministry of Science and Technology of China [2006CB101901]; National High Technology Research and Development Program of China [2006AA02Z309]; Shanghai Municipal Education Commission [10YZ01]; Innovation Funding of Shanghai University; National Key Laboratory of Plant Molecular Genetics; Shanghai Rising-Star Program [10QA1402700]; Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2009CSP002]; Shanghai Education Committee [B.10-0412-08-001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Innovation Funding of Shanghai University; National Key Laboratory of Plant Molecular Genetics; Shanghai Rising-Star Program; Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Education Committee	Dr Wei-hua Tang was partly supported by the Ministry of Science and Technology of China (Grant No. 2006CB101901). Dr Xing-Ming Zhao was partly supported by the National High Technology Research and Development Program of China (2006AA02Z309), Innovation Program of Shanghai Municipal Education Commission (10YZ01), Innovation Funding of Shanghai University, Open Funding of National Key Laboratory of Plant Molecular Genetics, Shanghai Rising-Star Program (10QA1402700). Dr Luonan Chen was supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences with Grant No. 2009CSP002, and supported by the Key Project of Shanghai Education Committee (B.10-0412-08-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294; Bickford LC, 2004, CURR OPIN STRUC BIOL, V14, P147, DOI 10.1016/j.sbi.2004.02.002; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bores-Walmsley MI, 2000, TRENDS MICROBIOL, V8, P133, DOI 10.1016/S0966-842X(00)01698-X; CAREY V, 2009, RBGL INTERFACE BOOST; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; ETTINGER WF, 1987, BIOCHEMISTRY-US, V26, P7883, DOI 10.1021/bi00398a052; Garcia-Higuera I, 1998, J BIOL CHEM, V273, P9041, DOI 10.1074/jbc.273.15.9041; Garvey GS, 2008, J BIOL CHEM, V283, P1660, DOI 10.1074/jbc.M705752200; Gioti A, 2006, J MOL BIOL, V358, P372, DOI 10.1016/j.jmb.2006.01.076; Gohre V, 2008, ANNU REV PHYTOPATHOL, V46, P189, DOI 10.1146/annurev.phyto.46.120407.110050; Guidi BW, 2004, J BIOL CHEM, V279, P29114, DOI 10.1074/jbc.M404426200; Gutkind JS, 1998, J BIOL CHEM, V273, P1839, DOI 10.1074/jbc.273.4.1839; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Kraus PR, 2003, BIOCHEM BIOPH RES CO, V311, P1151, DOI 10.1016/S0006-291X(03)01528-6; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenssen E, 2007, EUKARYOT CELL, V6, P2251, DOI 10.1128/EC.00327-06; LEWIN B, 2004, GENES 8; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Liu XP, 2007, INT J FOOD MICROBIOL, V119, P223, DOI 10.1016/j.ijfoodmicro.2007.07.054; Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Luttrell LM, 2005, J MOL NEUROSCI, V26, P253, DOI 10.1385/JMN:26:2-3:253; Mammoto A, 2000, J BIOL CHEM, V275, P13167, DOI 10.1074/jbc.C000096200; McMullen M, 1997, PLANT DIS, V81, P1340, DOI 10.1094/PDIS.1997.81.12.1340; Miedaner T, 2008, J PHYTOPATHOL, V156, P129, DOI 10.1111/j.1439-0434.2007.01394.x; Munoz I, 2003, YEAST, V20, P157, DOI 10.1002/yea.938; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Pestka JJ, 2005, J TOXICOL ENV HEAL B, V8, P39, DOI 10.1080/10937400590889458; Regenfelder E, 1997, EMBO J, V16, P1934, DOI 10.1093/emboj/16.8.1934; Sinha I, 2007, DEV CELL, V13, P421, DOI 10.1016/j.devcel.2007.06.011; Stergiopoulos I, 2003, PEST MANAG SCI, V59, P1333, DOI 10.1002/ps.766; SWEIGARD JA, 1992, MOL GEN GENET, V232, P174, DOI 10.1007/BF00279994; Tang Z, 2007, BIOCHEM J, V405, P21, DOI 10.1042/BJ20061523; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; WU Z, 2010, BMC SYSTEMS IN PRESS; Zeller CE, 2007, J BIOL CHEM, V282, P25168, DOI 10.1074/jbc.M702569200; Zhao XM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-57; Zhao XM, 2009, J PROTEOME RES, V8, P4714, DOI 10.1021/pr900415b; Zhao XM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn145; ZHAO XM, 2008, 2 INT S OPT SYST BIO, P115	46	51	51	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13021	10.1371/journal.pone.0013021	http://dx.doi.org/10.1371/journal.pone.0013021			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957229	Green Published, gold			2022-12-27	WOS:000282423300001
J	Wang, T; Yu, QJ; Chen, JA; Deng, B; Qian, LH; Le, YY				Wang, Ting; Yu, Qiujing; Chen, Juan; Deng, Bo; Qian, Lihua; Le, Yingying			PP2A Mediated AMPK Inhibition Promotes HSP70 Expression in Heat Shock Response	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; PANCREATIC BETA-CELLS; OKADAIC ACID; CERAMIDE; DEPHOSPHORYLATION; APOPTOSIS; GLUCOSE; 2A; PHOSPHORYLATION; ACCUMULATION	Background: Under stress, AMP-activated protein kinase (AMPK) plays a central role in energy balance, and the heat shock response is a protective mechanism for cell survival. The relationship between AMPK activity and heat shock protein (HSP) expression under stress is unclear. Methodology/Principal Findings: We found that heat stress induced dephosphorylation of AMPK alpha subunit (AMPK alpha) in various cell types from human and rodent. In HepG2 cells, the dephosphorylation of AMPK alpha under heat stress in turn caused dephosphorylation of acetyl-CoA carboxylase and upregulation of phosphoenolpyruvate carboxykinase, two downstream targets of AMPK, confirming the inhibition of AMPK activity by heat stress. Treatment of HepG2 cells with phosphatase 2A (PP2A) inhibitor okadaic acid or inhibition of PP2A expression by RNA interference efficiently reversed heat stress-induced AMPKa dephosphorylation, suggesting that heat stress inhibited AMPK through activation of PP2A. Heat stress-and other HSP inducer (CdCl2, celastrol, MG132)-induced HSP70 expression could be inhibited by AICAR, an AMPK specific activator. Inhibition of AMPKa expression by RNA interference reversed the inhibitory effect of AICAR on HSP70 expression under heat stress. These results indicate that AMPK inhibition under stress contribute to HSP70 expression. Mechanistic studies showed that activation of AMPK by AICAR had no effect on heat stress-induced HSF1 nuclear translocation, phosphorylation and binding with heat response element in the promoter region of HSP70 gene, but significantly decreased HSP70 mRNA stability. Conclusions/Significance: These results demonstrate that during heat shock response, PP2A mediated AMPK inhibition upregulates HSP70 expression at least partially through stabilizing its mRNA, which suggests a novel mechanism for HSP induction under stress.	[Wang, Ting] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Wang, T (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yyle@sibs.ac.cn	Le, Yingying/L-9785-2017	Le, Yingying/0000-0002-7990-3899; wang, ting/0000-0003-2257-0699	Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences [SIBS2008006]	Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006, Y. Le). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Favre B, 1997, J BIOL CHEM, V272, P13856, DOI 10.1074/jbc.272.21.13856; Gimeno-Alcaniz JV, 2003, J MOL BIOL, V333, P201, DOI 10.1016/j.jmb.2003.08.022; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200; Jung JH, 2010, J CELL PHYSIOL, V223, P408, DOI 10.1002/jcp.22049; Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3; Kodiha M, 2007, AM J PHYSIOL-CELL PH, V293, pC1427, DOI 10.1152/ajpcell.00176.2007; Kondo T, 2000, J BIOL CHEM, V275, P7668, DOI 10.1074/jbc.275.11.7668; Lee JY, 1996, J BIOL CHEM, V271, P13169, DOI 10.1074/jbc.271.22.13169; Li CY, 2010, CURR OPIN PHARMACOL, V10, P111, DOI 10.1016/j.coph.2009.11.009; Liangpunsakul S, 2010, AM J PHYSIOL-GASTR L, V298, pG1004, DOI 10.1152/ajpgi.00482.2009; Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Ruvolo PP, 1999, J BIOL CHEM, V274, P20296, DOI 10.1074/jbc.274.29.20296; Rylander MN, 2005, ANN NY ACAD SCI, V1066, P222, DOI 10.1196/annals.1363.009; Sharma A, 2010, CANCER SCI, V101, P1186, DOI 10.1111/j.1349-7006.2010.01516.x; SISTONEN L, 1994, MOL CELL BIOL, V14, P2087, DOI 10.1128/MCB.14.3.2087; Wang OM, 2008, ENDOCRINOLOGY, V149, P672, DOI 10.1210/en.2007-0106; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Wu Y, 2007, J BIOL CHEM, V282, P9777, DOI 10.1074/jbc.M608310200	26	18	20	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13096	10.1371/journal.pone.0013096	http://dx.doi.org/10.1371/journal.pone.0013096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957029	Green Submitted, Green Published, gold			2022-12-27	WOS:000282359300006
J	Weetman, D; Wilding, CS; Steen, K; Morgan, JC; Simard, F; Donnelly, MJ				Weetman, David; Wilding, Craig S.; Steen, Keith; Morgan, John C.; Simard, Frederic; Donnelly, Martin J.			Association Mapping of Insecticide Resistance in Wild Anopheles gambiae Populations: Major Variants Identified in a Low-Linkage Disequilbrium Genome	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; MOLECULAR-FORMS; WIDE ASSOCIATION; KDR MUTATION; TREATED NETS; MALARIA; SPECIATION; COMPLEX; AFRICA	Background: Association studies are a promising way to uncover the genetic basis of complex traits in wild populations. Data on population stratification, linkage disequilibrium and distribution of variant effect-sizes for different trait-types are required to predict study success but are lacking for most taxa. We quantified and investigated the impacts of these key variables in a large-scale association study of a strongly selected trait of medical importance: pyrethroid resistance in the African malaria vector Anopheles gambiae. Methodology/Principal Findings: We genotyped approximate to 1500 resistance-phenotyped wild mosquitoes from Ghana and Cameroon using a 1536-SNP array enriched for candidate insecticide resistance gene SNPs. Three factors greatly impacted study power. (1) Population stratification, which was attributable to co-occurrence of molecular forms (M and S), and cryptic within-form stratification necessitating both a partitioned analysis and genomic control. (2) All SNPs of substantial effect (odds ratio, OR. 2) were rare (minor allele frequency, MAF, 0.05). (3) Linkage disequilibrium (LD) was very low throughout most of the genome. Nevertheless, locally high LD, consistent with a recent selective sweep, and uniformly high ORs in each subsample facilitated significant direct and indirect detection of the known insecticide target site mutation kdr L1014F (OR< 6; P, 10 26), but with resistance level modified by local haplotypic background. Conclusion: Primarily as a result of very low LD in wild A. Gambiae, LD-based association mapping is challenging, but is feasible at least for major effect variants, especially where LD is enhanced by selective sweeps. Such variants will be of greatest importance for predictive diagnostic screening.	[Weetman, David; Wilding, Craig S.; Steen, Keith; Morgan, John C.; Donnelly, Martin J.] Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Liverpool L3 5QA, Merseyside, England; [Simard, Frederic] IRD, UR016, Lab Lutte Insectes Nuisibles LIN, Montpellier, France	Liverpool School of Tropical Medicine; University of Liverpool; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Weetman, D (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Grp, Pembroke Pl, Liverpool L3 5QA, Merseyside, England.	dweetman@liv.ac.uk	SIMARD, Frederic/J-9489-2016; Wilding, Craig S/C-5500-2012; Frederic, SIMARD/AFV-5001-2022; Weetman, David/M-1261-2014	SIMARD, Frederic/0000-0002-2871-5329; Wilding, Craig S/0000-0001-5818-2706; Frederic, SIMARD/0000-0002-2871-5329; steen, keith/0000-0002-8933-8643; Weetman, David/0000-0002-5820-1388; Donnelly, Martin/0000-0001-5218-1497	NIAID NIH HHS [R01 AI082734, R01AI082734-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082734] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cohuet A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-227; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; Corander J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-539; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2009, T ROY SOC TROP MED H, V103, P1113, DOI 10.1016/j.trstmh.2009.01.008; David JP, 2005, P NATL ACAD SCI USA, V102, P4080, DOI 10.1073/pnas.0409348102; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; Denholm I, 2002, SCIENCE, V297, P2222, DOI 10.1126/science.1077266; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Enayati A, 2010, ANNU REV ENTOMOL, V55, P569, DOI 10.1146/annurev-ento-112408-085423; Esnault C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001968; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Eyre-Walker A, 2010, P NATL ACAD SCI USA, V107, P1752, DOI 10.1073/pnas.0906182107; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jallow M, 2009, NAT GENET, V41, P657, DOI 10.1038/ng.388; Lynd A, 2010, MOL BIOL EVOL, V27, P1117, DOI 10.1093/molbev/msq002; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pinto J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001243; Pritchard JK, 2001, THEOR POPUL BIOL, V60, P227, DOI 10.1006/tpbi.2001.1543; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-163; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Soderlund DM, 2008, PEST MANAG SCI, V64, P610, DOI 10.1002/ps.1574; SOKAL RR, 1994, BIOMETRY; TABERNET PB, 2010, PLOS BIOL, V8; Teo YY, 2010, NAT REV GENET, V11, P149, DOI 10.1038/nrg2731; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Van Emden HF, 2004, PEST VECTOR CONTROL; Weill M, 2000, INSECT MOL BIOL, V9, P451, DOI 10.1046/j.1365-2583.2000.00206.x; Weill M, 2003, NATURE, V423, P136, DOI 10.1038/423136b; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White BJ, 2007, AM J TROP MED HYG, V76, P334; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; White BJ, 2007, PLOS GENET, V3, P2404, DOI 10.1371/journal.pgen.0030217; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; *WHO, 2008, WHOHTMGMP20081; Wilding CS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-320; Wilding CS, 2009, INSECT SCI, V16, P361, DOI 10.1111/j.1744-7917.2009.01260.x	57	48	50	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13140	10.1371/journal.pone.0013140	http://dx.doi.org/10.1371/journal.pone.0013140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20976111	Green Accepted, Green Published, gold			2022-12-27	WOS:000282359300028
J	Dong, LL; Zhang, XF; Liu, DC; Fan, HJ; Sun, JZ; Zhang, ZJ; Qin, HJ; Li, B; Hao, ST; Li, ZS; Wang, DW; Zhang, AM; Ling, HQ				Dong, Lingli; Zhang, Xiaofei; Liu, Dongcheng; Fan, Huajie; Sun, Jiazhu; Zhang, Zhongjuan; Qin, Huanju; Li, Bin; Hao, Shanting; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Ling, Hong-Qing			New Insights into the Organization, Recombination, Expression and Functional Mechanism of Low Molecular Weight Glutenin Subunit Genes in Bread Wheat	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; DOUBLED HAPLOID POPULATION; MAKING QUALITY; DURUM-WHEAT; DOUGH PROPERTIES; ALLELIC VARIATION; STORAGE PROTEINS; PROLAMIN GENES; RICH REGIONS; STS MARKERS	The bread-making quality of wheat is strongly influenced by multiple low molecular weight glutenin subunit (LMW-GS) proteins expressed in the seeds. However, the organization, recombination and expression of LMW-GS genes and their functional mechanism in bread-making are not well understood. Here we report a systematic molecular analysis of LMW-GS genes located at the orthologous Glu-3 loci (Glu-A3, B3 and D3) of bread wheat using complementary approaches (genome wide characterization of gene members, expression profiling, proteomic analysis). Fourteen unique LMW-GS genes were identified for Xiaoyan 54 (with superior bread-making quality). Molecular mapping and recombination analyses revealed that the three Glu-3 loci of Xiaoyan 54 harbored dissimilar numbers of LMW-GS genes and covered different genetic distances. The number of expressed LMW-GS in the seeds was higher in Xiaoyan 54 than in Jing 411 (with relatively poor bread-making quality). This correlated with the finding of higher numbers of active LMW-GS genes at the A3 and D3 loci in Xiaoyan 54. Association analysis using recombinant inbred lines suggested that positive interactions, conferred by genetic combinations of the Glu-3 locus alleles with more numerous active LMW-GS genes, were generally important for the recombinant progenies to attain high Zeleny sedimentation value (ZSV), an important indicator of bread-making quality. A higher number of active LMW-GS genes tended to lead to a more elevated ZSV, although this tendency was influenced by genetic background. This work provides substantial new insights into the genomic organization and expression of LMW-GS genes, and molecular genetic evidence suggesting that these genes contribute quantitatively to bread-making quality in hexaploid wheat. Our analysis also indicates that selection for high numbers of active LMW-GS genes can be used for improvement of bread-making quality in wheat breeding.	[Dong, Lingli; Zhang, Xiaofei; Liu, Dongcheng; Fan, Huajie; Sun, Jiazhu; Zhang, Zhongjuan; Qin, Huanju; Li, Bin; Hao, Shanting; Li, Zhensheng; Wang, Daowen; Zhang, Aimin; Ling, Hong-Qing] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Dong, LL (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	dwwang@genetics.ac.cn; amzhang@genetics.ac.cn; hqling@genetics.ac.cn	Ling, Hong-Qing/ABC-9451-2020	wang, dao wen/0000-0002-6230-8735; zhang, xiaofei/0000-0003-4516-9179	Ministry of Science and Technology of China [2006AA100102, 2006AA10A105, 2006AA10Z1B2, 2009CB118300]; National Natural Science Foundation of China [30821061]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Financial support for this work was provided by the Ministry of Science and Technology of China (grants 2006AA100102, 2006AA10A105, 2006AA10Z1B2, 2009CB118300) and the National Natural Science Foundation of China (grant 30821061). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appels R, 2001, EUPHYTICA, V119, P49, DOI 10.1023/A:1017542405338; AUTRAN JC, 1987, BIOCHIMIE, V69, P699, DOI 10.1016/0300-9084(87)90191-X; AXFORD DWE, 1979, CEREAL CHEM, V56, P582; Barro F, 1997, NAT BIOTECHNOL, V15, P1295, DOI 10.1038/nbt1197-1295; Bekes F, 2006, EUR J AGRON, V25, P155, DOI 10.1016/j.eja.2006.04.008; Blechl AE, 1996, NAT BIOTECHNOL, V14, P875, DOI 10.1038/nbt0796-875; BRANLARD G, 1992, THEOR APPL GENET, V84, P57, DOI 10.1007/BF00223981; Butow BJ, 2004, THEOR APPL GENET, V109, P1525, DOI 10.1007/s00122-004-1776-8; Cloutier S, 2001, J CEREAL SCI, V33, P143, DOI 10.1006/jcrs.2000.0359; Cornish G. B., 2006, Gliadin and glutenin: the unique balance of wheat quality, P243; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; DOVIDIO R, 1992, J CEREAL SCI, V16, P165, DOI 10.1016/S0733-5210(09)80148-3; Eagles HA, 2006, AUST J AGR RES, V57, P179, DOI 10.1071/AR05242; Eagles HA, 2002, AUST J AGR RES, V53, P367, DOI 10.1071/AR01074; Gao SC, 2007, PLANT MOL BIOL, V65, P189, DOI 10.1007/s11103-007-9208-1; Gill KS, 1996, GENETICS, V144, P1883; Gill KS, 1996, GENETICS, V143, P1001; Groos C, 2007, THEOR APPL GENET, V115, P313, DOI 10.1007/s00122-007-0563-8; GUPTA RB, 1989, THEOR APPL GENET, V77, P57, DOI 10.1007/BF00292316; GUPTA RB, 1990, THEOR APPL GENET, V80, P65, DOI 10.1007/BF00224017; GUPTA RB, 1991, CEREAL CHEM, V68, P328; He Z., 2001, HIST WHEAT BREEDING; He ZH, 2005, CEREAL CHEM, V82, P345, DOI 10.1094/CC-82-0345; Huang XQ, 2008, THEOR APPL GENET, V116, P953, DOI 10.1007/s00122-008-0727-1; Hussain A, 1997, CEREAL CHEM, V74, P791, DOI 10.1094/CCHEM.1997.74.6.791; Ikeda TM, 2006, THEOR APPL GENET, V112, P327, DOI 10.1007/s00122-005-0131-z; Ikeda TM, 2002, THEOR APPL GENET, V104, P680, DOI 10.1007/s001220100756; Jackson E. A., 1996, Journal of Genetics and Breeding, V50, P321; JACKSON EA, 1983, THEOR APPL GENET, V66, P29, DOI 10.1007/BF00281844; Johal J, 2004, THEOR APPL GENET, V109, P1028, DOI 10.1007/s00122-004-1711-z; JOSEPHIDES CM, 1987, CROP SCI, V27, P212, DOI 10.2135/cropsci1987.0011183X002700020016x; KIHARA H, 1944, AGR HORTIC, V19, P889, DOI DOI 10.1016/J.JGG.2011.07.002; Kuchel H, 2006, THEOR APPL GENET, V112, P1487, DOI 10.1007/s00122-006-0252-z; LEW EJL, 1992, CEREAL CHEM, V69, P508; Li Y, 2009, PLANT BREEDING, V128, P235, DOI 10.1111/j.1439-0523.2008.01578.x; Ma W, 2005, THEOR APPL GENET, V111, P410, DOI 10.1007/s00122-005-2001-0; MACRITCHIE F, 1987, J CEREAL SCI, V6, P259, DOI 10.1016/S0733-5210(87)80063-2; Mamone G, 2009, J MASS SPECTROM, V44, P1709, DOI 10.1002/jms.1680; Mann G, 2009, THEOR APPL GENET, V118, P1519, DOI 10.1007/s00122-009-1000-y; MASCI S, 1995, CEREAL CHEM, V72, P100; MCFADDEN ES, 1946, J HERED, V37, P81, DOI 10.1093/oxfordjournals.jhered.a105590; METAKOVSKY EV, 1990, AUST J AGR RES, V41, P289, DOI 10.1071/AR9900289; Nelson JC, 2006, EUPHYTICA, V149, P145, DOI 10.1007/s10681-005-9062-7; Osborne T, 1924, VEGETABLE PROTEINS, P154; Oury FX, 2010, EUPHYTICA, V171, P87, DOI 10.1007/s10681-009-9997-1; Patil RM, 2009, J CEREAL SCI, V49, P378, DOI 10.1016/j.jcs.2009.01.001; PAYNE PI, 1987, ANNU REV PLANT PHYS, V38, P141, DOI 10.1146/annurev.pp.38.060187.001041; PAYNE PI, 1988, J CEREAL SCI, V7, P229, DOI [10.1016/S0733-5210(88)80004-3, 10.1006/jcrs.1998.0194]; PAYNE PI, 1984, J CEREAL SCI, V2, P73, DOI 10.1016/S0733-5210(84)80020-X; PAYNE PI, 1981, J SCI FOOD AGR, V32, P51, DOI 10.1002/jsfa.2740320109; Pena R. J., 2002, Journal of Crop Production, V5, P1, DOI 10.1300/J144v05n01_02; Perretant MR, 2000, THEOR APPL GENET, V100, P1167, DOI 10.1007/s001220051420; POGNA NE, 1990, J CEREAL SCI, V11, P15, DOI 10.1016/S0733-5210(09)80178-1; Rakszegi M, 2008, J AGR FOOD CHEM, V56, P9750, DOI 10.1021/jf8009359; Raman R, 2009, GENOME, V52, P701, DOI [10.1139/G09-045, 10.1139/g09-045]; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; SHEWRY PR, 1995, BIO-TECHNOL, V13, P1185, DOI 10.1038/nbt1195-1185; SINGH NK, 1988, THEOR APPL GENET, V75, P628, DOI 10.1007/BF00289132; SINGH R, 1991, NATL ACAD SCI LETT, V14, P203; Spielmeyer W, 2000, GENETICS, V155, P361; TAO HP, 1989, J EXP BOT, V40, P1015, DOI 10.1093/jxb/40.9.1015; Uthayakumaran S, 1999, CEREAL CHEM, V76, P389, DOI 10.1094/CCHEM.1999.76.3.389; Wang LH, 2009, THEOR APPL GENET, V118, P525, DOI 10.1007/s00122-008-0918-9; Weegels PL, 1996, J CEREAL SCI, V23, P1, DOI 10.1006/jcrs.1996.0001; Wicker T, 2003, PLANT CELL, V15, P1186, DOI 10.1105/tpc.011023; Yahiaoui N, 2004, PLANT J, V37, P528, DOI 10.1046/j.1365-313X.2003.01977.x; Zanetti S., 1999, Genetics and breeding for crop quality and resistance. Proceedings of the XV EUCARPIA Congress, Viterbo, Italy, September 20-25, 1998., P357; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zhang PP, 2007, CEREAL CHEM, V84, P370, DOI 10.1094/CCHEM-84-4-0370; Zhang W, 2004, THEOR APPL GENET, V108, P1409, DOI 10.1007/s00122-003-1558-8; Zhang YL, 2009, CROP PASTURE SCI, V60, P587, DOI 10.1071/CP08392; Zhao XL, 2007, THEOR APPL GENET, V114, P451, DOI 10.1007/s00122-006-0445-5; Zhao XL, 2006, THEOR APPL GENET, V113, P1247, DOI 10.1007/s00122-006-0379-y	74	57	59	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13548	10.1371/journal.pone.0013548	http://dx.doi.org/10.1371/journal.pone.0013548			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975830	Green Submitted, Green Published, gold			2022-12-27	WOS:000283293800015
J	Bisio, A; Stucchi, N; Jacono, M; Fadiga, L; Pozzo, T				Bisio, Ambra; Stucchi, Natale; Jacono, Marco; Fadiga, Luciano; Pozzo, Thierry			Automatic versus Voluntary Motor Imitation: Effect of Visual Context and Stimulus Velocity	PLOS ONE			English	Article							KINEMATIC FEATURES; SOCIAL-INTERACTION; ACTION PERCEPTION; MANUAL GESTURES; ARM MOVEMENTS; ATTENTION; INTERFERENCE; COORDINATION; TIME	Automatic imitation is the tendency to reproduce observed actions involutarily. Though this topic has been widely treated, at present little is known about the automatic imitation of the kinematic features of an observed movement. The present study was designed to understand if the kinematics of a previously seen stimulus primes the executed action, and if this effect is sensitive to the kinds of stimuli presented. We proposed a simple imitation paradigm in which a dot or a human demonstrator moved in front of the participant who was instructed either to reach the final position of the stimulus or to imitate its motion with his or her right arm. Participants' movements were automatically contaminated by stimulus velocity when it moved according to biological laws, suggesting that automatic imitation was kinematic dependent. Despite that the performance, in term of reproduced velocity, improved in a context of voluntary imitation, subjects did not replicate the observed motions exactly. These effects were not affected by the kind of stimuli used, i.e., motor responses were influenced in the same manner after dot or human observation. These findings support the existence of low-level sensory-motor matching mechanisms that work on movement planning and represent the basis for higher levels of social interaction.	[Bisio, Ambra; Jacono, Marco; Fadiga, Luciano; Pozzo, Thierry] Italian Inst Technol, Dept Robot Brain & Cognit Sci, Genoa, Italy; [Bisio, Ambra] Univ Genoa, Dipartimento Informat Sistemist & Telemat, Genoa, Italy; [Stucchi, Natale] Univ Milano Bicocca, Dipartimento Psicol, Milan, Italy; [Fadiga, Luciano] Univ Ferrara, Dipartimento Sci Biomed & Terapie Avanzate, Sez Fisiol Umana, I-44100 Ferrara, Italy; [Pozzo, Thierry] INSERM, U887, Dijon, France	Istituto Italiano di Tecnologia - IIT; University of Genoa; University of Milano-Bicocca; University of Ferrara; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne	Bisio, A (corresponding author), Italian Inst Technol, Dept Robot Brain & Cognit Sci, Genoa, Italy.	ambra.bisio@iit.it	Bisio, Ambra/N-4309-2013; Fadiga, Luciano/AAC-7404-2022; Bisio, Ambra/AAM-4979-2020	Bisio, Ambra/0000-0002-9385-1714; Stucchi, Natale/0000-0002-7695-4068; fadiga, luciano/0000-0001-5691-5080; Pozzo, Thierry/0000-0002-0585-7965; Jacono, Marco/0000-0002-5750-4395				Berret B, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000194; Bove M, 2009, BRAIN RES BULL, V80, P122, DOI 10.1016/j.brainresbull.2009.04.008; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Byrne RW, 1998, BEHAV BRAIN SCI, V21, P667, DOI 10.1017/S0140525X98001745; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Castiello U, 2003, J EXP PSYCHOL HUMAN, V29, P416, DOI 10.1037/0096-1523.29.2.416; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Chong TTJ, 2009, NEUROPSYCHOLOGIA, V47, P786, DOI 10.1016/j.neuropsychologia.2008.12.008; Craighero L, 2002, NEUROPSYCHOLOGIA, V40, P492, DOI 10.1016/S0028-3932(01)00134-8; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Grosjean M, 2007, PSYCHOL SCI, V18, P95, DOI 10.1111/j.1467-9280.2007.01854.x; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Ivry RB, 2008, TRENDS COGN SCI, V12, P273, DOI 10.1016/j.tics.2008.04.002; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; JOHANSSON G, 1975, SCI AM, V232, P76, DOI 10.1038/scientificamerican0675-76; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; MORASSO P, 1981, EXP BRAIN RES, V42, P223; Noy L, 2009, BRAIN COGNITION, V69, P360, DOI 10.1016/j.bandc.2008.08.030; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Pozzo T, 2006, BEHAV BRAIN RES, V169, P75, DOI 10.1016/j.bbr.2005.12.005; Press C, 2005, COGNITIVE BRAIN RES, V25, P632, DOI 10.1016/j.cogbrainres.2005.08.020; Press C, 2008, BRAIN COGNITION, V67, P44, DOI 10.1016/j.bandc.2007.11.001; Prinz W., 2005, PERSPECT IMITATION N, V1, P141; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Stanley J, 2007, J EXP PSYCHOL HUMAN, V33, P915, DOI 10.1037/0096-1523.33.4.915; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Watanabe K, 2008, COGNITION, V106, P1514, DOI 10.1016/j.cognition.2007.06.001; Wohlschlager A, 2003, PHILOS T R SOC B, V358, P501, DOI 10.1098/rstb.2002.1257; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238	33	52	52	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13506	10.1371/journal.pone.0013506	http://dx.doi.org/10.1371/journal.pone.0013506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	667TI	20976006	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400014
J	Mosqueira, M; Willmann, G; Ruohola-Baker, H; Khurana, TS				Mosqueira, Matias; Willmann, Gabriel; Ruohola-Baker, Hannele; Khurana, Tejvir S.			Chronic Hypoxia Impairs Muscle Function in the Drosophila Model of Duchenne's Muscular Dystrophy (DMD)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HEAT-SHOCK FACTOR; HIGH-ALTITUDE; GENE ENCODES; PAS PROTEIN; MDX; ALPHA; MELANOGASTER; EXPRESSION; STRESS	Duchenne's muscular dystrophy (DMD) is a severe progressive myopathy caused by mutations in the DMD gene leading to a deficiency of the dystrophin protein. Due to ongoing muscle necrosis in respiratory muscles late-stage DMD is associated with respiratory insufficiency and chronic hypoxia (CH). To understand the effects of CH on dystrophin-deficient muscle in vivo, we exposed the Drosophila model for DMD (dmDys) to CH during a 16-day ascent to the summit of Mount Denali/McKinley (6194 meters above sea level). Additionally, dmDys and wild type (WT) flies were also exposed to CH in laboratory simulations of high altitude hypoxia. Expression profiling was performed using Affymetrix GeneChips (R) and validated using qPCR. Hypoxic dmDys differentially expressed 1281 genes, whereas the hypoxic WT flies differentially expressed 56 genes. Interestingly, a number of genes (e. g. heat shock proteins) were discordantly regulated in response to CH between dmDys and WT. We tested the possibility that the disparate molecular responses of dystrophin-deficient tissues to CH could adversely affect muscle by performing functional assays in vivo. Normoxic and CH WT and dmDys flies were challenged with acute hypoxia and time-to-recover determined as well as subjected to climbing tests. Impaired performance was noted for CH-dmDys compared to normoxic dmDys or WT flies (rank order: Normoxic-WT approximate to CH-WT> Normoxic-dmDys> CH-dmDys). These data suggest that dystrophin-deficiency is associated with a disparate, pathological hypoxic stress response(s) and is more sensitive to hypoxia induced muscle dysfunction in vivo. We hypothesize that targeting/correcting the disparate molecular response(s) to hypoxia may offer a novel therapeutic strategy in DMD.	[Mosqueira, Matias; Willmann, Gabriel; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Mosqueira, Matias; Willmann, Gabriel; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Ruohola-Baker, Hannele] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Ruohola-Baker, Hannele] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	University of Pennsylvania; University of Pennsylvania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Mosqueira, M (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	tsk@mail.med.upenn.edu	Mosqueira, Matias/C-5899-2019	Mosqueira, Matias/0000-0001-7744-9138	Muscular Dystrophy Association (MDA)	Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The expedition was supported by discounted supplies by Eastern Mountain Sports (http://www.ems.com) and Recreational Equipment Inc. (http://www.rei.com). Research was supported in part by a grant from the Muscular Dystrophy Association (MDA; http://www.mda.org).	Abraham RT, 2005, CURR BIOL, V15, pR139, DOI 10.1016/j.cub.2005.02.015; APEL ED, 1995, NEURON, V15, P115, DOI 10.1016/0896-6273(95)90069-1; Askew EW, 2002, TOXICOLOGY, V180, P107, DOI 10.1016/S0300-483X(02)00385-2; Azad P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005371; Bach JR, 1997, CHEST, V112, P1024, DOI 10.1378/chest.112.4.1024; Bailey DM, 1997, BRIT J SPORT MED, V31, P183, DOI 10.1136/bjsm.31.3.183; Baird NA, 2006, J BIOL CHEM, V281, P38675, DOI 10.1074/jbc.M608013200; BARBE F, 1994, EUR RESPIR J, V7, P1403, DOI 10.1183/09031936.94.07081403; Bassett DI, 2003, HUM MOL GENET, V12, pR265, DOI 10.1093/hmg/ddg279; Beck J, 2006, NEUROMUSCULAR DISORD, V16, P161, DOI 10.1016/j.nmd.2006.01.003; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; BORNMAN L, 1995, MUSCLE NERVE, V18, P23, DOI 10.1002/mus.880180105; Bornman L, 1996, MUSCLE NERVE, V19, P574; BRADLEY TJ, 2008, CONTROL RESP PATTERN, P211; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brutsaert TD, 2008, APPL PHYSIOL NUTR ME, V33, P582, DOI 10.1139/H08-009; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Chakkalakal JV, 2005, FASEB J, V19, P880, DOI 10.1096/fj.04-1956rev; CONSOULAS C, 1992, J INSECT PHYSIOL, V38, P997, DOI 10.1016/0022-1910(92)90009-3; COOPER BJ, 1988, NATURE, V334, P154, DOI 10.1038/334154a0; De Bruin PF, 2001, PEDIATR PULM, V31, P451, DOI 10.1002/ppul.1074; DeBruin PF, 1997, THORAX, V52, P472, DOI 10.1136/thx.52.5.472; Doran P, 2006, PROTEOMICS, V6, P4610, DOI 10.1002/pmic.200600082; ENGEL AG, 1994, FRANZINI ARMSTRONG C; Farkas GA, 2007, MUSCLE NERVE, V36, P708, DOI 10.1002/mus.20858; Fradkin LG, 2008, J NEUROSCI, V28, P5105, DOI 10.1523/JNEUROSCI.4950-07.2008; Gee SH, 1998, J NEUROSCI, V18, P128; Gosselin LE, 2003, MUSCLE NERVE, V28, P336, DOI 10.1002/mus.10431; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Greener MJ, 2000, FEBS LETT, V482, P13, DOI 10.1016/S0014-5793(00)02018-4; Gullan P. J., 1994, The insects: an outline of entomology.; Haycock JW, 1996, NEUROREPORT, V8, P357, DOI 10.1097/00001756-199612200-00070; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Huang H, 2007, PHYSIOL GENOMICS, V29, P260, DOI 10.1152/physiolgenomics.00166.2006; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; INKLEY SR, 1974, AM J MED, V56, P297, DOI 10.1016/0002-9343(74)90611-1; Ishizaki M, 2008, NEUROMUSCULAR DISORD, V18, P342, DOI 10.1016/j.nmd.2008.02.002; Jin H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-19; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Krishnan SN, 1997, J INSECT PHYSIOL, V43, P203, DOI 10.1016/S0022-1910(96)00084-4; Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002; Liu GW, 2006, PHYSIOL GENOMICS, V25, P134, DOI 10.1152/physiolgenomics.00262.2005; Liu MG, 2003, ARCH PHYS MED REHAB, V84, P818, DOI 10.1016/S0003-9993(02)04953-5; Lundby C, 2009, CELL MOL LIFE SCI, V66, P3615, DOI 10.1007/s00018-009-0146-8; MENDELL JR, 1971, SCIENCE, V172, P1143, DOI 10.1126/science.172.3988.1143; Michaud S, 1997, CELL MOL LIFE SCI, V53, P104, DOI 10.1007/PL00000572; MUKOYAMA M, 1987, J NEUROL SCI, V81, P155, DOI 10.1016/0022-510X(87)90092-X; Nambu JR, 1996, GENE, V172, P249, DOI 10.1016/0378-1119(96)00060-1; Neuman S, 2001, GENE, V263, P17, DOI 10.1016/S0378-1119(00)00584-9; Orosz A, 1996, MOL CELL BIOL, V16, P7018; OUARDA TL, 2008, AGING CELL, V7, P237; PARKER JM, 1974, NATURE, V247, P103, DOI 10.1038/247103b0; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Phillips MF, 2001, AM J RESP CRIT CARE, V164, P2191, DOI 10.1164/ajrccm.164.12.2103052; PRITI A, 2009, ANN NY ACAD SCI, V1177, P39; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Regulski M, 2004, CURR BIOL, V14, pR881, DOI 10.1016/j.cub.2004.09.068; Rideau Y, 1983, Acta Neurol (Napoli), V5, P118; Roberts RG, 1998, HUM MOL GENET, V7, P589, DOI 10.1093/hmg/7.4.589; RYDERCOOK AS, 1988, EMBO J, V7, P3017, DOI 10.1002/j.1460-2075.1988.tb03165.x; SANDER M, 2000, FUNCTIONAL MUSCLE IS, P13818; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Scrable H, 2009, EXP GERONTOL, V44, P93, DOI 10.1016/j.exger.2008.05.017; Shcherbata HR, 2007, EMBO J, V26, P481, DOI 10.1038/sj.emboj.7601503; SLAMA K, 1988, BIOL BULL-US, V175, P289, DOI 10.2307/1541570; SMITH PEM, 1988, AM REV RESPIR DIS, V137, P884, DOI 10.1164/ajrccm/137.4.884; Snoeckx LHEH, 2001, PHYSIOL REV, V81, P1461, DOI 10.1152/physrev.2001.81.4.1461; Sonnenfeld M, 1997, DEVELOPMENT, V124, P4571; THOMAS GD, 1998, IMPAIRED METABOLIC M, P15090; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van der Plas MC, 2006, J NEUROSCI, V26, P333, DOI 10.1523/JNEUROSCI.4069-05.2006; VANDERPLAS MC, 2007, MECH DEVELOP, P617; West JB, 2003, J APPL PHYSIOL, V94, P1702, DOI 10.1152/japplphysiol.00950.2002; West JB, 1996, J APPL PHYSIOL, V81, P1850, DOI 10.1152/jappl.1996.81.4.1850; West JB, 2000, ANN NY ACAD SCI, V899, P15; Yamada H, 1996, J NEUROCHEM, V66, P1518; Zhou D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000490	82	14	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13450	10.1371/journal.pone.0013450	http://dx.doi.org/10.1371/journal.pone.0013450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975992	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400007
J	Febrer, M; Goicoechea, JL; Wright, J; McKenzie, N; Song, XA; Lin, JK; Collura, K; Wissotski, M; Yu, Y; Ammiraju, JSS; Wolny, E; Idziak, D; Betekhtin, A; Kudrna, D; Hasterok, R; Wing, RA; Bevan, MW				Febrer, Melanie; Goicoechea, Jose Luis; Wright, Jonathan; McKenzie, Neil; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Wolny, Elzbieta; Idziak, Dominika; Betekhtin, Alexander; Kudrna, Dave; Hasterok, Robert; Wing, Rod A.; Bevan, Michael W.			An Integrated Physical, Genetic and Cytogenetic Map of Brachypodium distachyon, a Model System for Grass Research	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; BAC LIBRARIES; GENOME; CONSTRUCTION; CHROMOSOMES; ALIGNMENT; RESOURCE; COVERAGE; SEQUENCE; DATABASE	The pooid subfamily of grasses includes some of the most important crop, forage and turf species, such as wheat, barley and Lolium. Developing genomic resources, such as whole-genome physical maps, for analysing the large and complex genomes of these crops and for facilitating biological research in grasses is an important goal in plant biology. We describe a bacterial artificial chromosome (BAC)-based physical map of the wild pooid grass Brachypodium distachyon and integrate this with whole genome shotgun sequence (WGS) assemblies using BAC end sequences (BES). The resulting physical map contains 26 contigs spanning the 272 Mb genome. BES from the physical map were also used to integrate a genetic map. This provides an independent vaildation and confirmation of the published WGS assembly. Mapped BACs were used in Fluorescence In Situ Hybridisation (FISH) experiments to align the integrated physical map and sequence assemblies to chromosomes with high resolution. The physical, genetic and cytogenetic maps, integrated with whole genome shotgun sequence assemblies, enhance the accuracy and durability of this important genome sequence and will directly facilitate gene isolation.	[Febrer, Melanie; Wright, Jonathan; McKenzie, Neil; Bevan, Michael W.] John Innes Ctr, Norwich, Norfolk, England; [Goicoechea, Jose Luis; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod A.] Univ Arizona, Arizona Genom Inst, Sch Plant Sci, Tucson, AZ USA; [Goicoechea, Jose Luis; Song, Xiang; Lin, Jinke; Collura, Kristi; Wissotski, Marina; Yu, Yeisoo; Ammiraju, Jetty S. S.; Kudrna, Dave; Wing, Rod A.] Univ Arizona, Inst Collaborat Res BIO5, Tucson, AZ USA; [Wolny, Elzbieta; Idziak, Dominika; Betekhtin, Alexander; Hasterok, Robert] Univ Silesia, Dept Plant Anat & Cytol, Katowice, Poland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Arizona; University of Arizona; University of Silesia in Katowice	Febrer, M (corresponding author), John Innes Ctr, Norwich, Norfolk, England.	michael.bevan@bbsrc.ac.uk	Betekhtin, Alexander/O-4619-2018; Wing, Rod A/Z-2885-2019; Hasterok, Robert/A-1629-2008; song, xiang/A-2336-2012	Betekhtin, Alexander/0000-0001-6146-1669; Wing, Rod A/0000-0001-6633-6226; Idziak-Helmcke, Dominika/0000-0002-0713-2466; Hasterok, Robert/0000-0001-6667-2721; Yu, Yeisoo/0000-0002-8410-0310; Wolny, Elzbieta/0000-0001-7588-4830	Biological and Biotechnological Sciences Research Council [BB/E004725/1]; John Innes Centre; Polish Ministry of Science and Higher Education [N N303 570738]; UPGOW; European Social Fund; Biotechnology and Biological Sciences Research Council [BB/E004725/1] Funding Source: researchfish; BBSRC [BB/E004725/1] Funding Source: UKRI	Biological and Biotechnological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Centre; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); UPGOW; European Social Fund(European Social Fund (ESF)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by The Biological and Biotechnological Sciences Research Council Grant BB/E004725/1 to MWB and the John Innes Centre Core Strategic Grant. This work was partially supported by the Polish Ministry of Science and Higher Education Grant N N303 570738 to RH, DI and EW. DI and AB are recipients of a scholarship from the UPGOW project co-financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Chaparro C, 2007, NUCLEIC ACIDS RES, V35, pD66, DOI 10.1093/nar/gkl780; Garvin D, 2007, MODEL PLANTS CROP IM, P109; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Griffiths S, 2006, NATURE, V439, P749, DOI 10.1038/nature04434; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Hasterok R, 2006, GENETICS, V173, P349, DOI 10.1534/genetics.105.049726; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; IDZIAK D, 2010, THESIS U SILESIA KAT; Jenkins G, 2007, NAT PROTOC, V2, P88, DOI 10.1038/nprot.2006.490; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim H, 2007, GENETICS, V176, P379, DOI 10.1534/genetics.106.068783; Luo MC, 2003, GENOMICS, V82, P378, DOI 10.1016/S0888-7543(03)00128-9; Luo MZ, 2003, METH MOL B, V236, P3; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Moose SP, 2008, PLANT PHYSIOL, V147, P969, DOI 10.1104/pp.108.118232; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Mun JH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-280; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Smit A., REPEATMASKER OPEN 3; Soderlund C, 2000, GENOME RES, V10, P1772, DOI 10.1101/gr.GR-1375R; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; UNFRIED I, 1990, NUCLEIC ACIDS RES, V18, P4011, DOI 10.1093/nar/18.13.4011; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wolny E, 2009, ANN BOT-LONDON, V104, P873, DOI 10.1093/aob/mcp179; Xu ZY, 2004, GENOMICS, V84, P941, DOI 10.1016/j.ygeno.2004.08.014	35	40	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13461	10.1371/journal.pone.0013461	http://dx.doi.org/10.1371/journal.pone.0013461			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976139	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300030
J	Serrano-Sanchez, JA; Delgado-Guerra, S; Olmedillas, H; Guadalupe-Grau, A; Arteaga-Ortiz, R; Sanchis-Moysi, J; Dorado, C; Calbet, JAL				Serrano-Sanchez, Jose A.; Delgado-Guerra, Safira; Olmedillas, Hugo; Guadalupe-Grau, Amelia; Arteaga-Ortiz, Rafael; Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.			Adiposity and Age Explain Most of the Association between Physical Activity and Fitness in Physically Active Men	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE IPAQ; SKELETAL-MUSCLE; SHORT-FORM; RELIABILITY; VALIDATION; VALIDITY; POPULATION; 7-DAY; MASS; PERFORMANCE	Background: To determine if there is an association between physical activity assessed by the short version of the International Physical Activity Questionnaire (IPAQ) and cardiorespiratory and muscular fitness. Methodology/Principal Findings: One hundred and eighty-two young males (age range: 20-55 years) completed the short form of the IPAQ to assess physical activity. Body composition (dual-energy X-Ray absorptiometry), muscular fitness (static and dynamic muscle force and power, vertical jump height, running speed [ 30 m sprint], anaerobic capacity [ 300 m running test]) and cardiorespiratory fitness (estimated VO(2)max: 20 m shuttle run test) were also determined in all subjects. Activity-related energy expenditure of moderate and vigorous intensity (EEPA(moderate) and EEPA(vigorous), respectively) was inversely associated with indices of adiposity (r = -0.21 to -0.37, P<0.05). Cardiorespiratory fitness (VO(2)max) was positively associated with LogEEPA(moderate) (r = 0.26, P<0.05) and LogEEPA(vigorous) (r = 0.27). However, no association between VO(2)max with LogEEPA(moderate), LogEPPA(vigorous) and LogEEPA(total) was observed after adjusting for the percentage of body fat. Multiple stepwise regression analysis to predict VO(2)max from LogEEPA(walking), LogEEPA(moderate), LogEEPA(vigorous), LogEEPA(total), age and percentage of body fat (%fat) showed that the %fat alone explained 62% of the variance in VO(2)max and that the age added another 10%, while the other variables did not add predictive value to the model [VO(2)max = 129.6-(25.1 x Log %fat) - (34.0 x Log age); SEE: 4.3 ml.kg(-1).min(-1); R-2 = 0.72 (P<0.05)]. No positive association between muscular fitness-related variables and physical activity was observed, even after adjusting for body fat or body fat and age. Conclusions/Significance: Adiposity and age are the strongest predictors of VO(2)max in healthy men. The energy expended in moderate and vigorous physical activities is inversely associated with adiposity. Muscular fitness does not appear to be associated with physical activity as assessed by the IPAQ.	[Serrano-Sanchez, Jose A.; Delgado-Guerra, Safira; Olmedillas, Hugo; Guadalupe-Grau, Amelia; Sanchis-Moysi, Joaquin; Dorado, Cecilia; Calbet, Jose A. L.] Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain; [Arteaga-Ortiz, Rafael] Univ Las Palmas Gran Canaria, Dept Phys, Las Palmas Gran Canaria, Spain	Universidad de Las Palmas de Gran Canaria; Universidad de Las Palmas de Gran Canaria	Serrano-Sanchez, JA (corresponding author), Univ Las Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain.	lopezcalbet@gmail.com	Calbet, Jose A L/H-6693-2015; SANCHIS-MOYSI, JOAQUIN/H-7017-2015; Cecilia, Dorado-Garcia/B-4586-2010; Guadalupe-Grau, Amelia/H-4961-2016; Sanchis-Moysi, Joaquin/B-5561-2012; Olmedillas, Hugo/F-4809-2015; Dorado García, Cecilia/ABC-2792-2021; Serrano-Sanchez, Jose A/L-3691-2014	Calbet, Jose A L/0000-0002-9215-6234; SANCHIS-MOYSI, JOAQUIN/0000-0001-6602-7087; Cecilia, Dorado-Garcia/0000-0001-6616-6810; Guadalupe-Grau, Amelia/0000-0003-2573-4572; Olmedillas, Hugo/0000-0003-4625-2759; Serrano-Sanchez, Jose A/0000-0002-4868-8751; antunez, Ariel/0000-0002-2548-7885	Ministerio de Educacion y Ciencia [DEP2006-56076-C06-04/ACTI]; FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF)); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias [2006/1790001]	Ministerio de Educacion y Ciencia(Spanish Government); FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF))(European Commission); Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias	The study was supported by Ministerio de Educacion y Ciencia (DEP2006-56076-C06-04/ACTI) and FEDER (Fondo Europeo de Desarrollo Regional or European Regional Development Fund (ERDF)), Consejeria de Educacion, Cultura y Deportes del Gobierno de Canarias (2006/1790001 and FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara I, 2004, INT J OBESITY, V28, P1585, DOI 10.1038/sj.ijo.0802754; ARA I, 2010, INT J OBES LOND; Arteaga R, 2000, J SPORT MED PHYS FIT, V40, P26; Bi S, 2005, ENDOCRINOLOGY, V146, P1676, DOI 10.1210/en.2004-1441; Bojsen-Moller J, 2005, J APPL PHYSIOL, V99, P986, DOI 10.1152/japplphysiol.01305.2004; Bonnefoy M, 1996, EUR J APPL PHYSIOL, V74, P528; BOON RM, 2010, BR J SPORTS IN PRESS; Bratteby LE, 1997, EUR J CLIN NUTR, V51, P585, DOI 10.1038/sj.ejcn.1600449; Calbet JAL, 1997, EUR J APPL PHYSIOL O, V76, P308, DOI 10.1007/s004210050253; Calbet JAL, 2008, EUR J APPL PHYSIOL, V104, P587, DOI 10.1007/s00421-008-0774-y; Cao ZB, 2010, MED SCI SPORT EXER, V42, P179, DOI 10.1249/MSS.0b013e3181af238d; Caserotti P, 2008, SCAND J MED SCI SPOR, V18, P773, DOI 10.1111/j.1600-0838.2007.00732.x; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Duncan GE, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-47; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Fuentes T, 2010, EXP PHYSIOL, V95, P160, DOI 10.1113/expphysiol.2009.049270; Hagner W, 2009, MENOPAUSE, V16, P1009, DOI 10.1097/gme.0b013e31819c0924; Hagstromer M, 2006, PUBLIC HEALTH NUTR, V9, P755, DOI 10.1079/PHN2005898; Havlik RJ, 2005, AM HEART J, V150, P270, DOI 10.1016/j.ahj.2004.09.006; Johnson-Kozlow M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-7; Kaleth AS, 2010, DISABIL REHABIL, V32, P353, DOI 10.3109/09638280903166352; Kawaguchi M, 2005, AM J PHYSIOL-REG I, V288, pR1800, DOI 10.1152/ajpregu.00805.2004; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Leger LA, 1988, J SPORT SCI, V6, P93, DOI 10.1080/02640418808729800; Leon A S, 1996, J Cardiopulm Rehabil, V16, P183, DOI 10.1097/00008483-199605000-00006; Maddison R, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-62; Mader U, 2006, MED SCI SPORT EXER, V38, P1255, DOI 10.1249/01.mss.0000227310.18902.28; Nokes N, 2009, J SPORT MED PHYS FIT, V49, P136; Paalanne NP, 2009, MED SCI SPORT EXER, V41, P1997, DOI 10.1249/MSS.0b013e3181a7f3a6; PAPATHANASIOU G, 2009, EUR J CARDIOVASC PRE; Papathanasiou George, 2009, Hellenic J Cardiol, V50, P283; PENRY JT, 2010, J STRENGTH COND RES; Perez-Gomez J, 2008, APPL PHYSIOL NUTR ME, V33, P501, DOI 10.1139/H08-026; Philippaerts RM, 1999, INT J SPORTS MED, V20, P284, DOI 10.1055/s-2007-971132; Roeykens J, 1998, MED SCI SPORT EXER, V30, P1071, DOI 10.1097/00005768-199807000-00008; Roman B, 2006, MED SCI SPORT EXER, V38, pS563, DOI 10.1249/00005768-200605001-02341; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; SALTIN B, 1980, FED PROC, V39, P1506; Sanchis-Moysi J, 2010, SCAND J MED SCI SPOR, V20, P524, DOI 10.1111/j.1600-0838.2009.00969.x; Scheeres K, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-29; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807; Trapp EG, 2008, INT J OBESITY, V32, P684, DOI 10.1038/sj.ijo.0803781; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; Vicente-Rodriguez G, 2003, BONE, V33, P853, DOI 10.1016/j.bone.2003.08.003; WASHBURN RA, 1986, AM J EPIDEMIOL, V123, P563, DOI 10.1093/oxfordjournals.aje.a114277; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2	48	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13435	10.1371/journal.pone.0013435	http://dx.doi.org/10.1371/journal.pone.0013435			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976154	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300017
J	Udekwu, KI				Udekwu, Klas I.			Transcriptional and Post-Transcriptional Regulation of the Escherichia coli luxS mRNA; Involvement of the sRNA MicA	PLOS ONE			English	Article							SMALL NONCODING RNAS; ANTISENSE RNAS; AUTOINDUCER-2 PRODUCTION; DEPENDENT REGULATION; RIBONUCLEASE-III; EXPRESSION; BACTERIA; GENES; TYPHIMURIUM; DEGRADATION	Background: The small RNA (sRNA) MicA has been shown to post-transcriptionally regulate translation of the outer membrane protein A (OmpA) in Escherichia coli. It uses an antisense mechanism to down-regulate OmpA protein synthesis and induce mRNA degradation. MicA is genomically localized between the coding regions of the gshA and luxS genes and is divergently transcribed from its neighbours. Transcription of the luxS gene which originates within or upstream of the MicA sequence would thus be complementary to the sRNA. LuxS regulation is as yet unclear. Methodology/Principal Findings: In this report, I show that the luxS mRNA exists as three long (major) transcripts of sizes that suggest just such interaction. The sRNA MicA's expression affects the abundance of each of these luxS transcripts. The involvement of the ribonuclease, RNase III in the accumulation of the shortest transcript is demonstrated. When MicA accumulates during growth, or is induced to be over-expressed, the cleaved mRNA species is observed to increase in intensity. Using primer extension and 5'-RACE experiments in combination with sRNA overexpression plasmids, I identify the exact origin of two of the three luxS transcripts, one of which is seen to result from a previously unidentified sigma(5) dependent promoter. Conclusions/Significance: The presented data provides strong evidence that MicA functions in cis and in trans, targeting both luxS mRNA as well as the previously established ompA and phoP regulation. The proposed luxS regulation by MicA would be in tandem with another sRNA CyaR, shown recently to be involved in inhibiting translation of the luxS mRNA. Regulation of luxS expression is additionally shown to occur on a transcriptional level via sigma(5) with variable transcript levels in different growth phases unlike what was previously assumed. This is the first known case of an sRNA in E. coli which targets both in cis (luxS mRNA) and in trans (ompA and phoP mRNAs).	[Udekwu, Klas I.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Udekwu, KI (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden.	Klas.udekwu@emory.edu	Udekwu, Klas/I-4764-2012		Swedish Research Council; EU-STREP; Wallenberg consortium North	Swedish Research Council(Swedish Research CouncilEuropean Commission); EU-STREP(European Commission); Wallenberg consortium North	Funding for this project was from a Swedish Research Council (VR) grant to the author and the EU-STREP (Specific Targeted Research or Innovation Project) program (Functions of small RNAs across kingdoms, FOSRAK) as well as the Wallenberg consortium North, all to E. Gerhart H. Wagner in whose lab all experimental work was performed. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDEA M, 1990, EMBO J, V9, P3787, DOI 10.1002/j.1460-2075.1990.tb07592.x; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Bassler BL, 2006, CELL, V125, P237, DOI 10.1016/j.cell.2006.04.001; Beeston AL, 2002, J BACTERIOL, V184, P3450, DOI 10.1128/JB.184.13.3450-3456.2002; Bensing BA, 1996, P NATL ACAD SCI USA, V93, P7794, DOI 10.1073/pnas.93.15.7794; BLOMBERG P, 1990, EMBO J, V9, P2331, DOI 10.1002/j.1460-2075.1990.tb07405.x; Bralley P, 2004, J BACTERIOL, V186, P3160, DOI 10.1128/JB.186.10.3160-3172.2004; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; COORNAERT A, MOL MICROBIOLOGY, V76, P467; De Keersmaecker SCJ, 2006, TRENDS MICROBIOL, V14, P114, DOI 10.1016/j.tim.2006.01.003; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Kawamoto H, 2006, MOL MICROBIOL, V61, P1013, DOI 10.1111/j.1365-2958.2006.05288.x; KRINKE L, 1990, NUCLEIC ACIDS RES, V18, P4809, DOI 10.1093/nar/18.16.4809; LELONG C, 2007, MOL CELL PROTEOMICS; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Mitarai N, 2007, PHYS BIOL, V4, P164, DOI 10.1088/1478-3975/4/3/003; Mitarai N, 2009, P NATL ACAD SCI USA, V106, P10655, DOI 10.1073/pnas.0901466106; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Morita T, 2006, P NATL ACAD SCI USA, V103, P4858, DOI 10.1073/pnas.0509638103; Papamichail D, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-12; Pertzev AV, 2006, NUCLEIC ACIDS RES, V34, P3708, DOI 10.1093/nar/gkl459; Rasmussen AA, 2005, MOL MICROBIOL, V58, P1421, DOI 10.1111/j.1365-2958.2005.04911.x; ROBERTSON HD, 1982, CELL, V30, P669, DOI 10.1016/0092-8674(82)90270-7; Schauder S, 2001, MOL MICROBIOL, V41, P463, DOI 10.1046/j.1365-2958.2001.02532.x; Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; UDEKWU KI, 2007, NUCLEIC ACIDS RES; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Vogel J, 2007, CURR OPIN MICROBIOL, V10, P262, DOI 10.1016/j.mib.2007.06.001; Wagner EGH, 2002, TRENDS GENET, V18, P223, DOI 10.1016/S0168-9525(02)02658-6; Wagner EGH, 2002, ADV GENET, V46, P361; Wang L, 2005, J BACTERIOL, V187, P8350, DOI 10.1128/JB.187.24.8350-8360.2005; Wassarman KM, 1999, TRENDS MICROBIOL, V7, P37; Winzer K, 2002, MICROBIOL-SGM, V148, P909, DOI 10.1099/00221287-148-4-909; Xavier KB, 2003, CURR OPIN MICROBIOL, V6, P191, DOI 10.1016/S1369-5274(03)00028-6; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0	40	13	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13449	10.1371/journal.pone.0013449	http://dx.doi.org/10.1371/journal.pone.0013449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976191	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300022
J	Martinsson, K; Skogh, T; Mousavi, SA; Berg, T; Jonsson, JI; Hultman, P				Martinsson, Klara; Skogh, Thomas; Mousavi, Seyed Ali; Berg, Trond; Jonsson, Jan-Ingvar; Hultman, Per			Deficiency of Activating Fc gamma-Receptors Reduces Hepatic Clearance and Deposition of IC and Increases CIC Levels in Mercury-Induced Autoimmunity	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; SINUSOIDAL ENDOTHELIAL-CELLS; G-IMMUNE-COMPLEXES; ANTI-FIBRILLARIN AUTOANTIBODIES; RAT-LIVER; MEDIATED ENDOCYTOSIS; HIGH-AFFINITY; TREATED MICE; IN-VIVO; MURINE	Background: Inorganic mercury (Hg) induces a T-cell dependent, systemic autoimmune condition (HgIA) where activating Fc gamma-receptors (Fc gamma Rs) are important for the induction. In this study we examined the influence of activating Fc gamma Rs on circulating levels and organ localization of immune complexes (IC) in HgIA. Methods and Principal Findings: Mercury treated BALB/c wt mice showed a significant but modest increase of circulating IC (CIC) from day 12 until day 18 and day 35 for IgG2a- and IgG1- CIC, respectively. Mercury-treated mice lacking the transmembrane gamma-chain of activating Fc gamma Rs (FcR gamma(-/-)) had significantly higher CIC levels of both IgG1-CIC and IgG2a-CIC than wt mice during the treatment course. The hepatic uptake of preformed CIC was significantly more efficient in wt mice compared to Fc gamma R(-/-) mice, but also development of extrahepatic tissue IC deposits was delayed in FcR gamma(-/-) mice. After 35 days of Hg treatment the proportion of immune deposits, as well as the amounts was significantly reduced in vessel FcR gamma(-/-) mice compared to wt mice. Conclusions: We conclude that mice lacking functional activating Fc gamma Rs respond to Hg with increased levels and altered quality of CIC compared with wt mice. Lack of functional activating Fc gamma Rs delayed the elimination of CIC, but also significantly reduced extrahepatic tissue localization of CIC.	[Martinsson, Klara; Hultman, Per] Linkoping Univ, Dept Clin & Expt Med, Div Mol & Immunol Pathol AIR, Linkoping, Sweden; [Skogh, Thomas] Linkoping Univ, Dept Clin & Expt Med, Rheumatol Unit AIR, Linkoping, Sweden; [Jonsson, Jan-Ingvar] Linkoping Univ, Dept Clin & Expt Med, Expt Hematol Unit, Linkoping, Sweden; [Mousavi, Seyed Ali] Rikshosp Univ Hosp, Dept Med Genet, Med Genet Lab, Oslo, Norway; [Berg, Trond] Univ Oslo, Dept Mol Biosci, Oslo, Norway	Linkoping University; Linkoping University; Linkoping University; University of Oslo; National Hospital Norway; University of Oslo	Martinsson, K (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Dept Pharm & Therapeut, Liverpool L69 3BX, Merseyside, England.	klara.martinsson@liu.se	Skogh, Thomas/C-9692-2009	Skogh, Thomas/0000-0002-0153-9249; Martinsson, Klara/0000-0003-4492-9172; Jonsson, Jan-Ingvar/0000-0003-4814-978X	Swedish Research Council Branch of Medicine [9453]; County Council of Ostergotland; Ingrid Asp foundation	Swedish Research Council Branch of Medicine(Swedish Research Council); County Council of Ostergotland; Ingrid Asp foundation	The project was supported by the Swedish Research Council Branch of Medicine (project no. 9453), funds from the County Council of Ostergotland and Ingrid Asp foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SS, 1995, HEPATOLOGY, V22, P316, DOI 10.1002/hep.1840220143; Allhorn M, 2009, ANN NY ACAD SCI, V1173, P664, DOI 10.1111/j.1749-6632.2009.04739.x; Baudino L, 2006, SPRINGER SEMIN IMMUN, V28, P175, DOI 10.1007/s00281-006-0037-0; Berger SP, 2007, SEMIN IMMUNOPATHOL, V29, P375, DOI 10.1007/s00281-007-0090-3; Bergtold A, 2006, J IMMUNOL, V177, P7287, DOI 10.4049/jimmunol.177.10.7287; BOGERS WMJM, 1991, CLIN EXP IMMUNOL, V86, P328; Bolland S, 2000, IMMUNITY, V13, P277, DOI 10.1016/S1074-7613(00)00027-3; CHIA D, 1979, CLIN EXP IMMUNOL, V37, P399; Clynes R, 2005, CLIN EXP IMMUNOL, V141, P230, DOI 10.1111/j.1365-2249.2005.02847.x; Davies KA, 2002, ARTHRITIS RHEUM-US, V46, P1028, DOI 10.1002/art.10189; ENESTROM S, 1984, EXPERIENTIA, V40, P1234, DOI 10.1007/BF01946653; FENTON KA, AUTOIMMUNITY, V43, P179; Fismen S, 2009, LUPUS, V18, P597, DOI 10.1177/0961203308100512; Havarinasab S, 2006, TOXICOL APPL PHARM, V214, P43, DOI 10.1016/j.taap.2005.12.004; Havarinasab S, 2005, AUTOIMMUN REV, V4, P270, DOI 10.1016/j.autrev.2004.12.001; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Heyman B, 2003, IMMUNOL LETT, V88, P157, DOI 10.1016/S0165-2478(03)00078-6; HULTMAN P, 1988, CLIN EXP IMMUNOL, V71, P269; HULTMAN P, 1989, CLIN EXP IMMUNOL, V78, P470; HULTMAN P, 1994, FASEB J, V8, P1183, DOI 10.1096/fasebj.8.14.7958626; HULTMAN P, 1989, J CLIN LAB IMMUNOL, V29, P175; HULTMAN P, 1992, CLIN IMMUNOL IMMUNOP, V65, P98, DOI 10.1016/0090-1229(92)90212-7; HULTMAN P, 1995, CLIN IMMUNOL IMMUNOP, V77, P291, DOI 10.1006/clin.1995.1155; IZUI S, 1979, J EXP MED, V149, P1099, DOI 10.1084/jem.149.5.1099; Johansson AG, 1996, HEPATOLOGY, V24, P169, DOI 10.1053/jhep.1996.v24.pm0008707258; Kain R, 2008, NAT MED, V14, P1088, DOI 10.1038/nm.1874; Kavai M, 2007, AUTOIMMUN REV, V6, P497, DOI 10.1016/j.autrev.2007.01.017; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; Kleinau S, 2003, CURR PHARM DESIGN, V9, P1861, DOI 10.2174/1381612033454414; KOSUGI I, 1992, J HEPATOL, V16, P106, DOI 10.1016/S0168-8278(05)80102-3; Kotnik V, 2003, CROAT MED J, V44, P707; Lovdal T, 2000, J CELL SCI, V113, P3255; Martinsson K, 2006, CLIN EXP IMMUNOL, V144, P309, DOI 10.1111/j.1365-2249.2006.03057.x; Martinsson K, 2008, J AUTOIMMUN, V31, P22, DOI 10.1016/j.jaut.2008.01.002; Mjelle JE, 2007, ANN RHEUM DIS, V66, P1661, DOI 10.1136/ard.2007.070482; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Nangaku Masaomi, 2005, Clin Exp Nephrol, V9, P183, DOI 10.1007/s10157-005-0357-8; Oates JC, 2002, CURR OPIN RHEUMATOL, V14, P498, DOI 10.1097/00002281-200209000-00003; PITTMAN RC, 1983, BIOCHEM J, V212, P791, DOI 10.1042/bj2120791; RAVETCH J, NATURE IMMUNOLOGY, V11, P183; SASAKI T, 1991, AM J MED, V91, P355, DOI 10.1016/0002-9343(91)90152-N; SKOGH T, 1983, INT ARCH ALLER A IMM, V70, P238, DOI 10.1159/000233330; SKOGH T, 1985, IMMUNOLOGY, V55, P585; SKOGH T, 1983, IMMUNOLOGY, V49, P53; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tuzun E, 2006, J NEUROIMMUNOL, V174, P157, DOI 10.1016/j.jneuroim.2006.01.015; Weening JJ, 2004, KIDNEY INT, V65, P521, DOI 10.1111/j.1523-1755.2004.00443.x; Willcocks LC, 2008, J EXP MED, V205, P1573, DOI 10.1084/jem.20072413; Zabaleta-Lanz M, 2003, LUPUS, V12, P26, DOI 10.1191/0961203303lu259oa; Zabaleta-Lanz ME, 2006, LUPUS, V15, P845, DOI 10.1177/0961203306070002	52	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13413	10.1371/journal.pone.0013413	http://dx.doi.org/10.1371/journal.pone.0013413			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976163	Green Submitted, gold, Green Published			2022-12-27	WOS:000283043700013
J	Zwart, MP; Dieu, BTM; Hemerik, L; Vlak, JM				Zwart, Mark P.; Dieu, Bui Thi Minh; Hemerik, Lia; Vlak, Just M.			Evolutionary Trajectory of White Spot Syndrome Virus (WSSV) Genome Shrinkage during Spread in Asia	PLOS ONE			English	Article							POPULATION-GENETICS; SHRIMP AQUACULTURE; HEALTH MANAGEMENT; ADAPTATION; DNA; REDUCTION; VIRULENCE; QUANTIFICATION; INFECTION; SELECTION	Background: White spot syndrome virus (WSSV) is the sole member of the novel Nimaviridae family, and the source of major economic problems in shrimp aquaculture. WSSV appears to have rapidly spread worldwide after the first reported outbreak in the early 1990s. Genomic deletions of various sizes occur at two loci in the WSSV genome, the ORF14/15 and ORF23/24 variable regions, and these have been used as molecular markers to study patterns of viral spread over space and time. We describe the dynamics underlying the process of WSSV genome shrinkage using empirical data and a simple mathematical model. Methodology/Principal Findings: We genotyped new WSSV isolates from five Asian countries, and analyzed this information together with published data. Genome size appears to stabilize over time, and deletion size in the ORF23/24 variable region was significantly related to the time of the first WSSV outbreak in a particular country. Parameter estimates derived from fitting a simple mathematical model of genome shrinkage to the data support a geometric progression (k < 1) of the genomic deletions, with k = 0.371 +/- 0.150. Conclusions/Significance: The data suggest that the rate of genome shrinkage decreases over time before attenuating. Bioassay data provided support for a link between genome size and WSSV fitness in an aquaculture setting. Differences in genomic deletions between geographic WSSV isolates suggest that WSSV spread did not follow a smooth pattern of geographic radiation, suggesting spread of WSSV over long distances by commercial activities. We discuss two hypotheses for genome shrinkage, an adaptive and a neutral one. We argue in favor of the adaptive hypothesis, given that there is support for a link between WSSV genome size and fitness.	[Zwart, Mark P.; Dieu, Bui Thi Minh; Vlak, Just M.] Wageningen Univ, Virol Lab, Wageningen, Netherlands; [Zwart, Mark P.] Wageningen Univ, Quantitat Vet Epidemiol Grp, Wageningen, Netherlands; [Zwart, Mark P.] Univ Politecn Valencia, CSIC, Inst Biol Mol & Celular Plantas, Valencia, Spain; [Dieu, Bui Thi Minh] Can Tho Univ, Biotechnol Res & Dev Inst, Can Tho City, Vietnam; [Hemerik, Lia] Wageningen Univ, Biometris, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP); Can Tho University; Wageningen University & Research	Zwart, MP (corresponding author), Wageningen Univ, Virol Lab, Wageningen, Netherlands.	marzwa@upvnet.upv.es	Zwart, Mark P/B-3408-2018	Zwart, Mark P/0000-0003-4361-7636; Hemerik, Lia/0000-0002-6892-2840	Netherlands Organisation for Scientific Research (NWO); Science for Global Development (NWO WOTRO) [WB 83-207]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Science for Global Development (NWO WOTRO)	MPZ was supported in part by a Rubicon Grant from the Netherlands Organisation for Scientific Research (NWO, www.nwo.nl). BTMD was supported by a Science for Global Development (NWO WOTRO, www.nwo.nl/wotro) PhD scholarship (grant WB 83-207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2004, CRIT CARE, V8, P130, DOI 10.1186/cc2836; Bondad-Reantaso MG, 2005, VET PARASITOL, V132, P249, DOI 10.1016/j.vetpar.2005.07.005; Buckling A, 2009, NATURE, V457, P824, DOI 10.1038/nature07892; Bull JJ, 2004, EVOLUTION, V58, P692; Bull JJ, 1997, GENETICS, V147, P1497; Chapman RW, 2004, DIS AQUAT ORGAN, V59, P179, DOI 10.3354/dao059179; Corsin F, 2001, DIS AQUAT ORGAN, V47, P1, DOI 10.3354/dao047001; DEJONG MCM, 1994, VACCINE, V12, P761, DOI 10.1016/0264-410X(94)90229-1; Dieu BTM, 2004, J GEN VIROL, V85, P3607, DOI 10.1099/vir.0.80344-0; DIEU BTM, DIS ASIAN AQUACULTUR, V7; Dieu BTM, 2010, J GEN VIROL, V91, P1164, DOI 10.1099/vir.0.018028-0; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; Filee J, 2008, RES MICROBIOL, V159, P325, DOI 10.1016/j.resmic.2008.04.012; Gomez-Valero L, 2007, GENE, V389, P87, DOI 10.1016/j.gene.2006.10.001; Holder KK, 2001, GENETICS, V159, P1393; HUANG AS, 1973, ANNU REV MICROBIOL, V27, P101, DOI 10.1146/annurev.mi.27.100173.000533; KHOA LV, 2000, VIET NAM, P91; Kimura M., 1983, NEUTRAL THEORY MOL E; KONGKEO H, 1994, INFOFISH INT C AQ 21; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Lan YS, 2002, VIRUS RES, V90, P269, DOI 10.1016/S0168-1702(02)00231-9; Laramore SE, 2009, J AQUAT ANIM HEALTH, V21, P82, DOI 10.1577/H08-012.1; Lebel L, 2002, AMBIO, V31, P311, DOI 10.1639/0044-7447(2002)031[0311:ITASAI]2.0.CO;2; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Lotz JM, 1997, WORLD J MICROB BIOT, V13, P405, DOI 10.1023/A:1018572132529; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Madhi SA, 2021, SAFETY EFFICACY CHAD, DOI 10.1101/2021.02.10.21251247; Marks H, 2005, J GEN VIROL, V86, P2081, DOI 10.1099/vir.0.80895-0; Marks H, 2005, VIRUS RES, V110, P9, DOI 10.1016/j.virusres.2005.01.002; Marks H, 2004, ARCH VIROL, V149, P673, DOI 10.1007/s00705-003-0248-9; Moran NA, 2004, CURR OPIN GENET DEV, V14, P627, DOI 10.1016/j.gde.2004.09.003; Nilsson AI, 2005, P NATL ACAD SCI USA, V102, P12112, DOI 10.1073/pnas.0503654102; Ochman H, 2005, P NATL ACAD SCI USA, V102, P11959, DOI 10.1073/pnas.0505863102; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2002, EVOLUTION, V56, P1317, DOI 10.1111/j.0014-3820.2002.tb01446.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Park JE, 2009, ARCH VIROL, V154, P1709, DOI 10.1007/s00705-009-0489-3; Pradeep B, 2008, DIS AQUAT ORGAN, V78, P189, DOI 10.3354/dao01878; Pradeep B, 2009, J FISH DIS, V32, P801, DOI 10.1111/j.1365-2761.2009.01053.x; Pradeep B, 2008, VIROLOGY, V376, P24, DOI 10.1016/j.virol.2008.02.037; REGIDOR SE, 2005, CURRENT STATUS TRANS; Schoustra SE, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000250; Seok SH, 2004, DIS AQUAT ORGAN, V60, P85, DOI 10.3354/dao060085; Sokal R.R., 2012, BIOMETRY; Soto MA, 2001, J INVERTEBR PATHOL, V78, P9, DOI 10.1006/jipa.2001.5035; SOUR K, 2004, WETLANDS MANAGEMENT, P1; Tan Y, 2009, J FISH DIS, V32, P777, DOI 10.1111/j.1365-2761.2009.01055.x; Tang KFJ, 2000, AQUACULTURE, V189, P11, DOI 10.1016/S0044-8486(00)00367-7; Taylor DR, 2002, P NATL ACAD SCI USA, V99, P3690, DOI 10.1073/pnas.072660299; van Hoek MJA, 2007, MOL BIOL EVOL, V24, P2485, DOI 10.1093/molbev/msm183; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Vijayan KK, 2005, DIS AQUAT ORGAN, V63, P107, DOI 10.3354/dao063107; VISETH H, 2005, OVERVIEW AQUACULTURE; Vlak JM, 2005, 8 REP INT COMM TAX V, P187; VONMAGNUS P, 1954, ADV VIRUS RES, V2, P59, DOI 10.1016/S0065-3527(08)60529-1; Walker PJ, 2009, REV AQUACULT, V1, P125, DOI 10.1111/j.1753-5131.2009.01007.x; Witteveldt J, 2004, FISH SHELLFISH IMMUN, V16, P571, DOI 10.1016/j.fsi.2003.09.006; Wu JL, 2001, DIS AQUAT ORGAN, V47, P129, DOI 10.3354/dao047129; Xie XX, 2005, VIRUS RES, V108, P63, DOI 10.1016/j.virusres.2004.08.002; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zwart MP, 2008, J GEN VIROL, V89, P1220, DOI 10.1099/vir.0.83645-0; Zwart MP, 2010, BIOL CONTROL, V52, P77, DOI 10.1016/j.biocontrol.2009.10.002	63	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13400	10.1371/journal.pone.0013400	http://dx.doi.org/10.1371/journal.pone.0013400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976239	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000022
J	Ndamukong, I; Jones, DR; Lapko, H; Divecha, N; Avramova, Z				Ndamukong, Ivan; Jones, David R.; Lapko, Hanna; Divecha, Nullin; Avramova, Zoya			Phosphatidylinositol 5-Phosphate Links Dehydration Stress to the Activity of ARABIDOPSIS TRITHORAX-LIKE Factor ATX1	PLOS ONE			English	Article							PHD FINGER; SUBSTRATE-SPECIFICITY; MOLECULAR-BASIS; MYOTUBULARIN; IDENTIFICATION; PHOSPHOINOSITIDES; PTDINS5P; HOMOLOG; PATHWAY; PROTEIN	Background: Changes in gene expression enable organisms to respond to environmental stress. Levels of cellular lipid second messengers, such as the phosphoinositide PtdIns5P, change in response to a variety of stresses and can modulate the localization, conformation and activity of a number of intracellular proteins. The plant trithorax factor (ATX1) trimethylates the lysine 4 residue of histone H3 (H3K4me3) at gene coding sequences, which positively correlates with gene transcription. Microarray analysis has identified a target gene (WRKY70) that is regulated by both ATX1 and by the exogenous addition of PtdIns5P in Arabidopsis. Interestingly, ATX1 contains a PtdIns5P interaction domain (PHD finger) and thus, phosphoinositide signaling, may link environmental stress to changes in gene transcription. Principal Findings: Using the plant Arabidopsis as a model system, we demonstrate a link between PtdIns5P and the activity of the chromatin modifier ATX1 in response to dehydration stress. We show for the first time that dehydration leads to an increase in cellular PtdIns5P in Arabidopsis. The Arabidopsis homolog of myotubularin (AtMTM1) is capable of generating PtdIns5P and here, we show that AtMTM1 is essential for the induced increase in PtdIns5P upon dehydration. Furthermore, we demonstrate that the ATX1-dependent gene, WRKY70, is downregulated during dehydration and that lowered transcript levels are accompanied by a drastic reduction in H3K4me3 of its nucleosomes. We follow changes in WRKY70 nucleosomal K4 methylation as a model to study ATX1 activity at chromatin during dehydration stress. We found that during dehydration stress, the physical presence of ATX1 at the WRKY70 locus was diminished and that ATX1 depletion resulted from it being retained in the cytoplasm when PtdIns5P was elevated. The PHD of ATX1 and catalytically active AtMTM1 are required for the cytoplasmic localization of ATX1. Conclusions/Significance: The novelty of the manuscript is in the discovery of a mechanistic link between a chromatin modifying activity (ATX1) and a lipid (PtdIns5P) synthesis in a signaling pathway that ultimately results in altered expression of ATX1 dependent genes downregulated in response to dehydration stress.	[Ndamukong, Ivan; Lapko, Hanna; Avramova, Zoya] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA; [Jones, David R.; Divecha, Nullin] Univ Manchester, Paterson Inst Canc Res, Inositide Lab, Manchester, Lancs, England	University of Nebraska System; University of Nebraska Lincoln; Paterson Institute for Cancer Research; University of Manchester	Ndamukong, I (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	zavramova2@unl.edu		Lapko, Hanna/0000-0002-3490-4126; divecha, nullin/0000-0001-9695-6039	Cancer Research UK [NSF-EPS0701892, NSF-MCB0749504]	Cancer Research UK(Cancer Research UK)	The work was partially supported by (National Science Foundation) NSF-EPS0701892 and NSF-MCB0749504 awards to Z.A. Research at the Paterson Institute for Cancer Research is entirely funded by Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Venegas R, 2006, P NATL ACAD SCI USA, V103, P6049, DOI 10.1073/pnas.0600944103; Alvarez-Venegas R, 2003, CURR BIOL, V13, P627, DOI 10.1016/S0960-9822(03)00243-4; Alvarez-Venegas R, 2007, EPIGENETICS-US, V2, P106, DOI 10.4161/epi.2.2.4404; Alvarez-Venegas R, 2006, PLANT SIGNAL BEHAV, V1, P140, DOI 10.4161/psb.1.3.2997; Avramova ZV, 2002, PLANT PHYSIOL, V129, P40, DOI 10.1104/pp.010981; Begley MJ, 2006, P NATL ACAD SCI USA, V103, P927, DOI 10.1073/pnas.0510006103; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bensmihen S, 2004, FEBS LETT, V561, P127, DOI 10.1016/S0014-5793(04)00148-6; Boss Wendy E., 2006, V39, P181; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui XM, 1998, NAT GENET, V18, P331, DOI 10.1038/ng0498-331; Ding Y, 2009, PLANT SIGNAL BEHAV, V4, P1049, DOI 10.4161/psb.4.11.10103; Dove SK, 1997, NATURE, V390, P187, DOI 10.1038/36613; Firestein R, 2000, MOL CELL BIOL, V20, P4900, DOI 10.1128/MCB.20.13.4900-4909.2000; Firestein R, 2001, J CELL SCI, V114, P2921; Gozani O, 2003, CELL, V114, P99, DOI 10.1016/S0092-8674(03)00480-X; HEWLETT JD, 1963, PROTOPLASMA, V57, P381, DOI 10.1007/BF01252067; HOLLANDER, WOLFE NONPARAMETRIC; Jones DR, 2006, MOL CELL, V23, P685, DOI 10.1016/j.molcel.2006.07.014; Jones David R., 2009, V462, P75, DOI 10.1007/978-1-60327-115-8_5; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Jones DR, 1999, J BIOL CHEM, V274, P18407, DOI 10.1074/jbc.274.26.18407; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kim SA, 2002, J BIOL CHEM, V277, P4526, DOI 10.1074/jbc.M111087200; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Maehama T, 2000, ANAL BIOCHEM, V279, P248, DOI 10.1006/abio.2000.4497; MARTIN B, 1985, J BIOL CHEM, V260, P4932; Meijer HJG, 2001, BIOCHEM J, V360, P491, DOI 10.1042/0264-6021:3600491; Munnik T, 2009, J LIPID RES, V50, pS260, DOI 10.1194/jlr.R800098-JLR200; Nandurkar HH, 2003, P NATL ACAD SCI USA, V100, P8660, DOI 10.1073/pnas.1033097100; Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; PETERMAN KT, 2004, PLANT PHYSIOL, V136, P1; Petruk S, 2001, SCIENCE, V294, P1331, DOI 10.1126/science.1065683; Pical C, 1999, J BIOL CHEM, V274, P38232, DOI 10.1074/jbc.274.53.38232; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Saleh A, 2008, GENE, V423, P43, DOI 10.1016/j.gene.2008.06.022; Saleh A, 2008, NAT PROTOC, V3, P1018, DOI 10.1038/nprot.2008.66; Sbrissa D, 2002, J BIOL CHEM, V277, P47276, DOI 10.1074/jbc.M207576200; Schaletzky J, 2003, CURR BIOL, V13, P504, DOI 10.1016/S0960-9822(03)00132-5; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tronchere H, 2004, J BIOL CHEM, V279, P7304, DOI 10.1074/jbc.M311071200; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Urban A, 1997, NUCLEIC ACIDS RES, V25, P2227, DOI 10.1093/nar/25.11.2227; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	46	52	57	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13396	10.1371/journal.pone.0013396	http://dx.doi.org/10.1371/journal.pone.0013396			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967218	Green Published, gold			2022-12-27	WOS:000282869800051
J	Lachman, ME; Agrigoroaei, S				Lachman, Margie E.; Agrigoroaei, Stefan			Promoting Functional Health in Midlife and Old Age: Long-Term Protective Effects of Control Beliefs, Social Support, and Physical Exercise	PLOS ONE			English	Article							QUALITY-OF-LIFE; ELDERLY POPULATION; PERCEIVED CONTROL; ACTIVITY PROGRAMS; ALLOSTATIC LOAD; UNITED-STATES; RISK-FACTORS; DISABILITY; PREDICTORS; MACARTHUR	Background: Previous studies have examined physical risk factors in relation to functional health, but less work has focused on the protective role of psychological and social factors. We examined the individual and joint protective contribution of control beliefs, social support and physical exercise to changes in functional health, beyond the influence of health status and physical risk factors in middle-aged and older adults. Given that functional health typically declines throughout adulthood, it is important to identify modifiable factors that can be implemented to maintain functioning, improve quality of life, and reduce disability. Methodology/Principal Findings: We conducted a national longitudinal study, Midlife in the United States (MIDUS), with assessments in 1995-1996 and 2004-2006, and 3,626 community-residing adults, aged 32 to 84, were included in the analyses. Functional health (Physical Functioning subscale of the SF-36) and protective factors were measured at both occasions. While controlling for socio-demographic, health status, and physical risk factors (large waist circumference, smoking, and alcohol or drug problems), a composite of the three protective variables (control beliefs, social support, and physical exercise) at Time 1 was significantly related to functional health change. The more of these factors at Time 1, the better the health maintenance over 10 years. Among middle-aged and older adults, declines in health were significantly reduced with an increased number of protective factors. Conclusion/Significance: Age-related declines in health were reduced among those with more protective factors up to a decade earlier in life. Modifiable psychological, social, and physical protective factors, individually and in the aggregate, are associated with maintenance of functional health, beyond the damaging effects of physical risk factors. The results are encouraging for the prospect of developing interventions to promote functional health and for reducing public health expenditures for physical disability in later life.	[Lachman, Margie E.; Agrigoroaei, Stefan] Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA	Brandeis University	Lachman, ME (corresponding author), Brandeis Univ, Dept Psychol, Waltham, MA 02254 USA.	Lachman@brandeis.edu		Lachman, Margie/0000-0003-3027-8735	National Institute on Aging [PO1 AG20166, RO1 AG17920, RO1 AG032271]; NATIONAL INSTITUTE ON AGING [R01AG017920, P01AG020166, R01AG032271] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants (PO1 AG20166, RO1 AG17920, RO1 AG032271) from the National Institute on Aging (http://www.nia.nih.gov/). The first wave of the study was supported by the John D. and Catherine T. MacArthur Foundation Research Network on Successful Midlife Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert MS, 1995, PSYCHOL AGING, V10, P578, DOI 10.1037/0882-7974.10.4.578; Alley DE, 2007, JAMA-J AM MED ASSOC, V298, P2020, DOI 10.1001/jama.298.17.2020; Anderson RT, 1998, J GERONTOL B-PSYCHOL, V53, pS17, DOI 10.1093/geronb/53B.1.S17; Andrew MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002232; Antonucci T.C., 2001, HDB PSYCHOL AGING, P427, DOI DOI 10.1016/B0-08-043076-7/01699-5; Antonucci T.C., 2009, HDB THEORIES AGING, V2nd ed., P247; Berkman LF, 2003, JAMA-J AM MED ASSOC, V289, P3106; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Berkman LE, 2009, ANNU REV PUBL HEALTH, V30, P27, DOI 10.1146/annurev.publhealth.031308.100310; Boyle PA, 2007, J AM GERIATR SOC, V55, P195, DOI 10.1111/j.1532-5415.2007.01038.x; Brim O. G., 2004, HLTH ARE WE NATL STU; Britton A, 2008, J AM GERIATR SOC, V56, P1098, DOI 10.1111/j.1532-5415.2008.01740.x; Busetto L, 2009, J AM GERIATR SOC, V57, P1015, DOI 10.1111/j.1532-5415.2009.02273.x; Centers for Disease Control and Prevention National Center for Health Statistics, HLTH DAT INT; Chen HL, 2008, J AM GERIATR SOC, V56, P689, DOI 10.1111/j.1532-5415.2007.01624.x; Chipperfield JG, 2004, J AGING HEALTH, V16, P116, DOI 10.1177/0898264303260447; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Cooney MT, 2009, J AM COLL CARDIOL, V54, P1209, DOI 10.1016/j.jacc.2009.07.020; Cotter KA, 2010, PSYCHOL HEALTH, V25, P805, DOI 10.1080/08870440902883212; Ferrer E, 2010, CURR DIR PSYCHOL SCI, V19, P149, DOI 10.1177/0963721410370300; Ferrucci L, 1999, J AM GERIATR SOC, V47, P639, DOI 10.1111/j.1532-5415.1999.tb01583.x; Fiatarone MA, 1996, RES Q EXERCISE SPORT, V67, pS70; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Freedman VA, 2002, JAMA-J AM MED ASSOC, V288, P3137, DOI 10.1001/jama.288.24.3137; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; Fries JF, 2002, JAMA-J AM MED ASSOC, V288, P3164, DOI 10.1001/jama.288.24.3164; Gruenewald TL, 2009, J AM GERIATR SOC, V57, P1525, DOI 10.1111/j.1532-5415.2009.02389.x; GURALNIK JM, 1989, AM J PUBLIC HEALTH, V79, P703, DOI 10.2105/AJPH.79.6.703; Hanson GR, 2003, JAMA-J AM MED ASSOC, V289, P1031, DOI 10.1001/jama.289.8.1031; He XXZ, 2004, AM J PUBLIC HEALTH, V94, P1567, DOI 10.2105/AJPH.94.9.1567; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Hubbard RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006174; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; Jette AM, 1998, GERONTOLOGIST, V38, P412, DOI 10.1093/geront/38.4.412; Johnstone B, 2009, REHABIL PSYCHOL, V54, P422, DOI 10.1037/a0017758; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Kim JY, 2007, SOC SCI MED, V65, P2489, DOI 10.1016/j.socscimed.2007.07.022; King AC, 2000, J GERONTOL A-BIOL, V55, pM74; Krause N, 2003, RES AGING, V25, P559, DOI 10.1177/0164027503256695; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Lachman ME, 1986, PSYCHOL AGING, V1, P34, DOI 10.1037/0882-7974.1.1.34; Lachman ME, 2008, PSYCHOL SCI, V19, P889, DOI 10.1111/j.1467-9280.2008.02173.x; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lachman ME, 2004, ANNU REV PSYCHOL, V55, P305, DOI 10.1146/annurev.psych.55.090902.141521; Lachman ME, 1998, J PERS SOC PSYCHOL, V74, P763, DOI 10.1037/0022-3514.74.3.763; LACHMAN ME, 2004, HLTH ARE WE NATL STU; LACHMAN ME, HDB PSYCHOL IN PRESS; Levy BR, 2002, J GERONTOL B-PSYCHOL, V57, pP409, DOI 10.1093/geronb/57.5.P409; Manandhar MC, 1995, P NUTR SOC, V54, P677, DOI 10.1079/PNS19950067; MARMOT MG, 2004, STATUS SYNDROME SOCI, P319; Mavandadi S, 2007, J GERONTOL B-PSYCHOL, V62, pS361, DOI 10.1093/geronb/62.6.S361; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Miller RR, 2004, J AM GERIATR SOC, V52, P217, DOI 10.1046/j.0002-8614.2004.52057.x; MIROWSKY J, 1995, SOC PSYCHOL QUART, V58, P31, DOI 10.2307/2787141; MOR V, 1994, AM J PUBLIC HEALTH, V84, P1274, DOI 10.2105/AJPH.84.8.1274; Murabito JM, 2008, AM J PUBLIC HEALTH, V98, P1256, DOI 10.2105/AJPH.2007.128132; *NAT CTR HLTH STAT, 2008, HLTH US 2008 CHARTB; Newson RS, 2006, EXP AGING RES, V32, P341, DOI 10.1080/03610730600699134; Poortinga W, 2007, PREV MED, V44, P124, DOI 10.1016/j.ypmed.2006.10.006; POPE AM, 1991, DISABILITY AM NATL A; Radler BT, 2010, J AGING HEALTH, V22, P307, DOI 10.1177/0898264309358617; Rains SA, 2009, HUM COMMUN RES, V35, P309, DOI 10.1111/j.1468-2958.2009.01353.x; Rodin J, 1985, Annu Rev Gerontol Geriatr, V5, P3; RODIN J, 1986, SCIENCE, V233, P1271, DOI 10.1126/science.3749877; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Rowe JW, 1998, SUCCESSFUL AGING; Ruger JP, 2010, AM J PUBLIC HEALTH, V100, P41, DOI 10.2105/AJPH.2008.143651; Sapolsky R.M., 1998, WHY ZEBRAS DONT GET; Sarna L, 2008, QUAL LIFE RES, V17, P1217, DOI 10.1007/s11136-008-9404-8; Seeman TE, 1997, ARCH INTERN MED, V157, P2259; SEEMAN TE, 1995, J GERONTOL A-BIOL, V50, pM177, DOI 10.1093/gerona/50A.4.M177; Seeman TE, 2004, SOC SCI MED, V58, P1985, DOI 10.1016/S0277-9536(03)00402-7; Seeman TE, 2010, AM J PUBLIC HEALTH, V100, P100, DOI 10.2105/AJPH.2008.157388; SINGER BH, 2001, NEW HORIZONS HLTH IN; Spencer SM, 2008, J AM GERIATR SOC, V56, P553, DOI 10.1111/j.1532-5415.2007.01595.x; StataCorp, 2009, STAT STAT SOFTW; Stewart AL, 1992, MEASURING FUNCTIONIN, P67; Sturman MT, 2005, ARCH NEUROL-CHICAGO, V62, P1750, DOI 10.1001/archneur.62.11.1750; Syddall HE, 2009, J NUTR HEALTH AGING, V13, P57, DOI 10.1007/s12603-009-0010-4; van Dam RM, 2008, BRIT MED J, V337, pa1440, DOI [DOI 10.1136/BMJ.A1440, 10.1136/bmj.a1440]; Walen HR, 2000, J SOC PERS RELAT, V17, P5, DOI 10.1177/0265407500171001; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; White AM, 2009, AM J PUBLIC HEALTH, V99, P1872, DOI 10.2105/AJPH.2008.146894; Willcox BJ, 2006, JAMA-J AM MED ASSOC, V296, P2343, DOI 10.1001/jama.296.19.2343; Wrosch C, 2009, PSYCHOSOM MED, V71, P996, DOI 10.1097/PSY.0b013e3181ba6cd1; Yan TJ, 2009, GERONTOLOGIST, V49, P847, DOI 10.1093/geront/gnp113	86	100	103	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13297	10.1371/journal.pone.0013297	http://dx.doi.org/10.1371/journal.pone.0013297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20949016	Green Published, gold, Green Submitted			2022-12-27	WOS:000282748100023
J	Mulissa, Z; Jerene, D; Lindtjorn, B				Mulissa, Zewdie; Jerene, Degu; Lindtjorn, Bernt			Patients Present Earlier and Survival Has Improved, but Pre-ART Attrition Is High in a Six-Year HIV Cohort Data from Ethiopia	PLOS ONE			English	Article							COMBINATION ANTIRETROVIRAL THERAPY; FOLLOW-UP; SOUTH-AFRICA; MORTALITY; PROGRAM; CARE; COUNTRIES; CAMBODIA; OUTCOMES; SERVICE	Background: Previous studies showed higher early mortality rates among patients treated with antiretroviral drugs in settings with limited resources. One of the reasons was late presentation of patients to care. With improved access to HIV services, we expect improvements in disease stage at presentation. Our objective was to assess the effect of improved availability of HIV services on patient presentation to care and subsequent pre-ART and on-ART outcomes. Methodology and Principal Findings: At Arba Minch Hospital in Ethiopia, we reviewed baseline characteristics and outcomes of 2191 adult HIV patients. Nearly a half were in WHO stage III at presentation. About two-thirds of the patients (1428) started ART. Patients enrolled in the early phase (OR = 4.03, 95% CI 3.07-5.27), men (OR = 1.78, 95% CI 1.47-2.16), and those aged 45 years and above (OR = 2.04, 95% CI 1.48-2.82) were at higher risk of being in advanced clinical stage at presentation. The pretreatment mortality rate was 13.1 per 100 PYO, ranging from 1.4 in the rapid scale-up phase to 25.9 per 100 PYO in the early phase. A quarter of the patients were lost to follow-up before starting treatment. Being in less advanced stage (HR = 1.9, 95% CI = 1.6, 2.2), being in the recent cohort (HR = 2.0, 95% CI = 1.6, 2.6), and rural residence (HR = 1.8, 95% CI = 1.5, 2.2) were independent predictors of pre-ART loss to follow-up. Of those who started ART, 13.4% were lost to follow-up and 15.4% died. The survival improved during the study. Patients with advanced disease, men and older people had higher death rates. Conclusions and Significance: Patients started to present at earlier stages of their illness and death has decreased among adult HIV patients visiting Arba Minch Hospital. However, many patients were lost from pre-treatment follow-up. Early treatment start contributed to improved survival. Both pre-ART and on-ART patient retention mechanisms should be strengthened.	[Mulissa, Zewdie; Lindtjorn, Bernt] Arba Minch Hosp, Arba Minch, Ethiopia; [Jerene, Degu] WHO Country Off, Addis Ababa, Ethiopia; [Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Bergen, Norway	University of Bergen	Mulissa, Z (corresponding author), Arba Minch Hosp, Arba Minch, Ethiopia.	degujerene@yahoo.com	Lindtjorn, Bernt/K-9465-2018	Lindtjorn, Bernt/0000-0002-6267-6984; Mulissa, Zewdie/0000-0002-3947-9579	Centre for International Health, University of Bergen, Norway; WHO Country Office in Ethiopia	Centre for International Health, University of Bergen, Norway; WHO Country Office in Ethiopia	This study was financially supported by the Centre for International Health, University of Bergen, Norway. The WHO Country Office in Ethiopia provided additional financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, INT J TUBERC LUNG D, V13, P927; Amuron B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-290; Assefa Y, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000056; Bassett IV, 2009, JAIDS-J ACQ IMM DEF, V51, P135, DOI 10.1097/QAI.0b013e3181a44ef2; BASSETT IV, AIDS S1, V24, pS37; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Dou Zhi-hui, 2009, Zhonghua Yu Fang Yi Xue Za Zhi, V43, P1091; *FDRE, 2008, REP PROGR IMPL UN DE; *FDRE, 2002, POL ANT DRUGS SUPPL; Grabar S, 2006, J ANTIMICROB CHEMOTH, V57, P4, DOI 10.1093/jac/dki411; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Jerene D, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-136; Jerene Degu, 2006, AIDS Res Ther, V3, P10, DOI 10.1186/1742-6405-3-10; Jerene Degu, 2005, MedGenMed, V7, P66, DOI 10.1186/1758-2652-7-3-66; Keruly JC, 2007, CLIN INFECT DIS, V45, P1369, DOI 10.1086/522759; Kiboneka A, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b201; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; LUBEGA M, 2009, HLTH POLICY; *MOH, 2005, GUID US ANT DRUGS ET; *MOH HAPCO DACA, 2003, GUID US ANT DRUGS ET; Mugavero Michael J, 2008, Top HIV Med, V16, P156; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; SANTIAGO P, 2007, J WOMENS HEALTH, V16, P1052; Thai S, 2009, TROP MED INT HEALTH, V14, P1048, DOI 10.1111/j.1365-3156.2009.02334.x; WHO, 2009, UN ACC SCAL PRIOR HI	29	77	77	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13268	10.1371/journal.pone.0013268	http://dx.doi.org/10.1371/journal.pone.0013268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949010	Green Published, gold			2022-12-27	WOS:000282748100015
J	Roman, J; McCarthy, JJ				Roman, Joe; McCarthy, James J.			The Whale Pump: Marine Mammals Enhance Primary Productivity in a Coastal Basin	PLOS ONE			English	Article							STELLER SEA LIONS; ATLANTIC RIGHT WHALE; NORTH-ATLANTIC; EUMETOPIAS-JUBATUS; VERTICAL MIGRATION; SOUTHERN-OCEAN; BALEEN WHALES; GREY SEALS; FOOD; NITROGEN	It is well known that microbes, zooplankton, and fish are important sources of recycled nitrogen in coastal waters, yet marine mammals have largely been ignored or dismissed in this cycle. Using field measurements and population data, we find that marine mammals can enhance primary productivity in their feeding areas by concentrating nitrogen near the surface through the release of flocculent fecal plumes. Whales and seals may be responsible for replenishing 2.3x10(4) metric tons of N per year in the Gulf of Maine's euphotic zone, more than the input of all rivers combined. This upward "whale pump" played a much larger role before commercial harvest, when marine mammal recycling of nitrogen was likely more than three times atmospheric N input. Even with reduced populations, marine mammals provide an important ecosystem service by sustaining productivity in regions where they occur in high densities.	[Roman, Joe] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [McCarthy, James J.] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA	University of Vermont; Harvard University	Roman, J (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.	jroman@uvm.edu			Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR) [N00014-08-1-0630]; National Oceanographic Partnership Program (NOPP) [N00014-07-1-1029]; Museum of Comparative Zoology, Harvard University	Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR)(Office of Naval Research); National Oceanographic Partnership Program (NOPP); Museum of Comparative Zoology, Harvard University	Funding was supported by Stellwagen Bank National Marine Sanctuary, Office of Naval Research (ONR) grant N00014-08-1-0630, National Oceanographic Partnership Program (NOPP) grant N00014-07-1-1029, and the Museum of Comparative Zoology, Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar A., 1986, Reports of the International Whaling Commission Special Issue, P191; ANTIA NJ, 1974, J FISH RES BOARD CAN, V31, P1327, DOI 10.1139/f74-157; Barlow J, 2008, MAR ECOL PROG SER, V371, P285, DOI 10.3354/meps07695; Baumgartner MF, 2008, LIMNOL OCEANOGR, V53, P2197, DOI 10.4319/lo.2008.53.5_part_2.2197; Baumgartner MF, 2003, MAR ECOL PROG SER, V264, P123, DOI 10.3354/meps264123; Boyce DG, 2010, NATURE, V466, P591, DOI 10.1038/nature09268; Boyd Ian L., 1999, P218; Carlini AR, 2005, POLAR BIOL, V28, P769, DOI 10.1007/s00300-005-0004-6; Clapham Phil, 2003, Journal of Cetacean Research and Management, V5, P13; Corkeron PJ, 2009, BIOL LETTERS, V5, P204, DOI 10.1098/rsbl.2008.0628; Cornick LA, 2006, ECOL MODEL, V199, P107, DOI 10.1016/j.ecolmodel.2006.07.003; Croll DA, 2001, COMP BIOCHEM PHYS A, V129, P797, DOI 10.1016/S1095-6433(01)00348-8; Croll DA, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P202; Daunt F, 2006, CONSERV BIOL SER, P177, DOI 10.1017/CBO9780511541964.013; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Gaskin DE., 1982, ECOLOGY WHALES DOLPH; Gilbert JR, 2005, MAR MAMMAL SCI, V21, P519, DOI 10.1111/j.1748-7692.2005.tb01246.x; HAMNER P, 1977, SCIENCE, V195, P886, DOI 10.1126/science.841313; Hansen BJL, 2006, J SEA RES, V56, P329, DOI 10.1016/j.seares.2006.06.004; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Holt SJ, 2003, BIOSCIENCE, V53, P204; Huettmann F, 2001, ESTIMATES ABUNDANCE; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; HUTCHINS DA, 1995, LIMNOL OCEANOGR, V40, P989, DOI 10.4319/lo.1995.40.5.0989; KANWISHER JW, 1983, SCI AM, V248, P110, DOI 10.1038/scientificamerican0683-110; KATONA S, 1988, OCEANOGR MAR BIOL, V26, P553; Kenney Robert D., 1997, Journal of Northwest Atlantic Fishery Science, V22, P155; Kjeld M, 2003, CAN J ZOOL, V81, P606, DOI [10.1139/z03-041, 10.1139/Z03-041]; KOOYMAN GL, 1981, ANNU REV PHYSIOL, V43, P343, DOI 10.1146/annurev.ph.43.030181.002015; Lavery TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3527, DOI 10.1098/rspb.2010.0863; Lockyer C., 1981, FAO FISHERIES SERIES, V5, P379; LONGHURST AR, 1989, PROG OCEANOGR, V22, P47, DOI 10.1016/0079-6611(89)90010-4; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2004, ECOL APPL, V14, P1428, DOI 10.1890/03-5027; MAYO CA, 1990, CAN J ZOOL, V68, P2214, DOI 10.1139/z90-308; McCarthy JJ, 1999, DEEP-SEA RES PT II, V46, P1623, DOI 10.1016/S0967-0645(99)00038-7; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MICHAUD J, 2005, THESIS DALHOUSIE U; Michaud Josee, 2007, Endangered Species Research, V3, P77, DOI 10.3354/esr003077; MILLAR JS, 1990, FUNCT ECOL, V4, P5, DOI 10.2307/2389646; MORENO P, THESIS HARVARD U; Morissette L, 2010, FISH FISH, V11, P388, DOI 10.1111/j.1467-2979.2010.00366.x; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ortiz RM, 2001, J EXP BIOL, V204, P1831; PALKA D, 2000, NOAANMFSNEFSC0007; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; Pfister B, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P116; Powers K.D., 1987, P359; Prospero JM, 1996, BIOGEOCHEMISTRY, V35, P27, DOI 10.1007/BF02179824; Rabalais NN, 2002, AMBIO, V31, P102, DOI 10.1579/0044-7447-31.2.102; Roman J, 2003, SCIENCE, V301, P508, DOI 10.1126/science.1084524; RONALD K, 1984, CAN J ZOOL, V62, P1101, DOI 10.1139/z84-160; Smetacek V, 2005, NATURE, V437, P362, DOI 10.1038/nature04161; SMITH FA, NATURE GEOSCIENCE, V3, P374; SOWLES J, 2001, NITROGEN GULF MAINE; Sparling CE, 2007, BIOL LETTERS, V3, P94, DOI 10.1098/rsbl.2006.0566; Sparling CE, 2006, J COMP PHYSIOL B, V176, P505, DOI 10.1007/s00360-006-0072-0; Steinberg DK, 2002, DEEP-SEA RES PT I, V49, P1445, DOI 10.1016/S0967-0637(02)00037-7; Theobald MR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024384; Townsend DW, 1998, J MARINE SYST, V16, P283, DOI 10.1016/S0924-7963(97)00024-9; Trites AW, 2002, J ZOOL, V256, P547, DOI 10.1017/S0952836902000596; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; WARING GT, 2006, NMFSNE194; Weinrich M, 1998, J MAMMAL, V79, P163, DOI 10.2307/1382851; Willis J, 2007, EVOL ECOL RES, V9, P651; Winship AJ, 2002, MAR ECOL PROG SER, V229, P291, DOI 10.3354/meps229291	68	173	174	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13255	10.1371/journal.pone.0013255	http://dx.doi.org/10.1371/journal.pone.0013255			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949007	gold, Green Published			2022-12-27	WOS:000282748100008
J	Ghosh, AS; Ray, D; Dutta, S; Raha, S				Ghosh, Anupama Sardar; Ray, Doel; Dutta, Suman; Raha, Sanghamitra			EhMAPK, the Mitogen-Activated Protein Kinase from Entamoeba histolytica Is Associated with Cell Survival	PLOS ONE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; SIGNAL-REGULATED KINASES; MAP KINASES; PHOSPHORYLATION; IDENTIFICATION; EUKARYOTE; KINOME; GENES	Mitogen Activated Protein Kinases (MAPKs) are a class of serine/threonine kinases that regulate a number of different cellular activities including cell proliferation, differentiation, survival and even death. The pathogen Entamoeba histolytica possess a single homologue of a typical MAPK gene (EhMAPK) whose identification was previously reported by us but its functional implications remained unexplored. EhMAPK, the only mitogen-activated protein kinase from the parasitic protist Entamoeba histolytica with Threonine-X-Tyrosine (TXY) phosphorylation motif was cloned, expressed in E. coli and functionally characterized under different stress conditions. The expression profile of EhMAPK at the protein and mRNA level remained similar among untreated, heat shocked and hydrogen peroxide-treated samples in all cases of dose and time. But a significant difference was obtained in the phosphorylation status of the protein in response to different stresses. Heat shock at 43 degrees C or 0.5 mM H2O2 treatment enhanced the phosphorylation status of EhMAPK and augmented the kinase activity of the protein whereas 2.0 mM H2O2 treatment induced dephosphorylation of EhMAPK and loss of kinase activity. 2.0 mM H2O2 treatment reduced parasite viability significantly but heat shock and 0.5 mM H2O2 treatment failed to adversely affect E. histolytica viability. Therefore, a distinct possibility that activation of EhMAPK is associated with stress survival in E. histolytica is seen. Our study also gives a glimpse of the regulatory mechanism of the protein under in vivo conditions. Since the parasite genome lacks any typical homologue of mammalian MEK, the dual specificity kinases which are the upstream activators of MAPK, indications of the existence of some alternate regulatory mechanisms of the EhMAPK activity is perceived. These may include the autophosphorylation activity of the protein itself in combination with some upstream phosphatases which are not yet identified.	[Ghosh, Anupama Sardar; Ray, Doel; Dutta, Suman; Raha, Sanghamitra] Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India	Saha Institute of Nuclear Physics	Ghosh, AS (corresponding author), Saha Inst Nucl Phys, Crystallog & Mol Biol Div, Kolkata, India.	sanghamitra.raha@saha.ac.in		Ghosh, Anupama/0000-0002-4200-5091	Department of Atomic Energy, Government Of India	Department of Atomic Energy, Government Of India(Department of Atomic Energy (DAE))	This study was funded by the Department of Atomic Energy, Government Of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Anamika K, 2008, PROTEINS, V71, P995, DOI 10.1002/prot.21790; Andreeva AV, 2008, INT J PARASITOL, V38, P1279, DOI 10.1016/j.ijpara.2008.04.003; Bardwell L, 2006, BIOCHEM SOC T, V34, P837, DOI 10.1042/BST0340837; Chen W, 1998, MOL CELL BIOL, V18, P5178, DOI 10.1128/MCB.18.9.5178; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Ellis JG, 2003, J BIOL CHEM, V278, P1936, DOI 10.1074/jbc.M209274200; ERICKSON AK, 1990, J BIOL CHEM, V265, P19728; Ghosh AS, 2010, PARASITOL INT, V59, P166, DOI 10.1016/j.parint.2010.01.001; Hornberg JJ, 2005, ONCOGENE, V24, P5533, DOI 10.1038/sj.onc.1208817; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Lacey MR, 2007, J MOL EVOL, V64, P4, DOI 10.1007/s00239-005-0197-x; Lee JT, 2002, LEUKEMIA, V16, P486, DOI 10.1038/sj/leu/2402460; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Mishima K, 2002, ORAL ONCOL, V38, P468, DOI 10.1016/S1368-8375(01)00104-X; Morales MA, 2007, INT J PARASITOL, V37, P1187, DOI 10.1016/j.ijpara.2007.03.006; Ng DCH, 2000, J BIOL CHEM, V275, P40856, DOI 10.1074/jbc.M004639200; Pimienta G, 2007, CELL CYCLE, V6, P2628, DOI 10.4161/cc.6.21.4930; Rangarajan R, 2005, EMBO REP, V6, P464, DOI 10.1038/sj.embor.7400404; Ray D, 2005, GENE, V346, P41, DOI 10.1016/j.gene.2004.10.026; Vicente JB, 2009, CELL MICROBIOL, V11, P51, DOI 10.1111/j.1462-5822.2008.01236.x; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; WILSON K, 1991, J BIOL CHEM, V266, P1665	27	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13291	10.1371/journal.pone.0013291	http://dx.doi.org/10.1371/journal.pone.0013291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949043	gold, Green Published, Green Submitted			2022-12-27	WOS:000282676700021
J	Keenan, TM; Nelson, AD; Grinager, JR; Thelen, JC; Svendsen, CN				Keenan, Thomas M.; Nelson, Aaron D.; Grinager, Jeffrey R.; Thelen, Jarett C.; Svendsen, Clive N.			Real Time Imaging of Human Progenitor Neurogenesis	PLOS ONE			English	Article							NEURAL STEM-CELLS; CORTICAL DEVELOPMENT; PRECURSOR CELLS; NEURONS ARISE; RADIAL GLIA; IN-VITRO; SPECIFICATION; NEOCORTEX; DIFFERENTIATION; EXPRESSION	Human neural progenitors are increasingly being employed in drug screens and emerging cell therapies targeted towards neurological disorders where neurogenesis is thought to play a key role including developmental disorders, Alzheimer's disease, and depression. Key to the success of these applications is understanding the mechanisms by which neurons arise. Our understanding of development can provide some guidance but since little is known about the specifics of human neural development and the requirement that cultures be expanded in vitro prior to use, it is unclear whether neural progenitors obey the same developmental mechanisms that exist in vivo. In previous studies we have shown that progenitors derived from fetal cortex can be cultured for many weeks in vitro as undifferentiated neurospheres and then induced to undergo neurogenesis by removing mitogens and exposing them to supportive substrates. Here we use live time lapse imaging and immunocytochemical analysis to show that neural progenitors use developmental mechanisms to generate neurons. Cells with morphologies and marker profiles consistent with radial glia and recently described outer radial glia divide asymmetrically and symmetrically to generate multipolar intermediate progenitors, a portion of which express ASCL1. These multipolar intermediate progenitors subsequently divide symmetrically to produce CTIP2(+) neurons. This 3-cell neurogenic scheme echoes observations in rodents in vivo and in human fetal slice cultures in vitro, providing evidence that hNPCs represent a renewable and robust in vitro assay system to explore mechanisms of human neurogenesis without the continual need for fresh primary human fetal tissue. Knowledge provided by this and future explorations of human neural progenitor neurogenesis will help maximize the safety and efficacy of new stem cell therapies by providing an understanding of how to generate physiologically-relevant cell types that maintain their identities when placed in diagnostic or transplantation environments.	[Keenan, Thomas M.; Nelson, Aaron D.; Grinager, Jeffrey R.; Thelen, Jarett C.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Svendsen, Clive N.] Cedars Sinai Regenerat Med Inst, Los Angeles, CA USA	University of Wisconsin System; University of Wisconsin Madison; Cedars Sinai Medical Center	Keenan, TM (corresponding author), Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA.	clive.svendsen@cshs.org			National Institutes of Health [NIH T32 AG027455, NIH R21 NS060047-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institutes of Health (NIH T32 AG027455, NIH R21 NS060047-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2007, EXP NEUROL, V204, P512, DOI 10.1016/j.expneurol.2006.12.025; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Behrstock S, 2004, ANN NY ACAD SCI, V1019, P5, DOI 10.1196/annals.1297.002; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; BLINKOV SAMUIL M., 1968; Buchet D, 2009, NEUROSCI LETT, V456, P112, DOI 10.1016/j.neulet.2008.09.086; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Gal JS, 2006, J NEUROSCI, V26, P1045, DOI 10.1523/JNEUROSCI.4499-05.2006; HANSEN DV, 2010, NATURE; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Howard B, 2006, GLIA, V53, P57, DOI 10.1002/glia.20259; Klein SM, 2005, HUM GENE THER, V16, P509, DOI 10.1089/hum.2005.16.509; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Kowalczyk T, 2009, CEREB CORTEX; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Muller F, 2004, CELLS TISSUES ORGANS, V178, P93, DOI 10.1159/000081720; Nelson AD, 2006, MOL CELL NEUROSCI, V33, P29, DOI 10.1016/j.mcn.2006.06.003; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2002, J NEUROSCI, V22, P3161, DOI 10.1523/JNEUROSCI.22-08-03161.2002; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Ostenfeld T, 2004, STEM CELLS, V22, P798, DOI 10.1634/stemcells.22-5-798; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Ostenfeld T, 2002, J NEUROSCI RES, V69, P955, DOI 10.1002/jnr.10396; Perez-Alvarez MJ, 2008, J NEUROSCI RES, V86, P1871, DOI 10.1002/jnr.21623; Pluchino S, 2009, NEUROSCI LETT, V456, P101, DOI 10.1016/j.neulet.2008.03.097; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Regulier Etienne, 2004, V277, P199; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Svendsen CN, 1998, J NEUROSCI METH, V85, P141, DOI 10.1016/S0165-0270(98)00126-5; Tai YT, 2004, CURR OPIN PHARMACOL, V4, P98, DOI 10.1016/j.coph.2003.09.006; Tewarie RSN, 2009, J SPINAL CORD MED, V32, P105, DOI 10.1080/10790268.2009.11760761; Trounson A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-29; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Wright LS, 2006, EXP CELL RES, V312, P2107, DOI 10.1016/j.yexcr.2006.03.012; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102	47	12	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13187	10.1371/journal.pone.0013187	http://dx.doi.org/10.1371/journal.pone.0013187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949053	Green Submitted, Green Published, gold			2022-12-27	WOS:000282633700007
J	Arbesman, S; Laughlin, G				Arbesman, Samuel; Laughlin, Gregory			A Scientometric Prediction of the Discovery of the First Potentially Habitable Planet with a Mass Similar to Earth	PLOS ONE			English	Article								Background: The search for a habitable extrasolar planet has long interested scientists, but only recently have the tools become available to search for such planets. In the past decades, the number of known extrasolar planets has ballooned into the hundreds, and with it, the expectation that the discovery of the first Earth-like extrasolar planet is not far off. Methodology/Principal Findings: Here, we develop a novel metric of habitability for discovered planets and use this to arrive at a prediction for when the first habitable planet will be discovered. Using a bootstrap analysis of currently discovered exoplanets, we predict the discovery of the first Earth-like planet to be announced in the first half of 2011, with the likeliest date being early May 2011. Conclusions/Significance: Our predictions, using only the properties of previously discovered exoplanets, accord well with external estimates for the discovery of the first potentially habitable extrasolar planet and highlight the the usefulness of predictive scientometric techniques to understand the pace of scientific discovery in many fields.	[Arbesman, Samuel] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Arbesman, Samuel] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Laughlin, Gregory] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA	Harvard University; Harvard Medical School; Harvard University; University of California System; University of California Santa Cruz	Arbesman, S (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.	arbesman@hcp.med.harvard.edu						Arbesman S, 2011, SCIENTOMETRICS, V86, P245, DOI 10.1007/s11192-010-0232-6; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; de Solla Price Derek J., 1986, LITTLE SCI BIG SCI; Fridlund M, 2010, ASTROBIOLOGY, V10, P1, DOI [10.1089/ast.2009.0382, 10.1089/ast.2009.0368]; GROSSMAN L, 2004, TIME            1011; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Koh H, 2006, TECHNOL FORECAST SOC, V73, P1061, DOI 10.1016/j.techfore.2006.06.001; Landsberger HA, 1958, HAWTHORNE REVISITED; LAUGHLIN G, 2010, SYSTEMIC CHARACTERIZ; Mischna MA, 2000, ICARUS, V145, P546, DOI 10.1006/icar.2000.6380; Moore G., 1965, ELECTRONICS, V38, P114, DOI [DOI 10.1109/N-SSC.2006.4785860, DOI 10.1109/JPROC.1998.658762]; Santos NC, 2005, SCIENCE, V310, P251, DOI 10.1126/science.1100210; Schilling G, 2007, SCIENCE, V316, P528; SURVEY CP, 2010, EXOPLANET ORBIT DATA; Vogel G, 1999, SCIENCE, V286, P70, DOI 10.1126/science.286.5437.70; WORDSWORTH R, 2010, ARXIV10055098	18	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13061	10.1371/journal.pone.0013061	http://dx.doi.org/10.1371/journal.pone.0013061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957226	gold, Green Published, Green Submitted			2022-12-27	WOS:000282423300002
J	Pigati, L; Yaddanapudi, SCS; Iyengar, R; Kim, DJ; Hearn, SA; Danforth, D; Hastings, ML; Duelli, DM				Pigati, Lucy; Yaddanapudi, Sree C. S.; Iyengar, Ravi; Kim, Dong-Ja; Hearn, Steven A.; Danforth, David; Hastings, Michelle L.; Duelli, Dominik M.			Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells	PLOS ONE			English	Article							BREAST-CANCER; GENE-EXPRESSION; STEM-CELLS; CIRCULATING MICRORNAS; TAMOXIFEN RESISTANCE; TUMOR INVASION; MIR-200 FAMILY; MESSENGER-RNA; DUCTAL LAVAGE; EXOSOMES	MicroRNAs (miRNAs) in body fluids are candidate diagnostics for a variety of conditions and diseases, including breast cancer. One premise for using extracellular miRNAs to diagnose disease is the notion that the abundance of the miRNAs in body fluids reflects their abundance in the abnormal cells causing the disease. As a result, the search for such diagnostics in body fluids has focused on miRNAs that are abundant in the cells of origin. Here we report that released miRNAs do not necessarily reflect the abundance of miRNA in the cell of origin. We find that release of miRNAs from cells into blood, milk and ductal fluids is selective and that the selection of released miRNAs may correlate with malignancy. In particular, the bulk of miR-451 and miR-1246 produced by malignant mammary epithelial cells was released, but the majority of these miRNAs produced by non-malignant mammary epithelial cells was retained. Our findings suggest the existence of a cellular selection mechanism for miRNA release and indicate that the extracellular and cellular miRNA profiles differ. This selective release of miRNAs is an important consideration for the identification of circulating miRNAs as biomarkers of disease.	[Pigati, Lucy; Iyengar, Ravi; Kim, Dong-Ja; Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA; [Yaddanapudi, Sree C. S.; Hastings, Michelle L.; Duelli, Dominik M.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL USA; [Yaddanapudi, Sree C. S.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Bligh Canc Res Ctr, N Chicago, IL USA; [Hearn, Steven A.] Cold Spring Harbor Lab, Microscopy Facil, Cold Spring Harbor, NY 11724 USA; [Danforth, David] NCI, Surg Branch, CCR, NIH, Bethesda, MD 20892 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Chicago Medical School; Rosalind Franklin University Medical & Science; Cold Spring Harbor Laboratory; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pigati, L (corresponding author), Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Dept Pathol, N Chicago, IL 60064 USA.	Dominik.Duelli@Rosalindfranklin.edu	Hastings, MICHELLE L./AAK-6627-2021	Hearn, Stephen/0000-0002-2489-2424; Hastings, Michelle L./0000-0002-4253-9261	United States Department of Defense [W81XWH-08-1-0641]; American Cancer Society [08-29]; Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Center; NIH NCRR [S10 RR19325]; HRSA [C76 HF03610-01-00]; NATIONAL CANCER INSTITUTE [ZIASC006663] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019325] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); Rosalind Franklin University of Medicine and Science; Bligh Cancer Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the United States Department of Defense grant W81XWH-08-1-0641, and an American Cancer Society of Illinois Research Grant 08-29 to DMD, Rosalind Franklin University of Medicine and Science start-up funds and support of the Bligh Cancer Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the Midwest Proteome Center, funded by NIH NCRR S10 RR19325, and HRSA C76 HF03610-01-00 for services rendered.	Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Chen TS, 2010, NUCLEIC ACIDS RES, V38, P215, DOI 10.1093/nar/gkp857; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Cochrane DR, 2010, J ONCOL, V2010, DOI 10.1155/2010/821717; Coren LV, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-64; Danforth DN, 2006, J SURG ONCOL, V94, P555, DOI 10.1002/jso.20650; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dua RS, 2006, J CLIN ONCOL, V24, P1209, DOI 10.1200/JCO.2005.04.1830; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Duelli DM, 2000, NAT CELL BIOL, V2, P859, DOI 10.1038/35041112; Duelli D, 2007, NAT REV CANCER, V7, P968, DOI 10.1038/nrc2272; Duelli DM, 2007, CURR BIOL, V17, P431, DOI 10.1016/j.cub.2007.01.049; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Garzon R, 2007, ONCOGENE, V26, P4148, DOI 10.1038/sj.onc.1210186; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Go Attie T. J. J., 2008, V444, P291, DOI 10.1007/978-1-59745-066-9_23; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HATA T, 2010, BIOCH BIOPHYS RES CO; Heaphy CM, 2009, BREAST CANCER RES TR, V118, P229, DOI 10.1007/s10549-009-0504-0; Helvik SA, 2007, BIOINFORMATICS, V23, P142, DOI 10.1093/bioinformatics/btl570; Heneghan HM, 2010, J ONCOL, V2010, DOI 10.1155/2010/950201; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hossain A, 2006, MOL CELL BIOL, V26, P8191, DOI 10.1128/MCB.00242-06; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang Z, 2009, INT J CANC; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Jackson DB, 2009, P NATL ACAD SCI USA, V106, pE5, DOI 10.1073/pnas.0809999106; JOHNSTONE RM, 1991, J CELL PHYSIOL, V147, P27, DOI 10.1002/jcp.1041470105; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Khan SA, 2009, CANCER PREV RES, V2, P265, DOI 10.1158/1940-6207.CAPR-08-0119; Kosaka Nobuyoshi, 2010, Silence, V1, P7, DOI 10.1186/1758-907X-1-7; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Lang Julie E, 2007, Cancer Control, V14, P350; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Loud JT, 2009, CANCER EPIDEM BIOMAR, V18, P1243, DOI 10.1158/1055-9965.EPI-08-0795; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mathias Rommel A., 2009, V528, P227, DOI 10.1007/978-1-60327-310-7_16; MICHAEL A, 2009, ORAL DIS; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ohgaki K, 1998, GENE CHROMOSOME CANC, V23, P244, DOI 10.1002/(SICI)1098-2264(199811)23:3<244::AID-GCC6>3.3.CO;2-#; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Paweletz CP, 2001, DIS MARKERS, V17, P301, DOI 10.1155/2001/674959; Pegtel DM, 2010, P NATL ACAD SCI USA, V107, P6328, DOI 10.1073/pnas.0914843107; Peltier HJ, 2008, RNA, V14, P844, DOI 10.1261/rna.939908; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Ratajczak J, 2006, LEUKEMIA, V20, P847, DOI 10.1038/sj.leu.2404132; Schmittgen TD, 2008, METHODS, V44, P31, DOI 10.1016/j.ymeth.2007.09.006; Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Staubach S, 2009, PROTEOMICS, V9, P2820, DOI 10.1002/pmic.200800793; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Tsuchiya S, 2009, NUCLEIC ACIDS RES, V37, P3821, DOI 10.1093/nar/gkp255; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Varis A, 2002, CANCER RES, V62, P2625; Welsch U, 2007, ANN ANAT, V189, P131, DOI 10.1016/j.aanat.2006.09.010; Wilfred BR, 2007, MOL GENET METAB, V91, P209, DOI 10.1016/j.ymgme.2007.03.011; Williams AE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-172; Yamada H, 2008, GENE CHROMOSOME CANC, V47, P810, DOI 10.1002/gcc.20582; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu X, 2009, FEBS J, V276, P2201, DOI 10.1111/j.1742-4658.2009.06949.x; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24; Zhu Weizhu, 2009, BMC Res Notes, V2, P89, DOI 10.1186/1756-0500-2-89	105	449	482	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13515	10.1371/journal.pone.0013515	http://dx.doi.org/10.1371/journal.pone.0013515			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976003	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000283216400020
J	Mcbee, ME; Zeng, Y; Parry, N; Nagler, CR; Tannenbaum, SR; Schauer, DB				Mcbee, Megan E.; Zeng, Yu; Parry, Nicola; Nagler, Cathryn R.; Tannenbaum, Steven R.; Schauer, David B.			Multivariate Modeling Identifies Neutrophil- and Th17-Related Factors as Differential Serum Biomarkers of Chronic Murine Colitis	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CITROBACTER-RODENTIUM; NITRIC-OXIDE; BACTERIAL PATHOGEN; EXPRESSION; MICE; INFLAMMATION; ANTIBODIES; RECEPTOR; INFECTION	Background: Diagnosis of chronic intestinal inflammation, which characterizes inflammatory bowel disease (IBD), along with prediction of disease state is hindered by the availability of predictive serum biomarker. Serum biomarkers predictive of disease state will improve trials for therapeutic intervention, and disease monitoring, particularly in genetically susceptible individuals. Chronic inflammation during IBD is considered distinct from infectious intestinal inflammation thereby requiring biomarkers to provide differential diagnosis. To address whether differential serum biomarkers could be identified in murine models of colitis, immunological profiles from both chronic spontaneous and acute infectious colitis were compared and predictive serum biomarkers identified via multivariate modeling. Methodology/Principal Findings: Discriminatory multivariate modeling of 23 cytokines plus chlorotyrosine and nitrotyrosine (protein adducts from reactive nitrogen species and hypochlorite) in serum and tissue from two murine models of colitis was performed to identify disease-associated biomarkers. Acute C. rodentium-induced colitis in C57BL/6J mice and chronic spontaneous Helicobacter-dependent colitis in TLR4(-/-) x IL-10(-/-) mice were utilized for evaluation. Colon profiles of both colitis models were nearly identical with chemokines, neutrophil-and Th17-related factors highly associated with intestinal disease. In acute colitis, discriminatory disease-associated serum factors were not those identified in the colon. In contrast, the discriminatory predictive serum factors for chronic colitis were neutrophil-and Th17-related factors (KC, IL-12/23p40, IL-17, G-CSF, and chlorotyrosine) that were also elevated in colon tissue. Chronic colitis serum biomarkers were specific to chronic colitis as they were not discriminatory for acute colitis. Conclusions/Significance: Immunological profiling revealed strikingly similar colon profiles, yet distinctly different serum profiles for acute and chronic colitis. Neutrophil-and Th17-related factors were identified as predictive serum biomarkers of chronic colitis, but not acute colitis, despite their presence in colitic tissue of both diseases thereby demonstrating the utility of mathematical modeling for identifying disease-associated serum biomarkers.	[Mcbee, Megan E.; Zeng, Yu; Tannenbaum, Steven R.; Schauer, David B.] MIT, Biol Engn Dept, Cambridge, MA 02139 USA; [Parry, Nicola; Schauer, David B.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Mcbee, Megan E.; Nagler, Cathryn R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Chicago	Mcbee, ME (corresponding author), MIT, Biol Engn Dept, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mmcbee@bsd.uchicago.edu		Parry, Nicola/0000-0002-0446-5249	National Institutes of Health [P01 CA026731, DK 55678]; Singapore-MIT Alliance for Research and Technology-Infectious Diseases; Agilent Technologies; NATIONAL CANCER INSTITUTE [P01CA026731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055678] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Singapore-MIT Alliance for Research and Technology-Infectious Diseases; Agilent Technologies; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants P01 CA026731 (YZ, SRT, DBS), DK 55678 (CRN), and the Singapore-MIT Alliance for Research and Technology-Infectious Diseases (MEM, DBS) supported this work. Additional facilities and instrument support were provided by the United States Army Research Office through the Institute for Soldier Nanotechnologies at Massachusetts Institute of Technology (MIT), the National Institutes of Health for Environmental Health Sciences at MIT, and an equipment loan from Agilent Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Axtell RC, 2009, NAT IMMUNOL, V10, P453, DOI 10.1038/ni0509-453; Banks C, 2003, J PATHOL, V199, P28, DOI 10.1002/path.1245; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Carlson M, 2002, GUT, V50, P501, DOI 10.1136/gut.50.4.501; Chaluvadi MR, 2009, DRUG METAB DISPOS, V37, P366, DOI 10.1124/dmd.108.024240; Chin MP, 2008, NITRIC OXIDE-BIOL CH, V19, P266, DOI 10.1016/j.niox.2008.04.025; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Dann SM, 2008, J IMMUNOL, V180, P6816, DOI 10.4049/jimmunol.180.10.6816; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; EASTAFFLEUNG N, 2009, J CLIN IMMUNOL; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Fina D, 2008, GASTROENTEROLOGY, V134, P1038, DOI 10.1053/j.gastro.2008.01.041; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gibson DL, 2008, CELL MICROBIOL, V10, P388, DOI 10.1111/j.1462-5822.2007.01052.x; Gobert AP, 2004, J IMMUNOL, V173, P2109, DOI 10.4049/jimmunol.173.3.2109; Grimm MC, 1996, GUT, V38, P90, DOI 10.1136/gut.38.1.90; GRIMM MC, 1995, CLIN EXP IMMUNOL, V100, P291, DOI 10.1111/j.1365-2249.1995.tb03667.x; Hanauer SB, 2010, NAT REV GASTRO HEPAT, V7, P63, DOI 10.1038/nrgastro.2009.238; HARRISON JE, 1976, J BIOL CHEM, V251, P1371; Joossens S, 2006, GUT, V55, P1667, DOI 10.1136/gut.2005.089623; Khader SA, 2009, MUCOSAL IMMUNOL, V2, P403, DOI 10.1038/mi.2009.100; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lampinen M, 2008, INT J COLORECTAL DIS, V23, P939, DOI 10.1007/s00384-008-0509-x; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Lebeis SL, 2009, INFECT IMMUN, V77, P604, DOI 10.1128/IAI.00907-08; Leon AJ, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/580450; Li XH, 2008, WORLD J GASTROENTERO, V14, P5115, DOI 10.3748/wjg.14.5115; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Masuda A, 2008, INFECT IMMUN, V76, P1728, DOI 10.1128/IAI.01493-07; Matharu KS, 2009, GASTROENTEROLOGY, V137, P1380, DOI 10.1053/j.gastro.2009.07.004; MATHARU KS, 2009, GASTROENTEROLOGY, V1380, pE1381; Mcbee ME, 2008, INFECT IMMUN, V76, P4851, DOI 10.1128/IAI.00745-08; Melgar S, 2005, AM J PHYSIOL-GASTR L, V288, pG1328, DOI 10.1152/ajpgi.00467.2004; MITSUYAMA K, 1994, CLIN EXP IMMUNOL, V96, P432; Nagamine CM, 2008, INT J CANCER, V122, P832, DOI 10.1002/ijc.23175; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; PELLETIER M, 2009, BLOOD; Reimund JM, 1996, J CLIN IMMUNOL, V16, P144, DOI 10.1007/BF01540912; Rogers AB, 2006, LAB INVEST, V86, P526, DOI 10.1038/labinvest.3700407; Satsangi J, 1998, INFLAMM BOWEL DIS, V4, P18, DOI 10.1097/00054725-199802000-00004; Sendid B, 1998, AM J GASTROENTEROL, V93, P1306, DOI 10.1111/j.1572-0241.1998.00415.x; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003; Simmons CP, 2002, J IMMUNOL, V168, P1804, DOI 10.4049/jimmunol.168.4.1804; Spehlmann ME, 2009, J IMMUNOL, V183, P3332, DOI 10.4049/jimmunol.0900600; Ten Hove T, 2001, GASTROENTEROLOGY, V121, P1372, DOI 10.1053/gast.2001.29579; Tu Z, 2007, CLIN EXP IMMUNOL, V149, P186, DOI 10.1111/j.1365-2249.2007.03415.x; Vallance BA, 2002, INFECT IMMUN, V70, P6424, DOI 10.1128/IAI.70.11.6424-6435.2002; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yoshida M, 2006, J CLIN INVEST, V116, P2142, DOI 10.1172/JCI27821; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	56	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13277	10.1371/journal.pone.0013277	http://dx.doi.org/10.1371/journal.pone.0013277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976045	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700001
J	de Vries, R; Kretzschmar, M; Schellekens, JFP; Versteegh, FGA; Westra, TA; Roord, JJ; Postma, MJ				de Vries, Robin; Kretzschmar, Mirjam; Schellekens, Joop F. P.; Versteegh, Florens G. A.; Westra, Tjalke A.; Roord, John J.; Postma, Maarten J.			Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands: Using an Individual-Based Dynamic Model	PLOS ONE			English	Article							ECONOMIC-EVALUATION; UNITED-STATES; WHOLE-CELL; ACELLULAR VACCINE; BOOSTER; AGE; STRATEGIES; DIPHTHERIA; BENEFITS; TETANUS	Background: Despite widespread immunization programs, a clear increase in pertussis incidence is apparent in many developed countries during the last decades. Consequently, additional immunization strategies are considered to reduce the burden of disease. The aim of this study is to design an individual-based stochastic dynamic framework to model pertussis transmission in the population in order to predict the epidemiologic and economic consequences of the implementation of universal booster vaccination programs. Using this framework, we estimate the cost-effectiveness of universal adolescent pertussis booster vaccination at the age of 12 years in the Netherlands. Methods/Principal Findings: We designed a discrete event simulation (DES) model to predict the epidemiological and economic consequences of implementing universal adolescent booster vaccination. We used national age-specific notification data over the period 1996-2000-corrected for underreporting-to calibrate the model assuming a steady state situation. Subsequently, booster vaccination was introduced. Input parameters of the model were derived from literature, national data sources (e. g. costing data, incidence and hospitalization data) and expert opinions. As there is no consensus on the duration of immunity acquired by natural infection, we considered two scenarios for this duration of protection (i.e. 8 and 15 years). In both scenarios, total pertussis incidence decreased as a result of adolescent vaccination. From a societal perspective, the cost-effectiveness was estimated at (sic)4418/QALY (range: 3205-6364 (sic) per QALY) and (sic)6371/QALY (range: 4139-9549 (sic) per QALY) for the 8- and 15-year protection scenarios, respectively. Sensitivity analyses revealed that the outcomes are most sensitive to the quality of life weights used for pertussis disease. Conclusions/Significance: To our knowledge we designed the first individual-based dynamic framework to model pertussis transmission in the population. This study indicates that adolescent pertussis vaccination is likely to be a cost-effective intervention for The Netherlands. The model is suited to investigate further pertussis booster vaccination strategies.	[de Vries, Robin; Westra, Tjalke A.; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands; [Kretzschmar, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Kretzschmar, Mirjam] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Schellekens, Joop F. P.] Infect Dis Lab, Groningen, Netherlands; [Versteegh, Florens G. A.] Groene Hart Ziekenhuis, Dept Pediat, Gouda, Netherlands; [Roord, John J.] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Groningen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	de Vries, R (corresponding author), Univ Groningen, Dept Pharm, Unit Pharmacoepidemiol & Pharmacoecon, Groningen, Netherlands.	Robin.de.Vries@rug.nl	Datta, Samik/S-3822-2016; Westra, Tjalke/B-3971-2011	Versteegh, Florens G.A./0000-0003-4773-5592; Postma, Maarten/0000-0002-6306-3653; Kretzschmar, Mirjam/0000-0002-4394-7697	GlaxoSmithKline, The Netherlands	GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline)	This study was supported by an unrestricted grant from GlaxoSmithKline, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Beutels P, 1999, VACCINE, V17, P2400, DOI 10.1016/S0264-410X(99)00028-6; Bos Jasper M, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P247, DOI 10.1586/14737167.4.3.247; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Calugar A, 2006, CLIN INFECT DIS, V42, P981, DOI 10.1086/500321; Caro J Jaime, 2005, Pediatr Infect Dis J, V24, pS75, DOI 10.1097/01.inf.0000160918.72953.51; Caro JJ, 2005, PHARMACOECONOMICS, V23, P323, DOI 10.2165/00019053-200523040-00003; Casey JR, 2005, DRUGS, V65, P1367, DOI 10.2165/00003495-200565100-00005; Coudeville L, 2008, EPIDEMIOL INFECT, V136, P604, DOI 10.1017/S0950268807009041; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Melker HE, 2000, EMERG INFECT DIS, V6, P348, DOI 10.3201/eid0604.000404; de Melker HE, 2006, J INFECTION, V53, P106, DOI 10.1016/j.jinf.2005.10.020; DEGREEFF SC, 2003, 128507010 RIVM; deMelker HE, 1997, EMERG INFECT DIS, V3, P175, DOI 10.3201/eid0302.970211; DEMELKER HE, 1997, 128507005 NAT I PUBL; DESERRE, 2000, J INFECT DIS, V182, P174; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Edmunds WJ, 1999, STAT MED, V18, P3263, DOI 10.1002/(SICI)1097-0258(19991215)18:23&lt;3263::AID-SIM315&gt;3.0.CO;2-3; Edmunds WJ, 2002, VACCINE, V20, P1316, DOI 10.1016/S0264-410X(01)00473-X; Ekwueme DU, 2000, ARCH PEDIAT ADOL MED, V154, P797, DOI 10.1001/archpedi.154.8.797; FARRINGTON CP, 1992, INT J EPIDEMIOL, V21, P1014, DOI 10.1093/ije/21.5.1014; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Frampton James E, 2006, Paediatr Drugs, V8, P189, DOI 10.2165/00148581-200608030-00005; GRENFELL BT, 1985, J HYG-CAMBRIDGE, V95, P419, DOI 10.1017/S0022172400062859; Halperin SA, 2005, PEDIATR INFECT DIS J, V24, pS141, DOI 10.1097/01.inf.0000166163.02135.8b; Hethcote HW, 2004, VACCINE, V22, P2181, DOI 10.1016/j.vaccine.2003.11.053; Hethcote HW, 1997, MATH BIOSCI, V145, P89, DOI 10.1016/S0025-5564(97)00014-X; Hethcote HW, 1999, MATH BIOSCI, V158, P47, DOI 10.1016/S0025-5564(99)00004-8; Hinman A R, 1985, Dev Biol Stand, V61, P429; HINMAN AR, 1984, JAMA-J AM MED ASSOC, V251, P3109, DOI 10.1001/jama.251.23.3109; *HLTH CAR INS BOAR, 2006, DUTCH GUID PHARM RES; *HLTH CARE INS BOA, 2008, DUTCH GUID PHARM; *HLTH COUNC NETH, 2004, PUBL HLTH COUNC NETH; Hollingworth W, 2007, ACAD RADIOL, V14, P406, DOI 10.1016/j.acra.2007.01.007; Iskedjian M, 2004, VACCINE, V22, P4215, DOI 10.1016/j.vaccine.2004.04.025; Iskedjian M, 2001, PHARMACOECONOMICS, V19, P551, DOI 10.2165/00019053-200119050-00009; Iskedjian Michael, 2005, Paediatr Drugs, V7, P123, DOI 10.2165/00148581-200507020-00005; Jefferson T, 2003, VACCINE, V21, P2003, DOI 10.1016/S0264-410X(02)00770-3; Karnon J, 2003, HEALTH ECON, V12, P837, DOI 10.1002/hec.770; Kelton W. D., 2004, SIMULATION ARENA; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; KOPLAN JP, 1979, NEW ENGL J MED, V301, P906, DOI 10.1056/NEJM197910253011703; Kowalzik F, 2007, PEDIATR INFECT DIS J, V26, P238, DOI 10.1097/01.inf.0000256750.07118.ee; Lee GM, 2005, PEDIATRICS, V115, P1675, DOI 10.1542/peds.2004-2509; Lee GM, 2004, CLIN INFECT DIS, V39, P1572, DOI 10.1086/425006; Lee GM, 2008, VACCINE, V26, P3673, DOI 10.1016/j.vaccine.2008.04.068; Lee GM, 2007, AM J PREV MED, V32, P186, DOI 10.1016/j.amepre.2006.10.016; Lee Grace M, 2005, Health Qual Life Outcomes, V3, P17, DOI 10.1186/1477-7525-3-17; Lee LH, 2000, ARCH FAM MED, V9, P989, DOI 10.1001/archfami.9.10.989; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; Neppelenbroek S.E., 1999, Euro Surveill, V4, P133; OOSTENBRINK JB, 2004, GUIDELINE COSTING RE; Orenstein WA, 1999, CLIN INFECT DIS, V28, pS147, DOI 10.1086/515061; Pichichero ME, 2006, PEDIATRICS, V117, P1084, DOI 10.1542/peds.2005-1759; *PRISM, NAT LMR INF ONL FURT; Purdy KW, 2004, CLIN INFECT DIS, V39, P20, DOI 10.1086/421091; RAMSAY MEB, 1993, EPIDEMIOL INFECT, V111, P41, DOI 10.1017/S095026880005665X; RITECO JA, 1999, GUIDELINES PHARMACOE; Rothstein Edward, 2005, Pediatr Infect Dis J, V24, pS44, DOI 10.1097/01.inf.0000160912.58660.87; Schenk CA, 2005, LECT NOTES APPL COMP, V24, P19; Scuffham PA, 2004, VACCINE, V22, P2953, DOI 10.1016/j.vaccine.2003.11.057; Shaikh R, 1998, PEDIATRICS, V101, P323, DOI 10.1542/peds.101.2.323; Stevenson M, 2002, VACCINE, V20, P1778, DOI 10.1016/S0264-410X(02)00025-7; Tan Tina, 2005, Pediatr Infect Dis J, V24, pS10, DOI 10.1097/01.inf.0000160708.43944.99; Tormans G, 1998, EUR J PEDIATR, V157, P395, DOI 10.1007/s004310050837; van Amersfoorth SCM, 2005, J CLIN MICROBIOL, V43, P2837, DOI 10.1128/JCM.43.6.2837-2843.2005; van Boven M, 2000, MATH BIOSCI, V164, P161, DOI 10.1016/S0025-5564(00)00009-2; van Boven M, 2001, EPIDEMIOL INFECT, V127, P73; Van Rie A, 2004, VACCINE, V22, P3154, DOI 10.1016/j.vaccine.2004.01.067; Versteegh FGA, 2002, ACTA PAEDIATR, V91, P95, DOI 10.1080/080352502753458030; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Ward JI, 2005, NEW ENGL J MED, V353, P1555, DOI 10.1056/NEJMoa050824; Wendelboe Aaron M, 2005, Pediatr Infect Dis J, V24, pS58, DOI 10.1097/01.inf.0000160914.59160.41; ZHANG L, 2010, COCHRANE DB SYST REV, V1; DUTCH NATL IMMUNIZAT	75	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13392	10.1371/journal.pone.0013392	http://dx.doi.org/10.1371/journal.pone.0013392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976213	gold, Green Published			2022-12-27	WOS:000283043700005
J	Parguina, AF; Grigorian-Shamajian, L; Agra, RM; Teijeira-Fernandez, E; Rosa, I; Alonso, J; Vinuela-Roldan, JE; Seoane, A; Gonzalez-Juanatey, JR; Garcia, A				Fernandez Parguina, Andres; Grigorian-Shamajian, Lilian; Agra, Rosa M.; Teijeira-Fernandez, Elvis; Rosa, Isaac; Alonso, Jana; Vinuela-Roldan, Juan E.; Seoane, Ana; Ramon Gonzalez-Juanatey, Jose; Garcia, Angel			Proteins Involved in Platelet Signaling Are Differentially Regulated in Acute Coronary Syndrome: A Proteomic Study	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; 2-DIMENSIONAL GEL-ELECTROPHORESIS; ACTIVATED PLATELETS; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; PHOSPHORYLATION; MICROPARTICLES; PLASMA; PATHWAYS; SPARC	Background: Platelets play a fundamental role in pathological events underlying acute coronary syndrome (ACS). Because platelets do not have a nucleus, proteomics constitutes an optimal approach to follow platelet molecular events associated with the onset of the acute episode. Methodology/Principal Findings: We performed the first high-resolution two-dimensional gel electrophoresis-based proteome analysis of circulating platelets from patients with non-ST segment elevation ACS (NSTE-ACS). Proteins were identified by mass spectrometry and validations were by western blotting. Forty protein features (corresponding to 22 unique genes) were found to be differentially regulated between NSTE-ACS patients and matched controls with chronic ischemic cardiopathy. The number of differences decreased at day 5 (28) and 6 months after the acute event (5). Interestingly, a systems biology approach demonstrated that 16 of the 22 differentially regulated proteins identified are interconnected as part of a common network related to cell assembly and organization and cell morphology, processes very related to platelet activation. Indeed, 14 of those proteins are either signaling or cytoskeletal, and nine of them are known to participate in platelet activation by alpha IIb beta 3 and/or GPVI receptors. Several of the proteins identified participate in platelet activation through post-translational modifications, as shown here for ILK, Src and Talin. Interestingly, the platelet-secreted glycoprotein SPARC was down-regulated in NSTE-ACS patients compared to stable controls, which is consistent with a secretion process from activated platelets. Conclusions/Significance: The present study provides novel information on platelet proteome changes associated with platelet activation in NSTE-ACS, highlighting the presence of proteins involved in platelet signaling. This investigation paves the way for future studies in the search for novel platelet-related biomarkers and drug targets in ACS.	[Fernandez Parguina, Andres; Rosa, Isaac; Garcia, Angel] Univ Santiago de Compostela, Dept Farmacoloxia, Fac Farm, Santiago De Compostela, Spain; [Grigorian-Shamajian, Lilian; Agra, Rosa M.; Teijeira-Fernandez, Elvis; Seoane, Ana; Ramon Gonzalez-Juanatey, Jose] Univ Santiago, Serv Cardiol, Hosp Clin, Santiago De Compostela, Spain; [Grigorian-Shamajian, Lilian; Agra, Rosa M.; Teijeira-Fernandez, Elvis; Seoane, Ana; Ramon Gonzalez-Juanatey, Jose] Univ Santiago, Unidad Coronaria, Hosp Clin, Santiago De Compostela, Spain; [Grigorian-Shamajian, Lilian] Univ Vigo, Serv Cardiol, Complejo Hosp, Vigo 36310, Spain; [Alonso, Jana] Hosp Clin Univ, Lab Prote, Inst Invest Sanit, Santiago De Compostela, Spain; [Vinuela-Roldan, Juan E.] Hosp Clin Univ, Lab Inmunol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Vigo; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Parguina, AF (corresponding author), Univ Santiago de Compostela, Dept Farmacoloxia, Fac Farm, Santiago De Compostela, Spain.	angel.garcia@usc.es	Garcia, Angel/F-6736-2016; Rosa, Isaac/C-6233-2009; Fernández Parguiña, Andrés/B-9313-2009; Lorenzo, Jana Alonso/B-2869-2012	Garcia, Angel/0000-0003-1176-5917; Lorenzo, Jana Alonso/0000-0002-2304-8715; Rosa Benito, Isaac/0000-0001-8379-9150; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Vinuela, Juan Evaristo/0000-0001-7778-901X	Spanish Ministry of Science and Innovation: Ministerio de Ciencia e Innovacion de Espana (MICINN) [SAF2007-61773]; Xunta de Galicia - Conselleria de Economia e Industria [INCITE09PXIB203145PR]; Fundacion Mutua Madrilena (Spain)	Spanish Ministry of Science and Innovation: Ministerio de Ciencia e Innovacion de Espana (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia - Conselleria de Economia e Industria(Xunta de Galicia); Fundacion Mutua Madrilena (Spain)	Spanish Ministry of Science and Innovation: Ministerio de Ciencia e Innovacion de Espana (MICINN) [grant number SAF2007-61773]: http://www.micinn.es/portal/site/MICINN/. Xunta de Galicia - Conselleria de Economia e Industria (grant No: INCITE09PXIB203145PR): http://www.xunta.es. Fundacion Mutua Madrilena (Spain): http://www.fundacionmutua.es/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barderas MG, 2007, J PROTEOME RES, V6, P876, DOI 10.1021/pr0601990; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Brill A, 2005, CARDIOVASC RES, V67, P30, DOI 10.1016/j.cardiores.2005.04.007; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Dobaczewski M, 2010, J MOL CELL CARDIOL, V48, P504, DOI 10.1016/j.yjmcc.2009.07.015; ELMAKREM MAA, 2009, THROMB RES, V124, P683; Fox KAA, 2004, HEART, V90, P698, DOI 10.1136/hrt.2003.020321; Garcia A, 2006, BLOOD CELL MOL DIS, V36, P152, DOI 10.1016/j.bcmd.2005.12.013; Garcia A, 2005, MASS SPECTROM REV, V24, P918, DOI 10.1002/mas.20047; Garcia A, 2004, PROTEOMICS, V4, P656, DOI 10.1002/pmic.200300665; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Garcia A, 2007, PLATELETS, 2ND EDITION, P99, DOI 10.1016/B978-012369367-9/50767-9; Garcia Angel, 2007, V139, P339; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Gerszten RE, 2008, NATURE, V451, P949, DOI 10.1038/nature06802; Goldschmidt PJ, 2007, PLATELETS, 2ND EDITION, P629, DOI 10.1016/B978-012369367-9/50797-7; Grech ED, 2003, BRIT MED J, V326, P1379, DOI 10.1136/bmj.326.7403.1379; Hayashi M, 1999, ARCH BIOCHEM BIOPHYS, V371, P133, DOI 10.1006/abbi.1999.1427; Honda S, 2009, BLOOD, V113, P5304, DOI 10.1182/blood-2008-07-169136; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lindemann S, 2007, J THROMB HAEMOST, V5, P203, DOI 10.1111/j.1538-7836.2007.02517.x; Lindemann S, 2007, CURR OPIN LIPIDOL, V18, P566, DOI 10.1097/MOL.0b013e3282ef7c1e; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Mateos-Caceres PJ, 2004, J AM COLL CARDIOL, V44, P1578, DOI 10.1016/j.jacc.2004.06.073; Plow EF, 2007, PLATELETS, 2ND EDITION, P165, DOI 10.1016/B978-012369367-9/50770-9; Schellings MWM, 2009, J EXP MED, V206, P113, DOI 10.1084/jem.20081244; Senis YA, 2009, J THROMB HAEMOST, V7, P1718, DOI 10.1111/j.1538-7836.2009.03565.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smalley DM, 2007, THROMB HAEMOSTASIS, V97, P67, DOI 10.1160/TH06-02-0066; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takahashi M, 2001, OBES RES, V9, P388, DOI 10.1038/oby.2001.50; Thon JN, 2008, TRANSFUS MED REV, V22, P268, DOI 10.1016/j.tmrv.2008.05.004; Tucker KL, 2008, BLOOD, V112, P4523, DOI 10.1182/blood-2008-03-148502; Vivanco F, 2007, PROTEOM CLIN APPL, V1, P1102, DOI 10.1002/prca.200700190; Weyrich AS, 2004, SEMIN THROMB HEMOST, V30, P491, DOI 10.1055/s-2004-833484	37	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13404	10.1371/journal.pone.0013404	http://dx.doi.org/10.1371/journal.pone.0013404			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976234	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000024
J	Ramana, J; Gupta, D				Ramana, Jayashree; Gupta, Dinesh			Machine Learning Methods for Prediction of CDK-Inhibitors	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; SVM-BASED METHOD; PROTEIN; PHOSPHATASE; P57(KIP2); INTERACTS; TARGETS; TYPE-1; FAMILY; CANCER	Progression through the cell cycle involves the coordinated activities of a suite of cyclin/cyclin-dependent kinase (CDK) complexes. The activities of the complexes are regulated by CDK inhibitors (CDKIs). Apart from its role as cell cycle regulators, CDKIs are involved in apoptosis, transcriptional regulation, cell fate determination, cell migration and cytoskeletal dynamics. As the complexes perform crucial and diverse functions, these are important drug targets for tumour and stem cell therapeutic interventions. However, CDKIs are represented by proteins with considerable sequence heterogeneity and may fail to be identified by simple similarity search methods. In this work we have evaluated and developed machine learning methods for identification of CDKIs. We used different compositional features and evolutionary information in the form of PSSMs, from CDKIs and non-CDKIs for generating SVM and ANN classifiers. In the first stage, both the ANN and SVM models were evaluated using Leave-One-Out Cross-Validation and in the second stage these were tested on independent data sets. The PSSM-based SVM model emerged as the best classifier in both the stages and is publicly available through a user-friendly web interface at http://bioinfo.icgeb.res.in/cdkipred.	[Ramana, Jayashree; Gupta, Dinesh] Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Gupta, D (corresponding author), Int Ctr Genet Engn & Biotechnol, Struct & Computat Biol Grp, New Delhi, India.	dinesh@icgeb.res.in	Gupta, Dinesh/C-1079-2009; Ramana, Jayashree/GQQ-5678-2022; Gupta, Dinesh/AAW-4243-2020	Gupta, Dinesh/0000-0002-7548-8835; Gupta, Dinesh/0000-0002-7548-8835	Department of Biotechnology (DBT, India) at ICGEB; Council of Scientific and Industrial Research (CSIR, India)	Department of Biotechnology (DBT, India) at ICGEB(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR, India)(Council of Scientific & Industrial Research (CSIR) - India)	Department of Biotechnology (DBT, India) grant for "Bioinformatics infrastructure Facility'' at ICGEB and Council of Scientific and Industrial Research (CSIR, India) fellowship to Jayashree Ramana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Boyer MJ, 2008, GENE THER, V15, P117, DOI 10.1038/sj.gt.3303064; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Chang EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000656; Churchman ML, 2006, PLANT CELL, V18, P3145, DOI 10.1105/tpc.106.044834; De Vivo M, 2006, PROTEINS, V62, P89, DOI 10.1002/prot.20697; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FINN RD, NUCL ACIDS RES, V38, pD211; Fischer PM, 2003, EXPERT OPIN INV DRUG, V12, P955, DOI 10.1517/eoid.12.6.955.21792; Fischer PM, 2000, CURR MED CHEM, V7, P1213, DOI 10.2174/0929867003374048; Geyer JA, 2005, BBA-PROTEINS PROTEOM, V1754, P160, DOI 10.1016/j.bbapap.2005.07.031; Grant KM, 2004, ANTIMICROB AGENTS CH, V48, P3033, DOI 10.1128/AAC.48.8.3033-3042.2004; Guendel I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-7; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; HANNON GJ, 1994, P NATL ACAD SCI USA, V91, P1731, DOI 10.1073/pnas.91.5.1731; Hertz JA, 2018, INTRO THEORY NEURAL; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Jin RJ, 2008, CANCER RES, V68, P3601, DOI 10.1158/0008-5472.CAN-08-0073; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; JOSHUA NA, 2002, PROTEIN-STRUCT FUNCT, V46, P1; Kalita MK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002605; KEIICHI N, 1998, BIOESSAYS, V20, P1020; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Larson PS, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-68; Le Foll M, 2008, PLANT SCI, V175, P513, DOI 10.1016/j.plantsci.2008.05.022; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; LIANG H, 2008, CHINESE GERMAN J CLI, V7, P176; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; McInnes C, 2008, DRUG DISCOV TODAY, V13, P875, DOI 10.1016/j.drudis.2008.06.012; Molenaar JJ, 2009, P NATL ACAD SCI USA, V106, P12968, DOI 10.1073/pnas.0901418106; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; Nozato T, 2001, J MOL CELL CARDIOL, V33, P1493, DOI 10.1006/jmcc.2001.1412; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; POON RYC, 1995, SCIENCE, V270, P90, DOI 10.1126/science.270.5233.90; Ramana J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-445; Rumelhart D., 1986, PARALLEL DISTRIBUTED; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Vapnik N., 1998, STAT LEARNING THEORY; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139	40	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13357	10.1371/journal.pone.0013357	http://dx.doi.org/10.1371/journal.pone.0013357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967128	Green Published, gold, Green Submitted			2022-12-27	WOS:000282869800038
J	Shapiro, A; Lu, ZL; Huang, CB; Knight, E; Ennis, R				Shapiro, Arthur; Lu, Zhong-Lin; Huang, Chang-Bing; Knight, Emily; Ennis, Robert			Transitions between Central and Peripheral Vision Create Spatial/Temporal Distortions: A Hypothesis Concerning the Perceived Break of the Curveball	PLOS ONE			English	Article							2ND-ORDER MOTION; VISUAL-MOTION; CORTICAL MAGNIFICATION; STRIATE CORTEX; FULL-WAVE; CONTRAST; PERCEPTION; INTEGRATION; FREQUENCY; SHIFTS	Background: The human visual system does not treat all parts of an image equally: the central segments of an image, which fall on the fovea, are processed with a higher resolution than the segments that fall in the visual periphery. Even though the differences between foveal and peripheral resolution are large, these differences do not usually disrupt our perception of seamless visual space. Here we examine a motion stimulus in which the shift from foveal to peripheral viewing creates a dramatic spatial/temporal discontinuity. Methodology/Principal Findings: The stimulus consists of a descending disk (global motion) with an internal moving grating (local motion). When observers view the disk centrally, they perceive both global and local motion (i.e., observers see the disk's vertical descent and the internal spinning). When observers view the disk peripherally, the internal portion appears stationary, and the disk appears to descend at an angle. The angle of perceived descent increases as the observer views the stimulus from further in the periphery. We examine the first-and second-order information content in the display with the use of a three-dimensional Fourier analysis and show how our results can be used to describe perceived spatial/temporal discontinuities in real-world situations. Conclusions/Significance: The perceived shift of the disk's direction in the periphery is consistent with a model in which foveal processing separates first-and second-order motion information while peripheral processing integrates first-and second-order motion information. We argue that the perceived distortion may influence real-world visual observations. To this end, we present a hypothesis and analysis of the perception of the curveball and rising fastball in the sport of baseball. The curveball is a physically measurable phenomenon: the imbalance of forces created by the ball's spin causes the ball to deviate from a straight line and to follow a smooth parabolic path. However, the curveball is also a perceptual puzzle because batters often report that the flight of the ball undergoes a dramatic and nearly discontinuous shift in position as the ball nears home plate. We suggest that the perception of a discontinuous shift in position results from differences between foveal and peripheral processing.	[Shapiro, Arthur] American Univ, Dept Psychol, Washington, DC 20016 USA; [Lu, Zhong-Lin; Huang, Chang-Bing] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Knight, Emily] Mayo Clin, Rochester, MN USA; [Ennis, Robert] SUNY Coll Optometry, New York, NY 10010 USA	American University; University of Southern California; Mayo Clinic; State University of New York (SUNY) System; SUNY Optometry	Shapiro, A (corresponding author), American Univ, Dept Psychol, Washington, DC 20016 USA.	Arthur.Shapiro@American.edu	HUANG, CHANG-BING/D-3855-2011; Huang, Chang-Bing/AAE-2909-2020	Lauwereyns, Jan/0000-0003-0551-2550; Lu, Zhong-Lin/0000-0002-7295-727X; Knight, Emily/0000-0002-6971-1148; huang, chang bing/0000-0003-4694-0834	National Institutes of Health; US National Eye Institute [EY017491]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health grant to Zhong-Lin Lu. Portions of the work were supported by a grant from the the US National Eye Institute (EY017491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair R.K, 2002, PHYS BASEBALL; AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; Azzopardi P, 1996, NEUROSCIENCE, V72, P627, DOI 10.1016/0306-4522(95)00589-7; BAHILL T, 2004, BIOMEDICAL ENG PRINC, P257; Bressler DW, 2006, VISION RES, V46, P1120, DOI 10.1016/j.visres.2005.10.012; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHUBB C, 1989, P NATL ACAD SCI USA, V86, P2985, DOI 10.1073/pnas.86.8.2985; Chung STL, 2001, VISION RES, V41, P1833, DOI 10.1016/S0042-6989(01)00071-2; CORMACK R, 1992, VISION RES, V32, P73, DOI 10.1016/0042-6989(92)90114-X; Cropper SJ, 2001, J OPT SOC AM A, V18, P2237, DOI 10.1364/JOSAA.18.002237; DEVALOIS RL, 1991, VISION RES, V31, P1619, DOI 10.1016/0042-6989(91)90138-U; Falchier A, 2002, J NEUROSCI, V22, P5749; FESTINGER L, 1976, VISION RES, V16, P1377, DOI 10.1016/0042-6989(76)90155-3; GOREA A, 1993, P NATL ACAD SCI USA, V90, P11197, DOI 10.1073/pnas.90.23.11197; JOHNSTON A, 1995, VISION RES, V35, P1771, DOI 10.1016/0042-6989(94)00258-N; JOHNSTON A, 1995, VISION RES, V35, P1109, DOI 10.1016/0042-6989(94)00175-L; KNIGHT EJ, Z L L DRAMATICALLY D; Levi DM, 2008, VISION RES, V48, P635, DOI 10.1016/j.visres.2007.12.009; Levi DM, 2002, J VISION, V2, P167, DOI 10.1167/2.2.3; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; Lu ZL, 2001, J OPT SOC AM A, V18, P2331, DOI 10.1364/JOSAA.18.002331; Lu ZL, 1996, J OPT SOC AM A, V13, P2305, DOI 10.1364/JOSAA.13.002305; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MARKOV NT, 2008, 2151 SOC NEUR; Martin P.R., 2003, VISUAL NEUROSCIENCES, P410; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MCBEATH MK, 1990, PERCEPTION, V19, P545, DOI 10.1068/p190545; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Rider AT, 2009, J VISION, V9, DOI 10.1167/9.13.8; ROVAMO J, 1984, VISION RES, V24, P283, DOI 10.1016/0042-6989(84)90133-0; SHAPIRO AG, 2008, 8113 SOC NEUR; Smith AT, 1998, VISION RES, V38, P403, DOI 10.1016/S0042-6989(97)00134-X; SOLOMON JA, 1994, VISION RES, V34, P2239, DOI 10.1016/0042-6989(94)90105-8; TAUBER ES, 1977, PERCEPT PSYCHOPHYS, V22, P241, DOI 10.3758/BF03199685; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tse PU, 2006, VISION RES, V46, P3881, DOI 10.1016/j.visres.2006.06.010; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Watanabe T, 1998, HIGH LEVEL MOTION PR; WATTS RG, 2000, KEEP YOUR EYE BALL; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; ZHANG J, 1993, VISION RES, V33, P2721, DOI 10.1016/0042-6989(93)90231-K; [No title captured]	44	47	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13296	10.1371/journal.pone.0013296	http://dx.doi.org/10.1371/journal.pone.0013296			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967247	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800013
J	Liu-Yesucevitz, L; Bilgutay, A; Zhang, YJ; Vanderwyde, T; Citro, A; Mehta, T; Zaarur, N; McKee, A; Bowser, R; Sherman, M; Petrucelli, L; Wolozin, B				Liu-Yesucevitz, Liqun; Bilgutay, Aylin; Zhang, Yong-Jie; Vanderwyde, Tara; Citro, Allison; Mehta, Tapan; Zaarur, Nava; McKee, Ann; Bowser, Robert; Sherman, Michael; Petrucelli, Leonard; Wolozin, Benjamin			Tar DNA Binding Protein-43 (TDP-43) Associates with Stress Granules: Analysis of Cultured Cells and Pathological Brain Tissue	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; AMYOTROPHIC-LATERAL-SCLEROSIS; NUCLEAR FACTOR TDP-43; MOTOR-NEURON PROTEIN; RIBONUCLEOPROTEIN COMPLEXES; MESSENGER-RNA; P-BODIES; AGGREGATION; DISEASE; EXON-9	Tar DNA Binding Protein-43 (TDP-43) is a principle component of inclusions in many cases of frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS). TDP-43 resides predominantly in the nucleus, but in affected areas of ALS and FTLD-U central nervous system, TDP-43 is aberrantly processed and forms cytoplasmic inclusions. The mechanisms governing TDP-43 inclusion formation are poorly understood. Increasing evidence indicates that TDP-43 regulates mRNA metabolism by interacting with mRNA binding proteins that are known to associate with RNA granules. Here we show that TDP-43 can be induced to form inclusions in cell culture and that most TDP-43 inclusions co-localize with SGs. SGs are cytoplasmic RNA granules that consist of mixed protein - RNA complexes. Under stressful conditions SGs are generated by the reversible aggregation of prion-like proteins, such as TIA-1, to regulate mRNA metabolism and protein translation. We also show that disease-linked mutations in TDP-43 increased TDP-43 inclusion formation in response to stressful stimuli. Biochemical studies demonstrated that the increased TDP-43 inclusion formation is associated with accumulation of TDP-43 detergent insoluble complexes. TDP-43 associates with SG by interacting with SG proteins, such as TIA-1, via direct protein-protein interactions, as well as RNA-dependent interactions. The signaling pathway that regulates SGs formation also modulates TDP-43 inclusion formation. We observed that inclusion formation mediated by WT or mutant TDP-43 can be suppressed by treatment with translational inhibitors that suppress or reverse SG formation. Finally, using Sudan black to quench endogenous autofluorescence, we also demonstrate that TDP-43 positive-inclusions in pathological CNS tissue co-localize with multiple protein markers of stress granules, including TIA-1 and eIF3. These data provide support for accumulating evidence that TDP-43 participates in the SG pathway.	[Liu-Yesucevitz, Liqun; Bilgutay, Aylin; Vanderwyde, Tara; Citro, Allison; Mehta, Tapan; Zaarur, Nava; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Zhang, Yong-Jie; Petrucelli, Leonard] Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; [McKee, Ann; Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Bowser, Robert] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Sherman, Michael] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University; Mayo Clinic; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Boston University	Liu-Yesucevitz, L (corresponding author), Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA.	bwolozin@bu.edu	Zhang, Yong-Jie/G-3378-2011	Bilgutay, Aylin/0000-0003-3737-8114; Sherman, Michael/0000-0003-3345-073X	NIEHS (National Institute of Environmental Health Sciences) [ES15567]; NINDS (National Institute of Neurological Disorders and Stroke) [NS41786, NS66108]; Alzheimer Association; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015567, R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS073679, R01NS041786, R21NS066108] Funding Source: NIH RePORTER	NIEHS (National Institute of Environmental Health Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS (National Institute of Neurological Disorders and Stroke)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alzheimer Association(Alzheimer's AssociationBrightFocus Foundation); Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by NIEHS (National Institute of Environmental Health Sciences) ES15567, NINDS (National Institute of Neurological Disorders and Stroke) NS41786, NS66108, the Alzheimer Association and the Michael J. Fox Foundation (B.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Brandmeir NJ, 2008, ACTA NEUROPATHOL, V115, P123, DOI 10.1007/s00401-007-0315-5; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Buratti E, 2004, AM J HUM GENET, V74, P1322, DOI 10.1086/420978; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chernov K. G., 2009, J BIOL CHEM; COLOMBRITA C, 2009, J NEUROCHEM; CUSTER SK, 1997, HUM MOL GENET, V19, P1741; Del Razo LM, 2001, TOXICOL APPL PHARM, V177, P132, DOI 10.1006/taap.2001.9291; Dormann D., 2009, J NEUROCHEM; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Gitcho MA, 2008, ANN NEUROL; Goggin K, 2008, BBA-MOL CELL RES, V1783, P479, DOI 10.1016/j.bbamcr.2007.10.008; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LI Y, 2010, P NATL ACAD SCI US; Mercado PA, 2005, NUCLEIC ACIDS RES, V33, P6000, DOI 10.1093/nar/gki897; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Neumann M, 2007, ACTA NEUROPATHOL, V113, P543, DOI 10.1007/s00401-007-0221-x; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nonaka T, 2009, HUM MOL GENET; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Ule J, 2008, CURR OPIN NEUROBIOL, V18, P516, DOI 10.1016/j.conb.2008.09.018; VOLKENING K, 2009, BRAIN RES; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang IF, 2008, J NEUROCHEM, V105, P797, DOI 10.1111/j.1471-4159.2007.05190.x; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; WILS H, P NATL ACAD SCI US; WILS H, P NATL ACAD SCI US, V107; Winton MJ, 2008, FEBS LETT, V582, P2252, DOI 10.1016/j.febslet.2008.05.024; Winton MJ, 2008, J BIOL CHEM, V283, P13302, DOI 10.1074/jbc.M800342200; Zerbinatti CV, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-5; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhang YJ, 2009, P NATL ACAD SCI USA, V106, P7607, DOI 10.1073/pnas.0900688106; Zuccato E, 2004, J BIOL CHEM, V279, P16980, DOI 10.1074/jbc.M313439200	48	425	431	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13250	10.1371/journal.pone.0013250	http://dx.doi.org/10.1371/journal.pone.0013250			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948999	Green Published, gold, Green Accepted			2022-12-27	WOS:000282748100005
J	Powers, RW; Jeyabalan, A; Clifton, RG; Van Dorsten, P; Hauth, JC; Klebanoff, MA; Lindheimer, MD; Sibai, B; Landon, M; Miodovnik, M				Powers, Robert W.; Jeyabalan, Arun; Clifton, Rebecca G.; Van Dorsten, Peter; Hauth, John C.; Klebanoff, Mark A.; Lindheimer, Marshall D.; Sibai, Baha; Landon, Mark; Miodovnik, Menachem		Eunice Kennedy Shriver Natl Inst	Soluble fms-Like Tyrosine Kinase 1 (sFlt1), Endoglin and Placental Growth Factor (PlGF) in Preeclampsia among High Risk Pregnancies	PLOS ONE			English	Article							ANTIANGIOGENIC FACTORS; PREVENTION; WOMEN	Background: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng) and the pro-angiogenic growth factor PlGF are reported to precede the onset of preeclampsia weeks to months in low-risk pregnant women. The objective of this study was to investigate whether similar changes can be detected in pregnant women at high-risk to develop the syndrome. Methods: This study is a secondary analysis of the NICHD MFMU trial of aspirin to prevent preeclampsia in high-risk pregnancies. Serum samples were available from 194 women with pre-existing diabetes, 313 with chronic hypertension, 234 with multifetal gestation, and 252 with a history of preeclampsia in a previous pregnancy. Samples collected across pregnancy were analyzed in a blinded fashion for sFlt1, sEng and PlGF. Results: The odds of developing preeclampsia were significantly increased among women with multiple fetuses for each 2-fold elevation in sFlt1, sEng and the ratio of angiogenic factors (e.g. OR 2.18, 95% CI 1.46-3.32), and significantly decreased for each 2-fold elevation in circulating PlGF (OR 0.50, 95% CI 0.30-0.82) between 7 and 26 weeks' gestation. Cross-sectional analysis of the angiogenic factors across gestation showed significant differences during the third trimester in women who develop preeclampsia compared with appropriate controls in all high-risk groups. However, when data were examined in relation to the gestational week when preeclampsia was diagnosed only sFlt1 was significantly higher 2 to 5 weeks before the clinical onset of preeclampsia and only in women with previous preeclampsia. Conclusions: The pattern of elevated concentrations of sFlt1 and sEng, and low PlGF in high-risk pregnant subjects who develop preeclampsia is similar to that reported in low-risk pregnant women. However, differences in these factors among high-risk women who do and do not develop preeclampsia are modest, and do not appear to be clinically useful predictors in these high-risk pregnant women.	[Powers, Robert W.; Jeyabalan, Arun] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA; [Clifton, Rebecca G.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Van Dorsten, Peter] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Hauth, John C.] Univ Alabama Birmingham, Sch Med, Dept Obstet & Gynecol, Birmingham, AL USA; [Klebanoff, Mark A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA; [Lindheimer, Marshall D.] Univ Chicago, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Sibai, Baha] Univ Tennessee, Dept Obstet & Gynecol, Sch Med, Memphis, TN 38103 USA; [Landon, Mark] Ohio State Univ, Sch Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Miodovnik, Menachem] Univ Cincinnati, Sch Med, Dept Obstet & Gynecol, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Powers, RW (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA.	powersrw@upmc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, HD27917, NIH-2P01-HD30367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD021410, UG1HD027915, U10HD027917, U10HD027869, P01HD030367, U10HD036801, U10HD027915, UG1HD027869] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD021434, U01HD021434, U01HD036801, U01HD021414, U10HD027861, U10HD027860, U10HD027883, U10HD027905, U10HD021414, U01HD019897, U01HD021410, U10HD027889] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, and HD27917) and NIH-2P01-HD30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2006, AM J OBSTET GYNECOL, V194, P1034, DOI 10.1016/j.ajog.2005.10.192; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Levine RJ, 1996, CONTROL CLIN TRIALS, V17, P442, DOI 10.1016/S0197-2456(96)00106-7; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Maynard SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.08.042; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; Rana S, 2007, HYPERTENSION, V50, P137, DOI 10.1161/HYPERTENSIONAHA.107.087700; ROBERTS JM, 2009, MATERNAL FETAL MED, P651; Romero R, 2008, J MATERN-FETAL NEO M, V21, P9, DOI 10.1080/14767050701830480; Sibai BM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.071; Simas TAM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.030; Thadhani R, 2004, J CLIN ENDOCR METAB, V89, P770, DOI 10.1210/jc.2003-031244	16	107	115	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13263	10.1371/journal.pone.0013263	http://dx.doi.org/10.1371/journal.pone.0013263			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948996	Green Published, Green Accepted, gold			2022-12-27	WOS:000282748100012
J	Presman, DM; Alvarez, LD; Levi, V; Eduardo, S; Digman, MA; Marti, MA; Veleiro, AS; Burton, G; Pecci, A				Presman, Diego M.; Alvarez, Lautaro D.; Levi, Valeria; Eduardo, Silvina; Digman, Michelle A.; Marti, Marcelo A.; Veleiro, Adriana S.; Burton, Gerardo; Pecci, Adali			Insights on Glucocorticoid Receptor Activity Modulation through the Binding of Rigid Steroids	PLOS ONE			English	Article							RAY CRYSTAL-STRUCTURE; HUMAN BREAST-CANCER; NF-KAPPA-B; DNA-BINDING; LIVING CELLS; MOLECULAR-DYNAMICS; TRANSCRIPTION FACTORS; ANTAGONIST COMPLEXES; RESPONSE ELEMENT; IN-VIVO	Background: The glucocorticoid receptor (GR) is a transcription factor that regulates gene expression in a ligand-dependent fashion. This modular protein is one of the major pharmacological targets due to its involvement in both cause and treatment of many human diseases. Intense efforts have been made to get information about the molecular basis of GR activity. Methodology/Principal Findings: Here, the behavior of four GR-ligand complexes with different glucocorticoid and antiglucocorticoid properties were evaluated. The ability of GR-ligand complexes to oligomerize in vivo was analyzed by performing the novel Number and Brightness assay. Results showed that most of GR molecules form homodimers inside the nucleus upon ligand binding. Additionally, in vitro GR-DNA binding analyses suggest that ligand structure modulates GR-DNA interaction dynamics rather than the receptor's ability to bind DNA. On the other hand, by coimmunoprecipitation studies we evaluated the in vivo interaction between the transcriptional intermediary factor 2 (TIF2) coactivator and different GR-ligand complexes. No correlation was found between GR intranuclear distribution, cofactor recruitment and the homodimerization process. Finally, Molecular determinants that support the observed experimental GR LBD-ligand/TIF2 interaction were found by Molecular Dynamics simulation. Conclusions/Significance: The data presented here sustain the idea that in vivo GR homodimerization inside the nucleus can be achieved in a DNA-independent fashion, without ruling out a dependent pathway as well. Moreover, since at least one GR-ligand complex is able to induce homodimer formation while preventing TIF2 coactivator interaction, results suggest that these two events might be independent from each other. Finally, 21-hydroxy-6,19-epoxyprogesterone arises as a selective glucocorticoid with potential pharmacological interest. Taking into account that GR homodimerization and cofactor recruitment are considered essential steps in the receptor activation pathway, results presented here contribute to understand how specific ligands influence GR behavior.	[Presman, Diego M.; Levi, Valeria; Marti, Marcelo A.; Pecci, Adali] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Alvarez, Lautaro D.; Eduardo, Silvina; Veleiro, Adriana S.; Burton, Gerardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Organ, UMYMFOR CONICET, RA-1428 Buenos Aires, DF, Argentina; [Digman, Michelle A.] Univ Calif Irvine, Dept Biomed Engn, Fluorescence Dynam Lab, Irvine, CA USA; [Digman, Michelle A.] Univ Calif Irvine, Ctr Dev Biol, Opt Biol Core Facil, Irvine, CA 92717 USA; [Marti, Marcelo A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, INQUIMAE CONICET, Buenos Aires, DF, Argentina; [Presman, Diego M.; Pecci, Adali] Univ Buenos Aires, Fac Ciencias Exactas & Nat, IFIBYNE CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of California System; University of California Irvine; University of California System; University of California Irvine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Presman, DM (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina.	apecci@qb.fcen.uba.ar	Presman, Diego Martín/Y-6750-2019; Burton, Gerardo/AGF-6611-2022	Presman, Diego Martín/0000-0003-4515-8058; Burton, Gerardo/0000-0002-8559-7306; Alvarez, Lautaro Damian/0000-0001-8841-2330; Levi, Valeria/0000-0002-1666-4675; , Michelle/0000-0003-4611-7100; Marti, Marcelo/0000-0002-7911-9340	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET); University of Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)	Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT)(ANPCyT)	This work was supported by Consejo Nacional de Investigaciones Cientifico y Tecnicas (CONICET), the University of Buenos Aires (UBA), and Agencia Nacional de Promocion Cientifica y Tecnica (ANPCyT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, MOL ENDOCRINOL, V17, P2583, DOI 10.1210/me.2002-0305; Alvarez LD, 2008, J MED CHEM, V51, P1352, DOI 10.1021/jm800007w; Alvarez LD, 2008, CHEMMEDCHEM, V3, P1869, DOI 10.1002/cmdc.200800256; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Aumais JP, 1996, J BIOL CHEM, V271, P12568, DOI 10.1074/jbc.271.21.12568; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; BHANDARE R, AM J RESP CELL MOL B, V42, P9; Biggadike K, 2008, J MED CHEM, V51, P3349, DOI 10.1021/jm800279t; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Burton G, 2006, U.S. Patent, Patent No. [7,071,328, 7071328]; CAIRNS W, 1991, J BIOL CHEM, V266, P11221; CHALEPAKIS G, 1990, DNA CELL BIOL, V9, P355, DOI 10.1089/dna.1990.9.355; Cheatham TE, 1999, J BIOMOL STRUCT DYN, V16, P845, DOI 10.1080/07391102.1999.10508297; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Costas MA, 2000, BBA-MOL CELL RES, V1499, P122, DOI 10.1016/S0167-4889(00)00113-0; DAHLMANWRIGHT K, 1991, J BIOL CHEM, V266, P3107; DAHLMANWRIGHT K, 1990, J BIOL CHEM, V265, P14030; Dalal RB, 2008, MICROSC RES TECHNIQ, V71, P69, DOI 10.1002/jemt.20526; Dewint P, 2008, J IMMUNOL, V180, P2608, DOI 10.4049/jimmunol.180.4.2608; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Digman MA, 2009, P NATL ACAD SCI USA, V106, P2170, DOI 10.1073/pnas.0806036106; DROUIN J, 1992, MOL ENDOCRINOL, V6, P1299, DOI 10.1210/me.6.8.1299; ERIKSSON P, 1990, J BIOL CHEM, V265, P3535; Frego L, 2006, PROTEIN SCI, V15, P722, DOI 10.1110/ps.051781406; FRISCH MJ, 2004, GAUSSIAN 0O RC; Galigniana MD, 1998, MOL ENDOCRINOL, V12, P1903, DOI 10.1210/me.12.12.1903; GODOWSKI PJ, 1987, NATURE, V325, P365, DOI 10.1038/325365a0; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; GROYER A, 1987, NATURE, V328, P624, DOI 10.1038/328624a0; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guido EC, 1996, MOL ENDOCRINOL, V10, P1178, DOI 10.1210/me.10.10.1178; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; He YZ, 2002, J BIOL CHEM, V277, P49256, DOI 10.1074/jbc.M205536200; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HORWITZ KB, 1978, CANCER RES, V38, P2434; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iavarone C, 2003, J BIOL CHEM, V278, P50024, DOI 10.1074/jbc.M308617200; Kassel O, 2007, MOL CELL ENDOCRINOL, V275, P13, DOI 10.1016/j.mce.2007.07.003; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; KIM B, 1992, SCIENCE, V255, P203, DOI 10.1126/science.1553548; Kleiman A, 2007, MOL CELL ENDOCRINOL, V275, P98, DOI 10.1016/j.mce.2007.05.009; Kohler JJ, 1999, P NATL ACAD SCI USA, V96, P11735, DOI 10.1073/pnas.96.21.11735; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; LAI JS, 1992, P NATL ACAD SCI USA, V89, P6958, DOI 10.1073/pnas.89.15.6958; Li XT, 2003, MOL CELL BIOL, V23, P3763, DOI 10.1128/MCB.23.11.3763-3773.2003; LIPPMAN M, 1976, CANCER RES, V36, P4610; Liu WH, 1996, MOL ENDOCRINOL, V10, P1399, DOI 10.1210/me.10.11.1399; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; Madauss KP, 2008, BIOORG MED CHEM LETT, V18, P6097, DOI 10.1016/j.bmcl.2008.10.021; Marinissen MJ, 2004, MOL CELL, V14, P29, DOI 10.1016/S1097-2765(04)00153-4; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Mikuni S, 2007, FEBS LETT, V581, P389, DOI 10.1016/j.febslet.2006.12.038; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Nagaich AK, 2004, ANN NY ACAD SCI, V1024, P213, DOI 10.1196/annals.1321.002; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nojek IM, 2004, MEDICINA-BUENOS AIRE, V64, P135; Ogawa H, 2004, BIOCHEM BIOPH RES CO, V320, P218, DOI 10.1016/j.bbrc.2004.05.161; Pandit S, 2002, J BIOL CHEM, V277, P1538, DOI 10.1074/jbc.M105438200; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Raaijmakers HCA, 2009, J BIOL CHEM, V284, P19572, DOI 10.1074/jbc.M109.007872; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; ROBERSON S, 2009, J BIOL CHEM; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; Savory JGA, 2001, MOL CELL BIOL, V21, P781, DOI 10.1128/MCB.21.3.781-793.2001; Schaaf MJM, 2005, MOL ENDOCRINOL, V19, P1501, DOI 10.1210/me.2005-0050; Schoch GA, 2010, J MOL BIOL, V395, P568, DOI 10.1016/j.jmb.2009.11.011; Schulz M, 2002, J BIOL CHEM, V277, P26238, DOI 10.1074/jbc.M203268200; SegardMaurel I, 1996, BIOCHEMISTRY-US, V35, P1634, DOI 10.1021/bi951369h; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Stahn C, 2007, MOL CELL ENDOCRINOL, V275, P71, DOI 10.1016/j.mce.2007.05.019; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; TRUSS M, 1995, EMBO J, V14, P1737, DOI 10.1002/j.1460-2075.1995.tb07163.x; TSAI SY, 1988, CELL, V55, P361, DOI 10.1016/0092-8674(88)90059-1; van der Laan S, 2008, EUR J PHARMACOL, V585, P483, DOI 10.1016/j.ejphar.2008.01.060; VANSTEENSEL B, 1995, J CELL SCI, V108, P3003; Veleiro AS, 2010, CHEMMEDCHEM, V5, P649, DOI 10.1002/cmdc.201000014; Veleiro AS, 2005, J MED CHEM, V48, P5675, DOI 10.1021/jm049266x; VELEIRO AS, 1995, STEROIDS, V60, P268, DOI 10.1016/0039-128X(94)00052-E; Vicent GP, 1997, MOL PHARMACOL, V52, P749, DOI 10.1124/mol.52.4.749; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Walker D, 1999, METHODS, V19, P386, DOI 10.1006/meth.1999.0874; Wang Q, 2004, MOL ENDOCRINOL, V18, P1376, DOI 10.1210/me.2003-0421; WILLMANN T, 1986, NATURE, V324, P688, DOI 10.1038/324688a0; WRANGE O, 1989, J BIOL CHEM, V264, P5253	90	37	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13279	10.1371/journal.pone.0013279	http://dx.doi.org/10.1371/journal.pone.0013279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949009	gold, Green Published			2022-12-27	WOS:000282748100017
J	Gunaratne, GH; Gunaratne, PH; Seemann, L; Torok, A				Gunaratne, Gemunu H.; Gunaratne, Preethi H.; Seemann, Lars; Toeroek, Andrei			Using Effective Subnetworks to Predict Selected Properties of Gene Networks	PLOS ONE			English	Article							CLUSTER-ANALYSIS; EXPRESSION; TRANSFECTION; MODELS; MOTIFS	Background: Difficulties associated with implementing gene therapy are caused by the complexity of the underlying regulatory networks. The forms of interactions between the hundreds of genes, proteins, and metabolites in these networks are not known very accurately. An alternative approach is to limit consideration to genes on the network. Steady state measurements of these influence networks can be obtained from DNA microarray experiments. However, since they contain a large number of nodes, the computation of influence networks requires a prohibitively large set of microarray experiments. Furthermore, error estimates of the network make verifiable predictions impossible. Methodology/Principal Findings: Here, we propose an alternative approach. Rather than attempting to derive an accurate model of the network, we ask what questions can be addressed using lower dimensional, highly simplified models. More importantly, is it possible to use such robust features in applications? We first identify a small group of genes that can be used to affect changes in other nodes of the network. The reduced effective empirical subnetwork (EES) can be computed using steady state measurements on a small number of genetically perturbed systems. We show that the EES can be used to make predictions on expression profiles of other mutants, and to compute how to implement pre-specified changes in the steady state of the underlying biological process. These assertions are verified in a synthetic influence network. We also use previously published experimental data to compute the EES associated with an oxygen deprivation network of E. coli, and use it to predict gene expression levels on a double mutant. The predictions are significantly different from the experimental results for less than 30% of genes. Conclusions/Significance: The constraints imposed by gene expression levels of mutants can be used to address a selected set of questions about a gene network.	[Gunaratne, Gemunu H.; Seemann, Lars] Univ Houston, Dept Phys, Houston, TX 77204 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Gunaratne, Preethi H.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Toeroek, Andrei] Univ Houston, Dept Math, Houston, TX 77204 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; University of Houston System; University of Houston	Gunaratne, GH (corresponding author), Univ Houston, Dept Phys, Houston, TX 77204 USA.	gemunu@uh.edu			National Science Foundation [0607345]	National Science Foundation(National Science Foundation (NSF))	This work was partially funded by grant 0607345 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angeli D, 2008, NONLINEAR ANAL-REAL, V9, P128, DOI 10.1016/j.nonrwa.2006.09.006; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bernard C., 1957, INTRO ETUDE MED EXPT; Bertram J, 2006, CURR PHARM BIOTECHNO, V7, P277, DOI 10.2174/138920106777950825; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Carlsson G, 2009, DISCRETE COMPUT GEOM, V42, P71, DOI 10.1007/s00454-009-9176-0; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2003, J THEOR BIOL, V221, P309, DOI 10.1006/jtbi.2003.3071; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gill G, 2001, ESSAYS BIOCHEM, V37, P33, DOI 10.1042/bse0370033; Hauser K, 2009, CELL CYCLE, V8, P2718, DOI 10.4161/cc.8.17.9401; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Herrgard MJ, 2003, GENOME RES, V13, P2423, DOI 10.1101/gr.1330003; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Oltvai ZN, 2002, SCIENCE, V298, P763, DOI 10.1126/science.1078563; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Salmon KA, 2005, J BIOL CHEM, V280, P15084, DOI 10.1074/jbc.M414030200; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; TSUKAKOSHI M, 1984, APPL PHYS B-PHOTO, V35, P135, DOI 10.1007/BF00697702; van Someren E P, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P355; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; WADDINGTON CH, 1960, GENET RES, V1, P140, DOI 10.1017/S0016672300000136; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Yang K, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.60; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	42	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13080	10.1371/journal.pone.0013080	http://dx.doi.org/10.1371/journal.pone.0013080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949025	gold, Green Published, Green Submitted			2022-12-27	WOS:000282676700002
J	Ji, GX; Gu, AH; Zhou, Y; Shi, XG; Xia, YK; Long, Y; Song, L; Wang, SL; Wang, XR				Ji, Guixiang; Gu, Aihua; Zhou, Yong; Shi, Xiangguo; Xia, Yankai; Long, Yan; Song, Ling; Wang, Shoulin; Wang, Xinru			Interactions between Exposure to Environmental Polycyclic Aromatic Hydrocarbons and DNA Repair Gene Polymorphisms on Bulky DNA Adducts in Human Sperm	PLOS ONE			English	Article							URINARY METABOLITES; EXCISION-REPAIR; DAMAGE; SMOKING; XRCC1; EXPRESSION; FERTILITY; SMOKERS; CELLS; RISK	Background: Nucleotide excision repair (NER) and base excision repair (BER) are the primary mechanisms for repair of bulky adducts caused by chemical agents, such as PAHs. It is expected that polymorphisms in NER or BER genes may modulate individual susceptibility to PAHs exposure. Here, we evaluate the effects of PAHs exposure and polymorphisms in NER and BER pathway, alone or combined, on polycyclic aromatic hydrocarbon-DNA (PAH-DNA) adducts in human sperm. Methodology/Principal Findings: Sperm PAH-DNA adducts were measured by immunofluorescent assay using flow cytometry in a sample of 465 infertile adults. Polymorphisms of XPA, XPD, ERCC1, XPF, and XRCC1 were determined by polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. The PAHs exposure was detected as urinary 1-hydroxypyrene (1-OHP) levels. In multivariate models adjusted for potential confounders, we observed that XRCC1 5'pUTR -T/C, Arg194Trp, Arg399Gln polymorphisms were associated with increased sperm adduct levels. Furthermore, the stratified analysis indicated that adverse effects of XRCC1 Arg194Trp, Arg399Gln polymorphisms on PAH-DNA adducts were detected only in the high PAHs exposure group. Conclusions/Significance: These findings provided the first evidence that polymorphisms of XRCC1 may modify sperm PAH-DNA adduct levels and may be useful biomarkers to identify individuals susceptible to DNA damage resulting from PAHs exposure.	[Ji, Guixiang; Gu, Aihua; Shi, Xiangguo; Xia, Yankai; Long, Yan; Song, Ling; Wang, Shoulin; Wang, Xinru] Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Peoples R China; [Zhou, Yong] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	Nanjing Medical University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Ji, GX (corresponding author), Nanjing Med Univ, Inst Toxicol, Sch Publ Hlth, Key Lab Reprod Med, Nanjing, Peoples R China.	xrwang@njmu.edu.cn			National Basic Research Program of China [2009CB941703]; Key Project of National Natural Science Foundation of China [30930079]; National Science Foundation of China [30901210, 30800927]	National Basic Research Program of China(National Basic Research Program of China); Key Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by National Basic Research Program of China (973 Program, 2009CB941703); The Key Project of National Natural Science Foundation of China (30930079); The National Science Foundation of China (No. 30901210; No. 30800927). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x; Binkova B, 2007, MUTAT RES-FUND MOL M, V620, P49, DOI 10.1016/j.mrfmmm.2007.02.022; Braithwaite E, 1998, CARCINOGENESIS, V19, P1239, DOI 10.1093/carcin/19.7.1239; De Ruyck K, 2007, MUTAT RES-GEN TOX EN, V631, P101, DOI 10.1016/j.mrgentox.2007.03.010; Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756; Gaspari L, 2003, MUTAT RES-GEN TOX EN, V535, P155, DOI 10.1016/S1383-5718(02)00297-8; Georgiadis P, 2001, CARCINOGENESIS, V22, P1447, DOI 10.1093/carcin/22.9.1447; Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305; Horak S, 2003, ACTA BIOCHIM POL, V50, P197; Horak Stanislaw, 2007, Folia Histochem Cytobiol, V45 Suppl 1, pS99; Hu Y, 2006, BIOMARKERS, V11, P306, DOI 10.1080/13547500600626883; Ji GX, 2008, REPROD BIOMED ONLINE, V17, P36, DOI 10.1016/S1472-6483(10)60290-8; Ji GX, 2010, TOXICOL SCI, V116, P92, DOI 10.1093/toxsci/kfq112; Kelada SN, 2003, ENVIRON HEALTH PERSP, V111, P1055, DOI 10.1289/ehp.6065; Kuriyama SN, 2005, ENVIRON HEALTH PERSP, V113, P149, DOI 10.1289/ehp.7421; LEROYER A, SCI TOTAL ENV, V408, P1166; Matullo G, 2001, CARCINOGENESIS, V22, P1437, DOI 10.1093/carcin/22.9.1437; McCarty KM, 2009, ENVIRON HEALTH PERSP, V117, P552, DOI 10.1289/ehp.0800119; Nia AB, 2000, ENVIRON MOL MUTAGEN, V36, P127, DOI 10.1002/1098-2280(2000)36:2<127::AID-EM7>3.0.CO;2-G; PELTONEN K, 1995, J OCCUP ENVIRON MED, V37, P52, DOI 10.1097/00043764-199501000-00008; Piipari R, 2000, INT J CANCER, V86, P610, DOI 10.1002/(SICI)1097-0215(20000601)86:5<610::AID-IJC2>3.0.CO;2-M; Pratt MM, 2007, MUTAT RES-FUND MOL M, V624, P114, DOI 10.1016/j.mrfmmm.2007.04.008; Romano G, 1999, CANCER EPIDEM BIOMAR, V8, P91; Rundle A, 2000, CARCINOGENESIS, V21, P1281, DOI 10.1093/carcin/21.7.1281; Scherer G, 2000, CANCER EPIDEM BIOMAR, V9, P373; Schoket B, 1999, MUTAT RES-FUND MOL M, V424, P143, DOI 10.1016/S0027-5107(99)00015-9; Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055; Thompson LH, 2000, MUTAT RES-DNA REPAIR, V459, P1, DOI 10.1016/S0921-8777(99)00058-0; WALTER CA, 1994, SOMAT CELL MOLEC GEN, V20, P451, DOI 10.1007/BF02255837; Xia YK, 2009, ENVIRON SCI TECHNOL, V43, P4567, DOI 10.1021/es9000642; Xia YK, 2009, HUM REPROD, V24, P1067, DOI 10.1093/humrep/dep006; Xue WL, 2005, TOXICOL APPL PHARM, V206, P73, DOI 10.1016/j.taap.2004.11.006; Zenzes MT, 1999, FERTIL STERIL, V72, P330, DOI 10.1016/S0015-0282(99)00230-7; Zenzes MT, 1999, MOL HUM REPROD, V5, P125, DOI 10.1093/molehr/5.2.125; ZHANG YJ, 1995, CANCER EPIDEM BIOMAR, V4, P133; ZHOU ZQ, 1995, MUTAT RES LETT, V348, P111, DOI 10.1016/0165-7992(95)00053-4; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	38	21	24	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13145	10.1371/journal.pone.0013145	http://dx.doi.org/10.1371/journal.pone.0013145			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957144	Green Published, gold			2022-12-27	WOS:000282506100003
J	Brazelton, WJ; Baross, JA				Brazelton, William J.; Baross, John A.			Metagenomic Comparison of Two Thiomicrospira Lineages Inhabiting Contrasting Deep-Sea Hydrothermal Environments	PLOS ONE			English	Article							MID-ATLANTIC RIDGE; OXIDIZING BACTERIUM; SP-NOV; FIELD; VENT; CRUNOGENA; DIVERSITY; ECOSYSTEM; DATABASE; CHIMNEYS	Background: The most widespread bacteria in oxic zones of carbonate chimneys at the serpentinite-hosted Lost City hydrothermal field, Mid-Atlantic Ridge, belong to the Thiomicrospira group of sulfur-oxidizing chemolithoautotrophs. It is unclear why Thiomicrospira-like organisms thrive in these chimneys considering that Lost City hydrothermal fluids are notably lacking in hydrogen sulfide and carbon dioxide. Methodology/Principal Findings: Here we describe metagenomic sequences obtained from a Lost City carbonate chimney that are highly similar to the genome of Thiomicrospira crunogena XCL-2, an isolate from a basalt-hosted hydrothermal vent in the Pacific Ocean. Even though T. crunogena and Lost City Thiomicrospira inhabit different types of hydrothermal systems in different oceans, their genomic contents are highly similar. For example, sequences encoding the sulfur oxidation and carbon fixation pathways (including a carbon concentration mechanism) of T. crunogena are also present in the Lost City metagenome. Comparative genomic analyses also revealed substantial genomic changes that must have occurred since the divergence of the two lineages, including large genomic rearrangements, gene fusion events, a prophage insertion, and transposase activity. Conclusions/Significance: Our results show significant genomic similarity between Thiomicrospira organisms inhabiting different kinds of hydrothermal systems in different oceans, suggesting that these organisms are widespread and highly adaptable. These data also indicate genomic processes potentially associated with the adaptation of these lineages into strikingly different habitats.	[Brazelton, William J.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; Univ Washington, Ctr Astrobiol & Early Evolut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Brazelton, WJ (corresponding author), Univ Washington, Sch Oceanog, Seattle, WA 98195 USA.	braz@uw.edu			NOAA; NASA Astrobiology Institute through the Carnegie Institution for Science	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); NASA Astrobiology Institute through the Carnegie Institution for Science	This work was supported by NOAA Ocean Exploration and the NASA Astrobiology Institute through the Carnegie Institution for Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 1999, APPL ENVIRON MICROB, V65, P270; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barton HA, 2006, J MICROBIOL METH, V66, P21, DOI 10.1016/j.mimet.2005.10.005; Bradley AS, 2009, GEOCHIM COSMOCHIM AC, V73, P102, DOI 10.1016/j.gca.2008.10.005; Brazelton WJ, 2006, APPL ENVIRON MICROB, V72, P6257, DOI 10.1128/AEM.00574-06; Brazelton WJ, 2010, P NATL ACAD SCI USA, V107, P1612, DOI 10.1073/pnas.0905369107; Brazelton WJ, 2009, ISME J, V3, P1420, DOI 10.1038/ismej.2009.79; Brinkhoff T, 1997, APPL ENVIRON MICROB, V63, P3789, DOI 10.1128/AEM.63.10.3789-3796.1997; BUTTERFIELD DA, 2003, COMPOSITION EVOLUTIO, P127; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; DeChaine EG, 2006, ENVIRON MICROBIOL, V8, P1902, DOI 10.1111/j.1462-2920.2005.01113.x; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Dobrinski KP, 2010, APPL ENVIRON MICROB, V76, P3561, DOI 10.1128/AEM.00064-10; Dobrinski KP, 2005, J BACTERIOL, V187, P5761, DOI 10.1128/JB.187.16.5761-5766.2005; Dulov LE, 2005, MICROBIOLOGY+, V74, P97, DOI 10.1007/s11021-005-0035-6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EDMOND JM, 1979, EARTH PLANET SC LETT, V46, P19, DOI 10.1016/0012-821X(79)90062-1; FRUHGREEN GL, 2004, EOS T AGU, V85; Ghosh W, 2009, RES MICROBIOL, V160, P409, DOI 10.1016/j.resmic.2009.07.003; Jannasch H.W., 1995, GEOPHYS MONOGR SER, V91, P273, DOI DOI 10.1029/GM091P0273; JANNASCH HW, 1985, INT J SYST BACTERIOL, V35, P422, DOI 10.1099/00207713-35-4-422; JAVOR BJ, 1990, ARCH MICROBIOL, V154, P231, DOI 10.1007/BF00248960; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Ludwig KA, 2006, GEOCHIM COSMOCHIM AC, V70, P3625, DOI 10.1016/j.gca.2006.04.016; NISHIHARA H, 1991, INT J SYST BACTERIOL, V41, P130, DOI 10.1099/00207713-41-1-130; Proskurowski G, 2008, SCIENCE, V319, P604, DOI 10.1126/science.1151194; RUBY EG, 1982, J BACTERIOL, V149, P161, DOI 10.1128/JB.149.1.161-165.1982; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Schrenk MO, 2004, ENVIRON MICROBIOL, V6, P1086, DOI 10.1111/j.1462-2920.2004.00650.x; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Wirsen CO, 1998, APPL ENVIRON MICROB, V64, P4057	33	38	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13530	10.1371/journal.pone.0013530	http://dx.doi.org/10.1371/journal.pone.0013530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975831	Green Submitted, Green Published, gold			2022-12-27	WOS:000283293800007
J	Orozco-Solis, R; Matos, RJB; Guzman-Quevedo, O; de Souza, SL; Bihouee, A; Houlgatte, R; de Castro, RM; Bolanos-Jimenez, F				Orozco-Solis, Ricardo; Matos, Rhowena J. B.; Guzman-Quevedo, Omar; de Souza, Sandra Lopes; Bihouee, Audrey; Houlgatte, Remi; de Castro, Raul Manhaes; Bolanos-Jimenez, Francisco			Nutritional Programming in the Rat Is Linked to Long-Lasting Changes in Nutrient Sensing and Energy Homeostasis in the Hypothalamus	PLOS ONE			English	Article							LOW-PROTEIN DIET; GLYCOGEN-SYNTHASE KINASE-3; K-ATP CHANNEL; METABOLIC SYNDROME; GENE-EXPRESSION; INDUCED OBESITY; FOOD-INTAKE; FUNCTIONAL-ORGANIZATION; CIRCADIAN TRANSCRIPTION; PRENATAL INFLUENCES	Background: Nutrient deficiency during perinatal development is associated with an increased risk to develop obesity, diabetes and hypertension in the adulthood. However, the molecular mechanisms underlying the developmental programming of the metabolic syndrome remain largely unknown. Methodology/Principal Findings: Given the essential role of the hypothalamus in the integration of nutritional, endocrine and neuronal cues, here we have analyzed the profile of the hypothalamus transcriptome in 180 days-old rats born to dams fed either a control (200 g/kg) or a low-protein (80 g/kg) diet through pregnancy and lactation. From a total of 26 209 examined genes, 688 were up-regulated and 309 down-regulated (P<0.003) by early protein restriction. Further bioinformatic analysis of the data revealed that perinatal protein restriction permanently alters the expression of two gene clusters regulating common cellular processes. The first one includes several gate keeper genes regulating insulin signaling and nutrient sensing. The second cluster encompasses a functional network of nuclear receptors and co-regulators of transcription involved in the detection and use of lipid nutrients as fuel which, in addition, link temporal and nutritional cues to metabolism through their tight interaction with the circadian clock. Conclusions/Significance: Collectively, these results indicate that the programming of the hypothalamic circuits regulating energy homeostasis is a key step in the development of obesity associated with malnutrition in early life and provide a valuable resource for further investigating the role of the hypothalamus in the programming of the metabolic syndrome.	[Orozco-Solis, Ricardo; Matos, Rhowena J. B.; Guzman-Quevedo, Omar; Bolanos-Jimenez, Francisco] Univ Nantes, INRA, Nantes Atlantique Univ, Physiol Adaptat Nutr UMR1280, Nantes, France; [de Souza, Sandra Lopes] Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Anat, Recife, PE, Brazil; [Bihouee, Audrey; Houlgatte, Remi] INSERM, Inst Thorax, IFR26, U915, Nantes, France; [de Castro, Raul Manhaes] Univ Fed Pernambuco, Ctr Ciencias Saude, Dept Nutr, Recife, PE, Brazil	INRAE; Nantes Universite; Universidade Federal de Pernambuco; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Universidade Federal de Pernambuco	Orozco-Solis, R (corresponding author), Univ Nantes, INRA, Nantes Atlantique Univ, Physiol Adaptat Nutr UMR1280, Nantes, France.	Francisco.Bolanos@univ-nantes.fr	Bihouée, Audrey/D-4934-2015; Guzman Quevedo, Omar/ABU-5276-2022; de Castro, Raul Manhaes/A-1635-2014; Quevedo, omar Guzman/AAG-6327-2020; Houlgatte, Remi/P-3020-2017	Guzman Quevedo, Omar/0000-0003-1358-1783; Quevedo, omar Guzman/0000-0003-1358-1783; Bihouee, Audrey/0000-0002-8689-2083	INRA; La Region Pays de la Loire; L'Agence National de la Recherche [ANR-05-PNRA-009-02]	INRA; La Region Pays de la Loire(Region Pays de la Loire); L'Agence National de la Recherche(French National Research Agency (ANR))	This work was supported by INRA through a Young Team Action and by L'Agence National de la Recherche (ANR-05-PNRA-009-02). R. Orozco-Solis and O. Guzman-Quevedo are doctoral fellows from the Mexican Consejo Nacional de Ciencia y Tecnologia (CONACYT). S. Lopes de Souza and Rhowena Matos are the recipients of a post-doctoral fellowship from La Region Pays de la Loire. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bieswal F, 2006, OBESITY, V14, P1330, DOI 10.1038/oby.2006.151; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; de Freitas MS, 2003, BBA-MOL BASIS DIS, V1639, P8, DOI 10.1016/S0925-4439(03)00096-6; de Souza SL, 2008, EUR J NEUROSCI, V27, P1400, DOI 10.1111/j.1460-9568.2008.06105.x; Desai M, 2007, AM J PHYSIOL-REG I, V293, pR2306, DOI 10.1152/ajpregu.00783.2006; Desai M, 2007, REPROD SCI, V14, P329, DOI 10.1177/1933719107303983; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eldar-Finkelman H, 1999, DIABETES, V48, P1662, DOI 10.2337/diabetes.48.8.1662; Erhuma A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1702, DOI 10.1152/ajpendo.00605.2006; Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002; Guard DB, 2009, AM J PHYSIOL-REG I, V296, pR921, DOI 10.1152/ajpregu.90456.2008; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Ikenasio-Thorpe BA, 2007, J ENDOCRINOL, V193, P31, DOI 10.1677/joe.1.07017; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jensen CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003738; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Krechowec SO, 2006, J ENDOCRINOL, V189, P355, DOI 10.1677/joe.1.06679; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Levin BE, 2001, NAT NEUROSCI, V4, P459, DOI 10.1038/87405; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Man PS, 2008, NEUROPHARMACOLOGY, V55, P1, DOI 10.1016/j.neuropharm.2008.04.008; McMullen S, 2005, AM J PHYSIOL-REG I, V288, pR85, DOI 10.1152/ajpregu.00435.2004; Morrison CD, 2005, AM J PHYSIOL-ENDOC M, V289, pE1051, DOI 10.1152/ajpendo.00094.2005; Morton GJ, 2005, CELL METAB, V2, P411, DOI 10.1016/j.cmet.2005.10.009; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Orozco-Solis R, 2009, PHYSIOL BEHAV, V96, P481, DOI 10.1016/j.physbeh.2008.11.016; OROZCOSOLIS R, 2010, INT J OBESI IN PRESS; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Plagemann A, 2000, J NUTR, V130, P2582, DOI 10.1093/jn/130.10.2582; Plagemann A, 1999, REGUL PEPTIDES, V85, P109, DOI 10.1016/S0167-0115(99)00085-3; Plagemann A, 2000, NEUROPEPTIDES, V34, P1, DOI 10.1054/npep.1999.0778; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; SARDINHA FLC, NUTRITION, V22, P1152; Sato T, 2003, BIOCHEM BIOPH RES CO, V300, P167, DOI 10.1016/S0006-291X(02)02774-2; Schibler U, 2002, CELL, V111, P919, DOI 10.1016/S0092-8674(02)01225-4; Sieberts SK, 2007, MAMM GENOME, V18, P389, DOI 10.1007/s00335-007-9040-6; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wang CF, 2007, AM J PHYSIOL-REG I, V293, pR1003, DOI 10.1152/ajpregu.00011.2007; Woods SC, 2008, ANNU REV NUTR, V28, P295, DOI 10.1146/annurev.nutr.28.061807.155505; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; Yura S, 2005, CELL METAB, V1, P371, DOI 10.1016/j.cmet.2005.05.005; Zambrano E, 2006, J PHYSIOL-LONDON, V571, P221, DOI 10.1113/jphysiol.2005.100313	57	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13537	10.1371/journal.pone.0013537	http://dx.doi.org/10.1371/journal.pone.0013537			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975839	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800011
J	Corbett, KL; Losina, E; Nti, AA; Prokopetz, JJZ; Katz, JN				Corbett, Kelly L.; Losina, Elena; Nti, Akosua A.; Prokopetz, Julian J. Z.; Katz, Jeffrey N.			Population-Based Rates of Revision of Primary Total Hip Arthroplasty: A Systematic Review	PLOS ONE			English	Review							AGED 55 YEARS; PRIMARY OSTEOARTHRITIS; FOLLOW-UP; YOUNG-PATIENTS; REGISTER; REPLACEMENT; OLDER; IMPLANTS; TERM; DISEASE	Background: Most research on failure leading to revision total hip arthroplasty (THA) is reported from single centers. We searched PubMed between January 2000 and August 2010 to identify population-or community-based studies evaluating ten-year revision risks. We report ten-year revision risk using the Kaplan-Meier method, stratifying by age and fixation technique. Results: Thirteen papers met the inclusion criteria. Cemented prostheses had Kaplan-Meier estimates of revision-free implant survival of ten years ranging from 88% to 95%; uncemented prostheses had Kaplan-Meier estimates from 80% to 85%. Estimates ranged from 72% to 86% in patients less than 60 years old and from 90 to 96% in older patients. Conclusion: Data reported from national registries suggest revision risks of 5 to 20% ten years following primary THA. Revision risks are lower in older THA recipients. Uncemented implants may have higher ten-year rates of revision, regardless of age.	[Corbett, Kelly L.; Losina, Elena; Nti, Akosua A.; Prokopetz, Julian J. Z.; Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Losina, Elena; Katz, Jeffrey N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Losina, Elena] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University	Corbett, KL (corresponding author), Brigham & Womens Hosp, Dept Orthoped Surg, Orthoped & Arthrit Ctr Outcomes Res, 75 Francis St, Boston, MA 02115 USA.	jnkatz@partners.org		Corbett, Kelly/0000-0003-3211-2501; Losina, ELENA/0000-0002-3424-0892	National Institutes of Health (NIH)	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Institutes of Health (NIH). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldinger PR, 2003, ACTA ORTHOP SCAND, V74, P253, DOI 10.1080/00016470310014157; Allami MK, 2006, J BONE JOINT SURG BR, V88B, P1293, DOI 10.1302/0301-620X.88B10.17933; *AUSTR ORTH ASS JA, 2010, ANN REP 2009 AUSTR O; Berry DJ, 2002, J BONE JOINT SURG AM, V84A, P171, DOI 10.2106/00004623-200202000-00002; Callaghan JJ, 2004, J BONE JOINT SURG AM, V86A, P690, DOI 10.2106/00004623-200404000-00004; Eskelinen A, 2005, ACTA ORTHOP, V76, P28, DOI 10.1080/00016470510030292; Eskelinen A, 2006, ACTA ORTHOP, V77, P57, DOI 10.1080/17453670610045704; Espehaug B, 2009, ACTA ORTHOP, V80, P402, DOI 10.3109/17453670903161124; Furnes O, 2001, J BONE JOINT SURG BR, V83B, P579, DOI 10.1302/0301-620X.83B4.11223; Hailer NP, 2010, ACTA ORTHOP, V81, P34, DOI 10.3109/17453671003685400; Hallan G, 2007, J BONE JOINT SURG BR, V89B, P1574, DOI 10.1302/0301-620X.89B12.18969; HARRIS WH, 1986, CLIN ORTHOP RELAT R, P20; Herberts P, 2000, ACTA ORTHOP SCAND, V71, P111, DOI 10.1080/000164700317413067; Kavanagh B F, 1994, J Arthroplasty, V9, P229, DOI 10.1016/0883-5403(94)90076-0; Makela K, 2008, J BONE JOINT SURG BR, V90B, P1562, DOI 10.1302/0301-620X.90B12.21151; Makela KT, 2008, J BONE JOINT SURG AM, V90A, P2160, DOI 10.2106/JBJS.G.00870; Makela KT, 2010, ACTA ORTHOP, V81, P42, DOI 10.3109/17453671003635900; Malchau H, 2002, J BONE JOINT SURG AM, V84A, P2, DOI 10.2106/00004623-200200002-00002; Maloney WJ, 2001, J BONE JOINT SURG AM, V83A, P1582, DOI 10.2106/00004623-200110000-00020; McLaughlin JR, 2000, CLIN ORTHOP RELAT R, P153, DOI 10.1097/00003086-200004000-00019; *NZ JOINT REG, 2010, 10 YEAR REP; Ogino D, 2008, J BONE JOINT SURG AM, V90A, P1884, DOI 10.2106/JBJS.G.00147; Puolakka TJS, 2001, ACTA ORTHOP SCAND, V72, P433, DOI 10.1080/000164701753532745; Soderman P, 2000, ACTA ORTHOP SCAND, V71, P354, DOI 10.1080/000164700317393330; Soderman P, 2000, ACTA ORTHOP SCAND, V71, pCP1; Soderman P, 2001, ACTA ORTHOP SCAND, V72, P113, DOI 10.1080/000164701317323345; Wroblewski BM, 2002, J BONE JOINT SURG BR, V84B, P540, DOI 10.1302/0301-620X.84B4.10293	27	84	89	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13520	10.1371/journal.pone.0013520	http://dx.doi.org/10.1371/journal.pone.0013520			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976011	Green Submitted, Green Published, gold			2022-12-27	WOS:000283216400024
J	Cherkas, LF; Harris, JM; Levinson, E; Spector, TD; Prainsack, B				Cherkas, Lynn F.; Harris, Juliette M.; Levinson, Elana; Spector, Tim D.; Prainsack, Barbara			A Survey of UK Public Interest in Internet-Based Personal Genome Testing	PLOS ONE			English	Article							GENETIC RISK-ASSESSMENT; SMOKING-CESSATION; SUSCEPTIBILITY; DISEASE; EXPECTATIONS; BEHAVIORS; ATTITUDES; FEEDBACK; SMOKERS; IMPACT	Background: In view of the increasing availability of commercial internet-based Personal Genome Testing (PGT), this study aimed to explore the reasons why people would consider taking such a test and how they would use the genetic risk information provided. Methodology/Principal Findings: A self-completion questionnaire assessing public awareness and interest in PGT and motivational reasons for undergoing PGT was completed by 4,050 unselected adult volunteers from the UK-based TwinsUK register, aged 17 to 91 (response rate 62%). Only 13% of respondents were aware of the existence of PGT. After reading a brief summary about PGT, one in twenty participants (5%) were potentially interested at current prices (250) pound, however this proportion rose to half (50%) if the test was free of charge. Nearly all respondents who were interested in free PGT reported they would take the test to encourage them to adopt a healthier lifestyle if found to be at high genetic risk of a disease (93%). Around 4 in 5 respondents would have the test to convey genetic risk information to their children and a similar proportion felt that having a PGT would enable their doctor to monitor their health more closely. A TwinsUK research focus group also indicated that consumers would consult their GP to help interpret results of PGT. Conclusions/Significance: This hypothetical study suggests that increasing publicity and decreasing costs of PGT may lead to increased uptake, driven in part by the general public's desire to monitor and improve their health. Although the future extent of the clinical utility of PGT is currently unknown, it is crucial that consumers are well informed about the current limitations of PGT. Our results suggest that health professionals will inevitably be required to respond to individuals who have undergone PGT. This has implications for health service providers regarding both cost and time.	[Cherkas, Lynn F.; Harris, Juliette M.; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Levinson, Elana] Columbia Univ, Med Ctr, Dept Pediat, Div Mol Genet, New York, NY USA; [Prainsack, Barbara] Kings Coll London, Ctr Biomed & Soc CBAS, London WC2R 2LS, England	University of London; King's College London; Columbia University; University of London; King's College London	Cherkas, LF (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England.	lynn.cherkas@kcl.ac.uk	Prainsack, Barbara/AAF-5739-2021	Prainsack, Barbara/0000-0002-6335-1532	Department of Twin Research and Genetic Epidemiology [081878/Z/06/Z]; Wellcome Trust	Department of Twin Research and Genetic Epidemiology; Wellcome Trust(Wellcome TrustEuropean Commission)	Department of Twin Research and Genetic Epidemiology is supported by a grant (081878/Z/06/Z) by The Wellcome Trust (http://www.wellcome.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Arkadianos I, 2007, NUTR J, V6, DOI 10.1186/1475-2891-6-29; Audrain J, 1997, ADDICT BEHAV, V22, P741, DOI 10.1016/S0306-4603(97)00060-9; Beery TA, 2007, GENET TEST, V11, P111, DOI 10.1089/gte.2006.0527; Bunnik E, 2009, AM J BIOETHICS, V9, P23, DOI 10.1080/15265160902874429; Caulfield T, 2009, AM J BIOETHICS, V9, P48, DOI 10.1080/15265160902918770; Chao S, 2008, ALZ DIS ASSOC DIS, V22, P94, DOI 10.1097/WAD.0b013e31815a9dcc; Gaskell G, 2000, NAT BIOTECHNOL, V18, P935, DOI 10.1038/79403; GRAVES KD, TESTING BREAST UNPUB; *HARV MED SCH DEP, 2010, PERS GEN ED PROJ 201; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Ioannidis JPA, 2009, ANN INTERN MED, V150, P139, DOI 10.7326/0003-4819-150-2-200901200-00012; Ito H, 2006, PREV MED, V42, P102, DOI 10.1016/j.ypmed.2005.10.006; Khoury MJ, 2009, GENET MED, V11, P559, DOI 10.1097/GIM.0b013e3181b13a6c; Makeeva OA, 2009, PERS MED, V6, P329, DOI [10.2217/pme.09.14, 10.2217/PME.09.14]; McBride CM, 2002, CANCER EPIDEM BIOMAR, V11, P521; McBride CM, 2010, ANNU REV PUBL HEALTH, V31, P89, DOI 10.1146/annurev.publhealth.012809.103532; McBride CM, 2009, GENET MED, V11, P582, DOI 10.1097/GIM.0b013e3181b22c3a; McGowan ML, 2008, AM J BIOETHICS, V8, P18, DOI 10.1080/15265160802248302; McGuire AL, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902928209; Ng PC, 2009, NATURE, V461, P724, DOI 10.1038/461724a; *PPPG ESHG, 2010, STAT ESHG DIR TO CON; Sanderson SC, 2010, PUBLIC HEALTH GENOMI, V13, P116, DOI 10.1159/000226595; Sanderson SC, 2008, J HEALTH PSYCHOL, V13, P481, DOI 10.1177/1359105308088519; SIMON RM, 2009, GENDER DIFFERENCES K, DOI DOI 10.1177/0963662509335449; Telner DE, 2008, MED TEACH, V30, P192, DOI 10.1080/01421590701827353; *UK HL SCI TECHN C, 2009, GEN MED; *US SACCHS, 2010, DRAFT REP GEN ED TRA; Wright AJ, 2008, CLIN GENET, V73, P306, DOI 10.1111/j.1399-0004.2008.00964.x	29	83	83	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13473	10.1371/journal.pone.0013473	http://dx.doi.org/10.1371/journal.pone.0013473			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976053	gold, Green Published, Green Submitted			2022-12-27	WOS:000283114700010
J	Dong, XY; Tian, WH; Wang, G; Dong, ZY; Shen, W; Zheng, G; Wu, XB; Xue, JL; Wang, Y; Chen, JZ				Dong, Xiaoyan; Tian, Wenhong; Wang, Gang; Dong, Zheyue; Shen, Wei; Zheng, Gang; Wu, Xiaobing; Xue, Jinglun; Wang, Yue; Chen, Jinzhong			Establishment of an AAV Reverse Infection-Based Array	PLOS ONE			English	Article							VIRUS; TRANSFECTION; VECTORS; SEROTYPES	Background: The development of a convenient high-throughput gene transduction approach is critical for biological screening. Adeno-associated virus (AAV) vectors are broadly used in gene therapy studies, yet their applications in in vitro high-throughput gene transduction are limited. Principal Findings: We established an AAV reverse infection (RI)-based method in which cells were transduced by quantified recombinant AAVs (rAAVs) pre-coated onto 96-well plates. The number of pre-coated rAAV particles and number of cells loaded per well, as well as the temperature stability of the rAAVs on the plates, were evaluated. As the first application of this method, six serotypes or hybrid serotypes of rAAVs (AAV1, AAV2, AAV5/5, AAV8, AAV25 m, AAV28 m) were compared for their transduction efficiencies using various cell lines, including BHK21, HEK293, BEAS-2BS, HeLaS3, Huh7, Hepa1-6, and A549. AAV2 and AAV1 displayed high transduction efficiency; thus, they were deemed to be suitable candidate vectors for the RI-based array. We next evaluated the impact of sodium butyrate (NaB) treatment on rAAV vector-mediated reporter gene expression and found it was significantly enhanced, suggesting that our system reflected the biological response of target cells to specific treatments. Conclusions/Significance: Our study provides a novel method for establishing a highly efficient gene transduction array that may be developed into a platform for cell biological assays.	[Dong, Xiaoyan; Xue, Jinglun; Chen, Jinzhong] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Dong, Xiaoyan; Dong, Zheyue; Shen, Wei; Zheng, Gang] Beijing Fiveplus Mol Med Inst, Beijing, Peoples R China; [Tian, Wenhong; Wang, Gang; Wang, Yue] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Beijing, Peoples R China	Fudan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Dong, XY (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	euy-tokyo@umin.ac.jp; kingbellchen@fudan.edu.cn		Wu, Xiaobing/0000-0002-2823-2634	State Key Laboratory for Molecular Virology and Genetic Engineering of China [2008-s-0008]; Beijing FivePlus Molecular Medicine Institute	State Key Laboratory for Molecular Virology and Genetic Engineering of China; Beijing FivePlus Molecular Medicine Institute	This study was supported by the Research Programs of State Key Laboratory for Molecular Virology and Genetic Engineering of China (No. 2008-s-0008), and Beijing FivePlus Molecular Medicine Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett Jeffrey S., 1995, P55, DOI 10.1016/B978-012397570-6/50006-X; Carbone R, 2007, BIOMATERIALS, V28, P2244, DOI 10.1016/j.biomaterials.2006.12.026; Chen H, 2007, MICROSC MICROANAL, V13, P384, DOI 10.1017/S1431927607070808; Chen WY, 1997, P NATL ACAD SCI USA, V94, P5798, DOI 10.1073/pnas.94.11.5798; Choi VW, 2005, CURR GENE THER, V5, P299, DOI 10.2174/1566523054064968; Dong Xiaoyan, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P679; Erfle H, 2007, NAT PROTOC, V2, P392, DOI 10.1038/nprot.2006.483; HOGGAN MD, 1966, P NATL ACAD SCI USA, V55, P1467, DOI 10.1073/pnas.55.6.1467; Hueffer K, 2003, CURR OPIN MICROBIOL, V6, P392, DOI 10.1016/S1369-5274(03)00083-3; KNIPE DM, 2007, FIELDS VIROLOGY, P2438; Okazaki A, 2007, TISSUE ENG, V13, P245, DOI 10.1089/ten.2006.0185; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Rabinowitz JE, 2004, J VIROL, V78, P4421, DOI 10.1128/JVI.78.9.4421-4432.2004; Riviere C, 2006, GENE THER, V13, P1300, DOI 10.1038/sj.gt.3302766; Samulski R.J., 1999, COLD SPRING HARBOR M, P131; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324; Wu XB, 2001, CHINESE SCI BULL, V46, P485, DOI 10.1007/BF03187263; Wu ZJ, 1999, CHINESE SCI BULL, V44, P715, DOI 10.1007/BF02909710; Zabner J, 2000, J VIROL, V74, P3852, DOI 10.1128/JVI.74.8.3852-3858.2000	20	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13479	10.1371/journal.pone.0013479	http://dx.doi.org/10.1371/journal.pone.0013479			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976058	Green Submitted, Green Published, gold			2022-12-27	WOS:000283114700012
J	Sharma, R; Buras, E; Terashima, T; Serrano, F; Massaad, CA; Hu, LY; Bitner, B; Inoue, T; Chan, L; Pautler, RG				Sharma, Ruchi; Buras, Eric; Terashima, Tomoya; Serrano, Faridis; Massaad, Cynthia A.; Hu, Lingyun; Bitner, Brittany; Inoue, Taeko; Chan, Lawrence; Pautler, Robia G.			Hyperglycemia Induces Oxidative Stress and Impairs Axonal Transport Rates in Mice	PLOS ONE			English	Article							IN-VIVO; SUPEROXIDE-DISMUTASE; ANTIOXIDANT DEFENSE; DIABETIC-NEUROPATHY; PROTEIN; DYSFUNCTION; NEURONS; TAU; OVEREXPRESSION; PROTECTION	Background: While hyperglycemia-induced oxidative stress damages peripheral neurons, technical limitations have, in part, prevented in vivo studies to determine the effect of hyperglycemia on the neurons in the central nervous system (CNS). While olfactory dysfunction is indicated in diabetes, the effect of hyperglycemia on olfactory receptor neurons (ORNs) remains unknown. In this study, we utilized manganese enhanced MRI (MEMRI) to assess the impact of hyperglycemia on axonal transport rates in ORNs. We hypothesize that (i) hyperglycemia induces oxidative stress and is associated with reduced axonal transport rates in the ORNs and (ii) hyperglycemia-induced oxidative stress activates the p38 MAPK pathway in association with phosphorylation of tau protein leading to the axonal transport deficits. Research Design and Methods: T-1-weighted MEMRI imaging was used to determine axonal transport rates post-streptozotocin injection in wildtype (WT) and superoxide dismutase 2 (SOD2) overexpressing C57Bl/6 mice. SOD2 overexpression reduces mitochondrial superoxide load. Dihydroethidium staining was used to quantify the reactive oxygen species (ROS), specifically, superoxide (SO). Protein and gene expression levels were determined using western blotting and Q-PCR analysis, respectively. Results: STZ-treated WT mice exhibited significantly reduced axonal transport rates and significantly higher levels of ROS, phosphorylated p38 MAPK and tau protein as compared to the WT vehicle treated controls and STZ-treated SOD2 mice. The gene expression levels of p38 MAPK and tau remained unchanged. Conclusion: Increased oxidative stress in STZ-treated WT hyperglycemic mice activates the p38 MAPK pathway in association with phosphorylation of tau and attenuates axonal transport rates in the olfactory system. In STZ-treated SOD-overexpressing hyperglycemic mice in which superoxide levels are reduced, these deficits are reversed.	[Sharma, Ruchi; Serrano, Faridis; Massaad, Cynthia A.; Hu, Lingyun; Inoue, Taeko; Pautler, Robia G.] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Buras, Eric; Terashima, Tomoya; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Sharma, R (corresponding author), Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA.	rpautler@bcm.edu			DERC (Diabetes Endocrinology Research Center) [NIDDK-P30DK079638, HL-51586]; NIH/NIA [R01AG029977]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029977] Funding Source: NIH RePORTER	DERC (Diabetes Endocrinology Research Center); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by DERC (Diabetes Endocrinology Research Center), NIDDK-P30DK079638 (LC), HL-51586 (LC), and NIH/NIA R01AG029977 (RGP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; BURNETT K R, 1984, Magnetic Resonance Imaging, V2, P307, DOI 10.1016/0730-725X(84)90197-8; Chen HM, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-3; Clodfelder-Miller BJ, 2006, DIABETES, V55, P3320, DOI 10.2337/db06-0485; Cross DJ, 2008, NEUROIMAGE, V39, P915, DOI 10.1016/j.neuroimage.2007.08.036; Dennis JC, 2005, J NEUROCYTOL, V34, P3, DOI 10.1007/s11068-005-5044-x; Ho YS, 1998, AM J RESP CELL MOL, V18, P538, DOI 10.1165/ajrcmb.18.4.2959; HOUGH S, 1982, AM J PHYSIOL, V242, pE451, DOI 10.1152/ajpendo.1982.242.6.E451; Hu DY, 2006, J NEUROSCI, V26, P3933, DOI 10.1523/JNEUROSCI.5566-05.2006; Jagodic MM, 2007, J NEUROSCI, V27, P3305, DOI 10.1523/JNEUROSCI.4866-06.2007; Kowluru RA, 2006, FREE RADICAL BIO MED, V41, P1191, DOI 10.1016/j.freeradbiomed.2006.01.012; LEFLOCH JP, 1993, DIABETES CARE, V16, P934, DOI 10.2337/diacare.16.6.934; Levy J, 1999, ENDOCRINE, V10, P1, DOI 10.1385/ENDO:10:1:1; Maragos WF, 2000, BRAIN RES, V878, P218, DOI 10.1016/S0006-8993(00)02707-4; Massaad CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010561; Menne J, 2004, DIABETES, V53, P2101, DOI 10.2337/diabetes.53.8.2101; Munusamy S, 2009, FREE RADICAL BIO MED, V46, P1149, DOI 10.1016/j.freeradbiomed.2009.01.022; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Oh-Hashi K, 2001, FREE RADICAL BIO MED, V30, P213, DOI 10.1016/S0891-5849(00)00461-5; Pautler RG, 2004, NMR BIOMED, V17, P595, DOI 10.1002/nbm.942; Pautler RG, 2003, MAGNET RESON MED, V50, P33, DOI 10.1002/mrm.10498; Pautler RG, 1998, MAGNET RESON MED, V40, P740, DOI 10.1002/mrm.1910400515; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Price SA, 2004, DIABETES, V53, P1851, DOI 10.2337/diabetes.53.7.1851; Purves T, 2001, FASEB J, V15, P2508, DOI 10.1096/fj.01-0253hyp; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; SITHIPORN A, 2002, ANN NY ACAD SCI, V973, P359; SLOOT WN, 1994, BRAIN RES, P657; Smith KDB, 2007, NEUROIMAGE, V35, P1401, DOI 10.1016/j.neuroimage.2007.01.046; Terwel D, 2002, NEUROMOL MED, V2, P151, DOI 10.1385/NMM:2:2:151; Tindemans I, 2003, EUR J NEUROSCI, V18, P3352, DOI 10.1111/j.1460-9568.2003.03056.x; Tomlinson DR, 2008, J PERIPHER NERV SYST, V13, P112, DOI 10.1111/j.1529-8027.2008.00167.x; Vincent AM, 2007, EXP NEUROL, V208, P216, DOI 10.1016/j.expneurol.2007.07.017; Vincent AM, 2009, ANTIOXID REDOX SIGN, V11, P425, DOI 10.1089/ars.2008.2235; WEINSTOCK RS, 1993, PHYSIOL BEHAV, V53, P17, DOI 10.1016/0031-9384(93)90005-Z	35	64	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13463	10.1371/journal.pone.0013463	http://dx.doi.org/10.1371/journal.pone.0013463			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976160	gold, Green Submitted, Green Published			2022-12-27	WOS:000283045300032
J	Li, CS; Chen, C; Zheng, P; Liu, Y				Li, Chi-Shan; Chen, Chong; Zheng, Pan; Liu, Yang			Transgenic Expression of P1A Induced Thymic Tumor: A Role for Onco-Fetal Antigens in Tumorigenesis	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; C-MYC; REJECTION ANTIGEN; STEM-CELLS; N-MYC; GENE; MICE; CANCER; PROGENITORS; SECONDARY	P1A is the first known tumor rejection antigen. It is expressed in embryonic stem cells and multiple tumors but is silent in adult tissues except for the testis and placenta. Therefore, P1A represents a prototype for onco-fetal antigens. To test the potential function of P1A in tumorigenesis, we used a transgenic mouse expressing P1A in lymphoid cells. We observed that immunodeficient host P1A transgenic mice developed thymic tumors after 7 months of age and had shorter survival rates compared to control groups. Most of the 7 examined tumors displayed B cell lineage markers. The P1A transgenic bone marrow cells had higher proliferation ability and more potential progenitors compared to control bone marrow cells. To our knowledge, our data provided the first example that onco-fetal antigen can promote tumorigenesis.	[Li, Chi-Shan; Chen, Chong; Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA; [Liu, Yang] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI USA; [Zheng, Pan; Liu, Yang] Univ Michigan, Sch Med, Dis & Comprehens Canc Ctr, Program Mol Mech, Ann Arbor, MI USA; [Zheng, Pan] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA; [Li, Chi-Shan] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Toxicol Program, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Li, CS (corresponding author), Univ Michigan, Sch Med, Dept Surg, Sect Gen Surg,Div Immunotherapy, Ann Arbor, MI 48109 USA.	panz@umich.edu; yangl@med.umich.edu	Zheng, Pan/E-8691-2011	Zheng, Pan/0000-0003-2598-3544; Liu, Yang/0000-0002-9442-700X	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC1GM091648] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Boon T, 1996, J EXP MED, V183, P725, DOI 10.1084/jem.183.3.725; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Hadden JW, 2003, INT IMMUNOPHARMACOL, V3, P1061, DOI 10.1016/S1567-5769(03)00060-2; Kawamoto H, 1998, J IMMUNOL, V161, P3799; Magliocca JF, 2006, STEM CELLS DEV, V15, P707, DOI 10.1089/scd.2006.15.707; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MUELLER BU, 1995, J PEDIATR-US, V126, P1, DOI 10.1016/S0022-3476(95)70491-4; PENN I, 1994, CANCER DETECT PREV, V18, P241; RAMARATHINAM L, 1995, J IMMUNOL, V155, P5323; ROSENBAUM H, 1989, EMBO J, V8, P749, DOI 10.1002/j.1460-2075.1989.tb03435.x; ROSENBAUM H, 1990, EMBO J, V9, P897, DOI 10.1002/j.1460-2075.1990.tb08187.x; SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x; Sarma S, 1999, J EXP MED, V189, P811, DOI 10.1084/jem.189.5.811; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; SUN XH, 1994, CELL, V79, P893, DOI 10.1016/0092-8674(94)90078-7; Uyttenhove C, 1997, INT J CANCER, V70, P349, DOI 10.1002/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.3.CO;2-Z; UYTTENHOVE C, 1983, J EXP MED, V157, P1040, DOI 10.1084/jem.157.3.1040; VANDENEYNDE B, 1994, EUR J IMMUNOL, V24, P2740, DOI 10.1002/eji.1830241125; VANDENEYNDE B, 1991, J EXP MED, V173, P1373, DOI 10.1084/jem.173.6.1373; VANLOHUIZEN M, 1989, CELL, V56, P673, DOI 10.1016/0092-8674(89)90589-8; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	24	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13439	10.1371/journal.pone.0013439	http://dx.doi.org/10.1371/journal.pone.0013439			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976169	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700024
J	Xi, CW; Wu, JF				Xi, Chuanwu; Wu, Jianfeng			dATP/ATP, a Multifunctional Nucleotide, Stimulates Bacterial Cell Lysis, Extracellular DNA Release and Biofilm Development	PLOS ONE			English	Article							STAPHYLOCOCCUS-EPIDERMIDIS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; ATP; ACINETOBACTER; COMMUNICATION; INDUCTION; ADHERENCE	Background: Signaling by extracellular adenosine 59-triphosphase (eATP) is very common for cell-to-cell communication in many basic patho-physiological development processes. Rapid release of ATP into the extracellular environment from distressed or injured eukaryotic cells due to pathogens or other etiological factors can serve as a "danger signal'', activating host innate immunity. However, little is known about how or whether pathogenic bacteria respond to this "danger signal''. Methods and Principal Findings: Here we report that extracellular dATP/ATP can stimulate bacterial adhesion and biofilm formation via increased cell lysis and extracellular DNA (eDNA) release. We demonstrate that extracellular dATP/ATP also stimulates bacterial adherence in vitro to human bronchial epithelial cells. Conclusions and Significance: These data suggest that bacteria may sense extracellular dATP/ATP as a signal of "danger'' and form biofilms to protect them from host innate immunity. This study reveals a very important and unrecognized phenomenon that both bacteria and host cells could respond to a common important signal molecule in a race to adapt to the presence of one another. We propose that extracellular dATP/ATP functions as an "inter-domain'' warning signal that serves to induce protective measures in both Bacterial and Eukaryotic cells.	[Xi, Chuanwu; Wu, Jianfeng] Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Xi, CW (corresponding author), Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	cxi@umich.edu	Xi, Chuanwu/C-7432-2011	Xi, Chuanwu/0000-0002-7554-1915	University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098350] Funding Source: NIH RePORTER	University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work is supported by an internal funding to C.X. from the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BergogneBerezin E, 1996, CLIN MICROBIOL REV, V9, P148, DOI 10.1128/CMR.9.2.148; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; Di Virgilio F, 2007, PURINERG SIGNAL, V3, P1, DOI 10.1007/s11302-006-9048-5; Di Virgilio F, 2009, TRENDS NEUROSCI, V32, P79, DOI 10.1016/j.tins.2008.11.003; Flemming HC, 2001, WATER SCI TECHNOL, V43, P9, DOI 10.2166/wst.2001.0328; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hamilton HL, 2005, MOL MICROBIOL, V55, P1704, DOI 10.1111/j.1365-2958.2005.04521.x; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; Joly-Guillou ML, 2005, CLIN MICROBIOL INFEC, V11, P868, DOI 10.1111/j.1469-0691.2005.01227.x; Komlosi P, 2005, PHYSIOLOGY, V20, P86, DOI 10.1152/physiol.00002.2005; Komoszynski M, 1996, BBA-MOL CELL RES, V1310, P233, DOI 10.1016/0167-4889(95)00135-2; LaPaglia C, 1997, APPL ENVIRON MICROB, V63, P3158, DOI 10.1128/AEM.63.8.3158-3163.1997; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Neu TR, 1999, METHOD ENZYMOL, V310, P145; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Rachid S, 2000, ADV EXP MED BIOL, V485, P159; RAMPHAL R, 1983, INFECT IMMUN, V41, P345, DOI 10.1128/IAI.41.1.345-351.1983; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Spoering AL, 2006, CURR OPIN MICROBIOL, V9, P133, DOI 10.1016/j.mib.2006.02.004; Staudt C, 2004, BIOTECHNOL BIOENG, V88, P585, DOI 10.1002/bit.20241; Steinmoen H, 2002, P NATL ACAD SCI USA, V99, P7681, DOI 10.1073/pnas.112464599; Thomas VC, 2008, J BACTERIOL, V190, P5690, DOI 10.1128/JB.00314-08; Trautmann A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe6; Vilain S, 2009, APPL ENVIRON MICROB, V75, P2861, DOI 10.1128/AEM.01317-08; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Wolfaardt GM, 1998, MICROB ECOL, V35, P213, DOI 10.1007/s002489900077; Wu JF, 2009, APPL ENVIRON MICROB, V75, P5390, DOI 10.1128/AEM.00400-09; Xi CW, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2209962; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389	39	29	30	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13355	10.1371/journal.pone.0013355	http://dx.doi.org/10.1371/journal.pone.0013355			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976227	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000008
J	Andrews, G; Cuijpers, P; Craske, MG; McEvoy, P; Titov, N				Andrews, Gavin; Cuijpers, Pim; Craske, Michelle G.; McEvoy, Peter; Titov, Nickolai			Computer Therapy for the Anxiety and Depressive Disorders Is Effective, Acceptable and Practical Health Care: A Meta-Analysis	PLOS ONE			English	Article							COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; INTERNET-BASED TREATMENT; SOCIAL PHOBIA; SELF-HELP; PANIC DISORDER; PSYCHOTHERAPY; SEVERITY; EFFICACY; SIZE	Background: Depression and anxiety disorders are common and treatable with cognitive behavior therapy (CBT), but access to this therapy is limited. Objective: Review evidence that computerized CBT for the anxiety and depressive disorders is acceptable to patients and effective in the short and longer term. Method: Systematic reviews and data bases were searched for randomized controlled trials of computerized cognitive behavior therapy versus a treatment or control condition in people who met diagnostic criteria for major depression, panic disorder, social phobia or generalized anxiety disorder. Number randomized, superiority of treatment versus control (Hedges g) on primary outcome measure, risk of bias, length of follow up, patient adherence and satisfaction were extracted. Principal Findings: 22 studies of comparisons with a control group were identified. The mean effect size superiority was 0.88 (NNT 2.13), and the benefit was evident across all four disorders. Improvement from computerized CBT was maintained for a median of 26 weeks follow-up. Acceptability, as indicated by adherence and satisfaction, was good. Research probity was good and bias risk low. Effect sizes were non-significantly higher in comparisons with waitlist than with active treatment control conditions. Five studies comparing computerized CBT with traditional face-to-face CBT were identified, and both modes of treatment appeared equally beneficial. Conclusions: Computerized CBT for anxiety and depressive disorders, especially via the internet, has the capacity to provide effective acceptable and practical health care for those who might otherwise remain untreated.	[Andrews, Gavin; Titov, Nickolai] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia; [Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Craske, Michelle G.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [McEvoy, Peter] Ctr Clin Intervent, Perth, WA, Australia	University of New South Wales Sydney; Vrije Universiteit Amsterdam; University of California System; University of California Los Angeles	Andrews, G (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	gavina@unsw.edu.au	Cuijpers, Pim/G-1703-2013; Andrews, Gavin/J-6537-2012	Andrews, Gavin/0000-0002-4315-2173; Cuijpers, Pim/0000-0001-5497-2743; McEvoy, Peter/0000-0003-2924-6760; Titov, Nickolai/0000-0002-7268-729X	Australian National Health and Medical Research Council [630560]	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	GA, NT, PM, MC hold a grant for research on Internet Treatment from the Australian National Health and Medical Research Council registration #630560. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2005, BRIT J PSYCHIAT, V187, P456, DOI 10.1192/bjp.187.5.456; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson Gerhard, 2009, Cognitive Behaviour Therapy, V38, P196, DOI 10.1080/16506070903318960; Andrews G, 2004, BRIT J PSYCHIAT, V184, P526, DOI 10.1192/bjp.184.6.526; Berger T, 2009, J CLIN PSYCHOL, V65, P1021, DOI 10.1002/jclp.20603; BORENSTEIN M, 2007, COMPREHENSIVE META A; Botella C, 2009, BRIT J GUID COUNS, V37, P297, DOI 10.1080/03069880902957023; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; Carlbring P, 2005, BEHAV RES THER, V43, P1321, DOI 10.1016/j.brat.2004.10.002; Carlbring P, 2001, BEHAV THER, V32, P751, DOI 10.1016/S0005-7894(01)80019-8; Carlbring P, 2007, BRIT J PSYCHIAT, V190, P123, DOI 10.1192/bjp.bp.105.020107; Carlbring P, 2006, AM J PSYCHIAT, V163, P2119, DOI 10.1176/appi.ajp.163.12.2119; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Cuijpers Pim, 2009, Cognitive Behaviour Therapy, V38, P66, DOI 10.1080/16506070802694776; Duval S, 2009, J AM STAT ASSOC, V1, P1338; Fournier JC, 2010, JAMA-J AM MED ASSOC, V303, P47, DOI 10.1001/jama.2009.1943; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Goldberg DP, 2009, PSYCHOL MED, V39, P2043, DOI 10.1017/S0033291709990298; Haby MM, 2006, AUST NZ J PSYCHIAT, V40, P9, DOI 10.1080/j.1440-1614.2006.01736.x; Hedges LV, 1996, J EDUC BEHAV STAT, V21, P299, DOI 10.2307/1165338; Higgins J., 2009, COCHRANE HDB SYSTEMA; Issakidis C, 2004, ACTA PSYCHIAT SCAND, V109, P426, DOI 10.1111/j.1600-0047.2004.00264.x; Kay-Lambkin FJ, 2009, ADDICTION, V104, P378, DOI 10.1111/j.1360-0443.2008.02444.x; Kessler D, 2009, LANCET, V374, P628, DOI 10.1016/S0140-6736(09)61257-5; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kiropoulos LA, 2008, J ANXIETY DISORD, V22, P1273, DOI 10.1016/j.janxdis.2008.01.008; Klein B, 2006, J BEHAV THER EXP PSY, V37, P213, DOI 10.1016/j.jbtep.2005.07.001; Klein B, 2001, BEHAV COGN PSYCHOTH, V29, P113, DOI 10.1017/S1352465801001138; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Licinio J, 2010, MOL PSYCHIATR, V15, P445, DOI 10.1038/mp.2010.58; Marks IM, 2004, PSYCHOL MED, V34, P9, DOI 10.1017/S003329170300878X; *NAT I CLIN EXC, COMP COGN BEH THER D, V97; Perini S, 2009, AUST NZ J PSYCHIAT, V43, P571, DOI 10.1080/00048670902873722; Proudfoot J, 2004, BRIT J PSYCHIAT, V185, P46, DOI 10.1192/bjp.185.1.46; Richards J. C., 2006, CLIN PSYCHOL, V10, P2, DOI DOI 10.1080/13284200500378795; Robinson E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010942; ROYBYRNE PP, 2007, GUIDE TREATMENTS WOR, P395; SELMI PM, 1990, AM J PSYCHIAT, V147, P51; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P595, DOI 10.1080/00048670802119820; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P585, DOI 10.1080/00048670802119762; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010939; Titov N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010885; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P920, DOI 10.1080/00048670903179228; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P905, DOI 10.1080/00048670903179269; Titov N, 2009, AUST NZ J PSYCHIAT, V43, P754, DOI 10.1080/00048670903001992; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Weisberg RB, 2007, AM J PSYCHIAT, V164, P276, DOI 10.1176/appi.ajp.164.2.276; Weissman MM, 2006, ARCH GEN PSYCHIAT, V63, P925, DOI 10.1001/archpsyc.63.8.925; WIMS E, 2010, AUST NZ J P IN PRESS; Wright JH, 2005, AM J PSYCHIAT, V162, P1158, DOI 10.1176/appi.ajp.162.6.1158	50	688	702	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13196	10.1371/journal.pone.0013196	http://dx.doi.org/10.1371/journal.pone.0013196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	663FZ	20967242	gold, Green Published			2022-12-27	WOS:000282869800004
J	Mailloux, RJ; Adjeitey, CNK; Harper, ME				Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Harper, Mary-Ellen			Genipin-Induced Inhibition of Uncoupling Protein-2 Sensitizes Drug-Resistant Cancer Cells to Cytotoxic Agents	PLOS ONE			English	Article							PROTON LEAK; MITOCHONDRIAL; EXPRESSION; APOPTOSIS; DYSFUNCTION; HEPATOCYTES; GENIPOSIDE; METABOLISM; OXIDATION; MENADIONE	Uncoupling protein-2 (UCP2) is known to suppress mitochondrial reactive oxygen species (ROS) production and is employed by drug-resistant cancer cells to mitigate oxidative stress. Using the drug-sensitive HL-60 cells and the drug-resistant MX2 subline as model systems, we show that genipin, a UCP2 inhibitor, sensitizes drug-resistant cells to cytotoxic agents. Increased MX2 cell death was observed upon co-treatment with genipin and different doses of menadione, doxorubicin, and epirubicin. DCFH-DA fluorimetry revealed that the increase in MX2 cell death was accompanied by enhanced cellular ROS levels. The drug-induced increase in ROS was linked to genipin-mediated inhibition of mitochondrial proton leak. State 4 and resting cellular respiratory rates were higher in the MX2 cells in comparison to the HL-60 cells, and the increased respiration was readily suppressed by genipin in the MX2 cells. UCP2 accounted for a remarkable 37% of the resting cellular oxygen consumption indicating that the MX2 cells are functionally reliant on this protein. Higher amounts of UCP2 protein were detected in the MX2 versus the HL-60 mitochondria. The observed effects of genipin were absent in the HL-60 cells pointing to the selectivity of this natural product for drug-resistant cells. The specificity of genipin for UCP2 was confirmed using CHO cells stably expressing UCP2 in which genipin induced an similar to 22% decrease in state 4 respiration. These effects were absent in empty vector CHO cells expressing no UCP2. Thus, the chemical inhibition of UCP2 with genipin sensitizes multidrug-resistant cancer cells to cytotoxic agents.	[Mailloux, Ryan J.; Adjeitey, Cyril Nii-Klu; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	University of Ottawa	Mailloux, RJ (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	mharper@uottawa.ca	Harper, Mary-Ellen/C-3103-2009	Harper, Mary-Ellen/0000-0003-3864-5886; Mailloux, Ryan/0000-0003-3986-9830	Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes; Heart and Stroke Foundation of Canada; Molecular Function and Imaging group of the University of Ottawa Heart Institute	Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Molecular Function and Imaging group of the University of Ottawa Heart Institute	Funding was provided by the Canadian Institutes of Health Research: Institute of Nutrition, Metabolism and Diabetes for Mary-Ellen Harper, and Dr. Ryan Mailloux is the recipient of a Postdoctoral Fellowship from a Heart and Stroke Foundation of Canada Program Grant, awarded by the Molecular Function and Imaging group of the University of Ottawa Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; AZZU V, BIOCH BIOPHYS ACTA, V74, P5463; Baffy G, 2010, MITOCHONDRION, V10, P243, DOI 10.1016/j.mito.2009.12.143; BARNETT YA, 1995, MUTAT RES-DNAGING G, V338, P115, DOI 10.1016/0921-8734(95)00017-Z; Barrientos A, 1999, J BIOL CHEM, V274, P16188, DOI 10.1074/jbc.274.23.16188; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Carretero MV, 1998, FEBS LETT, V439, P55, DOI 10.1016/S0014-5793(98)01335-0; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chang YC, 2002, CHEM-BIOL INTERACT, V141, P243, DOI 10.1016/S0009-2797(02)00073-X; Collins P, 2002, BRIT J CANCER, V86, P372, DOI 10.1038/sj.bjc.6600074; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; Dang CV, 2010, CANCER RES, V70, P859, DOI 10.1158/0008-5472.CAN-09-3556; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Diao J, 2008, P NATL ACAD SCI USA, V105, P12057, DOI 10.1073/pnas.0710434105; Echtay KS, 2003, EMBO J, V22, P4103, DOI 10.1093/emboj/cdg412; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; Gouaze V, 2001, MOL PHARMACOL, V60, P488; HARKER WG, 1989, CANCER RES, V49, P4542; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Hurtaud C, 2007, CELL MOL LIFE SCI, V64, P1853, DOI 10.1007/s00018-007-7039-5; Kim BC, 2005, BIOCHEM PHARMACOL, V70, P1398, DOI 10.1016/j.bcp.2005.07.025; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Koo HJ, 2006, J ETHNOPHARMACOL, V103, P496, DOI 10.1016/j.jep.2005.08.011; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Mailloux RJ, 2010, FASEB J, V24, P2495, DOI 10.1096/fj.09-151803; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; McLeod CJ, 2005, J BIOL CHEM, V280, P33470, DOI 10.1074/jbc.M505258200; Muller I, 1998, INT J MOL MED, V1, P491; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; Park YK, 2008, NUTR RES, V28, P83, DOI 10.1016/j.nutres.2007.11.008; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Pecqueur C, 2009, IUBMB LIFE, V61, P762, DOI 10.1002/iub.188; Pilkington GJ, 2008, SEMIN CANCER BIOL, V18, P226, DOI 10.1016/j.semcancer.2007.12.006; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Santandreu FM, 2009, CELL PHYSIOL BIOCHEM, V24, P379, DOI 10.1159/000257430; Savagner F, 2001, J CLIN ENDOCR METAB, V86, P4920, DOI 10.1210/jc.86.10.4920; Seifert EL, 2008, J BIOL CHEM, V283, P25124, DOI 10.1074/jbc.M803871200; SHANNON JE, 1978, CRYOBIOLOGY, V15, P239, DOI 10.1016/0011-2240(78)90032-9; Sipos I, 2003, NEUROCHEM RES, V28, P1575, DOI 10.1023/A:1025634728227; SUZUKI YJ, 1992, FREE RADICAL RES COM, V16, P131, DOI 10.3109/10715769209049166; Swift LP, 2006, CANCER RES, V66, P4863, DOI 10.1158/0008-5472.CAN-05-3410; TETEF M, 1995, INVEST NEW DRUG, V13, P157, DOI 10.1007/BF00872865; THOR H, 1982, J BIOL CHEM, V257, P2419; Tortora G, 2007, DRUG RESIST UPDATE, V10, P81, DOI 10.1016/j.drup.2007.03.003; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhou H, 2009, ARCH BIOCHEM BIOPHYS, V486, P88, DOI 10.1016/j.abb.2009.02.017	53	74	77	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13289	10.1371/journal.pone.0013289	http://dx.doi.org/10.1371/journal.pone.0013289			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967268	gold, Green Submitted, Green Published			2022-12-27	WOS:000282869800012
J	Whitaker, HC; Kote-Jarai, Z; Ross-Adams, H; Warren, AY; Burge, J; George, A; Bancroft, E; Jhavar, S; Leongamornlert, D; Tymrakiewicz, M; Saunders, E; Page, E; Mitra, A; Mitchell, G; Lindeman, GJ; Evans, DG; Blanco, I; Mercer, C; Rubinstein, WS; Clowes, V; Douglas, F; Hodgson, S; Walker, L; Donaldson, A; Izatt, L; Dorkins, H; Male, A; Tucker, K; Stapleton, A; Lam, J; Kirk, J; Lilja, H; Easton, D; Cooper, C; Eeles, R; Neal, DE				Whitaker, Hayley C.; Kote-Jarai, Zsofia; Ross-Adams, Helen; Warren, Anne Y.; Burge, Johanna; George, Anne; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Mitchell, Gillian; Lindeman, Geoffrey J.; Evans, D. Gareth; Blanco, Ignacio; Mercer, Catherine; Rubinstein, Wendy S.; Clowes, Virginia; Douglas, Fiona; Hodgson, Shirley; Walker, Lisa; Donaldson, Alan; Izatt, Louise; Dorkins, Huw; Male, Alison; Tucker, Kathy; Stapleton, Alan; Lam, Jimmy; Kirk, Judy; Lilja, Hans; Easton, Douglas; Cooper, Colin; Eeles, Rosalind; Neal, David E.		IMPACT Study Steering Comm; IMPACT Study Collaborators; UK GPCS Collaborators	The rs10993994 Risk Allele for Prostate Cancer Results in Clinically Relevant Changes in Microseminoprotein-Beta Expression in Tissue and Urine	PLOS ONE			English	Article							94 AMINO-ACIDS; SECRETORY PROTEIN; PSP94 EXPRESSION; RADICAL PROSTATECTOMY; MESSENGER-RNA; MODEL; SUSCEPTIBILITY; ANGIOGENESIS; ASSOCIATION; PROGRESSION	Background: Microseminoprotein-beta (MSMB) regulates apoptosis and using genome-wide association studies the rs10993994 single nucleotide polymorphism in the MSMB promoter has been linked to an increased risk of developing prostate cancer. The promoter location of the risk allele, and its ability to reduce promoter activity, suggested that the rs10993994 risk allele could result in lowered MSMB in benign tissue leading to increased prostate cancer risk. Methodology/Principal Findings: MSMB expression in benign and malignant prostate tissue was examined using immunohistochemistry and compared with the rs10993994 genotype. Urinary MSMB concentrations were determined by ELISA and correlated with urinary PSA, the presence or absence of cancer, rs10993994 genotype and age of onset. MSMB levels in prostate tissue and urine were greatly reduced with tumourigenesis. Urinary MSMB was better than urinary PSA at differentiating men with prostate cancer at all Gleason grades. The high risk allele was associated with heterogeneity of MSMB staining and loss of MSMB in both tissue and urine in benign prostate. Conclusions: These data show that some high risk alleles discovered using genome-wide association studies produce phenotypic effects with potential clinical utility. We provide the first link between a low penetrance polymorphism for prostate cancer and a potential test in human tissue and bodily fluids. There is potential to develop tissue and urinary MSMB for a biomarker of prostate cancer risk, diagnosis and disease monitoring.	[Whitaker, Hayley C.; Ross-Adams, Helen; Burge, Johanna; George, Anne; Neal, David E.] CRUK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England; [Kote-Jarai, Zsofia; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Cooper, Colin; Eeles, Rosalind] Inst Canc Res, Sutton, Surrey, England; [Kote-Jarai, Zsofia; Bancroft, Elizabeth; Jhavar, Sameer; Leongamornlert, Daniel; Tymrakiewicz, Malgorzata; Saunders, Edward; Page, Elizabeth; Mitra, Anita; Cooper, Colin; Eeles, Rosalind] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England; [Warren, Anne Y.] Addenbrookes Hosp, Dept Pathol, Cambridge, England; [Mitchell, Gillian] Peter MacCallum Canc Inst, Melbourne, Vic, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Evans, D. Gareth] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Blanco, Ignacio] Catalonian Inst Oncol, Barcelona, Spain; [Mercer, Catherine] Princess Anne Hosp, Wessex Clin Genet Serv, Southampton, Hants, England; [Rubinstein, Wendy S.] NorthShore Univ Hlth Syst, Evanston, IL USA; [Clowes, Virginia] Addenbrookes Hosp, Dept Clin Genet, Cambridge, England; [Douglas, Fiona] Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England; [Hodgson, Shirley] St Georges Univ London, London, England; [Walker, Lisa] Churchill Hosp, Oxford Reg Genet Ctr, Oxford OX3 7LJ, England; [Donaldson, Alan] St Michaels Hosp, Bristol, Avon, England; [Izatt, Louise] Guys Hosp, London SE1 9RT, England; [Dorkins, Huw] Northwick Pk Hosp & Clin Res Ctr, Kennedy Galton Ctr, Harrow HA1 3UJ, Middx, England; [Male, Alison] Inst Child Hlth, London, England; [Tucker, Kathy] Prince Wales Hosp, Sydney, NSW, Australia; [Lam, Jimmy] Repatriat Gen Hosp, Adelaide, SA, Australia; [Kirk, Judy] Westmead Hosp, Familial Canc Serv, Westmead, NSW 2145, Australia; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Clin Labs, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Lilja, Hans] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Easton, Douglas] Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Cambridge, England	CRUK Cambridge Institute; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Manchester; Catalan Institute of Oncology; NorthShore University Health System; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; St Georges University London; University of Oxford; Guy's & St Thomas' NHS Foundation Trust; Imperial College London; University of London; University College London; Flinders University South Australia; University of Sydney; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cancer Research UK; University of Cambridge	Whitaker, HC (corresponding author), CRUK Cambridge Res Inst, Urooncol Res Grp, Cambridge, England.	Hayley.Whitaker@cancer.org.uk	Lilja, Hans/S-9703-2019; Blanco, Ignacio/AAN-5426-2021; Tobias, Edward/D-4246-2009; Blanco, Ignacio/D-2565-2013; Evans, D Gareth/AAB-4308-2022	Lilja, Hans/0000-0001-5871-7846; Blanco, Ignacio/0000-0002-7414-7481; Tobias, Edward/0000-0003-2649-7695; Blanco, Ignacio/0000-0002-7414-7481; Evans, D Gareth/0000-0002-8482-5784; Thorne, Heather/0000-0003-3610-2511; Eeles, Rosalind/0000-0002-3698-6241; Saunders, Ed/0000-0003-4343-3570; Bancroft, Elizabeth/0000-0002-5482-5660; Lindeman, Geoffrey/0000-0001-9386-2416; Leongamornlert, Daniel/0000-0002-3486-3168; Ross-Adams, Helen/0000-0003-1338-742X; Neal, David/0000-0002-6033-5086	University of Cambridge, Cancer Research UK [C522/A8072, C5047/A8385]; Institute of Cancer Research; Everyman Campaign; EU; Prostate Cancer Research Foundation; Cambridge Bio-medical Research Centre, Cambridge, UK; Bio-medical Research Centre at The Institute of Cancer Research; Royal Marsden NHS Foundation Trust; Biomedical Research Centre at Central Manchester Foundation Trust; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) [G0500966/75466]; Cancer Councils of Victoria and South Australia; Prostate Cancer Foundation of Australia; NorthShore University Health System; Ronald and Rita McAulay Foundation; National Cancer Institute; Swedish Cancer Society [3455]; Swedish Research Council (Medicine) [20095]; NATIONAL CANCER INSTITUTE [R33CA127768] Funding Source: NIH RePORTER; Cancer Research UK [10118] Funding Source: researchfish; Medical Research Council [G0900871] Funding Source: researchfish; MRC [G0900871] Funding Source: UKRI	University of Cambridge, Cancer Research UK(Cancer Research UKUniversity of Cambridge); Institute of Cancer Research; Everyman Campaign; EU(European Commission); Prostate Cancer Research Foundation; Cambridge Bio-medical Research Centre, Cambridge, UK; Bio-medical Research Centre at The Institute of Cancer Research; Royal Marsden NHS Foundation Trust(Royal Society of New ZealandMarsden Fund (NZ)); Biomedical Research Centre at Central Manchester Foundation Trust; National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT); Cancer Councils of Victoria and South Australia(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Prostate Cancer Foundation of Australia; NorthShore University Health System; Ronald and Rita McAulay Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council (Medicine)(Swedish Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to acknowledge the support of The University of Cambridge, Cancer Research UK (grant codes C522/A8072 and C5047/A8385), The Institute of Cancer Research, The Everyman Campaign, The EU FP7 Promark work package and Hutchison Whampoa Limited and The Prostate Cancer Research Foundation. The authors would like to acknowledge the support of the National Institute for Health Research which funds the Cambridge Bio-medical Research Centre, Cambridge, UK, the Bio-medical Research Centre at The Institute of Cancer Research and Royal Marsden NHS Foundation Trust and the Biomedical Research Centre at Central Manchester Foundation Trust. The authors would also like to acknowledge the support of the National Cancer Research Prostate Cancer: Mechanisms of Progression and Treatment (PROMPT) collaborative (grant code G0500966/75466) which has funded tissue and urine collections in Cambridge. The authors would also like to acknowledge the support of the Cancer Councils of Victoria and South Australia, the Prostate Cancer Foundation of Australia, the Victorian Cancer Agency, Jack and Judy Baker for their support at NorthShore University Health System and The Ronald and Rita McAulay Foundation which supports the IMPACT study collection. Douglas Easton is a Principal Research Fellow of Cancer Research UK. Hans Lilja is funded by the National Cancer Institute [grant numbers R33-CA127768-02]; Swedish Cancer Society [3455]; and Swedish Research Council (Medicine) [20095]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baijal-Gupta M, 2000, J ENDOCRINOL, V165, P425, DOI 10.1677/joe.0.1650425; Bjartell AS, 2007, CLIN CANCER RES, V13, P4130, DOI 10.1158/1078-0432.CCR-06-3031; Bolduc S, 2007, CUAJ-CAN UROL ASSOC, V1, P377; Chan PSF, 1999, PROSTATE, V41, P99; CHANG BL, 2009, HUM MOL GENET; DOCTOR VM, 1986, BRIT J CANCER, V53, P547, DOI 10.1038/bjc.1986.85; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; FORD D, 1994, LANCET, V343, P692, DOI 10.1016/S0140-6736(94)91578-4; Foster C, 2007, BRIT J CANCER, V96, P718, DOI 10.1038/sj.bjc.6603610; Gabril M, 2004, UROLOGY, V64, P1233, DOI 10.1016/j.urology.2004.07.034; Gabril MY, 2002, GENE THER, V9, P1589, DOI 10.1038/sj.gt.3301895; Imasato Y, 2000, J UROLOGY, V164, P1819, DOI 10.1016/S0022-5347(05)67113-3; KADER AK, 2009, PROSTATE; Kwong J, 2000, PROSTATE, V42, P219, DOI 10.1002/(SICI)1097-0045(20000215)42:3<219::AID-PROS8>3.0.CO;2-J; Lamy S, 2006, INT J CANCER, V118, P2350, DOI 10.1002/ijc.21615; LILJA H, 1988, PROSTATE, V12, P29, DOI 10.1002/pros.2990120105; Lou H, 2009, P NATL ACAD SCI USA, V106, P7933, DOI 10.1073/pnas.0902104106; Mitra AV, 2007, BJU INT, V99, P1350, DOI 10.1111/j.1464-410X.2007.06759.x; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Sakai H, 1999, PROSTATE, V38, P278; Shukeir N, 2003, CANCER RES, V63, P2072; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Thota A, 2003, J CELL BIOCHEM, V88, P999, DOI 10.1002/jcb.10425; Tsurusaki T, 1998, PROSTATE, V35, P109; Vanaja DK, 2003, CANCER RES, V63, P3877; VONDERKAMMER H, 1990, CLIN CHIM ACTA, V187, P207, DOI 10.1016/0009-8981(90)90106-3; WEIBER H, 1990, AM J PATHOL, V137, P593; WHITAKER HC, 2009, PROSTATE; Xuan JW, 1997, J CELL BIOCHEM, V65, P172, DOI 10.1002/(SICI)1097-4644(199705)65:2<172::AID-JCB4>3.3.CO;2-S; Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042	32	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13363	10.1371/journal.pone.0013363	http://dx.doi.org/10.1371/journal.pone.0013363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967219	Green Accepted, gold, Green Published			2022-12-27	WOS:000282869800041
J	Rolfo, A; Many, A; Racano, A; Tal, R; Tagliaferro, A; Ietta, F; Wang, JX; Post, M; Caniggia, I				Rolfo, Alessandro; Many, Ariel; Racano, Antonella; Tal, Reshef; Tagliaferro, Andrea; Ietta, Francesca; Wang, Jinxia; Post, Martin; Caniggia, Isabella			Abnormalities in Oxygen Sensing Define Early and Late Onset Preeclampsia as Distinct Pathologies	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; ENDOTHELIAL GROWTH-FACTOR; MITOCHONDRIAL COMPLEX-III; TUMOR-SUPPRESSOR PROTEIN; HUMAN PLACENTAL HYPOXIA; PROLYL-HYDROXYLASES; FACTOR-I; HIF PROLYL; TROPHOBLAST DIFFERENTIATION; TRANSCRIPTION FACTORS	Background: The pathogenesis of preeclampsia, a serious pregnancy disorder, is still elusive and its treatment empirical. Hypoxia Inducible Factor-1 (HIF-1) is crucial for placental development and early detection of aberrant regulatory mechanisms of HIF-1 could impact on the diagnosis and management of preeclampsia. HIF-1 alpha stability is controlled by O-2-sensing enzymes including prolyl hydroxylases (PHDs), Factor Inhibiting HIF (FIH), and E3 ligases Seven In Absentia Homologues (SIAHs). Here we investigated early- (E-PE) and late-onset (L-PE) human preeclamptic placentae and their ability to sense changes in oxygen tension occurring during normal placental development. Methods and Findings: Expression of PHD2, FIH and SIAHs were significantly down-regulated in E-PE compared to control and L-PE placentae, while HIF-1 alpha levels were increased. PHD3 expression was increased due to decreased FIH levels as demonstrated by siRNA FIH knockdown experiments in trophoblastic JEG-3 cells. E-PE tissues had markedly diminished HIF-1 alpha hydroxylation at proline residues 402 and 564 as assessed with monoclonal antibodies raised against hydroxylated HIF-1 alpha P402 or P564, suggesting regulation by PHD2 and not PHD3. Culturing villous explants under varying oxygen tensions revealed that E-PE, but not L-PE, placentae were unable to regulate HIF-1 alpha levels because PHD2, FIH and SIAHs did not sense a hypoxic environment. Conclusion: Disruption of oxygen sensing in E-PE vs. L-PE and control placentae is the first molecular evidence of the existence of two distinct preeclamptic diseases and the unique molecular O-2-sensing signature of E-PE placentae may be of diagnostic value when assessing high risk pregnancies and their severity.	[Rolfo, Alessandro; Many, Ariel; Racano, Antonella; Tal, Reshef; Tagliaferro, Andrea; Ietta, Francesca; Caniggia, Isabella] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Caniggia, Isabella] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada; [Racano, Antonella; Post, Martin; Caniggia, Isabella] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Post, Martin; Caniggia, Isabella] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Wang, Jinxia; Post, Martin] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Rolfo, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	caniggia@lunenfeld.ca	Rolfo, Alessandro/L-1089-2019; Caniggia, Isabella/G-6466-2013; Ietta, Francesca/I-5307-2013	Rolfo, Alessandro/0000-0001-6730-8067; Caniggia, Isabella/0000-0001-7340-2359; Tal, Reshef/0000-0002-2500-9904; Ietta, Francesca/0000-0002-2160-8790	Canadian Institutes of Health Research (CIHR) [MOP-14096]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR) Grant (MOP-14096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG, 2002, OBSTET GYNECOL, V99, P869; Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Ahmad S, 2004, CIRC RES, V95, P884, DOI 10.1161/01.RES.0000147365.86159.f5; Ahmed A, 1997, LANCET, V350, P826, DOI 10.1016/S0140-6736(05)62027-2; AHMED A, 1995, GROWTH FACTORS, V12, P235, DOI 10.3109/08977199509036883; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Aprelikova O, 2004, J CELL BIOCHEM, V92, P491, DOI 10.1002/jcb.20067; Barber A, 2001, FASEB J, V15, P1158, DOI 10.1096/fj.00-0376com; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2002, SCIENCE, V295, P807, DOI 10.1126/science.1069825; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Callapina M, 2005, FREE RADICAL BIO MED, V39, P925, DOI 10.1016/j.freeradbiomed.2005.05.009; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Caniggia I, 2000, J CLIN INVEST, V105, P577, DOI 10.1172/JCI8316; Caniggia I, 2002, PLACENTA, V23, pS47, DOI 10.1053/plac.2002.0815; Caniggia I, 2000, PLACENTA, V21, pS25, DOI 10.1053/plac.1999.0522; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chen YR, 2006, ACTA BIOCH BIOPH SIN, V38, P423, DOI 10.1111/j.1745-7270.2006.00174.x; CHESLEY LC, 1985, OBSTET GYNECOL, V65, P423; Chung JY, 2004, J CLIN ENDOCR METAB, V89, P2484, DOI 10.1210/jc.2003-031580; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Cui XL, 2006, PLACENTA, V27, P422, DOI 10.1016/j.placenta.2005.04.004; D'Angelo G, 2003, J BIOL CHEM, V278, P38183, DOI 10.1074/jbc.M302244200; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erez N, 2003, CANCER RES, V63, P8777; Genbacev O, 1996, J CLIN INVEST, V97, P540, DOI 10.1172/JCI118447; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Hung TH, 2001, AM J PATHOL, V159, P1031, DOI 10.1016/S0002-9440(10)61778-6; Huppertz B, 2006, AM J OBSTET GYNECOL, V195, P29, DOI 10.1016/j.ajog.2005.07.039; Ietta F, 2006, BIOL REPROD, V75, P112, DOI 10.1095/biolreprod.106.051557; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai A, 2004, ONCOGENE, V23, P7593, DOI 10.1038/sj.onc.1208016; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; Koga K, 2003, J CLIN ENDOCR METAB, V88, P2348, DOI 10.1210/jc.2002-021942; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Kozak KR, 1997, DEV BIOL, V191, P297, DOI 10.1006/dbio.1997.8758; Krebs C, 1996, AM J OBSTET GYNECOL, V175, P1534, DOI 10.1016/S0002-9378(96)70103-5; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li H, 2005, PLACENTA, V26, P210, DOI 10.1016/j.placenta.2004.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Lazaro M, 2006, FASEB J, V20, P828, DOI 10.1096/fj.05-5168hyp; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Masson N, 2003, J CELL SCI, V116, P3041, DOI 10.1242/jcs.00655; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Nakayama K, 2004, CELL CYCLE, V3, P1345, DOI 10.4161/cc.3.11.1207; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Nakayama K, 2007, BIOCHEM J, V401, P217, DOI 10.1042/BJ20061135; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Pijnenborg R, 1998, PLACENTA, V19, P569; Rajakumar A, 2000, BIOL REPROD, V63, P559, DOI 10.1095/biolreprod63.2.559; Rajakumar A, 2004, PLACENTA, V25, P763, DOI 10.1016/j.placenta.2004.02.011; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Soleymanlou N, 2005, J CLIN ENDOCR METAB, V90, P4299, DOI 10.1210/jc.2005-0078; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Tian YM, 2006, BIOCHEM J, V397, P179, DOI 10.1042/BJ20051996; Zamudio S, 2007, AM J PATHOL, V170, P2171, DOI 10.2353/ajpath.2007.061185; Zhou Jie, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P189, DOI 10.2174/187152506777698344; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	74	80	81	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13288	10.1371/journal.pone.0013288	http://dx.doi.org/10.1371/journal.pone.0013288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967267	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300017
J	Balu, B; Singh, N; Maher, SP; Adams, JH				Balu, Bharath; Singh, Naresh; Maher, Steven P.; Adams, John H.			A Genetic Screen for Attenuated Growth Identifies Genes Crucial for Intraerythrocytic Development of Plasmodium falciparum	PLOS ONE			English	Article							REVEALS; LIFE; EXPRESSION; PROTEINS; DESIGN; YEAST; ART	A majority of the Plasmodium falciparum genome codes for genes with unknown functions, which presents a major challenge to understanding the parasite's biology. Large-scale functional analysis of the parasite genome is essential to pave the way for novel therapeutic intervention strategies against the disease and yet difficulties in genetic manipulation of this deadly human malaria parasite have been a major hindrance for functional analysis of its genome. Here, we used a forward functional genomic approach to study P. falciparum and identify genes important for optimal parasite development in the disease-causing, intraerythrocytic stages. We analyzed 123 piggyBac insertion mutants of P. falciparum for proliferation efficiency in the intraerythrocytic stages, in vitro. Almost 50% of the analyzed mutants showed significant reduction in proliferation efficiency, with 20% displaying severe defects. Functional categorization of genes in the severely attenuated mutants revealed significant enrichment for RNA binding proteins, suggesting the significance of post-transcriptional gene regulation in parasite development and emphasizing its importance as an antimalarial target. This study demonstrates the feasibility of much needed forward genetics approaches for P. falciparum to better characterize its genome and accelerate drug and vaccine development.	[Balu, Bharath; Singh, Naresh; Maher, Steven P.; Adams, John H.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	Balu, B (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Tampa, FL 33620 USA.	jadams3@health.usf.edu	Adams, John H./ABB-8458-2020; Adams, John/G-1800-2015	Adams, John H./0000-0003-3707-7979; Adams, John/0000-0003-3707-7979; Maher, Steven/0000-0002-9560-5656	National Institutes of Health [R21 AI070888, R01 AI33656]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI070888, R01AI033656] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Financial support was provided by National Institutes of Health grants R21 AI070888 and R01 AI33656. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Balu B, 2007, INT J PARASITOL, V37, P1, DOI 10.1016/j.ijpara.2006.10.001; Balu B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-83; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Chu Angela M., 2008, V416, P205, DOI 10.1007/978-1-59745-321-9_14; Collart MA, 2003, GENE, V313, P1, DOI 10.1016/S0378-1119(03)00672-3; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gavigan CS, 2003, INT J PARASITOL, V33, P987, DOI 10.1016/S0020-7519(03)00125-5; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Hayes F, 2003, ANNU REV GENET, V37, P3, DOI 10.1146/annurev.genet.37.110801.142807; HOFMANN K, 1995, TRENDS BIOCHEM SCI, V20, P347, DOI 10.1016/S0968-0004(00)89072-6; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Otto TD, 2010, MOL MICROBIOL, V76, P12, DOI 10.1111/j.1365-2958.2009.07026.x; Persson KEM, 2006, J CLIN MICROBIOL, V44, P1665, DOI 10.1128/JCM.44.5.1665-1673.2006; Shock JL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r134; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; St Johnston D, 2002, NAT REV GENET, V3, P176, DOI 10.1038/nrg751; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Wuchty S, 2009, PROTEOMICS, V9, P1841, DOI 10.1002/pmic.200800383	26	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13282	10.1371/journal.pone.0013282	http://dx.doi.org/10.1371/journal.pone.0013282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949012	gold, Green Published, Green Submitted			2022-12-27	WOS:000282748100018
J	Jarrett, BR; Correa, C; Ma, KL; Louie, AY				Jarrett, Benjamin R.; Correa, Carlos; Ma, Kwan Liu; Louie, Angelique Y.			In Vivo Mapping of Vascular Inflammation Using Multimodal Imaging	PLOS ONE			English	Article							ATHEROSCLEROTIC PLAQUE RUPTURE; VULNERABLE PLAQUE; ANIMAL-MODELS; ARTERY PLAQUE; MICROPET-II; HIGH-RISK; THROMBOSIS; PERFORMANCE; MACROPHAGE; DISEASE	Background: Plaque vulnerability to rupture has emerged as a critical correlate to risk of adverse coronary events but there is as yet no clinical method to assess plaque stability in vivo. In the search to identify biomarkers of vulnerable plaques an association has been found between macrophages and plaque stability-the density and pattern of macrophage localization in lesions is indicative of probability to rupture. In very unstable plaques, macrophages are found in high densities and concentrated in the plaque shoulders. Therefore, the ability to map macrophages in plaques could allow noninvasive assessment of plaque stability. We use a multimodality imaging approach to noninvasively map the distribution of macrophages in vivo. The use of multiple modalities allows us to combine the complementary strengths of each modality to better visualize features of interest. Our combined use of Positron Emission Tomography and Magnetic Resonance Imaging (PET/MRI) allows high sensitivity PET screening to identify putative lesions in a whole body view, and high resolution MRI for detailed mapping of biomarker expression in the lesions. Methodology/Principal Findings: Macromolecular and nanoparticle contrast agents targeted to macrophages were developed and tested in three different mouse and rat models of atherosclerosis in which inflamed vascular plaques form spontaneously and/or are induced by injury. For multimodal detection, the probes were designed to contain gadolinium (T1 MRI) or iron oxide (T2 MRI), and Cu-64 (PET). PET imaging was utilized to identify regions of macrophage accumulation; these regions were further probed by MRI to visualize macrophage distribution at high resolution. In both PET and MR images the probes enhanced contrast at sites of vascular inflammation, but not in normal vessel walls. MRI was able to identify discrete sites of inflammation that were blurred together at the low resolution of PET. Macrophage content in the lesions was confirmed by histology. Conclusions/Significance: The multimodal imaging approach allowed high-sensitivity and high-resolution mapping of biomarker distribution and may lead to a clinical method to predict plaque probability to rupture.	[Jarrett, Benjamin R.; Louie, Angelique Y.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA; [Correa, Carlos; Ma, Kwan Liu] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Jarrett, BR (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.	aylouie@ucdavis.edu			National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering [R01EB000993]; Department of Energy [DESC0002289]; NCI [U24 CA 110804]; NATIONAL CANCER INSTITUTE [U24CA110804, P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Department of Energy(United States Department of Energy (DOE)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by the National Institutes of Health/National Institute of Biomedical Imaging and Bioengineering R01EB000993 (AYL and BRJ), and the Department of Energy DESC0002289 (AYL, CC, KM). Imaging work performed at the CMGI is supported in part by a NCI Small Animal Imaging Resource grant (U24 CA 110804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhatia V, 2003, SOUTH MED J, V96, P1142, DOI 10.1097/01.SMJ.0000089063.76530.04; Burke AP, 1997, NEW ENGL J MED, V336, P1276, DOI 10.1056/NEJM199705013361802; Calara F, 2001, J PATHOL, V195, P257, DOI 10.1002/path.915; Cherry SR, 2001, J CLIN PHARMACOL, V41, P482, DOI 10.1177/00912700122010357; Choudhury RP, 2002, ARTERIOSCL THROM VAS, V22, P1065, DOI 10.1161/01.ATV.0000019735.54479.2F; DAVIES MJ, 1993, BRIT HEART J, V69, P377; Fayad ZA, 2001, INT J CARDIAC IMAG, V17, P165, DOI 10.1023/A:1010611530845; Fayad ZA, 2001, CIRC RES, V89, P305, DOI 10.1161/hh1601.095596; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Fuster V, 2005, J AM COLL CARDIOL, V46, P1209, DOI 10.1016/j.jacc.2005.03.075; Gustafsson B, 2006, BIOCONJUGATE CHEM, V17, P538, DOI 10.1021/bc060018k; GUSTAFSSON B, 2006, BIOCONJUGATE C UNPUB; Hu WC, 2005, CARDIOVASC PATHOL, V14, P120, DOI 10.1016/j.carpath.2005.02.004; Jarrett BR, 2008, BIOCONJUGATE CHEM, V19, P1496, DOI 10.1021/bc800108v; Jarrett BR, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/3/035603; Johnson JL, 2001, ATHEROSCLEROSIS, V154, P399, DOI 10.1016/S0021-9150(00)00515-3; LeFont A, 2005, HEART, V89, P1262; Lowe HC, 2003, THROMB HAEMOSTASIS, V90, P774, DOI 10.1160/TH03-06-0374; Lutgens E, 2003, ARTERIOSCL THROM VAS, V23, P2123, DOI 10.1161/01.ATV.0000097783.01596.E2; MacNeill BD, 2003, ARTERIOSCL THROM VAS, V23, P1333, DOI 10.1161/01.ATV.0000080948.08888.BF; Mitra AK, 2004, CAN J PHYSIOL PHARM, V82, P860, DOI 10.1139/Y04-095; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nighoghossian N, 2005, STROKE, V36, P2764, DOI 10.1161/01.STR.0000190895.51934.43; PALMACCI S, 1993, SYNTHESIS POLYSACCHA, P1; Rekhter MD, 2002, CARDIOVASC RES, V54, P36, DOI 10.1016/S0008-6363(01)00537-5; Rosenfeld ME, 2000, ARTERIOSCL THROM VAS, V20, P2587, DOI 10.1161/01.ATV.20.12.2587; Shah PK, 2003, J AM COLL CARDIOL, V41, p15S, DOI 10.1016/S0735-1097(02)02834-6; Tai YC, 2003, PHYS MED BIOL, V48, P1519, DOI 10.1088/0031-9155/48/11/303; Tiong AY, 2005, AM HEART J, V150, P11, DOI 10.1016/j.ahj.2004.12.019; Tuzcu EM, 2003, J AM COLL CARDIOL, V42, P1033, DOI 10.1016/S0735-1097(03)00904-5; Volker W, 1997, ATHEROSCLEROSIS, V130, P29, DOI 10.1016/S0021-9150(96)06039-X; von Maltzahn G, 2008, BIOCONJUGATE CHEM, V19, P1570, DOI 10.1021/bc800077y; Williams H, 2002, ARTERIOSCL THROM VAS, V22, P788, DOI 10.1161/01.ATV.0000014587.66321.B4; Yang YF, 2004, PHYS MED BIOL, V49, P2527, DOI 10.1088/0031-9155/49/12/005; Zheng J, 2005, MAGNET RESON MED, V54, P1360, DOI 10.1002/mrm.20724; Zoldhelyi P, 2000, AM J PHYSIOL-HEART C, V279, pH3065, DOI 10.1152/ajpheart.2000.279.6.H3065	36	44	46	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13254	10.1371/journal.pone.0013254	http://dx.doi.org/10.1371/journal.pone.0013254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949008	Green Submitted, Green Published, gold			2022-12-27	WOS:000282748100007
J	Yuan, QA; Jantti, J				Yuan, Qiang; Jantti, Jussi			Functional Analysis of Phosphorylation on Saccharomyces cerevisiae Syntaxin 1 Homologues Sso1p and Sso2p	PLOS ONE			English	Article							PROSPORE MEMBRANE FORMATION; FILAMENTOUS GROWTH; PSEUDOHYPHAL DIFFERENTIATION; SECRETORY PATHWAY; SNARE COMPLEX; BUDDING YEAST; FUSION; PROTEINS; SPORULATION; EXOCYTOSIS	Background: The Saccharomyces cerevisiae syntaxin1 homologues Sso1p and Sso2p perform an essential function in membrane fusion in exocytosis. While deletion of either SSO1 or SSO2 causes no obvious phenotype in vegetatively grown cells, deletion of both genes is lethal. In sporulating diploid S. cerevisiae cells only Sso1p, but not Sso2p, is needed for membrane fusion during prospore membrane formation. Mass spectrometry and in vivo labeling data suggest that serines 23, 24, and 79 in Sso1p and serines 31 and 34 in Sso2p can be phosphorylated in vivo. Here we set out to assess the contribution of phosphorylation on Sso protein in vivo function. Principal Findings: Different mutant versions of SSO1 and SSO2 were generated to target the phosphorylation sites in Sso1p and Sso2p. Basal or overexpression of phospho-mimicking or putative non-phosphorylated Sso1p or Sso2p mutants resulted in no obvious growth phenotype. However, S79A and S79E mutations caused a mild defect in the ability of Sso1p to complement the temperature-sensitive growth phenotype of sso2-1 sso1 Delta cells. Combination of all mutations did not additionally compromise Sso1p in vivo function. When compared to the wild type SSO1 and SSO2, the phosphoamino acid mutants displayed similar genetic interactions with late acting sec mutants. Furthermore, diploid cells expressing only the mutant versions of Sso1p had no detectable sporulation defects. In addition to sporulation, also pseudohyphal and invasive growth modes are regulated by the availability of nutrients. In contrast to sporulating diploid cells, deletion of SSO1 or SSO2, or expression of the phospho-mutant versions of SSO1 or SSO2 as the sole copies of SSO genes caused no defects in haploid or diploid pseudohyphal and invasive growth. Conclusions: The identified phosphorylation sites do not significantly contribute to the in vivo functionality of Sso1p and Sso2p in S. cerevisiae.	[Yuan, Qiang; Jantti, Jussi] Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland	University of Helsinki	Yuan, QA (corresponding author), Univ Helsinki, Inst Biotechnol, Res Program Cell & Mol Biol, Helsinki, Finland.	jussi.jantti@helsinki.fi			Academy of Finland [124249, 133552]; Magnus Ehrnrooth Foundation; Institute of Biotechnology; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Magnus Ehrnrooth Foundation; Institute of Biotechnology; Helsinki Graduate School in Biotechnology and Molecular Biology	This work was financially supported by the Academy of Finland (Grants 124249 and 133552 to JJ), Magnus Ehrnrooth Foundation (JJ), and the Institute of Biotechnology. QY was supported by the Helsinki Graduate School in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Brachmann CB, 1998, YEAST, V14, P115; BRENNWALD P, 1994, CELL, V79, P245, DOI 10.1016/0092-8674(94)90194-5; CHOUDHARY C, 2010, NATURE REV MOL CELL, V10; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Enyenihi AH, 2003, GENETICS, V163, P47; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Jahn R, 2002, CURR OPIN CELL BIOL, V14, P488, DOI 10.1016/S0955-0674(02)00356-3; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jantti J, 1999, P NATL ACAD SCI USA, V96, P909, DOI 10.1073/pnas.96.3.909; Jantti J, 2002, J CELL SCI, V115, P409; Knop M, 2005, MOL BIOL CELL, V16, P4543, DOI 10.1091/mbc.E05-03-0243; Liu HP, 1996, GENETICS, V144, P967; Lorenz MC, 2000, MOL BIOL CELL, V11, P183, DOI 10.1091/mbc.11.1.183; Marash M, 2001, EMBO J, V20, P411, DOI 10.1093/emboj/20.3.411; Mendonsa R, 2009, EUKARYOT CELL, V8, P1094, DOI 10.1128/EC.00076-09; Moreno-Borchart AC, 2003, MICROBIOL RES, V158, P83, DOI 10.1078/0944-5013-00194; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Neiman AM, 2005, MICROBIOL MOL BIOL R, V69, P565, DOI 10.1128/MMBR.69.4.565-584.2005; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Oyen M, 2004, CURR GENET, V45, P76, DOI 10.1007/s00294-003-0462-8; Pan XW, 2000, CURR OPIN MICROBIOL, V3, P567, DOI 10.1016/S1369-5274(00)00142-9; Patwardhan P, 2007, CELL SIGNAL, V19, P2218, DOI 10.1016/j.cellsig.2007.06.006; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Schweiger R, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-6; SHERMAN F, 1991, P3; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Weber M, 2010, MOL BIOL CELL, V21, P1362, DOI 10.1091/mbc.E09-07-0546; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang HJ, 2008, J CELL BIOL, V183, P1089, DOI 10.1083/jcb.200809178	35	2	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13323	10.1371/journal.pone.0013323	http://dx.doi.org/10.1371/journal.pone.0013323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948969	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100031
J	Ribeiro-dos-Santos, A; Khayat, AS; Silva, A; Alencar, DO; Lobato, J; Luz, L; Pinheiro, DG; Varuzza, L; Assumpcao, M; Assumpcao, P; Santos, S; Zanette, DL; Silva, WA; Burbano, R; Darnet, S				Ribeiro-dos-Santos, Andrea; Khayat, Andre S.; Silva, Artur; Alencar, Dayse O.; Lobato, Jesse; Luz, Larissa; Pinheiro, Daniel G.; Varuzza, Leonardo; Assumpcao, Monica; Assumpcao, Paulo; Santos, Sidney; Zanette, Dalila L.; Silva, Wilson A., Jr.; Burbano, Rommel; Darnet, Sylvain			Ultra-Deep Sequencing Reveals the microRNA Expression Pattern of the Human Stomach	PLOS ONE			English	Article							CANCER-CELL-LINES; HELICOBACTER-PYLORI; TARGETS; METASTASIS; BIOGENESIS; SIGNATURES; PROFILES; GENOMICS; RNAS	Background: While microRNAs (miRNAs) play important roles in tissue differentiation and in maintaining basal physiology, little is known about the miRNA expression levels in stomach tissue. Alterations in the miRNA profile can lead to cell deregulation, which can induce neoplasia. Methodology/Principal Findings: A small RNA library of stomach tissue was sequenced using high-throughput SOLiD sequencing technology. We obtained 261,274 quality reads with perfect matches to the human miRnome, and 42% of known miRNAs were identified. Digital Gene Expression profiling (DGE) was performed based on read abundance and showed that fifteen miRNAs were highly expressed in gastric tissue. Subsequently, the expression of these miRNAs was validated in 10 healthy individuals by RT-PCR showed a significant correlation of 83.97% (P<0.05). Six miRNAs showed a low variable pattern of expression (miR-29b, miR-29c, miR-19b, miR-31, miR-148a, miR-451) and could be considered part of the expression pattern of the healthy gastric tissue. Conclusions/Significance: This study aimed to validate normal miRNA profiles of human gastric tissue to establish a reference profile for healthy individuals. Determining the regulatory processes acting in the stomach will be important in the fight against gastric cancer, which is the second-leading cause of cancer mortality worldwide.	[Ribeiro-dos-Santos, Andrea; Khayat, Andre S.; Silva, Artur; Alencar, Dayse O.; Lobato, Jesse; Luz, Larissa; Santos, Sidney; Burbano, Rommel; Darnet, Sylvain] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Pinheiro, Daniel G.; Zanette, Dalila L.; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Ribeirao Preto, Brazil; [Varuzza, Leonardo] Life Technol, Sao Paulo, Brazil; [Assumpcao, Monica; Assumpcao, Paulo] Fed Univ Para, Hosp Univ Joao Barros Barreto, BR-66059 Belem, Para, Brazil; [Zanette, Dalila L.; Silva, Wilson A., Jr.] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Reg Hemoterapia, Ribeirao Preto, Brazil; [Zanette, Dalila L.; Silva, Wilson A., Jr.] Inst Nacl Ciencia & Tecnol Celulas Troncos & Tera, Ribeirao Preto, Brazil	Universidade Federal do Para; Universidade de Sao Paulo; Thermo Fisher Scientific; Universidade Federal do Para; Universidade de Sao Paulo	Ribeiro-dos-Santos, A (corresponding author), Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil.	akely@ufpa.br	Ribeiro dos Santos, Ândrea Kely Campos/W-6339-2019; Guariz Pinheiro, Daniel/H-4604-2012; Silva, Artur/E-1474-2014; ZANETTE, DALILA/Q-3541-2016; Khayat, Andre/AAF-2415-2019; Luiz Silva, Artur da Costa da/AAI-3516-2021; Silva Jr, Wilson Araújo/E-9487-2011; DARNET, Sylvain Henri/G-4912-2012; Burbano, Rommel R/C-4149-2012; Santos, Ândrea Ribeiro dos/B-6061-2013	Ribeiro dos Santos, Ândrea Kely Campos/0000-0001-7001-1483; Guariz Pinheiro, Daniel/0000-0001-7062-5936; Silva, Artur/0000-0002-4082-1132; Luiz Silva, Artur da Costa da/0000-0002-4082-1132; Silva Jr, Wilson Araújo/0000-0001-9364-2886; DARNET, Sylvain Henri/0000-0001-6351-0903; Burbano, Rommel R/0000-0002-4872-234X; Santos, Ândrea Ribeiro dos/0000-0001-7001-1483; zanette, dalila l./0000-0001-9397-4127	Governo do Para/SEDECT/FAPESPA; PROPESP/UFPA; FADESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Governo do Para/SEDECT/FAPESPA(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPESP/UFPA; FADESP; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by the Genoma Paraense de Genomica e Proteomica Project (Governo do Para/SEDECT/FAPESPA), PROPESP/UFPA, FADESP and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen YH, 2009, BIOINFORMATICS, V25, P2514, DOI 10.1093/bioinformatics/btp486; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Fischbach W, 2009, DTSCH ARZTEBL INT, V106, P801, DOI 10.3238/arztebl.2009.0801; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hackenberg M, 2009, NUCLEIC ACIDS RES, V37, pW68, DOI 10.1093/nar/gkp347; Hu XX, 2009, GYNECOL ONCOL, V114, P457, DOI 10.1016/j.ygyno.2009.05.022; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Kuehn H., 2008, CURR PROTOC BIOINFOR, DOI [DOI 10.1002/0471250953.BI0712S22, 10.1002/0471250953.bi0712s22]; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langner Marini, 2009, Arq. Gastroenterol., V46, P328, DOI 10.1590/S0004-28032009000400015; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Magoha G A O, 2007, East Afr Med J, V84, pS3; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Merkerova M, 2010, STEM CELLS DEV, V19, P17, DOI 10.1089/scd.2009.0071; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Ricarte Filho Júlio C.M., 2006, Arq Bras Endocrinol Metab, V50, P1102, DOI 10.1590/S0004-27302006000600018; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	27	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13205	10.1371/journal.pone.0013205	http://dx.doi.org/10.1371/journal.pone.0013205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949028	Green Published, Green Submitted, gold			2022-12-27	WOS:000282676700008
J	Coffroth, MA; Poland, DM; Petrou, EL; Brazeau, DA; Holmberg, JC				Coffroth, Mary Alice; Poland, Daniel M.; Petrou, Eleni L.; Brazeau, Daniel A.; Holmberg, Jennie C.			Environmental Symbiont Acquisition May Not Be the Solution to Warming Seas for Reef-Building Corals	PLOS ONE			English	Article							GREAT-BARRIER-REEF; SCLERACTINIAN CORALS; ALGAL ENDOSYMBIONTS; THERMAL TOLERANCE; BLEACHING EVENT; CLIMATE-CHANGE; ZOOXANTHELLAE; SYMBIODINIUM; DIVERSITY; FLEXIBILITY	Background: Coral reefs worldwide are in decline. Much of the mortality can be attributed to coral bleaching (loss of the coral's intracellular photosynthetic algal symbiont) associated with global warming. How corals will respond to increasing oceanic temperatures has been an area of extensive study and debate. Recovery after a bleaching event is dependent on regaining symbionts, but the source of repopulating symbionts is poorly understood. Possibilities include recovery from the proliferation of endogenous symbionts or recovery by uptake of exogenous stress-tolerant symbionts. Methodology/Principal Findings: To test one of these possibilities, the ability of corals to acquire exogenous symbionts, bleached colonies of Porites divaricata were exposed to symbiont types not normally found within this coral and symbiont acquisition was monitored. After three weeks exposure to exogenous symbionts, these novel symbionts were detected in some of the recovering corals, providing the first experimental evidence that scleractinian corals are capable of temporarily acquiring symbionts from the water column after bleaching. However, the acquisition was transient, indicating that the new symbioses were unstable. Only those symbiont types present before bleaching were stable upon recovery, demonstrating that recovery was from the resident in situ symbiont populations. Conclusions/Significance: These findings suggest that some corals do not have the ability to adjust to climate warming by acquiring and maintaining exogenous, more stress-tolerant symbionts. This has serious ramifications for the success of coral reefs and surrounding ecosystems and suggests that unless actions are taken to reverse it, climate change will lead to decreases in biodiversity and a loss of coral reefs.	[Coffroth, Mary Alice] SUNY Buffalo, Grad Program Evolut Ecol & Behav, Dept Geol, Buffalo, NY 14260 USA; [Poland, Daniel M.; Petrou, Eleni L.; Holmberg, Jennie C.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA; [Brazeau, Daniel A.] SUNY Buffalo, Dept Pharmaceut Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Coffroth, MA (corresponding author), SUNY Buffalo, Grad Program Evolut Ecol & Behav, Dept Geol, Buffalo, NY 14260 USA.	Coffroth@buffalo.edu		Holmberg, Jennie/0000-0002-1106-4718	National Science Foundation [0424996]; UB Honors College	National Science Foundation(National Science Foundation (NSF)); UB Honors College	This work was supported by National Science Foundation (NSF-http://www.nsf.gov/) grant 0424996 awarded to Mary Alice Coffroth and a grant from the UB Honors College Research and Creative Activities Fund (http://honors.buffalo.edu/enrolled/research.php) awarded to Eleni Petrou. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrego D, 2008, P ROY SOC B-BIOL SCI, V275, P2273, DOI 10.1098/rspb.2008.0180; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Baker AC, 2003, ANNU REV ECOL EVOL S, V34, P661, DOI 10.1146/annurev.ecolsys.34.011802.132417; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; Brown BE, 1997, CORAL REEFS, V16, P129; BUDDEMEIER RW, 1993, BIOSCIENCE, V43, P320, DOI 10.2307/1312064; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Coffroth MA, 2001, MAR ECOL PROG SER, V222, P85, DOI 10.3354/meps222085; Deboer ML, 2007, COMP BIOCHEM PHYS D, V2, P63, DOI 10.1016/j.cbd.2006.11.003; Douglas AE, 2003, MAR POLLUT BULL, V46, P385, DOI 10.1016/S0025-326X(03)00037-7; Fabricius KE, 2004, MOL ECOL, V13, P2445, DOI 10.1111/j.1365-294X.2004.02230.x; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Glynn PW, 2001, B MAR SCI, V69, P79; GLYNN PW, 1983, ENVIRON CONSERV, V10, P149, DOI 10.1017/S0376892900012248; Goulet TL, 2006, MAR ECOL PROG SER, V321, P1, DOI 10.3354/meps321001; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1997, PHILOS T ROY SOC B, V352, P457, DOI 10.1098/rstb.1997.0033; Kinzie RA, 2001, BIOL BULL, V200, P51, DOI 10.2307/1543084; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2010, P ROY SOC B-BIOL SCI, V277, P2925, DOI 10.1098/rspb.2010.0385; LaJeunesse TC, 2009, P ROY SOC B-BIOL SCI, V276, P4139, DOI 10.1098/rspb.2009.1405; Lewis CL, 2004, SCIENCE, V304, P1490, DOI 10.1126/science.1097323; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Mieog JC, 2007, CORAL REEFS, V26, P449, DOI 10.1007/s00338-007-0244-8; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; POLNEFULLER M, 1991, J PHYCOL, V27, P552, DOI 10.1111/j.0022-3646.1991.00552.x; Rodriguez-Lanetty M, 2006, MAR BIOL, V149, P713, DOI 10.1007/s00227-006-0272-x; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sampayo EM, 2008, P NATL ACAD SCI USA, V105, P10444, DOI 10.1073/pnas.0708049105; Santos SR, 2003, MAR BIOTECHNOL, V5, P130, DOI 10.1007/s10126-002-0076-9; Santos SR, 2001, J PHYCOL, V37, P900, DOI 10.1046/j.1529-8817.2001.00194.x; Thornhill DJ, 2006, MAR BIOL, V148, P711, DOI 10.1007/s00227-005-0114-2; Toller WW, 2001, BIOL BULL-US, V201, P360, DOI 10.2307/1543614; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; Voolstra CR, 2009, MOL ECOL, V18, P1823, DOI 10.1111/j.1365-294X.2009.04167.x	37	72	73	2	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13258	10.1371/journal.pone.0013258	http://dx.doi.org/10.1371/journal.pone.0013258			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949064	gold, Green Submitted, Green Published			2022-12-27	WOS:000282633700021
J	Liu, JL; Piette, BMAG; Deeks, MJ; Franklin-Tong, VE; Hussey, PJ				Liu, Junli; Piette, Bernard M. A. G.; Deeks, Michael J.; Franklin-Tong, Vernonica E.; Hussey, Patrick J.			A Compartmental Model Analysis of Integrative and Self-Regulatory Ion Dynamics in Pollen Tube Growth	PLOS ONE			English	Article							TIP GROWTH; CALCIUM; MEMBRANE; OSCILLATIONS; PLANTS; HYDRODYNAMICS; CHANNELS; GTPASE; FLUXES; CELLS	Sexual reproduction in higher plants relies upon the polarised growth of pollen tubes. The growth-site at the pollen tube tip responds to signalling processes to successfully steer the tube to an ovule. Essential features of pollen tube growth are polarisation of ion fluxes, intracellular ion gradients, and oscillating dynamics. However, little is known about how these features are generated and how they are causally related. We propose that ion dynamics in biological systems should be studied in an integrative and self-regulatory way. Here we have developed a two-compartment model by integrating major ion transporters at both the tip and shank of pollen tubes. We demonstrate that the physiological features of polarised growth in the pollen tube can be explained by the localised distribution of transporters at the tip and shank. Model analysis reveals that the tip and shank compartments integrate into a self-regulatory dynamic system, however the oscillatory dynamics at the tip do not play an important role in maintaining ion gradients. Furthermore, an electric current travelling along the pollen tube contributes to the regulation of ion dynamics. Two candidate mechanisms for growth-induced oscillations are proposed: the transition of tip membrane into shank membrane, and growth-induced changes in kinetic parameters of ion transporters. The methodology and principles developed here are applicable to the study of ion dynamics and their interactions with other functional modules in any plant cellular system.	[Liu, Junli; Deeks, Michael J.; Hussey, Patrick J.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Piette, Bernard M. A. G.] Univ Durham, Dept Math Sci, Durham, England; [Liu, Junli; Piette, Bernard M. A. G.; Deeks, Michael J.; Hussey, Patrick J.] Univ Durham, Biophys Sci Inst, Durham, England; [Franklin-Tong, Vernonica E.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England	Durham University; Durham University; Durham University; University of Birmingham	Liu, JL (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	junli.liu@durham.ac.uk; p.j.hussey@durham.ac.uk	Franklin-Tong, Vernonica E/D-1287-2012	Deeks, Michael/0000-0001-5487-5732; Hussey, Patrick/0000-0002-7349-8722; Piette, Bernard/0000-0001-9777-603X; Franklin-Tong, Noni/0000-0003-1782-8413; Liu, Junli/0000-0001-8264-2450	Research Councils UK; Biotechnology and Biological Sciences Research Council (BBSRC); Science and Technology Facilities Council (STFC) [ST/H003649/1]; Science and Technology Facilities Council [ST/G000433/1] Funding Source: researchfish; STFC [ST/G000433/1] Funding Source: UKRI	Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	JL and PH gratefully acknowledge Research Councils UK and the Biotechnology and Biological Sciences Research Council (BBSRC) for funding in support of this work. BP was supported by the Science and Technology Facilities Council (STFC) grant ST/H003649/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker JD, 2007, ANN BOT-LONDON, V100, P1117, DOI 10.1093/aob/mcm208; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Certal AC, 2008, PLANT CELL, V20, P614, DOI 10.1105/tpc.106.047423; Chebli Y., 2007, FUNCT PLANT SCI BIOT, V1, P232; Cole RA, 2006, CURR OPIN PLANT BIOL, V9, P579, DOI 10.1016/j.pbi.2006.09.014; Dutta R, 2004, PLANT PHYSIOL, V135, P1398, DOI 10.1104/pp.104.041483; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Feijo JA, 1999, J CELL BIOL, V144, P483, DOI 10.1083/jcb.144.3.483; FELLE HH, 1994, PLANT PHYSIOL, V106, P1131, DOI 10.1104/pp.106.3.1131; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; Gaxiola RA, 2007, FEBS LETT, V581, P2204, DOI 10.1016/j.febslet.2007.03.050; Gradmann D, 1998, J MEMBRANE BIOL, V166, P51, DOI 10.1007/s002329900446; Gradmann D, 2001, AUST J PLANT PHYSIOL, V28, P577; Herrgard MJ, 2008, NAT BIOTECHNOL, V26, P1155, DOI 10.1038/nbt1492; Holdaway-Clarke TL, 2003, NEW PHYTOL, V159, P539, DOI 10.1046/j.1469-8137.2003.00847.x; HoldawayClarke TL, 1997, PLANT CELL, V9, P1999, DOI 10.1105/tpc.9.11.1999; Iwano M, 2009, PLANT PHYSIOL, V150, P1322, DOI 10.1104/pp.109.139329; KLIPP E, 2008, SYSTEMS BIOL TXB; Kroeger JH, 2008, J THEOR BIOL, V253, P363, DOI 10.1016/j.jtbi.2008.02.042; Lovy-Wheeler A, 2006, PLANT CELL, V18, P2182, DOI 10.1105/tpc.106.044867; MALHO R, 1994, PLANT J, V5, P331, DOI 10.1111/j.1365-313X.1994.00331.x; Messerli MA, 1999, J CELL SCI, V112, P1497; Messerli MA, 2004, PLANT J, V40, P799, DOI 10.1111/j.1365-313X.2004.02252.x; Messerli MA, 2003, PLANTA, V217, P147, DOI 10.1007/s00425-003-0972-0; Michard E, 2008, SEX PLANT REPROD, V21, P169, DOI 10.1007/s00497-008-0076-x; Michard E, 2009, INT J DEV BIOL, V53, P1609, DOI 10.1387/ijdb.072296em; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Pierson ES, 1996, DEV BIOL, V174, P160, DOI 10.1006/dbio.1996.0060; Roberts SK, 2006, NEW PHYTOL, V169, P647, DOI 10.1111/j.1469-8137.2006.01639.x; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Shabala S, 2006, J EXP BOT, V57, P171, DOI 10.1093/jxb/erj022; Voit E., 1991, CANONICAL NONLINEAR; WEISENSEEL MH, 1975, J CELL BIOL, V66, P556, DOI 10.1083/jcb.66.3.556; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; Zonia L, 2002, PLANT CELL, V14, P2233, DOI 10.1105/tpc.003830; Zonia L, 2001, SEX PLANT REPROD, V14, P111, DOI 10.1007/s004970100093; Zonia L, 2006, CELL BIOCHEM BIOPHYS, V46, P209, DOI 10.1385/CBB:46:3:209; Zonia L, 2010, J EXP BOT, V61, P1939, DOI 10.1093/jxb/erq073	39	17	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13157	10.1371/journal.pone.0013157	http://dx.doi.org/10.1371/journal.pone.0013157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949135	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000282568400004
J	Ye, Y; Yin, DT; Chen, L; Zhou, QS; Shen, RL; He, G; Yan, QT; Tong, ZY; Issekutz, AC; Shapiro, CL; Barsky, SH; Lin, HF; Li, JJ; Gao, JX				Ye, Yin; Yin, De-Tao; Chen, Li; Zhou, Quansheng; Shen, Rulong; He, Gang; Yan, Qingtao; Tong, Zhenyu; Issekutz, Andrew C.; Shapiro, Charles L.; Barsky, Sanford H.; Lin, Haifan; Li, Jian-Jian; Gao, Jian-Xin			Identification of Piwil2-Like (PL2L) Proteins that Promote Tumorigenesis	PLOS ONE			English	Article							PRECANCEROUS STEM-CELLS; HUMAN COLON-CANCER; RNA INTERFERENCE; ARGONAUTE FAMILY; DENDRITIC CELLS; PIWI; MOUSE; GENES; MILI; SPERMATOGENESIS	PIWIL2, a member of PIWI/AGO gene family, is expressed in the germline stem cells (GSCs) of testis for gametogenesis but not in adult somatic and stem cells. It has been implicated to play an important role in tumor development. We have previously reported that precancerous stem cells (pCSCs) constitutively express Piwil2 transcripts to promote their proliferation. Here we show that these transcripts de facto represent Piwil2-like (PL2L) proteins. We have identified several PL2L proteins including PL2L80, PL2L60, PL2L50 and PL2L40, using combined methods of Gene-Exon-Mapping Reverse Transcription Polymerase Chain Reaction (GEM RT-PCR), bioinformatics and a group of novel monoclonal antibodies. Among them, PL2L60 rather than Piwil2 and other PL2L proteins is predominantly expressed in various types of human and mouse tumor cells. It promotes tumor cell survival and proliferation in vitro through up-regulation of Stat3 and Bcl2 gene expressions, the cell cycle entry from G(0/1) into S-phase, and the nuclear expression of NF-kappa B, which contribute to the tumorigenicity of tumor cells in vivo. Consistently, PL2L proteins rather than Piwil2 are predominantly expressed in the cytoplasm or cytoplasm and nucleus of euchromatin-enriched tumor cells in human primary and metastatic cancers, such as breast and cervical cancers. Moreover, nuclear PL2L proteins are always co-expressed with nuclear NF-kappa B. These results reveal that PL2L60 can coordinate with NF-kappa B to promote tumorigenesis and might mediate a common pathway for tumor development without tissue restriction. The identification of PL2L proteins provides a novel insight into the mechanisms of cancer development as well as a novel bridge linking cancer diagnostics and anticancer drug development.	[Ye, Yin; Yin, De-Tao; Chen, Li; Shen, Rulong; He, Gang; Yan, Qingtao; Tong, Zhenyu; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Med Ctr, Dept Internal Med, Columbus, OH 43210 USA; [Shapiro, Charles L.; Barsky, Sanford H.; Gao, Jian-Xin] Ohio State Univ, Med Ctr, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yin, De-Tao] Zhengzhou Univ, Dept Gen Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhou, Quansheng] Soochow Univ, Jiangsu Inst Hematol, Affiliated Hosp 1, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Lin, Haifan] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Lin, Haifan] Yale Univ, Sch Med, Yale Stem Cell Ctr, New Haven, CT USA; [Li, Jian-Jian] Univ Calif Davis, Dept Radiat Oncol, Sacramento, CA 95817 USA; [Issekutz, Andrew C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Zhengzhou University; Soochow University - China; Yale University; Yale University; University of California System; University of California Davis; Dalhousie University	Ye, Y (corresponding author), Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA.	Jian-Xin.Gao@osumc.edu	Shen, Rulong/E-4079-2011	Li, Jian Jian/0000-0003-3694-9675	Strategy Initiative Grant (SIG); Immunology Program Award 2008; American Cancer Society [IRG-112367]	Strategy Initiative Grant (SIG); Immunology Program Award 2008; American Cancer Society(American Cancer Society)	This work is supported from Strategy Initiative Grant (SIG) 2006/2007 (OSU Medical College), Immunology Program Award 2008 (OSUCCC) and American Cancer Society IRG-112367 (JXG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; BUSSOLATI B, 2008, J CELL MOL MED; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Chen L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000293; CHIU CC, CORRECTED P IN PRESS; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Damonte P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2104; Dawe RK, 2004, NAT GENET, V36, P1141, DOI 10.1038/ng1104-1141; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Feng DQ, 2009, ONCOL REP, V22, P1129, DOI 10.3892/or_00000545; Folco HD, 2008, SCIENCE, V319, P94, DOI 10.1126/science.1150944; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gao JX, 2003, J IMMUNOL, V170, P5927, DOI 10.4049/jimmunol.170.12.5927; Gao JX, 2000, CELL IMMUNOL, V202, P41, DOI 10.1006/cimm.2000.1656; GAO JX, 2010, FIELD CANC BASIC SCI; Gao JX, 2009, DRUG DISCOV TODAY DI, V6, P5; Grandage VL, 2005, LEUKEMIA, V19, P586, DOI 10.1038/sj.leu.2403653; Grivna ST, 2006, P NATL ACAD SCI USA, V103, P13415, DOI 10.1073/pnas.0605506103; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; He G, 2010, AM J TRANSL RES, V2, P156; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jaronczyk K, 2005, BIOCHEM J, V387, P561, DOI 10.1042/BJ20041822; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kuramochi-Miyagawa S, 2001, MECH DEVELOP, V108, P121, DOI 10.1016/S0925-4773(01)00499-3; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee JH, 2010, CANCER RES, V70, P4569, DOI 10.1158/0008-5472.CAN-09-2670; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Lee JH, 2006, HUM MOL GENET, V15, P201, DOI 10.1093/hmg/ddi430; Lessard L, 2005, BRIT J CANCER, V93, P1019, DOI 10.1038/sj.bjc.6602796; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; LIU JSR, 2010, INT J CLIN EXP PATHO, V3, P10; MADER RM, 2009, DRUG DISCOV TODAY, V6, P1; Melcher R, 2000, CYTOGENET CELL GENET, V88, P145, DOI 10.1159/000015508; Nikpour P, 2009, CANCER EPIDEMIOL, V33, P271, DOI 10.1016/j.canep.2009.06.011; Preall JB, 2005, CELL, V123, P543, DOI 10.1016/j.cell.2005.11.006; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101; Ryu B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000594; Saito K, 2006, GENE DEV, V20, P2214, DOI 10.1101/gad.1454806; Sasaki T, 2003, GENOMICS, V82, P323, DOI 10.1016/S0888-7543(03)00129-0; Shen RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001652; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Sugimoto K, 2007, BIOCHEM BIOPH RES CO, V359, P497, DOI 10.1016/j.bbrc.2007.05.136; Tahbaz N, 2004, EMBO REP, V5, P189, DOI 10.1038/sj.embor.7400070; Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang JX, 2009, EMBO REP, V10, P1272, DOI 10.1038/embor.2009.197; Werbowetski-Ogilvie TE, 2008, TRENDS MOL MED, V14, P323, DOI 10.1016/j.molmed.2008.06.005; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	62	59	64	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13406	10.1371/journal.pone.0013406	http://dx.doi.org/10.1371/journal.pone.0013406			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975993	Green Submitted, Green Published, gold			2022-12-27	WOS:000283216400004
J	Palmadottir, VK; Gudmundsson, H; Hardarson, S; Arnadottir, M; Magnusson, T; Andresdottir, MB				Palmadottir, Vala Kolbrun; Gudmundsson, Hjalti; Hardarson, Sverrir; Arnadottir, Margret; Magnusson, Thorvaldur; Andresdottir, Margret B.			Incidence and Outcome of Acute Phosphate Nephropathy in Iceland	PLOS ONE			English	Article							ORAL SODIUM-PHOSPHATE; RENAL-FAILURE; CARDIOVASCULAR-DISEASE; POLYETHYLENE-GLYCOL; KIDNEY-DISEASE; RISK-FACTOR; BOWEL; ASSOCIATION	Background: Oral sodium phosphate solutions (OSPS) are widely used for bowel cleansing prior to colonoscopy and other procedures. Cases of renal failure due to acute phosphate nephropathy following OSPS ingestion have been documented in recent years, questioning the safety of OSPS. However, the magnitude of the problem remains unknown. Methodology/Principal Findings: We conducted a population based, retrospective analysis of medical records and biopsies of all cases of acute phosphate nephropathy that were diagnosed in our country in the period from January 2005 to October 2008. Utilizing the complete official sales figures of OSPS, we calculated the incidence of acute phosphate nephropathy in our country. Fifteen cases of acute phosphate nephropathy were diagnosed per 17,651 sold doses of OSPS (0.085%). Nine (60%) were women and mean age 69 years (range 56-75 years). Thirteen patients had a history of hypertension (87%) all of whom were treated with either ACE-I or ARB and/or diuretics. One patient had underlying DM type I and an active colitis and one patient had no risk factor for the development of acute phosphate nephropathy. Average baseline creatinine was 81.7 mu mol/L and 180.1 at the discovery of acute renal failure, mean 4.2 months after OSPS ingestion. No patient had a full recovery of renal function, and at the end of follow-up, 26.6 months after the OSPS ingestion, the average creatinine was 184.2 mu mol/L. The average eGFR declined from 73.5 ml/min/1.73 m(2) at baseline to 37.3 ml/min/1.73 m(2) at the end of follow-up. One patient reached end-stage renal disease and one patient died with progressive renal failure. Conclusion/Significance: Acute phosphate nephropathy developed in almost one out of thousand sold doses of OSPS. The consequences for kidney function were detrimental. This information can be used in other populations to estimate the impact of OSPS. Our data suggest that acute phosphate nephropathy may be greatly underreported worldwide.	[Palmadottir, Vala Kolbrun; Gudmundsson, Hjalti] Landspitali Univ Hosp, Dept Internal Med, Reykjavik, Iceland; [Hardarson, Sverrir] Landspitali Univ Hosp, Dept Pathol, Reykjavik, Iceland; [Arnadottir, Margret; Andresdottir, Margret B.] Landspitali Univ Hosp, Div Nephrol, Reykjavik, Iceland; [Magnusson, Thorvaldur] Akranes Hosp, Dept Internal Med, Akranes, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital	Palmadottir, VK (corresponding author), Landspitali Univ Hosp, Dept Internal Med, Reykjavik, Iceland.	mband@landspitali.is	Andrésdóttir, Margrét/L-4178-2019		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007121] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007121] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aasebo W, 2007, NEPHROL DIAL TRANSPL, V22, P920, DOI 10.1093/ndt/gfl694; Beyea A, 2007, AM J KIDNEY DIS, V50, P151, DOI 10.1053/j.ajkd.2007.03.005; Brunelli SM, 2007, J AM SOC NEPHROL, V18, P3199, DOI 10.1681/ASN.2007040440; Brunelli SM, 2009, AM J KIDNEY DIS, V53, P448, DOI 10.1053/j.ajkd.2008.09.022; Connor Andrew, 2008, BMJ, V337, pa182, DOI 10.1136/bmj.a182; Demoulin N, 2008, CLIN NEPHROL, V70, P176; Desmeules S, 2003, NEW ENGL J MED, V349, P1006, DOI 10.1056/NEJM200309043491020; Gonlusen G, 2006, ARCH PATHOL LAB MED, V130, P101; Gross CP, 2006, JAMA-J AM MED ASSOC, V296, P2815, DOI 10.1001/jama.296.23.2815; Hurst FP, 2007, J AM SOC NEPHROL, V18, P3192, DOI 10.1681/ASN.2007030349; Kim Han Jo, 2008, Kidney Research and Clinical Practice, V27, P374; KORETZ RL, 2006, GASTROENTEROLOGY, V130, P2242; Koretz Ronald L, 2006, Gastroenterology, V130, P2240, DOI 10.1053/j.gastro.2006.03.057; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Manley P, 2006, NEPHROL DIAL TRANSPL, V21, P2957, DOI 10.1093/ndt/gfl321; Markowitz GS, 2009, KIDNEY INT, V76, P1027, DOI 10.1038/ki.2009.308; Markowitz GS, 2005, J AM SOC NEPHROL, V16, P3389, DOI 10.1681/ASN.2005050496; Markowitz GS, 2005, NEPHROL DIAL TRANSPL, V20, P850, DOI 10.1093/ndt/gfh718; Markowitz GS, 2004, HUM PATHOL, V35, P675, DOI 10.1016/j.humpath.2003.12.005; McCullough PA, 2008, NEPHRON PHYSIOL, V109, pP61, DOI 10.1159/000142938; Ori Y, 2008, AM J MED SCI, V336, P309, DOI 10.1097/MAJ.0b013e318167410c; Rocuts AK, 2009, KIDNEY INT, V75, P987, DOI 10.1038/ki.2008.293; Russmann S, 2008, AM J GASTROENTEROL, V103, P2707, DOI 10.1111/j.1572-0241.2008.02201.x; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seeff LC, 2004, GASTROENTEROLOGY, V127, P1670, DOI 10.1053/j.gastro.2004.09.051; Slee TM, 2008, NETH J MED, V66, P438; Steinman TI, 2008, NEW ENGL J MED, V359, P951, DOI 10.1056/NEJMcpc0804600; VANNER SJ, 1990, AM J GASTROENTEROL, V85, P422; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2	29	18	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13484	10.1371/journal.pone.0013484	http://dx.doi.org/10.1371/journal.pone.0013484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976065	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700014
J	Yang, Y; Mohand-Said, S; Leveillard, T; Fontaine, V; Simonutti, M; Sahel, JA				Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain			Transplantation of Photoreceptor and Total Neural Retina Preserves Cone Function in P23H Rhodopsin Transgenic Rat	PLOS ONE			English	Article							SUPERIOR COLLICULUS; FETAL RETINA; SURVIVAL; MODEL; CELLS; ROD; RECONSTRUCTION; PROGENITORS; PROTEIN; RESCUE	Background: Transplantation as a therapeutic strategy for inherited retinal degeneration has been historically viewed to restore vision as a method by replacing the lost retinal cells and attempting to reconstruct the neural circuitry with stem cells, progenitor cells and mature neural retinal cells. Methods and Findings: We present evidence for an alternative strategy aimed at preventing the secondary loss of cones, the most crucial photoreceptors for vision, by transplanting normal photoreceptors cells into the eye of the P23H rat, a model of dominant retinitis pigmentosa. We carried out transplantation of photoreceptors or total neural retina in 3-month-old P23H rats and evaluated the function and cell counts 6 months after surgery. In both groups, cone loss was significantly reduced (10%) in the transplanted eyes where the cone outer segments were found to be considerably longer. This morphological effect correlated with maintenance of the visual function of cones as scored by photopic ERG recording, but more precisely with an increase in the photopic b-wave amplitudes by 100% and 78% for photoreceptor transplantation and whole retinal transplantation respectively. Conclusions: We demonstrate here that the transplanted tissue prevents the loss of cone function, which is further translated into cone survival.	[Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] INSERM, U968, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] Univ Paris 06, Inst Vis, UM80, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] CNRS, UMR 7210, Paris, France; [Yang, Ying; Mohand-Said, Saddek; Leveillard, Thierry; Fontaine, Valerie; Simonutti, Manuel; Sahel, Jose-Alain] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM DHOS CIC 503, Paris, France; [Sahel, Jose-Alain] UCL, Inst Ophthalmol, London, England; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of London; University College London; Fondation Adolphe de Rothschild	Yang, Y (corresponding author), INSERM, U968, Paris, France.	mohand@quinze-vingts.fr	Léveillard, Thierry/AAR-1804-2020; Sahel, Jose-Alain/F-3172-2017	Léveillard, Thierry/0000-0001-5692-8770; Sahel, Jose-Alain/0000-0002-4831-1153; YANG, YING/0000-0002-9245-4119	Inserm, EVI-GENORET; Foundation Fighting Blindness (USA)	Inserm, EVI-GENORET(Institut National de la Sante et de la Recherche Medicale (Inserm)); Foundation Fighting Blindness (USA)	This work was supported by Inserm, EVI-GENORET and Foundation Fighting Blindness (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramant RB, 2004, PROG RETIN EYE RES, V23, P475, DOI 10.1016/j.preteyeres.2004.05.003; Aramant RB, 1999, INVEST OPHTH VIS SCI, V40, P1557; Aramant RB, 2002, EXP EYE RES, V75, P115, DOI 10.1006/exer.2002.2001; Chacko DM, 2000, BIOCHEM BIOPH RES CO, V268, P842, DOI 10.1006/bbrc.2000.2153; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chrysostomou V, 2008, INVEST OPHTH VIS SCI, V49, P1116, DOI 10.1167/iovs.07-1158; CRONIN T, 2010, CELL DEATH DIFF 0205; Fontaine V, 1998, J NEUROSCI, V18, P9662; Francis PJ, 2009, INVEST OPHTH VIS SCI, V50, P3425, DOI 10.1167/iovs.08-2908; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Gamm DM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000338; GELLER AM, 1993, VISION RES, V33, P1509, DOI 10.1016/0042-6989(93)90144-L; GOURAS P, 1992, INVEST OPHTH VIS SCI, V33, P2579; Harvey A R, 1984, Brain Res, V314, P27; HORSBURGH GM, 1993, J COMP NEUROL, V327, P323, DOI 10.1002/cne.903270302; Kwan ASL, 1999, EXP NEUROL, V159, P21, DOI 10.1006/exnr.1999.7157; Lamba DA, 2009, CELL STEM CELL, V4, P73, DOI 10.1016/j.stem.2008.10.015; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; MCLOON SC, 1980, EXP BRAIN RES, V40, P273; MCLOON SC, 1983, J COMP NEUROL, V217, P376, DOI 10.1002/cne.902170403; Mohand-Said S, 2000, ARCH OPHTHALMOL-CHIC, V118, P807, DOI 10.1001/archopht.118.6.807; Mohand-Said S, 1998, P NATL ACAD SCI USA, V95, P8357, DOI 10.1073/pnas.95.14.8357; MohandSaid S, 1997, OPHTHALMIC RES, V29, P290, DOI 10.1159/000268027; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Radtke ND, 1999, AM J OPHTHALMOL, V128, P384, DOI 10.1016/S0002-9394(99)00250-0; Radtke ND, 2008, AM J OPHTHALMOL, V146, P172, DOI 10.1016/j.ajo.2008.04.009; Reh TA, 2006, NATURE, V444, P156, DOI 10.1038/444156a; ROYO PARIS E., 1959, GROWTH, V23, P313; Sauve Y, 2006, VISION RES, V46, P1459, DOI 10.1016/j.visres.2005.11.009; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Seiler MJ, 2008, EUR J NEUROSCI, V28, P208, DOI 10.1111/j.1460-9568.2008.06279.x; Seiler Magdalene J, 2005, Semin Ophthalmol, V20, P31, DOI 10.1080/08820530590921873; Seiler MJ, 2009, VET OPHTHALMOL, V12, P158, DOI 10.1111/j.1463-5224.2009.00693.x; SEILER MJ, 1994, DEV BRAIN RES, V80, P81, DOI 10.1016/0165-3806(94)90092-2; SIMONS DJ, 1985, DEV BRAIN RES, V21, P156, DOI 10.1016/0165-3806(85)90036-7; Stone LS, 1930, J EXP ZOOL, V55, P193, DOI 10.1002/jez.1400550112; SZEL A, 1992, EXP EYE RES, V55, P47; Wright AF, 1997, NAT GENET, V17, P132, DOI 10.1038/ng1097-132; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28	42	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13469	10.1371/journal.pone.0013469	http://dx.doi.org/10.1371/journal.pone.0013469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976047	gold, Green Published, Green Submitted			2022-12-27	WOS:000283114700007
J	Knauff, M; Budeck, C; Wolf, AG; Hamburger, K				Knauff, Markus; Budeck, Claudia; Wolf, Ann G.; Hamburger, Kai			The Illogicality of Stock-Brokers: Psychological Experiments on the Effects of Prior Knowledge and Belief Biases on Logical Reasoning in Stock Trading	PLOS ONE			English	Article							MENTAL MODELS; FRUGAL	Background: Explanations for the current worldwide financial crisis are primarily provided by economists and politicians. However, in the present work we focus on the psychological-cognitive factors that most likely affect the thinking of people on the economic stage and thus might also have had an effect on the progression of the crises. One of these factors might be the effect of prior beliefs on reasoning and decision-making. So far, this question has been explored only to a limited extent. Methods: We report two experiments on logical reasoning competences of nineteen stock-brokers with long-lasting vocational experiences at the stock market. The premises of reasoning problems concerned stock trading and the experiments varied whether or not their conclusions-a proposition which is reached after considering the premises-agreed with the brokers' prior beliefs. Half of the problems had a conclusion that was highly plausible for stock-brokers while the other half had a highly implausible conclusion. Results: The data show a strong belief bias. Stock-brokers were strongly biased by their prior knowledge. Lowest performance was found for inferences in which the problems caused a conflict between logical validity and the experts' belief. In these cases, the stock-brokers tended to make logically invalid inferences rather than give up their existing beliefs. Conclusions: Our findings support the thesis that cognitive factors have an effect on the decision-making on the financial market. In the present study, stock-brokers were guided more by past experience and existing beliefs than by logical thinking and rational decision-making. They had difficulties to disengage themselves from vastly anchored thinking patterns. However, we believe, that it is wrong to accuse the brokers for their "malfunctions'', because such hard-wired cognitive principles are difficult to suppress even if the person is aware of them.	[Knauff, Markus; Budeck, Claudia; Wolf, Ann G.; Hamburger, Kai] Univ Giessen, Giessen, Germany	Justus Liebig University Giessen	Knauff, M (corresponding author), Univ Giessen, Giessen, Germany.	markus.knauff@psychol.uni-giessen.de			German Research Foundation (DFG) [KN 465/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This research was supported by the German Research Foundation (DFG) grant KN 465/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHI MTH, 1981, COGNITIVE SCI, V5, P121, DOI 10.1207/s15516709cog0502_2; COKELY ET, 2009, PSYCCRITIQUES, V54; Dougherty MR, 2008, PSYCHOL REV, V115, P199, DOI 10.1037/0033-295X.115.1.199; Ericsson KA, 2009, DEVELOPMENT OF PROFESSIONAL EXPERTISE: TOWARD MEASUREMENT OF EXPERT PERFORMANCE AND DESIGN OF OPTIMAL LEARNING ENVIRONMENTS, P1, DOI 10.1017/CBO9780511609817; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Ericsson KA, 1996, ROAD EXCELLENCE ACQU; Evans J.S.B., 1989, BIAS HUMAN REASONING; Evans JST, 2003, TRENDS COGN SCI, V7, P454, DOI 10.1016/j.tics.2003.08.012; Feltovich P, 1997, EXPERTISE CONTEXT HU; Gigerenzer G, 1996, PSYCHOL REV, V103, P650, DOI 10.1037/0033-295X.103.4.650; Goel V, 2003, COGNITION, V87, pB11, DOI 10.1016/S0010-0277(02)00185-3; Goel V, 2007, TRENDS COGN SCI, V11, P435, DOI 10.1016/j.tics.2007.09.003; Jahn G, 2007, MEM COGNITION, V35, P2075, DOI 10.3758/BF03192939; Jeffrey R, 1981, FORMAL LOGIC; Johnson-Laird Philip Nicholas, 2006, WE REASON; Johnson-Laird PN, 2001, TRENDS COGN SCI, V5, P434, DOI 10.1016/S1364-6613(00)01751-4; Kahneman D., 1982, JUDGMENT UNCERTAINTY, DOI [10.1017/CBO9780511809477, DOI 10.1017/CBO9780511809477]; Keren G, 2009, PERSPECT PSYCHOL SCI, V4, P533, DOI 10.1111/j.1745-6924.2009.01164.x; KNAUFF M, 2009, ENCY NEUROSCIENCE, P3377; Knauff M, 1995, P 17 ANN C COGN SCI, P200; Knauff M, 2007, TOPOI-INT REV PHILOS, V26, P19, DOI 10.1007/s11245-006-9002-8; Knauff M, 2009, SPAT COGN COMPUT, V9, P109, DOI 10.1080/13875860902887605; Marewski JN, 2010, COGN PROCESS, V11, P103, DOI 10.1007/s10339-009-0337-0; Monti MM, 2007, NEUROIMAGE, V37, P1005, DOI 10.1016/j.neuroimage.2007.04.069; Oberauer K, 2006, COGNITIVE PSYCHOL, V53, P238, DOI 10.1016/j.cogpsych.2006.04.001; Ragni M., 2005, P 27 ANN COGN SCI C, P1797; Rauh R., 2005, SPAT COGN COMPUT, V5, P239, DOI DOI 10.1080/13875868.2005.9683805; Sloman SA, 1996, PSYCHOL BULL, V119, P3, DOI 10.1037/0033-2909.119.1.3; Sternberg R.J., 2001, COMPLEX COGNITION PS	29	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13483	10.1371/journal.pone.0013483	http://dx.doi.org/10.1371/journal.pone.0013483			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	665ON	20976157	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300040
J	Sabra-Makke, L; Tourrel-Cuzin, C; Denis, RGP; Moldes, M; Pegorier, JP; Luquet, S; Vasseur-Cognet, M; Bossard, P				Sabra-Makke, Lina; Tourrel-Cuzin, Cecile; Denis, Raphael G. P.; Moldes, Marthe; Pegorier, Jean-Paul; Luquet, Serge; Vasseur-Cognet, Mireille; Bossard, Pascale			The Nutritional Induction of COUP-TFII Gene Expression in Ventromedial Hypothalamic Neurons Is Mediated by the Melanocortin Pathway	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-II; BODY-WEIGHT; FOOD-INTAKE; RECEPTOR AGONISTS; NUCLEAR RECEPTOR; INSULIN ACTION; GLUCOSE; OBESITY; BRAIN; LEPTIN	Background: The nuclear receptor chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) is an important coordinator of glucose homeostasis. We report, for the first time, a unique differential regulation of its expression by the nutritional status in the mouse hypothalamus compared to peripheral tissues. Methodology/Principal Findings: Using hyperinsulinemic-euglycemic clamps and insulinopenic mice, we show that insulin upregulates its expression in the hypothalamus. Immunofluorescence studies demonstrate that COUP-TFII gene expression is restricted to a subpopulation of ventromedial hypothalamic neurons expressing the melanocortin receptor. In GT1-7 hypothalamic cells, the MC4-R agonist MTII leads to a dose dependant increase of COUP-TFII gene expression secondarily to a local increase in cAMP concentrations. Transfection experiments, using a COUP-TFII promoter containing a functional cAMP responsive element, suggest a direct transcriptional activation by cAMP. Finally, we show that the fed state or intracerebroventricular injections of MTII in mice induce an increased hypothalamic COUP-TFII expression associated with a decreased hepatic and pancreatic COUP-TFII expression. Conclusions/Significance: These observations strongly suggest that hypothalamic COUP-TFII gene expression could be a central integrator of insulin and melanocortin signaling pathway within the ventromedial hypothalamus. COUP-TFII could play a crucial role in brain integration of circulating signal of hunger and satiety involved in energy balance regulation.	[Sabra-Makke, Lina; Moldes, Marthe; Pegorier, Jean-Paul; Vasseur-Cognet, Mireille; Bossard, Pascale] Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS UMR 8104, Paris, France; [Tourrel-Cuzin, Cecile] Univ Paris 07, Lab Biol & Pathol Pancreas Endocrine, Paris, France; [Sabra-Makke, Lina; Moldes, Marthe; Pegorier, Jean-Paul; Vasseur-Cognet, Mireille; Bossard, Pascale] INSERM, U1016, Paris, France; [Denis, Raphael G. P.; Luquet, Serge] Univ Paris 07, Team HERGE, Unite Funct & Adapt Biol Biol Fonct & Adaptat, CNRS EAC 4413, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Sabra-Makke, L (corresponding author), Univ Paris 05, Inst Cochin, Dept Endocrinol Metab & Canc, CNRS UMR 8104, Paris, France.	mireille.vasseur@inserm.fr; pascale.bossard@inserm.fr	Vasseur, Mireille/L-6958-2017; Bossard, Pascale/O-6680-2017; Luquet, serge/AAT-1809-2021; Moldes-Garnaud, Marthe/E-4817-2017; Denis, Raphael/ABE-1758-2020	Vasseur, Mireille/0000-0001-6963-4114; Luquet, serge/0000-0001-8668-6645; Moldes-Garnaud, Marthe/0000-0002-9950-2267; Denis, Raphael/0000-0002-7677-7460; Tourrel-Cuzin, Cecile/0000-0002-5368-4018	ALFEDIAM-Antadir, France; Paris V University, France; Conseil national de la recherche scientifique du Liban; Fondation pour la Recherche Medicale	ALFEDIAM-Antadir, France; Paris V University, France; Conseil national de la recherche scientifique du Liban; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by grants from ALFEDIAM-Antadir, France, 2008, and from the BQR (Bonus Qualite Recherche), Paris V University, France, 2007. L. S. M. is the recipient of a doctoral fellowship from the Conseil national de la recherche scientifique du Liban and the Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Benoit G, 2006, PHARMACOL REV, V58, P798, DOI 10.1124/pr.58.4.10; Benoit SC, 2002, J NEUROSCI, V22, P9048; BJORKLUND A, 1987, INTEGRATED SYSTEMS 1; Bobard A, 2005, J BIOL CHEM, V280, P199, DOI 10.1074/jbc.M406522200; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Bossard P, 1998, DEVELOPMENT, V125, P4909; Cooney AJ, 2001, TRENDS ENDOCRIN MET, V12, P247, DOI 10.1016/S1043-2760(01)00424-6; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Fu LY, 2008, J NEUROSCI, V28, P5433, DOI 10.1523/JNEUROSCI.0749-08.2008; Fuentealba P, 2010, J NEUROSCI, V30, P1595, DOI 10.1523/JNEUROSCI.4199-09.2010; GANTZ I, 1993, J BIOL CHEM, V268, P15174; HETHERINGTON AW, 1983, NUTR REV, V41, P124; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; JONK LJC, 1994, MECH DEVELOP, V47, P81, DOI 10.1016/0925-4773(94)90098-1; Khong K, 2001, NEUROENDOCRINOLOGY, V74, P193, DOI 10.1159/000054686; KLUVER H, 1953, J NEUROPATH EXP NEUR, V12, P400; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lee CT, 2004, MOL CELL BIOL, V24, P10835, DOI 10.1128/MCB.24.24.10835-10843.2004; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Li LP, 2009, CELL METAB, V9, P77, DOI 10.1016/j.cmet.2008.12.002; Lou DQ, 1999, J BIOL CHEM, V274, P28385, DOI 10.1074/jbc.274.40.28385; MAGENIS RE, 1994, MAMM GENOME, V5, P503, DOI 10.1007/BF00369320; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x; Niswender KD, 2004, TRENDS ENDOCRIN MET, V15, P362, DOI 10.1016/j.tem.2004.07.009; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI200112954; Perilhou A, 2008, MOL CELL BIOL, V28, P6568, DOI 10.1128/MCB.02211-07; Perilhou A, 2008, MOL CELL BIOL, V28, P4588, DOI 10.1128/MCB.01191-07; Porte D, 2002, NUTR REV, V60, pS20, DOI 10.1301/002966402320634797; PORTE D, 2002, NUTR REV, V20, pS68; Sato I, 2005, J NEUROSCI, V25, P8657, DOI 10.1523/JNEUROSCI.2739-05.2005; Soosaar A, 1996, FEBS LETT, V391, P95, DOI 10.1016/0014-5793(96)00711-9; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Toda C, 2009, DIABETES, V58, P2757, DOI 10.2337/db09-0638; Tomassy GS, 2010, P NATL ACAD SCI USA, V107, P3576, DOI 10.1073/pnas.0911792107; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Torsoni MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE216, DOI 10.1152/ajpendo.00031.2003; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; Vaisse C, 2000, J CLIN INVEST, V106, P253, DOI 10.1172/JCI9238; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; VANHOUTEN M, 1979, NATURE, V282, P623, DOI 10.1038/282623a0; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yamamoto M, 1999, MECH DEVELOP, V84, P143, DOI 10.1016/S0925-4773(99)00054-4; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7; Zhou L, 2007, CELL METAB, V6, P398, DOI 10.1016/j.cmet.2007.10.008	57	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13464	10.1371/journal.pone.0013464	http://dx.doi.org/10.1371/journal.pone.0013464			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976162	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300033
J	Candiani, G; Pezzoli, D; Ciani, L; Chiesa, R; Ristori, S				Candiani, Gabriele; Pezzoli, Daniele; Ciani, Laura; Chiesa, Roberto; Ristori, Sandra			Bioreducible Liposomes for Gene Delivery: From the Formulation to the Mechanism of Action	PLOS ONE			English	Article							MEDIATED DNA-TRANSFECTION; CATIONIC LIPIDS; IN-VITRO; GEMINI SURFACTANTS; VESICLE FORMATION; NONVIRAL VECTORS; OXIDATIVE STRESS; DRUG-DELIVERY; PLASMID DNA; GLUTATHIONE	Background: A promising strategy to create stimuli-responsive gene delivery systems is to exploit the redox gradient between the oxidizing extracellular milieu and the reducing cytoplasm in order to disassemble DNA/cationic lipid complexes (lipoplexes). On these premises, we previously described the synthesis of SS14 redox-sensitive gemini surfactant for gene delivery. Although others have attributed the beneficial effects of intracellular reducing environment to reduced glutathione (GSH), these observations cannot rule out the possible implication of the redox milieu in its whole on transfection efficiency of bioreducible transfectants leaving the determinants of DNA release largely undefined. Methodology/Principal Findings: With the aim of addressing this issue, SS14 was here formulated into binary and ternary 100 nm-extruded liposomes and the effects of the helper lipid composition and of the SS14/helper lipids molar ratio on chemical-physical and structural parameters defining transfection effectiveness were investigated. Among all formulations tested, DOPC/DOPE/SS14 at 25: 50: 25 molar ratio was the most effective in transfection studies owing to the presence of dioleoyl chains and phosphatidylethanolamine head groups in co-lipids. The increase in SS14 content up to 50% along DOPC/DOPE/SS14 liposome series yielded enhanced transfection, up to 2.7-fold higher than that of the benchmark Lipofectamine 2000, without altering cytotoxicity of the corresponding lipoplexes at charge ratio 5. Secondly, we specifically investigated the redox-dependent mechanisms of gene delivery into cells through tailored protocols of transfection in GSH-depleted and repleted vs. increased oxidative stress conditions. Importantly, GSH specifically induced DNA release in batch and in vitro. Conclusions/Significance: The presence of helper lipids carrying unsaturated dioleoyl chains and phosphatidylethanolamine head groups significantly improved transfection efficiencies of DOPC/DOPE/SS14 lipoplexes. Most importantly, this study shows that intracellular GSH levels linearly correlated with transfection efficiency while oxidative stress levels did not, highlighting for the first time the pivotal role of GSH rather than oxidative stress in its whole in transfection of bioreducible vectors.	[Candiani, Gabriele; Pezzoli, Daniele; Chiesa, Roberto] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Dept Chem, Florence, Italy; [Ciani, Laura; Ristori, Sandra] Univ Florence, Ctr Colloid & Surface Sci CSGI, Florence, Italy	Polytechnic University of Milan; University of Florence; University of Florence	Candiani, G (corresponding author), Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy.	gabriele.candiani@polimi.it	Candiani, Gabriele/A-9744-2009; Pezzoli, Daniele/J-4308-2012; Chiesa, Roberto/N-2605-2013; Fanjul-Moles, María Luisa/C-8069-2011; Roberto, Chiesa/AAV-6476-2021; Ristori, Sandra/ABC-4731-2020; Ristori, Sandra/J-9887-2014	Candiani, Gabriele/0000-0003-0575-068X; Pezzoli, Daniele/0000-0002-6780-6979; Fanjul-Moles, María Luisa/0000-0003-2927-0154; Ristori, Sandra/0000-0003-0708-3956; Chiesa, Roberto/0000-0002-5317-6849	Politecnico di Milano; Italian Institute of Technology (IIT)	Politecnico di Milano; Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT)	We wish to thank Politecnico di Milano (Grant: 5 per Mille Junior) and the Italian Institute of Technology (IIT) for economic support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamy C, 2005, ARCH MAL COEUR VAISS, V98, P906; Adamy C, 2007, J MOL CELL CARDIOL, V43, P344, DOI 10.1016/j.yjmcc.2007.06.010; Allen RG, 2000, FREE RADICAL BIO MED, V28, P463, DOI 10.1016/S0891-5849(99)00242-7; Audouy S, 2000, J GENE MED, V2, P465, DOI 10.1002/1521-2254(200011/12)2:6<465::AID-JGM141>3.0.CO;2-Z; Bagnacani V, 2008, ORG LETT, V10, P3953, DOI 10.1021/ol801326d; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; Bajaj A, 2007, J MED CHEM, V50, P2432, DOI 10.1021/jm0611253; Bauhuber S, 2009, ADV MATER, V21, P3286, DOI 10.1002/adma.200802453; Bhattacharya S, 1997, CHEM COMMUN, P2287, DOI 10.1039/a704154c; Bhattacharya S, 1999, CHEM-EUR J, V5, P2335, DOI 10.1002/(SICI)1521-3765(19990802)5:8<2335::AID-CHEM2335>3.0.CO;2-U; Blessing T, 1998, P NATL ACAD SCI USA, V95, P1427, DOI 10.1073/pnas.95.4.1427; Bombelli C, 2005, J MED CHEM, V48, P5378, DOI 10.1021/jm050477r; Boomer JA, 2002, PHARMACEUT RES, V19, P1292, DOI 10.1023/A:1020342523694; Candiani G, 2008, J GENE MED, V10, P637, DOI 10.1002/jgm.1186; Candiani G, 2007, CHEMMEDCHEM, V2, P292, DOI 10.1002/cmdc.200600267; Caracciolo G, 2008, J PHYS CHEM B, V112, P11298, DOI 10.1021/jp803077n; Caracciolo G, 2007, BBA-BIOMEMBRANES, V1768, P2280, DOI 10.1016/j.bbamem.2007.06.027; Chen J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-10; Ciani L, 2004, BBA-BIOMEMBRANES, V1664, P70, DOI 10.1016/j.bbamem.2004.04.003; Ciani L, 2010, BIOPHYS CHEM, V151, P81, DOI 10.1016/j.bpc.2010.05.010; Congiu A, 2004, COLLOID SURFACE B, V36, P43, DOI 10.1016/j.colsurfb.2004.04.006; Damy T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004871; Eliyahu H, 2005, MOLECULES, V10, P34, DOI 10.3390/10010034; Ewert K, 2002, J MED CHEM, V45, P5023, DOI 10.1021/jm020233w; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; Ganta S, 2008, J CONTROL RELEASE, V126, P187, DOI 10.1016/j.jconrel.2007.12.017; Gao X, 2007, AAPS J, V9, pE92, DOI 10.1208/aapsj0901009; Gilge JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004015; Giordano C, 2006, J Appl Biomater Biomech, V4, P73; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Hui SW, 1996, BIOPHYS J, V71, P590, DOI 10.1016/S0006-3495(96)79309-8; Huynh GH, 2006, J CONTROL RELEASE, V110, P236, DOI 10.1016/j.jconrel.2005.09.053; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jeong JH, 2010, BIOCONJUGATE CHEM, V21, P296, DOI 10.1021/bc9003525; Kim A, 2004, BIOMATERIALS, V25, P305, DOI 10.1016/S0142-9612(03)00534-9; Kirby AJ, 2003, ANGEW CHEM INT EDIT, V42, P1448, DOI 10.1002/anie.200201597; Koynova R, 2005, BBA-BIOMEMBRANES, V1714, P63, DOI 10.1016/j.bbamem.2005.05.009; Kretzschmar M, 1996, EXP TOXICOL PATHOL, V48, P439; Limon-Pacheco JH, 2007, FREE RADICAL BIO MED, V43, P1335, DOI 10.1016/j.freeradbiomed.2007.06.028; LITZINGER DC, 1992, BIOCHIM BIOPHYS ACTA, V1113, P201, DOI 10.1016/0304-4157(92)90039-D; MacKay JA, 2008, MOL THER, V16, P893, DOI 10.1038/mt.2008.36; Manickam DS, 2008, BIOMATERIALS, V29, P2680, DOI 10.1016/j.biomaterials.2008.03.009; Manickam DS, 2010, J CONTROL RELEASE, V141, P77, DOI 10.1016/j.jconrel.2009.08.022; McGregor C, 2001, J AM CHEM SOC, V123, P6215, DOI 10.1021/ja005681c; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Ohashi T, 2002, FEBS LETT, V511, P21, DOI 10.1016/S0014-5793(01)03262-8; PINNADUWAGE P, 1989, BIOCHIM BIOPHYS ACTA, V985, P33, DOI 10.1016/0005-2736(89)90099-0; Ray G, 2000, BREAST CANCER RES TR, V59, P163, DOI 10.1023/A:1006357330486; Read ML, 2003, J GENE MED, V5, P232, DOI 10.1002/jgm.331; Saito G, 2003, ADV DRUG DELIVER REV, V55, P199, DOI 10.1016/S0169-409X(02)00179-5; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; Shang F, 2003, FREE RADICAL BIO MED, V34, P521, DOI 10.1016/S0891-5849(02)01304-7; Shangguan T, 2000, GENE THER, V7, P769, DOI 10.1038/sj.gt.3301156; Simberg D, 2001, J BIOL CHEM, V276, P47453, DOI 10.1074/jbc.M105588200; Skrzydlewska E, 2003, HEPATO-GASTROENTEROL, V50, P126; Tang FX, 1999, BIOCONJUGATE CHEM, V10, P791, DOI 10.1021/bc990016i; TEW KD, 1994, CANCER RES, V54, P4313; Thierry AR, 1997, GENE THER, V4, P226, DOI 10.1038/sj.gt.3300350; TURANOV AA, 2010, BIOCH J; Walker WE, 2004, J CONTROL RELEASE, V94, P245, DOI 10.1016/j.jconrel.2003.10.003; Wetzer B, 2001, BIOCHEM J, V356, P747, DOI 10.1042/0264-6021:3560747; Yang JP, 1997, GENE THER, V4, P950, DOI 10.1038/sj.gt.3300485; Yao JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009508; Zelphati O, 1996, P NATL ACAD SCI USA, V93, P11493, DOI 10.1073/pnas.93.21.11493	67	59	62	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13430	10.1371/journal.pone.0013430	http://dx.doi.org/10.1371/journal.pone.0013430			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976172	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700021
J	Tian, F; Lin, DD; Wu, JJ; Gao, YA; Zhang, DH; Ji, MJ; Wu, GL				Tian, Fang; Lin, Dandan; Wu, Jingjiao; Gao, Yanan; Zhang, Donghui; Ji, Minjun; Wu, Guanling			Immune Events Associated with High Level Protection against Schistosoma japonicum Infection in Pigs Immunized with UV-Attenuated Cercariae	PLOS ONE			English	Article							IRRADIATED CERCARIAE; CELL RESPONSES; MANSONI; MICE; VACCINATION; CHINA; EXPRESSION; CYTOKINES; ANTIGEN; MODEL	Background: The vaccination of radiation-attenuated Schistosoma japonicum cercariae can induce effective protection in artiodactyl, but the immune events related to protective immunity are not fully understood. To provide a paradigm for a human recombinant antigen vaccine, we have undertaken a vaccination and challenge experiment in pigs, which was recognized as an appropriate animal model in this type of study because of their similarity to human in immunology, and investigated the relative immune events induced by the radiation-attenuated S. japonicum cercariae. Methods and Findings: We found that pigs immunized once with 400 mu w UV-irradiated cercariae exhibited 63.84% and 71.82% reductions in worm burden and hepatic eggs respectively. Protective immunity in vaccinated pigs was associated with high level productions of IgM, total IgG, IgG1 and IgG2; IgG2 was significantly increased in the acute infection. IFN-gamma levels could be elicited by immunization. At week 6 post-infection, IFN-gamma, IL-4 and IL-10 levels also showed a dramatic rise synchronously in vaccinated pigs. Moreover, the granzyme b, nk-lysin, ifn gamma, il4 and il10 mRNA levels in early skin-draining lymph nodes of immunized pigs were higher than those in pigs with non-irradiated cercariae infection. In addition, cytotoxicity-related genes in the mesenteric lymph nodes were significantly upregulated in vaccinated pigs in the acute infection. Conclusion/Significance: Our results demonstrated that IFN-gamma and IgG2 antibody production, as well as genes related to cytotoxicity are associated with the high level protection induced by UV-irradiated Schistosoma japonicum vaccine. These findings indicated that optimal vaccination against S. japonicum required the induction of IFN-gamma, IgG2 antibody related to Th1 responses and cytotoxicity effect.	[Tian, Fang; Lin, Dandan; Wu, Jingjiao; Gao, Yanan; Zhang, Donghui; Ji, Minjun; Wu, Guanling] Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Zhang, Donghui; Ji, Minjun; Wu, Guanling] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Lin, Dandan] Jiangxi Prov Inst Parasit Dis, Nanchang, Jiangxi, Peoples R China; [Tian, Fang] Yangzhou Univ Med Coll, Dept Pathogen Biol & Immunol, Yangzhou, Jiangsu, Peoples R China	Nanjing Medical University	Tian, F (corresponding author), Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China.	jiminjun@njmu.edu.cn	Lin, Dandan/GRJ-2233-2022		National Science Foundation of China (NSFC) [30430600]; National Basic Research Program of China (973 Program) [2007CB513106]	National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Science Foundation of China (NSFC) (Project No. 30430600) and the National Basic Research Program of China (973 Program 2007CB513106). The funders had no role in study design, data collection and analysis decision to publish, or preparation of the manuscript.	Abdel-Hafeez EH, 2009, PARASITOL INT, V58, P36, DOI 10.1016/j.parint.2008.09.004; Bartley PB, 2008, AM J TROP MED HYG, V78, P929, DOI 10.4269/ajtmh.2008.78.929; Bickle QD, 2009, PARASITOLOGY, V136, P1621, DOI 10.1017/S0031182009005848; Bickle QD, 2001, VET PARASITOL, V100, P51, DOI 10.1016/S0304-4017(01)00483-6; Bogh HO, 1996, VET PARASITOL, V65, P21, DOI 10.1016/0304-4017(96)00942-9; Bogh HO, 1997, ACTA VET SCAND, V38, P147; BUTTERWORTH AE, 1994, TROP GEOGR MED, V46, P197; Buzza MS, 2006, BIOL CHEM, V387, P827, DOI 10.1515/BC.2006.106; Chen HG, 2000, VACCINE, V18, P2142, DOI 10.1016/S0264-410X(99)00541-1; COULSON PS, 1993, J IMMUNOL, V151, P3663; Crawley A, 2003, VACCINE, V21, P2911, DOI 10.1016/S0264-410X(03)00142-7; Crawley A, 2003, VET IMMUNOL IMMUNOP, V91, P141, DOI 10.1016/S0165-2427(02)00293-3; de Jesus AR, 2000, INFECT IMMUN, V68, P2797, DOI 10.1128/IAI.68.5.2797-2803.2000; Eberl M, 2001, INFECT IMMUN, V69, P5352, DOI 10.1128/IAI.69.9.5352-5362.2001; Ekkens MJ, 2007, INFECT IMMUN, V75, P2291, DOI 10.1128/IAI.01328-06; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hewitson JP, 2005, PARASITE IMMUNOL, V27, P271, DOI 10.1111/j.1365-3024.2005.00764.x; HSU SYL, 1984, AM J TROP MED HYG, V33, P891, DOI 10.4269/ajtmh.1984.33.891; Hu SY, 2006, J PATHOGEN BIOL, V1, P181; Johansen MV, 2000, ACTA TROP, V76, P85, DOI 10.1016/S0001-706X(00)00103-0; Kumar P., 1999, Parasitology International, V48, P109, DOI 10.1016/S1383-5769(99)00008-2; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU FL, 1995, PARASITE IMMUNOL, V17, P435, DOI 10.1111/j.1365-3024.1995.tb00911.x; McManus DP, 2008, CLIN MICROBIOL REV, V21, P225, DOI 10.1128/CMR.00046-07; Osada Y, 2001, PARASITE IMMUNOL, V23, P251, DOI 10.1046/j.1365-3024.2001.00379.x; Oswald IP, 2001, PARASITOLOGY, V122, P299, DOI 10.1017/S0031182001007399; PANCRE V, 1994, INFECT IMMUN, V62, P3723, DOI 10.1128/IAI.62.9.3723-3730.1994; RATCLIFFE EC, 1991, PARASITOLOGY, V103, P65, DOI 10.1017/S0031182000059308; RUPPEL A, 1990, PARASITOLOGY, V101, P23, DOI 10.1017/S0031182000079701; Sang YM, 2009, DEV COMP IMMUNOL, V33, P334, DOI 10.1016/j.dci.2008.05.006; Sato H, 1998, PARASITE IMMUNOL, V20, P337, DOI 10.1111/j.1365-3024.1998.158.x; SHI YE, 1990, EXP PARASITOL, V71, P100, DOI 10.1016/0014-4894(90)90012-2; SHI YE, 1993, PARASITOLOGY, V106, P459, DOI 10.1017/S0031182000076745; Techau ME, 2007, VET RES, V38, P25, DOI 10.1051/vetres:2006042; Torben W, 2007, EXP PARASITOL, V115, P121, DOI 10.1016/j.exppara.2006.07.004; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Williams DL, 2001, INFECT IMMUN, V69, P1134, DOI 10.1128/IAI.69.2.1134-1141.2001; Willingham A. L., 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P128; Willingham AL, 1998, AM J TROP MED HYG, V58, P248, DOI 10.4269/ajtmh.1998.58.248; Willingham AL, 1996, PARASITOL TODAY, V12, P132, DOI 10.1016/0169-4758(96)20001-8; Wu H, 1993, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V11, P41; WYNN TA, 1994, J IMMUNOL, V153, P5200; YUAN HC, 1993, CHINESE MED J-PEKING, V106, P563; Zhang YB, 1999, PARASITE IMMUNOL, V21, P111, DOI 10.1046/j.1365-3024.1999.00208.x; Zheng Jiang, 2009, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V27, P398; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	46	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13408	10.1371/journal.pone.0013408	http://dx.doi.org/10.1371/journal.pone.0013408			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976218	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700010
J	Wang, QH; Sun, SY; Khuri, F; Curran, WJ; Deng, XM				Wang, Qinhong; Sun, Shi-Yong; Khuri, Fadlo; Curran, Walter J.; Deng, Xingming			Mono- or Double-Site Phosphorylation Distinctly Regulates the Proapoptotic Function of Bax	PLOS ONE			English	Article							MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; CYTOCHROME-C RELEASE; BCL-X-L; CONFORMATIONAL-CHANGE; CELL-SURVIVAL; BH3 DOMAINS; PROTEIN; APOPTOSIS; ACTIVATION; FAMILY	Bax is the major multidomain proapoptotic molecule that is required for apoptosis. It has been reported that phosphorylation of Bax at serine(S) 163 or S184 activates or inactivates its proapoptotic function, respectively. To uncover the mechanism(s) by which phosphorylation regulates the proapoptotic function of Bax, a series of serine (S)-> alanine/glutamate (A/E) Bax mutants, including S163A, S184A, S163E, S184E, S163E/S184A (EA), S163A/S184E (AE), S163A/S184A (AA) and S163E/S184E (EE), were created to abrogate or mimic, respectively, either single or double-site phosphorylation. The compound Bax mutants (i.e. EA and AE) can flesh out the functional contribution of individual phosphorylation site(s). WT and each of these Bax mutants were overexpressed in Bax(-/-) MEF or lung cancer H157 cells and the proapoptotic activities were compared. Intriguingly, expression of any of Bax mutants containing the mutation S -> A at S184 (i.e. S184A, EA or AA) represents more potent proapoptotic activity as compared to WT Bax in association with increased 6A7 epitope conformational change, mitochondrial localization/insertion and prolonged half-life. In contrast, all Bax mutants containing the mutation S -> E at S184 (i.e. S184E, AE or EE) have a mobility-shift and fail to insert into mitochondrial membranes with decreased protein stability and less apoptotic activity. Unexpectedly, mutation either S -> A or S -> E at S163 site does not significantly affect the proapoptotic activity of Bax. These findings indicate that S184 but not S163 is the major phosphorylation site for functional regulation of Bax's activity. Therefore, manipulation of the phosphorylation status of Bax at S184 may represent a novel strategy for cancer treatment.	[Wang, Qinhong] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Sun, Shi-Yong; Khuri, Fadlo] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA; [Sun, Shi-Yong; Khuri, Fadlo; Curran, Walter J.; Deng, Xingming] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Curran, Walter J.; Deng, Xingming] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA	Duke University; Emory University; Emory University; Emory University	Wang, QH (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	xdeng4@emory.edu	Khuri, Fadlo R./AAU-4942-2020	Khuri, Fadlo R./0000-0002-8638-7618	Flight Attendant Medical Research Institute; Stop Children's Cancer, Inc.; Developmental Research Program Award of Emory SPORE in Head/Neck Cancer; Winship's Inaugural Kennedy Seed Grant; National Cancer Institute in National Institutes of Health [R01 CA112183, R01CA136534]; NATIONAL CANCER INSTITUTE [R01CA112183, R01CA136534] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Stop Children's Cancer, Inc.; Developmental Research Program Award of Emory SPORE in Head/Neck Cancer; Winship's Inaugural Kennedy Seed Grant; National Cancer Institute in National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Flight Attendant Medical Research Institute Clinical Innovator Awards, by an Award from Stop Children's Cancer, Inc., by a Developmental Research Program Award of Emory SPORE in Head/Neck Cancer, by Winship's Inaugural Kennedy Seed Grant, and by National Cancer Institute in National Institutes of Health Grants R01 CA112183 and R01CA136534. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; ARNOLD H, 2008, MOL CELL BIOL, V26, P2832; Cao XF, 2003, BLOOD, V102, P2605, DOI 10.1182/blood-2003-01-0211; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Choi SY, 2006, J BIOL CHEM, V281, P7049, DOI 10.1074/jbc.M512000200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Cuddeback SM, 2001, J BIOL CHEM, V276, P20559, DOI 10.1074/jbc.M101527200; Czabotar PE, 2009, CELL DEATH DIFFER, V16, P1187, DOI 10.1038/cdd.2009.83; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng XM, 2004, P NATL ACAD SCI USA, V101, P153, DOI 10.1073/pnas.2533920100; Deng XM, 2001, J BIOL CHEM, V276, P23681, DOI 10.1074/jbc.M100279200; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Ekert PG, 2001, J CELL BIOL, V152, P483, DOI 10.1083/jcb.152.3.483; Esposti MD, 2003, BIOCHEM BIOPH RES CO, V304, P455, DOI 10.1016/S0006-291X(03)00617-X; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; Kim BJ, 2006, J BIOL CHEM, V281, P21256, DOI 10.1074/jbc.M510644200; Krajewska M, 1997, CANCER RES, V57, P1605; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Marani M, 2002, MOL CELL BIOL, V22, P3577, DOI 10.1128/MCB.22.11.3577-3589.2002; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Reed JC, 2003, CANCER CELL, V3, P17, DOI 10.1016/S1535-6108(02)00241-6; Sharpe JC, 2004, BBA-MOL CELL RES, V1644, P107, DOI 10.1016/j.bbamcr.2003.10.016; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Toyota H, 2003, CANCER LETT, V189, P221, DOI 10.1016/S0304-3835(02)00552-9; Wang XD, 2001, GENE DEV, V15, P2922; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yamaguchi H, 2004, J BIOL CHEM, V279, P39431, DOI 10.1074/jbc.M401530200; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhao JF, 2009, MOL CANCER RES, V7, P1954, DOI 10.1158/1541-7786.MCR-09-0304	48	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13393	10.1371/journal.pone.0013393	http://dx.doi.org/10.1371/journal.pone.0013393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976235	Green Published, Green Submitted, gold			2022-12-27	WOS:000282941000018
J	Kano, S; Xiao, JH; Osorio, J; Ekker, M; Hadzhiev, Y; Muller, F; Casane, D; Magdelenat, G; Retaux, S				Kano, Shungo; Xiao, Jin-Hua; Osorio, Joana; Ekker, Marc; Hadzhiev, Yavor; Mueller, Ferenc; Casane, Didier; Magdelenat, Ghislaine; Retaux, Sylvie			Two Lamprey Hedgehog Genes Share Non-Coding Regulatory Sequences and Expression Patterns with Gnathostome Hedgehogs	PLOS ONE			English	Article							SONIC-HEDGEHOG; MULTIPLE ALIGNMENT; FLOOR PLATE; EVOLUTION; CONSERVATION; FOREBRAIN; ENHANCERS; ELEMENTS; DNA; ORGANIZATION	Hedgehog (Hh) genes play major roles in animal development and studies of their evolution, expression and function point to major differences among chordates. Here we focused on Hh genes in lampreys in order to characterize the evolution of Hh signalling at the emergence of vertebrates. Screening of a cosmid library of the river lamprey Lampetra fluviatilis and searching the preliminary genome assembly of the sea lamprey Petromyzon marinus indicate that lampreys have two Hh genes, named Hha and Hhb. Phylogenetic analyses suggest that Hha and Hhb are lamprey-specific paralogs closely related to Sonic/Indian Hh genes. Expression analysis indicates that Hha and Hhb are expressed in a Sonic Hh-like pattern. The two transcripts are expressed in largely overlapping but not identical domains in the lamprey embryonic brain, including a newly-described expression domain in the nasohypophyseal placode. Global alignments of genomic sequences and local alignment with known gnathostome regulatory motifs show that lamprey Hhs share conserved non-coding elements (CNE) with gnathostome Hhs albeit with sequences that have significantly diverged and dispersed. Functional assays using zebrafish embryos demonstrate gnathostome-like midline enhancer activity for CNEs contained in intron2. We conclude that lamprey Hh genes are gnathostome Shh-like in terms of expression and regulation. In addition, they show some lamprey-specific features, including duplication and structural (but not functional) changes in the intronic/regulatory sequences.	[Kano, Shungo; Xiao, Jin-Hua; Osorio, Joana; Ekker, Marc; Hadzhiev, Yavor; Mueller, Ferenc; Casane, Didier; Magdelenat, Ghislaine; Retaux, Sylvie] CNRS, Inst Alfred Fessard, UPR3294, Lab Neurobiol & Dev, Gif Sur Yvette, France; [Ekker, Marc] Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON, Canada; [Hadzhiev, Yavor; Mueller, Ferenc] Univ Birmingham, Dept Med & Mol Genet, Sch Clin & Expt Med, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Casane, Didier] Univ Paris 07, Paris, France; [Casane, Didier] CNRS, Lab Evolut Genomes & Speciat, UPR9034, Gif Sur Yvette, France; [Magdelenat, Ghislaine] CEA, Inst Genom, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Ottawa; University of Birmingham; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Kano, S (corresponding author), CNRS, Inst Alfred Fessard, UPR3294, Lab Neurobiol & Dev, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr	Muller, Ferenc/C-6426-2009	Hadzhiev, Yavor/0000-0002-1134-4904; mueller, ferenc/0000-0002-0996-774X; Osorio, Joana/0000-0003-2713-5370	ANR (Agence Nationale de la Recherche); GIS (Groupement d'Interet Scientifique) Genomique Marine; University of Ottawa (ME); CNRS (Centre National de la Recherche Scientifique); Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education; EMBO (European Molecular Biology Organisation)	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); GIS (Groupement d'Interet Scientifique) Genomique Marine; University of Ottawa (ME); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education; EMBO (European Molecular Biology Organisation)(European Molecular Biology Organization (EMBO))	Work supported by ANR (Agence Nationale de la Recherche)[MIDLINE] to SR, a GIS (Groupement d'Interet Scientifique) Genomique Marine to SR and DC, and by a collaborative student exchange grant between the University of Ottawa (ME) and the CNRS (Centre National de la Recherche Scientifique)(SR). JHX and SK were ANR postdoctoral fellows. JO was supported by a doctoral scholarship from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education, and a short-term scholarship from EMBO (European Molecular Biology Organisation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Brudno M, 2004, NUCLEIC ACIDS RES, V32, pW41, DOI 10.1093/nar/gkh361; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; BULLOCK TH, 1984, NEUROSCI LETT, V48, P145, DOI 10.1016/0304-3940(84)90010-7; Carr JL, 1998, J EXP ZOOL, V280, P73, DOI 10.1002/(SICI)1097-010X(19980101)280:1<73::AID-JEZ9>3.0.CO;2-E; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Epstein DJ, 1999, DEVELOPMENT, V126, P281; Ertzer R, 2007, DEV BIOL, V301, P578, DOI 10.1016/j.ydbio.2006.11.004; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Germot A, 2001, MOL BIOL EVOL, V18, P1668, DOI 10.1093/oxfordjournals.molbev.a003955; Guerin A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005374; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hadzhiev Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hufton AL, 2009, GENOME RES, V19, P2036, DOI 10.1101/gr.093237.109; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irvine SQ, 2002, J EXP ZOOL, V294, P47, DOI 10.1002/jez.10090; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; Kuraku S, 1999, J MOL EVOL, V49, P729, DOI 10.1007/PL00006595; KURAKU S, 2010, INTEGRATIVE IN PRESS; KURAKU S, 2008, MOL BIOL EVOLUTION; Kuraku S, 2006, ZOOL SCI, V23, P1053, DOI 10.2108/zsj.23.1053; LANG M, CONSERVATION S UNPUB; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lemos B, 2004, GENOMICS, V84, P511, DOI 10.1016/j.ygeno.2004.05.009; Mallatt J, 2007, MOL PHYLOGENET EVOL, V43, P1005, DOI 10.1016/j.ympev.2006.11.023; Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; McEwen GK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000762; Muller F, 1999, DEVELOPMENT, V126, P2103; NEAR TJ, 2009, J EXP ZOOLOG B; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Ohno S., 1970, P1; Osorio J, 2005, DEV BIOL, V288, P100, DOI 10.1016/j.ydbio.2005.08.042; Osorio J, 2008, DEV GENES EVOL, V218, P221, DOI 10.1007/s00427-008-0208-1; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Retaux S, 2010, INTEGR COMP BIOL, V50, P98, DOI 10.1093/icb/icq032; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sabarinadh C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-75; Shimeld SM, 1999, DEV GENES EVOL, V209, P40, DOI 10.1007/s004270050225; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Suda Y, 2009, DEV BIOL, V325, P282, DOI 10.1016/j.ydbio.2008.09.018; Takatori N, 2002, MECH DEVELOP, V116, P235, DOI 10.1016/S0925-4773(02)00150-8; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uchida K, 2003, J EXP ZOOL PART B, V300B, P32, DOI 10.1002/jez.b.00044; Vavouri T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r15; Venkatesh B, 2005, CURR BIOL, V15, pR82, DOI 10.1016/j.cub.2005.01.021; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; WOOLFE A, 2008, ORG CONSERVED ELEMEN, P307; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Zardoya R, 1996, TRENDS GENET, V12, P496, DOI 10.1016/S0168-9525(96)20014-9	58	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13332	10.1371/journal.pone.0013332	http://dx.doi.org/10.1371/journal.pone.0013332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967201	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800029
J	Helbing, D; Johansson, A				Helbing, Dirk; Johansson, Anders			Cooperation, Norms, and Revolutions: A Unified Game-Theoretical Approach	PLOS ONE			English	Article							SOCIAL NORMS; EVOLUTIONARY GAMES; MATHEMATICAL-MODEL; RANDOM REPLICATORS; COLLECTIVE ACTION; DYNAMICS; PUNISHMENT; ENFORCEMENT; STABILITY; EMERGENCE	Background: Cooperation is of utmost importance to society as a whole, but is often challenged by individual self-interests. While game theory has studied this problem extensively, there is little work on interactions within and across groups with different preferences or beliefs. Yet, people from different social or cultural backgrounds often meet and interact. This can yield conflict, since behavior that is considered cooperative by one population might be perceived as non-cooperative from the viewpoint of another. Methodology and Principal Findings: To understand the dynamics and outcome of the competitive interactions within and between groups, we study game-dynamical replicator equations for multiple populations with incompatible interests and different power (be this due to different population sizes, material resources, social capital, or other factors). These equations allow us to address various important questions: For example, can cooperation in the prisoner's dilemma be promoted, when two interacting groups have different preferences? Under what conditions can costly punishment, or other mechanisms, foster the evolution of norms? When does cooperation fail, leading to antagonistic behavior, conflict, or even revolutions? And what incentives are needed to reach peaceful agreements between groups with conflicting interests? Conclusions and Significance: Our detailed quantitative analysis reveals a large variety of interesting results, which are relevant for society, law and economics, and have implications for the evolution of language and culture as well.	[Helbing, Dirk; Johansson, Anders] ETH, Zurich, Switzerland; [Helbing, Dirk] Santa Fe Inst, Santa Fe, NM 87501 USA; [Helbing, Dirk] Collegium Budapest Inst Adv Study, Budapest, Hungary; [Johansson, Anders] UCL, Ctr Adv Spatial Anal, London, England	Swiss Federal Institutes of Technology Domain; ETH Zurich; The Santa Fe Institute; University of London; University College London	Helbing, D (corresponding author), ETH, Zurich, Switzerland.	dhelbing@ethz.ch	Johansson, Anders F/C-5551-2009		European Commission [231200]; ETH Competence Center [CH1-01 08-2]	European Commission(European CommissionEuropean Commission Joint Research Centre); ETH Competence Center	Partial support was provided by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through the project QLectives (grant no.: 231200) and the ETH Competence Center "Coping with Crises in Complex Socio-Economic Systems" (CCSS) through ETH Research Grant CH1-01 08-2 (Eidgenoessische Technische Hochschule/Swiss Federal Institute of Technology). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, EVOLUTIONARY GAME TH; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; AXELROD R, 1986, AM POLIT SCI REV, V80, P1095, DOI 10.2307/1960858; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bacharach M, 1997, GAME ECON BEHAV, V19, P1, DOI 10.1006/game.1997.0546; Bacharach M, 2000, GAME ECON BEHAV, V32, P220, DOI 10.1006/game.2000.0796; Bacharach M., 2006, INDIVIDUAL CHOICE; Banfield E.C., 1967, MORAL BASIS BACKWARD; Baronchelli A, 2008, INT J MOD PHYS C, V19, P785, DOI 10.1142/S0129183108012522; Ben Jacob E, 2004, TRENDS MICROBIOL, V12, P366, DOI 10.1016/j.tim.2004.06.006; Bendor J, 2001, AM J SOCIOL, V106, P1493, DOI 10.1086/321298; BENDOR J, 1990, J LAW ECON ORGAN, V6, P33; Bicchieri C., 2006, GRAMMAR SOC; BICCHIERI C, 2009, DYNAMICS NORMS; BINMORE K, 1994, J INST THEOR ECON, V150, P45; Binmore K, 2005, NATURAL JUSTICE; Blume A, 1998, GAME ECON BEHAV, V22, P171, DOI 10.1006/game.1997.0598; Bohnet I, 2001, AM POLIT SCI REV, V95, P131, DOI 10.1017/S0003055401000211; BONNER T, 1980, EVOLUTION CULTURE AN; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1994, J INST THEOR ECON, V150, P72; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2005, ORIGIN EVOLUTION CUL; Buskens V., 2002, SOCIAL NETWORKS TRUS, V30; Castelfranchi C., 1998, J ARTIFICIAL SOC SOC, V1; Castello X, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/12/308; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Chalub FACC, 2006, J THEOR BIOL, V241, P233, DOI 10.1016/j.jtbi.2005.11.028; Cialdini R.B., 1998, HDB SOCIAL PSYCHOL 4, P151; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Coleman J., 1990, FDN SOCIAL THEORY; Conte R, 1995, ARTIFICIAL SOCIETIES, P252; Conte R., 1999, Artificial Intelligence and Law, V7, P1, DOI 10.1023/A:1008397328506; Cressman R, 2003, ECON LEARN SOC EVOL, P1; CRESSMAN R, 1995, GAME ECON BEHAV, V11, P237, DOI 10.1006/game.1995.1050; CRESSMAN R, 1986, J MATH BIOL, V23, P221, DOI 10.1007/BF00276958; Cressman R, 2001, J THEOR BIOL, V211, P1, DOI 10.1006/jtbi.2001.2321; Cressman R, 1996, THEOR POPUL BIOL, V49, P189, DOI 10.1006/tpbi.1996.0011; DAVID PA, 1985, AM ECON REV, V75, P332; de Oliveira VM, 2000, PHYS REV LETT, V85, P4984, DOI 10.1103/PhysRevLett.85.4984; de Oliveira VM, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.148101; DIEDERICH S, 1989, PHYS REV A, V39, P4333, DOI 10.1103/PhysRevA.39.4333; Dignum F., 1999, Artificial Intelligence and Law, V7, P69, DOI 10.1023/A:1008315530323; Ehrlich PR, 2005, PLOS BIOL, V3, P943, DOI 10.1371/journal.pbio.0030194; ELLICKSON RC, 2001, SOCIAL NORMS, P35; Ellickson RC, 1991, ORDER LAW; ELSTER J, 1989, J ECON PERSPECT, V3, P99, DOI 10.1257/jep.3.4.99; Elster J., 1989, CEMENT SOC; Epstein J. M., 2001, Computational Economics, V18, P9, DOI 10.1023/A:1013810410243; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fent T, 2007, ADV COMPLEX SYST, V10, P271, DOI 10.1142/S0219525907000970; Flache A, 2001, JASSS-J ARTIF SOC S, V4; Flentge F, 2001, JASSS-J ARTIF SOC S, V4; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; Galan JM, 2005, JASSS-J ARTIF SOC S, V8; Galla T, 2006, J PHYS A-MATH GEN, V39, P3853, DOI 10.1088/0305-4470/39/15/001; Gintis H., 2000, GAME THEORY EVOLVING; Gintis Herbert, 2009, BOUNDS REASON GAME T; Griffin AS, 2004, NATURE, V430, P1024, DOI 10.1038/nature02744; Harsanyi J. C., 1988, GEN THEORY EQUILIBRI; HECHTER M, SOCIAL NORMS; HECKATHORN DD, 1990, AM SOCIOL REV, V55, P366, DOI 10.2307/2095762; Helbing D, 1996, THEOR DECIS, V40, P149, DOI 10.1007/BF00133171; HELBING D, 1991, BEHAV SCI, V36, P298, DOI 10.1002/bs.3830360405; HELBING D, 1994, J MATH SOCIOL, V19, P189, DOI 10.1080/0022250X.1994.9990143; HELBING D, 1992, LECT NOTES ECON MATH, V395, P330; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057102; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016112; Helbing D, 2009, P NATL ACAD SCI USA, V106, P3680, DOI 10.1073/pnas.0811503106; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hofbauer J., INT GAME THEORY REV, V4, P17; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Homans G.C., 1974, SOCIAL BEHAV ITS ELE; HORNE C, 2001, SOCIAL NORMS, P305; Horne C, 2008, RATION SOC, V20, P147, DOI 10.1177/1043463108089543; Horne Christine, 2001, SOCIAL NORMS; Kanazawa T, 2007, IEEE T SYST MAN CY A, V37, P132, DOI 10.1109/TSMCA.2006.886361; KANDORI M, 1992, REV ECON STUD, V59, P63, DOI 10.2307/2297925; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Kitts JA, 2006, SIMUL MODEL PRACT TH, V14, P407, DOI 10.1016/j.simpat.2005.09.006; Koford K. J., 1991, SOCIAL NORMS EC I; Kuhn T. S., 1996, STRUCTURE SCI REVOLU; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lindbeck A, 1999, Q J ECON, V114, P1, DOI 10.1162/003355399555936; MACAULAY S, 1963, AM SOCIOL REV, V28, P55, DOI 10.2307/2090458; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; MACY MW, 1998, J ARTIFICIAL SOC SOC, V1; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Moussaid M, 2009, P ROY SOC B-BIOL SCI, V276, P2755, DOI 10.1098/rspb.2009.0405; Nakamaru M, 2004, J THEOR BIOL, V230, P57, DOI 10.1016/j.jtbi.2004.04.028; Neumann M, 2008, JASSS-J ARTIF SOC S, V11; Nowak MA, 2002, NATURE, V417, P611, DOI 10.1038/nature00771; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2006, J THEOR BIOL, V243, P86, DOI 10.1016/j.jtbi.2006.06.004; OLIVER P, 1980, AM J SOCIOL, V85, P1356, DOI 10.1086/227168; Opp K.-D., 2001, MIND SOC, V3, P101, DOI DOI 10.1007/BF02512077; Opp Karl-Dieter., 2009, THEORIES POLITICAL P; OPP KD, 1979, KYKLOS, V32, P775; OPP KD, 1982, BRIT J SOC PSYCHOL, V21, P139, DOI 10.1111/j.2044-8309.1982.tb00522.x; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Ostrom E., 1990, GOVERNING COMMONS EV; Platteau J.P., 2000, I SOCIAL NORMS EC DE; POPITZ H, 1980, NORMATIVE KONSTRUKTI; Posner Eric A., 2000, LAW SOCIAL NORMS; Posner RA, 1999, INT REV LAW ECON, V19, P369, DOI 10.1016/S0144-8188(99)00013-7; Putnam R.D., 1994, MAKING DEMOCRACY WOR; RAUB W, 1990, AM J SOCIOL, V96, P626, DOI 10.1086/229574; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Saam NJ, 1999, J ARTIFICIAL SOC SOC, V2; SAMUELSON L, 1998, EVOLUTIONARY GAMES E, pCH5; Sato Y, 2005, PHYSICA D, V210, P21, DOI 10.1016/j.physd.2005.06.031; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHUSTER P, 1981, BIOL CYBERN, V40, P17, DOI 10.1007/BF00326677; Sethi R, 1996, AM ECON REV, V86, P766; Skyrms B, 2014, EVOLUTION SOCIAL CON, DOI 10.1017/CBO9781139924825; Skyrms B, 2003, STAG HUNT EVOLUTION; Stouffer SA, 1949, AM SOCIOL REV, V14, P707, DOI 10.2307/2086672; SUGDEN R, 1995, ECON J, V105, P533, DOI 10.2307/2235016; SUGDEN R, 1989, J ECON PERSPECT, V3, P85, DOI 10.1257/jep.3.4.85; Sugden R., 1998, EC VALUES ORG, P73, DOI DOI 10.1017/CB09781139174855.004; SUGDEN R, 1986, EVOLUTION RIGHTS; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Taylor C, 2004, B MATH BIOL, V66, P1621, DOI 10.1016/j.bulm.2004.03.004; Thebaud O, 2001, JASSS, V4, pU40; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Ullmann-Margalit Edna., 1977, EMERGENCE NORMS; VANDAMME E, 1994, EUR ECON REV, V38, P847, DOI 10.1016/0014-2921(94)90121-X; Voss T., 2001, SOCIAL NORMS, P105; Weidlich W, 2008, J ECON BEHAV ORGAN, V67, P1, DOI 10.1016/j.jebo.2007.02.002; Wilson, 2000, SOCIOBIOLOGY; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778; Zeeman E. C., 1977, CATASTROPHE THEORY	138	29	30	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e12530	10.1371/journal.pone.0012530	http://dx.doi.org/10.1371/journal.pone.0012530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	662KX	20967256	gold, Green Submitted, Green Published			2022-12-27	WOS:000282807300001
J	Abebe, G; Deribew, A; Apers, L; Woldemichael, K; Shiffa, J; Tesfaye, M; Abdissa, A; Deribie, F; Jira, C; Bezabih, M; Aseffa, A; Duchateau, L; Colebunders, R				Abebe, Gemeda; Deribew, Amare; Apers, Ludwig; Woldemichael, Kifle; Shiffa, Jaffer; Tesfaye, Markos; Abdissa, Alemseged; Deribie, Fetene; Jira, Chali; Bezabih, Mesele; Aseffa, Abraham; Duchateau, Luc; Colebunders, Robert			Knowledge, Health Seeking Behavior and Perceived Stigma towards Tuberculosis among Tuberculosis Suspects in a Rural Community in Southwest Ethiopia	PLOS ONE			English	Article							SMEAR-POSITIVE TUBERCULOSIS; PULMONARY TUBERCULOSIS; SERVICE DELAY; CARE SEEKING; GENDER; DIAGNOSIS; TB; PREVALENCE; PATIENT; WOMEN	Background: Perceived stigma and lack of awareness could contribute to the late presentation and low detection rate of tuberculosis (TB). We conducted a study in rural southwest Ethiopia among TB suspects to assess knowledge about and stigma towards TB and their health seeking behavior. Methods: A community based cross sectional survey was conducted from February to March 2009 in the Gilgel Gibe field research area. Any person 15 years and above with cough for at least 2 weeks was considered a TB suspect and included in the study. Data were collected by trained personnel using a pretested structured questionnaire. Logistic regression analysis was done using SPSS 15.0 statistical software. Results: Of the 476 pulmonary TB suspects, 395 (83.0%) had ever heard of TB; "evil eye'' (50.4%) was the commonly mentioned cause of TB. Individuals who could read and write were more likely to be aware about TB [(crude OR = 2.98, (95% CI: 1.25, 7.08)] and more likely to know that TB is caused by a microorganism [(adjusted OR = 3.16, (95% CI: 1.77, 5.65)] than non-educated individuals. Males were more likely to know the cause of TB [(adjusted OR = 1.92, (95% CI: 1.22, 3.03)] than females. 51.3% of TB suspects perceived that other people would consider them inferior if they had TB. High stigma towards TB was reported by 199(51.2%). 220 (46.2%) did not seek help for their illness. Individuals who had previous anti-TB treatment were more likely to have appropriate health seeking behavior [(adjusted OR = 3.65, (95% CI: 1.89, 7.06)] than those who had not. Conclusion: There was little knowledge about TB in the Gilgel Gibe field research area. We observed inappropriate health seeking behavior and stigma towards TB. TB control programs in Ethiopia should educate rural communities, particularly females and non-educated individuals, about the cause and the importance of early diagnosis and treatment of TB.	[Abebe, Gemeda; Abdissa, Alemseged; Deribie, Fetene; Bezabih, Mesele] Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia; [Deribew, Amare; Woldemichael, Kifle] Jimma Univ, Dept Epidemiol, Jimma, Ethiopia; [Apers, Ludwig; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Shiffa, Jaffer] Jimma Univ, Dept Internal Med, Jimma, Ethiopia; [Tesfaye, Markos] Jimma Univ, Dept Psychiat, Jimma, Ethiopia; [Jira, Chali] Jimma Univ, Dept Hlth Serv Management, Jimma, Ethiopia; [Aseffa, Abraham] Armauer Hanssen Res Inst, Addis Ababa, Ethiopia; [Duchateau, Luc] Univ Ghent, Dept Comparat Physiol & Biometr, B-9000 Ghent, Belgium; [Abebe, Gemeda; Deribew, Amare; Colebunders, Robert] Univ Antwerp, Dept Epidemiol & Social Med, B-2020 Antwerp, Belgium	Jimma University; Jimma University; Institute of Tropical Medicine (ITM); Jimma University; Jimma University; Jimma University; Ghent University; University of Antwerp	Abebe, G (corresponding author), Jimma Univ, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	gemeda.abebe@ju.edu.et	Abebe, Gemeda/AAB-8789-2019; Aseffa, Abraham/J-3248-2016; Tesfaye, Markos/H-9297-2019	Abebe, Gemeda/0000-0002-7172-9136; Aseffa, Abraham/0000-0002-8028-1150; Tesfaye, Markos/0000-0002-3351-701X; Deribew, Amare/0000-0003-2031-6080; Abdissa, Alemseged/0000-0001-6871-1958	Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS)	Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS)	The study was funded by the Directorate General for Development Cooperation (DGDC) through the Flemish Interuniversity Council (VLIR-UOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Rumman K, 2008, AM J TROP MED HYG, V79, P545, DOI 10.4269/ajtmh.2008.79.545; Ayuo P O, 2008, East Afr Med J, V85, P263; Baral SC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-211; Chang Ching Thon, 2007, Rural Remote Health, V7, P667; Demissie M, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-23; Demissie M, 2002, INT J TUBERC LUNG D, V6, P580; Demissie M., 2000, Ethiopian Journal of Health Development, V14, P277; Dodor EA, 2009, PSYCHOL HEALTH MED, V14, P170, DOI 10.1080/13548500802199753; Dujardin B, 1997, TROP MED INT HEALTH, V2, P715, DOI 10.1046/j.1365-3156.1997.d01-388.x; Getahun H, 1999, ETHIOPIAN MED J, V37, P147; Global Initiative for Asthma, 2009, PUBL WHO, V02-3659; Hoa NP, 2003, SCAND J PUBLIC HEALT, V31, P59, DOI 10.1080/14034950310015121; Hoa NR, 2004, INT J TUBERC LUNG D, V8, P603; Huong NT, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-110; Johansson E, 2000, HEALTH POLICY, V52, P33, DOI 10.1016/S0168-8510(00)00062-2; Karim F, 2007, HEALTH POLICY PLANN, V22, P329, DOI 10.1093/heapol/czm026; Kassu Afework, 2007, Journal of Microbiology Immunology and Infection, V40, P116; Kiwuwa MS, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-122; Long NH, 1999, SOC SCI MED, V49, P815, DOI 10.1016/S0277-9536(99)00171-9; MADEBO T, 1999, MED GEN MED, pE6; Mangesho P E, 2007, Tanzan Health Res Bull, V9, P38; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P7; Mesfin M. M., 2005, Ethiopian Journal of Health Development, V19, P21; Mesfin MM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-53; *MOH ETH, 2008, TUB LEPR TB HIV PREV; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P1042; Needham DM, 2001, TROP MED INT HEALTH, V6, P256, DOI 10.1046/j.1365-3156.2001.00709.x; Ouedraogo M, 2006, INT J TUBERC LUNG D, V10, P184; Shargie EB, 2006, INT J TUBERC LUNG D, V10, P87; Sharma N, 2007, ASIA-PAC J PUBLIC HE, V19, P10, DOI 10.1177/10105395070190020301; Shetty N, 2004, Commun Dis Public Health, V7, P77; Somma D, 2008, INT J TUBERC LUNG D, V12, P856; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Steen TW, 1999, SOC SCI MED, V48, P163, DOI 10.1016/S0277-9536(98)00329-3; Tatek Wondimu, 2007, Ethiopian Journal of Health Development, V21, P148; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; Wang Y, 2008, TROP MED INT HEALTH, V13, P927, DOI 10.1111/j.1365-3156.2008.02093.x; *WHO, 2009, GLOB TUB CONTR SHORT; WHO, STOP TB STRAT; Yimer S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-454	40	97	99	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13339	10.1371/journal.pone.0013339	http://dx.doi.org/10.1371/journal.pone.0013339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20948963	Green Published, gold, Green Submitted			2022-12-27	WOS:000282748100033
J	Laloux, G; Deghelt, M; de Barsy, M; Letesson, JJ; De Bolle, X				Laloux, Geraldine; Deghelt, Michael; de Barsy, Marie; Letesson, Jean-Jacques; De Bolle, Xavier			Identification of the Essential Brucella melitensis Porin Omp2b as a Suppressor of Bax-Induced Cell Death in Yeast in a Genome-Wide Screening	PLOS ONE			English	Article							MAMMALIAN-CELLS; SACCHAROMYCES-CEREVISIAE; BACTERIAL PATHOGENS; BCL-2 FAMILY; IN-VITRO; APOPTOSIS; PROTEINS; MEMBRANE; SYSTEM; MITOCHONDRIA	Background: Inhibition of apoptosis is one of the mechanisms selected by numerous intracellular pathogenic bacteria to control their host cell. Brucellae, which are the causative agent of a worldwide zoonosis, prevent apoptosis of infected cells, probably to support survival of their replication niche. Methodology/Principal Findings: In order to identify Brucella melitensis anti-apoptotic effector candidates, we performed a genome-wide functional screening in yeast. The B. melitensis ORFeome was screened to identify inhibitors of Bax-induced cell death in S. cerevisiae. B. melitensis porin Omp2b, here shown to be essential, prevents Bax lethal effect in yeast, unlike its close paralog Omp2a. Our results based on Omp2b size variants characterization suggest that signal peptide processing is required for Omp2b effect in yeast. Conclusion/Significance: We report here the first application to a bacterial genome-wide library of coding sequences of this "yeast-rescue" screening strategy, previously used to highlight several new apoptosis regulators. Our work provides B. melitensis proteins that are candidates for an anti-apoptotic function, and can be tested in mammalian cells in the future. Hypotheses on possible molecular mechanisms of Bax inhibition by the B. melitensis porin Omp2b are discussed.	[Laloux, Geraldine; Deghelt, Michael; de Barsy, Marie; Letesson, Jean-Jacques; De Bolle, Xavier] Univ Namur FUNDP, Dept Biol, Res Unit Mol Biol, Namur, Belgium	University of Namur	Laloux, G (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	xavier.debolle@fundp.ac.be	Laloux, Geraldine/AAF-9009-2021; Jean-Jacques, LETESSON/AHB-6921-2022; Laloux, Geraldine/N-4373-2017	Laloux, Geraldine/0000-0003-3230-1679; Laloux, Geraldine/0000-0003-3230-1679; De Bolle, Xavier/0000-0002-3845-3043; LETESSON, Jean-Jacques/0000-0002-5838-0224	FRFC (Fonds de la Recherche Fondamentale Collective) [2.4521.04, 2.4541.08]; ARC (Actions de Recherche Concertee) [04/09-325, 08/13-015]; University of Namur; FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique)	FRFC (Fonds de la Recherche Fondamentale Collective)(Fonds de la Recherche Scientifique - FNRS); ARC (Actions de Recherche Concertee); University of Namur; FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique)(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the FRFC (Fonds de la Recherche Fondamentale Collective, agreements 2.4521.04 and 2.4541.08), an ARC project (Actions de Recherche Concertee, agreements 04/09-325 and 08/13-015, French-Speaking Community of Belgium) and by the University of Namur. G. Laloux held a PhD fellowship from the FRS-FNRS (Fonds de la Recherche Scientifique - Fonds National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Chen SR, 2004, PLANT PHYSIOL, V135, P1630, DOI 10.1104/pp.103.038091; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Clement JM, 1995, J BIOTECHNOL, V43, P169, DOI 10.1016/0168-1656(95)00127-1; Dricot A, 2004, GENOME RES, V14, P2201, DOI 10.1101/gr.2456204; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Faherty CS, 2008, TRENDS MICROBIOL, V16, P173, DOI 10.1016/j.tim.2008.02.001; Forestier C, 1999, J IMMUNOL, V162, P6784; Greenhalf W, 1999, YEAST, V15, P1307, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1307::AID-YEA455>3.3.CO;2-V; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; HALL J, 1990, J BIOL CHEM, V265, P19996; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Khoury CM, 2008, BBA-MOL CELL RES, V1783, P1449, DOI 10.1016/j.bbamcr.2007.12.013; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Kozjak-Pavlovic V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000629; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamontagne J, 2007, J PROTEOME RES, V6, P1519, DOI 10.1021/pr060636a; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Levine A, 2001, J BIOL CHEM, V276, P46284, DOI 10.1074/jbc.M107375200; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; Massari P, 2003, CELL MICROBIOL, V5, P99, DOI 10.1046/j.1462-5822.2003.00257.x; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Moeller L, 2009, J EXP BOT, V60, P3337, DOI 10.1093/jxb/erp167; Muller A, 2000, EMBO J, V19, P5332, DOI 10.1093/emboj/19.20.5332; Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339; Niu H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000774; Paquet JY, 2001, J BACTERIOL, V183, P4839, DOI 10.1128/JB.183.16.4839-4847.2001; Polcic P, 2003, BIOCHEM J, V374, P393, DOI 10.1042/BJ20030690; Sanchez P, 2000, PLANT J, V21, P393, DOI 10.1046/j.1365-313x.2000.00690.x; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Walther DM, 2009, P NATL ACAD SCI USA, V106, P2531, DOI 10.1073/pnas.0807830106; Xu QL, 2000, METHOD ENZYMOL, V322, P283; Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zhang H, 2000, P NATL ACAD SCI USA, V97, P2597, DOI 10.1073/pnas.97.6.2597	44	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13274	10.1371/journal.pone.0013274	http://dx.doi.org/10.1371/journal.pone.0013274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949000	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100016
J	Hoppenrath, M; Leander, BS				Hoppenrath, Mona; Leander, Brian S.			Dinoflagellate Phylogeny as Inferred from Heat Shock Protein 90 and Ribosomal Gene Sequences	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; ELECTRON-MICROSCOPY; OXYRRHIS-MARINA; SP-NOV; EVOLUTIONARY HISTORY; PLANKTONIC DIATOMS; RDNA SEQUENCES; DNA-SEQUENCES; SUBUNIT RDNA; BODY SCALES	Background: Interrelationships among dinoflagellates in molecular phylogenies are largely unresolved, especially in the deepest branches. Ribosomal DNA (rDNA) sequences provide phylogenetic signals only at the tips of the dinoflagellate tree. Two reasons for the poor resolution of deep dinoflagellate relationships using rDNA sequences are (1) most sites are relatively conserved and (2) there are different evolutionary rates among sites in different lineages. Therefore, alternative molecular markers are required to address the deeper phylogenetic relationships among dinoflagellates. Preliminary evidence indicates that the heat shock protein 90 gene (Hsp90) will provide an informative marker, mainly because this gene is relatively long and appears to have relatively uniform rates of evolution in different lineages. Methodology/Principal Findings: We more than doubled the previous dataset of Hsp90 sequences from dinoflagellates by generating additional sequences from 17 different species, representing seven different orders. In order to concatenate the Hsp90 data with rDNA sequences, we supplemented the Hsp90 sequences with three new SSU rDNA sequences and five new LSU rDNA sequences. The new Hsp90 sequences were generated, in part, from four additional heterotrophic dinoflagellates and the type species for six different genera. Molecular phylogenetic analyses resulted in a paraphyletic assemblage near the base of the dinoflagellate tree consisting of only athecate species. However, Noctiluca was never part of this assemblage and branched in a position that was nested within other lineages of dinokaryotes. The phylogenetic trees inferred from Hsp90 sequences were consistent with trees inferred from rDNA sequences in that the backbone of the dinoflagellate clade was largely unresolved. Conclusions/Significance: The sequence conservation in both Hsp90 and rDNA sequences and the poor resolution of the deepest nodes suggests that dinoflagellates reflect an explosive radiation in morphological diversity in their recent evolutionary past. Nonetheless, the more comprehensive analysis of Hsp90 sequences enabled us to infer phylogenetic interrelationships of dinoflagellates more rigorously. For instance, the phylogenetic position of Noctiluca, which possesses several unusual features, was incongruent with previous phylogenetic studies. Therefore, the generation of additional dinoflagellate Hsp90 sequences is expected to refine the stem group of athecate species observed here and contribute to future multi-gene analyses of dinoflagellate interrelationships.	[Hoppenrath, Mona; Leander, Brian S.] Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Vancouver, BC, Canada; [Hoppenrath, Mona] Deutsch Zentrum Marine Biodiversitatsforsch, Forschungsinst Senckenberg, Wilhelmshaven, Germany	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Senckenberg Gesellschaft fur Naturforschung (SGN)	Hoppenrath, M (corresponding author), Univ British Columbia, Dept Zool, Canadian Inst Adv Res, Program Integrated Microbial Biodivers, Vancouver, BC, Canada.	leander@zoology.ubc.ca			Deutsche Forschungsgemeinschaft [Ho3267/1-1]; National Science and Engineering Research Council of Canada (NSERC) [NSERC 283091-09]; National Science Foundation's Assembling the Tree of Life (NSF) [EF-0629624]; Canadian Institute for Advanced Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation's Assembling the Tree of Life (NSF); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by a postdoctoral scholarship from the Deutsche Forschungsgemeinschaft (Grant Ho3267/1-1), by operating grants from the National Science and Engineering Research Council of Canada (NSERC 283091-09), the National Science Foundation's Assembling the Tree of Life (NSF #EF-0629624), and by the Canadian Institute for Advanced Research, Program in Integrated Microbial Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Breglia SA, 2007, J EUKARYOT MICROBIOL, V54, P86, DOI 10.1111/j.1550-7408.2006.00233.x; CAVALIERSMITH T, 1993, MICROBIOL REV, V57, P953, DOI 10.1128/MMBR.57.4.953-994.1993; Clarke K.J, 1972, British phycol J, V7, P357; CLARKE KJ, 1976, BRIT PHYCOL J, V11, P345, DOI 10.1080/00071617600650391; Daugbjerg N, 2000, PHYCOLOGIA, V39, P302, DOI 10.2216/i0031-8884-39-4-302.1; de Salas MF, 2003, J PHYCOL, V39, P1233, DOI 10.1111/j.0022-3646.2003.03-019.x; Edvardsen B, 2003, J PHYCOL, V39, P395, DOI 10.1046/j.1529-8817.2003.01252.x; Fast NM, 2002, J EUKARYOT MICROBIOL, V49, P30, DOI 10.1111/j.1550-7408.2002.tb00336.x; Fensome R.A., 1993, MICROPALEONTOLOGY, V7, P1; Fukuda Y, 2008, EUR J PROTISTOL, V44, P27, DOI 10.1016/j.ejop.2007.07.001; Fukuda Y, 2006, EUR J PROTISTOL, V42, P209, DOI 10.1016/j.ejop.2006.05.003; Gomez F, 2010, PROTIST, V161, P466, DOI 10.1016/j.protis.2009.12.005; Gribble KE, 2007, PHYCOLOGIA, V46, P315, DOI 10.2216/06-68.1; Gribble KE, 2006, J PHYCOL, V42, P1081, DOI 10.1111/j.1529-8817.2006.00267.x; Grzebyk D, 1998, J PHYCOL, V34, P1055, DOI 10.1046/j.1529-8817.1998.341055.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hackett JD, 2004, AM J BOT, V91, P1523, DOI 10.3732/ajb.91.10.1523; Handy SM, 2009, J PHYCOL, V45, P1163, DOI 10.1111/j.1529-8817.2009.00738.x; Hansen G, 2007, PHYCOL RES, V55, P25, DOI 10.1111/j.1440-1835.2006.00442.x; Hohfeld I, 1995, PHYCOLOGIA, V34, P508, DOI 10.2216/i0031-8884-34-6-508.1; Hoppenrath M, 2004, HELGOLAND MAR RES, V58, P243, DOI 10.1007/s10152-004-0190-6; Hoppenrath M., 2009, KL SENCKENBERG-REIHE, V49, P264; Hoppenrath M, 2008, J PHYCOL, V44, P451, DOI 10.1111/j.1529-8817.2008.00483.x; Hoppenrath M, 2007, PROTIST, V158, P209, DOI 10.1016/j.protis.2006.12.001; Hoppenrath M, 2007, J PHYCOL, V43, P366, DOI 10.1111/j.1529-8817.2007.00319.x; Hoppenrath M, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-116; Hoppenrath M, 2010, EUR J PROTISTOL, V46, P29, DOI 10.1016/j.ejop.2009.08.003; Iwataki M, 2004, PHYCOLOGIA, V43, P394, DOI 10.2216/i0031-8884-43-4-394.1; Jensen MH, 2009, J PHYCOL, V45, P1136, DOI 10.1111/j.1529-8817.2009.00741.x; Jorgensen MF, 2004, PHYCOL RES, V52, P284; Jorgensen MF, 2004, J PHYCOL, V40, P351, DOI 10.1111/j.1529-8817.2004.03131.x; Ki JS, 2010, EUR J PROTISTOL, V46, P111, DOI 10.1016/j.ejop.2009.11.001; Leander BS, 2004, J PHYCOL, V40, P341, DOI 10.1111/j.1529-8817.2004.03129.x; Leander BS, 2003, TRENDS ECOL EVOL, V18, P395, DOI 10.1016/S0169-5347(03)00152-6; Leander BS, 2003, INT J SYST EVOL MICR, V53, P345, DOI 10.1099/ijs.0.02284-0; Lindberg K, 2005, PHYCOLOGIA, V44, P416, DOI 10.2216/0031-8884(2005)44[416:SOWDIW]2.0.CO;2; Litaker RW, 1999, J PHYCOL, V35, P1379, DOI 10.1046/j.1529-8817.1999.3561379.x; Liu LY, 2007, P NATL ACAD SCI USA, V104, P696, DOI 10.1073/pnas.0607816103; MAROTEAUX L, 1985, BIOSYSTEMS, V18, P307, DOI 10.1016/0303-2647(85)90031-0; Mohammad-Noor N, 2007, PHYCOLOGIA, V46, P549, DOI 10.2216/06-94.1; Murray S, 2005, PROTIST, V156, P269, DOI 10.1016/j.protis.2005.05.003; Murray S, 2004, J PHYCOL, V40, P366, DOI 10.1046/j.1529-8817.2004.03132.x; Murray S, 2009, PROTIST, V160, P245, DOI 10.1016/j.protis.2008.12.004; Patterson DJ, 1999, AM NAT, V154, pS96, DOI 10.1086/303287; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saldarriaga JF, 2004, EUR J PROTISTOL, V40, P85, DOI 10.1016/j.ejop.2003.11.003; Saldarriaga JF, 2003, INT J SYST EVOL MICR, V53, P355, DOI 10.1099/ijs.0.02328-0; Saldarriaga JF, 2001, J MOL EVOL, V53, P204, DOI 10.1007/s002390010210; SCHNEPF E, 1993, HELGOLANDER MEERESUN, V47, P265, DOI 10.1007/BF02367168; SCHOLIN CA, 1994, J PHYCOL, V30, P999, DOI 10.1111/j.0022-3646.1994.00999.x; Sekida S, 2003, PHYCOLOGIA, V42, P661, DOI 10.2216/i0031-8884-42-6-661.1; Shalchian-Tabrizi K, 2006, J EUKARYOT MICROBIOL, V53, P217, DOI 10.1111/j.1550-7408.2006.00098.x; Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246; Slamovits CH, 2007, J MOL BIOL, V372, P356, DOI 10.1016/j.jmb.2007.06.085; Sparmann SF, 2008, PROTIST, V159, P383, DOI 10.1016/j.protis.2007.12.002; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stechmann A, 2003, J MOL EVOL, V57, P408, DOI 10.1007/s00239-003-2490-x; Tamura M, 2009, PHYCOL RES, V57, P304, DOI 10.1111/j.1440-1835.2009.00550.x; Taylor FJR, 2008, BIODIVERS CONSERV, V17, P407, DOI 10.1007/s10531-007-9258-3; Taylor F.J.R., 1987, BOT MONOGR, VVolume 21; Taylor FJR, 2004, PHYCOL RES, V52, P308, DOI 10.1111/j.1440-1835.2004.tb00341.x; TAYLOR FJR, 1980, BIOSYSTEMS, V13, P65, DOI 10.1016/0303-2647(80)90006-4; UHLIG G, 1972, ENTWICKLUNG NOCTILUC; WATANABE MM, 1990, J PHYCOL, V26, P741, DOI 10.1111/j.0022-3646.1990.00741.x; Yamaguchi A, 2006, PHYCOL RES, V54, P317, DOI 10.1111/j.1440-1835.2006.00438.x; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Zhang H, 2007, J MOL EVOL, V65, P463, DOI 10.1007/s00239-007-9038-4; ZINGMARK RG, 1970, J PHYCOL, V6, P122, DOI 10.1111/j.0022-3646.1970.00122.x	70	65	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13220	10.1371/journal.pone.0013220	http://dx.doi.org/10.1371/journal.pone.0013220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949037	Green Submitted, Green Published, gold			2022-12-27	WOS:000282676700009
J	Castiello, U; Becchio, C; Zoia, S; Nelini, C; Sartori, L; Blason, L; D'Ottavio, G; Bulgheroni, M; Gallese, V				Castiello, Umberto; Becchio, Cristina; Zoia, Stefania; Nelini, Cristian; Sartori, Luisa; Blason, Laura; D'Ottavio, Giuseppina; Bulgheroni, Maria; Gallese, Vittorio			Wired to Be Social: The Ontogeny of Human Interaction	PLOS ONE			English	Article							4-DIMENSIONAL SONOGRAPHY; TWIN PREGNANCIES; NEWBORN-INFANTS; FETAL BEHAVIOR; MOVEMENTS; COGNITION; INTENTION; GESTURES; FETUS	Background: Newborns come into the world wired to socially interact. Is a propensity to socially oriented action already present before birth? Twin pregnancies provide a unique opportunity to investigate the social pre-wiring hypothesis. Although various types of inter-twins contact have been demonstrated starting from the 11(th) week of gestation, no study has so far investigated the critical question whether intra-pair contact is the result of motor planning rather then the accidental outcome of spatial proximity. Methodology/Principal Findings: Kinematic profiles of movements in five pairs of twin foetuses were studied by using four-dimensional ultrasonography during two separate recording sessions carried out at the 14(th) and 18(th) week of gestation. We demonstrate that by the 14(th) week of gestation twin foetuses do not only display movements directed towards the uterine wall and self-directed movements, but also movements specifically aimed at the co-twin, the proportion of which increases between the 14(th) and 18(th) gestational week. Kinematic analysis revealed that movement duration was longer and deceleration time was prolonged for other-directed movements compared to movements directed towards the uterine wall. Similar kinematic profiles were observed for movements directed towards the co-twin and self-directed movements aimed at the eye-region, i.e. the most delicate region of the body. Conclusions/Significance: We conclude that performance of movements towards the co-twin is not accidental: already starting from the 14(th) week of gestation twin foetuses execute movements specifically aimed at the co-twin.	[Castiello, Umberto; Nelini, Cristian; Sartori, Luisa] Univ Padua, Dept Gen Psychol, Padua, Italy; [Becchio, Cristina] Univ Turin, Ctr Cognit Sci, Dept Psychol, Turin, Italy; [Zoia, Stefania; Blason, Laura; Bulgheroni, Maria] Inst Child Hlth IRCCS, Dept Paediat, Child Neurol & Psychiat Unit, Trieste, Italy; [D'Ottavio, Giuseppina] Inst Child Hlth IRCCS, Dept Obstet & Gynaecol, Unit Prenatal Diag, Trieste, Italy; [Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] IIT, Sect Parma, Parma, Italy	University of Padua; University of Turin; University of Parma	Castiello, U (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	umberto.castiello@unipd.it	Gallese, Vittorio/ABD-5097-2021; ZOIA, STEFANIA/HCI-1235-2022	Gallese, Vittorio/0000-0003-4815-3607; Sartori, Luisa/0000-0002-3838-8958; Becchio, Cristina/0000-0002-6845-0521; Bulgheroni, Maria/0000-0001-8484-9834; Castiello, Umberto/0000-0003-0629-1286	Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy [R.C. 44/03]; Ministero Italiano dell' Universite e della Ricerca; Regione Piemonte; Bando Scienze Umane e Sociali [L.R. n.4/2006]	Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy; Ministero Italiano dell' Universite e della Ricerca; Regione Piemonte(Regione Piemonte); Bando Scienze Umane e Sociali	This work was supported by grant R.C. 44/03 of the Institute of Child Health IRCCS, Burlo Garofolo, Trieste, Italy and by the Ministero Italiano dell' Universite e della Ricerca. C.B. was supported by a grant from the Regione Piemonte, Bando Scienze Umane e Sociali 2008, L.R. n.4/2006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel-Tison C, 2004, EARLY HUM DEV, V78, P15, DOI 10.1016/j.earlhumdev.2004.03.002; Andonotopo W, 2005, J MATERN-FETAL NEO M, V17, P165, DOI 10.1080/14767050400028717; Arabin B, 1996, ULTRASOUND OBST GYN, V8, P166, DOI 10.1046/j.1469-0705.1996.08030166.x; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Braten S, 2009, ADV CONSC RES, V76, P1; BUBER M, 1923, I THOU; D'Elia A, 2001, EARLY HUM DEV, V65, P139, DOI 10.1016/S0378-3782(01)00224-9; DEVRIES JIP, 1988, EARLY HUM DEV, V16, P85, DOI 10.1016/0378-3782(88)90089-8; Gallese V, 2009, DEV PSYCHOL, V45, P103, DOI 10.1037/a0014436; GENTILUCCI M, 1991, NEUROPSYCHOLOGIA, V29, P361, DOI 10.1016/0028-3932(91)90025-4; Hata T, 1998, GYNECOL OBSTET INVES, V46, P26, DOI 10.1159/000009991; Kurjak A, 2003, J PERINAT MED, V31, P496, DOI 10.1515/JPM.2003.076; MELTZOFF AN, 1983, CHILD DEV, V54, P702, DOI 10.2307/1130058; MELTZOFF AN, 1989, DEV PSYCHOL, V25, P954, DOI 10.1037/0012-1649.25.6.954; MYOWAYAMAKOSHI M, 2006, DO HUMAN FETUSES ANT, P289; Piontelli A, 1997, EARLY HUM DEV, V50, P39, DOI 10.1016/S0378-3782(97)00091-1; REDDY V, 2007, INFANTS KNOW MINDS; Reece E A, 1989, Obstet Gynecol Surv, V44, P544, DOI 10.1097/00006254-198907000-00010; REID VM, 2007, SOCIAL COGNITION INF; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Sasaki M, 2010, INT J GYNECOL OBSTET, V108, P104, DOI 10.1016/j.ijgo.2009.09.025; SIVAL DA, 1990, EARLY HUM DEV, V23, P233, DOI 10.1016/0378-3782(90)90014-A; Sparling JW, 1999, PHYS THER, V79, P24, DOI 10.1093/ptj/79.1.24; Striano T, 2006, TRENDS COGN SCI, V10, P471, DOI 10.1016/j.tics.2006.08.006; TONGSONG T, 1992, INT J GYNECOL OBSTET, V38, P87, DOI 10.1016/0020-7292(92)90041-G; Trevarthen C., 1993, PERCEIVED SELF ECOLO, P121, DOI [10.1017/CBO9780511664007.009, DOI 10.1017/CBO9780511664007.009]; TREVARTHEN C., 1979, SPEECH BEGINNING HUM, P321; von Hofsten C, 2007, DEVELOPMENTAL SCI, V10, P54, DOI 10.1111/j.1467-7687.2007.00564.x; von Hofsten C, 2009, SCAND J PSYCHOL, V50, P617, DOI 10.1111/j.1467-9450.2009.00780.x; Yigiter AB, 2006, J MATERN-FETAL NEO M, V19, P707, DOI 10.1080/14767050600924129; Zoia S, 2007, EXP BRAIN RES, V176, P217, DOI 10.1007/s00221-006-0607-3	32	99	100	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13199	10.1371/journal.pone.0013199	http://dx.doi.org/10.1371/journal.pone.0013199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660IN	20949058	Green Published, Green Submitted, gold			2022-12-27	WOS:000282633700008
J	Song, WW; Dou, XY; Qi, ZQ; Wang, Q; Zhang, X; Zhang, HF; Guo, M; Dong, SM; Zhang, ZG; Wang, P; Zheng, XB				Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Wang, Ping; Zheng, Xiaobo			R-SNARE Homolog MoSec22 Is Required for Conidiogenesis, Cell Wall Integrity, and Pathogenesis of Magnaporthe oryzae	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CHITIN SYNTHASE; RETROGRADE TRANSPORT; CALCOFLUOR WHITE; OXIDATIVE STRESS; GENE-EXPRESSION; NADPH OXIDASES; IDENTIFICATION; GRISEA	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate intracellular vesicle fusion, which is an essential cellular process of the eukaryotic cells. To investigate the role of SNARE proteins in the rice blast fungus Magnaporthe oryzae, MoSec22, an ortholog of Saccharomyces cerevisiae SNARE protein Sec22, was identified and the MoSEC22 gene disrupted. MoSec22 restored a S. cerevisiae sec22 mutant in resistance to cell wall perturbing agents, and the Delta Mosec22 mutant also exhibited defects in mycelial growth, conidial production, and infection of the host plant. Treatment with oxidative stress inducers indicated a breach in cell wall integrity, and staining and quantification assays suggested abnormal chitin deposition on the lateral walls of hyphae of the Delta Mosec22 mutant. Furthermore, hypersensitivity to the oxidative stress correlates with the reduced expression of the extracellular enzymes peroxidases and laccases. Our study thus provides new evidence on the conserved function of Sec22 among fungal organisms and indicates that MoSec22 has a role in maintaining cell wall integrity affecting the growth, morphogenesis, and virulence of M. oryzae.	[Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Zheng, Xiaobo] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Peoples R China; [Song, Wenwen; Dou, Xianying; Qi, Zhongqiang; Wang, Qi; Zhang, Xing; Zhang, Haifeng; Guo, Min; Dong, Suomeng; Zhang, Zhengguang; Zheng, Xiaobo] Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Wang, Ping] Louisiana State Univ, Dept Pediat, Hlth Sci Ctr, New Orleans, LA USA; [Wang, Ping] Louisiana State Univ, Res Inst Children, Hlth Sci Ctr, New Orleans, LA USA	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, ZG (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing, Peoples R China.	zhgzhang@njau.edu.cn	Zhang, Zhengguang/F-3917-2014		Special Fund for Agro-scientific Research in the Public Interest [200803008]; National Basic Research Program of China [2006CB101901]; Ministry of Education of China [NCET-07-0442]; Natural Science Foundations of China [30771394, 30971890]; US NIH/NIAID [AI054958]	Special Fund for Agro-scientific Research in the Public Interest; National Basic Research Program of China(National Basic Research Program of China); Ministry of Education of China(Ministry of Education, China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Special Fund for Agro-scientific Research in the Public Interest (200803008 to ZG Zhang), National Basic Research Program of China (2006CB101901 to Zhengguang Zhang), the New Century Excellent Scholar Project of the Ministry of Education of China (NCET-07-0442 to ZG Zhang), and the Natural Science Foundations of China (30771394 and 30971890 to XB Zheng). Research in Ping Wang lab was partially supported by a US grant (NIH/NIAID AI054958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TH, 1998, MICROBIOL MOL BIOL R, V62, P35, DOI 10.1128/MMBR.62.1.35-54.1998; APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Bulik DA, 2003, EUKARYOT CELL, V2, P886, DOI 10.1128/EC.2.5.886-900.2003; Burri L, 2004, TRAFFIC, V5, P45, DOI 10.1046/j.1600-0854.2003.00151.x; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55; Chen HJ, 2008, NUMER MATH-THEORY ME, V1, P1; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chi MH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000401; Choquer M, 2004, EUR J BIOCHEM, V271, P2153, DOI 10.1111/j.1432-1033.2004.04135.x; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Doke N, 1996, GENE, V179, P45, DOI 10.1016/S0378-1119(96)00423-4; Dufresne M, 2001, MOL PLANT MICROBE IN, V14, P300, DOI 10.1094/MPMI.2001.14.3.300; Ebbole DJ, 2007, ANNU REV PHYTOPATHOL, V45, P437, DOI 10.1146/annurev.phyto.45.062806.094346; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; ELORZA MV, 1983, J GEN MICROBIOL, V129, P1577; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fuchs U, 2005, PROTOPLASMA, V226, P75, DOI 10.1007/s00709-005-0109-3; Garzia A, 2009, MOL MICROBIOL, V71, P172, DOI 10.1111/j.1365-2958.2008.06520.x; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Gilbert MJ, 2006, NATURE, V440, P535, DOI 10.1038/nature04567; Guo M, 2010, MOL PLANT MICROBE IN, V23, P1053, DOI 10.1094/MPMI-23-8-1053; Gupta GD, 2002, FUNGAL GENET BIOL, V36, P1, DOI 10.1016/S1087-1845(02)00017-8; HARRIS SD, 1994, GENETICS, V136, P517; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; Igual JC, 1996, EMBO J, V15, P5001, DOI 10.1002/j.1460-2075.1996.tb00880.x; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kikuma T, 2007, AUTOPHAGY, V3, P128, DOI 10.4161/auto.3560; Kuratsu M, 2007, FUNGAL GENET BIOL, V44, P1310, DOI 10.1016/j.fgb.2007.04.012; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; Lesage G, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-8; Lipke PN, 1998, J BACTERIOL, V180, P3735, DOI 10.1128/JB.180.15.3735-3740.1998; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lussier M, 1997, GENETICS, V147, P435; Madrid MP, 2003, MOL MICROBIOL, V47, P257, DOI 10.1046/j.1365-2958.2003.03299.x; Martin-Udiroz M, 2004, MICROBIOL-SGM, V150, P3175, DOI 10.1099/mic.0.27236-0; Molina L, 2007, PLANT CELL, V19, P2293, DOI 10.1105/tpc.107.052332; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Ni L, 2001, MOL BIOL CELL, V12, P2147, DOI 10.1091/mbc.12.7.2147; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; RAM AFJ, 1995, FEBS LETT, V358, P165, DOI 10.1016/0014-5793(94)01418-Z; RONCERO C, 1985, J BACTERIOL, V163, P1180, DOI 10.1128/JB.163.3.1180-1185.1985; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sanderfoot AA, 2000, PLANT PHYSIOL, V124, P1558, DOI 10.1104/pp.124.4.1558; Segmuller N, 2008, MOL PLANT MICROBE IN, V21, P808, DOI 10.1094/MPMI-21-6-0808; Sesma A, 2004, NATURE, V431, P582, DOI 10.1038/nature02880; SHIMIZU J, 1994, MOL GEN GENET, V242, P641, DOI 10.1007/BF00283417; Silue D, 1998, PHYSIOL MOL PLANT P, V53, P239, DOI 10.1006/pmpp.1998.0180; Skamnioti P, 2007, PLANT CELL, V19, P2674, DOI 10.1105/tpc.107.051219; SLACK JK, 1994, NUCLEIC ACIDS RES, V22, P1316; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timberlake WE, 1991, CURR OPIN GENET DEV, V1, P351, DOI 10.1016/S0959-437X(05)80299-0; VALENT B, 1991, GENETICS, V127, P87; Wedlich-Soldner R, 2000, EMBO J, V19, P1974, DOI 10.1093/emboj/19.9.1974; WOOD PJ, 1983, J HISTOCHEM CYTOCHEM, V31, P823, DOI 10.1177/31.6.6841974; Yi M, 2009, PLANT CELL, V21, P681, DOI 10.1105/tpc.107.055988; Yukioka H, 1998, BBA-GENE STRUCT EXPR, V1442, P161, DOI 10.1016/S0167-4781(98)00159-6; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zheng W, 2007, EUKARYOT CELL, V6, P2240, DOI 10.1128/EC.00104-07; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	70	61	69	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13193	10.1371/journal.pone.0013193	http://dx.doi.org/10.1371/journal.pone.0013193			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949084	Green Submitted, Green Published, gold			2022-12-27	WOS:000282568400011
J	Nunes, A; Nogueira, PJ; Borrego, MJ; Gomes, JP				Nunes, Alexandra; Nogueira, Paulo J.; Borrego, Maria J.; Gomes, Joao P.			Adaptive Evolution of the Chlamydia trachomatis Dominant Antigen Reveals Distinct Evolutionary Scenarios for B- and T- cell Epitopes: Worldwide Survey	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI; CODON USAGE; NUCLEOTIDE SUBSTITUTIONS; GENE-EXPRESSION; INFECTED HUMANS; TISSUE TROPISM; HOST-CELL; SEROVAR; RECOMBINATION	Background: Chlamydia trachomatis is one of the most disseminated human pathogens, for which no vaccine is available yet. Understanding the impact of the host pressure on pathogen antigens is crucial, but so far it was only assessed for highly-restricted geographic areas. We aimed to evaluate the evolutionary picture of the chlamydial key antigen (MOMP), which is one of the leading multi-subunit vaccine candidates, in a worldwide basis. Methodology/Principal Findings: Using genetics, molecular evolution methods and mathematical modelling, we analyzed all MOMP sequences reported worldwide, composed by 5026 strains from 33 geographic regions of five continents. Overall, 35.9% of variants were detected. The evolutionary pattern of MOMP amino acid gains/losses was found to differ from the remaining chromosome, reflecting the demanding constraints of this porin, adhesin and dominant antigen. Amino acid changes were 4.3-fold more frequent in host-interacting domains (P<10(-12)), specifically within B-cell epitopes (P<10(-5)), where 25% of them are at fixation (P<10(-5)). According to the typical pathogen-host arms race, this rampant B-cell antigenic variation likely represents neutralization escape mutants, as some mutations were previously shown to abrogate neutralization of chlamydial infectivity in vitro. In contrast, T-cell clusters of diverse HLA specificities are under purifying selection, suggesting a strategy that may lead to immune subversion. Moreover, several silent mutations are at fixation, generating preferential codons that may influence expression, and may also reflect recombination-derived `hitchhikingeffect' from favourable nonsilent changes. Interestingly, the most prevalent C. trachomatis genotypes, E and F, showed a mutation rate 22.3-fold lower than that of the remainder (P<10(-20)), suggesting more fitted antigenic profiles. Conclusions/Significance: Globally, the adaptive evolution of the C. trachomatis dominant antigen is likely driven by its complex pathogenesis-related function and reflects distinct evolutionary antigenic scenarios that may benefit the pathogen, and thus should be taking into account in the development of a MOMP-based vaccine.	[Nunes, Alexandra; Borrego, Maria J.; Gomes, Joao P.] Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal; [Nogueira, Paulo J.] Natl Inst Hlth, Dept Epidemiol, Lisbon, Portugal		Nunes, A (corresponding author), Natl Inst Hlth, Dept Infect Dis, Lisbon, Portugal.	j.paulo.gomes@insa.min-saude.pt	Nogueira, Paulo/HDL-7482-2022; Nunes, Alexandra/ABE-3699-2020; Nogueira, Paulo Jorge/AAR-5605-2020	Nogueira, Paulo Jorge/0000-0001-8316-5035; Gomes, Joao Paulo/0000-0002-2697-2399; Nunes, Alexandra/0000-0001-6449-8053; Borrego, Maria Jose/0000-0002-8604-8800	Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/BIA-BCM/71117/2006]; FCT [SFRH/BD/25651/2005]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e a Tecnologia (FCT) grant to JPG (PTDC/BIA-BCM/71117/2006). AN is the recipient of the PhD Grant SFRH/BD/25651/2005 from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson SGE, 1998, TRENDS MICROBIOL, V6, P263, DOI 10.1016/S0966-842X(98)01312-2; Arno JN, 1998, J INFECT DIS, V178, P1713, DOI 10.1086/314478; Batteiger BE, 1996, INFECT IMMUN, V64, P2839, DOI 10.1128/IAI.64.7.2839-2841.1996; Batteiger BE, 1996, INFECT IMMUN, V64, P542, DOI 10.1128/IAI.64.2.542-547.1996; BRUNHAM R, 1994, J CLIN INVEST, V94, P458, DOI 10.1172/JCI117347; BRUNHAM RC, 1992, J INFECT DIS, V165, P1076, DOI 10.1093/infdis/165.6.1076; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Chamary JV, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r75; Ciurea A, 2000, P NATL ACAD SCI USA, V97, P2749, DOI 10.1073/pnas.040558797; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; de la Maza Luis M, 2002, Curr Opin Investig Drugs, V3, P980; Gao WW, 1997, MOL MICROBIOL, V25, P707, DOI 10.1046/j.1365-2958.1997.5081871.x; Giles TN, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-166; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Gomes JP, 2006, MICROBES INFECT, V8, P16, DOI 10.1016/j.micinf.2005.05.014; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hatch TP, 1996, J BACTERIOL, V178, P1; HAYES LJ, 1990, J GEN MICROBIOL, V136, P1559, DOI 10.1099/00221287-136-8-1559; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Igietseme Joseph U, 2003, Expert Rev Vaccines, V2, P129, DOI 10.1586/14760584.2.1.129; Igietseme Joseph U, 2004, Expert Rev Vaccines, V3, P23; Jordan IK, 2005, NATURE, V433, P633, DOI 10.1038/nature03306; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; KAPLAN NL, 1989, GENETICS, V123, P887; Kari L, 2009, J IMMUNOL, V182, P8063, DOI 10.4049/jimmunol.0804375; Kim SK, 1999, J IMMUNOL, V162, P6855; Kim SK, 2001, CURR OPIN IMMUNOL, V13, P429, DOI 10.1016/S0952-7915(00)00237-5; Komar AA, 1999, FEBS LETT, V462, P387, DOI 10.1016/S0014-5793(99)01566-5; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Lesnik T, 2000, J THEOR BIOL, V202, P175, DOI 10.1006/jtbi.1999.1047; Lu H, 2005, ACTA BIOCH BIOPH SIN, V37, P1, DOI 10.1093/abbs/37.1.1; Millman KL, 2001, J BACTERIOL, V183, P5997, DOI 10.1128/JB.183.20.5997-6008.2001; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nunes A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r153; Nunes A, 2009, J BACTERIOL, V191, P7182, DOI 10.1128/JB.00895-09; Ortiz L, 2000, INFECT IMMUN, V68, P1719, DOI 10.1128/IAI.68.3.1719-1723.2000; Ortiz L, 1996, J IMMUNOL, V157, P4554; PETERSON EM, 1988, J BACTERIOL, V170, P1389, DOI 10.1128/jb.170.3.1389-1392.1988; Resnikoff S, 2001, B WORLD HEALTH ORGAN, V79, P222; Rodriguez-Maranon MJ, 2002, PROTEIN SCI, V11, P1854, DOI 10.1110/ps.3650102; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Stephens R. S., 2002, CHLAMYDIAL INFECT; SU H, 1990, INFECT IMMUN, V58, P1017, DOI 10.1128/IAI.58.4.1017-1025.1990; Sun G, 2007, J BACTERIOL, V189, P6222, DOI 10.1128/JB.00552-07; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Wang Y, 2006, PROTEIN SCI, V15, P122, DOI 10.1110/ps.051616206; YUAN Y, 1989, INFECT IMMUN, V57, P1040, DOI 10.1128/IAI.57.4.1040-1049.1989; Zar J. H., 1996, BIOSTATISTICAL ANAL; ZHANG YX, 1989, INFECT IMMUN, V57, P636, DOI 10.1128/IAI.57.2.636-638.1989; ZHONG GM, 1991, INFECT IMMUN, V59, P1141, DOI 10.1128/IAI.59.3.1141-1147.1991; ZHONG GM, 1990, INFECT IMMUN, V58, P1450, DOI 10.1128/IAI.58.5.1450-1455.1990	57	36	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13171	10.1371/journal.pone.0013171	http://dx.doi.org/10.1371/journal.pone.0013171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957150	Green Published, Green Submitted, gold			2022-12-27	WOS:000282506100010
J	Feller, M; Adam, M; Zwahlen, M; Brazzola, P; Niggli, F; Kuehni, C				Feller, Martin; Adam, Martin; Zwahlen, Marcel; Brazzola, Pierluigi; Niggli, Felix; Kuehni, Claudia		SPOG; SNC	Family Characteristics as Risk Factors for Childhood Acute Lymphoblastic Leukemia: A Population-Based Case-Control Study	PLOS ONE			English	Article							PARENTAL AGE; BIRTH CHARACTERISTICS; CANCER; COHORT; ASSOCIATION; PREGNANCY; ETIOLOGY; SWEDEN	Background: To date, few risk factors for childhood acute lymphoblastic leukemia (ALL) have been confirmed and the scientific literature is full of controversial "evidence." We examined if family characteristics, particularly maternal and paternal age and number of older siblings, were risk factors for childhood acute lymphoblastic leukemia (ALL). Methodology/Principal Findings: In this population-based nationwide matched case-control study, patients 0-14 years of age with ALL diagnosed 1991-2006 and registered in the Swiss Childhood Cancer Registry were linked with their census records of 1990 and 2000. Eight controls per case were selected from the census. The association between family characteristics and ALL was analyzed by conditional logistic regressions. We found that increasing maternal age was associated with incidence of ALL in the offspring (OR per 5-year increase in maternal age 1.18, 95% CI 1.05-1.31; p = 0.004), remaining stable (trend OR 1.14, 95% CI 0.99-1.31; p = 0.060) after adjustment for other risk factors. The association with paternal age was weaker (OR per 5-year increase 1.14, 95% CI 1.01-1.28, p = 0.032) and disappeared after adjustments. Number of older siblings was not associated with risk of ALL in the overall group of children aged 0-14 years at diagnosis. However, we found a negative trend between number of older siblings and ALL diagnosed at age 0-4 years (OR per sibling 0.85, 95% CI 0.68-1.06; p = 0.141) and a positive trend for ALL diagnosed at age 5-9 (OR 1.34, 95% CI 1.05-1.72; p = 0.019), with some evidence for an effect modification (p-value for interaction = 0.040). Conclusions: As in other studies, increasing maternal, but not paternal age was associated with risk of ALL. We found only a weak association with the number of older siblings, suggesting a delay in disease manifestation rather than a decrease in incidence.	[Feller, Martin; Adam, Martin; Zwahlen, Marcel; Kuehni, Claudia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Adam, Martin] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Adam, Martin] Univ Basel, Basel, Switzerland; [Brazzola, Pierluigi] Osped Reg Bellinzona & Valli Bellinzona, Bellinzona, Switzerland; [Niggli, Felix] Univ Childrens Hosp Zurich, Pediat Oncol Unit, Zurich, Switzerland	University of Bern; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Regional Hospital of Bellinzona & Valleys, San Giovanni; University Children's Hospital Zurich	Feller, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	kuehni@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Niggli, Felix/L-6547-2017; Feller, Martin/I-7852-2016	Zwahlen, Marcel/0000-0002-6772-6346; Niggli, Felix/0000-0002-7553-3712; Feller, Martin/0000-0003-2519-836X; Kuehni, Claudia E./0000-0001-8957-2002	Swiss Cancer League [OCS-01869-02-2006]; University of Bern; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur Krebskranke Kinder Regio Basiliensis	Swiss Cancer League; University of Bern; Swiss Pediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur Krebskranke Kinder Regio Basiliensis	This study was funded by the Swiss Cancer League (OCS-01869-02-2006) and the University of Bern. The Childhood Cancer Registry is supported by the Swiss Pediatric Oncology Group, Kinderkrebshilfe Schweiz, Stiftung fur Krebskranke Kinder Regio Basiliensis, and numerous other sponsors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOPP M, 2008, INT J EPIDEMIOL; Brown RC, 2007, INT J EPIDEMIOL, V36, P724, DOI 10.1093/ije/dyl299; CNATTINGIUS S, 1995, J NATL CANCER I, V87, P908, DOI 10.1093/jnci/87.12.908; Dockerty JD, 2001, INT J EPIDEMIOL, V30, P1428, DOI 10.1093/ije/30.6.1428; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves MF, 1997, LANCET, V349, P344, DOI 10.1016/S0140-6736(96)09412-3; GREAVES MF, 1988, LEUKEMIA, V2, P120; Hemminki K, 1999, EPIDEMIOLOGY, V10, P271, DOI 10.1097/00001648-199905000-00014; Hjalgrim LL, 2004, JNCI-J NATL CANCER I, V96, P1549, DOI 10.1093/jnci/djh287; Johnson KJ, 2009, EPIDEMIOLOGY, V20, P475, DOI 10.1097/EDE.0b013e3181a5a332; Johnson KJ, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-7; KAYE SA, 1991, CANCER-AM CANCER SOC, V68, P1351, DOI 10.1002/1097-0142(19910915)68:6<1351::AID-CNCR2820680627>3.0.CO;2-J; Law GR, 2002, BRIT J CANCER, V86, P350, DOI 10.1038/sj/bjc/6600092; Ma XM, 2005, CANCER CAUSE CONTROL, V16, P1075, DOI 10.1007/s10552-005-0356-9; Maule MM, 2007, INT J EPIDEMIOL, V36, P691, DOI 10.1093/ije/dym115; Michel G, 2007, SWISS MED WKLY, V137, P502; Murray L, 2002, BRIT J CANCER, V86, P356, DOI 10.1038/sj.bjc.6600012; Reynolds P, 2002, AM J EPIDEMIOL, V155, P603, DOI 10.1093/aje/155.7.603; Schuz J, 1999, INT J EPIDEMIOL, V28, P631, DOI 10.1093/ije/28.4.631; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Stiller CA, 2008, BRIT J CANCER, V98, P1006, DOI 10.1038/sj.bjc.6604237; Stiller CA, 2004, ONCOGENE, V23, P6429, DOI 10.1038/sj.onc.1207717; Westergaard T, 1997, J NATL CANCER I, V89, P939, DOI 10.1093/jnci/89.13.939; Wong Donny I M, 2006, BMC Blood Disord, V6, P5, DOI 10.1186/1471-2326-6-5; Yip BH, 2006, INT J EPIDEMIOL, V35, P1495, DOI 10.1093/ije/dyl177	25	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13156	10.1371/journal.pone.0013156	http://dx.doi.org/10.1371/journal.pone.0013156			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957179	Green Submitted, Green Published, gold			2022-12-27	WOS:000282423300008
J	Moschetti, R; Dimitri, P; Caizzi, R; Junakovic, N				Moschetti, Roberta; Dimitri, Patrizio; Caizzi, Ruggiero; Junakovic, Nikolaj			Genomic Instability of I Elements of Drosophila melanogaster in Absence of Dysgenic Crosses	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; TRANSGENES; REACTIVITY; IDENTIFICATION	Retrotranspostion of I factors in the female germline of Drosophila melanogaster is responsible for the so called I-R hybrid dysgenesis, a phenomenon that produces a broad spectrum of genetic abnormalities including reduced fertility, increased frequency of mutations and chromosome loss. Transposition of I factor depends on cellular conditions that are established in the oocytes of the reactive females and transmitted to their daughters. The so-called reactivity is a cellular state that may exhibit variable levels of expression and represents a permissive condition for I transposition at high levels. Defective I elements have been proposed to be the genetic determinants of reactivity and, through their differential expression, to modulate transposition of active copies in somatic and/or germ line cells. Recently, control of transposable element activity in the germ line has been found to depend on pi-RNAs, small repressive RNAs interacting with Piwi-family proteins and derived from larger transposable elements (TE)-derived primary transcripts. In particular, maternally transmitted I-element piRNAs originating from the 42AB region of polytene chromosomes were found to be involved in control of I element mobility. In the present work, we use a combination of cytological and molecular approaches to study the activity of I elements in three sublines of the inducer y; cn bw; sp isogenic strain and in dysgenic and non-dysgenic genetic backgrounds. Overall, the results of FISH and Southern blotting experiments clearly show that I elements are highly unstable in the Montpellier subline in the absence of classical dysgenic conditions. Such instability appears to be correlated to the amount of 5' and 3' I element transcripts detected by quantitative and real-time RT-PCR. The results of this study indicate that I elements can be highly active in the absence of a dysgenic crosses. Moreover, in the light of our results caution should be taken to assimilate the genomic annotation data on transposable elements to all y; cn bw sp sublines.	[Moschetti, Roberta; Caizzi, Ruggiero] Univ Bari Aldo Moro, Dipartimento Genet & Microbiol, Bari, Italy; [Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Junakovic, Nikolaj] CNR, Ist Biol & Patol Mol, Rome, Italy	Universita degli Studi di Bari Aldo Moro; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Moschetti, R (corresponding author), Univ Bari Aldo Moro, Dipartimento Genet & Microbiol, Bari, Italy.	patrizio.dimitri@uniroma1.it		Caizzi, Ruggiero/0000-0002-4360-2808; Moschetti, Roberta/0000-0003-3035-1090	National Institutes of Health (NIH); Istituto Pasteur-Fondazione Cenci Bolognetti	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by grants from the National Institutes of Health (NIH) and Istituto Pasteur-Fondazione Cenci Bolognetti. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BIEMONT C, 1994, J MOL EVOL, V39, P466, DOI 10.1007/BF00173415; BRENNECKE J, 2008, P NATL ACAD SCI USA, V105, P14964; BRENNECKE J, 2007, CELL; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; BROWN AJL, 1987, GENET RES, V49, P121, DOI 10.1017/S0016672300026914; BUCHETON A, 1978, HEREDITY, V40, P207, DOI 10.1038/hdy.1978.22; BUCHETON A, 1984, CELL, V38, P153, DOI 10.1016/0092-8674(84)90536-1; BUCHETON A, 1992, GENETICA, V86, P175, DOI 10.1007/BF00133719; BUSSEAU I, 1994, GENETICA, V93, P101, DOI 10.1007/BF01435243; Chaboissier MC, 1998, P NATL ACAD SCI USA, V95, P11781, DOI 10.1073/pnas.95.20.11781; Chambeyron S, 2005, CYTOGENET GENOME RES, V110, P215, DOI 10.1159/000084955; CHAMBEYRON S, 2008, PIRNA MEDIATED NUCL; DIFRANCO C, 1992, GENETICA, V86, P1; Dimitri P, 2005, CYTOGENET GENOME RES, V110, P160, DOI 10.1159/000084948; *FLYB, 2010, DAT DROS GEN GEN; Gauthier E, 2000, GENETICS, V156, P1867; GUERREIRO MPG, 1995, CHANGES CHROMOSOMAL; JENSEN S, 1995, MOL GEN GENET, V248, P381, DOI 10.1007/BF02191637; Jensen S, 2002, GENETICS, V162, P1197; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Junakovic N, 2004, METH MOL B, V260, P41, DOI 10.1385/1-59259-755-6:041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malinsky S, 2000, GENETICS, V156, P1147; Pardue ML, 1986, DROSOPHILA PRACTICAL, P111; PASYUKOVA EG, 1993, MOL GEN GENET, V240, P302, DOI 10.1007/BF00277071; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Robin S, 2003, GENETICS, V164, P521; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; VAURY C, 1989, CHROMOSOMA, V98, P215, DOI 10.1007/BF00329686; Zakharenko LP, 2007, HEREDITY, V99, P525, DOI 10.1038/sj.hdy.6801029	31	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13142	10.1371/journal.pone.0013142	http://dx.doi.org/10.1371/journal.pone.0013142			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957225	Green Submitted, Green Published, gold			2022-12-27	WOS:000282423300005
J	Pereira, CP; Bachli, EB; Schaer, DJ; Schoedon, G				Pereira, Claudia P.; Bachli, Esther B.; Schaer, Dominik J.; Schoedon, Gabriele			Transcriptome Analysis Revealed Unique Genes as Targets for the Anti-inflammatory Action of Activated Protein C in Human Macrophages	PLOS ONE			English	Article							FACTOR-KAPPA-B; SELENOPROTEIN-P EXPRESSION; HUMAN ENDOTHELIAL-CELLS; ALPHA PRODUCTION; HUMAN MONOCYTES; SEVERE SEPSIS; ANTICOAGULANT; INFLAMMATION; ACETYLATION; RECRUITMENT	Background: Activated protein C (APC) has been introduced as a therapeutic agent for treatment of patients with severe sepsis due to its unique anticoagulant and anti-inflammatory properties in the vascular system. In this study we investigated novel targets for the anti-inflammatory action of APC in human macrophages. Methods: Using a genome-wide approach, effects of APC on the expression profile in inflammatory activated human macrophages were analyzed. Results: We identified, for the first time, genes that are specifically regulated by APC under inflammatory conditions, such as chromatin binding protein 4B (CHMP4B) and p300/CBP-associated factor (PCAF), thus indicating a role of APC in the epigenetic control of gene transcription. A functional assay showed the influence of APC in the acetyltransferase/deacetylase activity of nuclear extracts from inflamed macrophages. Conclusion: Our data sheds new light on APC targets in inflammation and opens new lines of investigation that may be explored in order to further elucidate its unique molecule properties.	[Pereira, Claudia P.; Schaer, Dominik J.; Schoedon, Gabriele] Univ Zurich Hosp, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland; [Pereira, Claudia P.; Schaer, Dominik J.; Schoedon, Gabriele] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Bachli, Esther B.] Uster Hosp, Med Clin, Uster, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Pereira, CP (corresponding author), Univ Zurich Hosp, Div Internal Med, Inflammat Res Unit, CH-8091 Zurich, Switzerland.	klinsog@usz.unizh.ch		Schaer, Dominik J./0000-0002-6468-4013				Abate-Shen C, 2002, NAT REV CANCER, V2, P777, DOI 10.1038/nrc907; Akamatsu M, 1999, J BIOL CHEM, V274, P35933, DOI 10.1074/jbc.274.50.35933; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; BREEDEN L, 1987, NATURE, V329, P651, DOI 10.1038/329651a0; Brown K M, 2001, Public Health Nutr, V4, P593; Cavaillon JM, 2005, CRIT CARE MED, V33, pS506, DOI 10.1097/01.CCM.0000185502.21012.37; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dreher I, 1997, J BIOL CHEM, V272, P29364, DOI 10.1074/jbc.272.46.29364; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; Franscini N, 2004, CIRCULATION, V110, P2903, DOI 10.1161/01.CIR.0000146344.49689.BB; Gabellini D, 2003, EMBO J, V22, P3715, DOI 10.1093/emboj/cdg340; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Keslacy S, 2007, MOL PHARMACOL, V71, P609, DOI 10.1124/mol.106.030171; Kipling D, 1997, TRENDS GENET, V13, P141, DOI 10.1016/S0168-9525(97)01098-6; Lee J.H., 2006, RES J MICROBIOL, V1, P1, DOI DOI 10.1007/S00418-006-0143-Z; Lehrke M, 2004, NAT MED, V10, P126, DOI 10.1038/nm0204-126; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Marino F, 2010, J BIOL CHEM, V285, P19145, DOI 10.1074/jbc.M110.119875; Martens N, 2004, EXP CELL RES, V298, P239, DOI 10.1016/j.yexcr.2004.04.002; MICHAELY P, 1993, J BIOL CHEM, V268, P22703; Mostert V, 2001, BIOFACTORS, V14, P135, DOI 10.1002/biof.5520140118; PEREIRA C, 2007, J THROMB HAEMOST, V5; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Reddy P, 2008, J CLIN INVEST, V118, P2562, DOI 10.1172/JCI34712; Rezaie AR, 2010, CURR MED CHEM, V17, P2059, DOI 10.2174/092986710791233706; Schmeck B, 2008, J IMMUNOL, V181, P940, DOI 10.4049/jimmunol.181.2.940; Schmeck B, 2008, CIRC RES, V102, P888, DOI 10.1161/CIRCRESAHA.107.161307; Stephenson DA, 2006, J IMMUNOL, V177, P2115, DOI 10.4049/jimmunol.177.4.2115; Toltl LJ, 2008, THROMB HAEMOSTASIS, V100, P582, DOI 10.1160/TH08-03-0159; Vincent JL, 2005, CRIT CARE MED, V33, P2266, DOI 10.1097/01.CCM.0000181729.46010.83; Weiler H, 2010, CRIT CARE MED, V38, pS18, DOI 10.1097/CCM.0b013e3181c9cbb5; White B, 2000, BRIT J HAEMATOL, V110, P130, DOI 10.1046/j.1365-2141.2000.02128.x; Yuksel M, 2002, THROMB HAEMOSTASIS, V88, P267	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15352	10.1371/journal.pone.0015352	http://dx.doi.org/10.1371/journal.pone.0015352			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976180	Green Submitted, Green Published, gold			2022-12-27	WOS:000283043700031
J	Fathallah-Shaykh, HM				Fathallah-Shaykh, Hassan M.			Dynamics of the Drosophila Circadian Clock: Theoretical Anti-Jitter Network and Controlled Chaos	PLOS ONE			English	Article							TRANSCRIPTIONAL REPRESSOR; MATHEMATICAL-MODEL; LYAPUNOV EXPONENTS; TIM; OSCILLATIONS; REGULATORS; TIMELESS; HOMOLOG; PERIOD; LOOP	Background: Electronic clocks exhibit undesirable jitter or time variations in periodic signals. The circadian clocks of humans, some animals, and plants consist of oscillating molecular networks with peak-to-peak time of approximately 24 hours. Clockwork orange (CWO) is a transcriptional repressor of Drosophila direct target genes. Methodology/Principal Findings: Theory and data from a model of the Drosophila circadian clock support the idea that CWO controls anti-jitter negative circuits that stabilize peak-to-peak time in light-dark cycles (LD). The orbit is confined to chaotic attractors in both LD and dark cycles and is almost periodic in LD; furthermore, CWO diminishes the Euclidean dimension of the chaotic attractor in LD. Light resets the clock each day by restricting each molecular peak to the proximity of a prescribed time. Conclusions/Significance: The theoretical results suggest that chaos plays a central role in the dynamics of the Drosophila circadian clock and that a single molecule, CWO, may sense jitter and repress it by its negative loops.	[Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Math, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Fathallah-Shaykh, Hassan M.] Univ Alabama, Dept Biomed & Mech Engn, Birmingham, AL USA; [Fathallah-Shaykh, Hassan M.] UAB Comprehens Neurosci & Canc Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Fathallah-Shaykh, HM (corresponding author), Univ Alabama, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA.	hfathall@uab.edu		Fathallah-Shaykh, Hassan/0000-0002-2690-7685				Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DICCI L, 1995, APPL NUMER MATH, V17, P275; Dieci L, 1997, SIAM J NUMER ANAL, V34, P402, DOI 10.1137/S0036142993247311; Fathallah-Shaykh HM, 2009, BIOPHYS J, V97, P2399, DOI 10.1016/j.bpj.2009.08.018; GEIST K, 1990, PROG THEOR PHYS, V83, P875, DOI 10.1143/PTP.83.875; GOLDBERGER AL, 1992, IEEE ENG MED BIOL, V11, P47, DOI 10.1109/51.139036; Goldbeter A, 2001, CHAOS, V11, P247, DOI 10.1063/1.1345727; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Kadener S, 2007, GENE DEV, V21, P1675, DOI 10.1101/gad.1552607; Leloup JC, 1999, J THEOR BIOL, V198, P445, DOI 10.1006/jtbi.1999.0924; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Tsumoto K, 2006, J THEOR BIOL, V239, P101, DOI 10.1016/j.jtbi.2005.07.017	17	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e11207	10.1371/journal.pone.0011207	http://dx.doi.org/10.1371/journal.pone.0011207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967246	gold, Green Submitted, Green Published			2022-12-27	WOS:000282869800001
J	Lines, ER; Coomes, DA; Purves, DW				Lines, Emily R.; Coomes, David A.; Purves, Drew W.			Influences of Forest Structure, Climate and Species Composition on Tree Mortality across the Eastern US	PLOS ONE			English	Article							INTERSPECIFIC VARIATION; SIZE DISTRIBUTIONS; METABOLIC ECOLOGY; GROWTH; RESPONSES; MODELS; VARIABILITY; INCREASE; DYNAMICS; SURVIVAL	Few studies have quantified regional variation in tree mortality, or explored whether species compositional changes or within-species variation are responsible for regional patterns, despite the fact that mortality has direct effects on the dynamics of woody biomass, species composition, stand structure, wood production and forest response to climate change. Using Bayesian analysis of over 430,000 tree records from a large eastern US forest database we characterised tree mortality as a function of climate, soils, species and size (stem diameter). We found (1) mortality is U-shaped vs. stem diameter for all 21 species examined; (2) mortality is hump-shaped vs. plot basal area for most species; (3) geographical variation in mortality is substantial, and correlated with several environmental factors; and (4) individual species vary substantially from the combined average in the nature and magnitude of their mortality responses to environmental variation. Regional variation in mortality is therefore the product of variation in species composition combined with highly varied mortality-environment correlations within species. The results imply that variation in mortality is a crucial part of variation in the forest carbon cycle, such that including this variation in models of the global carbon cycle could significantly narrow uncertainty in climate change predictions.	[Lines, Emily R.; Coomes, David A.] Univ Cambridge, Forest Conservat & Ecol Grp, Dept Plant Sci, Cambridge, England; [Purves, Drew W.] Microsoft Res Cambridge, Cambridge, England	University of Cambridge; Microsoft	Lines, ER (corresponding author), Univ Cambridge, Forest Conservat & Ecol Grp, Dept Plant Sci, Cambridge, England.	Emily.Lines@plantsci.cam.ac.uk	Lines, Emily/B-4646-2013; Coomes, David/H-5630-2011	Coomes, David/0000-0002-8261-2582; Lines, Emily/0000-0002-5357-8741	Microsoft Research	Microsoft Research(Microsoft)	Emily Lines was supported by a Microsoft Research studentship awarded to Cambridge University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Batista WB, 2003, J ECOL, V91, P197, DOI 10.1046/j.1365-2745.2003.00754.x; Bonan GB, 2003, GLOBAL CHANGE BIOL, V9, P1543, DOI 10.1046/j.1365-2486.2003.00681.x; BUCHMAN RG, 1983, CAN J FOREST RES, V13, P601, DOI 10.1139/x83-087; Burgi M, 2000, J BIOGEOGR, V27, P1123, DOI 10.1046/j.1365-2699.2000.00484.x; BUSING RT, 1994, FOREST ECOL MANAG, V64, P41, DOI 10.1016/0378-1127(94)90125-2; Caspersen JP, 2001, OIKOS, V92, P160, DOI 10.1034/j.1600-0706.2001.920119.x; Chao KJ, 2008, J ECOL, V96, P281, DOI 10.1111/j.1365-2745.2007.01343.x; Chen HYH, 1998, FOREST ECOL MANAG, V106, P169, DOI 10.1016/S0378-1127(97)00309-5; Coomes DA, 2003, ECOL LETT, V6, P980, DOI 10.1046/j.1461-0248.2003.00520.x; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; de Graaf NR, 1999, FOREST ECOL MANAG, V124, P123, DOI 10.1016/S0378-1127(99)00057-2; *FIA DB, 2008, FIA DAT US GUID V4 0; FOSTER DR, 1988, J ECOL, V76, P105, DOI 10.2307/2260457; Fuller TL, 1998, ECOSYSTEMS, V1, P76; Esteban LG, 2010, TREES-STRUCT FUNCT, V24, P19, DOI 10.1007/s00468-009-0375-3; Gelman A., 1996, BAYESIAN STAT, V5, P599; Gelman A., 2004, BAYESIAN DATA ANAL; Gomez-Aparicio L, 2008, OIKOS, V117, P1683, DOI 10.1111/j.1600-0706.2008.16814.x; Gratzer G, 2004, CAN J FOREST RES, V34, P1093, DOI [10.1139/x03-281, 10.1139/X03-281]; Hanson PJ, 2001, TREE PHYSIOL, V21, P345, DOI 10.1093/treephys/21.6.345; He HS, 1999, ECOL MODEL, V114, P213, DOI 10.1016/S0304-3800(98)00147-1; Hilborn Ray, 1997, V28; Ibanez I, 2007, ECOL MONOGR, V77, P163, DOI 10.1890/06-1097; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; JOYCE LA, 1995, PRODUCTIVITY AM FORE; KITTEL T, 1995, J BIOGEOGR, V22, P867; KOBE RK, 1995, ECOL APPL, V5, P517, DOI 10.2307/1942040; Kobe RK, 1999, ECOLOGY, V80, P187, DOI 10.1890/0012-9658(1999)080[0187:LGPATT]2.0.CO;2; Kronfuss H, 1999, PHYTON-ANN REI BOT A, V39, P99; Kurz WA, 2008, NATURE, V452, P987, DOI 10.1038/nature06777; LIU Y, 1993, AM MIDL NAT, V129, P19, DOI 10.2307/2426431; Loehle C, 1998, J BIOGEOGR, V25, P735, DOI 10.1046/j.1365-2699.1998.2540735.x; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Matala J, 2005, ECOL MODEL, V181, P173, DOI 10.1016/j.ecolmodel.2004.06.030; McMahon SM, 2010, P NATL ACAD SCI USA, V107, P3611, DOI 10.1073/pnas.0912376107; Miao SL, 2009, AM NAT, V173, P113, DOI 10.1086/593307; MITCHELL K J, 1969, Yale University School of Forestry Bulletin, P1; Monserud RA, 1999, FOREST ECOL MANAG, V113, P109, DOI 10.1016/S0378-1127(98)00419-8; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Motzkin G, 1999, J VEG SCI, V10, P903, DOI 10.2307/3237315; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; New M, 1999, J CLIMATE, V12, P829, DOI 10.1175/1520-0442(1999)012<0829:RTCSTC>2.0.CO;2; PACALA SW, 1994, CAN J FOREST RES, V24, P2172, DOI 10.1139/x94-280; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2009, P R SOC B, V276, P1477, DOI 10.1098/rspb.2008.1241; Purves DW, 2004, GLOBAL CHANGE BIOL, V10, P1737, DOI 10.1111/j.1365-2486.2004.00844.x; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Rizzo DM, 2003, FRONT ECOL ENVIRON, V1, P197, DOI 10.1890/1540-9295(2003)001[0197:SODECA]2.0.CO;2; Rolland C., 1993, Tree-Ring Bulletin, V53, P1; RUSSELL EWB, 1993, J ECOL, V81, P647, DOI 10.2307/2261663; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; Taylor SL, 2007, FOREST ECOL MANAG, V253, P188, DOI 10.1016/j.foreco.2007.07.016; Umeki K, 2002, ECOL RES, V17, P575, DOI 10.1046/j.1440-1703.2002.00516.x; Vaganov EA, 2009, OECOLOGIA, V161, P729, DOI 10.1007/s00442-009-1421-y; van Mantgem PJ, 2007, ECOL LETT, V10, P909, DOI 10.1111/j.1461-0248.2007.01080.x; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Villela DM, 2006, J BIOGEOGR, V33, P506, DOI 10.1111/j.1365-2699.2005.01453.x; Welker SL, 2008, FOREST SCI, V54, P8; Wunder J, 2006, ECOL MODEL, V197, P196, DOI 10.1016/j.ecolmodel.2006.02.037; Wyckoff PH, 2002, J ECOL, V90, P604, DOI 10.1046/j.1365-2745.2002.00691.x; Yang YQ, 2003, ECOL MODEL, V163, P209, DOI 10.1016/S0304-3800(03)00008-5	66	115	117	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13212	10.1371/journal.pone.0013212	http://dx.doi.org/10.1371/journal.pone.0013212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967250	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800006
J	Zhukovsky, MA; Basmaciogullari, S; Pacheco, B; Wang, LP; Madani, N; Haim, H; Sodroski, J				Zhukovsky, Mikhail A.; Basmaciogullari, Stephane; Pacheco, Beatriz; Wang, Liping; Madani, Navid; Haim, Hillel; Sodroski, Joseph			Thermal Stability of the Human Immunodeficiency Virus Type 1 (HIV-1) Receptors, CD4 and CXCR4, Reconstituted in Proteoliposomes	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CHEMOKINE RECEPTOR; MEMBRANE-VESICLES; CRYSTAL-STRUCTURE; SMALL-MOLECULE; FUNCTIONAL-ANALYSIS; IMMUNOGLOBULIN-G; MEDIATED FUSION; TYROSINE KINASE; CELLS	Background: The entry of human immunodeficiency virus (HIV-1) into host cells involves the interaction of the viral exterior envelope glycoprotein, gp120, and receptors on the target cell. The HIV-1 receptors are CD4 and one of two chemokine receptors, CCR5 or CXCR4. Methodology/Principal Findings: We created proteoliposomes that contain CD4, the primary HIV-1 receptor, and one of the coreceptors, CXCR4. Antibodies against CD4 and CXCR4 specifically bound the proteoliposomes. CXCL12, the natural ligand for CXCR4, and the small-molecule CXCR4 antagonist, AMD3100, bound the proteoliposomes with affinities close to those associated with the binding of these molecules to cells expressing CXCR4 and CD4. The HIV-1 gp120 exterior envelope glycoprotein bound tightly to proteoliposomes expressing only CD4 and, in the presence of soluble CD4, bound weakly to proteoliposomes expressing only CXCR4. The thermal stability of CD4 and CXCR4 inserted into liposomes was examined. Thermal denaturation of CXCR4 followed second-order kinetics, with an activation energy (E-a) of 269 kJ/mol (64.3 kcal/mol) and an inactivation temperature (T-i) of 56 degrees C. Thermal inactivation of CD4 exhibited a reaction order of 1.3, an E-a of 278 kJ/mol (66.5 kcal/mol), and a T-i of 52.2 degrees C. The second-order denaturation kinetics of CXCR4 is unusual among G protein-coupled receptors, and may result from dimeric interactions between CXCR4 molecules. Conclusions/Significance: Our studies with proteoliposomes containing the native HIV-1 receptors allowed an examination of the binding of biologically important ligands and revealed the higher-order denaturation kinetics of these receptors. CD4/CXCR4-proteoliposomes may be useful for the study of virus-target cell interactions and for the identification of inhibitors.	[Zhukovsky, Mikhail A.; Basmaciogullari, Stephane; Pacheco, Beatriz; Wang, Liping; Madani, Navid; Haim, Hillel; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Zhukovsky, Mikhail A.] Max Planck Inst Biophys Chem, Dept Struct Dynam Biochem Syst, D-37077 Gottingen, Germany; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Max Planck Society; Harvard University; Harvard T.H. Chan School of Public Health	Zhukovsky, MA (corresponding author), Univ Saarland, Chair Biol Expt Phys, D-6600 Saarbrucken, Germany.	joseph_sodroski@dfci.harvard.edu	Pacheco, Beatriz/Y-5100-2019; Zhukovskiy, Mikhail/Q-5386-2018	Pacheco, Beatriz/0000-0003-0057-1973; Haim, Hillel/0000-0002-6071-5089	National Institutes of Health [AI24755, AI42848]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042848, T32AI007387, R37AI024755, R01AI024755] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by two grants (AI24755 and AI42848) from the National Institutes of Health (http://www.nih.gov), by a gift from the late William F. McCarty-Cooper, and by funds from the International AIDS Vaccine Initiative (http://www.iavi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhatib G, 2007, EUR J MED RES, V12, P375; Alkhatib G, 2009, CURR OPIN HIV AIDS, V4, P96, DOI 10.1097/COH.0b013e328324bbec; Aymard C, 2000, ENZYME MICROB TECH, V27, P612, DOI 10.1016/S0141-0229(00)00258-1; Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698; Babcock GJ, 2003, J BIOL CHEM, V278, P3378, DOI 10.1074/jbc.M210140200; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Bailey A, 2005, ARCH BIOCHEM BIOPHYS, V439, P211, DOI 10.1016/j.abb.2005.05.010; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Baribaud F, 2001, J VIROL, V75, P8957, DOI 10.1128/JVI.75.19.8957-8967.2001; Basmaciogullari S, 2006, VIROLOGY, V353, P52, DOI 10.1016/j.virol.2006.05.027; Bee MS, 2007, J BIOL CHEM, V282, P32471, DOI 10.1074/jbc.M703909200; Benitez-Cardoza CG, 2001, BIOCHEMISTRY-US, V40, P9049, DOI 10.1021/bi010528w; BERMAN AL, 1981, VISION RES, V21, P731, DOI 10.1016/0042-6989(81)90082-1; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Bourgeois R, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-31; Brelot A, 1999, J VIROL, V73, P2576, DOI 10.1128/JVI.73.4.2576-2586.1999; BROUILLETTE CG, 1989, PROTEINS, V5, P38, DOI 10.1002/prot.340050106; Busillo JM, 2007, BBA-BIOMEMBRANES, V1768, P952, DOI 10.1016/j.bbamem.2006.11.002; Byun JS, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-47; Calarese DA, 2005, P NATL ACAD SCI USA, V102, P13372, DOI 10.1073/pnas.0505763102; Cao JS, 2007, FOOD AGR IMMUNOL, V18, P17, DOI 10.1080/09540100701220267; Carnec X, 2005, J VIROL, V79, P1930, DOI 10.1128/JVI.79.3.1930-1933.2005; Castile JD, 1999, INT J PHARM, V188, P87, DOI 10.1016/S0378-5173(99)00207-0; Chen CC, 2000, J FOOD SCI, V65, P188, DOI 10.1111/j.1365-2621.2000.tb15977.x; Cioci F, 1998, BIOTECHNOL TECH, V12, P855, DOI 10.1023/A:1008839912640; Claeysen S, 2001, EMBO REP, V2, P61, DOI 10.1093/embo-reports/kve003; CUDD A, 1990, J ACQ IMMUN DEF SYND, V3, P109; DANNENBERG F, 1988, J FOOD SCI, V53, P258, DOI 10.1111/j.1365-2621.1988.tb10223.x; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Devesa F, 2002, EUR J BIOCHEM, V269, P5163, DOI 10.1046/j.1432-1033.2002.03213.x; DEVRIJ W, 1989, EUR J BIOCHEM, V178, P763; Dominguez E, 2001, J DAIRY RES, V68, P511, DOI 10.1017/S0022029901004927; Doms RW, 2000, VIROLOGY, V276, P229, DOI 10.1006/viro.2000.0612; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; El-Loly M. M., 2007, International Journal of Dairy Science, V2, P292; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; FLASHER D, 1994, BBA-BIOMEMBRANES, V1194, P185, DOI 10.1016/0005-2736(94)90219-4; Fotopoulos G, 2002, P NATL ACAD SCI USA, V99, P9410, DOI 10.1073/pnas.142586899; Fricker SP, 2006, BIOCHEM PHARMACOL, V72, P588, DOI 10.1016/j.bcp.2006.05.010; Fulton AM, 2009, CURR ONCOL REP, V11, P125, DOI 10.1007/s11912-009-0019-1; Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003; Haque ME, 2001, BIOCHEMISTRY-US, V40, P4340, DOI 10.1021/bi002030k; HEALEY D, 1990, J EXP MED, V172, P1233, DOI 10.1084/jem.172.4.1233; Hendrix CW, 2004, JAIDS-J ACQ IMM DEF, V37, P1253, DOI 10.1097/01.qai.0000137371.80695.ef; HILL CG, 1977, INTRO CHEM ENG KINET, P24; HOEKSTRA D, 1984, BIOCHEMISTRY-US, V23, P5675, DOI 10.1021/bi00319a002; Hogaboam CM, 2005, PHARMACOL THERAPEUT, V107, P314, DOI 10.1016/j.pharmthera.2005.02.006; Huang ZW, 1997, BIOPOLYMERS, V43, P367, DOI 10.1002/(SICI)1097-0282(1997)43:5<367::AID-BIP3>3.0.CO;2-T; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Jacobs A, 2008, VACCINE, V26, P3026, DOI 10.1016/j.vaccine.2007.12.026; Jeremic A, 2004, CELL BIOL INT, V28, P19, DOI 10.1016/j.cellbi.2003.11.004; Juarez J, 2004, CURR PHARM DESIGN, V10, P1245, DOI 10.2174/1381612043452640; Karlsson GB, 1997, J VIROL, V71, P4218, DOI 10.1128/JVI.71.6.4218-4225.1997; KASAHARA M, 1977, J BIOL CHEM, V252, P7384; Kawai T, 2009, CURR OPIN HEMATOL, V16, P20, DOI 10.1097/MOH.0b013e32831ac557; Klasse PJ, 1999, J VIROL, V73, P7453, DOI 10.1128/JVI.73.9.7453-7466.1999; KNAPP W, 1989, LEUCOCYTE TYPING, V4; Kolena J, 2002, EXP CLIN ENDOCR DIAB, V110, P77, DOI 10.1055/s-2002-23490; Lassalle MW, 1998, BIOCHEMISTRY-US, V37, P8465, DOI 10.1021/bi9730691; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Liang XY, 2008, CHEM BIOL DRUG DES, V72, P97, DOI 10.1111/j.1747-0285.2008.00681.x; LICHAN E, 1995, FOOD RES INT, V28, P9, DOI 10.1016/0963-9969(95)93325-O; Lin CT, 1999, J AGR FOOD CHEM, V47, P2944, DOI 10.1021/jf981355t; LING AC, 1978, J FOOD SCI, V43, P1307, DOI 10.1111/j.1365-2621.1978.tb15295.x; Lucisano M., 1994, Italian Journal of Food Science, V6, P185; LUKASHEVA EV, 1991, BIOCHEMISTRY-MOSCOW+, V56, P738; Madani N, 2007, J VIROL, V81, P532, DOI 10.1128/JVI.01079-06; Magerus-Chatinet A, 2007, VIROLOGY, V362, P67, DOI 10.1016/j.virol.2006.11.035; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mainer G, 1997, J FOOD SCI, V62, P1034, DOI 10.1111/j.1365-2621.1997.tb15032.x; Mastrobattista E, 2002, J BIOL CHEM, V277, P27135, DOI 10.1074/jbc.M200429200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MENGER FM, 1995, ANGEW CHEM INT EDIT, V34, P2091, DOI 10.1002/anie.199520911; MICELI MC, 1993, ADV IMMUNOL, V53, P59, DOI 10.1016/S0065-2776(08)60498-8; Mines M, 2007, CURR MED CHEM, V14, P2456, DOI 10.2174/092986707782023686; Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Navratilova I, 2005, ANAL BIOCHEM, V339, P271, DOI 10.1016/j.ab.2004.12.017; NEET KE, 1994, PROTEIN SCI, V3, P2167, DOI 10.1002/pro.5560031202; Nehete PN, 2002, ANTIVIR RES, V56, P233, DOI 10.1016/S0166-3542(02)00130-4; Nguyen DH, 2005, EXP CELL RES, V304, P559, DOI 10.1016/j.yexcr.2004.11.022; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; PARR GR, 1976, BIOCHEMISTRY-US, V15, P857, DOI 10.1021/bi00649a020; Pollegioni L, 2003, PROTEIN SCI, V12, P1018, DOI 10.1110/ps.0234603; PURI A, 1992, J ACQ IMMUN DEF SYND, V5, P915; RAMASWAMY HS, 1989, J FOOD SCI, V54, P1322, DOI 10.1111/j.1365-2621.1989.tb05983.x; Rawat SS, 2008, MOL MEMBR BIOL, V25, P83, DOI 10.1080/09687680701613713; Rawat SS, 2006, GLYCOCONJUGATE J, V23, P189, DOI 10.1007/s10719-006-7924-4; Rawat SS, 2004, VIROLOGY, V318, P55, DOI 10.1016/j.virol.2003.08.042; RENOSTO F, 1985, J BIOL CHEM, V260, P1535; Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; RUDD CE, 1988, P NATL ACAD SCI USA, V85, P5190, DOI 10.1073/pnas.85.14.5190; Ryu EK, 2007, PROTEINS, V67, P1193, DOI 10.1002/prot.21350; SADANA A, 1988, J BIOTECHNOL, V7, P95, DOI 10.1016/0168-1656(88)90057-0; SADANA A, 1993, THERMOSTABILITY ENZY, P84; Saito K, 2003, J BIOL CHEM, V278, P14732, DOI 10.1074/jbc.M301086200; SATTENTAU QJ, 1988, AIDS, V2, P101, DOI 10.1097/00002030-198804000-00005; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Seibert C, 2004, CURR PHARM DESIGN, V10, P2041, DOI 10.2174/1381612043384312; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shibata Y, 2009, J MOL BIOL, V390, P262, DOI 10.1016/j.jmb.2009.04.068; SHNYROV VL, 1977, VISION RES, V17, P169, DOI 10.1016/0042-6989(77)90079-7; Simm M, 1996, J BIOL CHEM, V271, P28266, DOI 10.1074/jbc.271.45.28266; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Steffens CM, 2004, J VIROL, V78, P9573, DOI 10.1128/JVI.78.17.9573-9578.2004; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; STOFOROS NG, 1995, FOOD CONTROL, V6, P81, DOI 10.1016/0956-7135(95)98911-J; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Stromberg A, 2000, P NATL ACAD SCI USA, V97, P7, DOI 10.1073/pnas.97.1.7; Sudo Y, 2003, PHOTOCHEM PHOTOBIOL, V78, P511, DOI 10.1562/0031-8655(2003)078<0511:IONPPS>2.0.CO;2; Tamamura H, 2005, EXPERT OPIN THER TAR, V9, P1267, DOI 10.1517/14728222.9.6.1267; Traikia M, 2000, EUR BIOPHYS J BIOPHY, V29, P184, DOI 10.1007/s002490000077; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Van Broekhoven CL, 2001, IMMUNOL CELL BIOL, V79, P274, DOI 10.1046/j.1440-1711.2001.01010.x; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Viard M, 2003, GLYCOCONJUGATE J, V20, P213, DOI 10.1023/B:GLYC.0000024253.48791.d9; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2009, PROTEIN EXPRES PURIF, V65, P204, DOI 10.1016/j.pep.2009.01.014; Weber J, 2006, AIDS REV, V8, P60; Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; ZALE SE, 1984, ANN NY ACAD SCI, V434, P20, DOI 10.1111/j.1749-6632.1984.tb29794.x; Zhukovsky MA, 2007, ARCH BIOCHEM BIOPHYS, V465, P101, DOI 10.1016/j.abb.2007.05.005	126	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13249	10.1371/journal.pone.0013249	http://dx.doi.org/10.1371/journal.pone.0013249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967243	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800008
J	Liu, J; Lluis, A; Illi, S; Layland, L; Olek, S; von Mutius, E; Schaub, B				Liu, Jing; Lluis, Anna; Illi, Sabina; Layland, Laura; Olek, Sven; von Mutius, Erika; Schaub, Bianca			T Regulatory Cells in Cord Blood-FOXP3 Demethylation as Reliable Quantitative Marker	PLOS ONE			English	Article							DNA METHYLATION ANALYSIS; FUNCTIONAL-CHARACTERIZATION; FOXP3; IMPAIRMENT; EXPRESSION; INDUCTION; ALLERGY; BLOOD	Background: Regulatory T-cells (Tregs), characterized as CD4+CD25(hi) T-cells expressing FOXP3, play a crucial role in controlling healthy immune development during early immune maturation. Recently, FOXP3 demethylation was suggested to be a novel marker for natural Tregs in adults. In cord blood, the role and function of Tregs and its demethylation is poorly understood. We assessed FOXP3 demethylation in cord blood in relation to previously used Treg markers such as CD4(+)CD25(hi), FOXP3 mRNA, protein expression, and suppressive Treg function. Methodology: Cord blood mononuclear cells (CBMC) were isolated from 70 healthy neonates, stimulated for 3 days with the microbial stimulus lipid A (LpA), and allergen Dermatophagoides pteronyssinus (Derp1). Tregs (CD4+CD25(hi), intracellular, mRNA FOXP3 expression, isolated cells), DNA methylation of the FOXP3-locus and suppressive Treg function were assessed. Principal Findings: Demethylation of FOXP3 in whole blood was specific for isolated CD4+CD25(hi) Tregs. Demethylation of FOXP3 was positively correlated with unstimulated and LpA-stimulated FOXP3 mRNA-expression (p <= 0.05), and CD4(+)CD25(hi) T-cells (p <= 0.03). Importantly, increased FOXP3 demethylation correlated with more efficient suppressive capacity of Tregs (r = 0.72, p = 0.005). Furthermore, FOXP3 demethylation was positively correlated with Th2 cytokines (IL-5, IL-13) following LpA-stimulation (p = 0.006/0.04), with Th2 and IL-17 following Derp1+LpA-stimulations (p <= 0.009), but not Th1 cytokines (IFN-gamma). Conclusions: FOXP3 demethylation reliable quantifies Tregs in cord blood. FOXP3 demethylation corresponds well with the suppressive potential of Tregs. The resulting strict correlation with functionally suppressive Tregs and the relative ease of measurement render it into a valuable novel marker for large field studies assessing Tregs as qualitative marker indicative of functional activity.	[Liu, Jing; Lluis, Anna; Illi, Sabina; von Mutius, Erika; Schaub, Bianca] Univ Munich, Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany; [Liu, Jing] Ji Lin Univ, Hosp 2, Dept Resp Med, Changchun, Peoples R China; [Layland, Laura] Tech Univ Munich, Inst Med Microbiol, Munich, Germany; [Olek, Sven] Epiontis GmbH, Berlin, Germany	University of Munich; Jilin University; Technical University of Munich; Epiontis GmbH	Liu, J (corresponding author), Univ Munich, Univ Childrens Hosp Munich, Dept Pulm & Allergy, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Bayerische Forschungsstiftung; GALTRAIN; Munich University	Bayerische Forschungsstiftung; GALTRAIN; Munich University	Bayerische Forschungsstiftung, GALTRAIN, Munich University Grant (all BS). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. Additional funding was received through Epiontis (SO). SO is employed by Epiontis GmbH, and has supervised performance of experiments, and contributed analysis tools for these experiments.	Allan SE, 2007, INT IMMUNOL, V19, P345, DOI 10.1093/intimm/dxm014; Baecher-Allan C, 2004, SEMIN IMMUNOL, V16, P89, DOI 10.1016/j.smim.2003.12.005; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baron U, 2006, EPIGENETICS-US, V1, P55, DOI 10.4161/epi.1.1.2643; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Hartl D, 2007, J ALLERGY CLIN IMMUN, V119, P1258, DOI 10.1016/j.jaci.2007.02.023; Jartti T, 2007, J ALLERGY CLIN IMMUN, V120, P177, DOI 10.1016/j.jaci.2007.03.008; Jonuleit H, 2001, J EXP MED, V193, P1285, DOI 10.1084/jem.193.11.1285; Kleinewietfeld M, 2009, BLOOD, V113, P827, DOI 10.1182/blood-2008-04-150524; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Pace L, 2006, J IMMUNOL, V176, P3900, DOI 10.4049/jimmunol.176.7.3900; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Prescott SL, 2008, ALLERGY, V63, P1481, DOI 10.1111/j.1398-9995.2008.01778.x; Prescott SL, 1999, LANCET, V353, P196, DOI 10.1016/S0140-6736(98)05104-6; Schaub B, 2008, ALLERGY, V63, P1438, DOI 10.1111/j.1398-9995.2008.01685.x; Schaub B, 2008, J ALLERGY CLIN IMMUN, V121, P1491, DOI 10.1016/j.jaci.2008.04.010; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Skapenko A, 2005, J IMMUNOL, V175, P6107, DOI 10.4049/jimmunol.175.9.6107; Smith M, 2008, J ALLERGY CLIN IMMUN, V121, P1460, DOI 10.1016/j.jaci.2008.03.025; Umetsu DT, 2006, IMMUNOL REV, V212, P238, DOI 10.1111/j.0105-2896.2006.00413.x; Walker MR, 2003, J CLIN INVEST, V112, P1437, DOI 10.1172/JCI200319441; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Zen Y, 2007, HEPATOLOGY, V45, P1538, DOI 10.1002/hep.21697; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2007, EUR J IMMUNOL, V37, P21, DOI 10.1002/eji.200636929	36	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13267	10.1371/journal.pone.0013267	http://dx.doi.org/10.1371/journal.pone.0013267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967272	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300010
J	Richards, EL; van Oosterhout, C; Cable, J				Richards, E. Loys; van Oosterhout, Cock; Cable, Joanne			Sex-Specific Differences in Shoaling Affect Parasite Transmission in Guppies	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; FRESH-WATER FISHES; 2 WILD POPULATIONS; POECILIA-RETICULATA; GYRODACTYLUS-TURNBULLI; TRINIDADIAN GUPPY; JUVENILE STICKLEBACKS; SCHOOLING BEHAVIOR; MATING TACTICS; SELECTION	Background: Individuals have to trade-off the costs and benefits of group membership during shoaling behaviour. Shoaling can increase the risk of parasite transmission, but this cost has rarely been quantified experimentally. Guppies (Poecilia reticulata) are a model system for behavioural studies, and they are commonly infected by gyrodactylid parasites, notorious fish pathogens that are directly transmitted between guppy hosts. Methodology/Principal Findings: Parasite transmission in single sex shoals of male and female guppies were observed using an experimental infection of Gyrodactylus turnbulli. Parasite transmission was affected by sex-specific differences in host behaviour, and significantly more parasites were transmitted when fish had more frequent and more prolonged contact with each other. Females shoaled significantly more than males and had a four times higher risk to contract an infection. Conclusions/Significance: Intersexual differences in host behaviours such as shoaling are driven by differences in natural and sexual selection experienced by both sexes. Here we show that the potential benefits of an increased shoaling tendency are traded off against increased risks of contracting an infectious parasite in a group-living species.	[Richards, E. Loys; Cable, Joanne] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [van Oosterhout, Cock] Univ Hull, Evolutionary Biol Grp, Kingston Upon Hull HU6 7RX, N Humberside, England	Cardiff University; University of Hull	Richards, EL (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	cablej@cardiff.ac.uk	Cable, Joanne/A-4360-2010	Cable, Joanne/0000-0002-8510-7055; van Oosterhout, Cock/0000-0002-5653-738X	Natural Environment Research Council (NERC) [NER/S/A/2006/14328, NER/J/S/2002/00706]; Natural Environment Research Council [NER/J/S/2002/00706] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (NERC) case studentship (NER/S/A/2006/14328) in association with the Waltham Centre for Pet Nutrition to LR and an Advanced NERC Research Fellowship (NER/J/S/2002/00706) to JC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber I, 1996, P ROY SOC B-BIOL SCI, V263, P1095, DOI 10.1098/rspb.1996.0161; Barber I, 2000, REV FISH BIOL FISHER, V10, P131, DOI 10.1023/A:1016658224470; Barber I, 1998, J FISH BIOL, V53, P1365, DOI 10.1111/j.1095-8649.1998.tb00256.x; BROWN CR, 1986, ECOLOGY, V67, P737; Cable J, 2007, INT J PARASITOL, V37, P1449, DOI 10.1016/j.ijpara.2007.04.013; Cable J, 2007, BIOL J LINN SOC, V90, P647, DOI 10.1111/j.1095-8312.2006.00755.x; Cable J, 2002, INT J PARASITOL, V32, P255, DOI 10.1016/S0020-7519(01)00330-7; Cable J, 2002, J PARASITOL, V88, P183, DOI 10.1645/0022-3395(2002)088[0183:BFTITV]2.0.CO;2; CABLE J, ECOLOGY EVO IN PRESS; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Croft DP, 2003, OIKOS, V100, P429, DOI 10.1034/j.1600-0706.2003.12023.x; DUGATKIN LA, 1994, ENVIRON BIOL FISH, V39, P215, DOI 10.1007/BF00004940; ENDLER JA, 1995, TRENDS ECOL EVOL, V10, P22, DOI 10.1016/S0169-5347(00)88956-9; Griffiths SW, 1998, ANIM BEHAV, V56, P689, DOI 10.1006/anbe.1998.0767; HARRIS PD, 1992, J PARASITOL, V78, P912, DOI 10.2307/3283329; Helfman GS, 2009, DIVERSITY FISHES BIO; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Houde AE, 1997, SEX COLOUR MATE CHOI; Kolluru GR, 2009, BEHAV ECOL, V20, P131, DOI 10.1093/beheco/arn124; Kolluru GR, 2005, BEHAV ECOL, V16, P294, DOI 10.1093/beheco/arh161; Krause J, 1996, ETHOLOGY, V102, P40, DOI 10.1111/j.1439-0310.1996.tb01102.x; Krause J, 2002, LIVING GROUPS; Magurran A. E., 1983, BEHAV ECOL SOCIOBIOL, V12, P142; MAGURRAN AE, 1985, Z TIERPSYCHOL, V67, P167; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; PITCHER TJ, 1982, BEHAV ECOL SOCIOBIOL, V10, P149, DOI 10.1007/BF00300175; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; POULIN R, 1989, CAN J ZOOL, V67, P14, DOI 10.1139/z89-003; POULIN R, 1989, BEHAV ECOL SOCIOBIOL, V24, P251, DOI 10.1007/BF00295205; POULIN R, 1991, OECOLOGIA, V86, P390, DOI 10.1007/BF00317606; RANTA E, 1992, OECOLOGIA, V89, P150, DOI 10.1007/BF00319028; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Reznick DN, 1996, AM NAT, V147, P319, DOI 10.1086/285854; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; Schelkle B, 2009, DIS AQUAT ORGAN, V86, P65, DOI 10.3354/dao02087; SCOTT ME, 1982, PARASITOLOGY, V85, P217, DOI 10.1017/S0031182000055207; Tobler M, 2008, ENVIRON BIOL FISH, V81, P29, DOI 10.1007/s10641-006-9153-x; van Oosterhout C, 2008, INT J PARASITOL, V38, P541, DOI 10.1016/j.ijpara.2007.09.016; van Oosterhout C, 2007, INT J PARASITOL, V37, P805, DOI 10.1016/j.ijpara.2006.12.016; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; Van Oosterhout C, 2003, BIOL J LINN SOC, V79, P645, DOI 10.1046/j.1095-8312.2003.00203.x; Van Oosterhout C, 2007, CONSERV BIOL, V21, P1573, DOI 10.1111/j.1523-1739.2007.00809.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x	43	51	51	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13285	10.1371/journal.pone.0013285	http://dx.doi.org/10.1371/journal.pone.0013285			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949014	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000282748100019
J	Rogers, RL; Van Seuningen, I; Gould, J; Hertzog, PJ; Naylor, MJ; Pritchard, MA				Rogers, Renee L.; Van Seuningen, Isabelle; Gould, Jodee; Hertzog, Paul J.; Naylor, Matthew J.; Pritchard, Melanie A.			Transcript Profiling of Elf5(+/-) Mammary Glands during Pregnancy Identifies Novel Targets of Elf5	PLOS ONE			English	Article							INTRAMEMBRANE ERBB2 LIGAND; RECEPTOR TYROSINE KINASE; PANCREATIC-CANCER CELLS; MUC4/SIALOMUCIN COMPLEX; EPITHELIAL-CELLS; BREAST-CANCER; EXPRESSION; MUC4; GENE; PHOSPHORYLATION	Background: Elf5, an epithelial specific Ets transcription factor, plays a crucial role in the pregnancy-associated development of the mouse mammary gland. Elf5(+/-) embryos do not survive, however the Elf5(+/-) mammary gland displays a severe pregnancy-associated developmental defect. While it is known that Elf5 is crucial for correct mammary development and lactation, the molecular mechanisms employed by Elf5 to exert its effects on the mammary gland are largely unknown. Principal Findings: Transcript profiling was used to investigate the transcriptional changes that occur as a result of Elf5 haploinsufficiency in the Elf5(+/-) mouse model. We show that the development of the mouse Elf5(+/-) mammary gland is delayed at a transcriptional and morphological level, due to the delayed increase in Elf5 protein in these glands. We also identify a number of potential Elf5 target genes, including Mucin 4, whose expression, is directly regulated by the binding of Elf5 to an Ets binding site within its promoter. Conclusion: We identify novel transcriptional targets of Elf5 and show that Muc4 is a direct target of Elf5, further elucidating the mechanisms through which Elf5 regulates proliferation and differentiation in the mammary gland.	[Rogers, Renee L.; Gould, Jodee; Hertzog, Paul J.; Pritchard, Melanie A.] Monash Inst Med Res, Ctr Funct Genom & Human Dis, Clayton, Vic, Australia; [Van Seuningen, Isabelle] Ctr Rech Jean Pierre Aubert, INSERM, U837, Lille, France; [Rogers, Renee L.; Naylor, Matthew J.] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia; [Naylor, Matthew J.] Univ New S Wales, St Vincents Hosp Clin Sch, Fac Med, Sydney, NSW, Australia	Monash University; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney	Rogers, RL (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia.	r.rogers@garvan.org.au; melanie.pritchard@med.monash.edu.au	Hertzog, Paul J/I-7053-2013; VAN SEUNINGEN, Isabelle/N-6176-2016; Hertzog, Paul J/G-6734-2013	Hertzog, Paul J/0000-0002-1373-8472; VAN SEUNINGEN, Isabelle/0000-0002-3131-2694; Hertzog, Paul J/0000-0002-1373-8472	Australian Postgraduate Award; Women in Scientific Excellence (WISE) award; Australian Research Council; National Health and Medical Research Council; National Breast Cancer Foundation of Australia; Gardiner Foundation; Ligue Nationale contre le Cancer	Australian Postgraduate Award(Australian Government); Women in Scientific Excellence (WISE) award; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation of Australia; Gardiner Foundation; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer)	RLR was the recipient of an Australian Postgraduate Award and a Women in Scientific Excellence (WISE) award. The authors also wish to thank the Australian Research Council (MAP), National Health and Medical Research Council (MAP), National Breast Cancer Foundation of Australia (MN), Gardiner Foundation (RLR, MAP) and Ligue Nationale contre le Cancer (Equipe labellisee 2008, IVS) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carraway KL, 2001, J MAMMARY GLAND BIOL, V6, P323, DOI 10.1023/A:1011327708973; Carraway KL, 1999, J BIOL CHEM, V274, P5263, DOI 10.1074/jbc.274.9.5263; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Donnison M, 2005, DEVELOPMENT, V132, P2299, DOI 10.1242/dev.01819; Fauquette V, 2005, BIOCHEM J, V386, P35, DOI 10.1042/BJ20040706; GROENEN MAM, 1995, GENE, V158, P189, DOI 10.1016/0378-1119(95)00138-V; Harris J, 2006, MOL ENDOCRINOL, V20, P1177, DOI 10.1210/me.2005-0473; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jepson S, 2002, ONCOGENE, V21, P7524, DOI 10.1038/sj.onc.1205970; Jonckheere N, 2007, J BIOL CHEM, V282, P22638, DOI 10.1074/jbc.M700905200; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Locke D, 2000, J CELL PHYSIOL, V183, P228; Naylor MJ, 2005, MOL ENDOCRINOL, V19, P1868, DOI 10.1210/me.2004-0254; Oakes SR, 2008, J MAMMARY GLAND BIOL, V13, P13, DOI 10.1007/s10911-008-9069-5; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Oakes SR, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1411; Oettgen P, 1999, J BIOL CHEM, V274, P29439, DOI 10.1074/jbc.274.41.29439; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Perez A, 2003, J BIOL CHEM, V278, P36942, DOI 10.1074/jbc.M300264200; Perrais M, 2001, J BIOL CHEM, V276, P30923, DOI 10.1074/jbc.M104204200; Price-Schiavi SA, 2005, J CELL PHYSIOL, V203, P44, DOI 10.1002/jcp.20200; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Ramsauer VP, 2003, J BIOL CHEM, V278, P30142, DOI 10.1074/jbc.M303220200; ROBINSON GW, 1995, DEVELOPMENT, V121, P2079; Shepherd T, 2001, J MAMMARY GLAND BIOL, V6, P129, DOI 10.1023/A:1009576801226; Thomas RS, 2000, ADV EXP MED BIOL, V480, P123; YANG Y, 1994, MEMBERS FATTY ACID B; Yaniw D, 2005, CELL RES, V15, P423, DOI 10.1038/sj.cr.7290310; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Yuan ZL, 2004, MOL CELL BIOL, V24, P9390, DOI 10.1128/MCB.24.21.9390-9400.2004; YULEE LY, 1983, J BIOL CHEM, V258, P794; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538	32	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13150	10.1371/journal.pone.0013150	http://dx.doi.org/10.1371/journal.pone.0013150			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949099	Green Published, gold			2022-12-27	WOS:000282633700006
J	DeLong, JP; Burger, O; Hamilton, MJ				DeLong, John P.; Burger, Oskar; Hamilton, Marcus J.			Current Demographics Suggest Future Energy Supplies Will Be Inadequate to Slow Human Population Growth	PLOS ONE			English	Article							FERTILITY	Influential demographic projections suggest that the global human population will stabilize at about 9-10 billion people by mid-century. These projections rest on two fundamental assumptions. The first is that the energy needed to fuel development and the associated decline in fertility will keep pace with energy demand far into the future. The second is that the demographic transition is irreversible such that once countries start down the path to lower fertility they cannot reverse to higher fertility. Both of these assumptions are problematic and may have an effect on population projections. Here we examine these assumptions explicitly. Specifically, given the theoretical and empirical relation between energy-use and population growth rates, we ask how the availability of energy is likely to affect population growth through 2050. Using a cross-country data set, we show that human population growth rates are negatively related to per-capita energy consumption, with zero growth occurring at,13 kW, suggesting that the global human population will stop growing only if individuals have access to this amount of power. Further, we find that current projected future energy supply rates are far below the supply needed to fuel a global demographic transition to zero growth, suggesting that the predicted leveling-off of the global population by mid-century is unlikely to occur, in the absence of a transition to an alternative energy source. Direct consideration of the energetic constraints underlying the demographic transition results in a qualitatively different population projection than produced when the energetic constraints are ignored. We suggest that energetic constraints be incorporated into future population projections.	[DeLong, John P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Burger, Oskar] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hamilton, Marcus J.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Hamilton, Marcus J.] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Hamilton, Marcus J.] Santa Fe Inst, Santa Fe, NM 87501 USA	Yale University; Stanford University; University of New Mexico; University of New Mexico; The Santa Fe Institute	DeLong, JP (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.	john.delong@yale.edu		Burger, Oskar/0000-0002-7552-5851; DeLong, John/0000-0003-0558-8213	NSF	NSF(National Science Foundation (NSF))	MJH and OB were supported by grants from NSF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLD POP PROSP 2008; Bongaarts J, 2009, PHILOS T R SOC B, V364, P2985, DOI 10.1098/rstb.2009.0137; Burger O, 2010, P R SOC B, V277, P773, DOI 10.1098/rspb.2009.1450; CLEVELAND CJ, 1984, SCIENCE, V225, P890, DOI 10.1126/science.225.4665.890; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cohen JE, 1996, MANY PEOPLE CAN EART; DELONG JP, 2009, ISME J, V1, P9; DEMENY P, 1988, POPUL DEV REV, V14, P213, DOI 10.2307/2808097; Frankenfield DC, 2003, J AM DIET ASSOC, V103, P1152, DOI 10.1016/S0002-8223(03)00982-9; Hall C, 2001, BIOSCIENCE, V51, P663, DOI 10.1641/0006-3568(2001)051[0663:TNTRTN]2.0.CO;2; Hamilton MJ, 2009, P NATL ACAD SCI USA, V106, P12255, DOI 10.1073/pnas.0905708106; Holdren JP, 2008, SCIENCE, V319, P424, DOI 10.1126/science.1153386; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Lutz W., 2004, END WORLD POPULATION; Mace R, 2008, SCIENCE, V319, P764, DOI 10.1126/science.1153960; Moses ME, 2003, ECOL LETT, V6, P295, DOI 10.1046/j.1461-0248.2003.00446.x; Mulder MB, 1998, TRENDS ECOL EVOL, V13, P266, DOI 10.1016/S0169-5347(98)01357-3; Myrskyla M, 2009, NATURE, V460, P741, DOI 10.1038/nature08230; Nehring R, 2009, PHILOS T R SOC B, V364, P3067, DOI 10.1098/rstb.2009.0170; Nel WP, 2010, APPL ENERG, V87, P168, DOI 10.1016/j.apenergy.2009.06.003; ODUM HT, 1971, ENV POWER SOC; Palmer M, 2004, SCIENCE, V304, P1251, DOI 10.1126/science.1095780; Pearl R, 1927, Q REV BIOL, V2, P532, DOI 10.1086/394288; Schade Carleton, 2010, Environment Development and Sustainability, V12, P245, DOI 10.1007/s10668-009-9192-5; Short RV, 2009, PHILOS T R SOC B, V364, P2971, DOI 10.1098/rstb.2009.0144; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; Smil V, 2000, ANNU REV ENERG ENV, V25, P21, DOI 10.1146/annurev.energy.25.1.21; STERN DI, 1993, ENERG ECON, V15, P137, DOI 10.1016/0140-9883(93)90033-N; Thompson WS, 1929, AM J SOCIOL, V34, P959, DOI 10.1086/214874; *WORLD RES I, 2010, EARTHTR ENV INF	31	19	19	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13206	10.1371/journal.pone.0013206	http://dx.doi.org/10.1371/journal.pone.0013206			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957155	gold, Green Published, Green Submitted			2022-12-27	WOS:000282506100015
J	Dubar, G; Azria, E; Tesniere, A; Dupont, H; Le Ray, C; Baugnon, T; Matheron, S; Luton, D; Richard, JC; Launay, O; Tsatsaris, V; Goffinet, F; Mignon, A				Dubar, Gregory; Azria, Elie; Tesniere, Antoine; Dupont, Herve; Le Ray, Camille; Baugnon, Thomas; Matheron, Sophie; Luton, Dominique; Richard, Jean-Christophe; Launay, Odile; Tsatsaris, Vassilis; Goffinet, Francois; Mignon, Alexandre		French Registry 2009 A H1N1v Pregn	French Experience of 2009 A/H1N1v Influenza in Pregnant Women	PLOS ONE			English	Article							H1N1 INFLUENZA; PANDEMIC INFLUENZA; A H1N1; INFECTION; OUTCOMES	Background: The first reports on the pandemic influenza 2009 A/H1N1v from the USA, Mexico, and Australia indicated that this disease was associated with a high mortality in pregnant women. The aim of this study was to describe and compare the characteristics of severe critically ill and non-severe pregnant women with 2009 A/H1N1v-related illness in France. Methodology/Principal Findings: A national registry was created to screen pregnant women with laboratory-confirmed 2009 A/H1N1v influenza. Three hundred and fifteen patients from 46 French hospitals were included: 40 patients were admitted to intensive care units (severe outcomes), 111 were hospitalized in obstetric or medical wards (moderate outcomes), and 164 were outpatients (mild outcomes). The 2009 A/H1N1v influenza illness occurred during all pregnancy trimesters, but most women (54%), notably the severe patients (70%), were in the third trimester. Among the severe patients, twenty (50%) underwent mechanical ventilation, and eleven (28%) were treated with extracorporeal membrane oxygenation. Three women died from A/H1N1v influenza. We found a strong association between the development of a severe outcome and both coexisting illnesses (adjusted odds ratio [OR], 5.1; 95% confidence interval [CI], 2.2-11.8) and a delay in oseltamivir treatment after the onset of symptoms (. 3 or 5 days) (adjusted OR, 4.8; 95% CI, 1.9-12.1 and 61.2, 95% CI; 14.4-261.3, respectively). Among the 140 deliveries after 22 weeks of gestation known to date, 19 neonates (14%) were admitted to a neonatal intensive care unit, mainly for preterm delivery, and two neonates died. None of these neonates developed 2009 A/H1N1v infection. Conclusions: This series confirms the high incidence of complications in pregnant women infected with pandemic A/H1N1v observed in other countries but depicts a lower overall maternal and neonatal mortality and morbidity than indicated in the USA or Australia. Moreover, our data demonstrate the benefit of early oseltamivir treatment in this specific population.	[Dubar, Gregory; Tesniere, Antoine; Mignon, Alexandre] Univ Paris 05, Hop Cochin, AP HP, Dept Anesthesie Reanimat, Paris, France; [Azria, Elie] Univ Paris Diderot, Hop Bichat, AP HP, Serv Gynecol Obstet, Paris, France; [Dupont, Herve] Univ Amiens, Hop Amiens, Dept Anesthesie Reanimat, Amiens, France; [Le Ray, Camille; Tsatsaris, Vassilis; Goffinet, Francois] Univ Paris 05, Hop Cochin, AP HP, Serv Gynecol Obstet, Paris, France; [Baugnon, Thomas] Univ Paris 05, Hop Necker, AP HP, Dept Anesthesie Reanimat, Paris, France; [Matheron, Sophie] Univ Paris Diderot, Hop Bichat, AP HP, Serv Malad Infect & Trop, Paris, France; [Luton, Dominique] Univ Paris Diderot, Hop Beaujon, AP HP, Serv Gynecol Obstet, Paris, France; [Richard, Jean-Christophe] Univ Rouen, Hop Charles Nicolle, Serv Reanimat Med, Rouen, France; [Launay, Odile] Univ Paris 05, Hop Cochin, AP HP, Ctr Invest Clin Vaccinol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU de Rouen; Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Dubar, G (corresponding author), Univ Paris 05, Hop Cochin, AP HP, Dept Anesthesie Reanimat, Paris, France.	alexandre.mignon@cch.aphp.fr	Matheron, Sophie/D-7420-2017; Dupont, Herve/D-1259-2010	Matheron, Sophie/0000-0001-7879-6553; Le Ray, Camille/0000-0003-0891-1063; GOFFINET, Francois/0000-0001-9643-0299; Azria, Elie/0000-0002-6159-6253				*CNGOF, 2009, REC PRIS CHARG GRIPP; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Greer LG, 2010, OBSTET GYNECOL, V115, P711, DOI 10.1097/AOG.0b013e3181d44752; HANSLIK T, 2010, PLOS CURR INFLUENZA; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Hewagama S, 2010, CLIN INFECT DIS, V50, P686, DOI 10.1086/650460; *INVS, 2009, MOD SURV DECL GRIPP; *INVS, 2009, B EP GRIPP A; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Lim ML, 2010, BJOG-INT J OBSTET GY, V117, P551, DOI 10.1111/j.1471-0528.2010.02522.x; Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; SANTE MDL, 2009, STRATEGIE NATL PRISE; Seppelt I, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1279; Siston AM, 2010, JAMA-J AM MED ASSOC, V303, P1517, DOI 10.1001/jama.2010.479; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	24	66	70	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13112	10.1371/journal.pone.0013112	http://dx.doi.org/10.1371/journal.pone.0013112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957195	Green Published, Green Submitted, gold			2022-12-27	WOS:000282506100001
J	Kokal, I; Keysers, C				Kokal, Idil; Keysers, Christian			Granger Causality Mapping during Joint Actions Reveals Evidence for Forward Models That Could Overcome Sensory-Motor Delays	PLOS ONE			English	Article							TEMPORAL POLYSENSORY AREA; MIRROR NEURON SYSTEM; REACTION-TIME-TASK; FMRI DATA; SENSITIVE CELLS; CEREBELLUM; MOVEMENT; BRAIN; CORTEX; SYNCHRONIZATION	Studies investigating joint actions have suggested a central role for the putative mirror neuron system (pMNS) because of the close link between perception and action provided by these brain regions [1,2,3]. In contrast, our previous functional magnetic resonance imaging (fMRI) experiment demonstrated that the BOLD response of the pMNS does not suggest that it directly integrates observed and executed actions during joint actions [4]. To test whether the pMNS might contribute indirectly to the integration process by sending information to brain areas responsible for this integration (integration network), here we used Granger causality mapping (GCM) [5]. We explored the directional information flow between the anterior sites of the pMNS and previously identified integrative brain regions. We found that the left BA44 sent more information than it received to both the integration network (left thalamus, right middle occipital gyrus and cerebellum) and more posterior nodes of the pMNS (BA2). Thus, during joint actions, two anatomically separate networks therefore seem effectively connected and the information flow is predominantly from anterior to posterior areas of the brain. These findings suggest that the pMNS is involved indirectly in joint actions by transforming observed and executed actions into a common code and is part of a generative model that could predict the future somatosensory and visual consequences of observed and executed actions in order to overcome otherwise inevitable neural delays.	[Kokal, Idil; Keysers, Christian] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Keysers, Christian] Royal Netherlands Acad Arts & Sci KNAW, Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Groningen; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Kokal, I (corresponding author), Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	c.keysers@nin.knaw.nl	Keysers, Christian/H-6251-2013	Keysers, Christian/0000-0002-2845-5467	European Commission; N.W.O.	European Commission(European CommissionEuropean Commission Joint Research Centre); N.W.O.(Netherlands Organization for Scientific Research (NWO))	The study was supported by a Marie Curie Excellent Grant of the European Commission and an N.W.O. VIDI grant to CK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM JJ, 1991, PERCEPT MOTOR SKILL, V73, P863, DOI 10.2466/PMS.73.7.863-866; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; Blakemore SJ, 2000, NEUROREPORT, V11, pR11, DOI 10.1097/00001756-200008030-00002; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Del Giudice M, 2009, DEVELOPMENTAL SCI, V12, P350, DOI 10.1111/j.1467-7687.2008.00783.x; Demiris J, 2002, FROM ANIM ANIMAT, P327; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Dum RP, 2003, J NEUROPHYSIOL, V89, P634, DOI 10.1152/jn.00626.2002; Dunlap K, 1910, PSYCHOL REV, V17, P399, DOI 10.1037/h0074736; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etzel JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003690; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Hietanen JK, 1996, BEHAV BRAIN RES, V76, P155, DOI 10.1016/0166-4328(95)00193-X; HIETANEN JK, 1993, EXP BRAIN RES, V93, P117; Iacoboni M, 2001, P NATL ACAD SCI USA, V98, P13995, DOI 10.1073/pnas.241474598; Jabbi M, 2008, EMOTION, V8, P775, DOI 10.1037/a0014194; JOHNSON WS, 1898, STUDIES YALE PSYCHOL, V6, P51; KELLER PE, 2008, COGNITIVE SOCIAL PER, P205; Keller PE, 2007, CONSCIOUS COGN, V16, P102, DOI 10.1016/j.concog.2005.12.004; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Keysers C, 2003, EXP BRAIN RES, V153, P628, DOI 10.1007/s00221-003-1603-5; Keysers C, 2010, NAT REV NEUROSCI, V11, P417, DOI 10.1038/nrn2833; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KNOBLICH G, 2002, MIRROR NEURONS EVOLU, P115; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; MICHIE PT, 1976, PHYSIOL BEHAV, V16, P311, DOI 10.1016/0031-9384(76)90138-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Miyake I., 1902, STUD YALE PSYCHOL LA, V10, P1; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; Newman-Norlund RD, 2008, NEUROIMAGE, V41, P169, DOI 10.1016/j.neuroimage.2008.02.026; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Schaal S, 2003, PHILOS T R SOC B, V358, P537, DOI 10.1098/rstb.2002.1258; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Sebanz N, 2006, J COGNITIVE NEUROSCI, V18, P859, DOI 10.1162/jocn.2006.18.5.859; Sebanz N, 2006, TRENDS COGN SCI, V10, P70, DOI 10.1016/j.tics.2005.12.009; STEIN JF, 1992, PHYSIOL REV, V72, P967, DOI 10.1152/physrev.1992.72.4.967; Szymaszek A, 2006, NEUROSCI LETT, V403, P190, DOI 10.1016/j.neulet.2006.04.062; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2	51	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13507	10.1371/journal.pone.0013507	http://dx.doi.org/10.1371/journal.pone.0013507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975836	gold, Green Published, Green Submitted			2022-12-27	WOS:000283293800004
J	Cheney, KM; McKnight, A				Cheney, Kelly M.; McKnight, Aine			Interferon-Alpha Mediates Restriction of Human Immunodeficiency Virus Type-1 Replication in Primary Human Macrophages at an Early Stage of Replication	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; HIV-1 INFECTION; T-CELLS; ANTIRETROVIRAL THERAPY; POSTENTRY BLOCK; IFN-ALPHA; PROTEIN; MECHANISMS; INHIBITION; MONOCYTES	Type I interferons (IFN alpha and beta) are induced directly in response to viral infection, resulting in an antiviral state for the cell. In vitro studies have shown that IFN alpha is a potent inhibitor of viral replication; however, its role in HIV-1 infection is incompletely understood. In this study we describe the ability of IFN alpha to restrict HIV-1 infection in primary human macrophages in contrast to peripheral blood mononuclear cells and monocyte-derived dendritic cells. Inhibition to HIV-1 replication in cells pretreated with IFN alpha occurred at an early stage in the virus life cycle. Late viral events such as budding and subsequent rounds of infection were not affected by IFN alpha treatment. Analysis of early and late HIV-1 reverse transcripts and integrated proviral DNA confirmed an early post entry role for IFN alpha. First strand cDNA synthesis was slightly reduced but late and integrated products were severely depleted, suggesting that initiation or the nucleic acid intermediates of reverse transcription are targeted. The depletion of integrated provirus is disproportionally greater than that of viral cDNA synthesis suggesting the possibility of a least an additional later target. A role for either cellular protein APOBEC3G or tetherin in this IFN alpha mediated restriction has been excluded. Vpu, previously shown by others to rescue a viral budding restriction by tetherin, could not overcome this IFN alpha induced effect. Determining both the viral determinants and cellular proteins involved may lead to novel therapeutic approaches. Our results add to the understanding of HIV-1 restriction by IFN alpha.	[Cheney, Kelly M.; McKnight, Aine] Queen Mary Univ London, Barts & London Sch Med & Dent, London, England	University of London; Queen Mary University London	Cheney, KM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, London, England.	a.mcknight@qmul.ac.uk		McKnight, Aine/0000-0002-8113-817X	MRC [G117/547]; Wellcome Trust [WT075853MA]; EU [LSHP-CT-2004-503487]; Medical Research Council [G117/547] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); EU(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by an MRC Senior Non-Clinical Fellowship awarded to AM (G117/547) and a Wellcome Trust grant (WT075853MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Matthias Dittmar for helpful discussions and critical reading of the manuscript. The monoclonal antibodies to p24 (EVA365 and 366) were provided by the EU Programme EVA Centre for AIDS Reagents, NIBSC, UK (AVIP Contract Number LSHP-CT-2004-503487). The following cell lines were obtained through the NIH AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH: ACH-2 and 8E5/LAV from Dr. Thomas Folks, OM-10.1 from Dr. Salvatore Butera.	BACAREGEN L, 1994, J VIROL, V68, P7559, DOI 10.1128/JVI.68.11.7559-7565.1994; Bergamaschi A, 2009, J VIROL, V83, P4854, DOI 10.1128/JVI.00187-09; BUTERA ST, 1994, J VIROL, V68, P2726, DOI 10.1128/JVI.68.4.2726-2730.1994; Chen KY, 2006, J VIROL, V80, P7645, DOI 10.1128/JVI.00206-06; CLOUSE KA, 1989, J IMMUNOL, V142, P431; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; GENDELMAN HE, 1990, J IMMUNOL, V145, P2669; GENDELMAN HE, 1990, AIDS RES HUM RETROV, V6, P1045, DOI 10.1089/aid.1990.6.1045; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Goujon C, 2010, J VIROL, V84, P9254, DOI 10.1128/JVI.00854-10; Gramberg T, 2010, J VIROL, V84, P1387, DOI 10.1128/JVI.01437-09; Greenwell-Wild T, 2009, BLOOD, V114, P1864, DOI 10.1182/blood-2009-03-211540; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Katabira ET, 1998, SEX TRANSM INFECT, V74, P265, DOI 10.1136/sti.74.4.265; Kaushik R, 2009, CELL HOST MICROBE, V6, P68, DOI 10.1016/j.chom.2009.05.022; Krown SE, 2006, JAIDS-J ACQ IMM DEF, V41, P149, DOI 10.1097/01.qai.0000194237.15831.23; Krown SE, 2002, J INTERF CYTOK RES, V22, P295, DOI 10.1089/107999002753675712; LANE HC, 1990, ANN INTERN MED, V112, P805, DOI 10.7326/0003-4819-112-11-805; Liszewski MK, 2009, METHODS, V47, P254, DOI 10.1016/j.ymeth.2009.01.002; Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185; Marchant D, 2006, J GEN VIROL, V87, P411, DOI 10.1099/vir.0.81391-0; MCKNIGHT A, 1994, VIROLOGY, V201, P8, DOI 10.1006/viro.1994.1260; MEYLAN PRA, 1993, VIROLOGY, V193, P138, DOI 10.1006/viro.1993.1110; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neumann AU, 2007, AIDS, V21, P1855, DOI 10.1097/QAD.0b013e32825eaba7; Peng G, 2006, J EXP MED, V203, P41, DOI 10.1084/jem.20051512; PITHA PM, 1994, ANTIVIR RES, V24, P205, DOI 10.1016/0166-3542(94)90068-X; Reeves JD, 1999, J VIROL, V73, P7795, DOI 10.1128/JVI.73.9.7795-7804.1999; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; SHIRAZI Y, 1993, VIROLOGY, V193, P303, DOI 10.1006/viro.1993.1126; Soda Y, 1999, BIOCHEM BIOPH RES CO, V258, P313, DOI 10.1006/bbrc.1999.0633; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stylianou E, 2000, CLIN EXP IMMUNOL, V119, P479, DOI 10.1046/j.1365-2249.2000.01144.x; TSANG J, 2009, AIDS; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; YAMAMOTO JK, 1986, J INTERFERON RES, V6, P143, DOI 10.1089/jir.1986.6.143; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	41	43	43	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13521	10.1371/journal.pone.0013521	http://dx.doi.org/10.1371/journal.pone.0013521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975956	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400025
J	Siegel, C; Hallstrom, T; Skerka, C; Eberhardt, H; Uzonyi, B; Beckhaus, T; Karas, M; Wallich, R; Stevenson, B; Zipfel, PF; Kraiczy, P				Siegel, Corinna; Hallstroem, Teresia; Skerka, Christine; Eberhardt, Hannes; Uzonyi, Barbara; Beckhaus, Tobias; Karas, Michael; Wallich, Reinhard; Stevenson, Brian; Zipfel, Peter F.; Kraiczy, Peter			Complement Factor H-Related Proteins CFHR2 and CFHR5 Represent Novel Ligands for the Infection-Associated CRASP Proteins of Borrelia burgdorferi	PLOS ONE			English	Article							ACQUIRING SURFACE PROTEIN-1; LYME-DISEASE SPIROCHETE; REGULATORS FACTOR-H; INHIBITOR FACTOR-H; BINDING-SITES; HUMAN SERUM; C-TERMINUS; FUNCTIONAL-CHARACTERIZATION; FAMILY PROTEINS; IMMUNE EVASION	Background: One virulence property of Borrelia burgdorferi is its resistance to innate immunity, in particular to complement-mediated killing. Serum-resistant B. burgdorferi express up to five distinct complement regulator-acquiring surface proteins (CRASP) which interact with complement regulator factor H (CFH) and factor H-like protein 1 (FHL1) or factor H-related protein 1 (CFHR1). In the present study we elucidate the role of the infection-associated CRASP-3 and CRASP-5 protein to serve as ligands for additional complement regulatory proteins as well as for complement resistance of B. burgdorferi. Methodology/Principal Findings: To elucidate whether CRASP-5 and CRASP-3 interact with various human proteins, both borrelial proteins were immobilized on magnetic beads. Following incubation with human serum, bound proteins were eluted and separated by Glycine-SDS-PAGE. In addition to CFH and CFHR1, complement regulators CFHR2 and CFHR5 were identified as novel ligands for both borrelial proteins by employing MALDI-TOF. To further assess the contributions of CRASP-3 and CRASP-5 to complement resistance, a serum-sensitive B. garinii strain G1 which lacks all CFH-binding proteins was used as a valuable model for functional analyses. Both CRASPs expressed on the B. garinii outer surface bound CFH as well as CFHR1 and CFHR2 in ELISA. In contrast, live B. garinii bound CFHR1, CFHR2, and CFHR5 and only miniscute amounts of CFH as demonstrated by serum adsorption assays and FACS analyses. Further functional analysis revealed that upon NHS incubation, CRASP-3 or CRASP-5 expressing borreliae were killed by complement. Conclusions/Significance: In the absence of CFH and the presence of CFHR1, CFHR2 and CFHR5, assembly and integration of the membrane attack complex was not efficiently inhibited indicating that CFH in co-operation with CFHR1, CFHR2 and CFHR5 supports complement evasion of B. burgdorferi.	[Siegel, Corinna; Kraiczy, Peter] Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany; [Hallstroem, Teresia; Skerka, Christine; Eberhardt, Hannes; Uzonyi, Barbara; Zipfel, Peter F.] Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Beckhaus, Tobias; Karas, Michael] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Wallich, Reinhard] Heidelberg Univ, Inst Immunol, D-6900 Heidelberg, Germany; [Stevenson, Brian] Univ Kentucky, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA; [Zipfel, Peter F.] Univ Jena, Jena, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hans Knoll Institute (HKI); Goethe University Frankfurt; Ruprecht Karls University Heidelberg; University of Kentucky; Friedrich Schiller University of Jena	Siegel, C (corresponding author), Univ Hosp Frankfurt, Inst Med Microbiol & Infect Control, Frankfurt, Germany.	Kraiczy@em.uni-frankfurt.de	Uzonyi, Barbara/J-3973-2018	Uzonyi, Barbara/0000-0002-9680-1974	Deutsche Forschungsgemeinschaft [Kr3383/1-2]; U.S. National Institutes of Health [AI44254]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in part, by the Deutsche Forschungsgemeinschaft grant Kr3383/1-2 to P. Kraiczy and U.S. National Institutes of Health grant AI44254 to B. Stevenson. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Alitalo A, 2005, EUR J IMMUNOL, V35, P3043, DOI 10.1002/eji.200526354; Alitalo A, 2004, J IMMUNOL, V172, P6195, DOI 10.4049/jimmunol.172.10.6195; Alitalo A, 2002, J IMMUNOL, V169, P3847, DOI 10.4049/jimmunol.169.7.3847; Alitalo A, 2001, INFECT IMMUN, V69, P3685, DOI 10.1128/IAI.69.6.3685-3691.2001; Arlaud GJ, 2007, MOL IMMUNOL, V44, P3809, DOI 10.1016/j.molimm.2007.06.147; Aslam M, 2001, J MOL BIOL, V309, P1117, DOI 10.1006/jmbi.2001.4720; BreitnerRuddock S, 1997, MED MICROBIOL IMMUN, V185, P253, DOI 10.1007/s004300050038; Brooks CS, 2005, J IMMUNOL, V175, P3299, DOI 10.4049/jimmunol.175.5.3299; Bykowski T, 2007, INFECT IMMUN, V75, P4227, DOI 10.1128/IAI.00604-07; El-Hage N, 2001, MICROBIOL-SGM, V147, P821, DOI 10.1099/00221287-147-4-821; ESTALLER C, 1991, J IMMUNOL, V146, P3190; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Foldvari G, 2005, EMERG INFECT DIS, V11, P1794; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Grosskinsky S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004858; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Hartmann K, 2006, MOL MICROBIOL, V61, P1220, DOI 10.1111/j.1365-2958.2006.05318.x; Haupt K, 2008, INT J MED MICROBIOL, V298, P287, DOI 10.1016/j.ijmm.2007.11.010; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hauser U, 1999, J CLIN MICROBIOL, V37, P2241, DOI 10.1128/JCM.37.7.2241-2247.1999; Heinen S, 2009, BLOOD, V114, P2439, DOI 10.1182/blood-2009-02-205641; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Herzberger P, 2007, INFECT IMMUN, V75, P4817, DOI 10.1128/IAI.00532-07; Hovis KM, 2006, INFECT IMMUN, V74, P1967, DOI 10.1128/IAI.74.3.1967-1972.2006; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2008, TRENDS IMMUNOL, V29, P380, DOI 10.1016/j.it.2008.04.008; Kraiczy P, 2004, J BIOL CHEM, V279, P2421, DOI 10.1074/jbc.M308343200; Kraiczy P, 2003, EUR J IMMUNOL, V33, P697, DOI 10.1002/eji.200323571; Kraiczy P, 2001, INT IMMUNOPHARMACOL, V1, P393, DOI 10.1016/S1567-5769(00)00041-2; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Kraiczy P, 2001, INFECT IMMUN, V69, P7800, DOI 10.1128/IAI.69.12.7800-7809.2001; KUHN S, 1995, GENE, V162, P225, DOI 10.1016/0378-1119(95)00360-I; KUHN S, 1995, J IMMUNOL, V155, P5663; Mbow ML, 2002, HYBRIDOMA HYBRIDOM, V21, P179, DOI 10.1089/153685902760173890; McDowell JV, 2003, INFECT IMMUN, V71, P3597, DOI 10.1128/IAI.71.6.3597-3602.2003; McRae JL, 2005, J IMMUNOL, V174, P6250, DOI 10.4049/jimmunol.174.10.6250; McRae JL, 2001, J BIOL CHEM, V276, P6747, DOI 10.1074/jbc.M007495200; Metts MS, 2003, INFECT IMMUN, V71, P3587, DOI 10.1128/IAI.71.6.3587-3596.2003; Michel H, 2004, MED MICROBIOL IMMUN, V193, P219, DOI 10.1007/s00430-003-0196-8; Miller JC, 2003, INFECT IMMUN, V71, P6943, DOI 10.1128/IAI.71.12.6943-6952.2003; Miller JC, 2006, MICROB PATHOGENESIS, V41, P43, DOI 10.1016/j.micpath.2006.04.004; Okemefuna AI, 2009, J MOL BIOL, V391, P119, DOI 10.1016/j.jmb.2009.06.013; Okemefuna AI, 2009, J MOL BIOL, V391, P98, DOI 10.1016/j.jmb.2009.06.010; Oppermann M, 2006, CLIN EXP IMMUNOL, V144, P342, DOI 10.1111/j.1365-2249.2006.03071.x; Park CT, 1996, J BIOL CHEM, V271, P18054, DOI 10.1074/jbc.271.30.18054; Park CT, 2000, BLOOD, V95, P198, DOI 10.1182/blood.V95.1.198.001k31_198_204; Prodinger WM, 1998, BIOCHEM J, V331, P41, DOI 10.1042/bj3310041; Richter D, 2004, APPL ENVIRON MICROB, V70, P6414, DOI 10.1128/AEM.70.11.6414-6419.2004; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Samuels D S, 1995, Methods Mol Biol, V47, P253; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Siegel C, 2008, J BIOL CHEM, V283, P34855, DOI 10.1074/jbc.M805844200; SKERKA C, 1991, J BIOL CHEM, V266, P12015; SKERKA C, 1992, J IMMUNOL, V148, P3313; Skerka C, 2008, VACCINE, V26, pI9, DOI 10.1016/j.vaccine.2008.11.021; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; Stevenson B, 2002, INFECT IMMUN, V70, P491, DOI 10.1128/IAI.70.2.491-497.2002; Stevenson B, 2002, INFECT IMMUN, V70, P5307, DOI 10.1128/IAI.70.9.5307-5311.2002; Stevenson B, 1998, INFECT IMMUN, V66, P2648, DOI 10.1128/IAI.66.6.2648-2654.1998; Stevenson B, 2006, WIEN KLIN WOCHENSCHR, V118, P643, DOI 10.1007/s00508-006-0690-2; TIMMANN C, 1991, J IMMUNOL, V146, P1265; VanDam AP, 1997, INFECT IMMUN, V65, P1228, DOI 10.1128/IAI.65.4.1228-1236.1997; von Lackum K, 2005, INFECT IMMUN, V73, P7398, DOI 10.1128/IAI.73.11.7398-7405.2005; Wallich R, 2005, INFECT IMMUN, V73, P2351, DOI 10.1128/IAI.73.4.2351-2359.2005; Wang GQ, 1999, J CLIN MICROBIOL, V37, P3025, DOI 10.1128/JCM.37.9.3025-3028.1999; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971	70	51	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13519	10.1371/journal.pone.0013519	http://dx.doi.org/10.1371/journal.pone.0013519			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975954	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400023
J	Wang, F; Fu, XQ; Chen, X; Chen, XB; Zhao, YF				Wang, Fei; Fu, Xueqi; Chen, Xia; Chen, Xinbin; Zhao, Yunfeng			Mitochondrial Uncoupling Inhibits p53 Mitochondrial Translocation in TPA-Challenged Skin Epidermal JB6 Cells	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; PROTON LEAK; CANCER-CELLS; OXIDATIVE STRESS; RESPIRATION RATE; MUTANT P53; PROTEIN-2; ACTIVATION; APOPTOSIS; EXPRESSION	The tumor suppressor p53 is known to be able to trigger apoptosis in response to DNA damage, oncogene activation, and certain chemotherapeutic drugs. In addition to its transcriptional activation, a fraction of p53 translocates to mitochondria at the very early stage of apoptosis, which eventually contributes to the loss of mitochondrial membrane potential, generation of reactive oxygen species (ROS), cytochrome c release, and caspase activation. However, the mitochondrial events that affect p53 translocation are still unclear. Since mitochondrial uncoupling has been suggested to contribute to cancer development, herein, we studied whether p53 mitochondrial translocation and subsequent apoptosis were affected by mitochondrial uncoupling using chemical protonophores, and further verified the results using a siRNA approach in murine skin epidermal JB6 cells. Our results showed that mitochondrial uncoupling blocked p53 mitochondrial translocation induced by 12-O-tetradecanoylphorbol 13-acetate (TPA), a known tumor promoter to induce p53-mediated apoptosis in skin carcinogenesis. This blocking effect, in turn, led to preservation of mitochondrial functions, and eventually suppression of caspase activity and apoptosis. Moreover, uncoupling protein 2 (UCP2), a potential suppressor of ROS in mitochondria, is important for TPA-induced cell transformation in JB6 cells. UCP2 knock down cells showed enhanced p53 mitochondrial translocation, and were less prone to form colonies in soft agar after TPA treatment. Altogether, our data suggest that mitochondrial uncoupling may serve as an important regulator of p53 mitochondrial translocation and p53-mediated apoptosis during early tumor promotion. Therefore, targeting mitochondrial uncoupling may be considered as a novel treatment strategy for cancer.	[Wang, Fei; Zhao, Yunfeng] LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA; [Wang, Fei; Fu, Xueqi; Chen, Xia] Jilin Univ, Coll Life Sci, Changchun 130023, Peoples R China; [Chen, Xinbin] Univ Calif Davis, Dept Surg & Radiol Sci, Davis, CA 95616 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Jilin University; University of California System; University of California Davis	Wang, F (corresponding author), LSU Hlth Sci Ctr Shreveport, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA USA.	yzhao1@lsuhsc.edu			National Cancer Institute [R03CA128077]; LSUHSC-S; NATIONAL CANCER INSTITUTE [R03CA128077] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); LSUHSC-S; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grant Number R03CA128077 from the National Cancer Institute and LSUHSC-S Start-up Package. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch-Machin MA, 1993, METHODS TOXICOL, V2, P51; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; Brand MD, 1999, INT J OBESITY, V23, pS4, DOI 10.1038/sj.ijo.0800936; BRAND MD, 1990, BIOCHIM BIOPHYS ACTA, V1018, P128, DOI 10.1016/0005-2728(90)90232-S; BROWN GC, 1991, BIOCHIM BIOPHYS ACTA, V1059, P55, DOI 10.1016/S0005-2728(05)80187-2; COLBURN NH, 1978, CANCER RES, V38, P624; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Derdak Z, 2008, CANCER RES, V68, P2813, DOI 10.1158/0008-5472.CAN-08-0053; Echtay KS, 2007, FREE RADICAL BIO MED, V43, P1351, DOI 10.1016/j.freeradbiomed.2007.08.011; Gogvadze V, 2008, TRENDS CELL BIOL, V18, P165, DOI 10.1016/j.tcb.2008.01.006; Halliwell B, 2007, BIOCHEM J, V401, P1, DOI 10.1042/BJ20061131; Harper ME, 2002, FASEB J, V16, P1550, DOI 10.1096/fj.02-0541com; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; Horimoto M, 2004, CLIN CANCER RES, V10, P6203, DOI 10.1158/1078-0432.CCR-04-0419; Hwang PM, 2001, NAT MED, V7, P1111, DOI 10.1038/nm1001-1111; Kowaltowski AJ, 1998, FEBS LETT, V425, P213, DOI 10.1016/S0014-5793(98)00231-2; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu JF, 2008, FEBS LETT, V582, P1319, DOI 10.1016/j.febslet.2008.03.013; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Moll UM, 2005, CURR OPIN CELL BIOL, V17, P631, DOI 10.1016/j.ceb.2005.09.007; Moll UM, 2001, FEBS LETT, V493, P65, DOI 10.1016/S0014-5793(01)02284-0; NegreSalvayre A, 1997, FASEB J, V11, P809, DOI 10.1096/fasebj.11.10.9271366; PORTER RK, 1995, AM J PHYSIOL-REG I, V269, pR1213, DOI 10.1152/ajpregu.1995.269.5.R1213; Rolfe DFS, 1999, AM J PHYSIOL-CELL PH, V276, pC692, DOI 10.1152/ajpcell.1999.276.3.C692; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; SUN Y, 1993, P NATL ACAD SCI USA, V90, P2827, DOI 10.1073/pnas.90.7.2827; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Yan WS, 2008, CANCER RES, V68, P6789, DOI 10.1158/0008-5472.CAN-08-0810; Zhao YF, 2006, FREE RADICAL BIO MED, V40, P1234, DOI 10.1016/j.freeradbiomed.2005.11.009; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835; Zhao YF, 2005, CANCER RES, V65, P1401, DOI 10.1158/0008-5472.CAN-04-3334; Zhao YF, 2002, ONCOGENE, V21, P3836, DOI 10.1038/sj.onc.1205477; Zhao YF, 2006, CARCINOGENESIS, V27, P1692, DOI 10.1093/carcin/bgl037	40	23	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13459	10.1371/journal.pone.0013459	http://dx.doi.org/10.1371/journal.pone.0013459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976134	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300028
J	Sicuri, E; Bardaji, A; Nhampossa, T; Maixenchs, M; Nhacolo, A; Nhalungo, D; Alonso, PL; Menendez, C				Sicuri, Elisa; Bardaji, Azucena; Nhampossa, Tacilta; Maixenchs, Maria; Nhacolo, Ariel; Nhalungo, Delino; Alonso, Pedro L.; Menendez, Clara			Cost-Effectiveness of Intermittent Preventive Treatment of Malaria in Pregnancy in Southern Mozambique	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; PLACEBO-CONTROLLED TRIAL; SULFADOXINE-PYRIMETHAMINE; ANTIMALARIAL REGIMENS; MATERNAL MORTALITY; PLACENTAL MALARIA; EFFICACY; CHLOROQUINE; WOMEN; CHILDREN	Background: Malaria in pregnancy is a public health problem for endemic countries. Economic evaluations of malaria preventive strategies in pregnancy are needed to guide health policies. Methods and Findings: This analysis was carried out in the context of a trial of malaria intermittent preventive treatment in pregnancy with sulphadoxine-pyrimethamine (IPTp-SP), where both intervention groups received an insecticide treated net through the antenatal clinic (ANC) in Mozambique. The cost-effectiveness of IPTp-SP on maternal clinical malaria and neonatal survival was estimated. Correlation and threshold analyses were undertaken to assess the main factors affecting the economic outcomes and the cut-off values beyond which the intervention is no longer cost-effective. In 2007 US$, the incremental cost-effectiveness ratio (ICER) for maternal malaria was 41.46 US$ (95% CI 20.5, 96.7) per disability-adjusted life-year (DALY) averted. The ICER per DALY averted due to the reduction in neonatal mortality was 1.08 US$ (95% CI 0.43, 3.48). The ICER including both the effect on the mother and on the newborn was 1.02 US$ (95% CI 0.42, 3.21) per DALY averted. Efficacy was the main factor affecting the economic evaluation of IPTp-SP. The intervention remained cost-effective with an increase in drug cost per dose up to 11 times in the case of maternal malaria and 183 times in the case of neonatal mortality. Conclusions: IPTp-SP was highly cost-effective for both prevention of maternal malaria and reduction of neonatal mortality in Mozambique. These findings are likely to hold for other settings where IPTp-SP is implemented through ANC visits. The intervention remained cost-effective even with a significant increase in drug and other intervention costs. Improvements in the protective efficacy of the intervention would increase its cost-effectiveness. Provision of IPTp with a more effective, although more expensive drug than SP may still remain a cost-effective public health measure to prevent malaria in pregnancy.	[Sicuri, Elisa; Bardaji, Azucena; Alonso, Pedro L.; Menendez, Clara] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Sicuri, Elisa; Bardaji, Azucena; Alonso, Pedro L.; Menendez, Clara] CIBERESP, Barcelona, Spain; [Nhampossa, Tacilta; Maixenchs, Maria; Nhacolo, Ariel; Nhalungo, Delino; Alonso, Pedro L.; Menendez, Clara] CISM, Maputo, Mozambique; [Nhampossa, Tacilta] Minist Saude, Inst Nacl Saude, Direccao Nacl Saude, Maputo, Mozambique	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Centro de Investigacao em Saude de Manhica	Sicuri, E (corresponding author), Univ Barcelona, Hosp Clin IDIBAPS, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.	elisa.sicuri@cresib.cat	Menéndez, Clara/Q-3446-2016; Alonso, Pedro L/AAZ-3645-2020; Bardají, Azucena/AAE-9145-2019; Sicuri, Elisa/L-8012-2014; Alonso, Azucena Bardají/V-5978-2018	Menéndez, Clara/0000-0002-2641-6907; Alonso, Pedro L/0000-0003-3292-3443; Sicuri, Elisa/0000-0002-2499-2732; Alonso, Azucena Bardají/0000-0002-5135-0540; Maixenchs, Maria/0000-0002-5782-8197	Bill & Melinda Gates Foundation through the IPTi (Intermittent Preventive Treatment of malaria in infants) Consortium; CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica); Banco de Bilbao, Vizcaya, Argentaria Foundation [BBVA 02-20]; Spanish Agency for International Cooperation (AECI)	Bill & Melinda Gates Foundation through the IPTi (Intermittent Preventive Treatment of malaria in infants) Consortium; CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica); Banco de Bilbao, Vizcaya, Argentaria Foundation; Spanish Agency for International Cooperation (AECI)	Elisa Sicuri is supported by a grant from the Bill & Melinda Gates Foundation through the IPTi (Intermittent Preventive Treatment of malaria in infants) Consortium and by a CIBERESP (Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica) fellowship. The main trial received funding from the Banco de Bilbao, Vizcaya, Argentaria Foundation (grant number BBVA 02-20). The Centro de Investigacao em Saude de Manhica (CISM), receives major core funding from the Spanish Agency for International Cooperation (AECI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abacassamo F, 2004, TROP MED INT HEALTH, V9, P200, DOI 10.1046/j.1365-3156.2003.01182.x; ALONSO P, 2002, MANHICA DSS MOZAMBIQ; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; [Anonymous], 2016, WORLD DEV IND; [Anonymous], 2004, STRATEGIC FRAMEWORK; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Becker-Dreps SI, 2009, AM J TROP MED HYG, V81, P496, DOI 10.4269/ajtmh.2009.81.496; Briand V, 2009, J INFECT DIS, V200, P991, DOI 10.1086/605474; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; Chase C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-132; COCHRAN WG, 1963, SAMPLING TECHINQUES; Conteh L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010313; Crawley J, 2007, LANCET INFECT DIS, V7, P145, DOI 10.1016/S1473-3099(07)70026-9; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2005, BRIT J PSYCHIAT, V187, P106, DOI 10.1192/bjp.187.2.106; Goodman CA, 2001, AM J TROP MED HYG, V64, P45, DOI 10.4269/ajtmh.2001.64.45; Greenwood B, 2007, LANCET INFECT DIS, V7, P169, DOI 10.1016/S1473-3099(07)70028-2; Hammerich A, 2002, TROP MED INT HEALTH, V7, P573, DOI 10.1046/j.1365-3156.2002.00898.x; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Hutton G, 2009, B WORLD HEALTH ORGAN, V87, P123, DOI 10.2471/BLT.08.051961; International Labour Organization, 2008, GLOB WAG REP 2008 09; Kalemli-Ozcan S, 2000, J DEV ECON, V62, P1, DOI 10.1016/S0304-3878(00)00073-0; Kalemli-Ozcan S, 2002, J ECON GROWTH, V7, P411, DOI 10.1023/A:1020831902045; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Manzi F, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-165; Mbaye A, 2006, TROP MED INT HEALTH, V11, P992, DOI 10.1111/j.1365-3156.2006.01649.x; Mbonye AK, 2008, T ROY SOC TROP MED H, V102, P685, DOI 10.1016/j.trstmh.2008.04.016; *MEAS DHS, 2003, MOC INQ DEM SAUD; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Menendez C, 2008, PLOS MED, V5, P220, DOI 10.1371/journal.pmed.0050044; Menendez C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009438; *MISAU, 2002, EST AN CUST CORR UN; Murray CJL, 1996, GLOBAL BURDEN DIS, VI, P990; Musgrove P, 1993, Bull Pan Am Health Organ, V27, P284; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Plowe CV, 2009, J INFECT DIS, V200, P1646, DOI 10.1086/646613; *PROGR NAC CONTR M, 2005, DOC ESTR CONTR MAL M; Rushby JF, 2001, HEALTH POLICY PLANN, V16, P326, DOI 10.1093/heapol/16.3.326; SCHULTZ LJ, 1994, AM J TROP MED HYG, V51, P515, DOI 10.4269/ajtmh.1994.51.515; Schultz LJ, 1996, AM J TROP MED HYG, V55, P87, DOI 10.4269/ajtmh.1996.55.87; SCHULTZ LJ, 1995, B WORLD HEALTH ORGAN, V73, P207; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sinha A, 2007, LANCET, V369, P389, DOI 10.1016/S0140-6736(07)60195-0; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; TERKUILE FO, 2005, CAN TREATMENT UNPUB; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; *WHO, 2000, WHO EXP COMM MAL; *WHOSIS, 2006, LIF TABL MOZ; Wolfe EB, 2001, AM J TROP MED HYG, V64, P178, DOI 10.4269/ajtmh.2001.64.178; *WORLD BANK, 1993, COMMUN DIS REP CDR W, V3, P137; World Health Organization. Regional Office for Africa, 2004, STRATEGIC FRAMEWORK; Worrall E, 2007, LANCET INFECT DIS, V7, P156, DOI 10.1016/S1473-3099(07)70027-0; Zhou XH, 1997, ANN INTERN MED, V127, P752, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00063; 2007, INT DRUG PRICE INDIC	57	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13407	10.1371/journal.pone.0013407	http://dx.doi.org/10.1371/journal.pone.0013407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976217	Green Submitted, gold, Green Published			2022-12-27	WOS:000283043700009
J	Bhatnagar, S; Panguluri, SK; Gupta, SK; Dahiya, S; Lundy, RF; Kumar, A				Bhatnagar, Shephali; Panguluri, Siva K.; Gupta, Sanjay K.; Dahiya, Saurabh; Lundy, Robert F.; Kumar, Ashok			Tumor Necrosis Factor-alpha Regulates Distinct Molecular Pathways and Gene Networks in Cultured Skeletal Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; TNF-ALPHA; MYOGENIC DIFFERENTIATION; EXPRESSION PATTERNS; SIGNALING PATHWAYS; ADAPTIVE IMMUNITY; MYOD PROTEIN; WEAK INDUCER; ACTIVATION; ATROPHY	Background: Skeletal muscle wasting is a debilitating consequence of large number of disease states and conditions. Tumor necrosis factor-alpha (TNF-alpha) is one of the most important muscle-wasting cytokine, elevated levels of which cause significant muscular abnormalities. However, the underpinning molecular mechanisms by which TNF-alpha causes skeletal muscle wasting are less well-understood. Methodology/Principal Findings: We have used microarray, quantitative real-time PCR (QRT-PCR), Western blot, and bioinformatics tools to study the effects of TNF-alpha on various molecular pathways and gene networks in C2C12 cells (a mouse myoblastic cell line). Microarray analyses of C2C12 myotubes treated with TNF-alpha (10 ng/ml) for 18h showed differential expression of a number of genes involved in distinct molecular pathways. The genes involved in nuclear factor-kappa B (NF-kappaB) signaling, 26s proteasome pathway, Notch1 signaling, and chemokine networks are the most important ones affected by TNF-alpha. The expression of some of the genes in microarray dataset showed good correlation in independent QRT-PCR and Western blot assays. Analysis of TNF-treated myotubes showed that TNF-alpha augments the activity of both canonical and alternative NF-kappa B signaling pathways in myotubes. Bioinformatics analyses of microarray dataset revealed that TNF-alpha affects the activity of several important pathways including those involved in oxidative stress, hepatic fibrosis, mitochondrial dysfunction, cholesterol biosynthesis, and TGF-beta signaling. Furthermore, TNF-alpha was found to affect the gene networks related to drug metabolism, cell cycle, cancer, neurological disease, organismal injury, and abnormalities in myotubes. Conclusions: TNF-alpha regulates the expression of multiple genes involved in various toxic pathways which may be responsible for TNF-induced muscle loss in catabolic conditions. Our study suggests that TNF-alpha activates both canonical and alternative NF-kappa B signaling pathways in a time-dependent manner in skeletal muscle cells. The study provides novel insight into the mechanisms of action of TNF-alpha in skeletal muscle cells.	[Bhatnagar, Shephali; Panguluri, Siva K.; Gupta, Sanjay K.; Dahiya, Saurabh; Lundy, Robert F.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA	University of Louisville	Bhatnagar, S (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA.	ashok.kumar@louisville.edu	Dahiya, Saurabh/AAE-6006-2022; Gupta/ABE-4368-2020; Panguluri, Siva Kumar/A-3084-2008	Dahiya, Saurabh/0000-0002-8236-8241; Kumar, Ashok/0000-0001-8571-2848	National Institutes of Health [RO1 AG029623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grant RO1 AG029623 to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Adams V, 2008, FRONT BIOSCI-LANDMRK, V13, P302, DOI 10.2741/2680; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Bertazza L, 2008, FRONT BIOSCI-LANDMRK, V13, P2736, DOI 10.2741/2881; Bhatnagar S, 2010, J MOL MED, V88, P155, DOI 10.1007/s00109-009-0550-4; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; De Paepe B, 2007, ANN NY ACAD SCI, V1109, P441, DOI 10.1196/annals.1398.050; DIMAURO S, 1981, SCIENCE, V212, P1277, DOI 10.1126/science.6262916; Do MS, 2006, YONSEI MED J, V47, P729, DOI 10.3349/ymj.2006.47.5.729; Dobrowolny G, 2008, CELL METAB, V8, P425, DOI 10.1016/j.cmet.2008.09.002; Dogra C, 2006, J BIOL CHEM, V281, P10327, DOI 10.1074/jbc.M511131200; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Dogra C, 2007, J BIOL CHEM, V282, P15000, DOI 10.1074/jbc.M608668200; Eikermann M, 2006, INTENS CARE MED, V32, P251, DOI 10.1007/s00134-005-0029-x; Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003; Filippatos GS, 2005, CURR OPIN CLIN NUTR, V8, P249, DOI 10.1097/01.mco.0000165002.08955.5b; Giresi PG, 2005, PHYSIOL GENOMICS, V21, P253, DOI 10.1152/physiolgenomics.00249.2004; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Guan E, 1996, J EXP MED, V183, P2025, DOI 10.1084/jem.183.5.2025; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; JOHANSEN KM, 1989, J CELL BIOL, V109, P2427, DOI 10.1083/jcb.109.5.2427; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Ladner KJ, 2003, J BIOL CHEM, V278, P2294, DOI 10.1074/jbc.M207129200; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li H, 2009, HUM MOL GENET, V18, P2584, DOI 10.1093/hmg/ddp191; Li H, 2009, J BIOL CHEM, V284, P4439, DOI 10.1074/jbc.M805546200; Li YP, 2003, FASEB J, V17, P1048, DOI 10.1096/fj.02-0759com; Li YP, 1998, FASEB J, V12, P871, DOI 10.1096/fasebj.12.10.871; Li YP, 2001, CURR OPIN RHEUMATOL, V13, P483, DOI 10.1097/00002281-200111000-00005; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; Maecker H, 2005, CELL, V123, P931, DOI 10.1016/j.cell.2005.09.022; Mihatsch K, 2009, CARDIOVASC RES, V81, P108, DOI 10.1093/cvr/cvn276; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Muller FL, 2007, AM J PHYSIOL-REG I, V293, pR1159, DOI 10.1152/ajpregu.00767.2006; Panguluri SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008760; Qin B, 2010, EXP BIOL MED, V235, P199, DOI 10.1258/ebm.2009.009169; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Romanello V, 2010, EMBO J, V29, P1774, DOI 10.1038/emboj.2010.60; Spate U, 2004, CURR OPIN CLIN NUTR, V7, P265, DOI 10.1097/01.mco.0000126344.88494.de; SPIEGELMAN BM, 1993, CELL, V73, P625, DOI 10.1016/0092-8674(93)90243-J; Srivastava AK, 2007, J BIOL CHEM, V282, P35113, DOI 10.1074/jbc.M705329200; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tessier PA, 1997, J IMMUNOL, V159, P3595; Tisdale MJ, 1997, J NATL CANCER I, V89, P1763, DOI 10.1093/jnci/89.23.1763; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Vieira SM, 2009, BRIT J PHARMACOL, V158, P779, DOI 10.1111/j.1476-5381.2009.00367.x; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Zhang LP, 2009, J AM SOC NEPHROL, V20, P604, DOI 10.1681/ASN.2008060628	62	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13262	10.1371/journal.pone.0013262	http://dx.doi.org/10.1371/journal.pone.0013262			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967264	Green Published, Green Submitted, gold			2022-12-27	WOS:000282807300009
J	Fukushima, H; Hirata, S; Ueno, A; Matsuda, G; Fuwa, K; Sugama, K; Kusunoki, K; Hirai, M; Hiraki, K; Tomonaga, M; Hasegawa, T				Fukushima, Hirokata; Hirata, Satoshi; Ueno, Ari; Matsuda, Goh; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo; Hirai, Masahiro; Hiraki, Kazuo; Tomonaga, Masaki; Hasegawa, Toshikazu			Neural Correlates of Face and Object Perception in an Awake Chimpanzee (Pan Troglodytes) Examined by Scalp-Surface Event-Related Potentials	PLOS ONE			English	Article							VISUAL EVOKED-POTENTIALS; HUMANS HOMO-SAPIENS; MISMATCH NEGATIVITY; SOCIAL EXPERIENCE; VOCAL PERCEPTION; RECOGNITION; BRAIN; SPECIALIZATION; EXPERTISE; MONKEY	Background: The neural system of our closest living relative, the chimpanzee, is a topic of increasing research interest. However, electrophysiological examinations of neural activity during visual processing in awake chimpanzees are currently lacking. Methodology/Principal Findings: In the present report, skin-surface event-related brain potentials (ERPs) were measured while a fully awake chimpanzee observed photographs of faces and objects in two experiments. In Experiment 1, human faces and stimuli composed of scrambled face images were displayed. In Experiment 2, three types of pictures (faces, flowers, and cars) were presented. The waveforms evoked by face stimuli were distinguished from other stimulus types, as reflected by an enhanced early positivity appearing before 200 ms post stimulus, and an enhanced late negativity after 200 ms, around posterior and occipito-temporal sites. Face-sensitive activity was clearly observed in both experiments. However, in contrast to the robustly observed face-evoked N170 component in humans, we found that faces did not elicit a peak in the latency range of 150-200 ms in either experiment. Conclusions/Significance: Although this pilot study examined a single subject and requires further examination, the observed scalp voltage patterns suggest that selective processing of faces in the chimpanzee brain can be detected by recording surface ERPs. In addition, this non-invasive method for examining an awake chimpanzee can be used to extend our knowledge of the characteristics of visual cognition in other primate species.	[Fukushima, Hirokata; Ueno, Ari; Matsuda, Goh; Hirai, Masahiro; Hiraki, Kazuo; Hasegawa, Toshikazu] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan; [Fukushima, Hirokata; Hirai, Masahiro] Japan Soc Promot Sci, Tokyo, Japan; [Hirata, Satoshi; Fuwa, Kohki; Sugama, Keiko; Kusunoki, Kiyo] Hayashibara Biochemical Labs Inc, Great Ape Res Inst, Tamano, Japan; [Hirai, Masahiro] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada; [Ueno, Ari] Univ Shiga Prefecture, Sch Human Cultures, Dept Human Relat Studies, Hikone, Japan; [Tomonaga, Masaki] Kyoto Univ, Primate Res Inst, Sect Language & Intelligence, Inuyama, Aichi 484, Japan; [Fukushima, Hirokata] Keio Univ, Dept Psychol, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Hayashibara Biochemical Laboratories, Inc.; Queens University - Canada; University Shiga Prefecture; Kyoto University; Keio University	Fukushima, H (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan.	hirof@ardbeg.c.u-tokyo.ac.jp			Center for Evolutionary Cognitive Science at The University of Tokyo; JSPS [20680015, 18200018, 19300091, 20002001]	Center for Evolutionary Cognitive Science at The University of Tokyo; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by the Center for Evolutionary Cognitive Science at The University of Tokyo. This study was also financially supported by Grants-in-Aid for Scientific Research (grant numbers 20680015 to SH, 18200018 to HK, 19300091 and 20002001 to MT) from JSPS (http://www.jsps.go.jp/english/e-grants/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADEY WR, 1963, SCIENCE, V141, P832, DOI 10.1126/science.141.3584.932; BARRETT SE, 1988, NEUROPSYCHOLOGIA, V26, P105, DOI 10.1016/0028-3932(88)90034-6; Barton RA, 1998, P ROY SOC B-BIOL SCI, V265, P1933, DOI 10.1098/rspb.1998.0523; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERNTSON GG, 1993, DEV PSYCHOBIOL, V26, P305, DOI 10.1002/dev.420260602; BOYSEN ST, 1985, ELECTROEN CLIN NEURO, V62, P150, DOI 10.1016/0168-5597(85)90027-9; Burrows AM, 2006, J ANAT, V208, P153, DOI 10.1111/j.1469-7580.2006.00523.x; Dahl CD, 2009, CURR BIOL, V19, P509, DOI 10.1016/j.cub.2009.01.061; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; de Haan M, 2002, J COGNITIVE NEUROSCI, V14, P199, DOI 10.1162/089892902317236849; DERENZI E, 1994, NEUROPSYCHOLOGIA, V32, P893, DOI 10.1016/0028-3932(94)90041-8; Eifuku S, 2004, J NEUROPHYSIOL, V91, P358, DOI 10.1152/jn.00198.2003; Fagot J, 1999, J COMP PSYCHOL, V113, P3, DOI 10.1037/0735-7036.113.1.3; FUJITA K, 1990, INT J PRIMATOL, V11, P553, DOI 10.1007/BF02197057; FUJITA K, 1993, PRIMATES, V34, P141, DOI 10.1007/BF02381385; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Halit H, 2003, NEUROIMAGE, V19, P1180, DOI 10.1016/S1053-8119(03)00076-4; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Idani G., 2006, PRIMATE PERSPECTIVES, P29; Imura T, 2008, BEHAV PROCESS, V77, P306, DOI 10.1016/j.beproc.2007.07.006; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; Kano F, 2009, P R SOC B, V276, P1949, DOI 10.1098/rspb.2008.1811; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiani R, 2005, J NEUROPHYSIOL, V94, P1587, DOI 10.1152/jn.00540.2004; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Martin-Malivel J, 2007, BEHAV NEUROSCI, V121, P1145, DOI 10.1037/0735-7044.121.6.1145; Matsuno T, 2004, BEHAV BRAIN RES, V148, P157, DOI 10.1016/S0166-4328(03)00185-2; Matsuno T., 2007, JAPANESE J PSYCHONOM, V25, P281; Parr LA, 1999, NATURE, V399, P647, DOI 10.1038/21345; Parr LA, 2003, ANN NY ACAD SCI, V1000, P56, DOI 10.1196/annals.1280.005; Parr LA, 1998, J COGNITIVE NEUROSCI, V10, P615, DOI 10.1162/089892998563013; Parr LA, 2008, J COMP PSYCHOL, V122, P390, DOI 10.1037/0735-7036.122.4.390; Parr LA, 2006, BRAIN COGNITION, V62, P30, DOI 10.1016/j.bandc.2006.03.006; Parr LA, 2009, CURR BIOL, V19, P50, DOI 10.1016/j.cub.2008.11.048; PERRETT DI, 1988, BEHAV BRAIN RES, V29, P245, DOI 10.1016/0166-4328(88)90029-0; PINEDA JA, 1994, COGNITIVE BRAIN RES, V2, P1, DOI 10.1016/0926-6410(94)90015-9; Rilling JK, 2007, P NATL ACAD SCI USA, V104, P17146, DOI 10.1073/pnas.0705132104; Rossion B, 2002, PSYCHOL SCI, V13, P250, DOI 10.1111/1467-9280.00446; Sato A, 1997, JPN PSYCHOL RES, V39, P191, DOI 10.1111/1468-5884.00053; SEECK M, 1992, EXP BRAIN RES, V92, P338; Springer SP, 1997, LEFT BRAIN RIGHT BRA; Taglialatela JP, 2008, CURR BIOL, V18, P343, DOI 10.1016/j.cub.2008.01.049; Taglialatela JP, 2009, CEREB CORTEX, V19, P1151, DOI 10.1093/cercor/bhn157; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanaka M, 2007, ANIM COGN, V10, P169, DOI 10.1007/s10071-006-0056-1; Thierry G, 2007, NAT NEUROSCI, V10, P505, DOI 10.1038/nn1864; Tomonaga M, 2007, PRIMATES, V48, P1, DOI 10.1007/s10329-006-0011-4; UENO A, 2009, BIOL LETT; Ueno A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001442; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; Ungerleider L.G., 1982, ANAL VISUAL BEHAV	54	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13366	10.1371/journal.pone.0013366	http://dx.doi.org/10.1371/journal.pone.0013366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967284	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300030
J	Baggaley, RF; Burgin, J; Campbell, OMR				Baggaley, Rebecca F.; Burgin, Joanna; Campbell, Oona M. R.			The Potential of Medical Abortion to Reduce Maternal Mortality in Africa: What Benefits for Tanzania and Ethiopia?	PLOS ONE			English	Article							VAGINAL MISOPROSTOL; COST-EFFECTIVENESS; UTERINE RUPTURE; TERMINATION; PREGNANCY; MIFEPRISTONE; INTERVENTIONS; MORBIDITY; ATTITUDES; EFFICACY	Background: Unsafe abortion is estimated to account for 13% of maternal mortality globally. Medical abortion is a safe alternative. Methods: By estimating mortality risks for unsafe and medical abortion and childbirth for Tanzania and Ethiopia, we modelled changes in maternal mortality that are achievable if unsafe abortion were replaced by medical abortion. We selected Ethiopia and Tanzania because of their high maternal mortality ratios (MMRatios) and contrasting situations regarding health care provision and abortion legislation. We focused on misoprostol-only regimens due to the drug's low cost and accessibility. We included the impact of medical abortion on women who would otherwise choose unsafe abortion and on women with unwanted/mistimed pregnancies who would otherwise carry to term. Results: Thousands of lives could be saved each year in each country by implementing medical abortion using misoprostol (2122 in Tanzania and 2551 in Ethiopia assuming coverage equals family planning services levels: 56% for Tanzania, 31% for Ethiopia). Changes in MMRatios would be less pronounced because the intervention would also affect national birth rates. Conclusions: This is the first analysis of impact of medical abortion provision which takes into account additional potential users other than those currently using unsafe abortion. Thousands of women's lives could be saved, but this may not be reflected in as substantial changes in MMRatios because of medical abortion's demographic impact. Therefore policy makers must be aware of the inability of some traditional measures of maternal mortality to detect the real benefits offered by such an intervention.	[Baggaley, Rebecca F.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Burgin, Joanna] Marie Stopes Int, Med Dev Team, London, England; [Campbell, Oona M. R.] London Sch Hyg & Trop Med, Dept Epidemiol & Publ Hlth, Infect Dis Epidemiol Unit, London WC1, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Baggaley, RF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England.	r.baggaley@imperial.ac.uk		Baggaley, Rebecca/0000-0002-4688-3924; Campbell, Oona/0000-0002-9311-0115	Wellcome Trust [GR082623MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	RFB thanks the Wellcome Trust (www.wellcome.ac.uk) for funding [GR082623MA]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*A GUTM I, 1999, SHAR RESP WOM; Bankole A, 2008, J BIOSOC SCI, V40, P247, DOI 10.1017/S0021932007002283; BARBOSA RM, 1993, STUD FAMILY PLANN, V24, P236, DOI 10.2307/2939191; Bartlett LA, 2004, OBSTET GYNECOL, V103, P729, DOI 10.1097/01.AOG.0000116260.81570.60; Berer M, 2005, REPROD HEALTH MATTER, V13, P25, DOI 10.1016/S0968-8080(05)26204-3; Berer M, 2009, B WORLD HEALTH ORGAN, V87, P58, DOI 10.2471/BLT.07.050138; Bhattacharjee N, 2008, AUST NZ J OBSTET GYN, V48, P165, DOI 10.1111/j.1479-828X.2008.00831.x; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Billings DL, 2004, REPROD HEALTH MATTER, V12, P57, DOI 10.1016/S0968-8080(04)24010-1; Carbonell JLL, 2001, CONTRACEPTION, V63, P131, DOI 10.1016/S0010-7824(01)00189-5; Carbonell JLL, 1997, CONTRACEPTION, V55, P165, DOI 10.1016/S0010-7824(97)00020-6; Central Statistical Agency [Ethiopia] and ORC Macro, 2006, ETH DEM HLTH SURV 20; COSTA SH, 1993, LANCET, V341, P1258, DOI 10.1016/0140-6736(93)91156-G; Coyaji K, 2002, CONTRACEPTION, V66, P33, DOI 10.1016/S0010-7824(02)00309-8; Creinin Mitchell D., 2000, American Journal of Obstetrics and Gynecology, V183, pS3; Fernandez MM, 2009, INT J GYNECOL OBSTET, V105, P180, DOI 10.1016/j.ijgo.2008.12.016; GEBRESELASSIE H, 2002, RESPONDING UNSAFE AB; Gebreselassie H, 2010, INT PERSPECT SEX R H, V36, P6, DOI 10.1363/ipsrh.36.006.10; Goyal V, 2009, OBSTET GYNECOL, V113, P1117, DOI 10.1097/AOG.0b013e31819dbfe2; Grimes DA, 2005, CONTRACEPTION, V71, P161, DOI 10.1016/j.contraception.2004.12.001; Grimes DA, 2006, LANCET, V368, P1908, DOI 10.1016/S0140-6736(06)69481-6; Grossman D, 2008, REPROD HEALTH MATTER, V16, P173, DOI 10.1016/S0968-8080(08)31379-2; Hajri Selma, 2004, Afr J Reprod Health, V8, P63, DOI 10.2307/3583307; Hamoda H, 2005, CONTRACEPTION, V71, P327, DOI 10.1016/j.contraception.2004.10.015; Harper CC, 2007, INT J GYNECOL OBSTET, V98, P66, DOI 10.1016/j.ijgo.2007.03.009; Harries J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-296; Harrison A, 2000, HEALTH POLICY PLANN, V15, P424, DOI 10.1093/heapol/15.4.424; Henshaw SK, 1999, INT FAM PLAN PERSPEC, V25, pS30, DOI 10.2307/2991869; Hu D, 2009, BJOG-INT J OBSTET GY, V116, P768, DOI 10.1111/j.1471-0528.2009.02142.x; Hu D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000750; Jain JK, 2002, HUM REPROD, V17, P1477, DOI 10.1093/humrep/17.6.1477; Jowett M, 2000, HEALTH POLICY, V53, P201, DOI 10.1016/S0168-8510(00)00089-0; Kahn JG, 2000, CONTRACEPTION, V61, P29, DOI 10.1016/S0010-7824(99)00115-8; Kapp N, 2007, OBSTET GYNECOL, V110, P1304, DOI 10.1097/01.AOG.0000289577.32274.a5; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Levin C, 2009, REPROD HEALTH MATTER, V17, P120, DOI 10.1016/S0968-8080(09)33432-1; Lovold A, 2008, INT J GYNECOL OBSTET, V103, P276, DOI 10.1016/j.ijgo.2008.08.009; Majoko F, 2002, INT J GYNECOL OBSTET, V76, P77, DOI 10.1016/S0020-7292(01)00553-7; Miller S, 2005, BJOG-INT J OBSTET GY, V112, P1291, DOI 10.1111/j.1471-0528.2005.00704.x; Morhe ESK, 2007, INT J GYNECOL OBSTET, V98, P70, DOI 10.1016/j.ijgo.2007.02.023; Mundle S, 2007, CONTRACEPTION, V76, P66, DOI 10.1016/j.contraception.2007.03.010; *NBS TANZ ORC MACR, 2005, TANZ DEM HLTH SURV 2; Ngoc NTN, 1999, INT FAM PLAN PERSPEC, V25, P10, DOI 10.2307/2991896; Prata N, 2009, HEALTH POLICY, V89, P131, DOI 10.1016/j.healthpol.2008.05.007; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Turner KL, 2008, REPROD HEALTH MATTER, V16, P108, DOI 10.1016/S0968-8080(08)31389-5; *UN, 2009, STAT DEM YB; *UN, UN WEBS MILL DEV GOA; *UN, 2007, AB POL GLOB VIEW; United Nations, 2008, MILL DEV GOALS REP; von Hertzen H, 2007, LANCET, V369, P1938, DOI 10.1016/S0140-6736(07)60914-3; Warriner IK., 2006, PREVENTING UNSAFE AB; *WHO, MAT MORT 2005 EST DE; *WHO, 1994, WHOFSEMSM9411; Willmott FJ, 2008, BJOG-INT J OBSTET GY, V115, P1575, DOI 10.1111/j.1471-0528.2008.01928.x; Winikoff B, 1997, INT FAM PLAN PERSPEC, V23, P73, DOI 10.2307/2950827; *WORLD BANK, 2007, NHP DISC PAP POP ISS; World Health Organization, 2004, UNS AB GLOB REG EST	58	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13260	10.1371/journal.pone.0013260	http://dx.doi.org/10.1371/journal.pone.0013260			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	661SK	20948995	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000282748100010
J	Christensen, MS; Lundbye-Jensen, J; Grey, MJ; Vejlby, AD; Belhage, B; Nielsen, JB				Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Vejlby, Alexandra Damgaard; Belhage, Bo; Nielsen, Jens Bo			Illusory Sensation of Movement Induced by Repetitive Transcranial Magnetic Stimulation	PLOS ONE			English	Article							ELECTRICAL-STIMULATION; SOMATOSENSORY CORTEX; MOTOR CORTEX; SENSE; CONSEQUENCES; CEREBELLUM; READINESS; INTENTION; VARIANCE; FEEDBACK	Human movement sense relies on both somatosensory feedback and on knowledge of the motor commands used to produce the movement. We have induced a movement illusion using repetitive transcranial magnetic stimulation over primary motor cortex and dorsal premotor cortex in the absence of limb movement and its associated somatosensory feedback. Afferent and efferent neural signalling was abolished in the arm with ischemic nerve block, and in the leg with spinal nerve block. Movement sensation was assessed following trains of high-frequency repetitive transcranial magnetic stimulation applied over primary motor cortex, dorsal premotor cortex, and a control area (posterior parietal cortex). Magnetic stimulation over primary motor cortex and dorsal premotor cortex produced a movement sensation that was significantly greater than stimulation over the control region. Movement sensation after dorsal premotor cortex stimulation was less affected by sensory and motor deprivation than was primary motor cortex stimulation. We propose that repetitive transcranial magnetic stimulation over dorsal premotor cortex produces a corollary discharge that is perceived as movement.	[Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Nielsen, Jens Bo] Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark; [Christensen, Mark Schram] Univ Copenhagen, Hvidovre Hosp, Danish Res Ctr Magnet Resonance, DK-2650 Hvidovre, Denmark; [Christensen, Mark Schram; Lundbye-Jensen, Jesper; Grey, Michael James; Nielsen, Jens Bo] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Vejlby, Alexandra Damgaard] Herlev Hosp, Dept Anaesthesiol, DK-2730 Herlev, Denmark; [Belhage, Bo] Bispebjerg Hosp, Dept Anaesthesiol, DK-2400 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Bispebjerg Hospital	Christensen, MS (corresponding author), Univ Copenhagen, Dept Exercise & Sport Sci, Copenhagen, Denmark.	markc@drcmr.dk	Grey, Michael J/B-4029-2011; Lundbye-Jensen, Jesper/ABH-4025-2020; Nielsen, Jens Bo/C-7632-2015	Lundbye-Jensen, Jesper/0000-0003-3144-861X; Nielsen, Jens Bo/0000-0001-5568-2916	Danish Medical Research Council [09-062846/FSS]	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the Danish Medical Research Council (09-062846/FSS) (http://www.fi.dk/). The Simon Spies Foundation donated the MR-scanner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASSIAN VE, 1989, BRAIN RES, V479, P355, DOI 10.1016/0006-8993(89)91640-5; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; BRASILNETO JP, 1992, NEUROLOGY, V42, P1302, DOI 10.1212/WNL.42.7.1302; BROMAGE PR, 1964, BRIT J ANAESTH, V36, P342, DOI 10.1093/bja/36.6.342; Christensen MS, 2007, NAT NEUROSCI, V10, P417, DOI 10.1038/nn1873; Christensen MS, 2007, CEREB CORTEX, V17, P1906, DOI 10.1093/cercor/bhl101; Cotterill RMJ, 2001, PROG NEUROBIOL, V64, P1, DOI 10.1016/S0301-0082(00)00058-7; Crapse TB, 2008, NAT REV NEUROSCI, V9, P587, DOI 10.1038/nrn2457; Cunnington R, 2003, NEUROIMAGE, V20, P404, DOI 10.1016/S1053-8119(03)00291-X; Desmurget M, 2009, SCIENCE, V324, P811, DOI 10.1126/science.1169896; Ellaway PH, 2004, J PHYSIOL-LONDON, V556, P651, DOI 10.1113/jphysiol.2003.060483; FRIED I, 1991, J NEUROSCI, V11, P3656; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; Gandevia SC, 2002, ADV EXP MED BIOL, V508, P61; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; Haggard P, 2004, COGNITIVE BRAIN RES, V19, P52, DOI 10.1016/j.cogbrainres.2003.10.018; Holmes G, 1917, BRAIN, V40, P461, DOI 10.1093/brain/40.4.461; KORNHUBE.HH, 1965, PFLUG ARCH GES PHYS, V284, P1, DOI 10.1007/BF00412364; LIBET B, 1964, J NEUROPHYSIOL, V27, P546, DOI 10.1152/jn.1964.27.4.546; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 2003, NEUROREPORT, V14, P2135, DOI 10.1097/00001756-200312020-00001; SADATO N, 1995, ANN NEUROL, V37, P74, DOI 10.1002/ana.410370114; Scarff JE, 1940, ARCH NEURO PSYCHIATR, V44, P243, DOI 10.1001/archneurpsyc.1940.02280080003001; Schwartz AB, 2004, SCIENCE, V303, P380, DOI 10.1126/science.1087788; Shibasaki H, 2006, CLIN NEUROPHYSIOL, V117, P2341, DOI 10.1016/j.clinph.2006.04.025; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503	29	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13301	10.1371/journal.pone.0013301	http://dx.doi.org/10.1371/journal.pone.0013301			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948962	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000282748100027
J	Hellens, RP; Moreau, C; Lin-Wang, K; Schwinn, KE; Thomson, SJ; Fiers, MWEJ; Frew, TJ; Murray, SR; Hofer, JMI; Jacobs, JME; Davies, KM; Allan, AC; Bendahmane, A; Coyne, CJ; Timmerman-Vaughan, GM; Ellis, THN				Hellens, Roger P.; Moreau, Carol; Lin-Wang, Kui; Schwinn, Kathy E.; Thomson, Susan J.; Fiers, Mark W. E. J.; Frew, Tonya J.; Murray, Sarah R.; Hofer, Julie M. I.; Jacobs, Jeanne M. E.; Davies, Kevin M.; Allan, Andrew C.; Bendahmane, Abdelhafid; Coyne, Clarice J.; Timmerman-Vaughan, Gail M.; Ellis, T. H. Noel			Identification of Mendel's White Flower Character	PLOS ONE			English	Article							SEQUENCE; PEA; ALIGNMENT; GENOME; FAMILY; GENES; EXPRESSION; EVOLUTION; GENETICS; ENCODES	Background: The genetic regulation of flower color has been widely studied, notably as a character used by Mendel and his predecessors in the study of inheritance in pea. Methodology/Principal Findings: We used the genome sequence of model legumes, together with their known synteny to the pea genome to identify candidate genes for the A and A2 loci in pea. We then used a combination of genetic mapping, fast neutron mutant analysis, allelic diversity, transcript quantification and transient expression complementation studies to confirm the identity of the candidates. Conclusions/Significance: We have identified the pea genes A and A2. A is the factor determining anthocyanin pigmentation in pea that was used by Gregor Mendel 150 years ago in his study of inheritance. The A gene encodes a bHLH transcription factor. The white flowered mutant allele most likely used by Mendel is a simple G to A transition in a splice donor site that leads to a mis-spliced mRNA with a premature stop codon, and we have identified a second rare mutant allele. The A2 gene encodes a WD40 protein that is part of an evolutionarily conserved regulatory complex.	[Hellens, Roger P.; Lin-Wang, Kui; Allan, Andrew C.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Moreau, Carol; Hofer, Julie M. I.; Ellis, T. H. Noel] John Innes Ctr Plant Sci Res, Dept Crop Genet, Norwich NR4 7UH, Norfolk, England; [Schwinn, Kathy E.; Davies, Kevin M.] New Zealand Inst Plant & Food Res Ltd, Palmerston North, New Zealand; [Thomson, Susan J.; Fiers, Mark W. E. J.; Frew, Tonya J.; Murray, Sarah R.; Jacobs, Jeanne M. E.; Timmerman-Vaughan, Gail M.] New Zealand Inst Plant & Food Res Ltd, Christchurch, New Zealand; [Coyne, Clarice J.] Washington State Univ, USDA ARS, Western Reg Plant Intro Stn, Pullman, WA 99164 USA; [Bendahmane, Abdelhafid] URGV, Evry, France	New Zealand Institute for Plant & Food Research Ltd; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; New Zealand Institute for Plant & Food Research Ltd; New Zealand Institute for Plant & Food Research Ltd; United States Department of Agriculture (USDA); Washington State University; UDICE-French Research Universities; Universite Paris Saclay	Hellens, RP (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.	noel.ellis@bbsrc.ac.uk	Fiers, Mark WEJ/E-6755-2010; Allan, Andrew C/L-3253-2016; Schwinn, Kathy/S-4662-2017; Timmerman-Vaughan, Gail/J-7574-2013	Fiers, Mark WEJ/0000-0001-5694-2409; Allan, Andrew C/0000-0003-1944-7067; Schwinn, Kathy/0000-0002-6337-3627; Moreau, Carol/0000-0001-5826-3928; Jacobs, Jeanne/0000-0002-1047-1039; Thomson, Susan/0000-0001-7127-9414; Hofer, Julie/0000-0002-0158-7574; Ellis, Thomas Henry Noel/0000-0001-6726-9950; Davies, Kevin/0000-0001-5652-5015; Timmerman-Vaughan, Gail/0000-0001-5538-6383; Hellens, Roger/0000-0003-2094-0887	Foundation for Research, Science and Technology, New Zealand; Biotechnology and Biological Science Research Council, United Kingdom; Department for Environment, Food and Rural Affairs [AR0711]; EU [FOOD-CT-2004-506223]	Foundation for Research, Science and Technology, New Zealand(New Zealand Foundation for Research, Science and Technology); Biotechnology and Biological Science Research Council, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); EU(European Commission)	R.P.H. and co-workers were funded by The Foundation for Research, Science and Technology, New Zealand. T.H.N.E. and co-workers were funded by the Biotechnology and Biological Science Research Council, United Kingdom and acknowledge support from the Department for Environment, Food and Rural Affairs (AR0711) and the EU FP6 project 'Grain Legumes' FOOD-CT-2004-506223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Cannon SB, 2006, P NATL ACAD SCI USA, V103, P14959, DOI 10.1073/pnas.0603228103; Choi HK, 2004, P NATL ACAD SCI USA, V101, P15289, DOI 10.1073/pnas.0402251101; Chung BYW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-120; Coyne CJ, 2007, GENOME, V50, P871, DOI 10.1139/G07-063; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; DECRESCENZI P, 1805, RURALIA COMMODA COMM, P239; Delcher Arthur L, 2003, Curr Protoc Bioinformatics, VChapter 10, DOI 10.1002/0471250953.bi1003s00; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FINER JJ, 1992, PLANT CELL REP, V11, P323, DOI 10.1007/BF00233358; Fisher R. A., 1936, Ann Sci London, V1, P115, DOI 10.1080/00033793600200111; GOODRICH J, 1992, CELL, V68, P955, DOI 10.1016/0092-8674(92)90038-E; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; HARKER CL, 1990, PLANT CELL, V2, P185, DOI 10.1105/tpc.2.3.185; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Jing RC, 2005, GENETICS, V171, P741, DOI 10.1534/genetics.105.045112; Jing RC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-44; Kalo P, 2004, MOL GENET GENOMICS, V272, P235, DOI 10.1007/s00438-004-1055-z; Knight T.A., 1799, PHILOS T R SOC LOND, V89, P195, DOI [10.1098/rstl.1799.0013, DOI 10.1098/RSTL.1799.0013]; Koes R, 2005, TRENDS PLANT SCI, V10, P236, DOI 10.1016/j.tplants.2005.03.002; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Laucou V, 1998, THEOR APPL GENET, V97, P905, DOI 10.1007/s001220050971; LUDWIG SR, 1989, P NATL ACAD SCI USA, V86, P7092, DOI 10.1073/pnas.86.18.7092; Marx G.A., 1989, PISUM NEWSL, V21, P35; Mendel G., 1866, VERHAND NATURF VER B, V4, P3, DOI DOI 10.5962/BHL.TITLE.61004; Ming R, 2008, NATURE, V452, P991, DOI 10.1038/nature06856; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Olby R., 1985, ORIGINS MENDELISM; OROZCO BM, 1993, PLANT PHYSIOL, V102, P227, DOI 10.1104/pp.102.1.227; Peel GJ, 2009, PLANT J, V59, P136, DOI 10.1111/j.1365-313X.2009.03885.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schwinn K, 2006, PLANT CELL, V18, P831, DOI 10.1105/tpc.105.039255; Spelt C, 2002, PLANT CELL, V14, P2121, DOI 10.1105/tpc.003772; Uimari A, 1998, MOL GEN GENET, V257, P198, DOI 10.1007/s004380050639	36	81	88	2	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13230	10.1371/journal.pone.0013230	http://dx.doi.org/10.1371/journal.pone.0013230			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949001	Green Submitted, gold, Green Published			2022-12-27	WOS:000282748100004
J	Liu, M; Haataja, L; Wright, J; Wickramasinghe, NP; Hua, QX; Phillips, NF; Barbetti, F; Weiss, MA; Arvan, P				Liu, Ming; Haataja, Leena; Wright, Jordan; Wickramasinghe, Nalinda P.; Hua, Qing-Xin; Phillips, Nelson F.; Barbetti, Fabrizio; Weiss, Michael A.; Arvan, Peter			Mutant INS-Gene Induced Diabetes of Youth: Proinsulin Cysteine Residues Impose Dominant-Negative Inhibition on Wild-Type Proinsulin Transport	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; PANCREATIC BETA-CELLS; INSULIN-GENE; B-CHAIN; GLUCOSE-HOMEOSTASIS; SECRETORY PATHWAY; MOLECULAR-BIOLOGY; MAMMALIAN-CELLS; MUTATIONS; PROTEIN	Recently, a syndrome of Mutant INS-gene-induced Diabetes of Youth (MIDY, derived from one of 26 distinct mutations) has been identified as a cause of insulin-deficient diabetes, resulting from expression of a misfolded mutant proinsulin protein in the endoplasmic reticulum (ER) of insulin-producing pancreatic beta cells. Genetic deletion of one, two, or even three alleles encoding insulin in mice does not necessarily lead to diabetes. Yet MIDY patients are INS-gene heterozygotes; inheritance of even one MIDY allele, causes diabetes. Although a favored explanation for the onset of diabetes is that insurmountable ER stress and ER stress response from the mutant proinsulin causes a net loss of beta cells, in this report we present three surprising and interlinked discoveries. First, in the presence of MIDY mutants, an increased fraction of wild-type proinsulin becomes recruited into nonnative disulfide-linked protein complexes. Second, regardless of whether MIDY mutations result in the loss, or creation, of an extra unpaired cysteine within proinsulin, Cys residues in the mutant protein are nevertheless essential in causing intracellular entrapment of co-expressed wild-type proinsulin, blocking insulin production. Third, while each of the MIDY mutants induces ER stress and ER stress response; ER stress and ER stress response alone appear insufficient to account for blockade of wild-type proinsulin. While there is general agreement that ultimately, as diabetes progresses, a significant loss of beta cell mass occurs, the early events described herein precede cell death and loss of beta cell mass. We conclude that the molecular pathogenesis of MIDY is initiated by perturbation of the disulfide-coupled folding pathway of wild-type proinsulin.	[Liu, Ming; Haataja, Leena; Wright, Jordan; Arvan, Peter] Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Wickramasinghe, Nalinda P.; Hua, Qing-Xin; Phillips, Nelson F.; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Barbetti, Fabrizio] Bambino Gesu Pediat Hosp, Lab Mol Endocrinol & Metab, Sci Inst IRCCS, Rome, Italy; [Barbetti, Fabrizio] Univ Tor Vergata, Dept Internal Med, Rome, Italy	University of Michigan System; University of Michigan; Case Western Reserve University; IRCCS Bambino Gesu; University of Rome Tor Vergata	Liu, M (corresponding author), Univ Michigan, Med Ctr, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA.	michael.weiss@case.edu; parvan@umich.edu	Wright, Jordan/AAO-4376-2021; Barbetti, Fabrizio/AAK-9106-2021; Barbetti, Fabrizio/I-7351-2018; Wickramasinghe, Nalinda P/F-9465-2010	Wright, Jordan/0000-0002-2043-0150; Barbetti, Fabrizio/0000-0003-4687-980X; Barbetti, Fabrizio/0000-0003-4687-980X; Wickramasinghe, Nalinda P./0000-0002-8700-2775	National Institutes of Health (NIH) [R01 DK48280]; Molecular Biology DNA Sequencing Core of the Michigan Diabetes Research and Training Center [P60 DK20572]; University of Michigan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, P60DK020572, R01DK048280] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Molecular Biology DNA Sequencing Core of the Michigan Diabetes Research and Training Center; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported primarily by National Institutes of Health (NIH) R01 DK48280 (to P.A.), and also by a pilot and feasibility grant (to M.L.) and the Molecular Biology and DNA Sequencing Core of the Michigan Diabetes Research and Training Center (P60 DK20572). The authors gratefully acknowledge William and Dolores Brehm for their general support of diabetes research at the University of Michigan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babaya N, 2006, DIABETOLOGIA, V49, P1222, DOI 10.1007/s00125-006-0241-4; BARBETTI F, 1990, J CLIN ENDOCR METAB, V71, P164, DOI 10.1210/jcem-71-1-164; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Duvillie B, 2002, ENDOCRINOLOGY, V143, P1530, DOI 10.1210/en.143.4.1530; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Feng LJ, 2003, J BIOL CHEM, V278, P31486, DOI 10.1074/jbc.M305690200; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; GUPTA S, 2010, DIABETES IN PRESS; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hodish I, 2010, J BIOL CHEM, V285, P685, DOI 10.1074/jbc.M109.038042; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, P NATL ACAD SCI USA, V90, P582, DOI 10.1073/pnas.90.2.582; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; HUANG XF, 1994, J BIOL CHEM, V269, P20838; INOUYE K, 1979, J AM CHEM SOC, V101, P751, DOI 10.1021/ja00497a051; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Leroux L, 2001, DIABETES, V50, pS150, DOI 10.2337/diabetes.50.2007.S150; Leroux Loic, 2003, Int J Exp Diabesity Res, V4, P7; Liu M, 2005, J BIOL CHEM, V280, P13209, DOI 10.1074/jbc.C400475200; Liu M, 2003, J BIOL CHEM, V278, P14798, DOI 10.1074/jbc.M212070200; LIU M, 2010, TRENDS ENDO IN PRESS; Liu M, 2007, P NATL ACAD SCI USA, V104, P15841, DOI 10.1073/pnas.0702697104; Luo SZ, 2003, J BIOL CHEM, V278, P37375, DOI 10.1074/jbc.M303619200; Marchand A, 2006, J BIOL CHEM, V281, P19124, DOI 10.1074/jbc.M602157200; Marchetti P, 2007, DIABETOLOGIA, V50, P2486, DOI 10.1007/s00125-007-0816-8; Matveyenko AV, 2008, DIABETES OBES METAB, V10, P23, DOI 10.1111/j.1463-1326.2008.00939.x; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; Meur G, 2010, DIABETES, V59, P653, DOI 10.2337/db09-1091; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Park SY, 2010, BIOCHEM BIOPH RES CO, V391, P1449, DOI 10.1016/j.bbrc.2009.12.090; Polak M, 2008, DIABETES, V57, P1115, DOI 10.2337/db07-1358; Rajan S, 2010, AM J PHYSIOL-ENDOC M, V298, pE403, DOI 10.1152/ajpendo.00592.2009; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Steiner DF, 2009, DIABETES OBES METAB, V11, P189, DOI 10.1111/j.1463-1326.2009.01106.x; Steiner DF, 1997, SCIENCE, V277, P531, DOI 10.1126/science.277.5325.531; STEINER DF, 1992, DIABETOLOGIA, V35, pS41, DOI 10.1007/BF00586278; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; STOY J, 2008, PEDIAT DIABETES; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; VINIK A, 1988, HORM METAB RES, V20, P1, DOI 10.1055/s-2007-1010736; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Yamaguchi S, 2008, CELL METAB, V7, P269, DOI 10.1016/j.cmet.2008.01.008; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang BY, 2003, J BIOL CHEM, V278, P3687, DOI 10.1074/jbc.M209474200; Zito E, 2010, J CELL BIOL, V188, P821, DOI 10.1083/jcb.200911086	64	85	89	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13333	10.1371/journal.pone.0013333	http://dx.doi.org/10.1371/journal.pone.0013333			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948967	Green Submitted, gold, Green Published			2022-12-27	WOS:000282748100032
J	Milhiet, PE; Yamamoto, D; Berthoumieu, O; Dosset, P; Le Grimellec, C; Verdier, JM; Marchal, S; Ando, T				Milhiet, Pierre-Emmanuel; Yamamoto, Daisuke; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian; Verdier, Jean-Michel; Marchal, Stephane; Ando, Toshio			Deciphering the Structure, Growth and Assembly of Amyloid-Like Fibrils Using High-Speed Atomic Force Microscopy	PLOS ONE			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; IN-VITRO; SUPRAMOLECULAR ASSEMBLIES; BIOMOLECULAR PROCESSES; HUMAN LITHOSTATHINE; CALCIUM-CARBONATE; CRYSTAL-STRUCTURE; PROTEIN FIBRILS; ALPHA-SYNUCLEIN	Formation of fibrillar structures of proteins that deposit into aggregates has been suggested to play a key role in various neurodegenerative diseases. However mechanisms and dynamics of fibrillization remains to be elucidated. We have previously established that lithostathine, a protein overexpressed in the pre-clinical stages of Alzheimer's disease and present in the pathognomonic lesions associated with this disease, form fibrillar aggregates after its N-terminal truncation. In this paper we visualized, using high-speed atomic force microscopy (HS-AFM), growth and assembly of lithostathine protofibrils under physiological conditions with a time resolution of one image/s. Real-time imaging highlighted a very high velocity of elongation. Formation of fibrils via protofibril lateral association and stacking was also monitored revealing a zipper-like mechanism of association. We also demonstrate that, like other amyloid beta peptides, two lithostathine protofibrils can associate to form helical fibrils. Another striking finding is the propensity of the end of a growing protofibril or fibril to associate with the edge of a second fibril, forming false branching point. Taken together this study provides new clues about fibrillization mechanism of amyloid proteins.	[Milhiet, Pierre-Emmanuel; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian] INSERM, U554, Montpellier, France; [Milhiet, Pierre-Emmanuel; Berthoumieu, Olivia; Dosset, Patrice; Le Grimellec, Christian] Univ Montpellier, CNRS, UMR 5048, Ctr Biochim Struct, F-34059 Montpellier, France; [Yamamoto, Daisuke; Ando, Toshio] Kanazawa Univ, Dept Phys, Grad Sch Sci & Technol, Kanazawa, Ishikawa 920, Japan; [Verdier, Jean-Michel; Marchal, Stephane] INSERM, U710, Montpellier, France; [Verdier, Jean-Michel; Marchal, Stephane] Univ Montpellier 2, Montpellier, France; [Verdier, Jean-Michel; Marchal, Stephane] EPHE, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Kanazawa University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE)	Milhiet, PE (corresponding author), INSERM, U554, Montpellier, France.	pem@cbs.cnrs.fr	MARCHAL, stéphane/M-4324-2017; ANDO, Toshio/E-7054-2015	MARCHAL, stéphane/0000-0002-1101-7890; ANDO, Toshio/0000-0001-8819-154X; VERDIER, Jean-Michel/0000-0002-7252-1556; Milhiet, Pierre-Emmanuel/0000-0002-0410-5956	Agence Nationale de la Recherche (ANR); Physique et Chimie du Vivant (PCV); Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST);  [AFM-MB-PROT];  [HS-Bio-AFM]	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Physique et Chimie du Vivant (PCV); Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); ; 	This work was supported by the Agence Nationale de la Recherche (ANR), Physique et Chimie du Vivant (PCV) program, grant #AFM-MB-PROT and #HS-Bio-AFM, and by Core Research for Evolutional Science and Technology/Japan Science and Technology Agency)(CREST/JST, DY and TA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CB, 2009, BIOPHYS J, V96, P1529, DOI 10.1016/j.bpj.2008.11.024; Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0; Ando T, 2007, J MOL RECOGNIT, V20, P448, DOI 10.1002/jmr.843; BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024; BERNARD JP, 1992, GASTROENTEROLOGY, V103, P1277, DOI 10.1016/0016-5085(92)91516-7; Bertrand JA, 1996, EMBO J, V15, P2678, DOI 10.1002/j.1460-2075.1996.tb00628.x; Blake C, 1996, STRUCTURE, V4, P989, DOI 10.1016/S0969-2126(96)00104-9; Cerini C, 1999, J BIOL CHEM, V274, P22266, DOI 10.1074/jbc.274.32.22266; DECARO A, 1979, BIOCHEM BIOPH RES CO, V87, P1176, DOI 10.1016/S0006-291X(79)80031-5; Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fay N, 2003, J BIOL CHEM, V278, P30199, DOI 10.1074/jbc.M303000200; Geider S, 1996, CALCIFIED TISSUE INT, V59, P33, DOI 10.1007/s002239900082; Gerbaud V, 2000, J BIOL CHEM, V275, P1057, DOI 10.1074/jbc.275.2.1057; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Gregoire C, 2001, EMBO J, V20, P3313, DOI 10.1093/emboj/20.13.3313; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jimenez JL, 1999, EMBO J, V18, P815, DOI 10.1093/emboj/18.4.815; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; Karsai A, 2008, EUR BIOPHYS J BIOPHY, V37, P1133, DOI 10.1007/s00249-007-0253-0; Kellermayer MSZ, 2008, P NATL ACAD SCI USA, V105, P141, DOI 10.1073/pnas.0704305105; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kopito RR, 2000, NAT CELL BIOL, V2, pE207, DOI 10.1038/35041139; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Laurine E, 2003, J BIOL CHEM, V278, P51770, DOI 10.1074/jbc.M306767200; Lee BI, 2003, J BIOL INORG CHEM, V8, P341, DOI 10.1007/s00775-002-0421-8; Mauro V, 2008, HISTOL HISTOPATHOL, V23, P1195, DOI 10.14670/HH-23.1195; Meinhardt J, 2009, J MOL BIOL, V386, P869, DOI 10.1016/j.jmb.2008.11.005; Mesquida P, 2007, J MATER SCI-MATER M, V18, P1325, DOI 10.1007/s10856-006-0075-0; Moreno-Herrero F, 2004, BIOPHYS J, V86, P517, DOI 10.1016/S0006-3495(04)74130-2; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Paulson HL, 2000, BRAIN PATHOL, V10, P293, DOI 10.1111/j.1750-3639.2000.tb00263.x; PERFETTI R, 1994, TRANSPLANT P, V26, P733; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5596, DOI 10.1073/pnas.042681599; Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399; Pignol D, 1995, PROTEINS, V23, P604, DOI 10.1002/prot.340230418; Ranson N, 2006, PROTEIN SCI, V15, P2481, DOI 10.1110/ps.062215206; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sekikawa A, 2005, GUT, V54, P1437, DOI 10.1136/gut.2004.053587; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Walker LC, 2000, NEUROBIOL AGING, V21, P559, DOI 10.1016/S0197-4580(00)00160-3; Yagi H, 2007, BIOCHEMISTRY-US, V46, P15009, DOI 10.1021/bi701842n	50	53	53	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13240	10.1371/journal.pone.0013240	http://dx.doi.org/10.1371/journal.pone.0013240			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949034	Green Published, gold			2022-12-27	WOS:000282676700014
J	Prigent, J; Mazuet, C; Boquet, D; Lamourette, P; Volland, H; Popoff, MR; Creminon, C; Simon, S				Prigent, Julie; Mazuet, Christelle; Boquet, Didier; Lamourette, Patricia; Volland, Herve; Popoff, Michel R.; Creminon, Christophe; Simon, Stephanie			Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A	PLOS ONE			English	Article							TOXIN TYPE-A; MONOCLONAL-ANTIBODIES; HYBRIDOMAS; IDENTIFICATION; ANTITOXIN; STRAINS; GENES; ASSAY	Botulinum neurotoxins, produced by Clostridium botulinum bacteria, are the causative agent of botulism. This disease only affects a few hundred people each year, thus ranking it among the orphan diseases. However, botulinum toxin type A (BoNT/A) is the most potent toxin known to man. Due to their potency and ease of production, these toxins were classified by the Centers for Disease Control and Prevention (CDC) as Category A biothreat agents. For several biothreat agents, like BoNT/A, passive immunotherapy remains the only possible effective treatment allowing in vivo neutralization, despite possible major side effects. Recently, several mouse monoclonal antibodies directed against a recombinant fragment of BoNT/A were produced in our laboratory and most efficiently neutralised the neurotoxin. In the present work, the most powerful one, TA12, was selected for chimerisation. The variable regions of this antibody were thus cloned and fused with the constant counterparts of human IgG1 (kappa light and gamma 1 heavy chains). Chimeric antibody production was evaluated in mammalian myeloma cells (SP2/0-Ag14) and insect cells (Sf9). After purifying the recombinant antibody by affinity chromatography, the biochemical properties of chimeric and mouse antibody were compared. Both have the same very low affinity constant (close to 10 pM) and the chimeric antibody exhibited a similar capacity to its parent counterpart in neutralising the toxin in vivo. Its strong affinity and high neutralising potency make this chimeric antibody interesting for immunotherapy treatment in humans in cases of poisoning, particularly as there is a probable limitation of the immunological side effects observed with classical polyclonal antisera from heterologous species.	[Prigent, Julie; Boquet, Didier; Lamourette, Patricia; Volland, Herve; Creminon, Christophe; Simon, Stephanie] CEA Saclay, Serv Pharmacol & Immunoanal, iBiTec S, CEA, F-91191 Gif Sur Yvette, France; [Mazuet, Christelle; Popoff, Michel R.] Inst Pasteur, Unite Toxines & Bacteries Anaerobies, Paris, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Prigent, J (corresponding author), CEA Saclay, Serv Pharmacol & Immunoanal, iBiTec S, CEA, F-91191 Gif Sur Yvette, France.	stephanie.simon@cea.fr	Mazuet, Christelle/O-7731-2016; Simon, Stephanie/E-4289-2012; Popoff, Michel/O-7719-2016	Mazuet, Christelle/0000-0001-7619-9050; Simon, Stephanie/0000-0002-6071-8255; Popoff, Michel/0000-0001-9305-8989; BOQUET, Didier/0000-0002-4048-7867	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables)(French Atomic Energy Commission); IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees); NRBC (Nuclear Radiological Biological and Chemical Risks)	This study was supported by a grant from the PhD programme of the CEA (Commissariat a l'Energie Atomique et aux Energies Renouvelables) (Julie Prigent) and funded by the IMASSA (Institut de Medecine Aerospatiale du Service de Sante des Armees) and NRBC (Nuclear Radiological Biological and Chemical Risks) programmes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekar SP, 2008, J IMMUNOL METHODS, V333, P156, DOI 10.1016/j.jim.2008.01.015; Adekar SP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003023; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Arnon SS, 2007, PEDIATRICS, V119, P785, DOI 10.1542/peds.2006-0646; BLACK RE, 1980, AM J MED, V69, P567, DOI 10.1016/0002-9343(80)90469-6; Boquet D, 2000, ANAL BIOCHEM, V284, P221, DOI 10.1006/abio.2000.4711; BURGEN ASV, 1949, J PHYSIOL-LONDON, V109, P10, DOI 10.1113/jphysiol.1949.sp004364; Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; Centers for Disease Control and Prevention, 1998, HDB EP CLIN LAB WORK; Chen F, 1998, INFECT IMMUN, V66, P2420, DOI 10.1128/IAI.66.6.2420-2425.1998; Cheng LW, 2009, INFECT IMMUN, V77, P4305, DOI 10.1128/IAI.00405-09; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; Dee KU, 1997, BIOTECHNOL PROGR, V13, P14, DOI 10.1021/bp960086t; Dembek ZF, 2007, DISASTER MED PUBLIC, V1, P122, DOI 10.1097/DMP.0b013e318158c5fd; DIGHIERO G, 1983, J IMMUNOL, V131, P2267; Dokmetjian J, 2000, VACCINE, V18, P2698, DOI 10.1016/S0264-410X(00)00066-9; Drake AW, 2004, ANAL BIOCHEM, V328, P35, DOI 10.1016/j.ab.2003.12.025; ELLMAN GL, 1961, J LAB CLIN MED, V57, P813; *EUR PHARM, 2002, BOT ANT; Foran PG, 2003, J BIOL CHEM, V278, P1363, DOI 10.1074/jbc.M209821200; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; HATHEWAY CH, 1984, J INFECT DIS, V150, P407, DOI 10.1093/infdis/150.3.407; Hines HB, 2005, APPL ENVIRON MICROB, V71, P4478, DOI 10.1128/AEM.71.8.4478-4486.2005; Hober S, 2007, J CHROMATOGR B, V848, P40, DOI 10.1016/j.jchromb.2006.09.030; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Inoue K, 1996, INFECT IMMUN, V64, P1589, DOI 10.1128/IAI.64.5.1589-1594.1996; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Liang MF, 2001, J IMMUNOL METHODS, V247, P119, DOI 10.1016/S0022-1759(00)00322-7; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; MAZUET C, 2010, CHARACTERISATION BOT; Mowry MC, 2004, PROTEIN EXPRES PURIF, V37, P399, DOI 10.1016/j.pep.2004.06.022; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Popoff MR, 1995, CURR TOP MICROBIOL, V195, P1; Poulain B., 2003, Annales de Readaptation et de Medecine Physique, V46, P265, DOI 10.1016/S0168-6054(03)00114-4; Shapiro RL, 1998, ANN INTERN MED, V129, P221, DOI 10.7326/0003-4819-129-3-199808010-00011; SHULMAN M, 1978, NATURE, V276, P269, DOI 10.1038/276269a0; Simpson LL, 2004, ANNU REV PHARMACOL, V44, P167, DOI 10.1146/annurev.pharmtox.44.101802.121554; Smith TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001271; Smith TJ, 2005, INFECT IMMUN, V73, P5450, DOI 10.1128/IAI.73.9.5450-5457.2005; Sobel J, 2005, CLIN INFECT DIS, V41, P1167, DOI 10.1086/444507; Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003; TACKET CO, 1984, AM J MED, V76, P794, DOI 10.1016/0002-9343(84)90988-4; Tavallaie M, 2004, FEBS LETT, V572, P299, DOI 10.1016/j.febslet.2004.06.094; Volland H, 2008, J IMMUNOL METHODS, V330, P120, DOI 10.1016/j.jim.2007.11.006	46	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13245	10.1371/journal.pone.0013245	http://dx.doi.org/10.1371/journal.pone.0013245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20967241	gold, Green Published, Green Submitted			2022-12-27	WOS:000282676700017
J	Oliveira, LJ; McClellan, S; Hansen, PJ				Oliveira, Lilian J.; McClellan, Steve; Hansen, Peter J.			Differentiation of the Endometrial Macrophage during Pregnancy in the Cow	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; HUMAN DECIDUAL MACROPHAGES; PHENOTYPIC CHARACTERIZATION; TRANSENDOTHELIAL MIGRATION; ALTERNATIVE ACTIVATION; MONONUCLEAR PHAGOCYTES; GENE-EXPRESSION; BOVINE; CELLS; PLACENTATION	Background: The presence of conceptus alloantigens necessitates changes in maternal immune function. One player in this process may be the macrophage. In the cow, there is large-scale recruitment of macrophages expressing CD68 and CD14 to the uterine endometrium during pregnancy. Methodology/Principal Findings: In the present study, the function of endometrial macrophages during pregnancy was inferred by comparison of the transcriptome of endometrial CD14(+) cells isolated from pregnant cows as compared to that of blood CD14(+) cells. The pattern of gene expression was largely similar for CD14(+) cells from both sources, suggesting that cells from both tissues are from the monocyte/macrophage lineage. A total of 1,364 unique genes were differentially expressed, with 680 genes upregulated in endometrial CD14(+) cells as compared to blood CD14(+) cells and with 674 genes downregulated in endometrial CD14(+) cells as compared to blood CD14(+) cells. Twelve genes characteristic of M2 activated macrophages (SLCO2B1, GATM, MRC1, ALDH1A1, PTGS1, RNASE6, CLEC7A, DPEP2, CD163, CCL22, CCL24, and CDH1) were upregulated in endometrial CD14(+) cells. M2 macrophages play roles in immune regulation, tissue remodeling, angiogenesis and apoptosis. Consistent with a role in tissue remodeling, there was overrepresentation of differentially expressed genes in endometrium for three ontologies related to proteolysis. A role in apoptosis is suggested by the observation that the most overrepresented gene in endometrial CD14(+) cells was GZMA. Conclusions: Results indicate that at least a subpopulation of endometrial macrophages cells differentiates along an M2 activation pathway during pregnancy and that the cells are likely to play roles in immune regulation, tissue remodeling, angiogenesis, and apoptosis.	[Oliveira, Lilian J.; Hansen, Peter J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Oliveira, Lilian J.; Hansen, Peter J.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [McClellan, Steve] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Flow Cytometry Core Lab, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Oliveira, LJ (corresponding author), Univ Sao Paulo, Fac Anim Sci & Food Engn, Sao Paulo, Brazil.	Hansen@animal.ufl.edu	Oliveira, Lilian/F-2898-2010; J., Oliveira L./V-9028-2017; Hansen, Peter/AAI-4693-2021	Oliveira, Lilian/0000-0003-1402-8373; J., Oliveira L./0000-0003-1402-8373; Hansen, Peter/0000-0003-3061-9333	University of Florida Foundation	University of Florida Foundation(University of Florida)	Research was supported by the University of Florida Foundation Research Opportunity Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2004, AM J REPROD IMMUNOL, V51, P275, DOI 10.1111/j.1600-0897.2004.00156.x; Al-Shahrour F, 2007, NUCLEIC ACIDS RES, V35, pW91, DOI 10.1093/nar/gkm260; Allavena P, 2008, IMMUNOL REV, V222, P155, DOI 10.1111/j.1600-065X.2008.00607.x; AMBRUS JL, 1990, J IMMUNOL, V144, P1549; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chen L, 2009, ENDOCRINOLOGY, V150, P966, DOI 10.1210/en.2008-0571; Cupurdija K, 2004, AM J REPROD IMMUNOL, V51, P117, DOI 10.1046/j.8755-8920.2003.00128.x; Dambaeva SV, 2009, J REPROD IMMUNOL, V80, P57, DOI 10.1016/j.jri.2008.12.006; Davies CJ, 2006, AM J REPROD IMMUNOL, V55, P188, DOI 10.1111/j.1600-0897.2005.00364.x; Davies CJ, 2004, ANIM REPROD SCI, V82-3, P267, DOI 10.1016/j.anireprosci.2004.05.016; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Facciotti PR, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-25; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gomez TM, 2004, NEURON, V42, P1, DOI 10.1016/S0896-6273(04)00188-6; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Green JA, 1998, REV REPROD, V3, P62; Gustafsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002078; Hashizume K, 2007, J REPROD DEVELOP, V53, P1, DOI 10.1262/jrd.18123; Heikkinen J, 2003, CLIN EXP IMMUNOL, V131, P498, DOI 10.1046/j.1365-2249.2003.02092.x; HUNT JS, 1985, J LEUKOCYTE BIOL, V38, P255, DOI 10.1002/jlb.38.2.255; Jensen K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-224; Johnson-Leger CA, 2002, BLOOD, V100, P2479, DOI 10.1182/blood-2001-11-0098; Kim JS, 2007, PLACENTA, V28, P571, DOI 10.1016/j.placenta.2006.07.007; Kim JS, 2006, BLOOD, V108, P1821, DOI 10.1182/blood-2005-10-009191; KING A, 1993, HUM REPROD, V8, P2061, DOI 10.1093/oxfordjournals.humrep.a137982; Kzhyshkowska J, 2008, J IMMUNOL, V180, P3028, DOI 10.4049/jimmunol.180.5.3028; Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106; Mackler AM, 2000, BIOL REPROD, V62, P1193, DOI 10.1095/biolreprod62.5.1193; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; NODEN DM, 1990, EMBRYOLOGY DOMESTIC; Oliveira LJ, 2008, REPRODUCTION, V136, P481, DOI 10.1530/REP-08-0218; Oliveira LJ, 2009, AM J REPROD IMMUNOL, V62, P418, DOI 10.1111/j.1600-0897.2009.00761.x; Onofre Gabriela, 2009, Acta Medica (Hradec Kralove), V52, P57; Paape MJ, 1996, AM J VET RES, V57, P477; Padua MB, 2010, FASEB J, V24, P526, DOI 10.1096/fj.09-138453; Rosbottom A, 2008, INFECT IMMUN, V76, P2352, DOI 10.1128/IAI.01780-06; Salamonsen LA, 2007, SEMIN REPROD MED, V25, P437, DOI 10.1055/s-2007-991041; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003; Tekin S, 2004, AM J REPROD IMMUNOL, V51, P56, DOI 10.1046/j.8755-8920.2003.00125.x; Thaxton JE, 2009, J IMMUNOL, V183, P1144, DOI 10.4049/jimmunol.0900788; Thomson AJ, 1999, HUM REPROD, V14, P229, DOI 10.1093/humrep/14.1.229; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Underhill DM, 2007, IMMUNOL REV, V219, P75, DOI 10.1111/j.1600-065X.2007.00548.x; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598; Williams PJ, 2009, J REPROD IMMUNOL, V82, P24, DOI 10.1016/j.jri.2009.08.001; Yoav B, 1995, J ROY STAT SOC, V57, P289; Young JD, 1999, NAT MED, V5, P1424; Zhang H, 2002, AM J PATHOL, V160, P2219, DOI 10.1016/S0002-9440(10)61169-8	55	53	54	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13213	10.1371/journal.pone.0013213	http://dx.doi.org/10.1371/journal.pone.0013213			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949061	gold, Green Published, Green Submitted			2022-12-27	WOS:000282633700011
J	Hendrick, OM; Ide, JS; Luo, X; Li, CSR				Hendrick, Olivia M.; Ide, Jaime S.; Luo, Xi; Li, Chiang-Shan R.			Dissociable Processes of Cognitive Control during Error and Non-Error Conflicts: A Study of the Stop Signal Task	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; FRONTAL-LOBE DAMAGE; EVENT-RELATED FMRI; PREFRONTAL CORTEX; EXECUTIVE FUNCTIONS; RESPONSE CONFLICT; TEMPORAL DYNAMICS; PERFORMANCE; INHIBITION; NUCLEUS	Background: Conflict detection and subsequent behavioral adjustment are critical to daily life, and how this process is controlled has been increasingly of interest. A medial cortical region which includes the anterior cingulate cortex (ACC) has been theorized to act as a conflict detector that can direct prefrontal activity for behavioral adjustments. This conflict monitoring hypothesis was supported by many imaging studies of the Stroop task, with a focus on non-error processes. Here we sought to examine whether this circuit could be generalized to the stop signal task (SST), another behavioral paradigm widely used to study cognitive control. In particular, with a procedure to elicit errors in the SST, we examined whether error and non-error control were mediated by the same pathways. Methodology/Principal Findings: In functional magnetic resonance imaging of 60 healthy adults, we demonstrated that the medial cortical activity during stop success (SS) as compared to go success (G) trials is correlated with increased prefrontal activity in post-stop SS as compared to post-go SS trials, though this correlation was not specific to the medial cortical region. Furthermore, thalamic and insular rather than medial cortical activation during stop error (SE) as compared to G trials correlated with increased prefrontal activity in post-stop SS as compared to post-go SS trials. Conclusions/Significance: Taken together, these new findings challenge a specific role of the ACC and support distinct pathways for error and non-error conflict processing in cognitive control.	[Hendrick, Olivia M.; Li, Chiang-Shan R.] Yale Univ, Sch Med, Interdept Neurosci Program, New Haven, CT 06520 USA; [Ide, Jaime S.; Li, Chiang-Shan R.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Luo, Xi] Yale Univ, Sch Med, Dept Stat, New Haven, CT USA; [Li, Chiang-Shan R.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Hendrick, OM (corresponding author), Yale Univ, Sch Med, Interdept Neurosci Program, New Haven, CT 06520 USA.	chiang-shan.li@yale.edu	Li, Chiang-Shan Ray/J-2813-2016; Farr, Olivia/H-6929-2019; Luo, Xi/B-9361-2014; Ide, Jaime/B-6615-2014	Li, Chiang-Shan Ray/0000-0002-9393-1212; Farr, Olivia/0000-0002-5182-3432; Luo, Xi/0000-0002-0909-9372; Ide, Jaime/0000-0002-7223-1102; Lauwereyns, Jan/0000-0003-0551-2550	National Institutes of Health [R01DA023248, K02DA026990, R21AA018004]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA018004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023248, K02DA026990] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants R01DA023248 (Li), K02DA026990 (Li), and R21AA018004 (Li). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Drug Abuse, National Center for Research Resources, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baird A, 2006, BRAIN COGNITION, V60, P166, DOI 10.1016/j.bandc.2005.11.003; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellebaum C, 2005, BRAIN, V128, P1139, DOI 10.1093/brain/awh474; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; BRAET W, 2009, NEUROIMAGE, V47, P39; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brown JW, 2009, PSYCHOL RES-PSYCH FO, V73, P744, DOI 10.1007/s00426-008-0198-7; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Cameron OG, 2002, PSYCHOSOM MED, V64, P851, DOI 10.1097/01.PSY.0000038939.33335.32; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2002, NEURON, V33, P653, DOI 10.1016/S0896-6273(02)00588-3; Davis KD, 2005, J NEUROSCI, V25, P8402, DOI 10.1523/JNEUROSCI.2315-05.2005; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Diamond ME, 2007, NEURON, V56, P578, DOI 10.1016/j.neuron.2007.11.006; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Erickson KI, 2004, HUM BRAIN MAPP, V21, P98, DOI 10.1002/hbm.10158; Fassbender C, 2004, COGNITIVE BRAIN RES, V20, P132, DOI 10.1016/j.cogbrainres.2004.02.007; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Gruber O, 2004, ACTA PSYCHOL, V115, P105, DOI 10.1016/j.actpsy.2003.12.003; Hajcak G, 2005, BIOL PSYCHOL, V70, P67, DOI 10.1016/j.biopsycho.2004.12.001; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hajcak G, 2008, BRAIN COGNITION, V68, P15, DOI 10.1016/j.bandc.2008.02.118; Hester R, 2004, CEREB CORTEX, V14, P986, DOI 10.1093/cercor/bhh059; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; IDE JS, NEUROIMAGE IN PRESS; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Jones EG, 2002, PHILOS T R SOC B, V357, P1659, DOI 10.1098/rstb.2002.1168; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Lebrecht S, 2008, NEURON, V59, P841, DOI 10.1016/j.neuron.2008.09.007; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2008, NEUROSCIENCE, V155, P1142, DOI 10.1016/j.neuroscience.2008.06.062; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; MACCORQUODALE K, 1948, PSYCHOL REV, V55, P95, DOI 10.1037/h0056029; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Mitchell AS, 2007, J NEUROSCI, V27, P11289, DOI 10.1523/JNEUROSCI.1914-07.2007; Modirrousta M, 2008, J NEUROSCI, V28, P14000, DOI 10.1523/JNEUROSCI.4450-08.2008; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Ploran EJ, 2007, J NEUROSCI, V27, P11912, DOI 10.1523/JNEUROSCI.3522-07.2007; Ramautar JR, 2006, BRAIN RES, V1105, P143, DOI 10.1016/j.brainres.2006.02.091; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Sommer MA, 2004, J NEUROPHYSIOL, V91, P1403, DOI 10.1152/jn.00740.2003; Stepniewska I, 2007, NEUROSCIENCE, V147, P727, DOI 10.1016/j.neuroscience.2007.03.054; Stuss DT, 2001, NEUROPSYCHOLOGIA, V39, P771, DOI 10.1016/S0028-3932(01)00013-6; Ullsperger M, 2004, CORTEX, V40, P593, DOI 10.1016/S0010-9452(08)70155-2; Ullsperger M, 2001, NEUROIMAGE, V14, P1387, DOI 10.1006/nimg.2001.0935; Urbain N, 2007, NEURON, V56, P714, DOI 10.1016/j.neuron.2007.10.023; VENDRELL P, 1995, NEUROPSYCHOLOGIA, V33, P341, DOI 10.1016/0028-3932(94)00116-7; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wagner G, 2006, NEUROPSYCHOLOGIA, V44, P2337, DOI 10.1016/j.neuropsychologia.2006.05.014; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; Wittfoth M, 2008, BRAIN RES, V1194, P118, DOI 10.1016/j.brainres.2007.11.067; YAMAMOTO T, 1992, BRAIN RES, V579, P315, DOI 10.1016/0006-8993(92)90067-J	77	48	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13155	10.1371/journal.pone.0013155	http://dx.doi.org/10.1371/journal.pone.0013155			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949134	Green Published, Green Submitted, gold			2022-12-27	WOS:000282568400003
J	Becker, PD; Legrand, N; van Geelen, CMM; Noerder, M; Huntington, ND; Lim, A; Yasuda, E; Diehl, SA; Scheeren, FA; Ott, M; Weijer, K; Wedemeyer, H; Di Santo, JP; Beaumont, T; Guzman, CA; Spits, H				Becker, Pablo D.; Legrand, Nicolas; van Geelen, Caroline M. M.; Noerder, Miriam; Huntington, Nicholas D.; Lim, Annick; Yasuda, Etsuko; Diehl, Sean A.; Scheeren, Ferenc A.; Ott, Michael; Weijer, Kees; Wedemeyer, Heiner; Di Santo, James P.; Beaumont, Tim; Guzman, Carlos A.; Spits, Hergen			Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated "Human Immune System'' Mice	PLOS ONE			English	Article							MEMORY B-CELLS; GERMINAL-CENTER FORMATION; HEMATOPOIETIC STEM-CELLS; RAG2(-/-)GAMMA(-/-)(C) MICE; VIRUS-INFECTION; MOUSE MODEL; HU MICE; IN-VIVO; RESPONSES; DIFFERENTIATION	Background: Passive transfer of antibodies not only provides immediate short-term protection against disease, but also can be exploited as a therapeutic tool. However, the 'humanization' of murine monoclonal antibodies (mAbs) is a time-consuming and expensive process that has the inherent drawback of potentially altering antigenic specificity and/or affinity. The immortalization of human B cells represents an alternative for obtaining human mAbs, but relies on the availability of biological samples from vaccinated individuals or convalescent patients. In this work we describe a novel approach to generate fully human mAbs by combining a humanized mouse model with a new B cell immortalization technique. Methodology/Principal Findings: After transplantation with CD34(+)CD38(-) human hematopoietic progenitor cells, BALB/c Rag2(-/-)IL-2R gamma c(-/-) mice acquire a human immune system and harbor B cells with a diverse IgM repertoire. "Human Immune System'' mice were then immunized with two commercial vaccine antigens, tetanus toxoid and hepatitis B surface antigen. Sorted human CD19(+)CD27(+) B cells were retrovirally transduced with the human B cell lymphoma (BCL)-6 and BCL-XL genes, and subsequently cultured in the presence of CD40-ligand and IL-21. This procedure allows generating stable B cell receptor-positive B cells that secrete immunoglobulins. We recovered stable B cell clones that produced IgM specific for tetanus toxoid and the hepatitis B surface antigen, respectively. Conclusion/Significance: This work provides the proof-of-concept for the usefulness of this novel method based on the immunization of humanized mice for the rapid generation of human mAbs against a wide range of antigens.	[Becker, Pablo D.; Noerder, Miriam; Guzman, Carlos A.] Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Legrand, Nicolas; Diehl, Sean A.; Scheeren, Ferenc A.; Weijer, Kees; Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Ctr Immunol Amsterdam, Dept Cell Biol & Histol, NL-1105 AZ Amsterdam, Netherlands; [van Geelen, Caroline M. M.; Yasuda, Etsuko; Beaumont, Tim; Spits, Hergen] AIMM Therapeut, Amsterdam, Netherlands; [Huntington, Nicholas D.; Di Santo, James P.] Inst Pasteur, Cytokines & Lymphoid Dev Unit, Paris, France; [Huntington, Nicholas D.; Lim, Annick; Di Santo, James P.] Inst Pasteur, INSERM, U668, F-75724 Paris, France; [Ott, Michael; Wedemeyer, Heiner] Hannover Med Sch, Twincore Ctr Expt & Clin Infect Res, Clin Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; University of Amsterdam; Academic Medical Center Amsterdam; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research	Becker, PD (corresponding author), Helmholtz Ctr Infect Res HZI, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany.	Hergen.Spits@amc.uva.nl	Di Santo, James P/M-4298-2014; Legrand, Nicolas/B-1794-2009; Huntington, NICHOLAS/AAV-4704-2020; Diehl, Sean/C-7166-2008; Diehl, Sean/AAE-2779-2020; Spits, Hergen/N-2581-2019; Legrand, Nicolas/B-1794-2009	Di Santo, James P/0000-0002-7146-1862; Legrand, Nicolas/0000-0002-0236-7653; Huntington, NICHOLAS/0000-0002-5267-7211; Diehl, Sean/0000-0001-9700-235X; Diehl, Sean/0000-0001-9700-235X; Spits, Hergen/0000-0003-3269-8338; Legrand, Nicolas/0000-0002-0900-3051; Becker, Pablo Daniel/0000-0003-1980-1230; Scheeren, Ferenc/0000-0002-8304-9023	Bill and Melinda Gates Foundation; Wijnand M. Pon Foundation; College de France; Fondation pour la Recherche Medicale (FRM); Institut Pasteur; Institut National de la Sante et de la Recherche Medicale (INSERM); Human Frontiers Science Program; National Institutes of Health (NIH-NIAID) [F32 AI063846]; Excellence Cluster "From Regenerative Biology to reconstructive Therapy''; German Research Foundation [EXC 62/1]; AIMM Therapeutic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI063846] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wijnand M. Pon Foundation; College de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Human Frontiers Science Program(Human Frontier Science Program); National Institutes of Health (NIH-NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Excellence Cluster "From Regenerative Biology to reconstructive Therapy''; German Research Foundation(German Research Foundation (DFG)); AIMM Therapeutic; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Bill and Melinda Gates Foundation "Grand Challenges in Global Health'' Program (GC4 - "Human Vaccine Consortium''; http://www.hv-consortium.org/), the Wijnand M. Pon Foundation, College de France, Fondation pour la Recherche Medicale (FRM), Institut Pasteur and the Institut National de la Sante et de la Recherche Medicale (INSERM). N.D.H. was supported by the Human Frontiers Science Program. S.A.D. was supported by the National Institutes of Health (NIH-NIAID grant # F32 AI063846). C.A. G. was supported by a grant from the Excellence Cluster "From Regenerative Biology to reconstructive Therapy'' by the German Research Foundation (EXC 62/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also in part financially supported by AIMM Therapeutic who did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agematsu K, 2000, IMMUNOL TODAY, V21, P204, DOI 10.1016/S0167-5699(00)01605-4; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Baker M, 2005, NAT BIOTECHNOL, V23, P1065, DOI 10.1038/nbt0905-1065; Carballido JM, 2000, NAT MED, V6, P103, DOI 10.1038/71434; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Diehl SA, 2008, J IMMUNOL, V180, P4805, DOI 10.4049/jimmunol.180.7.4805; Gimeno R, 2004, BLOOD, V104, P3886, DOI 10.1182/blood-2004-02-0656; Huntington ND, 2009, J EXP MED, V206, P25, DOI 10.1084/jem.20082013; Ito R, 2008, CURR TOP MICROBIOL, V324, P95; Jackson SM, 2008, ADV IMMUNOL, V98, P151, DOI 10.1016/S0065-2776(08)00405-7; Jakobovits A, 2007, NAT BIOTECHNOL, V25, P1134, DOI 10.1038/nbt1337; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Legrand N, 2006, J IMMUNOL, V176, P2053, DOI 10.4049/jimmunol.176.4.2053; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Legrand Nicolas, 2008, V415, P65, DOI 10.1007/978-1-59745-570-1_4; Lim A, 2008, INT IMMUNOL, V20, P105, DOI 10.1093/intimm/dxm125; Manz MG, 2007, IMMUNITY, V26, P537, DOI 10.1016/j.immuni.2007.05.001; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; O'Connell RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012009; Pendley C, 2003, CURR OPIN MOL THER, V5, P172; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Scheeren FA, 2005, NAT IMMUNOL, V6, P303, DOI 10.1038/ni1172; Scheeren FA, 2008, J EXP MED, V205, P2033, DOI 10.1084/jem.20070447; Scott CT, 2007, NAT BIOTECHNOL, V25, P1075, DOI 10.1038/nbt1007-1075; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tonomura N, 2008, BLOOD, V111, P4293, DOI 10.1182/blood-2007-11-121319; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; van Lent AU, 2009, J IMMUNOL, V183, P7645, DOI 10.4049/jimmunol.0902019; VONBEHRING E, 1991, MOL IMMUNOL, V28, P1319; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	45	44	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13137	10.1371/journal.pone.0013137	http://dx.doi.org/10.1371/journal.pone.0013137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957227	Green Published, gold			2022-12-27	WOS:000282423300004
J	O'Donnell, EF; Saili, KS; Koch, DC; Kopparapu, PR; Farrer, D; Bisson, WH; Mathew, LK; Sengupta, S; Kerkvliet, NI; Tanguay, RL; Kolluri, SK				O'Donnell, Edmond F.; Saili, Katerine S.; Koch, Daniel C.; Kopparapu, Prasad R.; Farrer, David; Bisson, William H.; Mathew, Lijoy K.; Sengupta, Sumitra; Kerkvliet, Nancy I.; Tanguay, Robert L.; Kolluri, Siva Kumar			The Anti-Inflammatory Drug Leflunomide Is an Agonist of the Aryl Hydrocarbon Receptor	PLOS ONE			English	Article							CELL-CYCLE REGULATION; AH DIOXIN RECEPTOR; RETINOBLASTOMA PROTEIN; NUCLEAR TRANSLOCATOR; RHEUMATOID-ARTHRITIS; HEPATOMA-CELLS; IMMUNE-SYSTEM; IN-VITRO; ACTIVATION; EXPRESSION	Background: The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity and biological activity of dioxins and related chemicals. The AhR influences a variety of processes involved in cellular growth and differentiation, and recent studies have suggested that the AhR is a potential target for immune-mediated diseases. Methodology/Principal Findings: During a screen for molecules that activate the AhR, leflunomide, an immunomodulatory drug presently used in the clinic for the treatment of rheumatoid arthritis, was identified as an AhR agonist. We aimed to determine whether any biological activity of leflunomide could be attributed to a previously unappreciated interaction with the AhR. The currently established mechanism of action of leflunomide involves its metabolism to A771726, possibly by cytochrome P450 enzymes, followed by inhibition of de novo pyrimidine biosynthesis by A771726. Our results demonstrate that leflunomide, but not its metabolite A771726, caused nuclear translocation of AhR into the nucleus and increased expression of AhR-responsive reporter genes and endogenous AhR target genes in an AhR-dependent manner. In silico Molecular Docking studies employing AhR ligand binding domain revealed favorable binding energy for leflunomide, but not for A771726. Further, leflunomide, but not A771726, inhibited in vivo epimorphic regeneration in a zebrafish model of tissue regeneration in an AhR-dependent manner. However, suppression of lymphocyte proliferation by leflunomide or A771726 was not dependent on AhR. Conclusions: These data reveal that leflunomide, an anti-inflammatory drug, is an agonist of the AhR. Our findings link AhR activation by leflunomide to inhibition of fin regeneration in zebrafish. Identification of alternative AhR agonists is a critical step in evaluating the AhR as a therapeutic target for the treatment of immune disorders.	[O'Donnell, Edmond F.; Koch, Daniel C.; Kopparapu, Prasad R.; Bisson, William H.; Kolluri, Siva Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Canc Res Lab, Corvallis, OR 97331 USA; [O'Donnell, Edmond F.; Saili, Katerine S.; Koch, Daniel C.; Kopparapu, Prasad R.; Farrer, David; Bisson, William H.; Mathew, Lijoy K.; Sengupta, Sumitra; Kerkvliet, Nancy I.; Tanguay, Robert L.; Kolluri, Siva Kumar] Oregon State Univ, Environm Hlth Sci Ctr, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Bisson, William H.] Univ Geneva, Sch Pharmaceut Sci, Pharmaceut Biochem Grp, Geneva, Switzerland	Oregon State University; Oregon State University; University of Geneva	O'Donnell, EF (corresponding author), Oregon State Univ, Environm Hlth Sci Ctr, Canc Res Lab, Corvallis, OR 97331 USA.	Siva.Kolluri@Oregonstate.edu	Sengupta, Sumitra/G-1814-2017	Sengupta, Sumitra/0000-0003-2861-5608; /0000-0001-9516-9690; Saili, Katerine/0000-0001-5759-1006	National Institute of Environmental Health Sciences (NIEHS) [ES016651, T32ES07060]; National Science Foundation [0641409]; Environmental Health Sciences Center, NIEHS [P30 ES00210]; Department of Defense [W81XWH-10-1-0160]; National Cancer Institute [1F31CA144571-01]; NATIONAL CANCER INSTITUTE [F31CA144571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060, P30ES000210, R01ES016651, P42ES016465] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Science Foundation(National Science Foundation (NSF)); Environmental Health Sciences Center, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the National Institute of Environmental Health Sciences (NIEHS) grant number ES016651, the National Science Foundation grant number 0641409, and the Aquatic Biomedical Models and the Cell Imaging and Analysis Facility Cores of the Environmental Health Sciences Center, NIEHS grant number P30 ES00210. EFO, KSS, DCK and DF were supported by NIEHS training grant (T32ES07060). EFO is supported by a pre-doctoral fellowship from the Department of Defense Breast Cancer Research Program (W81XWH-10-1-0160), and DCK is supported by the National Research Service Award (1F31CA144571-01) from the National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Bisson WH, 2009, J MED CHEM, V52, P5635, DOI 10.1021/jm900199u; Blankenship A, 1997, MOL PHARMACOL, V52, P667, DOI 10.1124/mol.52.4.667; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FAN Y, CANC RES, V70, P212; Fritz WA, 2007, CARCINOGENESIS, V28, P497, DOI 10.1093/carcin/bgl179; Ftitz WA, 2009, BIOCHEM PHARMACOL, V77, P1151, DOI 10.1016/j.bcp.2008.12.015; Fujii-Kuriyama Y, 2005, BIOCHEM BIOPH RES CO, V338, P311, DOI 10.1016/j.bbrc.2005.08.162; Garrison PM, 1996, FUND APPL TOXICOL, V30, P194, DOI 10.1006/faat.1996.0056; Gasiewicz TA, 2008, CRIT REV EUKAR GENE, V18, P279, DOI 10.1615/CritRevEukarGeneExpr.v18.i4.10; Grabar PB, 2009, DRUG METAB DISPOS, V37, P2061, DOI 10.1124/dmd.109.027482; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; HANKINSON O, 1979, P NATL ACAD SCI USA, V76, P373, DOI 10.1073/pnas.76.1.373; HOFFMAN EC, 1991, SCIENCE, V252, P954, DOI 10.1126/science.1852076; Hu WY, 2007, MOL PHARMACOL, V71, P1475, DOI 10.1124/mol.106.032748; Kalgutkar AS, 2003, DRUG METAB DISPOS, V31, P1240, DOI 10.1124/dmd.31.10.1240; Kerkvliet NI, 2009, IMMUNOTHERAPY-UK, V1, P539, DOI 10.2217/IMT.09.24; Kerkvliet NI, 2009, BIOCHEM PHARMACOL, V77, P746, DOI 10.1016/j.bcp.2008.11.021; Kolluri SK, 2008, CANCER CELL, V14, P285, DOI 10.1016/j.ccr.2008.09.002; Kolluri SK, 2003, MOL CELL BIOL, V23, P8651, DOI 10.1128/MCB.23.23.8651-8667.2003; Kolluri SK, 2005, P NATL ACAD SCI USA, V102, P2525, DOI 10.1073/pnas.0409721102; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Li H, 2000, SCIENCE, V289, P1159, DOI 10.1126/science.289.5482.1159; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Ma Q, 1996, MOL CELL BIOL, V16, P2144; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Mathew LK, 2008, FASEB J, V22, P3087, DOI 10.1096/fj.08-109009; Mathew LK, 2006, MOL PHARMACOL, V69, P257, DOI 10.1124/mol.105.018044; Miceli-Richard C, 2003, EXPERT OPIN PHARMACO, V4, P987, DOI 10.1517/14656566.4.6.987; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NumayamaTsuruta K, 1997, EUR J BIOCHEM, V246, P486, DOI 10.1111/j.1432-1033.1997.00486.x; Puga A, 2002, CHEM-BIOL INTERACT, V141, P117, DOI 10.1016/S0009-2797(02)00069-8; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Safe S, 2002, INT J ONCOL, V20, P1123; Safe S, 2001, TOXICOL LETT, V120, P1, DOI 10.1016/S0378-4274(01)00301-0; Stevens EA, 2009, IMMUNOLOGY, V127, P299, DOI 10.1111/j.1365-2567.2009.03054.x; Stockinger Brigitta, 2009, Journal of Biology (London), V8, P61, DOI 10.1186/jbiol170; Sy SKB, 2001, EUR J CLIN PHARMACOL, V57, P377, DOI 10.1007/s002280100330; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Weiss C, 2005, ONCOGENE, V24, P4975, DOI 10.1038/sj.onc.1208679; Weiss C, 1996, EXP CELL RES, V226, P154, DOI 10.1006/excr.1996.0214; Zodrow JM, 2003, TOXICOL SCI, V76, P151, DOI 10.1093/toxsci/kfg205	45	83	88	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13128	10.1371/journal.pone.0013128	http://dx.doi.org/10.1371/journal.pone.0013128			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957046	gold, Green Published, Green Submitted			2022-12-27	WOS:000282359300022
J	Lyke, KE; Laurens, M; Adams, M; Billingsley, PF; Richman, A; Loyevsky, M; Chakravarty, S; Plowe, CV; Sim, BKL; Edelman, R; Hoffman, SL				Lyke, Kirsten E.; Laurens, Matthew; Adams, Matthew; Billingsley, Peter F.; Richman, Adam; Loyevsky, Mark; Chakravarty, Sumana; Plowe, Christopher V.; Sim, B. Kim Lee; Edelman, Robert; Hoffman, Stephen L.			Plasmodium falciparum Malaria Challenge by the Bite of Aseptic Anopheles stephensi Mosquitoes: Results of a Randomized Infectivity Trial	PLOS ONE			English	Article							VACCINE; EFFICACY; HUMANS; IMMUNIZATION; PARASITEMIA; VOLUNTEERS; THERAPY; REGION; SAFETY	Background: Experimental infection of malaria-naive volunteers by the bite of Plasmodium falciparum-infected mosquitoes is a preferred means to test the protective effect of malaria vaccines and drugs. The standard model relies on the bite of five infected mosquitoes to induce malaria. We examined the efficacy of malaria transmission using mosquitoes raised aseptically in compliance with current Good Manufacturing Practices (cGMPs). Methods and Findings: Eighteen adults aged 18-40 years were randomized to receive 1, 3 or 5 bites of Anopheles stephensi mosquitoes infected with the chloroquine-sensitive NF54 strain of P. falciparum. Seventeen participants developed malaria; fourteen occurring on Day 11. The mean prepatent period was 10.9 days (9-12 days). The geometric mean parasitemia was 15.7 parasites/mu L (range: 4-70) by microscopy. Polymerase chain reaction (PCR) detected parasites 3.1 (range: 0-4) days prior to microscopy. The geometric mean sporozoite load was 16,753 sporozoites per infected mosquito (range: 1,000-57,500). A 1-bite participant withdrew from the study on Day 13 post-challenge and was PCR and smear negative. Conclusions: The use of aseptic, cGMP-compliant P. falciparum-infected mosquitoes is safe, is associated with a precise prepatent period compared to the standard model and appears more efficient than the standard approach, as it led to infection in 100% (6/6) of volunteers exposed to three mosquito bites and 83% (5/6) of volunteers exposed to one mosquito bite.	[Lyke, Kirsten E.; Laurens, Matthew; Adams, Matthew; Plowe, Christopher V.; Edelman, Robert] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Laurens, Matthew; Plowe, Christopher V.] Univ Maryland, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21201 USA; [Billingsley, Peter F.; Richman, Adam; Loyevsky, Mark; Chakravarty, Sumana; Sim, B. Kim Lee; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Sim, B. Kim Lee] Prot Potential LLC, Rockville, MD USA	University System of Maryland; University of Maryland Baltimore; Howard Hughes Medical Institute; University System of Maryland; University of Maryland Baltimore; Sanaria Inc.	Lyke, KE (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.	KLyke@medicine.umaryland.edu	Laurens, Matthew/E-7293-2013	Laurens, Matthew/0000-0003-3874-581X	National Institute of Allergy and Infectious Diseases [N01-AI25461]; Sanaria, Inc. [NF54]; Doris Duke; Burroughs-Wellcome Fund/American Society; Doris Duke Charitable Foundation; Howard Hughes Medical Institute; NIAID/DMID/VTEU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025461] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sanaria, Inc.; Doris Duke(Doris Duke Charitable Foundation (DDCF)); Burroughs-Wellcome Fund/American Society(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID/DMID/VTEU(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The conduct of the trial was supported by a Vaccine Testing and Evaluation Unit contract N01-AI25461 from the National Institute of Allergy and Infectious Diseases. Mosquito rearing and infection by cultured NF54 parasites was supported by the study sponsor, Sanaria, Inc. KEL is supported by a Doris Duke Clinical Scientist Development Award. MBL is supported by the Burroughs-Wellcome Fund/American Society of Tropical Medicine and Hygiene Postdoctoral Fellowship in Tropical Infectious Diseases. CVP is supported by a Doris Duke Distinguished Clinical Scientist Award from the Doris Duke Charitable Foundation and CVP, MBL and MA are supported by the Howard Hughes Medical Institute. The Malaria Vaccine Initiative (MVI) supported the development by Sanaria, Inc. of a Biologics Master File for Aseptic Anopheles stephensi Mosquitoes Infected with Plasmodium falciparum Sporozoites. PFB, AR, ML, SC, BKLS, and SLH are employees of Sanaria, Inc. and/or Protein Potential, LLC representing the sponsors of the study and participated in development of study design, data collection and analysis, publication decisions and manuscript publication. NIAID/DMID/VTEU, the funders of the study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PFB, AR,ML, SC, BKLS, and SLH are employees of Sanaria, Inc. and/or Protein Potential, LLC representing the sponsors of the study and participated in development of study design, data collection and analysis, publication decisions and manuscript publication. The funding sponsor, however, was NIAID/DMID/VTEU and members of this organization played no role in the development of the manuscript or publication. These affiliations do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2010, LANCET, V375, P1407, DOI 10.1016/S0140-6736(10)60601-0; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; BEIER JC, 1991, AM J TROP MED HYG, V44, P564, DOI 10.4269/ajtmh.1991.44.564; Brown EM, 2000, HIST PSYCHIATR, V11, P371, DOI 10.1177/0957154X0001104403; CHULAY JD, 1986, AM J TROP MED HYG, V35, P66, DOI 10.4269/ajtmh.1986.35.66; Church LWP, 1997, J INFECT DIS, V175, P915, DOI 10.1086/513990; CLYDE DF, 1975, AM J TROP MED HYG, V24, P397, DOI 10.4269/ajtmh.1975.24.397; DAVIS JR, 1989, T ROY SOC TROP MED H, V83, P748, DOI 10.1016/0035-9203(89)90315-5; DRIVER JR, 1926, J AM MED ASS; Epstein JE, 2007, J INFECT DIS, V196, P145, DOI 10.1086/518510; FRIES LF, 1992, INFECT IMMUN, V60, P1834, DOI 10.1128/IAI.60.5.1834-1839.1992; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; GITHEKO AK, 1992, T ROY SOC TROP MED H, V86, P355, DOI 10.1016/0035-9203(92)90216-Y; GUNDERSON JH, 1987, SCIENCE, V238, P933, DOI 10.1126/science.3672135; HERRINGTON DA, 1988, TROP GEOGR MED, V40, P124; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; JEFFERY G. M., 1959, ANN TROP MED AND PARASITOL, V53, P51; Jinj Y, 2007, INFECT IMMUN, V75, P5532, DOI 10.1128/IAI.00600-07; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; MCCUTCHAN TF, 1988, MOL BIOCHEM PARASIT, V28, P63, DOI 10.1016/0166-6851(88)90181-8; Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005; Moorthy V S, 2009, Vaccine, V27, P5719, DOI 10.1016/j.vaccine.2009.07.049; MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434, DOI 10.1128/JCM.27.7.1434-1437.1989; MURPHY JR, 1990, ANTIMICROB AGENTS CH, V34, P676, DOI 10.1128/AAC.34.4.676; Nieman AE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-277; RICKMAN LS, 1990, AM J TROP MED HYG, V43, P441, DOI 10.4269/ajtmh.1990.43.441; Spring MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005254; Takala SL, 2009, PARASITE IMMUNOL, V31, P560, DOI 10.1111/j.1365-3024.2009.01138.x; Verhage DF, 2005, NETH J MED, V63, P52	31	34	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13490	10.1371/journal.pone.0013490	http://dx.doi.org/10.1371/journal.pone.0013490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042404	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800002
J	Martens, S; Korucuoglu, O; Smid, HGOM; Nieuwenstein, MR				Martens, Sander; Korucuoglu, Ozlem; Smid, Henderikus G. O. M.; Nieuwenstein, Mark R.			Quick Minds Slowed Down: Effects of Rotation and Stimulus Category on the Attentional Blink	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; RESOURCE DEPLETION; MENTAL ROTATION; TASK; SELECTION; MEMORY; CONJUNCTIONS; WHOLE	Background: Most people show a remarkable deficit to report the second of two targets when presented in close temporal succession, reflecting an attentional restriction known as the 'attentional blink' (AB). However, there are large individual differences in the magnitude of the effect, with some people showing no such attentional restrictions. Methodology/Principal Findings: Here we present behavioral and electrophysiological evidence suggesting that these 'non-blinkers' can use alphanumeric category information to select targets at an early processing stage. When such information was unavailable and target selection could only be based on information that is processed relatively late (rotation), even non-blinkers show a substantial AB. Electrophysiologically, in non-blinkers this resulted in enhanced distractor-related prefrontal brain activity, as well as delayed target-related occipito-parietal activity (P3). Conclusion/Significance: These findings shed new light on possible strategic mechanisms that may underlie individual differences in AB magnitude and provide intriguing clues as to how temporal restrictions as reflected in the AB can be overcome.	[Martens, Sander; Korucuoglu, Ozlem; Smid, Henderikus G. O. M.] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Smid, Henderikus G. O. M.] Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen	Martens, S (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@med.umcg.nl	Martens, Sander/C-5353-2008	Nieuwenstein, M.R./0000-0002-9602-3463; Martens, Sander/0000-0001-8237-7984				Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Dell'Acqua R, 2009, J EXP PSYCHOL HUMAN, V35, P338, DOI 10.1037/a0013555; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; DUNCAN J, 1983, PERCEPT PSYCHOPHYS, V33, P533, DOI 10.3758/BF03202935; Dux PE, 2007, COGNITION, V104, P47, DOI 10.1016/j.cognition.2006.05.004; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Dux PE, 2005, PSYCHOL SCI, V16, P775, DOI 10.1111/j.1467-9280.2005.01613.x; DUX PE, 2008, PLOS ONE, V3; Esterman M, 2004, PSYCHON B REV, V11, P681, DOI 10.3758/BF03196620; Hamilton JP, 2006, PSYCHON B REV, V13, P1074, DOI 10.3758/BF03213928; Harris IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002256; Heil M, 2002, PSYCHOPHYSIOLOGY, V39, P535, DOI 10.1017/S0048577202020449; ILAN AB, 1994, J EXP PSYCHOL HUMAN, V20, P520, DOI 10.1037/0096-1523.20.3.520; JOLICOEUR P, 1992, J EXP PSYCHOL HUMAN, V18, P371, DOI 10.1037/0096-1523.18.2.371; JONIDES J, 1972, PERCEPT PSYCHOPHYS, V12, P457, DOI 10.3758/BF03210934; Keil A, 2009, PSYCHOPHYSIOLOGY, V46, P718, DOI 10.1111/j.1469-8986.2009.00824.x; KENEMANS JL, 1993, ELECTROEN CLIN NEURO, V88, P51, DOI 10.1016/0168-5597(93)90028-N; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; Martens S, 2002, J EXP PSYCHOL HUMAN, V28, P1275, DOI 10.1037//0096-1523.28.6.1275; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; Nieuwenstein MR, 2007, ACTA PSYCHOL, V125, P319, DOI 10.1016/j.actpsy.2006.08.006; Nieuwenstein MR, 2006, PSYCHOL SCI, V17, P471, DOI 10.1111/j.1467-9280.2006.01730.x; Nieuwenstein MR, 2009, J EXP PSYCHOL HUMAN, V35, P159, DOI 10.1037/0096-1523.35.1.159; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Passingham R., 1995, FRONTAL LOBES VOLUNT; Potter MC, 2008, J MEM LANG, V58, P907, DOI 10.1016/j.jml.2007.12.002; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Schneider W., 2002, E PRIME USERS GUIDE; Shapiro K, 1997, PSYCHOL SCI, V8, P95, DOI 10.1111/j.1467-9280.1997.tb00689.x; Shapiro KL, 1997, J EXP PSYCHOL HUMAN, V23, P504, DOI 10.1037/0096-1523.23.2.504; Smid HGOM, 1999, PSYCHOPHYSIOLOGY, V36, P264, DOI 10.1017/S0048577299971135; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Wijers AA, 1989, THESIS U GRONINGEN G; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	45	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13509	10.1371/journal.pone.0013509	http://dx.doi.org/10.1371/journal.pone.0013509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	668TQ	20975838	gold, Green Published, Green Submitted			2022-12-27	WOS:000283293800005
J	Ottoni, C; Primativo, G; Kashani, BH; Achilli, A; Martinez-Labarga, C; Biondi, G; Torroni, A; Rickards, O				Ottoni, Claudio; Primativo, Giuseppina; Kashani, Baharak Hooshiar; Achilli, Alessandro; Martinez-Labarga, Cristina; Biondi, Gianfranco; Torroni, Antonio; Rickards, Olga			Mitochondrial Haplogroup H1 in North Africa: An Early Holocene Arrival from Iberia	PLOS ONE			English	Article							LAST GLACIAL MAXIMUM; HUMAN GENETIC HISTORY; HUMAN MTDNA; DNA; POPULATION; EUROPE; EXPANSION; PERSPECTIVE; SEQUENCES; CLIMATE	The Tuareg of the Fezzan region (Libya) are characterized by an extremely high frequency (61%) of haplogroup H1, a mitochondrial DNA (mtDNA) haplogroup that is common in all Western European populations. To define how and when H1 spread from Europe to North Africa up to the Central Sahara, in Fezzan, we investigated the complete mitochondrial genomes of eleven Libyan Tuareg belonging to H1. Coalescence time estimates suggest an arrival of the European H1 mtDNAs at about 8,000-9,000 years ago, while phylogenetic analyses reveal three novel H1 branches, termed H1v, H1w and H1x, which appear to be specific for North African populations, but whose frequencies can be extremely different even in relatively close Tuareg villages. Overall, these findings support the scenario of an arrival of haplogroup H1 in North Africa from Iberia at the beginning of the Holocene, as a consequence of the improvement in climate conditions after the Younger Dryas cold snap, followed by in situ formation of local H1 sub-haplogroups. This process of autochthonous differentiation continues in the Libyan Tuareg who, probably due to isolation and recent founder events, are characterized by village-specific maternal mtDNA lineages.	[Ottoni, Claudio; Primativo, Giuseppina; Martinez-Labarga, Cristina; Rickards, Olga] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Ottoni, Claudio] Univ Ziekenhuizen, Lab Forens Genet & Mol Archaeol, Leuven, Belgium; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Archaeol Sci, Leuven, Belgium; [Ottoni, Claudio] Katholieke Univ Leuven, Ctr Human Genet, Leuven, Belgium; [Kashani, Baharak Hooshiar; Achilli, Alessandro; Torroni, Antonio] Univ Pavia, Dipartimento Genet Microbiol, I-27100 Pavia, Italy; [Achilli, Alessandro] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Biondi, Gianfranco] Univ Aquila, Dipartimento Sci Ambientali, I-67100 Laquila, Italy	University of Rome Tor Vergata; KU Leuven; KU Leuven; University of Pavia; University of Perugia; University of L'Aquila	Ottoni, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	rickards@uniroma2.it	Torroni, Antonio/E-1557-2011; Ottoni, Claudio/AFM-1230-2022; Ottoni, Claudio/AFM-1348-2022; MARTINEZ-LABARGA, CRISTINA M/K-6011-2014; Rickards, Olga/L-7878-2015; Achilli, Alessandro/I-9236-2012	Torroni, Antonio/0000-0002-4163-4478; Ottoni, Claudio/0000-0001-8870-1589; MARTINEZ-LABARGA, CRISTINA M/0000-0003-0439-0379; Rickards, Olga/0000-0003-2880-7466; Achilli, Alessandro/0000-0001-6871-3451	Italian Ministry of the University [2003100945_002, 20073RH73W_001, RBFR08U07M_001]; University of Rome Tor Vergata; University of Rome La Sapienza	Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR)); University of Rome Tor Vergata; University of Rome La Sapienza	This study was supported by grants from the Italian Ministry of the University, Progetti Ricerca Interesse Nazionale "Nomads and sedentary people. Reconstruction of the genetic history of ancient and extant populations from Libya and Western Sahara'' (protocol 2003100945_002 to OR) and "The peopling of the European continent: the mitochondrial DNA and Y chromosome perspectives" (protocol 20073RH73W_001 to AT), FIRB-Futuro in Ricerca 2008 "The parallel genetic history of humans and domesticated animals'' (protocol RBFR08U07M_001 to AA), Fondazione Alma Mater Ticinensis (to AT), the University of Rome Tor Vergata (Ricerche di Ateneo, ex 60% 2003-2004) allotted to OR and Grandi Scavi di Ateneo, University of Rome La Sapienza, entrusted to Prof. Savino di Lernia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; Adams JM, 1997, J ARCHAEOL SCI, V24, P623, DOI 10.1006/jasc.1996.0146; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Behar DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002062; Brandstatter A, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-191; Camps G., 1974, CIVILISATIONS PREHIS; Cherni L, 2009, AM J PHYS ANTHROPOL, V139, P253, DOI 10.1002/ajpa.20979; Clark PU, 2009, SCIENCE, V325, P710, DOI 10.1126/science.1172873; Comas D, 2000, HUM GENET, V107, P312, DOI 10.1007/s004390000370; Costa MD, 2009, MECH AGEING DEV, V130, P222, DOI 10.1016/j.mad.2008.12.001; Coudray C, 2009, ANN HUM GENET, V73, P196, DOI 10.1111/j.1469-1809.2008.00493.x; DOLUKHANOV P, 1993, CULTURAL TRANSFORMAT; Ennafaa H, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-8; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gamble C, 2005, CAMB ARCHAEOL J, V15, P193, DOI 10.1017/S0959774305000107; Gamble C, 2004, PHILOS T R SOC B, V359, P243, DOI 10.1098/rstb.2003.1396; GIAZZI F, ETUDE INITIALE RESER; Gonzalez-Perez E, 2010, AM J PHYS ANTHROPOL, V141, P430, DOI 10.1002/ajpa.21161; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HASSAN FA, 2002, DROUGHTS FOOD CULTUR; HASSAN FA, 1996, 10 C PANAFRICAN ASS, P83; Kayser M, 2010, CURR BIOL, V20, pR194, DOI 10.1016/j.cub.2009.12.004; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Loogvali EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008260; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Macaulay V, 1999, AM J HUM GENET, V64, P232, DOI 10.1086/302204; Majumder PP, 2010, CURR BIOL, V20, pR184, DOI 10.1016/j.cub.2009.11.053; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; METSPALU M, 2006, MITOCHONDRIAL DNA EV, P181; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Ottoni C, 2009, ANN HUM GENET, V73, P438, DOI 10.1111/j.1469-1809.2009.00526.x; Pala M, 2009, AM J HUM GENET, V84, P814, DOI 10.1016/j.ajhg.2009.05.004; Pereira L, 2010, EUR J HUM GENET, V18, P915, DOI 10.1038/ejhg.2010.21; Plaza S, 2003, ANN HUM GENET, V67, P312, DOI 10.1046/j.1469-1809.2003.00039.x; Richards M., 2006, MITOCHONDRIAL DNA EV, P225; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Sadr K, 2004, J AFR HIST, V45, P492, DOI 10.1017/S0021853704229930; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Smith RL, 2003, J WORLD HIST, V14, P459, DOI 10.1353/jwh.2003.0060; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Spain Daphne, 1992, GENDERED SPACES; Tarasov PE, 1999, CLIM DYNAM, V15, P227, DOI 10.1007/s003820050278; Torroni A, 2001, AM J HUM GENET, V69, P1348, DOI 10.1086/324511; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001	48	39	39	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13378	10.1371/journal.pone.0013378	http://dx.doi.org/10.1371/journal.pone.0013378			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975840	gold, Green Submitted, Green Published			2022-12-27	WOS:000283293800001
J	Nishiguchi, KM; Kataoka, K; Kachi, S; Komeima, K; Terasaki, H				Nishiguchi, Koji M.; Kataoka, Keiko; Kachi, Shu; Komeima, Keiichi; Terasaki, Hiroko			Regulation of Pathologic Retinal Angiogenesis in Mice and Inhibition of VEGF-VEGFR2 Binding by Soluble Heparan Sulfate	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; EXTRACELLULAR DOMAIN; DIABETIC-RETINOPATHY; AQUEOUS-HUMOR; VEGF RECEPTOR; PROTEOGLYCANS; EXPRESSION; NEOVASCULARIZATION; SYNDECAN-1	Development of the retinal vascular network is strictly confined within the neuronal retina, allowing the intraocular media to be optically transparent. However, in retinal ischemia, pro-angiogenic factors (including vascular endothelial growth factor-A, VEGF-A) induce aberrant guidance of retinal vessels into the vitreous. Here, we show that the soluble heparan sulfate level in murine intraocular fluid is high particularly during ocular development. When the eyes of young mice with retinal ischemia were treated with heparan sulfate-degrading enzyme, the subsequent aberrant angiogenesis was greatly enhanced compared to PBS-injected contralateral eyes; however, increased angiogenesis was completely antagonized by simultaneous injection of heparin. Intraocular injection of heparan sulfate or heparin alone in these eyes resulted in reduced neovascularization. In cell cultures, the porcine ocular fluid suppressed the dose-dependent proliferation of human umbilical vein endothelial cells (HUVECs) mediated by VEGF-A. Ocular fluid and heparin also inhibited the migration and tube formation by these cells. The binding of VEGF-A and HUVECs was reduced under a high concentration of heparin or ocular fluid compared to lower concentrations of heparin. In vitro assays demonstrated that the ocular fluid or soluble heparan sulfate or heparin inhibited the binding of VEGF-A and immobilized heparin or VEGF receptor 2 but not VEGF receptor 1. The recognition that the high concentration of soluble heparan sulfate in the ocular fluid allows it to serve as an endogenous inhibitor of aberrant retinal vascular growth provides a platform for modulating heparan sulfate/heparin levels to regulate angiogenesis.	[Nishiguchi, Koji M.; Kataoka, Keiko; Kachi, Shu; Komeima, Keiichi; Terasaki, Hiroko] Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan	Nagoya University	Nishiguchi, KM (corresponding author), Nagoya Univ, Grad Sch Med, Dept Ophthalmol, Nagoya, Aichi 4648601, Japan.	kojinish@med.nagoya-u.ac.jp	Kataoka, Keiko/B-2806-2016; Terasaki, Hiroko/M-5054-2014	Kataoka, Keiko/0000-0002-8795-6536; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21791676]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grant (B) 21791676, a Grant-in Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Collen A, 2000, CANCER RES, V60, P6196; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Dougher AM, 1997, GROWTH FACTORS, V14, P257, DOI 10.3109/08977199709021524; Fannon M, 2003, FASEB J, V17, P902, DOI 10.1096/fj.02-0935fje; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Funatsu H, 2005, GRAEF ARCH CLIN EXP, V243, P3, DOI 10.1007/s00417-004-0950-7; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Halfter W, 2000, DEV BIOL, V220, P111, DOI 10.1006/dbio.2000.9649; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Inatani M, 2002, INVEST OPHTH VIS SCI, V43, P1616; Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Koga T, 2003, CURR EYE RES, V27, P75, DOI 10.1076/ceyr.27.2.75.15950; LINDAHL B, 1995, BIOCHEM J, V306, P177, DOI 10.1042/bj3060177; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; Ono K, 1999, GLYCOBIOLOGY, V9, P705, DOI 10.1093/glycob/9.7.705; Ozaki H, 2000, AM J PATHOL, V156, P697, DOI 10.1016/S0002-9440(10)64773-6; Park M, 1999, BIOCHEM BIOPH RES CO, V264, P730, DOI 10.1006/bbrc.1999.1580; PIERCE EA, 1995, P NATL ACAD SCI USA, V92, P905, DOI 10.1073/pnas.92.3.905; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Shih SC, 2003, J CLIN INVEST, V112, P50, DOI 10.1172/JCI200317808; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stalmans I, 2002, J CLIN INVEST, V109, P327, DOI 10.1172/jci0214362; Su G, 2007, J BIOL CHEM, V282, P14906, DOI 10.1074/jbc.M611739200; TESSLER S, 1994, J BIOL CHEM, V269, P12456; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Vaughan-Thomas A, 2000, INVEST OPHTH VIS SCI, V41, P3299	37	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13493	10.1371/journal.pone.0013493	http://dx.doi.org/10.1371/journal.pone.0013493			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975989	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400010
J	Kakefuda, K; Oyagi, A; Ishisaka, M; Tsuruma, K; Shimazawa, M; Yokota, K; Shirai, Y; Horie, K; Saito, N; Takeda, J; Hara, H				Kakefuda, Kenichi; Oyagi, Atsushi; Ishisaka, Mitsue; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Yokota, Koichi; Shirai, Yasuhito; Horie, Kyoji; Saito, Naoaki; Takeda, Junji; Hara, Hideaki			Diacylglycerol Kinase beta Knockout Mice Exhibit Lithium-Sensitive Behavioral Abnormalities	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; MOLECULAR-CLONING; PREFRONTAL CORTEX; PHOSPHORYLATION; INHIBITION; GSK-3	Background: Diacylglycerol kinase (DGK) is an enzyme that phosphorylates diacylglycerol (DG) to produce phosphatidic acid (PA). DGK beta is widely distributed in the central nervous system, such as the olfactory bulb, cerebral cortex, striatum, and hippocampus. Recent studies reported that the splice variant at the COOH-terminal of DGK beta was related to bipolar disorder, but its detailed mechanism is still unknown. Methodology/Principal Findings: In the present study, we performed behavioral tests using DGK beta knockout (KO) mice to investigate the effects of DGK beta deficits on psychomotor behavior. DGK beta KO mice exhibited some behavioral abnormalities, such as hyperactivity, reduced anxiety, and reduced depression. Additionally, hyperactivity and reduced anxiety were attenuated by the administration of the mood stabilizer, lithium, but not haloperidol, diazepam, or imipramine. Moreover, DGK beta KO mice showed impairment in Akt-glycogen synthesis kinase (GSK) 3 beta signaling and cortical spine formation. Conclusions/Significance: These findings suggest that DGK beta KO mice exhibit lithium-sensitive behavioral abnormalities that are, at least in part, due to the impairment of Akt- GSK3 beta signaling and cortical spine formation.	[Kakefuda, Kenichi; Oyagi, Atsushi; Ishisaka, Mitsue; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Yokota, Koichi] Carna Biosci In, Kobe, Hyogo, Japan; [Shirai, Yasuhito; Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan; [Horie, Kyoji; Takeda, Junji] Osaka Univ, Grad Sch Med, Dept Social & Environm Med, Suita, Osaka, Japan	Gifu Pharmaceutical University; Kobe University; Osaka University	Kakefuda, K (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Shirai, Yasuhito/O-3255-2018	Horie, Kyoji/0000-0001-9036-8180	Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding of this work was provided only by the Gifu Pharmaceutical University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adachi N, 2005, MOL BRAIN RES, V139, P288, DOI 10.1016/j.molbrainres.2005.06.007; Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Beaulieu JM, 2008, CELL, V132, P125, DOI 10.1016/j.cell.2007.11.041; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Caricasole A, 2002, J BIOL CHEM, V277, P4790, DOI 10.1074/jbc.M110249200; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; CORNE SJ, 1967, PSYCHOPHARMACOLOGIA, V11, P65, DOI 10.1007/BF00401509; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Sarno P, 2002, NEUROPHARMACOLOGY, V43, P1158, DOI 10.1016/S0028-3908(02)00215-0; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GELENBERG AJ, 1989, NEW ENGL J MED, V321, P1489, DOI 10.1056/NEJM198911303212201; GOTO K, 1993, P NATL ACAD SCI USA, V90, P7598, DOI 10.1073/pnas.90.16.7598; Gould TD, 2007, NEUROPSYCHOPHARMACOL, V32, P2173, DOI 10.1038/sj.npp.1301338; Horie K, 2003, MOL CELL BIOL, V23, P9189, DOI 10.1128/MCB.23.24.9189-9207.2003; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Keng VW, 2005, NAT METHODS, V2, P763, DOI 10.1038/NMETH795; Kimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003540; Liu CH, 2007, J EXP MED, V204, P781, DOI 10.1084/jem.20061856; Liu F, 2006, FEBS LETT, V580, P6269, DOI 10.1016/j.febslet.2006.10.033; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Oyagi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007461; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Pierri JN, 2001, ARCH GEN PSYCHIAT, V58, P466, DOI 10.1001/archpsyc.58.5.466; Prickaerts J, 2006, J NEUROSCI, V26, P9022, DOI 10.1523/JNEUROSCI.5216-05.2006; Quiroz JA, 2004, MOL INTERV, V4, P259, DOI 10.1124/mi.4.5.6; Rosoklija G, 2000, ARCH GEN PSYCHIAT, V57, P349, DOI 10.1001/archpsyc.57.4.349; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Schulze TG, 2009, MOL PSYCHIATR, V14, P487, DOI 10.1038/mp.2008.134; Shansky RM, 2009, CEREB CORTEX, V19, P2479, DOI 10.1093/cercor/bhp003; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Topham MK, 1999, J BIOL CHEM, V274, P11447, DOI 10.1074/jbc.274.17.11447; van Blitterswijk WJ, 2000, CELL SIGNAL, V12, P595, DOI 10.1016/S0898-6568(00)00113-3; VEREBEY K, 1981, PSYCHOPHARMACOLOGY, V75, P44, DOI 10.1007/BF00433500; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200	40	47	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13447	10.1371/journal.pone.0013447	http://dx.doi.org/10.1371/journal.pone.0013447			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976192	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300021
J	Graebsch, A; Roche, S; Kostrewa, D; Soding, J; Niessing, D				Graebsch, Almut; Roche, Stephane; Kostrewa, Dirk; Soeding, Johannes; Niessing, Dierk			Of Bits and Bugs - On the Use of Bioinformatics and a Bacterial Crystal Structure to Solve a Eukaryotic Repeat-Protein Structure	PLOS ONE			English	Article							PUR-ALPHA; STRUCTURE PREDICTION; SEQUENCE; BINDING; QUALITY; RNA; CRYSTALLIZATION; FAMILIES; SERVER; NMR	Pur-alpha is a nucleic acid-binding protein involved in cell cycle control, transcription, and neuronal function. Initially no prediction of the three-dimensional structure of Pur-alpha was possible. However, recently we solved the X-ray structure of Pur-alpha from the fruitfly Drosophila melanogaster and showed that it contains a so-called PUR domain. Here we explain how we exploited bioinformatics tools in combination with X-ray structure determination of a bacterial homolog to obtain diffracting crystals and the high-resolution structure of Drosophila Pur-alpha. First, we used sensitive methods for remote-homology detection to find three repetitive regions in Pur-alpha. We realized that our lack of understanding how these repeats interact to form a globular domain was a major problem for crystallization and structure determination. With our information on the repeat motifs we then identified a distant bacterial homolog that contains only one repeat. We determined the bacterial crystal structure and found that two of the repeats interact to form a globular domain. Based on this bacterial structure, we calculated a computational model of the eukaryotic protein. The model allowed us to design a crystallizable fragment and to determine the structure of Drosophila Pur-alpha. Key for success was the fact that single repeats of the bacterial protein self-assembled into a globular domain, instructing us on the number and boundaries of repeats to be included for crystallization trials with the eukaryotic protein. This study demonstrates that the simpler structural domain arrangement of a distant prokaryotic protein can guide the design of eukaryotic crystallization constructs. Since many eukaryotic proteins contain multiple repeats or repeating domains, this approach might be instructive for structural studies of a range of proteins.	[Graebsch, Almut; Roche, Stephane; Niessing, Dierk] Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany; [Graebsch, Almut; Roche, Stephane; Kostrewa, Dirk; Soeding, Johannes; Niessing, Dierk] Univ Munich, Dept Biochem, Gene Ctr, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Graebsch, A (corresponding author), Helmholtz Zentrum Munchen, Inst Biol Struct, Munich, Germany.	niessing@helmholtz-muenchen.de	Niessing, Dierk/AAE-4936-2022; Niessing, Dierk/M-4619-2014; Söding, Johannes/A-3341-2013	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X; Söding, Johannes/0000-0001-9642-8244	Helmholtz Association [VG-NH 142]; Deutsche Forschungsgemeinschaft [FOR855, SFB646, SFB 646]; Max-Planck Institute for Biochemistry (Martinsried, Germany)	Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max-Planck Institute for Biochemistry (Martinsried, Germany)	This work was supported by the Helmholtz Association (VG-NH 142 to D.N.) and the Deutsche Forschungsgemeinschaft (FOR855 and SFB646 to D.N.; SFB 646 to J.S.). S. R. is a fellow of the Human Frontiers Science Program organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Andrea Hildebrand and Sigrun Jaklin for their help. We acknowledge the support by the crystallization facility of the Max-Planck Institute for Biochemistry (Martinsried, Germany). We thank the European Synchrotron Radiation Facility (ESRF) as well as Swiss Light Source (SLS) for provision of synchrotron radiation facilities. We are grateful to Alan Cheung for data collection at SLS. We are grateful to Stephen K. Burley for his support during early stages of this project.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761; BERGEMANN AD, 1992, MOL CELL BIOL, V12, P5673, DOI 10.1128/MCB.12.12.5673; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bjorklund AK, 2006, PLOS COMPUT BIOL, V2, P959, DOI 10.1371/journal.pcbi.0020114; Chayen NE, 2008, NAT METHODS, V5, P147, DOI 10.1038/NMETH.F.203; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fischer D, 2006, CURR OPIN STRUC BIOL, V16, P178, DOI 10.1016/j.sbi.2006.03.004; Gallia GL, 2000, NUCLEIC ACIDS RES, V28, P3197, DOI 10.1093/nar/28.17.3197; Gao Xia, 2005, Journal of Structural and Functional Genomics, V6, P129, DOI 10.1007/s10969-005-1918-5; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Khalili K, 2003, MOL CELL BIOL, V23, P6857, DOI 10.1128/MCB.23.19.6857-6875.2003; Koehl P, 2002, J MOL BIOL, V323, P551, DOI 10.1016/S0022-2836(02)00971-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marcotte EM, 1999, J MOL BIOL, V293, P151, DOI 10.1006/jmbi.1999.3136; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldfield CJ, 2005, PROTEINS, V59, P444, DOI 10.1002/prot.20446; Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102; Price WN, 2009, NAT BIOTECHNOL, V27, P51, DOI 10.1038/nbt.1514; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sadreyev RI, 2007, NUCLEIC ACIDS RES, V35, pW653, DOI 10.1093/nar/gkm293; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savchenko A, 2003, PROTEINS, V50, P392, DOI 10.1002/prot.10282; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soding J, 2006, NUCLEIC ACIDS RES, V34, pW374, DOI 10.1093/nar/gkl195; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitaker S, 2009, REV MEX ING QUIM, V8, P1; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428	49	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13402	10.1371/journal.pone.0013402	http://dx.doi.org/10.1371/journal.pone.0013402			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976240	gold, Green Published, Green Submitted			2022-12-27	WOS:000282941000023
J	Wieczorek, L; Maas, JW; Muglia, LM; Vogt, SK; Muglia, LJ				Wieczorek, Lindsay; Maas, James W., Jr.; Muglia, Lisa M.; Vogt, Sherri K.; Muglia, Louis J.			Temporal and Regional Regulation of Gene Expression by Calcium-Stimulated Adenylyl Cyclase Activity during Fear Memory	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA; RAT-BRAIN; MICE; TYPE-8; LOCALIZATION; ACTIVATION; RECEPTORS	Background: The Ca2+-stimulated adenylyl cyclases (ACs), AC1 and AC8, are key components of long-term memory processing. AC1 and AC8 double knockout mice (Adcy1(-/-) Adcy8(-/-); DKO) display impaired fear memory processing; the mechanism of this impairment is largely unknown. Methodology/Principal Findings: We hypothesize that the Ca2+-stimulated ACs modulate long-lasting transcriptional changes essential for fear memory consolidation and maintenance. Here, we report a genome-wide study of gene expression changes associated with conditioned fear (CF) memory in wild-type and DKO mice to identify AC-dependent gene regulatory changes that occur in the amygdala and hippocampus at baseline and different time points after CF learning. We observed an overall decrease in transcriptional changes in DKO mice across all time points, but most strikingly, at periods when memory consolidation and retention should be occurring. Further, we identified a shared set of transcription factor binding sites in genes upregulated in wild-type mice that were associated with downregulated genes in DKO mice. To prove the temporal and regional importance of AC activity on different stages of memory processing, the tetracycline-off system was used to produce mice with forebrain-specific inducible expression of AC8 on a DKO background. CF behavioral results reveal that adult restoration of AC8 activity in the forebrain is sufficient for intact learning, while cessation of this expression at any time point across learning causes memory deficits. Conclusions/Significance: Overall, these studies demonstrate that the Ca2+-stimulated ACs contribute to the formation and maintenance of fear memory by a network of long-term transcriptional changes.	[Wieczorek, Lindsay; Maas, James W., Jr.; Vogt, Sherri K.] Washington Univ, Dept Pediat & Dev Biol, St Louis, MO 63130 USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Muglia, Lisa M.; Muglia, Louis J.] Vanderbilt Univ, Vanderbilt Kennedy Ctr, Nashville, TN USA	Washington University (WUSTL); Vanderbilt University; Vanderbilt University; Vanderbilt University	Wieczorek, L (corresponding author), Washington Univ, Dept Pediat & Dev Biol, St Louis, MO 63130 USA.	louis.muglia@vanderbilt.edu			National Institutes of Health [F31MH843913, R01AG18876, R01MH079010]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH079010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institutes of Health (www.nih.gov) to LW (F31MH843913) and LJM (R01AG18876; R01MH079010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright TD, 2000, CURR OPIN NEUROBIOL, V10, P612, DOI 10.1016/S0959-4388(00)00132-X; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CALI JJ, 1994, J BIOL CHEM, V269, P12190; Carlson ES, 2009, J NUTR, V139, P672, DOI 10.3945/jn.108.096354; Conti AC, 2007, NEUROSCIENCE, V146, P713, DOI 10.1016/j.neuroscience.2007.01.045; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Ferguson GD, 2004, PHYSIOLOGY, V19, P271, DOI 10.1152/physiol.00010.2004; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Gass P, 2001, PHYSIOL BEHAV, V73, P811, DOI 10.1016/S0031-9384(01)00518-2; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; HILL HD, 1988, ANAL BIOCHEM, V170, P203, DOI 10.1016/0003-2697(88)90109-1; LIVINGSTONE MS, 1984, CELL, V37, P205, DOI 10.1016/0092-8674(84)90316-7; MATSUOKA I, 1992, J NEUROSCI, V12, P3350; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Muglia LM, 1999, J NEUROSCI, V19, P2051; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Schaefer ML, 2000, J NEUROSCI, V20, P4809; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stork O, 1999, CELL MOL LIFE SCI, V55, P575, DOI 10.1007/s000180050316; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Villacres EC, 1998, J NEUROSCI, V18, P3186; Wang HB, 2004, NAT NEUROSCI, V7, P635, DOI 10.1038/nn1248; Wang HB, 2003, J NEUROSCI, V23, P9710; Wei F, 2002, NEURON, V36, P713, DOI 10.1016/S0896-6273(02)01019-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; XIA ZG, 1991, NEURON, V6, P431, DOI 10.1016/0896-6273(91)90251-T; Zhang M, 2008, J NEUROSCI, V28, P4736, DOI 10.1523/JNEUROSCI.1177-08.2008	35	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13385	10.1371/journal.pone.0013385	http://dx.doi.org/10.1371/journal.pone.0013385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976279	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000016
J	Andrade, GS; Serrao, JE; Zanuncio, JC; Zanuncio, TV; Leite, GLD; Polanczyk, RA				Andrade, Gilberto Santos; Serrao, Jose Eduardo; Zanuncio, Jose Cola; Zanuncio, Teresinha Vinha; Demolin Leite, Germano Leao; Polanczyk, Ricardo Antonio			Immunity of an Alternative Host Can Be Overcome by Higher Densities of Its Parasitoids Palmistichus elaeisis and Trichospilus diatraeae	PLOS ONE			English	Article							LASALLE HYMENOPTERA EULOPHIDAE; TRICHOGRAMMA-PRETIOSUM RILEY; PLUTELLA-XYLOSTELLA L.; COTESIA-PLUTELLAE; THERMAL REQUIREMENTS; ENDOPARASITOID WASP; DIAMONDBACK MOTH; LEPIDOPTERA; SUPERPARASITISM; DEFENSE	Interactions of the parasitoids Palmistichus elaeisis Delvare & LaSalle and Trichospilus diatraeae Cherian & Margabandhu (Hymenoptera: Eulophidae) with its alternative host Anticarsia gemmatalis (Hubner) (Lepidoptera: Noctuidae) affect the success or failure of the mass production of these parasitoids for use in integrated pest management programs. The aim of this study was to evaluate changes in the cellular defense and encapsulation ability of A. gemmatalis pupae against P. elaeisis or T. diatraeae in adult parasitoid densities of 1, 3, 5, 7, 9, 11 or 13 parasitoids/pupae. We evaluated the total quantity of circulating hemocytes and the encapsulation rate versus density. Increasing parasitoid density reduced the total number of hemocytes in the hemolymph and the encapsulation rate by parasitized pupae. Furthermore, densities of P. elaeisis above 5 parasitoids/pupae caused higher reduction in total hemocyte numbers. The encapsulation rate fell with increasing parasitoid density. However, parasitic invasion by both species induced generally similar responses. The reduction in defensive capacity of A. gemmatalis is related to the adjustment of the density of these parasitoids to their development in this host. Thus, the role of the density of P. elaeisis or T. diatraeae by pupa is induced suppression of cellular defense and encapsulation of the host, even without them possesses a co-evolutionary history. Furthermore, these findings can predict the success of P. elaeisis and T. diatraeae in the control of insect pests through the use of immunology as a tool for evaluation of natural enemies.	[Andrade, Gilberto Santos; Zanuncio, Jose Cola; Zanuncio, Teresinha Vinha] Univ Fed Vicosa, Dept Biol Anim, BIOAGRO, Vicosa, MG, Brazil; [Serrao, Jose Eduardo] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil; [Demolin Leite, Germano Leao] Univ Fed Minas Gerais, Inst Ciencias Agrarias, Montes Claros, Brazil; [Polanczyk, Ricardo Antonio] Univ Estado Sao Paulo, Dept Protecao Plantas, Univ Estadual Paulista Julio Mesquita Filho UNESP, Sao Paulo, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Minas Gerais; Universidade Estadual Paulista	Andrade, GS (corresponding author), Univ Fed Vicosa, Dept Biol Anim, BIOAGRO, Vicosa, MG, Brazil.	zanuncio@ufv.br	Polanczyk, R A/C-4714-2012; Polanczyk, Ricardo Antonio/AAS-6336-2020; Polanczyk, Ricardo A/N-7237-2017; Andrade, Gilberto/I-5892-2013; Serrão, Jose Eduardo/H-2935-2012	Polanczyk, Ricardo Antonio/0000-0003-0769-9902; Polanczyk, Ricardo A/0000-0003-0769-9902; Andrade, Gilberto/0000-0001-7234-2980; 	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latief M, 2008, INSECT BIOCHEM MOLEC, V38, P136, DOI 10.1016/j.ibmb.2007.10.001; Amaya KE, 2005, J INSECT PHYSIOL, V51, P505, DOI 10.1016/j.jinsphys.2004.11.019; Andrade GS, 2009, ACTA SCI-AGRON, V31, P569, DOI 10.4025/actasciagron.v31i4.808; Asgari S, 1997, J GEN VIROL, V78, P3061, DOI 10.1099/0022-1317-78-11-3061; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Carton Y, 2008, INSECT SCI, V15, P67, DOI 10.1111/j.1744-7917.2008.00188.x; Chapman R.F., 1998, INSECTS STRUCTURE FU, V4th ed.; Cheng TC, 2008, DEV COMP IMMUNOL, V32, P464, DOI 10.1016/j.dci.2007.03.010; Cotter SC, 2004, J EVOLUTION BIOL, V17, P421, DOI 10.1046/j.1420-9101.2003.00655.x; De Souza DJ, 2008, J INSECT PHYSIOL, V54, P828, DOI 10.1016/j.jinsphys.2008.03.001; GREENE GL, 1976, J ECON ENTOMOL, V69, P487, DOI 10.1093/jee/69.4.487; Hoch G, 2004, ENTOMOL EXP APPL, V113, P77, DOI 10.1111/j.0013-8703.2004.00203.x; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Mendel Z, 2007, PHYTOPARASITICA, V35, P330, DOI 10.1007/BF02980694; Moreira MD, 2009, NEOTROP ENTOMOL, V38, P237, DOI 10.1590/S1519-566X2009000200011; Nalini M, 2009, PHYSIOL ENTOMOL, V34, P110, DOI 10.1111/j.1365-3032.2008.00657.x; Narayanan K, 2004, CURR SCI INDIA, V86, P800; Paron M. R., 2000, Scientia Agricola, V57, P355, DOI 10.1590/S0103-90162000000200025; Pech LL, 1996, J CELL SCI, V109, P2053; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pereira FF, 2008, PHYTOPARASITICA, V36, P304, DOI 10.1007/BF02980777; Pereira FF, 2009, BRAZ J BIOL, V69, P865, DOI 10.1590/S1519-69842009000400014; Pereira FF, 2009, NEOTROP ENTOMOL, V38, P660, DOI 10.1590/S1519-566X2009000500016; Pereira FF, 2008, BRAZ ARCH BIOL TECHN, V51, P259, DOI 10.1590/S1516-89132008000200004; Pereira FF, 2004, NEOTROP ENTOMOL, V33, P231, DOI 10.1590/S1519-566X2004000200014; Pratissoli D, 2005, BRAZ ARCH BIOL TECHN, V48, P523, DOI 10.1590/S1516-89132005000500003; Pratissoli D, 2009, REV BRAS ENTOMOL, V53, P151, DOI 10.1590/S0085-56262009000100032; Rantala MJ, 2007, HEREDITY, V98, P329, DOI 10.1038/sj.hdy.6800945; Rantala MJ, 2004, BEHAV ECOL, V15, P187, DOI 10.1093/beheco/arg103; Reed DA, 2007, BIOL CONTROL, V41, P214, DOI 10.1016/j.biocontrol.2007.01.010; Renault S, 2002, J INSECT PHYSIOL, V48, P297, DOI 10.1016/S0022-1910(01)00174-3; Ribeiro C, 2006, J INSECT PHYSIOL, V52, P417, DOI 10.1016/j.jinsphys.2006.01.005; Richards EH, 2000, COMP BIOCHEM PHYS B, V127, P289, DOI 10.1016/S0305-0491(00)00255-8; Shelby KS, 1999, J INSECT PHYSIOL, V45, P507, DOI 10.1016/S0022-1910(98)00144-9; Silva-Torres CSA, 2009, ENTOMOL EXP APPL, V133, P65, DOI 10.1111/j.1570-7458.2009.00903.x; Soares MA, 2009, REV COLOMB ENTOMOL, V35, P62; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Strand MR, 2008, INSECT SCI, V15, P1, DOI 10.1111/j.1744-7917.2008.00183.x; STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335; Suzuki M, 2007, J INSECT PHYSIOL, V53, P1072, DOI 10.1016/j.jinsphys.2007.06.006; Tena A, 2008, ANIM BEHAV, V76, P789, DOI 10.1016/j.anbehav.2008.05.007; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Uckan F, 2004, ANN ENTOMOL SOC AM, V97, P775, DOI 10.1603/0013-8746(2004)097[0775:DOVCFT]2.0.CO;2; VANALPHEN JJM, 1990, ANNU REV ENTOMOL, V35, P59, DOI 10.1146/annurev.en.35.010190.000423; Wu ML, 2008, J INVERTEBR PATHOL, V99, P186, DOI 10.1016/j.jip.2008.07.005; Yamamoto D, 2007, ECOL ENTOMOL, V32, P221; Zanuncio JC, 2008, COLEOPTS BULL, V62, P64, DOI 10.1649/1015.1	49	26	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13231	10.1371/journal.pone.0013231	http://dx.doi.org/10.1371/journal.pone.0013231			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20975929	Green Published, gold			2022-12-27	WOS:000282869800007
J	Deloumeau, A; Bayard, S; Coquerel, Q; Dechelotte, P; Bole-Feysot, C; Carlander, B; De Cock, VC; Fetissov, SO; Dauvilliers, Y				Deloumeau, Aude; Bayard, Sophie; Coquerel, Quentin; Dechelotte, Pierre; Bole-Feysot, Christine; Carlander, Bertrand; De Cock, Valerie Cochen; Fetissov, Serguei O.; Dauvilliers, Yves			Increased Immune Complexes of Hypocretin Autoantibodies in Narcolepsy	PLOS ONE			English	Article							OREXIN; NEUROPEPTIDES; ANTIBODIES; MUTATION; ONSET	Background: Hypocretin peptides participate in the regulation of sleep-wake cycle while deficiency in hypocretin signaling and loss of hypocretin neurons are causative for narcolepsy-cataplexy. However, the mechanism responsible for alteration of the hypocretin system in narcolepsy-cataplexy and its relevance to other central hypersomnias remain unknown. Here we studied whether central hypersomnias can be associated with autoantibodies reacting with hypocretin-1 peptide present as immune complexes. Methodology: Serum levels of free and dissociated (total) autoantibodies reacting with hypocretin-1 peptide were measured by enzyme-linked immunosorbent assay and analyzed with regard to clinical parameters in 82 subjects with narcolepsy-cataplexy, narcolepsy without cataplexy or idiopathic hypersomnia and were compared to 25 healthy controls. Principal Findings: Serum levels of total but not free IgG autoantibodies against hypocretin-1 were increased in narcolepsy-cataplexy. Increased levels of complexed IgG autoantibodies against hypocretin-1 were found in all patients groups with a further increase in narcolepsy-cataplexy. Levels of total IgM hypocretin-1 autoantibodies were also elevated in all groups of patients. Increased levels of anti-idiotypic IgM autoantibodies reacting with hypocretin-1 IgG autoantibodies affinity purified from sera of subjects with narcolepsy-cataplexy were found in all three groups of patients. Disease duration correlated negatively with serum levels of hypocretin-1 IgG and IgM autoantibodies and with anti-idiotypic IgM autoantibodies. Conclusion: Central hypersomnias and particularly narcolepsy-cataplexy are characterized by higher serum levels of autoantibodies directed against hypocretin-1 which are present as immune complexes most likely with anti-idiotypic autoantibodies suggesting their relevance to the mechanism of sleep-wake cycle regulation.	[Deloumeau, Aude; Coquerel, Quentin; Dechelotte, Pierre; Bole-Feysot, Christine; Fetissov, Serguei O.] Univ Rouen, Digest Syst & Nutr Lab ADEN EA 4311, Rouen Inst Med Res & Innovat, Federat Inst Peptide Res IFR23, Rouen, France; [Bayard, Sophie; Carlander, Bertrand; De Cock, Valerie Cochen; Dauvilliers, Yves] Montpellier Univ Hosp Gui de Chauliac, Dept Neurol, Natl Reference Network Narcolepsy, Montpellier, France; [Bayard, Sophie; Dauvilliers, Yves] INSERM, U888, Montpellier, France	Universite de Rouen Normandie; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier	Deloumeau, A (corresponding author), Univ Rouen, Digest Syst & Nutr Lab ADEN EA 4311, Rouen Inst Med Res & Innovat, Federat Inst Peptide Res IFR23, Rouen, France.	Serguei.Fetissov@univ-rouen.fr; ydauvilliers@yahoo.fr	Fetissov, Sergueï O/H-6023-2016	Fetissov, Sergueï O/0000-0002-2491-4945; Bayard, Sophie/0000-0003-0767-4924; Dauvilliers, yves/0000-0003-0683-6506	NARSAD: The Mental Health Research Association, USA	NARSAD: The Mental Health Research Association, USA(NARSAD)	S.F. was supported by NARSAD: The Mental Health Research Association, USA, 2007 Independent Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; Aran A, 2009, SLEEP, V32, P979, DOI 10.1093/sleep/32.8.979; AVRAMEAS S, 1991, IMMUNOL TODAY, V12, P154; Black JL, 2005, SLEEP, V28, P427, DOI 10.1093/sleep/28.4.427; CARSKADON MA, 1986, SLEEP, V9, P519, DOI 10.1093/sleep/9.4.519; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cvetkovic-Lopes V, 2010, J CLIN INVEST, V120, P713, DOI 10.1172/JCI41366; Dauvilliers Y, 2003, J NEUROL NEUROSUR PS, V74, P1667, DOI 10.1136/jnnp.74.12.1667; Dauvilliers Y, 2009, NEUROLOGY, V73, P1333, DOI 10.1212/WNL.0b013e3181bd1344; Dauvilliers Y, 2001, NEUROLOGY, V57, P2029, DOI 10.1212/WNL.57.11.2029; Dauvilliers Y, 2007, LANCET, V369, P499, DOI 10.1016/S0140-6736(07)60237-2; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DOGAN I, 2009, NAT IMMUNOL ADV; Fetissov SO, 2008, NUTRITION, V24, P348, DOI 10.1016/j.nut.2007.12.006; GRABAR P, 1975, CLIN IMMUNOL IMMUNOP, V4, P453, DOI 10.1016/0090-1229(75)90087-2; HALLMAYER J, 2009, NAT GENET; Higuchi S, 2002, NEUROSCI LETT, V318, P61, DOI 10.1016/S0304-3940(01)02476-4; Jackson MW, 2008, J NEUROSCI, V28, P13303, DOI 10.1523/JNEUROSCI.4489-08.2008; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Nishino Seiji, 2002, Sleep Med, V3, P377, DOI 10.1016/S1389-9457(02)00078-3; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Overeem S, 2008, SLEEP MED REV, V12, P95, DOI 10.1016/j.smrv.2007.07.010; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Ripley B, 2001, NEUROLOGY, V57, P2253, DOI 10.1212/WNL.57.12.2253; ROSSI F, 1989, IMMUNOL REV, V110, P135, DOI 10.1111/j.1600-065X.1989.tb00031.x; ROY BF, 1988, ANN NEUROL, V24, P57, DOI 10.1002/ana.410240111; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sinno MH, 2009, PSYCHONEUROENDOCRINO, V34, P140, DOI 10.1016/j.psyneuen.2008.08.021; Smith AJF, 2004, LANCET, V364, P2122, DOI 10.1016/S0140-6736(04)17553-3; Tafuri S, 2009, NEUROPEPTIDES, V43, P73, DOI 10.1016/j.npep.2009.01.003; Tanaka S, 2006, SLEEP, V29, P633, DOI 10.1093/sleep/29.5.633; Tanaka S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009555; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Thannickal TC, 2009, SLEEP, V32, P993, DOI 10.1093/sleep/32.8.993	36	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13320	10.1371/journal.pone.0013320	http://dx.doi.org/10.1371/journal.pone.0013320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967199	Green Published, gold			2022-12-27	WOS:000282869800022
J	Kadono, T; Tran, D; Errakhi, R; Hiramatsu, T; Meimoun, P; Briand, J; Iwaya-Inoue, M; Kawano, T; Bouteau, F				Kadono, Takashi; Tran, Daniel; Errakhi, Rafik; Hiramatsu, Takuya; Meimoun, Patrice; Briand, Joel; Iwaya-Inoue, Mari; Kawano, Tomonori; Bouteau, Francois			Increased Anion Channel Activity Is an Unavoidable Event in Ozone-Induced Programmed Cell Death	PLOS ONE			English	Article							VACUOLAR PROCESSING ENZYME; SALICYLIC-ACID SIGNAL; ARABIDOPSIS-THALIANA; PLASMA-MEMBRANE; ABSCISIC-ACID; OXIDATIVE BURST; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ETHYLENE SYNTHESIS; CYTOSOLIC CALCIUM; SUSPENSION CELLS	Background: Ozone is a major secondary air pollutant often reaching high concentrations in urban areas under strong daylight, high temperature and stagnant high-pressure systems. Ozone in the troposphere is a pollutant that is harmful to the plant. Principal Findings: By exposing cells to a strong pulse of ozonized air, an acute cell death was observed in suspension cells of Arabidopsis thaliana used as a model. We demonstrated that O-3 treatment induced the activation of a plasma membrane anion channel that is an early prerequisite of O-3-induced cell death in A. thaliana. Our data further suggest interplay of anion channel activation with well known plant responses to O-3, Ca2+ influx and NADPH-oxidase generated reactive oxygen species (ROS) in mediating the oxidative cell death. This interplay might be fuelled by several mechanisms in addition to the direct ROS generation by O-3; namely, H2O2 generation by salicylic and abscisic acids. Anion channel activation was also shown to promote the accumulation of transcripts encoding vacuolar processing enzymes, a family of proteases previously reported to contribute to the disruption of vacuole integrity observed during programmed cell death. Significance: Collectively, our data indicate that anion efflux is an early key component of morphological and biochemical events leading to O-3-induced programmed cell death. Because ion channels and more specifically anion channels assume a crucial position in cells, an understanding about the underlying role(s) for ion channels in the signalling pathway leading to programmed cell death is a subject that warrants future investigation.	[Kadono, Takashi; Tran, Daniel; Errakhi, Rafik; Meimoun, Patrice; Briand, Joel; Kawano, Tomonori; Bouteau, Francois] Univ Paris 07, Lab Electrophysiol Membranes, Inst Biol Plantes, Orsay, France; [Kadono, Takashi; Iwaya-Inoue, Mari] Kyushu Univ, Fac Agr, Higashi Ku, Fukuoka 812, Japan; [Hiramatsu, Takuya; Kawano, Tomonori; Bouteau, Francois] Univ Kitakyushu, Grad Sch Environm Engn, Wakamatsu Ku, Kitakyushu, Fukuoka, Japan	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Kyushu University; University of Kitakyushu	Kadono, T (corresponding author), Univ Paris 07, Lab Electrophysiol Membranes, Inst Biol Plantes, Bat 630, Orsay, France.	daniel.tran@univ-paris-diderot.fr	Tran, Daniel/AAD-9339-2019; Tran, Daniel/I-4422-2012; Kadono, Takashi/N-4561-2015	Tran, Daniel/0000-0002-5669-8618; Kadono, Takashi/0000-0003-1710-9216; Meimoun, Patrice/0000-0002-7027-6075; Kawano, Tomonori/0000-0002-6876-9399; Bouteau, francois/0000-0003-0243-338X	MESR (Ministere de l'Enseignement Superieur et de la Recherche); Japan Society for the Promotion of Science	MESR (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by MESR (Ministere de l'Enseignement Superieur et de la Recherche) to LEM. Takashi Kadono gratefully acknowledges the financial support from the Japan Society for the Promotion of Science (** http://www.jsps.go.jp/english/e-pd/pddc.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors R, 2009, PLANT J, V58, P1, DOI 10.1111/j.1365-313X.2008.03756.x; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; Baier M, 2005, PLANT CELL ENVIRON, V28, P1012, DOI 10.1111/j.1365-3040.2005.01326.x; Bortner CD, 2007, ARCH BIOCHEM BIOPHYS, V462, P176, DOI 10.1016/j.abb.2007.01.020; Bouizgarne B, 2006, MOL PLANT MICROBE IN, V19, P550, DOI 10.1094/MPMI-19-0550; Brault M, 2004, PLANT PHYSIOL, V135, P231, DOI 10.1104/pp.104.039255; Cessna SG, 2001, PLANTA, V214, P126, DOI 10.1007/s004250100596; Cho MH, 1996, P NATL ACAD SCI USA, V93, P8134, DOI 10.1073/pnas.93.15.8134; Clayton H, 1999, PLANT J, V17, P575, DOI 10.1046/j.1365-313X.1999.00411.x; Colcombet J, 2009, FUNCT PLANT BIOL, V36, P832, DOI 10.1071/FP09096; Dauphin A, 2001, PHYSIOL PLANTARUM, V113, P79, DOI 10.1034/j.1399-3054.2001.1130111.x; De Angeli A, 2007, FEBS LETT, V581, P2367, DOI 10.1016/j.febslet.2007.04.003; Errakhi R, 2008, J EXP BOT, V59, P4259, DOI 10.1093/jxb/ern267; Errakhi R, 2008, J EXP BOT, V59, P3121, DOI 10.1093/jxb/ern166; Evans NH, 2005, PLANT J, V41, P615, DOI 10.1111/j.1365-313X.2004.02325.x; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gauthier A, 2007, PLANT SIGNAL BEHAV, V2, P86, DOI 10.4161/psb.2.2.4015; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hara-Nishimura I, 2005, CURR OPIN PLANT BIOL, V8, P404, DOI 10.1016/j.pbi.2005.05.016; Hatsugai N, 2006, APOPTOSIS, V11, P905, DOI 10.1007/s10495-006-6601-1; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Haymes KM, 2004, J AGR FOOD CHEM, V52, P5456, DOI 10.1021/jf0497962; HEDRICH R, 1990, EMBO J, V9, P3889, DOI 10.1002/j.1460-2075.1990.tb07608.x; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; Kadono T, 2006, PLANT SIGNAL BEHAV, V1, P312, DOI 10.4161/psb.1.6.3518; Kangasjarvi J, 2005, PLANT CELL ENVIRON, V28, P1021, DOI 10.1111/j.1365-3040.2005.01325.x; KANGASJARVI J, 1994, PLANT CELL ENVIRON, V17, P783, DOI 10.1111/j.1365-3040.1994.tb00173.x; Kawano T, 2000, J EXP BOT, V51, P685, DOI 10.1093/jexbot/51.345.685; Kawano T, 2004, Z NATURFORSCH C, V59, P684; Kawano T, 1998, PLANT CELL PHYSIOL, V39, P721, DOI 10.1093/oxfordjournals.pcp.a029426; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kinoshita T, 1995, PLANT CELL PHYSIOL, V36, P1555; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Lam E, 2005, TRENDS CELL BIOL, V15, P124, DOI 10.1016/j.tcb.2005.01.001; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lamotte O, 2006, FREE RADICAL BIO MED, V40, P1369, DOI 10.1016/j.freeradbiomed.2005.12.006; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Liu RS, 2007, AM J PHYSIOL-RENAL, V292, pF1867, DOI 10.1152/ajprenal.00515.2006; Meimoun P, 2009, PLANT SIGNAL BEHAV, V4, P830, DOI 10.4161/psb.4.9.9396; Moeder W, 2002, PLANT PHYSIOL, V130, P1918, DOI 10.1104/pp.009712; MOORE R, 1984, Planta (Heidelberg), V162, P342, DOI 10.1007/BF00396746; NAKANO M, 1986, ANAL BIOCHEM, V159, P363, DOI 10.1016/0003-2697(86)90354-4; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Okada Y, 2006, J MEMBRANE BIOL, V209, P21, DOI 10.1007/s00232-005-0836-6; Overmyer K, 2000, PLANT CELL, V12, P1849, DOI 10.1105/tpc.12.10.1849; Overmyer K, 2005, PLANT PHYSIOL, V137, P1092, DOI 10.1104/pp.104.055681; Pasqualini S, 2003, PLANT PHYSIOL, V133, P1122, DOI 10.1104/pp.103.026591; Patel S, 2009, FREE RADICAL RES, V43, P514, DOI 10.1080/10715760902887276; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Pell EJ, 1997, PHYSIOL PLANTARUM, V100, P264, DOI 10.1034/j.1399-3054.1997.1000207.x; Rao MV, 2001, PLANTA, V213, P682, DOI 10.1007/s004250100618; Rao MV, 2000, PLANT MOL BIOL, V44, P345, DOI 10.1023/A:1026548726807; Reboutier D, 2005, PLANT PHYSIOL BIOCH, V43, P567, DOI 10.1016/j.plaphy.2005.03.003; Reboutier D, 2002, MOL PLANT MICROBE IN, V15, P932, DOI 10.1094/MPMI.2002.15.9.932; Reboutier D, 2007, J CELL SCI, V120, P3271, DOI 10.1242/jcs.011098; Reboutier D, 2008, PLANT SIGNAL BEHAV, V3, P314, DOI 10.4161/psb.3.5.5304; Roberts SK, 2006, NEW PHYTOL, V169, P647, DOI 10.1111/j.1469-8137.2006.01639.x; Roelfsema MRG, 2004, PLANT J, V37, P578, DOI 10.1111/j.1365-313X.2003.01985.x; Sandermann H, 1998, TRENDS PLANT SCI, V3, P47, DOI 10.1016/S1360-1385(97)01162-X; Sandermann H, 2008, BIOCHEM BIOPH RES CO, V366, P271, DOI 10.1016/j.bbrc.2007.12.018; Sano T, 2006, FEBS LETT, V580, P597, DOI 10.1016/j.febslet.2005.12.074; SATOH S, 1980, PLANT CELL PHYSIOL, V21, P939; SCHROEDER JI, 1992, P NATL ACAD SCI USA, V89, P5025, DOI 10.1073/pnas.89.11.5025; Sharma YK, 1997, FREE RADICAL BIO MED, V23, P480, DOI 10.1016/S0891-5849(97)00108-1; Tamaoki M, 2003, PLANTA, V216, P552, DOI 10.1007/s00425-002-0894-2; Tamaoki M, 2008, PLANT SIGNAL BEHAV, V3, P166, DOI 10.4161/psb.3.3.5538; Terta M, 2010, MOL PLANT MICROBE IN, V23, P139, DOI 10.1094/MPMI-23-2-0139; Torsethaugen G, 1999, P NATL ACAD SCI USA, V96, P13577, DOI 10.1073/pnas.96.23.13577; Trouverie J, 2008, PLANT CELL PHYSIOL, V49, P1495, DOI 10.1093/pcp/pcn126; Tuominen H, 2004, PLANT J, V39, P59, DOI 10.1111/j.1365-313X.2004.02107.x; Umemura K, 2009, PLANT J, V57, P463, DOI 10.1111/j.1365-313X.2008.03697.x; Vahala J, 2003, PLANT PHYSIOL, V132, P185, DOI 10.1104/pp.102.018887; VAHISALU T, 2010, PLANT J; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; van Doorn WG, 2005, TRENDS PLANT SCI, V10, P117, DOI 10.1016/j.tplants.2005.01.006; WARD JM, 1995, PLANT CELL, V7, P833, DOI 10.1105/tpc.7.7.833; Wendehenne D, 2002, PLANT CELL, V14, P1937, DOI 10.1105/tpc.002295; Wrzaczek M, 2009, P NATL ACAD SCI USA, V106, P5412, DOI 10.1073/pnas.0808980106; YOKAWA K, 2004, ITE LETT BATTER NEW, V5, P49; Yu SP, 2000, P NATL ACAD SCI USA, V97, P9360, DOI 10.1073/pnas.97.17.9360; YU YB, 1979, ARCH BIOCHEM BIOPHYS, V198, P280, DOI 10.1016/0003-9861(79)90420-X	82	39	43	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13373	10.1371/journal.pone.0013373	http://dx.doi.org/10.1371/journal.pone.0013373			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967217	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800045
J	Xiao, XD; Zhu, ZY; Dankmeyer, JL; Wormald, MM; Fast, RL; Worsham, PL; Cote, CK; Amemiya, K; Dimitrov, DS				Xiao, Xiaodong; Zhu, Zhongyu; Dankmeyer, Jennifer L.; Wormald, Michael M.; Fast, Randy L.; Worsham, Patricia L.; Cote, Christopher K.; Amemiya, Kei; Dimitrov, Dimiter S.			Human Anti-Plague Monoclonal Antibodies Protect Mice from Yersinia pestis in a Bubonic Plague Model	PLOS ONE			English	Article							V-ANTIGEN; PNEUMONIC PLAGUE; FUSION PROTEIN; VIRULENCE; F1; VACCINE; LCRV; RESISTANCE; INFECTION; IMMUNITY	Yersinia pestis is the etiologic agent of plague that has killed more than 200 million people throughout the recorded history of mankind. Antibiotics may provide little immediate relief to patients who have a high bacteremia or to patients infected with an antibiotic resistant strain of plague. Two virulent factors of Y. pestis are the capsid F1 protein and the low-calcium response (Lcr) V-protein or V-antigen that have been proven to be the targets for both active and passive immunization. There are mouse monoclonal antibodies (mAbs) against the F1- and V-antigens that can passively protect mice in a murine model of plague; however, there are no anti-Yersinia pestis monoclonal antibodies available for prophylactic or therapeutic treatment in humans. We identified one anti-F1-specific human mAb (m252) and two anti-V-specific human mAb (m253, m254) by panning a naive phage-displayed Fab library against the F1- and V-antigens. The Fabs were converted to IgG1s and their binding and protective activities were evaluated. M252 bound weakly to peptides located at the F1 N-terminus where a protective mouse anti-F1 mAb also binds. M253 bound strongly to a V-antigen peptide indicating a linear epitope; m254 did not bind to any peptide from a panel of 53 peptides suggesting that its epitope may be conformational. M252 showed better protection than m253 and m254 against a Y, pestis challenge in a plague mouse model. A synergistic effect was observed when the three antibodies were combined. Incomplete to complete protection was achieved when m252 was given at different times post-challenge. These antibodies can be further studied to determine their potential as therapeutics or prophylactics in Y. pestis infection in humans.	[Xiao, Xiaodong; Zhu, Zhongyu; Dimitrov, Dimiter S.] NCI, Prot Interact Grp, Ctr Canc Res Nanobiol Program, NIH, Frederick, MD 21701 USA; [Zhu, Zhongyu] NCI, BSP, Sci Applicat Int Corp Frederick Inc, Frederick, MD 21701 USA; [Dankmeyer, Jennifer L.; Wormald, Michael M.; Fast, Randy L.; Worsham, Patricia L.; Cote, Christopher K.; Amemiya, Kei] USA, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Xiao, XD (corresponding author), Medimmune LLC, Gaithersburg, MD USA.	kei.amemiya@us.army.mil; dimiter.dimitrov@nih.gov			National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research; National Cancer Institute, NIH [N01-CO-12400]; National Institute of Allergy and Infectious Diseases; Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA) [1.1A0018_07_RD_B]; SAIC-Frederick, Inc.; U.S. Government; NATIONAL CANCER INSTITUTE [ZIABC011156] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA)(United States Department of DefenseDefense Threat Reduction Agency); SAIC-Frederick, Inc.; U.S. Government; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research, by federal funds from the National Cancer Institute, NIH, under contract N01-CO-12400, by the National Institute of Allergy and Infectious Diseases Biodefense Program to Dimiter S. Dimitrov and agency Joint Science and Technology Office Defense Threat Reduction Agency (JUSTO/DTRA) proposal no. 1.1A0018_07_RD_B to Kei Amemiya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. SAIC-Frederick, Inc., as one of the funders of this study, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SAIC-Fredereick, Inc. is a wholly owned subsidiary of Science Applications International Corporation and operates exclusively under a single, long-term contract to the National Cancer Institute, part of the U.S. National Institutes of Health. All funding is derived from the U.S. Government. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albrecht MT, 2007, INFECT IMMUN, V75, P5425, DOI 10.1128/IAI.00261-07; Anderson GW, 1998, AM J TROP MED HYG, V58, P793, DOI 10.4269/ajtmh.1998.58.793; Anderson GW, 1996, INFECT IMMUN, V64, P4580, DOI 10.1128/IAI.64.11.4580-4585.1996; Anderson GW, 1997, AM J TROP MED HYG, V56, P471, DOI 10.4269/ajtmh.1997.56.471; [Anonymous], 2003, Wkly Epidemiol Rec, V78, P130; Broms JE, 2007, J BACTERIOL, V189, P8417, DOI 10.1128/JB.00936-07; Burton DR, 2001, PHAGE DISPLAY LAB MA, V1st; Casadevall A, 2002, EMERG INFECT DIS, V8, P833, DOI 10.3201/eid0808.010516; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Cowan C, 2005, INFECT IMMUN, V73, P6127, DOI 10.1128/IAI.73.9.6127-6137.2005; DiMezzo TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006281; DOLL JM, 1994, AM J TROP MED HYG, V51, P109, DOI 10.4269/ajtmh.1994.51.109; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Fields KA, 1999, INFECT IMMUN, V67, P4801, DOI 10.1128/IAI.67.9.4801-4813.1999; Galimand M, 1997, NEW ENGL J MED, V337, P677, DOI 10.1056/NEJM199709043371004; Heath DG, 1998, VACCINE, V16, P1131, DOI 10.1016/S0264-410X(98)80110-2; Hill J, 2003, INFECT IMMUN, V71, P2234, DOI 10.1128/IAI.71.4.2234-2238.2003; Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997; Hwang WYK, 2005, METHODS, V36, P3, DOI 10.1016/j.ymeth.2005.01.001; LAWTON WD, 1963, J IMMUNOL, V91, P179; Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476; Park JW, 2001, ADV PROTEIN CHEM, V56, P369; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x; Powell BS, 2005, BIOTECHNOL PROGR, V21, P1490, DOI 10.1021/bp050098r; Titball RW, 2004, EXPERT OPIN BIOL TH, V4, P965, DOI 10.1517/14712598.4.6.965; TURNER A, 2001, IMMUNOLOGY, P65; Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Welkos SL, 1995, CONTRIB TO MICROBIOL, V13, P299; Williamson ED, 1999, CLIN EXP IMMUNOL, V116, P107; Williamson ED, 2005, INFECT IMMUN, V73, P3598, DOI 10.1128/IAI.73.6.3598-3608.2005; WILLIAMSON ED, 1995, FEMS IMMUNOL MED MIC, V12, P223, DOI 10.1111/j.1574-695X.1995.tb00196.x; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Xiao Xiaodong, 2007, Recent Pat Antiinfect Drug Discov, V2, P171, DOI 10.2174/157489107782497272; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104; Zilinskas RA, 2006, CRIT REV MICROBIOL, V32, P47, DOI 10.1080/10408410500496896	37	23	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13047	10.1371/journal.pone.0013047	http://dx.doi.org/10.1371/journal.pone.0013047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20976274	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800002
J	Certel, SJ; Leung, A; Lin, CY; Perez, P; Chiang, AS; Kravitz, EA				Certel, Sarah J.; Leung, Adelaine; Lin, Chih-Yung; Perez, Philip; Chiang, Ann-Shyn; Kravitz, Edward A.			Octopamine Neuromodulatory Effects on a Social Behavior Decision-Making Network in Drosophila Males	PLOS ONE			English	Article							MALE COURTSHIP BEHAVIOR; LOCUS-COERULEUS; NEURAL CIRCUITRY; CEREBRAL-CORTEX; MUSHROOM BODY; FRUIT-FLY; NEURONS; MELANOGASTER; BRAIN; MODULATION	Situations requiring rapid decision-making in response to dynamic environmental demands occur repeatedly in natural environments. Neuromodulation can offer important flexibility to the output of neural networks in coping with changing conditions, but the contribution of individual neuromodulatory neurons in social behavior networks remains relatively unknown. Here we manipulate the Drosophila octopaminergic system and assay changes in adult male decision-making in courtship and aggression paradigms. When the functional state of OA neural circuits is enhanced, males exhibit elevated courtship behavior towards other males in both behavioral contexts. Eliminating the expression of the male form of the neural sex determination factor, Fruitless (Fru(M)), in three OA suboesophageal ganglia (SOG) neurons also leads to increased male-male courtship behavior in these same contexts. We analyzed the fine anatomical structure through confocal examination of labeled single neurons to determine the arborization patterns of each of the three Fru(M)-positive OA SOG neurons. These neurons send processes that display mirror symmetric, widely distributed arbors of endings within brain regions including the ventrolateral protocerebra, the SOG and the peri-esophageal complex. The results suggest that a small subset of OA neurons have the potential to provide male selective modulation of behavior at a single neuron level.	[Certel, Sarah J.; Leung, Adelaine; Perez, Philip; Kravitz, Edward A.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Chiang, Ann-Shyn] Natl Tsing Hua Univ, Brain Res Ctr, Hsinchu, Taiwan; [Certel, Sarah J.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Lin, Chih-Yung; Chiang, Ann-Shyn] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	Harvard University; Harvard Medical School; National Tsing Hua University; University of Montana System; University of Montana; National Tsing Hua University	Certel, SJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	sarah.certel@umontana.edu	Leung, Adelaine/F-4132-2011; Leung, Adelaine/AAV-3357-2021	Leung, Adelaine/0000-0002-2849-4474; 	National Institute of General Medical Sciences [GM-067645, GM-074675]; National Institutes of Health Center of Biomedical Research Excellence [P20RR015583]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015583] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067645, R01GM074675] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health Center of Biomedical Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants (http://www.nigms.nih.gov/; GM-067645; GM-074675) from the National Institute of General Medical Sciences to EAK and a National Institutes of Health Center of Biomedical Research Excellence grant P20RR015583 to SJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Balaban P M, 2008, Neurosci Behav Physiol, V38, P453, DOI 10.1007/s11055-008-9002-9; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; BEAUDET A, 1981, J PHYSIOLOGY PARIS, V77, P193; BEAUDET A, 1978, NEUROSCIENCE, V3, P851, DOI 10.1016/0306-4522(78)90115-X; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Briggman KL, 2008, ANNU REV NEUROSCI, V31, P271, DOI 10.1146/annurev.neuro.31.060407.125552; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Chen J, 2009, J COMP NEUROL, V515, P441, DOI 10.1002/cne.22088; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Chiang AS, 2001, J COMP NEUROL, V440, P1, DOI 10.1002/cne.1365; Cholewa J, 2009, ZOOLOGY, V112, P251, DOI 10.1016/j.zool.2008.10.004; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Dacks AM, 2005, J COMP NEUROL, V488, P255, DOI 10.1002/cne.20556; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Dierick HA, 2007, NAT PROTOC, V2, P2712, DOI 10.1038/nprot.2007.404; Doernberg SB, 2001, J COMP PHYSIOL A, V187, P91, DOI 10.1007/s003590000178; DOW MA, 1975, NATURE, V254, P511, DOI 10.1038/254511a0; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Eckhoff P, 2009, J NEUROSCI, V29, P4301, DOI 10.1523/JNEUROSCI.5024-08.2009; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Evans Peter D., 2005, Invertebrate Neuroscience, V5, P111, DOI 10.1007/s10158-005-0001-z; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gaudry Q, 2009, NAT NEUROSCI, V12, P1450, DOI 10.1038/nn.2400; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HASSELMO ME, 1995, BEHAV BRAIN RES, V67, P1, DOI 10.1016/0166-4328(94)00113-T; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Homberg U, 2004, NATURWISSENSCHAFTEN, V91, P199, DOI 10.1007/s00114-004-0525-9; HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Jones NG, 2003, CURR BIOL, V13, P1064, DOI 10.1016/S0960-9822(03)00380-4; KANZAKI R, 1992, BRAIN RES, V587, P211, DOI 10.1016/0006-8993(92)90999-P; Kim YC, 2007, GENES BRAIN BEHAV, V6, P201, DOI 10.1111/j.1601-183X.2006.00241.x; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Kononenko NL, 2007, CELL TISSUE RES, V330, P179, DOI 10.1007/s00441-007-0425-3; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Kristan WB, 2008, CURR BIOL, V18, pR928, DOI 10.1016/j.cub.2008.07.081; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Langer SZ, 2008, NEUROCHEM INT, V52, P26, DOI 10.1016/j.neuint.2007.04.031; Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006; MAEDA T, 1991, COMP BIOCHEM PHYS C, V98, P193, DOI 10.1016/0742-8413(91)90195-Y; MAEDA T, 1972, BRAIN RES, V36, P19, DOI 10.1016/0006-8993(72)90763-9; Maeda T, 2000, J CHEM NEUROANAT, V18, P57, DOI 10.1016/S0891-0618(99)00051-4; Manoli DS, 2006, TRENDS NEUROSCI, V29, P444, DOI 10.1016/j.tins.2006.06.006; Manoli DS, 2004, NATURE, V430, P564, DOI 10.1038/nature02713; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Middleton CA, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-17; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Monastirioti M, 1996, J NEUROSCI, V16, P3900; MONASTIRIOTI M, 1995, J COMP NEUROL, V356, P275, DOI 10.1002/cne.903560210; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Nadim F, 2008, J NEUROSCI, V28, P11806, DOI 10.1523/JNEUROSCI.3796-08.2008; Otsuna H, 2006, J COMP NEUROL, V497, P928, DOI 10.1002/cne.21015; PARNAVELAS JG, 1989, TRENDS NEUROSCI, V12, P315, DOI 10.1016/0166-2236(89)90037-4; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Rodriguez-Valentin R, 2006, J CELL PHYSIOL, V209, P183, DOI 10.1002/jcp.20722; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Shea-Brown E, 2008, NEURAL COMPUT, V20, P2863, DOI 10.1162/neco.2008.03-07-487; Sinakevitch I, 2006, J COMP NEUROL, V494, P460, DOI 10.1002/cne.20799; Siwicki KK, 2009, CURR OPIN NEUROBIOL, V19, P200, DOI 10.1016/j.conb.2009.04.001; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Tomchik SM, 2009, NEURON, V64, P510, DOI 10.1016/j.neuron.2009.09.029; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; WELBERGEN P, 1987, BEHAVIOUR, V101, P253, DOI 10.1163/156853987X00017; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Yu AJ, 2005, NEURON, V46, P681, DOI 10.1016/j.neuron.2005.04.026; Yurkovic A, 2006, P NATL ACAD SCI USA, V103, P17519, DOI 10.1073/pnas.0608211103; ZHOU C, 2008, NAT NEUROSCI	87	59	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13248	10.1371/journal.pone.0013248	http://dx.doi.org/10.1371/journal.pone.0013248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967276	gold, Green Submitted, Green Published			2022-12-27	WOS:000282807300006
J	Martin, C; Chen, SB; Heilos, D; Sauer, G; Hunt, J; Shaw, AG; Sims, PFG; Jackson, DA; Lovric, J				Martin, Catherine; Chen, Songbi; Heilos, Daniela; Sauer, Guido; Hunt, Jessica; Shaw, Alexander George; Sims, Paul Francis George; Jackson, Dean Andrew; Lovric, Josip			Changed Genome Heterochromatinization Upon Prolonged Activation of the Raf/ERK Signaling Pathway	PLOS ONE			English	Article							NONHISTONE CHROMOSOMAL-PROTEIN; CELL-CYCLE ARREST; TELOMERE LENGTH; GROWTH ARREST; HISTONE H3; REGULATED KINASE; STEM-CELLS; IN-VITRO; LYSINE 9; HP1	The Raf/ERK (Extracellular Signal Regulated Kinase) signal transduction pathway controls numerous cellular processes, including growth, differentiation, cellular transformation and senescence. ERK activation is thought to involve complex spatial and temporal regulation, to achieve a high degree of specificity, though precisely how this is achieved remains to be confirmed. We report here that prolonged activation of a conditional form of c-Raf-1 (BXB-ER) leads to profound changes in the level and distribution of a heterochromatic histone mark. In mouse fibroblasts, the heterochromatic trimethylation of lysine 9 in histone H3 (H3K9Me3) is normally confined to pericentromeric regions. However, following ERK activation a genome-wide redistribution of H3K9Me3 correlates with loss of the histone modification from chromocentres and the appearance of numerous punctuate sites throughout the interphase nucleus. These epigenetic changes during interphase correlate with altered chromosome structure during mitosis, where robust H3K9Me3 signals appear within telomeric heterochromatin. This pattern of heterochromatinization is distinct from previously described oncogene induced senescence associated heterochromatin foci (SAHF), which are excluded from telomeres. The H3K9Me3 histone mark is known to bind the major heterochromatin protein HP1 and we show that the alterations in the distribution of this histone epistate correlate with redistribution of HP1 beta throughout the nucleus. Interestingly while ERK activation is fully reversible, the observed chromatin changes induced by epigenetic modifications are not reversible once established. We describe for the first time a link from prolonged ERK activation to stable changes in genome organization through redistribution of heterochromatic domains involving the telomeres. These epigenetic changes provide a possible mechanism through which prolonged activation of Raf/ERK can lead to growth arrest or the induction of differentiation, senescence and cancer.	[Martin, Catherine; Heilos, Daniela; Hunt, Jessica; Shaw, Alexander George; Sims, Paul Francis George; Jackson, Dean Andrew; Lovric, Josip] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Chen, Songbi] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Hainan, Peoples R China; [Sauer, Guido] Max Planck Inst Dev Biol, Tubingen, Germany	University of Manchester; Chinese Academy of Tropical Agricultural Sciences; Max Planck Society	Martin, C (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England.	Josip.Lovric@manchester.ac.uk	Hunt, Jessica/GRO-4060-2022; Shaw, Alex/GWC-7464-2022	Shaw, Alex/0000-0002-3166-872X; Lovric, Josip/0000-0002-0338-6581; Lupinek, Daniela/0000-0001-5749-9701	Biotechnology and Biological Science Research Council, UK [D00327X]; PFGS; BBSRC [BB/D00327X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D00327X/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); PFGS; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Biotechnology and Biological Science Research Council, UK, project Grant D00327X to DJ, JL and PFGS. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Ayoub N, 2008, NATURE, V453, P682, DOI 10.1038/nature06875; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Blasco MA, 2005, EMBO J, V24, P1095, DOI 10.1038/sj.emboj.7600598; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Cerda MC, 1999, BIOL CELL, V91, P55, DOI 10.1016/S0248-4900(99)80031-8; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Courtois-Cox S, 2008, ONCOGENE, V27, P2801, DOI 10.1038/sj.onc.1210950; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Evan GI, 2009, CURR OPIN GENET DEV, V19, P25, DOI 10.1016/j.gde.2008.11.009; Fanton CP, 2001, J BIOL CHEM, V276, P18871, DOI 10.1074/jbc.M011514200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gilson E, 2007, CELL CYCLE, V6, P2486, DOI 10.4161/cc.6.20.4798; Gorelik G, 2009, AUTOIMMUN REV, V8, P196, DOI 10.1016/j.autrev.2008.07.043; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; HARLEY CB, 2008, NAT REV CANCER, V67, P179; Herbig U, 2006, MECH AGEING DEV, V127, P16, DOI 10.1016/j.mad.2005.09.002; Hingorani SR, 2003, CANCER RES, V63, P5198; Hiragami K, 2005, CELL MOL LIFE SCI, V62, P2711, DOI 10.1007/s00018-005-5287-9; Houben R, 2009, J INVEST DERMATOL, V129, P406, DOI 10.1038/jid.2008.214; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; JAMES TC, 1986, MOL CELL BIOL, V6, P3862, DOI 10.1128/MCB.6.11.3862; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kappei D, 2008, MECH AGEING DEV, V129, P17, DOI 10.1016/j.mad.2007.10.009; Koike N, 2000, FEBS LETT, V467, P17, DOI 10.1016/S0014-5793(00)01105-4; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; LINDARDOPOULOS S, 1995, CANCER RES, V55, P5168; Lovric J, 1998, J BIOL CHEM, V273, P22848; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Martin C, 2009, J CELL SCI, V122, P1551, DOI 10.1242/jcs.046284; Mayr C, 2003, CHROMOSOME RES, V11, P471, DOI 10.1023/A:1024978711705; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meehan RR, 2003, EMBO J, V22, P3164, DOI 10.1093/emboj/cdg306; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Minc E., 2001, Methods in Cell Science, V23, P171, DOI 10.1023/A:1013168323754; Muchardt C, 2002, EMBO REP, V3, P975, DOI 10.1093/embo-reports/kvf194; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; NIAULT T, 2010, CARCINOGENESIS; Nittis T, 2008, BIOCHIMIE, V90, P5, DOI 10.1016/j.biochi.2007.08.009; O'Connor MS, 2009, BIOTECHNOL PROGR, V25, P1130, DOI 10.1002/btpr.223; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Olsen CL, 2002, ONCOGENE, V21, P6328, DOI 10.1038/sj.onc.1205780; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Probst AV, 2008, DIFFERENTIATION, V76, P15, DOI 10.1111/j.1432-0436.2007.00220.x; QUELLE DE, 1995, ONCOGENE, V11, P635; Ravi RK, 1999, J CELL BIOCHEM, V72, P458, DOI 10.1002/(SICI)1097-4644(19990315)72:4<458::AID-JCB2>3.0.CO;2-C; Schreck R, 2006, INT J CANCER, V119, P2261, DOI 10.1002/ijc.22144; Schubeler D, 2000, GENE DEV, V14, P940; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Sumimoto H, 2006, J EXP MED, V203, P1651, DOI 10.1084/jem.20051848; Teller K, 2007, P NATL ACAD SCI USA, V104, P14970, DOI 10.1073/pnas.0704285104; Tombes RM, 1998, BIOCHEM J, V330, P1451; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Weng NP, 2001, J LEUKOCYTE BIOL, V70, P861; Woods D, 1997, MOL CELL BIOL, V17, P5598, DOI 10.1128/MCB.17.9.5598; Ye XF, 2007, MOL CELL BIOL, V27, P2452, DOI 10.1128/MCB.01592-06; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang RG, 2007, CELL CYCLE, V6, P784, DOI 10.4161/cc.6.7.4079; Zhao T, 2001, J BIOL CHEM, V276, P9512, DOI 10.1074/jbc.M010098200; Zhu JY, 1998, GENE DEV, V12, P2997, DOI 10.1101/gad.12.19.2997	77	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13322	10.1371/journal.pone.0013322	http://dx.doi.org/10.1371/journal.pone.0013322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967285	Green Published, Green Submitted, gold			2022-12-27	WOS:000282807300024
J	Galardi-Castilla, M; Garciandia, A; Suarez, T; Sastre, L				Galardi-Castilla, Maria; Garciandia, Ane; Suarez, Teresa; Sastre, Leandro			The Dictyostelium discoideum acaA Gene Is Transcribed from Alternative Promoters during Aggregation and Multicellular Development	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; NUCLEOTIDE PHOSPHODIESTERASE GENE; STALK CELL-DIFFERENTIATION; ADENYLYL-CYCLASE ACA; DNA-BINDING FACTOR; SOCIAL AMEBAS; PRESPORE DIFFERENTIATION; EXTRACELLULAR CAMP; MESSENGER-RNAS; CYCLIC-AMP	Background: Extracellular cAMP is a key extracellular signaling molecule that regulates aggregation, cell differentiation and morphogenesis during multi-cellular development of the social amoeba Dictyostelium discoideum. This molecule is produced by three different adenylyl cyclases, encoded by the genes acaA, acrA and acgA, expressed at different stages of development and in different structures. Methodology/Principal Findings: This article describes the characterization of the promoter region of the acaA gene, showing that it is transcribed from three different alternative promoters. The distal promoter, promoter 1, is active during the aggregation process while the more proximal promoters are active in tip-organiser and posterior regions of the structures. A DNA fragment containing the three promoters drove expression to these same regions and similar results were obtained by in situ hybridization. Analyses of mRNA expression by quantitative RT-PCR with specific primers for each of the three transcripts also demonstrated their different temporal patterns of expression. Conclusions/Significance: The existence of an aggregation-specific promoter can be associated with the use of cAMP as chemo-attractant molecule, which is specific for some Dictyostelium species. Expression at late developmental stages indicates that adenylyl cyclase A might play a more important role in post-aggregative development than previously considered.	[Galardi-Castilla, Maria; Sastre, Leandro] Univ Autonoma Madrid, CSIC, Inst Invest Biomed, Madrid, Spain; [Garciandia, Ane; Suarez, Teresa] CSIC, Ctr Invest Biol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Galardi-Castilla, M (corresponding author), Univ Autonoma Madrid, CSIC, Inst Invest Biomed, Madrid, Spain.	lsastre@iib.uam.es	Galardi-Castilla, María/L-6439-2014; Suarez, Teresa/M-9126-2016	Galardi-Castilla, María/0000-0003-2455-6671; Suarez, Teresa/0000-0002-4553-3818; Sastre, Leandro/0000-0003-3613-5938	Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion) [BFU2008-02249, SAF2007-66175-C02-01]; Consejo Superior de Investigaciones Cientificas	Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejo Superior de Investigaciones Cientificas	The study was funded by the Spanish Secretary of Science and Innovation (Ministerio de Ciencia e Innovacion) through grants BFU2008-02249 and SAF2007-66175-C02-01. MG-C and AG were supported by JAE predoctoral fellowships from the Consejo Superior de Investigaciones Cientificas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2005, P NATL ACAD SCI USA, V102, P6385, DOI 10.1073/pnas.0502238102; Alvarez-Curto E, 2007, DEVELOPMENT, V134, P959, DOI 10.1242/dev.02775; Anjard C, 1998, DEVELOPMENT, V125, P4067; ANNESLEY SJ, 2009, MOL CELL BI IN PRESS; BARKLIS E, 1983, CELL, V32, P1139, DOI 10.1016/0092-8674(83)90297-0; BERKS M, 1988, DEV BIOL, V126, P108, DOI 10.1016/0012-1606(88)90244-8; BERKS M, 1990, DEVELOPMENT, V110, P977; Chisholm RL, 2004, NAT REV MOL CELL BIO, V5, P531, DOI 10.1038/nrm1427; DETTERBECK S, 1994, DEVELOPMENT, V120, P2847; Dormann D, 2000, PHILOS T R SOC B, V355, P983, DOI 10.1098/rstb.2000.0634; Escalante R, 2001, DEV BIOL, V235, P314, DOI 10.1006/dbio.2001.0303; Escalante R, 2006, DICTYOSTELIUM DISCOI, P230; ESCH RK, 1991, GENE DEV, V5, P9, DOI 10.1101/gad.5.1.9; FAURE M, 1990, MOL CELL BIOL, V10, P1921, DOI 10.1128/MCB.10.5.1921; Fukuzawa M, 2000, DEVELOPMENT, V127, P2705; Galardi-Castilla M, 2008, DEV BIOL, V316, P260, DOI 10.1016/j.ydbio.2008.01.026; HARWOOD AJ, 1992, CELL, V69, P615, DOI 10.1016/0092-8674(92)90225-2; HOPPER NA, 1993, DEVELOPMENT, V119, P147; Jin T, 2006, EUR J CELL BIOL, V85, P905, DOI 10.1016/j.ejcb.2006.04.008; Kim HJ, 1998, J BIOL CHEM, V273, P30859, DOI 10.1074/jbc.273.47.30859; KONIJN TM, 1967, P NATL ACAD SCI USA, V58, P1152, DOI 10.1073/pnas.58.3.1152; Kriebel PW, 2004, IUBMB LIFE, V56, P541, DOI 10.1080/15216540400013887; LOUIS JM, 1993, P NATL ACAD SCI USA, V90, P5969, DOI 10.1073/pnas.90.13.5969; Maeda M, 2004, SCIENCE, V304, P875, DOI 10.1126/science.1094647; MANN SKO, 1993, DEVELOPMENT, V119, P135; MEHDY MC, 1983, CELL, V32, P763, DOI 10.1016/0092-8674(83)90062-4; Pang KM, 1999, PLASMID, V41, P187, DOI 10.1006/plas.1999.1391; PARENT CA, 1995, J BIOL CHEM, V270, P22693, DOI 10.1074/jbc.270.39.22693; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; PITT GS, 1993, GENE DEV, V7, P2172, DOI 10.1101/gad.7.11.2172; PODGORSKI GJ, 1989, MOL CELL BIOL, V9, P3938, DOI 10.1128/MCB.9.9.3938; RAPER KENNETH B., 1940, JOUR ELISHA MITCHELL SCI SOC, V56, P241; Ritchie AV, 2008, MOL BIOL EVOL, V25, P2109, DOI 10.1093/molbev/msn156; Saran S, 2002, J MUSCLE RES CELL M, V23, P793, DOI 10.1023/A:1024483829878; Schaap P, 2007, BIOESSAYS, V29, P635, DOI 10.1002/bies.20599; Schaap P, 2006, SCIENCE, V314, P661, DOI 10.1126/science.1130670; Schilde C, 2004, DEVELOPMENT, V131, P4555, DOI 10.1242/dev.01330; SCHULKES C, 1995, FEBS LETT, V368, P381, DOI 10.1016/0014-5793(95)00676-Z; SHAULSKY G, 1993, DEV BIOL, V160, P85, DOI 10.1006/dbio.1993.1288; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; SIEGERT F, 1995, CURR BIOL, V5, P937, DOI 10.1016/S0960-9822(95)00184-9; Siol O, 2006, EUKARYOT CELL, V5, P658, DOI 10.1128/EC.5.4.658-664.2006; SMITH E, 1980, J EMBRYOL EXP MORPH, V57, P233; Soderbom F, 1999, DEVELOPMENT, V126, P5463; vanEs S, 1996, J BIOL CHEM, V271, P23623, DOI 10.1074/jbc.271.39.23623; Verkerke-van Wijk I, 2001, DEV BIOL, V234, P151, DOI 10.1006/dbio.2001.0232; Wang B, 1999, DEV BIOL, V208, P1, DOI 10.1006/dbio.1998.9193; Wang HY, 2010, INT J DEV BIOL, V54, P161, DOI 10.1387/ijdb.082723hw; Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006; Williams JG, 2006, EMBO REP, V7, P694, DOI 10.1038/sj.embor.7400714; Winckler T, 2004, EUKARYOT CELL, V3, P1349, DOI 10.1128/EC.3.5.1349-1358.2004	51	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13286	10.1371/journal.pone.0013286	http://dx.doi.org/10.1371/journal.pone.0013286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949015	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100020
J	Hentschke, M; Berneking, L; Campos, CB; Buck, F; Ruckdeschel, K; Aepfelbacher, M				Hentschke, Moritz; Berneking, Laura; Campos, Cristina Belmar; Buck, Friedrich; Ruckdeschel, Klaus; Aepfelbacher, Martin			Yersinia Virulence Factor YopM Induces Sustained RSK Activation by Interfering with Dephosphorylation	PLOS ONE			English	Article							RIBOSOMAL S6 KINASE; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; HUMAN CYTOMEGALOVIRUS-INFECTION; SARCOMA-ASSOCIATED HERPESVIRUS; COFFIN-LOWRY-SYNDROME; PESTIS YOPM; MOTIF PHOSPHORYLATION; RECOMBINANT PROTEINS; EFFECTOR FUNCTIONS; STEP PURIFICATION	Background: Pathogenic yersiniae inject several effector proteins (Yops) into host cells, which subverts immune functions and enables the bacteria to survive within the host organism. YopM, whose deletion in enteropathogenic yersiniae results in a dramatic loss of virulence, has previously been shown to form a complex with and activate the multifunctional kinases PKN2 and RSK1 in transfected cells. Methodology/Principal Findings: In a near physiological approach with double-affinity-tagged YopM being translocated into the macrophage cell line J774A. 1 via the natural type three secretion system of Yersinia we verified the interaction of YopM with PKN2 and RSK1 and detected association with additional PKN and RSK isoforms. In transfected and infected cells YopM induced sustained phosphorylation of RSK at its activation sites serine-380 and serine-221 even in the absence of signalling from its upstream kinase ERK1/2, suggesting inhibition of dephosphorylation. ATP-depletion and in vitro assays using purified components directly confirmed that YopM shields RSK isoforms from phosphatase activity towards serines 380 and 221. Conclusions/Significance: Our study suggests that during Yersinia infection YopM induces sustained activation of RSK by blocking dephosphorylation of its activatory phosphorylation sites. This may represent a novel mode of action of a bacterial virulence factor.	[Hentschke, Moritz; Berneking, Laura; Campos, Cristina Belmar; Ruckdeschel, Klaus; Aepfelbacher, Martin] Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Buck, Friedrich] Univ Med Ctr Eppendorf, Inst Clin Chem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hentschke, M (corresponding author), Univ Med Ctr Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	m.hentschke@uke.de	Berneking, Laura/GNP-5002-2022	Berneking, Laura/0000-0001-9166-2533	Deutsche Forschungsgemeinschaft DFG [HE 5875/1-1]; Werner-Otto-Stiftung [4/72]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Werner-Otto-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (HE 5875/1-1) and the Werner-Otto-Stiftung (4/72) to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 2007, THROMB HAEMOSTASIS, V98, P521, DOI 10.1160/TH07-03-0173; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Balendran A, 2000, J BIOL CHEM, V275, P20806, DOI 10.1074/jbc.M000421200; Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006; Bliska JB, 2006, ACS CHEM BIOL, V1, P349, DOI 10.1021/cb600261k; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Boland A, 1998, MICROB PATHOGENESIS, V25, P343, DOI 10.1006/mpat.1998.0247; Chaturvedi D, 2009, J BIOL CHEM, V284, P23670, DOI 10.1074/jbc.M109.032813; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dettori R, 2009, J BIOL CHEM, V284, P30318, DOI 10.1074/jbc.M109.051151; Doehn U, 2004, BIOCHEM J, V382, P425, DOI 10.1042/BJ20040948; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Haraga A, 2006, CELL MICROBIOL, V8, P837, DOI 10.1111/j.1462-5822.2005.00670.x; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hentschke M, 2003, BIOCHEM BIOPH RES CO, V312, P975, DOI 10.1016/j.bbrc.2003.11.025; Hentschke M, 2002, EUR J BIOCHEM, V269, P4086, DOI 10.1046/j.1432-1033.2002.03102.x; Hetzer C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000151; Heusipp G, 2006, MICROBIOL-SGM, V152, P1327, DOI 10.1099/mic.0.28697-0; Hoffmann R, 2004, CELL MICROBIOL, V6, P377, DOI 10.1111/j.1462-5822.2004.00365.x; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004; Koberle M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000551; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Kuang E, 2009, J BIOL CHEM, V284, P13958, DOI 10.1074/jbc.M900025200; Larreaa MD, 2009, P NATL ACAD SCI USA, V106, P9268, DOI 10.1073/pnas.0805057106; Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580; McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200; MCPHEE JB, INFECT IMMUN; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Mukai H, 2003, J BIOCHEM, V133, P17, DOI 10.1093/jb/mvg019; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Poirier R, 2007, BEHAV GENET, V37, P31, DOI 10.1007/s10519-006-9116-1; REISNER BS, 1992, INFECT IMMUN, V60, P5242, DOI 10.1128/IAI.60.12.5242-5252.1992; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Richards SA, 2001, MOL CELL BIOL, V21, P7470, DOI 10.1128/MCB.21.21.7470-7480.2001; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Ruckdeschel K, 2008, IMMUNOBIOLOGY, V213, P261, DOI 10.1016/j.imbio.2007.11.001; Sauvonnet N, 2002, J BIOL CHEM, V277, P25133, DOI 10.1074/jbc.M203239200; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Skrzypek E, 2003, INFECT IMMUN, V71, P937, DOI 10.1128/IAI.71.2.937-947.2003; Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x; STOFKOHAHN RE, 1992, FEBS LETT, V302, P274, DOI 10.1016/0014-5793(92)80458-S; Takahashi M, 1998, P NATL ACAD SCI USA, V95, P11566, DOI 10.1073/pnas.95.20.11566; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251; Trulzsch K, 2004, INFECT IMMUN, V72, P5227, DOI 10.1128/IAI.72.9.5227-5234.2004; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Ye Z, 2009, INFECT IMMUN, V77, P3791, DOI 10.1128/IAI.00284-09; Yoon SO, 2008, MOL CELL, V29, P362, DOI 10.1016/j.molcel.2007.12.024; Zhu YQ, 2008, NAT STRUCT MOL BIOL, V15, P1302, DOI 10.1038/nsmb.1517	63	44	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13165	10.1371/journal.pone.0013165	http://dx.doi.org/10.1371/journal.pone.0013165			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957203	Green Submitted, Green Published, gold			2022-12-27	WOS:000282506100008
J	Schlievert, PM; Chuang-Smith, ON; Peterson, ML; Cook, LCC; Dunny, GM				Schlievert, Patrick M.; Chuang-Smith, Olivia N.; Peterson, Marnie L.; Cook, Laura C. C.; Dunny, Gary M.			Enterococcus faecalis Endocarditis Severity in Rabbits Is Reduced by IgG Fabs Interfering with Aggregation Substance	PLOS ONE			English	Article							INFECTIVE ENDOCARDITIS; ENHANCE PATHOGENICITY; TERMINAL DOMAIN; BINDING; VIRULENCE; INTERNALIZATION; ANTIBODIES; CONTRIBUTE; MSCRAMM; MODEL	Background: Enterococcus faecalis is a significant cause of infective endocarditis, an infection of the heart endothelium leading to vegetation formation (microbes, fibrin, platelets, and host cells attached to underlying endothelial tissue). Our previous research determined that enterococcal aggregation substance (AS) is an important virulence factor in causation of endocarditis, although endocarditis may occur in the absence of AS production. Production of AS by E. faecalis causes the organism to form aggregates through AS binding to enterococcal binding substance. In this study, we assessed the ability of IgGs and IgG Fabs against AS to provide protection against AS(+) E. faecalis endocarditis. Methodology/Principal Findings: When challenged with AS(+) E. faecalis, 10 rabbits actively immunized against AS(+) E. faecalis developed more significant vegetations than 9 animals immunized against AS(-) E. faecalis, and 9/10 succumbed compared to 2/9 (p<0.005), suggesting enhanced aggregation by IgG contributes significantly to disease. IgG antibodies against AS also enhanced enterococcal aggregation as tested in vitro. In contrast, Fab fragments of IgG from rabbits immunized against purified AS, when passively administered to rabbits (6/group) immediately before challenge with AS(+) E. faecalis, reduced total vegetation (endocarditis lesion) microbial counts (7.9x10(6) versus 2.0x10(5), p = 0.02) and size (40 mg versus 10, p = 0.05). In vitro, the Fabs prevented enterococcal aggregation. Conclusions/Significance: The data confirm the role of AS in infective endocarditis formation and suggest that use of Fabs against AS will provide partial protection from AS(+) E. faecalis illness.	[Schlievert, Patrick M.; Chuang-Smith, Olivia N.; Peterson, Marnie L.; Cook, Laura C. C.; Dunny, Gary M.] Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Schlievert, PM (corresponding author), Univ Minnesota, Sch Med, Dept Microbiol, Minneapolis, MN 55455 USA.	schli001@umn.edu	Cook, Laura C/T-7185-2017	Cook, Laura C/0000-0002-7079-9570; Schlievert, Patrick/0000-0001-8314-9369	United States Public Health Service [HL51987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051987] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States Public Health Service grant HL51987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOMSTERHAUTAMAA DA, 1988, METHOD ENZYMOL, V165, P37; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; CHRISTIE PJ, 1988, J BACTERIOL, V170, P5161, DOI 10.1128/jb.170.11.5161-5168.1988; Chuang ON, 2009, INFECT IMMUN, V77, P539, DOI 10.1128/IAI.01034-08; HIRT H, 1993, EUR J BIOCHEM, V211, P711, DOI 10.1111/j.1432-1033.1993.tb17600.x; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; KAYE D, 2004, INFECT DIS, P569; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; McCormick JK, 2002, J INFECT DIS, V185, P994, DOI 10.1086/339604; McCormick JK, 2001, INFECT IMMUN, V69, P3305, DOI 10.1128/IAI.69.5.3305-3314.2001; MURRAY BE, 1990, CLIN MICROBIOL REV, V3, P46, DOI 10.1128/CMR.3.1.46-65.1990; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; Rakita RM, 1999, INFECT IMMUN, V67, P6067, DOI 10.1128/IAI.67.11.6067-6075.1999; RICE LB, 1991, REV INFECT DIS, V13, P1; Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223; Schlievert PM, 1997, ADV EXP MED BIOL, V418, P789; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Waters CM, 2004, MOL MICROBIOL, V52, P1159, DOI 10.1111/j.1365-2958.2004.04045.x; Waters CM, 2003, INFECT IMMUN, V71, P5682, DOI 10.1128/IAI.71.10.5682-5689.2003; WILSON W, 2007, CIRCULATION	20	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13194	10.1371/journal.pone.0013194	http://dx.doi.org/10.1371/journal.pone.0013194			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957231	gold, Green Published, Green Submitted			2022-12-27	WOS:000282423300018
J	Takanashi, T; Nakano, R; Surlykke, A; Tatsuta, H; Tabata, J; Ishikawa, Y; Skals, N				Takanashi, Takuma; Nakano, Ryo; Surlykke, Annemarie; Tatsuta, Haruki; Tabata, Jun; Ishikawa, Yukio; Skals, Niels			Variation in Courtship Ultrasounds of Three Ostrinia Moths with Different Sex Pheromones	PLOS ONE			English	Article							EUROPEAN CORN-BORER; ADZUKI BEAN BORER; REPRODUCTIVE ISOLATION; NUBILALIS LEPIDOPTERA; PYRALIDAE; FURNACALIS; SCAPULALIS; STRAINS; HEARING; SONGS	Moths use ultrasounds as well as pheromones for sexual communication. In closely related moth species, variations in ultrasounds and pheromones are likely to profoundly affect mate recognition, reproductive isolation, and speciation. The European corn borer, Ostrinia nubilalis, and its Asian congeners, Ostrinia furnacalis and Ostrinia scapulalis, exhibit within-species and between-species variation in their pheromone communication. Recently, we reported ultrasound communication in O. furnacalis; however, variations in ultrasounds in the three congeners have not been addressed to date. Here we investigated features of ultrasound production and hearing in O. nubilalis and O. scapulalis, and compared them with those of O. furnacalis. As in O. furnacalis, males of O. nubilalis and O. scapulalis produced ultrasounds during courtship by rubbing specialized scales on the wings against scales on the thorax. The covering of these scales with nail polish muffled the sounds and significantly reduced mating success in O. nubilalis, showing the importance of ultrasound signaling in mating. The ultrasounds produced by O. nubilalis and O. scapulalis were similar, consisting of long trains of pairs of pulses with a main energy at 40 kHz, but distinctly different from the ultrasound produced by O. furnacalis, consisting of groups of pulses peaking at 50 kHz and with substantially more energy up to 80 kHz. Despite overall similarities, temporal features and patterns of amplitude modulation differed significantly among the geographic populations of O. nubilalis and O. scapulalis, which differed in pheromone type. In contrast, no significant difference in hearing was found among the three species with regard to the most sensitive frequencies and hearing threshold levels. The patterns of variations in the songs and pheromones well reflected those of the phylogenetic relationships, implying that ultrasound and pheromone communications have diverged concordantly. Our results suggest that concordant evolution in sexual signals such as courtship ultrasounds and sex pheromones occurs in moths.	[Takanashi, Takuma] Forestry & Forest Prod Res Inst, Ibaraki, Japan; [Nakano, Ryo] Natl Inst Fruit Tree Sci, Ibaraki, Japan; [Surlykke, Annemarie; Skals, Niels] Univ So Denmark, Inst Biol, Odense, Denmark; [Tatsuta, Haruki] Univ Ryukyus, Grad Sch Agr, Okinawa, Japan; [Tabata, Jun] Natl Inst Agroenvironm Sci, Biodivers Div, Ibaraki, Japan; [Ishikawa, Yukio] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; National Agriculture & Food Research Organization - Japan; University of Southern Denmark; University of the Ryukyus; National Institute for Agro-Environmental Sciences (NIAES) Japan; University of Tokyo	Takanashi, T (corresponding author), Forestry & Forest Prod Res Inst, Ibaraki, Japan.	takanasi@affrc.go.jp	Nakano, Ryo/C-2342-2011; Ishikawa, Yukio/J-5676-2019	Ishikawa, Yukio/0000-0003-3067-2513; Tabata, Jun/0000-0001-9095-2694; Tatsuta, Haruki/0000-0001-8847-8874	Japan Society for the Promotion of Science; Forestry and Forest Products Research Institute (FFPRI); Encourage Model for Researchers with Family Responsibilities of FFPRI; Danish Natural Science Research Council; Grants-in-Aid for Scientific Research [21780050] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Forestry and Forest Products Research Institute (FFPRI); Encourage Model for Researchers with Family Responsibilities of FFPRI; Danish Natural Science Research Council(Danish Natural Science Research Council); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by research grants from the Japan Society for the Promotion of Science (T.T., R.N., Y.I.), the Forestry and Forest Products Research Institute (FFPRI) (T.T., R.N., Y.I.), Encourage Model for Researchers with Family Responsibilities of FFPRI (TT), and the Danish Natural Science Research Council (A.S., N.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya L, 1998, BEHAV ECOL, V9, P552, DOI 10.1093/beheco/9.6.552; AGEE HR, 1969, ANN ENTOMOL SOC AM, V62, P1364, DOI 10.1093/aesa/62.6.1364; Ando T, 2004, TOP CURR CHEM, V239, P51, DOI 10.1007/b95449; ANDO T, 1980, AGR BIOL CHEM TOKYO, V44, P2643, DOI 10.1080/00021369.1980.10864390; Bengtsson M, 2006, ENVIRON ENTOMOL, V35, P1238, DOI 10.1603/0046-225X(2006)35[1238:FTROZS]2.0.CO;2; Chatfield C., 2004, ANAL TIME SERIES INT; Conner WE, 1999, J EXP BIOL, V202, P1711; Dopman EB, 2010, EVOLUTION, V64, P881, DOI 10.1111/j.1558-5646.2009.00883.x; Frolov AN, 2007, BIOL J LINN SOC, V91, P49, DOI 10.1111/j.1095-8312.2007.00779.x; Greenfield MD, 2002, SIGNALERS RECEIVERS; Greenfield MD, 2009, ETHOLOGY, V115, P1137, DOI 10.1111/j.1439-0310.2009.01700.x; Hoshizaki S, 2008, EUR J ENTOMOL, V105, P545, DOI 10.14411/eje.2008.073; Huang YP, 1997, J CHEM ECOL, V23, P2791, DOI 10.1023/A:1022567111508; Huang YP, 1998, J CHEM ECOL, V24, P2079, DOI 10.1023/A:1020737726636; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Jang YW, 1998, EVOLUTION, V52, P1383, DOI [10.2307/2411308, 10.1111/j.1558-5646.1998.tb02020.x]; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; KLUN JA, 1975, ENVIRON ENTOMOL, V4, P891, DOI 10.1093/ee/4.6.891; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; Lofstedt C, 1997, INSECT PHEROMONE RESEARCH, P473; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Marcus LF, 1990, SPECIAL PUBLICATION, V2, P77; MINET J, 2003, LEPIDOPTERA MOTHS BU, V2, P289; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakano R, 2009, J EXP BIOL, V212, P4072, DOI 10.1242/jeb.032466; NAKANO R, 2010, BIOL LETT IN PRESS; Nakano R, 2008, P NATL ACAD SCI USA, V105, P11812, DOI 10.1073/pnas.0804056105; Nakano R, 2006, NATURWISSENSCHAFTEN, V93, P292, DOI 10.1007/s00114-006-0100-7; Nakano R, 2010, PHYSIOL ENTOMOL, V35, P76, DOI 10.1111/j.1365-3032.2009.00712.x; Nakano Ryo, 2009, Communicative & Integrative Biology, V2, P123; Pelozuelo L, 2004, J CHEM ECOL, V30, P335, DOI 10.1023/B:JOEC.0000017981.03762.ed; Pelozuelo L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000555; PENA A, 1988, J CHEM ECOL, V14, P1359, DOI 10.1007/BF01020140; R Core Team, 2020, R LANG ENV STAT COMP; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Skals N, 2005, J EXP BIOL, V208, P595, DOI 10.1242/jeb.01400; SPANGLER HG, 1988, ANNU REV ENTOMOL, V33, P59, DOI 10.1146/annurev.en.33.010188.000423; SURLYKKE A, 1989, NATURWISSENSCHAFTEN, V76, P132, DOI 10.1007/BF00366610; Tabata J, 2003, J CHEM ECOL, V29, P2749, DOI 10.1023/B:JOEC.0000008018.52213.65; Takanashi T, 2005, BIOL J LINN SOC, V84, P143, DOI 10.1111/j.1095-8312.2005.00421.x; Thomas Y, 2003, EVOLUTION, V57, P261; Verhoeven KJF, 2005, OIKOS, V108, P643, DOI 10.1111/j.0030-1299.2005.13727.x; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x	44	21	22	6	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13144	10.1371/journal.pone.0013144	http://dx.doi.org/10.1371/journal.pone.0013144			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957230	gold, Green Published, Green Submitted			2022-12-27	WOS:000282423300006
J	Gamazon, ER; Im, HK; Duan, SW; Lussier, YA; Cox, NJ; Dolan, ME; Zhang, W				Gamazon, Eric R.; Im, Hae-Kyung; Duan, Shiwei; Lussier, Yves A.; Cox, Nancy J.; Dolan, M. Eileen; Zhang, Wei			ExprTarget: An Integrative Approach to Predicting Human MicroRNA Targets	PLOS ONE			English	Article							GENE-EXPRESSION; DATABASE; CANCER	Variation in gene expression has been observed in natural populations and associated with complex traits or phenotypes such as disease susceptibility and drug response. Gene expression itself is controlled by various genetic and non-genetic factors. The binding of a class of small RNA molecules, microRNAs (miRNAs), to mRNA transcript targets has recently been demonstrated to be an important mechanism of gene regulation. Because individual miRNAs may regulate the expression of multiple gene targets, a comprehensive and reliable catalogue of miRNA-regulated targets is critical to understanding gene regulatory networks. Though experimental approaches have been used to identify many miRNA targets, due to cost and efficiency, current miRNA target identification still relies largely on computational algorithms that aim to take advantage of different biochemical/thermodynamic properties of the sequences of miRNAs and their gene targets. A novel approach, ExprTarget, therefore, is proposed here to integrate some of the most frequently invoked methods (miRanda, PicTar, TargetScan) as well as the genome-wide HapMap miRNA and mRNA expression datasets generated in our laboratory. To our knowledge, this dataset constitutes the first miRNA expression profiling in the HapMap lymphoblastoid cell lines. We conducted diagnostic tests of the existing computational solutions using the experimentally supported targets in TarBase as gold standard. To gain insight into the biases that arise from such an analysis, we investigated the effect of the choice of gold standard on the evaluation of the various computational tools. We analyzed the performance of ExprTarget using both ROC curve analysis and cross-validation. We show that ExprTarget greatly improves miRNA target prediction relative to the individual prediction algorithms in terms of sensitivity and specificity. We also developed an online database, ExprTargetDB, of human miRNA targets predicted by our approach that integrates gene expression profiling into a broader framework involving important features of miRNA target site predictions.	[Gamazon, Eric R.; Lussier, Yves A.; Cox, Nancy J.; Dolan, M. Eileen] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Im, Hae-Kyung] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Lussier, Yves A.; Dolan, M. Eileen] Univ Chicago, Comm Clin Pharmacol & Pharmacogenom, Chicago, IL 60637 USA; [Lussier, Yves A.; Dolan, M. Eileen] Univ Chicago, Comprehens Canc Res Ctr, Chicago, IL 60637 USA; [Lussier, Yves A.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Cox, Nancy J.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Duan, Shiwei] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Zhang, Wei] Univ Illinois, Coll Med, Inst Human Genet, Chicago, IL USA; [Zhang, Wei] Univ Illinois, Coll Med, Dept Pediat, Chicago, IL USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Gamazon, ER (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	edolan@medicine.bsd.uchicago.edu; weizhan1@uic.edu	Lussier, Yves/N-4891-2017; Gamazon, Eric/I-6873-2018; Duan, Shiwei/AAA-4782-2022; Duan, Shiwei/J-9633-2012	Lussier, Yves/0000-0001-9854-1005; Gamazon, Eric/0000-0003-4204-8734; Duan, Shiwei/0000-0001-7682-2877; Im, Hae Kyung/0000-0003-0333-5685	Pharmacogenetics of Anticancer Agents Research Group; National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [U01GM61393]; National Institutes of Health/National Cancer Institute [CA139278, U54 CA121852]; NIH/NCI Breast SPORE [P50 CA125183]; University of Chicago Comprehensive Cancer Research Center; NIH/NIGMS [U01GM61374]; NATIONAL CANCER INSTITUTE [U54CA121852, P50CA125183, R21CA139278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393, U01GM061374] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [K22LM008308] Funding Source: NIH RePORTER	Pharmacogenetics of Anticancer Agents Research Group; National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NCI Breast SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Comprehensive Cancer Research Center; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded through the Pharmacogenetics of Anticancer Agents Research Group (http://www.pharmacogenetics.org/) by the National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) grant U01GM61393, National Institutes of Health/National Cancer Institute grants CA139278 and U54 CA121852, NIH/NCI Breast SPORE P50 CA125183, and the University of Chicago Comprehensive Cancer Research Center Pilot Project Program. Data deposits are supported by the NIH/NIGMS grant U01GM61374 (http://www.pharmgkb.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bacher Ulrike, 2009, Briefings in Functional Genomics & Proteomics, V8, P184, DOI 10.1093/bfgp/elp011; Barringhaus KG, 2009, CIRCULATION, V119, P2217, DOI 10.1161/CIRCULATIONAHA.107.715839; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gamazon ER, 2010, P NATL ACAD SCI USA, V107, P9287, DOI 10.1073/pnas.1001827107; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Papadopoulos GL, 2009, NUCLEIC ACIDS RES, V37, pD155, DOI 10.1093/nar/gkn809; R Development Core Team, 2005, R LANG ENV STAT COMP; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Seo D, 2006, J AM COLL CARDIOL, V48, P227, DOI 10.1016/j.jacc.2006.02.070; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Welsh M, 2009, PHARMACOL REV, V61, P413, DOI 10.1124/pr.109.001461; Xu B, 2010, BRAIN RES, V1338, P78, DOI 10.1016/j.brainres.2010.03.109; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015; Zhang W, 2009, CURR PHARM DESIGN, V15, P3782, DOI 10.2174/138161209789649475; Zhang W, 2009, HUM GENET, V125, P81, DOI 10.1007/s00439-008-0601-x	41	59	61	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13534	10.1371/journal.pone.0013534	http://dx.doi.org/10.1371/journal.pone.0013534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975837	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800009
J	Maisonnasse, A; Lenoir, JC; Beslay, D; Crauser, D; Le Conte, Y				Maisonnasse, Alban; Lenoir, Jean-Christophe; Beslay, Dominique; Crauser, Didier; Le Conte, Yves			E-beta-Ocimene, a Volatile Brood Pheromone Involved in Social Regulation in the Honey Bee Colony (Apis mellifera)	PLOS ONE			English	Article							DIVISION-OF-LABOR; HYPOPHARYNGEAL GLAND; QUEEN; AGE; COMMUNICATION; RECOGNITION; HYMENOPTERA; CONFLICT; BEHAVIOR; ESTERS	Background: In honey bee colony, the brood is able to manipulate and chemically control the workers in order to sustain their own development. A brood ester pheromone produced primarily by old larvae (4 and 5 days old larvae) was first identified as acting as a contact pheromone with specific effects on nurses in the colony. More recently a new volatile brood pheromone has been identified: E-beta-ocimene, which partially inhibits ovary development in workers. Methodology and Principal Finding: Our analysis of E-beta-ocimene production revealed that young brood (newly hatched to 3 days old) produce the highest quantity of E-beta-ocimene relative to their body weight. By testing the potential action of this molecule as a non-specific larval signal, due to its high volatility in the colony, we demonstrated that in the presence of E-beta-ocimene nest workers start to forage earlier in life, as seen in the presence of real brood. Conclusions/Significance: In this way, young larvae are able to assign precedence to the task of foraging by workers in order to increase food stores for their own development. Thus, in the complexity of honey bee chemical communication, E-beta-ocimene, a pheromone of young larvae, provides the brood with the means to express their nutritional needs to the workers.	[Maisonnasse, Alban; Lenoir, Jean-Christophe; Beslay, Dominique; Crauser, Didier; Le Conte, Yves] INRA, Lab Biol & Protect & Abeille, UMR 406, Avignon, France	INRAE	Maisonnasse, A (corresponding author), INRA, Lab Biol & Protect & Abeille, UMR 406, Avignon, France.	alban.maisonnasse@avignon.inra.fr	Le Conte, Yves/AAP-2379-2021; Le Conte, Yves M/B-3246-2016; Le Conte, Yves/M-4442-2018	Le Conte, Yves/0000-0002-8466-5370; Le Conte, Yves M/0000-0002-8466-5370; Le Conte, Yves/0000-0002-8466-5370	Human Frontier Science Program [RGP0042/2007C101]	Human Frontier Science Program(Human Frontier Science Program)	Funds were provided by Human Frontier Science Program (RGP0042/2007C101) (http://www.hfsp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2009, EXP GERONTOL, V44, P467, DOI 10.1016/j.exger.2009.02.013; ARNOLD G, 1994, CR ACAD SCI III-VIE, V317, P511; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; Dampney JR, 2004, APIDOLOGIE, V35, P83, DOI 10.1051/apido:2003067; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; FREE JB, 1983, ANIM BEHAV, V31, P539, DOI 10.1016/S0003-3472(83)80077-3; GIRAY T, 1994, BEHAV ECOL SOCIOBIOL, V35, P13, DOI 10.1007/BF00167054; Heinze J, 2009, J EXP BIOL, V212, P1775, DOI 10.1242/jeb.015008; Heinze K, 2004, ADV STUD BEHAV, V34, P1, DOI 10.1016/S0065-3454(04)34001-5; Hoover SER, 2005, BEHAV ECOL SOCIOBIOL, V59, P278, DOI 10.1007/s00265-005-0039-2; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; HUANG ZY, 1991, J INSECT BEHAV, V4, P305, DOI 10.1007/BF01048280; Johnson BR, 2010, BEHAV ECOL SOCIOBIOL, V64, P305, DOI 10.1007/s00265-009-0874-7; KELLER L, 1993, ANIM BEHAV, V45, P787, DOI 10.1006/anbe.1993.1092; KOENIGER N, 1985, APIMONDIA, P106; Le Conte Y., 1995, Chemoecology, V5/6, P6, DOI 10.1007/BF01259967; LE CONTE Y, 1994, NATURWISSENSCHAFTEN, V81, P462, DOI 10.1007/BF01136651; LE CONTE Y, 1990, NATURWISSENSCHAFTEN, V77, P334, DOI 10.1007/BF01138390; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; LE CONTE Y, 1995, J ECON ENTOMOL, V88, P798, DOI 10.1093/jee/88.4.798; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leoncini I, 2004, P NATL ACAD SCI USA, V101, P17559, DOI 10.1073/pnas.0407652101; Maisonnasse A, 2009, APIDOLOGIE, V40, P562, DOI 10.1051/apido/2009024; Mohammedi A, 1998, NATURWISSENSCHAFTEN, V85, P455, DOI 10.1007/s001140050531; Mohammedi A, 1996, CR ACAD SCI III-VIE, V319, P769; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; Pankiw T, 1998, BEHAV ECOL SOCIOBIOL, V44, P193, DOI 10.1007/s002650050531; Pankiw T, 2004, NATURWISSENSCHAFTEN, V91, P575, DOI 10.1007/s00114-004-0568-y; Pankiw T, 1996, J CHEM ECOL, V22, P605, DOI 10.1007/BF02033573; Pankiw T, 2007, J INSECT BEHAV, V20, P173, DOI 10.1007/s10905-007-9071-6; Pankiw T, 2007, APIDOLOGIE, V38, P156, DOI 10.1051/apido:2006066; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; Peters L, 2010, J INSECT PHYSIOL, V56, P132, DOI 10.1016/j.jinsphys.2009.09.014; Ratnieks FLW, 2006, ANNU REV ENTOMOL, V51, P581, DOI 10.1146/annurev.ento.51.110104.151003; Ratnieks FLW, 2008, TRENDS ECOL EVOL, V23, P45, DOI 10.1016/j.tree.2007.09.013; Schmickl T, 2002, BEHAV ECOL SOCIOBIOL, V51, P415, DOI 10.1007/s00265-002-0457-3; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Stabentheiner A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008967; TROUILLER J, 1991, NATURWISSENSCHAFTEN, V78, P368, DOI 10.1007/BF01131612; Tsuruda JM, 2009, BEHAV ECOL SOCIOBIOL, V64, P161, DOI 10.1007/s00265-009-0833-3; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Winston M., 1987, The biology of the honey bee.	46	83	90	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13531	10.1371/journal.pone.0013531	http://dx.doi.org/10.1371/journal.pone.0013531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042405	Green Published, Green Submitted, gold			2022-12-27	WOS:000283293800008
J	Ramirez, GP; Martinez, AS; Fernandez, VM; Bielsa, GC; Farina, WM				Ramirez, Gabriela P.; Martinez, Andres S.; Fernandez, Vanesa M.; Corti Bielsa, Gonzalo; Farina, Walter M.			The Influence of Gustatory and Olfactory Experiences on Responsiveness to Reward in the Honeybee	PLOS ONE			English	Article							SUCROSE-RESPONSE THRESHOLDS; DIVISION-OF-LABOR; APIS-MELLIFERA L.; BOMBUS-TERRESTRIS; JUVENILE-HORMONE; SOCIAL INSECT; FLORAL ODORS; TRANSMISSION DYNAMICS; PROBOSCIS EXTENSION; FORAGING BEHAVIOR	Background: Honeybees (Apis mellifera) exhibit an extraordinarily tuned division of labor that depends on age polyethism. This adjustment is generally associated with the fact that individuals of different ages display different response thresholds to given stimuli, which determine specific behaviors. For instance, the sucrose-response threshold (SRT) which largely depends on genetic factors may also be affected by the nectar sugar content. However, it remains unknown whether SRTs in workers of different ages and tasks can differ depending on gustatory and olfactory experiences. Methodology: Groups of worker bees reared either in an artificial environment or else in a queen-right colony, were exposed to different reward conditions at different adult ages. Gustatory response scores (GRSs) and odor-memory retrieval were measured in bees that were previously exposed to changes in food characteristics. Principal Findings: Results show that the gustatory responses of pre-foraging-aged bees are affected by changes in sucrose solution concentration and also to the presence of an odor provided it is presented as scented sucrose solution. In contrast no differences in worker responses were observed when presented with odor only in the rearing environment. Fast modulation of GRSs was observed in older bees (12-16 days of age) which are commonly involved in food processing tasks within the hive, while slower modulation times were observed in younger bees (commonly nurse bees, 6-9 days of age). This suggests that older food-processing bees have a higher plasticity when responding to fluctuations in resource information than younger hive bees. Adjustments in the number of trophallaxis events were also found when scented food circulated inside the nest, and this was positively correlated with the differences in timing observed in gustatory responsiveness and memory retention for hive bees of different age classes. Conclusions: This work demonstrates the accessibility of chemosensory information in the honeybee colonies with respect to incoming nectar. The modulation of the sensory-response systems within the hive can have important effects on the dynamics of food transfer and information propagation.	[Ramirez, Gabriela P.; Martinez, Andres S.; Fernandez, Vanesa M.; Corti Bielsa, Gonzalo; Farina, Walter M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Grp Estudio Insectos Sociales,IFIBYNE CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Ramirez, GP (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Biodiversidad & Biol Expt, Grp Estudio Insectos Sociales,IFIBYNE CONICET, Buenos Aires, DF, Argentina.	walter@fbmc.fcen.uba.ar		Martinez, Andres/0000-0003-4629-4617; Farina, Walter/0000-0001-6411-489X	National Agency for Scientific and Tecnological promotion [PICT 2006 01-1155]; University of Buenos Aires [X077]; National Council on Scientific and Technical Research [PIP 112-200801-00150]; Guggenheim fellowship	National Agency for Scientific and Tecnological promotion; University of Buenos Aires(University of Buenos Aires); National Council on Scientific and Technical Research; Guggenheim fellowship	This study was supported by grants from the National Agency for Scientific and Tecnological promotion (PICT 2006 01-1155), University of Buenos Aires (X077), National Council on Scientific and Technical Research (PIP 112-200801-00150) and Guggenheim fellowship to WMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenas A, 2009, EUR J NEUROSCI, V30, P1498, DOI 10.1111/j.1460-9568.2009.06940.x; Arenas A, 2008, J COMP PHYSIOL A, V194, P629, DOI 10.1007/s00359-008-0337-z; Arenas A, 2007, NATURWISSENSCHAFTEN, V94, P218, DOI 10.1007/s00114-006-0176-0; Arenas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008046; Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bloch G, 2002, J INSECT PHYSIOL, V48, P1123, DOI 10.1016/S0022-1910(02)00205-6; Breed MD, 2004, INSECT SOC, V51, P12, DOI 10.1007/s00040-003-0698-9; Dornhaus A, 2005, BEHAV ECOL, V16, P661, DOI 10.1093/beheco/ari040; Dornhaus A, 2001, BEHAV ECOL SOCIOBIOL, V50, P570, DOI 10.1007/s002650100395; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Farina WM, 2007, NATURWISSENSCHAFTEN, V94, P55, DOI 10.1007/s00114-006-0157-3; Farina WM, 2005, P ROY SOC B-BIOL SCI, V272, P1923, DOI 10.1098/rspb.2005.3172; Farina WM, 2000, J COMP PHYSIOL A, V186, P239, DOI 10.1007/s003590050424; Fernandez VM, 2009, J COMP PHYSIOL A, V195, P759, DOI 10.1007/s00359-009-0453-4; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; FREE JB, 1969, NATURE, V222, P778, DOI 10.1038/222778a0; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Gil M, 2005, J EXP BIOL, V208, P671, DOI 10.1242/jeb.01474; Gordon DM, 2007, NATURE, V446, P143, DOI 10.1038/446143a; Goyret J, 2005, NATURWISSENSCHAFTEN, V92, P440, DOI 10.1007/s00114-005-0016-7; Gruter C, 2007, INSECT SOC, V54, P87, DOI 10.1007/s00040-007-0915-z; Gruter C, 2009, TRENDS ECOL EVOL, V24, P242, DOI 10.1016/j.tree.2008.12.007; Gruter C, 2006, BEHAV ECOL SOCIOBIOL, V60, P707, DOI 10.1007/s00265-006-0214-0; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Jassim O, 2000, J INSECT PHYSIOL, V46, P243, DOI 10.1016/S0022-1910(99)00176-6; KNUDSEN JT, 1993, PHYTOCHEMISTRY, V33, P253, DOI 10.1016/0031-9422(93)85502-I; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; LOGAN FA, 1960, INCENTIVE; Martinez A, 2008, BEHAV ECOL SOCIOBIOL, V62, P529, DOI 10.1007/s00265-007-0477-0; Mc Cabe SI, 2007, J COMP PHYSIOL A, V193, P1089, DOI 10.1007/s00359-007-0260-8; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Molet M, 2009, NATURWISSENSCHAFTEN, V96, P213, DOI 10.1007/s00114-008-0465-x; Mujagic S, 2009, J COMP PHYSIOL A, V195, P325, DOI 10.1007/s00359-008-0409-0; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Naug D, 2007, P ROY SOC B-BIOL SCI, V274, P61, DOI 10.1098/rspb.2006.3695; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NUNEZ JA, 1971, PHYSIS, V81, P869; Pacheco J, 2008, ANIM BEHAV, V76, P1641, DOI 10.1016/j.anbehav.2008.08.001; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pankiw T, 1999, J COMP PHYSIOL A, V185, P207, DOI 10.1007/s003590050379; Pankiw T, 2000, BEHAV ECOL SOCIOBIOL, V47, P265, DOI 10.1007/s002650050664; Pankiw T, 2004, BEHAV ECOL SOCIOBIOL, V55, P286, DOI 10.1007/s00265-003-0714-0; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pankiw T, 2001, J COMP PHYSIOL A, V187, P293, DOI 10.1007/s003590100201; Pirez N, 2004, BEHAV ECOL SOCIOBIOL, V55, P574, DOI 10.1007/s00265-003-0749-2; Provecho Y, 2009, J EXP BIOL, V212, P3221, DOI 10.1242/jeb.033506; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; Robinson GE, 1997, ARCH INSECT BIOCHEM, V35, P559, DOI 10.1002/(SICI)1520-6327(1997)35:4<559::AID-ARCH13>3.0.CO;2-9; ROCES F, 1990, OECOLOGIA, V83, P261, DOI 10.1007/BF00317762; Rosch G.A, 1925, Z VERGL PHYSIOL, V2, P571; Roussel E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004197; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Scheiner R, 1999, J COMP PHYSIOL A, V185, P1, DOI 10.1007/s003590050360; Scheiner R, 2002, BEHAV BRAIN RES, V136, P545, DOI 10.1016/S0166-4328(02)00205-X; Scheiner R, 2001, NEUROBIOL LEARN MEM, V76, P138, DOI 10.1006/nlme.2000.3996; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Sokal, 2000, BIOMETRY PRINCIPLES; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Vergoz V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000288; von Frisch K., 1923, ZOOL JBER ABT      3, V40, P1; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Zar JH, 1999, BIOSTATISTICAL ANAL	66	14	14	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13498	10.1371/journal.pone.0013498	http://dx.doi.org/10.1371/journal.pone.0013498			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975953	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400013
J	Marques, RB; Dits, NF; Erkens-Schulze, S; van Weerden, WM; Jenster, G				Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Weerden, Wytske M.; Jenster, Guido			Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-GROWTH; VAV FAMILY; CROSS-TALK; METASTATIC PROGRESSION; EXCHANGE FACTOR; UP-REGULATION; TWIST; CYCLIN; AMPLIFICATION	Background: Prostate cancer is initially dependent on androgens for survival and growth, making hormonal therapy the cornerstone treatment for late-stage tumors. However, despite initial remission, the cancer will inevitably recur. The present study was designed to investigate how androgen-dependent prostate cancer cells eventually survive and resume growth under androgen-deprived and antiandrogen supplemented conditions. As model system, we used the androgen-responsive PC346C cell line and its therapy-resistant sublines: PC346DCC, PC346Flu1 and PC346Flu2. Methodology/Principal Findings: Microarray technology was used to analyze differences in gene expression between the androgen-responsive and therapy-resistant PC346 cell lines. Microarray analysis revealed 487 transcripts differentially-expressed between the androgen-responsive and the therapy-resistant cell lines. Most of these genes were common to all three therapy-resistant sublines and only a minority (similar to 5%) was androgen-regulated. Pathway analysis revealed enrichment in functions involving cellular movement, cell growth and cell death, as well as association with cancer and reproductive system disease. PC346DCC expressed residual levels of androgen receptor (AR) and showed significant down-regulation of androgen-regulated genes (p-value = 10(-7)). Up-regulation of VAV3 and TWIST1 oncogenes and repression of the DKK3 tumor-suppressor was observed in PC346DCC, suggesting a potential AR bypass mechanism. Subsequent validation of these three genes in patient samples confirmed that expression was deregulated during prostate cancer progression. Conclusions/Significance: Therapy-resistant growth may result from adaptations in the AR pathway, but androgen-independence may also be achieved by alternative survival mechanisms. Here we identified TWIST1, VAV3 and DKK3 as potential players in the bypassing of the AR pathway, making them good candidates as biomarkers and novel therapeutical targets.	[Marques, Rute B.; Dits, Natasja F.; Erkens-Schulze, Sigrun; van Weerden, Wytske M.; Jenster, Guido] Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Marques, RB (corresponding author), Erasmus MC, Josephine Nefkens Inst, Dept Urol, Rotterdam, Netherlands.	g.jenster@erasmusmc.nl			Netherlands Organization for Scientific Research (NWO), through ZonMW [903-46-187]; Dutch Cancer Society (KWF) [NKB97-1479, DDHK 2001-2455]	Netherlands Organization for Scientific Research (NWO), through ZonMW(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society (KWF)(KWF Kankerbestrijding)	The work presented in this manuscript was financially supported by the Netherlands Organization for Scientific Research (NWO), through ZonMW grant 903-46-187, and by the Dutch Cancer Society (KWF), through grants NKB97-1479 and DDHK 2001-2455. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asim M, 2008, ONCOGENE, V27, P3596, DOI 10.1038/sj.onc.1211016; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Baugh LR, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.5.e29; Berry PA, 2008, MOL CELL ENDOCRINOL, V288, P30, DOI 10.1016/j.mce.2008.02.024; Best CJM, 2005, CLIN CANCER RES, V11, P6823, DOI 10.1158/1078-0432.CCR-05-0585; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Brown RSD, 2002, J PATHOL, V198, P237, DOI 10.1002/path.1206; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Chen Y, 1996, CELL GROWTH DIFFER, V7, P1571; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cinar B, 2001, CANCER RES, V61, P7310; Colomba A, 2008, ONCOGENE, V27, P2728, DOI 10.1038/sj.onc.1210921; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Culig Z, 1997, DRUG AGING, V10, P50, DOI 10.2165/00002512-199710010-00005; Culig Z, 2004, GROWTH FACTORS, V22, P179, DOI 10.1080/08977190412331279908; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Dong JT, 2001, CANCER METAST REV, V20, P173, DOI 10.1023/A:1015575125780; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Dupont J, 2001, J BIOL CHEM, V276, P26699, DOI 10.1074/jbc.M102664200; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Eisenberger MA, 1998, NEW ENGL J MED, V339, P1036, DOI 10.1056/NEJM199810083391504; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Fribourg AF, 2000, CELL GROWTH DIFFER, V11, P361; Gregory CW, 2001, J ANDROL, V22, P537; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; Gurumurthy S, 2001, CANCER METAST REV, V20, P225, DOI 10.1023/A:1015583310759; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Hsieh SY, 2004, ONCOGENE, V23, P9183, DOI 10.1038/sj.onc.1208138; Hu L, 2008, CANCER RES, V68, P4296, DOI 10.1158/0008-5472.CAN-08-0067; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jenster G, 1999, SEMIN ONCOL, V26, P407; Kawano Y, 2006, ONCOGENE, V25, P6528, DOI 10.1038/sj.onc.1209661; Koivisto P, 1997, CANCER RES, V57, P314; Kwok WK, 2007, CARCINOGENESIS, V28, P2467, DOI 10.1093/carcin/bgm185; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lee ECY, 2004, ARCH ANDROLOGY, V50, P27, DOI 10.1080/01485010490250498; Linja MJ, 2001, CANCER RES, V61, P3550; Liu Y, 2008, CANCER RES, V68, P6396, DOI 10.1158/0008-5472.CAN-08-0645; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lodygin D, 2005, CANCER RES, V65, P4218, DOI 10.1158/0008-5472.CAN-04-4407; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Lu S, 1997, CANCER RES, V57, P4511; Lyons LS, 2006, MOL ENDOCRINOL, V20, P1061, DOI 10.1210/me.2005-0346; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; Marques RB, 2006, EUR UROL, V49, P245, DOI 10.1016/j.eururo.2005.12.035; Marques RB, 2005, INT J CANCER, V117, P221, DOI 10.1002/ijc.21201; MENDIRATTA P, 2009, J CLIN ONCOL; Moores SL, 2000, MOL CELL BIOL, V20, P6364, DOI 10.1128/MCB.20.17.6364-6373.2000; Movilla N, 1999, MOL CELL BIOL, V19, P7870; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Saeb-Parsy K, 2008, BRIT J CANCER, V99, P663, DOI 10.1038/sj.bjc.6604513; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Tamura K, 2007, CANCER RES, V67, P5117, DOI 10.1158/0008-5472.CAN-06-4040; Taneja SS, 2002, J CELL BIOCHEM, V84, P188, DOI 10.1002/jcb.1278; Taplin ME, 2003, J CLIN ONCOL, V21, P2673, DOI 10.1200/JCO.2003.11.102; Tararova ND, 2007, PROSTATE, V67, P1801, DOI 10.1002/pros.20662; TATAROV O, 2007, TRANSLATIONAL ONCOGE, V2, P85; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Trenkle T, 2000, GENE, V245, P139, DOI 10.1016/S0378-1119(00)00026-3; van der Heul-Nieuwenhuijsen L, 2006, BJU INT, V98, P886, DOI 10.1111/j.1464-410X.2006.06427.x; VANDERKWAST TH, 1991, INT J CANCER, V48, P189, DOI 10.1002/ijc.2910480206; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Veldhoven A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-192; VELDSCHOLTE J, 1990, BIOCHEM BIOPH RES CO, V173, P534, DOI 10.1016/S0006-291X(05)80067-1; Verma RS, 1999, CANCER INVEST, V17, P441, DOI 10.3109/07357909909021436; Wang Y, 2007, CURR CANCER DRUG TAR, V7, P591, DOI 10.2174/156800907781662248; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Yuen HF, 2007, HISTOPATHOLOGY, V50, P648, DOI 10.1111/j.1365-2559.2007.02665.x; Zeng LY, 2000, MOL CELL BIOL, V20, P9212, DOI 10.1128/MCB.20.24.9212-9224.2000; Zenzmaier C, 2008, PROSTATE, V68, P540, DOI 10.1002/pros.20711; Zhang YQ, 2007, PATHOLOGY, V39, P470, DOI 10.1080/00313020701570053; Zhu ML, 2008, ENDOCR-RELAT CANCER, V15, P841, DOI 10.1677/ERC-08-0084	80	68	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13500	10.1371/journal.pone.0013500	http://dx.doi.org/10.1371/journal.pone.0013500			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976069	Green Submitted, Green Published, gold			2022-12-27	WOS:000283114700020
J	Ramser, EM; Wolters, G; Dityateva, G; Dityatev, A; Schachner, M; Tilling, T				Ramser, Elisa M.; Wolters, Gerrit; Dityateva, Galina; Dityatev, Alexander; Schachner, Melitta; Tilling, Thomas			The 14-3-3 zeta Protein Binds to the Cell Adhesion Molecule L1, Promotes L1 Phosphorylation by CKII and Influences L1-Dependent Neurite Outgrowth	PLOS ONE			English	Article							SERINE PHOSPHORYLATION; NEURONAL MIGRATION; RAF-1 ACTIVATION; KINASE-ACTIVITY; GROWTH CONES; EXOENZYME S; TRAFFICKING; TRANSPORT; EXPRESSION; BRAIN	Background: The cell adhesion molecule L1 is crucial for mammalian nervous system development. L1 acts as a mediator of signaling events through its intracellular domain, which comprises a putative binding site for 14-3-3 proteins. These regulators of diverse cellular processes are abundant in the brain and preferentially expressed by neurons. In this study, we investigated whether L1 interacts with 14-3-3 proteins, how this interaction is mediated, and whether 14-3-3 proteins influence the function of L1. Methodology/Principal Findings: By immunoprecipitation, we demonstrated that 14-3-3 proteins are associated with L1 in mouse brain. The site of 14-3-3 interaction in the L1 intracellular domain (L1ICD), which was identified by site-directed mutagenesis and direct binding assays, is phosphorylated by casein kinase II (CKII), and CKII phosphorylation of the L1ICD enhances binding of the 14-3-3 zeta isoform (14-3-3 zeta). Interestingly, in an in vitro phosphorylation assay, 14-3-3 zeta promoted CKII-dependent phosphorylation of the L1ICD. Given that L1 phosphorylation by CKII has been implicated in L1-triggered axonal elongation, we investigated the influence of 14-3-3 zeta on L1-dependent neurite outgrowth. We found that expression of a mutated form of 14-3-3 zeta, which impairs interactions of 14-3-3 zeta with its binding partners, stimulated neurite elongation from cultured rat hippocampal neurons, supporting a functional connection between L1 and 14-3-3 zeta. Conclusions/Significance: Our results suggest that 14-3-3 zeta, a novel direct binding partner of the L1ICD, promotes L1 phosphorylation by CKII in the central nervous system, and regulates neurite outgrowth, an important biological process triggered by L1.	[Ramser, Elisa M.; Wolters, Gerrit; Dityateva, Galina; Dityatev, Alexander; Schachner, Melitta; Tilling, Thomas] Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany; [Dityateva, Galina; Dityatev, Alexander] Italian Inst Technol, Dept Neurosci & Brain Technol, Genoa, Italy; [Schachner, Melitta] Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ USA; [Schachner, Melitta] Rutgers State Univ, Dept Cell Biol & Neurosci, Piscataway, NJ USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Istituto Italiano di Tecnologia - IIT; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Ramser, EM (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Wolters-Eisfeld, Gerrit/H-8333-2019; Dityatev, Alexander/A-4034-2008	Wolters-Eisfeld, Gerrit/0000-0002-2984-6515; Dityatev, Alexander/0000-0002-0472-0553	German Federal Ministry of Education and Research [0311762/8]; New Jersey Commission for Spinal Cord Research	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); New Jersey Commission for Spinal Cord Research	The study was partially supported by the German Federal Ministry of Education and Research, project no. 0311762/8 (to M. S.), and the New Jersey Commission for Spinal Cord Research (to M. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken A, 1996, TRENDS CELL BIOL, V6, P341, DOI 10.1016/0962-8924(96)10029-5; APPEL F, 1995, J NEUROBIOL, V28, P297, DOI 10.1002/neu.480280304; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Cavet ME, 2003, J BIOL CHEM, V278, P18376, DOI 10.1074/jbc.M208475200; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Chen BS, 2009, NEURON, V62, P471, DOI 10.1016/j.neuron.2009.04.015; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Clark GJ, 1997, J BIOL CHEM, V272, P20990, DOI 10.1074/jbc.272.34.20990; Dahme M, 1997, NAT GENET, V17, P346, DOI 10.1038/ng1197-346; Daro E, 1996, P NATL ACAD SCI USA, V93, P9559, DOI 10.1073/pnas.93.18.9559; Demyanenko GP, 1999, J NEUROSCI, V19, P4907; DENT P, 1995, SCIENCE, V268, P1902, DOI 10.1126/science.7604263; Dityateva G, 2003, J NEUROSCI METH, V130, P65, DOI 10.1016/S0165-0270(03)00202-4; FANTL WJ, 1994, NATURE, V371, P612, DOI 10.1038/371612a0; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Goransson O, 2006, J CELL SCI, V119, P4059, DOI 10.1242/jcs.03097; Gutwein P, 2005, CLIN CANCER RES, V11, P2492, DOI 10.1158/1078-0432.CCR-04-1688; Gutwein P, 2002, FASEB J, V16, P292, DOI 10.1096/fj.02-0430fje; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Henriksson ML, 2000, BIOCHEM J, V349, P697, DOI 10.1042/bj3490697; Hortsch M, 2000, MOL CELL NEUROSCI, V15, P1, DOI 10.1006/mcne.1999.0809; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; Kalus I, 2003, J BIOL CHEM, V278, P10381, DOI 10.1074/jbc.M208351200; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kamiguchi H, 1998, J NEUROSCI, V18, P3749, DOI 10.1523/jneurosci.18-10-03749.1998; Kamiguchi H, 2000, J NEUROSCI, V20, P3676, DOI 10.1523/JNEUROSCI.20-10-03676.2000; Kenwrick S, 2000, HUM MOL GENET, V9, P879, DOI 10.1093/hmg/9.6.879; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Leshchyns'ka I, 2003, J CELL BIOL, V161, P625, DOI 10.1083/jcb.200303020; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Long KE, 2000, J NEUROBIOL, V44, P230, DOI 10.1002/1097-4695(200008)44:2<230::AID-NEU12>3.0.CO;2-W; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; MIURA M, 1991, FEBS LETT, V289, P91, DOI 10.1016/0014-5793(91)80915-P; Mohajeri MH, 1996, EUR J NEUROSCI, V8, P1085, DOI 10.1111/j.1460-9568.1996.tb01276.x; Moore B. W., 1967, SPECIFIC ACID PROTEI; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakata A, 2007, J NEUROSCI RES, V85, P723, DOI 10.1002/jnr.21185; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsil T, 2001, CELL, V105, P257, DOI 10.1016/S0092-8674(01)00316-6; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Reuther GW, 1996, VITAM HORM, V52, P149, DOI 10.1016/S0083-6729(08)60410-0; Rong JA, 2007, J BIOL CHEM, V282, P4748, DOI 10.1074/jbc.M609057200; Sadik G, 2009, J NEUROCHEM, V108, P33, DOI 10.1111/j.1471-4159.2008.05716.x; Sarno S, 2001, FEBS LETT, V496, P44, DOI 10.1016/S0014-5793(01)02404-8; Schaefer AW, 2002, J CELL BIOL, V157, P1223, DOI 10.1083/jcb.200203024; Schmitz D, 2008, GROWTH HORM IGF RES, V18, P245, DOI 10.1016/j.ghir.2007.10.002; Shen YH, 2003, MOL BIOL CELL, V14, P4721, DOI 10.1091/mbc.E02-12-0821; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Takeda Y, 1996, J NEUROCHEM, V66, P2338; Toyo-oka K, 2003, NAT GENET, V34, P274, DOI 10.1038/ng1169; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wong EV, 1996, J NEUROCHEM, V66, P779; Wong EV, 1996, J BIOL CHEM, V271, P18217, DOI 10.1074/jbc.271.30.18217; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511	68	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13462	10.1371/journal.pone.0013462	http://dx.doi.org/10.1371/journal.pone.0013462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976158	Green Submitted, Green Published, gold			2022-12-27	WOS:000283045300031
J	Dessing, MC; Butter, LM; Teske, GJ; Claessen, N; van der Loos, CM; Vogl, T; Roth, J; van der Poll, T; Florquin, S; Leemans, JC				Dessing, Mark C.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; van der Loos, Chris M.; Vogl, Thomas; Roth, Johannes; van der Poll, Tom; Florquin, Sandrine; Leemans, Jaklien C.			S100A8/A9 Is Not Involved in Host Defense against Murine Urinary Tract Infection	PLOS ONE			English	Article							CALCIUM-BINDING PROTEIN; TOLL-LIKE RECEPTORS; S100 PROTEINS; ANTIMICROBIAL ACTIVITY; PLASMINOGEN-ACTIVATOR; ACUTE PYELONEPHRITIS; UROLOGIC DISEASES; AMERICA PROJECT; KIDNEY-DISEASE; CALPROTECTIN	Background: Inflammation is commonly followed by the release of endogenous proteins called danger associated molecular patterns (DAMPs) that are able to warn the host for eminent danger. S100A8/A9 subunits are DAMPs that belong to the S100 family of calcium binding proteins. S100A8/A9 complexes induce an inflammatory response and their expression correlates with disease severity in several inflammatory disorders. S100A8/A9 promote endotoxin-and Escherichia (E.) coli-induced sepsis showing its contribution in systemic infection. The role of S100A8/A9 during a local infection of the urinary tract system caused by E. coli remains unknown. Methodology/Principal Findings: We investigated the contribution of S100A8/A9 in acute urinary tract infection (UTI) by instilling 2 different doses of uropathogenic E. coli transurethrally in wild type (WT) and S100A9 knockout (KO) mice. Subsequently, we determined bacterial outgrowth, neutrophilic infiltrate and inflammatory mediators in bladder and kidney 24 and 48 hours later. UTI resulted in a substantial increase of S100A8/A9 protein in bladder and kidney tissue of WT mice. S100A9 KO mice displayed similar bacterial load in bladder or kidney homogenate compared to WT mice using 2 different doses at 2 different time points. S100A9 deficiency had little effect on the inflammatory responses to E. Coli-induced UTI infection, as assessed by myeloperoxidase activity in bladder and kidneys, histopathologic analysis, and renal and bladder cytokine concentrations. Conclusions: We show that despite high S100A8/A9 expression in bladder and kidney tissue upon UTI, S100A8/A9 does not contribute to an effective host response against E. Coli in the urinary tract system.	[Dessing, Mark C.; Butter, Loes M.; Teske, Gwendoline J.; Claessen, Nike; van der Loos, Chris M.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Vogl, Thomas; Roth, Johannes] Univ Munster, Inst Immunol, Munster, Germany; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Munster; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Dessing, MC (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands.	m.c.dessing@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020; Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722	Dutch Kidney Foundation	Dutch Kidney Foundation	This study has been financially supported by the Dutch Kidney Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders HJ, 2007, CURR OPIN NEPHROL HY, V16, P177, DOI 10.1097/MNH.0b013e32803fb767; Anders HJ, 2004, J AM SOC NEPHROL, V15, P854, DOI 10.1097/01.ASN.0000121781.89599.16; BRANDTZAEG P, 1995, ADV EXP MED BIOL, V371, P201; Cornish CJ, 1996, J CELL PHYSIOL, V166, P427, DOI 10.1002/(SICI)1097-4652(199602)166:2<427::AID-JCP21>3.0.CO;2-6; Czaja CA, 2007, CLIN INFECT DIS, V45, P273, DOI 10.1086/519268; EDGEWORTH J, 1989, NATURE, V342, P189, DOI 10.1038/342189a0; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Eue I, 2000, INT IMMUNOL, V12, P1593, DOI 10.1093/intimm/12.11.1593; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Freedman AL, 2005, J UROLOGY, V173, P949, DOI 10.1097/01.ju.0000152092.03931.9a; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Mambula SS, 2000, INFECT IMMUN, V68, P6257, DOI 10.1128/IAI.68.11.6257-6264.2000; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; MCNAMARA MP, 1988, LANCET, V2, P1163; Newton RA, 1998, J IMMUNOL, V160, P1427; Nisapakultorn K, 2001, INFECT IMMUN, V69, P3692, DOI 10.1128/IAI.69.6.3692-3696.2001; Passey RJ, 1999, J IMMUNOL, V163, P2209; Perez-Alvarez MJ, 2000, REGUL PEPTIDES, V88, P41, DOI 10.1016/S0167-0115(99)00118-4; Raquil MA, 2008, J IMMUNOL, V180, P3366, DOI 10.4049/jimmunol.180.5.3366; Reyes L, 2009, INFECT IMMUN, V77, P4265, DOI 10.1128/IAI.00458-09; Roelofs JJTH, 2006, KIDNEY INT, V70, P1942, DOI 10.1038/sj.ki.5001947; Roelofs JJTH, 2009, NEPHROL DIAL TRANSPL, V24, P801, DOI 10.1093/ndt/gfn562; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Rouschop KMA, 2006, J IMMUNOL, V177, P7225, DOI 10.4049/jimmunol.177.10.7225; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; SANTHANAGOPALAN V, 1995, J INFECT DIS, V171, P1289, DOI 10.1093/infdis/171.5.1289; Sivick KE, 2010, INFECT IMMUN, V78, P568, DOI 10.1128/IAI.01000-09; SOHNLE PG, 1991, J INFECT DIS, V163, P187, DOI 10.1093/infdis/163.1.187; Sohnle PG, 1996, J INFECT DIS, V174, P1369, DOI 10.1093/infdis/174.6.1369; Sohnle PG, 2000, J INFECT DIS, V182, P1272, DOI 10.1086/315810; STEINBAKK M, 1990, LANCET, V336, P763, DOI 10.1016/0140-6736(90)93237-J; van der Loos CM, 2008, J HISTOTECHNOL, V31, P119, DOI 10.1179/his.2008.31.3.119; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; van Zoelen MAD, 2009, AM J RESP CRIT CARE, V180, P1098, DOI 10.1164/rccm.200810-1552OC; Vandal K, 2003, J IMMUNOL, V171, P2602, DOI 10.4049/jimmunol.171.5.2602; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638	42	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13394	10.1371/journal.pone.0013394	http://dx.doi.org/10.1371/journal.pone.0013394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976233	gold, Green Published, Green Submitted			2022-12-27	WOS:000282941000019
J	Manoj, KM; Gade, SK; Mathew, L				Manoj, Kelath Murali; Gade, Sudeep Kumar; Mathew, Lazar			Cytochrome P450 Reductase: A Harbinger of Diffusible Reduced Oxygen Species	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; C REDUCTASE; OXIDATION; ACTIVATION; MECHANISM; BINDING; P4502C9	The bi-enzymatic system of cytochrome P450 (CYP, a hemoprotein) and cytochrome P450 reductase (CPR, a diflavoenzyme) mediate the redox metabolism of diverse indigenous and xenobiotic molecules in various cellular and organ systems, using oxygen and NADPH. Curiously, when a 1: 1 ratio is seen to be optimal for metabolism, the ubiquitous CYP: CPR distribution ratio is 10 to 100: 1 or higher. Further, the NADPH equivalents consumed in these in vitro or in situ assemblies usually far exceeded the amount of substrate metabolized. We aimed to find the rationale to explain for these two oddities. We report here that CPR is capable of activating molecular oxygen on its own merit, generating diffusible reduced oxygen species (DROS). Also, in the first instance for a flavoprotein, CPR is shown to deplete peroxide via diffusible radical mediated process, thereby leading to the formation of water (but without significant evolution of oxygen). We also quantitatively demonstrate that the rate of oxygen activation and peroxide depletion by CPR accounts for the major reactivity in the CYP+CPR mixture. We show unambiguously that CPR is able to regulate the concentration of diffusible reduced oxygen species in the reaction milieu. These findings point out that CPR mediated processes are bound to be energetically 'wasteful' and potentially 'hazardous' owing to the unavoidable nature of the CPR to generate and deplete DROS. Hence, we can understand that CPR is distributed at low densities in cells. Some of the activities that were primarily attributed to the heme-center of CYP are now established to be a facet of the flavins of CPR. The current approach of modeling drugs to minimize "uncoupling" on the basis of erstwhile hypothesis stands questionable, considering the ideas brought forth in this work.	[Manoj, Kelath Murali; Gade, Sudeep Kumar; Mathew, Lazar] VIT Univ, Heme Flavin Lab, Sch Bio Sci & Technol, Ctr Biomed Res, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Manoj, KM (corresponding author), VIT Univ, Heme Flavin Lab, Sch Bio Sci & Technol, Ctr Biomed Res, Vellore, Tamil Nadu, India.	muralimanoj@vit.ac.in			Satyamjayatu: The Science Foundation; VIT University	Satyamjayatu: The Science Foundation; VIT University	This research was partially funded by "Satyamjayatu: The Science Foundation" and departmental student research funds from VIT University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUST SD, 1972, BIOCHEM BIOPH RES CO, V47, P1133, DOI 10.1016/0006-291X(72)90952-7; Bernhardt R, 2006, J BIOTECHNOL, V124, P128, DOI 10.1016/j.jbiotec.2006.01.026; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Francis K, 2005, J BIOL CHEM, V280, P5195, DOI 10.1074/jbc.M411249200; Guengerich FP, 2002, BIOL CHEM, V383, P1553, DOI 10.1515/BC.2002.175; Hayashi Seiko, 2005, Drug Metab Pharmacokinet, V20, P14, DOI 10.2133/dmpk.20.14; JIANG ZY, 1990, FEBS LETT, V268, P69, DOI 10.1016/0014-5793(90)80974-N; Joo H, 1999, NATURE, V399, P670, DOI 10.1038/21395; KING MM, 1975, J BIOL CHEM, V250, P6496; Manoj KM, 2006, BBA-PROTEINS PROTEOM, V1764, P1325, DOI 10.1016/j.bbapap.2006.05.012; Manoj KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010601; Martinez CA, 2000, CURR ORG CHEM, V4, P263, DOI 10.2174/1385272003376265; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MIWA GT, 1979, J BIOL CHEM, V254, P5695; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Murataliev MB, 2004, BBA-PROTEINS PROTEOM, V1698, P1, DOI 10.1016/j.bbapap.2003.10.003; Narasimhulu S, 2007, BBA-GEN SUBJECTS, V1770, P360, DOI 10.1016/j.bbagen.2006.09.018; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; PEDERSON TC, 1975, BIOCHIM BIOPHYS ACTA, V385, P232, DOI 10.1016/0304-4165(75)90351-7; Petlicki J, 1998, J CHEM SOC FARADAY T, V94, P2763, DOI 10.1039/a804551h; POULOS TL, 1992, FASEB J, V6, P674, DOI 10.1096/fasebj.6.2.1537455; RUTTER R, 1982, J BIOL CHEM, V257, P7958; SAWYER DT, 1981, ACCOUNTS CHEM RES, V14, P393, DOI 10.1021/ar00072a005; SELLERS RM, 1980, ANALYST, V105, P950, DOI 10.1039/an9800500950; Silverman R.B., 2002, ORGANIC CHEM ENZYME, V2nd; SLIGAR SG, 1976, P NATL ACAD SCI USA, V73, P1078, DOI 10.1073/pnas.73.4.1078; Testa B, 1995, METABOLISM DRUGS OTH; Wester MR, 2004, J BIOL CHEM, V279, P35630, DOI 10.1074/jbc.M405427200; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Yun CH, 2006, CURR DRUG METAB, V7, P411, DOI 10.2174/138920006776873472; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018	36	29	32	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13272	10.1371/journal.pone.0013272	http://dx.doi.org/10.1371/journal.pone.0013272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967245	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800009
J	Kumar, A; Xu, J; Brady, S; Gao, H; Yu, DH; Reuben, J; Mehta, K				Kumar, Anupam; Xu, Jia; Brady, Samuel; Gao, Hui; Yu, Dihua; Reuben, James; Mehta, Kapil			Tissue Transglutaminase Promotes Drug Resistance and Invasion by Inducing Mesenchymal Transition in Mammary Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; CANCER-CELLS; BINDING-PROTEIN; RESPONSE ELEMENT; OVARIAN-CANCER; CROSS-LINKING; ACTIVATION; EXPRESSION; GROWTH; BETA	Recent observations that aberrant expression of tissue transglutaminase (TG2) promotes growth, survival, and metastasis of multiple tumor types is of great significance and could yield novel therapeutic targets for improved patient outcomes. To accomplish this, a clear understanding of how TG2 contributes to these phenotypes is essential. Using mammary epithelial cell lines (MCF10A, MCF12A, MCF7 and MCF7/RT) as a model system, we determined the impact of TG2 expression on cell growth, cell survival, invasion, and differentiation. Our results show that TG2 expression promotes drug resistance and invasive functions by inducing epithelial-mesenchymal transition (EMT). Thus, TG2 expression supported anchorage-independent growth of mammary epithelial cells in soft-agar, disrupted the apical-basal polarity, and resulted in disorganized acini structures when grown in 3D-culture. At molecular level, TG2 expression resulted in loss of E-cadherin and increased the expression of various transcriptional repressors (Snail1, Zeb1, Zeb2 and Twist1). Tumor growth factor-beta (TGF-beta) failed to induce EMT in cells lacking TG2 expression, suggesting that TG2 is a downstream effector of TGF-beta-induced EMT. Moreover, TG2 expression induced stem cell-like phenotype in mammary epithelial cells as revealed by enrichment of CD44(+)/CD24(-/low) cell populations. Overall, our studies show that aberrant expression of TG2 is sufficient for inducing EMT in epithelial cells and establish a strong link between TG2 expression and progression of metastatic breast disease.	[Kumar, Anupam; Brady, Samuel; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Brady, Samuel; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	kumar, Anupam/AFM-6318-2022	Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261	Susan G. Komen for the Cure Foundation [KG080078]	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by a grant (KG080078) from Susan G. Komen for the Cure Foundation (http://ww5.komen.org). The sponsor had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Balklava Z, 2002, J BIOL CHEM, V277, P16567, DOI 10.1074/jbc.M109836200; Cao LY, 2008, CARCINOGENESIS, V29, P1893, DOI 10.1093/carcin/bgn158; Chandrashekar R, 1998, P NATL ACAD SCI USA, V95, P531, DOI 10.1073/pnas.95.2.531; CHEN WC, 1991, J CELL BIOL, V114, P319, DOI 10.1083/jcb.114.2.319; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Chua HL, 2007, ONCOGENE, V26, P711, DOI 10.1038/sj.onc.1209808; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Im MJ, 1997, CELL SIGNAL, V9, P477, DOI 10.1016/S0898-6568(97)00049-1; Jung SA, 2007, INVEST OPHTH VIS SCI, V48, P1952, DOI 10.1167/iovs.06-1164; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kim Y, 2010, MOL IMMUNOL, V47, P1010, DOI 10.1016/j.molimm.2009.11.017; Kotsakis P, 2007, AMINO ACIDS, V33, P373, DOI 10.1007/s00726-007-0516-1; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Micalizzi DS, 2009, FUTURE ONCOL, V5, P1129, DOI 10.2217/FON.09.94; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Nunes I, 1997, J CELL BIOL, V136, P1151, DOI 10.1083/jcb.136.5.1151; Orlowski RZ, 2002, TRENDS MOL MED, V8, P385, DOI 10.1016/S1471-4914(02)02375-4; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Quan G, 2005, ARCH DERMATOL RES, V297, P84, DOI 10.1007/s00403-005-0582-8; Ritter SJ, 1998, J BIOL CHEM, V273, P12798, DOI 10.1074/jbc.273.21.12798; Sabbah M, 2008, DRUG RESIST UPDATE, V11, P123, DOI 10.1016/j.drup.2008.07.001; Satpathy M, 2009, J BIOL CHEM, V284, P15390, DOI 10.1074/jbc.M808331200; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Siegel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001861; Telci D, 2009, J BIOL CHEM, V284, P29547, DOI 10.1074/jbc.M109.041806; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Verderio EAM, 2003, J BIOL CHEM, V278, P42604, DOI 10.1074/jbc.M303303200; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2007, DRUG RESIST UPDATE, V10, P144, DOI 10.1016/j.drup.2007.06.002; Wang ZW, 2009, CANCER RES, V69, P2400, DOI 10.1158/0008-5472.CAN-08-4312; Wu Y, 2009, CANCER CELL, V15, P416, DOI 10.1016/j.ccr.2009.03.016; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	50	85	94	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13390	10.1371/journal.pone.0013390	http://dx.doi.org/10.1371/journal.pone.0013390			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967228	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300034
J	Ding, LL; Kuhne, WW; Hinton, DE; Song, JA; Dynan, WS				Ding, Lingling; Kuhne, Wendy W.; Hinton, David E.; Song, Jian; Dynan, William S.			Quantifiable Biomarkers of Normal Aging in the Japanese Medaka Fish (Oryzias latipes)	PLOS ONE			English	Article							CYSTIC DEGENERATION/SPONGIOSIS HEPATIS; GERM-CELL MUTAGENESIS; LYSOSOMAL AXIS THEORY; LIFE-SPAN; VERTEBRATE MODEL; IN-VIVO; GRADUAL SENESCENCE; ZEBRAFISH; TELEOST; ACCUMULATION	Background: Small laboratory fish share many anatomical and histological characteristics with other vertebrates, yet can be maintained in large numbers at low cost for lifetime studies. Here we characterize biomarkers associated with normal aging in the Japanese medaka (Oryzias latipes), a species that has been widely used in toxicology studies and has potential utility as a model organism for experimental aging research. Principal Findings: The median lifespan of medaka was approximately 22 months under laboratory conditions. We performed quantitative histological analysis of tissues from age-grouped individuals representing young adults (6 months old), mature adults (16 months old), and adults that had survived beyond the median lifespan (24 months). Livers of 24-month old individuals showed extensive morphologic changes, including spongiosis hepatis, steatosis, ballooning degeneration, inflammation, and nuclear pyknosis. There were also phagolysosomes, vacuoles, and residual bodies in parenchymal cells and congestion of sinusoidal vessels. Livers of aged individuals were characterized by increases in lipofuscin deposits and in the number of TUNEL-positive apoptotic cells. Some of these degenerative characteristics were seen, to a lesser extent, in the livers of 16-month old individuals, but not in 6-month old individuals. The basal layer of the dermis showed an age-dependent decline in the number of dividing cells and an increase in senescence-associated beta-galactosidase. The hearts of aged individuals were characterized by fibrosis and lipofuscin deposition. There was also a loss of pigmented cells from the retinal epithelium. By contrast, age-associated changes were not apparent in skeletal muscle, the ocular lens, or the brain. Significance: The results provide a set of markers that can be used to trace the process of normal tissue aging in medaka and to evaluate the effect of environmental stressors.	[Ding, Lingling; Kuhne, Wendy W.; Dynan, William S.] Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA; [Ding, Lingling; Song, Jian] Wuhan Univ, Sch Med, Dept Anat & Embryol, Wuhan, Hubei, Peoples R China; [Kuhne, Wendy W.] Savannah River Natl Lab, Aiken, SC USA; [Hinton, David E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	University System of Georgia; Augusta University; Wuhan University; United States Department of Energy (DOE); Savannah River National Laboratory; Duke University	Ding, LL (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Augusta, GA 30912 USA.	wdynan@mcg.edu		Dynan, William/0000-0002-4045-5662; Kuhne, Wendy/0000-0002-0501-1919	U.S. Department of Energy Low Dose Radiation Research Program (DOE) [FG02-03ERG3649, DE-SC0002343]; National Research Service Award [1F32ES015663-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES015663] Funding Source: NIH RePORTER	U.S. Department of Energy Low Dose Radiation Research Program (DOE)(United States Department of Energy (DOE)); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	U.S. Department of Energy Low Dose Radiation Research Program (DOE FG02-03ERG3649 and DE-SC0002343) and National Research Service Award (1F32ES015663-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au DWT, 2009, COMP BIOCHEM PHYS C, V149, P161, DOI 10.1016/j.cbpc.2008.08.005; Bannasch P, 2003, TOXICOL PATHOL, V31, P566, DOI 10.1080/01926230390224700; BANNASCH P, 2002, TOXICOL PATHOL, V30, P216; Boorman GA, 1997, TOXICOL PATHOL, V25, P202, DOI 10.1177/019262339702500210; Brunk UT, 2002, EUR J BIOCHEM, V269, P1996, DOI 10.1046/j.1432-1033.2002.02869.x; Cellerino A, 2009, AGING MED, P157, DOI 10.1007/978-1-60327-507-1_10; COUCH JA, 1991, TOXICOL PATHOL, V19, P237, DOI 10.1177/019262339101900306; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dunlop RA, 2009, IUBMB LIFE, V61, P522, DOI 10.1002/iub.189; EGAMI N, 1973, EXP GERONTOL, V8, P219, DOI 10.1016/0531-5565(73)90029-6; EGAMI N, 1971, EXP GERONTOL, V6, P379, DOI 10.1016/0531-5565(71)90007-6; EGAMI N, 1969, EXP GERONTOL, V4, P127, DOI 10.1016/0531-5565(69)90035-7; EGAMI NOBUO, 1962, ANNOT ZOOL JAPAN, V35, P188; Elmore LW, 2008, EXP BIOL MED, V233, P958, DOI 10.3181/0712-RM-345; Furutani-Seiki M, 2004, MECH DEVELOP, V121, P629, DOI 10.1016/j.mod.2004.05.010; Genade T, 2005, AGING CELL, V4, P223, DOI 10.1111/j.1474-9726.2005.00165.x; Gerhard GS, 2007, AGEING RES REV, V6, P64, DOI 10.1016/j.arr.2007.02.007; GOMORI G, 1950, AM J CLIN PATHOL, V20, P661, DOI 10.1093/ajcp/20.7_ts.661; Greiling TMS, 2009, MOL VIS, V15, P2313; Hatakeyama H, 2008, MECH AGEING DEV, V129, P550, DOI 10.1016/j.mad.2008.05.006; Hawkins William E., 2003, Toxicologic Pathology, V31, P88; Hinton D E, 1984, Natl Cancer Inst Monogr, V65, P239; Hinton TG, 2004, J ENVIRON RADIOACTIV, V74, P43, DOI 10.1016/j.jenvrad.2004.01.014; Hobbie KR, 2009, COMP BIOCHEM PHYS C, V149, P141, DOI 10.1016/j.cbpc.2008.07.013; Hyodo-Taguchi Y., 1989, P185; Ijiri K, 2003, ADV SPACE B, V9, P201, DOI 10.1016/S1569-2574(03)09008-7; Karbe E, 2002, TOXICOL PATHOL, V30, P216, DOI 10.1080/019262302753559551; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kishi S, 2004, ANN NY ACAD SCI, V1019, P521, DOI 10.1196/annals.1297.097; Kishi S, 2003, EXP GERONTOL, V38, P777, DOI 10.1016/S0531-5565(03)00108-6; Kishi S, 2009, GERONTOLOGY, V55, P430, DOI 10.1159/000228892; Kishi S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000152; Kong RYC, 2008, AQUAT TOXICOL, V86, P131, DOI 10.1016/j.aquatox.2007.10.011; Kuhne WW, 2009, RADIAT RES, V172, P473, DOI 10.1667/RR1556.1; LIU RK, 1975, J GERONTOL, V30, P129, DOI 10.1093/geronj/30.2.129; Malek RL, 2004, COMP BIOCHEM PHYS C, V138, P363, DOI 10.1016/j.cca.2004.08.014; MASAHITO P, 1989, JPN J CANCER RES, V80, P1058, DOI 10.1111/j.1349-7006.1989.tb02259.x; PATNAIK BK, 1994, GERONTOLOGY, V40, P113, DOI 10.1159/000213582; Shima A, 2004, MECH DEVELOP, V121, P599, DOI 10.1016/j.mod.2004.03.011; SHIMA A, 1978, EXP GERONTOL, V13, P51, DOI 10.1016/0531-5565(78)90030-X; Shimada A, 2005, P NATL ACAD SCI USA, V102, P6063, DOI 10.1073/pnas.0500895102; Taniguchi Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r116; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Winn RN, 2008, ENVIRON MOL MUTAGEN, V49, P173, DOI 10.1002/em.20364; Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704; WOODHEAD AD, 1984, EXP GERONTOL, V19, P383, DOI 10.1016/0531-5565(84)90048-2; Yen K, 2004, EXP GERONTOL, V39, P947, DOI 10.1016/j.exger.2004.03.016	47	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13287	10.1371/journal.pone.0013287	http://dx.doi.org/10.1371/journal.pone.0013287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949019	Green Published, gold, Green Submitted			2022-12-27	WOS:000282748100021
J	Ke, FY; Luu, YK; Hadjiargyrou, M; Liang, DH				Ke, Fuyou; Luu, Yen Kim; Hadjiargyrou, Michael; Liang, Dehai			Characterizing DNA Condensation and Conformational Changes in Organic Solvents	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CALF THYMUS DNA; LIGHT-SCATTERING; GENE DELIVERY; ETHANOL; ENCAPSULATION; COMPLEXES; ENTRAPMENT; THERAPY; TOROIDS	Organic solvents offer a new approach to formulate DNA into novel structures suitable for gene delivery. In this study, we examined the in situ behavior of DNA in N, N-dimethylformamide (DMF) at low concentration via laser light scattering (LLS), TEM, UV absorbance and Zeta potential analysis. Results revealed that, in DMF, a 21bp oligonucleotide remained intact, while calf thymus DNA and supercoiled plasmid DNA were condensed and denatured. During condensation and denaturation, the size was decreased by a factor of 8-10, with calf thymus DNA forming spherical globules while plasmid DNA exhibited a toroid-like conformation. In the condensed state, DNA molecules were still able to release the counterions to be negatively charged, indicating that the condensation was mainly driven by the excluded volume interactions. The condensation induced by DMF was reversible for plasmid DNA but not for calf thymus DNA. When plasmid DNA was removed from DMF and resuspended in an aqueous solution, the DNA was quickly regained a double stranded configuration. These findings provide further insight into the behavior and condensation mechanism of DNA in an organic solvent and may aid in developing more efficient non-viral gene delivery systems.	[Ke, Fuyou; Liang, Dehai] Peking Univ, Coll Chem & Mol Engn, Minist Educ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China; [Ke, Fuyou; Liang, Dehai] Peking Univ, Coll Chem & Mol Engn, Minist Educ, Key Lab Polymer Chem & Phys, Beijing 100871, Peoples R China; [Luu, Yen Kim; Hadjiargyrou, Michael] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Peking University; Peking University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Ke, FY (corresponding author), Peking Univ, Coll Chem & Mol Engn, Minist Educ, Beijing Natl Lab Mol Sci, Beijing 100871, Peoples R China.	michael.hadjiargyrou@sunysb.edu; dliang@pku.edu.cn	Hadjiargyrou, Michael/H-7191-2018	Hadjiargyrou, Michael/0000-0001-8927-2333	National Natural Science Foundation of China [20774004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (20774004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, DNA INTERACTIONS POL; Bailey AL, 2000, BBA-BIOMEMBRANES, V1468, P239, DOI 10.1016/S0005-2736(00)00264-9; Bonner G, 2000, BIOTECHNOL BIOENG, V68, P339, DOI 10.1002/(SICI)1097-0290(20000505)68:3<339::AID-BIT12>3.0.CO;2-O; Brown MD, 2001, INT J PHARMACEUT, V229, P1, DOI 10.1016/S0378-5173(01)00861-4; Budker VG, 2002, BIOPHYS J, V82, P1570, DOI 10.1016/S0006-3495(02)75508-2; BURCHARD W, 1983, ADV POLYM SCI, V48, P1; Conwell CC, 2003, P NATL ACAD SCI USA, V100, P9296, DOI 10.1073/pnas.1533135100; Cui SX, 2007, J AM CHEM SOC, V129, P14710, DOI 10.1021/ja074776c; Ewert K, 2004, CURR MED CHEM, V11, P133, DOI 10.2174/0929867043456160; Ewert KK, 2005, EXPERT OPIN BIOL TH, V5, P33, DOI 10.1517/14712598.5.1.33; FORSTER S, 1995, ADV POLYM SCI, V120, P51; Guo CL, 2009, J PHYS CHEM B, V113, P6068, DOI 10.1021/jp810126f; HAGERMAN PJ, 1981, BIOPOLYMERS, V20, P1503, DOI 10.1002/bip.1981.360200710; Hayes ME, 2006, GENE THER, V13, P646, DOI 10.1038/sj.gt.3302699; HELMKAMP GK, 1961, J AM CHEM SOC, V83, P138, DOI 10.1021/ja01462a027; Huang H, 2009, ANGEW CHEM INT EDIT, V48, P4594, DOI 10.1002/anie.200900533; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795; Koltover I, 1998, SCIENCE, V281, P78, DOI 10.1126/science.281.5373.78; Korobko AV, 2006, J PHYS CHEM B, V110, P14550, DOI 10.1021/jp057363b; Korobko AV, 2005, LANGMUIR, V21, P34, DOI 10.1021/la047967r; LEE CH, 1981, P NATL ACAD SCI-BIOL, V78, P2838, DOI 10.1073/pnas.78.5.2838; Liang DH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni171; Lin Z, 1998, NUCLEIC ACIDS RES, V26, P3228, DOI 10.1093/nar/26.13.3228; Luu YK, 2003, J CONTROL RELEASE, V89, P341, DOI 10.1016/S0168-3659(03)00097-X; Marty R, 2009, NUCLEIC ACIDS RES, V37, P849, DOI 10.1093/nar/gkn1003; Matzeu M, 1999, COLLOID SURFACE B, V13, P157, DOI 10.1016/S0927-7765(99)00005-3; Maurer N, 2001, BIOPHYS J, V80, P2310, DOI 10.1016/S0006-3495(01)76202-9; Maurstad G, 2003, J PHYS CHEM B, V107, P8172, DOI 10.1021/jp0271965; Mel'nikov SM, 1999, J AM CHEM SOC, V121, P1130, DOI 10.1021/ja981491e; Mikhailenko SV, 2000, BIOMACROMOLECULES, V1, P597, DOI 10.1021/bm0055403; Noguchi H, 1998, J CHEM PHYS, V109, P5070, DOI 10.1063/1.477121; Osada K, 2005, ANGEW CHEM INT EDIT, V44, P3544, DOI 10.1002/anie.200500201; Osfouri S, 2005, J PHYS CHEM B, V109, P19929, DOI 10.1021/jp053057m; Ou ZY, 2005, J CHEM PHYS, V123, DOI 10.1063/1.1940054; PISKUR J, 1995, FEBS LETT, V375, P174, DOI 10.1016/0014-5793(95)01206-T; Ramos JEB, 2005, J PHYS CHEM B, V109, P23661, DOI 10.1021/jp0527103; Roy KB, 1999, J PHYS CHEM B, V103, P5117, DOI 10.1021/jp983306p; Sedlak M, 1996, J CHEM PHYS, V105, P10123, DOI 10.1063/1.472841; Shen MR, 2000, J AM CHEM SOC, V122, P4833, DOI 10.1021/ja000200a; Skjorringe T, 2009, J CONTROL RELEASE, V139, P140, DOI 10.1016/j.jconrel.2009.06.009; WILSON RW, 1979, BIOCHEMISTRY-US, V18, P2192, DOI 10.1021/bi00578a009; Yoshikawa Y, 1999, LANGMUIR, V15, P4085, DOI 10.1021/la981159g; Zhang C, 2008, J PHYS CHEM B, V112, P3552, DOI 10.1021/jp0776560; Zhang ZL, 2002, BIOPHYS CHEM, V97, P7, DOI 10.1016/S0301-4622(02)00006-6	45	24	27	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13308	10.1371/journal.pone.0013308	http://dx.doi.org/10.1371/journal.pone.0013308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949017	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100030
J	Beskow, LM; Friedman, JY; Hardy, NC; Lin, L; Weinfurt, KP				Beskow, Laura M.; Friedman, Joelle Y.; Hardy, N. Chantelle; Lin, Li; Weinfurt, Kevin P.			Developing a Simplified Consent Form for Biobanking	PLOS ONE			English	Article							INFORMED-CONSENT; CLINICAL-TRIALS; BIOREPOSITORIES; ACT	Background: Consent forms have lengthened over time and become harder for participants to understand. We sought to demonstrate the feasibility of creating a simplified consent form for biobanking that comprises the minimum information necessary to meet ethical and regulatory requirements. We then gathered preliminary data concerning its content from hypothetical biobank participants. Methodology/Principal Findings: We followed basic principles of plain-language writing and incorporated into a 2-page form (not including the signature page) those elements of information required by federal regulations and recommended by best practice guidelines for biobanking. We then recruited diabetes patients from community-based practices and randomized half (n = 56) to read the 2-page form, first on paper and then a second time on a tablet computer. Participants were encouraged to use "More information'' buttons on the electronic version whenever they had questions or desired further information. These buttons led to a series of "Frequently Asked Questions'' (FAQs) that contained additional detailed information. Participants were asked to identify specific sentences in the FAQs they thought would be important if they were considering taking part in a biorepository. On average, participants identified 7 FAQ sentences as important (mean 6.6, SD 14.7, range: 0-71). No one sentence was highlighted by a majority of participants; further, 34 (60.7%) participants did not highlight any FAQ sentences. Conclusions: Our preliminary findings suggest that our 2-page form contains the information that most prospective participants identify as important. Combining simplified forms with supplemental material for those participants who desire more information could help minimize consent form length and complexity, allowing the most substantively material information to be better highlighted and enabling potential participants to read the form and ask questions more effectively.	[Beskow, Laura M.] Duke Univ, Duke Inst Genome Sci & Policy, Ctr Genome Eth Law & Policy, Durham, NC 27710 USA; [Beskow, Laura M.; Weinfurt, Kevin P.] Duke Univ, Duke Translat Med Inst, Durham, NC USA; [Friedman, Joelle Y.; Hardy, N. Chantelle; Lin, Li; Weinfurt, Kevin P.] Duke Univ, Sch Med, Duke Clin Res Inst, Ctr Clin & Genet Econ, Durham, NC USA	Duke University; Duke University; Duke University	Beskow, LM (corresponding author), Duke Univ, Duke Inst Genome Sci & Policy, Ctr Genome Eth Law & Policy, Durham, NC 27710 USA.	laura.beskow@duke.edu			Measurement to Understand Re-Classification of Disease of Cabarrus and Kannapolis (MURDOCK) Study; National Institutes of Health [1UL1RR024128]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER	Measurement to Understand Re-Classification of Disease of Cabarrus and Kannapolis (MURDOCK) Study; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by funding from the Measurement to Understand Re-Classification of Disease of Cabarrus and Kannapolis (MURDOCK) Study and by a grant from the National Institutes of Health Clinical and Translational Science Award 1UL1RR024128 to Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albala Ilene, 2010, IRB, V32, P7; *ASS AM MED COLL, 2007, INF CONS DOC GROUP K; Bergenmar M, 2008, EUR J CANCER, V44, P2627, DOI 10.1016/j.ejca.2008.08.013; Beskow LM, 2008, SCIENCE, V322, P1054, DOI 10.1126/science.1164100; Beskow LM, 2008, CANCER EPIDEM BIOMAR, V17, P1440, DOI 10.1158/1055-9965.EPI-08-0086; Beskow LM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000952; Beskow LM, 2010, GENET MED, V12, P567, DOI 10.1097/GIM.0b013e3181ead64d; Bookman EB, 2006, AM J MED GENET A, V140A, P1033, DOI 10.1002/ajmg.a.31195; Breese P, 2004, ANN INTERN MED, V141, P897, DOI 10.7326/0003-4819-141-11-200412070-00034; EISEMAN E, 2003, CASE STUDIES EXISTIN; GROSSMAN SA, 1994, J CLIN ONCOL, V12, P2211, DOI 10.1200/JCO.1994.12.10.2211; Hamburg MA, 2010, NEW ENGL J MED, V363, P301, DOI 10.1056/NEJMp1006304; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Jefford M, 2011, SUPPORT CARE CANCER, V19, P371, DOI 10.1007/s00520-010-0829-6; Jefford MH, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2006.10.3341; Joffe S, 2001, LANCET, V358, P1772, DOI 10.1016/S0140-6736(01)06805-2; LOVERDE ME, 1989, J GEN INTERN MED, V4, P410, DOI 10.1007/BF02599693; *NAT CANC I OFF BI, 2007, CUST OWN ISS BIOSP R; *NAT CTR ED STAT, 2003, NAT ASS AD LIT KEY F; *NAT HUM GEN RES I, 2009, EL MED REC GEN EMERG; National Bioethics Advisory Committee, 1999, RES INV HUM BIOL MAT, V1; [National Cancer Institute National Institute of Health US Department of Health and Human Services], 2007, BEST PRACT BIOSP RES; National Cancer Institute, 1998, SIMPL INF CONS DOC; National Institutes of Health, CERT CONF KIOSK; *NIH, 2007, GEN WID ASS STUD GWA; Paasche-Orlow MK, 2003, NEW ENGL J MED, V348, P721, DOI 10.1056/NEJMsa021212; *PERS MED COAL, 2009, CAS PERS MED; President's Council of Advisors on Science and Technology, 2008, PRIORITIES PERSONALI; Ridpath JR, 2007, PRISM READABILITY TO; Sharp SM, 2004, AM J CLIN ONCOL-CANC, V27, P570, DOI 10.1097/01.coc.0000135925.83221.b3; Silverman H, 2001, CRIT CARE MED, V29, P235, DOI 10.1097/00003246-200102000-00002; U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES, 2008, GUID RES INV COD PRI; WACAT, 1982, INF LEAFL; White LJ, 1996, ACAD EMERG MED, V3, P745, DOI 10.1111/j.1553-2712.1996.tb03509.x	34	68	70	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13302	10.1371/journal.pone.0013302	http://dx.doi.org/10.1371/journal.pone.0013302			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949049	Green Published, gold			2022-12-27	WOS:000282676700023
J	Menzies, JRW; Porrill, J; Dutia, M; Dean, P				Menzies, John R. W.; Porrill, John; Dutia, Mayank; Dean, Paul			Synaptic Plasticity in Medial Vestibular Nucleus Neurons: Comparison with Computational Requirements of VOR Adaptation	PLOS ONE			English	Article							LONG-TERM DEPRESSION; DEEP CEREBELLAR NUCLEI; D-ASPARTATE RECEPTORS; MOSSY FIBER EPSCS; VESTIBULOOCULAR REFLEX; GLUTAMATE RECEPTORS; DEVELOPMENTAL SHIFT; INSTRUCTIVE SIGNALS; NMDA RECEPTORS; NERVOUS-SYSTEM	Background: Vestibulo-ocular reflex (VOR) gain adaptation, a longstanding experimental model of cerebellar learning, utilizes sites of plasticity in both cerebellar cortex and brainstem. However, the mechanisms by which the activity of cortical Purkinje cells may guide synaptic plasticity in brainstem vestibular neurons are unclear. Theoretical analyses indicate that vestibular plasticity should depend upon the correlation between Purkinje cell and vestibular afferent inputs, so that, in gain-down learning for example, increased cortical activity should induce long-term depression (LTD) at vestibular synapses. Methodology/Principal Findings: Here we expressed this correlational learning rule in its simplest form, as an anti-Hebbian, heterosynaptic spike-timing dependent plasticity interaction between excitatory (vestibular) and inhibitory (floccular) inputs converging on medial vestibular nucleus (MVN) neurons (input-spike-timing dependent plasticity, iSTDP). To test this rule, we stimulated vestibular afferents to evoke EPSCs in rat MVN neurons in vitro. Control EPSC recordings were followed by an induction protocol where membrane hyperpolarizing pulses, mimicking IPSPs evoked by flocculus inputs, were paired with single vestibular nerve stimuli. A robust LTD developed at vestibular synapses when the afferent EPSPs coincided with membrane hyperpolarisation, while EPSPs occurring before or after the simulated IPSPs induced no lasting change. Furthermore, the iSTDP rule also successfully predicted the effects of a complex protocol using EPSP trains designed to mimic classical conditioning. Conclusions: These results, in strong support of theoretical predictions, suggest that the cerebellum alters the strength of vestibular synapses on MVN neurons through hetero-synaptic, anti-Hebbian iSTDP. Since the iSTDP rule does not depend on post-synaptic firing, it suggests a possible mechanism for VOR adaptation without compromising gaze-holding and VOR performance in vivo.	[Menzies, John R. W.; Dutia, Mayank] Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Porrill, John; Dean, Paul] Univ Sheffield, Dept Psychol, Sheffield S10 2TN, S Yorkshire, England	University of Edinburgh; University of Sheffield	Menzies, JRW (corresponding author), Univ Edinburgh, Sch Biomed Sci, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	p.dean@sheffield.ac.uk		Menzies, John/0000-0001-8133-4763	Engineering and Physical Science Research Council [GR/T10602/01]	Engineering and Physical Science Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Science Research Council under its Novel Computation Initiative (grant GR/T10602/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Alvina K, 2008, NAT NEUROSCI, V11, P1256, DOI 10.1038/nn.2195; Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; Babalian A, 1997, NEUROSCIENCE, V81, P405, DOI 10.1016/S0306-4522(97)00069-9; Babalian AL, 2000, J NEUROPHYSIOL, V84, P2514, DOI 10.1152/jn.2000.84.5.2514; Bagnall MW, 2008, NEURON, V60, P343, DOI 10.1016/j.neuron.2008.10.002; Bagnall MW, 2007, J NEUROSCI, V27, P2318, DOI 10.1523/JNEUROSCI.4322-06.2007; Bagnall MW, 2009, J NEUROSCI, V29, P10104, DOI 10.1523/JNEUROSCI.2087-09.2009; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Beraneck M, 2007, J NEUROPHYSIOL, V98, P1549, DOI 10.1152/jn.00590.2007; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Biesdorf S, 2008, J NEUROPHYSIOL, V99, P1758, DOI 10.1152/jn.01207.2007; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Broussard DM, 2009, EUR J NEUROSCI, V29, P502, DOI 10.1111/j.1460-9568.2008.06604.x; Campanac E, 2008, J PHYSIOL-LONDON, V586, P779, DOI 10.1113/jphysiol.2007.147017; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; Dutia MB, 1998, EXP BRAIN RES, V118, P148, DOI 10.1007/s002210050266; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Gauck V, 2003, J NEUROSCI, V23, P8109; Gerstner W, 2002, SPIKING NEURON MODEL; Gittis AH, 2008, J NEUROPHYSIOL, V99, P2060, DOI 10.1152/jn.01389.2007; Gittis AH, 2007, J NEUROPHYSIOL, V97, P3986, DOI 10.1152/jn.00141.2007; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; GRASSI S, 1995, BRAIN RES, V699, P183, DOI 10.1016/0006-8993(95)00895-W; Grassi S, 2004, J PHYSIOL-LONDON, V560, P767, DOI 10.1113/jphysiol.2004.069658; Grassi S, 2001, PROG NEUROBIOL, V64, P527, DOI 10.1016/S0301-0082(00)00070-8; Guilding C, 2005, NEUROREPORT, V16, P1415, DOI 10.1097/01.wnr.0000176519.42218.a6; Him A, 2001, BRAIN RES, V908, P58, DOI 10.1016/S0006-8993(01)02600-2; Hospedales TM, 2008, NEURAL COMPUT, V20, P756, DOI 10.1162/neco.2007.09-06-339; Huterer M, 2002, J NEUROPHYSIOL, V88, P13, DOI 10.1152/jn.2002.88.1.13; Ito M, 1998, TRENDS COGN SCI, V2, P313, DOI 10.1016/S1364-6613(98)01222-4; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jirenhed DA, 2007, J NEUROSCI, V27, P2493, DOI 10.1523/JNEUROSCI.4202-06.2007; Johnston AR, 1996, NEUROSCI LETT, V219, P17, DOI 10.1016/S0304-3940(96)13152-9; Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001; Ke MC, 2009, NAT NEUROSCI, V12, P1171, DOI 10.1038/nn.2366; KINNEY GA, 1994, J NEUROPHYSIOL, V72, P1588, DOI 10.1152/jn.1994.72.4.1588; Kubota S, 2009, NEURAL NETWORKS, V22, P527, DOI 10.1016/j.neunet.2009.06.012; Kuner T, 1996, J NEUROSCI, V16, P3549; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Lin YJ, 1996, MOL BRAIN RES, V43, P57, DOI 10.1016/S0169-328X(96)00146-5; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Masuda N, 2008, J COMPUT NEUROSCI, V24, P137, DOI 10.1007/s10827-007-0045-7; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Morrison A, 2008, BIOL CYBERN, V98, P459, DOI 10.1007/s00422-008-0233-1; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Papoulis A., 1991, PROBABILITY RANDOM V; Peterson BW, 1996, ANN NY ACAD SCI, V781, P499, DOI 10.1111/j.1749-6632.1996.tb15723.x; Porrill J, 2007, PLOS COMPUT BIOL, V3, P1935, DOI 10.1371/journal.pcbi.0030197; Pugh JR, 2008, J NEUROSCI, V28, P10549, DOI 10.1523/JNEUROSCI.2061-08.2008; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Puyal J, 2003, J PHYSIOL-LONDON, V553, P427, DOI 10.1113/jphysiol.2003.051995; Ramachandran R, 2005, J NEUROPHYSIOL, V93, P2028, DOI 10.1152/jn.00832.2004; Ramachandran R, 2006, J NEUROPHYSIOL, V96, P1061, DOI 10.1152/jn.00281.2006; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Sans NA, 2000, DEV BRAIN RES, V123, P41, DOI 10.1016/S0165-3806(00)00082-1; SEJNOWSKI TJ, 1977, J MATH BIOL, V4, P303, DOI 10.1007/BF00275079; Sekirnjak C, 2003, J NEUROSCI, V23, P6392; Sjostrom PJ, 2008, PHYSIOL REV, V88, P769, DOI 10.1152/physrev.00016.2007; SMITH PF, 1990, BRAIN RES, V513, P149, DOI 10.1016/0006-8993(90)91101-L; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; STONE LS, 1990, J NEUROPHYSIOL, V63, P1262, DOI 10.1152/jn.1990.63.5.1262; Straka H, 2005, PROG NEUROBIOL, V76, P349, DOI 10.1016/j.pneurobio.2005.10.002; TAKAHASHI Y, 1994, BRAIN RES, V659, P287, DOI 10.1016/0006-8993(94)90895-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Williams SR, 2007, NEURON, V56, P947, DOI 10.1016/j.neuron.2007.12.004	77	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13182	10.1371/journal.pone.0013182	http://dx.doi.org/10.1371/journal.pone.0013182			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957149	Green Published, gold, Green Accepted			2022-12-27	WOS:000282506100012
J	Tchankouo-Nguetcheu, S; Khun, H; Pincet, L; Roux, P; Bahut, M; Huerre, M; Guette, C; Choumet, V				Tchankouo-Nguetcheu, Stephane; Khun, Huot; Pincet, Laurence; Roux, Pascal; Bahut, Muriel; Huerre, Michel; Guette, Catherine; Choumet, Valerie			Differential Protein Modulation in Midguts of Aedes aegypti Infected with Chikungunya and Dengue 2 Viruses	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DISULFIDE-ISOMERASE; FLAVIVIRUS INFECTIONS; VIRAL INTERACTIONS; OXIDATIVE STRESS; GENOME SEQUENCE; GENE-EXPRESSION; MEMBRANE-FUSION; LIFE-CYCLE; HOST-CELL	Background: Arthropod borne virus infections cause several emerging and resurgent infectious diseases. Among the diseases caused by arboviruses, dengue and chikungunya are responsible for a high rate of severe human diseases worldwide. The midgut of mosquitoes is the first barrier for pathogen transmission and is a target organ where arboviruses must replicate prior to infecting other organs. A proteomic approach was undertaken to characterize the key virus/vector interactions and host protein modifications that happen in the midgut for viral transmission to eventually take place. Methodology and Principal Findings: Using a proteomics differential approach with two-Dimensional Differential in-Gel Electrophoresis (2D-DIGE), we defined the protein modulations in the midgut of Aedes aegypti that were triggered seven days after an oral infection (7 DPI) with dengue 2 (DENV-2) and chikungunya (CHIKV) viruses. Gel profile comparisons showed that the level of 18 proteins was modulated by DENV-2 only and 12 proteins were modulated by CHIKV only. Twenty proteins were regulated by both viruses in either similar or different ways. Both viruses caused an increase of proteins involved in the generation of reactive oxygen species, energy production, and carbohydrate and lipid metabolism. Midgut infection by DENV-2 and CHIKV triggered an antioxidant response. CHIKV infection produced an increase of proteins involved in detoxification. Conclusion/Significance: Our study constitutes the first analysis of the protein response of Aedes aegypti's midgut infected with viruses belonging to different families. It shows that the differentially regulated proteins in response to viral infection include structural, redox, regulatory proteins, and enzymes for several metabolic pathways. Some of these proteins like antioxidant are probably involved in cell protection. On the other hand, we propose that the modulation of other proteins like transferrin, hsp60 and alpha glucosidase, may favour virus survival, replication and transmission, suggesting a subversion of the insect cell metabolism by the arboviruses.	[Tchankouo-Nguetcheu, Stephane; Pincet, Laurence; Choumet, Valerie] Inst Pasteur, Unite Genet Mol Bunyavirus, Paris, France; [Khun, Huot; Huerre, Michel] Inst Pasteur, Unite Rech & Expertise Histotechnol & Pathol, Paris, France; [Bahut, Muriel; Guette, Catherine] Univ Angers, Angers, France; [Guette, Catherine] Ctr Lutte Canc Paul Papin, Lab Oncopharmacol, Angers, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite d'Angers; UNICANCER; Institut de Cancerologie de l'Ouest (ICO)	Tchankouo-Nguetcheu, S (corresponding author), Inst Pasteur, Unite Genet Mol Bunyavirus, Paris, France.	vchoumet@pasteur.fr	Guette, Catherine/L-2519-2015	Guette, Catherine/0000-0003-1779-9931; Pincet, Laurence/0000-0002-2885-5188	ANR Entomochik	ANR Entomochik(French National Research Agency (ANR))	ANR Entomochik. The funders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; Baron OL, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.4101; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Blandin S, 2004, M S-MED SCI, V20, P740, DOI 10.1051/medsci/2004208-9740; Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083; Charrier C, 2006, MICROBIOL-SGM, V152, P179, DOI [10.1099/mic.0.28412-0, 10.1099/MIC.0.28412-0]; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Corona M, 2006, INSECT MOL BIOL, V15, P687, DOI 10.1111/j.1365-2583.2006.00695.x; Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; Dieng H, 2007, MED VET ENTOMOL, V21, P278, DOI 10.1111/j.1365-2915.2007.00693.x; Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895; Fan YJ, 2010, GENETICS, V184, P141, DOI 10.1534/genetics.109.109553; Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001; FINNERTY V, 1979, GENETICS, V91, P695; Friedman DB, 2009, METHOD ENZYMOL, V463, P515, DOI 10.1016/S0076-6879(09)63030-5; Guo XA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-380; Hertel L, 2004, J VIROL, V78, P11988, DOI 10.1128/JVI.78.21.11988-12011.2004; Jacob R, 2004, J BIOL CHEM, V279, P3680, DOI 10.1074/jbc.C300503200; Jaramillo-Gutierrez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-154; Jiang XM, 1999, J BIOL CHEM, V274, P2416, DOI 10.1074/jbc.274.4.2416; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; Kim JW, 2005, TRENDS BIOCHEM SCI, V30, P142, DOI 10.1016/j.tibs.2005.01.005; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; Lefevre T, 2006, PLOS PATHOG, V2, P633, DOI 10.1371/journal.ppat.0020072; Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018; Mercado-Curiel RF, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-118; Missirlis F, 2003, BIOL CHEM, V384, P463, DOI 10.1515/BC.2003.052; Mohankumar K, 2006, VIRUS RES, V118, P130, DOI 10.1016/j.virusres.2005.12.002; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Nichol H, 2002, ANNU REV ENTOMOL, V47, P535, DOI 10.1146/annurev.ento.47.091201.145237; Ogino T, 2001, BIOCHEM BIOPH RES CO, V285, P447, DOI 10.1006/bbrc.2001.5160; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x; Radyuk SN, 2001, FREE RADICAL BIO MED, V31, P1090, DOI 10.1016/S0891-5849(01)00692-X; REED L. J., 1938, AMER JOUR HYG, V27, P493; Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Shaw ML, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000085; Smith GA, 2002, ANNU REV CELL DEV BI, V18, P135, DOI 10.1146/annurev.cellbio.18.012502.105920; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; Suresh DR, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-61; Toba G, 2000, GENE, V253, P179, DOI 10.1016/S0378-1119(00)00246-8; Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168; Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292; Vennestrom J, 2007, EXP PARASITOL, V115, P53, DOI 10.1016/j.exppara.2006.05.008; Wasinpiyamongkol L, 2010, PROTEOMICS, V10, P1906, DOI 10.1002/pmic.200900626; WEAVER SC, 1988, J VIROL, V62, P2083, DOI 10.1128/JVI.62.6.2083-2090.1988; Woodring Jennifer L., 1996, P51; Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002; Yocupicio-Monroy RME, 2003, J VIROL, V77, P3067, DOI 10.1128/JVI.77.5.3067-3076.2003; Zhao LM, 2009, J MED ENTOMOL, V46, P490, DOI 10.1603/033.046.0312	63	97	99	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13149	10.1371/journal.pone.0013149	http://dx.doi.org/10.1371/journal.pone.0013149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957153	Green Published, gold, Green Submitted			2022-12-27	WOS:000282506100004
J	Faghihi, MA; Kocerha, J; Modarresi, F; Engstrom, PG; Chalk, AM; Brothers, SP; Koesema, E; St Laurent, G; Wahlestedt, C				Faghihi, Mohammad Ali; Kocerha, Jannet; Modarresi, Farzaneh; Engstroem, Paer G.; Chalk, Alistair M.; Brothers, Shaun P.; Koesema, Eric; St Laurent, Georges, III; Wahlestedt, Claes			RNAi Screen Indicates Widespread Biological Function for Human Natural Antisense Transcripts	PLOS ONE			English	Article							NONCODING RNAS; EXPRESSION; EVOLUTION; GENOME; CANCER; GENES; MAPS	Natural antisense transcripts represent a class of regulatory RNA molecules, which are characterized by their complementary sequence to another RNA transcript. Extensive sequencing efforts suggest that natural antisense transcripts are prevalent throughout the mammalian genome; however, their biological significance has not been well defined. We performed a loss-of-function RNA interference (RNAi) screen, which targeted 797 evolutionary conserved antisense transcripts, and found evidence for a regulatory role for a number of natural antisense transcripts. Specifically, we found that natural antisense transcripts for CCPG1 and RAPGEF3 may functionally disrupt signaling pathways and corresponding biological phenotypes, such as cell viability, either independently or in parallel with the corresponding sense transcript. Our results show that the large-scale siRNA screen can be applied to evaluate natural antisense transcript modulation of fundamental cellular events.	[Faghihi, Mohammad Ali; Kocerha, Jannet; Modarresi, Farzaneh; Brothers, Shaun P.; Wahlestedt, Claes] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Koesema, Eric; Wahlestedt, Claes] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA; [Engstroem, Paer G.] Bioinformat Inst, Cambridge, England; [Chalk, Alistair M.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Natl Ctr Adult Stem Cell Res, Brisbane, Qld 4111, Australia; [St Laurent, Georges, III] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [St Laurent, Georges, III] Univ Antioquia, Immunovirol Biogenisis Grp, Medellin, Colombia	Scripps Research Institute; Scripps Research Institute; European Molecular Biology Laboratory (EMBL); Griffith University; Brown University; Universidad de Antioquia	Faghihi, MA (corresponding author), Scripps Res Inst, Dept Neurosci, Jupiter, FL USA.	clawah@scripps.edu	Faghihi, Mohammad Ali/AAD-7159-2020; Faghihi, Mohammad Ali/AAH-3139-2019; Chalk, Alistair/O-3522-2019; Brothers, Shaun/G-8690-2012	Faghihi, Mohammad Ali/0000-0002-8330-9067; Chalk, Alistair/0000-0002-9630-6236; Koesema, Eric/0000-0002-7743-0127; Engstrom, Par/0000-0001-5265-2121; Brothers, Shaun/0000-0003-2184-4037	Scripps Florida Funding Corporation; National Institute of Neurological Disorders and Stroke [5R01NS063974]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063974] Funding Source: NIH RePORTER	Scripps Florida Funding Corporation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work has been supported in part by the Scripps Florida Funding Corporation and by the National Institute of Neurological Disorders and Stroke (5R01NS063974). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472; AMARAL PP, 2008, MAMM GENOME; Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chalk AM, 2004, BIOCHEM BIOPH RES CO, V319, P264, DOI 10.1016/j.bbrc.2004.04.181; Chang JTC, 2007, MOL CANCER THER, V6, P2271, DOI 10.1158/1535-7163.MCT-06-0801; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Faghihi MA, 2009, NAT REV MOL CELL BIO, V10, P637, DOI 10.1038/nrm2738; Fahey ME, 2002, COMP FUNCT GENOM, V3, P244, DOI 10.1002/cfg.173; Frith Martin C, 2006, RNA Biol, V3, P40; Hayashizaki Y, 2006, PLOS GENET, V2, P492, DOI 10.1371/journal.pgen.0020063; Jolly C, 2006, NUCLEIC ACIDS RES, V34, P5508, DOI 10.1093/nar/gkl711; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kassner PD, 2008, COMB CHEM HIGH T SCR, V11, P175, DOI 10.2174/138620708783877744; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Khalil AM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001486; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Laurent GS, 2007, TRENDS NEUROSCI, V30, P612, DOI 10.1016/j.tins.2007.10.002; Lehner B, 2002, TRENDS GENET, V18, P63, DOI 10.1016/S0168-9525(02)02598-2; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipovich L, 2006, J MOL EVOL, V62, P73, DOI 10.1007/s00239-005-0041-3; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Mattick JS, 2005, SCIENCE, V309, P1527, DOI 10.1126/science.1117806; Mercer TR, 2008, P NATL ACAD SCI USA, V105, P716, DOI 10.1073/pnas.0706729105; Misra UK, 2009, J CELL BIOCHEM, V108, P998, DOI 10.1002/jcb.22333; Moynihan TP, 1998, GENOMICS, V51, P124, DOI 10.1006/geno.1998.5257; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P998, DOI 10.1038/nsmb0908-998c; Osato N, 2007, GENETICS, V176, P1299, DOI 10.1534/genetics.106.069484; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rossignol F, 2002, GENE, V299, P135, DOI 10.1016/S0378-1119(02)01049-1; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shendure J, 2002, GENOME BIOL, V3; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Suderman M, 2007, BIOINFORMATICS, V23, P2651, DOI 10.1093/bioinformatics/btm401; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Wang J, 2004, NATURE, V431, DOI 10.1038/nature03016; WATANABE T, 2008, NATURE; Willingham AT, 2006, COLD SPRING HARB SYM, V71, P101, DOI 10.1101/sqb.2006.71.068; Willingham AT, 2004, ONCOGENE, V23, P8392, DOI 10.1038/sj.onc.1208217; Willingham AT, 2005, SCIENCE, V309, P1570, DOI 10.1126/science.1115901; Yelin R, 2003, NAT BIOTECHNOL, V21, P379, DOI 10.1038/nbt808; Yin YF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-319; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	56	29	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13177	10.1371/journal.pone.0013177	http://dx.doi.org/10.1371/journal.pone.0013177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957177	Green Published, gold			2022-12-27	WOS:000282423300014
J	Criscuolo, F; Font-Sala, C; Bouillaud, F; Poulin, N; Trabalon, M				Criscuolo, Francois; Font-Sala, Candide; Bouillaud, Frederic; Poulin, Nicolas; Trabalon, Marie			Increased ROS Production: A Component of the Longevity Equation in the Male Mygalomorph, Brachypelma albopilosa	PLOS ONE			English	Article							TARANTULAS APHONOPELMA-ANAX; HISTORY TRADE-OFFS; OXIDATIVE STRESS; ENERGY-METABOLISM; LIFE-SPAN; THERAPHOSIDAE; EVOLUTION; ECOLOGY; ARANEAE; GENDER	Background: The diversity of longevities encountered in wildlife is one of the most intriguing problems in biology. Evolutionary biologists have proposed different theories to explain how longevity variability may be driven by bad genes expression in late life or by gene pleiotropic effects. This reflexion has stimulated, in the last ten years, an active research on the proximal mechanisms that can shape lifespan. Reactive oxygen species (ROS), i.e., the by-products of oxidative metabolism, have emerged as the main proximate cause of ageing. Because ROS are mainly produced by the mitochondria, their production is linked to metabolic rate, and this may explain the differences in longevity between large and small species. However, their implication in the sex difference in longevity within a species has never been tested, despite the fact that these differences are widespread in the animal kingdom. Methodology/Principal Findings: Mitochondrial superoxide production of hemolymph immune cells and antioxidant and oxidative damages plasma levels were measured in adult male and female B. albopilosa at different ages. We found that female spiders are producing less mitochondrial superoxide, are better protected against oxidative attack and are then suffering less oxidative damages than males at adulthood. Conclusions/Significance: In tarantulas, once reaching sexual maturity, males have a life expectancy reduced to 1 to 2 years, while females can still live for 20 years, in spite of the fact that females continue to grow and moult. This study evidences an increased exposure of males to oxidative stress due to an increase in mitochondrial superoxide production and a decrease in hemolymph antioxidant defences. Such a phenomenon is likely to be part of the explanation for the sharp reduction of longevity accompanying male tarantula maturity. This opens several fundamental research roads in the future to better understand how reproduction and longevity are linked in an original ageing model.	[Criscuolo, Francois; Poulin, Nicolas; Trabalon, Marie] Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, CNRS UDS, UMR 7178, Strasbourg, France; [Font-Sala, Candide; Bouillaud, Frederic] Univ Paris 05, BIOTRAM, CNRS UPR9078, Fac Med Necker Enfants Malades, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Cite	Criscuolo, F (corresponding author), Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, CNRS UDS, UMR 7178, Strasbourg, France.	francois.criscuolo@c-strasbourg.fr	Bouillaud, Frédéric R/L-3238-2017	Bouillaud, Frédéric R/0000-0002-7518-9237; Poulin, Nicolas/0000-0003-2740-7559	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by finding from Centre National de la Recherche Scientifique (CNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2004, ECOL LETT, V7, P363, DOI 10.1111/j.1461-0248.2004.00594.x; Austad SN, 1997, EXP GERONTOL, V32, P23, DOI 10.1016/S0531-5565(96)00059-9; Beckman KB, 1997, FASEB J, V11, pA1290; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; Bonduriansky R, 2008, FUNCT ECOL, V22, P443, DOI 10.1111/j.1365-2435.2008.01417.x; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Costantini D, 2007, J EXP BIOL, V210, P1238, DOI 10.1242/jeb.002741; Costantini D, 2006, COMP BIOCHEM PHYS A, V145, P137, DOI 10.1016/j.cbpa.2006.06.002; Criscuolo F, 2005, AM NAT, V166, P686, DOI 10.1086/497439; Deerenberg C, 1997, P ROY SOC B-BIOL SCI, V264, P1021, DOI 10.1098/rspb.1997.0141; Demetrius L, 2004, J GERONTOL A-BIOL, V59, P902, DOI 10.1093/gerona/59.9.B902; Foelix R., 2011, BIOL SPIDERS, V3; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; HARMAN D, 1979, AGE, V2, P109, DOI 10.1007/BF02432216; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Harshman LG, 2007, TRENDS ECOL EVOL, V22, P80, DOI 10.1016/j.tree.2006.10.008; Ide T, 2002, ARTERIOSCL THROM VAS, V22, P438, DOI 10.1161/hq0302.104515; Ilmonen P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002143; Janowski-Bell ME, 1999, J ARACHNOL, V27, P503; KAWAHARA M, 2009, NAT BIOTECHNOL, V25, P1045; Keller L, 2006, EXP GERONTOL, V41, P553, DOI 10.1016/j.exger.2006.04.002; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Locht A, 1999, J ARACHNOL, V27, P196; Marshall SD, 1996, ETHOLOGY, V102, P32; McKean KA, 2001, P NATL ACAD SCI USA, V98, P7904, DOI 10.1073/pnas.131216398; Monaghan P, 2008, FUNCT ECOL, V22, P371, DOI 10.1111/j.1365-2435.2008.01418.x; Mozo J, 2006, BIOCHEM J, V393, P431, DOI 10.1042/BJ20050494; Nilsson JA, 2002, P ROY SOC B-BIOL SCI, V269, P1735, DOI 10.1098/rspb.2002.2071; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Olsson M, 2009, NATURWISSENSCHAFTEN, V96, P25, DOI 10.1007/s00114-008-0444-2; Owens IPF, 1999, TRENDS ECOL EVOL, V14, P170, DOI 10.1016/S0169-5347(98)01580-8; Partridge L, 2006, TRENDS ECOL EVOL, V21, P334, DOI 10.1016/j.tree.2006.02.008; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Perez VI, 2009, BBA-GEN SUBJECTS, V1790, P1005, DOI 10.1016/j.bbagen.2009.06.003; PEREZMILES F, 2005, J ARACHNOL, V25, P137; Rattan SIS, 2004, MECH AGEING DEV, V125, P285, DOI 10.1016/j.mad.2004.01.006; Rogowitz GL, 2000, J EXP BIOL, V203, P1131; Rolff J, 2001, CAN J ZOOL, V79, P2176, DOI 10.1139/cjz-79-12-2176; ROSEN GM, 1995, FASEB J, V9, P200, DOI 10.1096/fasebj.9.2.7540156; Shillington C, 2005, COMP BIOCHEM PHYS A, V142, P439, DOI 10.1016/j.cbpa.2005.09.010; Shillington C, 2002, J EXP BIOL, V205, P2909; Shillington C, 2002, CAN J ZOOL, V80, P251, DOI 10.1139/Z01-227; SMITH DWE, 1989, BIOL REV, V64, P1, DOI 10.1111/j.1469-185X.1989.tb00635.x; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; Tatar M, 2003, SCIENCE, V299, P1346, DOI 10.1126/science.1081447; Terry DF, 2008, J GERONTOL A-BIOL, V63, P809, DOI 10.1093/gerona/63.8.809; VALERIO CE, 1980, REV BIOL TROP, V28, P271; Vieira C, 2000, GENETICS, V154, P213; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; WIERSMA P, 2004, P R SOC LOND B S, V5, pS360; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	52	27	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13104	10.1371/journal.pone.0013104	http://dx.doi.org/10.1371/journal.pone.0013104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957044	gold, Green Submitted, Green Published			2022-12-27	WOS:000282359300010
J	Caceres, A; Shang, F; Wawrousek, E; Liu, Q; Avidan, O; Cvekl, A; Yang, Y; Haririnia, A; Storaska, A; Fushman, D; Kuszak, J; Dudek, E; Smith, D; Taylor, A				Caceres, Andrea; Shang, Fu; Wawrousek, Eric; Liu, Qing; Avidan, Orna; Cvekl, Ales; Yang, Ying; Haririnia, Aydin; Storaska, Andrew; Fushman, David; Kuszak, Jer; Dudek, Edward; Smith, Donald; Taylor, Allen			Perturbing the Ubiquitin Pathway Reveals How Mitosis Is Hijacked to Denucleate and Regulate Cell Proliferation and Differentiation In Vivo	PLOS ONE			English	Article							ALPHA-A-CRYSTALLIN; LENS; DEGRADATION; CHAINS; PROTEINS; NEURODEGENERATION; EXPRESSION; PROTEOMICS; COMPLEX; GROWTH	Background: The eye lens presents a unique opportunity to explore roles for specific molecules in cell proliferation, differentiation and development because cells remain in place throughout life and, like red blood cells and keratinocytes, they go through the most extreme differentiation, including removal of nuclei and cessation of protein synthesis. Ubiquitination controls many critical cellular processes, most of which require specific lysines on ubiquitin (Ub). Of the 7 lysines (K) least is known about effects of modification of K6. Methodology and Principal Findings: We replaced K6 with tryptophan (W) because K6 is the most readily modified K and W is the most structurally similar residue to biotin. The backbone of K6W-Ub is indistinguishable from that of Wt-Ub. K6W-Ub is effectively conjugated and deconjugated but the conjugates are not degraded via the ubiquitin proteasome pathways (UPP). Expression of K6W-ubiquitin in the lens and lens cells results in accumulation of intracellular aggregates and also slows cell proliferation and the differentiation program, including expression of lens specific proteins, differentiation of epithelial cells into fibers, achieving proper fiber cell morphology, and removal of nuclei. The latter is critical for transparency, but the mechanism by which cell nuclei are removed has remained an age old enigma. This was also solved by expressing K6W-Ub. p27(kip), a UPP substrate accumulates in lenses which express K6W-Ub. This precludes phosphorylation of nuclear lamin by the mitotic kinase, a prerequisite for disassembly of the nuclear membrane. Thus the nucleus remains intact and DNAseII beta neither gains entry to the nucleus nor degrades the DNA. These results could not be obtained using chemical proteasome inhibitors that cannot be directed to specific tissues. Conclusions and Significance: K6W-Ub provides a novel, genetic means to study functions of the UPP because it can be targeted to specific cells and tissues. A fully functional UPP is required to execute most stages of lens differentiation, specifically removal of cell nuclei. In the absence of a functional UPP, small aggregate prone, cataractous lenses are formed.	[Caceres, Andrea; Shang, Fu; Liu, Qing; Avidan, Orna; Dudek, Edward; Smith, Donald; Taylor, Allen] Tufts Univ, Lab Nutr & Vis Res, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Wawrousek, Eric] NEI, Mol & Dev Biol Lab, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Cvekl, Ales; Yang, Ying] Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10467 USA; [Cvekl, Ales; Yang, Ying] Albert Einstein Coll Med, Dept Visual Sci & Genet, Bronx, NY 10467 USA; [Haririnia, Aydin; Storaska, Andrew; Fushman, David] Univ Maryland, Dept Chem & Biochem, Ctr Biomol Struct & Org, College Pk, MD 20742 USA; [Kuszak, Jer] Rush Univ, Med Ctr, Dept Ophthalmol, Chicago, IL 60612 USA; [Kuszak, Jer] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA	Tufts University; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University System of Maryland; University of Maryland College Park; Rush University; Rush University	Caceres, A (corresponding author), Tufts Univ, Lab Nutr & Vis Res, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA.	allen.taylor@tufts.edu	Cvekl, Ales/B-2427-2013; Wawrousek, Eric/A-4547-2008		NIH [GM065334]; American Health Assistant Foundation [RO1 13250]; Johnson and Johnson; NATIONAL EYE INSTITUTE [ZICEY000458, R01EY013250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistant Foundation; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by NIH grant GM065334 (to D. F.) and to AT NEI RO1 13250, American Health Assistant Foundation, Johnson and Johnson Focused Giving Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Ciechanover A, 2006, ISR J CHEM, V46, P121, DOI 10.1560/380V-VWLX-XDRT-CB7K; De Maria A, 2007, INVEST OPHTH VIS SCI, V48, P5638, DOI 10.1167/iovs.07-0782; Dudek EJ, 2005, FASEB J, V19, P1707, DOI 10.1096/fj.05-4049fje; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Gao CY, 1999, EXP EYE RES, V69, P695, DOI 10.1006/exer.1999.0749; Griep AE, 2006, SEMIN CELL DEV BIOL, V17, P686, DOI 10.1016/j.semcdb.2006.10.004; Groothuis TAM, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-21; Hatakeyama S, 2001, J BIOL CHEM, V276, P33111, DOI 10.1074/jbc.M102755200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; JAHNGENHODGE J, 1992, EXP EYE RES, V55, P897, DOI 10.1016/0014-4835(92)90016-L; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Klionsky DJ, 2006, NATURE, V441, P819, DOI 10.1038/441819a; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Liu Q, 2006, MOL VIS, V12, P931; Lovicu FJ, 2005, DEV BIOL, V280, P1, DOI 10.1016/j.ydbio.2005.01.020; Morimoto RI, 2009, J GERONTOL A-BIOL, V64, P167, DOI 10.1093/gerona/gln071; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Rattner A, 2006, NAT REV NEUROSCI, V7, P860, DOI 10.1038/nrn2007; SHANG F, 1995, BIOCHEM J, V307, P297, DOI 10.1042/bj3070297; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shi YR, 2009, J CELL SCI, V122, P1607, DOI 10.1242/jcs.045203; Ueda Y, 2002, INVEST OPHTH VIS SCI, V43, P205; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Weber GF, 2005, J BIOL CHEM, V280, P22135, DOI 10.1074/jbc.M414270200; WICKLIFFE K, 2009, CHEM REV; Wolf L, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-88; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang Y, 2006, EMBO J, V25, P2107, DOI 10.1038/sj.emboj.7601114; Yang YG, 2006, DNA REPAIR, V5, P885, DOI 10.1016/j.dnarep.2006.05.004; Yoshida H, 2005, NATURE, V437, P754, DOI 10.1038/nature03964; Yun MH, 2009, BIOCHEM SOC T, V37, P597, DOI 10.1042/BST0370597; Zandy AJ, 2007, INVEST OPHTH VIS SCI, V48, P293, DOI 10.1167/iovs.06-0656; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162	44	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13331	10.1371/journal.pone.0013331	http://dx.doi.org/10.1371/journal.pone.0013331			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975996	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400002
J	Cong, LM; Takeda, M; Hamanaka, Y; Gonda, K; Watanabe, M; Kumasaka, M; Kobayashi, Y; Kobayashi, M; Ohuchi, N				Cong, Liman; Takeda, Motohiro; Hamanaka, Yohei; Gonda, Kohsuke; Watanabe, Mika; Kumasaka, Masutaka; Kobayashi, Yoshio; Kobayashi, Masaki; Ohuchi, Noriaki			Uniform Silica Coated Fluorescent Nanoparticles: Synthetic Method, Improved Light Stability and Application to Visualize Lymph Network Tracer	PLOS ONE			English	Article							NODE BIOPSY; BREAST-CANCER; QUANTUM DOTS; SENTINEL	Background: The sentinel lymph node biopsy (SLNB) was developed as a new modality in the surgical diagnosis of lymph node metastases. Dye and radioisotope are major tracers for the detection of sentinel lymph nodes (SLN). Dye tends to excessively infiltrate into the interstitium due to their small size ( less than several nanometers), resulting in difficulties in maintaining clear surgical fields. Radioisotopes are available in limited number of hospitals. Fluorescent nanoparticles are good candidates for SLN tracer to solve these problems, as we can choose suitable particle size and fluorescence wavelength of near-infrared. However, the use of nanoparticles faces safety issues, and many attempts have been performed by giving insulating coats on nanoparticles. In addition, the preparation of the uniform insulating layer is important to decrease variations in the quality as an SLN tracer. Methodology/Principal Findings: We herein succeeded in coating fluorescent polystyrene nanoparticles of 40 nm with uniform silica layer of 13 nm by the modified Stober method. The light stability of silica coated nanoparticles was 1.3-fold greater than noncoated nanoparticles. The popliteal lymph node could be visualized by the silica coated nanoparticles with injection in the rat feet. Conclusions/Significance: The silica coated nanoparticles in lymph nodes could be observed by transmission electron microscope, suggesting that our silica coating method is useful as a SLN tracer with highly precise distribution of nanoparticles in histological evaluation. We also demonstrated for the first time that a prolonged enhancement of SLN is caused by the phagocytosis of fluorescent nanoparticles by both macrophages and dendritic cells.	[Cong, Liman; Takeda, Motohiro; Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Sendai, Miyagi 980, Japan; [Hamanaka, Yohei; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Surg Oncol, Sendai, Miyagi 980, Japan; [Watanabe, Mika; Ohuchi, Noriaki] Tohoku Univ Hosp, Dept Pathol, Sendai, Miyagi, Japan; [Kumasaka, Masutaka; Kobayashi, Masaki] Tohoku Inst Technol, Dept Elect & Intelligent Syst, Sendai, Miyagi 982, Japan; [Kobayashi, Yoshio] Ibaraki Univ, Coll Engn, Dept Biomol Funct Engn, Hitachi, Ibaraki, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku Institute Technology; Ibaraki University	Cong, LM (corresponding author), Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Sendai, Miyagi 980, Japan.	motot@med.tohoku.ac.jp	Hamanaka, Yohei/GVS-1245-2022; Kobayashi, Yoshio/N-1451-2015	Hamanaka, Yohei/0000-0003-4169-7767; Kobayashi, Yoshio/0000-0002-8540-3962	Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Tohoku University Graduate School of Medicine; COE Program; Grants-in-Aid for Scientific Research [22500440] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Tohoku University Graduate School of Medicine; COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research in Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by Grants-in-aid for Research Projects, Promotion of Advanced Medical Technology from the Ministry of Health, Labor and Welfare of Japan. The authors also acknowledge the support of the Biomedical Research Core of Tohoku University Graduate School of Medicine, the 21st Century COE Program "Future Medical Engineering based on Bio-nanotechnology" and the Global COE Program "Global Nano-Biomedical Engineering Education and Research Network Center" committed by the Japan Society for the Promotion of Science, Japan-China Medical Association and Konica Minolta Medical and Graphic, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y; Bonnema J, 2002, ANN ONCOL, V13, P1531, DOI 10.1093/annonc/mdf319; Gonda K, 2010, J BIOL CHEM, V285, P2750, DOI 10.1074/jbc.M109.075374; Gu S., 2005, E-POLYMERS, V64, P1; Josephson Lee, 2003, Mol Imaging, V2, P18, DOI 10.1162/153535003765276255; Keshtgar MRS, 2005, EJSO-EUR J SURG ONC, V31, P134, DOI 10.1016/j.ejso.2004.08.008; Kim K, 2006, LANGMUIR, V22, P8083, DOI 10.1021/la0612015; Kim S, 2004, NAT BIOTECHNOL, V22, P93, DOI 10.1038/nbt920; Kobayashi M, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2364600; Kobayashi Y, 2005, J COLLOID INTERF SCI, V283, P392, DOI 10.1016/j.jcis.2004.08.184; Kobayashi Y, 2004, COLLOID SURFACE A, V242, P47, DOI 10.1016/j.colsurfa.2004.04.052; KOBAYASHI Y, 2005, E-POLYMERS, V52, P1; Nakajima M, 2005, CANCER SCI, V96, P353, DOI 10.1111/j.1349-7006.2005.00053.x; Sato K, 2007, J SURG ONCOL, V96, P322, DOI 10.1002/jso.20866; Sato Kazuhiko, 2007, Breast Cancer, V14, P354, DOI 10.2325/jbcs.14.354; Sharma R, 2008, ANN NY ACAD SCI, V1131, P13, DOI 10.1196/annals.1413.002; Shen J, 2007, CANCER-AM CANCER SOC, V109, P1255, DOI 10.1002/cncr.22540; Soltesz EG, 2006, ANN SURG ONCOL, V13, P386, DOI 10.1245/ASO.2006.04.025; Soltesz EG, 2005, ANN THORAC SURG, V79, P269, DOI 10.1016/j.athoracsur.2004.06.055; Takeda M, 2008, BREAST CANCER-TOKYO, V15, P145, DOI 10.1007/s12282-008-0037-0; TANGOKU A, 2006, J MED INVEST, V54, P1; Tuohy JL, 2009, VET COMP ONCOL, V7, P81, DOI 10.1111/j.1476-5829.2009.00183.x; Yang M, 2000, P NATL ACAD SCI USA, V97, P1206, DOI 10.1073/pnas.97.3.1206	23	22	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13167	10.1371/journal.pone.0013167	http://dx.doi.org/10.1371/journal.pone.0013167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976187	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300005
J	Mellor, D; Prieto, E; Mathieson, L; Moscato, P				Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo			A Kernelisation Approach for Multiple d-Hitting Set and Its Application in Optimal Multi-Drug Therapeutic Combinations	PLOS ONE			English	Article							CANCER; DOCETAXEL; PROTEIN; CHEMOTHERAPY; ARRY-142886; AZD6244; POTENT; TIME	Therapies consisting of a combination of agents are an attractive proposition, especially in the context of diseases such as cancer, which can manifest with a variety of tumor types in a single case. However uncovering usable drug combinations is expensive both financially and temporally. By employing computational methods to identify candidate combinations with a greater likelihood of success we can avoid these problems, even when the amount of data is prohibitively large. HITTING SET is a combinatorial problem that has useful application across many fields, however as it is NP-complete it is traditionally considered hard to solve exactly. We introduce a more general version of the problem (alpha,beta,d)-HITTING SET, which allows more precise control over how and what the hitting set targets. Employing the framework of Parameterized Complexity we show that despite being NP-complete, the (alpha,beta,d) HITTING SET problem is fixed-parameter tractable with a kernel of size O(alpha dk(d)) when we parameterize by the size k of the hitting set and the maximum number alpha of the minimum number of hits, and taking the maximum degree d of the target sets as a constant. We demonstrate the application of this problem to multiple drug selection for cancer therapy, showing the flexibility of the problem in tailoring such drug sets. The fixed-parameter tractability result indicates that for low values of the parameters the problem can be solved quickly using exact methods. We also demonstrate that the problem is indeed practical, with computation times on the order of 5 seconds, as compared to previous Hitting Set applications using the same dataset which exhibited times on the order of 1 day, even with relatively relaxed notions for what constitutes a low value for the parameters. Furthermore the existence of a kernelization for (alpha,beta,d)-HITTING SET indicates that the problem is readily scalable to large datasets.	[Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia; [Mellor, Drew; Prieto, Elena; Mathieson, Luke; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, Newcastle, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Mellor, D (corresponding author), Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Newcastle, NSW 2308, Australia.	pablo.moscato@newcastle.edu.au	MOSCATO, PABLO ALBERTO/G-7668-2013; Prieto, Elena/G-7614-2013	Prieto, Elena/0000-0002-3814-6692; Moscato, Pablo/0000-0003-2570-5966; Mathieson, Luke/0000-0001-6470-2296	Hunter Medical Research Institute; University of Newcastle; ARC [DP0773279]	Hunter Medical Research Institute; University of Newcastle; ARC(Australian Research Council)	The authors acknowledge the support of the Hunter Medical Research Institute, The University of Newcastle, and ARC Discovery Project DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Khzam FN, 2010, J COMPUT SYST SCI, V76, P524, DOI 10.1016/j.jcss.2009.09.002; ALBAIN KS, 1990, J CLIN ONCOL, V8, P1563, DOI 10.1200/JCO.1990.8.9.1563; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Cotta C, 2003, J COMPUT SYST SCI, V67, P686, DOI 10.1016/S0022-0000(03)00081-3; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; Davies S., 1994, P AAAI S RELEVANCE, P41; DEKLEER J, 1992, ARTIF INTELL, V56, P197, DOI 10.1016/0004-3702(92)90027-U; Downey R.G., 1999, MG COMP SCI; Feige U, 1998, J ACM, V45, P634, DOI 10.1145/285055.285059; Fernau H., 2005, PARAMETERIZED ALGORI; FLAMANT F, 1984, CANCER, V54, P1687, DOI 10.1002/1097-0142(19841015)54:8<1687::AID-CNCR2820540833>3.0.CO;2-U; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; FU KK, 1979, CANCER TREAT REP, V63, P351; Garey M.R., 1979, COMPUTERS INTRACTABI; Haus UU, 2008, J COMPUT BIOL, V15, P259, DOI 10.1089/cmb.2007.0229; Hvidsten TR, 2003, BIOINFORMATICS, V19, P1116, DOI 10.1093/bioinformatics/btg047; IBM, ILOG CPLEX; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; LEIPINS GE, 1991, HDB GENETIC ALGORITH, P237; Lorenzi PL, 2009, MOL CANCER THER, V8, P713, DOI 10.1158/1535-7163.MCT-08-0921; Lyseng-Williamson KA, 2005, DRUGS, V65, P2513, DOI 10.2165/00003495-200565170-00007; Niedermeier R., 2006, INVITATION FIXED PAR; PAZ A, 1981, THEOR COMPUT SCI, V15, P251, DOI 10.1016/0304-3975(81)90081-5; Perez EA, 2010, ANN ONCOL, V21, P269, DOI 10.1093/annonc/mdp512; PEYTON JD, 2009, J CLIN ONCOL, V27, P9027; Polyzos A, 2010, BREAST CANCER RES TR, V119, P95, DOI 10.1007/s10549-009-0468-0; Rao RD, 2006, J CLIN ONCOL, V24, p463S; REITER R, 1987, ARTIF INTELL, V32, P57, DOI 10.1016/0004-3702(87)90062-2; Ruchkys DP, 2002, 14TH SYMPOSIUM ON COMPUTER ARCHITECTURE AND HIGH PERFORMANCE COMPUTING, PROCEEDINGS, P75, DOI 10.1109/CAHPC.2002.1180762; Shin SY, 2010, CANCER LETT, V287, P231, DOI 10.1016/j.canlet.2009.06.019; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Slamon D, 2009, CANCER RES, V69, P62; Sparano JA, 2009, J CLIN ONCOL, V27, P4522, DOI 10.1200/JCO.2008.20.5013; Vazirani V., 2001, APPROXIMATION ALGORI; Vazquez A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-81; Vinterbo SA, 2005, BIOINFORMATICS, V21, P1964, DOI 10.1093/bioinformatics/bti287; Yeh TC, 2007, CLIN CANCER RES, V13, P1576, DOI 10.1158/1078-0432.CCR-06-1150	38	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13055	10.1371/journal.pone.0013055	http://dx.doi.org/10.1371/journal.pone.0013055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976188	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300001
J	Momcilovic, O; Knobloch, L; Fornsaglio, J; Varum, S; Easley, C; Schatten, G				Momcilovic, Olga; Knobloch, Leah; Fornsaglio, Jamie; Varum, Sandra; Easley, Charles; Schatten, Gerald			DNA Damage Responses in Human Induced Pluripotent Stem Cells and Embryonic Stem Cells	PLOS ONE			English	Article							STRAND BREAKS; MOUSE; PHOSPHORYLATION; GENERATION; NANOG; APOPTOSIS; CLONING; ARREST; REPAIR; ABSENT	Background: Induced pluripotent stem (iPS) cells have the capability to undergo self-renewal and differentiation into all somatic cell types. Since they can be produced through somatic cell reprogramming, which uses a defined set of transcription factors, iPS cells represent important sources of patient-specific cells for clinical applications. However, before these cells can be used in therapeutic designs, it is essential to understand their genetic stability. Methodology/Principal Findings: Here, we describe DNA damage responses in human iPS cells. We observe hypersensitivity to DNA damaging agents resulting in rapid induction of apoptosis after gamma-irradiation. Expression of pluripotency factors does not appear to be diminished after irradiation in iPS cells. Following irradiation, iPS cells activate checkpoint signaling, evidenced by phosphorylation of ATM, NBS1, CHEK2, and TP53, localization of ATM to the double strand breaks (DSB), and localization of TP53 to the nucleus of NANOG-positive cells. We demonstrate that iPS cells temporary arrest cell cycle progression in the G(2) phase of the cell cycle, displaying a lack of the G(1)/S cell cycle arrest similar to human embryonic stem (ES) cells. Furthermore, both cell types remove DSB within six hours of gamma-irradiation, form RAD51 foci and exhibit sister chromatid exchanges suggesting homologous recombination repair. Finally, we report elevated expression of genes involved in DNA damage signaling, checkpoint function, and repair of various types of DNA lesions in ES and iPS cells relative to their differentiated counterparts. Conclusions/Significance: High degrees of similarity in DNA damage responses between ES and iPS cells were found. Even though reprogramming did not alter checkpoint signaling following DNA damage, dramatic changes in cell cycle structure, including a high percentage of cells in the S phase, increased radiosensitivity and loss of DNA damage-induced G(1)/S cell cycle arrest, were observed in stem cells generated by induced pluripotency.	[Momcilovic, Olga] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Knobloch, Leah; Fornsaglio, Jamie] Seton Hill Univ, Greensburg, PA USA; [Varum, Sandra] Univ Pittsburgh, Pittsburgh Dev Ctr, Pittsburgh, PA USA; [Easley, Charles; Schatten, Gerald] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Momcilovic, O (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA.	schattengp@upmc.edu	Schatten, Gerald/B-3253-2009	Schatten, Gerald/0000-0001-5206-7782	National Institute of Child Health and Human Development [1PO1HD047675]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a grant from the National Institute of Child Health and Human Development, http://www.nichd.nih.gov/, 1PO1HD047675. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Anderson Carl W., 1992, Critical Reviews in Eukaryotic Gene Expression, V2, P283; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banath JP, 2009, EXP CELL RES, V315, P1505, DOI 10.1016/j.yexcr.2008.12.007; Banuelos CA, 2008, DNA REPAIR, V7, P1471, DOI 10.1016/j.dnarep.2008.05.005; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; FINNIE NJ, 1995, P NATL ACAD SCI USA, V92, P320, DOI 10.1073/pnas.92.1.320; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Li G, 2002, P NATL ACAD SCI USA, V99, P832, DOI 10.1073/pnas.022649699; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; MAYNARD S, 2008, STEM CELLS; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SERRANO L, STEM CELLS DEV; SINGH DK, AGING CELL; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; TICHY ED, STEM CELLS DEV; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	39	122	126	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13410	10.1371/journal.pone.0013410	http://dx.doi.org/10.1371/journal.pone.0013410			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976220	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700012
J	Chu, CH; Lo, WC; Wang, HW; Hsu, YC; Hwang, JK; Lyu, PC; Pai, TW; Tang, CY				Chu, Chia-Han; Lo, Wei-Cheng; Wang, Hsin-Wei; Hsu, Yen-Chu; Hwang, Jenn-Kang; Lyu, Ping-Chiang; Pai, Tun-Wen; Tang, Chuan Yi			Detection and Alignment of 3D Domain Swapping Proteins Using Angle-Distance Image-Based Secondary Structural Matching Techniques	PLOS ONE			English	Article							HUMAN CYSTATIN-C; CRYSTAL-STRUCTURE; CIRCULAR PERMUTATION; SIMILARITY SEARCHES; AMYLOID FORMATION; DIMER; MECHANISM; RESOLUTION; TOOL; OLIGOMERIZATION	This work presents a novel detection method for three-dimensional domain swapping (DS), a mechanism for forming protein quaternary structures that can be visualized as if monomers had "opened'' their "closed'' structures and exchanged the opened portion to form intertwined oligomers. Since the first report of DS in the mid 1990s, an increasing number of identified cases has led to the postulation that DS might occur in a protein with an unconstrained terminus under appropriate conditions. DS may play important roles in the molecular evolution and functional regulation of proteins and the formation of depositions in Alzheimer's and prion diseases. Moreover, it is promising for designing auto-assembling biomaterials. Despite the increasing interest in DS, related bioinformatics methods are rarely available. Owing to a dramatic conformational difference between the monomeric/closed and oligomeric/open forms, conventional structural comparison methods are inadequate for detecting DS. Hence, there is also a lack of comprehensive datasets for studying DS. Based on angle-distance (A-D) image transformations of secondary structural elements (SSEs), specific patterns within A-D images can be recognized and classified for structural similarities. In this work, a matching algorithm to extract corresponding SSE pairs from A-D images and a novel DS score have been designed and demonstrated to be applicable to the detection of DS relationships. The Matthews correlation coefficient (MCC) and sensitivity of the proposed DS-detecting method were higher than 0.81 even when the sequence identities of the proteins examined were lower than 10%. On average, the alignment percentage and root-mean-square distance (RMSD) computed by the proposed method were 90% and 1.8 angstrom for a set of 1,211 DS-related pairs of proteins. The performances of structural alignments remain high and stable for DS-related homologs with less than 10% sequence identities. In addition, the quality of its hinge loop determination is comparable to that of manual inspection. This method has been implemented as a web-based tool, which requires two protein structures as the input and then the type and/or existence of DS relationships between the input structures are determined according to the A-D image-based structural alignments and the DS score. The proposed method is expected to trigger large-scale studies of this interesting structural phenomenon and facilitate related applications.	[Chu, Chia-Han; Tang, Chuan Yi] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan; [Lo, Wei-Cheng; Lyu, Ping-Chiang] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Lo, Wei-Cheng; Hwang, Jenn-Kang] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Wang, Hsin-Wei; Hsu, Yen-Chu; Pai, Tun-Wen] Natl Taiwan Ocean Univ, Dept Comp Sci & Engn, Chilung, Taiwan; [Tang, Chuan Yi] Providence Univ, Dept Comp Sci & Informat Engn, Taichung, Taiwan	National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; National Taiwan Ocean University; Providence University - Taiwan	Chu, CH (corresponding author), Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 30043, Taiwan.	twp@mail.ntou.edu.tw; cytang@pu.edu.tw	Chu, Chu/T-6038-2019	Lo, Wei-Cheng/0000-0001-8865-5113	National Science Council, Taiwan [99-2745-B-009-001-ASP, 99-2811-M-007-073, 99-3112-B-007-003, 98-2221-E-019-031-MY2, 97-2221-E-007-080-MY3]; Ministry of Education, Taiwan	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This work was funded by the National Science Council, Taiwan (http://www.nsc.gov.tw) with NSC grant number 99-2745-B-009-001-ASP (Academic Summit Program) to Jenn-Kang Hwang; 99-2811-M-007-073 and 99-3112-B-007-003 to Ping-Chiang Lyu; 98-2221-E-019-031-MY2 to Tun-Wen Pai; 97-2221-E-007-080-MY3 to Chuan Yi Tang. The Ministry of Education, Taiwan also funded this study with the Development Plan for World Class University and Research Centers of Excellence (MOU ATU Plan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov NN, 1996, PROTEINS, V25, P354, DOI 10.1002/(SICI)1097-0134(199607)25:3<354::AID-PROT7>3.3.CO;2-W; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barbosa JARG, 2002, P NATL ACAD SCI USA, V99, P1859, DOI 10.1073/pnas.022476199; Bennett MJ, 2004, STRUCTURE, V12, P1339, DOI 10.1016/j.str.2004.07.004; BENNETT MJ, 1994, PROTEIN SCI, V3, P1444, DOI 10.1002/pro.5560030911; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cameron AD, 1997, EMBO J, V16, P3386, DOI 10.1093/emboj/16.12.3386; Chu CH, 2008, J MOL RECOGNIT, V21, P442, DOI 10.1002/jmr.914; Crane BR, 1999, EMBO J, V18, P6271, DOI 10.1093/emboj/18.22.6271; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Dundas J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-388; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Janowski R, 2004, J MOL BIOL, V341, P151, DOI 10.1016/j.jmb.2004.06.013; Janowski R, 2001, NAT STRUCT BIOL, V8, P316, DOI 10.1038/86188; Jaskolski M, 2001, ACTA BIOCHIM POL, V48, P807; Jmol, JMOL OP SOURC JAV VI; Jung J, 2000, PROTEIN ENG, V13, P535, DOI 10.1093/protein/13.8.535; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAPATTO R, 1991, J MOL BIOL, V222, P1067, DOI 10.1016/0022-2836(91)90594-V; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Lo WC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r11; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pW545, DOI 10.1093/nar/gkp291; Lo WC, 2009, NUCLEIC ACIDS RES, V37, pD328, DOI 10.1093/nar/gkn679; Lo WC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-307; Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Nagarkar RP, 2010, BIOPOLYMERS, V94, P141, DOI 10.1002/bip.21332; Ogihara NL, 2001, P NATL ACAD SCI USA, V98, P1404, DOI 10.1073/pnas.98.4.1404; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Raveh B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000295; Rousseau F, 2001, P NATL ACAD SCI USA, V98, P5596, DOI 10.1073/pnas.101542098; Sauder JM, 2000, PROTEINS, V40, P6, DOI 10.1002/(SICI)1097-0134(20000701)40:1<6::AID-PROT30>3.0.CO;2-7; Schiering N, 2000, BIOCHEMISTRY-US, V39, P13376, DOI 10.1021/bi0012336; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Shih ESC, 2004, PROTEINS, V56, P519, DOI 10.1002/prot.20124; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Staniforth RA, 2001, EMBO J, V20, P4774, DOI 10.1093/emboj/20.17.4774; Suhrer SJ, 2007, BIOINFORMATICS, V23, P513, DOI 10.1093/bioinformatics/btl594; TRINKL S, 1994, PROTEIN SCI, V3, P1392, DOI 10.1002/pro.5560030905; Vesterstrom J, 2006, J COMPUT BIOL, V13, P43, DOI 10.1089/cmb.2006.13.43; Yang SC, 2004, P NATL ACAD SCI USA, V101, P13786, DOI 10.1073/pnas.0403724101; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zegers I, 1999, P NATL ACAD SCI USA, V96, P818, DOI 10.1073/pnas.96.3.818; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331	60	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13361	10.1371/journal.pone.0013361	http://dx.doi.org/10.1371/journal.pone.0013361			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976204	gold, Green Submitted, Green Published			2022-12-27	WOS:000282941000010
J	Tiberio, P; Cavadini, E; Abolafio, G; Formelli, F; Appierto, V				Tiberio, Paola; Cavadini, Elena; Abolafio, Gabriella; Formelli, Franca; Appierto, Valentina			4-oxo-N-(4-hydroxyphenyl)retinamide: Two Independent Ways to Kill Cancer Cells	PLOS ONE			English	Article							FENRETINIDE-INDUCED APOPTOSIS; OVARIAN-CARCINOMA CELLS; BREAST-CANCER; DEPENDENT MECHANISM; TOPICAL TREATMENT; ACTIVATED GENE-1; RANDOMIZED-TRIAL; ER STRESS; DEATH; 4-OXO-FENRETINIDE	Background: The retinoid 4-oxo-N-(4-hydroxyphenyl) retinamide (4-oxo-4-HPR) is a polar metabolite of fenretinide (4-HPR) very effective in killing cancer cells of different histotypes, able to inhibit 4-HPR-resistant cell growth and to act synergistically in combination with the parent drug. Unlike 4-HPR and other retinoids, 4-oxo-4-HPR inhibits tubulin polymerization, leading to multipolar spindle formation and mitotic arrest. Here we investigated whether 4-oxo-4-HPR, like 4-HPR, triggered cell death also via reactive oxygen species (ROS) generation and whether its antimicrotubule activity was related to a ROS-dependent mechanism in ovarian (A2780), breast (T47D), cervical (HeLa) and neuroblastoma (SK-N-BE) cancer cell lines. Methodology/Principal Findings: We provided evidence that 4-oxo-4-HPR, besides acting as an antimicrotubule agent, induced apoptosis through a signaling cascade starting from ROS generation and involving endoplasmic reticulum (ER) stress response, Jun N-terminal Kinase (JNK) activation, and upregulation of the proapoptotic PLAcental Bone morphogenetic protein (PLAB). Through time-course analysis and inhibition of the ROS-related signaling pathway (upstream by vitamin C and downstream by PLAB silencing), we demonstrated that the antimitotic activity of 4-oxo-4-HPR was independent from the oxidative stress induced by the retinoid. In fact, ROS generation occurred earlier than mitotic arrest (within 30 minutes and 2 hours, respectively) and abrogation of the ROS-related signaling pathway did not prevent the 4-oxo-4-HPR-induced mitotic arrest. Conclusions/Significance: These data indicate that 4-oxo-4-HPR anticancer activity is due to at least two independent mechanisms and provide an explanation of the ability of 4-oxo-4-HPR to be more potent than the parent drug and to be effective also in 4-HPR-resistant cell lines. In addition, the double mechanism of action could allow 4-oxo-4-HPR to efficiently target tumour and to eventually counteract the development of drug resistance.	[Tiberio, Paola; Cavadini, Elena; Abolafio, Gabriella; Formelli, Franca; Appierto, Valentina] Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Fdn IRCCS, I-20133 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan	Tiberio, P (corresponding author), Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Fdn IRCCS, Via Venezian 1, I-20133 Milan, Italy.	paola.tiberio@istitutotumori.mi.it	Appierto, Valentina/B-9325-2017; Abolafio, Gabriella/AAC-2861-2019	Appierto, Valentina/0000-0002-8726-6981; Abolafio, Gabriella/0000-0003-1077-5187	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy	Associazione Italiana per la Ricerca sul Cancro, Milan, Italy(Fondazione AIRC per la ricerca sul cancro)	The study was supported by grants from the Associazione Italiana per la Ricerca sul Cancro (http://www.airc.it), Milan, Italy, through grants and a fellowship (P. Tiberio). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre J, 2007, CANCER RES, V67, P3512, DOI 10.1158/0008-5472.CAN-06-3914; Alexandre J, 2006, INT J CANCER, V119, P41, DOI 10.1002/ijc.21685; Appierto V, 2007, ONCOGENE, V26, P3952, DOI 10.1038/sj.onc.1210171; Appierto V, 2004, CELL DEATH DIFFER, V11, P270, DOI 10.1038/sj.cdd.4401349; Appierto V, 2009, MOL CANCER THER, V8, P3360, DOI 10.1158/1535-7163.MCT-09-0798; Appierto V, 2009, CARCINOGENESIS, V30, P824, DOI 10.1093/carcin/bgp067; Bourgarel-Rey V, 2009, BIOCHEM PHARMACOL, V78, P1148, DOI 10.1016/j.bcp.2009.06.025; Chiesa F, 2005, INT J CANCER, V115, P625, DOI 10.1002/ijc.20923; Chua YS, 2010, MOL CANCER THER, V9, P224, DOI 10.1158/1535-7163.MCT-09-1003; De Palo G, 2002, GYNECOL ONCOL, V86, P24, DOI 10.1006/gyno.2002.6663; DELIA D, 1995, BLOOD, V85, P359, DOI 10.1182/blood.V85.2.359.bloodjournal852359; Durrant D, 2008, GYNECOL ONCOL, V110, P110, DOI 10.1016/j.ygyno.2008.02.031; Hail N, 2006, APOPTOSIS, V11, P1677, DOI 10.1007/s10495-006-9289-3; Jutooru I, 2009, MOL CARCINOGEN, V48, P692, DOI 10.1002/mc.20518; Kang MH, 2008, JNCI-J NATL CANCER I, V100, P580, DOI 10.1093/jnci/djn076; Khawaja NR, 2008, MOL PHARMACOL, V74, P1072, DOI 10.1124/mol.108.048405; Lee SH, 2010, CARCINOGENESIS, V31, P719, DOI 10.1093/carcin/bgq016; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Moglia D, 1996, CANCER LETT, V110, P87, DOI 10.1016/S0304-3835(96)04475-8; Nagy L, 1998, CELL DEATH DIFFER, V5, P11, DOI 10.1038/sj.cdd.4400337; Pignatelli M, 2005, CARCINOGENESIS, V26, P81, DOI 10.1093/carcin/bgh308; Poruchynsky MS, 2001, BIOCHEM PHARMACOL, V62, P1469, DOI 10.1016/S0006-2952(01)00804-8; Reed JC, 1999, J NATL CANCER I, V91, P1099, DOI 10.1093/jnci/91.13.1099; Rubio S, 2010, MOL CARCINOGEN, V49, P32, DOI 10.1002/mc.20574; Sgadari C, 2000, J IMMUNOL, V165, P509, DOI 10.4049/jimmunol.165.1.509; Shim M, 2008, MOL CANCER THER, V7, P961, DOI 10.1158/1535-7163.MCT-07-0470; Ting CM, 2010, BIOCHEM PHARMACOL, V79, P825, DOI 10.1016/j.bcp.2009.10.018; TRADATI N, 1994, CANCER LETT, V76, P109, DOI 10.1016/0304-3835(94)90385-9; Valsecchi M, 2010, J LIPID RES, V51, P1832, DOI 10.1194/jlr.M004010; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Veronesi U, 1999, J NATL CANCER I, V91, P1847, DOI 10.1093/jnci/91.21.1847; Villani MG, 2006, CANCER RES, V66, P3238, DOI 10.1158/0008-5472.CAN-05-3362; Villani MG, 2004, CLIN CANCER RES, V10, P6265, DOI 10.1158/1078-0432.CCR-04-0655; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yoshioka H, 2008, J BIOL CHEM, V283, P33129, DOI 10.1074/jbc.M805248200	35	8	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13362	10.1371/journal.pone.0013362	http://dx.doi.org/10.1371/journal.pone.0013362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976277	Green Published, gold, Green Submitted			2022-12-27	WOS:000282941000011
J	Andriantsoanirina, V; Ratsimbasoa, A; Bouchier, C; Tichit, M; Jahevitra, M; Rabearimanana, S; Raherinjafy, R; Mercereau-Puijalon, O; Durand, R; Menard, D				Andriantsoanirina, Valerie; Ratsimbasoa, Arsene; Bouchier, Christiane; Tichit, Magali; Jahevitra, Martial; Rabearimanana, Stephane; Raherinjafy, Rogelin; Mercereau-Puijalon, Odile; Durand, Remy; Menard, Didier			Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr-1, Not Pfcrt in Madagascar	PLOS ONE			English	Article							RESISTANT PLASMODIUM-FALCIPARUM; ANTIMALARIAL-DRUG-RESISTANCE; BASE-LINE DATA; SULFADOXINE-PYRIMETHAMINE; AFRICAN CHILDREN; EFFICACY; AMODIAQUINE; MORTALITY; IMPACT; PATTERNS	Molecular studies have demonstrated that mutations in the Plasmodium falciparum chloroquine resistance transporter gene (Pfcrt) play a major role in chloroquine resistance, while mutations in P. falciparum multidrug resistance gene (Pfmdr-1) act as modulator. In Madagascar, the high rate of chloroquine treatment failure (44%) appears disconnected from the overall level of in vitro CQ susceptibility (prevalence of CQ-resistant parasites <5%) or Pfcrt mutant isolates (<1%), strongly contrasting with sub-Saharan African countries. Previous studies showed a high frequency of Pfmdr-1 mutant parasites (>60% of isolates) but did not explore their association with P. falciparum chloroquine resistance. To document the association of Pfmdr-1 alleles with chloroquine resistance in Madagascar, 249 P. falciparum samples collected from patients enrolled in a chloroquine in vivo efficacy study were genotyped in Pfcrt/Pfmdr-1 genes as well as the estimation of the Pfmdr-1 copy number. Except 2 isolates, all samples displayed a wild-type Pfcrt allele without Pfmdr-1 amplification. Chloroquine treatment failures were significantly associated with Pfmdr-1 86Y mutant codon (OR = 4.6). The cumulative incidence of recurrence of patients carrying the Pfmdr-1 86Y mutation at day 0 (21 days) was shorter than patients carrying Pfmdr-1 86N wild type codon (28 days). In an independent set of 90 selected isolates, in vitro susceptibility to chloroquine was not associated with Pfmdr-1 polymorphisms. Analysis of two microsatellites flanking Pfmdr-1 allele showed that mutations occurred on multiple genetic backgrounds. In Madagascar, Pfmdr-1 polymorphism is associated with late chloroquine clinical failures and unrelated with in vitro susceptibility or Pfcrt genotype. These results highlight the limits of the current in vitro tests routinely used to monitor CQ drug resistance in this unique context. Gaining insight about the mechanisms that regulate polymorphism in Pfmdr1 remains important, particularly regarding the evolution and spread of Pfmdr-1 alleles in P. falciparum populations under changing drug pressure which may have important consequences in terms of antimalarial use management.	[Andriantsoanirina, Valerie; Jahevitra, Martial; Rabearimanana, Stephane; Raherinjafy, Rogelin; Menard, Didier] Inst Pasteur Madagascar, Antananarivo, Madagascar; [Ratsimbasoa, Arsene] Minist Sante, Antananarivo, Madagascar; [Bouchier, Christiane; Tichit, Magali; Mercereau-Puijalon, Odile; Menard, Didier] Inst Pasteur, Paris, France; [Durand, Remy] Hop Avicenne, AP HP, F-93009 Bobigny, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Andriantsoanirina, V (corresponding author), Inst Pasteur Madagascar, Antananarivo, Madagascar.	dmenard@pasteur.fr	Mercereau-Puijalon, Odile/AAA-2242-2020; Ratsimbasoa, Arsene/AAE-9306-2020; Andriantsoanirina, Valérie/T-9693-2019; Menard, Didier/O-3294-2013	Menard, Didier/0000-0003-1357-4495; Andriantsoanirina, Valerie/0000-0002-2695-2566	Institut de Medecine et d'Emiologie Appliquee (IMEA), Fondation Leon MBA, Paris, France; Genomics Platform, Pasteur Genopole, Pasteur Institute, France; Global Fund [MDG-304-G05-M]; Institut Pasteur de Madagascar; Direction des Affaires Internationales (Institut Pasteur)	Institut de Medecine et d'Emiologie Appliquee (IMEA), Fondation Leon MBA, Paris, France; Genomics Platform, Pasteur Genopole, Pasteur Institute, France(Swiss National Science Foundation (SNSF)); Global Fund; Institut Pasteur de Madagascar; Direction des Affaires Internationales (Institut Pasteur)	This study was supported by grants from the Institut de Medecine et d'Emiologie Appliquee (IMEA), Fondation Leon MBA, Paris, France and the Genomics Platform, Pasteur Genopole, Pasteur Institute, France. Samples collection in Madagascar was funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria, round 3 (Community Action to Roll Back Malaria, grant no. MDG-304-G05-M). Valerie Andriantsoanirina is a graduate PhD student funded by the Institut Pasteur de Madagascar (Bourse "Girard") and the Direction des Affaires Internationales (Institut Pasteur). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriantsoanirina V, 2010, SCAND J INFECT DIS, V42, P22, DOI 10.3109/00365540903289670; Andriantsoanirina V, 2009, ANTIMICROB AGENTS CH, V53, P4588, DOI 10.1128/AAC.00610-09; de Monbrison F, 2003, T ROY SOC TROP MED H, V97, P387, DOI 10.1016/S0035-9203(03)90065-4; Djimde A, 2001, NEW ENGL J MED, V344, P257, DOI 10.1056/NEJM200101253440403; Duraisingh MT, 2005, ACTA TROP, V94, P181, DOI 10.1016/j.actatropica.2005.04.008; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Juliano JJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-47; Kazadi WM, 2003, TROP MED INT HEALTH, V8, P868, DOI 10.1046/j.1365-3156.2003.01098.x; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehlotra RK, 2008, ANTIMICROB AGENTS CH, V52, P2212, DOI 10.1128/AAC.00089-08; Menard D, 2005, AM J TROP MED HYG, V72, P581, DOI 10.4269/ajtmh.2005.72.581; Menard D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-55; Mita T, 2009, PARASITOL INT, V58, P201, DOI 10.1016/j.parint.2009.04.004; MOUCHET J, 2004, BIODIVERSITE  PALUDI; NEI M, 1978, GENETICS, V89, P583; Ogungbamigbe TO, 2008, MEM I OSWALDO CRUZ, V103, P79, DOI 10.1590/S0074-02762008000100012; Ogwang S, 2003, WIEN KLIN WOCHENSCHR, V115, P45; Rakotonirina H, 2008, AM J TROP MED HYG, V78, P217, DOI 10.4269/ajtmh.2008.78.217; Randrianarivelojosia M, 2006, T ROY SOC TROP MED H, V100, P826, DOI 10.1016/j.trstmh.2005.10.009; Razakandrainibe R, 2009, ACTA TROP, V111, P160, DOI 10.1016/j.actatropica.2009.04.007; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; Rowe AK, 2006, INT J EPIDEMIOL, V35, P691, DOI 10.1093/ije/dyl027; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; Sirima SB, 2003, T ROY SOC TROP MED H, V97, P345, DOI 10.1016/S0035-9203(03)90166-0; Snow RW, 2001, TRENDS PARASITOL, V17, P593, DOI 10.1016/S1471-4922(01)02031-1; Sutherland CJ, 2002, AM J TROP MED HYG, V67, P578, DOI 10.4269/ajtmh.2002.67.578; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Valderramos SG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000887; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; Wellems TE, 2009, J CLIN INVEST, V119, P2496, DOI 10.1172/JCI38307; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450	35	26	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13281	10.1371/journal.pone.0013281	http://dx.doi.org/10.1371/journal.pone.0013281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967251	gold, Green Published			2022-12-27	WOS:000282869800011
J	Cowper-Smith, CD; Lau, EYY; Helmick, CA; Eskes, GA; Westwood, DA				Cowper-Smith, Christopher D.; Lau, Esther Y. Y.; Helmick, Carl A.; Eskes, Gail A.; Westwood, David A.			Neural Coding of Movement Direction in the Healthy Human Brain	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; DORSOLATERAL PREFRONTAL CORTEX; CORTICAL REPRESENTATION; NEURONAL-ACTIVITY; FMRI ADAPTATION; ARM MOVEMENTS; TETRAPLEGIA; PREMOTOR; ORGANIZATION; ACTIVATION	Neurophysiological studies in monkeys show that activity of neurons in primary cortex (M1), pre-motor cortex (PMC), and cerebellum varies systematically with the direction of reaching movements. These neurons exhibit preferred direction tuning, where the level of neural activity is highest when movements are made in the preferred direction (PD), and gets progressively lower as movements are made at increasing degrees of offset from the PD. Using a functional magnetic resonance imaging adaptation (fMRI-A) paradigm, we show that PD coding does exist in regions of the human motor system that are homologous to those observed in non-human primates. Consistent with predictions of the PD model, we show adaptation (i.e., a lower level) of the blood oxygen level dependent (BOLD) time-course signal in M1, PMC, SMA, and cerebellum when consecutive wrist movements were made in the same direction (0 degrees offset) relative to movements offset by 90 degrees or 180 degrees. The BOLD signal in dorsolateral prefrontal cortex adapted equally in all movement offset conditions, mitigating against the possibility that the present results are the consequence of differential task complexity or attention to action in each movement offset condition.	[Cowper-Smith, Christopher D.] Dalhousie Univ, Dept Psychol, Halifax, NS, Canada; [Lau, Esther Y. Y.] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Helmick, Carl A.; Eskes, Gail A.] Dalhousie Univ, Dept Psychiat, Halifax, NS, Canada; [Westwood, David A.] Dalhousie Univ, Sch Hlth & Human Performance, Halifax, NS, Canada	Dalhousie University; University of Hong Kong; Dalhousie University; Dalhousie University	Cowper-Smith, CD (corresponding author), Dalhousie Univ, Dept Psychol, Halifax, NS, Canada.	David.Westwood@DAL.CA		Eskes, Gail/0000-0001-5867-9616; Westwood, David/0000-0003-3317-0447	Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation; Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS); Nova Scotia Health Research Foundation (NSHRF); Sir Edward Youde Memorial Overseas Fellowship; Dalhousie Faculty of Medicine Clinical Research; CIHR	Nova Scotia Health Research Foundation; Dalhousie Medical Research Foundation; Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS)(Canadian Institutes of Health Research (CIHR)); Nova Scotia Health Research Foundation (NSHRF); Sir Edward Youde Memorial Overseas Fellowship; Dalhousie Faculty of Medicine Clinical Research; CIHR(Canadian Institutes of Health Research (CIHR))	This research was funded by the Nova Scotia Health Research Foundation and the Dalhousie Medical Research Foundation. CCS was supported by studentships from the Canadian Institutes of Health Research/Institutes de recherche en sante du Canada (CIHR/IRCS) and the Nova Scotia Health Research Foundation (NSHRF). This research was previously published as part of CCS' MSc thesis. EL was supported by the Sir Edward Youde Memorial Overseas Fellowship, and GE was supported by a Dalhousie Faculty of Medicine Clinical Research Scholar Award. DW was supported by a CIHR New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirikian B, 2000, NEUROSCI RES, V36, P73, DOI 10.1016/S0168-0102(99)00112-1; Bedard P, 2008, EXP BRAIN RES, V188, P63, DOI 10.1007/s00221-008-1339-3; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; Bitterman Y, 2008, NATURE, V451, P197, DOI 10.1038/nature06476; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Chong TTJ, 2008, CURR BIOL, V18, P1576, DOI 10.1016/j.cub.2008.08.068; Chouinard PA, 2009, NEUROIMAGE, V48, P696, DOI 10.1016/j.neuroimage.2009.07.020; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Donoghue JP, 2007, J PHYSIOL-LONDON, V579, P603, DOI 10.1113/jphysiol.2006.127209; Eisenberg M, 2010, J NEUROSCI, V30, P8897, DOI 10.1523/JNEUROSCI.0007-10.2010; FORTIER PA, 1989, J NEUROPHYSIOL, V62, P198, DOI 10.1152/jn.1989.62.1.198; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Horenstein C, 2009, HUM BRAIN MAPP, V30, P1397, DOI 10.1002/hbm.20610; Hoshi E, 2006, NEUROSCI RES, V54, P73, DOI 10.1016/j.neures.2005.10.013; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; Kapreli E, 2006, NEUROIMAGE, V32, P1709, DOI 10.1016/j.neuroimage.2006.05.043; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kroliczak G, 2008, J NEUROPHYSIOL, V100, P2627, DOI 10.1152/jn.01376.2007; Lewis PA, 2004, NEUROPSYCHOLOGIA, V42, P1301, DOI 10.1016/j.neuropsychologia.2004.03.001; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; Naselaris T, 2006, J NEUROPHYSIOL, V96, P3237, DOI 10.1152/jn.00488.2006; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Passingham RE, 1996, PHILOS T ROY SOC B, V351, P1473, DOI 10.1098/rstb.1996.0132; SCHWARTZ AB, 1993, J NEUROPHYSIOL, V70, P28, DOI 10.1152/jn.1993.70.1.28; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055	36	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13330	10.1371/journal.pone.0013330	http://dx.doi.org/10.1371/journal.pone.0013330			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967197	gold, Green Published			2022-12-27	WOS:000282869800028
J	Wang, MH; Marinotti, O; James, AA; Walker, E; Githure, J; Yan, GY				Wang, Mei-Hui; Marinotti, Osvaldo; James, Anthony A.; Walker, Edward; Githure, John; Yan, Guiyun			Genome-Wide Patterns of Gene Expression during Aging in the African Malaria Vector Anopheles gambiae	PLOS ONE			English	Article							DROSOPHILA LIFE-SPAN; AEDES-AEGYPTI DIPTERA; OXIDATIVE STRESS; MOSQUITO AGE; CELL-DEATH; CUTICULAR HYDROCARBONS; MICROARRAY ANALYSIS; C-ELEGANS; MELANOGASTER; CULICIDAE	The primary means of reducing malaria transmission is through reduction in longevity in days of the adult female stage of the Anopheles vector. However, assessing chronological age is limited to crude physiologic methods which categorize the females binomially as either very young (nulliparous) or not very young (parous). Yet the epidemiologically relevant reduction in life span falls within the latter category. Age-grading methods that delineate chronological age, using accurate molecular surrogates based upon gene expression profiles, will allow quantification of the longevity-reducing effects of vector control tools aimed at the adult, female mosquito. In this study, microarray analyses of gene expression profiles in the African malaria vector Anopheles gambiae were conducted during natural senescence of females in laboratory conditions. Results showed that detoxification-related and stress-responsive genes were up-regulated as mosquitoes aged. A total of 276 transcripts had age-dependent expression, independently of blood feeding and egg laying events. Expression of 112 (40.6%) of these transcripts increased or decreased monotonically with increasing chronologic age. Seven candidate genes for practical age assessment were tested by quantitative gene amplification in the An. gambiae G3 strain in a laboratory experiment and the Mbita strain in field enclosures set up in western Kenya under conditions closely resembling natural ones. Results were similar between experiments, indicating that senescence is marked by changes in gene expression and that chronological age can be gauged accurately and repeatedly with this method. These results indicate that the method may be suitable for accurate gauging of the age in days of field-caught, female An. gambiae.	[Wang, Mei-Hui; Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA; [Marinotti, Osvaldo; James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA; [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Walker, Edward] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Githure, John] Int Ctr Insect Physiol & Ecol, Div Human Hlth, Nairobi, Kenya	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Michigan State University; International Centre of Insect Physiology & Ecology (ICIPE)	Wang, MH (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92717 USA.	guiyuny@uci.edu		Marinotti, Osvaldo/0000-0002-7173-7160; James, Anthony/0000-0001-5577-3308	Ellison Medical Foundation; National Institutes of Health [R21 AI078463]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078463] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank three anonymous referees for their constructive comments on the manuscript and the Ellison Medical Foundation sponsors the 2009 Molecular Biology of Aging Summer Course for M-H Wang.; This study was funded by National Institutes of Health, R21 AI078463. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGARWAL S, 1994, MECH AGEING DEV, V75, P11, DOI 10.1016/0047-6374(94)90024-8; Ahmed AM, 2001, INSECT MOL BIOL, V10, P347, DOI 10.1046/j.0962-1075.2001.00273.x; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], 2008, WORLD MAL REP 2008; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bell R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000414; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; Desena ML, 1999, J MED ENTOMOL, V36, P811, DOI 10.1093/jmedent/36.6.811; Desena ML, 1999, J MED ENTOMOL, V36, P824, DOI 10.1093/jmedent/36.6.824; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; GIRAUDO M, 2010, GENOMIC INSIGHTS PES, V97, P115; Golden TR, 2006, EXP GERONTOL, V41, P1040, DOI 10.1016/j.exger.2006.06.034; Golden TR, 2004, AGING CELL, V3, P111, DOI 10.1111/j.1474-9728.2004.00095.x; Gorski SM, 2003, CURR BIOL, V13, P358, DOI 10.1016/S0960-9822(03)00082-4; Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Hastie T., 2009, UNSUPERVISED LEARNIN; Hill AA, 2000, SCIENCE, V290, P809, DOI 10.1126/science.290.5492.809; Hodjati MH, 1999, B ENTOMOL RES, V89, P329, DOI 10.1017/S0007485399000462; Hugo LE, 2008, J MED ENTOMOL, V45, P353, DOI 10.1603/0022-2585(2008)45[353:EOMAGT]2.0.CO;2; Hugo LE, 2006, AM J TROP MED HYG, V74, P462, DOI 10.4269/ajtmh.2006.74.462; Jensen HR, 2006, INSECT MOL BIOL, V15, P329, DOI 10.1111/j.1365-2583.2006.00648.x; Kang HL, 2002, P NATL ACAD SCI USA, V99, P838, DOI 10.1073/pnas.022631999; Kim AJ, 2004, GENE, V343, P79, DOI 10.1016/j.gene.2004.08.031; Knols Bart G.J., 2002, Malaria Journal, V1, pUnpaginated, DOI 10.1186/1475-2875-1-19; Lai CQ, 2007, MECH AGEING DEV, V128, P237, DOI 10.1016/j.mad.2006.12.003; LANCIANI CA, 1993, J AM MOSQUITO CONTR, V9, P158; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Li B, 2005, GENE, V360, P131, DOI 10.1016/j.gene.2005.07.001; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; Liu Y, 2008, INSECT MOL BIOL, V17, P91, DOI 10.1111/j.1365-2583.2007.00785.x; Luckhart S, 2007, DEV COMP IMMUNOL, V31, P647, DOI 10.1016/j.dci.2006.10.005; MACDONALD G, 1968, B WORLD HEALTH ORGAN, V38, P743; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; Martin DN, 2007, CELL DEATH DIFFER, V14, P916, DOI 10.1038/sj.cdd.4402098; Martinez-Lara E, 2002, MAR ENVIRON RES, V54, P263, DOI 10.1016/S0141-1136(02)00188-5; Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192; McCarroll SA, 2004, NAT GENET, V36, P197, DOI 10.1038/ng1291; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Minakawa N, 2006, AM J TROP MED HYG, V75, P448, DOI 10.4269/ajtmh.2006.75.448; Morey M, 2003, FEBS LETT, V534, P111, DOI 10.1016/S0014-5793(02)03790-0; Nirmala X, 2005, INSECT MOL BIOL, V14, P95, DOI 10.1111/j.1365-2583.2005.00535.x; Norry FM, 2009, J INSECT PHYSIOL, V55, P1050, DOI 10.1016/j.jinsphys.2009.07.009; Okanda F.M., 2002, Malaria Journal, pUnpaginated, DOI 10.1186/1475-2875-1-10; Okech BA, 2003, J MED ENTOMOL, V40, P657, DOI 10.1603/0022-2585-40.5.657; Pletcher SD, 2005, AGEING RES REV, V4, P451, DOI 10.1016/j.arr.2005.06.007; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; Polovodova V., 1949, MED PARASITOL, V28, P352; Ribeiro JMC, 2004, INSECT MOL BIOL, V13, P449, DOI 10.1111/j.0962-1075.2004.00503.x; Semeiks JR, 2005, MECH AGEING DEV, V126, P193, DOI 10.1016/j.mad.2004.09.028; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Silver J. B, 2008, MOSQUITO ECOLOGY FIE; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P575, DOI 10.1016/S0891-5849(02)00886-9; Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Zou S, 2000, P NATL ACAD SCI USA, V97, P13726, DOI 10.1073/pnas.260496697	59	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13359	10.1371/journal.pone.0013359	http://dx.doi.org/10.1371/journal.pone.0013359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967211	Green Published, gold			2022-12-27	WOS:000282869800039
J	Bygrave, H; Kranzer, K; Hilderbrand, K; Whittal, J; Jouquet, G; Goemaere, E; Vlahakis, N; Trivino, L; Makakole, L; Ford, N				Bygrave, Helen; Kranzer, Katharina; Hilderbrand, Katherine; Whittal, Jonathan; Jouquet, Guillaume; Goemaere, Eric; Vlahakis, Nathalie; Trivino, Laura; Makakole, Lipontso; Ford, Nathan			Trends in Loss to Follow-Up among Migrant Workers on Antiretroviral Therapy in a Community Cohort in Lesotho	PLOS ONE			English	Article							HIV TREATMENT; OUTCOMES	Background: The provision of antiretroviral therapy (ART) to migrant populations raises particular challenges with respect to ensuring adequate treatment support, adherence, and retention in care. We assessed rates of loss to follow-up for migrant workers compared with non-migrant workers in a routine treatment programme in Morjia, Lesotho. Design: All adult patients (>= 18 years) initiating ART between January 1, 2008, and December 31, 2008, and followed up until the end of 2009, were included in the study. We described rates of loss to follow-up according to migrant status by Kaplan-Meier estimates, and used Poisson regression to model associations between migrant status and loss to follow-up controlling for potential confounders identified a priori. Results: Our cohort comprised 1185 people, among whom 12% (148) were migrant workers. Among the migrant workers, median age was 36.1 (29.6-45.9) and the majority (55%) were male. We found no statistically significant differences between baseline characteristics and migrant status. Rates of lost to follow up were similar between migrants and non-migrants in the first 3 months but differences increased thereafter. Between 3 and 6 months after initiating antiretroviral therapy, migrants had a 2.78-fold increased rate of defaulting (95% CI 1.15-6.73); between 6 and 12 months the rate was 2.36 times greater (95% CI 1.18-4.73), whereas after 1 year the rate was 6.69 times greater (95% CI 3.18-14.09). Conclusions: Our study highlights the need for programme implementers to take into account the specific challenges that may influence continuity of antiretroviral treatment and care for migrant populations.	[Bygrave, Helen; Jouquet, Guillaume; Vlahakis, Nathalie; Trivino, Laura] Med Sans Frontieres, Morija, Lesotho; [Kranzer, Katharina] London Sch Hyg & Trop Med, London WC1, England; [Hilderbrand, Katherine; Whittal, Jonathan; Goemaere, Eric; Ford, Nathan] Med Sans Frontieres, Cape Town, South Africa; [Hilderbrand, Katherine; Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Makakole, Lipontso] Scott Hosp, Morija, Lesotho	University of London; London School of Hygiene & Tropical Medicine; University of Cape Town	Bygrave, H (corresponding author), Med Sans Frontieres, Morija, Lesotho.	helenbygrave@hotmail.com	Kranzer, Katharina/O-8845-2014	Kranzer, Katharina/0000-0001-5691-7270				AIDS and Rights Alliance for Southern Africa, 2008, MIN SECT TUB MIGR LA; AKUGIZIBWE P, 2009, TIMES S AFRICA  0218; [Anonymous], 2007, HIV AIDS STI STRATEG; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Cohen R, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-23; Culbert H, 2007, PLOS MED, V4, P794, DOI 10.1371/journal.pmed.0040129; Dahab M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-63; FURIN J, 2008, ANN NY ACAD SCI, P12; GENG EH, J ACQUIR IMMUNE DEFI, V53, P405; *INT ORG MIGR, 2010, INT LAB C 99 SESS GE; *INT ORG MIGR, 2002, POS PAP HIV AIDS MIG; KRANZER K, 2010, J ACQUIR IMMUNE 0908; McCarthy K, 2009, INT J STD AIDS, V20, P858, DOI 10.1258/ijsa.2009.009258; *MED SANS FRONT, 2010, PROV NURS DRIV COMM; Meekers D, 2000, INT J STD AIDS, V11, P21, DOI 10.1258/0956462001914850; *MIN HLTH SOC WELF, 2007, LES NAT ART IN PRESS; SADC, 2009, FUNCT MIN STAND NAT; Saether ST, 2007, TROP MED INT HEALTH, V12, P999, DOI 10.1111/j.1365-3156.2007.01879.x; Schopper D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000115; *UN DEV PROGR, 2009, HUM DEV REP 2009; VEAREY J, 2008, ASSESSING NONCITIZEN; 2009, NURSE DRIVEN COMMUNI	22	32	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13198	10.1371/journal.pone.0013198	http://dx.doi.org/10.1371/journal.pone.0013198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20976289	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000282676700006
J	Antonacci, D; Norscia, I; Palagi, E				Antonacci, Daniela; Norscia, Ivan; Palagi, Elisabetta			Stranger to Familiar: Wild Strepsirhines Manage Xenophobia by Playing	PLOS ONE			English	Article							MALE VERREAUXS SIFAKA; BONOBOS PAN-PANISCUS; PROPITHECUS-VERREAUXI; ADULT PLAY; KIRINDY FOREST; SOCIAL PLAY; BEHAVIOR; BENEFITS; SIGNALS; REPRODUCTION	The power of play in limiting xenophobia is a well-known phenomenon in humans. Yet, the evidence in social animals remains meager. Here, we aim to determine whether play promotes social tolerance toward strangers in one of the most basal group of primates, the strepsirhines. We observed two groups of wild lemurs (Propithecus verreauxi, Verreaux's sifaka) during the mating season. Data were also collected on nine visiting, outgroup males. We compared the distribution of play, grooming, and aggressive interactions across three conditions: OUT (resident/outgroup interactions), IN (resident/resident interactions in presence of outgroups) and BL-IN (baseline of resident/resident interactions in absence of outgroups). Play frequency between males was higher in OUT than in IN and BL-IN conditions; whereas, grooming was more frequent in IN than in OUT and BL-IN conditions. Aggression rates between resident and outgroup males were significantly higher than those between residents. However, aggressions between resident and outgroup males significantly decreased after the first play session and became comparable with resident-resident aggression levels. The presence of strangers in a well-established group implies the onset of novel social circumstances, which sifaka males cope with by two different tactics: grooming with ingroup males and playing with outgroup ones. The grooming peak, concurrently with the visit of outgroups, probably represents a social shield adopted by resident males to make their pre-existing affiliation more evident to the stranger "audience''. Being mostly restricted to unfamiliar males, adult play in sifaka appears to have a role in managing new social situations more than in maintaining old relationships. In particular, our results indicate not only that play is the interface between strangers but also that it has a specific function in reducing xenophobia. In conclusion, play appears to be an ice-breaker mechanism in the critical process that "upgrades'' an individual from stranger to familiar.	[Antonacci, Daniela; Norscia, Ivan; Palagi, Elisabetta] Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy; [Palagi, Elisabetta] CNR, Inst Cognit Sci & Technol, Unit Cognit Primatol, Rome, Italy; [Palagi, Elisabetta] CNR, Inst Cognit Sci & Technol, Ctr Primate, Rome, Italy	University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR)	Antonacci, D (corresponding author), Univ Pisa, Ctr Interdipartimentale Museo Storia Nat & Terr, Pisa, Italy.	betta.palagi@museo.unipi.it	Norscia, Ivan/J-3321-2015	Norscia, Ivan/0000-0002-1618-7717	Giardino Zoologico di Pistoia; Parco Zoo Punta Verde; Parco Zoo di Falconara (ITALY)	Giardino Zoologico di Pistoia; Parco Zoo Punta Verde; Parco Zoo di Falconara (ITALY)	The present study was funded by Giardino Zoologico di Pistoia, Parco Zoo Punta Verde, Parco Zoo di Falconara (ITALY). The funding covered only field and travel expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2002, SOCIOBIOLOGY NEW SYN; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Aureli F, 2007, BIOL LETTERS, V3, P147, DOI 10.1098/rsbl.2007.0041; Benadi G, 2008, AM J PRIMATOL, V70, P956, DOI 10.1002/ajp.20588; Brockman DK, 1999, INT J PRIMATOL, V20, P375, DOI 10.1023/A:1020500804442; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; BYERS JA, 1995, AM NAT, V146, P25, DOI 10.1086/285785; Cashdan E, 2001, CURR ANTHROPOL, V42, P760, DOI 10.1086/323821; Charles-Dominique P., 1977, ECOLOGY BEHAV NOCTUR; Drea CM, 1996, ANIM BEHAV, V51, P1323, DOI 10.1006/anbe.1996.0136; DUNBAR RIM, 1991, FOLIA PRIMATOL, V57, P121, DOI 10.1159/000156574; Eisenberg J.F., 1976, Smithsonian Contributions to Zoology, VNo. 213, P1; Fagen Robert, 1993, P182; Goodall J., 1986, CHIMPANZEES GOMBE PA; Gray P, 2009, AM J PLAY, V1, P476; HAYAKI H, 1985, Primates, V26, P343, DOI 10.1007/BF02382452; HERRERO S, 1977, J MAMMAL, V58, P441, DOI 10.2307/1379352; JOLLY A, 1972, FOLIA PRIMATOL, V17, P335, DOI 10.1159/000155454; Jolly A., 1966, LEMUR BEHAV MADAGASC; Jolly Alison, 2006, P32, DOI 10.1007/978-0-387-34126-2_3; KANO T, 1984, FOLIA PRIMATOL, V43, P36, DOI 10.1159/000156169; Kappeler PM, 2008, BEHAV ECOL SOCIOBIOL, V62, P1007, DOI 10.1007/s00265-007-0528-6; Kappeler PM, 2009, AM J PHYS ANTHROPOL, V140, P487, DOI 10.1002/ajpa.21091; Kappeler PM, 1998, BEHAV ECOL SOCIOBIOL, V42, P411, DOI 10.1007/s002650050455; Kaufman AB, 2009, ANIM BEHAV, V78, P1487, DOI 10.1016/j.anbehav.2009.09.014; KLEIMAN DG, 1983, Z TIERPSYCHOL, V62, P1; Klein ZA, 2010, DEV PSYCHOBIOL, V52, P62, DOI 10.1002/dev.20413; Lawler RR, 2007, AM J PHYS ANTHROPOL, V132, P267, DOI 10.1002/ajpa.20507; Lewis R. J., 2004, THESIS DUKE U DURHAM; Lewis RJ, 2008, INT J PRIMATOL, V29, P1249, DOI 10.1007/s10764-008-9304-3; Lewis RJ, 2007, INT J PRIMATOL, V28, P159, DOI 10.1007/s10764-006-9107-3; MACKINNON J, 1974, ANIM BEHAV, V22, P3, DOI 10.1016/S0003-3472(74)80054-0; Mancini G, 2009, BEHAV PROCESS, V82, P286, DOI 10.1016/j.beproc.2009.07.007; Martin P., 2007, MEASURING BEHAV INTR, V3; MENDOZA SP, 1986, PHYSIOL BEHAV, V38, P795, DOI 10.1016/0031-9384(86)90045-4; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Norscia I, 2008, INT J PRIMATOL, V29, P1099, DOI 10.1007/s10764-008-9259-4; Norscia I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004679; Pages E., 1980, P97; Palagi E, 2006, AM J PHYS ANTHROPOL, V129, P418, DOI 10.1002/ajpa.20289; Palagi E, 2004, ETHOLOGY, V110, P949, DOI 10.1111/j.1439-0310.2004.01035.x; Palagi E, 2008, ANIM BEHAV, V76, P737, DOI 10.1016/j.anbehav.2008.04.016; Palagi E, 2007, AM J PHYS ANTHROPOL, V134, P219, DOI 10.1002/ajpa.20657; Palagi E, 2007, DEV PSYCHOBIOL, V49, P433, DOI 10.1002/dev.20219; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Palagi E, 2009, J COMP PSYCHOL, V123, P1, DOI 10.1037/0735-7036.123.1.1; Pellegrini AD, 1998, CHILD DEV, V69, P577, DOI 10.2307/1132187; Pellegrini AD., 2009, ROLE PLAY HUMAN DEV, DOI [10.1093/acprof:oso/9780195367324.001.0001, DOI 10.1093/ACPROF:OSO/9780195367324.001.0001]; Pellegrini AD, 2007, DEV REV, V27, P261, DOI 10.1016/j.dr.2006.09.001; Pellis S. M., 2009, PLAYFUL BRAIN VENTUR; Pellis SM, 1996, AGGRESS VIOLENT BEH, V1, P249, DOI 10.1016/1359-1789(95)00016-X; Pellis SM, 2002, COGNITIVE ANIMAL, P421; Pellis SM, 2000, ETHOLOGY, V106, P1083, DOI 10.1046/j.1439-0310.2000.00627.x; Pellis SM, 1999, ETHOLOGY, V105, P783, DOI 10.1046/j.1439-0310.1999.00457.x; Pereira Michael E., 1993, P285; Peterson JB, 2005, DEVELOPMENTAL ORIGINS OF AGGRESSION, P133; RICHARD AF, 2003, NATURAL HIST MADAGAS, P1345; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Smith EO., 1978, SOCIAL PLAY PRIMATES, P169, DOI [10.1016/B978-0-12-652750-6.50012-2, DOI 10.1016/B978-0-12-652750-6.50012-2]; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Swaddling J., 2002, ANCIENT OLYMPIC GAME; Tanner JE, 2010, ANIM COGN, V13, P591, DOI 10.1007/s10071-009-0308-y; Tattersall I., 1982, PRIMATES MADAGASCAR, DOI 10.1002/ajpa.1330590417; Thompson KV, 1998, ANIMAL PLAY EVOLUTIO, P183; WADE TD, 1976, BEHAVIOUR, V56, P194, DOI 10.1163/156853976X00028; Wrangham RW, 1999, YEARB PHYS ANTHROPOL, V42, P1; [No title captured]	68	42	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13218	10.1371/journal.pone.0013218	http://dx.doi.org/10.1371/journal.pone.0013218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949052	gold, Green Submitted, Green Published			2022-12-27	WOS:000282633700013
J	Dynesius, M; Gibb, H; Hjalten, J				Dynesius, Mats; Gibb, Heloise; Hjalten, Joakim			Surface Covering of Downed Logs: Drivers of a Neglected Process in Dead Wood Ecology	PLOS ONE			English	Article							SAPROXYLIC BEETLES; BOREAL FORESTS; PICEA-ABIES; SUCCESSIONAL STAGE; FUNCTIONAL-GROUPS; SPRUCE FOREST; SUBSTRATE; CONSERVATION; BRYOPHYTES; DIVERSITY	Many species use coarse woody debris (CWD) and are disadvantaged by the forestry-induced loss of this resource. A neglected process affecting CWD is the covering of the surfaces of downed logs caused by sinking into the ground (increasing soil contact, mostly covering the underside of the log), and dense overgrowth by ground vegetation. Such cover is likely to profoundly influence the quality and accessibility of CWD for wood-inhabiting organisms, but the factors affecting covering are largely unknown. In a five-year experiment we determined predictors of covering rate of fresh logs in boreal forests and clear-cuts. Logs with branches were little covered because they had low longitudinal ground contact. For branchless logs, longitudinal ground contact was most strongly related to estimated peat depth (positive relation). The strongest predictor for total cover of branchless logs was longitudinal ground contact. To evaluate the effect on cover of factors other than longitudinal ground contact, we separately analyzed data from only those log sections that were in contact with the ground. Four factors were prominent predictors of percentage cover of such log sections: estimated peat depth, canopy shade (both increasing cover), potential solar radiation calculated from slope and slope aspect, and diameter of the log (both reducing cover). Peat increased cover directly through its low resistance, which allowed logs to sink and soil contact to increase. High moisture and low temperatures in pole-ward facing slopes and under a canopy favor peat formation through lowered decomposition and enhanced growth of peat-forming mosses, which also proved to rapidly overgrow logs. We found that in some boreal forests, peat and fast-growing mosses can rapidly cover logs lying on the ground. When actively introducing CWD for conservation purposes, we recommend that such rapid covering is avoided, thereby most likely improving the CWD's longevity as habitat for many species.	[Dynesius, Mats] Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden; [Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic, Australia; [Hjalten, Joakim] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden	Umea University; La Trobe University; Swedish University of Agricultural Sciences	Dynesius, M (corresponding author), Umea Univ, Dept Ecol & Environm Sci, Umea, Sweden.	mats.dynesius@emg.umu.se	Dynesius, Mats/A-6219-2009; Gibb, Heloise/B-8338-2013	Dynesius, Mats/0000-0003-0628-4203; Gibb, Heloise/0000-0001-7194-0620; Hjalten, Joakim/0000-0002-8279-6633	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning [2004-1521]; Kempe foundation [SMK-2443]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); Kempe foundation	The study was supported by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas # 2004-1521, URL: www.formas.se) and by the Kempe foundation (# SMK-2443, URL: www.kempe.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahti T., 1968, Annales Botanici Fennici, Helsinki, V5, P168; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ANDERSSON LI, 1991, HOLARCTIC ECOL, V14, P121; [Anonymous], 2007, JMP VERS 7, P1989; Astrom M, 2007, ECOLOGY, V88, P749, DOI 10.1890/06-0613; Bisbee KE, 2001, OECOLOGIA, V129, P261, DOI 10.1007/s004420100719; Boulanger Y, 2007, ENVIRON ENTOMOL, V36, P128, DOI 10.1603/0046-225X-36.1.128; Caruso A, 2008, BIOL CONSERV, V141, P47, DOI 10.1016/j.biocon.2007.08.021; CHEVAN A, 1991, AM STAT, V45, P90, DOI 10.2307/2684366; Crites S, 1998, CAN J BOT, V76, P641, DOI 10.1139/cjb-76-4-641; Dynesius M, 2009, ECOLOGY, V90, P1042, DOI 10.1890/07-1822.1; Edman M, 2006, FOREST ECOL MANAG, V232, P12, DOI 10.1016/j.foreco.2006.05.001; Fenton NJ, 2007, CAN J BOT, V85, P43, DOI 10.1139/B06-148; Fridman J, 2000, FOREST ECOL MANAG, V131, P23, DOI 10.1016/S0378-1127(99)00208-X; Gerdol R, 1998, ARCTIC ALPINE RES, V30, P388, DOI 10.2307/1552011; Gibb H, 2006, BIOL CONSERV, V129, P437, DOI 10.1016/j.biocon.2005.11.010; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Grove SJ, 2001, FOREST ECOL MANAG, V154, P35, DOI 10.1016/S0378-1127(00)00618-6; GROVE SJ, 2000, ECOLOGICAL MANAGEMEN, V1, P62; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1989, AM MIDL NAT, V121, P112, DOI 10.2307/2425662; Hilszczanski J, 2005, BIOL CONSERV, V126, P456, DOI 10.1016/j.biocon.2005.06.026; Hjalten J, 2007, BASIC APPL ECOL, V8, P364, DOI 10.1016/j.baae.2006.08.003; Hura CE, 2004, NAT AREA J, V24, P57; Johansson T, 2007, FOREST ECOL MANAG, V242, P496, DOI 10.1016/j.foreco.2007.01.062; Jonsell M, 1998, BIODIVERS CONSERV, V7, P749, DOI 10.1023/A:1008888319031; Jonsell M, 2003, FOREST ECOL MANAG, V175, P425, DOI 10.1016/S0378-1127(02)00143-3; Jonsell M, 1999, J INSECT CONSERV, V3, P145, DOI 10.1023/A:1009665513184; Jonsson BG, 2000, J VEG SCI, V11, P51, DOI 10.2307/3236775; Kushnevskaya H, 2007, FOREST ECOL MANAG, V250, P25, DOI 10.1016/j.foreco.2007.03.006; Linder P, 1998, BIOL CONSERV, V85, P9, DOI 10.1016/S0006-3207(97)00168-7; LINDSTROM K, 2003, THESIS UMEA U UMEA; Mac Nally R, 2000, BIODIVERS CONSERV, V9, P655, DOI 10.1023/A:1008985925162; McAlister S, 1997, J VEG SCI, V8, P115, DOI 10.2307/3237249; MCCULLOUGH HA, 1948, ECOLOGY, V29, P508, DOI 10.2307/1932645; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; Naesset E, 1999, CAN J FOREST RES, V29, P372, DOI 10.1139/cjfr-29-3-372; Odor P, 2004, J BRYOL, V26, P79, DOI 10.1179/037366804225021038; Okland B, 1996, BIODIVERS CONSERV, V5, P75, DOI 10.1007/BF00056293; OLSSON J, 2008, THESIS UMEA U UMEA; Page S, 2009, ECOSYSTEMS, V12, P888, DOI 10.1007/s10021-008-9216-2; Patterson H.D., 1974, P 8 INT BIOM C BIOM, P197; Peltonen M, 1998, FOREST ECOL MANAG, V103, P141, DOI 10.1016/S0378-1127(97)00187-4; R Core Team, 2018, R LANG ENV STAT COMP; Rambo TR, 1998, BRYOLOGIST, V101, P366, DOI 10.1639/0007-2745(1998)101[366:BSAWCW]2.0.CO;2; Rayner ADM, 1988, FUNGAL DECOMPOSITION; Repola J, 2006, SILVA FENN, V40, P673, DOI 10.14214/sf.322; Rudolphi J, 2005, SCAND J FOREST RES, V20, P235, DOI 10.1080/02827580510036201; Searle S. R., 1992, VARIANCE COMPONENTS; Siitonen J, 2000, BIOL CONSERV, V94, P211, DOI 10.1016/S0006-3207(99)00174-3; Siitonen Juha, 2001, Ecological Bulletins, V49, P11; SODERSTROM L, 1988, NORD J BOT, V8, P89, DOI 10.1111/j.1756-1051.1988.tb01709.x; Sverdrup-Thygeson A, 2002, BIOL CONSERV, V106, P347, DOI 10.1016/S0006-3207(01)00261-0; WALSH C, 2004, R LANGUAGE ENV STAT; WOLFINGER R, 1994, SIAM J SCI COMPUT, V15, P1294, DOI 10.1137/0915079	55	25	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13237	10.1371/journal.pone.0013237	http://dx.doi.org/10.1371/journal.pone.0013237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949062	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700019
J	McAdam, M; Sakita, J; Tarivonda, L; Pang, J; Frazer, IH				McAdam, Margaret; Sakita, Jerol; Tarivonda, Len; Pang, James; Frazer, Ian H.			Evaluation of a Cervical Cancer Screening Program Based on HPV Testing and LLETZ Excision in a Low Resource Setting	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; LESION SIZE; RISK; NEOPLASIA; PREVENTION; WOMEN	We conducted studies in Vanuatu to evaluate potential screening and treatment strategies to assist with control of cervical cancer. In a pilot study of 496 women, visual inspection and cytology were evaluated as screening tests for detection of CIN 2 or worse (CIN2+), observed in 21 of 206 subjects biopsied on the basis of abnormal visual inspection or cytology. Sensitivity of visual inspection with Lugol's Iodine for detection of CIN2+ on biopsy was 0.63, specificity was 0.32, and the positive predictive value was 0.09. For HSIL cytology, sensitivity was 0.99, specificity was 0.77, and the positive predictive value was 0.88. HSIL cytology was significantly more sensitive and had a significantly higher PPV for CIN 2+ than visual inspection (p<0.01). In a further study of 514 women, we compared testing for HR HPV and cytology as predictors of biopsy proven CIN 2+. Sensitivity of HSIL cytology for CIN2+ as established by loop excision of the cervix was 0.81, specificity was 0.94, and positive predictive value was 0.48. Sensitivity of a positive test for HR HPV for detection of CIN2+ was non-significantly different from cytology at 0.81, specificity was 0.94, and positive predictive value was 0.42. Combining the two tests gave a significantly lower sensitivity of 0.63, a specificity of 0.98, and a positive predictive value of 0.68. For women over 30 in a low resource setting without access to cytology, a single locally conduced test for high risk HPV with effective intervention could reduce cervical cancer risk as effectively as intervention based on cytology conducted in an accredited laboratory.	[McAdam, Margaret; Pang, James; Frazer, Ian H.] Univ Queensland, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia; [Sakita, Jerol; Tarivonda, Len] Minist Hlth, Dept Publ Hlth, Port Vila, Efate, Vanuatu	University of Queensland	McAdam, M (corresponding author), Univ Queensland, Univ Queensland Diamantina Inst, Brisbane, Qld, Australia.	i.frazer@uq.edu.au	Frazer, Ian/A-1137-2007	Frazer, Ian/0000-0002-8002-4680	Ausaid (Department of Foreign Affairs and Trade); Wesley Medical Institute	Ausaid (Department of Foreign Affairs and Trade); Wesley Medical Institute	Funding from Ausaid (Department of Foreign Affairs and Trade) and the Wesley Medical Institute followed competitive peer reviewed funding applications. All gifts of services and reagents were unrestricted donations. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbyn M, 2008, INT J CANCER, V123, P153, DOI 10.1002/ijc.23489; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; Australia, 2005, SCREENING PREVENT CE; Chirenje Z M, 2001, J Obstet Gynaecol, V21, P617; Cibas ES, 2007, GYNECOL ONCOL, V104, P702, DOI 10.1016/j.ygyno.2006.10.048; Denny L, 2005, JAMA-J AM MED ASSOC, V294, P2173, DOI 10.1001/jama.294.17.2173; Furber SE, 1997, AUST NZ J OBSTET GYN, V37, P107, DOI 10.1111/j.1479-828X.1997.tb02230.x; Gage JC, 2006, OBSTET GYNECOL, V108, P264, DOI 10.1097/01.AOG.0000220505.18525.85; Garland SM, 2008, VACCINE, V26, pM80, DOI 10.1016/j.vaccine.2008.05.041; Grce M, 2009, EXPERT REV MOL DIAGN, V9, P851, DOI [10.1586/erm.09.64, 10.1586/ERM.09.64]; JARMULOWICZ MR, 1989, BRIT J OBSTET GYNAEC, V96, P1061, DOI 10.1111/j.1471-0528.1989.tb03381.x; Khan MJ, 2005, JNCI-J NATL CANCER I, V97, P1072, DOI 10.1093/jnci/dji187; McCredie MRE, 2008, LANCET ONCOL, V9, P425, DOI 10.1016/S1470-2045(08)70103-7; Mitchell H, 2005, CANCER CYTOPATHOL, V105, P185, DOI 10.1002/cncr.21181; Pretorius Robert G, 2006, J Low Genit Tract Dis, V10, P45, DOI 10.1097/01.lgt.0000192697.31291.42; Ronco G, 2010, LANCET ONCOL, V11, P249, DOI 10.1016/S1470-2045(09)70360-2; Sankaranarayanan R, 2003, INT J CANCER, V106, P404, DOI 10.1002/ijc.11245; Sankaranarayanan R, 2003, PRACTICAL MANUAL VIS, P1; Sankaranarayanan R, 2009, INT J GYNECOL OBSTET, V104, P95, DOI 10.1016/j.ijgo.2008.09.009; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Shastri SS, 2005, B WORLD HEALTH ORGAN, V83, P186; Smith RA, 2009, CA-CANCER J CLIN, V59, P27, DOI 10.3322/caac.20008; TIDBURY P, 1992, BRIT J OBSTET GYNAEC, V99, P583, DOI 10.1111/j.1471-0528.1992.tb13825.x; Wright Thomas C Jr, 2003, J Natl Cancer Inst Monogr, P66; 1996, B WHO, V74, P345	25	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13266	10.1371/journal.pone.0013266	http://dx.doi.org/10.1371/journal.pone.0013266			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949059	Green Published, gold			2022-12-27	WOS:000282633700022
J	Wise, JK; Sena, K; Vranizan, K; Pollock, JF; Healy, KE; Hughes, WF; Sumner, DR; Virdi, AS				Wise, Joel K.; Sena, Kotaro; Vranizan, Karen; Pollock, Jacob F.; Healy, Kevin E.; Hughes, W. Frank; Sumner, D. Rick; Virdi, Amarjit S.			Temporal Gene Expression Profiling during Rat Femoral Marrow Ablation-Induced Intramembranous Bone Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; PHOSPHATE-COATED IMPLANTS; MATRIX METALLOPROTEINASES; LOCAL APPLICATION; TITANIUM IMPLANT; CLUSTER-ANALYSIS; WNT; PATHWAY; SURFACE; THROMBOSPONDIN-2	Enhanced understanding of differential gene expression and biological pathways associated with distinct phases of intramembranous bone regeneration following femoral marrow ablation surgery will improve future advancements regarding osseointegration of joint replacement implants, biomaterials design, and bone tissue engineering. A rat femoral marrow ablation model was performed and genome-wide microarray data were obtained from samples at 1, 3, 5, 7, 10, 14, 28, and 56 days post-ablation, with intact bones serving as controls at Day 0. Bayesian model-based clustering produced eight distinct groups amongst 9,062 significant gene probe sets based on similar temporal expression profiles, which were further categorized into three major temporal classes of increased, variable, and decreased expression. Osteoblastic-and osteoclastic-associated genes were found to be significantly expressed within the increased expression groups. Chondrogenesis was not detected histologically. Adipogenic marker genes were found within variable/decreased expression groups, emphasizing that adipogenesis was inhibited during osteogenesis. Differential biological processes and pathways associated with each major temporal group were identified, and significantly expressed genes involved were visually represented by heat maps. It was determined that the increased expression group exclusively contains genes involved in pathways for matrix metalloproteinases (MMPs), Wnt signaling, TGF-beta signaling, and inflammatory pathways. Only the variable expression group contains genes associated with glycolysis and gluconeogenesis, the notch signaling pathway, natural killer cell mediated cytotoxicity, and the B cell receptor signaling pathway. The decreased group exclusively consists of genes involved in heme biosynthesis, the p53 signaling pathway, and the hematopoietic cell lineage. Significant biological pathways and transcription factors expressed at each time point post-ablation were also identified. These data present the first temporal gene expression profiling analysis of the rat genome during intramembranous bone regeneration induced by femoral marrow ablation.	[Wise, Joel K.; Sena, Kotaro; Hughes, W. Frank; Sumner, D. Rick; Virdi, Amarjit S.] Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA; [Vranizan, Karen] Univ Calif Berkeley, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Vranizan, Karen] Univ Calif Berkeley, Funct Genom Lab, Berkeley, CA 94720 USA; [Pollock, Jacob F.; Healy, Kevin E.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Healy, Kevin E.] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA	Rush University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Wise, JK (corresponding author), Rush Univ, Med Ctr, Dept Anat & Cell Biol, Chicago, IL 60612 USA.	amarjit_virdi@rush.edu	Sena, Kotaro/A-8033-2013	Sena, Kotaro/0000-0003-0612-1826; Sumner, Dale/0000-0001-9575-3862	Grainger Foundation; National Institutes of Health (NIH) [T32 AR052272]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR052272] Funding Source: NIH RePORTER	Grainger Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by The Grainger Foundation and a National Institutes of Health (NIH) Institutional Training Grant (T32 AR052272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL S, 1969, ANAT RECORD, V164, P101, DOI 10.1002/ar.1091640107; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BAB IA, 1995, BONE, V17, pS437, DOI 10.1016/8756-3282(95)00323-6; Bais M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005393; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Baksh D, 2007, J CELL PHYSIOL, V212, P817, DOI 10.1002/jcp.21080; Behonick DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001150; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Chung EH, 2006, J BIOMED MATER RES A, V79A, P815, DOI 10.1002/jbm.a.30809; De Ranieri A, 2005, BONE, V37, P55, DOI 10.1016/j.bone.2005.03.011; De Ranieri A, 2005, J BIOMED MATER RES B, V74B, P712, DOI 10.1002/jbm.b.30293; De Ranieri A, 2005, BONE, V36, P931, DOI 10.1016/j.bone.2005.01.019; Delany AM, 2009, J CELL COMMUN SIGNAL, V3, P227, DOI 10.1007/s12079-009-0076-0; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Greco JA, 2010, BURNS, V36, P192, DOI 10.1016/j.burns.2009.06.211; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Hamilton DW, 2008, J CELL COMMUN SIGNAL, V2, P9, DOI 10.1007/s12079-008-0023-5; Hankenson KD, 2002, J BONE MINER RES, V17, P415, DOI 10.1359/jbmr.2002.17.3.415; Hara T, 1999, J BONE JOINT SURG BR, V81B, P705, DOI 10.1302/0301-620X.81B4.9138; Hilton MJ, 2008, NAT MED, V14, P306, DOI 10.1038/nm1716; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishizaka M, 1996, BONE, V19, P589, DOI 10.1016/S8756-3282(96)00303-1; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Jeong JA, 2007, STEM CELLS, V25, P994, DOI 10.1634/stemcells.2006-0604; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashimaa TG, 2009, HUM PATHOL, V40, P226, DOI 10.1016/j.humpath.2008.07.008; Katoh M, 2006, INT J MOL MED, V17, P681; Katoh M, 2006, INT J MOL MED, V18, P517; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Kuroda S, 2005, CALCIFIED TISSUE INT, V77, P212, DOI 10.1007/s00223-004-0267-x; Kuroda S, 2004, J BIOMED MATER RES A, V70A, P66, DOI 10.1002/jbm.a.30062; LIANG CT, 1992, BONE, V13, P435, DOI 10.1016/8756-3282(92)90087-D; Lind M, 1996, J BONE JOINT SURG BR, V78B, P377, DOI 10.1302/0301-620X.78B3.0780377; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Nah HD, 2000, J BONE MINER RES, V15, P522, DOI 10.1359/jbmr.2000.15.3.522; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PATT HM, 1975, EXP HEMATOL, V3, P135; Pedemonte E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-65; Ramoni MF, 2002, P NATL ACAD SCI USA, V99, P9121, DOI 10.1073/pnas.132656399; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Sato H, 1997, THROMB HAEMOSTASIS, V78, P497; Schmidmaier G, 2002, J BIOMED MATER RES, V63, P168, DOI 10.1002/jbm.10130; Sena K, 2010, J BIOMED MATER RES A, V92A, P1210, DOI 10.1002/jbm.a.32461; Simon R, 2007, CANCER INFORM, V3, P11; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sumner DR, 2001, J ORTHOP RES, V19, P85; SUMNER DR, 2006, JOINT REPLACEMENTS B, P727; SUVA LJ, 1993, J BONE MINER RES, V8, P379; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Velardo MJ, 2004, J NEUROSCI, V24, P8562, DOI 10.1523/JNEUROSCI.3316-04.2004; Wang WB, 2009, MOL BIOTECHNOL, V43, P221, DOI 10.1007/s12033-009-9199-z; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang Q, 2008, TISSUE ENG PT A, V14, P237, DOI 10.1089/tea.2007.0261; Zhong N, 2006, BONE, V39, P5, DOI 10.1016/j.bone.2005.12.008; Zucker S, 1998, J BIOL CHEM, V273, P1216, DOI 10.1074/jbc.273.2.1216	65	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e12987	10.1371/journal.pone.0012987	http://dx.doi.org/10.1371/journal.pone.0012987			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957030	Green Published, gold, Green Submitted			2022-12-27	WOS:000282359300001
J	Lu, Z; Moraes, C; Ye, G; Simmons, CA; Sun, Y				Lu, Zhe; Moraes, Christopher; Ye, George; Simmons, Craig A.; Sun, Yu			Single Cell Deposition and Patterning with a Robotic System	PLOS ONE			English	Article							CALCIFICATION; PLATFORM; MATRIX	Integrating single-cell manipulation techniques in traditional and emerging biological culture systems is challenging. Microfabricated devices for single cell studies in particular often require cells to be spatially positioned at specific culture sites on the device surface. This paper presents a robotic micromanipulation system for pick-and-place positioning of single cells. By integrating computer vision and motion control algorithms, the system visually tracks a cell in real time and controls multiple positioning devices simultaneously to accurately pick up a single cell, transfer it to a desired substrate, and deposit it at a specified location. A traditional glass micropipette is used, and whole- and partial-cell aspiration techniques are investigated to manipulate single cells. Partially aspirating cells resulted in an operation speed of 15 seconds per cell and a 95% success rate. In contrast, the whole- cell aspiration method required 30 seconds per cell and achieved a success rate of 80%. The broad applicability of this robotic manipulation technique is demonstrated using multiple cell types on traditional substrates and on open-top microfabricated devices, without requiring modifications to device designs. Furthermore, we used this serial deposition process in conjunction with an established parallel cell manipulation technique to improve the efficiency of single cell capture from similar to 80% to 100%. Using a robotic micromanipulation system to position single cells on a substrate is demonstrated as an effective stand-alone or bolstering technology for single-cell studies, eliminating some of the drawbacks associated with standard single-cell handling and manipulation techniques.	[Lu, Zhe; Moraes, Christopher; Simmons, Craig A.; Sun, Yu] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Moraes, Christopher; Ye, George; Simmons, Craig A.; Sun, Yu] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University of Toronto	Lu, Z (corresponding author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.	sun@mie.utoronto.ca	Simmons, Craig/A-5880-2008; Simmons, Craig/ABA-2015-2020	Simmons, Craig/0000-0001-7729-1772; Simmons, Craig/0000-0001-7729-1772; Sun, Yu/0000-0001-7895-0741; Moraes, Christopher/0000-0002-8950-2212	Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Research and Innovation; Ontario Graduate Scholarship; Canada Research Chairs in Mechanobiology	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Canada Research Chairs in Mechanobiology(Canada Research Chairs)	We acknowledge financial support from the Natural Sciences and Engineering Research Council of Canada, the Ontario Ministry of Research and Innovation, the Ontario Graduate Scholarship program to CM, and the Canada Research Chairs in Mechanobiology to CAS, and in Micro and Nano Engineering systems to YS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Bhola PD, 2009, J CELL SCI, V122, P4296, DOI 10.1242/jcs.055590; Bradski G., 2008, LEARNING OPENCV; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chen JH, 2009, AM J PATHOL, V174, P1109, DOI 10.2353/ajpath.2009.080750; Cheung WY, 2008, J HEART VALVE DIS, V17, P674; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024; Faley S, 2008, LAB CHIP, V8, P1700, DOI 10.1039/b719799c; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; Flaim CJ, 2008, STEM CELLS DEV, V17, P29, DOI 10.1089/scd.2007.0085; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Gherardini L, 2005, ULTRASOUND MED BIOL, V31, P261, DOI 10.1016/j.ultrasmedbio.2004.10.010; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; HOROYAN M, 1990, CELL BIOPHYS, V17, P243, DOI 10.1007/BF02990720; Hosokawa M, 2009, ANAL CHEM, V81, P5308, DOI 10.1021/ac900535h; Lu ZG, 2010, IEEE INT C INT ROBOT; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; McDonald JC, 2000, ELECTROPHORESIS, V21, P27, DOI 10.1002/(SICI)1522-2683(20000101)21:1<27::AID-ELPS27>3.0.CO;2-C; Mirsaidov U, 2008, LAB CHIP, V8, P2174, DOI 10.1039/b807987k; Moraes C, 2010, LAB CHIP, V10, P227, DOI 10.1039/b914460a; Moraes C, 2010, BIOMATERIALS, V31, P577, DOI 10.1016/j.biomaterials.2009.09.068; Moraes C, 2009, J MICROMECH MICROENG, V19, DOI 10.1088/0960-1317/19/6/065015; Nickels K, 2002, IMAGE VISION COMPUT, V20, P47, DOI 10.1016/S0262-8856(01)00076-2; Rettig JR, 2005, ANAL CHEM, V77, P5628, DOI 10.1021/ac0505977; Rosenthal A, 2007, BIOMATERIALS, V28, P3208, DOI 10.1016/j.biomaterials.2007.03.023; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Voldman J, 2006, ANNU REV BIOMED ENG, V8, P425, DOI 10.1146/annurev.bioeng.8.061505.095739; Wang WH, 2007, INT J ROBOT RES, V26, P821, DOI 10.1177/0278364907080254; Yeo WS, 2006, LANGMUIR, V22, P10816, DOI 10.1021/la061212y; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394	36	46	54	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13542	10.1371/journal.pone.0013542	http://dx.doi.org/10.1371/journal.pone.0013542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	21042403	Green Published, gold, Green Submitted			2022-12-27	WOS:000283293800012
J	Herrmann, I; Baeuerle, PA; Friedrich, M; Murr, A; Filusch, S; Ruttinger, D; Majdoub, MW; Sharma, S; Kufer, P; Raum, T; Munz, M				Herrmann, Ines; Baeuerle, Patrick A.; Friedrich, Matthias; Murr, Alexander; Filusch, Susanne; Ruettinger, Dominik; Majdoub, Mariam W.; Sharma, Sherven; Kufer, Peter; Raum, Tobias; Muenz, Markus			Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells	PLOS ONE			English	Article							CANCER STEM-CELLS; EP-CAM; IMMUNOTHERAPEUTIC TARGET; BISPECIFIC ANTIBODIES; THERAPEUTIC WINDOW; ANTITUMOR-ACTIVITY; ADHESION MOLECULE; OVARIAN-CANCER; BREAST-CANCER; BITE ANTIBODY	With their resistance to genotoxic and anti-proliferative drugs and potential to grow tumors and metastases from very few cells, cancer stem or tumor-initiating cells (TICs) are a severe limitation for the treatment of cancer by conventional therapies. Here, we explored whether human T cells that are redirected via an EpCAM/CD3-bispecific antibody called MT110 can lyse colorectal TICs and prevent tumor growth from TICs. MT110 recognizes EpCAM, a cell adhesion molecule expressed on TICs from diverse human carcinoma, which was recently shown to promote tumor growth through engagement of elements of the wnt pathway. MT110 was highly potent in mediating complete redirected lysis of KRAS-, PI3 kinase- and BRAF-mutated colorectal TICs, as demonstrated in a soft agar assay. In immunodeficient mice, MT110 prevented growth of tumors from a 5,000-fold excess of a minimally tumorigenic TIC dose. T cells engaged by MT110 may provide a potent therapeutic means to eradicate TICs and bulk tumor cells derived thereof.	[Herrmann, Ines; Baeuerle, Patrick A.; Friedrich, Matthias; Murr, Alexander; Filusch, Susanne; Ruettinger, Dominik; Kufer, Peter; Raum, Tobias; Muenz, Markus] Micromet AG, Munich, Germany; [Baeuerle, Patrick A.] Micromet Inc, Bethesda, MD USA; [Majdoub, Mariam W.] Celprogen Inc, San Pedro, CA USA; [Sharma, Sherven] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Sharma, Sherven] Greater Los Angeles Healthcare Syst, Mol Gene Med Lab, Los Angeles, CA USA	Amgen; Amgen Research Munich GmbH; Micromet AG; University of California System; University of California Los Angeles	Herrmann, I (corresponding author), Micromet AG, Munich, Germany.	Patrick.baeuerle@micromet-inc.com			Micromet	Micromet(Amgen)	Funding of this study has been exclusively supplied by Micromet, a publically listed company. This funder played a role in study design, data collection and analysis, and decision to publish. Celprogen, another company, helped Micromet with preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amann M, 2009, CANCER IMMUNOL IMMUN, V58, P95, DOI 10.1007/s00262-008-0529-y; Amann M, 2008, CANCER RES, V68, P143, DOI 10.1158/0008-5472.CAN-07-2182; Amann M, 2009, J IMMUNOTHER, V32, P452, DOI 10.1097/CJI.0b013e3181a1c097; Baeuerle PA, 2007, BRIT J CANCER, V96, P417, DOI 10.1038/sj.bjc.6603494; Baeuerle PA, 2003, CURR OPIN MOL THER, V5, P413; BAEUERLE PA, 2009, RATIONALE TREATMENT, P179; Baeuerle PA, 2009, CURR OPIN MOL THER, V11, P22; Bargou R, 2008, SCIENCE, V321, P974, DOI 10.1126/science.1158545; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Chaudry MA, 2007, BRIT J CANCER, V96, P1013, DOI 10.1038/sj.bjc.6603505; Chen HC, 2003, CANCER LETT, V201, P97, DOI 10.1016/j.canlet.2003.07.007; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Fong D, 2008, J CLIN PATHOL, V61, P31, DOI 10.1136/jcp.2006.037333; FRIEDRICH M, 2010, AACR 2010; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Gastl G, 2000, LANCET, V356, P1981, DOI 10.1016/S0140-6736(00)03312-2; Gires O, 2009, NAT REV CANCER, V9, P143, DOI 10.1038/nrc2499-c1; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Heinemann V, 2009, CANCER TREAT REV, V35, P262, DOI 10.1016/j.ctrv.2008.11.005; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kischel R, 2009, AACR 2009; Kufer P, 2004, TRENDS BIOTECHNOL, V22, P238, DOI 10.1016/j.tibtech.2004.03.006; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; LOUPAKIS F, 2009, J CLIN ONCOL; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; McLaughlin PMJ, 2001, CANCER RES, V61, P4105; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Munz M, 2009, CANCER RES, V69, P5627, DOI 10.1158/0008-5472.CAN-09-0654; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince S, 2008, AM J CLIN PATHOL, V129, P424, DOI 10.1309/H8JEEAEB69J3KYND; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schlereth B, 2006, CANCER IMMUNOL IMMUN, V55, P785, DOI 10.1007/s00262-005-0082-x; Schlereth B, 2005, CANCER RES, V65, P2882, DOI 10.1158/0008-5472.CAN-04-2637; Schmelzer E, 2008, FRONT BIOSCI-LANDMRK, V13, P3096, DOI 10.2741/2911; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Spizzo G, 2006, GYNECOL ONCOL, V103, P483, DOI 10.1016/j.ygyno.2006.03.035; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; Wang Y, 2008, CELL STEM CELL, V2, P297, DOI 10.1016/j.stem.2008.03.014; Went P, 2006, BRIT J CANCER, V94, P128, DOI 10.1038/sj.bjc.6602924; Wolf E, 2005, DRUG DISCOV TODAY, V10, P1237, DOI 10.1016/S1359-6446(05)03554-3; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Yamashita T, 2008, CANCER RES, V68, P1451, DOI 10.1158/0008-5472.CAN-07-6013	51	74	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13474	10.1371/journal.pone.0013474	http://dx.doi.org/10.1371/journal.pone.0013474			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976159	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300037
J	Pasquet, A; Messou, E; Gabillard, D; Minga, A; Depoulosky, A; Deuffic-Burban, S; Losina, E; Freedberg, KA; Danel, C; Anglaret, X; Yazdanpanah, Y				Pasquet, Armelle; Messou, Eugene; Gabillard, Delphine; Minga, Albert; Depoulosky, Ayeby; Deuffic-Burban, Sylvie; Losina, Elena; Freedberg, Kenneth A.; Danel, Christine; Anglaret, Xavier; Yazdanpanah, Yazdan			Impact of Drug Stock-Outs on Death and Retention to Care among HIV-Infected Patients on Combination Antiretroviral Therapy in Abidjan, Cote d'Ivoire	PLOS ONE			English	Article							RESOURCE-POOR SETTINGS; SUB-SAHARAN AFRICA; HIV-1-INFECTED PATIENTS; INCOME COUNTRIES; SOUTH-AFRICA; SCALING-UP; COHORT; ADHERENCE; DETERMINANTS; MORTALITY	Background: To evaluate the type and frequency of antiretroviral drug stock-outs, and their impact on death and interruption in care among HIV-infected patients in Abidjan, Cote d'Ivoire. Methods and Findings: We conducted a cohort study of patients who initiated combination antiretroviral therapy (cART) in three adult HIV clinics between February 1, 2006 and June 1, 2007. Follow-up ended on February 1, 2008. The primary outcome was cART regimen modification, defined as at least one drug substitution, or discontinuation for at least one month due to drug stock-outs at the clinic pharmacy. The secondary outcome for patients who were on cART for at least six months was interruption in care, or death. A Cox regression model with time-dependent variables was used to assess the impact of antiretroviral drug stock-outs on interruption in care or death. Overall, 1,554 adults initiated cART and were followed for a mean of 13.2 months. During this time, 72 patients discontinued treatment and 98 modified their regimen because of drug stock-outs. Stock-outs involved nevirapine and fixed-dose combination zidovudine/lamivudine in 27% and 51% of cases. Of 1,554 patients, 839 (54%) initiated cART with fixed-dose stavudine/lamivudine/nevirapine and did not face stock-outs during the study period. Among the 975 patients who were on cART for at least six months, stock-out-related cART discontinuations increased the risk of interruption in care or death (adjusted hazard ratio [HR], 2.83; 95%CI, 1.25-6.44) but cART modifications did not (adjusted HR, 1.21; 95%CI, 0.46-3.16). Conclusions: cART stock-outs affected at least 11% of population on treatment. Treatment discontinuations due to stock-outs were frequent and doubled the risk of interruption in care or death. These stock-outs did not involve the most common first-line regimen. As access to cART continues to increase in sub-Saharan Africa, first-line regimens should be standardized to decrease the probability of drug stock-outs.	[Pasquet, Armelle; Yazdanpanah, Yazdan] Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Messou, Eugene; Depoulosky, Ayeby] Programme Aconda, Abidjan, Cote Ivoire; [Gabillard, Delphine; Minga, Albert; Danel, Christine; Anglaret, Xavier] INSERM, U897, Bordeaux, France; [Minga, Albert; Danel, Christine; Anglaret, Xavier] Programme PACCI, Abidjan, Cote Ivoire; [Deuffic-Burban, Sylvie] INSERM, U995, Lille, France; [Deuffic-Burban, Sylvie; Yazdanpanah, Yazdan] Fac Med Lille, EA 2694, Lille, France; [Losina, Elena; Freedberg, Kenneth A.] Massachusetts Gen Hosp, Boston, MA 02114 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Harvard University; Massachusetts General Hospital	Pasquet, A (corresponding author), Ctr Hosp Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France.	armellepasquet@hotmail.com	Deuffic-Burban, Sylvie/O-3293-2017; Franzeck, Fabian C/B-5055-2011; Anglaret, Xavier/F-7333-2013; Anglaret, Xavier/T-2757-2019	Deuffic-Burban, Sylvie/0000-0003-3241-7647; Anglaret, Xavier/0000-0003-3319-8423; Losina, ELENA/0000-0002-3424-0892	Agence Nationale de Recherches sur le SIDA et les patites virales; National Institute of Allergy and Infectious Diseases [K24 AI062476, R01 AI058736]; Boehringer-Ingelheim; Bristol-Myers Squibb; Gilead Sciences; Glaxo-SmithKline; Merck-Sharp and Dohme-Chibret; Pfizer; Roche; Schering Plough; Tibotec; Janssen-Cilag; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058736, K24AI062476] Funding Source: NIH RePORTER	Agence Nationale de Recherches sur le SIDA et les patites virales(ANRS); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boehringer-Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); Glaxo-SmithKline(GlaxoSmithKline); Merck-Sharp and Dohme-Chibret; Pfizer(Pfizer); Roche(Roche Holding); Schering Plough(Merck & CompanySchering Plough Corporation); Tibotec; Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Agence Nationale de Recherches sur le SIDA et les patites virales; and the National Institute of Allergy and Infectious Diseases K24 AI062476 and R01 AI058736. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; With the exception of Yazdan Yazdanpanah and Sylvie Deuffic-Burban none of the authors report any association that might pose a conflict of interest. Dr. Yazdanpanah has received travel grants, consultancy fees and honoraria for presentation at workshops from Boehringer-Ingelheim, Bristol-Myers Squibb, Gilead Sciences, Glaxo-SmithKline, Merck-Sharp and Dohme-Chibret, Pfizer, Roche, Schering Plough and Tibotec. Mrs. Deuffic-Burban has received grants from Roche and Janssen-Cilag. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Anglaret X, 2004, JAIDS-J ACQ IMM DEF, V35, P320, DOI 10.1097/00126334-200403010-00015; Boulle A, 2007, ANTIVIR THER, V12, P753; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brinkhof MWG, 2008, B WORLD HEALTH ORGAN, V86, P559, DOI 10.2471/BLT.07.044248; Calmy A, 2006, AIDS, V20, P1163, DOI 10.1097/01.aids.0000226957.79847.d6; Cesar C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010490; CROW EL, 1959, BIOMETRIKA, V46, P441, DOI 10.2307/2333541; Dalal RP, 2008, JAIDS-J ACQ IMM DEF, V47, P101, DOI 10.1097/QAI.0b013e31815b833a; De Beaudrap P, 2008, EUR J EPIDEMIOL, V23, P227, DOI 10.1007/s10654-007-9221-3; de Olalla PG, 2002, J ACQ IMMUN DEF SYND, V30, P105, DOI 10.1097/00042560-200205010-00014; Diabate S, 2007, AIDS, V21, P1799, DOI 10.1097/QAD.0b013e3282a5667b; Eholie SP, 2007, JAIDS-J ACQ IMM DEF, V45, P355; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Ferradini L, 2006, LANCET, V367, P1335, DOI 10.1016/S0140-6736(06)68580-2; Fischer A, 2006, HIV MED, V7, P64, DOI 10.1111/j.1468-1293.2005.00338.x; GAIL MH, 1972, ANN INTERN MED, V76, P815, DOI 10.7326/0003-4819-76-5-815; GEYE A, 2007, STRAT BUILD NAT SCAL; Harries AD, 2007, B WORLD HEALTH ORGAN, V85, P152, DOI 10.2471/BLT.06.032060; Keiser O, 2007, ANTIVIR THER, V12, P1157; Laniece I, 2003, AIDS, V17, pS103, DOI 10.1097/00002030-200317003-00014; Lawn SD, 2006, CLIN INFECT DIS, V43, P770, DOI 10.1086/507095; MARTIN W, 2008, B WORLD HEALTH ORGAN, V86, P497; Messou E, 2010, AIDS, V24, P93, DOI 10.1097/QAD.0b013e32832ec1c3; Minga A, 2007, B WORLD HEALTH ORGAN, V85, P116, DOI 10.2471/BLT.06.032292; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Scott Menard, 1995, APPL LOGISTIC REGRES; Stringer JSA, 2006, JAMA-J AM MED ASSOC, V296, P782, DOI 10.1001/jama.296.7.782; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Tuboi SH, 2005, JAIDS-J ACQ IMM DEF, V40, P324, DOI 10.1097/01.qai.0000182627.28595.01; *UNAIDS WHO, 2008, REP GLOB AIDS EP; Walgate R, 2002, B WORLD HEALTH ORGAN, V80, P259; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; Weidle PJ, 2002, LANCET, V360, P34, DOI 10.1016/S0140-6736(02)09330-3; *WHO UNAIDS UNICEF, 2007, UN ACC SCAL PRIOR HI; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea; World Health Organization, 2009, RAP ADV ANT THER HIV; 2003, LANCET, V361, P1799	38	88	88	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13414	10.1371/journal.pone.0013414	http://dx.doi.org/10.1371/journal.pone.0013414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976211	gold, Green Submitted, Green Published			2022-12-27	WOS:000283043700014
J	Soliman, A; Michelsen, KS; Karahashi, H; Lu, J; Meng, FJ; Qu, XW; Crother, TR; Rabizadeh, S; Chen, SA; Caplan, MS; Arditi, M; Jilling, T				Soliman, Antoine; Michelsen, Kathrin S.; Karahashi, Hisae; Lu, Jing; Meng, Fan Jing; Qu, Xiaowu; Crother, Timothy R.; Rabizadeh, Shervin; Chen, Shuang; Caplan, Michael S.; Arditi, Moshe; Jilling, Tamas			Platelet-Activating Factor Induces TLR4 Expression in Intestinal Epithelial Cells: Implication for the Pathogenesis of Necrotizing Enterocolitis	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; FACTOR-KAPPA-B; ISCHEMIC BOWEL NECROSIS; VEIN ENDOTHELIAL-CELLS; FACTOR ACETYLHYDROLASE; BACTERIAL LIPOPOLYSACCHARIDE; GENE-EXPRESSION; UP-REGULATION; CUTTING EDGE; RAT MODEL	Necrotizing enterocolitis (NEC) is a leading cause of morbidity and mortality in neonatal intensive care units, however its pathogenesis is not completely understood. We have previously shown that platelet activating factor (PAF), bacteria and TLR4 are all important factors in the development of NEC. Given that Toll-like receptors (TLRs) are expressed at low levels in enterocytes of the mature gastrointestinal tract, but were shown to be aberrantly over-expressed in enterocytes in experimental NEC, we examined the regulation of TLR4 expression and signaling by PAF in intestinal epithelial cells using human and mouse in vitro cell lines, and the ex vivo rat intestinal loop model. In intestinal epithelial cell (IEC) lines, PAF stimulation yielded upregulation of both TLR4 mRNA and protein expression and led to increased IL-8 secretion following stimulation with LPS (in an otherwise LPS minimally responsive cell line). PAF stimulation resulted in increased human TLR4 promoter activation in a dose dependent manner. Western blotting and immunohistochemical analysis showed PAF induced STAT3 phosphorylation and nuclear translocation in IEC, and PAF-induced TLR4 expression was inhibited by STAT3 and NFkB Inhibitors. Our findings provide evidence for a mechanism by which PAF augments inflammation in the intestinal epithelium through abnormal TLR4 upregulation, thereby contributing to the intestinal injury of NEC.	[Soliman, Antoine; Michelsen, Kathrin S.; Karahashi, Hisae; Crother, Timothy R.; Rabizadeh, Shervin; Chen, Shuang; Arditi, Moshe] Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA; [Lu, Jing; Caplan, Michael S.; Jilling, Tamas] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Lu, Jing; Meng, Fan Jing; Qu, Xiaowu; Caplan, Michael S.; Jilling, Tamas] Evanston NW Healthcare Res Inst, Evanston, IL USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine	Soliman, A (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90024 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127; Jilling, Tamas/0000-0002-6200-3851	National Institutes of Health [R01AI058128, RO1DK062960, T32 HD007549]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007549, R01HD037581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK089076, R01DK062960] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded in part by National Institutes of Health R01AI058128 (MA), R01HD037581 (MSC), RO1DK062960 (TJ). AS was supported through a fellowship training grant (NIH T32 HD007549, PI Sherin U. Devaskar, University of California Los Angeles). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Abreu MT, 2001, J IMMUNOL, V167, P1609, DOI 10.4049/jimmunol.167.3.1609; ACKERMAN Z, 1990, SCAND J GASTROENTERO, V25, P925, DOI 10.3109/00365529008997614; Akira S, 2003, J BIOL CHEM, V278, P38105, DOI 10.1074/jbc.R300028200; Amer MD, 2004, BIOL NEONATE, V85, P159, DOI 10.1159/000075306; AUGERON C, 1984, CANCER RES, V44, P3961; BARLOW B, 1974, J PEDIATR SURG, V9, P587, DOI 10.1016/0022-3468(74)90093-1; Benveniste J, 1988, Prog Clin Biol Res, V282, P73; CAPLAN MS, 1990, GASTROENTEROLOGY, V99, P979, DOI 10.1016/0016-5085(90)90616-9; Caplan MS, 1997, PEDIATR RES, V42, P779, DOI 10.1203/00006450-199712000-00010; CAPLAN MS, 1994, CLIN PERINATOL, V21, P235, DOI 10.1016/S0095-5108(18)30343-9; Caplan MS, 1997, J PEDIATR GASTR NUTR, V24, P296, DOI 10.1097/00005176-199703000-00012; CAPLAN MS, 1990, J PEDIATR, V117, P47; Cario E, 2000, INFECT IMMUN, V68, P7010, DOI 10.1128/IAI.68.12.7010-7017.2000; Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966; De Plaen IG, 2000, BRIT J PHARMACOL, V129, P307, DOI 10.1038/sj.bjp.0703055; Deo DD, 2004, J BIOL CHEM, V279, P3497, DOI 10.1074/jbc.M304497200; Deo DD, 2002, J BIOL CHEM, V277, P21237, DOI 10.1074/jbc.M110955200; Edelson MB, 1999, PEDIATRICS, V103, P766, DOI 10.1542/peds.103.4.766; ELIAKIM R, 1988, GASTROENTEROLOGY, V95, P1167, DOI 10.1016/0016-5085(88)90346-0; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Fusunyan RD, 2001, PEDIATR RES, V49, P589, DOI 10.1203/00006450-200104000-00023; GONZALEZCRUSSI F, 1983, AM J PATHOL, V112, P127; Hajjar AM, 2001, J IMMUNOL, V166, P15, DOI 10.4049/jimmunol.166.1.15; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; HSUEH W, 1987, FASEB J, V1, P403, DOI 10.1096/fasebj.1.5.3678700; HSUEH W, 1986, AM J PATHOL, V122, P231; Ishii S, 1997, EMBO J, V16, P133, DOI 10.1093/emboj/16.1.133; Jilling T, 2004, PEDIATR RES, V55, P622, DOI 10.1203/01.PDR.0000113463.70435.74; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Kald B, 1996, DIGESTION, V57, P472, DOI 10.1159/000201376; KLIEGMAN RM, 1990, J PEDIATR S, V117, P2; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Lu J, 2004, AM J PHYSIOL-GASTR L, V286, pG340, DOI 10.1152/ajpgi.00182.2003; Lukashova V, 2001, J BIOL CHEM, V276, P24113, DOI 10.1074/jbc.M100720200; MCINTIRE FC, 1967, BIOCHEMISTRY-US, V6, P2363, DOI 10.1021/bi00860a011; Means TK, 1999, J IMMUNOL, V163, P3920; Melmed G, 2003, J IMMUNOL, V170, P1406, DOI 10.4049/jimmunol.170.3.1406; Naik S, 2001, J PEDIATR GASTR NUTR, V32, P449, DOI 10.1097/00005176-200104000-00011; Panopoulos AD, 2002, J BIOL CHEM, V277, P19001, DOI 10.1074/jbc.M112271200; Qureshi N, 1995, Prog Clin Biol Res, V392, P151; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Seo KH, 2004, CANCER RES, V64, P6482, DOI 10.1158/0008-5472.CAN-03-2774; Seo KH, 2006, CANCER RES, V66, P4681, DOI 10.1158/0008-5472.CAN-05-3186; Stafforini DM, 1999, J CLIN INVEST, V103, P989, DOI 10.1172/JCI5574; SUN XM, 1988, J CLIN INVEST, V81, P1328, DOI 10.1172/JCI113459; Suzuki M, 2003, INFECT IMMUN, V71, P3503, DOI 10.1128/IAI.71.6.3503-3511.2003; VENABLE ME, 1993, J LIPID RES, V34, P691; Wang H, 1997, BIOCHEM J, V322, P603, DOI 10.1042/bj3220603; Zhang FX, 1999, J BIOL CHEM, V274, P7611, DOI 10.1074/jbc.274.12.7611; Zimmerman GA, 2002, CRIT CARE MED, V30, pS294, DOI 10.1097/00003246-200205001-00020	53	46	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15044	10.1371/journal.pone.0015044	http://dx.doi.org/10.1371/journal.pone.0015044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976181	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700029
J	Laird, AS; Van Hoecke, A; De Muynck, L; Timmers, M; Van den Bosch, L; Van Damme, P; Robberecht, W				Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim			Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; TARDBP MUTATIONS; INCLUSIONS; DEMENTIA; ALS; FAMILY	Mislocalization, aberrant processing and aggregation of TAR DNA-binding protein 43 (TDP-43) is found in the neurons affected by two related diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal lobe dementia (FTLD). These TDP-43 abnormalities are seen when TDP-43 is mutated, such as in familial ALS, but also in FTLD, caused by null mutations in the progranulin gene. They are also found in many patients with sporadic ALS and FTLD, conditions in which only wild type TDP-43 is present. The common pathological hallmarks and symptomatic cross over between the two diseases suggest that TDP-43 and progranulin may be mechanistically linked. In this study we aimed to address this link by establishing whether overexpression of mutant TDP-43 or knock-down of progranulin in zebrafish embryos results in motor neuron phenotypes and whether human progranulin is neuroprotective against such phenotypes. Mutant TDP-43 (A315T mutation) induced a motor axonopathy characterized by short axonal outgrowth and aberrant branching, similar, but more severe, than that induced by mutant SOD1. Knockdown of the two zebrafish progranulin genes, grna and grnb, produced a substantial decrease in axonal length, with knockdown of grna alone producing a greater decrease in axonal length than grnb. Progranulin overexpression rescued the axonopathy induced by progranulin knockdown. Interestingly, progranulin also rescued the mutant TDP-43 induced axonopathy, whilst it failed to affect the mutant SOD1-induced phenotype. TDP-43 was found to be nuclear in all conditions described. The findings described here demonstrate that progranulin is neuroprotective in vivo and may have therapeutic potential for at least some forms of motor neuron degeneration.	[Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven, Neurobiol Lab, Dept Expt Neurol, Leuven, Belgium; [Van Damme, Philip; Robberecht, Wim] Katholieke Univ Leuven, Dept Neurol, Leuven, Belgium; [Laird, Angela S.; Van Hoecke, Annelies; De Muynck, Louis; Timmers, Mieke; Van den Bosch, Ludo; Van Damme, Philip; Robberecht, Wim] VIB, Vesalius Res Ctr, Leuven, Belgium	KU Leuven; KU Leuven; Flanders Institute for Biotechnology (VIB)	Laird, AS (corresponding author), Katholieke Univ Leuven, Neurobiol Lab, Dept Expt Neurol, Leuven, Belgium.	wim.robberecht@uz.kuleuven.be	Van Damme, Philip/A-6464-2009; Van Den Bosch, Ludo/B-7258-2012	Van Damme, Philip/0000-0002-4010-2357; De Muynck, Louis/0000-0003-4432-945X; Van Den Bosch, Ludo/0000-0003-0104-4067; Laird, Angela/0000-0002-6860-9192	K.U. Leuven; E von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Fund of Scientific Research, Flanders (FWO-V); Stichting Alzheimer Onderzoek-Belgium (SAO-FRMA) [08615]; Institute for Science and Technology, Flanders (IWT-V); Belgian Federal Science Policy Office [P6/43]	K.U. Leuven(KU Leuven); E von Behring Chair for Neuromuscular and Neurodegenerative Disorders; Fund of Scientific Research, Flanders (FWO-V)(FWO); Stichting Alzheimer Onderzoek-Belgium (SAO-FRMA); Institute for Science and Technology, Flanders (IWT-V); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	This study was supported by grants from the K.U. Leuven. WR is supported through the E von Behring Chair for Neuromuscular and Neurodegenerative Disorders and by the Interuniversity Attraction Pole program P6/43 of the Belgian Federal Science Policy Office. PVD holds a clinical investigatorship from the Fund of Scientific Research, Flanders (FWO-V) and is supported by 'Stichting Alzheimer Onderzoek-Belgium' (SAO-FRMA #08615). AVH and LDM hold PhD grants from the Institute for Science and Technology, Flanders (IWT-V). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Benussi L, 2009, NEUROBIOL DIS, V33, P379, DOI 10.1016/j.nbd.2008.11.008; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gitcho MA, 2008, ANN NEUROL, V63, P535, DOI 10.1002/ana.21344; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kabashi E, 2010, HUM MOL GENET, V19, P671, DOI 10.1093/hmg/ddp534; Krishnan J, 2006, EXP NEUROL, V200, P301, DOI 10.1016/j.expneurol.2006.02.135; Lemmens R, 2009, J NEUROL NEUROSUR PS, V80, P354, DOI 10.1136/jnnp.2008.157677; Lemmens R, 2007, HUM MOL GENET, V16, P2359, DOI 10.1093/hmg/ddm193; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Lomen-Hoerth C, 2004, DEMENT GERIATR COGN, V17, P337, DOI 10.1159/000077167; Luquin N, 2009, NEUROMUSCULAR DISORD, V19, P696, DOI 10.1016/j.nmd.2009.07.005; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Mackenzie IRA, 2005, J NEUROPATH EXP NEUR, V64, P730, DOI 10.1097/01.jnen.0000174335.27708.0a; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V118, P605, DOI 10.1007/s00401-009-0581-5; Rutherford NJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000193; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sleegers K, 2009, ANN NEUROL, V65, P603, DOI 10.1002/ana.21621; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Suzuki M, 2009, J REPROD DEVELOP, V55, P351, DOI 10.1262/jrd.20249; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2008, LANCET NEUROL, V7, P409, DOI 10.1016/S1474-4422(08)70071-1; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Wils H, 2010, P NATL ACAD SCI USA, V107, P3858, DOI 10.1073/pnas.0912417107	33	104	116	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13368	10.1371/journal.pone.0013368	http://dx.doi.org/10.1371/journal.pone.0013368			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967127	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800043
J	Bauer, CMT; Zavitz, CCJ; Botelho, FM; Lambert, KN; Brown, EG; Mossman, KL; Taylor, JD; Stampfli, MR				Bauer, Carla M. T.; Zavitz, Caleb C. J.; Botelho, Fernando M.; Lambert, Kristen N.; Brown, Earl G.; Mossman, Karen L.; Taylor, John D.; Staempfli, Martin R.			Treating Viral Exacerbations of Chronic Obstructive Pulmonary Disease: Insights from a Mouse Model of Cigarette Smoke and H1N1 Influenza Infection	PLOS ONE			English	Article							COPD EXACERBATIONS; DENDRITIC CELLS; LUNG-DISEASE; VIRUS; MICE; AIRWAY; INFLAMMATION; IMMUNE; VACCINATION; RECEPTORS	Background: Chronic obstructive pulmonary disease is a progressive lung disease that is punctuated by periods of exacerbations (worsening of symptoms) that are attributable to viral infections. While rhinoviruses are most commonly isolated viruses during episodes of exacerbation, influenza viruses have the potential to become even more problematic with the increased likelihood of an epidemic. Methodology and Principal Findings: This study examined the impact of current and potential pharmacological targets namely the systemic corticosteroid dexamethasone and the peroxisome proliferator-activated receptor- gamma agonist pioglitazone on the outcome of infection in smoke-exposed mice. C57BL/6 mice were exposed to room air or cigarette smoke for 4 days and subsequently inoculated with an H1N1 influenza A virus. Interventions were delivered daily during the course of infection. We show that smoke-exposed mice have an exacerbated inflammatory response following infection. While smoke exposure did not compromise viral clearance, precision cut lung slices from smoke-exposed mice showed greater expression of CC (MCP-1, -3), and CXC (KC, MIP-2, GCP-2) chemokines compared to controls when stimulated with a viral mimic or influenza A virus. While dexamethasone treatment partially attenuated the inflammatory response in the broncho-alveolar lavage of smoke-exposed, virally-infected animals, viral-induced neutrophilia was steroid insensitive. In contrast to controls, dexamethasone-treated smoke-exposed influenza-infected mice had a worsened health status. Pioglitazone treatment of virally-infected smoke-exposed mice proved more efficacious than the steroid intervention. Further mechanistic evaluation revealed that a deficiency in CCR2 did not improve the inflammatory outcome in smoke-exposed, virally-infected animals. Conclusions and Significance: This animal model of cigarette smoke and H1N1 influenza infection demonstrates that smoke-exposed animals are differentially primed to respond to viral insult. While providing a platform to test pharmacological interventions, this model demonstrates that treating viral exacerbations with alternative anti-inflammatory drugs, such as PPAR-gamma agonists should be further explored since they showed greater efficacy than systemic corticosteroids.	[Bauer, Carla M. T.] McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada; [Zavitz, Caleb C. J.; Botelho, Fernando M.; Mossman, Karen L.; Staempfli, Martin R.] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON, Canada; [Lambert, Kristen N.] McMaster Univ, Mol Biol Undergrad Program, Hamilton, ON, Canada; [Brown, Earl G.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Mossman, Karen L.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Taylor, John D.] AstraZeneca R&D, Lund, Sweden; [Staempfli, Martin R.] McMaster Univ, Dept Med, Hamilton, ON, Canada	McMaster University; McMaster University; McMaster University; University of Ottawa; McMaster University; AstraZeneca; McMaster University	Bauer, CMT (corresponding author), McMaster Univ, Med Sci Grad Program, Hamilton, ON, Canada.	stampfli@mcmaster.ca	Zavitz, Caleb CJ/D-4659-2009	Zavitz, Caleb CJ/0000-0002-1097-041X; Stampfli, Martin/0000-0003-4918-5889	Canadian Institutes of Health Research; AstraZeneca, Sweden; Canadian Thoracic Society; RxD/CIHR	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); AstraZeneca, Sweden(AstraZeneca); Canadian Thoracic Society; RxD/CIHR(Canadian Institutes of Health Research (CIHR))	The work described herein was in-part funded by the Canadian Institutes of Health Research, and AstraZeneca, Sweden. CMTB holds a Canadian Thoracic Society Studentship, MRS holds a CIHR New Investigator Award, and KLM holds an Rx&D/CIHR Health Sciences Career Award. JDT at AstraZeneca participated in study design and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bauer CM, 2010, AM J RESP CRIT CARE, V181; Bauer CM, 2010, AM J RESP CRIT CARE, V181; BAUER CM, 2009, EUR RESPIR J, V34, pA178; Belvisi MG, 2008, CHEST, V134, P152, DOI 10.1378/chest.08-0019; Belvisi MG, 2009, BRIT J PHARMACOL, V158, P994, DOI 10.1111/j.1476-5381.2009.00373.x; Bergner A, 2002, J GEN PHYSIOL, V119, P187, DOI 10.1085/jgp.119.2.187; Birrell MA, 2004, EUR RESPIR J, V24, P18, DOI 10.1183/09031936.04.00098303; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; BROWN EG, 1990, J VIROL, V64, P4523, DOI 10.1128/JVI.64.9.4523-4533.1990; Caschler GJ, 2008, AM J RESP CELL MOL, V38, P218, DOI 10.1165/rcmb.2007-0053OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Dawson TC, 2000, AM J PATHOL, V156, P1951, DOI 10.1016/S0002-9440(10)65068-7; Drannik AG, 2004, AM J RESP CRIT CARE, V170, P1164, DOI 10.1164/rccm.200311-1521OC; Gaschler GJ, 2009, AM J RESP CRIT CARE, V179, P666, DOI 10.1164/rccm.200808-1306OC; Gold PM, 2009, RESP CARE, V54, P1040; Gorse GJ, 2006, CHEST, V130, P1109, DOI 10.1378/chest.130.4.1109; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Hansel TT, 2009, LANCET, V374, P744, DOI 10.1016/S0140-6736(09)61342-8; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Khan MA, 2007, EUR RESPIR J, V30, P691, DOI 10.1183/09031936.00025907; Lin KL, 2008, J IMMUNOL, V180, P2562, DOI 10.4049/jimmunol.180.4.2562; Liu D, 2005, CRIT CARE MED, V33, P2309, DOI 10.1097/01.CCM.0000183161.81503.7D; Mallia Patrick, 2005, Proc Am Thorac Soc, V2, P361, DOI 10.1513/pats.200504-025SR; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Niewoehner DE, 2006, AM J MED, V119, pS38, DOI 10.1016/j.amjmed.2006.08.006; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Robbins CS, 2006, AM J RESP CRIT CARE, V174, P1342, DOI 10.1164/rccm.200604-561OC; Rodriguez-Roisin R, 2000, CHEST, V117, p398S, DOI 10.1378/chest.117.5_suppl_2.398S; Roque R, 2006, IMMUNOPHARM IMMUNOT, V28, P13, DOI 10.1080/08923970600623541; Shah P, 2010, EXPERT OPIN DRUG SAF, V9, P347, DOI 10.1517/14740331003623218; Sharma R, 2009, PULM PHARMACOL THER, V22, P183, DOI 10.1016/j.pupt.2008.11.011; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Tashkin Donald P, 2010, Int J Chron Obstruct Pulmon Dis, V5, P41; Vlahos R, 2006, PULM PHARMACOL THER, V19, P12, DOI 10.1016/j.pupt.2005.02.006; Wedzicha JA, 2001, AM J RESP CRIT CARE, V164, P1757, DOI 10.1164/ajrccm.164.10.2108049a; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Wesseling Geertjan, 2007, Int J Chron Obstruct Pulmon Dis, V2, P5, DOI 10.2147/copd.2007.2.1.5; WILT T, 2005, AHRQ EVIDENCE REPORT; Wongsurakiat P, 2004, CHEST, V125, P2011, DOI 10.1378/chest.125.6.2011; Wright JL, 2002, CHEST, V122, p301S, DOI 10.1378/chest.122.6_suppl.301S; Xu T, 2009, EUR RESPIR J, V33, P852, DOI 10.1183/09031936.00130507	43	69	70	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13251	10.1371/journal.pone.0013251	http://dx.doi.org/10.1371/journal.pone.0013251			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967263	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300007
J	Gao, RB; Dong, LB; Dong, J; Wen, LY; Zhang, Y; Yu, HJ; Feng, ZJ; Chen, MM; Tan, Y; Mo, ZJ; Liu, HY; Fan, YY; Li, KX; Li, CKF; Li, DX; Yang, WZ; Shu, YL				Gao, Rongbao; Dong, Libo; Dong, Jie; Wen, Leying; Zhang, Ye; Yu, Hongjie; Feng, Zijian; Chen, Minmei; Tan, Yi; Mo, Zhaojun; Liu, Haiyan; Fan, Yunyan; Li, Kunxiong; Li, Chris Ka-Fai; Li, Dexin; Yang, Weizhong; Shu, Yuelong			A Systematic Molecular Pathology Study of a Laboratory Confirmed H5N1 Human Case	PLOS ONE			English	Article							INFLUENZA-A H5N1; VIRUS-INFECTION; HUMAN-DISEASE; PATHOGENESIS; CELLS; APOPTOSIS; MACROPHAGES; MORTALITY; CYTOKINES; CHILD	Autopsy studies have shown that human highly pathogenic avian influenza virus (H5N1) can infect multiple human organs other than just the lungs, and that possible causes of organ damage are either viral replication and/or dysregulation of cytokines and chemokines. Uncertainty still exists, partly because of the limited number of cases analysed. In this study, a full autopsy including 5 organ systems was conducted on a confirmed H5N1 human fatal case (male, 42 years old) within 18 hours of death. In addition to the respiratory system (lungs, bronchus and trachea), virus was isolated from cerebral cortex, cerebral medullary substance, cerebellum, brain stem, hippocampus ileum, colon, rectum, ureter, aortopulmonary vessel and lymph-node. Real time RT-PCR evidence showed that matrix and hemagglutinin genes were positive in liver and spleen in addition to positive tissues with virus isolation. Immunohistochemistry and in-situ hybridization stains showed accordant evidence of viral infection with real time RT-PCR except bronchus. Quantitative RT-PCR suggested that a high viral load was associated with increased host responses, though the viral load was significantly different in various organs. Cells of the immunologic system could also be a target for virus infection. Overall, the pathogenesis of HPAI H5N1 virus was associated both with virus replication and with immunopathologic lesions. In addition, immune cells cannot be excluded from playing a role in dissemination of the virus in vivo.	[Gao, Rongbao; Dong, Libo; Dong, Jie; Wen, Leying; Zhang, Ye; Li, Dexin; Shu, Yuelong] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Dept Influenza,Chinese Natl Influenza Ctr, Beijing, Peoples R China; [Yu, Hongjie; Feng, Zijian; Yang, Weizhong] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Chen, Minmei; Tan, Yi; Mo, Zhaojun] Ctr Dis Control & Prevent Guangxi Zhuang Autonomo, Dept Infect Dis, Nanning, Peoples R China; [Liu, Haiyan; Fan, Yunyan] Nanning City Ctr Dis Control & Prevent, Dept Infect Dis, Nanning, Peoples R China; [Li, Kunxiong] Guangxi Med Univ, Affiliated Hosp 1, Nanning, Peoples R China; [Li, Chris Ka-Fai] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC,Human Immunol Unit, Oxford OX3 9DU, England	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Guangxi Medical University; University of Oxford	Gao, RB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, State Key Lab Mol Virol & Genet Engn, Dept Influenza,Chinese Natl Influenza Ctr, Beijing, Peoples R China.	rongbaogao@163.com; yshu@cnic.org.cn	Yu, Hongjie/GZK-5351-2022; LI, chris/HDO-6232-2022; Yang, Wei/HIA-0360-2022		Chinese National Key Technology RD Program [2006BAD06A15]; Chinese Nature Science Foundation [30599433]; Chinese Basic Science Research Program [2005CB523006]; Medical Research Council; EU [SP5B-CT-2006-044161]; National Special Program for Infectious Diseases Control and Prevention [2008ZX10004-002, 2008ZX10004-013, 2008ZX10004-001, 2009ZX10004-101]	Chinese National Key Technology RD Program(National Key Technology R&D Program); Chinese Nature Science Foundation; Chinese Basic Science Research Program; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU(European Commission); National Special Program for Infectious Diseases Control and Prevention	This study was partly funded by Chinese National Key Technology R&D Program (2006BAD06A15), Chinese Nature Science Foundation key project (30599433), Chinese Basic Science Research Program (973) key project (2005CB523006), Medical Research Council project and EU FLUINNATE project (SP5B-CT-2006-044161), National Special Program for Infectious Diseases Control and Prevention (2008ZX10004-002, 2008ZX10004-013, 2008ZX10004-001 and 2009ZX10004-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apisarnthanarak A, 2004, EMERG INFECT DIS, V10, P1321; Baskin CR, 2009, P NATL ACAD SCI USA, V106, P3455, DOI 10.1073/pnas.0813234106; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Buchy P, 2007, J CLIN VIROL, V39, P164, DOI 10.1016/j.jcv.2007.04.010; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Chu VC, 2004, P NATL ACAD SCI USA, V101, P18153, DOI 10.1073/pnas.0405172102; Chutinimitkul S, 2006, EMERG INFECT DIS, V12, P1041, DOI 10.3201/eid1206.060227; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Di Trani L, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-87; Fehrenbach H, 2001, RESP RES, V2, P33, DOI 10.1186/rr36; Fronhoffs S, 2002, MOL CELL PROBE, V16, P99, DOI 10.1006/mcpr.2002.0405; Fujimoto S, 1998, LANCET, V352, P873, DOI 10.1016/S0140-6736(98)12449-2; Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Krucken J, 2005, INFECT IMMUN, V73, P6390, DOI 10.1128/IAI.73.10.6390-6398.2005; La Gruta NL, 2007, IMMUNOL CELL BIOL, V85, P85, DOI 10.1038/sj.icb.7100026; Lee MS, 2001, J VIROL METHODS, V97, P13, DOI 10.1016/S0166-0934(01)00301-9; Li L, 2005, CLIN INFECT DIS, V41, P815, DOI 10.1086/432720; Li YG, 2008, BIOCHEM BIOPH RES CO, V371, P484, DOI 10.1016/j.bbrc.2008.04.123; Lipatov AS, 2005, J GEN VIROL, V86, P1121, DOI 10.1099/vir.0.80663-0; Mok CKP, 2007, J GEN VIROL, V88, P1275, DOI 10.1099/vir.0.82423-0; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Peiris JSM, 2007, CLIN MICROBIOL REV, V20, P243, DOI 10.1128/CMR.00037-06; Peiris JSM, 2004, LANCET, V363, P617, DOI 10.1016/S0140-6736(04)15595-5; Sato K, 2002, J INFECT DIS, V185, P1139, DOI 10.1086/340040; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Sharma AK, 2007, AM J PHYSIOL-LUNG C, V293, pL105, DOI 10.1152/ajplung.00470.2006; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Uiprasertkui M, 2007, EMERG INFECT DIS, V13, P708, DOI 10.3201/eid1305.060572; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WHO, 2005, REC LAB TESTS ID AV; *WHO, 2009, INFL A H1N1 PAND AL; *WHO, 2009, CUM NUMB CONF HUM CA; Yu HJ, 2006, LANCET, V367, P84, DOI 10.1016/S0140-6736(05)67894-4; Yu HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002985; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; Zhou JF, 2006, J INFECT DIS, V193, P945, DOI 10.1086/500954; Zhou JF, 2006, J INFECT DIS, V194, P61, DOI 10.1086/504690	53	32	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13315	10.1371/journal.pone.0013315	http://dx.doi.org/10.1371/journal.pone.0013315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20976271	Green Published, gold, Green Submitted			2022-12-27	WOS:000282807300022
J	Morteau, O; Blundell, S; Chakera, A; Bennett, S; Christou, CM; Mason, PD; Cornall, RJ; O'Callaghan, CA				Morteau, Olivier; Blundell, Samkeliso; Chakera, Aron; Bennett, Sophia; Christou, Charita M.; Mason, Philip D.; Cornall, Richard J.; O'Callaghan, Christopher A.			Renal Transplant Immunosuppression Impairs Natural Killer Cell Function In Vitro and In Vivo	PLOS ONE			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; NK CELLS; KIDNEY-TRANSPLANTATION; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; RECEPTOR NKG2D; CYCLOSPORINE-A; HLA-E; CYTOTOXICITY; BLOOD	Background: Despite an increasing awareness of the importance of innate immunity, the roles of natural killer (NK) cells in transplant rejection and antiviral and cancer immunity during immunosuppression have not been clearly defined. Methods: To address this issue we have developed a quantitative assay of NK cell function that can be used on clinical samples and have studied the influence of immunosuppression on NK cell function. NK cell degranulation and intracellular interferon (IFN)-gamma production were determined by flow cytometry of peripheral blood samples. Results: Overnight ex vivo treatment of peripheral blood cells from healthy controls with ciclosporin or tacrolimus inhibited NK cell degranulation and IFN-gamma production in a dose-dependent manner. A similar impairment of function was seen in NK cells from patients treated in vivo with calcineurin inhibitors. In the early post-transplant period, there was a variable reduction of NK cell counts after treatment with alemtuzumab and basiliximab. Conclusions: The functional inhibition of NK cells in early transplant patients coincides with the period of maximum susceptibility to viral infections. The ability to assay NK cell function in clinical samples allows assessment of the impact of immunosuppression on these effector cells. This information may be helpful in guiding the titration of immunosuppression in the clinical setting.	[Morteau, Olivier; Blundell, Samkeliso; Chakera, Aron; Bennett, Sophia; Christou, Charita M.; Cornall, Richard J.; O'Callaghan, Christopher A.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England; [Chakera, Aron; Mason, Philip D.; Cornall, Richard J.; O'Callaghan, Christopher A.] Churchill Hosp, Oxford Kidney Unit, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Morteau, O (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	richard.cornall@ndm.ox.ac.uk; chris.ocallaghan@ndm.ox.ac.uk			National Institute for Health Research (NIHR) Oxford Comprehensive Biomedical Research Centre (BRC); Medical Research Council [G116/165] Funding Source: researchfish; MRC [G116/165] Funding Source: UKRI	National Institute for Health Research (NIHR) Oxford Comprehensive Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Institute for Health Research (NIHR) Oxford Comprehensive Biomedical Research Centre (BRC) Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas E, 2009, CELL IMMUNOL, V254, P149, DOI 10.1016/j.cellimm.2008.08.007; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Auchincloss H, 1998, ANNU REV IMMUNOL, V16, P433, DOI 10.1146/annurev.immunol.16.1.433; Beilke JN, 2005, NAT MED, V11, P1059, DOI 10.1038/nm1296; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BLANCHO G, 1992, TRANSPLANTATION, V53, P1242, DOI 10.1097/00007890-199206000-00014; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brett S, 1996, IMMUNOLOGY, V88, P13, DOI 10.1046/j.1365-2567.1996.d01-650.x; Buggins AGS, 2002, BLOOD, V100, P1715, DOI 10.1182/blood.V100.5.1715.h81702001715_1715_1720; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; CHEN SH, 1983, TRANSPLANTATION, V35, P127, DOI 10.1097/00007890-198302000-00004; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hadaya K, 2008, AM J TRANSPLANT, V8, P2674, DOI 10.1111/j.1600-6143.2008.02431.x; INTRONA M, 1981, TRANSPLANTATION, V31, P113, DOI 10.1097/00007890-198102000-00004; ISAACS JD, 1992, LANCET, V340, P748, DOI 10.1016/0140-6736(92)92294-P; Jacobs R, 2001, EUR J IMMUNOL, V31, P3121, DOI 10.1002/1521-4141(2001010)31:10<3121::AID-IMMU3121>3.0.CO;2-4; Kimikawa M, 2001, CLIN TRANSPLANT, V15, P324, DOI 10.1034/j.1399-0012.2001.150504.x; Kroemer A, 2008, J IMMUNOL, V180, P7818, DOI 10.4049/jimmunol.180.12.7818; Laffont S, 2008, BLOOD, V112, P661, DOI 10.1182/blood-2007-10-120089; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lin SJ, 2008, CYTOTHERAPY, V10, P397, DOI 10.1080/14653240802129885; Lundin J, 2004, LEUKEMIA, V18, P484, DOI 10.1038/sj.leu.2403258; Mahalati K, 2000, J UROLOGY, V163, P37, DOI 10.1016/S0022-5347(05)67967-0; Manilay JO, 1998, CURR OPIN IMMUNOL, V10, P532, DOI 10.1016/S0952-7915(98)80219-7; Mistry AR, 2007, IMMUNOLOGY, V121, P439, DOI 10.1111/j.1365-2567.2007.02652.x; Norman PJ, 2005, SEMIN HEMATOL, V42, P65, DOI 10.1053/j.seminhematol.2005.01.007; O'Callaghan CA, 2001, IMMUNITY, V15, P201, DOI 10.1016/S1074-7613(01)00187-X; O'Callaghan CA, 1998, IMMUNOL REV, V163, P129, DOI 10.1111/j.1600-065X.1998.tb01192.x; Osterborg A, 1997, EUR J HAEMATOL, V58, P5; Penack O, 2005, LEUKEMIA, V19, P835, DOI 10.1038/sj.leu.2403704; Petersson E, 1997, TRANSPLANTATION, V63, P1138, DOI 10.1097/00007890-199704270-00014; Pores-Fernando AT, 2009, CELL IMMUNOL, V254, P105, DOI 10.1016/j.cellimm.2008.07.004; RIECHMANN L, 1988, NATURE, V332, P323, DOI 10.1038/332323a0; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Seiler M, 2007, AM J TRANSPLANT, V7, P423, DOI 10.1111/j.1600-6143.2006.01625.x; Vacher-Coponat H, 2006, TRANSPLANTATION, V82, P558, DOI 10.1097/01.tp.0000229390.01369.4a; van Leeuwen MT, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c570; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wai LE, 2008, TRANSPLANTATION, V85, P145, DOI 10.1097/01.tp.0000296817.28053.7b; Wang H, 2007, BLOOD, V110, P1530, DOI 10.1182/blood-2006-10-048173; WASIK M, 1991, TRANSPLANTATION, V51, P268, DOI 10.1097/00007890-199101000-00045; WELSH RM, 1977, NATURE, V268, P646, DOI 10.1038/268646a0; Yu G, 2006, J EXP MED, V203, P1851, DOI 10.1084/jem.20060603	45	48	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13294	10.1371/journal.pone.0013294	http://dx.doi.org/10.1371/journal.pone.0013294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967261	gold, Green Submitted, Green Published			2022-12-27	WOS:000282807300019
J	Schmid, A; Gianella, S; von Wyl, V; Metzner, KJ; Scherrer, AU; Niederost, B; Althaus, CF; Rieder, P; Grube, C; Joos, B; Weber, R; Fischer, M; Gunthard, HF				Schmid, Adrian; Gianella, Sara; von Wyl, Viktor; Metzner, Karin J.; Scherrer, Alexandra U.; Niederost, Barbara; Althaus, Claudia F.; Rieder, Philip; Grube, Christina; Joos, Beda; Weber, Rainer; Fischer, Marek; Gunthard, Huldrych F.			Profound Depletion of HIV-1 Transcription in Patients Initiating Antiretroviral Therapy during Acute Infection	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; STRUCTURED TREATMENT INTERRUPTIONS; CD4(+) T-LYMPHOCYTES; PERIPHERAL-BLOOD; GENE-EXPRESSION; PLASMA VIREMIA; VIRAL REPLICATION; IMMUNE-RESPONSES; IN-VIVO	Background: Although combination antiretroviral therapy (cART) initiated in the acute phase of HIV-1 infection may prevent expansion of the latent reservoir, its benefits remain controversial. In the current study, HIV-1 RNA transcription patterns in peripheral blood mononuclear cells (PBMC) were monitored during acute cART to assess the effect of early treatment on cellular viral reservoirs. Methodology/Principal Findings: Acutely HIV-1 infected patients (n = 24) were treated within 3-15 weeks after infection. Patients elected to cease treatment after >= 1 year of therapy. HIV-1 DNA (vDNA), HIV-1 RNA species expressed both in latently and productively infected cells, unspliced (UsRNA), multiply spliced (MsRNA-tatrev; MsRNA-nef), and PBMC-associated extracellular virion RNA (vRex), expressed specifically by productively infected cells, were quantified in PBMC by patient matched real-time PCR prior, during and post cART. In a matched control-group of patients on successful cART started during chronic infection (n = 15), UsRNA in PBMC and vDNA were measured cross-sectionally. In contrast to previous reports, PBMC-associated HIV-1 RNAs declined to predominantly undetectable levels on cART. After cART cessation, UsRNA, vRex, and MsRNA-tatrev rebounded to levels not significantly different to those at baseline (p>0.1). In contrast, MsRNA-nef remained significantly lower as compared to pretreatment (p = 0.015). UsRNA expressed at the highest levels of all viral RNAs, was detectable on cART in 42% of patients with cART initiated during acute infection as opposed to 87% of patients on cART initiated during chronic infection (Fisher's exact test; p = 0.008). Accordingly, UsRNA levels were 105-fold lower in the acute as compared to the chronic group. Conclusion: Early intervention resulted in profound depletion of PBMC expressing HIV-1 RNA. This is contrary to chronically infected patients who predominantly showed continuous UsRNA expression on cART. Thus, antiretroviral treatment initiated during the acute phase of infection prevented establishment or expansion of long-lived transcriptionally active viral cellular reservoirs in peripheral blood.	[Schmid, Adrian; Gianella, Sara; von Wyl, Viktor; Metzner, Karin J.; Scherrer, Alexandra U.; Niederost, Barbara; Althaus, Claudia F.; Rieder, Philip; Grube, Christina; Joos, Beda; Weber, Rainer; Fischer, Marek; Gunthard, Huldrych F.] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland	University of Zurich; University Zurich Hospital	Schmid, A (corresponding author), Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland.	marek.fischer@usz.ch; huldrych.guenthard@usz.ch	Weber, Rainer/D-5175-2012; gunthard, huldrych f/F-1724-2011; Metzner, Karin J/G-5319-2011; Joos, Beda/D-5547-2009	gunthard, huldrych f/0000-0002-1142-6723; Metzner, Karin J/0000-0003-4862-1503; Joos, Beda/0000-0002-3082-8875; von Wyl, Viktor/0000-0002-8754-9797; Gianella, Sara/0000-0002-9927-0849	Swiss National Science Foundation [324730-116035, -130865, 3100A0-112670]; Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich; Olga-Mayenfisch Stiftung; Hartmann-Muller Stiftung; Klaus Hermann Stiftung; Jubilaumsstiftung Swiss Life; Novartis Foundation; Ciba-Geigy Jubilee Foundation; Abbott, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich; Olga-Mayenfisch Stiftung; Hartmann-Muller Stiftung; Klaus Hermann Stiftung; Jubilaumsstiftung Swiss Life; Novartis Foundation(Novartis); Ciba-Geigy Jubilee Foundation; Abbott, Switzerland(Abbott Laboratories)	This work was supported by the Swiss National Science Foundation (grant # 324730-116035 and -130865 to HFG, grant # 3100A0-112670 to MF and HFG), by grants from the Stiftung fur Wissenschaftliche Forschung an der Universitat Zurich, Olga-Mayenfisch Stiftung, Hartmann-Muller Stiftung, Klaus Hermann Stiftung, and the Jubilaumsstiftung Swiss Life to MF; a fellowship of the Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation to VVW. The SHCS drug resistance database is supported by the SHCS research foundation. The Zurich HIV Transcription study was supported by an unrestricted research grant from Abbott, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Altfeld M, 2001, J EXP MED, V193, P169, DOI 10.1084/jem.193.2.169; Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Anton PA, 2003, AIDS, V17, P53, DOI 10.1097/00002030-200301030-00008; Barber SA, 2006, J INFECT DIS, V193, P963, DOI 10.1086/500983; Christopherson C, 2000, J CLIN MICROBIOL, V38, P630, DOI 10.1128/JCM.38.2.630-634.2000; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clerc O, 2010, J CLIN VIROL, V47, P376, DOI 10.1016/j.jcv.2010.01.013; COHN ML, 1959, J CLIN INVEST, V38, P1349, DOI 10.1172/JCI103910; Craigo JK, 2004, AIDS RES HUM RETROV, V20, P1196, DOI 10.1089/aid.2004.20.1196; Dahl V, 2010, ANTIVIR RES, V85, P286, DOI 10.1016/j.antiviral.2009.09.016; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Delwart E, 2002, AIDS, V16, P189, DOI 10.1097/00002030-200201250-00007; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Egger M, 1997, BMJ-BRIT MED J, V315, P1194, DOI 10.1136/bmj.315.7117.1194; Ehrlich P, 1913, LANCET, V2, P445; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Fagard C, 2003, ARCH INTERN MED, V163, P1220, DOI 10.1001/archinte.163.10.1220; Farnham PG, 2010, APPL HEALTH ECON HEA, V8, P75, DOI 10.2165/11531890-000000000-00000; Feinberg MB, 1996, LANCET, V348, P239, DOI 10.1016/S0140-6736(96)06231-9; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2000, AIDS RES HUM RETROV, V16, P1135, DOI 10.1089/088922200414974; Fischer M, 2004, J INFECT DIS, V190, P1979, DOI 10.1086/425983; Fischer M, 2004, J INFECT DIS, V189, P273, DOI 10.1086/380797; Fischer M, 2003, AIDS, V17, P195, DOI 10.1097/00002030-200301240-00009; Fischer M, 2002, ANTIVIR THER, V7, P91; Fischer M, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-107; Fomsgaard A, 2008, AIDS RES HUM RETROV, V24, P463, DOI 10.1089/aid.2006.0294; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; GalettoLacour A, 1996, J INFECT DIS, V173, P1388, DOI 10.1093/infdis/173.6.1388; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Grossman Z, 1999, NAT MED, V5, P1099, DOI 10.1038/13410; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Gulick RM, 1997, NEW ENGL J MED, V337, P734, DOI 10.1056/NEJM199709113371102; Gunthard HF, 2000, J INFECT DIS, V181, P522, DOI 10.1086/315260; Gunthard HF, 2001, J INFECT DIS, V183, P1318, DOI 10.1086/319864; Hermankova M, 2003, J VIROL, V77, P7383, DOI 10.1128/JVI.77.13.7383-7392.2003; Huber M, 2006, PLOS MED, V3, P2078, DOI 10.1371/journal.pmed.0030441; Joos B, 2005, J VIROL, V79, P9026, DOI 10.1128/JVI.79.14.9026-9037.2005; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kaiser P, 2007, J VIROL, V81, P9693, DOI 10.1128/JVI.00492-07; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Lisziewicz J, 1999, NEW ENGL J MED, V340, P1683, DOI 10.1056/NEJM199905273402114; Lowy A, 2005, AIDS CARE, V17, P698, DOI 10.1080/09540120412331336689; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Nguyen A, 2008, HIV MED, V9, P142, DOI 10.1111/j.1468-1293.2007.00537.x; Opravil M, 2000, J ACQ IMMUN DEF SYND, V23, P17; Otero M, 2003, AIDS RES HUM RETROV, V19, P1097, DOI 10.1089/088922203771881194; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; RIEDER P, 2010, AIDS; Roscic-Mrkic B, 2003, BLOOD, V102, P1169, DOI 10.1182/blood-2003-02-0488; Rosenberg ES, 2000, NATURE, V407, P523, DOI 10.1038/35035103; Sagar M, 2003, J VIROL, V77, P12921, DOI 10.1128/JVI.77.23.12921-12926.2003; Smith DM, 2005, J INFECT DIS, V192, P438, DOI 10.1086/431682; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Strain MC, 2005, J INFECT DIS, V191, P1410, DOI 10.1086/428777; Streeck H, 2008, J EXP MED, V205, P1789, DOI 10.1084/jem.20080281; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; VONWY, 2007, ARCH INTERN MED, V167, P1782; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Worm SW, 2010, J INFECT DIS, V201, P318, DOI 10.1086/649897; Yang OO, 2005, J VIROL, V79, P860, DOI 10.1128/JVI.79.2.860-868.2005; YUKL SGS, 2010, J INFECT DI IN PRESS; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565	73	75	76	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13310	10.1371/journal.pone.0013310	http://dx.doi.org/10.1371/journal.pone.0013310			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967271	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300021
J	Pinna, A; Soranzo, N; de la Fuente, A				Pinna, Andrea; Soranzo, Nicola; de la Fuente, Alberto			From Knockouts to Networks: Establishing Direct Cause-Effect Relationships through Graph Analysis	PLOS ONE			English	Article							GENE REGULATORY NETWORKS; RECONSTRUCTION; ALGORITHM; DREAM	Background: Reverse-engineering gene networks from expression profiles is a difficult problem for which a multitude of techniques have been developed over the last decade. The yearly organized DREAM challenges allow for a fair evaluation and unbiased comparison of these methods. Results: We propose an inference algorithm that combines confidence matrices, computed as the standard scores from single-gene knockout data, with the down-ranking of feed-forward edges. Substantial improvements on the predictions can be obtained after the execution of this second step. Conclusions: Our algorithm was awarded the best overall performance at the DREAM4 In Silico 100-gene network sub-challenge, proving to be effective in inferring medium-size gene regulatory networks. This success demonstrates once again the decisive importance of gene expression data obtained after systematic gene perturbations and highlights the usefulness of graph analysis to increase the reliability of inference.	[Pinna, Andrea; Soranzo, Nicola; de la Fuente, Alberto] Ctr Adv Studies Res & Dev CRS4 Bioinformat, Pula, Italy		Pinna, A (corresponding author), Ctr Adv Studies Res & Dev CRS4 Bioinformat, Pula, Italy.	alf@crs4.it		Soranzo, Nicola/0000-0003-3627-5340; Soranzo, Nicole/0000-0003-1095-3852	Regional Authorities of Sardinia	Regional Authorities of Sardinia	This work was partly supported by The Regional Authorities of Sardinia (http://www.sardegnaricerche.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Brazhnik P, 2002, TRENDS BIOTECHNOL, V20, P467, DOI 10.1016/S0167-7799(02)02053-X; Butte A J, 2000, Pac Symp Biocomput, P418; D'haeseleer P, 1999, Pac Symp Biocomput, P41; de la Fuente A, 2004, BIOINFORMATICS, V20, P3565, DOI 10.1093/bioinformatics/bth445; de la Fuente A, 2002, TRENDS GENET, V18, P395, DOI 10.1016/S0168-9525(02)02692-6; de la Fuente A., 2010, HDB RES COMPUTATIONA, P1; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Gustafsson M, 2009, ANN NY ACAD SCI, V1158, P265, DOI 10.1111/j.1749-6632.2008.03764.x; Liu B, 2008, GENETICS, V178, P1763, DOI 10.1534/genetics.107.080069; Marbach D, 2010, P NATL ACAD SCI USA, V107, P6286, DOI 10.1073/pnas.0913357107; Marbach D, 2009, J COMPUT BIOL, V16, P229, DOI 10.1089/cmb.2008.09TT; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Mendes P, 2003, BIOINFORMATICS, V19, pII122, DOI 10.1093/bioinformatics/btg1069; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Prill RJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009202; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Rice JJ, 2005, BIOINFORMATICS, V21, P765, DOI 10.1093/bioinformatics/bti064; Rockman MV, 2008, NATURE, V456, P738, DOI 10.1038/nature07633; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Scheinine A, 2009, ANN NY ACAD SCI, V1158, P287, DOI 10.1111/j.1749-6632.2008.04100.x; Soranzo N, 2007, BIOINFORMATICS, V23, P1640, DOI 10.1093/bioinformatics/btm163; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; Stolovitzky Gustavo, 2009, Ann N Y Acad Sci, V1158, pix, DOI 10.1111/j.1749-6632.2009.04470.x; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Wagner A, 2001, BIOINFORMATICS, V17, P1183, DOI 10.1093/bioinformatics/17.12.1183; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yip KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008121	34	55	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e12912	10.1371/journal.pone.0012912	http://dx.doi.org/10.1371/journal.pone.0012912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949005	Green Published, gold, Green Submitted			2022-12-27	WOS:000282748100001
J	Ohshima, K; Inoue, K; Fujiwara, A; Hatakeyama, K; Kanto, K; Watanabe, Y; Muramatsu, K; Fukuda, Y; Ogura, S; Yamaguchi, K; Mochizuki, T				Ohshima, Keiichi; Inoue, Kanako; Fujiwara, Akemi; Hatakeyama, Keiichi; Kanto, Kaori; Watanabe, Yuko; Muramatsu, Koji; Fukuda, Yorikane; Ogura, Shun-ichiro; Yamaguchi, Ken; Mochizuki, Tohru			Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line	PLOS ONE			English	Article							PERITONEAL DISSEMINATION; INTERCELLULAR TRANSFER; CIRCULATING MICRORNAS; MEMBRANE-VESICLES; TUMOR; SERUM; MICROVESICLES; BIOMARKERS; MARKER; EXPRESSION	Background: Exosomes play a major role in cell-to-cell communication, targeting cells to transfer exosomal molecules including proteins, mRNAs, and microRNAs (miRNAs) by an endocytosis-like pathway. miRNAs are small noncoding RNA molecules on average 22 nucleotides in length that regulate numerous biological processes including cancer pathogenesis and mediate gene down-regulation by targeting mRNAs to induce RNA degradation and/or interfering with translation. Recent reports imply that miRNAs can be stably detected in circulating plasma and serum since miRNAs are packaged by exosomes to be protected from RNA degradation. Thus, profiling exosomal miRNAs are in need to clarify intercellular signaling and discover a novel disease marker as well. Methodology/Principal Findings: Exosomes were isolated from cultured cancer cell lines and their quality was validated by analyses of transmission electron microscopy and western blotting. One of the cell lines tested, a metastatic gastric cancer cell line, AZ-P7a, showed the highest RNA yield in the released exosomes and distinctive shape in morphology. In addition, RNAs were isolated from cells and culture media, and profiles of these three miRNA fractions were obtained using microarray analysis. By comparing signal intensities of microarray data and the following validation using RT-PCR analysis, we found that let-7 miRNA family was abundant in both the intracellular and extracellular fractions from AZ-P7a cells, while low metastatic AZ-521, the parental cell line of AZ-P7a, as well as other cancer cell lines showed no such propensity. Conclusions/Significance: The enrichment of let-7 miRNA family in the extracellular fractions, particularly, in the exosomes from AZ-P7a cells may reflect their oncogenic characteristics including tumorigenesis and metastasis. Since let-7 miRNAs generally play a tumor-suppressive role as targeting oncogenes such as RAS and HMGA2, our results suggest that AZ-P7a cells release let-7 miRNAs via exosomes into the extracellular environment to maintain their oncogenesis.	[Ohshima, Keiichi; Inoue, Kanako; Fujiwara, Akemi; Hatakeyama, Keiichi; Kanto, Kaori; Watanabe, Yuko; Ogura, Shun-ichiro; Mochizuki, Tohru] Shizuoka Canc Ctr Res Inst, Div Med Genet, Shizuoka, Japan; [Muramatsu, Koji] Shizuoka Canc Ctr Hosp, Div Pathol, Shizuoka, Japan; [Fukuda, Yorikane] Tokyo Univ Agr & Technol, Grad Sch Engn, Div Biotechnol & Life Sci, Tokyo, Japan; [Yamaguchi, Ken] Shizuoka Canc Ctr Hosp & Res Inst, Shizuoka, Japan	Shizuoka Cancer Center; Shizuoka Cancer Center; Tokyo University of Agriculture & Technology; Shizuoka Cancer Center	Ohshima, K (corresponding author), Shizuoka Canc Ctr Res Inst, Div Med Genet, Shizuoka, Japan.	k.ohshima@scchr.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The work was supported by a grant in cooperation with Innovative Technology and Advanced Research in Evolutional Area (CITY AREA) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed FE, 2007, EXPERT REV MOL DIAGN, V7, P569, DOI 10.1586/14737159.7.5.569; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Brueckner B, 2007, CANCER RES, V67, P1419, DOI 10.1158/0008-5472.CAN-06-4074; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Davis DM, 2007, NAT REV IMMUNOL, V7, P238, DOI 10.1038/nri2020; Fukui R, 2005, J SURG RES, V129, P94, DOI 10.1016/j.jss.2005.04.030; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Hanke M, UROL ONCOL IN PRESS; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Ichim TE, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-37; Iinuma H, 2002, INT J CANCER, V99, P130, DOI 10.1002/ijc.10242; Ji H, 2008, ELECTROPHORESIS, V29, P2660, DOI 10.1002/elps.200800015; Keller S, 2007, KIDNEY INT, V72, P1095, DOI 10.1038/sj.ki.5002486; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Michael A, 2010, ORAL DIS, V16, P34, DOI 10.1111/j.1601-0825.2009.01604.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nishimori H, 2000, JPN J CANCER RES, V91, P715, DOI 10.1111/j.1349-7006.2000.tb01004.x; Ogura S, 2008, PROTEOM CLIN APPL, V2, P1620, DOI 10.1002/prca.200800039; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; POUTSIAKA DD, 1985, J IMMUNOL, V134, P138; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Sasaki K, 2002, CANCER RES, V62, P4894; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Xiao WH, 2010, WORLD J GASTROENTERO, V16, P2371, DOI 10.3748/wjg.v16.i19.2371	43	447	488	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13247	10.1371/journal.pone.0013247	http://dx.doi.org/10.1371/journal.pone.0013247			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949044	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700018
J	Duquette, PM; Zhou, X; Yap, NL; MacLaren, EJ; Lu, JJ; Wallace, VA; Chen, HH				Duquette, Philippe M.; Zhou, Xun; Yap, Nida Lerma; MacLaren, Erik J.; Lu, Jesse J.; Wallace, Valerie A.; Chen, Hsiao-Huei			Loss of LMO4 in the Retina Leads to Reduction of GABAergic Amacrine Cells and Functional Deficits	PLOS ONE			English	Article							NEURAL-TUBE CLOSURE; LIM DOMAIN; NEGATIVE REGULATION; FATE SPECIFICATION; PROGENITOR CELLS; CEREBRAL-CORTEX; MOTOR-NEURON; PROTEIN LMO4; INNER-EAR; TRANSCRIPTION	Background: LMO4 is a transcription cofactor expressed during retinal development and in amacrine neurons at birth. A previous study in zebrafish reported that morpholino RNA ablation of one of two related genes, LMO4b, increases the size of eyes in embryos. However, the significance of LMO4 in mammalian eye development and function remained unknown since LMO4 null mice die prior to birth. Methodology/Principal Findings: We observed the presence of a smaller eye and/or coloboma in similar to 40% LMO4 null mouse embryos. To investigate the postnatal role of LMO4 in retinal development and function, LMO4 was conditionally ablated in retinal progenitor cells using the Pax6 alpha-enhancer Cre/LMO4flox mice. We found that these mice have fewer Bhlhb5-positive GABAergic amacrine and OFF-cone bipolar cells. The deficit appears to affect the postnatal wave of Bhlhb5+ neurons, suggesting a temporal requirement for LMO4 in retinal neuron development. In contrast, cholinergic and dopaminergic amacrine, rod bipolar and photoreceptor cell numbers were not affected. The selective reduction in these interneurons was accompanied by a functional deficit revealed by electroretinography, with reduced amplitude of b-waves, indicating deficits in the inner nuclear layer of the retina. Conclusions/Significance: Inhibitory GABAergic interneurons play a critical function in controlling retinal image processing, and are important for neural networks in the central nervous system. Our finding of an essential postnatal function of LMO4 in the differentiation of Bhlhb5-expressing inhibitory interneurons in the retina may be a general mechanism whereby LMO4 controls the production of inhibitory interneurons in the nervous system.	[Duquette, Philippe M.; Zhou, Xun; Yap, Nida Lerma; MacLaren, Erik J.; Lu, Jesse J.; Chen, Hsiao-Huei] Ottawa Hosp Res Inst, Ctr Stroke Recovery, Ottawa, ON, Canada; [Wallace, Valerie A.] Ottawa Hosp Res Inst, Program Mol Med, Ottawa, ON, Canada; [Wallace, Valerie A.; Chen, Hsiao-Huei] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Chen, Hsiao-Huei] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Wallace, Valerie A.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Wallace, Valerie A.] Univ Ottawa, Inst Eye, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Duquette, PM (corresponding author), Ottawa Hosp Res Inst, Ctr Stroke Recovery, Ottawa, ON, Canada.	hchen@uottawa.ca		Chen, Hsiao-Huei/0000-0003-2914-6057	Ontario Ministry of Research and Innovation; Canada Foundation for Innovation; CIHR [MOP-179197, RMF92100]; Heart and Stroke Foundation of Canada; Foundation Fighting Blindness and Stem Cell Network of Canada; Ontario Graduate Scholarship	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Foundation Fighting Blindness and Stem Cell Network of Canada; Ontario Graduate Scholarship(Ontario Graduate Scholarship)	This work was supported by an Early Researcher Award from the Ontario Ministry of Research and Innovation (HHC), by infrastructure support from the Ontario Research Fund (HHC) and the Canada Foundation for Innovation (HHC), and by CIHR grants (MOP-179197). HHC is a recipient of a New Investigator Award from the Heart and Stroke Foundation of Canada. VAW is supported by CIHR (RMF92100), Foundation Fighting Blindness and Stem Cell Network of Canada. PMD is a recipient of an Ontario Graduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado DM, 2009, DEV DYNAM, V238, P3093, DOI 10.1002/dvdy.22149; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bramblett DE, 2004, NEURON, V43, P779, DOI 10.1016/j.neuron.2004.08.032; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Chen HH, 2003, CURR OPIN NEUROBIOL, V13, P96, DOI 10.1016/S0959-4388(03)00006-0; Chen HH, 2002, DEVELOPMENT, V129, P4879; de la Calle-Mustienes E, 2003, DEV BIOL, V264, P564, DOI 10.1016/j.ydbio.2003.09.002; Deng M, 2010, DEV BIOL, V338, P38, DOI 10.1016/j.ydbio.2009.11.003; Feng L, 2006, DEVELOPMENT, V133, P4815, DOI 10.1242/dev.02664; Gomez-Smith M, 2010, CELL MOL LIFE SCI, V67, P949, DOI 10.1007/s00018-009-0223-z; Hahm KM, 2004, MOL CELL BIOL, V24, P2074, DOI 10.1128/MCB.24.5.2074-2082.2004; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Inoue T, 2002, DEVELOPMENT, V129, P831; Joshi K, 2009, NEURON, V61, P839, DOI 10.1016/j.neuron.2009.02.011; Joshi PS, 2008, NEURON, V60, P258, DOI 10.1016/j.neuron.2008.08.006; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Kubo F, 2009, DEVELOPMENT, V136, P1823, DOI 10.1242/dev.029272; Lee SK, 2005, MOL CELL NEUROSCI, V28, P205, DOI 10.1016/j.mcn.2004.04.010; Leonard KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000314; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Manetopoulos C, 2003, BIOCHEM BIOPH RES CO, V307, P891, DOI 10.1016/S0006-291X(03)01298-1; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; McCollum CW, 2007, DEV BIOL, V309, P373, DOI 10.1016/j.ydbio.2007.07.004; Medina CF, 2009, HUM MOL GENET, V18, P966, DOI 10.1093/hmg/ddn424; Morrison D, 2002, J MED GENET, V39, P16, DOI 10.1136/jmg.39.1.16; Morrow EM, 1999, DEVELOPMENT, V126, P23; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Pan L, 2008, DEVELOPMENT, V135, P1981, DOI 10.1242/dev.010751; Ross SE, 2010, NEURON, V65, P886, DOI 10.1016/j.neuron.2010.02.025; Schock SC, 2008, J NEUROSCI, V28, P12433, DOI 10.1523/JNEUROSCI.2897-08.2008; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Song MR, 2009, DEVELOPMENT, V136, P2923, DOI 10.1242/dev.037986; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tse E, 2004, MOL CELL BIOL, V24, P2063, DOI 10.1128/MCB.24.5.2063-2073.2004; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 2008, BRAIN RES, V1192, P61, DOI 10.1016/j.brainres.2007.06.018; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465	39	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13232	10.1371/journal.pone.0013232	http://dx.doi.org/10.1371/journal.pone.0013232			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949055	gold, Green Submitted, Green Published			2022-12-27	WOS:000282633700018
J	Lander, B; Hanley, GE; Atkinson-Grosjean, J				Lander, Bryn; Hanley, Gillian E.; Atkinson-Grosjean, Janet			Clinician-Scientists in Canada: Barriers to Career Entry and Progress	PLOS ONE			English	Article							PHYSICIAN-SCIENTIST; KNOWLEDGE TRANSLATION; HEALTH; INVESTIGATOR	Background: Clinician-scientists play an important role in translating between research and clinical practice. Significant concerns about a decline in their numbers have been raised. Potential barriers for career entry and progress are explored in this study. Methods: Case-study research methods were used to identify barriers perceived by clinician-scientists and their research teams in two Canadian laboratories. These perceptions were then compared against statistical analysis of data from Canadian Institutes of Health Research (CIHR) databases on grant and award performance of clinician-scientists and non-clinical PhDs for fiscal years 2000 to 2008. Results: Three main barriers were identified through qualitative analysis: research training, research salaries, and research grants. We then looked for evidence of these barriers in the Canada-wide statistical dataset for our study period. Clinician-scientists had a small but statistically significant higher mean number of degrees (3.3) than non-clinical scientists (3.2), potentially confirming the perception of longer training times. But evidence of the other two barriers was equivocal. For example, while overall growth in salary awards was minimal, awards to clinician-scientists increased by 45% compared to 6.3% for non-clinical PhDs. Similarly, in terms of research funding, awards to clinician-scientists increased by more than 25% compared with 5% for non-clinical PhDs. However, clinician-scientist-led grants funded under CIHR's Clinical thematic area decreased significantly from 61% to 51% (p-value<0.001) suggesting that clinician-scientists may be shifting their attention to other research domains. Conclusion: While clinician-scientists continue to perceive barriers to career entry and progress, quantitative results suggest improvements over the last decade. Clinician-scientists are awarded an increasing proportion of CIHR research grants and salary awards. Given the translational importance of this group, however, it may be prudent to adopt specific policy and funding incentives to ensure the ongoing viability of the career path.	[Lander, Bryn; Hanley, Gillian E.] Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada; [Atkinson-Grosjean, Janet] Univ British Columbia, Coll Interdisciplinary Studies, W Maurice Young Ctr Appl Eth, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Lander, B (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Ctr Hlth Serv & Policy Res, Vancouver, BC V5Z 1M9, Canada.	janetat@interchange.ubc.ca		Hanley, Gillian/0000-0001-9594-0545	Genome Canada; Pathogenomics of Innate Immunity project	Genome Canada(Genome Canada); Pathogenomics of Innate Immunity project	The research was funded by Genome Canada (www.genomecanada.ca) under Competition 3, as part of the Pathogenomics of Innate Immunity project (http://www.genomebc.com/portfolio/projects/health-projects/current/the-pathogenomics-of-innate-immunity-pi2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSONGROSJEA, 2006, PUBLIC SCI PRIVATE I; BENDAVID J, 1960, AM J SOCIOL, V65, P557, DOI 10.1086/222786; Bernstein A, 2003, CAN MED ASSOC J, V169, P567; *CIRH, 2002, CLIN SCI YEST TOD TO; Department of Health (Research and Development Directorate), 2006, BEST RES BEST HLTH N; Estabrooks CA, 2006, J CONTIN EDUC HEALTH, V26, P25, DOI 10.1002/chp.48; Estabrooks CA, 2008, RES POLICY, V37, P1066, DOI 10.1016/j.respol.2008.04.006; Goldstein JL, 1997, J CLIN INVEST, V99, P2803, DOI 10.1172/JCI119470; JANSSON SM, 2010, QUALITATIVE HLTH RES, V10, P131; Khadaroo RG, 2002, CLIN INVEST MED, V25, P260; Kotchen TA, 2004, JAMA-J AM MED ASSOC, V291, P836, DOI 10.1001/jama.291.7.836; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Nason E, 2008, HLTH MED RES CANADA; NATHAN DG, 1998, JAMA-J AM MED ASSOC, V208, P1427; Phillipson EA, 2002, CLIN INVEST MED, V25, P23; Raghavan M, 2007, CLIN INVEST MED, V30, pE152; Rosenberg LE, 1999, J CLIN INVEST, V103, P1621, DOI 10.1172/JCI7304; Rothschild V., 1971, ORG MANAGEMENT GOVT; Roy CC, 1997, CLIN INVEST MED, V20, P283; Scott SD, 2008, QUAL HEALTH RES, V18, P347, DOI 10.1177/1049732307313354; Shine KI, 1998, JAMA-J AM MED ASSOC, V280, P1442, DOI 10.1001/jama.280.16.1442; WEATHERALL DJ, 1991, BRIT MED J, V302, P1002, DOI 10.1136/bmj.302.6783.1002; WYNGAARDEN JB, 1979, NEW ENGL J MED, V301, P1254, DOI 10.1056/NEJM197912063012303	23	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13168	10.1371/journal.pone.0013168	http://dx.doi.org/10.1371/journal.pone.0013168			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957175	gold, Green Published, Green Submitted			2022-12-27	WOS:000282423300010
J	Hsu, CT; Patton, DF; Mistlberger, RE; Steele, AD				Hsu, Cynthia T.; Patton, Danica F.; Mistlberger, Ralph E.; Steele, Andrew D.			Palatable Meal Anticipation in Mice	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; ACCUMBENS SHELL; C57BL/6J MICE; FOOD; RATS; DOPAMINE; REWARD; ENTRAINMENT; MECHANISMS; ZEITGEBER	The ability to sense time and anticipate events is a critical skill in nature. Most efforts to understand the neural and molecular mechanisms of anticipatory behavior in rodents rely on daily restricted food access, which induces a robust increase of locomotor activity in anticipation of daily meal time. Interestingly, rats also show increased activity in anticipation of a daily palatable meal even when they have an ample food supply, suggesting a role for brain reward systems in anticipatory behavior, and providing an alternate model by which to study the neurobiology of anticipation in species, such as mice, that are less well adapted to "stuff and starve'' feeding schedules. To extend this model to mice, and exploit molecular genetic resources available for that species, we tested the ability of wild-type mice to anticipate a daily palatable meal. We observed that mice with free access to regular chow and limited access to highly palatable snacks of chocolate or "Fruit Crunchies'' avidly consumed the snack but did not show anticipatory locomotor activity as measured by running wheels or video-based behavioral analysis. However, male mice receiving a snack of high fat chow did show increased food bin entry prior to access time and a modest increase in activity in the two hours preceding the scheduled meal. Interestingly, female mice did not show anticipation of a daily high fat meal but did show increased activity at scheduled mealtime when that meal was withdrawn. These results indicate that anticipation of a scheduled food reward in mice is behavior, diet, and gender specific.	[Hsu, Cynthia T.; Steele, Andrew D.] CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA; [Patton, Danica F.; Mistlberger, Ralph E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada	California Institute of Technology; Simon Fraser University	Hsu, CT (corresponding author), CALTECH, Div Biol, Broad Fellows Program Brain Circuitry, Pasadena, CA 91125 USA.	mistlber@sfu.ca; steelea@caltech.edu			Ellison Medical Foundation; Eating Disorders Research Klarman Family Foundation; Natural Sciences and Engineering Research Council of Canada	Ellison Medical Foundation(Lawrence Ellison Foundation); Eating Disorders Research Klarman Family Foundation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Broad Fellows in Brain Circuitry Program at Caltech (ADS), an Ellison Medical Foundation New Scholar Award (ADS), a Grants Program in Eating Disorders Research Klarman Family Foundation (ADS), and an operating grant (REM) and Postgraduate Scholarship (DFP) from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE H, 1989, PHYSIOL BEHAV, V45, P397, DOI 10.1016/0031-9384(89)90146-7; Angeles-Castellanos M, 2008, NEUROSCIENCE, V155, P297, DOI 10.1016/j.neuroscience.2008.06.001; Antle MC, 2009, EUR J NEUROSCI, V30, P1643, DOI 10.1111/j.1460-9568.2009.06959.x; Arble DM, 2009, OBESITY, V17, P2100, DOI 10.1038/oby.2009.264; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; BOULOS Z, 1980, NEUROSCI BIOBEHAV R, V4, P119, DOI 10.1016/0149-7634(80)90010-X; Caba M, 2009, EUR J NEUROSCI, V30, P1697, DOI 10.1111/j.1460-9568.2009.06964.x; Challet E, 2009, EUR J NEUROSCI, V30, P1676, DOI 10.1111/j.1460-9568.2009.06962.x; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; Hsu JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011802; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Marchant EG, 1997, BRAIN RES, V765, P273, DOI 10.1016/S0006-8993(97)00571-4; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mendoza J, 2005, NEUROSCIENCE, V133, P293, DOI 10.1016/j.neuroscience.2005.01.064; Mendoza J, 2005, BEHAV BRAIN RES, V158, P133, DOI 10.1016/j.bbr.2004.08.016; MISTLBERGER R, 1987, PHYSIOL BEHAV, V41, P219, DOI 10.1016/0031-9384(87)90356-8; Mistlberger RE, 2009, EUR J NEUROSCI, V30, P1718, DOI 10.1111/j.1460-9568.2009.06965.x; Mistlberger RE, 1999, PHYSIOL BEHAV, V66, P329, DOI 10.1016/S0031-9384(98)00311-4; MISTLBERGER RE, 1992, BEHAV BRAIN RES, V47, P159, DOI 10.1016/S0166-4328(05)80122-6; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; MISTLBERGER RE, 1994, NEUROSCI BIOBEHAV R, V18, P171, DOI 10.1016/0149-7634(94)90023-X; Pendergast JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004860; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; SAHR AE, 2008, AM J PHYSIOL-REG I, V463, pR463; SHIBATA S, 1995, J PHARMACOL EXP THER, V274, P688; Steele AD, 2007, P NATL ACAD SCI USA, V104, P1983, DOI 10.1073/pnas.0610779104; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stephan FK, 1998, PHYSIOL BEHAV, V65, P277, DOI 10.1016/S0031-9384(98)00166-8; Verwey M, 2009, EUR J NEUROSCI, V30, P1650, DOI 10.1111/j.1460-9568.2009.06960.x; Webb IC, 2009, EUR J NEUROSCI, V30, P1739, DOI 10.1111/j.1460-9568.2009.06966.x	30	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e12903	10.1371/journal.pone.0012903	http://dx.doi.org/10.1371/journal.pone.0012903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941366	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000282312600009
J	Lynch, CJ; Shah, ZH; Allison, SJ; Ahmed, SU; Ford, J; Warnock, LJ; Li, H; Serrano, M; Milner, J				Lynch, Cian J.; Shah, Zahid H.; Allison, Simon J.; Ahmed, Shafiq U.; Ford, Jack; Warnock, Lorna J.; Li, Han; Serrano, Manuel; Milner, Jo			SIRT1 Undergoes Alternative Splicing in a Novel Auto-Regulatory Loop with p53	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; CALORIE RESTRICTION; GENE-EXPRESSION; MESSENGER-RNA; CELL-SURVIVAL; DEACETYLASE ACTIVITY; GENOMIC STABILITY; PROTEIN STABILITY; ARF/P53 PATHWAY; TRANSGENIC MICE	Background: The NAD-dependent deacetylase SIRT1 is a nutrient-sensitive coordinator of stress-tolerance, multiple homeostatic processes and healthspan, while p53 is a stress-responsive transcription factor and our paramount tumour suppressor. Thus, SIRT1-mediated inhibition of p53 has been identified as a key node in the common biology of cancer, metabolism, development and ageing. However, precisely how SIRT1 integrates such diverse processes remains to be elucidated. Methodology/Principal Findings: Here we report that SIRT1 is alternatively spliced in mammals, generating a novel SIRT1 isoform: SIRT1-Delta Exon8. We show that SIRT1-Delta Exon8 is expressed widely throughout normal human and mouse tissues, suggesting evolutionary conservation and critical function. Further studies demonstrate that the SIRT1-Delta Exon8 isoform retains minimal deacetylase activity and exhibits distinct stress sensitivity, RNA/protein stability, and protein-protein interactions compared to classical SIRT1-Full-Length (SIRT1-FL). We also identify an auto-regulatory loop whereby SIRT1-Delta Exon8 can regulate p53, while in reciprocal p53 can influence SIRT1 splice variation. Conclusions/Significance: We characterize the first alternative isoform of SIRT1 and demonstrate its evolutionary conservation in mammalian tissues. The results also reveal a new level of inter-dependency between p53 and SIRT1, two master regulators of multiple phenomena. Thus, previously-attributed SIRT1 functions may in fact be distributed between SIRT1 isoforms, with important implications for SIRT1 functional studies and the current search for SIRT1-activating therapeutics to combat age-related decline.	[Li, Han; Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumour Suppress Grp, Madrid, Spain; [Lynch, Cian J.; Shah, Zahid H.; Allison, Simon J.; Ahmed, Shafiq U.; Ford, Jack; Warnock, Lorna J.; Milner, Jo] Univ York, Dept Biol, YCR Res Unit p53, York YO10 5DD, N Yorkshire, England	Centro Nacional de Investigaciones Oncologicas (CNIO); University of York - UK	Lynch, CJ (corresponding author), Spanish Natl Canc Res Ctr CNIO, Mol Oncol Program, Tumour Suppress Grp, Madrid, Spain.	clynch@cnio.es; ajm24@york.ac.uk	Serrano, Manuel/H-2634-2015; Shah, Zahid/G-9410-2014; Lynch, Cian/AIC-5510-2022; Allison, Simon/AAC-2027-2019; Lynch, Cian J/K-2191-2017	Serrano, Manuel/0000-0001-7177-9312; Shah, Zahid/0000-0001-7165-8780; Lynch, Cian/0000-0003-0187-3527; Lynch, Cian J/0000-0003-0187-3527; Ahmed, Shafiq U/0000-0001-8701-6889; Allison, Simon/0000-0002-5766-2377	Korner International Travelling Fellowship; MICINN; CNIO; MICINN (SAF and CONSOLIDER); Regional Government of Madrid; European Union; European Research Council (ERC); 'Marcelino Botin' Foundation; Yorkshire Cancer Research	Korner International Travelling Fellowship; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); CNIO; MICINN (SAF and CONSOLIDER)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Regional Government of Madrid; European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); 'Marcelino Botin' Foundation; Yorkshire Cancer Research	Grant support: Korner International Travelling Fellowship awarded to C.J.L. Juan de la Cierva Fellowship awarded to H. L. from MICINN. Work in the laboratory of M. S. is funded by the CNIO and by grants from the MICINN (SAF and CONSOLIDER), the Regional Government of Madrid, the European Union, the European Research Council (ERC), and the 'Marcelino Botin' Foundation. Work in the p53 Cancer Research Unit of JM is funded by Yorkshire Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007305; An P, 2007, PLOS BIOL, V5, P263, DOI 10.1371/journal.pbio.0050036; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Avalos JL, 2002, MOL CELL, V10, P523, DOI 10.1016/S1097-2765(02)00628-7; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Campisi J, 2008, AGING CELL, V7, P281, DOI 10.1111/j.1474-9726.2008.00383.x; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Cheng ZY, 2009, MOL CELL PROTEOMICS, V8, P45, DOI 10.1074/mcp.M800224-MCP200; Choi J, 1999, CELL MOL LIFE SCI, V55, P38, DOI 10.1007/s000180050268; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Gabut M, 2005, MOL CELL BIOL, V25, P3286, DOI 10.1128/MCB.25.8.3286-3294.2005; Galy B, 2001, ONCOGENE, V20, P4613, DOI 10.1038/sj.onc.1204630; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Ghidelli S, 2001, EMBO J, V20, P4522, DOI 10.1093/emboj/20.16.4522; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; Gottlieb E, 1997, EMBO J, V16, P1381, DOI 10.1093/emboj/16.6.1381; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jiang M, 2002, ONCOGENE, V21, P6041, DOI 10.1038/sj.onc.1205878; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Lavu S, 2008, NAT REV DRUG DISCOV, V7, P841, DOI 10.1038/nrd2665; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Liu B, 2009, J BIOL CHEM, V284, P32288, DOI 10.1074/jbc.M109.045856; Ljungman M, 2001, ONCOGENE, V20, P5964, DOI 10.1038/sj.onc.1204734; Long JC, 2009, BIOCHEM J, V417, P15, DOI 10.1042/BJ20081501; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Lynch CJ, 2006, ONCOGENE, V25, P3463, DOI 10.1038/sj.onc.1209387; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maisse C, 2003, BIOCHEM PHARMACOL, V66, P1555, DOI 10.1016/S0006-2952(03)00511-2; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Matheu A, 2007, NATURE, V448, P375, DOI 10.1038/nature05949; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McCord RA, 2009, AGING-US, V1, P109, DOI 10.18632/aging.100011; Miller SJ, 2000, MOL CELL BIOL, V20, P8420, DOI 10.1128/MCB.20.22.8420-8431.2000; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Milner J, 2009, CURR PHARM DESIGN, V15, P39, DOI 10.2174/138161209787185841; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; MOSNER J, 1995, EMBO J, V14, P4442, DOI 10.1002/j.1460-2075.1995.tb00123.x; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; OBEROSLER P, 1993, EMBO J, V12, P2389, DOI 10.1002/j.1460-2075.1993.tb05893.x; Olovnikov IA, 2009, SEMIN CANCER BIOL, V19, P32, DOI 10.1016/j.semcancer.2008.11.005; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Riley KJL, 2007, BIOCHEMISTRY-US, V46, P2480, DOI 10.1021/bi061480v; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sasaki T, 2006, AGING CELL, V5, P413, DOI 10.1111/j.1474-9726.2006.00235.x; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2007, NATURE, V450, P440, DOI 10.1038/nature06268; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Warnock LJ, 2008, ONCOGENE, V27, P1639, DOI 10.1038/sj.onc.1210787; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Xiao R, 2007, MOL CELL BIOL, V27, P5393, DOI 10.1128/MCB.00288-07; Yamamoto H, 2007, MOL ENDOCRINOL, V21, P1745, DOI 10.1210/me.2007-0079; Zhang DY, 2009, J BIOL CHEM, V284, P20917, DOI 10.1074/jbc.M109.020073; Zhao KH, 2003, NAT STRUCT BIOL, V10, P864, DOI 10.1038/nsb978; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515	84	38	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2010	5	10							e13502	10.1371/journal.pone.0013502	http://dx.doi.org/10.1371/journal.pone.0013502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	668TQ	20975832	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000283293800003
J	Anderson, HE; Kagansky, A; Wardle, J; Rappsilber, J; Allshire, RC; Whitehall, SK				Anderson, Holly E.; Kagansky, Alexander; Wardle, Josephine; Rappsilber, Juri; Allshire, Robin C.; Whitehall, Simon K.			Silencing Mediated by the Schizosaccharomyces pombe HIRA Complex Is Dependent upon the Hpc2-Like Protein, Hip4	PLOS ONE			English	Article							ASSEMBLY FACTOR-I; FISSION YEAST; HISTONE CHAPERONE; CHROMOSOME SEGREGATION; HETEROCHROMATIN FOCI; DNA-SYNTHESIS; CELL-CYCLE; RNAI; CHROMATIN; TRANSCRIPTION	Background: HIRA (or Hir) proteins are conserved histone chaperones that function in multi-subunit complexes to mediate replication-independent nucleosome assembly. We have previously demonstrated that the Schizosaccharomyces pombe HIRA proteins, Hip1 and Slm9, form a complex with a TPR repeat protein called Hip3. Here we have identified a new subunit of this complex. Methodology/Principal Findings: To identify proteins that interact with the HIRA complex, rapid affinity purifications of Slm9 were performed. Multiple components of the chaperonin containing TCP-1 complex (CCT) and the 19S subunit of the proteasome reproducibly co-purified with Slm9, suggesting that HIRA interacts with these complexes. Slm9 was also found to interact with a previously uncharacterised protein (SPBC947.08c), that we called Hip4. Hip4 contains a HRD domain which is a characteristic of the budding yeast and human HIRA/Hir-binding proteins, Hpc2 and UBN1. Co-precipitation experiments revealed that Hip4 is stably associated with all of the other components of the HIRA complex and deletion of hip4(+) resulted in the characteristic phenotypes of cells lacking HIRA function, such as temperature sensitivity, an elongated cell morphology and hypersensitivity to the spindle poison, thiabendazole. Moreover, loss of Hip4 function alleviated the heterochromatic silencing of reporter genes located in the mating type locus and centromeres and was associated with increased levels of non-coding transcripts derived from centromeric repeat sequences. Hip4 was also found to be required for the distinct form of silencing that controls the expression of Tf2 LTR retrotransposons. Conclusions/Significance: Overall, these results indicate that Hip4 is an integral component of the HIRA complex that is required for transcriptional silencing at multiple loci.	[Anderson, Holly E.; Wardle, Josephine; Whitehall, Simon K.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Kagansky, Alexander; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland; [Kagansky, Alexander; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Inst Cell Biol, Edinburgh, Midlothian, Scotland	Newcastle University - UK; University of Edinburgh; University of Edinburgh	Anderson, HE (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England.	S.K.Whitehall@ncl.ac.uk	Rappsilber, Juri/ABF-3328-2020; Rappsilber, Juri/B-7265-2015; Kagansky, Alexander/B-3137-2011	Rappsilber, Juri/0000-0001-5999-1310; Kagansky, Alexander/0000-0002-6219-6892; Allshire, Robin/0000-0002-8005-3625	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E014445/1]; Medical Research Council [G0301153]; EC [084229/Z/07/Z]; Wellcome Trust [084229/Z/07/Z, 065061/Z]; BBSRC [BB/E014445/1] Funding Source: UKRI; MRC [G0301153] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E014445/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EC(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Doctoral Training Grant to H. E. A, a BBSRC Project Grant (BB/E014445/1) to S. K. W., a Medical Research Council Strategic grant (G0301153) to R. C. A., an EC Marie-Curie Excellence grant (MEXT-CT-014171) to J.R, a Wellcome Trust Senior Research fellowship (084229/Z/07/Z) to J.R. and a Wellcome Trust Programme grant (065061/Z) to R. C. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Anderson HE, 2009, MOL CELL BIOL, V29, P5158, DOI 10.1128/MCB.00698-09; Balaji S, 2009, MOL BIOSYST, V5, P269, DOI 10.1039/b816424j; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Banumathy G, 2009, MOL CELL BIOL, V29, P758, DOI 10.1128/MCB.01047-08; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Blackwell C, 2004, MOL CELL BIOL, V24, P4309, DOI 10.1128/MCB.24.10.4309-4320.2004; Bowen NJ, 2003, GENOME RES, V13, P1984, DOI 10.1101/gr.1191603; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Craven RA, 1998, GENE, V221, P59, DOI 10.1016/S0378-1119(98)00434-X; Dekker C, 2008, EMBO J, V27, P1827, DOI 10.1038/emboj.2008.108; Durand-Dubief M, 2007, EMBO J, V26, P2477, DOI 10.1038/sj.emboj.7601690; Ekwall K, 1999, GENETICS, V153, P1153; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Greenall A, 2006, J BIOL CHEM, V281, P8732, DOI 10.1074/jbc.M512170200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guo MJ, 2008, PLANT CELL, V20, P48, DOI 10.1105/tpc.107.056127; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kanoh J, 2000, GENETICS, V155, P623; Kaufman PD, 1998, MOL CELL BIOL, V18, P4793, DOI 10.1128/MCB.18.8.4793; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Koues OI, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-5; Malay AD, 2008, J BIOL CHEM, V283, P14022, DOI 10.1074/jbc.M800594200; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Phelps-Durr TL, 2005, PLANT CELL, V17, P2886, DOI 10.1105/tpc.105.035477; Pidoux AL, 2004, CHROMOSOME RES, V12, P521, DOI 10.1023/B:CHRO.0000036586.81775.8b; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Qian ZJ, 1998, MOL CELL BIOL, V18, P4783, DOI 10.1128/MCB.18.8.4783; Ransom M, 2009, J BIOL CHEM, V284, P23461, DOI 10.1074/jbc.M109.019562; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Sharp JA, 2001, CURR BIOL, V11, P463, DOI 10.1016/S0960-9822(01)00140-3; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Thon G, 2000, GENETICS, V155, P551; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	49	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13488	10.1371/journal.pone.0013488	http://dx.doi.org/10.1371/journal.pone.0013488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976105	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000283045300042
J	van der Tol, A; Van Biesen, W; Verbeke, F; De Groote, G; Vermeiren, F; Eeckhaut, K; Vanholder, R				van der Tol, Arjan; Van Biesen, Wim; Verbeke, Francis; De Groote, Guy; Vermeiren, Frans; Eeckhaut, Kathleen; Vanholder, Raymond			Towards a Rational Screening Strategy for Albuminuria: Results from the Unreferred Renal Insufficiency Trial	PLOS ONE			English	Article							HEART-RATE; GENERAL-POPULATION; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; DIABETIC NEPHROPATHY; INCREASED RISK; FOLLOW-UP; MICROALBUMINURIA; HYPERTENSION; EVENTS	Background: There remains debate about the screening strategies for albuminuria. This study evaluated whether a screening strategy in an apparently healthy population based on basic clinical and biochemical parameters could be more effective than a strategy where screening for albuminuria is performed unselectively. Methodology/Principal Findings: The Unreferred Renal Insufficiency (URI) Study is a cross-sectional study on the prevalence of metabolic risk factors in Belgian workers, volunteering to be screened during a routine yearly occupational check-up. Subjects (n = 295) with treated hypertension, known diabetes, treated dyslipidaemia, cardiovascular and renal disease were excluded. Among 1,191 apparently healthy subjects, 23% had unknown hypertension, 13% had impaired glucose tolerance, 15.4% had normoalbuminuria, 4.2% had microalbuminuria and 0.4% had macroalbuminuria. Subjects with resting heart rate >= 85 bpm, plasma glucose >= 5.6 mmol/L and blood pressure >= 140/90 mmHg were associated with albuminuria of any degree. A strategy where only subjects with at least one of these risk factors (n = 431) were screened for albuminuria, would identify all subjects with macroalbuminuria (5/5), 64% of those with microalbuminuria (32/50), and less than half of those with normoalbuminuria (81/183). An alternative strategy whereby subjects were first screened for presence of albuminuria, and additional cardiovascular risk factors were only measured in subjects positive for albuminuria (n = 238), would identify only 27% (118/431) of the subjects with additional and potentially modifiable cardiovascular risk factors. On the other hand, half of the subjects in this study with albuminuria (120/238, of which 102 had normoalbuminuria), had no additional cardiovascular risk factor at all. Conclusions: Screening an apparently healthy population directly for albuminuria will result in a high percentage of false positives, mostly measured in the normal range. Screening for microalbuminuria and macroalbuminuria based on presence of additional, potentially modifiable risk factors appears to be more beneficial.	[van der Tol, Arjan; Van Biesen, Wim; Verbeke, Francis; Vanholder, Raymond] Ghent Univ Hosp, Div Renal, Dept Internal Med, B-9000 Ghent, Belgium; [De Groote, Guy] CRI Lab, Ghent, Belgium; [Vermeiren, Frans; Eeckhaut, Kathleen] Occupat Hlth Care Adhesia, Ghent, Belgium	Ghent University; Ghent University Hospital	van der Tol, A (corresponding author), Ghent Univ Hosp, Div Renal, Dept Internal Med, B-9000 Ghent, Belgium.	Arjan.vandertol@ugent.be			Hoffman-La Roche, Basel, Switzerland	Hoffman-La Roche, Basel, Switzerland	This study was partially funded by an unrestricted grant from Hoffman-La Roche, Basel, Switzerland. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, LANCET, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Bakris GL, 2004, JAMA-J AM MED ASSOC, V292, P2227, DOI 10.1001/jama.292.18.2227; Bigazzi R, 1998, J HYPERTENS, V16, P1325, DOI 10.1097/00004872-199816090-00014; Bohm M, 2008, J HYPERTENS, V26, P18; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; *ERA EDTA REG, 2009, ERA EDTA REG 2007 AN; ERA-EDTA Registry, 2003, ERA EDTA REG 1998 AN; Facchini FS, 1996, AM J HYPERTENS, V9, P1013, DOI 10.1016/0895-7061(96)87747-8; Fried L, 2009, J AM SOC NEPHROL, V20, P686, DOI 10.1681/ASN.2009020147; Genuth S, 2003, DIABETES CARE, V26, P3160; GILLMAN MW, 1993, AM HEART J, V125, P1148, DOI 10.1016/0002-8703(93)90128-V; Hallan SI, 2006, BMJ-BRIT MED J, V333, P1047, DOI 10.1136/bmj.39001.657755.BE; Hallan SI, 2010, J NEPHROL, V23, P147; Heathcote KL, 2009, CLIN INVEST MED, V32, pE261; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hillege HL, 2001, J INTERN MED, V249, P519, DOI 10.1046/j.1365-2796.2001.00833.x; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Inoue T, 2009, CLIN EXP NEPHROL, V13, P487, DOI 10.1007/s10157-009-0193-3; Jouven X, 2009, AM J CARDIOL, V103, P279, DOI 10.1016/j.amjcard.2008.08.071; Keane WF, 2006, CLIN J AM SOC NEPHRO, V1, P761, DOI 10.2215/CJN.01381005; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Klausen KP, 2007, J INTERN MED, V262, P470, DOI 10.1111/j.1365-2796.2007.01839.x; Klausen KP, 2006, J INTERN MED, V260, P231, DOI 10.1111/j.1365-2796.2006.01679.x; Kramer A, 2009, NEPHROL DIAL TRANSPL, V24, P3557, DOI 10.1093/ndt/gfp519; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Metcalf PA, 1997, INT J OBESITY, V21, P203, DOI 10.1038/sj.ijo.0800388; Mogensen CE, 1999, DIABETOLOGIA, V42, P263, DOI 10.1007/s001250051151; Nielen MMJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-381; Palatini P, 2009, PROG CARDIOVASC DIS, V52, P1, DOI 10.1016/j.pcad.2009.06.001; Ritz E, 2000, DIABETES METAB, V26, P54; Romundstad S, 2003, CLIN NEPHROL, V59, P241; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; STEHOUWER CDA, 1990, ARCH INTERN MED, V150, P373, DOI 10.1001/archinte.150.2.373; Turnbull F, 2003, LANCET, V362, P1527; van der Velde M, 2009, J AM SOC NEPHROL, V20, P852, DOI 10.1681/ASN.2008060655; WALKER WG, 1992, JAMA-J AM MED ASSOC, V268, P3085, DOI 10.1001/jama.268.21.3085; Warram JH, 1996, J AM SOC NEPHROL, V7, P930; Weir MR, 2010, AM J NEPHROL, V31, P469, DOI 10.1159/000292500; *WHO, WHO STEPS SURV 3; WILSON JMG, 1968, B OFIC SANIT PANAM, V65, P281; Witte EC, 2009, J AM SOC NEPHROL, V20, P436, DOI 10.1681/ASN.2008030292; CONCISE 2009 ANN DAT	43	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13328	10.1371/journal.pone.0013328	http://dx.doi.org/10.1371/journal.pone.0013328			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967254	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800027
J	Wang, QA; Shen, BR; Zheng, PL; Feng, H; Chen, LA; Zhang, J; Zhang, CX; Zhang, GZ; Teng, JL; Chen, JG				Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Chen, Liang; Zhang, Jing; Zhang, Chuanxi; Zhang, Guozheng; Teng, Junlin; Chen, Jianguo			Silkworm Coatomers and Their Role in Tube Expansion of Posterior Silkgland	PLOS ONE			English	Article							BOMBYX-MORI; TARGETED DISRUPTION; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; MEMBRANE-TRANSPORT; SEQUENCE ALIGNMENT; PROTEIN-TRANSPORT; GOLGI TRANSPORT; COAT PROTEINS; GAMMA-COP	Background: Coat protein complex I (COPI) vesicles, coated by seven coatomer subunits, are mainly responsible for Golgito- ER transport. Silkworm posterior silkgland (PSG), a highly differentiated secretory tissue, secretes fibroin for silk production, but many physiological processes in the PSG cells await further investigation. Methodology/Principal Findings: Here, to investigate the role of silkworm COPI, we cloned six silkworm COPI subunits (alpha,beta,beta', delta, epsilon, and zeta-COP), determined their peak expression in day 2 in fifth-instar PSG, and visualized the localization of COPI, as a coat complex, with cis-Golgi. By dsRNA injection into silkworm larvae, we suppressed the expression of alpha-, beta'- and gamma-COP, and demonstrated that COPI subunits were required for PSG tube expansion. Knockdown of alpha-COP disrupted the integrity of Golgi apparatus and led to a narrower glandular lumen of the PSG, suggesting that silkworm COPI is essential for PSG tube expansion. Conclusions/Significance: The initial characterization reveals the essential roles of silkworm COPI in PSG. Although silkworm COPI resembles the previously characterized coatomers in other organisms, some surprising findings require further investigation. Therefore, our results suggest the silkworm as a model for studying intracellular transport, and would facilitate the establishment of silkworm PSG as an efficient bioreactor.	[Wang, Qiao; Shen, Birong; Zheng, Pengli; Feng, Hui; Chen, Liang; Zhang, Jing; Teng, Junlin; Chen, Jianguo] Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China; [Zhang, Chuanxi] Zhejiang Univ, Inst Insect Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Guozheng] Chinese Acad Agr Sci, Sericultural Res Inst, Hangzhou, Zhejiang, Peoples R China	Peking University; Peking University; Zhejiang University; Chinese Academy of Agricultural Sciences	Wang, QA (corresponding author), Peking Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Bioengn, Key Lab Cell Proliferat & Differentiat,Minist Edu, Beijing 100871, Peoples R China.	junlinteng@pku.edu.cn; chenjg@pku.edu.cn	Zhang, Chuan-Xi/K-7978-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Wang, Qiao/0000-0001-6416-1733; Shen, Birong/0000-0002-1208-506X; Zheng, Pengli/0000-0002-3797-4023	National Natural Science Foundation of China (NSFC) [30670659, 30771086, 30721064]; Major State Basic Research Development Program of China [2006CB500700, 2006CB910700, 2010CB833705]; National High Technology Research and Development Program of China [2006AA10A119]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The funders include the National Natural Science Foundation of China (NSFC) (30670659, 30771086, 30721064)(website: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm), the Major State Basic Research Development Program of China (973 Program) (2006CB500700,2006CB910700,2010CB833705)(website: http://www.973.gov.cn/English/Index.aspx), and the National High Technology Research and Development Program of China (863 Program) (2006AA10A119)(website: http://www.863.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Chen W, 2008, PLOS BIOL, V6, P1927, DOI 10.1371/journal.pbio.0060209; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; GERICH B, 1995, P NATL ACAD SCI USA, V92, P3229, DOI 10.1073/pnas.92.8.3229; Glick BS, 2009, ANNU REV CELL DEV BI, V25, P113, DOI 10.1146/annurev.cellbio.24.110707.175421; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241; Hahn Y, 2000, FEBS LETT, V482, P31, DOI 10.1016/S0014-5793(00)02033-0; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Houdebine LM, 2000, TRANSGENIC RES, V9, P305, DOI 10.1023/A:1008934912555; Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.ibmb.2004.10.002; Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200; Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964; Kakei M, 2005, J INSECT PHYSIOL, V51, P17, DOI 10.1016/j.jinsphys.2004.10.012; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuoka T, 2000, DEV GENES EVOL, V210, P120, DOI 10.1007/s004270050018; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nishikawa T, 2001, EUR J BIOCHEM, V268, P5295, DOI 10.1046/j.0014-2956.2001.02461.x; Ohnishi A, 2006, P NATL ACAD SCI USA, V103, P4398, DOI 10.1073/pnas.0511270103; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a; Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; RODEMS SM, 1995, J VIROL, V69, P5368, DOI 10.1128/JVI.69.9.5368-5375.1995; SASAKI S, 1981, J CELL SCI, V50, P19; Shi XZ, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-5; SHIMURA K, 1976, J BIOCHEM-TOKYO, V80, P693, DOI 10.1093/oxfordjournals.jbchem.a131328; Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018; Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060; Tabunoki H, 2004, FEBS LETT, V567, P175, DOI 10.1016/j.febslet.2004.04.067; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; TASHIRO Y, 1968, J CELL BIOL, V38, P574, DOI 10.1083/jcb.38.3.574; Teng JL, 2001, J CELL BIOL, V155, P65, DOI 10.1083/jcb.200106025; Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771; Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008; WANG Q, FRONTIERS BIOSCIENCE; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; WHITNEY JA, 1995, CELL, V83, P703; Wurm FM, 2003, NAT BIOTECHNOL, V21, P34, DOI 10.1038/nbt0103-34; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210	56	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13252	10.1371/journal.pone.0013252	http://dx.doi.org/10.1371/journal.pone.0013252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967265	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300008
J	Pradhan, RK; Qi, F; Beard, DA; Dash, RK				Pradhan, Ranjan K.; Qi, Feng; Beard, Daniel A.; Dash, Ranjan K.			Characterization of Membrane Potential Dependency of Mitochondrial Ca2+ Uptake by an Improved Biophysical Model of Mitochondrial Ca2+ Uniporter	PLOS ONE			English	Article							CALCIUM-UPTAKE; TRANSPORT; KINETICS; HEART; PHYSIOLOGY	Mitochondrial Ca2+ uniporter is the primary influx pathway for Ca2+ into respiring mitochondria, and hence plays a key role in mitochondrial Ca2+ homeostasis. Though the mechanism of extra-matrix Ca2+ dependency of mitochondrial Ca2+ uptake has been well characterized both experimentally and mathematically, the mechanism of membrane potential (DY) dependency of mitochondrial Ca2+ uptake has not been completely characterized. In this paper, we perform a quantitative reevaluation of a previous biophysical model of mitochondrial Ca2+ uniporter that characterized the possible mechanism of DY dependency of mitochondrial Ca2+ uptake. Based on a model simulation analysis, we show that model predictions with a variant assumption (Case 2: external and internal Ca2+ binding constants for the uniporter are distinct), that provides the best possible description of the DY dependency, are highly sensitive to variation in matrix [Ca2+], indicating limitations in the variant assumption (Case 2) in providing physiologically plausible description of the observed DY dependency. This sensitivity is attributed to negative estimate of a biophysical parameter that characterizes binding of internal Ca2+ to the uniporter. Reparameterization of the model with additional nonnengativity constraints on the biophysical parameters showed that the two variant assumptions (Case 1 and Case 2) are indistinguishable, indicating that the external and internal Ca2+ binding constants for the uniporter may be equal (Case 1). The model predictions in this case are insensitive to variation in matrix [Ca2+] but do not match the DY dependent data in the domain Delta Psi <= 120 mV. To effectively characterize this DY dependency, we reformulate the DY dependencies of the rate constants of Ca2+ translocation via the uniporter by exclusively redefining the biophysical parameters associated with the free-energy barrier of Ca2+ translocation based on a generalized, non-linear Goldman-Hodgkin-Katz formulation. This alternate uniporter model has all the characteristics of the previous uniporter model and is also able to characterize the possible mechanisms of both the extra-matrix Ca2+ and DY dependencies of mitochondrial Ca2+ uptake. In addition, the model is insensitive to variation in matrix [Ca2+], predicting relatively stable physiological operation. The model is critical in developing mechanistic, integrated models of mitochondrial bioenergetics and Ca2+ handling.	[Pradhan, Ranjan K.] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Pradhan, RK (corresponding author), Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA.	rdash@mcw.edu			National Institutes of Health [R01-HL072011, R01-HL095122]; American Heart Association [SDG-0735093N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072011, R01HL095122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants R01-HL072011 (DAB) and R01-HL095122 (RKD) and American Heart Association grant SDG-0735093N (RKD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; BRAGADIN M, 1979, BIOCHEMISTRY-US, V18, P5972, DOI 10.1021/bi00593a033; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cortassa S, 2006, BIOPHYS J, V91, P1564, DOI [10.1529/biophysj.105.076174, 10.1529/biophysj.106.076174]; CROMPTON M, 1976, EUR J BIOCHEM, V69, P429, DOI 10.1111/j.1432-1033.1976.tb10927.x; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; Dash RK, 2009, BIOPHYS J, V96, P1318, DOI 10.1016/j.bpj.2008.11.005; Duchen MR, 2000, CELL CALCIUM, V28, P339, DOI 10.1054/ceca.2000.0170; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; FALL CP, COMPUTATIONAL CELL B, P468; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Gunter TE, 2009, BBA-BIOENERGETICS, V1787, P1291, DOI 10.1016/j.bbabio.2008.12.011; JOUAVILLE LS, 1995, NATURE, V377, P438, DOI 10.1038/377438a0; Keener J. P., 1998, MATH PHYSL, P766; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; LAUGER P, 1973, BIOCHIM BIOPHYS ACTA, V311, P423, DOI 10.1016/0005-2736(73)90323-4; Lauger P, 1973, Membranes, V2, P1; Magnus G, 1997, AM J PHYSIOL-CELL PH, V273, pC717, DOI 10.1152/ajpcell.1997.273.2.C717; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Marhl M, 1998, BIOPHYS CHEM, V71, P125, DOI 10.1016/S0301-4622(97)00139-7; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; MCCORMACK JG, 1989, BIOCHIM BIOPHYS ACTA, V973, P420, DOI 10.1016/S0005-2728(89)80384-6; Naghdi S, 2010, J CELL SCI, V123, P2553, DOI 10.1242/jcs.070151; Nguyen MHT, 2007, AM J PHYSIOL-CELL PH, V292, pC2004, DOI 10.1152/ajpcell.00271.2006; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Pradhan RK, 2010, BIOPHYS J, V98, P218, DOI 10.1016/j.bpj.2009.10.005; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; SCARPA A, 1973, J GEN PHYSIOL, V62, P756, DOI 10.1085/jgp.62.6.756; VINOGRADOV A, 1973, J BIOL CHEM, V248, P5527; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; WOODBURY JW, 1971, CHEM DYNAMICS PAPERS	35	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13278	10.1371/journal.pone.0013278	http://dx.doi.org/10.1371/journal.pone.0013278			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949039	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700020
J	Garcia-Prieto, E; Gonzalez-Lopez, A; Cabrera, S; Astudillo, A; Gutierrez-Fernandez, A; Fanjul-Fernandez, M; Batalla-Solis, E; Puente, XS; Fueyo, A; Lopez-Otin, C; Albaiceta, GM				Garcia-Prieto, Emilio; Gonzalez-Lopez, Adrian; Cabrera, Sandra; Astudillo, Aurora; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Batalla-Solis, Estefania; Puente, Xose S.; Fueyo, Antonio; Lopez-Otin, Carlos; Albaiceta, Guillermo M.			Resistance to Bleomycin-Induced Lung Fibrosis in MMP-8 Deficient Mice Is Mediated by Interleukin-10	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; MATRIX METALLOPROTEINASES; INFLAMMATION; GENE; BRONCHIOLIZATION; OVEREXPRESSION; SUSCEPTIBILITY; EXPRESSION; MULTIPLE; CANCER	Background: Matrix metalloproteinases (MMPs) may have pro and antifibrotic roles within the lungs, due to its ability to modulate collagen turnover and immune mediators. MMP-8 is a collagenase that also cleaves a number of cytokines and chemokines. Methodology and Principal Findings: To evaluate its relevance in lung fibrosis, wildtype and Mmp8(-/-) mice were treated with either intratracheal bleomycin or saline, and lungs were harvested at different time points. Fibrosis, collagen, collagenases, gelatinases, TGF beta and IL-10 were measured in lung tissue. Mmp8(-/-) mice developed less fibrosis than their wildtype counterparts. This was related to an increase in lung inflammatory cells, MMP-9 and IL-10 levels in these mutant animals. In vitro experiments showed that MMP-8 cleaves murine and human IL-10, and tissue from knockout animals showed decreased IL-10 processing. Additionally, lung fibroblasts from these mice were cultured in the presence of bleomycin and collagen, IL-10 and STAT3 activation (downstream signal in response to IL-10) measured by western blotting. In cell cultures, bleomycin increased collagen synthesis only in wildtype mice. Fibroblasts from knockout mice did not show increased collagen synthesis, but increased levels of unprocessed IL-10 and STAT3 phosphorylation. Blockade of IL-10 reverted this phenotype, increasing collagen in cultures. Conclusions: According to these results, we conclude that the absence of MMP-8 has an antifibrotic effect by increasing IL-10 and propose that this metalloprotease could be a relevant modulator of IL-10 metabolism in vivo.	[Garcia-Prieto, Emilio; Gonzalez-Lopez, Adrian; Fueyo, Antonio; Albaiceta, Guillermo M.] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Biol Func, Oviedo, Spain; [Cabrera, Sandra; Gutierrez-Fernandez, Ana; Fanjul-Fernandez, Miriam; Puente, Xose S.; Lopez-Otin, Carlos] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, Oviedo, Spain; [Astudillo, Aurora] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Cirugia & Especialidades Medicoquirurg, Oviedo, Spain; [Garcia-Prieto, Emilio; Albaiceta, Guillermo M.] Inst Salud Carlos III, CIBER Enfermedades Resp, Hosp Univ Cent Asturias, Unidad Cuidados Intens, Oviedo, Spain	University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III	Albaiceta, GM (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Biol Func, Oviedo, Spain.	Guillermo.muniz@sespa.princast.es	López-Otín, Carlos/AAB-2106-2020; Gutierrez-Fernandez, Ana/ABG-6678-2020; Puente, Xosé S./ADB-0672-2022; Gonzalez, Adrian/AAD-2269-2021; García-Prieto, Emilio/AAR-7946-2021; Gutierrez-Fernandez, Ana/AAS-9954-2021; Garcia-Prieto, Emilio/ABG-6744-2020; Albaiceta, Guillermo/AAU-5069-2020; Fueyo, Antonio/ABH-3243-2020	López-Otín, Carlos/0000-0001-6964-1904; Puente, Xosé S./0000-0001-9525-1483; García-Prieto, Emilio/0000-0002-2011-3059; Gutierrez-Fernandez, Ana/0000-0002-9287-8843; Albaiceta, Guillermo/0000-0002-9276-3253; Fueyo, Antonio/0000-0002-7121-9398; Astudillo Gonzalez, Maria Aurora/0000-0001-8947-8809; Cabrera Benitez, Sandra/0000-0003-3700-3371; Miriam, Fanjul Fernandez/0000-0002-0074-2325; Gonzalez-Lopez, Adrian/0000-0001-5347-278X	Fondo de Investigacion Sanitaria [PI07/0597]; Ministerio de Ciencia e Innovacion; Fundacion M. Botin; European Union (FP7 MicroEnviMet); FICYT [COF-08-20]; Universidad de Oviedo [UNOV-09-BECDOC]; CONACYT; Obra Social Cajastur-Asturias, Spain	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacion M. Botin; European Union (FP7 MicroEnviMet); FICYT; Universidad de Oviedo; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Obra Social Cajastur-Asturias, Spain	Supported by grants from Fondo de Investigacion Sanitaria (PI07/0597), Ministerio de Ciencia e Innovacion, Fundacion M. Botin and European Union (FP7 MicroEnviMet). AGL is the recipient of a grant from FICYT (COF-08-20) and Universidad de Oviedo (UNOV-09-BECDOC). EBS is the recipient of a grant from FICYT (COF-08-20). SC is the recipient of a grant from CONACYT. Instituto Universitario de Oncologia is supported by Obra Social Cajastur-Asturias, Spain. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Albaiceta GM, 2009, AM J RESP CELL  0603; Arai T, 2000, AM J PHYSIOL-LUNG C, V278, pL914, DOI 10.1152/ajplung.2000.278.5.L914; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Baglole CJ, 2005, METH MOLEC MED, V117, P115; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barbarin V, 2005, AM J PHYSIOL-LUNG C, V288, pL841, DOI 10.1152/ajplung.00329.2004; Betsuyaku T, 2000, AM J PATHOL, V157, P525, DOI 10.1016/S0002-9440(10)64563-4; Cabrera S, 2007, INT J BIOCHEM CELL B, V39, P2324, DOI 10.1016/j.biocel.2007.06.022; Dolinay T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001601; Garantziotis S, 2006, AM J RESP CELL MOL, V35, P662, DOI 10.1165/rcmb.2006-0055OC; Giambartolomei GH, 2002, INFECT IMMUN, V70, P1881, DOI 10.1128/IAI.70.4.1881-1888.2002; Greenlee KJ, 2007, PHYSIOL REV, V87, P69, DOI 10.1152/physrev.00022.2006; Gueders MM, 2005, J IMMUNOL, V175, P2589, DOI 10.4049/jimmunol.175.4.2589; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Jensen-Taubman SM, 1998, INT J CANCER, V75, P489, DOI 10.1002/(SICI)1097-0215(19980209)75:4<489::AID-IJC1>3.0.CO;2-P; Kradin RL, 2004, EXP MOL PATHOL, V76, P205, DOI 10.1016/j.yexmp.2003.12.010; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Kunugi S, 2001, LAB INVEST, V81, P1309, DOI 10.1038/labinvest.3780344; Maher TM, 2007, EUR RESPIR J, V30, P835, DOI 10.1183/09031936.00069307; McKeown S, 2009, EUR RESPIR J, V33, P77, DOI 10.1183/09031936.00060708; Miriam F-F, 2010, BIOCHIM BIOPHYS ACTA, V1803, P3, DOI DOI 10.1016/J.BBAMCR.2009.07.004; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nakagome K, 2006, THORAX, V61, P886, DOI 10.1136/thx.2005.056317; O'Reilly PJ, 2008, CURR OPIN PHARMACOL, V8, P242, DOI 10.1016/j.coph.2008.02.003; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Pardo Annie, 2006, Proc Am Thorac Soc, V3, P383, DOI 10.1513/pats.200601-012TK; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Walter Nicholas, 2006, Proc Am Thorac Soc, V3, P330, DOI 10.1513/pats.200602-016TK; Zhou Xiaoxia, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P465, DOI 10.2174/156800805774912926; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	38	71	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13242	10.1371/journal.pone.0013242	http://dx.doi.org/10.1371/journal.pone.0013242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949050	Green Published, Green Submitted, gold			2022-12-27	WOS:000208952200005
J	Song, AX; Zhou, CJ; Peng, Y; Gao, XC; Zhou, ZR; Fu, QS; Hong, J; Lin, DH; Hu, HY				Song, Ai-Xin; Zhou, Chen-Jie; Peng, Yu; Gao, Xue-Chao; Zhou, Zi-Ren; Fu, Qing-Shan; Hong, Jing; Lin, Dong-Hai; Hu, Hong-Yu			Structural Transformation of the Tandem Ubiquitin-Interacting Motifs in Ataxin-3 and Their Cooperative Interactions with Ubiquitin Chains	PLOS ONE			English	Article							POLYGLUTAMINE DISEASE PROTEIN; DEUBIQUITINATING ENZYME ATAXIN-3; MACHADO-JOSEPH-DISEASE; NMR SOLUTION STRUCTURE; BINDING DOMAINS; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; RECOGNITION; SYSTEM; PROTEASOME	The ubiquitin-interacting motif (UIM) is a short peptide with dual function of binding ubiquitin (Ub) and promoting ubiquitination. We elucidated the structures and dynamics of the tandem UIMs of ataxin-3 (AT3-UIM12) both in free and Ub-bound forms. The solution structure of free AT3-UIM12 consists of two alpha-helices and a flexible linker, whereas that of the Ub-bound form is much more compact with hydrophobic contacts between the two helices. NMR dynamics indicates that the flexible linker becomes rigid when AT3-UIM12 binds with Ub. Isothermal titration calorimetry and NMR titration demonstrate that AT3-UIM12 binds diUb with two distinct affinities, and the linker plays a critical role in association of the two helices in diUb binding. These results provide an implication that the tandem UIM12 interacts with Ub or diUb in a cooperative manner through an allosteric effect and dynamics change of the linker region, which might be related to its recognitions with various Ub chains and ubiquitinated substrates.	[Song, Ai-Xin; Zhou, Chen-Jie; Gao, Xue-Chao; Zhou, Zi-Ren; Fu, Qing-Shan; Hu, Hong-Yu] Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Peng, Yu; Hong, Jing; Lin, Dong-Hai] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Song, AX (corresponding author), Chinese Acad Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	dhlin@mail.shcnc.ac.cn; hyhu@sibs.ac.cn	Fu, Qingshan/E-8083-2015; Hu, Hong-Yu/AAQ-2633-2020; Fu, Qingshan/E-1405-2015; Chou, Steven Ziren/M-1995-2014	Fu, Qingshan/0000-0002-7445-2355; Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30600103, 30670431, 30870485]; Shanghai Institutes for Biological Sciences [2008KIP201]; National Basic Research Program of China [2006CB806508, 2006CB910305, 2007CB914304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Institutes for Biological Sciences(Chinese Academy of Sciences); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the grants from the National Natural Science Foundation of China (30600103, 30670431 and 30870485), the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences (2008KIP201, CAS), and the National Basic Research Program of China (2006CB806508, 2006CB910305 and 2007CB914304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Berke SJS, 2005, J BIOL CHEM, V280, P32026, DOI 10.1074/jbc.M506084200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burnett B, 2003, HUM MOL GENET, V12, P3195, DOI 10.1093/hmg/ddg344; Chai YH, 2004, J BIOL CHEM, V279, P3605, DOI 10.1074/jbc.M310939200; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Chang YG, 2006, PROTEIN SCI, V15, P1248, DOI 10.1110/ps.051995006; Choi JY, 2007, MOL CELL NEUROSCI, V34, P69, DOI 10.1016/j.mcn.2006.10.002; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Flick K, 2006, NAT CELL BIOL, V8, P509, DOI 10.1038/ncb1402; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Gao YG, 2006, STRUCTURE, V14, P1755, DOI 10.1016/j.str.2006.09.014; Goto J, 1997, NEUROSCI RES, V28, P373, DOI 10.1016/S0168-0102(97)00056-4; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Hu HY, 2004, J BIOL CHEM, V279, P39736, DOI 10.1074/jbc.M402842200; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Masino L, 2003, FEBS LETT, V549, P21, DOI 10.1016/S0014-5793(03)00748-8; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Miller SLH, 2007, J BIOL CHEM, V282, P10096, DOI 10.1074/jbc.M611151200; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Ogura K, 2006, J BIOL CHEM, V281, P3660, DOI 10.1074/jbc.M505193200; Ohno A, 2005, STRUCTURE, V13, P521, DOI 10.1016/j.str.2005.01.011; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Penengo L, 2006, CELL, V124, P1183, DOI 10.1016/j.cell.2006.02.020; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Raasi Shahri, 2005, V301, P47; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; ROSENBERG RN, 1992, MOVEMENT DISORD, V7, P193, DOI 10.1002/mds.870070302; Sato Y, 2009, EMBO J, V28, P2461, DOI 10.1038/emboj.2009.160; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sims JJ, 2009, NAT STRUCT MOL BIOL, V16, P883, DOI 10.1038/nsmb.1637; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tarlac V, 2003, J NEUROSCI RES, V74, P406, DOI 10.1002/jnr.10746; Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723; VIJAYKUMAR S, 1987, J MOL BIOL, V194, P531, DOI 10.1016/0022-2836(87)90679-6; WANG AC, 1995, J BIOMOL NMR, V5, P376; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Winborn BJ, 2008, J BIOL CHEM, V283, P26436, DOI 10.1074/jbc.M803692200; Young P, 1998, J BIOL CHEM, V273, P5461, DOI 10.1074/jbc.273.10.5461; Zhang NX, 2009, MOL CELL, V35, P280, DOI 10.1016/j.molcel.2009.06.010	61	35	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13202	10.1371/journal.pone.0013202	http://dx.doi.org/10.1371/journal.pone.0013202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949063	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700009
J	Jiroutova, K; Koreny, L; Bowler, C; Obornik, M				Jiroutova, Katerina; Koreny, Ludek; Bowler, Chris; Obornik, Miroslav			A Gene in the Process of Endosymbiotic Transfer	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; NUCLEOTIDE-SEQUENCE; CHLOROPLAST GENOMES; EVOLUTION; PROTEIN; REVEALS; DNA; TRANSFORMATION; PLASTIDS; NUCLEUS	ackground: The endosymbiotic birth of organelles is accompanied by massive transfer of endosymbiont genes to the eukaryotic host nucleus. In the centric diatom Thalassiosira pseudonana the Psb28 protein is encoded in the plastid genome while a second version is nuclear-encoded and possesses a bipartite N-terminal presequence necessary to target the protein into the diatom complex plastid. Thus it can represent a gene captured during endosymbiotic gene transfer. Methodology/Principal Findings: To specify the origin of nuclear-and plastid-encoded Psb28 in T. pseudonana we have performed extensive phylogenetic analyses of both mentioned genes. We have also experimentally tested the intracellular location of the nuclear-encoded Psb28 protein (nuPsb28) through transformation of the diatom Phaeodactylum tricornutum with the gene in question fused to EYFP. Conclusions/Significance: We show here that both versions of the psb28 gene in T. pseudonana are transcribed. We also provide experimental evidence for successful targeting of the nuPsb28 fused with EYFP to the diatom complex plastid. Extensive phylogenetic analyses demonstrate that nucleotide composition of the analyzed genes deeply influences the tree topology and that appropriate methods designed to deal with a compositional bias of the sequences and the long branch attraction artefact (LBA) need to be used to overcome this obstacle. We propose that nuclear psb28 in T. pseudonana is a duplicate of a plastid localized version, and that it has been transferred from its endosymbiont.	[Jiroutova, Katerina; Koreny, Ludek; Obornik, Miroslav] Acad Sci Czech Republ, Inst Parasitol, CR-37005 Ceske Budejovice, Czech Republic; [Jiroutova, Katerina; Koreny, Ludek; Obornik, Miroslav] Univ S Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Bowler, Chris] Ecole Normale Super, CNRS, UMR8197, Inst Biol, Paris, France	Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Jiroutova, K (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	obornik@paru.cas.cz	Koreny, Ludek/G-9766-2014; Obornik, Miroslav/G-9350-2014; Bowler, Chris/AAC-6256-2019	Bowler, Chris/0000-0003-3835-6187; Koreny, Ludek/0000-0002-9979-3172	Ministry of Education of the Czech Republic [MSMT 6007665801]; Academy of Sciences of the Czech Republic [z60220518]; Grant Agency of the Academy of Sciences of the Czech Republic [IAA601410907]; Agence Nationale de la Recherche (ANR)	Ministry of Education of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Academy of Sciences of the Czech Republic(Czech Academy of SciencesGrant Agency of the Czech Republic); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR))	This work was supported by the Ministry of Education of the Czech Republic (MSMT 6007665801), Research Plan of the Academy of Sciences of the Czech Republic (z60220518) and the Grant Agency of the Academy of Sciences of the Czech Republic to M.O. (IAA601410907), and the Agence Nationale de la Recherche (ANR) to C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apt KE, 1996, MOL GEN GENET, V252, P572, DOI 10.1007/s004380050264; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Cattolico RA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-211; Chepurnov VA, 2004, INT REV CYTOL, V237, P91; Delwiche CF, 1999, AM NAT, V154, pS164, DOI 10.1086/303291; Dobakova M, 2009, PLANT PHYSIOL, V149, P1076, DOI 10.1104/pp.108.130039; Douglas SE, 1999, J MOL EVOL, V48, P236, DOI 10.1007/PL00006462; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Gruber A, 2007, PLANT MOL BIOL, V64, P519, DOI 10.1007/s11103-007-9171-x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang CY, 2004, P NATL ACAD SCI USA, V101, P9710, DOI 10.1073/pnas.0400853101; Jarvis P, 2008, NEW PHYTOL, V179, P257, DOI 10.1111/j.1469-8137.2008.02452.x; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kilian O, 2005, PLANT J, V41, P175, DOI 10.1111/j.1365-313X.2004.02294.x; Kroth PG, 2002, INT REV CYTOL, V221, P191; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Maheswari U, 2009, NUCLEIC ACIDS RES, V37, pD1001, DOI 10.1093/nar/gkn905; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Moustafa A, 2009, SCIENCE, V324, P1724, DOI 10.1126/science.1172983; Nassoury N, 2005, BBA-MOL CELL RES, V1743, P5, DOI 10.1016/j.bbamcr.2004.09.017; Nisbet RER, 2004, CURR BIOL, V14, pR1048, DOI 10.1016/j.cub.2004.11.043; Obornik M, 2009, INT J PARASITOL, V39, P1, DOI 10.1016/j.ijpara.2008.07.010; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Poulsen N, 2006, J PHYCOL, V42, P1059, DOI 10.1111/j.1529-8817.2006.00269.x; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Sheppard AE, 2008, PLANT PHYSIOL, V148, P328, DOI 10.1104/pp.108.119107; Shi LX, 2004, BBA-BIOENERGETICS, V1608, P75, DOI 10.1016/j.bbabio.2003.12.004; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Stirewalt VL, 1995, PLANT MOL BIOL REP, V13, P327, DOI 10.1007/BF02669186; SWOFFORD D.L., 2000, PHYLOGENETIC ANAL US; Van de Peer Y, 2002, GENE, V295, P205, DOI 10.1016/S0378-1119(02)00689-3	38	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13234	10.1371/journal.pone.0013234	http://dx.doi.org/10.1371/journal.pone.0013234			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949086	Green Submitted, gold, Green Published			2022-12-27	WOS:000282568400020
J	Minas, M; Papaioannou, AI; Tsaroucha, A; Daniil, Z; Hatzoglou, C; Sgantzos, M; Gourgoulianis, KI; Kostikas, K				Minas, Markos; Papaioannou, Andriana I.; Tsaroucha, Agori; Daniil, Zoe; Hatzoglou, Chrissi; Sgantzos, Markos; Gourgoulianis, Konstantinos I.; Kostikas, Konstantinos			Body Composition in Severe Refractory Asthma: Comparison with COPD Patients and Healthy Smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BIOELECTRICAL-IMPEDANCE ANALYSIS; FAT-FREE MASS; SKINFOLD-THICKNESS; GLOBAL STRATEGY; DIETARY HABITS; OBESITY; PREVALENCE; MANAGEMENT; MORTALITY	Background: Body composition is an important parameter for patients with chronic obstructive pulmonary disease (COPD) whereas the association between asthma and obesity is not fully understood. The impact of severe refractory asthma (SRA) on fat free mass (FFM) has not been investigated. Methodology and Principal Findings: 213 subjects (70 healthy smokers, 71 COPD patients and 72 asthma patients) without significant comorbidities were included in the study. In all patients, body composition assessment (using bioelectrical impendance analysis, skinfold and anthropometric measurements) and spirometry were performed. Differences in fat free mass index (FFMI) between groups were assessed and determinants of FFMI in asthma were evaluated. Patients with SRA had lower values of FFMI compared to patients with mild-to-moderate asthma [18.0(17.3-18.3)-19.5(18.4-21.5), p<0.001], despite the fact that they were more obese. The levels of FFMI in SRA were lower than those of GOLD stage I-III COPD and comparable to those of stage IV COPD patients [18.0(17.3-18.3)-18.8(17.8-20.1), p = ns]. These differences were present even after proper adjustments for sex, age, smoking status, daily dose of inhaled corticosteroids (ICS) and daily use of oral corticosteroids (OCS). In multivariate analysis, independent predictors of FFMI in asthmatic patients were age, use of OCS and the presence of SRA, but not smoking, sex or cumulative dose of ICS used. Conclusions and Significance: SRA is related to the presence of low FFMI that is comparable to that of GOLD stage IV COPD. The impact of this observation on asthma mechanisms and outcomes should be further investigated in large prospective studies.	[Minas, Markos; Papaioannou, Andriana I.; Tsaroucha, Agori; Daniil, Zoe; Gourgoulianis, Konstantinos I.; Kostikas, Konstantinos] Univ Thessaly Med Sch, Dept Resp Med, Larisa, Greece; [Hatzoglou, Chrissi] Univ Thessaly Med Sch, Dept Physiol, Larisa, Greece; [Sgantzos, Markos] Univ Thessaly Med Sch, Dept Anat, Larisa, Greece	University of Thessaly; University of Thessaly; University of Thessaly	Minas, M (corresponding author), Univ Thessaly Med Sch, Dept Resp Med, Larisa, Greece.	markosminas@hotmail.com	Sgantzos, Markos N/AAE-9340-2019	Sgantzos, Markos N/0000-0001-6337-4534; Kostikas, Konstantinos/0000-0003-0774-3942				[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1999, AM J RESP CRIT CARE, V159, pS1; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Beckett WS, 2001, AM J RESP CRIT CARE, V164, P2045, DOI 10.1164/ajrccm.164.11.2004235; Beuther DA, 2007, AM J RESP CRIT CARE, V175, P661, DOI 10.1164/rccm.200611-1717OC; Bigaard J, 2004, OBES RES, V12, P1042, DOI 10.1038/oby.2004.131; Bottai M, 2002, EUR RESPIR J, V20, P665, DOI 10.1183/09031936.02.01282001; Chandalia M, 2007, J DIABETES COMPLICAT, V21, P128, DOI 10.1016/j.jdiacomp.2006.10.004; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Forte Freitas Ismael, 2005, ALAN, V55, P124; Garcia AL, 2005, OBES RES, V13, P626, DOI 10.1038/oby.2005.67; Gronberg AM, 2005, J HUM NUTR DIET, V18, P445, DOI 10.1111/j.1365-277X.2005.00649.x; Harik-Khan RI, 2002, CHEST, V121, P370, DOI 10.1378/chest.121.2.370; Heitmann BL, 2000, INT J OBESITY, V24, P33, DOI 10.1038/sj.ijo.0801082; Holgate ST, 2006, LANCET, V368, P780, DOI 10.1016/S0140-6736(06)69288-X; Ischaki E, 2007, CHEST, V132, P164, DOI 10.1378/chest.06-2789; Ketel IJG, 2007, EUR J ENDOCRINOL, V156, P655, DOI 10.1530/EJE-06-0730; KOUKOULIS GN, HORMONES ATHENS, V9, P253; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Kyle UG, 2004, CLIN NUTR, V23, P1226, DOI 10.1016/j.clnu.2004.06.004; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Larsson I, 2006, AM J CLIN NUTR, V83, P252; Lerario MC, 2006, BRIT J NUTR, V96, P86, DOI 10.1079/BJN20061798; Milias GA, 2006, LIPIDS HEALTH DIS, V5, DOI 10.1186/1476-511X-5-5; Miller A, 2009, RESPIROLOGY, V14, P411, DOI 10.1111/j.1440-1843.2009.01499.x; Ochs-Balcom HM, 2006, CHEST, V129, P853, DOI 10.1378/chest.129.4.853; Peterson MJ, 2003, AM J CLIN NUTR, V77, P1186, DOI 10.1093/ajcn/77.5.1186; Pitsavos C, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-206; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Roditis ML, 2009, J PEDIATR ENDOCR MET, V22, P389; Saint-Pierre P, 2006, ALLERGY, V61, P79, DOI 10.1111/j.1398-9995.2005.00953.x; SCHOLS AMWJ, 1991, AM J CLIN NUTR, V53, P421, DOI 10.1093/ajcn/53.2.421; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Slinde F, 2005, RESP MED, V99, P1004, DOI 10.1016/j.rmed.2004.09.024; Targowski Tomasz, 2004, Pol Merkur Lekarski, V17, P567; Tzanakis N, 2004, CHEST, V125, P892, DOI 10.1378/chest.125.3.892; Vestbo J, 2006, AM J RESP CRIT CARE, V173, P79, DOI 10.1164/rccm.200505-969OC; Wannamethee SG, 2005, AM J CLIN NUTR, V82, P996, DOI 10.1093/ajcn/82.5.996	40	9	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13233	10.1371/journal.pone.0013233	http://dx.doi.org/10.1371/journal.pone.0013233			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949085	Green Submitted, Green Published, gold			2022-12-27	WOS:000282568400019
J	Nogales-Gadea, G; Mormeneo, E; Garcia-Consuegra, I; Rubio, JC; Orozco, A; Arenas, J; Martin, MA; Lucia, A; Gomez-Foix, AM; Marti, R; Andreu, AL				Nogales-Gadea, Gisela; Mormeneo, Emma; Garcia-Consuegra, Ines; Rubio, Juan C.; Orozco, Anna; Arenas, Joaquin; Martin, Miguel A.; Lucia, Alejandro; Gomez-Foix, Anna M.; Marti, Ramon; Andreu, Antoni L.			Expression of Glycogen Phosphorylase Isoforms in Cultured Muscle from Patients with McArdle's Disease Carrying the p.R771PfsX33 PYGM Mutation	PLOS ONE			English	Article							MESSENGER-RNA DECAY; MYOPHOSPHORYLASE DEFICIENCY; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; TERMINATION-CODON; GENE-EXPRESSION; IDENTIFICATION; MECHANISMS; RESPONSES; DISORDER	Background: Mutations in the PYGM gene encoding skeletal muscle glycogen phosphorylase (GP) cause a metabolic disorder known as McArdle's disease. Previous studies in muscle biopsies and cultured muscle cells from McArdle patients have shown that PYGM mutations abolish GP activity in skeletal muscle, but that the enzyme activity reappears when muscle cells are in culture. The identification of the GP isoenzyme that accounts for this activity remains controversial. Methodology/Principal Findings: In this study we present two related patients harbouring a novel PYGM mutation, p.R771PfsX33. In the patients' skeletal muscle biopsies, PYGM mRNA levels were similar to 60% lower than those observed in two matched healthy controls; biochemical analysis of a patient muscle biopsy resulted in undetectable GP protein and GP activity. A strong reduction of the PYGM mRNA was observed in cultured muscle cells from patients and controls, as compared to the levels observed in muscle tissue. In cultured cells, PYGM mRNA levels were negligible regardless of the differentiation stage. After a 12 day period of differentiation similar expression of the brain and liver isoforms were observed at the mRNA level in cells from patients and controls. Total GP activity (measured with AMP) was not different either; however, the active GP activity and immunoreactive GP protein levels were lower in patients' cell cultures. GP immunoreactivity was mainly due to brain and liver GP but muscle GP seemed to be responsible for the differences. Conclusions/Significance: These results indicate that in both patients' and controls' cell cultures, unlike in skeletal muscle tissue, most of the protein and GP activities result from the expression of brain GP and liver GP genes, although there is still some activity resulting from the expression of the muscle GP gene. More research is necessary to clarify the differential mechanisms of metabolic adaptations that McArdle cultures undergo in vitro.	[Nogales-Gadea, Gisela; Marti, Ramon; Andreu, Antoni L.] Hosp Univ Vall Hebron, Inst Recerca, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain; [Mormeneo, Emma; Orozco, Anna; Gomez-Foix, Anna M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Barcelona, Spain; [Garcia-Consuegra, Ines; Rubio, Juan C.; Arenas, Joaquin; Martin, Miguel A.] Hosp Univ 12 Octubre, Ctr Invest, Madrid, Spain; [Lucia, Alejandro] Univ Europea Madrid, Madrid, Spain; [Nogales-Gadea, Gisela; Garcia-Consuegra, Ines; Rubio, Juan C.; Martin, Miguel A.; Marti, Ramon; Andreu, Antoni L.] Inst Salud Carlos III, Spanish Network Res Rare Dis CIBERER, Madrid, Spain; [Mormeneo, Emma; Orozco, Anna; Gomez-Foix, Anna M.] Inst Salud Carlos III, Diabet & Associated Metab Disorders CIBERDEM, Madrid, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); University of Barcelona; Hospital Universitario 12 de Octubre; European University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; Instituto de Salud Carlos III	Nogales-Gadea, G (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, Dept Patol Mitocondrial & Neuromuscular, Barcelona, Spain.	rmarti@ir.vhebron.net	Nogales-Gadea, Gisela/N-4004-2014; Martí, Ramon/Q-3442-2016; Martin, Miguel A/S-2758-2018; Lucia, Alejandro/M-2759-2014	Nogales-Gadea, Gisela/0000-0002-7414-212X; Martí, Ramon/0000-0002-8273-9540; Martin, Miguel A/0000-0003-4741-772X; Lucia, Alejandro/0000-0002-3025-2060; Arenas, Joaquin/0000-0002-2877-5049; ANDREU, antonio luis/0000-0002-3936-3234; Lucia, Alejandro/0000-0002-5565-0997	CIBER de Enfermedades Raras, Spain; MCI; FIS, Madrid, Spain [CA05/0039]; ISCIII; Comunidad de Madrid; Instituto de Salud Carlos III; Fondo de Investigacian Sanitaria (FIS) [PI0890246, PI061183, PI07/0347]; Ministerio de Ciencia y Innovacion (MCI) [SAF2009-07559]; CIBER de Enfermedades Raras; CIBER de Diabetes y Enfermedades Metabalicas Asociadas; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras	CIBER de Enfermedades Raras, Spain; MCI; FIS, Madrid, Spain(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); Comunidad de Madrid(Comunidad de Madrid); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo de Investigacian Sanitaria (FIS)(Instituto de Salud Carlos III); Ministerio de Ciencia y Innovacion (MCI); CIBER de Enfermedades Raras; CIBER de Diabetes y Enfermedades Metabalicas Asociadas; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras	GN was supported by a contract from CIBER de Enfermedades Raras, Spain. EM was the recipient of a FPI fellowship from the MCI. IG was supported by a contract from FIS, Madrid, Spain. JCR was supported by a contract from FIS (CA05/0039). MAM was supported by the programme 'Intensificacion de la Actividad Investigadora' from ISCIII, and Comunidad de Madrid. This work was supported by grants from Instituto de Salud Carlos III, Fondo de Investigacian Sanitaria (FIS) grant number: PI0890246, PI061183, PI07/0347; Ministerio de Ciencia y Innovacion (MCI) grant number SAF2009-07559; CIBER de Enfermedades Raras and CIBER de Diabetes y Enfermedades Metabalicas Asociadas, which is an ISCIII project, Spain; Fundacion Isabel Gemio para la investigacion en distrofias musculares y otras enfermedades raras. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTRAM C, 1993, HUM MOL GENET, V2, P1291, DOI 10.1093/hmg/2.8.1291; Buchbinder JL, 2001, ANNU REV BIOPH BIOM, V30, P191, DOI 10.1146/annurev.biophys.30.1.191; CRERAR MM, 1995, J BIOL CHEM, V270, P13748, DOI 10.1074/jbc.270.23.13748; DIMAURO S, 1979, ANN NEUROL, V5, P422, DOI 10.1002/ana.410050504; DiMauro S, 1977, Trans Am Neurol Assoc, V102, P112; DIMAURO S, 1978, ANN NEUROL, V3, P60, DOI 10.1002/ana.410030109; Ferrer-Martinez A, 2006, GENE, V384, P145, DOI 10.1016/j.gene.2006.07.042; Frischmeyer PA, 1999, HUM MOL GENET, V8, P1893, DOI 10.1093/hmg/8.10.1893; Garcia-Consuegra I, 2009, J MED GENET, V46, P198, DOI 10.1136/jmg.2008.059469; GILBOE DP, 1972, ANAL BIOCHEM, V47, P20, DOI 10.1016/0003-2697(72)90274-6; Haller RG, 2002, ARCH NEUROL-CHICAGO, V59, P1395, DOI 10.1001/archneur.59.9.1395; Holcik M, 2007, EMBO REP, V8, P639, DOI 10.1038/sj.embor.7400988; HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621; Imamura M, 2005, HUM MOL GENET, V14, P775, DOI 10.1093/hmg/ddi072; KINNIBURGH AJ, 1982, NUCLEIC ACIDS RES, V10, P5421, DOI 10.1093/nar/10.18.5421; Kubisch C, 1998, HUM MUTAT, V12, P27, DOI 10.1002/(SICI)1098-1004(1998)12:1<27::AID-HUMU4>3.0.CO;2-#; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; Lualdi S, 2006, BBA-MOL BASIS DIS, V1762, P478, DOI 10.1016/j.bbadis.2006.01.003; Lucia A, 2008, NAT CLIN PRACT NEURO, V4, P568, DOI 10.1038/ncpneuro0913; Martin M A, 2000, Hum Mutat, V15, P294, DOI 10.1002/(SICI)1098-1004(200003)15:3<294::AID-HUMU13>3.0.CO;2-H; Martinuzzi A, 1999, AM J PATHOL, V154, P1893, DOI 10.1016/S0002-9440(10)65447-8; MARTINUZZI A, 1993, J CLIN INVEST, V92, P1774, DOI 10.1172/JCI116766; Mate-Munoz JL, 2007, CLIN J SPORT MED, V17, P297; MCARDLE B, 1951, CLIN SCI, V10, P12; MEIENHOFER MC, 1977, ARCH NEUROL-CHICAGO, V34, P779, DOI 10.1001/archneur.1977.00500240067013; MOMMAERTS WFHM, 1959, P NATL ACAD SCI USA, V45, P791, DOI 10.1073/pnas.45.6.791; Montori-Grau M, 2007, BIOCHEM J, V405, P107, DOI 10.1042/BJ20061572; Montori-Grau M, 2009, EXP GERONTOL, V44, P426, DOI 10.1016/j.exger.2009.03.005; Nagy E, 1998, TRENDS BIOCHEM SCI, V23, P198, DOI 10.1016/S0968-0004(98)01208-0; NEWGARD CB, 1988, J BIOL CHEM, V263, P3850; Nielsen JN, 2002, AM J PHYSIOL-ENDOC M, V282, pE1267, DOI 10.1152/ajpendo.00526.2001; Nogales-Gadea G, 2007, CURR NEUROL NEUROSCI, V7, P84, DOI 10.1007/s11910-007-0026-2; Nogales-Gadea G, 2008, HUM MUTAT, V29, P277, DOI 10.1002/humu.20649; Nunes PM, 2008, CARBOHYD RES, V343, P1486, DOI 10.1016/j.carres.2008.04.004; PAZUR JH, 1960, J BIOL CHEM, V235, P297; Perrin-Vidoz L, 2002, HUM MOL GENET, V11, P2805, DOI 10.1093/hmg/11.23.2805; Raymond F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-125; ROELOFS RI, 1972, SCIENCE, V177, P795, DOI 10.1126/science.177.4051.795; Rubio JC, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9474; SATO K, 1977, BIOCHEM BIOPH RES CO, V78, P663, DOI 10.1016/0006-291X(77)90230-3; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; SCHMID R, 1959, J CLIN INVEST, V38, P2044, DOI 10.1172/JCI103983; Sohn EH, 2008, NEUROMUSCULAR DISORD, V18, P886, DOI 10.1016/j.nmd.2008.06.384; THOMAS JA, 1968, ANAL BIOCHEM, V25, P486, DOI 10.1016/0003-2697(68)90127-9; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TSUJINO S, 1993, NEW ENGL J MED, V329, P241, DOI 10.1056/NEJM199307223290404	47	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13164	10.1371/journal.pone.0013164	http://dx.doi.org/10.1371/journal.pone.0013164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957198	Green Published, Green Submitted, gold			2022-12-27	WOS:000282506100007
J	Brodin, P; Lakshmikanth, T; Mehr, R; Johansson, MH; Duru, AD; Achour, A; Salmon-Divon, M; Karre, K; Hoglund, P; Johansson, S				Brodin, Petter; Lakshmikanth, Tadepally; Mehr, Ramit; Johansson, Maria H.; Duru, Adil Doganay; Achour, Adnane; Salmon-Divon, Mali; Karre, Klas; Hoglund, Petter; Johansson, Sofia			Natural Killer Cell Tolerance Persists Despite Significant Reduction of Self MHC Class I on Normal Target Cells in Mice	PLOS ONE			English	Article							INHIBITORY LY49 RECEPTORS; NK CELLS; NKG2D RECEPTOR; KNOCKOUT MICE; T-CELLS; EXPRESSION; EDUCATION; CIS; MOLECULES; REJECTION	Background: A major group of murine inhibitory receptors on Natural Killer (NK) cells belong to the Ly49 receptor family and recognize MHC class I molecules. Infected or transformed target cells frequently downmodulate MHC class I molecules and can thus avoid CD8(+) T cell attack, but may at the same time develop NK cell sensitivity, due to failure to express inhibitory ligands for Ly49 receptors. The extent of MHC class I downregulation needed on normal cells to trigger NK cell effector functions is not known. Methodology/Principal Findings: In this study, we show that cells expressing MHC class I to levels well below half of the host level are tolerated in an in vivo assay in mice. Hemizygous expression (expression from only one allele) of MHC class I was sufficient to induce Ly49 receptor downmodulation on NK cells to a similar degree as homozygous expression, despite a strongly reduced cell surface level of MHC class I. Co-expression of weaker MHC class I ligands in the host did not have any further effect on the degree of Ly49 downmodulation. Furthermore, a single MHC class I allele could downmodulate up to three Ly49 receptors on individual NK cells. Only when NK cells simultaneously expressed several Ly49 receptors and hemizygous MHC class I levels, a putative threshold for Ly49 downmodulation was reached. Conclusion: Collectively, our findings suggest that in interactions between NK cells and normal untransformed cells, MHC class I molecules are in most cases expressed in excess compared to what is functionally needed to ensure self tolerance and to induce maximal Ly49 downmodulation. We speculate that the reason for this is to maintain a safety margin for otherwise normal, autologous cells over a range of MHC class I expression levels, in order to ensure robustness in NK cell tolerance.	[Brodin, Petter; Lakshmikanth, Tadepally; Johansson, Maria H.; Karre, Klas; Hoglund, Petter] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Mehr, Ramit; Salmon-Divon, Mali] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Duru, Adil Doganay; Achour, Adnane] Karolinska Inst, Dept Med, Ctr Infect Med, Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Johansson, Sofia] AlbaNova Univ Ctr, Royal Inst Technol, Dept Appl Phys Expt Biomol Phys, Stockholm, Sweden; [Salmon-Divon, Mali] European Bioinformat Inst, European Mol Biol Lab, Cambridge, England	Karolinska Institutet; Bar Ilan University; Karolinska Institutet; Karolinska University Hospital; Royal Institute of Technology; European Molecular Biology Laboratory (EMBL)	Brodin, P (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.	sofj@kth.se	Johansson, Sofia/B-9043-2011; Brodin, Petter/C-3317-2011; Höglund, Petter/AAV-7443-2021; Salmon-Divon, Mali/AAG-4479-2019; Tadepally, Lakshmikanth/P-5154-2019	Johansson, Sofia/0000-0002-9295-6266; Brodin, Petter/0000-0002-8103-0046; Salmon-Divon, Mali/0000-0002-7272-0846; Tadepally, Lakshmikanth/0000-0001-7256-5770; Mehr, Ramit/0000-0002-4303-6834; Duru, Adil/0000-0002-5844-913X; Achour, Adnane/0000-0003-0432-710X	Swedish Cancer Society; Wenner-Gren Institute; Karolinska Institutet; Swedish Foundation for Strategic Research; Aake Wiberg foundation; Magnus Bergwall foundation; Royal Swedish Academy of Sciences; Swedish Research Council; Marianne and Marcus Wallenberg Foundation; Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT); Mary Beves Stiftelse; Swedish National Board of Health and Welfare	Swedish Cancer Society(Swedish Cancer Society); Wenner-Gren Institute; Karolinska Institutet(Karolinska Institutet); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Aake Wiberg foundation; Magnus Bergwall foundation; Royal Swedish Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission); Marianne and Marcus Wallenberg Foundation; Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT); Mary Beves Stiftelse; Swedish National Board of Health and Welfare	S.J. was financed by a post-doc position from the Swedish Cancer Society (presently) and from the Wenner-Gren Institute (2006-2008). Grants were received from Karolinska Institutet to SJ, MHJ, TLK, PH, AA and KK; from the Swedish Foundation for Strategic Research and the Swedish Cancer Society to AA, KK and PH; from the Aake Wiberg foundation, the Magnus Bergwall foundation, and the Royal Swedish Academy of Sciences to MHJ and SJ; from the Swedish Research Council, the Marianne and Marcus Wallenberg Foundation and The Swedish Foundation for International Cooperation in Research and Higher Educationt (STINT) to AA and PH; from Mary Beves Stiftelse to PB; and from the Swedish National Board of Health and Welfare to AA and MHJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Andersson KE, 2007, EUR J IMMUNOL, V37, P516, DOI 10.1002/eji.200636693; Andersson M, 1998, J IMMUNOL, V161, P6475; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Back J, 2007, P NATL ACAD SCI USA, V104, P3978, DOI 10.1073/pnas.0607418104; Back J, 2009, IMMUNITY, V31, P598, DOI 10.1016/j.immuni.2009.07.007; BIEBERICH C, 1986, MOL CELL BIOL, V6, P1339, DOI 10.1128/MCB.6.4.1339; BRODIN P, 2009, TRENDS IMMUNOL; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; CHALIFOUR A, 2009, IMMUNITY; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Dimasi N, 2005, IMMUNOL CELL BIOL, V83, P1, DOI 10.1111/j.1440-1711.2005.01301.x; Doucey MA, 2004, NAT IMMUNOL, V5, P328, DOI 10.1038/ni1043; FERNANDEZ NC, 2005, BLOOD; GIDLUND M, 1978, NATURE, V273, P759, DOI 10.1038/273759a0; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; Hoglund P, 1998, EUR J IMMUNOL, V28, P370, DOI 10.1002/(SICI)1521-4141(199801)28:01<370::AID-IMMU370>3.0.CO;2-W; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Johansson MH, 1998, EUR J IMMUNOL, V28, P4198, DOI 10.1002/(SICI)1521-4141(199812)28:12<4198::AID-IMMU4198>3.0.CO;2-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Johansson S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006046; Joncker NT, 2008, IMMUNOL REV, V224, P85, DOI 10.1111/j.1600-065X.2008.00658.x; Jonsson AH, 2010, J IMMUNOL, V184, P3424, DOI 10.4049/jimmunol.0904057; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kase A, 1998, J IMMUNOL, V161, P6133; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Manilay JO, 1998, INT IMMUNOL, V10, P1943, DOI 10.1093/intimm/10.12.1943; Nakamura MC, 2000, J EXP MED, V192, P447, DOI 10.1084/jem.192.3.447; Oberg L, 2004, EUR J IMMUNOL, V34, P1646, DOI 10.1002/eji.200424913; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; OlssonAlheim MY, 1997, J IMMUNOL, V159, P3189; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Perarnau B, 1999, EUR J IMMUNOL, V29, P1243, DOI 10.1002/(SICI)1521-4141(199904)29:04<1243::AID-IMMU1243>3.0.CO;2-A; Regunathan J, 2005, BLOOD, V105, P233, DOI 10.1182/blood-2004-03-1075; Roth C, 2000, IMMUNITY, V13, P143, DOI 10.1016/S1074-7613(00)00015-7; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; SIJTS AJAM, 1994, J VIROL, V68, P6038, DOI 10.1128/JVI.68.9.6038-6046.1994; Sjostrom A, 2001, J EXP MED, V194, P1519, DOI 10.1084/jem.194.10.1519; STORKUS WJ, 1989, P NATL ACAD SCI USA, V86, P2361, DOI 10.1073/pnas.86.7.2361; STRINGFELLOW DA, 1972, ANTIMICROB AGENTS CH, V2, P73, DOI 10.1128/AAC.2.2.73; Sundback J, 2002, J IMMUNOL, V168, P793, DOI 10.4049/jimmunol.168.2.793; Vahlne G, 2010, EUR J IMMUNOL, V40, P813, DOI 10.1002/eji.200939755; van Stipdonk MJB, 2009, CANCER RES, V69, P7784, DOI 10.1158/0008-5472.CAN-09-1724; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Zimmer J, 2001, J EXP MED, V194, P1531, DOI 10.1084/jem.194.10.1531	54	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13174	10.1371/journal.pone.0013174	http://dx.doi.org/10.1371/journal.pone.0013174			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957233	Green Submitted, gold, Green Published			2022-12-27	WOS:000282423300012
J	Tomlinson, KL; Davies, GCG; Sutton, DJ; Palframan, RT				Tomlinson, Kate L.; Davies, Gareth C. G.; Sutton, Daniel J.; Palframan, Roger T.			Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite	PLOS ONE			English	Article							SMOOTH-MUSCLE; ALLERGEN CHALLENGE; IL-13 EXPRESSION; EXPERIMENTAL ASTHMA; CYNOMOLGUS MONKEYS; LUNG INFLAMMATION; TGF-BETA; RECEPTOR; CELLS; RESPONSES	Background: Repeated exposure to inhaled allergen can cause airway inflammation, remodeling and dysfunction that manifests as the symptoms of allergic asthma. We have investigated the role of the cytokine interleukin-13 (IL-13) in the generation and persistence of airway cellular inflammation, bronchial remodeling and deterioration in airway function in a model of allergic asthma caused by chronic exposure to the aeroallergen House Dust Mite (HDM). Methodology/Principal Findings: Mice were exposed to HDM via the intranasal route for 4 consecutive days per week for up to 8 consecutive weeks. Mice were treated either prophylactically or therapeutically with a potent neutralising anti-IL-13 monoclonal antibody (mAb) administered subcutaneously (s.c.). Airway cellular inflammation was assessed by flow cytometry, peribronchial collagen deposition by histocytochemistry and airway hyperreactivity (AHR) by invasive measurement of lung resistance (R-L) and dynamic compliance (C-dyn). Both prophylactic and therapeutic treatment with an anti-IL-13 mAb significantly inhibited (P < 0.05) the generation and maintenance of chronic HDM-induced airway cellular inflammation, peribronchial collagen deposition, epithelial goblet cell upregulation. AHR to inhaled methacholine was reversed by prophylactic but not therapeutic treatment with anti-IL-13 mAb. Both prophylactic and therapeutic treatment with anti-IL-13 mAb significantly reversed (P < 0.05) the increase in baseline R-L and the decrease in baseline C-dyn caused by chronic exposure to inhaled HDM. Conclusions/Significance: These data demonstrate that in a model of allergic lung disease driven by chronic exposure to a clinically relevant aeroallergen, IL-13 plays a significant role in the generation and persistence of airway inflammation, remodeling and dysfunction.	[Tomlinson, Kate L.; Davies, Gareth C. G.; Sutton, Daniel J.; Palframan, Roger T.] UCB, Immunol Res, Slough, Berks, England	UCB Pharma SA	Palframan, RT (corresponding author), UCB, Immunol Res, Slough, Berks, England.	Roger.Palframan@UCB.com		Davies, Gareth/0000-0001-5180-3143	UCB	UCB(UCB Pharma SA)	This study was funded entirely by UCB (www.ucb.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors were employees of UCB at the time these studies were performed.	Batra V, 2004, CLIN EXP ALLERGY, V34, P437, DOI 10.1111/j.1365-2222.2004.01885.x; Berry LM, 2009, INT IMMUNOPHARMACOL, V9, P201, DOI 10.1016/j.intimp.2008.11.001; Berry MA, 2004, J ALLERGY CLIN IMMUN, V114, P1106, DOI 10.1016/j.jaci.2004.08.032; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bree A, 2007, J ALLERGY CLIN IMMUN, V119, P1251, DOI 10.1016/j.jaci.2007.02.009; Brightling CE, 2003, CLIN EXP ALLERGY, V33, P1711, DOI 10.1111/j.1365-2222.2003.01827.x; Chiou YL, 2009, J CELL PHYSIOL, V220, P311, DOI 10.1002/jcp.21764; de Vries JE, 1998, J ALLERGY CLIN IMMUN, V102, P165, DOI 10.1016/S0091-6749(98)70080-6; Espinosa K, 2003, J ALLERGY CLIN IMMUN, V111, P1032, DOI 10.1067/mai.2003.1451; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Grunstein MM, 2002, AM J PHYSIOL-LUNG C, V282, pL520, DOI 10.1152/ajplung.00343.2001; Hewitt CRA, 1998, ALLERGY, V53, P60, DOI 10.1111/j.1398-9995.1998.tb05000.x; Holgate ST, 2004, CLIN EXP ALLERGY, V34, P632, DOI 10.1111/j.1365-2222.2004.1916.x; HUANG SK, 1995, J IMMUNOL, V155, P2688; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kasaian MT, 2008, J PHARMACOL EXP THER, V325, P882, DOI 10.1124/jpet.108.136515; Kasaian MT, 2007, AM J RESP CELL MOL, V36, P368, DOI 10.1165/rcmb.2006-0244OC; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kroegel C, 1996, EUR RESPIR J, V9, P899, DOI 10.1183/09031936.96.09050899; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Langley SJ, 2003, ANN ALLERG ASTHMA IM, V91, P398, DOI 10.1016/S1081-1206(10)61688-2; Prieto J, 2000, RESP MED, V94, P806, DOI 10.1053/rmed.2000.0826; Rogers DF, 2007, RESP CARE, V52, P1134; Saha SK, 2008, J ALLERGY CLIN IMMUN, V121, P685, DOI 10.1016/j.jaci.2008.01.005; Taube C, 2002, J IMMUNOL, V169, P6482, DOI 10.4049/jimmunol.169.11.6482; Tliba O, 2003, BRIT J PHARMACOL, V140, P1159, DOI 10.1038/sj.bjp.0705558; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Rensen ELJ, 2009, ALLERGY, V64, P72, DOI 10.1111/j.1398-9995.2008.01881.x; Warner SM, 2008, CURR OPIN ALLERGY CL, V8, P44, DOI 10.1097/ACI.0b013e3282f3b5cb; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 2002, J IMMUNOL, V169, P4613, DOI 10.4049/jimmunol.169.8.4613; Willart MAM, 2009, CLIN EXP ALLERGY, V39, P12, DOI 10.1111/j.1365-2222.2008.03118.x; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wynn TA, 2003, ANNU REV IMMUNOL, V21, P425, DOI 10.1146/annurev.immunol.21.120601.141142; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909	39	43	44	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13136	10.1371/journal.pone.0013136	http://dx.doi.org/10.1371/journal.pone.0013136			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957211	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300026
J	Poat, B; Hazari, S; Chandra, PK; Gunduz, F; Balart, LA; Alvarez, X; Dash, S				Poat, Bret; Hazari, Sidhartha; Chandra, Partha K.; Gunduz, Feyza; Balart, Luis A.; Alvarez, Xavier; Dash, Srikanta			SH2 Modified STAT1 Induces HLA-I Expression and Improves IFN-gamma Signaling in IFN-alpha Resistant HCV Replicon Cells (Publication with Expression of Concern. See vol. 17, 2022)	PLOS ONE			English	Article; Publication with Expression of Concern							HEPATITIS-C VIRUS; INTERFERON-ALPHA; GENE-EXPRESSION; PLUS RIBAVIRIN; MESSENGER-RNA; RECEPTOR; LIVER; GENOTYPE; THERAPY; PROTEIN	Background: We have developed multiple stable cell lines containing subgenomic HCV RNA that are resistant to treatment with interferon alpha (IFN-alpha Characterization of these IFN-alpha resistant replicon cells showed defects in the phosphorylation and nuclear translocation of STAT1 and STAT2 proteins due to a defective Jak-STAT pathway. Methodology/Principal Findings: In this study, we have developed an alternative strategy to overcome interferon resistance in a cell culture model by improving intracellular STAT1 signaling. An engineered STAT1-CC molecule with double cysteine substitutions in the Src-homology 2 (SH2) domains of STAT1 (at Ala-656 and Asn-658) efficiently phosphorylates and translocates to the nucleus of IFN-resistant cells in an IFN-gamma dependent manner. Transfection of a plasmid clone containing STAT1-CC significantly activated the GAS promoter compared to wild type STAT1 and STAT3. The activity of the engineered STAT1-CC is dependent upon the phosphorylation of tyrosine residue 701, since the construct with a substituted phenylalanine residue at position 701 (STAT1-CC-Y701F) failed to activate GAS promoter in the replicon cells. Intracellular expression of STAT1-CC protein showed phosphorylation and nuclear translocation in the resistant cell line after IFN-gamma treatment. Transient transfection of STAT1-CC plasmid clone into an interferon resistant cell line resulted in inhibition of viral replication and viral clearance in an IFN-gamma dependent manner. Furthermore, the resistant replicon cells transfected with STAT1-CC constructs significantly up regulated surface HLA-1 expression when compared to the wild type and Y to F mutant controls. Conclusions: These results suggest that modification of the SH2 domain of the STAT1 molecule allows for improved IFN-gamma signaling through increased STAT1 phosphorylation, nuclear translocation, HLA-1 surface expression, and prolonged interferon antiviral gene activation.	[Poat, Bret; Hazari, Sidhartha; Chandra, Partha K.; Gunduz, Feyza; Dash, Srikanta] Dept Pathol & Lab Med, New Orleans, LA USA; [Gunduz, Feyza; Balart, Luis A.; Dash, Srikanta] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Alvarez, Xavier] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA	Tulane University; Tulane University	Poat, B (corresponding author), Dept Pathol & Lab Med, New Orleans, LA USA.	sdash@tulane.edu			National Cancer Institute [CA127481, CA129776]; Louisiana Cancer Research Consortium; Tulane Cancer Center; Louisiana Board of Regents; National Institutes of Health [RR000164]; NATIONAL CANCER INSTITUTE [R21CA129776, R01CA127481] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Louisiana Cancer Research Consortium; Tulane Cancer Center; Louisiana Board of Regents; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by funds received from the National Cancer Institute (CA127481, CA129776), Louisiana Cancer Research Consortium, and Tulane Cancer Center. Louisiana Board of Regents provided a graduate fellowship to BP. This work was also supported partially by National Institutes of Health Grant RR000164 (XAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Brown RS, 2003, LIVER TRANSPLANT, V9, pS10, DOI 10.1053/jlts.2003.50244; Chen LM, 2010, GASTROENTEROLOGY, V138, P1123, DOI 10.1053/j.gastro.2009.10.046; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Cheney IW, 2002, J VIROL, V76, P11148, DOI 10.1128/JVI.76.21.11148-11154.2002; Dash S, 2005, LIVER INT, V25, P580, DOI 10.1111/j.1478-3231.2005.01082.x; Decker T, 1997, J INTERF CYTOK RES, V17, P121, DOI 10.1089/jir.1997.17.121; Frese M, 2002, HEPATOLOGY, V35, P694, DOI 10.1053/jhep.2002.31770; Fujiwara D, 2004, J VIRAL HEPATITIS, V11, P136, DOI 10.1046/j.1365-2893.2003.00477.x; Gao B, 2004, HEPATOLOGY, V39, P880, DOI 10.1002/hep.20139; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Hazari S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-36; Hazari S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-89; He YP, 2002, VIRAL IMMUNOL, V15, P95, DOI 10.1089/088282402317340260; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kim WR, 2002, HEPATOLOGY, V36, pS30, DOI 10.1053/jhep.2002.36791; Kumashiro R, 2002, HEPATOL RES, V22, P20, DOI 10.1016/S1386-6346(01)00113-9; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Liddle FJ, 2006, BIOCHEMISTRY-US, V45, P5599, DOI 10.1021/bi0525674; Liu JH, 2009, CELL HOST MICROBE, V5, P72, DOI 10.1016/j.chom.2008.11.008; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Melen K, 2000, J HEPATOL, V33, P764, DOI 10.1016/S0168-8278(00)80308-6; Meng XW, 2005, WORLD J GASTROENTERO, V11, P3962; Morita K, 1998, J CLIN GASTROENTEROL, V26, P135, DOI 10.1097/00004836-199803000-00010; Pestka S, 2000, BIOPOLYMERS, V55, P254, DOI 10.1002/1097-0282(2000)55:4<254::AID-BIP1001>3.0.CO;2-1; Radaeva S, 2002, GASTROENTEROLOGY, V122, P1020, DOI 10.1053/gast.2002.32388; SAEZROYUELA F, 1991, HEPATOLOGY, V13, P327, DOI 10.1002/hep.1840130220; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Soza A, 2005, J HEPATOL, V43, P67, DOI 10.1016/j.jhep.2005.02.023; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sy Theodore, 2006, Int J Med Sci, V3, P41; Taniguchi H, 2007, INTERVIROLOGY, V50, P32, DOI 10.1159/000096310; Taylor DR, 2000, MICROBES INFECT, V2, P1743, DOI 10.1016/S1286-4579(00)01329-0; Trepo C, 2000, J VIRAL HEPATITIS, V7, P250; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Zhang Y, 2005, J BIOL CHEM, V280, P34306, DOI 10.1074/jbc.M503263200; Zhong MH, 2005, P NATL ACAD SCI USA, V102, P3966, DOI 10.1073/pnas.0501063102; Zhou F, 2009, INT REV IMMUNOL, V28, P239, DOI 10.1080/08830180902978120	42	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13117	10.1371/journal.pone.0013117	http://dx.doi.org/10.1371/journal.pone.0013117			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20949125	gold, Green Published, Green Submitted			2022-12-27	WOS:000282312600032
J	Jiang, WB; Hong, Y; Peng, JBA; Fu, ZQ; Feng, XG; Liu, JM; Shi, YJ; Lin, JJ				Jiang, Weibin; Hong, Yang; Peng, Jinbiao; Fu, Zhiqiang; Feng, Xingang; Liu, Jinming; Shi, Yaojun; Lin, Jiaojiao			Study on Differences in the Pathology, T Cell Subsets and Gene Expression in Susceptible and Non-Susceptible Hosts Infected with Schistosoma japonicum	PLOS ONE			English	Article							CATHEPSIN-S; PARASITE; SPLEEN; NOTCH	More than 40 kinds of mammals in China are known to be naturally infected with Schistosoma japonicum (S. japonicum); Microtus fortis (M. fortis), a species of vole, is the only mammal in which the schistosomes cannot mature or cause significant pathogenic changes. In the current study, we compared the differences in pathology by Hematoxylin-eosin staining and in changes in the T cell subsets with flow cytometry as well as gene expression using genome oligonucleotide microarrays in the lung and liver, before challenge and 10 days post-infection with schistosomes in a S. japonicum-susceptible mouse model of infection, a non-susceptible rat model and the non-permissive host, M. fortis. The results demonstrated that S. japonicum promoted a more intensive immune response and more pathological lesions in M. fortis and rats than in mice. Hematoxylin-eosin staining revealed that the immune effector cells involved were mainly eosinophilic granulocytes supplemented with heterophilic granulocytes and macrophages. The analysis of splenic T cell subsets showed that CD4(+) T cell subsets and the CD4(+)/CD8(+) ratio were increased, while the CD8(+) T cell subsets decreased remarkably in rats; whereas the CD8(+) T cell subsets were increased, but the CD4(+)/CD8(+) ratio was decreased significantly in mice. The analysis of the pattern of gene expression suggested that some immune-associated genes and apoptosis-inducing genes up-regulated, while some development-associated genes were down-regulated in the infected M. fortis compared to the uninfected controls; the three different hosts have different response mechanisms to schistosome infection. The results of this study will be helpful for identifying the key molecules in the immune response to S. japonicum in M. fortis and for understanding more about the underlying mechanism of the response, as well as for elucidating the interaction between S. japonicum and its hosts.	[Jiang, Weibin; Hong, Yang; Peng, Jinbiao; Fu, Zhiqiang; Feng, Xingang; Liu, Jinming; Shi, Yaojun; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China; [Jiang, Weibin] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; East China Normal University	Jiang, WB (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China.	JJlin@shvri.ac.cn			National Basic Research Program of China [2007CB513108]; National Science & Technology Major Project [2008ZX10004-011]; National High Technology Research and Development Program of China [2006AA10A207-1]	National Basic Research Program of China(National Basic Research Program of China); National Science & Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by the National Basic Research Program of China (No. 2007CB513108), http://www.973.gov.cn/ReadItem.aspx? itemid=578; the National Science & Technology Major Project (No. 2008ZX10004-011), http://www.nmp.gov.cn/zxjs/crb/; and the National High Technology Research and Development Program of China (No. 2006AA10A207-1), http://www.863.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Or RL, 2000, MATH BIOSCI, V163, P35; BRIGGS MH, 1972, BIOCHIM BIOPHYS ACTA, V280, P481, DOI 10.1016/0005-2760(72)90256-1; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Caraher EM, 2000, J IMMUNOL METHODS, V244, P29, DOI 10.1016/S0022-1759(00)00249-0; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Dallman MJ, 2005, CURR OPIN IMMUNOL, V17, P259, DOI 10.1016/j.coi.2005.04.002; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FUKUDA K, 1993, INT J PARASITOL, V23, P757, DOI 10.1016/0020-7519(93)90072-7; HE HB, 1992, HUNAN MED, V9, P65; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; HE YX, 1989, CHIN J PARASITOL PAR, V7, P15; Hou SX, 2002, DEV CELL, V3, P765, DOI 10.1016/S1534-5807(02)00376-3; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Ihle JN, 1996, CELL, V84, P331, DOI 10.1016/S0092-8674(00)81277-5; JIA RC, 2008, CHIN J BIOTECH, V24, P733; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; LI FK, 1965, ACTA PARASITOL SIN, V2, P103; Li H., 2000, CHIN J VET PARASITOL, V8, P12; Liu J, 1996, INT J IMMUNOPHARMACO, V18, P449, DOI 10.1016/S0192-0561(96)00049-5; Liu J. S., 1992, CHIN J SCHISTO CONTR, V4, P350; Liu JinMing, 2001, Acta Parasitologica et Medica Entomologica Sinica, V8, P212; Liu WM, 2004, DRUG NEWS PERSPECT, V17, P357, DOI 10.1358/dnp.2004.17.6.829027; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Riese RJ, 1996, IMMUNITY, V4, P357, DOI 10.1016/S1074-7613(00)80249-6; Saule P, 2002, J PARASITOL, V88, P849, DOI 10.1645/0022-3395(2002)088[0849:EVOHTA]2.0.CO;2; Seigneuric R, 2007, RADIOTHER ONCOL, V83, P374, DOI 10.1016/j.radonc.2007.05.002; [孙军 Sun Jun], 2004, [北京大学学报. 自然科学版, Acta Scientiarum Naturalium Universitatis Pekinensis], V40, P532; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Qinglin, 2002, Chinese Journal of Zoonoses, V18, P65; WHO, 2002, WHO TECH REP SER; Wu K., 1957, CHIN VET J, V3, P98	33	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13494	10.1371/journal.pone.0013494	http://dx.doi.org/10.1371/journal.pone.0013494			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976156	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300044
J	Pagani, L; Semenova, EA; Moriggi, E; Revell, VL; Hack, LM; Lockley, SW; Arendt, J; Skene, DJ; Meier, F; Izakovic, J; Wirz-Justice, A; Cajochen, C; Sergeeva, OJ; Cheresiz, SV; Danilenko, KV; Eckert, A; Brown, SA				Pagani, Lucia; Semenova, Ekaterina A.; Moriggi, Ermanno; Revell, Victoria L.; Hack, Lisa M.; Lockley, Steven W.; Arendt, Josephine; Skene, Debra J.; Meier, Fides; Izakovic, Jan; Wirz-Justice, Anna; Cajochen, Christian; Sergeeva, Oksana J.; Cheresiz, Sergei V.; Danilenko, Konstantin V.; Eckert, Anne; Brown, Steven A.			The Physiological Period Length of the Human Circadian Clock In Vivo Is Directly Proportional to Period in Human Fibroblasts	PLOS ONE			English	Article							GENE-EXPRESSION; MELATONIN RHYTHMS; INTRINSIC PERIOD; ENTRAINMENT; PACEMAKER; SLEEP; TEMPERATURE; INSIGHTS; SYSTEM; TIME	Background: Diurnal behavior in humans is governed by the period length of a circadian clock in the suprachiasmatic nuclei of the brain hypothalamus. Nevertheless, the cell-intrinsic mechanism of this clock is present in most cells of the body. We have shown previously that for individuals of extreme chronotype ("larks" and "owls"), clock properties measured in human fibroblasts correlated with extreme diurnal behavior. Methodology/Principal Findings: In this study, we have measured circadian period in human primary fibroblasts taken from normal individuals and, for the first time, compared it directly with physiological period measured in vivo in the same subjects. Human physiological period length was estimated via the secretion pattern of the hormone melatonin in two different groups of sighted subjects and one group of totally blind subjects, each using different methods. Fibroblast period length was measured via cyclical expression of a lentivirally delivered circadian reporter. Within each group, a positive linear correlation was observed between circadian period length in physiology and in fibroblast gene expression. Interestingly, although blind individuals showed on average the same fibroblast clock properties as sighted ones, their physiological periods were significantly longer. Conclusions/Significance: We conclude that the period of human circadian behaviour is mostly driven by cellular clock properties in normal individuals and can be approximated by measurement in peripheral cells such as fibroblasts. Based upon differences among sighted and blind subjects, we also speculate that period can be modified by prolonged unusual conditions such as the total light deprivation of blindness.	[Pagani, Lucia; Meier, Fides; Eckert, Anne] Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland; [Semenova, Ekaterina A.; Sergeeva, Oksana J.; Danilenko, Konstantin V.] Russian Acad Med Sci, Siberian Branch, Inst Internal Med, Novosibirsk, Russia; [Moriggi, Ermanno; Brown, Steven A.] Univ Zurich, Dept Pharmacol & Toxicol, Zurich, Switzerland; [Revell, Victoria L.; Hack, Lisa M.; Arendt, Josephine; Skene, Debra J.] Univ Surrey, Fac Hlth & Med Sci, Ctr Chronobiol, Guildford GU2 5XH, Surrey, England; [Lockley, Steven W.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Circadian Physiol Program,Div Sleep Med, Boston, MA 02115 USA; [Izakovic, Jan] Univ Basel Hosp, Dept Dermatol, CH-4031 Basel, Switzerland; [Wirz-Justice, Anna; Cajochen, Christian] Psychiat Univ Clin Basel, Ctr Chronobiol, Basel, Switzerland; [Cheresiz, Sergei V.] Russian Acad Sci, Inst Cytol & Genet, Siberian Branch, Novosibirsk 630090, Russia	University of Basel; Russian Academy of Medical Sciences; Russian Academy of Sciences; University of Zurich; University of Surrey; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Basel; University of Basel; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Pagani, L (corresponding author), Psychiat Univ Clin Basel, Neurobiol Lab Brain Aging & Mental Hlth, Basel, Switzerland.	anne.eckert@upkbs.ch; steven.brown@pharma.uzh.ch	Cajochen, Christian/N-6748-2014; Semenova, Ekaterina/R-9152-2016; Danilenko, Konstantin V./E-1250-2015	Danilenko, Konstantin V./0000-0002-2096-4216; Eckert, Anne/0000-0002-9341-3669; Skene, Debra/0000-0001-8202-6180; Lockley, Steven/0000-0001-5209-2881	Swiss National Science Foundation; Velux Foundation; 6th European Framework Project EUCLOCK [018741]; E.U. [LSHM-CT-2006-018741]; Desiree & Niels Yde Foundation; Fonds der Freiwilligen Akademischen Gesellschaft Basel	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); 6th European Framework Project EUCLOCK(European Commission); E.U.(European Commission); Desiree & Niels Yde Foundation; Fonds der Freiwilligen Akademischen Gesellschaft Basel	This work was supported by grants from the Swiss National Science Foundation, the Velux Foundation, and the 6th European Framework Project EUCLOCK (#018741), from E.U. #LSHM-CT-2006-018741, from the Desiree & Niels Yde Foundation, and from the Fonds der Freiwilligen Akademischen Gesellschaft Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDHOUS ME, 1988, ANN CLIN BIOCHEM, V25, P298, DOI 10.1177/000456328802500319; Blatter K, 2007, PHYSIOL BEHAV, V90, P196, DOI 10.1016/j.physbeh.2006.09.009; Brown SA, 2005, PLOS BIOL, V3, P1813, DOI 10.1371/journal.pbio.0030338; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; Carskadon MA, 1999, NEUROSCI LETT, V260, P129, DOI 10.1016/S0304-3940(98)00971-9; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Dijk DJ, 2000, CHRONOBIOL INT, V17, P285, DOI 10.1081/CBI-100101049; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Gachon F, 2004, CHROMOSOMA, V113, P103, DOI 10.1007/s00412-004-0296-2; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Izumo M, 2003, P NATL ACAD SCI USA, V100, P16089, DOI 10.1073/pnas.2536313100; Koorengevel KM, 2002, J BIOL RHYTHM, V17, P463, DOI 10.1177/074873002237140; Kowalska E, 2007, COLD SPRING HARB SYM, V72, P301, DOI 10.1101/sqb.2007.72.014; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Middleton B, 1997, J BIOL RHYTHM, V12, P467, DOI 10.1177/074873049701200508; Mistlberger RE, 2005, J BIOL RHYTHM, V20, P339, DOI 10.1177/0748730405277982; Nakamura Kouji, 1996, Hokkaido Journal of Medical Science, V71, P403; Ptacek LJ, 2007, COLD SPRING HARB SYM, V72, P273; REME CE, 1991, J BIOL RHYTHM, V6, P5, DOI 10.1177/074873049100600104; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; VANREETH O, 1994, P SOC EXP BIOL MED, V206, P138; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Wright KP, 2005, J BIOL RHYTHM, V20, P168, DOI 10.1177/0748730404274265; Wright KP, 2001, P NATL ACAD SCI USA, V98, P14027, DOI 10.1073/pnas.201530198; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	29	66	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13376	10.1371/journal.pone.0013376	http://dx.doi.org/10.1371/journal.pone.0013376			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	21042402	Green Published, Green Accepted, gold			2022-12-27	WOS:000283043700003
J	Radoslavov, G; Jordanova, R; Teofanova, D; Georgieva, K; Hristov, P; Salomone-Stagni, M; Liebau, E; Bankov, I				Radoslavov, Georgi; Jordanova, Rositsa; Teofanova, Denitsa; Georgieva, Katya; Hristov, Petar; Salomone-Stagni, Marco; Liebau, Eva; Bankov, Ilia			A Novel Secretory Poly-Cysteine and Histidine-Tailed Metalloprotein (Ts-PCHTP) from Trichinella spiralis (Nematoda)	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; SECONDARY STRUCTURE; BINDING SITES; PROTEIN; SEQUENCE; PREDICTION; CLONING; DOMAIN; ZINC; IDENTIFICATION	Background: Trichinella spiralis is an unusual parasitic intracellular nematode causing dedifferentiation of the host myofiber. Trichinella proteomic analyses have identified proteins that act at the interface between the parasite and the host and are probably important for the infection and pathogenesis. Many parasitic proteins, including a number of metalloproteins are unique for the nematodes and trichinellids and therefore present good targets for future therapeutic developments. Furthermore, detailed information on such proteins and their function in the nematode organism would provide better understanding of the parasite-host interactions. Methodology/Principal Findings: In this study we report the identification, biochemical characterization and localization of a novel poly-cysteine and histidine-tailed metalloprotein (Ts-PCHTP). The native Ts-PCHTP was purified from T. spiralis muscle larvae that were isolated from infected rats as a model system. The sequence analysis showed no homology with other proteins. Two unique poly-cysteine domains were found in the amino acid sequence of Ts-PCHTP. This protein is also the first reported natural histidine tailed protein. It was suggested that Ts-PCHTP has metal binding properties. Total Reflection X-ray Fluorescence (TXRF) assay revealed that it binds significant concentrations of iron, nickel and zinc at protein: metal ratio of about 1:2. Immunohistochemical analysis showed that the Ts-PCHTP is localized in the cuticle and in all tissues of the larvae, but that it is not excreted outside the parasite. Conclusions/Significance: Our data suggest that Ts-PCHTP is the first described member of a novel nematode poly-cysteine protein family and its function could be metal storage and/or transport. Since this protein family is unique for parasites from Superfamily Trichinelloidea its potential applications in diagnostics and treatment could be exploited in future.	[Radoslavov, Georgi; Teofanova, Denitsa; Georgieva, Katya; Hristov, Petar; Bankov, Ilia] Bulgarian Acad Sci, Dept Biochem, Inst Expt Pathol & Parasitol, Sofia, Bulgaria; [Jordanova, Rositsa; Salomone-Stagni, Marco] DESY, European Mol Biol Lab, Hamburg Outstn, D-2000 Hamburg, Germany; [Liebau, Eva] Univ Munster, Inst Zoophysiol, Munster, Germany	Bulgarian Academy of Sciences; Medical University Sofia; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Munster	Radoslavov, G (corresponding author), Bulgarian Acad Sci, Dept Biochem, Inst Expt Pathol & Parasitol, Sofia, Bulgaria.	gradoslavov@gmail.com	Radoslavov, Georgi/AAO-5374-2021; Teofanova, Denitsa/AAK-3183-2021	Radoslavov, Georgi/0000-0003-0550-3291; Hristov, Peter/0000-0002-7756-4571; Teofanova, Denitsa/0000-0002-0467-485X; Georgieva, K/0000-0003-1490-1734	Deutsche Forschungsgemeinschaft (DFG) [LI 793/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This investigation was supported by the Deutsche Forschungsgemeinschaft (DFG) grant LI 793/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, 1991, BIOCHEM J, V280, P233, DOI 10.1042/bj2800233; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2004, PREDICTION N GLYCOSY; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi F, 2009, VET PARASITOL, V159, P258, DOI 10.1016/j.vetpar.2008.10.038; CLOS J, 1994, PROTEIN EXPRES PURIF, V5, P133, DOI 10.1006/prep.1994.1020; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Despommier D.D., 2005, PARASITIC DIS; Despommier DD, 1998, PARASITOL TODAY, V14, P318, DOI 10.1016/S0169-4758(98)01287-3; Fu BQ, 2005, VET PARASITOL, V132, P27, DOI 10.1016/j.vetpar.2005.05.059; Gare D, 2004, MOL BIOCHEM PARASIT, V134, P257, DOI 10.1016/j.molbiopara.2004.01.001; Garnier J, 1996, METHOD ENZYMOL, V266, P540; GARRETT R, 2005, SCIENCE, V181, P1037; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gattiker A, 2002, PROTEOMICS, V2, P1435, DOI 10.1002/1615-9861(200210)2:10<1435::AID-PROT1435>3.0.CO;2-9; GREGORY DS, 1993, PROTEIN ENG, V6, P29, DOI 10.1093/protein/6.1.29; HENGEN PN, 1995, TRENDS BIOCHEM SCI, V20, P285, DOI 10.1016/S0968-0004(00)89045-3; Jones AL, 2005, IMMUNOL CELL BIOL, V83, P106, DOI 10.1111/j.1440-1711.2005.01320.x; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; Jordanova R, 2005, FEBS J, V272, P180, DOI 10.1111/j.1432-1033.2004.04398.x; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Liu CL, 2002, J INORG BIOCHEM, V88, P77, DOI 10.1016/S0162-0134(01)00337-3; Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MATTHEWS DJ, 1995, CURR OPIN BIOTECH, V6, P419, DOI 10.1016/0958-1669(95)80071-9; Maurer-Stroh S, 2003, BIOL CHEM, V384, P977, DOI 10.1515/BC.2003.110; Mitreva Makedonka, 2006, WormBook, P1; Nagano I, 2009, PARASITOL RES, V104, P197, DOI 10.1007/s00436-008-1248-1; Park J, 1998, J MOL BIOL, V284, P1201, DOI 10.1006/jmbi.1998.2221; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettitt J, 2008, RNA, V14, P760, DOI 10.1261/rna.948008; POZIO E, 1992, J PARASITOL, V78, P647, DOI 10.2307/3283539; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6; Robinson MW, 2007, MOL BIOCHEM PARASIT, V151, P9, DOI 10.1016/j.molbiopara.2006.09.008; Robinson MW, 2005, PROTEOMICS, V5, P4525, DOI 10.1002/pmic.200402057; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scott WG, 2007, CURR OPIN STRUC BIOL, V17, P280, DOI 10.1016/j.sbi.2007.05.003; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sole VA, 2007, SPECTROCHIM ACTA B, V62, P63, DOI 10.1016/j.sab.2006.12.002; SREERAMA N, 1994, BIOCHEMISTRY-US, V33, P10022, DOI 10.1021/bi00199a028; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314; WRIGHT KA, 1979, J PARASITOL, V65, P441, DOI 10.2307/3280292; Wu WK, 2008, PARASITOL RES, V102, P251, DOI 10.1007/s00436-007-0755-9; Wu WK, 2006, PARASITOL RES, V98, P281, DOI 10.1007/s00436-005-0056-0; Wylie T, 2004, NUCLEIC ACIDS RES, V32, pD423, DOI 10.1093/nar/gkh010; YAMASHITA MM, 1990, P NATL ACAD SCI USA, V87, P5648, DOI 10.1073/pnas.87.15.5648; YILU, 2005, ENCY INORGANIC CHEM, V5, P3159; Zarlenga DS, 2009, VET PARASITOL, V159, P210, DOI 10.1016/j.vetpar.2008.10.061; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	54	9	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13343	10.1371/journal.pone.0013343	http://dx.doi.org/10.1371/journal.pone.0013343			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967224	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800033
J	Jeyabalan, A; Powers, RW; Clifton, RG; Van Dorsten, P; Hauth, JC; Klebanoff, MA; Lindheimer, MD; Sibai, B; Landon, M; Miodovnik, M				Jeyabalan, Arun; Powers, Robert W.; Clifton, Rebecca G.; Van Dorsten, Peter; Hauth, John C.; Klebanoff, Mark A.; Lindheimer, Marshall D.; Sibai, Baha; Landon, Mark; Miodovnik, Menachem		Eunice Kennedy Shriver Natl Inst C; Human Dev Maternal-Fetal Med Units	Effect of Smoking on Circulating Angiogenic Factors in High Risk Pregnancies	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CIGARETTE-SMOKING; MATERNAL SMOKING; SOLUBLE ENDOGLIN; PREECLAMPSIA; WOMEN; HYPERTENSION; RECEPTOR; OUTCOMES; SMOKERS	Objective: Changes in maternal concentrations of the anti-angiogenic factors, soluble fms-like tyrosine kinase 1 (sFlt1) and soluble endoglin (sEng), and the pro-angiogenic placental growth factor (PlGF) precede the development of preeclampsia in healthy women. The risk of preeclampsia is reduced in women who smoke during pregnancy. The objective of this study was to investigate whether smoking affects concentrations of angiogenic factors (sFlt1, PlGF, and sEng) in women at high risk for developing preeclampsia. Study Design: We performed a secondary analysis of serum samples from 993 high-risk women (chronic hypertension, diabetes, multifetal gestation, and previous preeclampsia) in a preeclampsia prevention trial. sFlt1, sEng and PlGF were measured in serum samples obtained at study entry, which was prior to initiation of aspirin (median 19.0 weeks' [interquartile range of 16.0-22.6 weeks']). Smoking status was determined by self-report. Results: sFlt1 was not significantly different in smokers from any high-risk groups compared to their nonsmoking counterparts. PlGF was higher among smokers compared to nonsmokers among diabetic women (142.7 [77.4-337.3] vs 95.9 [48.5-180.7] pg/ml, p = 0.005) and women with a history of preeclampsia (252.2 [137.1-486.0] vs 152.2 [73.6-253.7] pg/ml, p = 0.001). sEng was lower in smokers with multifetal gestations (5.8 [4.6-6.5] vs 6.8 [5.5-8.7] ng/ml, p = 0.002) and trended lower among smokers with diabetes (4.9 [3.8-5.6] vs 5.3 [4.3-6.3] ng/ml, p = 0.05). Smoking was not associated with a lower incidence of preeclampsia in any of these groups. Conclusions: In certain high-risk groups, smoking is associated with changes in the concentrations of these factors towards a pro-angiogenic direction during early pregnancy; however, there was no apparent association between smoking and the development of preeclampsia in our cohort.	[Jeyabalan, Arun; Powers, Robert W.] Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA; [Clifton, Rebecca G.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Van Dorsten, Peter] Med Univ S Carolina, Dept Obstet & Gynecol, Charleston, SC 29425 USA; [Hauth, John C.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Med Sch Birmingham, Birmingham, AL 35294 USA; [Klebanoff, Mark A.] Eunice Kennedy Shriver NICHHD, Bethesda, MD USA; [Lindheimer, Marshall D.] Univ Chicago, Sch Med, Dept Obstet & Gynecol, Chicago, IL 60637 USA; [Sibai, Baha] Univ Tennessee, Sch Med, Dept Obstet & Gynecol, Memphis, TN USA; [Landon, Mark] Ohio State Univ, Sch Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA; [Miodovnik, Menachem] Univ Cincinnati, Sch Med, Dept Obstet & Gynecol, Cincinnati, OH USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; George Washington University; Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Chicago; University of Tennessee System; University of Tennessee Health Science Center; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati	Jeyabalan, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Obstet Gynecol & Womens Hlth, Pittsburgh, PA 15260 USA.	ajeyabalan@mail.magee.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, HD27917, NIH-2P01-HD30367]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD027869, P01HD030367, U10HD021410, U10HD027917, UG1HD027915, UG1HD027869, U10HD036801, U10HD027915] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD036801, U10HD021434, U10HD027861, U10HD027860, U01HD021414, U01HD021434, U10HD021414, U10HD027883, U10HD027905, U01HD021410, U01HD019897, U10HD027889] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD19897, HD36801, HD21410, HD21414, HD21434, HD27860, HD27861, HD27869, HD27883, HD27889, HD27905, HD27915, and HD27917) and NIH-2P01-HD30367. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belgore FM, 2000, BRIT J BIOMED SCI, V57, P207; Caritis S, 1998, NEW ENGL J MED, V338, P701, DOI 10.1056/NEJM199803123381101; Castles A, 1999, AM J PREV MED, V16, P208, DOI 10.1016/S0749-3797(98)00089-0; *CDCP, 2004, MMWR; Chappell LC, 2008, HYPERTENSION, V51, P1002, DOI 10.1161/HYPERTENSIONAHA.107.107565; Conde-Agudelo A, 1999, AM J OBSTET GYNECOL, V181, P1026, DOI 10.1016/S0002-9378(99)70341-8; Contreras KR, 2010, J PERINATOL, V30, P319, DOI 10.1038/jp.2009.175; COONROD DV, 1995, OBSTET GYNECOL, V85, P645, DOI 10.1016/0029-7844(95)00049-W; Cundy T, 2002, DIABETIC MED, V19, P482, DOI 10.1046/j.1464-5491.2002.00729.x; Engel SM, 2009, AM J EPIDEMIOL, V169, P33, DOI 10.1093/aje/kwn293; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; England LJ, 2007, NICOTINE TOB RES, V9, P1005, DOI 10.1080/14622200701491255; Janakiraman V, 2009, NICOTINE TOB RES, V11, P679, DOI 10.1093/ntr/ntp049; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Karumanchi SA, 2010, HYPERTENSION, V55, P1100, DOI 10.1161/HYPERTENSIONAHA.109.148973; Khoury J C, 2004, J Matern Fetal Neonatal Med, V15, P44, DOI 10.1080/14767050310001650716; Klebanoff MA, 1998, AM J EPIDEMIOL, V148, P259; Levine R, 2006, AM J OBSTET GYNECOL, V195, pS37, DOI 10.1016/j.ajog.2006.10.100; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Martin CL, 2000, BRIT J OBSTET GYNAEC, V107, P745, DOI 10.1111/j.1471-0528.2000.tb13335.x; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Mehendale R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.025; Ness RB, 2008, AM J EPIDEMIOL, V168, P427, DOI 10.1093/aje/kwn140; Powers RW, 2005, AM J OBSTET GYNECOL, V193, P185, DOI 10.1016/j.ajog.2004.11.038; POWERS RW, 2010, PLOS ONE IN PRESS; Schmidt-Lucke C, 2005, INT J CARDIOL, V100, P207, DOI 10.1016/j.ijcard.2004.05.046; Sinclair SH, 2006, EXPERT REV MED DEVIC, V3, P301, DOI 10.1586/17434440.3.3.301; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082	30	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13270	10.1371/journal.pone.0013270	http://dx.doi.org/10.1371/journal.pone.0013270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967275	Green Published, gold, Green Accepted			2022-12-27	WOS:000282807300012
J	Weidenmaier, C; McLoughlin, RM; Lee, JC				Weidenmaier, Christopher; McLoughlin, Rachel M.; Lee, Jean C.			The Zwitterionic Cell Wall Teichoic Acid of Staphylococcus aureus Provokes Skin Abscesses in Mice by a Novel CD4+T-Cell-Dependent Mechanism	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; CAPSULAR POLYSACCHARIDES; NASAL COLONIZATION; ANTIMICROBIAL PEPTIDES; ENDOTHELIAL-CELLS; T-CELLS; EXPRESSION; VIRULENCE; INFECTIONS; RESISTANCE	Zwitterionic polysaccharide (ZPS) components of the bacterial cell envelope have been shown to exert a major histocompatibility complex (MHC) II-dependent activation of CD4+ T cells, which in turn can modulate the outcome and progression of infections in animal models. We investigated the impact of zwitterionic cell wall teichoic acid (WTA) produced by Staphylococcus aureus on the development of skin abscesses in a mouse model. We also compared the relative biological activities of WTA and capsular polysaccharide (CP), important S. aureus pathogenicity factors, in abscess formation. Expression of both WTA and CP markedly affected the ability of S. aureus to induce skin abscess formation in mice. Purified wild-type zwitterionic WTA was more active in inducing abscess formation than negatively charged mutant WTA or purified CP8. To assess the ability of purified native WTA to stimulate T cell proliferation in vitro, we co-cultivated WTA with human T-cells and antigen presenting cells in the presence and absence of various inhibitors of MHC-II presentation. Wild-type WTA induced T cell proliferation to a significantly greater extent than negatively charged WTA. T cell activation was dependent on the presentation of WTA on MHC II, since inhibitors of MHC II-dependent presentation and antibodies to MHC II significantly reduced T cell proliferation. T cells activated in vitro with wild-type WTA, but not negatively charged WTA, induced abscess formation when injected subcutaneously into wild-type mice. CD4-/- mice similarly injected with WTA failed to develop abscesses. Our results demonstrate that the zwitterionic WTA of S. aureus induces CD4+ T-cell proliferation in an MHCII-dependent manner, which in turn modulates abscess formation in a mouse skin infection model. An understanding of this novel T cell-dependent host response to staphylococcal abscess formation may lead to the development of new strategies to combat S. aureus skin and soft tissue infections.	[Weidenmaier, Christopher] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Weidenmaier, C (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA.	jclee@rics.bwh.harvard.edu		Lee, Jean/0000-0002-8094-5180; McLoughlin, Rachel/0000-0003-4553-018X; Weidenmaier, Christopher/0000-0003-4107-739X	Deutsche Forschungsgesellschaft	Deutsche Forschungsgesellschaft(German Research Foundation (DFG))	CW was supported by a fellowship from the Deutsche Forschungsgesellschaft (http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddiley J, 1972, Essays Biochem, V8, P35; Bernal P, 2009, J ANTIMICROB CHEMOTH, V63, P1156, DOI 10.1093/jac/dkp094; Brown S, 2008, CHEM BIOL, V15, P12, DOI 10.1016/j.chembiol.2007.11.011; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Cobb BA, 2005, CELL MICROBIOL, V7, P1398, DOI 10.1111/j.1462-5822.2005.00591.x; Cobb BA, 2008, GLYCOBIOLOGY, V18, P707, DOI 10.1093/glycob/cwn050; Cocchiaro JL, 2006, MOL MICROBIOL, V59, P948, DOI 10.1111/j.1365-2958.2005.04978.x; Doss M, J LEUKOC BIOL, V87, P79; Durr MC, 2006, CELL MICROBIOL, V8, P207, DOI 10.1111/j.1462-5822.2005.00610.x; Herbert S, 2001, J BACTERIOL, V183, P4609, DOI 10.1128/JB.183.15.4609-4613.2001; HUGHES AH, 1973, BIOCHEM J, V132, P83, DOI 10.1042/bj1320083; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Kalka-Moll WM, 2002, J IMMUNOL, V169, P6149, DOI 10.4049/jimmunol.169.11.6149; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; Koprivnjak T, 2008, INFECT IMMUN, V76, P2169, DOI 10.1128/IAI.01705-07; Kraus D, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-85; LEE JC, 1993, INFECT IMMUN, V61, P1853, DOI 10.1128/IAI.61.5.1853-1858.1993; Luong T, 2002, INFECT IMMUN, V70, P444, DOI 10.1128/IAI.70.2.444-450.2002; Magnotti LJ, 1998, ANN SURG, V228, P518, DOI 10.1097/00000658-199810000-00008; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; McLoughlin RM, 2008, J IMMUNOL, V181, P1323, DOI 10.4049/jimmunol.181.2.1323; McLoughlin RM, 2006, P NATL ACAD SCI USA, V103, P10408, DOI 10.1073/pnas.0508961103; Montgomery CP, 2008, J INFECT DIS, V198, P561, DOI 10.1086/590157; Moreillon P, 2003, SCAND J INFECT DIS, V35, P632, DOI 10.1080/00365540310016259; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Nilsson IM, 1997, INFECT IMMUN, V65, P4216, DOI 10.1128/IAI.65.10.4216-4221.1997; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Portoles M, 2001, INFECT IMMUN, V69, P917, DOI 10.1128/IAI.69.2.917-923.2001; SAXENA S, 1997, EMERG INFECT DIS, V16, P530; SCHLAG M, MOL MICROBIOL; Stevens DL, 2009, J INFECTION, V59, pS32, DOI 10.1016/S0163-4453(09)60006-2; Thakker M, 1998, INFECT IMMUN, V66, P5183, DOI 10.1128/IAI.66.11.5183-5189.1998; TOMASZ A, 1975, J SUPRAMOL STR CELL, V3, P1, DOI 10.1002/jss.400030102; Tzianabos AO, 2001, P NATL ACAD SCI USA, V98, P9365, DOI 10.1073/pnas.161175598; Tzianabos AO, 2000, INFECT IMMUN, V68, P6650, DOI 10.1128/IAI.68.12.6650-6655.2000; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005; Weidenmaier C, 2005, J INFECT DIS, V191, P1771, DOI 10.1086/429692; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Weidenmaier C, 2008, INT J MED MICROBIOL, V298, P505, DOI 10.1016/j.ijmm.2007.11.006	49	32	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13227	10.1371/journal.pone.0013227	http://dx.doi.org/10.1371/journal.pone.0013227			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949105	Green Published, Green Submitted, gold			2022-12-27	WOS:000282633700016
J	Zach, S; Felk, S; Gillardon, F				Zach, Susanne; Felk, Sandra; Gillardon, Frank			Signal Transduction Protein Array Analysis Links LRRK2 to Ste20 Kinases and PKC Zeta That Modulate Neuronal Plasticity	PLOS ONE			English	Article								Background: Dominant mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson's disease, however, the underlying pathogenic mechanisms are poorly understood. Several in vitro studies have shown that the most frequent mutation, LRRK2(G2019S), increases kinase activity and impairs neuronal survival. LRRK2 has been linked to the mitogen-activated protein kinase kinase kinase family and the receptor-interacting protein kinases based on sequence similarity within the kinase domain and in vitro substrate phosphorylation. Methodology/Principal Findings: We used an unbiased proteomic approach to identify the kinase signaling pathways wherein LRRK2 may be active. By incubation of protein microarrays containing 260 signal transduction proteins we detected four arrayed Ste20 serine/threonine kinase family members (TAOK3, STK3, STK24, STK25) as novel LRRK2 substrates and LRRK2 interacting proteins, respectively. Moreover, we found that protein kinase C (PKC) zeta binds and phosphorylates LRRK2 both in vitro and in vivo. Conclusions/Significance: Ste20 kinases and PKC zeta contribute to neuronal Tau phosphorylation, neurite outgrowth and synaptic plasticity under physiological conditions. Our data suggest that these kinases may also be involved in synaptic dysfunction and neurite fragmentation in transgenic mice and in human PD patients carrying toxic gain-of-function LRRK2 mutations.	[Zach, Susanne; Felk, Sandra; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany	Boehringer Ingelheim	Gillardon, F (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany.	Frank.Gillardon@boehringer-ingelheim.com						Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Chen C, 2009, ENVIRON SCI ENG TECH, P29; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Li YP, 2009, NAT NEUROSCI, V12, P826, DOI 10.1038/nn.2349; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; Liu XF, 2009, J NEUROSCI, V29, P12229, DOI 10.1523/JNEUROSCI.2842-09.2009; Lorber B, 2009, NAT NEUROSCI, V12, P1407, DOI 10.1038/nn.2414; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Melrose H, 2008, FUTUR NEUROL, V3, P669, DOI 10.2217/14796708.3.6.669; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Pombo CM, 1996, EMBO J, V15, P4537, DOI 10.1002/j.1460-2075.1996.tb00831.x; Sacktor TC, 2008, PROG BRAIN RES, V169, P27, DOI 10.1016/S0079-6123(07)00002-7; Strange K, 2006, PHYSIOLOGY, V21, P61, DOI 10.1152/physiol.00139.2005; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Taymans JM, 2010, BIOESSAYS, V32, P227, DOI 10.1002/bies.200900163; Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447; Wang LZ, 2008, J NEUROSCI, V28, P3384, DOI 10.1523/JNEUROSCI.0185-08.2008	31	33	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13191	10.1371/journal.pone.0013191	http://dx.doi.org/10.1371/journal.pone.0013191			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949042	Green Published, gold, Green Submitted			2022-12-27	WOS:000208952200003
J	Price, GE; Soboleski, MR; Lo, CY; Misplon, JA; Quirion, MR; Houser, KV; Pearce, MB; Pappas, C; Tumpey, TM; Epstein, SL				Price, Graeme E.; Soboleski, Mark R.; Lo, Chia-Yun; Misplon, Julia A.; Quirion, Mary R.; Houser, Katherine V.; Pearce, Melissa B.; Pappas, Claudia; Tumpey, Terrence M.; Epstein, Suzanne L.			Single-Dose Mucosal Immunization with a Candidate Universal Influenza Vaccine Provides Rapid Protection from Virulent H5N1, H3N2 and H1N1 Viruses	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; A VIRUS; RECOMBINANT ADENOVIRUS; DENDRITIC CELLS; IMMUNE-RESPONSES; IN-VIVO; HETEROSUBTYPIC IMMUNITY; INTRANASAL IMMUNIZATION; MATRIX PROTEIN-2; ANTIGENIC DRIFT	Background: The sudden emergence of novel influenza viruses is a global public health concern. Conventional influenza vaccines targeting the highly variable surface glycoproteins hemagglutinin and neuraminidase must antigenically match the emerging strain to be effective. In contrast, "universal'' vaccines targeting conserved viral components could be used regardless of viral strain or subtype. Previous approaches to universal vaccination have required protracted multi-dose immunizations. Here we evaluate a single dose universal vaccine strategy using recombinant adenoviruses (rAd) expressing the conserved influenza virus antigens matrix 2 and nucleoprotein. Methodology/Principal Findings: In BALB/c mice, administration of rAd via the intranasal route was superior to intramuscular immunization for induction of mucosal responses and for protection against highly virulent H1N1, H3N2, or H5N1 influenza virus challenge. Mucosally vaccinated mice not only survived, but had little morbidity and reduced lung virus titers. Protection was observed as early as 2 weeks post-immunization, and lasted at least 10 months, as did antibodies and lung T cells with activated phenotypes. Virus-specific IgA correlated with but was not essential for protection, as demonstrated in studies with IgA-deficient animals. Conclusion/Significance: Mucosal administration of NP and M2-expressing rAd vectors provided rapid and lasting protection from influenza viruses in a subtype-independent manner. Such vaccines could be used in the interval between emergence of a new virus strain and availability of strain-matched vaccines against it. This strikingly effective single-dose vaccination thus represents a candidate off-the-shelf vaccine for emergency use during an influenza pandemic.	[Price, Graeme E.; Soboleski, Mark R.; Lo, Chia-Yun; Misplon, Julia A.; Quirion, Mary R.; Epstein, Suzanne L.] US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA; [Houser, Katherine V.; Pearce, Melissa B.; Pappas, Claudia; Tumpey, Terrence M.] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Price, GE (corresponding author), US FDA, Div Cellular & Gene Therapies, Ctr Biol Evaluat & Res, Rockville, MD 20857 USA.	suzanne.epstein@fda.hhs.gov		Misplon, Julia/0000-0001-9614-5922; Epstein, Suzanne/0000-0002-6311-6890	National Institute of Allergy and Infectious Diseases Trans-NIH/FDA; Office of Public Health Medical Emergency Counter-Measures; FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative	National Institute of Allergy and Infectious Diseases Trans-NIH/FDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of Public Health Medical Emergency Counter-Measures; FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative	This work was supported by grants from the National Institute of Allergy and Infectious Diseases Trans-NIH/FDA Intramural Biodefense Program, the Office of Public Health Medical Emergency Counter-Measures, and the FDA's Center for Biologics Evaluation and Research (CBER) pandemic influenza initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barouch DH, 2005, HUM GENE THER, V16, P149, DOI 10.1089/hum.2005.16.149; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Boon ACM, 2002, J VIROL, V76, P2567, DOI 10.1128/JVI.76.5.2567-2572.2002; BOZIC CR, 1995, J IMMUNOL, V154, P6048; Brown LE, 2009, IMMUNOL CELL BIOL, V87, P300, DOI 10.1038/icb.2009.16; Bui HH, 2007, P NATL ACAD SCI USA, V104, P246, DOI 10.1073/pnas.0609330104; Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; CHEN KS, 1988, J GEN VIROL, V69, P2779, DOI 10.1099/0022-1317-69-11-2779; Damjanovic Daniela, 2008, Genet Vaccines Ther, V6, P5, DOI 10.1186/1479-0556-6-5; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Edelstein ML, 2007, J GENE MED, V9, P833, DOI 10.1002/jgm.1100; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Epstein SL, 2005, VACCINE, V23, P5404, DOI 10.1016/j.vaccine.2005.04.047; Epstein Suzanne L, 2003, Expert Rev Anti Infect Ther, V1, P627, DOI 10.1586/14787210.1.4.627; Finn JD, 2009, J VIROL, V83, P12027, DOI 10.1128/JVI.00593-09; Gao WT, 2006, J VIROL, V80, P1959, DOI 10.1128/JVI.80.4.1959-1964.2006; Harriman GR, 1999, J IMMUNOL, V162, P2521; Harvey BG, 1999, J VIROL, V73, P6729, DOI 10.1128/JVI.73.8.6729-6742.1999; Heiny AT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001190; Hoelscher MA, 2006, LANCET, V367, P475, DOI 10.1016/S0140-6736(06)68076-8; Hogan RJ, 2001, J IMMUNOL, V166, P1813, DOI 10.4049/jimmunol.166.3.1813; Holman DH, 2008, VACCINE, V26, P2627, DOI 10.1016/j.vaccine.2008.02.053; Jegerlehner A, 2002, VACCINE, V20, P3104, DOI 10.1016/S0264-410X(02)00266-9; Jelley-Gibbs DM, 2007, J IMMUNOL, V178, P7563, DOI 10.4049/jimmunol.178.12.7563; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Julia V, 2002, IMMUNITY, V16, P271, DOI 10.1016/S1074-7613(02)00276-5; Karzon DT, 1996, SEMIN VIROL, V7, P265, DOI 10.1006/smvy.1996.0033; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lemiale F, 2003, J VIROL, V77, P10078, DOI 10.1128/JVI.77.18.10078-10087.2003; Leroux-Roels I, 2009, EXPERT REV VACCINES, V8, P401, DOI 10.1586/ERV.09.15; Lo CY, 2008, VACCINE, V26, P2062, DOI 10.1016/j.vaccine.2008.02.047; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; McKelvey T, 2004, GENE THER, V11, P791, DOI 10.1038/sj.gt.3302232; Murphy BR, 2002, VIRAL IMMUNOL, V15, P295, DOI 10.1089/08828240260066242; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Rao SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009812; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Roy S, 2007, VACCINE, V25, P6845, DOI 10.1016/j.vaccine.2007.07.035; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; SMEENK CA, 1994, J VIROL, V68, P530, DOI 10.1128/JVI.68.1.530-534.1994; Stobie L, 2000, P NATL ACAD SCI USA, V97, P8427, DOI 10.1073/pnas.160197797; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Szabo SJ, 2003, ANNU REV IMMUNOL, V21, P713, DOI 10.1146/annurev.immunol.21.120601.140942; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Tatsis N, 2006, GENE THER, V13, P421, DOI 10.1038/sj.gt.3302675; Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; Thorner AR, 2006, J VIROL, V80, P12009, DOI 10.1128/JVI.01749-06; Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Van Kampen KR, 2005, VACCINE, V23, P1029, DOI 10.1016/j.vaccine.2004.07.043; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; Wang J, 2004, J IMMUNOL, V173, P6357, DOI 10.4049/jimmunol.173.10.6357; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Xu Q, 2009, GENE THER, V16, P367, DOI 10.1038/gt.2008.181; Yamaguchi T, 2007, HUM GENE THER, V18, P753, DOI 10.1089/hum.2007.016; YOUNG HA, 1995, J LEUKOCYTE BIOL, V58, P373, DOI 10.1002/jlb.58.4.373; Yu JR, 2008, J VIROL, V82, P2350, DOI 10.1128/JVI.02372-07; Zammit DJ, 2006, IMMUNITY, V24, P439, DOI 10.1016/j.immuni.2006.01.015; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988; Zeng H, 2007, J VIROL, V81, P12439, DOI 10.1128/JVI.01134-07; Zhang Y, 2001, MOL THER, V3, P697, DOI 10.1006/mthe.2001.0329; Zharikova D, 2005, J VIROL, V79, P6644, DOI 10.1128/JVI.79.11.6644-6654.2005; Zhong L, 1999, EUR J IMMUNOL, V29, P964, DOI 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; 2009, MMWR MORB MORTAL WKL, V59, P44	72	105	111	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13162	10.1371/journal.pone.0013162	http://dx.doi.org/10.1371/journal.pone.0013162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20976273	Green Submitted, gold, Green Published			2022-12-27	WOS:000282423300009
J	Ferri, F; Stoianov, IP; Gianelli, C; D'Amico, L; Borghi, AM; Gallese, V				Ferri, Francesca; Stoianov, Ivilin Peev; Gianelli, Claudia; D'Amico, Luigi; Borghi, Anna M.; Gallese, Vittorio			When Action Meets Emotions: How Facial Displays of Emotion Influence Goal-Related Behavior	PLOS ONE			English	Article							MOTOR CORTEX EXCITABILITY; SOCIAL COGNITION; ARM FLEXION; EXPRESSIONS; AVOIDANCE; RECOGNITION; INFORMATION; PERCEPTION; EXTENSION; DISGUST	Many authors have proposed that facial expressions, by conveying emotional states of the person we are interacting with, influence the interaction behavior. We aimed at verifying how specific the effect is of the facial expressions of emotions of an individual (both their valence and relevance/specificity for the purpose of the action) with respect to how the action aimed at the same individual is executed. In addition, we investigated whether and how the effects of emotions on action execution are modulated by participants' empathic attitudes. We used a kinematic approach to analyze the simulation of feeding others, which consisted of recording the 'feeding trajectory'' by using a computer mouse. Actors could express different highly arousing emotions, namely happiness, disgust, anger, or a neutral expression. Response time was sensitive to the interaction between valence and relevance/specificity of emotion: disgust caused faster response. In addition, happiness induced slower feeding time and longer time to peak velocity, but only in blocks where it alternated with expressions of disgust. The kinematic profiles described how the effect of the specificity of the emotional context for feeding, namely a modulation of accuracy requirements, occurs. An early acceleration in kinematic relative-to-neutral feeding profiles occurred when actors expressed positive emotions (happiness) in blocks with specific-to-feeding negative emotions (disgust). On the other hand, the end-part of the action was slower when feeding happy with respect to neutral faces, confirming the increase of accuracy requirements and motor control. These kinematic effects were modulated by participants' empathic attitudes. In conclusion, the social dimension of emotions, that is, their ability to modulate others' action planning/execution, strictly depends on their relevance and specificity to the purpose of the action. This finding argues against a strict distinction between social and nonsocial emotions.	[Ferri, Francesca; Gallese, Vittorio] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Gallese, Vittorio] Italian Inst Technol, Brain Ctr Motor & Social Cognit, Parma, Italy; [Borghi, Anna M.] CNR, Inst Cognit Sci & Technol, Rome, Italy; [D'Amico, Luigi] Univ G dAnnunzio, Inst Psychiat, Chieti, Italy; [Stoianov, Ivilin Peev] Univ Padua, Dept Gen Psychol, Padua, Italy; [Gianelli, Claudia; Borghi, Anna M.] Univ Bologna, Dept Psychol, Bologna, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); G d'Annunzio University of Chieti-Pescara; University of Padua; University of Bologna	Ferri, F (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	francesca.ferri@nemo.unipr.it	Stoianov, Ivilin/AAX-8528-2020; Gianelli, Claudia/AAC-1518-2019; Ferri, Francesca/AAC-2527-2022; Gallese, Vittorio/ABD-5097-2021; Stoianov, Ivilin/G-5904-2011; Ferretti, Federico/AAR-9553-2021	Ferri, Francesca/0000-0003-1821-5870; Gallese, Vittorio/0000-0003-4815-3607; Stoianov, Ivilin/0000-0003-0642-259X; Ferretti, Federico/0000-0002-5446-6522; Gianelli, Claudia/0000-0002-3970-9055; Borghi, Anna M./0000-0001-9455-8408	MUR (Ministry of University and Research); European Union [216125]	MUR (Ministry of University and Research)(Ministry of Education, Universities and Research (MIUR)); European Union(European Commission)	This work was supported by MUR (Ministry of University and Research) and the European Union FP7 (Seventh Framework Programme) project ROSSI (Emergence of Communication in RObots through Sensorimotor and Social Interaction) grant agreement number 216125. FF and VG were also supported by the EU grant DISCOS (Disorders and Coherence of the Embodied Self). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Aviezer H, 2008, PSYCHOL SCI, V19, P724, DOI 10.1111/j.1467-9280.2008.02148.x; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BONINO S, PROCESSI CONDIVISION; Britton JC, 2006, NEUROIMAGE, V31, P397, DOI 10.1016/j.neuroimage.2005.11.027; CACIOPPO JT, 1993, J PERS SOC PSYCHOL, V65, P5; CARUANA F, 2008, INTRACORTICAL MICROS; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Darwin C., 1872, EXPRESSIONS EMOTIONS; Davis M., 1996, EMPATHY SOCIAL PSYCH; Davis M. H., 1980, JSAS CATALOG SELECTE, V10, P1, DOI DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; Dumouchel P., 1995, EMOTIONS ESSAI CORPS; Ekman Paul, 1972, NEBRASKA S MOTIVATIO, V19, P207, DOI DOI 10.1037/0022-3514.53.4.712; Elliot AJ, 2001, EDUC PSYCHOL REV, V13, P73, DOI 10.1023/A:1009009018235; Ferri F, 2010, EXP BRAIN RES, V203, P637, DOI 10.1007/s00221-010-2271-x; Fichtenholtz HM, 2004, COGNITIVE BRAIN RES, V20, P67, DOI 10.1016/j.cogbrainres.2004.01.006; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Forster J, 1997, PERCEPT MOTOR SKILL, V85, P1419, DOI 10.2466/pms.1997.85.3f.1419; Freeman JB, 2009, PSYCHOL SCI, V20, P1183, DOI 10.1111/j.1467-9280.2009.02422.x; Freina L, 2009, MEM COGNITION, V37, P493, DOI 10.3758/MC.37.4.493; Fridlund A. J., 1997, PSYCHOL FACIAL EXPRE, P103, DOI [10.1017/CBO9780511659911.007, DOI 10.1017/CBO9780511659911.007]; Fridlund A.J., 1994, HUMAN FACIAL EXPRESS; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallese V, 2007, PHILOS T R SOC B, V362, P659, DOI 10.1098/rstb.2006.2002; GOELEVEN E, 2000, COGNITION EMOTION, P1; Hajcak G, 2007, PSYCHOPHYSIOLOGY, V44, P91, DOI 10.1111/j.1469-8986.2006.00487.x; Halberstadt J, 2009, PSYCHOL SCI, V20, P1254, DOI 10.1111/j.1467-9280.2009.02432.x; Hatfield E., 1993, CURR DIR PSYCHOL SCI, V2, P96, DOI [DOI 10.1111/1467-8721.EP10770953, 10.1111/1467-8721.ep10770953]; Heuer K, 2007, BEHAV RES THER, V45, P2990, DOI 10.1016/j.brat.2007.08.010; Horstmann G, 2003, EMOTION, V3, P150, DOI 10.1037/1528-3542.3.2.150; Izard C. E., 1997, PSYCHOL FACIAL EXPRE, V2, P57, DOI DOI 10.1017/CBO9780511659911.005; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; Leslie KR, 2004, NEUROIMAGE, V21, P601, DOI 10.1016/j.neuroimage.2003.09.038; Marsh AA, 2005, EMOTION, V5, P119, DOI 10.1037/1528-3542.5.1.119; Mead G. H., 1934, MIND SELF SOC; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Oberman LM, 2007, SOC NEUROSCI-UK, V2, P167, DOI 10.1080/17470910701391943; Oliveri M, 2003, EXP BRAIN RES, V149, P214, DOI 10.1007/s00221-002-1346-8; Repacholi BM, 1997, DEV PSYCHOL, V33, P12, DOI 10.1037/0012-1649.33.1.12; Rotteveel M, 2004, EMOTION, V4, P156, DOI 10.1037/1528-3542.4.2.156; Schneider W., 2002, E PRIME VERSION 20 C; Schneider W., 2002, E PRIME USERS GUIDE; Seidel EM, 2010, J EXP PSYCHOL HUMAN, V36, P500, DOI 10.1037/a0018169; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Wilkowski BM, 2010, J PERS SOC PSYCHOL, V98, P201, DOI 10.1037/a0017992	52	27	27	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13126	10.1371/journal.pone.0013126	http://dx.doi.org/10.1371/journal.pone.0013126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	656TI	20957204	gold, Green Published			2022-12-27	WOS:000282359300020
J	Standar, K; Kreikemeyer, B; Redanz, S; Munter, WL; Laue, M; Podbielski, A				Standar, Kerstin; Kreikemeyer, Bernd; Redanz, Sylvio; Muenter, Wanja L.; Laue, Michael; Podbielski, Andreas			Setup of an In Vitro Test System for Basic Studies on Biofilm Behavior of Mixed-Species Cultures with Dental and Periodontal Pathogens	PLOS ONE			English	Article							GROUP-A STREPTOCOCCI; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AGGREGATIBACTER-ACTINOMYCETEMCOMITANS; ORAL BIOFILMS; SUBGINGIVAL PLAQUE; SURFACES; GROWTH; COLONIZATION; ADHESION; BACTERIA	Background: Caries and periodontitis are important human diseases associated with formation of multi-species biofilms. The involved bacteria are intensively studied to understand the molecular basis of the interactions in such biofilms. This study established a basic in vitro single and mixed-species culture model for oral bacteria combining three complimentary methods. The setup allows a rapid screening for effects in the mutual species interaction. Furthermore, it is easy to handle, inexpensive, and reproducible. Methods: Streptococcus mitis, S. salivarius and S. sanguinis, typical inhabitants of the healthy oral cavity, S. mutans as main carriogenic species, and Porphyromonas gingivalis, Fusobacterium nucleatum, Parvimonas micra, S. intermedius and Aggregatibacter actinomycetemcomitans as periodontitis-associated bacteria, were investigated for their biofilm forming ability. Different liquid growth media were evaluated. Safranin-staining allowed monitoring of biofilm formation under the chosen conditions. Viable counts and microscopy permitted investigation of biofilm behavior in mixed-species and transwell setups. Findings: S. mitis, F. nucleatum, P. gingivalis and P. micra failed to form biofilm structures. S. mutans, S. sanguinis, S. intermedius and S. salivarius established abundant biofilm masses in CDM/sucrose. A. actinomycetemcomitans formed patchy monolayers. For in depth analysis S. mitis, S. mutans and A. actinomycetemcomitans were chosen, because i) they are representatives of the physiological-, cariogenic and periodontitis-associated bacterial flora, respectively and ii) their difference in their biofilm forming ability. Microscopic analysis confirmed the results of safranin staining. Investigation of two species combinations of S. mitis with either S. mutans or A. actinomycetemcomitans revealed bacterial interactions influencing biofilm mass, biofilm structure and cell viability. Conclusions: This setup shows safranin staining, microscopic analysis and viable counts together are crucial for basic examination and evaluation of biofilms. Our experiment generated meaningful results, exemplified by the noted S. mitis influence, and allows a fast decision about the most important bacterial interactions which should be investigated in depth.	[Standar, Kerstin; Kreikemeyer, Bernd; Redanz, Sylvio; Muenter, Wanja L.; Podbielski, Andreas] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Laue, Michael] Univ Hosp Rostock, Inst Pathol, Electron Microscop Ctr, Rostock, Germany	University of Rostock; University of Rostock	Standar, K (corresponding author), Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	bernd.kreikemeyer@med.uni-rostock.de	Redanz, Sylvio/AAH-1369-2020	Kreikemeyer, Bernd/0000-0001-9527-5098; Redanz, Sylvio/0000-0003-1541-2545	Federal Ministry of Education and Research (BMBF) [FKZ 0313801M, FKZ 0313936B]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by grants from the Federal Ministry of Education and Research (BMBF) in the framework of the PathoGenoMic Plus program (FKZ 0313801M) and ERANet PathoGenoMics I program (FKZ 0313936B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe JJ, 2009, INFECT IMMUN, V77, P2896, DOI 10.1128/IAI.00126-09; Bowden GHW, 1999, METHOD ENZYMOL, V310, P216; Bowen WH, 2002, CRIT REV ORAL BIOL M, V13, P126, DOI 10.1177/154411130201300203; Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x; Brown SA, 2007, J BACTERIOL, V189, P6407, DOI 10.1128/JB.00554-07; CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318, DOI 10.1128/IAI.37.1.318-326.1982; COWAN MM, 1992, J GEN MICROBIOL, V138, P2707, DOI 10.1099/00221287-138-12-2707; Dawes C, 2008, J AM DENT ASSOC, V139, p18S, DOI 10.14219/jada.archive.2008.0351; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; FESSIA SL, 1991, PERITON DIALYSIS INT, V11, P144; Fine DH, 1999, MICROBIOL-SGM, V145, P1335, DOI 10.1099/13500872-145-6-1335; Fine DH, 1999, ARCH ORAL BIOL, V44, P1063, DOI 10.1016/S0003-9969(99)00089-8; Foster JS, 2003, BIOL BULL-US, V204, P200, DOI 10.2307/1543559; GARCIAMENDOZA A, 1993, J MED MICROBIOL, V39, P434, DOI 10.1099/00222615-39-6-434; Gomez-Suarez C, 2001, APPL ENVIRON MICROB, V67, P2531, DOI 10.1128/AEM.67.6.2531-2537.2001; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Haase EM, 2006, ARCH ORAL BIOL, V51, P299, DOI 10.1016/j.archoralbio.2005.09.002; Haffajee AD, 2006, PERIODONTOL 2000, V42, P219, DOI 10.1111/j.1600-0757.2006.00191.x; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Inoue T, 2003, MICROBIOL IMMUNOL, V47, P877, DOI 10.1111/j.1348-0421.2003.tb03454.x; Kaplan JB, 2003, J BACTERIOL, V185, P1399, DOI 10.1128/JB.185.4.1399-1404.2003; LARSEN T, 1995, APMIS, V103, P339, DOI 10.1111/j.1699-0463.1995.tb01117.x; LAW DJ, 1978, ANTIMICROB AGENTS CH, V13, P473, DOI 10.1128/AAC.13.3.473; Lembke C, 2006, APPL ENVIRON MICROB, V72, P2864, DOI 10.1128/AEM.72.4.2864-2875.2006; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Leriche V, 2000, J APPL MICROBIOL, V88, P594, DOI 10.1046/j.1365-2672.2000.01000.x; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Mager DL, 2003, J CLIN PERIODONTOL, V30, P644, DOI 10.1034/j.1600-051X.2003.00376.x; Ohta H, 2001, MICROBIOL-SGM, V147, P2461, DOI 10.1099/00221287-147-9-2461; Oliveira Mara R T R, 2007, J Oral Sci, V49, P141; Oliver JD, 2005, J MICROBIOL, V43, P93; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Periasamy S, 2009, INFECT IMMUN, V77, P3542, DOI 10.1128/IAI.00345-09; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Riep B, 2009, J CLIN MICROBIOL, V47, P1705, DOI 10.1128/JCM.01387-08; Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66; SJOLLEMA J, 1990, FEMS MICROBIOL LETT, V69, P263; Sliepen I, 2008, ORAL MICROBIOL IMMUN, V23, P520, DOI 10.1111/j.1399-302X.2008.00456.x; Sliepen I, 2009, ORAL MICROBIOL IMMUN, V24, P390, DOI 10.1111/j.1399-302X.2009.00531.x; Slots J, 1999, PERIODONTOL 2000, V20, P82, DOI 10.1111/j.1600-0757.1999.tb00159.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; SREENIVASAN PK, 1993, ORAL MICROBIOL IMMUN, V8, P361, DOI 10.1111/j.1399-302X.1993.tb00612.x; Stingu CS, 2008, J MED MICROBIOL, V57, P495, DOI 10.1099/jmm.0.47649-0; TALARICO TL, 1989, ANTIMICROB AGENTS CH, V33, P674, DOI 10.1128/AAC.33.5.674; Teughels W, 2007, J DENT RES, V86, P611, DOI 10.1177/154405910708600706; Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0; Van Hoogmoed CG, 2008, ORAL MICROBIOL IMMUN, V23, P43, DOI 10.1111/j.1399-302X.2007.00388.x; van Hoogmoed CG, 2000, APPL ENVIRON MICROB, V66, P659, DOI 10.1128/AEM.66.2.659-663.2000; van Winkelhoff AJ, 2002, J CLIN PERIODONTOL, V29, P1023, DOI 10.1034/j.1600-051X.2002.291107.x; VANDERIJN I, 1980, INFECT IMMUN, V27, P444, DOI 10.1128/IAI.27.2.444-448.1980; XU HS, 1982, MICROBIAL ECOL, V8, P313, DOI 10.1007/BF02010671	53	39	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13135	10.1371/journal.pone.0013135	http://dx.doi.org/10.1371/journal.pone.0013135			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957048	Green Submitted, gold, Green Published			2022-12-27	WOS:000282359300025
J	Kassim, SH; Li, H; Vandenberghe, LH; Hinderer, C; Bell, P; Marchadier, D; Wilson, A; Cromley, D; Redon, V; Yu, H; Wilson, JM; Rader, DJ				Kassim, Sadik H.; Li, Hui; Vandenberghe, Luk H.; Hinderer, Christian; Bell, Peter; Marchadier, Dawn; Wilson, Aisha; Cromley, Debra; Redon, Valeska; Yu, Hongwei; Wilson, James M.; Rader, Daniel J.			Gene Therapy in a Humanized Mouse Model of Familial Hypercholesterolemia Leads to Marked Regression of Atherosclerosis	PLOS ONE			English	Article							HELPER-DEPENDENT ADENOVIRUS; ADENOASSOCIATED VIRUS; LIVER-TRANSPLANTATION; CHOLESTEROL LEVELS; HEMOPHILIA-B; T-CELLS; MICE; VECTORS; DEFICIENCY; DISEASE	Background: Familial hypercholesterolemia (FH) is an autosomal codominant disorder caused by mutations in the low-density lipoprotein receptor (LDLR) gene. Homozygous FH patients (hoFH) have severe hypercholesterolemia leading to life threatening atherosclerosis in childhood and adolescence. Mice with germ line interruptions in the Ldlr and Apobec1 genes (Ldlr(-/-)Apobec1(-/-)) simulate metabolic and clinical aspects of hoFH, including atherogenesis on a chow diet. Methods/Principal Findings: In this study, vectors based on adeno-associated virus 8 (AAV8) were used to deliver the gene for mouse Ldlr (mLDLR) to the livers of Ldlr(-/-)Apobec1(-/)-mice. A single intravenous injection of AAV8. mLDLR was found to significantly reduce plasma cholesterol and non-HDL cholesterol levels in chow-fed animals at doses as low as 3 x 10(9) genome copies/mouse. Whereas Ldlr(-/-)Apobec1(-/-) mice fed a western-type diet and injected with a control AAV8. null vector experienced a further 65% progression in atherosclerosis over 2 months compared with baseline mice, Ldlr(-/-)Apobec1(-/-) mice treated with AAV8.mLDLR realized an 87% regression of atherosclerotic lesions after 3 months compared to baseline mice. Immunohistochemical analyses revealed a substantial remodeling of atherosclerotic lesions. Conclusions/Significance: Collectively, the results presented herein suggest that AAV8-based gene therapy for FH may be feasible and support further development of this approach. The pre-clinical data from these studies will enable for the effective translation of gene therapy into the clinic for treatment of FH.	[Kassim, Sadik H.; Vandenberghe, Luk H.; Hinderer, Christian; Bell, Peter; Yu, Hongwei; Wilson, James M.] Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA; [Li, Hui; Marchadier, Dawn; Wilson, Aisha; Cromley, Debra; Redon, Valeska; Rader, Daniel J.] Univ Penn, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Kassim, SH (corresponding author), Univ Penn, Dept Pathol & Lab Med, Gene Therapy Program, Philadelphia, PA 19104 USA.	rader@mail.med.upenn.edu	VANDENBERGHE, LUC H./ABH-1765-2020; Wilson, James M/F-9220-2011; Vandenberghe, Luk H./J-6395-2014; Vandenberghe, Luk H/B-4678-2008	VANDENBERGHE, LUC H./0000-0002-3508-4924; Wilson, James M/0000-0002-9630-3131; Vandenberghe, Luk H./0000-0002-3508-4924; Vandenberghe, Luk H/0000-0002-3508-4924	National Heart Lung and Blood Institute [P01-HL059407]; National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK047757]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047757] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart Lung and Blood Institute P01-HL059407 (JMW) and National Institute of Diabetes and Digestive and Kidney Diseases P30-DK047757 (JMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beigel R, 2009, J CLIN APHERESIS, V24, P219, DOI 10.1002/jca.20215; BILHEIMER DW, 1984, NEW ENGL J MED, V311, P1658, DOI 10.1056/NEJM198412273112603; Borberg H, 2009, TRANSFUS APHER SCI, V41, P49, DOI 10.1016/j.transci.2009.05.013; Breous E, 2009, HEPATOLOGY, V50, P612, DOI 10.1002/hep.23043; Calcedo R, 2009, J INFECT DIS, V199, P381, DOI 10.1086/595830; Chen SJ, 2000, MOL THER, V2, P256, DOI 10.1006/mthe.2000.0122; Cichon G, 2004, J GENE MED, V6, P166, DOI 10.1002/jgm.473; Daugherty A, 2002, AM J MED SCI, V323, P3, DOI 10.1097/00000441-200201000-00002; DECKELBAUM RJ, 1977, NEW ENGL J MED, V296, P465, DOI 10.1056/NEJM197703032960901; Gao GP, 2004, J VIROL, V78, P6381, DOI 10.1128/JVI.78.12.6381-6388.2004; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gao GP, 2009, HUM GENE THER, V20, P930, DOI 10.1089/hum.2009.060; Garg A, 2002, J CLIN ENDOCR METAB, V87, P3019, DOI 10.1210/jc.87.7.3019; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; GROSSMAN M, 1995, NAT MED, V1, P1148, DOI 10.1038/nm1195-1148; GROSSMAN M, 1994, NAT GENET, V6, P335, DOI 10.1038/ng0494-335; Hasbrouck NC, 2008, GENE THER, V15, P870, DOI 10.1038/gt.2008.71; HIBBITT OC, 2009, MOL THER; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Kitajima K, 2006, ARTERIOSCL THROM VAS, V26, P1852, DOI 10.1161/01.ATV.0000231520.26490.54; Kozarsky KF, 1996, NAT GENET, V13, P54, DOI 10.1038/ng0596-54; KOZARSKY KF, 1994, J BIOL CHEM, V269, P13695; Lebherz C, 2004, J GENE MED, V6, P663, DOI 10.1002/jgm.554; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mays LE, 2009, J IMMUNOL, V182, P6051, DOI 10.4049/jimmunol.0803965; McCaffrey AP, 2008, MOL THER, V16, P931, DOI 10.1038/mt.2008.37; Moghadasian MH, 2001, LAB INVEST, V81, P1173, DOI 10.1038/labinvest.3780331; NESS GC, 1994, ARCH BIOCHEM BIOPHYS, V315, P199, DOI 10.1006/abbi.1994.1490; Nomura S, 2004, GENE THER, V11, P1540, DOI 10.1038/sj.gt.3302310; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; RELA M, 1995, TRANSPLANT INT, V8, P41, DOI 10.1007/BF00366709; RUSSELL JC, CARDIOVASCULAR PATHO, V15, P318; Sanan DA, 1998, P NATL ACAD SCI USA, V95, P4544, DOI 10.1073/pnas.95.8.4544; Sarkar R, 2004, BLOOD, V103, P1253, DOI 10.1182/blood-2003-08-2954; SCANU AM, 1988, J LIPID RES, V29, P1671; SCHALE S, 2009, REGULATORY REQUIREME, P1; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tangirala RK, 2001, J BIOL CHEM, V276, P261, DOI 10.1074/jbc.M003324200; Thompson GR, 2003, ATHEROSCLEROSIS, V167, P1, DOI 10.1016/S0021-9150(02)00251-4; THOMPSON GR, 1995, LANCET, V345, P811, DOI 10.1016/S0140-6736(95)92961-4; Tsukamoto K, 2000, MOL THER, V1, P189, DOI 10.1006/mthe.2000.0028; Vaessen SFC, 2007, CURR GENE THER, V7, P35, DOI 10.2174/156652307779940261; Vandenberghe LH, 2006, NAT MED, V12, P967, DOI 10.1038/nm1445; WANG L, 2009, MOL THERAPY; Wang LL, 2010, MOL THER, V18, P126, DOI 10.1038/mt.2009.245; Wang LL, 2005, BLOOD, V105, P3079, DOI 10.1182/blood-2004-10-3867; Wright JF, 2008, GENE THER, V15, P840, DOI 10.1038/gt.2008.65; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009	50	54	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13424	10.1371/journal.pone.0013424	http://dx.doi.org/10.1371/journal.pone.0013424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976059	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700004
J	Anand-Apte, B; Ebrahem, Q; Cutler, A; Farage, E; Sugimoto, M; Hollyfield, J; Folkman, J				Anand-Apte, Bela; Ebrahem, Quteba; Cutler, Alecia; Farage, Eric; Sugimoto, Masahiko; Hollyfield, Joe; Folkman, Judah			Betacellulin Induces Increased Retinal Vascular Permeability in Mice	PLOS ONE			English	Article							RECOMBINANT HUMAN BETACELLULIN; EPIDERMAL-GROWTH-FACTOR; DIABETIC-RETINOPATHY; BETA-CELLS; BARRIER BREAKDOWN; FACTOR RECEPTOR; EGF FAMILY; ACTIVIN-A; GLUCOSE; ERYTHROPOIETIN	Background: Diabetic maculopathy, the leading cause of vision loss in patients with type 2 diabetes, is characterized by hyper-permeability of retinal blood vessels with subsequent formation of macular edema and hard exudates. The degree of hyperglycemia and duration of diabetes have been suggested to be good predictors of retinal complications. Intervention studies have determined that while intensive treatment of diabetes reduced the development of proliferative diabetic retinopathy it was associated with a two to three-fold increased risk of severe hypoglycemia. Thus we hypothesized the need to identify downstream glycemic targets, which induce retinal vascular permeability that could be targeted therapeutically without the additional risks associated with intensive treatment of the hyperglycemia. Betacellulin is a 32 kD member of the epidermal growth factor family with mitogenic properties for the retinal pigment epithelial cells. This led us to hypothesize a role for betacellulin in the retinal vascular complications associated with diabetes. Methods and Findings: In this study, using a mouse model of diabetes, we demonstrate that diabetic mice have accentuated retinal vascular permeability with a concomitant increased expression of a cleaved soluble form of betacellulin (s-Btc) in the retina. Intravitreal injection of soluble betacellulin induced retinal vascular permeability in normoglycemic and hyperglycemic mice. Western blot analysis of retinas from patients with diabetic retinopathy showed an increase in the active soluble form of betacellulin. In addition, an increase in the levels of A disintegrin and metalloproteinase (ADAM)-10 which plays a role in the cleavage of betacellulin was seen in the retinas of diabetic mice and humans. Conclusions: These results suggest that excessive amounts of betacellulin in the retina may contribute to the pathogenesis of diabetic macular edema.	[Anand-Apte, Bela; Ebrahem, Quteba; Cutler, Alecia; Farage, Eric; Sugimoto, Masahiko; Hollyfield, Joe] Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA; [Anand-Apte, Bela; Hollyfield, Joe] Cleveland Clin, Lerner Coll Med, Lerner Res Inst, Dept Mol Med, Cleveland, OH 44106 USA; [Folkman, Judah] Childrens Hosp, Boston, MA 02115 USA	Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Harvard University; Boston Children's Hospital	Anand-Apte, B (corresponding author), Cleveland Clin, Lerner Coll Med, Cole Eye Inst, Dept Ophthalmol, Cleveland, OH 44106 USA.	anandab@ccf.org			US National Institutes of Health [EY016490, CA106415, EY015638]; Research to Prevent Blindness (RPB) Challenge Grant; RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE [R01CA106415] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016490, R24EY015638, R01EY020861] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness (RPB) Challenge Grant(Research to Prevent Blindness (RPB)); RPB Lew Wasserman award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by US National Institutes of Health EY016490, CA106415, EY015638, Research to Prevent Blindness (RPB) Challenge Grant and RPB Lew Wasserman award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aiello LP, 2008, NEW ENGL J MED, V359, P967, DOI 10.1056/NEJMcibr0804551; Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AMER DIABET ASSOC, 1993, DIABETES, V42, P1555; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arjamaa O, 2006, EXP EYE RES, V83, P473, DOI 10.1016/j.exer.2006.01.016; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Chew EY, N ENGL J MED, V363, P233; Funatsu H, 2003, OPHTHALMOLOGY, V110, P1690, DOI 10.1016/S0161-6420(03)00568-2; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; JOHANSEN J, 1994, ACTA OPHTHALMOL, V72, P347; Keenan HA, 2007, DIABETES CARE, V30, P1995, DOI 10.2337/dc06-2222; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P520, DOI 10.1001/archopht.1984.01040030398010; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Li L, 2004, DIABETES, V53, P608, DOI 10.2337/diabetes.53.3.608; Li L, 2003, AM J PHYSIOL-ENDOC M, V285, pE577, DOI 10.1152/ajpendo.00120.2003; Manzoni P, 2005, NEW ENGL J MED, V353, P2190; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Miyagawa J, 1999, ENDOCR J, V46, P755, DOI 10.1507/endocrj.46.755; ORCHARD TJ, 1990, DIABETES, V39, P1116, DOI 10.2337/diabetes.39.9.1116; Ponnuchamy B, 2008, CIRC RES, V102, P1139, DOI 10.1161/CIRCRESAHA.108.177394; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Riese DJ, 1996, ONCOGENE, V12, P345; Riese DJ, 1996, J BIOL CHEM, V271, P20047, DOI 10.1074/jbc.271.33.20047; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sahin U, 2007, FEBS LETT, V581, P41, DOI 10.1016/j.febslet.2006.11.074; Sanderson MP, 2006, J CELL BIOCHEM, V99, P609, DOI 10.1002/jcb.20968; Sanderson MP, 2005, J BIOL CHEM, V280, P1826, DOI 10.1074/jbc.M408804200; Schulz B, 2008, CIRC RES, V102, P1192, DOI 10.1161/CIRCRESAHA.107.169805; Seno M, 1996, GROWTH FACTORS, V13, P181, DOI 10.3109/08977199609003220; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHING Y, 1993, SCIENCE, V259, P1604, DOI 10.1126/science.8456283; Tong ZZ, 2008, P NATL ACAD SCI USA, V105, P6998, DOI 10.1073/pnas.0800454105; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; WATANABE T, 1994, J BIOL CHEM, V269, P9966; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yamamoto K, 2000, DIABETES, V49, P2021, DOI 10.2337/diabetes.49.12.2021	41	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13444	10.1371/journal.pone.0013444	http://dx.doi.org/10.1371/journal.pone.0013444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976146	Green Published, gold, Green Submitted			2022-12-27	WOS:000283045300019
J	Gargouri, Y; Hajjem, C; Lariviere, V; Gingras, Y; Carr, L; Brody, T; Harnad, S				Gargouri, Yassine; Hajjem, Chawki; Lariviere, Vincent; Gingras, Yves; Carr, Les; Brody, Tim; Harnad, Stevan			Self-Selected or Mandated, Open Access Increases Citation Impact for Higher Quality Research	PLOS ONE			English	Article							DOWNLOADS; SCIENCE	Background: Articles whose authors have supplemented subscription-based access to the publisher's version by self-archiving their own final draft to make it accessible free for all on the web ("Open Access'', OA) are cited significantly more than articles in the same journal and year that have not been made OA. Some have suggested that this "OA Advantage'' may not be causal but just a self-selection bias, because authors preferentially make higher-quality articles OA. To test this we compared self-selective self-archiving with mandatory self-archiving for a sample of 27,197 articles published 2002-2006 in 1,984 journals. Methdology/Principal Findings: The OA Advantage proved just as high for both. Logistic regression analysis showed that the advantage is independent of other correlates of citations (article age; journal impact factor; number of co-authors, references or pages; field; article type; or country) and highest for the most highly cited articles. The OA Advantage is real, independent and causal, but skewed. Its size is indeed correlated with quality, just as citations themselves are (the top 20% of articles receive about 80% of all citations). Conclusions/Significance: The OA advantage is greater for the more citable articles, not because of a quality bias from authors self-selecting what to make OA, but because of a quality advantage, from users self-selecting what to use and cite, freed by OA from the constraints of selective accessibility to subscribers only. It is hoped that these findings will help motivate the adoption of OA self-archiving mandates by universities, research institutions and research funders.	[Gargouri, Yassine; Hajjem, Chawki] Univ Quebec, Inst Cognit Sci, Montreal, PQ H3C 3P8, Canada; [Lariviere, Vincent] Univ Quebec, Observ Sci & Technol, Montreal, PQ H3C 3P8, Canada; [Gingras, Yves] Univ Quebec, Canada Res Chair Hist & Sociol Sci, Montreal, PQ H3C 3P8, Canada; [Harnad, Stevan] Univ Quebec, Canada Res Chair Cognit Sci, Montreal, PQ H3C 3P8, Canada; [Carr, Les; Brody, Tim; Harnad, Stevan] Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England	University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; University of Quebec; University of Quebec Montreal; University of Southampton	Gargouri, Y (corresponding author), Univ Quebec, Inst Cognit Sci, Montreal, PQ H3C 3P8, Canada.	harnad@uqam.ca	GIngras, Yves/AAQ-7556-2020; Lariviere, Vincent/AAF-3179-2019; Harnad, Stevan R/A-1010-2008	Harnad, Stevan/0000-0001-6153-1129; Carr, Leslie/0000-0002-2113-9680				Adler NJ, 2009, ACAD MANAG LEARN EDU, V8, P72, DOI 10.5465/AMLE.2009.37012181; Bernard N, 1909, ANN SCI NATURELLES B, V9, P1; Bjork BC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011273; Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Brody T., 2007, CTWATCH Q, V3; BRODY T, 2003, CITEBASE SEARCH AUTO; Brody T, 2006, J AM SOC INF SCI TEC, V57, P1060, DOI 10.1002/asi.20373; CARR L, 2009, IEEE INTELLIGENT SYS, V24; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Cronin B., 1984, CITATION PROCESS ROL; Cronin B, 2006, J AM SOC INF SCI TEC, V57, P1275, DOI 10.1002/asi.20354; Davis PM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a568; Davis PM, 2007, SCIENTOMETRICS, V71, P203, DOI 10.1007/s11192-007-1661 -8; De Bellis N., 2009, BIBLIOMETRICS CITATI; De Robbio A., 2007, BOLL AIB, P257; DIAMOND AM, 1986, J HUM RESOUR, V21, P200; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Garfield, 1973, ESSAYS INFORM SCI, V1, P406; GARFIELD E, 1955, SCIENCE, V122, P108, DOI 10.1126/science.122.3159.108; GARFIELD E, 1988, CURRENT COMMENTS, V44; Giles C. L., 1998, Digital 98 Libraries. Third ACM Conference on Digital Libraries, P89, DOI 10.1145/276675.276685; HAJJEM C, 2005, IEEE DATA ENG B, V28, P39; Hamard S., 2009, COGNITION DISTRIBUTE; Harnad S., 2004, D LIB MAGAZINE, V10; Harnad S, 2009, SCIENTOMETRICS, V79, P147, DOI 10.1007/s11192-009-0409-z; Harzing A.W., 2008, ETHICS SCI ENV POLIT, V8, P61, DOI DOI 10.3354/ESEP00076; Henneken E. A., 2006, J ELECT PUBLISHING, V9; Henneken EA, 2009, J INFORMETR, V3, P1, DOI 10.1016/j.joi.2008.10.001; HITCHCOCK S, 2010, EFFECT OPEN ACCESS D; HOLMES A, 2001, LIB INFORM MANAGEMEN, V61; Jacobs N, 2006, CHANDOS INF PROF SER, P1; JACSO P, 2006, LIB TRENDS, V56, P784; Kurtz M., 2007, ASTROPHYS J, P1, DOI [10.48550/arXiv.0709.0896, DOI 10.48550/ARXIV.0709.0896]; Kurtz M, 2006, CHANDOS INF PROF SER, P45; Kurtz MJ, 2005, INFORM PROCESS MANAG, V41, P1395, DOI 10.1016/j.ipm.2005.03.010; Lariviere V, 2009, J AM SOC INF SCI TEC, V60, P858, DOI 10.1002/asi.21011; Lawrence S, 2001, NATURE, V411, P521, DOI 10.1038/35079151; Moed HF, 2005, J AM SOC INF SCI TEC, V56, P1088, DOI 10.1002/asi.20200; Moed HF., 2005, CITATION ANAL RES EV; MOED HF, 2006, J AM SOC INFORM SCI, V58, P2145; Norris M, 2008, J AM SOC INF SCI TEC, V59, P1963, DOI 10.1002/asi.20898; Odlyzko A, 2006, CHANDOS INF PROF SER, P39; Oppenheim, 1996, SERIALS, V9, P155, DOI 10.1629/09155; Page Lawrence, 1999, 199966 STANF INFOLAB; SALE A, 2006, 1 MONDAY, V11; SEGLEN PO, 1992, J AM SOC INFORM SCI, V43, P628, DOI 10.1002/(SICI)1097-4571(199210)43:9<628::AID-ASI5>3.0.CO;2-0; SMITH C, 2010, 5 INT C OP REP MADR; Swan A, 2008, SERIALS REV, V34, P31, DOI 10.1016/j.serrev.2007.12.006; Wallace ML, 2009, J INFORMETR, V3, P296, DOI 10.1016/j.joi.2009.03.010	52	259	269	1	119	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13636	10.1371/journal.pone.0013636	http://dx.doi.org/10.1371/journal.pone.0013636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	665ON	20976155	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000283045300045
J	Saygin, AP; Cook, J; Blakemore, SJ				Saygin, Ayse Pinar; Cook, Jennifer; Blakemore, Sarah-Jayne			Unaffected Perceptual Thresholds for Biological and Non-Biological Form-from-Motion Perception in Autism Spectrum Conditions	PLOS ONE			English	Article							MIRROR NEURON SYSTEM; VISUAL-PERCEPTION; RECOGNITION; CHILDREN; DEFICITS	Background: Perception of biological motion is linked to the action perception system in the human brain, abnormalities within which have been suggested to underlie impairments in social domains observed in autism spectrum conditions (ASC). However, the literature on biological motion perception in ASC is heterogeneous and it is unclear whether deficits are specific to biological motion, or might generalize to form-from-motion perception. Methodology and Principal Findings: We compared psychophysical thresholds for both biological and non-biological form- from-motion perception in adults with ASC and controls. Participants viewed point-light displays depicting a walking person (Biological Motion), a translating rectangle (Structured Object) or a translating unfamiliar shape (Unstructured Object). The figures were embedded in noise dots that moved similarly and the task was to determine direction of movement. The number of noise dots varied on each trial and perceptual thresholds were estimated adaptively. We found no evidence for an impairment in biological or non-biological object motion perception in individuals with ASC. Perceptual thresholds in the three conditions were almost identical between the ASC and control groups. Discussion and Conclusions: Impairments in biological motion and non-biological form-from-motion perception are not across the board in ASC, and are only found for some stimuli and tasks. We discuss our results in relation to other findings in the literature, the heterogeneity of which likely relates to the different tasks performed. It appears that individuals with ASC are unaffected in perceptual processing of form-from-motion, but may exhibit impairments in higher order judgments such as emotion processing. It is important to identify more specifically which processes of motion perception are impacted in ASC before a link can be made between perceptual deficits and the higher-level features of the disorder.	[Saygin, Ayse Pinar] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Cook, Jennifer; Blakemore, Sarah-Jayne] UCL, Inst Cognit Neurosci, London, England	University of California System; University of California San Diego; University of London; University College London	Saygin, AP (corresponding author), Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA.	saygin@cogsci.ucsd.edu	Cook, Jennifer/ABC-4134-2021; Saygin, Ayse Pinar/A-7126-2009; Blakemore, Sarah-Jayne/A-1792-2010	Cook, Jennifer/0000-0003-4916-8667; Saygin, Ayse Pinar/0000-0002-0859-9500; Blakemore, Sarah-Jayne/0000-0002-1690-2805	European Commission; Wellcome Trust; Royal Society	European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was supported by the European Commission, the Wellcome Trust, and the Royal Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom V, 1997, PERCEPTION, V26, P1539, DOI 10.1068/p261539; ANNAZ D, DEV SCI IN PRESS; [Anonymous], 1994, DSMIV DIAGN STAT MAN; Atkinson AP, 2007, COGNITION, V104, P59, DOI 10.1016/j.cognition.2006.05.005; Atkinson AP, 2009, NEUROPSYCHOLOGIA, V47, P3023, DOI 10.1016/j.neuropsychologia.2009.05.019; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Beintema JA, 2006, PERCEPT PSYCHOPHYS, V68, P613, DOI 10.3758/BF03208763; Bertone A, 2003, J COGNITIVE NEUROSCI, V15, P218, DOI 10.1162/089892903321208150; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; Cavanagh P, 2001, COGNITION, V80, P47, DOI 10.1016/S0010-0277(00)00153-0; CHANG DHF, 2008, PERCEPTION ANIMACY D; CHOW GC, 1960, ECONOMETRICA, V28, P591, DOI 10.2307/1910133; Cook J, 2009, NEUROPSYCHOLOGIA, V47, P3275, DOI 10.1016/j.neuropsychologia.2009.07.010; Del Viva MM, 2006, VISION RES, V46, P1242, DOI 10.1016/j.visres.2005.10.018; Dinstein I, 2010, NEURON, V66, P461, DOI 10.1016/j.neuron.2010.03.034; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Freitag CM, 2008, NEUROPSYCHOLOGIA, V46, P1480, DOI 10.1016/j.neuropsychologia.2007.12.025; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; GILAIEDOTAN S, 2010, VIS SCI SOC M UNPUB; Herrington JD, 2007, RES AUTISM SPECT DIS, V1, P14, DOI 10.1016/j.rasd.2006.07.002; Hiris E, 2007, J VISION, V7, DOI 10.1167/7.12.4; Hubert B, 2007, J AUTISM DEV DISORD, V37, P1386, DOI 10.1007/s10803-006-0275-y; Iacoboni M, 2006, NAT REV NEUROSCI, V7, P942, DOI 10.1038/nrn2024; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Klin A, 2008, DEVELOPMENTAL SCI, V11, P40, DOI 10.1111/j.1467-7687.2007.00608.x; Klin A, 2009, NATURE, V459, P257, DOI 10.1038/nature07868; Koldewyn K, 2010, BRAIN, V133, P599, DOI 10.1093/brain/awp272; Lange J, 2006, J VISION, V6, P836, DOI 10.1167/6.8.6; LORD C, 1989, J AUTISM DEV DISORD, V19, P185, DOI 10.1007/BF02211841; Loucks J, 2009, COGNITION, V111, P84, DOI 10.1016/j.cognition.2008.12.010; Milne E, 2002, J CHILD PSYCHOL PSYC, V43, P255, DOI 10.1111/1469-7610.00018; Milne E, 2006, J AUTISM DEV DISORD, V36, P225, DOI 10.1007/s10803-005-0052-3; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401, DOI 10.1111/j.2044-835X.1997.tb00738.x; MURPHY P, 2009, NEUROPSYCHOLOGIA; Oberman LM, 2007, PSYCHOL BULL, V133, P310, DOI 10.1037/0033-2909.133.2.310; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Pellicano E, 2005, NEUROPSYCHOLOGIA, V43, P1044, DOI 10.1016/j.neuropsychologia.2004.10.003; Pollick FE, 2001, COGNITION, V82, pB51, DOI 10.1016/S0010-0277(01)00147-0; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Simmons DR, 2009, VISION RES, V49, P2705, DOI 10.1016/j.visres.2009.08.005; Spencer J, 2000, NEUROREPORT, V11, P2765, DOI 10.1097/00001756-200008210-00031; Spencer JV, 2006, PERCEPTION, V35, P1047, DOI 10.1068/p5328; Thirkettle M, 2009, J VISION, V9, DOI 10.1167/9.3.28; THIRY MC, 2009, AATCC REV, V9, P28; Thurman SM, 2008, J VISION, V8, DOI 10.1167/8.3.28; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Tsermentseli S, 2008, J AUTISM DEV DISORD, V38, P1201, DOI 10.1007/s10803-007-0500-3; Vangeneugden J, 2009, CEREB CORTEX, V19, P593, DOI 10.1093/cercor/bhn109; VANKEMENADE B, 2010, VIS SCI SOC M UNPUB; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Williams JHG, 2001, NEUROSCI BIOBEHAV R, V25, P287, DOI 10.1016/S0149-7634(01)00014-8	57	65	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13491	10.1371/journal.pone.0013491	http://dx.doi.org/10.1371/journal.pone.0013491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	665ON	20976151	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000283045300043
J	Wittekindt, NE; Padhi, A; Schuster, SC; Qi, J; Zhao, FQ; Tomsho, LP; Kasson, LR; Packard, M; Cross, P; Poss, M				Wittekindt, Nicola E.; Padhi, Abinash; Schuster, Stephan C.; Qi, Ji; Zhao, Fangqing; Tomsho, Lynn P.; Kasson, Lindsay R.; Packard, Michael; Cross, Paul; Poss, Mary			Nodeomics: Pathogen Detection in Vertebrate Lymph Nodes Using Meta-Transcriptomics	PLOS ONE			English	Article							GARDNERELLA-VAGINALIS; HELICOBACTER-PYLORI; VIRAL REPLICATION; GENE-EXPRESSION; RNA; IDENTIFICATION; MICROBIOME; DIVERSITY; DISEASES; GENOME	The ongoing emergence of human infections originating from wildlife highlights the need for better knowledge of the microbial community in wildlife species where traditional diagnostic approaches are limited. Here we evaluate the microbial biota in healthy mule deer (Odocoileus hemionus) by analyses of lymph node meta-transcriptomes. cDNA libraries from five individuals and two pools of samples were prepared from retropharyngeal lymph node RNA enriched for polyadenylated RNA and sequenced using Roche-454 Life Sciences technology. Protein-coding and 16S ribosomal RNA ( rRNA) sequences were taxonomically profiled using protein and rRNA specific databases. Representatives of all bacterial phyla were detected in the seven libraries based on protein-coding transcripts indicating that viable microbiota were present in lymph nodes. Residents of skin and rumen, and those ubiquitous in mule deer habitat dominated classifiable bacterial species. Based on detection of both rRNA and protein-coding transcripts, we identified two new proteobacterial species; a Helicobacter closely related to Helicobacter cetorum in the Helicobacter pylori/Helicobacter acinonychis complex and an Acinetobacter related to Acinetobacter schindleri. Among viruses, a novel gamma retrovirus and other members of the Poxviridae and Retroviridae were identified. We additionally evaluated bacterial diversity by amplicon sequencing the hypervariable V6 region of 16S rRNA and demonstrate that overall taxonomic diversity is higher with the meta-transcriptomic approach. These data provide the most complete picture to date of the microbial diversity within a wildlife host. Our research advances the use of meta-transcriptomics to study microbiota in wildlife tissues, which will facilitate detection of novel organisms with pathogenic potential to human and animals.	[Wittekindt, Nicola E.; Schuster, Stephan C.; Qi, Ji; Zhao, Fangqing; Tomsho, Lynn P.; Kasson, Lindsay R.; Packard, Michael] Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Padhi, Abinash; Schuster, Stephan C.; Poss, Mary] Penn State Univ, Ctr Infect Dis Dynam, Dept Biol, University Pk, PA 16802 USA; [Cross, Paul] US Geol Survey, No Rocky Mt Sci Ctr, Bozeman, MT USA; [Poss, Mary] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Wittekindt, NE (corresponding author), Penn State Univ, Ctr Comparat Genom & Bioinformat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	mposs@bx.psu.edu	Zhao, Fangqing/P-6309-2019; QI, JI/E-2797-2016; Wittekindt, Nicola/G-3469-2013	Wittekindt, Nicola/0000-0002-3310-0919; Zhao, Fangqing/0000-0002-6216-1235	United States Geological Service [06HQAG0141, 06131HS001]; Science & Technology Directorate, Department of Homeland Security,; Fogarty International Center, National Institutes of Health; Gordon and Betty Moore Foundation	United States Geological Service; Science & Technology Directorate, Department of Homeland Security,(United States Department of Homeland Security (DHS)); Fogarty International Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This work was supported by United States Geological Service 06HQAG0141, subcontract 06131HS001. MP was supported, in part, by the RAPIDD program of the Science & Technology Directorate, Department of Homeland Security, and the Fogarty International Center, National Institutes of Health. S. C. S. was supported by the Gordon and Betty Moore Foundation. Any use of trade, product, or firm names is for descriptive purposes only and does not imply endorsement by the U. S. Government. Field data collection was partially funded by the sale of hunting and fishing licenses in Montana, and matching Federal Aid in Wildlife Restoration grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; ALEXANDERSEN S, 1988, J VIROL, V62, P1495, DOI 10.1128/JVI.62.5.1495-1507.1988; Bonneau M, 2006, J LEUKOCYTE BIOL, V79, P268, DOI 10.1189/jlb.0605288; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; CATLIN BW, 1992, CLIN MICROBIOL REV, V5, P213, DOI 10.1128/CMR.5.3.213-237.1992; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Demma LJ, 2008, AM J TROP MED HYG, V78, P811, DOI 10.4269/ajtmh.2008.78.811; Dortet L, 2006, J CLIN MICROBIOL, V44, P4471, DOI 10.1128/JCM.01535-06; EATON KA, 1993, INT J SYST BACTERIOL, V43, P99, DOI 10.1099/00207713-43-1-99; Falagas ME, 2009, FUTURE MICROBIOL, V4, P1103, DOI 10.2217/FMB.09.84; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gilbert MTP, 2007, SCIENCE, V317, P1927, DOI 10.1126/science.1146971; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gundi VAKB, 2009, MICROBIOL-SGM, V155, P2333, DOI 10.1099/mic.0.026054-0; Harper CG, 2002, J CLIN MICROBIOL, V40, P4536, DOI 10.1128/JCM.40.12.4536-4543.2002; Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033; Honkavuori KS, 2008, EMERG INFECT DIS, V14, P1883, DOI 10.3201/eid1412.080984; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kirby AC, 2009, J IMMUNOL, V183, P1983, DOI 10.4049/jimmunol.0901089; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; LaMere SA, 2009, J VIROL, V83, P12956, DOI 10.1128/JVI.01354-09; Lazarevic V, 2009, J MICROBIOL METH, V79, P266, DOI 10.1016/j.mimet.2009.09.012; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Mannioui A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-106; Miller W, 2009, GENOME RES, V19, P213, DOI 10.1101/gr.082628.108; MORGAN EA, 2009, AM J DERMATOPATHOL; Mulder IE, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-79; Munson L, 1999, J ZOO WILDLIFE MED, V30, P342; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Oliveira AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008644; OXLEY AP, 2010, ENV MICROBIOL; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rhyan JC, 2010, VET PATHOL, V47, P34, DOI 10.1177/0300985809354466; Scholz HC, 2009, VECTOR-BORNE ZOONOT, V9, P153, DOI 10.1089/vbz.2008.0036; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; St John AL, 2009, NAT MED, V15, P1259, DOI 10.1038/nm.2036; Suzuki H, 2009, GASTRIC CANCER, V12, P79, DOI 10.1007/s10120-009-0507-x; Takanashi S, 2009, J CLIN VIROL, V44, P161, DOI 10.1016/j.jcv.2008.11.011; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Urich T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002527; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259	63	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13432	10.1371/journal.pone.0013432	http://dx.doi.org/10.1371/journal.pone.0013432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976145	Green Published, gold			2022-12-27	WOS:000283045300015
J	Diez-Padrisa, N; Bassat, Q; Machevo, S; Quinto, L; Morais, L; Nhampossa, T; O'Callaghan-Gordo, C; Torres, A; Alonso, PL; Roca, A				Diez-Padrisa, Nuria; Bassat, Quique; Machevo, Sonia; Quinto, Llorenc; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Torres, Antoni; Alonso, Pedro L.; Roca, Anna			Procalcitonin and C-Reactive Protein for Invasive Bacterial Pneumonia Diagnosis among Children in Mozambique, a Malaria-Endemic Area	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; COMMUNITY-ACQUIRED PNEUMONIA; PLACEBO-CONTROLLED TRIAL; RURAL MOZAMBIQUE; STREPTOCOCCUS-PNEUMONIAE; VIRUS-INFECTION; EFFICACY; SURVEILLANCE; METAANALYSIS; MENINGITIS	Background: Pneumonia is the major cause of mortality and morbidity in children worldwide. Procalcitonin (PCT) and C-reactive protein (CRP) are used in developed countries to differentiate between viral and bacterial causes of pneumonia. Validity of these markers needs to be further explored in Africa. Methodology and Principal Findings: We assessed the utility of PCT and CRP to differentiate viral from invasive bacterial pneumonia in children <5 years hospitalized with clinical severe pneumonia (CSP) in rural Mozambique, a malaria-endemic area with high HIV prevalence. Prognostic capacity of these markers was also evaluated. Out of 835 children with CSP, 87 fulfilled definition of viral pneumonia and 89 of invasive bacterial pneumonia. In absence of malaria parasites, levels of PCT and CRP were lower in the viral group when compared to the invasive bacterial one (PCT: median = 0.21 versus 8.31 ng/ml, p < 0.001; CRP: 18.3 vs. 185.35 mg/l, p < 0.001). However, in presence of malaria parasites distribution between clinical groups overlapped (PCT: median = 23.1 vs. 21.75 ng/ml, p = 0.825; CRP: median = 96.8 vs. 217.4 mg/l, p = 0.052). None of the two markers could predict mortality. Conclusions: Presence of malaria parasites should be taken into consideration, either for clinical or epidemiological purposes, if using PCT or CRP to differentiate viral from invasive bacterial pneumonia in malaria-endemic areas.	[Diez-Padrisa, Nuria; Bassat, Quique; Quinto, Llorenc; O'Callaghan-Gordo, Cristina; Alonso, Pedro L.; Roca, Anna] Univ Barcelona, Ctr Recerca Salut Int Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain; [Diez-Padrisa, Nuria; Bassat, Quique; Machevo, Sonia; Morais, Luis; Nhampossa, Tacilta; O'Callaghan-Gordo, Cristina; Alonso, Pedro L.; Roca, Anna] Ctr Invest Saude Manhica, Manhica, Mozambique; [Bassat, Quique] Ctr Invest Biomed Red CIBER Epidemiol & Salud Pub, Barcelona, Spain; [Machevo, Sonia] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Nhampossa, Tacilta] Inst Nacl Saude, Minist Saude, Maputo, Mozambique; [Torres, Antoni] Univ Barcelona, Serv Pneumol, Inst Clin Torax, Inst Invest Biomed August Pi & Sunyer,Hosp Clin, Barcelona, Spain; [Torres, Antoni] Ctr Invest Biomed Red CIBER Enfermedades Resp, Bunyola, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Eduardo Mondlane University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES	Diez-Padrisa, N (corresponding author), Univ Barcelona, Ctr Recerca Salut Int Barcelona, Hosp Clin, Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain.	aroca@clinic.ub.es	Bassat, Quique/P-2341-2016; Diez-Padrisa, Nuria/AAE-1000-2020; Torres, Antoni/H-6128-2017; Alonso, Pedro L/AAZ-3645-2020	Bassat, Quique/0000-0003-0875-7596; Torres, Antoni/0000-0002-8643-2167; Alonso, Pedro L/0000-0003-3292-3443; O'Callaghan-Gordo, Cristina/0000-0002-4229-2991; Quinto, Llorenc/0000-0001-9992-6951	Bill and Melinda Gates Foundation [45 452]; Spanish Agency of International Cooperation [CM05/00134, RYC-2008-02777]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Spanish Agency of International Cooperation(Spanish Government)	This study has been supported by grant of the Bill and Melinda Gates Foundation (45 452, http://www.gatesfoundation.org/Pages/home.aspx). The Centro de Investigacao em Saude da Manhica (CISM) receives major core funding from the Spanish Agency of International Cooperation (http://www.aecid.es/ation (FIS: CM05/00134 and Raman y Cajal: RYC-2008-02777, respectively; http://www.micinn.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, GUID TREATM MAL; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carrol ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006621; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cheung YB, 2008, TROP MED INT HEALTH, V13, P603, DOI 10.1111/j.1365-3156.2008.02050.x; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; de Andrade ALSS, 2004, INT J EPIDEMIOL, V33, P173, DOI 10.1093/ije/dyh025; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; HURT N, 1994, CLIN DIAGN LAB IMMUN, V1, P437, DOI 10.1128/CDLI.1.4.437-444.1994; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Loscertales MP, 2002, PEDIATR INFECT DIS J, V21, P148, DOI 10.1097/00006454-200202000-00013; Madhi SA, 2005, PLOS MED, V2, P147, DOI 10.1371/journal.pmed.0020038; Madhi SA, 2005, CLIN INFECT DIS, V40, P1511, DOI 10.1086/429828; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; McGuire W, 1996, T ROY SOC TROP MED H, V90, P10, DOI 10.1016/S0035-9203(96)90461-7; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Nhacolo AQ, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-291; O'Callaghan-Gordo C, PEDIAT INFE IN PRESS; Roca A, 2009, CLIN INFECT DIS, V48, pS172, DOI 10.1086/596497; Roca A, 2006, TROP MED INT HEALTH, V11, P1422, DOI 10.1111/j.1365-3156.2006.01697.x; Roca A, 2010, VACCINE, V28, P4851, DOI 10.1016/j.vaccine.2010.03.060; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Scott JAG, 2008, J CLIN INVEST, V118, P1291, DOI 10.1172/JCI33947; SIGAUQUE B, 2009, J TROP PEDIAT, P11601; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Tsolia MN, 2004, CLIN INFECT DIS, V39, P681, DOI 10.1086/422996; Valles X, 2006, TROP MED INT HEALTH, V11, P358, DOI 10.1111/j.1365-3156.2006.01565.x; van der Meer V, 2005, BRIT MED J, V331, P26, DOI 10.1136/bmj.38483.478183.EB	33	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13226	10.1371/journal.pone.0013226	http://dx.doi.org/10.1371/journal.pone.0013226			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976241	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000282941000002
J	Gardiner, NM; Munday, PL; Nilsson, GE				Gardiner, Naomi M.; Munday, Philip L.; Nilsson, Goran E.			Counter-Gradient Variation in Respiratory Performance of Coral Reef Fishes at Elevated Temperatures	PLOS ONE			English	Article							CLIMATE-CHANGE; THERMAL TOLERANCE; EVOLUTIONARY SIGNIFICANCE; HYPOXIA TOLERANCE; OXYGEN LIMITATION; LARVAL DURATION; RESPONSES; IMPACTS; COUNTERGRADIENT; ECTOTHERMS	The response of species to global warming depends on how different populations are affected by increasing temperature throughout the species' geographic range. Local adaptation to thermal gradients could cause populations in different parts of the range to respond differently. In aquatic systems, keeping pace with increased oxygen demand is the key parameter affecting species' response to higher temperatures. Therefore, respiratory performance is expected to vary between populations at different latitudes because they experience different thermal environments. We tested for geographical variation in respiratory performance of tropical marine fishes by comparing thermal effects on resting and maximum rates of oxygen uptake for six species of coral reef fish at two locations on the Great Barrier Reef (GBR), Australia. The two locations, Heron Island and Lizard Island, are separated by approximately 1200 km along a latitudinal gradient. We found strong counter-gradient variation in aerobic scope between locations in four species from two families (Pomacentridae and Apogonidae). High-latitude populations (Heron Island, southern GBR) performed significantly better than low-latitude populations (Lizard Island, northern GBR) at temperatures up to 5 degrees C above average summer surface-water temperature. The other two species showed no difference in aerobic scope between locations. Latitudinal variation in aerobic scope was primarily driven by up to 80% higher maximum rates of oxygen uptake in the higher latitude populations. Our findings suggest that compensatory mechanisms in high-latitude populations enhance their performance at extreme temperatures, and consequently, that high-latitude populations of reef fishes will be less impacted by ocean warming than will low latitude populations.	[Gardiner, Naomi M.; Munday, Philip L.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia; [Gardiner, Naomi M.; Munday, Philip L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [Nilsson, Goran E.] Univ Oslo, Dept Mol Biosci, Physiol Programme, Oslo, Norway	James Cook University; James Cook University; University of Oslo	Gardiner, NM (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia.	naomi.gardiner@jcu.edu.au	Gardiner, Naomi/C-9671-2015; Nilsson, Göran Erik/Q-6129-2019; Nilsson, Goran E/K-7668-2012; Munday, Philip L/F-5443-2011	Gardiner, Naomi/0000-0002-6319-8881; Nilsson, Goran E/0000-0002-3195-3053; Munday, Philip L/0000-0001-9725-2498	ARC Centre of Excellence for Coral Reef Studies, James Cook University; University of Oslo; Australian Research Council	ARC Centre of Excellence for Coral Reef Studies, James Cook University(Australian Research Council); University of Oslo; Australian Research Council(Australian Research Council)	This work was financed by the ARC Centre of Excellence for Coral Reef Studies, James Cook University, and the University of Oslo. PLM is supported by an Australian Research Council Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G., 2005, REEF FISH IDENTIFICA; Allen G. R., 1991, DAMSELFISHES WORLD; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Bay LK, 2006, MAR BIOL, V149, P1247, DOI 10.1007/s00227-006-0276-6; Bindoff NL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P385; Brierley AS, 2009, CURR BIOL, V19, pR602, DOI 10.1016/j.cub.2009.05.046; Chapman LJ, 2000, ECOL LETT, V3, P387, DOI 10.1046/j.1461-0248.2000.00160.x; Conover DO, 2009, ANN NY ACAD SCI, V1168, P100, DOI 10.1111/j.1749-6632.2009.04575.x; CONOVER DO, 1995, TRENDS ECOL EVOL, V10, P248, DOI 10.1016/S0169-5347(00)89081-3; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DOHERTY PJ, 1995, ECOLOGY, V76, P2373, DOI 10.2307/2265814; Fangue NA, 2006, J EXP BIOL, V209, P2859, DOI 10.1242/jeb.02260; Farrell AP, 2008, PHYSIOL BIOCHEM ZOOL, V81, P697, DOI 10.1086/592057; Gardiner NM, 2005, MAR ECOL PROG SER, V305, P163, DOI 10.3354/meps305163; Gardner JL, 2009, P ROY SOC B-BIOL SCI, V276, P3845, DOI 10.1098/rspb.2009.1011; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; GONZALEZ RJ, 1992, J EXP BIOL, V163, P317; GOOLISH EM, 1991, BIOL REV, V66, P33, DOI 10.1111/j.1469-185X.1991.tb01134.x; Grebmeier JM, 2006, SCIENCE, V311, P1461, DOI 10.1126/science.1121365; Lai JCC, 2006, J EXP BIOL, V209, P2734, DOI 10.1242/jeb.02279; LEVINS RICHARD, 1968; Lough JM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034634; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Munch SB, 2009, P NATL ACAD SCI USA, V106, P13860, DOI 10.1073/pnas.0900300106; Munday PL, 1997, J FISH BIOL, V51, P931, DOI 10.1006/jfbi.1997.0498; Nilsson G. E., 2010, RESP PHYSL VERTEBRAT; Nilsson GE, 2007, P ROY SOC B-BIOL SCI, V274, P79, DOI 10.1098/rspb.2006.3706; Nilsson GE, 2010, COMP BIOCHEM PHYS A, V156, P389, DOI 10.1016/j.cbpa.2010.03.009; Nilsson GE, 2009, GLOBAL CHANGE BIOL, V15, P1405, DOI 10.1111/j.1365-2486.2008.01767.x; Ostlund-Nilsson S, 2004, P ROY SOC B-BIOL SCI, V271, P1015, DOI 10.1098/rspb.2004.2700; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2009, FISH PHYSIOL, V27, P143, DOI 10.1016/S1546-5098(08)00004-6; Poloczanska ES, 2007, OCEANOGR MAR BIOL, V45, P407; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Randall JE, 1997, FISHES GREAT BARRIER; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schaack S, 2003, CAN J ZOOL, V81, P430, DOI 10.1139/Z03-009; Schroer M, 2009, J EXP MAR BIOL ECOL, V372, P22, DOI 10.1016/j.jembe.2009.02.001; Schulte PM, 2007, J THERM BIOL, V32, P152, DOI 10.1016/j.jtherbio.2007.01.012; Sollid J, 2006, RESP PHYSIOL NEUROBI, V154, P241, DOI 10.1016/j.resp.2006.02.006; Tewksbury JJ, 2008, SCIENCE, V320, P1296, DOI 10.1126/science.1159328; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a	46	78	79	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13299	10.1371/journal.pone.0013299	http://dx.doi.org/10.1371/journal.pone.0013299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949020	Green Published, gold, Green Accepted			2022-12-27	WOS:000282748100025
J	Larkin, EA; Stiles, BG; Ulrich, RG				Larkin, Eileen A.; Stiles, Bradley G.; Ulrich, Robert G.			Inhibition of Toxic Shock by Human Monoclonal Antibodies against Staphylococcal Enterotoxin B	PLOS ONE			English	Article							OF-THE-LITERATURE; INTRAVENOUS IMMUNOGLOBULIN; CROSS-REACTIVITY; MURINE MODEL; DOUBLE-BLIND; IN-VITRO; AUREUS; SUPERANTIGENS; INFECTIONS; RESISTANT	Background: Staphylococcus aureus is implicated in many opportunistic bacterial infections around the world. Rising antibiotic resistance and few alternative methods of treatment are just two looming problems associated with clinical management of S. aureus. Among numerous virulence factors produced by S. aureus, staphylococcal enterotoxin (SE) B is a secreted protein that binds T-cell receptor and major histocompatibility complex class II, potentially causing toxic shock mediated by pathological activation of T cells. Recombinant monoclonal antibodies that target SEB and block receptor interactions can be of therapeutic value. Methodology/Principal Findings: The inhibitory and biophysical properties of ten human monoclonal antibodies, isolated from a recombinant library by panning against SEB vaccine (STEBVax), were examined as bivalent Fabs and native full-length IgG (Mab). The best performing Fabs had binding affinities equal to polyclonal IgG, low nanomolar IC(50)s against SEB in cell culture assays, and protected mice from SEB-induced toxic shock. The orthologous staphylococcal proteins, SEC1 and SEC2, as well as streptococcal pyrogenic exotoxin C were recognized by several Fabs. Four Fabs against SEB, with the lowest IC(50)s, were converted into native full-length Mabs. Although SEB-binding kinetics were identical between each Fab and respective Mab, a 250-fold greater inhibition of SEB-induced T-cell activation was observed with two Mabs. Conclusions/Significance: Results suggest that these human monoclonal antibodies possess high affinity, target specificity, and toxin neutralization qualities essential for any therapeutic agent.	[Larkin, Eileen A.; Stiles, Bradley G.; Ulrich, Robert G.] USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA; [Larkin, Eileen A.; Ulrich, Robert G.] Hood Coll, Dept Biomed Sci, Frederick, MD 21701 USA; [Stiles, Bradley G.] Wilson Coll, Dept Biol, Chambersburg, PA USA		Larkin, EA (corresponding author), USA, Med Res Inst Infect Dis, Dept Immunol, Frederick, MD USA.	bstiles@wilson.edu; rulrich@bioanalysis.org			Joint Science and Technology Office [3.1003 07 RD B]	Joint Science and Technology Office	Funding was provided by The Joint Science and Technology Office 3.1003 07 RD B. This research was supported in part by an appointment of EAL to the Postgraduate Research Participation Program at the Medical Research Institute of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews MM, 2001, CLIN INFECT DIS, V32, P1470, DOI 10.1086/320170; BAKER T, 2006, COMPREHENSIVE SOURCE, P872; Balbir-Gurman A, 2007, CLIN EXP RHEUMATOL, V25, pS28; Bavari S, 1999, J INFECT DIS, V180, P1365, DOI 10.1086/314977; BAVARI S, 1995, INFECT IMMUN, V63, P423, DOI 10.1128/IAI.63.2.423-429.1995; BOHACH GA, 1988, INFECT IMMUN, V56, P400, DOI 10.1128/IAI.56.2.400-404.1988; Boles JW, 2003, CLIN IMMUNOL, V108, P51, DOI 10.1016/S1521-6616(03)00066-4; BONVENTRE PF, 1988, INFECT IMMUN, V56, P135, DOI 10.1128/IAI.56.1.135-141.1988; Boucher HW, 2008, CLIN INFECT DIS, V46, pS344, DOI 10.1086/533590; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; Darenberg J, 2003, CLIN INFECT DIS, V37, P333, DOI 10.1086/376630; DELONGE M, 2007, J PEDIAT, V151, P260; Descloux E, 2008, EUR J CLIN MICROBIOL, V27, P37, DOI 10.1007/s10096-007-0405-2; Glowalla E, 2009, INFECT IMMUN, V77, P2719, DOI 10.1128/IAI.00617-08; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Hassoun Ali, 2007, Am J Geriatr Pharmacother, V5, P48, DOI 10.1016/j.amjopharm.2007.03.001; Hot A, 2008, AM J HEMATOL, V83, P159, DOI 10.1002/ajh.21008; Hu DL, 2008, J MED MICROBIOL, V57, P1106, DOI 10.1099/jmm.0.2008/002790-0; Jarraud S, 2001, J IMMUNOL, V166, P669, DOI 10.4049/jimmunol.166.1.669; Kakita M, 2006, INFECT IMMUN, V74, P3682, DOI 10.1128/IAI.01731-05; Kansal R, 2007, J CLIN IMMUNOL, V27, P327, DOI 10.1007/s10875-007-9072-4; Kato Kumiko, 2007, Allergol Int, V56, P439, DOI 10.2332/allergolint.O-06-462; KIENLE E, 1989, MED MICROBIOL IMMUN, V178, P127, DOI 10.1007/BF00198011; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Lamothe F, 1995, CLIN INFECT DIS, V21, P1469, DOI 10.1093/clinids/21.6.1469; LANG AB, 1993, J IMMUNOL, V151, P466; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LEE ACM, 1980, INFECT IMMUN, V27, P431, DOI 10.1128/IAI.27.2.431-434.1980; Maragakis LL, 2008, EXPERT REV ANTI-INFE, V6, P751, DOI 10.1586/14787210.6.5.751; Maree CL, 2007, EMERG INFECT DIS, V13, P236, DOI 10.3201/eid1302.060781; MARR JC, 1993, INFECT IMMUN, V61, P4254, DOI 10.1128/IAI.61.10.4254-4262.1993; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Marton JP, 2008, CURR MED RES OPIN, V24, P2821, DOI [10.1185/03007990802365169, 10.1185/03007990802365169 ]; Mata S, 2007, EUR J NEUROL, V14, P1147, DOI 10.1111/j.1468-1331.2007.01929.x; NORRBYTEGLUND A, 2007, SUPERANTIGENS MOL BA, P197; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; Ohlsen K, 2010, INT J MED MICROBIOL, V300, P402, DOI 10.1016/j.ijmm.2010.04.015; Pai Jennifer C, 2009, Recent Pat Antiinfect Drug Discov, V4, P1; Parsonnet J, 2005, J CLIN MICROBIOL, V43, P4628, DOI 10.1128/JCM.43.9.4628-4634.2005; Patel R, 2000, J INFECT DIS, V181, P230, DOI 10.1086/315198; Perez CM, 1997, AM J MED, V102, P111, DOI 10.1016/S0002-9343(96)00304-X; Poivell C, 2007, PEDIATR INFECT DIS J, V26, P759, DOI 10.1097/INF.0b013e3180618c15; Sakata K, 2007, EUR J PEDIATR, V166, P565, DOI 10.1007/s00431-006-0280-3; Schaffer AC, 2008, INT J ANTIMICROB AG, V32, pS71, DOI 10.1016/j.ijantimicag.2008.06.009; Schlievert PM, 2001, J ALLERGY CLIN IMMUN, V108, pS107, DOI 10.1067/mai.2001.117820; SPERO L, 1978, J IMMUNOL, V120, P86; Stiles B. G., 2005, Clinical Microbiology Newsletter, V27, P179, DOI 10.1016/j.clinmicnews.2005.11.001; STILES BG, 1995, INFECT IMMUN, V63, P1229, DOI 10.1128/IAI.63.4.1229-1234.1995; Stiles BG, 1999, INFECT IMMUN, V67, P1521, DOI 10.1128/IAI.67.3.1521-1525.1999; Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001; TAKEI S, 1993, J CLIN INVEST, V91, P602, DOI 10.1172/JCI116240; THOMPSON NE, 1984, INFECT IMMUN, V45, P281, DOI 10.1128/IAI.45.1.281-285.1984; Tilahun ME, 2010, INFECT IMMUN, V78, P2801, DOI 10.1128/IAI.01121-09; Uchiyama T., 2006, COMPREHENSIVE SOURCE, V3rd, P830, DOI [10.1016/B978-012088445-2/50055-X, DOI 10.1016/B978-012088445-2/50055-X]; ULRICH RG, 1995, NAT STRUCT BIOL, V2, P554, DOI 10.1038/nsb0795-554; Ulrich RG, 2000, FEMS IMMUNOL MED MIC, V27, P1; Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5; Vernachio JH, 2006, ANTIMICROB AGENTS CH, V50, P511, DOI 10.1128/AAC.50.2.511-518.2006; Vucic S, 2007, CLIN NEUROPHYSIOL, V118, P1980, DOI 10.1016/j.clinph.2007.05.001; Weems JJ, 2006, ANTIMICROB AGENTS CH, V50, P2751, DOI 10.1128/AAC.00096-06; Weisman LE, 2007, ARCH PEDIATRIE, V14, pS31, DOI 10.1016/S0929-693X(07)80008-X; Woody MA, 1997, VACCINE, V15, P133, DOI 10.1016/S0264-410X(96)00166-1; Wu H, 2008, CURR TOP MICROBIOL, V317, P103; Yanagisawa Chie, 2007, Journal of Infection and Chemotherapy, V13, P368, DOI 10.1007/s10156-007-0551-6	65	45	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13253	10.1371/journal.pone.0013253	http://dx.doi.org/10.1371/journal.pone.0013253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949003	gold, Green Submitted, Green Published			2022-12-27	WOS:000282748100006
J	Chege, D; Chai, YJ; Huibner, S; McKinnon, L; Wachihi, C; Kimani, M; Jaoko, W; Kimani, J; Ball, TB; Plummer, FA; Kaul, R; Rebbapragada, A				Chege, Duncan; Chai, Yijie; Huibner, Sanja; McKinnon, Lyle; Wachihi, Charles; Kimani, Makubo; Jaoko, Walter; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert; Rebbapragada, Anuradha			Evaluation of a Quantitative Real-Time PCR Assay to Measure HIV-Specific Mucosal CD8+T Cell Responses in the Cervix	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; FEMALE GENITAL-TRACT; MONONUCLEAR-CELLS; CYTOKINE EXPRESSION; INFECTED WOMEN; BLOOD; IMMUNITY; DNA; QUANTIFICATION	Several candidate HIV vaccines aim to induce virus-specific cellular immunity particularly in the genital tract, typically the initial site of HIV acquisition. However, standardized and sensitive methods for evaluating HIV-specific immune responses at the genital level are lacking. Therefore we evaluated real-time quantitative PCR (qPCR) as a potential platform to measure these responses. beta-Actin and GAPDH were identified as the most stable housekeeping reference genes in peripheral blood mononuclear cells (PBMCs) and cervical mononuclear cells (CMCs) respectively and were used for normalizing transcript mRNA expression. HIV-specific cellular T cell immune responses to a pool of optimized CD8+ HIV epitopes (HIV epitope pool) and Staphylococcal enterotoxin B (SEB) superantigen control were assayed in HIV infected PBMC by qPCR, with parallel assessment of cytokine protein production. Peak HIV-specific mRNA expression of IFN gamma, IL-2 and TNF alpha occurred after 3, 5 and 12 hours respectively. PBMCs were titrated to cervical appropriate cell numbers to determine minimum required assay input cell numbers; qPCR retained sensitivity with input of at least 2.5x10(4) PBMCs. This optimized qPCR assay was then used to assess HIV-specific cellular T cell responses in cytobrush-derived cervical T cells from HIV positive individuals. SEB induced IFN gamma mRNA transcription was detected in CMCs and correlated positively with IFNc protein production. However, qPCR was unable to detect HIV-induced cytokine mRNA production in the cervix of HIV-infected women despite robust detection of gene induction in PBMCs. In conclusion, although qPCR can be used to measure ex vivo cellular immune responses to HIV in blood, HIV-specific responses in the cervix may fall below the threshold of qPCR detection. Nonetheless, this platform may have a potential role in measuring mitogen-induced immune responses in the genital tract.	[Chege, Duncan; Chai, Yijie; Huibner, Sanja; McKinnon, Lyle; Kaul, Rupert] Univ Toronto, Dept Med, Toronto, ON, Canada; [Kaul, Rupert] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Rebbapragada, Anuradha] Ontario Agcy Hlth Protect & Promot, Publ Hlth Lab Toronto, Toronto, ON, Canada; [Rebbapragada, Anuradha] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [McKinnon, Lyle; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB, Canada; [Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.] Publ Hlth Agcy Canada, Natl HIV & Retrovirol Labs, Lab HIV Immunol, Winnipeg, MB, Canada; [McKinnon, Lyle; Wachihi, Charles; Kimani, Makubo; Jaoko, Walter; Kimani, Joshua; Ball, T. Blake; Plummer, Francis A.; Kaul, Rupert] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Manitoba; Public Health Agency of Canada; University of Nairobi	Chege, D (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	duncan.chege@utoronto.ca	Jaoko, Walter/AAN-5048-2020	Kaul, Rupert/0000-0002-1586-4093; Jaoko, Walter/0000-0002-7134-6581; McKinnon, Lyle/0000-0002-7157-0700	Bill and Melinda Gates Foundation; Canadian Institutes of Health Research [37873]; Ontario Graduate Student Science and Technology; Canadian Research Chair	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Student Science and Technology; Canadian Research Chair(Canada Research Chairs)	This work was in part supported by the Bill and Melinda Gates Foundation and the Canadian Institutes of Health Research through the Grand Challenges in Global Health Initiative (grant# 37873); the Ontario Graduate Student Science and Technology Scholarships (DC salary) and the Canadian Research Chair Program (RK salary support). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, J IMMUNOL, V164, P4968, DOI 10.4049/jimmunol.164.9.4968; BERE A, 2010, J IMMUNOLOG IN PRESS; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Daud II, 2008, CLIN VACCINE IMMUNOL, V15, P1369, DOI 10.1128/CVI.00074-08; Demberg T, 2009, INT REV IMMUNOL, V28, P20, DOI 10.1080/08830180802684331; FLEISCHER B, 1991, IMMUNOL RES, V10, P349, DOI 10.1007/BF02919720; Geiss GK, 2000, VIROLOGY, V266, P8, DOI 10.1006/viro.1999.0044; Girard MP, 2008, VACCINE, V26, P3969, DOI [10.1016/j.vaccine.2008.04.051, 10.1016/j.vaccine.2008.03.006]; Graziosi C, 1996, P NATL ACAD SCI USA, V93, P4386, DOI 10.1073/pnas.93.9.4386; Gumbi PP, 2008, J VIROL, V82, P8529, DOI 10.1128/JVI.00183-08; Hartel C, 2001, J IMMUNOL METHODS, V249, P63, DOI 10.1016/S0022-1759(00)00334-3; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kaul R, 2003, AIDS, V17, P1139, DOI 10.1097/00002030-200305230-00004; Kaul R, 2000, J IMMUNOL, V164, P1602, DOI 10.4049/jimmunol.164.3.1602; Kaul R, 2001, IMMUNOL LETT, V79, P3, DOI 10.1016/S0165-2478(01)00260-7; Kruse N, 2001, J IMMUNOL METHODS, V247, P131, DOI 10.1016/S0022-1759(00)00316-1; Listvanova S, 2003, J IMMUNOL METHODS, V281, P27, DOI 10.1016/S0022-1759(03)00267-9; McEvers K, 2005, VACCINE, V23, P4128, DOI 10.1016/j.vaccine.2005.03.022; Musey L, 2003, J VIROL, V77, P291, DOI 10.1128/JVI.77.1.291-300.2003; Musey L, 1997, J EXP MED, V185, P293, DOI 10.1084/jem.185.2.293; Mygind T, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-17; Nicol AF, 2006, EXP MOL PATHOL, V81, P42, DOI 10.1016/j.yexmp.2006.01.002; Nkwanyana NN, 2009, IMMUNOLOGY, V128, pe746, DOI 10.1111/j.1365-2567.2009.03077.x; Proft T, 1998, J EXP MED, V187, P819, DOI 10.1084/jem.187.6.819; Quayle AJ, 2004, AIDS RES HUM RETROV, V20, P543, DOI 10.1089/088922204323087796; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Shacklett BL, 2000, AIDS, V14, P1911, DOI 10.1097/00002030-200009080-00005; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; Steinau M, 2006, J MOL DIAGN, V8, P113, DOI 10.2353/jmoldx.2006.050088; Stordeur P, 2002, J IMMUNOL METHODS, V259, P55, DOI 10.1016/S0022-1759(01)00489-6; Subbramanian RA, 2003, J VIROL, V77, P10113, DOI 10.1128/JVI.77.18.10113-10118.2003; Toye B, 1998, J CLIN MICROBIOL, V36, P2356, DOI 10.1128/JCM.36.8.2356-2358.1998; *UNAIDS ORG WH, 2009, UNAIDS0936EJC1700E O; van Wanrooij EJA, 2005, ARTERIOSCL THROM VAS, V25, P2642, DOI 10.1161/01.ATV.0000192018.90021.c0; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Verkooyen RP, 1996, J CLIN MICROBIOL, V34, P3072, DOI 10.1128/JCM.34.12.3072-3074.1996; Vernazza PL, 1999, AIDS, V13, P155, DOI 10.1097/00002030-199902040-00003; Watson S, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-130; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	42	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13077	10.1371/journal.pone.0013077	http://dx.doi.org/10.1371/journal.pone.0013077			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949096	Green Submitted, Green Published, gold			2022-12-27	WOS:000282633700005
J	Roquilly, A; Gautreau, L; Segain, JP; de Coppet, P; Sebille, V; Jacqueline, C; Caillon, J; Potel, G; Lejus, C; Josien, R; Asehnoune, K				Roquilly, Antoine; Gautreau, Laetitia; Segain, Jean Pierre; de Coppet, Pierre; Sebille, Veronique; Jacqueline, Cedric; Caillon, Jocelyne; Potel, Gilles; Lejus, Corinne; Josien, Regis; Asehnoune, Karim			CpG-ODN and MPLA Prevent Mortality in a Murine Model of Post-Hemorrhage-Staphyloccocus aureus Pneumonia	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; DENDRITIC CELL SUBSETS; DR ANTIGEN EXPRESSION; HEAD-TRAUMA PATIENTS; ACUTE LUNG INJURY; POLYMICROBIAL SEPSIS; RISK-FACTORS; MONONUCLEAR-CELLS; INNATE IMMUNITY; TNF PRODUCTION	Infections are the most frequent cause of complications in trauma patients. Post-traumatic immune suppression (IS) exposes patients to pneumonia (PN). The main pathogen involved in PN is Methicillin Susceptible Staphylococcus aureus (MSSA). Dendritic cells () may be centrally involved in the IS. We assessed the consequences of hemorrhage on pneumonia outcomes and investigated its consequences on DCs functions. A murine model of hemorrhagic shock with a subsequent MSSA pneumonia was used. Hemorrhage decreased the survival rate of infected mice, increased systemic dissemination of sepsis and worsened inflammatory lung lesions. The mRNA expression of Tumor Necrosis Factor-alpha (TNF-alpha), Interferon-beta (IFN-beta) and Interleukin (IL)-12p40 were mitigated for hemorrhaged-mice. The effects of hemorrhage on subsequent PN were apparent on the pDCs phenotype (reduced MHC class II, CD80, and CD86 molecule membrane expression). In addition, hemorrhage dramatically decreased CD8(+) cDCs- and CD8(-) cDCs- induced allogeneic T-cell proliferation during PN compared with mice that did not undergo hemorrhage. In conclusion, hemorrhage increased morbidity and mortality associated with PN; induced severe phenotypic disturbances of the pDCs subset and functional alterations of the cDCs subset. After hemorrhage, a preventive treatment with CpG-ODN or Monophosphoryl Lipid A increased transcriptional activity in DCs (TNF-alpha, IFN-beta and IL-12p40) and decreased mortality of post-hemorrhage MSSA pneumonia.	[Roquilly, Antoine; Jacqueline, Cedric; Caillon, Jocelyne; Potel, Gilles; Asehnoune, Karim] Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France; [Roquilly, Antoine; Lejus, Corinne; Asehnoune, Karim] Ctr Hosp Univ Nantes, Hotel Dieu HME, Serv Anesthesie Reanimat Chirurg, Nantes, France; [Gautreau, Laetitia; Josien, Regis] INSERM, Unite Mixte Rech 643, Nantes, France; [Segain, Jean Pierre; de Coppet, Pierre] Univ Nantes, Inst Natl Rech Agron, Unite Mixte Rech Physiol Adaptat Nutr 1280, Nantes, France; [Sebille, Veronique] Univ Nantes, Fac Pharm, Cellule Biostat Cellule Promot Rech Clin, Nantes, France; [Sebille, Veronique] Univ Nantes, Fac Pharm, EA 4275, Nantes, France; [Josien, Regis] Ctr Hosp Univ Nantes, Immunol Lab, Nantes, France; [Josien, Regis] ITUN, Nantes, France	Nantes Universite; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Nantes Universite; Nantes Universite; Nantes Universite; Nantes Universite; CHU de Nantes	Roquilly, A (corresponding author), Univ Nantes, Fac Med, Lab UPRES EA Therapeut Clin & Expt Infect 3826, Nantes, France.	karim.asehnoune@chu-nantes.fr	Josien, Regis/U-4405-2019; Sébille, Véronique/L-8761-2015; Rolland, Laetitia Gautreau/L-3081-2015; Josien, Regis/L-7468-2015; CAILLON, Jocelyne/AAF-8179-2020; Roquilly, Antoine/P-9826-2017; Sebille, Veronique/I-3309-2015; Jacqueline, Cédric/G-5650-2010; Gautreau-Rolland, Laetitia/AAC-8059-2019	Josien, Regis/0000-0001-7900-7413; Jacqueline, Cédric/0000-0001-9606-5930; Gautreau-Rolland, Laetitia/0000-0003-0113-488X; Sebille, Veronique/0000-0002-0780-7742	Societe Francaise d'Anesthesie Reanimation (SFAR); Centaure Foundation; Fondation pour la Recherche Medicale; Progreffe Foundation	Societe Francaise d'Anesthesie Reanimation (SFAR); Centaure Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Progreffe Foundation	This work was supported by a grant from the Societe Francaise d'Anesthesie Reanimation (SFAR) and institutional sources. K Asehnoune was a recipient of funding from SFAR. L. Gautreau was recipient of funding from the Centaure Foundation, Fondation pour la Recherche Medicale and Progreffe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Adib-Conquy M, 2003, AM J RESP CRIT CARE, V168, P158, DOI 10.1164/rccm.200209-1077OC; Adib-Conquy M, 2001, J LEUKOCYTE BIOL, V70, P30; Agbaht K, 2007, INTENS CARE MED, V33, P1387, DOI 10.1007/s00134-007-0729-5; Asehnoune K, 2006, RESUSCITATION, V68, P127, DOI 10.1016/j.resuscitation.2005.05.015; Asehnoune K, 2006, CYTOKINE, V34, P212, DOI 10.1016/j.cyto.2006.05.003; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bandiera GW, 1999, J TRAUMA, V47, P932, DOI 10.1097/00005373-199911000-00020; Boutoille D, 2009, EXP LUNG RES, V35, P263, DOI 10.1080/01902140802632290; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; CHEADLE WG, 1991, AM J SURG, V161, P639, DOI 10.1016/0002-9610(91)91247-G; Czaja AS, 2009, J TRAUMA, V67, P805, DOI 10.1097/TA.0b013e318185e1fb; Damsgaard CT, 2009, J IMMUNOL METHODS, V340, P95, DOI 10.1016/j.jim.2008.10.005; Ditschkowski M, 1999, ANN SURG, V229, P246, DOI 10.1097/00000658-199902000-00013; ESRIG BC, 1977, SURG GYNECOL OBSTET, V144, P915; Fitzgerald KA, 2007, SCIENCE, V316, P1574, DOI 10.1126/science.1144483; Flohe SB, 2006, J LEUKOCYTE BIOL, V79, P473, DOI 10.1189/jlb.0705413; Henrich D, 2009, J SURG RES, V154, P239, DOI 10.1016/j.jss.2008.06.038; HERSHMAN MJ, 1990, BRIT J SURG, V77, P204, DOI 10.1002/bjs.1800770225; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawasaki T, 2006, J IMMUNOL, V177, P4514, DOI 10.4049/jimmunol.177.7.4514; Keel M, 1996, J TRAUMA, V40, P907, DOI 10.1097/00005373-199606000-00008; Kim JY, 2005, AM J PHYSIOL-LUNG C, V288, pL958, DOI 10.1152/ajplung.00359.2004; Klinman DM, 2004, NAT REV IMMUNOL, V4, P248, DOI 10.1038/nri1329; Lepelletier D, 2010, J NEUROSURG ANESTH, V22, P32, DOI 10.1097/ANA.0b013e3181bdf52f; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnotti Louis J, 2004, Surg Infect (Larchmt), V5, P237, DOI 10.1089/sur.2004.5.237; Marie C, 1998, BLOOD, V91, P3439, DOI 10.1182/blood.V91.9.3439.3439_3439_3446; Mata-Haro V, 2007, SCIENCE, V316, P1628, DOI 10.1126/science.1138963; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; MEGJUGORAC NJ, 2009, J LEUKOC BIOL; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Muehlstedt SG, 2002, CRIT CARE MED, V30, P1322, DOI 10.1097/00003246-200206000-00029; Osborn TM, 2004, CRIT CARE MED, V32, P2234, DOI 10.1097/01.CCM.0000145586.23276.0F; Ouabed A, 2008, J IMMUNOL, V180, P5862, DOI 10.4049/jimmunol.180.9.5862; Papia G, 1999, J TRAUMA, V47, P923, DOI 10.1097/00005373-199911000-00018; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Pene F, 2008, J IMMUNOL, V181, P8513, DOI 10.4049/jimmunol.181.12.8513; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Poehlmann H, 2009, CRIT CARE, V13, DOI 10.1186/cc7969; Pulendran B, 2008, CURR OPIN IMMUNOL, V20, P61, DOI 10.1016/j.coi.2007.10.009; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; ROBINSON A, 1991, CRIT CARE MED, V19, P1285, DOI 10.1097/00003246-199110000-00011; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Salio M, 2004, J EXP MED, V199, P567, DOI 10.1084/jem.20031059; Spolarics Z, 2003, CRIT CARE MED, V31, P1722, DOI 10.1097/01.CCM.0000063579.43470.AA; STEPHAN RN, 1987, ARCH SURG-CHICAGO, V122, P62; Thibault R, 2007, GASTROENTEROLOGY, V133, P1916, DOI 10.1053/j.gastro.2007.08.041; Ueno H, 2007, IMMUNOL REV, V219, P118, DOI 10.1111/j.1600-065X.2007.00551.x; Weighardt H, 2000, J IMMUNOL, V165, P4537, DOI 10.4049/jimmunol.165.8.4537	52	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13228	10.1371/journal.pone.0013228	http://dx.doi.org/10.1371/journal.pone.0013228			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949109	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700017
J	Wen, Y; Li, J; Xiong, MQ; Peng, Y; Yao, WM; Hong, J; Lin, DH				Wen, Yi; Li, Jun; Xiong, Minqian; Peng, Yu; Yao, Wenming; Hong, Jing; Lin, Donghai			Solution Structure and Dynamics of the I214V Mutant of the Rabbit Prion Protein	PLOS ONE			English	Article							MODEL-FREE APPROACH; MAGNETIC-RESONANCE RELAXATION; NMR STRUCTURE; ORDER PARAMETERS; AMYLOID FIBRILS; HEAT-CAPACITY; SCRAPIE; BINDING; SHEEP; RESIDUES	Background: The conformational conversion of the host-derived cellular prion protein (PrPC) into the disease-associated scrapie isoform (PrPSc) is responsible for the pathogenesis of transmissible spongiform encephalopathies (TSEs). Various single-point mutations in PrP(C)s could cause structural changes and thereby distinctly influence the conformational conversion. Elucidation of the differences between the wild-type rabbit PrPC (RaPrPC) and various mutants would be of great help to understand the ability of RaPrPC to be resistant to TSE agents. Methodology/Principal Findings: We determined the solution structure of the I214V mutant of RaPrPC (91-228) and detected the backbone dynamics of its structured C-terminal domain (121-228). The I214V mutant displays a visible shift of surface charge distribution that may have a potential effect on the binding specificity and affinity with other chaperones. The number of hydrogen bonds declines dramatically. Urea-induced transition experiments reveal an obvious decrease in the conformational stability. Furthermore, the NMR dynamics analysis discloses a significant increase in the backbone flexibility on the pico- to nanosecond time scale, indicative of lower energy barrier for structural rearrangement. Conclusions/Significance: Our results suggest that both the surface charge distribution and the intrinsic backbone flexibility greatly contribute to species barriers for the transmission of TSEs, and thereby provide valuable hints for understanding the inability of the conformational conversion for RaPrPC	[Wen, Yi; Li, Jun; Xiong, Minqian; Peng, Yu; Yao, Wenming; Hong, Jing; Lin, Donghai] Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China; [Lin, Donghai] Xiamen Univ, Coll Chem & Chem Engn, Key Lab Chem Biol Fujian Prov, Xiamen, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Xiamen University	Wen, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, NMR Lab, Shanghai 200031, Peoples R China.	dhlin@mail.shcnc.ac.cn	li, jun/A-1197-2011; Lin, Donghai/A-1482-2011	Peng, Yu/0000-0003-2039-9015	National Natural Science Foundation of China [30730026, 30570352]; National Science & Technology, China [2009ZX09301-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology, China	This work was supported by grants from the National Natural Science Foundation of China (Nos. 30730026, 30570352) and National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program,'' China (No. 2009ZX09301-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; ALONSO DOV, 1991, BIOCHEMISTRY-US, V30, P5974, DOI 10.1021/bi00238a023; Bae SH, 2009, BIOCHEMISTRY-US, V48, P8120, DOI 10.1021/bi900923b; BELT PBGM, 1995, J GEN VIROL, V76, P509, DOI 10.1099/0022-1317-76-3-509; Blinov N, 2009, BIOCHEMISTRY-US, V48, P1488, DOI 10.1021/bi802043h; Calzolai L, 2000, P NATL ACAD SCI USA, V97, P8340, DOI 10.1073/pnas.97.15.8340; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Christen B, 2008, J MOL BIOL, V383, P306, DOI 10.1016/j.jmb.2008.08.045; Christen B, 2009, J MOL BIOL, V389, P833, DOI 10.1016/j.jmb.2009.04.040; CLORE GM, 1990, J AM CHEM SOC, V112, P4989, DOI 10.1021/ja00168a070; CLOUSCARD C, 1995, J GEN VIROL, V76, P2097, DOI 10.1099/0022-1317-76-8-2097; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cole R, 2003, J BIOMOL NMR, V26, P203, DOI 10.1023/A:1023808801134; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.bi.60.070191.004051; Donne DG, 1997, P NATL ACAD SCI USA, V94, P13452, DOI 10.1073/pnas.94.25.13452; Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311; FARROW NA, 1995, J BIOMOL NMR, V6, P153, DOI 10.1007/BF00211779; Garcia FL, 2000, P NATL ACAD SCI USA, V97, P8334, DOI 10.1073/pnas.97.15.8334; GIBBS CJ, 1973, SCIENCE, V182, P67, DOI 10.1126/science.182.4107.67; Gossert AD, 2005, P NATL ACAD SCI USA, V102, P646, DOI 10.1073/pnas.0409008102; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Hornemann S, 2004, EMBO REP, V5, P1159, DOI 10.1038/sj.embor.7400297; Hunter N, 1997, TRENDS MICROBIOL, V5, P331, DOI 10.1016/S0966-842X(97)01081-0; James TL, 1997, P NATL ACAD SCI USA, V94, P10086, DOI 10.1073/pnas.94.19.10086; Kaneko K, 1997, P NATL ACAD SCI USA, V94, P10069, DOI 10.1073/pnas.94.19.10069; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kay LE, 1998, NAT STRUCT BIOL, V5, P156, DOI 10.1038/nsb0298-156; Kirby L, 2010, BIOCHEMISTRY-US, V49, P1448, DOI 10.1021/bi901855z; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lefevre JF, 1996, BIOCHEMISTRY-US, V35, P2674, DOI 10.1021/bi9526802; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu H, 1999, BIOCHEMISTRY-US, V38, P5362, DOI 10.1021/bi982878x; Lu XJ, 2007, P NATL ACAD SCI USA, V104, P1510, DOI 10.1073/pnas.0608447104; Lysek DA, 2005, P NATL ACAD SCI USA, V102, P640, DOI 10.1073/pnas.0408937102; O'Sullivan DBD, 2009, PROTEIN SCI, V18, P410, DOI 10.1002/pro.44; PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027; PENG JW, 1992, J MAGN RESON, V98, P308, DOI 10.1016/0022-2364(92)90135-T; PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X; PRIVALOV PL, 1990, J MOL BIOL, V213, P385, DOI 10.1016/S0022-2836(05)80198-6; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Riek R, 1998, P NATL ACAD SCI USA, V95, P11667, DOI 10.1073/pnas.95.20.11667; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Spyracopoulos L, 2006, J BIOMOL NMR, V36, P215, DOI 10.1007/s10858-006-9083-0; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Viles JH, 2001, BIOCHEMISTRY-US, V40, P2743, DOI 10.1021/bi002898a; Vorberg I, 2003, J VIROL, V77, P2003, DOI 10.1128/JVI.77.3.2003-2009.2003; Walsh P, 2009, STRUCTURE, V17, P417, DOI 10.1016/j.str.2008.12.018; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WEN Y, 2010, J BIOL CHEM IN PRESS; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yin SM, 2003, PROTEIN EXPRES PURIF, V32, P104, DOI 10.1016/S1046-5928(03)00195-5; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang JP, 2010, J THEOR BIOL, V264, P119, DOI 10.1016/j.jtbi.2010.01.024; Zhang YB, 2000, J BIOL CHEM, V275, P33650, DOI 10.1074/jbc.C000483200	64	29	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13273	10.1371/journal.pone.0013273	http://dx.doi.org/10.1371/journal.pone.0013273			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949107	Green Published, gold			2022-12-27	WOS:000282633700023
J	Mattiuzzo, G; Takeuchi, Y				Mattiuzzo, Giada; Takeuchi, Yasuhiro			Suboptimal Porcine Endogenous Retrovirus Infection in Non-Human Primate Cells: Implication for Preclinical Xenotransplantation	PLOS ONE			English	Article							CROSS-SPECIES TRANSMISSION; LIVING PIG-TISSUE; LARGE WHITE-PIG; IN-VITRO; HOST-RANGE; MINIATURE SWINE; NO EVIDENCE; SUBGROUP-A; PERV; IDENTIFICATION	Background: Porcine endogenous retrovirus (PERV) poses a potential risk of zoonotic infection in xenotransplantation. Preclinical transplantation trials using non-human primates (NHP) as recipients of porcine xenografts present the opportunity to assess the zoonosis risk in vivo. However, PERV poorly infects NHP cells for unclear reasons and therefore NHP may represent a suboptimal animal model to assess the risk of PERV zoonoses. We investigated the mechanism responsible for the low efficiency of PERV-A infection in NHP cells. Principal Findings: Two steps, cell entry and exit, were inefficient for the replication of high-titer, human-tropic A/C recombinant PERV. A restriction factor, tetherin, is likely to be responsible for the block to matured virion release, supported by the correlation between the levels of inhibition and tetherin expression. In rhesus macaque, cynomolgus macaque and baboon the main receptor for PERV entry, PERV-A receptor 1 (PAR-1), was found to be genetically deficient: PAR-1 genes in these species encode serine at amino acid 109 in place of the leucine in human PAR-1. This genetic defect inevitably impacts in vivo sensitivity to PERV infection of these species. In contrast, African green monkey (AGM) PAR-1 is functional, but PERV infection is still poor. Although the mechanism is unclear, tunicamycin treatment, which removes N-glycosylated sugar chains, increases PERV infection, suggesting a possible role for the glycosylation of the receptors. Conclusions: Since cynomolgus macaque and baboon, species often used in pig-to-NHP xenotransplantation experiments, have a defective PAR-1, they hardly represent an ideal animal model to assess the risk of PERV transmission in xenotransplantation. Alternatively, NHP species, like AGM, whose both PARs are functional may represent a better model than baboon and cynomolgus macaque for PERV zoonosis in vivo studies.	[Mattiuzzo, Giada; Takeuchi, Yasuhiro] UCL, Div Infect & Immun, Wohl Virion Ctr, London, England	University of London; University College London	Mattiuzzo, G (corresponding author), UCL, Div Infect & Immun, Wohl Virion Ctr, London, England.	y.takeuchi@ucl.ac.uk			European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health) [LSHB-CT-2006-037377]	European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health)	This work was supported by the European Sixth Framework Programme (Life Science, Genomics and Biotechnology for Health) funded project LSHB-CT-2006-037377. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi DE, 1998, J VIROL, V72, P4503, DOI 10.1128/JVI.72.5.4503-4507.1998; Bartosch B, 2004, J VIROL, V78, P13880, DOI 10.1128/JVI.78.24.13880-13890.2004; Bartosch B, 2002, J GEN VIROL, V83, P2231, DOI 10.1099/0022-1317-83-9-2231; Blusch JH, 2000, J VIROL, V74, P7687, DOI 10.1128/JVI.74.16.7687-7690.2000; Bosch S, 2000, J VIROL, V74, P8575, DOI 10.1128/JVI.74.18.8575-8581.2000; Clemenceau B, 2001, DIABETOLOGIA, V44, P2044, DOI 10.1007/s001250100010; Cunningham DA, 2001, TRENDS CARDIOVAS MED, V11, P190, DOI 10.1016/S1050-1738(01)00104-9; Denner J, 2003, Ann Transplant, V8, P39; Denner J, 2008, ARCH VIROL, V153, P1421, DOI 10.1007/s00705-008-0141-7; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Edamura K, 2004, J VET MED SCI, V66, P129, DOI 10.1292/jvms.66.129; Ekser B, 2009, TRANSPL IMMUNOL, V21, P87, DOI 10.1016/j.trim.2008.10.005; Elliott RB, 2000, CELL TRANSPLANT, V9, P895, DOI 10.1177/096368970000900616; Ericsson TA, 2003, P NATL ACAD SCI USA, V100, P6759, DOI 10.1073/pnas.1138025100; Gemeniano M, 2006, VIROLOGY, V346, P108, DOI 10.1016/j.virol.2005.10.021; Heneine W, 1998, LANCET, V352, P695, DOI 10.1016/S0140-6736(98)07145-1; Herring C, 2001, J VIROL, V75, P12252, DOI 10.1128/JVI.75.24.12252-12265.2001; Lavillette D, 2002, J VIROL, V76, P6442, DOI 10.1128/JVI.76.13.6442-6452.2002; Lee JH, 2002, J VIROL, V76, P5548, DOI 10.1128/JVI.76.11.5548-5556.2002; LeTissier P, 1997, NATURE, V389, P681, DOI 10.1038/39489; Li Z, 2004, VIRUS RES, V105, P167, DOI 10.1016/j.virusres.2004.05.007; Marcucci KT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-3; Marin M, 2003, J VIROL, V77, P2936, DOI 10.1128/JVI.77.5.2936-2945.2003; Martin U, 1999, TRANSPLANT P, V31, P913, DOI 10.1016/S0041-1345(98)01832-6; Mattiuzzo G, 2008, CURR OPIN ORGAN TRAN, V13, P184, DOI 10.1097/MOT.0b013e3282f7961e; Mattiuzzo G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-93; Mattiuzzo G, 2010, J VIROL, V84, P2618, DOI 10.1128/JVI.01928-09; Moscoso I, 2005, TRANSPLANTATION, V79, P777, DOI 10.1097/01.TP.0000152662.55720.83; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Niebert M, 2002, J VIROL, V76, P2714, DOI 10.1128/JVI.76.6.2714-2720.2002; Nishitai R, 2005, J SURG RES, V124, P45, DOI 10.1016/j.jss.2004.09.006; Oldmixon BA, 2002, J VIROL, V76, P3045, DOI 10.1128/JVI.76.6.3045-3048.2002; Paradis K, 1999, SCIENCE, V285, P1236, DOI 10.1126/science.285.5431.1236; Patience C, 1998, LANCET, V352, P699, DOI 10.1016/S0140-6736(98)04369-4; Patience C, 1997, NAT MED, V3, P282, DOI 10.1038/nm0397-282; Patience C, 2001, J VIROL, V75, P2771, DOI 10.1128/JVI.75.6.2771-2775.2001; Ritzhaupt A, 2002, J VIROL, V76, P11312, DOI 10.1128/JVI.76.22.11312-11320.2002; Rogel-Gaillard C, 1999, CYTOGENET CELL GENET, V85, P205, DOI 10.1159/000015294; Scobie L, 2009, CURR OPIN ORGAN TRAN, V14, P175, DOI 10.1097/MOT.0b013e328327984d; Simon A R, 2003, Ann Transplant, V8, P24; Specke V, 2001, J GEN VIROL, V82, P837, DOI 10.1099/0022-1317-82-4-837; Specke V, 2009, XENOTRANSPLANTATION, V16, P34, DOI 10.1111/j.1399-3089.2009.00508.x; Switzer WM, 2001, TRANSPLANTATION, V71, P959, DOI 10.1097/00007890-200104150-00022; Takeuchi Y, 1998, J VIROL, V72, P9986, DOI 10.1128/JVI.72.12.9986-9991.1998; Templin C, 2000, TRANSPLANT P, V32, P1163, DOI 10.1016/S0041-1345(00)01167-2; Wilson CA, 2008, CELL MOL LIFE SCI, V65, P3399, DOI 10.1007/s00018-008-8498-z; Wilson CA, 2000, J VIROL, V74, P49, DOI 10.1128/JVI.74.1.49-56.2000; Wilson CA, 1998, J VIROL, V72, P3082, DOI 10.1128/JVI.72.4.3082-3087.1998; Wood A, 2009, J GEN VIROL, V90, P702, DOI 10.1099/vir.0.007377-0; Wood JC, 2004, J VIROL, V78, P2494, DOI 10.1128/JVI.78.5.2494-2501.2004; Yan Y, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-2	51	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13203	10.1371/journal.pone.0013203	http://dx.doi.org/10.1371/journal.pone.0013203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949092	Green Published, Green Submitted, gold			2022-12-27	WOS:000282568400014
J	An, RS; Grewal, PS				An, Ruisheng; Grewal, Parwinder S.			Molecular Mechanisms of Persistence of Mutualistic Bacteria Photorhabdus in the Entomopathogenic Nematode Host	PLOS ONE			English	Article							TRANSCRIBED SEQUENCES SCOTS; ESCHERICHIA-COLI; GENE-EXPRESSION; STEINERNEMA-CARPOCAPSAE; XENORHABDUS-NEMATOPHILA; SELECTIVE CAPTURE; STATIONARY-PHASE; VIBRIO-FISCHERI; LUMINESCENS; MACROPHAGES	Symbioses between microbes and animals are ubiquitous, yet little is known about the intricate mechanisms maintaining such associations. In an emerging mutualistic model system, insect-pathogenic bacteria Photorhabdus and their insect-parasitic nematode partner Heterorhabditis, we found that the bacteria undergo major transcriptional reshaping in the nematode intestine. Besides general starvation mechanisms, the bacteria induce cellular acidification to slow down growth, switch to pentose phosphate pathway to overcome oxidative stress and nutrition limitation, and shed motility but develop biofilm to persist in the nematode intestine until being released into the insect hemolymph. These findings demonstrate how the symbiotic bacteria reduce their nutritional dependence on the enduring nematode partner to ensure successful transmission of the couple to the next insect host.	[An, Ruisheng; Grewal, Parwinder S.] Ohio State Univ, Dept Entomol, Wooster, OH USA	University System of Ohio; Ohio State University	An, RS (corresponding author), Ohio State Univ, Dept Entomol, Wooster, OH USA.	grewal.4@osu.edu	An, Ruisheng/C-9738-2009	An, Ruisheng/0000-0003-2000-3623	Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio	Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio(Ohio State University)	This project was supported by a competitive grant from the Ohio Agricultural Research and Development Center, The Ohio State University, Wooster, Ohio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adin DA, 2008, APPL ENVIRON MICROB, V74, P633, DOI 10.1128/AEM.02138-07; An RS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-433; Andrassy I., 1976, EVOLUTION BASIS SYST; Barrios AFG, 2006, BIOTECHNOL BIOENG, V93, P188, DOI 10.1002/bit.20681; Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005; Braschler TR, 2003, APPL ENVIRON MICROB, V69, P4268, DOI 10.1128/AEM.69.7.4268-4271.2003; Buendia-Claveria AM, 2003, MICROBIOL-SGM, V149, P1807, DOI 10.1099/mic.0.26099-0; BUTLER JS, 1986, J MOL BIOL, V192, P767, DOI 10.1016/0022-2836(86)90027-6; Clarke DJ, 2008, CELL MICROBIOL, V10, P2159, DOI 10.1111/j.1462-5822.2008.01209.x; Daigle F, 2001, MOL MICROBIOL, V41, P1211, DOI 10.1046/j.1365-2958.2001.02593.x; DeLoney CR, 2002, J BACTERIOL, V184, P5121, DOI 10.1128/JB.184.18.5121-5129.2002; Derzelle S, 2004, MICROBIOL-SGM, V150, P897, DOI 10.1099/mic.0.26563-0; Duchaud E, 2003, NAT BIOTECHNOL, V21, P1307, DOI 10.1038/nbt886; Easom CA, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-168; Emelianoff V, 2008, EVOLUTION, V62, P932, DOI 10.1111/j.1558-5646.2008.00319.x; FERGUSON GP, 1995, MOL MICROBIOL, V17, P1025, DOI 10.1111/j.1365-2958.1995.mmi_17061025.x; Ferguson GP, 1997, J BACTERIOL, V179, P1007, DOI 10.1128/jb.179.4.1007-1012.1997; Flores-Lara Y, 2007, J INVERTEBR PATHOL, V95, P110, DOI 10.1016/j.jip.2007.01.006; Fresquet V, 2004, BIOCHEMISTRY-US, V43, P10619, DOI 10.1021/bi048972x; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; FROUSSARD P, 1992, NUCLEIC ACIDS RES, V20, P2900, DOI 10.1093/nar/20.11.2900; FUTAI M, 1989, ANNU REV BIOCHEM, V58, P111; Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581; Graham JE, 1999, P NATL ACAD SCI USA, V96, P11554, DOI 10.1073/pnas.96.20.11554; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; HECK KL, 1975, ECOLOGY, V56, P1459, DOI 10.2307/1934716; Huang Y, 2007, APPL ENVIRON MICROB, V73, P7522, DOI 10.1128/AEM.01481-07; Karp PD, 2005, NUCLEIC ACIDS RES, V33, P6083, DOI 10.1093/nar/gki892; Kaya Harry K., 1997, P281, DOI 10.1016/B978-012432555-5/50016-6; Kelly DJ, 2001, FEMS MICROBIOL REV, V25, P405, DOI 10.1111/j.1574-6976.2001.tb00584.x; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; LEE EH, 1991, P NATL ACAD SCI USA, V88, P3029, DOI 10.1073/pnas.88.8.3029; LUNAU S, 1993, NEMATOLOGICA, V39, P385, DOI 10.1163/187529293X00330; Martens EC, 2005, MOL MICROBIOL, V58, P28, DOI 10.1111/j.1365-2958.2005.04742.x; MASAI H, 1994, EMBO J, V13, P5338, DOI 10.1002/j.1460-2075.1994.tb06868.x; McFall-Ngai M, 2008, NAT REV MICROBIOL, V6, P789, DOI 10.1038/nrmicro1982; Mendz GL, 1996, MICROBIOL-UK, V142, P2959, DOI 10.1099/13500872-142-10-2959; Mitani DK, 2004, BIOL CONTROL, V29, P382, DOI 10.1016/j.biocontrol.2003.07.005; Muela A, 2008, FEMS MICROBIOL ECOL, V64, P28, DOI 10.1111/j.1574-6941.2008.00453.x; PINNER E, 1993, J BIOL CHEM, V268, P1729; Ruby EG, 2008, NAT REV MICROBIOL, V6, P752, DOI 10.1038/nrmicro1958; SELVAN S, 1993, J PARASITOL, V79, P167, DOI 10.2307/3283503; Suga K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000671; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Thaden JJ, 2000, J AM AGING ASSOC, V23, P75, DOI 10.1007/s11357-000-0008-7; Tropel D, 2004, MICROBIOL MOL BIOL R, V68, P474, DOI 10.1128/MMBR.68.3.474-500.2004; Wang YL, 2006, NUCLEIC ACIDS RES, V34, P613, DOI 10.1093/nar/gkj438; Wood TK, 2006, APPL MICROBIOL BIOT, V72, P361, DOI 10.1007/s00253-005-0263-8; Yilmaz EI, 2008, J IND MICROBIOL BIOT, V35, P1, DOI 10.1007/s10295-007-0259-8; Zhu XC, 2008, MICROBES INFECT, V10, P1274, DOI 10.1016/j.micinf.2008.07.025	50	20	21	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13154	10.1371/journal.pone.0013154	http://dx.doi.org/10.1371/journal.pone.0013154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957199	gold, Green Published, Green Submitted			2022-12-27	WOS:000282506100005
J	Shi, T; Mazumdar, T; DeVecchio, J; Duan, ZH; Agyeman, A; Aziz, M; Houghton, JA				Shi, Ting; Mazumdar, Tapati; DeVecchio, Jennifer; Duan, Zhong-Hui; Agyeman, Akwasi; Aziz, Mohammad; Houghton, Janet A.			cDNA Microarray Gene Expression Profiling of Hedgehog Signaling Pathway Inhibition in Human Colon Cancer Cells	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; TRANSCRIPTION FACTOR; DNA-REPLICATION; TARGET GENES; GROWTH; NETWORK; ARREST; GLI2; DIFFERENTIATION; CARCINOGENESIS	Background: Hedgehog (HH) signaling plays a critical role in normal cellular processes, in normal mammalian gastrointestinal development and differentiation, and in oncogenesis and maintenance of the malignant phenotype in a variety of human cancers. Increasing evidence further implicates the involvement of HH signaling in oncogenesis and metastatic behavior of colon cancers. However, genomic approaches to elucidate the role of HH signaling in cancers in general are lacking, and data derived on HH signaling in colon cancer is extremely limited. Methodology/Principal Findings: To identify unique downstream targets of the GLI genes, the transcriptional regulators of HH signaling, in the context of colon carcinoma, we employed a small molecule inhibitor of both GLI1 and GLI2, GANT61, in two human colon cancer cell lines, HT29 and GC3/c1. Cell cycle analysis demonstrated accumulation of GANT61-treated cells at the G1/S boundary. cDNA microarray gene expression profiling of 18,401 genes identified Differentially Expressed Genes (DEGs) both common and unique to HT29 and GC3/c1. Analyses using GenomeStudio (statistics), Matlab (heat map), Ingenuity (canonical pathway analysis), or by qRT-PCR, identified p21(Cip1) (CDKN1A) and p15(Ink4b) (CDKN2B), which play a role in the G1/S checkpoint, as up-regulated genes at the G1/S boundary. Genes that determine further cell cycle progression at G1/S including E2F2, CYCLIN E2 (CCNE2), CDC25A and CDK2, and genes that regulate passage of cells through G2/M (CYCLIN A2 [CCNA2], CDC25C, CYCLIN B2 [CCNB2], CDC20 and CDC2 [CDK1], were down-regulated. In addition, novel genes involved in stress response, DNA damage response, DNA replication and DNA repair were identified following inhibition of HH signaling. Conclusions/Significance: This study identifies genes that are involved in HH-dependent cellular proliferation in colon cancer cells, and following its inhibition, genes that regulate cell cycle progression and events downstream of the G1/S boundary.	[Shi, Ting; Mazumdar, Tapati; DeVecchio, Jennifer; Agyeman, Akwasi; Aziz, Mohammad; Houghton, Janet A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44195 USA; [Duan, Zhong-Hui] Univ Akron, Dept Comp Sci, Akron, OH 44325 USA	Cleveland Clinic Foundation; University System of Ohio; University of Akron	Shi, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Canc Biol, 9500 Euclid Ave, Cleveland, OH 44195 USA.	houghtj@ccf.org	Aziz, Mohammad Azhar/F-7486-2013	Aziz, Mohammad Azhar/0000-0002-0798-5063	National Cancer Institute [RO1 CA 32613, RO1 108929]; Cleveland Clinic; NATIONAL CANCER INSTITUTE [R01CA032613, R01CA108929] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cleveland Clinic; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support from National Cancer Institute awards RO1 CA 32613 (JAH), RO1 108929 (JAH), and from the Cleveland Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Alinger B, 2009, VIRCHOWS ARCH, V454, P369, DOI 10.1007/s00428-009-0753-7; Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Berger JH, 2007, CURR MOL MED, V7, P63, DOI 10.2174/156652407779940477; Bian YH, 2007, WORLD J GASTROENTERO, V13, P1659, DOI 10.3748/wjg.v13.i11.1659; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Choi S, 2009, PHARM RES-DORDR, V26, P2280, DOI 10.1007/s11095-009-9944-9; Dormoy V, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-123; Eichberger T, 2006, GENOMICS, V87, P616, DOI 10.1016/j.ygeno.2005.12.003; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Gartel AL, 2002, MOL CANCER THER, V1, P639; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; HARPER JW, 1995, MOL BIOL CELL, V6, P387, DOI 10.1091/mbc.6.4.387; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Katoh Y, 2009, CURR MOL MED, V9, P873, DOI 10.2174/156652409789105570; Katoh Y, 2008, INT J ONCOL, V33, P881, DOI 10.3892/ijo_00000076; Katoh Y, 2006, INT J MOL MED, V18, P1019; Keen N, 2009, CANCER METAST REV, V28, P185, DOI 10.1007/s10555-009-9184-9; Koyama M, 2007, MOL CANCER THER, V6, P1579, DOI 10.1158/1535-7163.MCT-06-0814; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; McDonald ER, 2000, INT J ONCOL, V16, P871; Monzo M, 2006, CANCER LETT, V233, P117, DOI 10.1016/j.canlet.2005.03.001; Nguyen V, 2005, DEVELOPMENT, V132, P3267, DOI 10.1242/dev.01905; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Nurse P, 2000, CELL, V100, P71, DOI 10.1016/S0092-8674(00)81684-0; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Oniscu A, 2004, J PATHOL, V203, P909, DOI 10.1002/path.1591; Polager S, 2002, ONCOGENE, V21, P437, DOI 10.1038/sj.onc.1205102; Regl G, 2004, ONCOGENE, V23, P1263, DOI 10.1038/sj.onc.1207240; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P4505, DOI 10.1073/pnas.0504337103; Riobo NA, 2006, CANCER RES, V66, P839, DOI 10.1158/0008-5472.CAN-05-2539; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sandhu C, 2000, ONCOGENE, V19, P5314, DOI 10.1038/sj.onc.1203908; Sarangi A, 2009, ONCOGENE, V28, P3468, DOI 10.1038/onc.2009.208; Schnidar H, 2009, CANCER RES, V69, P1284, DOI 10.1158/0008-5472.CAN-08-2331; Stark GR, 2006, MOL BIOTECHNOL, V32, P227, DOI 10.1385/MB:32:3:227; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Thiyagarajan S, 2007, CANCER RES, V67, P10642, DOI 10.1158/0008-5472.CAN-07-2015; Tillman DM, 2003, CANCER RES, V63, P5118; van den Brink GR, 2004, NAT GENET, V36, P1038, DOI 10.1038/ng1004-1038; VARNAT F, MECH DEV, V127, P73; VARNAT F, 2009, MECH DEV; Varnat F, 2009, EMBO MOL MED, V1, P338, DOI 10.1002/emmm.200900039; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Yoshikawa K, 2009, J GASTROENTEROL, V44, P1113, DOI 10.1007/s00535-009-0110-2; Yu M, 2009, J BIOL CHEM, V284, P5620, DOI 10.1074/jbc.M809172200	56	57	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13054	10.1371/journal.pone.0013054	http://dx.doi.org/10.1371/journal.pone.0013054			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957031	Green Published, gold, Green Submitted			2022-12-27	WOS:000282359300003
J	Parnell, JJ; Rompato, G; Latta, LC; Pfrender, ME; Van Nostrand, JD; He, ZL; Zhou, JZ; Andersen, G; Champine, P; Ganesan, B; Weimer, BC				Parnell, J. Jacob; Rompato, Giovanni; Latta, Leigh C.; Pfrender, Michael E.; Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong; Andersen, Gary; Champine, Patti; Ganesan, Balasubramanian; Weimer, Bart C.			Functional Biogeography as Evidence of Gene Transfer in Hypersaline Microbial Communities	PLOS ONE			English	Article							GREAT-SALT-LAKE; CODON USAGE; DIVERSITY; EVOLUTION; GENOME; DNA; RECOMBINATION; MICROARRAY; PATTERNS; BACTERIA	Background: Horizontal gene transfer (HGT) plays a major role in speciation and evolution of bacteria and archaea by controlling gene distribution within an environment. However, information that links HGT to a natural community using relevant population-genetics parameters and spatial considerations is scarce. The Great Salt Lake (Utah, USA) provides an excellent model for studying HGT in the context of biogeography because it is a contiguous system with dispersal limitations due to a strong selective salinity gradient. We hypothesize that in spite of the barrier to phylogenetic dispersal, functional characteristics-in the form of HGT-expand beyond phylogenetic limitations due to selective pressure. Methodology and Results: To assay the functional genes and microorganisms throughout the GSL, we used a 16S rRNA oligonucleotide microarray (Phylochip) and a functional gene array (GeoChip) to measure biogeographic patterns of nine microbial communities. We found a significant difference in biogeography based on microarray analyses when comparing Sorensen similarity values for presence/absence of function and phylogeny (Student's t-test; p = 0.005). Conclusion and Significance: Biogeographic patterns exhibit behavior associated with horizontal gene transfer in that informational genes (16S rRNA) have a lower similarity than functional genes, and functional similarity is positively correlated with lake-wide selective pressure. Specifically, high concentrations of chromium throughout GSL correspond to an average similarity of chromium resistance genes that is 22% higher than taxonomic similarity. This suggests active HGT may be measured at the population level in microbial communities and these biogeographic patterns may serve as a model to study bacteria adaptation and speciation.	[Parnell, J. Jacob; Rompato, Giovanni; Champine, Patti; Ganesan, Balasubramanian; Weimer, Bart C.] Utah State Univ, Ctr Integrated BioSyst, Logan, UT 84322 USA; [Latta, Leigh C.; Pfrender, Michael E.; Weimer, Bart C.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Ganesan, Balasubramanian] Utah State Univ, Dept Nutr & Food Sci, Logan, UT 84322 USA; [Pfrender, Michael E.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Van Nostrand, Joy D.; He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Bot & Microbiol, Inst Environm Genom, Norman, OK 73019 USA; [Andersen, Gary] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Oklahoma System; University of Oklahoma - Norman; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Parnell, JJ (corresponding author), Utah State Univ, Ctr Integrated BioSyst, Logan, UT 84322 USA.	jacob.parnell@usu.edu	He, Zhili/C-2879-2012; 吴, 昊/AAB-1620-2020; Weimer, Bart/AAK-8501-2021; Weimer, Bart C/G-6928-2012; Andersen, Gary/G-2792-2015; Pfrender, Micheal E./C-5065-2019; Van Nostrand, Joy D/F-1740-2016	He, Zhili/0000-0001-8225-7333; Weimer, Bart/0000-0002-7471-1978; Weimer, Bart C/0000-0002-7471-1978; Andersen, Gary/0000-0002-1618-9827; Van Nostrand, Joy D/0000-0001-9548-6450	National Science Foundation [DEB-021212487]; United States Department of Agriculture CSREES [2006-34526-17001]; Utah Agricultural Experiment Station at Utah State University	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Utah Agricultural Experiment Station at Utah State University	Funding for this project was provided by National Science Foundation grant DEB-021212487 to MEP, and a grant from the United States Department of Agriculture CSREES 2006-34526-17001. This project was supported by the Utah Agricultural Experiment Station at Utah State University as journal paper number 8091. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Azad RK, 2007, NUCLEIC ACIDS RES, V35, P4629, DOI 10.1093/nar/gkm204; Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318; Branco R, 2008, J BACTERIOL, V190, P6996, DOI 10.1128/JB.00289-08; Brandt KK, 2001, MICROBIAL ECOL, V41, P1; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Brown JR, 2003, NAT REV GENET, V4, P121, DOI 10.1038/nrg1000; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Feil EJ, 2001, P NATL ACAD SCI USA, V98, P182, DOI 10.1073/pnas.98.1.182; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; Kloster M, 2008, NUCLEIC ACIDS RES, V36, P3819, DOI 10.1093/nar/gkn288; Kurland CG, 2003, P NATL ACAD SCI USA, V100, P9658, DOI 10.1073/pnas.1632870100; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Lonergan DJ, 1996, J BACTERIOL, V178, P2402, DOI 10.1128/jb.178.8.2402-2408.1996; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Naftz D, 2008, APPL GEOCHEM, V23, P1731, DOI 10.1016/j.apgeochem.2008.03.002; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Parnell JJ, 2009, MOL ECOL, V18, P1455, DOI 10.1111/j.1365-294X.2009.04128.x; Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219; Putonti C, 2006, MOL BIOL EVOL, V23, P1863, DOI 10.1093/molbev/msl053; Raes J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r10; Slater FR, 2008, FEMS MICROBIOL ECOL, V66, P3, DOI 10.1111/j.1574-6941.2008.00505.x; Smets BF, 2005, NAT REV MICROBIOL, V3, P675, DOI 10.1038/nrmicro1253; Strom SL, 2008, SCIENCE, V320, P1043, DOI 10.1126/science.1153527; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Tamames J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-136; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Tsirigos A, 2005, NUCLEIC ACIDS RES, V33, P922, DOI 10.1093/nar/gki187; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Wang FP, 2009, P NATL ACAD SCI USA, V106, P4840, DOI 10.1073/pnas.0810418106; Wu QL, 2006, APPL ENVIRON MICROB, V72, P5478, DOI 10.1128/AEM.00767-06; Xia XH, 2002, GENETICS, V161, P1385; Yergeau E, 2007, ISME J, V1, P163, DOI 10.1038/ismej.2007.24; Zhou JZ, 2008, P NATL ACAD SCI USA, V105, P7768, DOI 10.1073/pnas.0709016105; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	47	41	42	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2010	5	9							e12919	10.1371/journal.pone.0012919	http://dx.doi.org/10.1371/journal.pone.0012919			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	653KV	20957119	Green Published, gold, Green Submitted			2022-12-27	WOS:000282091100023
J	Gorostiaga, EM; Navarro-Amezqueta, I; Cusso, R; Hellsten, Y; Calbet, JAL; Guerrero, M; Granados, C; Gonzalez-Izal, M; Ibanez, J; Izquierdo, M				Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Cusso, Roser; Hellsten, Ylva; Calbet, Jose A. L.; Guerrero, Mario; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel			Anaerobic Energy Expenditure and Mechanical Efficiency during Exhaustive Leg Press Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ELECTRICAL-STIMULATION; INTERMITTENT EXERCISE; QUADRICEPS MUSCLE; HEAT-PRODUCTION; ISOMETRIC CONTRACTIONS; GLYCOGEN-PHOSPHORYLASE; INTENSE EXERCISE; DYNAMIC EXERCISE; POWER OUTPUT	Information about anaerobic energy production and mechanical efficiency that occurs over time during short-lasting maximal exercise is scarce and controversial. Bilateral leg press is an interesting muscle contraction model to estimate anaerobic energy production and mechanical efficiency during maximal exercise because it largely differs from the models used until now. This study examined the changes in muscle metabolite concentration and power output production during the first and the second half of a set of 10 repetitions to failure (10RM) of bilateral leg press exercise. On two separate days, muscle biopsies were obtained from vastus lateralis prior and immediately after a set of 5 or a set of 10 repetitions. During the second set of 5 repetitions, mean power production decreased by 19% and the average ATP utilisation accounted for by phosphagen decreased from 54% to 19%, whereas ATP utilisation from anaerobic glycolysis increased from 46 to 81%. Changes in contraction time and power output were correlated to the changes in muscle Phosphocreatine (PCr; r = -0.76; P < 0.01) and lactate (r = -0.91; P < 0.01), respectively, and were accompanied by parallel decreases (P < 0.01-0.05) in muscle energy charge (0.6%), muscle ATP/ADP (8%) and ATP/AMP (19%) ratios, as well as by increases in ADP content (7%). The estimated average rate of ATP utilisation from anaerobic sources during the final 5 repetitions fell to 83% whereas total anaerobic ATP production increased by 9% due to a 30% longer average duration of exercise (18.4 +/- 4.0 vs 14.2 +/- 2.1 s). These data indicate that during a set of 10RM of bilateral leg press exercise there is a decrease in power output which is associated with a decrease in the contribution of PCr and/or an increase in muscle lactate. The higher energy cost per repetition during the second 5 repetitions is suggestive of decreased mechanical efficiency.	[Gorostiaga, Esteban M.; Navarro-Amezqueta, Ion; Granados, Cristina; Gonzalez-Izal, Miriam; Ibanez, Javier; Izquierdo, Mikel] Govt Navarre, Studies Res & Sport Med Ctr, Navarra, Spain; [Cusso, Roser; Guerrero, Mario] Univ Barcelona, Dept Physiol Sci 1, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Hellsten, Ylva] Univ Copenhagen, Copenhagen Muscle Res Ctr, Mol Physiol Grp, Sect Human Physiol,Dept Exercise & Sport Sci, Copenhagen, Denmark; [Calbet, Jose A. L.] Univ Palmas Gran Canaria, Dept Phys Educ, Las Palmas Gran Canaria, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Copenhagen; Universidad de Las Palmas de Gran Canaria	Gorostiaga, EM (corresponding author), Govt Navarre, Studies Res & Sport Med Ctr, Navarra, Spain.	egorosta@cfnavarra.es	Izquierdo, Mikel/O-8049-2019; Calbet, Jose A L/H-6693-2015; Izquierdo, Mikel/A-4894-2010; Hellsten, Ylva/B-3420-2015	Calbet, Jose A L/0000-0002-9215-6234; Izquierdo, Mikel/0000-0002-1506-4272; Hellsten, Ylva/0000-0002-2435-9558; Granados, Cristina/0000-0002-8366-8932; Guerrero, Mario/0000-0002-9912-661X; antunez, Ariel/0000-0002-2548-7885	Spanish Ministry of Education [DEP200656076]	Spanish Ministry of Education(Spanish Government)	This study was supported by the Spanish Ministry of Education (National Plan of R&D+I 2004-2007, Key action "Sport and Physical Activity'' DEP200656076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson DE, 1977, CELLULAR ENERGY META, DOI DOI 10.1016/C2009-0-03136-5; AWAN MZ, 1970, BIOCHIM BIOPHYS ACTA, V216, P229, DOI 10.1016/0005-2728(70)90176-3; Bangsbo J, 2001, AM J PHYSIOL-ENDOC M, V280, pE956, DOI 10.1152/ajpendo.2001.280.6.E956; BANGSBO J, 1990, J PHYSIOL-LONDON, V422, P539, DOI 10.1113/jphysiol.1990.sp018000; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BERGSTROM M, 1988, J APPL PHYSIOL, V65, P1500, DOI 10.1152/jappl.1988.65.4.1500; BOGDANIS GC, 1995, J PHYSIOL-LONDON, V482, P467, DOI 10.1113/jphysiol.1995.sp020533; Bogdanis GC, 1998, ACTA PHYSIOL SCAND, V163, P261, DOI 10.1046/j.1365-201x.1998.00378.x; Bolgla LA, 2008, J SPORT REHABIL, V17, P1, DOI 10.1123/jsr.17.1.1; Boobis LH, 1987, EXERCISE BENEFITS LI, P116; CHASIOTIS D, 1987, J APPL PHYSIOL, V63, P167, DOI 10.1152/jappl.1987.63.1.167; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V335, P197, DOI 10.1113/jphysiol.1983.sp014528; CHEETHAM ME, 1986, J APPL PHYSIOL, V61, P54, DOI 10.1152/jappl.1986.61.1.54; DAWSON MJ, 1978, NATURE, V274, P861, DOI 10.1038/274861a0; DUDLEY GA, 1985, AM J PHYSIOL, V248, pC43, DOI 10.1152/ajpcell.1985.248.1.C43; DUDLEY GA, 1991, AVIAT SPACE ENVIR MD, V62, P543; EDWARDS RHT, 1975, J PHYSIOL-LONDON, V251, P303, DOI 10.1113/jphysiol.1975.sp011094; EDWARDS RHT, 1972, J PHYSIOL-LONDON, V220, P335, DOI 10.1113/jphysiol.1972.sp009710; ESSEN B, 1977, J PHYSIOL-LONDON, V265, P489, DOI 10.1113/jphysiol.1977.sp011726; GAITANOS GC, 1993, J APPL PHYSIOL, V75, P712, DOI 10.1152/jappl.1993.75.2.712; Gonzalez-Alonso J, 2000, J PHYSIOL-LONDON, V524, P603, DOI 10.1111/j.1469-7793.2000.00603.x; Gonzalez-Izal M, 2010, J ELECTROMYOGR KINES, V20, P233, DOI 10.1016/j.jelekin.2009.03.011; HULTMAN E, 1983, J PHYSIOL-LONDON, V345, P525, DOI 10.1113/jphysiol.1983.sp014994; HULTMAN E, 1986, J PHYSIOL-LONDON, V374, P493, DOI 10.1113/jphysiol.1986.sp016093; HULTMAN E, 1991, SCI PROG, V75, P361; JONES NL, 1985, J APPL PHYSIOL, V59, P132, DOI 10.1152/jappl.1985.59.1.132; Karatzaferi C, 2003, AM J PHYSIOL-CELL PH, V284, pC816, DOI 10.1152/ajpcell.00291.2002; KARLSSON J, 1970, J APPL PHYSIOL, V29, P598, DOI 10.1152/jappl.1970.29.5.598; KARLSSON J, 1971, ACTA PHYSIOL SCAND, V82, P115, DOI 10.1111/j.1748-1716.1971.tb04948.x; Krustrup P, 2003, J PHYSIOL-LONDON, V549, P255, DOI 10.1113/jphysiol.2002.035089; Krustrup P, 2009, J PHYSIOL-LONDON, V587, P1843, DOI 10.1113/jphysiol.2008.166397; KUSHMERICK MJ, 1985, J EXP BIOL, V115, P165; Lowry O H, 1971, Curr Probl Clin Biochem, V3, P63; MEDBO JI, 1993, J APPL PHYSIOL, V75, P1654, DOI 10.1152/jappl.1993.75.4.1654; NORMAN B, 1991, CLIN PHYSIOL, V11, P375, DOI 10.1111/j.1475-097X.1991.tb00666.x; Parolin ML, 1999, AM J PHYSIOL-ENDOC M, V277, pE890, DOI 10.1152/ajpendo.1999.277.5.E890; REN JM, 1988, ACTA PHYSIOL SCAND, V133, P101, DOI 10.1111/j.1748-1716.1988.tb08386.x; SAHLIN K, 1989, J APPL PHYSIOL, V67, P648, DOI 10.1152/jappl.1989.67.2.648; SAHLIN K, 1978, PFLUG ARCH EUR J PHY, V374, P193, DOI 10.1007/BF00581301; SAHLIN K, 1975, BIOCHEM J, V152, P173, DOI 10.1042/bj1520173; SELLEVOLD OFM, 1986, J MOL CELL CARDIOL, V18, P517, DOI 10.1016/S0022-2828(86)80917-8; SPRIET LL, 1987, J APPL PHYSIOL, V62, P611, DOI 10.1152/jappl.1987.62.2.611; STORER TW, 1990, MED SCI SPORT EXER, V22, P704, DOI 10.1249/00005768-199010000-00024; TULLSON PC, 1995, J APPL PHYSIOL, V78, P146, DOI 10.1152/jappl.1995.78.1.146; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x	45	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13486	10.1371/journal.pone.0013486	http://dx.doi.org/10.1371/journal.pone.0013486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976067	gold, Green Published			2022-12-27	WOS:000283114700016
J	Matthews, TD; Edwards, R; Maloy, S				Matthews, T. David; Edwards, Robert; Maloy, Stanley			Chromosomal Rearrangements Formed by rrn Recombination Do Not Improve Replichore Balance in Host-Specific Salmonella enterica Serovars	PLOS ONE			English	Article							ESCHERICHIA-COLI-CHROMOSOME; RIBOSOMAL-RNA GENES; NADPH PHAGOCYTE OXIDASE; REPLICATION FORK TRAP; GENOME SEQUENCE; YERSINIA-PESTIS; INTRACELLULAR SALMONELLA; HOMOLOGOUS RECOMBINATION; ANTIMICROBIAL ACTIONS; TERMINUS REGION	Background: Most of the,2,600 serovars of Salmonella enterica have a broad host range as well as a conserved gene order. In contrast, some Salmonella serovars are host-specific and frequently exhibit large chromosomal rearrangements from recombination between rrn operons. One hypothesis explaining these rearrangements suggests that replichore imbalance introduced from horizontal transfer of pathogenicity islands and prophages drives chromosomal rearrangements in an attempt to improve balance. Methodology/Principal Findings: This hypothesis was directly tested by comparing the naturally-occurring chromosomal arrangement types to the theoretically possible arrangement types, and estimating their replichore balance using a calculator. In addition to previously characterized strains belonging to host-specific serovars, the arrangement types of 22 serovar Gallinarum strains was also determined. Only 48 out of 1,440 possible arrangement types were identified in 212 host-specific strains. While the replichores of most naturally-occurring arrangement types were well-balanced, most theoretical arrangement types had imbalanced replichores. Furthermore, the most common types of rearrangements did not change replichore balance. Conclusions/Significance: The results did not support the hypothesis that replichore imbalance causes these rearrangements, and suggest that the rearrangements could be explained by aspects of a host-specific lifestyle.	[Matthews, T. David; Edwards, Robert; Maloy, Stanley] San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA; [Edwards, Robert] San Diego State Univ, Dept Comp Sci, San Diego, CA 92182 USA; [Edwards, Robert] Argonne Natl Lab, Div Math & Comp Sci, Argonne, IL 60439 USA	California State University System; San Diego State University; California State University System; San Diego State University; United States Department of Energy (DOE); Argonne National Laboratory	Matthews, TD (corresponding author), San Diego State Univ, Dept Biol, Ctr Microbial Sci, San Diego, CA 92182 USA.	smaloy@sciences.sdsu.edu	Maloy, Stanley/AAA-7095-2019; Edwards, Robert/Q-1691-2019	Maloy, Stanley/0000-0001-9900-4367; Edwards, Robert/0000-0001-8383-8949	Natioinal Institute of Health [1U54CA132384, 1U54CA132379]; NATIONAL CANCER INSTITUTE [U54CA132384, U54CA132379] Funding Source: NIH RePORTER	Natioinal Institute of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant from the National Institute of Health (# 1U54CA132384 and # 1U54CA132379). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alokam S, 2002, J BACTERIOL, V184, P6190, DOI 10.1128/JB.184.22.6190-6197.2002; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carpentier AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-84; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Clegg S, 2002, J BACTERIOL, V184, P1209, DOI 10.1128/jb.184.4.1209-1213.2002; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Couturier E, 2006, MOL MICROBIOL, V59, P1506, DOI 10.1111/j.1365-2958.2006.05046.x; Darling AE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000128; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Deng W, 2002, J BACTERIOL, V184, P4601, DOI 10.1128/JB.184.16.4601-4611.2002; DESAI UJ, 1995, BIOTECHNIQUES, V19, P780; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; Edwards RA, 2002, TRENDS MICROBIOL, V10, P94, DOI 10.1016/S0966-842X(01)02293-4; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Esnault E, 2007, PLOS GENET, V3, P2486, DOI 10.1371/journal.pgen.0030226; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; EWING WH, 1986, GENUS SALMONELLA EDW, P181; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Gallois A, 2001, J IMMUNOL, V166, P5741, DOI 10.4049/jimmunol.166.9.5741; Guibourdenche M, 2010, RES MICROBIOL, V161, P26, DOI 10.1016/j.resmic.2009.10.002; Guijo MI, 2001, GENETICS, V157, P1413; HAACK KR, 1995, GENETICS, V141, P1245; Helm RA, 2003, GENETICS, V165, P951; Helm RA, 2001, APPL ENVIRON MICROB, V67, P3295, DOI 10.1128/AEM.67.7.3295-3298.2001; HELM RA, 2003, ANAL CHROMOSOMAL REA; HILL CW, 1981, P NATL ACAD SCI-BIOL, V78, P7069, DOI 10.1073/pnas.78.11.7069; HILL CW, 1988, GENETICS, V119, P771; HILL CW, 1977, J MOL BIOL, V116, P407, DOI 10.1016/0022-2836(77)90077-8; HILL CW, 1982, J BACTERIOL, V149, P449, DOI 10.1128/JB.149.2.449-457.1982; HILL TM, 1996, ESCHERICHIA COLI SAL, P1602; Iguchi A, 2006, GENE, V372, P199, DOI 10.1016/j.gene.2006.01.005; Jeong KS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r86; Jumas-Bilak E, 1998, MOL MICROBIOL, V27, P99, DOI 10.1046/j.1365-2958.1998.00661.x; Kothapalli S, 2005, J BACTERIOL, V187, P2638, DOI 10.1128/JB.187.8.2638-2650.2005; KUEMPEL PL, 1991, NEW BIOL, V3, P799; LI J, 1993, J MED MICROBIOL, V38, P129, DOI 10.1099/00222615-38-2-129; Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Liu GR, 2002, J BACTERIOL, V184, P2626, DOI 10.1128/JB.184.10.2626-2633.2002; Liu SL, 1998, FEMS MICROBIOL LETT, V164, P275, DOI 10.1016/S0378-1097(98)00225-0; LIU SL, 1995, J BACTERIOL, V177, P6585, DOI 10.1128/jb.177.22.6585-6592.1995; LIU SL, 1994, J BACTERIOL, V176, P1014, DOI 10.1128/JB.176.4.1014-1024.1994; LIU SL, 1995, P NATL ACAD SCI USA, V92, P1018, DOI 10.1073/pnas.92.4.1018; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Liu WQ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-290; Liu WQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004510; LOUARN JM, 1985, MOL GEN GENET, V201, P467, DOI 10.1007/BF00331341; Mastroeni P, 2000, J EXP MED, V192, P237, DOI 10.1084/jem.192.2.237; Morton RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-369; Niki H, 2000, GENE DEV, V14, P212; Olsen JE, 1996, J MED MICROBIOL, V45, P413, DOI 10.1099/00222615-45-6-413; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Petrosino JF, 2006, J BACTERIOL, V188, P6977, DOI 10.1128/JB.00506-06; Pomeroy B. S., 1984, DISEASES POULTRY, P79; POPOFF M.Y., 2005, BERGEYS MANUAL SYSTE, V2, P764; SCHMID MB, 1987, J BACTERIOL, V169, P2872, DOI 10.1128/jb.169.6.2872-2875.1987; Shu SE, 2000, FEMS MICROBIOL LETT, V182, P93, DOI 10.1111/j.1574-6968.2000.tb08880.x; SNOEYENBOS GH, 1984, DISEASES POULTRY, P66; Song JZ, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-17; Sousa C, 1997, MICROBIOL-SGM, V143, P2071, DOI 10.1099/00221287-143-6-2071; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Vazquez-Torres A, 2000, SCIENCE, V287, P1655, DOI 10.1126/science.287.5458.1655; Vazquez-Torres A, 2001, TRENDS MICROBIOL, V9, P29, DOI 10.1016/S0966-842X(00)01897-7; Vazquez-Torres A, 2000, J EXP MED, V192, P227, DOI 10.1084/jem.192.2.227; Wu KY, 2005, J BACTERIOL, V187, P4720, DOI 10.1128/JB.187.14.4720-4727.2005; [No title captured]	74	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13503	10.1371/journal.pone.0013503	http://dx.doi.org/10.1371/journal.pone.0013503			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976060	gold, Green Submitted, Green Published			2022-12-27	WOS:000283114700022
J	Tecklenburg-Lund, S; Mickleborough, TD; Turner, LA; Fly, AD; Stager, JM; Montgomery, GS				Tecklenburg-Lund, Sandra; Mickleborough, Timothy D.; Turner, Louise A.; Fly, Alyce D.; Stager, Joel M.; Montgomery, Gregory S.			Randomized Controlled Trial of Fish Oil and Montelukast and Their Combination on Airway Inflammation and Hyperpnea-Induced Bronchoconstriction	PLOS ONE			English	Article							EXERCISE-INDUCED BRONCHOCONSTRICTION; EXHALED NITRIC-OXIDE; MAST-CELL ACTIVATION; EUCAPNIC VOLUNTARY HYPERVENTILATION; POLYUNSATURATED FATTY-ACIDS; BREATH CONDENSATE PH; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; INDUCED ASTHMA; LEUKOTRIENES	Background: Both fish oil and montelukast have been shown to reduce the severity of exercise-induced bronchoconstriction (EIB). The purpose of this study was to compare the effects of fish oil and montelukast, alone and in combination, on airway inflammation and bronchoconstriction induced by eucapnic voluntary hyperpnea (EVH) in asthmatics. Methods: In this model of EIB, twenty asthmatic subjects with documented hyperpnea-induced bronchoconstriction (HIB) entered a randomized double-blind trial. All subjects entered on their usual diet (pre-treatment, n = 20) and then were randomly assigned to receive either one active 10 mg montelukast tablet and 10 placebo fish oil capsules (n = 10) or one placebo montelukast tablet and 10 active fish oil capsules totaling 3.2 g EPA and 2.0 g DHA (n = 10) taken daily for 3-wk. Thereafter, all subjects (combination treatment; n = 20) underwent another 3-wk treatment period consisting of a 10 mg active montelukast tablet or 10 active fish oil capsules taken daily. Results: While HIB was significantly inhibited (p<0.05) by montelukast, fish oil and combination treatment compared to pre-treatment, there was no significant difference (p>0.017) between treatment groups; percent fall in forced expiratory volume in 1-sec was -18.4 +/- 2.1%, -9.3 +/- 2.8%, -11.6 +/- 2.8% and -10.8 +/- 1.7% on usual diet (pre-treatment), fish oil, montelukast and combination treatment respectively. All three treatments were associated with a significant reduction (p<0.05) in FENO, exhaled breathe condensate pH and cysteinyl-leukotrienes, while the fish oil and combination treatment significantly reduced (p<0.05) urinary 9 alpha, 11 beta- prostaglandin F-2 after EVH compared to the usual diet; however, there was no significant difference (p>0.017) in these biomarkers between treatments. Conclusion: While fish oil and montelukast are both effective in attenuating airway inflammation and HIB, combining fish oil with montelukast did not confer a greater protective effect than either intervention alone. Fish oil supplementation should be considered as an alternative treatment for EIB.	[Tecklenburg-Lund, Sandra; Mickleborough, Timothy D.; Turner, Louise A.; Stager, Joel M.] Indiana Univ, Dept Kinesiol, Human Performance & Exercise Biochem Lab, Bloomington, IN 47405 USA; [Fly, Alyce D.] Indiana Univ, Dept Appl Hlth Sci, Bloomington, IN 47405 USA; [Montgomery, Gregory S.] Indiana Univ Sch Med, Indianapolis, IN USA; [Tecklenburg-Lund, Sandra] Nebraska Wesleyan Univ, Lincoln, NE USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Tecklenburg-Lund, S (corresponding author), Indiana Univ, Dept Kinesiol, Human Performance & Exercise Biochem Lab, Bloomington, IN 47405 USA.	tmickleb@indiana.edu	Montgomery, Gregory/AAE-2544-2020; Lund, Sandy/AAD-8308-2020	Montgomery, Gregory/0000-0002-4232-2070; Mickleborough, Timothy/0000-0002-5118-268X; Turner, Louise/0000-0003-0847-2232; Fly, Alyce/0000-0001-7814-3675	Faculty Research Support Program, Indiana University; Indiana University	Faculty Research Support Program, Indiana University; Indiana University	This work was supported by a grant from the Faculty Research Support Program, Indiana University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Merck provided the montelukast and placebo tablets, and Nordic Naturals the fish oil and placebo capsules.	Accordino R, 2008, RESP MED, V102, P377, DOI 10.1016/j.rmed.2007.10.014; Anderson SD, 2005, CURR ALLERGY ASTHM R, V5, P116, DOI 10.1007/s11882-005-0084-y; Anderson SD, 2001, BRIT J SPORT MED, V35, P344, DOI 10.1136/bjsm.35.5.344; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1999, Am J Respir Crit Care Med, V160, P2104; BEASLEY CRW, 1987, J CLIN INVEST, V79, P978, DOI 10.1172/JCI112909; Brannan JD, 2003, EUR RESPIR J, V22, P491, DOI 10.1183/09031936.03.00113403; Brummel NE, 2009, J ASTHMA, V46, P683, DOI 10.1080/02770900902972178; Calder PC, 2007, PROSTAG LEUKOTR ESS, V77, P327, DOI 10.1016/j.plefa.2007.10.015; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Dahlen B, 2002, J ALLERGY CLIN IMMUN, V109, P789, DOI 10.1067/mai.2002.123306; Dahlen SE, 2004, THORAX, V59, P453, DOI 10.1136/thx.2004.026641; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; Drazen JM, 2002, ADV EXP MED BIOL, V507, P217; Duong M, 2008, CHEST, V133, P404, DOI 10.1378/chest.07-2048; ElHalawani SM, 2003, CHEST, V124, P639, DOI 10.1378/chest.124.2.639; FINNERTY JP, 1992, AM REV RESPIR DIS, V145, P746, DOI 10.1164/ajrccm/145.4_Pt_1.746; Ghiro L, 2002, EUR RESPIR J, V20, P630, DOI 10.1183/09031936.02.01512002; Gorjao R, 2006, CLIN NUTR, V25, P923, DOI 10.1016/j.clnu.2006.03.004; Grimminger F, 2000, AM J PHYSIOL-LUNG C, V278, pL268, DOI 10.1152/ajplung.2000.278.2.L268; Hallstrand TS, 2007, AM J RESP CRIT CARE, V176, P1072, DOI 10.1164/rccm.200707-1088OC; Hallstrand TS, 2009, CURR ALLERGY ASTHM R, V9, P18, DOI 10.1007/s11882-009-0003-8; Hallstrand TS, 2005, AM J RESP CRIT CARE, V172, P679, DOI 10.1164/rccm.200412-1667OC; Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hunt JF, 2000, AM J RESP CRIT CARE, V161, P694, DOI 10.1164/ajrccm.161.3.9911005; Kanazawa H, 2000, J ALLERGY CLIN IMMUN, V106, P1081, DOI 10.1067/mai.2000.110803; Kippelen P, 2010, MED SCI SPORT EXER, V42, P273, DOI 10.1249/MSS.0b013e3181b541b1; Koczulla R, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-78; Lee JY, 2004, J BIOL CHEM, V279, P16971, DOI 10.1074/jbc.M312990200; LEE TH, 1985, NEW ENGL J MED, V312, P1217, DOI 10.1056/NEJM198505093121903; Leff JA, 1998, NEW ENGL J MED, V339, P147, DOI 10.1056/NEJM199807163390302; Lund TK, 2009, BRIT J SPORT MED, V43, P1131, DOI 10.1136/bjsm.2008.054924; Martin RE, 1998, J NEUROSCI RES, V54, P805, DOI 10.1002/(SICI)1097-4547(19981215)54:6<805::AID-JNR8>3.0.CO;2-4; Mickleborough TD, 2006, CHEST, V129, P39, DOI 10.1378/chest.129.1.39; Mickleborough TD, 2005, MED SCI SPORT EXER, V37, P904, DOI 10.1249/01.mss.0000166949.11296.2b; Mickleborough TD, 2003, AM J RESP CRIT CARE, V168, P1181, DOI 10.1164/rccm.200303-373OC; Mickleborough TD, 2008, EXERC SPORT SCI REV, V36, P135, DOI 10.1097/JES.0b013e31817be827; Mickleborough TD, 2009, CLIN NUTR, V28, P71, DOI 10.1016/j.clnu.2008.10.012; Montuschi P, 2002, J ALLERGY CLIN IMMUN, V109, P615, DOI 10.1067/mai.2002.122461; O'Byrne PM, 2009, CLIN EXP ALLERGY, V39, P181, DOI 10.1111/j.1365-2222.2008.03172.x; O'Byrne PM, 2009, J ALLERGY CLIN IMMUN, V124, P397, DOI 10.1016/j.jaci.2009.05.029; O'Byrne PM, 2000, AM J RESP CRIT CARE, V161, pS68, DOI 10.1164/ajrccm.161.supplement_1.ltta-14; O'Sullivan S, 1998, CLIN EXP ALLERGY, V28, P1332; O'Sullivan S, 1998, EUR RESPIR J, V12, P345, DOI 10.1183/09031936.98.12020345; Parsons JP, 2009, EXPERT REV CLIN IMMU, V5, P357, DOI [10.1586/eci.09.15, 10.1586/ECI.09.15]; Pearlman DS, 2006, ANN ALLERG ASTHMA IM, V97, P98, DOI 10.1016/S1081-1206(10)61377-4; Philip G, 2007, J ASTHMA, V44, P213, DOI 10.1080/02770900701209806; Reisman J, 2006, BMC Complement Altern Med, V6, P26, DOI 10.1186/1472-6882-6-26; Rundell KW, 2005, BRIT J SPORT MED, V39, P232, DOI 10.1136/bjsm.2004.014282; Rundell KW, 2001, MED SCI SPORT EXER, V33, P208; Sandrini A, 2003, CHEST, V124, P1334, DOI 10.1378/chest.124.4.1334; Schubert R, 2009, INT ARCH ALLERGY IMM, V148, P321, DOI 10.1159/000170386; Scollo M, 2000, AM J RESP CRIT CARE, V161, P1047, DOI 10.1164/ajrccm.161.3.9905043; TECKLENBURG SL, 2007, RESP MED IN PRESS; THIEN FCK, 1993, J IMMUNOL, V150, P3546; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; Weldon SM, 2007, J NUTR BIOCHEM, V18, P250, DOI 10.1016/j.jnutbio.2006.04.003; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086	59	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13487	10.1371/journal.pone.0013487	http://dx.doi.org/10.1371/journal.pone.0013487			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976161	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000283045300041
J	Canault, M; Certel, K; Schatzberg, D; Wagner, DD; Hynes, RO				Canault, Matthias; Certel, Kaan; Schatzberg, Daphne; Wagner, Denisa D.; Hynes, Richard O.			The Lack of ADAM17 Activity during Embryonic Development Causes Hemorrhage and Impairs Vessel Formation	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; JUNCTIONAL ADHESION MOLECULE; CONVERTING-ENZYME; IN-VITRO; INFLAMMATORY RESPONSES; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; DEFICIENT MICE; GROWTH-FACTOR; NOTCH	Background: ADAM17/TACE activity is important during embryonic development. We wished to investigate possible roles of this metalloprotease, focusing on vascular development. Methodology/Principal Findings: Mice mutant in the enzymatic activity of ADAM17 were examined at various stages of embryonic development for vascular pattern and integrity using markers for vessel wall cells. We observed hemorrhage and edema starting at embryonic day E14.5 and becoming more severe as development proceeded; prior to embryonic day E14.5, embryos appeared normal. Staining for PECAM-1/CD31 revealed abnormalities in the patterns of branching of the embryonic vasculature at E14.5. Conclusions/Significance: These abnormalities preceded association of pericytes or monocyte/macrophage cells with the affected vessels and, therefore, presumably arise from defects in endothelial function consequent upon failure of ADAM17 to cleave one or more substrates involved in vascular development, such as Notch, Delta, VEGFR2 or JAM-A. Our study demonstrates a role for ADAM17 in modulating embryonic vessel development and function.	[Canault, Matthias; Schatzberg, Daphne; Wagner, Denisa D.] Immune Dis Inst, Boston, MA USA; [Canault, Matthias; Schatzberg, Daphne; Wagner, Denisa D.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Canault, Matthias; Wagner, Denisa D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Certel, Kaan; Hynes, Richard O.] Howard Hughes Med Inst, Chevy Chase, MA USA; [Certel, Kaan; Hynes, Richard O.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Canault, M (corresponding author), Immune Dis Inst, Boston, MA USA.	wagner@idi.harvard.edu; rohynes@mit.edu	Canault, Matthias/H-5128-2013	Canault, Matthias/0000-0002-7880-5250	National Heart, Lung, and Blood Institute of the National Institutes of Health [P01 HL066105, P01 HL056949]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056949, P01HL066105] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health grants P01 HL066105 (D. D. W. and R.O.H.) and P01 HL056949 (D. D. W.) and support from the Howard Hughes Medical Institute, of which R.O.H. is an investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Bergmeier W, 2004, CIRC RES, V95, P677, DOI 10.1161/01.RES.0000143899.73453.11; Berkowitz EA, 1996, CELL GROWTH DIFFER, V7, P1271; Black RA, 2002, INT J BIOCHEM CELL B, V34, P1, DOI 10.1016/S1357-2725(01)00097-8; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; Cooke VG, 2006, ARTERIOSCL THROM VAS, V26, P2005, DOI 10.1161/01.ATV.0000234923.79173.99; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; Garton KJ, 2006, J LEUKOCYTE BIOL, V79, P1105, DOI 10.1189/jlb.0106038; Gooz P, 2009, BIOCHEM BIOPH RES CO, V380, P33, DOI 10.1016/j.bbrc.2009.01.013; Holderfield MT, 2008, CIRC RES, V102, P637, DOI 10.1161/CIRCRESAHA.107.167171; Jakobsson L, 2009, BIOCHEM SOC T, V37, P1233, DOI 10.1042/BST0371233; Kisucka J, 2006, P NATL ACAD SCI USA, V103, P855, DOI 10.1073/pnas.0510412103; Koenen RR, 2009, BLOOD, V113, P4799, DOI 10.1182/blood-2008-04-152330; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li JL, 2009, FRONT BIOSCI-LANDMRK, V14, P3094, DOI 10.2741/3438; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Peschon JJ, 1998, SCIENCE, V282, P1281, DOI 10.1126/science.282.5392.1281; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Reiss K, 2006, PHARMACOL THERAPEUT, V111, P985, DOI 10.1016/j.pharmthera.2006.02.009; Ruuls SR, 2001, IMMUNITY, V15, P533, DOI 10.1016/S1074-7613(01)00215-1; Schmitt FC, 1999, AM J SURG PATHOL, V23, P358, DOI 10.1097/00000478-199903000-00023; Shi W, 2003, DEV BIOL, V261, P371, DOI 10.1016/S0012-1606(03)00315-4; Siekmann AF, 2008, BIOESSAYS, V30, P303, DOI 10.1002/bies.20736; Swendeman S, 2008, CIRC RES, V103, P916, DOI 10.1161/CIRCRESAHA.108.184416; Thurston G, 2008, BRIT J CANCER, V99, P1204, DOI 10.1038/sj.bjc.6604484; Weskamp G, 2010, CIRC RES, V106, P932, DOI 10.1161/CIRCRESAHA.109.207415; Willuweit A, 2001, J IMMUNOL, V167, P3944, DOI 10.4049/jimmunol.167.7.3944; Zhao JS, 2001, DEV BIOL, V232, P204, DOI 10.1006/dbio.2001.0176	31	24	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13433	10.1371/journal.pone.0013433	http://dx.doi.org/10.1371/journal.pone.0013433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976179	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700022
J	Wang, ZM; Hildesheim, A; Wang, SS; Herrero, R; Gonzalez, P; Burdette, L; Hutchinson, A; Thomas, G; Chanock, SJ; Yu, K				Wang, Zhaoming; Hildesheim, Allan; Wang, Sophia S.; Herrero, Rolando; Gonzalez, Paula; Burdette, Laurie; Hutchinson, Amy; Thomas, Gilles; Chanock, Stephen J.; Yu, Kai			Genetic Admixture and Population Substructure in Guanacaste Costa Rica	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GENOME-WIDE ASSOCIATION; CENTRAL VALLEY; X-CHROMOSOME; PIGMENTATION; INFERENCE; PROGRAM; SLC24A5; MARKERS; CANCER	The population of Costa Rica (CR) represents an admixture of major continental populations. An investigation of the CR population structure would provide an important foundation for mapping genetic variants underlying common diseases and traits. We conducted an analysis of 1,301 women from the Guanacaste region of CR using 27,904 single nucleotide polymorphisms (SNPs) genotyped on a custom Illumina InfiniumII iSelect chip. The program STRUCTURE was used to compare the CR Guanacaste sample with four continental reference samples, including HapMap Europeans (CEU), East Asians (JPT+CHB), West African Yoruba (YRI), as well as Native Americans (NA) from the Illumina iControl database. Our results show that the CR Guanacaste sample comprises a three-way admixture estimated to be 43% European, 38% Native American and 15% West African. An estimated 4% residual Asian ancestry may be within the error range. Results from principal components analysis reveal a correlation between genetic and geographic distance. The magnitude of linkage disequilibrium (LD) measured by the number of tagging SNPs required to cover the same region in the genome in the CR Guanacaste sample appeared to be weaker than that observed in CEU, JPT+CHB and NA reference samples but stronger than that of the HapMap YRI sample. Based on the clustering pattern observed in both STRUCTURE and principal components analysis, two subpopulations were identified that differ by approximately 20% in LD block size averaged over all LD blocks identified by Haploview. We also show in a simulated association study conducted within the two subpopulations, that the failure to account for population stratification (PS) could lead to a noticeable inflation in the false positive rate. However, we further demonstrate that existing PS adjustment approaches can reduce the inflation to an acceptable level for gene discovery.	[Wang, Zhaoming; Hildesheim, Allan; Wang, Sophia S.; Burdette, Laurie; Hutchinson, Amy; Chanock, Stephen J.; Yu, Kai] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Wang, Zhaoming; Burdette, Laurie; Hutchinson, Amy] NCI, Core Genotyping Facil, SAIC Frederick Inc, Frederick, MD 21701 USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Populat Sci, Div Etiol, Duarte, CA 91010 USA; [Wang, Sophia S.] City Hope Natl Med Ctr, Duarte, CA USA; [Herrero, Rolando; Gonzalez, Paula] Proyecto Epidemiol Guanacaste, San Jose, Costa Rica; [Thomas, Gilles] Univ Lyon 1, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; City of Hope; Beckman Research Institute of City of Hope; City of Hope; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Wang, ZM (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.	yuka@mail.nih.gov	Hildesheim, Allan/B-9760-2015; Wang, Zhaoming/R-5527-2018	Hildesheim, Allan/0000-0003-0257-2363; Wang, Zhaoming/0000-0001-7556-3869; WANG, SOPHIA/0000-0003-2597-9393	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; NATIONAL CANCER INSTITUTE [ZIACP010201] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carvajal-Carmona LG, 2003, HUM GENET, V112, P534, DOI 10.1007/s00439-002-0899-8; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giardina E, 2008, CURR GENOMICS, V9, P110, DOI 10.2174/138920208784139528; Herrero R, 2000, JNCI-J NATL CANCER I, V92, P464, DOI 10.1093/jnci/92.6.464; HERRERO R, 1997, PAN AM J PUBLIC HLTH, V1, P362; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lambert CA, 2010, AM J HUM GENET, V86, P34, DOI 10.1016/j.ajhg.2009.12.002; Martinez Cruzado J.C., 2002, KACIKE J CARIBBEAN A; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; McVean G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000686; Morera B, 2004, REV BIOL TROP, V52, P629; Morera B, 2003, ANN HUM GENET, V67, P71, DOI 10.1046/j.1469-1809.2003.00010.x; OLIEN MD, 1980, ETHNOHISTORY, V27, P13; Parra EJ, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.018887; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2010, HUM MOL GENET, V19, P411, DOI 10.1093/hmg/ddp505; Pfaff CL, 2001, AM J HUM GENET, V68, P198, DOI 10.1086/316935; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; PRITCHARD JK, 2007, DOCUMENTATION STRUCT; Reed FA, 2006, CURR OPIN GENET DEV, V16, P597, DOI 10.1016/j.gde.2006.10.008; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schaffner SF, 2004, NAT REV GENET, V5, P43, DOI 10.1038/nrg1247; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Wang S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000037; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Yu K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002551; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	32	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13336	10.1371/journal.pone.0013336	http://dx.doi.org/10.1371/journal.pone.0013336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967209	Green Submitted, Green Published, gold			2022-12-27	WOS:000282869800031
J	Yatsushiro, S; Yamamura, S; Yamaguchi, Y; Shinohara, Y; Tamiya, E; Horii, T; Baba, Y; Kataoka, M				Yatsushiro, Shouki; Yamamura, Shohei; Yamaguchi, Yuka; Shinohara, Yasuo; Tamiya, Eiichi; Horii, Toshihiro; Baba, Yoshinobu; Kataoka, Masatoshi			Rapid and Highly Sensitive Detection of Malaria-Infected Erythrocytes Using a Cell Microarray Chip	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; LABORATORY DIAGNOSIS; FLOW-CYTOMETRY; MICROSCOPY; TESTS	Background: Malaria is one of the major human infectious diseases in many endemic countries. For prevention of the spread of malaria, it is necessary to develop an early, sensitive, accurate and conventional diagnosis system. Methods and Findings: A cell microarray chip was used to detect for malaria-infected erythrocytes. The chip, with 20,944 microchambers (105 mu m width and 50 mu m depth), was made from polystyrene, and the formation of monolayers of erythrocytes in the microchambers was observed. Cultured Plasmodium falciparum strain 3D7 was used to examine the potential of the cell microarray chip for malaria diagnosis. An erythrocyte suspension in a nuclear staining dye, SYTO 59, was dispersed on the chip surface, followed by 10 min standing to allow the erythrocytes to settle down into the microchambers. About 130 erythrocytes were accommodated in each microchamber, there being over 2,700,000 erythrocytes in total on a chip. A microarray scanner was employed to detect any fluorescence-positive erythrocytes within 5 min, and 0.0001% parasitemia could be detected. To examine the contamination by leukocytes of purified erythrocytes from human blood, 20 mu l of whole blood was mixed with 10 ml of RPMI 1640, and the mixture was passed through a leukocyte isolation filter. The eluted portion was centrifuged at 1,000xg for 2 min, and the pellet was dispersed in 1.0 ml of medium. SYTO 59 was added to the erythrocyte suspension, followed by analysis on a cell microarray chip. Similar accommodation of cells in the microchambers was observed. The number of contaminating leukocytes was less than 1 on a cell microarray chip. Conclusion: The potential of the cell microarray chip for the detection of malaria-infected erythrocytes was shown, it offering 10-100 times higher sensitivity than that of conventional light microscopy and easy operation in 15 min with purified erythrocytes.	[Yatsushiro, Shouki; Yamamura, Shohei; Yamaguchi, Yuka; Baba, Yoshinobu; Kataoka, Masatoshi] Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Takamatsu, Kagawa, Japan; [Shinohara, Yasuo] Univ Tokushima, Grad Sch Pharmaceut Sci, Dept Mol & Pharmaceut Biotechnol, Tokushima 770, Japan; [Shinohara, Yasuo] Univ Tokushima, Div Prot Express, Inst Genome Res, Tokushima 770, Japan; [Tamiya, Eiichi] Osaka Univ, Dept Appl Phys, Grad Sch Engn, Suita, Osaka 565, Japan; [Horii, Toshihiro] Osaka Univ, Microbial Dis Res Inst, Dept Mol Protozool, Suita, Osaka 565, Japan; [Baba, Yoshinobu] Nagoya Univ, Dept Appl Chem, Grad Sch Engn, Nagoya, Aichi 46401, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Tokushima University; Tokushima University; Osaka University; Osaka University; Nagoya University	Yatsushiro, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Hlth Technol Res Ctr, Takamatsu, Kagawa, Japan.	m-kataoka@aist.go.jp	Kataoka, Masatoshi/M-6925-2018; yamamura, shohei/M-8071-2018; YATSUSHIRO, shouki/M-8155-2018; Tamiya, Eiichi/M-6111-2018	Kataoka, Masatoshi/0000-0001-9779-8319; yamamura, shohei/0000-0002-4971-4560; YATSUSHIRO, shouki/0000-0002-6123-1561; Tamiya, Eiichi/0000-0002-7646-4827; Horii, Toshihiro/0000-0002-3000-2045	Japan Society for the Promotion of Science [20790094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by grants in aid (20790094) for young scientists from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carlo D.D., 2006, ANAL CHEM, V78, P7918, DOI [DOI 10.1021/AC069490P, 10.1021/ac069490p]; Cheng Q, 1997, AM J TROP MED HYG, V57, P495, DOI 10.4269/ajtmh.1997.57.495; Gama BE, 2007, EXP PARASITOL, V116, P427, DOI 10.1016/j.exppara.2007.02.011; Guy R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-89; Jimenez-Diaz MB, 2005, CYTOM PART A, V67A, P27, DOI 10.1002/cyto.a.20169; Jin A, 2009, NAT MED, V15, P1088, DOI 10.1038/nm.1966; Li QG, 2007, CYTOM PART A, V71A, P297, DOI 10.1002/cyto.a.20380; Mason DP, 2002, ACTA TROP, V82, P51, DOI 10.1016/S0001-706X(02)00031-1; MILNE LM, 1994, J CLIN PATHOL, V47, P740, DOI 10.1136/jcp.47.8.740; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; PAYNE D, 1988, B WORLD HEALTH ORGAN, V66, P621; Perandin F, 2004, J CLIN MICROBIOL, V42, P1214, DOI 10.1128/JCM.42.3.1214-1219.2004; Steketee RW, 1996, AM J TROP MED HYG, V55, P50, DOI 10.4269/ajtmh.1996.55.50; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; VANDERHEYDE HC, 1995, CLIN DIAGN LAB IMMUN, V2, P417, DOI 10.1128/CDLI.2.4.417-425.1995; Warhurst DC, 1996, J CLIN PATHOL, V49, P533, DOI 10.1136/jcp.49.7.533; *WHO, 2006, GUID WHOS ROL SECT W, P8; *WHO, 2000, NEW PERSP MAL DIAGN, P11; *WHO, 2008, WORLD MAL REP 2008, pR8; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632	21	31	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13179	10.1371/journal.pone.0013179	http://dx.doi.org/10.1371/journal.pone.0013179			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967248	Green Submitted, gold, Green Published			2022-12-27	WOS:000282869800003
J	Shi, G; Sohn, KC; Choi, DK; Kim, YJ; Kim, SJ; Ou, BS; Piao, YJ; Lee, YH; Yoon, TJ; Lee, Y; Seo, YJ; Kim, CD; Lee, JH				Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Kim, Yu-Jin; Kim, Seong-Jin; Ou, Bai-Sheng; Piao, Yong-Jun; Lee, Young Ho; Yoon, Tae-Jin; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon			Brn2 Is a Transcription Factor Regulating Keratinocyte Differentiation with a Possible Role in the Pathogenesis of Lichen Planus	PLOS ONE			English	Article							T-CELL SUBSETS; POU-DOMAIN; EXPRESSION; APOPTOSIS; INVOLUCRIN; MELANOMA; GENE; HYPOTHALAMUS; PROTEIN-1; ACTIVATOR	Terminal differentiation of skin keratinocytes is a vertically directed multi-step process that is tightly controlled by the sequential expression of a variety of genes. In this study, we investigated the role of the POU domain-containing transcription factor Brn2 in keratinocyte differentiation. Immunohistochemical analysis showed that Brn2 is expressed primarily in the upper granular layer. Consistent with its epidermal localization, Brn2 expression was highly induced at 14 days after calcium treatment of cultured normal human epidermal keratinocytes. When Brn2 was overexpressed by adenoviral transduction, Brn2 led to increased expression of the differentiation-related genes involucrin, filaggrin, and loricrin in addition to inhibition of their proliferation. Chromatin immunoprecipitation demonstrated that Brn2 bound to the promoter regions of these differentiation-related genes. We injected the purified Brn2 adenovirus into rat skin, which led to a thickened epidermis with increased amounts of differentiation related markers. The histopathologic features of adenovirus-Brn2 injected skin tissues looked similar to the features of lichen planus, a human skin disease showing chronic inflammation and well-differentiated epidermal changes. Moreover, Brn2 is shown to be expressed in almost all cell nuclei of the thickened epidermis of lichen planus, and Brn2 also attracts T lymphocytes. Our results demonstrate that Brn2 is probably a transcriptional factor playing an important role in keratinocyte differentiation and probably also in the pathogenesis of lichen planus lesions.	[Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea; [Shi, Ge; Sohn, Kyung-Cheol; Choi, Dae-Kyoung; Lee, Young; Seo, Young-Joon; Kim, Chang Deok; Lee, Jeung-Hoon] Chungnam Natl Univ, Sch Med, Res Inst Med Sci, Taejon, South Korea; [Kim, Seong-Jin] Chonnam Natl Univ, Sch Med, Dept Dermatol, Kwangju, South Korea; [Shi, Ge; Ou, Bai-Sheng] Guangxi Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Dermatol, Nanning, Peoples R China; [Piao, Yong-Jun] Dalian Med Univ, Affiliated Hosp 1, Dept Dermatol, Dalian, Peoples R China; [Lee, Young Ho] Chungnam Natl Univ, Dept Anat, Sch Med, Taejon, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Dept Dermatol, Jinju, South Korea; [Yoon, Tae-Jin] Gyeongsang Natl Univ, Sch Med, Inst Hlth Sci, Jinju, South Korea	Chungnam National University; Chungnam National University; Chonnam National University; Guangxi University of Chinese Medicine; Dalian Medical University; Chungnam National University; Gyeongsang National University; Gyeongsang National University	Shi, G (corresponding author), Chungnam Natl Univ, Sch Med, Dept Dermatol, Taejon, South Korea.	jhoon@cnu.ac.kr		Lee, Young/0000-0001-9205-1785; Kim, Chang Deok/0000-0001-9341-6491; Seo, Young-Joon/0000-0002-4955-590X	National Research Foundation of Korea [KRF-2008-314-E00152]; Korea Ministry of Health, Welfare and Family Affairs [01-PJ3-PG6-01GN12-0001]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Ministry of Health, Welfare and Family Affairs	This study was supported by a grant of the National Research Foundation of Korea (KRF-2008-314-E00152), and a grant of the Korea Health 21 R&D Project from the Korea Ministry of Health, Welfare and Family Affairs (01-PJ3-PG6-01GN12-0001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bloor BK, 1999, ORAL SURG ORAL MED O, V88, P187, DOI 10.1016/S1079-2104(99)70116-2; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Cook AL, 2008, PIGM CELL MELANOMA R, V21, P611, DOI 10.1111/j.1755-148X.2008.00510.x; de Boer OJ, 2007, J HISTOCHEM CYTOCHEM, V55, P891, DOI 10.1369/jhc.6A7119.2007; Dekker NP, 1997, J ORAL PATHOL MED, V26, P170, DOI 10.1111/j.1600-0714.1997.tb00453.x; Delhase M, 1996, J BIOL CHEM, V271, P32349, DOI 10.1074/jbc.271.50.32349; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; EISEN T, 1995, ONCOGENE, V11, P2157; EISENBERG E, 1987, ORAL SURG ORAL MED O, V64, P313, DOI 10.1016/0030-4220(87)90011-9; Fajas L, 2002, DEV CELL, V3, P39, DOI 10.1016/S1534-5807(02)00190-9; FUJII H, 1993, NEURON, V11, P1197, DOI 10.1016/0896-6273(93)90231-F; Goodall J, 2004, MOL CELL BIOL, V24, P2923, DOI 10.1128/MCB.24.7.2923-2931.2004; Goodall J, 2004, MOL CELL BIOL, V24, P2915, DOI 10.1128/MCB.24.7.2915-2922.2004; HASHIMOTO K, 1976, ACTA DERM-VENEREOL, V56, P187; HOHL D, 1993, AM J DERMATOPATH, V15, P20, DOI 10.1097/00000372-199302000-00004; Ichikawa E, 1997, ARCH DERMATOL RES, V289, P519, DOI 10.1007/s004030050233; ISHII T, 1987, J ORAL PATHOL MED, V16, P356, DOI 10.1111/j.1600-0714.1987.tb00708.x; Jang SI, 2000, J BIOL CHEM, V275, P15295, DOI 10.1074/jbc.275.20.15295; JUNGELL P, 1989, SCAND J DENT RES, V97, P361; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kikuchi Arata, 1992, Journal of Dermatological Science, V4, P83, DOI 10.1016/0923-1811(92)90063-H; KILPI AM, 1987, SCAND J DENT RES, V95, P174; KILPI AM, 1988, P FINN DENT SOC, V84, P5; Lee JJ, 2005, ORAL SURG ORAL MED O, V99, P471, DOI 10.1016/j.tripleo.2004.10.018; LI P, 1993, GENE DEV, V7, P2483, DOI 10.1101/gad.7.12b.2483; MATTHEWS JB, 1984, BRIT J DERMATOL, V111, P587, DOI 10.1111/j.1365-2133.1984.tb06629.x; MEDENICA M, 1977, ACTA DERM-VENEREOL, V57, P55; Nakai S, 1995, GENE DEV, V9, P3109, DOI 10.1101/gad.9.24.3109; Neppleberg E, 2001, EUR J ORAL SCI, V109, P361, DOI 10.1034/j.1600-0722.2001.00081.x; Piao YJ, 2005, EXP DERMATOL, V14, P356, DOI 10.1111/j.0906-6705.2005.00272.x; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schonemann MD, 1995, GENE DEV, V9, P3122, DOI 10.1101/gad.9.24.3122; Seo EY, 2005, GENOMICS, V86, P528, DOI 10.1016/j.ygeno.2005.06.013; Shimizu M, 1997, ARCH DERMATOL RES, V289, P527, DOI 10.1007/s004030050234; Sohn KC, 2009, J DERMATOL SCI, V54, P6, DOI 10.1016/j.jdermsci.2008.11.006; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; STURM RA, 1994, PIGM CELL RES, V7, P235, DOI 10.1111/j.1600-0749.1994.tb00055.x; Tollefson Ann E, 2007, Methods Mol Med, V130, P223; VERRIJZER CP, 1993, BIOCHIM BIOPHYS ACTA, V1173, P1, DOI 10.1016/0167-4781(93)90237-8; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; WEEDON D, 1980, CLIN EXP DERMATOL, V5, P425, DOI 10.1111/j.1365-2230.1980.tb01728.x; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; Welter JF, 1996, J BIOL CHEM, V271, P14727, DOI 10.1074/jbc.271.25.14727; Yoon HK, 2008, BIOCHEM BIOPH RES CO, V377, P662, DOI 10.1016/j.bbrc.2008.10.051	44	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13216	10.1371/journal.pone.0013216	http://dx.doi.org/10.1371/journal.pone.0013216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967260	Green Published, Green Submitted, gold			2022-12-27	WOS:000282807300005
J	McGillivary, G; Bakaletz, LO				McGillivary, Glen; Bakaletz, Lauren O.			The Multifunctional Host Defense Peptide SPLUNC1 Is Critical for Homeostasis of the Mammalian Upper Airway	PLOS ONE			English	Article							NONTYPABLE HAEMOPHILUS-INFLUENZAE; RESPIRATORY SYNCYTIAL VIRUS; ACUTE OTITIS-MEDIA; NASAL LAVAGE FLUID; ANTIMICROBIAL PEPTIDE; EUSTACHIAN-TUBE; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-AERUGINOSA; SURFACTANT PROTEIN; PLUNC GENE	Otitis media (OM) is a highly prevalent pediatric disease caused by normal flora of the nasopharynx that ascend the Eustachian tube and enter the middle ear. As OM is a disease of opportunity, it is critical to gain an increased understanding of immune system components that are operational in the upper airway and aid in prevention of this disease. SPLUNC1 is an antimicrobial host defense peptide that is hypothesized to contribute to the health of the airway both through bactericidal and non-bactericidal mechanisms. We used small interfering RNA (siRNA) technology to knock down expression of the chinchilla ortholog of human SPLUNC1 (cSPLUNC1) to begin to determine the role that this protein played in prevention of OM. We showed that knock down of cSPLUNC1 expression did not impact survival of nontypeable Haemophilus influenzae, a predominant causative agent of OM, in the chinchilla middle ear under the conditions tested. In contrast, expression of cSPLUNC1 was essential for maintenance of middle ear pressure and efficient mucociliary clearance, key defense mechanisms of the tubotympanum. Collectively, our data have provided the first in vivo evidence that cSPLUNC1 functions to maintain homeostasis of the upper airway and, thereby, is critical for protection of the middle ear.	[McGillivary, Glen; Bakaletz, Lauren O.] Ohio State Univ, Coll Med, Ctr Microbial Pathogenesis, Res Inst Nationwide Childrens Hosp, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	McGillivary, G (corresponding author), Ohio State Univ, Coll Med, Ctr Microbial Pathogenesis, Res Inst Nationwide Childrens Hosp, Columbus, OH 43210 USA.	Lauren.Bakaletz@nationwidechildrens.org	Bakaletz, Lauren/GMW-8490-2022		NIDCD/NIH [K99 DC008966, R01 DC005847]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K99DC008966, R01DC005847] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grant K99 DC008966 to G. M. and R01 DC005847 to L.O.B from the NIDCD/NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKALETZ LO, 1989, ANN OTO RHINOL LARYN, V98, P278, DOI 10.1177/000348948909800408; BAKALETZ LO, 2002, OTITIS MEDIA, P259; Bartlett JA, 2008, J LEUKOCYTE BIOL, V83, P1201, DOI 10.1189/jlb.0507302; Bingle CD, 2000, BBA-GENE STRUCT EXPR, V1493, P363, DOI 10.1016/S0167-4781(00)00196-2; Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704; Bingle L, 2005, J PATHOL, V205, P491, DOI 10.1002/path.1726; Bingle L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-79; Bondy J, 2000, PEDIATRICS, V105, part. no., DOI 10.1542/peds.105.6.e72; Caye-Thomasen P, 2004, OTOL NEUROTOL, V25, P14; Chu HW, 2007, J IMMUNOL, V179, P3995, DOI 10.4049/jimmunol.179.6.3995; Di YP, 2003, J BIOL CHEM, V278, P1165, DOI 10.1074/jbc.M210523200; GAKHAR L, PLOS ONE, V5, pE9098; Garcia-Caballero A, 2009, P NATL ACAD SCI USA, V106, P11412, DOI 10.1073/pnas.0903609106; GAZZANOSANTORO H, 1992, INFECT IMMUN, V60, P4754, DOI 10.1128/IAI.60.11.4754-4761.1992; Ghafouri B, 2004, BBA-PROTEINS PROTEOM, V1699, P57, DOI 10.1016/j.bbapap.2004.01.001; Ghafouri B, 2003, BIOCHEM SOC T, V31, P810, DOI 10.1042/BST0310810; Glasser SW, 2008, J IMMUNOL, V181, P621, DOI 10.4049/jimmunol.181.1.621; Grimm D, 2007, J CLIN INVEST, V117, P3633, DOI 10.1172/JCI34129; Harris RH, 2004, J BIOL CHEM, V279, P20250, DOI 10.1074/jbc.M400499200; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Herr C, 2007, EXPERT OPIN BIOL TH, V7, P1449, DOI 10.1517/14712598.7.9.1449; Huttner KM, 1999, PEDIATR RES, V45, P785, DOI 10.1203/00006450-199906000-00001; Jiang ZL, 1999, INFECT IMMUN, V67, P187, DOI 10.1128/IAI.67.1.187-192.1999; Jung HH, 2003, LARYNGOSCOPE, V113, P432, DOI 10.1097/00005537-200303000-00008; Kaplan B, 1997, PEDIATR INFECT DIS J, V16, pS9, DOI 10.1097/00006454-199702001-00003; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Lee HY, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-12; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lim DJ, 2000, VACCINE, V19, pS17, DOI 10.1016/S0264-410X(00)00273-5; MARGOLIS RH, 1994, ANN OTOL RHINOL LA S, V163, P34; Mason KM, 2005, INFECT IMMUN, V73, P599, DOI 10.1128/IAI.73.1.599-608.2005; McDonald RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005726; McGillivary G, 2007, MOL IMMUNOL, V44, P2446, DOI 10.1016/j.molimm.2006.10.008; McGillivary G, 2009, CELL MICROBIOL, V11, P1399, DOI 10.1111/j.1462-5822.2009.01339.x; McGuire JF, 2002, INT J PEDIATR OTORHI, V66, P1, DOI 10.1016/S0165-5876(02)00203-3; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Novotny LA, 2006, VACCINE, V24, P4804, DOI 10.1016/j.vaccine.2006.03.021; PATEL J, 1992, INT J PEDIATR OTORHI, V23, P15, DOI 10.1016/0165-5876(92)90075-Z; Raqib R, 2006, P NATL ACAD SCI USA, V103, P9178, DOI 10.1073/pnas.0602888103; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; Schuerman L, 2009, VACCINE, V27, P5748, DOI 10.1016/j.vaccine.2009.07.070; SEILLY DJ, 1982, MED LAB SCI, V39, P71; Shimada J, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-134; Zhou FJ, 2008, PEDIATRICS, V121, P253, DOI 10.1542/peds.2007-0619; Zhou HD, 2008, MOL CELL BIOCHEM, V309, P191, DOI 10.1007/s11010-007-9659-3	46	44	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13224	10.1371/journal.pone.0013224	http://dx.doi.org/10.1371/journal.pone.0013224			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949060	Green Submitted, gold, Green Published			2022-12-27	WOS:000282633700015
J	Park, J; Kim, Y; Choi, S; Koh, H; Lee, SH; Kim, JM; Chung, J				Park, Jeehye; Kim, Yongsung; Choi, Sekyu; Koh, Hyongjong; Lee, Sang-Hee; Kim, Jin-Man; Chung, Jongkyeong			Drosophila Porin/VDAC Affects Mitochondrial Morphology	PLOS ONE			English	Article								Voltage-dependent anion channel (VDAC) has been suggested to be a mediator of mitochondrial-dependent cell death induced by Ca2+ overload, oxidative stress and Bax-Bid activation. To confirm this hypothesis in vivo, we generated and characterized Drosophila VDAC (porin) mutants and found that Porin is not required for mitochondrial apoptosis, which is consistent with the previous mouse studies. We also reported a novel physiological role of Porin. Loss of porin resulted in locomotive defects and male sterility. Intriguingly, porin mutants exhibited elongated mitochondria in indirect flight muscle, whereas Porin overexpression produced fragmented mitochondria. Through genetic analysis with the components of mitochondrial fission and fusion, we found that the elongated mitochondria phenotype in porin mutants were suppressed by increased mitochondrial fission, but enhanced by increased mitochondrial fusion. Furthermore, increased mitochondrial fission by Drp1 expression suppressed the flight defects in the porin mutants. Collectively, our study showed that loss of Drosophila Porin results in mitochondrial morphological defects and suggested that the defective mitochondrial function by Porin deficiency affects the mitochondrial remodeling process.	[Park, Jeehye; Kim, Yongsung; Choi, Sekyu; Chung, Jongkyeong] Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul, South Korea; [Kim, Yongsung; Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul, South Korea; [Choi, Sekyu] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Koh, Hyongjong] Dong A Univ, Dept Pharmacol, Coll Med, Pusan, South Korea; [Lee, Sang-Hee; Kim, Jin-Man] Chungnam Natl Univ, Sch Med, Dept Pathol, Taejon, South Korea; [Chung, Jongkyeong] Seoul Natl Univ, Inst Mol Biol & Genet, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Dong A University; Chungnam National University; Seoul National University (SNU)	Chung, J (corresponding author), Seoul Natl Univ, Natl Creat Res Initiat Ctr Energy Homeostasis Reg, Seoul, South Korea.	jkc@snu.ac.kr		Choi, Sekyu/0000-0003-2928-0942; KIM, JIN MAN/0000-0003-0905-9730; Koh, Hyongjong/0000-0003-2594-4799	Korean National Creative Research Initiatives Program - Ministry of Education, Science and Technology [2010-0018291]; World Class Institute Program of National Research Foundation of Korea - Ministry of Education, Science and Technology of Korea	Korean National Creative Research Initiatives Program - Ministry of Education, Science and Technology; World Class Institute Program of National Research Foundation of Korea - Ministry of Education, Science and Technology of Korea	This research was supported by a grant from the Korean National Creative Research Initiatives Program (2010-0018291), funded by the Ministry of Education, Science and Technology. Y. Kim is supported by World Class Institute Program of National Research Foundation of Korea funded by the Ministry of Education, Science and Technology of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Baines CP, 2007, NAT CELL BIOL, V9, P550, DOI 10.1038/ncb1575; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Colussi PA, 2000, J CELL BIOL, V148, P703, DOI 10.1083/jcb.148.4.703; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; Gazaryan IG, 2007, NEUROCHEM RES, V32, P917, DOI 10.1007/s11064-006-9252-2; Graham BH, 2005, MOL GENET METAB, V85, P308, DOI 10.1016/j.ymgme.2005.03.009; Graham BH, 2010, J BIOL CHEM, V285, P11143, DOI 10.1074/jbc.M109.080317; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Jang C, 2008, J CELL BIOL, V183, P11, DOI 10.1083/jcb.200807052; Komarov AG, 2004, BIOPHYS J, V86, P152, DOI 10.1016/S0006-3495(04)74093-X; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lee S, 2007, DEV NEUROBIOL, V67, P1533, DOI 10.1002/dneu.20526; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Oliva M, 1998, FEBS LETT, V430, P327, DOI 10.1016/S0014-5793(98)00693-0; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; Tsujimoto Y, 2007, APOPTOSIS, V12, P835, DOI 10.1007/s10495-006-0525-7; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073	25	44	44	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13151	10.1371/journal.pone.0013151	http://dx.doi.org/10.1371/journal.pone.0013151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V32LH	20949033	Green Published, gold, Green Submitted			2022-12-27	WOS:000208952200001
J	Styrkarsdottir, U; Halldorsson, BV; Gudbjartsson, DF; Tang, NLS; Koh, JM; Xiao, SM; Kwok, TCY; Kim, GS; Chan, JCN; Cherny, S; Lee, SH; Kwok, A; Ho, S; Gretarsdottir, S; Kostic, JP; Palsson, ST; Sigurdsson, G; Sham, PC; Kim, BJ; Kung, AWC; Kim, SY; Woo, J; Leung, PC; Kong, A; Thorsteinsdottir, U; Stefansson, K				Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel F.; Tang, Nelson L. S.; Koh, Jung-Min; Xiao, Su-mei; Kwok, Timothy C. Y.; Kim, Ghi Su; Chan, Juliana C. N.; Cherny, Stacey; Lee, Seung Hun; Kwok, Anthony; Ho, Suzanne; Gretarsdottir, Solveig; Kostic, Jelena Pop; Palsson, Stefan Th.; Sigurdsson, Gunnar; Sham, Pak C.; Kim, Beom-Jun; Kung, Annie W. C.; Kim, Shin-Yoon; Woo, Jean; Leung, Ping-C.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			European Bone Mineral Density Loci Are Also Associated with BMD in East-Asian Populations	PLOS ONE			English	Article							RECEPTOR-RELATED PROTEIN-5; GENOME-WIDE ASSOCIATION; HONG-KONG CHINESE; OSTEOPOROTIC FRACTURES; GENETIC-LOCI; WOMEN; VARIANTS; POLYMORPHISM; MASS; LRP5	Most genome-wide association (GWA) studies have focused on populations of European ancestry with limited assessment of the influence of the sequence variants on populations of other ethnicities. To determine whether markers that we have recently shown to associate with Bone Mineral Density (BMD) in Europeans also associate with BMD in East-Asians we analysed 50 markers from 23 genomic loci in samples from Korea (n = 1,397) and two Chinese Hong Kong sample sets (n = 3,869 and n = 785). Through this effort we identified fourteen loci that associated with BMD in East-Asian samples using a false discovery rate (FDR) of 0.05; 1p36 (ZBTB40, P = 4.3x10(-9)), 1p31 (GPR177, P = 0.00012), 3p22 (CTNNB1, P = 0.00013), 4q22 (MEPE, P = 0.0026), 5q14 (MEF2C, P = 1.3x10(-5)), 6q25 (ESR1, P = 0.0011), 7p14 (STARD3NL, P = 0.00025), 7q21 (FLJ42280, P = 0.00017), 8q24 (TNFRSF11B, P = 3.4x10(-5)), 11p15 (SOX6, P = 0.00033), 11q13 (LRP5, P = 0.0033), 13q14 (TNFSF11, P = 7.5x10(-5)), 16q24 (FOXL1, P = 0.0010) and 17q21 (SOST, P = 0.015). Our study marks an early effort towards the challenge of cataloguing bone density variants shared by many ethnicities by testing BMD variants that have been established in Europeans, in East-Asians.	[Styrkarsdottir, Unnur; Halldorsson, Bjarni V.; Gudbjartsson, Daniel F.; Gretarsdottir, Solveig; Kostic, Jelena Pop; Palsson, Stefan Th.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] DeCODE Genet, Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, Reykjavik, Iceland; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Fac Med, Dept Chem, Hong Kong, Hong Kong, Peoples R China; [Tang, Nelson L. S.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Fac Med, Lab Genet Dis Susceptibil, Hong Kong, Hong Kong, Peoples R China; [Koh, Jung-Min; Kim, Ghi Su; Lee, Seung Hun; Kim, Beom-Jun] Univ Ulsan, Coll Med, Asan Med Ctr, Div Endocrinol & Metab, Seoul, South Korea; [Koh, Jung-Min; Kim, Ghi Su; Lee, Seung Hun; Kim, Beom-Jun; Kim, Shin-Yoon] Kyungpook Natl Univ Hosp, Skeletal Dis Genome Res Ctr, Taegu, South Korea; [Xiao, Su-mei; Kung, Annie W. C.] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Xiao, Su-mei; Kung, Annie W. C.] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Kwok, Timothy C. Y.; Chan, Juliana C. N.; Woo, Jean] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Hong Kong, Hong Kong, Peoples R China; [Cherny, Stacey; Sham, Pak C.] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne] Chinese Univ Hong Kong, Fac Med, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Sigurdsson, Gunnar] Univ Hosp, Dept Endocrinol & Metab, Reykjavik, Iceland; [Sigurdsson, Gunnar; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, Reykjavik, Iceland; [Kim, Shin-Yoon] Kyungpook Natl Univ Sch Med, Dept Orthoped Surg, Taegu, South Korea	Reykjavik University; Chinese University of Hong Kong; Chinese University of Hong Kong; University of Ulsan; Asan Medical Center; Kyungpook National University; Kyungpook National University Hospital; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Landspitali National University Hospital; University of Iceland; Kyungpook National University	Styrkarsdottir, U (corresponding author), DeCODE Genet, Reykjavik, Iceland.	unnur.styrkarsdottir@decode.is; kari.stefansson@decode.is	Kwok, Timothy/C-3725-2008; Stefansson, Kari/AAE-7187-2019; Tang, Nelson L/P-5018-2017; Woo, Jean/K-2625-2014; Kwok, Anthony/AAL-4289-2020; Cherny, Stacey S/B-3315-2008; Chan, Juliana/B-7918-2016	Kwok, Timothy/0000-0001-9253-3549; Tang, Nelson L/0000-0002-3607-5819; Woo, Jean/0000-0001-7593-3081; Kwok, Anthony/0000-0002-3918-9205; Cherny, Stacey S/0000-0002-0269-3352; Chan, Juliana/0000-0003-1325-1194; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Styrkarsdottir, Unnur/0000-0001-8146-8278; Halldorsson, Bjarni/0000-0003-0756-0767	European Community [FP7/2007-2013, HEALTH-F2-2008-201865-GEFOS]; Korea Healthcare Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea [A010252]; Research Grants Council of Hong Kong [CUHK 4101/02M]; Chinese University of Hong Kong; Centre for Nutritional Studies; School of Public Health and Primary Care; Hong Kong Jockey Club Charities Foundation; Hong Kong Research Grant Council; HKU Foundation; University of Hong Kong; deCODE Genetics	European Community(European Commission); Korea Healthcare Technology; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Chinese University of Hong Kong(Chinese University of Hong Kong); Centre for Nutritional Studies; School of Public Health and Primary Care; Hong Kong Jockey Club Charities Foundation; Hong Kong Research Grant Council(Hong Kong Research Grants Council); HKU Foundation(University of Hong Kong); University of Hong Kong(University of Hong Kong); deCODE Genetics	This work was supported by deCODE Genetics and funded in part by the European Community's Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F2-2008-201865-GEFOS. The Korean study was supported by a grant from the Korea Healthcare Technology R& D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (Project No.: A010252). The Chinese Hong Kong-I study was supported in part by grants from Research Grants Council of Hong Kong, (CUHK 4101/02M), Direct Grant from the Chinese University of Hong Kong, the Centre for Nutritional Studies, School of Public Health and Primary Care, and the Hong Kong Jockey Club Charities Foundation. The Hong Kong-II study was supported by Hong Kong Research Grant Council; The Bone Health fund of HKU Foundation; Matching Grant, CRCG Grant and The Osteoporosis Research Fund of The University of Hong Kong. The study design, data generation (in part), overall analysis of data, decision to publish and preparation of the manuscript was lead by employees of deCODE Genetics, a funder of this study.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Ezura Y, 2007, BONE, V40, P997, DOI 10.1016/j.bone.2005.06.025; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kiel DP, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S14; Kim GS, 2005, J BONE MINER RES, V20, P1342, DOI 10.1359/JBMR.050320; Kung AWC, 2006, BONE, V39, P1097, DOI 10.1016/j.bone.2006.04.029; Kung AWC, 2010, AM J HUM GENET, V86, P229, DOI 10.1016/j.ajhg.2009.12.014; Kung AWC, 1998, BONE, V22, P389, DOI 10.1016/S8756-3282(97)00301-3; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lau EMC, 1996, J BONE MINER RES, V11, P1364; Lau HHL, 2006, J BONE MINER METAB, V24, P226, DOI 10.1007/s00774-005-0676-6; Lynn HS, 2005, OSTEOPOROSIS INT, V16, P1663, DOI 10.1007/s00198-005-1899-z; Mizuguchi T, 2004, J HUM GENET, V49, P80, DOI 10.1007/s10038-003-0111-6; Peacock M, 2002, ENDOCR REV, V23, P303, DOI 10.1210/er.23.3.303; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rivadeneira F, 2009, NAT GENET, V41, P1199, DOI 10.1038/ng.446; Sigurdsson G, 2008, J BONE MINER RES, V23, P1584, DOI 10.1359/JBMR.080507; Stacey SN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001029; Styrkarsdottir U, 2008, NEW ENGL J MED, V358, P2355, DOI 10.1056/NEJMoa0801197; Styrkarsdottir U, 2009, NAT GENET, V41, P15, DOI 10.1038/ng.284; THORLEIFSSON G, 2010, NAT GENET IN PRESS; Timpson NJ, 2009, HUM MOL GENET, V18, P1510, DOI 10.1093/hmg/ddp052; Urano T, 2004, J BONE MINER METAB, V22, P341, DOI 10.1007/s00774-003-0492-9; van Meurs JBJ, 2008, JAMA-J AM MED ASSOC, V299, P1277, DOI 10.1001/jama.299.11.1277; Xiong DH, 2009, AM J HUM GENET, V84, P388, DOI 10.1016/j.ajhg.2009.01.025; Zhang ZL, 2005, ACTA PHARMACOL SIN, V26, P1111, DOI 10.1111/j.1745-7254.2005.00173.x	31	69	74	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13217	10.1371/journal.pone.0013217	http://dx.doi.org/10.1371/journal.pone.0013217			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949110	Green Published, Green Submitted, gold			2022-12-27	WOS:000282633700012
J	Zang-Edou, ES; Bisvigou, U; Taoufiq, Z; Lekoulou, F; Lekana-Douki, JB; Traore, Y; Mazier, D; Toure-Ndouo, FS				Zang-Edou, Estelle S.; Bisvigou, Ulrick; Taoufiq, Zacharie; Lekoulou, Faustin; Lekana-Douki, Jean Bernard; Traore, Yves; Mazier, Dominique; Toure-Ndouo, Fousseyni S.			Inhibition of Plasmodium falciparum Field Isolates-Mediated Endothelial Cell Apoptosis by Fasudil: Therapeutic Implications for Severe Malaria	PLOS ONE			English	Article							INFECTED ERYTHROCYTES; CEREBRAL MALARIA; NITRIC-OXIDE; MICROVASCULAR SEQUESTRATION; CYTOCHROME-C; BRAIN; EXPRESSION; ADHESION; CYTOADHERENCE; PATHOGENESIS	Plasmodium falciparum infection can abruptly progress to severe malaria, a life-threatening complication resulting from sequestration of parasitized red blood cells (PRBC) in the microvasculature of various organs such as the brain and lungs. PRBC adhesion can induce endothelial cell (EC) activation and apoptosis, thereby disrupting the blood-brain barrier. Moreover, hemozoin, the malarial pigment, induces the erythroid precursor apoptosis. Despite the current efficiency of antimalarial drugs in killing parasites, severe malaria still causes up to one million deaths every year. A new strategy targeting both parasite elimination and EC protection is urgently needed in the field. Recently, a rho-kinase inhibitior Fasudil, a drug already in clinical use in humans for cardio- and neuro-vascular diseases, was successfully tested on laboratory strains of P. falciparum to protect and to reverse damages of the endothelium. We therefore assessed herein whether Fasudil would have a similar efficiency on P. falciparum taken directly from malaria patients using contact and non-contact experiments. Seven (23.3%) of 30 PRBC preparations from different patients were apoptogenic, four (13.3%) acting by cytoadherence and three (10%) via soluble factors. None of the apoptogenic PRBC preparations used both mechanisms indicating a possible mutual exclusion of signal transduction ligand. Three PRBC preparations (42.9%) induced EC apoptosis by cytoadherence after 4 h of coculture ("rapid transducers''), and four (57.1%) after a minimum of 24 h ("slow transducers''). The intensity of apoptosis increased with time. Interestingly, Fasudil inhibited EC apoptosis mediated both by cell-cell contact and by soluble factors but did not affect PRBC cytoadherence. Fasudil was found to be able to prevent endothelium apoptosis from all the P. falciparum isolates tested. Our data provide evidence of the strong anti-apoptogenic effect of Fasudil and show that endothelial cell-P. falciparum interactions are more complicated than previously thought. These findings may warrant clinical trials of Fasudil in severe malaria management.	[Zang-Edou, Estelle S.; Bisvigou, Ulrick; Lekoulou, Faustin; Lekana-Douki, Jean Bernard; Toure-Ndouo, Fousseyni S.] CIRMF, Franceville, Gabon; [Taoufiq, Zacharie; Mazier, Dominique] INSERM, U511, Paris, France; [Traore, Yves] Univ Ouagadougou, Ouagadougou, Burkina Faso; [Mazier, Dominique] Univ Paris 06, UMR S511, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Zang-Edou, ES (corresponding author), CIRMF, Franceville, Gabon.	fousseyni@yahoo.fr	Bisvigou, Ulrick/GXA-0039-2022	Taoufiq, Zacharie/0000-0003-4893-0322	Total Gabon; Gabonese government; Ministere Francais des Affaires Etrangeres	Total Gabon(Total SA); Gabonese government; Ministere Francais des Affaires Etrangeres	This work has been supported by Total Gabon, the Gabonese government and Ministere Francais des Affaires Etrangeres. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Brown H, 2001, AM J TROP MED HYG, V64, P207, DOI 10.4269/ajtmh.2001.64.207; Cernuda-Morollon E, 2006, CIRC RES, V98, P757, DOI 10.1161/01.RES.0000210579.35304.d3; Choi BM, 2002, J BIOCHEM MOL BIOL, V35, P116; Combes V, 2006, INT J PARASITOL, V36, P541, DOI 10.1016/j.ijpara.2006.02.005; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; Dimmeler S, 1997, CIRC RES, V81, P970; Dondorp AM, 2004, ACTA TROP, V89, P309, DOI 10.1016/j.actatropica.2003.10.004; Francischetti IMB, 2007, J THROMB HAEMOST, V5, P155, DOI 10.1111/j.1538-7836.2006.02232.x; Girard M, 2003, INT J PARASITOL, V33, P713, DOI 10.1016/S0020-7519(03)00033-X; GOODYER ID, 1994, ANN TROP MED PARASIT, V88, P209, DOI 10.1080/00034983.1994.11812859; Hirooka Yoshitaka, 2005, Am J Cardiovasc Drugs, V5, P31, DOI 10.2165/00129784-200505010-00005; HO M, 1991, INFECT IMMUN, V59, P2135, DOI 10.1128/IAI.59.6.2135-2139.1991; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Idro R, 2005, LANCET NEUROL, V4, P827, DOI 10.1016/S1474-4422(05)70247-7; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Kim TH, 2000, J BIOL CHEM, V275, P39474, DOI 10.1074/jbc.M003370200; Kim YM, 1997, BIOCHEM BIOPH RES CO, V236, P655, DOI 10.1006/bbrc.1997.7031; KREMSNER PG, 1988, J INFECT DIS, V158, P1368, DOI 10.1093/infdis/158.6.1368; Lamikanra AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008446; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARIANNA M, 2009, MALARIA J, V8, P12; MARSH K, 1987, T ROY SOC TROP MED H, V81, P514, DOI 10.1016/0035-9203(87)90184-2; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; Mazier D, 2000, PARASITE IMMUNOL, V22, P613, DOI 10.1046/j.1365-3024.2000.00342.x; Muanza K, 1996, RES IMMUNOL, V147, P149, DOI 10.1016/0923-2494(96)83167-1; Nakakuki T, 2005, ARTERIOSCL THROM VAS, V25, P2088, DOI 10.1161/01.ATV.0000183607.50230.9f; OCKENHOUSE CF, 1991, J INFECT DIS, V164, P163, DOI 10.1093/infdis/164.1.163; Pino P, 2003, J INFECT DIS, V187, P1283, DOI 10.1086/373992; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; Pongponratn E, 2003, AM J TROP MED HYG, V69, P345, DOI 10.4269/ajtmh.2003.69.345; PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168; Ridley RG, 2002, P NATL ACAD SCI USA, V99, P13362, DOI 10.1073/pnas.232483699; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; Rouzine IM, 2003, P NATL ACAD SCI USA, V100, P3473, DOI 10.1073/pnas.262796299; Saavedra JE, 1997, J MED CHEM, V40, P1947, DOI 10.1021/jm9701031; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Siau A, 2007, J INFECT DIS, V196, P1603, DOI 10.1086/522012; Silamut K, 1999, AM J PATHOL, V155, P395, DOI 10.1016/S0002-9440(10)65136-X; Stiles JK, 2004, MOL BIOCHEM PARASIT, V133, P229, DOI 10.1016/j.molbiopara.2003.10.011; Taoufiq Z, 2008, J INFECT DIS, V197, P1062, DOI 10.1086/528988; Taoufiq Z, 2006, MOL BIOCHEM PARASIT, V150, P166, DOI 10.1016/j.molbiopara.2006.07.008; TAYLOR TE, 2004, NAT MED, V187, P1283; Toure FS, 2008, PARASITE IMMUNOL, V30, P47; Toure FS, 2007, CLIN MED RES, V5, P106, DOI 10.3121/cmr.2007.696; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tripathi AK, 2007, J INFECT DIS, V195, P942, DOI 10.1086/512083; *UNICEF WHO, 2005, WORLD MAL REP; vanHensbroek MB, 1996, NEW ENGL J MED, V335, P69, DOI 10.1056/NEJM199607113350201; Wassmer SC, 2005, PLOS MED, V2, P885, DOI 10.1371/journal.pmed.0020245; Wilson NO, 2008, MOL BIOCHEM PARASIT, V162, P172, DOI 10.1016/j.molbiopara.2008.09.003; WILSON PD, 2005, BIOCH J IMMEDIATE PU, V237; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	54	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13221	10.1371/journal.pone.0013221	http://dx.doi.org/10.1371/journal.pone.0013221			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949056	gold, Green Published, Green Submitted			2022-12-27	WOS:000282633700014
J	Moore, DJ; Zienkiewicz, J; Kendall, PL; Liu, DY; Liu, XY; Veach, RA; Collins, RD; Hawiger, J				Moore, Daniel J.; Zienkiewicz, Jozef; Kendall, Peggy L.; Liu, Danya; Liu, Xueyan; Veach, Ruth Ann; Collins, Robert D.; Hawiger, Jacek			In Vivo Islet Protection by a Nuclear Import Inhibitor in a Mouse Model of Type 1 Diabetes	PLOS ONE			English	Article							NF-KAPPA-B; ANTI-CD3 MONOCLONAL-ANTIBODY; PANCREATIC LYMPH-NODES; BETA-CELL APOPTOSIS; T-CELLS; LOCALIZATION SEQUENCE; INTERFERON-GAMMA; DENDRITIC CELLS; INNATE IMMUNITY; APC FUNCTION	In Background: Insulin-dependent Type 1 diabetes (T1D) is a devastating autoimmune disease that destroys beta cells within the pancreatic islets and afflicts over 10 million people worldwide. These patients face life-long risks for blindness, cardiovascular and renal diseases, and complications of insulin treatment. New therapies that protect islets from autoimmune destruction and allow continuing insulin production are needed. Increasing evidence regarding the pathomechanism of T1D indicates that islets are destroyed by the relentless attack by autoreactive immune cells evolving from an aberrant action of the innate, in addition to adaptive, immune system that produces islet-toxic cytokines, chemokines, and other effectors of islet inflammation. We tested the hypothesis that targeting nuclear import of stress-responsive transcription factors evoked by agonist-stimulated innate and adaptive immunity receptors would protect islets from autoimmune destruction. Principal Findings: Here we show that a first-in-class inhibitor of nuclear import, cSN50 peptide, affords in vivo islet protection following a 2-day course of intense treatment in NOD mice, which resulted in a diabetes-free state for one year without apparent toxicity. This nuclear import inhibitor precipitously reduces the accumulation of islet-destructive autoreactive lymphocytes while enhancing activation-induced cell death of T and B lymphocytes derived from autoimmune diabetes-prone, non-obese diabetic (NOD) mice that develop T1D. Moreover, in this widely used model of human T1D we noted attenuation of pro-inflammatory cytokine and chemokine production in immune cells. Conclusions: These results indicate that a novel form of immunotherapy that targets nuclear import can arrest inflammation-driven destruction of insulin-producing beta cells at the site of autoimmune attack within pancreatic islets during the progression of T1D.	[Moore, Daniel J.; Zienkiewicz, Jozef; Liu, Danya; Liu, Xueyan; Veach, Ruth Ann; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37235 USA; [Moore, Daniel J.] Vanderbilt Univ, Med Ctr, Dept Pediat, Ian Burr Div Endocrinol & Diabet, Nashville, TN 37232 USA; [Kendall, Peggy L.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Collins, Robert D.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Liu, Danya] Emory Univ, Dept Surg, Atlanta, GA 30322 USA; [Liu, Danya] Emory Univ, Emory Transplant Ctr, Atlanta, GA 30322 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Emory University; Emory University	Moore, DJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol & Immunol, Nashville, TN 37235 USA.	jacek.hawiger@vanderbilt.edu	Moore, Daniel J/A-4924-2008; Moore, Daniel/V-6145-2019	Moore, Daniel J/0000-0002-6889-9345; Moore, Daniel/0000-0002-6889-9345; Kendall, Peggy/0000-0002-0516-654X; Veach, Ruth Ann/0000-0003-0038-8802	US National Institutes of Health [5PO1HL068744]; Department of Microbiology and Immunology; Price Family Discovery Fund; NRSA Fellowship [1F32DK083161-01]; Endocrine Fellows Foundation; NIH [5K08DK070924-05]; NIH for the Vanderbilt Ingram Cancer Center [2P30 CA 68485, P30DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068744] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK070924, P30DK058404, F32DK083161] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Microbiology and Immunology; Price Family Discovery Fund; NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Fellows Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH for the Vanderbilt Ingram Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by US National Institutes of Health grant 5PO1HL068744, by Department of Microbiology and Immunology funds, and by the Price Family Discovery Fund, the generous gift of the Price family to the Ian Burr Division of Endocrinology and Diabetes. DJM was supported by the Ruth Kirschstein NRSA Fellowship 1F32DK083161-01 and by a research grant from the Endocrine Fellows Foundation. PLK was supported by NIH Career Development Award 5K08DK070924-05. The Cell Imaging Core Services were supported by NIH grant 2P30 CA 68485 for the Vanderbilt Ingram Cancer Center and by NIH grant P30DK058404 to the Digestive Disease Research Center at Vanderbilt University Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablamunits V, 1999, J AUTOIMMUN, V13, P383, DOI 10.1006/jaut.1999.0331; Arreaza G, 2003, CLIN IMMUNOL, V107, P103, DOI 10.1016/S1521-6616(03)00049-4; BAXTER AG, 1991, CLIN EXP IMMUNOL, V85, P464; CHATENOUD L, 1994, P NATL ACAD SCI USA, V91, P123, DOI 10.1073/pnas.91.1.123; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Eizirik DL, 2001, DIABETOLOGIA, V44, P2115, DOI 10.1007/s001250100021; Eldor R, 2006, P NATL ACAD SCI USA, V103, P5072, DOI 10.1073/pnas.0508166103; FOULIS AK, 1991, J PATHOL, V165, P97, DOI 10.1002/path.1711650203; Greeley SAW, 2001, J IMMUNOL, V167, P4351, DOI 10.4049/jimmunol.167.8.4351; Hawiger J, 2001, IMMUNOL RES, V23, P99, DOI 10.1385/IR:23:2-3:099; Hayashi T, 1999, MOL CELL BIOL, V19, P8646; Herold KC, 2005, DIABETES, V54, P1763, DOI 10.2337/diabetes.54.6.1763; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Hu CY, 2007, J CLIN INVEST, V117, P3857, DOI 10.1172/JCI32405; Huang XL, 2008, ENDOCR REV, V29, P603, DOI 10.1210/er.2008-0006; Hussain S, 2005, J IMMUNOL, V174, P680, DOI 10.4049/jimmunol.174.2.680; Hussain S, 2004, DIABETES, V53, P2003, DOI 10.2337/diabetes.53.8.2003; JensenUrstad KJ, 1996, DIABETES, V45, P1253, DOI 10.2337/diabetes.45.9.1253; Kendall PL, 2004, EUR J IMMUNOL, V34, P2387, DOI 10.1002/eji.200324744; Koulmanda M, 2008, P NATL ACAD SCI USA, V105, P16242, DOI 10.1073/pnas.0808031105; Koulmanda M, 2007, P NATL ACAD SCI USA, V104, P13074, DOI 10.1073/pnas.0705863104; LEE KU, 1988, DIABETES, V37, P989, DOI 10.2337/diabetes.37.7.989; Li FX, 2003, P NATL ACAD SCI USA, V100, P12935, DOI 10.1073/pnas.2231861100; LIN YZ, 1995, J BIOL CHEM, V270, P14255, DOI 10.1074/jbc.270.24.14255; Liu DY, 2009, MOL THER, V17, P796, DOI 10.1038/mt.2009.18; Liu DY, 2004, J BIOL CHEM, V279, P48434, DOI 10.1074/jbc.M407190200; Liu DY, 2004, J BIOL CHEM, V279, P19239, DOI 10.1074/jbc.M313442200; Liu XY, 2000, J BIOL CHEM, V275, P16774; Liuwantara D, 2006, DIABETES, V55, P2491, DOI 10.2337/db06-0142; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Mangge H, 2004, EXP CLIN ENDOCR DIAB, V112, P378, DOI 10.1055/s-2004-821023; Matos M, 2004, DIABETES, V53, P2310, DOI 10.2337/diabetes.53.9.2310; Noorchashm H, 2000, J IMMUNOL, V165, P4685, DOI 10.4049/jimmunol.165.8.4685; Noorchashm H, 1999, CELL IMMUNOL, V195, P75, DOI 10.1006/cimm.1999.1522; Papaccio G, 2005, J CELL PHYSIOL, V204, P124, DOI 10.1002/jcp.20276; Pasare C, 2004, IMMUNITY, V21, P733, DOI 10.1016/j.immuni.2004.10.006; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Poligone B, 2002, J IMMUNOL, V168, P188, DOI 10.4049/jimmunol.168.1.188; Ramamoorthy A, 2007, BIOCHEMISTRY-US, V46, P965, DOI 10.1021/bi061895g; Rasschaert J, 2005, J BIOL CHEM, V280, P33984, DOI 10.1074/jbc.M502213200; Salojin KV, 1998, IMMUNOL TODAY, V19, P468, DOI 10.1016/S0167-5699(98)01326-7; Sen P, 2003, J IMMUNOL, V170, P1770, DOI 10.4049/jimmunol.170.4.1770; Serreze DV, 2001, J IMMUNOL, V166, P1352, DOI 10.4049/jimmunol.166.2.1352; SIGNORE A, 1994, HISTOCHEMISTRY, V101, P263, DOI 10.1007/BF00315913; Skyler JS, 2008, ANN NY ACAD SCI, V1150, P190, DOI 10.1196/annals.1447.055; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Thornley TB, 2006, J IMMUNOL, V176, P1561, DOI 10.4049/jimmunol.176.3.1561; Torgerson TR, 1998, J IMMUNOL, V161, P6084; Veach RA, 2004, J BIOL CHEM, V279, P11425, DOI 10.1074/jbc.M311089200; WEBB SR, 1994, J IMMUNOL, V152, P586; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wheat W, 2004, EUR J IMMUNOL, V34, P1395, DOI 10.1002/eji.200324490; Xiu Y, 2008, J IMMUNOL, V180, P2863, DOI 10.4049/jimmunol.180.5.2863; Yang ZD, 2002, DIABETOLOGIA, V45, P1307, DOI 10.1007/s00125-002-0901-y; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	57	14	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13235	10.1371/journal.pone.0013235	http://dx.doi.org/10.1371/journal.pone.0013235			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949090	Green Published, gold, Green Submitted			2022-12-27	WOS:000282568400021
J	Xue, G; Mei, LL; Chen, CS; Lu, ZL; Poldrack, RA; Dong, Q				Xue, Gui; Mei, Leilei; Chen, Chuansheng; Lu, Zhong-Lin; Poldrack, Russell A.; Dong, Qi			Facilitating Memory for Novel Characters by Reducing Neural Repetition Suppression in the Left Fusiform Cortex	PLOS ONE			English	Article							WORD FORM AREA; NEUROFUNCTIONAL PREDICTORS; DEVELOPMENTAL DYSLEXIA; FUNCTIONAL-PROPERTIES; RECOGNITION MEMORY; WRITING SYSTEM; BRAIN ACTIVITY; TASKS; FMRI; EXPERIENCE	Background: The left midfusiform and adjacent regions have been implicated in processing and memorizing familiar words, yet its role in memorizing novel characters has not been well understood. Methodology/Principal Findings: Using functional MRI, the present study examined the hypothesis that the left midfusiform is also involved in memorizing novel characters and spaced learning could enhance the memory by enhancing the left midfusiform activity during learning. Nineteen native Chinese readers were scanned while memorizing the visual form of 120 Korean characters that were novel to the subjects. Each character was repeated four times during learning. Repetition suppression was manipulated by using two different repetition schedules: massed learning and spaced learning, pseudo-randomly mixed within the same scanning session. Under the massed learning condition, the four repetitions were consecutive (with a jittered inter-repetition interval to improve the design efficiency). Under the spaced learning condition, the four repetitions were interleaved with a minimal inter-repetition lag of 6 stimuli. Spaced learning significantly improved participants' performance during the recognition memory test administered one hour after the scan. Stronger left midfusiform and inferior temporal gyrus activities during learning (summed across four repetitions) were associated with better memory of the characters, based on both within-and cross-subjects analyses. Compared to massed learning, spaced learning significantly reduced neural repetition suppression and increased the overall activities in these regions, which were associated with better memory for novel characters. Conclusions/Significance: These results demonstrated a strong link between cortical activity in the left midfusiform and memory for novel characters, and thus challenge the visual word form area (VWFA) hypothesis. Our results also shed light on the neural mechanisms of the spacing effect in memorizing novel characters.	[Xue, Gui; Mei, Leilei; Dong, Qi] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Xue, Gui; Lu, Zhong-Lin] Univ So Calif, Dept Psychol, Los Angeles, CA 90089 USA; [Mei, Leilei; Chen, Chuansheng] Univ Calif Irvine, Dept Psychol & Social Behav, Irvine, CA USA; [Poldrack, Russell A.] Univ Texas Austin, Imaging Res Ctr, Austin, TX 78712 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Poldrack, Russell A.] Univ Texas Austin, Dept Neurobiol, Austin, TX 78712 USA	Beijing Normal University; University of Southern California; University of California System; University of California Irvine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Xue, G (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	guixue@gmail.com	Xue, Gui/A-1762-2009	Xue, Gui/0000-0001-7891-8151; Lu, Zhong-Lin/0000-0002-7295-727X; Poldrack, Russell/0000-0001-6755-0259; Chen, Chuansheng/0000-0002-8224-1005	Program for New Century Excellent Talents in University; National Science Foundation [BCS 0823624, BCS 0823495]; National Institute of Health [HD057884-01A2]; 111 Project of China [B07008]; Direct For Social, Behav & Economic Scie [0823624] Funding Source: National Science Foundation; Division Of Behavioral and Cognitive Sci [0823495] Funding Source: National Science Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057884] Funding Source: NIH RePORTER	Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 111 Project of China(Ministry of Education, China - 111 Project); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the Program for New Century Excellent Talents in University, the National Science Foundation (grant numbers BCS 0823624 and BCS 0823495), the National Institute of Health (grant number HD057884-01A2), and the 111 Project of China (B07008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Arthur W, 1998, HUM PERFORM, V11, P57, DOI 10.1207/s15327043hup1101_3; Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Barton JJS, 2010, J COGNITIVE NEUROSCI, V22, P1649, DOI 10.1162/jocn.2009.21286; Brem S, 2006, NEUROIMAGE, V29, P822, DOI 10.1016/j.neuroimage.2005.09.023; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brozinsky CJ, 2005, HIPPOCAMPUS, V15, P557, DOI 10.1002/hipo.20087; Bruno JL, 2008, NEUROIMAGE, V39, P1988, DOI 10.1016/j.neuroimage.2007.10.044; Callan DE, 2010, HUM BRAIN MAPP, V31, P645, DOI 10.1002/hbm.20894; Cepeda NJ, 2006, PSYCHOL BULL, V132, P354, DOI 10.1037/0033-2909.132.3.354; Chen CS, 2007, NEUROPSYCHOLOGIA, V45, P741, DOI 10.1016/j.neuropsychologia.2006.08.018; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cohen L, 2004, NEUROPSYCHOLOGIA, V42, P1768, DOI 10.1016/j.neuropsychologia.2004.04.018; Cornoldi C., 1977, ITALIAN J PSYCHOL, V4, P65; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dempster FN, 1989, EDUC PSYCHOL REV, V1, P309, DOI 10.1007/BF01320097; Dong Q, 2008, NEUROSCI LETT, V430, P87, DOI 10.1016/j.neulet.2007.09.078; Donovan JJ, 1999, J APPL PSYCHOL, V84, P795, DOI 10.1037/0021-9010.84.5.795; Epelbaum S, 2008, CORTEX, V44, P962, DOI 10.1016/j.cortex.2008.05.003; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; GREENE RL, 1989, J EXP PSYCHOL LEARN, V15, P371, DOI 10.1037/0278-7393.15.3.371; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Hintzman D. L., 1974, THEORIES COGNITIVE P, P77; James KH, 2005, COGN AFFECT BEHAV NE, V5, P452, DOI 10.3758/CABN.5.4.452; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Liu C, 2008, NEUROIMAGE, V40, P1350, DOI 10.1016/j.neuroimage.2007.10.014; Mammarella N, 2004, EUR J COGN PSYCHOL, V16, P387, DOI 10.1080/09541440340000042; Mammarella N, 2002, MEM COGNITION, V30, P1238, DOI 10.3758/BF03213406; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; McCrory EJ, 2005, BRAIN, V128, P261, DOI 10.1093/brain/awh340; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; Mumford J., 2007, GUIDE CALCULATING PE; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Pelli DG, 2006, VISION RES, V46, P4646, DOI 10.1016/j.visres.2006.04.023; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Proverbio AM, 2006, COGN NEUROPSYCHOL, V23, P355, DOI 10.1080/02643290442000536; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Russo R, 1998, J EXP PSYCHOL LEARN, V24, P161, DOI 10.1037/0278-7393.24.1.161; Russo R, 2002, J EXP PSYCHOL LEARN, V28, P819, DOI 10.1037//0278-7393.28.5.819; Sayres R, 2006, J NEUROPHYSIOL, V95, P995, DOI 10.1152/jn.00500.2005; Schlaggar BL, 2007, ANNU REV NEUROSCI, V30, P475, DOI 10.1146/annurev.neuro.28.061604.135645; Shaywitz BA, 2002, BIOL PSYCHIAT, V52, P101, DOI 10.1016/S0006-3223(02)01365-3; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; SNYDER PJ, 1993, CORTEX, V29, P115, DOI 10.1016/S0010-9452(13)80216-X; STARK S, 2008, MEMORY, P1; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Van der Mark S, 2009, NEUROIMAGE, V47, P1940, DOI 10.1016/j.neuroimage.2009.05.021; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; XUE G, 2010, J COGNITIVE NEUROSCI; Xue G, 2008, NEUROIMAGE, V39, P2025, DOI 10.1016/j.neuroimage.2007.10.021; Xue G, 2007, J COGNITIVE NEUROSCI, V19, P1643, DOI 10.1162/jocn.2007.19.10.1643; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Xue G, 2006, J COGNITIVE NEUROSCI, V18, P923, DOI 10.1162/jocn.2006.18.6.923; YONELINAS AP, 1994, J EXP PSYCHOL LEARN, V20, P1341, DOI 10.1037/0278-7393.20.6.1341	65	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13204	10.1371/journal.pone.0013204	http://dx.doi.org/10.1371/journal.pone.0013204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659LQ	20949093	Green Published, gold			2022-12-27	WOS:000282568400015
J	Millard, M; Pathania, D; Shabaik, Y; Taheri, L; Deng, JX; Neamati, N				Millard, Melissa; Pathania, Divya; Shabaik, Yumna; Taheri, Laleh; Deng, Jinxia; Neamati, Nouri			Preclinical Evaluation of Novel Triphenylphosphonium Salts with Broad-Spectrum Activity	PLOS ONE			English	Article							PHOSPHONIUM SALTS; CELL-GROWTH; CU-64-LABELED TRIPHENYLPHOSPHONIUM; LIPOPHILIC CATIONS; BREAST-CANCER; IN-VITRO; CARCINOMA; PROLIFERATION; BIOLOGY; DNA	Background: Recently, there has been a surge of interest in developing compounds selectively targeting mitochondria for the treatment of neoplasms. The critical role of mitochondria in cellular metabolism and respiration supports this therapeutic rationale. Dysfunction in the processes of energy production and metabolism contributes to attenuation of response to pro-apoptotic stimuli and increased ROS production both of which are implicated in the initiation and progression of most human cancers. Methodology/Principal Findings: A high-throughput MTT-based screen of over 10,000 drug-like small molecules for antiproliferative activity identified the phosphonium salts TP187, 197 and 421 as having IC50 concentrations in the submicromolar range. TP treatment induced cell cycle arrest independent of p53 status, as determined by analysis of DNA content in propidium iodide stained cells. In a mouse model of human breast cancer, TP-treated mice showed significantly decreased tumor growth compared to vehicle or paclitaxel treated mice. No toxicities or organ damage were observed following TP treatment. Immunohistochemical staining of tissue sections from TP187-treated tumors demonstrated a decrease in cellular proliferation and increased caspase-3 cleavage. The fluorescent properties of analog TP421 were exploited to assess subcellular uptake of TP compounds, demonstrating mitochondrial localization. Following mitochondrial uptake cells exhibited decreased oxygen consumption and concomittant increase in mitochondrial superoxide production. Proteomics analysis of results from a 600 target antibody microarray demonstrated that TP compounds significantly affected signaling pathways relevant to growth and proliferation. Conclusions/Significance: Through our continued interest in designing compounds targeting cancer-cell metabolism, the Warburg effect, and mitochondria we recently discovered a series of novel, small-molecule compounds containing a triphenylphosphine moiety that show remarkable activity in a panel of cancer cell lines as well as in a mouse model of human breast cancer. The mechanism of action includes mitochondrial localization causing decreased oxygen consumption, increased superoxide production and attenuated growth factor signaling.	[Millard, Melissa; Pathania, Divya; Shabaik, Yumna; Taheri, Laleh; Deng, Jinxia; Neamati, Nouri] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA	University of Southern California	Millard, M (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA.	neamati@usc.edu			Congressionally Directed Medical Research Program (CDMRP); Sharon and William Cockrell Endowed Cancer Research Fund	Congressionally Directed Medical Research Program (CDMRP)(United States Department of Defense); Sharon and William Cockrell Endowed Cancer Research Fund	This study was supported in part by funds from the Congressionally Directed Medical Research Program (CDMRP) Breast Cancer Concept Award and the Sharon and William Cockrell Endowed Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergeron KL, 2009, MUTAT RES-GEN TOX EN, V673, P141, DOI 10.1016/j.mrgentox.2009.01.002; BLANK B, 1975, J MED CHEM, V18, P952, DOI 10.1021/jm00243a021; CARMICHAEL J, 1987, CANCER RES, V47, P936; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Cooper WA, 2001, MAGNET RESON MED, V45, P1001, DOI 10.1002/mrm.1133; CROMLISH JA, 1989, J BIOL CHEM, V264, P18100; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DEBY C, 1990, BIOCHEM PHARMACOL, V39, P399, DOI 10.1016/0006-2952(90)90043-K; DUBOIS RJ, 1978, J MED CHEM, V21, P303, DOI 10.1021/jm00201a016; Filomeni G, 2005, CELL DEATH DIFFER, V12, P1555, DOI 10.1038/sj.cdd.4401754; FRIDOVICH I, 1978, SCIENCE, V201, P875, DOI 10.1126/science.210504; Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193; GRINIUS LL, 1970, BIOCHIM BIOPHYS ACTA, V216, P1, DOI 10.1016/0005-2728(70)90153-2; Haga N, 2010, CANC SCI; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; ISOLA JJ, 1990, CANCER, V65, P1180, DOI 10.1002/1097-0142(19900301)65:5<1180::AID-CNCR2820650525>3.0.CO;2-7; Kim YS, 2008, J MED CHEM, V51, P2971, DOI 10.1021/jm7015045; KINNAMON KE, 1977, J MED CHEM, V20, P741, DOI 10.1021/jm00216a001; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Manetta A, 1996, GYNECOL ONCOL, V60, P203, DOI 10.1006/gyno.1996.0026; Modica-Napolitano JS, 2001, ADV DRUG DELIVER REV, V49, P63, DOI 10.1016/S0169-409X(01)00125-9; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; Munshi A, 2005, METH MOLEC MED, V110, P21; Murphy MP, 2008, BBA-BIOENERGETICS, V1777, P1028, DOI 10.1016/j.bbabio.2008.03.029; Pathania D, 2009, ADV DRUG DELIVER REV, V61, P1250, DOI 10.1016/j.addr.2009.05.010; RIDEOUT D, 1994, INT J CANCER, V57, P247, DOI 10.1002/ijc.2910570220; RIDEOUT DC, 1989, ANTI-CANCER DRUG DES, V4, P265; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Smolkova K, 2010, J BIOENERG BIOMEMBR, V42, P55, DOI 10.1007/s10863-009-9267-x; STEINBECK MJ, 1993, J BIOL CHEM, V268, P15649; VERONESE SM, 1993, CANCER, V71, P3926, DOI 10.1002/1097-0142(19930615)71:12<3926::AID-CNCR2820711221>3.0.CO;2-2; Wang JJ, 2007, J MED CHEM, V50, P5057, DOI 10.1021/jm0704088; WARBURG O, 1956, SCIENCE, V123, P310; WITTIG G, 1980, SCIENCE, V210, P600, DOI 10.1126/science.210.4470.600	35	94	97	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13131	10.1371/journal.pone.0013131	http://dx.doi.org/10.1371/journal.pone.0013131			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957228	Green Submitted, gold, Green Published			2022-12-27	WOS:000282423300003
J	Revel, M; Dejean, A; Cereghino, R; Roux, O				Revel, Messika; Dejean, Alain; Cereghino, Regis; Roux, Olivier			An Assassin among Predators: The Relationship between Plant-Ants, Their Host Myrmecophytes and the Reduviidae Zelus annulosus	PLOS ONE			English	Article							HETEROPTERA; ALEYRODIDAE; HERBIVORES; HEMIPTERA; PARASITE; BEHAVIOR; BUG	Tropical plants frequently live in association with ants that protect their foliage from defoliators. Among them, myrmecophytes have evolved mutualisms with a limited number of plant-ants that they shelter and feed, and, in return, benefit from some protection. Hirtella physophora (Chrysobalanaceae), for example, houses Allomerus decemarticulatus (Myrmicinae) that build gallery-shaped traps to catch large prey. In French Guiana, we frequently observed the assassin bug Zelus annulosus (Reduviidae, Harpactorinae) on the leaves of H. physophora. Here, we studied the distribution of Zelus annulosus among understory plants in the Guianese rainforest and found it only on pubescent plants, including H. Physophora, whether or not it was sheltering an A. decemarticulatus colony, but only rarely on other myrmecophytes. The relationship between Z. annulosus and its host plants is, then, also mutualistic, as the plant trichomes act as an enemy-free space protecting the nymphs from large predatory ants, while the nymphs protect their host-plants from herbivorous insects. Through their relationship with A. decemarticulatus colonies, Z. annulosus individuals are protected from army ants, while furnishing nothing in return. In those cases where H. physophora sheltered both an A. decemarticulatus colony and Z. annulosus nymphs, certain plant individuals repeatedly sheltered nymphs, indicating that female bugs may select not only pubescent plants but also particular H. physophora treelets having characteristics more favourable to the development of their progeny.	[Revel, Messika; Dejean, Alain; Roux, Olivier] Ecofog Ecol Forets Guyane, CNRS, UMR 8172, Kourou, France; [Cereghino, Regis] CNRS, UMR 5245, EcoLab Lab Ecol Fonct, Toulouse, France; [Cereghino, Regis] Univ Toulouse, UPS, INPT, EcoLab, Toulouse, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Revel, M (corresponding author), Ecofog Ecol Forets Guyane, CNRS, UMR 8172, Campus Agron,BP 709, Kourou, France.	olivier.roux@ecofog.gf	CEREGHINO, Regis/G-9500-2011; Roux, Olivier/A-1181-2011; Roux, Olivier/I-5675-2016	Cereghino, Regis/0000-0003-3981-3159; Revel, Messika/0000-0002-8000-8170; Roux, Olivier/0000-0001-5440-0219; Dejean, Alain/0000-0002-3561-2248	French Centre National de la Recherche Scientifique; European Community	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Community(European Commission)	This study was funded by the Programme Amazonie II of the French Centre National de la Recherche Scientifique (project 2ID) and the Programme Convergence 2007-2013, Region Guyane from the European Community (project DEGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berenger JM, 1997, CR ACAD SCI III-VIE, V320, P1007, DOI 10.1016/S0764-4469(97)82474-2; Bernays EA, 1994, HOST PLANT SELECTION; Bronstein JL, 2001, ECOL LETT, V4, P277, DOI 10.1046/j.1461-0248.2001.00218.x; Cetintas R, 2009, FLA ENTOMOL, V92, P538, DOI 10.1653/024.092.0402; Cobben R. H., 1978, EVOLUTIONARY TREND 2, V78-5; Corbara B, 2009, CR BIOL, V332, P470, DOI 10.1016/j.crvi.2009.01.003; DAVIDSON DW, 1989, BIOTROPICA, V21, P64, DOI 10.2307/2388444; Dejean A, 2005, NATURE, V434, P973, DOI 10.1038/434973a; Dejean A, 2001, SOCIOBIOLOGY, V37, P571; Dejean A, 2006, BIOL J LINN SOC, V89, P91, DOI 10.1111/j.1095-8312.2006.00660.x; Fowler Harold G., 1996, Revista Brasileira de Entomologia, V40, P71; Gaume L, 1998, CR ACAD SCI III-VIE, V321, P593, DOI 10.1016/S0764-4469(98)80462-9; Grangier J, 2008, NATURWISSENSCHAFTEN, V95, P909, DOI 10.1007/s00114-008-0398-4; HARIDASS ET, 1987, P INDIAN AS-ANIM SCI, V96, P485, DOI 10.1007/BF03179603; HAVILAND MAUD D., 1931, ZOOLOGICA [NEW YORK], V7, P129; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Heil M, 2009, P NATL ACAD SCI USA, V106, P18091, DOI 10.1073/pnas.0904304106; Holldobler B., 1990, pi; JOLIVET P, 1996, ANTS PLANTS EXAMPLE, P304; Kautz S, 2009, EVOLUTION, V63, P839, DOI 10.1111/j.1558-5646.2008.00594.x; LaPierre L, 2007, NATURWISSENSCHAFTEN, V94, P997, DOI 10.1007/s00114-007-0270-y; LETOURNEAU DK, 1983, OECOLOGIA, V60, P122, DOI 10.1007/BF00379331; LETOURNEAU DK, 1990, SCIENCE, V248, P215, DOI 10.1126/science.248.4952.215; LEVIN DA, 1973, Q REV BIOL, V48, P3, DOI 10.1086/407484; MCAUSLANE HJ, 1995, ENVIRON ENTOMOL, V24, P1135, DOI 10.1093/ee/24.5.1135; MILLER N. C. E., 1953, TRANS ZOOL SOC LONDON, V27, P541; Miller N. C. E., 1942, Proceedings of the Royal Entomological Society of London (A), V17, P49; Osses F, 2007, P ENTOMOL SOC WASH, V109, P331; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rico-Gray V., 2007, ECOLOGY EVOLUTION AN; Ruiz-Gonzalez MX, 2010, BIOTROPICA, V42, P402, DOI 10.1111/j.1744-7429.2010.00645.x; Schuh RT, 1995, TRUE BUGS WORLD HEMI; Solano PJ, 2003, SOCIOBIOLOGY, V41, P605; STONER A, 1975, Journal of the Kansas Entomological Society, V48, P185; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Tallamy DW, 2004, J INSECT BEHAV, V17, P431, DOI 10.1023/B:JOIR.0000042532.50112.0c; USINGER R. L., 1958, PAN PACIFIC ENT, V34, P52; VANLENTEREN JC, 1995, J APPL ENTOMOL, V119, P553, DOI 10.1111/j.1439-0418.1995.tb01335.x; Yu DW, 1998, P ROY SOC B-BIOL SCI, V265, P375, DOI 10.1098/rspb.1998.0305	40	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13110	10.1371/journal.pone.0013110	http://dx.doi.org/10.1371/journal.pone.0013110			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957040	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300014
J	Brinckmann, A; Weiss, C; Wilbert, F; von Moers, A; Zwirner, A; Stoltenburg-Didinger, G; Wilichowski, E; Schuelke, M				Brinckmann, Anja; Weiss, Claudia; Wilbert, Friederike; von Moers, Arpad; Zwirner, Angelika; Stoltenburg-Didinger, Gisela; Wilichowski, Ekkehard; Schuelke, Markus			Regionalized Pathology Correlates with Augmentation of mtDNA Copy Numbers in a Patient with Myoclonic Epilepsy with Ragged-Red Fibers (MERRF-Syndrome)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MUTATION; ANTERIOR CINGULATE CORTEX; TISSUE DISTRIBUTION; CLINICAL PHENOTYPE; TRANSFER RNA(LYS); OXIDATIVE STRESS; RNALYS MUTATION; HUMAN-CELLS; DISEASE; SEGREGATION	Human patients with myoclonic epilepsy with ragged-red fibers (MERRF) suffer from regionalized pathology caused by a mutation in the mitochondrial DNA (m.8344A -> G). In MERRF-syndrome brain and skeletal muscles are predominantly affected, despite mtDNA being present in any tissue. In the past such tissue-specificity could not be explained by varying mtDNA mutation loads. In search for a region-specific pathology in human individuals we determined the mtDNA/nDNA ratios along with the mutation loads in 43 different post mortem tissue samples of a 16-year-old female MERRF patient and in four previously healthy victims of motor vehicle accidents. In brain and muscle we further determined the quantity of mitochondrial proteins (COX subunits II and IV), transcription factors (NRF1 and TFAM), and VDAC1 (Porin) as a marker for the mitochondrial mass. In the patient the mutation loads varied merely between 89-100%. However, mtDNA copy numbers were increased 3-7 fold in predominantly affected brain areas (e.g. hippocampus, cortex and putamen) and in skeletal muscle. Similar increases were absent in unaffected tissues (e.g. heart, lung, kidney, liver, and gastrointestinal organs). Such mtDNA copy number increase was not paralleled by an augmentation of mitochondrial mass in some investigated tissues, predominantly in the most affected tissue regions of the brain. We thus conclude that "futile'' stimulation of mtDNA replication per se or a secondary failure to increase the mitochondrial mass may contribute to the regionalized pathology seen in MERRF-syndrome.	[Brinckmann, Anja; Weiss, Claudia; Wilbert, Friederike; Zwirner, Angelika; Schuelke, Markus] Charite, Dept Neuropediat, Berlin, Germany; [von Moers, Arpad] DRK Kliniken Westend, Berlin, Germany; [Stoltenburg-Didinger, Gisela] Charite, Dept Neuropathol, Berlin, Germany; [Wilichowski, Ekkehard] Univ Gottingen, Dept Pediat & Pediat Neurol, Gottingen, Germany; [Wilbert, Friederike; Schuelke, Markus] Charite, NeuroCure Clin Res Ctr, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brinckmann, A (corresponding author), Charite, Dept Neuropediat, Berlin, Germany.	markus.schuelke@charite.de		Schuelke, Markus/0000-0003-2824-3891; Weiss, Claudia/0000-0001-6167-5878	Deutsche Forschungsgemeinschaft [SFB 665 TP C4]; NeuroCure Cluster of Excellence at the Charite, Berlin [Exc 257]; German ministry of education and research (BMBF, Bonn, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NeuroCure Cluster of Excellence at the Charite, Berlin; German ministry of education and research (BMBF, Bonn, Germany)(Federal Ministry of Education & Research (BMBF))	The project was funded by the Deutsche Forschungsgemeinschaft within the SFB 665 TP C4 "Developmental Disorders of the Nervous System'' and the NeuroCure Cluster of Excellence (Exc 257) at the Charite, Berlin. M. S. is a member of the German network for mitochondrial disorders (mitoNET, 01GM0866), funded by the German ministry of education and research (BMBF, Bonn, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Battersby BJ, 2007, NAT GENET, V39, P571, DOI 10.1038/ng0507-571; BOULET L, 1992, AM J HUM GENET, V51, P1187; Brinckmann A, 2007, J MOL MED-JMM, V85, P163, DOI 10.1007/s00109-006-0112-y; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Foran DR, 2006, J FORENSIC SCI, V51, P766, DOI 10.1111/j.1556-4029.2006.00176.x; FUKUHARA N, 1980, J NEUROL SCI, V47, P117, DOI 10.1016/0022-510X(80)90031-3; Gittins R, 2004, BRAIN RES, V1013, P212, DOI 10.1016/j.brainres.2004.03.064; Gittins R, 2004, BRAIN RES BULL, V63, P155, DOI 10.1016/j.brainresbull.2004.02.005; HAMMANS SR, 1993, BRAIN, V116, P617, DOI 10.1093/brain/116.3.617; Hori A, 2009, NUCLEIC ACIDS RES, V37, P749, DOI 10.1093/nar/gkn993; Huang CC, 2002, J BIOMED SCI, V9, P527, DOI 10.1007/BF02254979; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; LERTRIT P, 1992, HUM GENET, V90, P251; LOMBES A, 1992, NEUROMUSCULAR DISORD, V2, P323, DOI 10.1016/S0960-8966(06)80003-9; MATTHEWS PM, 1994, J MED GENET, V31, P41, DOI 10.1136/jmg.31.1.41; Moreno-Loshuertos R, 2006, NAT GENET, V38, P1261, DOI 10.1038/ng1897; OLDFORS A, 1995, ACTA NEUROPATHOL, V90, P328; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; SPARACO M, 1993, J NEUROPATH EXP NEUR, V52, P1, DOI 10.1097/00005072-199301000-00001; TANNO Y, 1993, NEUROLOGY, V43, P1198, DOI 10.1212/WNL.43.6.1198; Wei YH, 2001, ANN NY ACAD SCI, V928, P97; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499	30	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13513	10.1371/journal.pone.0013513	http://dx.doi.org/10.1371/journal.pone.0013513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976001	Green Submitted, Green Published, gold			2022-12-27	WOS:000283216400018
J	Vallenback, P; Ghatnekar, L; Bengtsson, BO				Vallenback, Pernilla; Ghatnekar, Lena; Bengtsson, Bengt O.			Structure of the Natural Transgene PgiC2 in the Common Grass Festuca ovina	PLOS ONE			English	Article							HORIZONTAL TRANSFER; GENE-TRANSFER; NUCLEAR; PLANT; POA	Background: A horizontal gene transfer has brought an active nuclear gene, PgiC2, from a polyploid Poa species (P. palustris or a close relative) into the common grass sheep's fescue (Festuca ovina). The donor and the receptor species are strictly reproductively separated, and PgiC2 occurs in a polymorphic state within F. ovina. The active gene copy is normally closely linked to a very similar pseudogene. Methodology/Principal Findings: By genome walking we have obtained the up-and downstream sequences of PgiC2 and of corresponding genes in the donor and recipient species. Comparisons of these sequences show that the complete upstream region necessary for the gene's expression is included in the transferred segment. About 1 kb upstream of PgiC2 a fragment with transposition associated properties has been found (TAF). It is present in P. palustris and its polyploid relatives, though not at the homologous position, and is absent from many other grasses, including non-transgenic F. ovina plants. It is possible that it is a part of a transposing element involved in getting the gene into a transferring agent and/or into the recipient chromosome. Conclusions/Significance: The close similarity of the up-and downstream regions with the corresponding regions in P. palustris excludes all suggestions that PgiC2 is not a HGT but the result of a duplication within the F. ovina lineage. The small size of the genetic material transferred, the complex nature of the PgiC2 locus, and the associated fragment with transposition associated properties suggest that the horizontal transfer occurred via a vector and not via illegitimate pollination.	[Vallenback, Pernilla; Ghatnekar, Lena; Bengtsson, Bengt O.] Lund Univ, Dept Biol, Lund, Sweden	Lund University	Vallenback, P (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	pernilla.vallenback@cob.lu.se			Nilsson-Ehle Foundation; Lindstrom Foundation; Erik Philip-Sorensen Foundation; Trygger Foundation	Nilsson-Ehle Foundation; Lindstrom Foundation; Erik Philip-Sorensen Foundation; Trygger Foundation	This work was supported by the Nilsson-Ehle, Lindstrom, Erik Philip-Sorensen and Trygger Funds and Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergthorsson U, 2003, NATURE, V424, P197, DOI 10.1038/nature01743; Bock R, 2010, TRENDS PLANT SCI, V15, P11, DOI 10.1016/j.tplants.2009.10.001; DAVIES DR, 1974, HEREDITY, V32, P267, DOI 10.1038/hdy.1974.30; Davis CC, 2005, P ROY SOC B-BIOL SCI, V272, P2237, DOI 10.1098/rspb.2005.3226; Davis CC, 2004, SCIENCE, V305, P676, DOI 10.1126/science.1100671; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Gaut BS, 2000, PLANT SYST EVOL, V224, P33, DOI 10.1007/BF00985265; Ghatnekar L, 2006, P ROY SOC B-BIOL SCI, V273, P395, DOI 10.1098/rspb.2005.3355; Ghatnekar L, 1999, HEREDITY, V83, P451, DOI 10.1038/sj.hdy.6885750; GRIME JP, 1982, NATURE, V299, P151, DOI 10.1038/299151a0; HEGI G, ILLUSTRIERTE FLORA M, V1; KNOBLOCH IW, CHECK LIST CROSSES G; LAURIE DA, 1990, STADLER GEN, P95; Richardson AO, 2007, J EXP BOT, V58, P1, DOI 10.1093/jxb/erl148; Torrecilla P, 2002, SYST BOT, V27, P241; VALLENBACK P, THESIS LUND U LUND; Vallenback P, 2008, MOL PHYLOGENET EVOL, V46, P890, DOI 10.1016/j.ympev.2007.11.031; Vallenback P, 2010, GENETICA, V138, P355, DOI 10.1007/s10709-009-9425-4	18	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13529	10.1371/journal.pone.0013529	http://dx.doi.org/10.1371/journal.pone.0013529			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976007	Green Published, gold			2022-12-27	WOS:000283216400029
J	Cedile, O; Popa, N; Pollet-Villard, F; Garmy, N; Ibrahim, EC; Boucraut, J				Cedile, Oriane; Popa, Natalia; Pollet-Villard, Frederic; Garmy, Nicolas; Ibrahim, El Cherif; Boucraut, Jose			The NKG2D Ligands RAE-1 delta and RAE-1 epsilon Differ with Respect to Their Receptor Affinity, Expression Profiles and Transcriptional Regulation	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CELL-SURFACE PROTEINS; CLASS-I; CUTTING EDGE; NK CELLS; TUMOR-CELLS; FAMILY; MACROPHAGES; MOLECULES; MICE	Background: RAE-1 is a ligand of the activating receptor NKG2D expressed by NK cells, NKT, gamma delta T and some CD8(+)T lymphocytes. RAE-1 is overexpressed in tumor cell lines and its expression is induced after viral infection and genotoxic stress. We have recently demonstrated that RAE-1 is expressed in the adult subventricular zone (SVZ) from C57BL/6 mice. RAE-1 is also expressed in vitro by neural stem/progenitor cells (NSPCs) and plays a non-immune role in cell proliferation. The C57BL/6 mouse genome contains two rae-1 genes, rae-1 delta and rae-1 epsilon encoding two different proteins. The goals of this study are first to characterize the in vivo and in vitro expression of each gene and secondly to elucidate the mechanisms underlying their respective expression, which are far from known. Principal Findings: We observed that Rae-1 delta and Rae-1 epsilon transcripts are differentially expressed according to tissues, pathological conditions and cell lines. Embryonic tissue and the adult SVZ mainly expressed Rae-1 delta transcripts. The NSPCs derived from the SVZ also mainly expressed RAE-1 delta. The interest of this result is especially related to the observation that RAE-1 delta is a weak NKG2D ligand compared to RAE-1 epsilon. On the contrary, cell lines expressed either similar levels of RAE-1 delta and RAE-1 epsilon proteins or only RAE-1 epsilon. Since the protein expression correlated with the level of transcripts for each rae-1 gene, we postulated that transcriptional regulation is one of the main processes explaining the difference between RAE-1 delta and RAE-1 epsilon expression. We indeed identified two different promoter regions for each gene: one mainly involved in the control of rae-1 delta gene expression and the other in the control of rae-1 epsilon expression. Conclusions/Significance: RAE-1 delta and RAE-1 epsilon differ with respect to their function and the control of their expression. Immune function would be mainly exerted by RAE-1 epsilon and non-immune function by RAE-1 delta.	[Cedile, Oriane; Popa, Natalia; Pollet-Villard, Frederic; Garmy, Nicolas; Boucraut, Jose] Univ Paul Cezanne, Fac Med, Univ Mediterranee, CRN2M,CNRS,UMR 6231, Marseille, France; [Ibrahim, El Cherif] Univ Aix Marseille 2, Fac Med, NICN, CNRS,UMR 6184, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Cedile, O (corresponding author), Univ Paul Cezanne, Fac Med, Univ Mediterranee, CRN2M,CNRS,UMR 6231, Marseille, France.	jose.boucraut@univmed.fr	IBRAHIM, El Chérif/K-3899-2016	IBRAHIM, El Chérif/0000-0003-3973-7862; Boucraut, Jose/0000-0002-3471-7769	CNRS (Centre National de la Recherche Scientifique); AFM (Association Francaise contre la Myopathie); LFSEP (Ligue Francaise contre la Sclerose en Plaques)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); AFM (Association Francaise contre la Myopathie)(Association Francaise contre les Myopathies); LFSEP (Ligue Francaise contre la Sclerose en Plaques)	Our research is supported by CNRS (Centre National de la Recherche Scientifique) funding, and grants from the AFM (Association Francaise contre la Myopathie, OC (fellowship), JB), the LFSEP (Ligue Francaise contre la Sclerose en Plaques, OC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arapovic J, 2009, J VIROL, V83, P8198, DOI 10.1128/JVI.02549-08; Backstrom E, 2007, SCAND J IMMUNOL, V65, P353, DOI 10.1111/j.1365-3083.2007.01912.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Cheng HYM, 2007, CELL CYCLE, V6, P3034, DOI 10.4161/cc.6.24.5106; Cho MK, 2002, NITRIC OXIDE-BIOL CH, V6, P319, DOI 10.1006/niox.2001.0415; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Ehrlich R, 2000, IMMUNITY, V13, P585, DOI 10.1016/S1074-7613(00)00058-3; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Hamerman JA, 2004, J IMMUNOL, V172, P2001, DOI 10.4049/jimmunol.172.4.2001; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Li PW, 2002, IMMUNITY, V16, P77, DOI 10.1016/S1074-7613(02)00258-3; Lodoen M, 2003, J EXP MED, V197, P1245, DOI 10.1084/jem.20021973; Mammolenti M, 2004, STEM CELLS, V22, P1101, DOI 10.1634/stemcells.22-6-1101; Mandairon N, 2003, NEUROSCIENCE, V119, P507, DOI 10.1016/S0306-4522(03)00172-6; Nausch N, 2006, J IMMUNOL, V176, P7, DOI 10.4049/jimmunol.176.1.7; Nomura M, 1996, J BIOCHEM-TOKYO, V120, P987; Ogasawara K, 2005, J CLIN IMMUNOL, V25, P534, DOI 10.1007/s10875-005-8786-4; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Peng W, 2007, MOL MEMBR BIOL, V24, P475, DOI 10.1080/09687680701359408; Poimenidi E, 2009, ANTICANCER RES, V29, P349; POPA N, GLIA IN PRESS; Rabinovich BA, 2008, IMMUNOL CELL BIOL, V86, P489, DOI 10.1038/icb.2008.41; Samarakoon A, 2009, MOL IMMUNOL, V46, P1011, DOI 10.1016/j.molimm.2008.09.035; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Strong RK, 2002, MOL IMMUNOL, V38, P1029, DOI 10.1016/S0161-5890(02)00032-9; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Yadav D, 2009, J IMMUNOL, V182, P39, DOI 10.4049/jimmunol.182.1.39; ZHI L, BIOCHEMISTRY, V49, P2443; Zou ZH, 1996, J BIOCHEM-TOKYO, V119, P319	37	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13466	10.1371/journal.pone.0013466	http://dx.doi.org/10.1371/journal.pone.0013466			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976056	Green Submitted, Green Published, gold			2022-12-27	WOS:000283114700006
J	Del Giacco, L; Pistocchi, A; Ghilardi, A				Del Giacco, Luca; Pistocchi, Anna; Ghilardi, Anna			prox1b Activity Is Essential in Zebrafish Lymphangiogenesis	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; VASCULAR DEVELOPMENT; LYMPHATIC-SYSTEM; EXPRESSION; GENE; MODEL	Background: The lymphatic vascular system, draining interstitial fluids from most tissues and organs, exerts crucial functions in several physiological and pathological processes. Lymphatic system development depends on Prox1, the first marker to be expressed in the endothelial cells of the cardinal vein from where lymph vessels originate. Prox1 ortholog in the optically clear, easily manipulated zebrafish model has been previously isolated and its contribution to lymphangiogenesis has been clarified. Because of a round of genome duplication occurred at the base of teleosts radiation, several zebrafish genes have been retained in duplicate through evolution. We investigated for the presence of additional prox1 genes and determined their role in zebrafish lymphangiogenesis. Methodology/Principal Findings: We isolated a second ortholog, named prox1b, and analyzed its expression during development by whole mount in situ hybridization ( WISH). We detected strong prox1b expression in the endothelium of the posterior cardinal vein ( PCV) from where lymphatic precursors originate. To analyze prox1b involvement in lymphangiogenesis we utilized the fli1:GFP transgenics and followed the formation of the toracic duct (TD), the primary lymph vessel in fish, after prox1b knockdown. Our findings clearly demonstrated that the absence of prox1b activity severely hampers the formation of the TD. Conclusions/Significance: This work provides substantial progress toward the understanding of zebrafish lymphangiogenesis. In light of the features shared by the lymphatic systems of zebrafish and higher vertebrates, the establishment of such lymphatic model will provide a powerful tool to study, for instance, disorders of body fluid homeostasis, inflammation and cancer metastasis, and may ultimately contribute to novel therapies.	[Del Giacco, Luca; Ghilardi, Anna] Univ Milan, Dept Biol, Milan, Italy; [Pistocchi, Anna] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy	University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Del Giacco, L (corresponding author), Univ Milan, Dept Biol, Milan, Italy.	luca.delgiacco@unimi.it	Del Giacco, Luca P C/A-5812-2014; GHILARDI, ANNA/AAI-9596-2020; Pistocchi, Anna/A-6228-2014	GHILARDI, ANNA/0000-0002-8830-5997; Pistocchi, Anna/0000-0001-9467-2542	Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST)	Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST)	The study was financed by the Fondo per gli Investimenti nella Ricerca Scientifica e Tecnologica (FIRST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixel MG, 2008, GENE DEV, V22, P3232, DOI 10.1101/gad.1751908; Deguchi T, 2009, GENE EXPR PATTERNS, V9, P341, DOI 10.1016/j.gep.2009.02.004; Flores MV, 2010, DEV DYNAM, V239, P2128, DOI 10.1002/dvdy.22328; Glasgow E, 1998, MECH DEVELOP, V76, P175, DOI 10.1016/S0925-4773(98)00121-X; Hassan B, 1997, P NATL ACAD SCI USA, V94, P10991, DOI 10.1073/pnas.94.20.10991; Hogan BM, 2009, NAT GENET, V41, P396, DOI 10.1038/ng.321; JOWETT T, 1994, TRENDS GENET, V10, P73, DOI 10.1016/0168-9525(94)90220-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liu YW, 2003, MOL CELL BIOL, V23, P7243, DOI 10.1128/MCB.23.20.7243-7255.2003; Makinena T, 2007, CELL MOL LIFE SCI, V64, P1915, DOI 10.1007/s00018-007-7040-z; Ny A, 2005, NAT MED, V11, P998, DOI 10.1038/nm1285; Pistocchi A, 2008, DEV DYNAM, V237, P3916, DOI 10.1002/dvdy.21798; Pistocchi A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-27; Postlethwait JH, 2007, J EXP ZOOL PART B, V308B, P563, DOI 10.1002/jez.b.21137; THISSE C, 1993, DEVELOPMENT, V119, P1203; Tomarev SI, 1998, BIOCHEM BIOPH RES CO, V248, P684, DOI 10.1006/bbrc.1998.8989; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	21	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13170	10.1371/journal.pone.0013170	http://dx.doi.org/10.1371/journal.pone.0013170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976189	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300006
J	Frech, C; Chen, N				Frech, Christian; Chen, Nansheng			Genome-Wide Comparative Gene Family Classification	PLOS ONE			English	Article							CLUSTERING PROTEIN SEQUENCES; CAENORHABDITIS-ELEGANS; MODULAR ARCHITECTURE; CHEMORECEPTOR GENES; PHYLOGENETIC TREES; IDENTIFICATION; DATABASE; EVOLUTION; DUPLICATION; RECEPTORS	Correct classification of genes into gene families is important for understanding gene function and evolution. Although gene families of many species have been resolved both computationally and experimentally with high accuracy, gene family classification in most newly sequenced genomes has not been done with the same high standard. This project has been designed to develop a strategy to effectively and accurately classify gene families across genomes. We first examine and compare the performance of computer programs developed for automated gene family classification. We demonstrate that some programs, including the hierarchical average-linkage clustering algorithm MC-UPGMA and the popular Markov clustering algorithm TRIBE-MCL, can reconstruct manual curation of gene families accurately. However, their performance is highly sensitive to parameter setting, i.e. different gene families require different program parameters for correct resolution. To circumvent the problem of parameterization, we have developed a comparative strategy for gene family classification. This strategy takes advantage of existing curated gene families of reference species to find suitable parameters for classifying genes in related genomes. To demonstrate the effectiveness of this novel strategy, we use TRIBE-MCL to classify chemosensory and ABC transporter gene families in C. elegans and its four sister species. We conclude that fully automated programs can establish biologically accurate gene families if parameterized accordingly. Comparative gene family classification finds optimal parameters automatically, thus allowing rapid insights into gene families of newly sequenced species.	[Frech, Christian; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Frech, C (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	chenn@sfu.ca	Chen, Nansheng/E-6450-2012		NSERC (Canada)	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study is supported by a NSERC (Canada) Discovery Grant (to NC). NC is a Michael Smith Foundation for Health Research (MSFHR) Scholar and a Canadian Institutes of Health Research (CIHR) New Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2002, BIOINFORMATICS, V18, P908, DOI 10.1093/bioinformatics/18.7.908; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Barriere A, 2009, GENOME RES, V19, P470, DOI 10.1101/gr.081851.108; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bolten E, 2001, BIOINFORMATICS, V17, P935, DOI 10.1093/bioinformatics/17.10.935; Chen CY, 2006, PATTERN RECOGN, V39, P2356, DOI 10.1016/j.patcog.2005.12.008; Chen NS, 2005, P NATL ACAD SCI USA, V102, P146, DOI 10.1073/pnas.0408307102; Chen YH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S4-S10; DAYHOFF MO, 1976, FED PROC, V35, P2132; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Enright AJ, 2000, BIOINFORMATICS, V16, P451, DOI 10.1093/bioinformatics/16.5.451; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Harlow TJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-45; Heger A, 2001, BIOINFORMATICS, V17, P272, DOI 10.1093/bioinformatics/17.3.272; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Huerta-Cepas J, 2008, NUCLEIC ACIDS RES, V36, pD491, DOI 10.1093/nar/gkm899; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; JACCARD A, 2008, B SOC VAUDOISES SCI, V44; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Kaplan N, 2005, NUCLEIC ACIDS RES, V33, pD216, DOI 10.1093/nar/gki007; Kelil A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-286; Kim S, 2006, INT J DATA MIN BIOIN, V1, P178, DOI 10.1504/IJDMB.2006.010855; Krause A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-15; Krause A, 1998, BIOINFORMATICS, V14, P430, DOI 10.1093/bioinformatics/14.5.430; Kriventseva E. V., 2005, ENCY GENETICS GENOMI, V6, P92; Kriventseva EV, 2001, CURR OPIN STRUC BIOL, V11, P334, DOI 10.1016/S0959-440X(00)00211-6; Kriventseva EV, 2001, NUCLEIC ACIDS RES, V29, P33, DOI 10.1093/nar/29.1.33; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee D, 2005, PROTEINS, V59, P603, DOI 10.1002/prot.20409; Li H, 2006, NUCLEIC ACIDS RES, V34, pD572, DOI 10.1093/nar/gkj118; Loewenstein Y, 2008, BIOINFORMATICS, V24, pI41, DOI 10.1093/bioinformatics/btn174; Ma QC, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-242; Meinel T, 2005, NUCLEIC ACIDS RES, V33, pD226; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; *NCBI, 2008, BLASTCLUST V2 2 19; Paccanaro A, 2006, NUCLEIC ACIDS RES, V34, P1571, DOI 10.1093/nar/gkj515; Pipenbacher P, 2002, BIOINFORMATICS, V18, pS182, DOI 10.1093/bioinformatics/18.suppl_2.S182; Ponting CP, 2008, NAT REV GENET, V9, P689, DOI 10.1038/nrg2413; RAHMAN SA, 2008, REV PROTEIN SEQUENCE; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Robertson HM, 2001, CHEM SENSES, V26, P151, DOI 10.1093/chemse/26.2.151; ROBERTSON HM, 2006, PUTATIVE CHEMORECEPT, P1; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sheps JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r15; Sperisen P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-216; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Tetko IV, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-82; Thomas JH, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-42; Thomas JH, 2006, GENETICS, V172, P127, DOI 10.1534/genetics.104.040030; Thomas JH, 2005, P NATL ACAD SCI USA, V102, P4476, DOI 10.1073/pnas.0406469102; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wittkop T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-396; Wu CH, 2003, COMPUT BIOL CHEM, V27, P37, DOI 10.1016/S1476-9271(02)00098-1; Yona G, 1999, PROTEINS, V37, P360, DOI 10.1002/(SICI)1097-0134(19991115)37:3<360::AID-PROT5>3.0.CO;2-Z; Zhao ZY, 2007, GENETICS, V175, P1407, DOI 10.1534/genetics.106.066720	62	23	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13409	10.1371/journal.pone.0013409	http://dx.doi.org/10.1371/journal.pone.0013409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976221	Green Published, Green Submitted, gold			2022-12-27	WOS:000283043700011
J	Giampa, C; Laurenti, D; Anizilotti, S; Bernardi, G; Menniti, FS; Fusco, FR				Giampa, Carmela; Laurenti, Daunia; Anizilotti, Serenella; Bernardi, Giorgio; Menniti, Frank S.; Fusco, Francesca Romana			Inhibition of the Striatal Specific Phosphodiesterase PDE10A Ameliorates Striatal and Cortical Pathology in R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							CREB-BINDING PROTEIN; ENRICHED PHOSPHODIESTERASE; MEDIATED TRANSCRIPTION; NEUROTROPHIC FACTOR; IMMUNOHISTOCHEMICAL LOCALIZATION; NEURONAL VULNERABILITY; CAG REPEAT; CELL-DEATH; RAT-BRAIN; MICE	Background: Huntington's disease is a devastating neurodegenerative condition for which there is no therapy to slow disease progression. The particular vulnerability of striatal medium spiny neurons to Huntington's pathology is hypothesized to result from transcriptional dysregulation within the cAMP and CREB signaling cascades in these neurons. To test this hypothesis, and a potential therapeutic approach, we investigated whether inhibition of the striatal-specific cyclic nucleotide phosphodiesterase PDE10A would alleviate neurological deficits and brain pathology in a highly utilized model system, the R6/2 mouse. Methodology/Principal Findings: R6/2 mice were treated with the highly selective PDE10A inhibitor TP-10 from 4 weeks of age until euthanasia. TP-10 treatment significantly reduced and delayed the development of the hind paw clasping response during tail suspension, deficits in rotarod performance, and decrease in locomotor activity in an open field. Treatment prolonged time to loss of righting reflex. These effects of PDE10A inhibition on neurological function were reflected in a significant amelioration in brain pathology, including reduction in striatal and cortical cell loss, the formation of striatal neuronal intranuclear inclusions, and the degree of microglial activation that occurs in response to the mutant huntingtin-induced brain damage. Striatal and cortical levels of phosphorylated CREB and BDNF were significantly elevated. Conclusions/Significance: Our findings provide experimental support for targeting the cAMP and CREB signaling pathways and more broadly transcriptional dysregulation as a therapeutic approach to Huntington's disease. It is noteworthy that PDE10A inhibition in the R6/2 mice reduces striatal pathology, consistent with the localization of the enzyme in medium spiny neurons, and also cortical pathology and the formation of neuronal nuclear inclusions. These latter findings suggest that striatal pathology may be a primary driver of these secondary pathological events. More significantly, our studies point directly to an accessible new therapeutic approach to slow Huntington's disease progression, namely, PDE10A inhibition. There is considerable activity throughout the pharmaceutical industry to develop PDE10A inhibitors for the treatment of basal ganglia disorders. The present results strongly support the investigation of PDE10A inhibitors as a much needed new treatment approach to Huntington's disease.	[Giampa, Carmela; Laurenti, Daunia; Anizilotti, Serenella; Bernardi, Giorgio; Fusco, Francesca Romana] European Ctr Brain Res, Santa Lucia Fdn IRCCS Hosp, Lab Neuroanat, Rome, Italy; [Bernardi, Giorgio] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Menniti, Frank S.] Mnemosyne Pharmaceut Inc, Providence, RI USA	IRCCS Santa Lucia; University of Rome Tor Vergata	Giampa, C (corresponding author), European Ctr Brain Res, Santa Lucia Fdn IRCCS Hosp, Lab Neuroanat, Rome, Italy.	f.fusco@hsantalucia.it	anzilotti, Serenella/I-8686-2018; Fusco, Francesca R/K-1080-2018	Fusco, Francesca R/0000-0003-2226-523X; Menniti, Frank/0000-0003-2612-9534; anzilotti, serenella/0000-0002-8729-0009; , Giampa/0000-0002-1763-5665	Pfizer Inc., Groton [CT 06355]; Pfizer Inc.	Pfizer Inc., Groton(Pfizer); Pfizer Inc.(Pfizer)	This work was funded by a grant from Pfizer Inc., Groton, CT 06355. Dr. F. Menniti was involved in the initial design, analysis and manuscript preparation while an employee of Pfizer Inc.; This work was funded through a grant from Pfizer Inc. and Pfizer Inc. supplied the compound, TP-10, used in these studies. This work was initiated while Dr. Menniti was an employee of the company; however, Dr. Menniti is no longer with Pfizer. The purpose of the grant was to fund the basic research presented in the manuscript with the full acknowledgment that the results would be published. In this way, all of the organizations interested in developing new therapies for Huntington's disease would have access to the published results. It is the hope of the authors that the work encourages further research into the potential therapeutic benefit of PDE10A inhibition in the treatment of Huntington's disease, regardless of whether such further research is for profit or not for profit. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chappie T, 2009, CURR OPIN DRUG DISC, V12, P458; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Coskran TM, 2006, J HISTOCHEM CYTOCHEM, V54, P1205, DOI 10.1369/JHC.6A6930.2006; Cramer H, 1984, Adv Neurol, V40, P431; DELAMONTE SM, 1988, J NEUROPATH EXP NEUR, V47, P516, DOI 10.1097/00005072-198809000-00003; DeMarch Z, 2008, NEUROBIOL DIS, V30, P375, DOI 10.1016/j.nbd.2008.02.010; DeMarch Z, 2007, NEUROBIOL DIS, V25, P266, DOI 10.1016/j.nbd.2006.09.006; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Fusco FR, 1999, J NEUROSCI, V19, P1189; Fusco FR, 2003, EUR J NEUROSCI, V18, P1093, DOI 10.1046/j.1460-9568.2003.02844.x; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Giampa C, 2006, EUR J NEUROSCI, V23, P11, DOI 10.1111/j.1460-9568.2005.04545.x; GIAMPA C, 2009, NEUROBIOLOG IN PRESS; Gines S, 2003, HUM MOL GENET, V12, P497, DOI 10.1093/hmg/ddg046; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hansson O, 2003, BRAIN RES, V970, P47, DOI 10.1016/S0006-8993(02)04275-0; Hersch Steven M, 2004, NeuroRx, V1, P298, DOI 10.1007/BF03206614; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kehler J, 2009, EXPERT OPIN THER PAT, V19, P1715, DOI 10.1517/13543770903431050; KLEIMAN RJ, 2010, NEUROSCIENC IN PRESS; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Ma TC, 2007, NEUROSCI LETT, V411, P98, DOI 10.1016/j.neulet.2006.10.039; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacKenzie SJ, 2000, BIOCHEM J, V347, P571, DOI 10.1042/0264-6021:3470571; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Perrin V, 2009, EXP NEUROL, V215, P191, DOI 10.1016/j.expneurol.2008.10.008; Sano H, 2008, J NEUROCHEM, V105, P546, DOI 10.1111/j.1471-4159.2007.05152.x; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Seeger TF, 2003, BRAIN RES, V985, P113, DOI 10.1016/S0006-8993(03)02754-9; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P386, DOI 10.1016/j.neuropharm.2006.04.013; Siuciak JA, 2006, NEUROPHARMACOLOGY, V51, P374, DOI 10.1016/j.neuropharm.2006.01.012; Stack EC, 2006, BBA-MOL BASIS DIS, V1762, P373, DOI 10.1016/j.bbadis.2005.11.002; Stack EC, 2007, EXPERT OPIN INV DRUG, V16, P1933, DOI 10.1517/13543784.16.12.1933; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Strick CA, 2010, NEUROPHARMACOLOGY, V58, P444, DOI 10.1016/j.neuropharm.2009.09.008; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Sugars KL, 2004, J BIOL CHEM, V279, P4988, DOI 10.1074/jbc.M310226200; Verhoest PR, 2009, J MED CHEM, V52, P7946, DOI 10.1021/jm9015334; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wyttenbach A, 2001, HUM MOL GENET, V10, P1829, DOI 10.1093/hmg/10.17.1829; Xie Z, 2006, NEUROSCIENCE, V139, P597, DOI 10.1016/j.neuroscience.2005.12.042; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581; Zuccato C, 2008, BRAIN PATHOL, V18, P225, DOI 10.1111/j.1750-3639.2007.00111.x; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	56	145	149	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13417	10.1371/journal.pone.0013417	http://dx.doi.org/10.1371/journal.pone.0013417			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976216	gold, Green Published, Green Submitted			2022-12-27	WOS:000283043700016
J	Kao, PF; Davis, DA; Banigan, MG; Vanderburg, CR; Seshadri, S; Delalle, I				Kao, Patricia F.; Davis, David A.; Banigan, Meredith G.; Vanderburg, Charles R.; Seshadri, Sudha; Delalle, Ivana			Modulators of Cytoskeletal Reorganization in CA1 Hippocampal Neurons Show Increased Expression in Patients at Mid-Stage Alzheimer's Disease	PLOS ONE			English	Article							BDNF MESSENGER-RNA; LONG-TERM-MEMORY; NEUROTROPHIC FACTOR; GROWTH CONES; HUMAN BRAIN; IN-VITRO; F-ACTIN; PROTEIN; TRKB; RAT	During the progression of Alzheimer's disease (AD), hippocampal neurons undergo cytoskeletal reorganization, resulting in degenerative as well as regenerative changes. As neurofibrillary tangles form and dystrophic neurites appear, sprouting neuronal processes with growth cones emerge. Actin and tubulin are indispensable for normal neurite development and regenerative responses to injury and neurodegenerative stimuli. We have previously shown that actin capping protein beta2 subunit, Capzb2, binds tubulin and, in the presence of tau, affects microtubule polymerization necessary for neurite outgrowth and normal growth cone morphology. Accordingly, Capzb2 silencing in hippocampal neurons resulted in short, dystrophic neurites, seen in neurodegenerative diseases including AD. Here we demonstrate the statistically significant increase in the Capzb2 expression in the postmortem hippocampi in persons at mid-stage, Braak and Braak stage (BB) III-IV, non-familial AD in comparison to controls. The dynamics of Capzb2 expression in progressive AD stages cannot be attributed to reactive astrocytosis. Moreover, the increased expression of Capzb2 mRNA in CA1 pyramidal neurons in AD BB III-IV is accompanied by an increased mRNA expression of brain derived neurotrophic factor (BDNF) receptor tyrosine kinase B (TrkB), mediator of synaptic plasticity in hippocampal neurons. Thus, the up-regulation of Capzb2 and TrkB may reflect cytoskeletal reorganization and/or regenerative response occurring in hippocampal CA1 neurons at a specific stage of AD progression.	[Kao, Patricia F.; Davis, David A.; Delalle, Ivana] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Banigan, Meredith G.; Vanderburg, Charles R.] Massachusetts Gen Hosp, Harvard NeuroDiscovery Ctr, Adv Tissue Res Ctr, Charlestown, MA USA; [Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	Boston University; Harvard University; Massachusetts General Hospital; Boston University	Kao, PF (corresponding author), Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA.	idelalle@bu.edu	Vanderburg, Charles/C-4516-2013	Vanderburg, Charles/0000-0001-8979-5054; Delalle, Ivana/0000-0002-1873-3064; Seshadri, Sudha/0000-0001-6135-2622	National Institutes of Health [T32 AG00015-21]; NATIONAL INSTITUTE ON AGING [Z01AG000015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Patricia Kao and David Davis were supported by the National Institutes of Health grant T32 AG00015-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Angelucci F, 2010, CURR ALZHEIMER RES, V7, P15, DOI 10.2174/156720510790274473; Arendt T, 1997, J NEUROSCI, V17, P516; Avwenagha O, 2003, J NEUROCYTOL, V32, P1077, DOI 10.1023/B:NEUR.0000021903.24849.6c; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Berchtold NC, 2010, NEUROSCIENCE, V167, P588, DOI 10.1016/j.neuroscience.2010.02.050; Braak H, 1997, NEUROBIOL AGING, V18, pS85, DOI 10.1016/S0197-4580(97)00062-6; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Croll SD, 1998, BRAIN RES, V812, P200, DOI 10.1016/S0006-8993(98)00993-7; Davis DA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000208; Duan WZ, 2001, J MOL NEUROSCI, V16, P1, DOI 10.1385/JMN:16:1:1; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; FUJIMURA RK, J ALZHEIMERS DIS, V19, P97; Goutan E, 1998, MOL BRAIN RES, V59, P154, DOI 10.1016/S0169-328X(98)00156-9; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Kitanishi T, 2010, GENES CELLS, V15, P737, DOI 10.1111/j.1365-2443.2010.01411.x; Knaepen K, 2010, SPORTS MED, V40, P765, DOI 10.2165/11534530-000000000-00000; Kuzumaki N, 2010, SYNAPSE, V64, P611, DOI 10.1002/syn.20768; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Laske C, 2006, J NEURAL TRANSM, V113, P1217, DOI 10.1007/s00702-005-0397-y; Li Y, 2007, PHARMACOGENOMICS, V8, P1747, DOI 10.2217/14622416.8.12.1747; Linnarsson S, 1997, EUR J NEUROSCI, V9, P2581, DOI 10.1111/j.1460-9568.1997.tb01687.x; Lu Y, 2008, NEUROBIOL LEARN MEM, V89, P312, DOI 10.1016/j.nlm.2007.08.018; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MCKEE AC, 1989, ANN NEUROL, V26, P652, DOI 10.1002/ana.410260511; McMurray CT, 2000, CELL DEATH DIFFER, V7, P861, DOI 10.1038/sj.cdd.4400764; Mejillano MR, 2004, CELL, V118, P363, DOI 10.1016/j.cell.2004.07.019; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; NATHAN BP, 1995, J BIOL CHEM, V270, P19791, DOI 10.1074/jbc.270.34.19791; Nelson TJ, 2004, HIPPOCAMPUS, V14, P46, DOI 10.1002/hipo.10152; NICHOLS NR, 1993, NEUROBIOL AGING, V14, P421, DOI 10.1016/0197-4580(93)90100-P; Pasinetti Giulio Maria, 2007, V35, P159; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poon WW, 2011, NEUROBIOL AGING, V32, P821, DOI 10.1016/j.neurobiolaging.2009.05.012; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Sabo SL, 2003, J NEUROSCI, V23, P5407; Schaaf MJM, 2001, BRAIN RES, V915, P227, DOI 10.1016/S0006-8993(01)02855-4; SCHAFER DA, 1994, J CELL BIOL, V127, P453, DOI 10.1083/jcb.127.2.453; Scheibel A B, 1979, Res Publ Assoc Res Nerv Ment Dis, V57, P107; Spira ME, 2003, J COMP NEUROL, V457, P293, DOI 10.1002/cne.10569; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Verghese J, 2003, NEW ENGL J MED, V348, P2508, DOI 10.1056/NEJMoa022252; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13337	10.1371/journal.pone.0013337	http://dx.doi.org/10.1371/journal.pone.0013337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967212	Green Published, gold			2022-12-27	WOS:000282869800032
J	Kil, DY; Boler, BMV; Apanavicius, CJ; Schook, LB; Swanson, KS				Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.			Age and Diet Affect Gene Expression Profiles in Canine Liver Tissue	PLOS ONE			English	Article							HIGH-FAT DIET; OXIDATIVE STRESS; ADIPOSE-TISSUE; NONALCOHOLIC STEATOHEPATITIS; CALORIC RESTRICTION; YOUNG-ADULT; PROTEIN; METABOLISM; CELLS; MICE	Background: The liver plays a central role in nutrient and xenobiotic metabolism, but its functionality declines with age. Senior dogs suffer from many of the chronic hepatic diseases as elderly humans, with age-related alterations in liver function influenced by diet. However, a large-scale molecular analysis of the liver tissue as affected by age and diet has not been reported in dogs. Methodology/Principal Findings: Liver tissue samples were collected from six senior (12-year old) and six young adult (1-year old) female beagles fed an animal protein-based diet (APB) or a plant protein-based diet (PPB) for 12 months. Total RNA in the liver tissue was extracted and hybridized to Affymetrix GeneChip (R) Canine Genome Arrays. Using a 2.0-fold cutoff and false discovery rate <0.10, our results indicated that expression of 234 genes was altered by age, while 137 genes were differentially expressed by diet. Based on functional classification, genes affected by age and/or diet were involved in cellular development, nutrient metabolism, and signal transduction. In general, gene expression suggested that senior dogs had an increased risk of the progression of liver disease and dysfunction, as observed in aged humans and rodents. In particular for aged liver, genes related to inflammation, oxidative stress, and glycolysis were up-regulated, whereas genes related to regeneration, xenobiotic metabolism, and cholesterol trafficking were down-regulated. Diet-associated changes in gene expression were more common in young adult dogs (33 genes) as compared to senior dogs (3 genes). Conclusion: Our results provide molecular insight pertaining to the aged canine liver and its predisposition to disease and abnormalities. Therefore, our data may aid in future research pertaining to age-associated alterations in hepatic function or identification of potential targets for nutritional management as a means to decrease incidence of age-dependent liver dysfunction.	[Kil, Dong Yong; Boler, Brittany M. Vester; Apanavicius, Carolyn J.; Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Schook, Lawrence B.; Swanson, Kelly S.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; Univ Illinois, Dept Vet Clin Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Kil, DY (corresponding author), Univ Illinois, Dept Anim Sci, 328 Mumford Hall, Urbana, IL 61801 USA.	ksswanso@illinois.edu		Schook, Lawrence/0000-0002-6580-8364; Swanson, Kelly/0000-0001-5518-3076	Pyxis Genomics, Inc., Chicago, IL; National Center for Supercomputing Applications (NCSA); University of Illinois; NCSA/UIUC Faculty	Pyxis Genomics, Inc., Chicago, IL; National Center for Supercomputing Applications (NCSA); University of Illinois; NCSA/UIUC Faculty	This research was supported by Pyxis Genomics, Inc., Chicago, IL, and the National Center for Supercomputing Applications (NCSA) and the University of Illinois, under the auspices of the NCSA/UIUC Faculty Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AAFCO, 2003, OFF PUBL AAFCO; Aliya S, 2003, MOL CELL BIOCHEM, V253, P319, DOI 10.1023/A:1026036521852; Angers M, 2008, BIOCHEM J, V416, P347, DOI 10.1042/BJ20080165; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergen WG, 2005, J NUTR, V135, P2499, DOI 10.1093/jn/135.11.2499; Bingle L, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-61; Birkner E, 2009, BIOL TRACE ELEM RES, V129, P137, DOI 10.1007/s12011-008-8306-5; Bouchard D, 2006, LANCET ONCOL, V7, P167, DOI 10.1016/S1470-2045(06)70579-4; Cao SX, 2001, P NATL ACAD SCI USA, V98, P10630, DOI 10.1073/pnas.191313598; Chang WC, 2005, CAN J PHYSIOL PHARM, V83, P423, DOI 10.1139/Y05-028; Chatila Khaled, 2007, Cardiovascular & Hematological Agents in Medicinal Chemistry, V5, P21; Comai S, 2005, CLIN CHIM ACTA, V360, P67, DOI 10.1016/j.cccn.2005.04.013; Costello LC, 2005, MOL CELL BIOCHEM, V280, P1, DOI 10.1007/s11010-005-8841-8; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; DANIELLO A, 1993, J BIOL CHEM, V268, P26941; Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014; Drake AJ, 2005, ENDOCRINOLOGY, V146, P913, DOI 10.1210/en.2004-1063; Elliott SP, 2003, INFECT IMMUN, V71, P6543, DOI 10.1128/IAI.71.11.6543-6552.2003; Endo Y, 2002, J NUTR, V132, P3632, DOI 10.1093/jn/132.12.3632; Flowers MI, 2009, BBA-MOL CELL BIOL L, V1791, P85, DOI 10.1016/j.bbalip.2008.12.011; Folmer V, 2003, J NUTR, V133, P2165, DOI 10.1093/jn/133.7.2165; Goto S, 2009, FREE RADICAL BIO MED, V46, P1392, DOI 10.1016/j.freeradbiomed.2009.02.025; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hijona E, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/837419; Hoensch H, 2006, CURR MED RES OPIN, V22, P1075, DOI 10.1185/030079906X112480; Hoskins JD, 2004, GERIATR GERONTOL INT, P189; Jin JL, 2009, MOL CELL BIOL, V29, P3867, DOI 10.1128/MCB.00456-09; Jones KL, 2004, MOL CELL ENDOCRINOL, V225, P119, DOI 10.1016/j.mce.2004.07.010; Karten B, 2009, BBA-MOL CELL BIOL L, V1791, P659, DOI 10.1016/j.bbalip.2009.01.025; Kuzmuk KN, 2005, J NUTR, V135, P1940, DOI 10.1093/jn/135.8.1940; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee SH, 2009, J IMMUNOL, V183, P7931, DOI 10.4049/jimmunol.0902012; LEPAGE G, 1986, J LIPID RES, V27, P114; Li Z, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-21; Maruo Y, 2005, CURR DRUG METAB, V6, P91, DOI 10.2174/1389200053586064; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Middelbos IS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004481; Morton NM, 2004, ENDOCRINOLOGY, V145, P2707, DOI 10.1210/en.2003-1674; Nakamura MT, 2004, ANNU REV NUTR, V24, P345, DOI 10.1146/annurev.nutr.24.121803.063211; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Priatel JJ, 2010, J IMMUNOL, V184, P666, DOI 10.4049/jimmunol.0803521; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Roberts CK, 2006, METABOLISM, V55, P928, DOI 10.1016/j.metabol.2006.02.022; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; SCHNEEMAN BO, 1993, J NUTR, V123, P1328, DOI 10.1093/jn/123.7.1328; Smith JV, 2004, CURR OPIN CLIN NUTR, V7, P615, DOI 10.1097/00075197-200411000-00005; Smyth GK, 2004, STAT APPL GENETICS M; SPINOLA M, 2002, MOL CANCER, V9, P62; Sumiyoshi M, 2010, BRIT J NUTR, V103, P378, DOI 10.1017/S0007114509991772; Swanson KS, 2008, J ANIM PHYSIOL AN N, V92, P246, DOI 10.1111/j.1439-0396.2007.00737.x; Swanson KS, 2009, NEUROBIOL AGING, V30, P1314, DOI 10.1016/j.neurobiolaging.2007.10.017; Swanson KS, 2009, ARCH ANIM NUTR, V63, P160, DOI 10.1080/17450390902733934; Swanson KS, 2004, J ANIM SCI, V82, P1713; Vester BM, 2009, BRIT J NUTR, V102, P1136, DOI 10.1017/S0007114509371652; Vilar L, 2008, NUTRITION, V24, P1097, DOI 10.1016/j.nut.2008.05.017; Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Zeeh J, 2002, GERONTOLOGY, V48, P121, DOI 10.1159/000052829; Zhang H, 2009, LIPIDS, V44, P643, DOI 10.1007/s11745-009-3313-7	60	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13319	10.1371/journal.pone.0013319	http://dx.doi.org/10.1371/journal.pone.0013319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967283	gold, Green Published, Green Submitted			2022-12-27	WOS:000282807300023
J	Saharay, M; Guo, H; Smith, JC				Saharay, Moumita; Guo, Hong; Smith, Jeremy C.			Catalytic Mechanism of Cellulose Degradation by a Cellobiohydrolase, CelS	PLOS ONE			English	Article							FREE-ENERGY LANDSCAPE; TRICHODERMA-REESEI; ACTIVE-SITE; MOLECULAR-DYNAMICS; GLYCOSYL HYDROLASES; CLOSTRIDIUM-CELLULOLYTICUM; ANGSTROM RESOLUTION; QM/MM SIMULATIONS; PROCESSIVE ACTION; CRYSTAL-STRUCTURE	The hydrolysis of cellulose is the bottleneck in cellulosic ethanol production. The cellobiohydrolase CelS from Clostridium thermocellum catalyzes the hydrolysis of cello-oligosaccharides via inversion of the anomeric carbon. Here, to examine key features of the CelS-catalyzed reaction, QM/MM (SCCDFTB/MM) simulations are performed. The calculated free energy profile for the reaction possesses a 19 kcal/mol barrier. The results confirm the role of active site residue Glu87 as the general acid catalyst in the cleavage reaction and show that Asp255 may act as the general base. A feasible position in the reactant state of the water molecule responsible for nucleophilic attack is identified. Sugar ring distortion as the reaction progresses is quantified. The results provide a computational approach that may complement the experimental design of more efficient enzymes for biofuel production.	[Saharay, Moumita; Guo, Hong; Smith, Jeremy C.] Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA; [Guo, Hong; Smith, Jeremy C.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Saharay, M (corresponding author), Univ Tennessee, Oak Ridge Natl Lab, Ctr Biophys Mol, Oak Ridge, TN USA.	smithjc@ornl.gov	saharay, moumita/K-7397-2012; smith, jeremy c/B-7287-2012	smith, jeremy c/0000-0002-2978-3227	BioEnergy Science Center (BESC); Office of Biological and Environmental Research in the DOE Office of Science; National Science Foundation	BioEnergy Science Center (BESC)(United States Department of Energy (DOE)); Office of Biological and Environmental Research in the DOE Office of Science(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF))	The authors acknowledge funding from the BioEnergy Science Center (BESC). BESC is a U. S. Department of Energy Bioenergy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. This research was supported in part by the National Science Foundation through TeraGrid (64) resources provided by NICS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Bayer EA, 1998, J STRUCT BIOL, V124, P221, DOI 10.1006/jsbi.1998.4065; BEGUIN P, 1994, FEMS MICROBIOL REV, V13, P25, DOI 10.1016/0168-6445(94)90099-X; Beguin P, 1996, CRIT REV BIOCHEM MOL, V31, P201, DOI 10.3109/10409239609106584; Biarnes X, 2006, J BIOL CHEM, V281, P1432, DOI 10.1074/jbc.M507643200; Biarnes X, 2007, J AM CHEM SOC, V129, P10686, DOI 10.1021/ja068411o; Bondar AN, 2004, STRUCTURE, V12, P1281, DOI 10.1016/j.str.2004.04.016; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROOKS CL, 1985, BIOPOLYMERS, V24, P843, DOI 10.1002/bip.360240509; Clarke A J, 1997, BIODEGRADATION CELLU; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; CREUZET N, 1983, FEMS MICROBIOL LETT, V20, P347, DOI 10.1111/j.1574-6968.1983.tb00145.x; Cui Q, 2001, J PHYS CHEM B, V105, P569, DOI 10.1021/jp0029109; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1998, BIOCHEMISTRY-US, V37, P11707, DOI 10.1021/bi981315i; Davies GJ, 2003, BIOCHEM SOC T, V31, P523, DOI 10.1042/BST0310523; Demain AL, 2005, MICROBIOL MOL BIOL R, V69, P124, DOI 10.1128/MMBR.69.1.124-154.2005; Elstner M, 2003, J MOL STRUC-THEOCHEM, V632, P29, DOI 10.1016/S0166-1280(03)00286-0; Ensing B, 2005, P NATL ACAD SCI USA, V102, P6755, DOI 10.1073/pnas.0408094102; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Formaneck M.S, 2002, J THEOR COMPUT CHEM, V1, P53, DOI [10.1142/s0219633602000075, DOI 10.1142/S0219633602000075]; Greig IR, 2007, CHEM COMMUN, P3747, DOI 10.1039/b705607a; Guerin DMA, 2002, J MOL BIOL, V316, P1061, DOI 10.1006/jmbi.2001.5404; Guimaraes BG, 2002, J MOL BIOL, V320, P587, DOI 10.1016/S0022-2836(02)00497-7; Guo H, 2001, P NATL ACAD SCI USA, V98, P9032, DOI 10.1073/pnas.141230998; Harjunpaa V, 1996, EUR J BIOCHEM, V240, P584, DOI 10.1111/j.1432-1033.1996.0584h.x; HARRIS EMS, 1993, BIOCHEMISTRY-US, V32, P1618, DOI 10.1021/bi00057a028; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Henrissat B, 1997, MOL MICROBIOL, V23, P848, DOI 10.1046/j.1365-2958.1997.2661629.x; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IRWIN DC, 1993, BIOTECHNOL BIOENG, V42, P1002, DOI 10.1002/bit.260420811; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Koivula A, 1996, PROTEIN ENG, V9, P691, DOI 10.1093/protein/9.8.691; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; Ly HD, 1999, ANNU REV BIOCHEM, V68, P487, DOI 10.1146/annurev.biochem.68.1.487; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Parsiegla G, 2000, BIOCHEMISTRY-US, V39, P11238, DOI 10.1021/bi001139p; Parsiegla G, 1998, EMBO J, V17, P5551, DOI 10.1093/emboj/17.19.5551; Parsiegla G, 2008, J MOL BIOL, V375, P499, DOI 10.1016/j.jmb.2007.10.039; Petersen L, 2009, J PHYS CHEM B, V113, P7331, DOI 10.1021/jp811470d; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Riccardi D, 2008, BIOCHEMISTRY-US, V47, P2369, DOI 10.1021/bi701950j; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sattelmeyer KW, 2006, J PHYS CHEM A, V110, P13551, DOI 10.1021/jp064544k; SCHINDLER M, 1977, BIOCHEMISTRY-US, V16, P423, DOI 10.1021/bi00622a013; Sheppard AN, 2009, J AM CHEM SOC, V131, P2530, DOI 10.1021/ja803879k; Shoham Y, 1999, TRENDS MICROBIOL, V7, P275, DOI 10.1016/S0966-842X(99)01533-4; SINGH UC, 1986, J COMPUT CHEM, V7, P718, DOI 10.1002/jcc.540070604; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; STRYNADKA NCJ, 1991, J MOL BIOL, V220, P401, DOI 10.1016/0022-2836(91)90021-W; SWOPE WC, 1982, J CHEM PHYS, V76, P637, DOI 10.1063/1.442716; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; Varrot A, 2003, STRUCTURE, V11, P855, DOI 10.1016/S0969-2126(03)00124-2; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; WARSHEL A, 1976, J MOL BIOL, V103, P227, DOI 10.1016/0022-2836(76)90311-9; Watson JN, 2003, BIOCHEMISTRY-US, V42, P12682, DOI 10.1021/bi035396g; Zhang YK, 2000, J CHEM PHYS, V112, P3483, DOI 10.1063/1.480503	65	27	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e12947	10.1371/journal.pone.0012947	http://dx.doi.org/10.1371/journal.pone.0012947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967294	Green Published, gold			2022-12-27	WOS:000282807300002
J	Helmerhorst, EJ; Zamakhchari, M; Schuppan, D; Oppenheim, FG				Helmerhorst, Eva J.; Zamakhchari, Maram; Schuppan, Detlef; Oppenheim, Frank G.			Discovery of a Novel and Rich Source of Gluten-Degrading Microbial Enzymes in the Oral Cavity	PLOS ONE			English	Article							CELIAC-DISEASE; PROLYL ENDOPEPTIDASES; GLIADIN PEPTIDES; SPRUE; TRANSGLUTAMINASE; IDENTIFICATION; DIVERSITY; PROTEASES; EPITOPES; THERAPY	Background: Celiac disease is a T cell mediated-inflammatory enteropathy caused by the ingestion of gluten in genetically predisposed individuals carrying HLA-DQ2 or HLA-DQ8. The immunogenic gliadin epitopes, containing multiple glutamine and proline residues, are largely resistant to degradation by gastric and intestinal proteases. Salivary microorganisms however exhibit glutamine endoprotease activity, discovered towards glutamine-and proline-rich salivary proteins. The aim was to explore if gliadins can serve as substrates for oral microbial enzymes. Methodology/Principal Findings: Proteolytic activity in suspended dental plaque was studied towards a) gliadin-derived paranitroanilide(pNA)-linked synthetic enzyme substrates b) a mixture of natural gliadins and c) synthetic highly immunogenic gliadin peptides (33-mer of alpha 2-gliadin and 26-mer of gamma-gliadin). In addition, gliadin zymography was conducted to obtain the approximate molecular weights and pH activity profiles of the gliadin-degrading oral enzymes and liquid iso-electric focusing was performed to establish overall enzyme iso-electric points. Plaque bacteria efficiently hydrolyzed Z-YPQ-pNA, Z-QQP-pNA, Z-PPF-pNA and Z-PFP-pNA, with Z-YPQ-pNA being most rapidly cleaved. Gliadin immunogenic domains were extensively degraded in the presence of oral bacteria. Gliadin zymography revealed that prominent enzymes exhibit molecular weights > 70 kD and are active over a broad pH range from 3 to 10. Liquid iso-electric focusing indicated that most gliadin-degrading enzymes are acidic in nature with iso-electric points between 2.5 and 4.0. Conclusions/Significance: This is the first reported evidence for gluten-degrading microorganisms associated with the upper gastro-intestinal tract. Such microorganisms may play a hitherto unappreciated role in the digestion of dietary gluten and thus protection from celiac disease in subjects at risk.	[Helmerhorst, Eva J.; Zamakhchari, Maram; Oppenheim, Frank G.] Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA; [Schuppan, Detlef] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Gastroenterol, Boston, MA 02215 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Helmerhorst, EJ (corresponding author), Boston Univ, Henry M Goldman Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA.	helmer@bu.edu		Helmerhorst, Eva/0000-0002-4803-3018	National Institutes of Health [AI087803, DE18132, DK073254, AI078385, DE05672, DE7652]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078385, R01AI087803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE007652] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE005672, R01DE005672, F31DE005672, R21DE018132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK073254] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health: AI087803 (EJH), DE18132 (EJH), DK073254 (DS), AI078385 (DS) DE05672 (FO) and DE7652 (FO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; ABE T, 1977, BIOCHEMISTRY-US, V16, P5495, DOI 10.1021/bi00644a016; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Biagi F, 2001, EUR J GASTROEN HEPAT, V13, P561, DOI 10.1097/00042737-200105000-00016; Camp JG, 2009, GASTROENTEROLOGY, V136, P1989, DOI 10.1053/j.gastro.2009.02.075; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; DeSesso JM, 2001, FOOD CHEM TOXICOL, V39, P209, DOI 10.1016/S0278-6915(00)00136-8; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Gass J, 2007, CELL MOL LIFE SCI, V64, P345, DOI 10.1007/s00018-006-6317-y; Gass J, 2007, GASTROENTEROLOGY, V133, P472, DOI 10.1053/j.gastro.2007.05.028; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Helmerhorst EJ, 2008, J BIOL CHEM, V283, P19957, DOI 10.1074/jbc.M708282200; Jabri B, 2006, NAT CLIN PRACT GASTR, V3, P516, DOI 10.1038/ncpgasthep0582; Koning F, 2005, BEST PRACT RES CL GA, V19, P373, DOI 10.1016/j.bpg.2005.02.003; Koning F, 2003, J MOL RECOGNIT, V16, P333, DOI 10.1002/jmr.641; Koning F, 2003, SCIENCE, V299, P513, DOI 10.1126/science.299.5606.513; LAMKIN MS, 1993, CRIT REV ORAL BIOL M, V4, P251, DOI 10.1177/10454411930040030101; MAEDA N, 1985, J BIOL CHEM, V260, P1123; Messana I, 2008, MOL CELL PROTEOMICS, V7, P911, DOI 10.1074/mcp.M700501-MCP200; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2004, BIOCHEM J, V383, P311, DOI 10.1042/BJ20040907; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Siegel M, 2006, CHEM BIOL, V13, P649, DOI 10.1016/j.chembiol.2006.04.009; Stenman SM, 2009, ANN MED, V41, P390, DOI 10.1080/07853890902878138; Stepniak D, 2006, AM J PHYSIOL-GASTR L, V291, pG621, DOI 10.1152/ajpgi.00034.2006; Sun XL, 2009, FASEB J, V23, P2691, DOI 10.1096/fj.09-131045; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Troncone R, 2008, CURR OPIN CLIN NUTR, V11, P329, DOI 10.1097/MCO.0b013e3282f795f8; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	35	65	68	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13264	10.1371/journal.pone.0013264	http://dx.doi.org/10.1371/journal.pone.0013264			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948997	Green Published, gold			2022-12-27	WOS:000282748100013
J	Pan, J; Zhang, Q; Wang, YA; You, M				Pan, Jing; Zhang, Qi; Wang, Yian; You, Ming			26S Proteasome Activity Is Down-Regulated in Lung Cancer Stem-Like Cells Propagated In Vitro	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; SIDE POPULATION CELLS; BETA-CATENIN; PROSPECTIVE IDENTIFICATION; VIVO; DIFFERENTIATION; TUMORS; EXPRESSION; RESISTANCE; PHENOTYPE	Cancer stem cells (CSCs) are a small subset of cancer cells capable of self-renewal and tumor maintenance. Eradicating cancer stem cells, the root of tumor origin and recurrence, has emerged as one promising approach to improve lung cancer survival. Cancer stem cells are reported to reside in the side population (SP) of cultured lung cancer cells. We report here the coexistence of a distinct population of non-SP (NSP) cells that have equivalent self-renewal capacity compared to SP cells in a lung tumor sphere assay. Compared with the corresponding cells in monolayer cultures, lung tumor spheres, formed from human non-small cell lung carcinoma cell lines A549 or H1299, showed marked morphologic differences and increased expression of the stem cell markers CD133 and OCT3/4. Lung tumor spheres also exhibited increased tumorigenic potential as only 10,000 lung tumor sphere cells were required to produce xenografts tumors in nude mice, whereas the same number of monolayer cells failed to induce tumors. We also demonstrate that lung tumor spheres showed decreased 26S proteasome activity compared to monolayer. By using the ZsGreen-cODC (C-terminal sequence that directs degradation of Ornithine Decarboxylase) reporter assay in NSCLC cell lines, only less than 1% monolayer cultures were ZsGreen positive indicating low 26S proteasome, whereas lung tumor sphere showed increased numbers of ZsGreen-positive cells, suggesting the enrichment of CSCs in sphere cultures.	[Pan, Jing; Zhang, Qi; Wang, Yian; You, Ming] Washington Univ, Sch Med, Dept Surg, Siteman Canc Ctr, St Louis, MO 63110 USA	Siteman Cancer Center; Washington University (WUSTL)	Pan, J (corresponding author), Washington Univ, Sch Med, Dept Surg, Siteman Canc Ctr, St Louis, MO 63110 USA.	youm@wudosis.wustl.edu			NIH [R01CA134682]; NATIONAL CANCER INSTITUTE [R01CA134682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by NIH grant R01CA134682. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Eaker Shannon S, 2004, Methods Mol Biol, V263, P161; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Fekete MR, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-114; Ferrandina G, 2008, INT J GYNECOL CANCER, V18, P506, DOI 10.1111/j.1525-1438.2007.01056.x; Gebb SA, 2000, DEV DYNAM, V217, P159, DOI 10.1002/(SICI)1097-0177(200002)217:2<159::AID-DVDY3>3.0.CO;2-9; Glas R, 1998, NATURE, V392, P618, DOI 10.1038/33443; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hosford GE, 2003, AM J PHYSIOL-LUNG C, V285, pL161, DOI 10.1152/ajplung.00285.2002; Kane RC, 2003, ONCOLOGIST, V8, P508, DOI 10.1634/theoncologist.8-6-508; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kraft HJ, 1996, J BIOL CHEM, V271, P12873, DOI 10.1074/jbc.271.22.12873; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Mahller YY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004235; Morita Y, 2006, BLOOD, V108, P2850, DOI 10.1182/blood-2006-03-010207; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Platet N, 2007, FEBS LETT, V581, P1435, DOI 10.1016/j.febslet.2007.02.071; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prasad A, 2008, J BIOL CHEM, V283, P26624, DOI 10.1074/jbc.M800679200; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Semba S, 2000, ENDOCR PATHOL, V11, P243, DOI 10.1385/EP:11:3:243; Singh SK, 2003, CANCER RES, V63, P5821; Srivastava VK, 2008, CYTOM PART A, V73A, P940, DOI 10.1002/cyto.a.20633; Tilignac T, 2002, CANCER RES, V62, P2771; Vlashi E, 2009, JNCI-J NATL CANCER I, V101, P350, DOI 10.1093/jnci/djn509; White MJ, 1996, J NEUROSCI METH, V70, P195, DOI 10.1016/S0165-0270(96)00118-5; Zhou S, 2002, P NATL ACAD SCI USA, V99, P12339, DOI 10.1073/pnas.192276999	39	54	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13298	10.1371/journal.pone.0013298	http://dx.doi.org/10.1371/journal.pone.0013298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949018	Green Published, Green Submitted, gold			2022-12-27	WOS:000282748100024
J	Dessing, JC; Craig, CM				Dessing, Joost C.; Craig, Cathy M.			Bending It Like Beckham: How to Visually Fool the Goalkeeper	PLOS ONE			English	Article							TARGET MOTION; MANUAL INTERCEPTIONS; ARM MOVEMENTS; AREA MT; ACCELERATION; MODEL; SPEED; BALL; PERCEPTION; OCCLUSION	Background: As bending free-kicks becomes the norm in modern day soccer, implications for goalkeepers have largely been ignored. Although it has been reported that poor sensitivity to visual acceleration makes it harder for expert goalkeepers to perceptually judge where the curved free-kicks will cross the goal line, it is unknown how this affects the goalkeeper's actual movements. Methodology/Principal Findings: Here, an in-depth analysis of goalkeepers' hand movements in immersive, interactive virtual reality shows that they do not fully account for spin-induced lateral ball acceleration. Hand movements were found to be biased in the direction of initial ball heading, and for curved free-kicks this resulted in biases in a direction opposite to those necessary to save the free-kick. These movement errors result in less time to cover a now greater distance to stop the ball entering the goal. These and other details of the interceptive behaviour are explained using a simple mathematical model which shows how the goalkeeper controls his movements online with respect to the ball's current heading direction. Furthermore our results and model suggest how visual landmarks, such as the goalposts in this instance, may constrain the extent of the movement biases. Conclusions: While it has previously been shown that humans can internalize the effects of gravitational acceleration, these results show that it is much more difficult for goalkeepers to account for spin-induced visual acceleration, which varies from situation to situation. The limited sensitivity of the human visual system for detecting acceleration, suggests that curved free-kicks are an important goal-scoring opportunity in the game of soccer.	[Dessing, Joost C.] York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada; [Dessing, Joost C.] Vrije Univ Amsterdam, Res Inst MOVE, Fac Human Movement Sci, Amsterdam, Netherlands; [Dessing, Joost C.] York Univ, Canadian Act & Percept Network CAPnet, Toronto, ON M3J 2R7, Canada; [Craig, Cathy M.] Queens Univ Belfast, Sch Psychol, Belfast BT7 1NN, Antrim, North Ireland	York University - Canada; Vrije Universiteit Amsterdam; York University - Canada; Queens University Belfast	Dessing, JC (corresponding author), York Univ, Ctr Vis Res, Toronto, ON M3J 2R7, Canada.	joost@yorku.ca	Craig, Cathy/D-9833-2014	Craig, Cathy/0000-0001-5509-1120	Netherlands Organization for Scientific Research (NWO) [451-05-016]; Starting Independent Researchers [210007-TEMPUS_G]; European Research Council	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Starting Independent Researchers; European Research Council(European Research Council (ERC)European Commission)	Research supported by grant 451-05-016 (Veni) of the Netherlands Organization for Scientific Research (NWO; http://www.nwo.nl), awarded to Joost C. Dessing, and a Starting Independent Researchers grant 210007-TEMPUS_G awarded to Cathy M. Craig by the European Research Council (http://erc.europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABLER TG, 1993, J EXP PSYCHOL HUMAN, V19, P15, DOI 10.1037/0096-1523.19.1.15; Bennett SJ, 2007, J NEUROPHYSIOL, V98, P1405, DOI 10.1152/jn.00132.2007; Bray Y, 2003, J SPORT SCI, V21, P75, DOI 10.1080/0264041031000070994; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Bullock D, 1998, CEREB CORTEX, V8, P48, DOI 10.1093/cercor/8.1.48; BULLOCK D, 1988, PSYCHOL REV, V95, P49, DOI 10.1037/0033-295X.95.1.49; Craig CM, 2009, ATTEN PERCEPT PSYCHO, V71, P515, DOI 10.3758/APP.71.3.515; Craig CM, 2006, NATURWISSENSCHAFTEN, V93, P97, DOI 10.1007/s00114-005-0071-0; Dessing JC, 2005, J COGNITIVE NEUROSCI, V17, P668, DOI 10.1162/0898929053467604; Dessing JC, 2004, BIOL CYBERN, V91, P377, DOI 10.1007/s00422-004-0520-4; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; GOTTSDANKER RM, 1956, PSYCHOL BULL, V53, P477, DOI 10.1037/h0045160; Lisberger SG, 1999, J NEUROSCI, V19, P2224; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MCBEATH MK, 1990, PERCEPTION, V19, P545, DOI 10.1068/p190545; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Mrotek LA, 2007, EXP BRAIN RES, V178, P99, DOI 10.1007/s00221-006-0717-y; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Price NSC, 2005, J NEUROPHYSIOL, V94, P3451, DOI 10.1152/jn.00564.2005; ROSENBAUM DA, 1975, J EXP PSYCHOL HUMAN, V1, P395, DOI 10.1037/0096-1523.1.4.395; Savelsbergh GJP, 2002, J SPORT SCI, V20, P279, DOI 10.1080/026404102317284826; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; Schlack A, 2007, J NEUROSCI, V27, P11009, DOI 10.1523/JNEUROSCI.3165-07.2007; SCHMERLER J, 1976, PERCEPTION, V5, P167, DOI 10.1068/p050167; SMITH J, 2010, 11 INT WORKSH EC PSY; Tarr MJ, 2002, NAT NEUROSCI, V5, P1089, DOI 10.1038/nn948; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003	30	50	50	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13161	10.1371/journal.pone.0013161	http://dx.doi.org/10.1371/journal.pone.0013161			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	659LQ	20949130	gold, Green Published, Green Submitted			2022-12-27	WOS:000282568400006
J	Mee, JA; Rowe, L				Mee, Jonathan A.; Rowe, Locke			Distribution of Phoxinus eos, Phoxinus neogaeus, and Their Asexually-Reproducing Hybrids (Pisces: Cyprinidae) in Algonquin Provincial Park, Ontario	PLOS ONE			English	Article							NORTHERN REDBELLY DACE; FINESCALE DACE; MORPHOLOGY; AGREEMENT; FISH	Hybrid Phoxinus are one of the few asexually reproducing vertebrates species. The distribution of hybrid Phoxinus among lakes in Algonquin Park, Ontario, was evaluated relative to the distribution of parental species and relative to physiochemical lake characteristics. No association between the distribution of hybrids and the distribution of parental species was found, suggesting that the hybrids can successfully coexist with either parental species. In addition, we found no association between hybrid distribution and the physiochemical characteristics of lakes, suggesting that the hybrids are generalists with respect to the ecological niches available in Algonquin Park. There was a difference between the physiochemical characteristics of lakes with and without the parental species P. neogaeus. The lakes containing P. neogaeus were lower elevation than the lakes containing the other parental species, P. eos. The difference in distribution between the parental species may therefore be due to different dispersal abilities, to later arrival following post-glacial dispersal, or to differences in ecology. These results suggest that asexual reproduction is a successful strategy for hybrid Phoxinus in Algonquin Park because these sperm-dependent asexual hybrids are able to survive and persist regardless of which parental species is present, and regardless of the physiochemical characteristics of their habitat.	[Mee, Jonathan A.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of British Columbia; University of Toronto	Mee, JA (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	mee@zoology.ubc.ca		Mee, Jonathan/0000-0003-0688-1390	National Science and Engineering Research Council of Canada [A - 266071 - 2003]	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by the National Science and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) - Postgraduate Scholarship A - 266071 - 2003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2006, CURR BIOL, V16, pR696, DOI 10.1016/j.cub.2006.07.063; Angers B, 2007, MOL ECOL, V16, P4562, DOI 10.1111/j.1365-294X.2007.03511.x; Avise J., 2008, CLONALITY GENETICS E; Bell G, 1982, MASTERPIECE NATURE E; Binet MC, 2005, J FISH BIOL, V67, P1169, DOI 10.1111/j.1095-8649.2005.00802.x; COCHRAN PA, 1988, ENVIRON BIOL FISH, V22, P235, DOI 10.1007/BF00005384; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darwin CH., 1962, J P LINNEAN SOC BOT, V6, P77; Dawley R. M, 1989, EVOLUTION ECOLOGY UN; DAWLEY RM, 1987, COPEIA, P275, DOI 10.2307/1445762; Doeringsfeld MR, 2004, EVOLUTION, V58, P1261; ELDER JF, 1995, P NATL ACAD SCI USA, V92, P5001, DOI 10.1073/pnas.92.11.5001; FELSENSTEIN J, 1974, GENETICS, V78, P737; Goddard K. A., 1989, EVOLUTION ECOLOGY UN, P269; Goddard KA, 1998, J HERED, V89, P151, DOI 10.1093/jhered/89.2.151; Massicotte R, 2008, CAN J FISH AQUAT SCI, V65, P2016, DOI 10.1139/F08-114; Mee JA, 2006, CAN J ZOOL, V84, P808, DOI 10.1139/Z06-064; MEE JA, 2010, EVOLUTION IN PRESS; NEW JG, 1962, COPEIA, P147; PHILLIPS GL, 1969, COPEIA, P501; Quinlan R, 2003, FRESHWATER BIOL, V48, P1676, DOI 10.1046/j.1365-2427.2003.01105.x; Schlosser IJ, 1998, ECOLOGY, V79, P953, DOI 10.1890/0012-9658(1998)079[0953:NROCAS]2.0.CO;2; Schlupp I, 2005, ANNU REV ECOL EVOL S, V36, P399, DOI 10.1146/annurev.ecolsys.36.102003.152629; SMITH JM, 1971, J THEOR BIOL, V30, P319, DOI 10.1016/0022-5193(71)90058-0; STASIAK RH, 1977, COPEIA, P771; TITUS K, 1984, AM MIDL NAT, V111, P1, DOI 10.2307/2425535; WILLIAMS GC, 1973, J THEOR BIOL, V39, P545, DOI 10.1016/0022-5193(73)90067-2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	29	2	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13185	10.1371/journal.pone.0013185	http://dx.doi.org/10.1371/journal.pone.0013185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957232	Green Submitted, Green Published, gold			2022-12-27	WOS:000282423300017
J	Wilkie, KTR; Mertl, AL; Traniello, JFA				Wilkie, Kari T. Ryder; Mertl, Amy L.; Traniello, James F. A.			Species Diversity and Distribution Patterns of the Ants of Amazonian Ecuador	PLOS ONE			English	Article							TROPICAL RAIN-FOREST; VERTICAL STRATIFICATION; ELEVATIONAL GRADIENT; FUNCTIONAL-GROUPS; WORLD ANTS; HYMENOPTERA; BIODIVERSITY; COMMUNITIES; FORMICIDAE; ASSEMBLAGES	Ants are among the most diverse, abundant and ecologically significant organisms on earth. Although their species richness appears to be greatest in the New World tropics, global patterns of ant diversity and distribution are not well understood. We comprehensively surveyed ant diversity in a lowland primary rainforest in Western Amazonia, Ecuador using canopy fogging, pitfall traps, baits, hand collecting, mini-Winkler devices and subterranean probes to sample ants. A total of 489 ant species comprising 64 genera in nine subfamilies were identified from samples collected in only 0.16 square kilometers. The most species-rich genera were Camponotus, Pheidole, Pseudomyrmex, Pachycondyla, Brachymyrmex, and Crematogaster. Camponotus and Pseudomyrmex were most diverse in the canopy, while Pheidole was most diverse on the ground. The three most abundant ground-dwelling ant genera were Pheidole, Solenopsis and Pyramica. Crematogaster carinata was the most abundant ant species in the canopy; Wasmannia auropunctata was most abundant on the ground, and the army ant Labidus coecus was the most abundant subterranean species. Ant species composition among strata was significantly different: 80% of species were found in only one stratum, 17% in two strata, and 3% in all three strata. Elevation and the number of logs and twigs available as nest sites were significant predictors of ground-dwelling ant species richness. Canopy species richness was not correlated with any ecological variable measured. Subterranean species richness was negatively correlated with depth in the soil. When ant species were categorized using a functional group matrix based on diet, nest-site preference and foraging ecology, the greatest diversity was found in Omnivorous Canopy Nesters. Our study indicates ant species richness is exceptionally high at Tiputini. We project 647-736 ant species in this global hotspot of biodiversity. Considering the relatively small area surveyed, this region of western Amazonia appears to support the most diverse ant fauna yet recorded.	[Wilkie, Kari T. Ryder; Mertl, Amy L.; Traniello, James F. A.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Wilkie, KTR (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	kryderwilkie@gmail.com			NSF [IOB 0725013]	NSF(National Science Foundation (NSF))	This research was partially supported by NSF Grant IOB 0725013 to J. Traniello and W. Gronenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti D, 2000, BIOL DIVERSITY HDB S; ALONSO L, 2001, URUBAMBA BIODIVERSIT; Andersen A.N., 2000, GLOBAL ECOLOGY RAINF, P25; Andersen AN, 1997, J BIOGEOGR, V24, P433, DOI 10.1111/j.1365-2699.1997.00137.x; ANDERSEN AN, 1995, J BIOGEOGR, V22, P15, DOI 10.2307/2846070; Armbrecht I, 2004, SCIENCE, V304, P284, DOI 10.1126/science.1094981; Bass MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008767; Basset Y, 2003, ARTHROPODS OF TROPICAL FORESTS, P17; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Bernard E, 2001, J TROP ECOL, V17, P115, DOI 10.1017/S0266467401001079; BRANDAO C R F, 1990, Arquivos de Zoologia (Sao Paulo), V31, P411; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; BROWN W L JR, 1978, Studia Entomologica, V20, P549; BROWN W L JR, 1976, Studia Entomologica, V19, P67; BROWN WILLIAM L., 1958, BULL MUS COMP ZOOL HARVARD UNIV, V118, P173; Bruhl CA, 1998, J TROP ECOL, V14, P285, DOI 10.1017/S0266467498000224; Bruhl CA, 1999, J TROP ECOL, V15, P265, DOI 10.1017/S0266467499000802; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Colwell RK, 2013, ESTIMATES STAT ESTIM; Davidson DW, 1997, BIOL J LINN SOC, V61, P153, DOI 10.1006/bijl.1996.0128; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DAVIDSON DW, 1988, ECOLOGY, V69, P1138, DOI 10.2307/1941268; DELABIE JHC, 1995, PEDOBIOLOGIA, V39, P423; DINIZ J L M, 1990, Revista Brasileira de Entomologia, V34, P277; Erwin Terry L., 2005, Proceedings of the California Academy of Sciences, V56, P72; Fernandez F, 2003, SOCIOBIOLOGY, V41, P633; Fernandez F, 2006, REV COLOMB ENTOMOL, V32, P97; Fisher BL, 1999, FIELD ZOOL, P129; Fisher BL, 1999, ECOL APPL, V9, P714, DOI 10.1890/1051-0761(1999)009[0714:IIEACS]2.0.CO;2; Fisher Brian L., 1996, Fieldiana Zoology, V85, P93; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Floren A, 2000, OECOLOGIA, V123, P129, DOI 10.1007/s004420050998; Floren A, 2002, OECOLOGIA, V131, P137, DOI 10.1007/s00442-002-0874-z; Fowler Harold G., 2000, Tropical Ecology, V41, P73; GUNADI B, 1993, EUR J SOIL BIOL, V29, P133; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hoffmann BD, 2003, AUSTRAL ECOL, V28, P444, DOI 10.1046/j.1442-9993.2003.01301.x; Hortal J, 2006, J ANIM ECOL, V75, P274, DOI 10.1111/j.1365-2656.2006.01048.x; Kaspari M, 2000, P ROY SOC B-BIOL SCI, V267, P485, DOI 10.1098/rspb.2000.1026; KEMPF W W, 1973, Studia Entomologica, V16, P225; KUGLER C, 1982, SEARCH AGR ITHACA, V24, P1; KUSNEZOV N, 1957, EVOLUTION, V11, P298, DOI 10.1111/j.1558-5646.1957.tb02898.x; Lattke John E., 1995, Journal of Hymenoptera Research, V4, P137; LEVEY DJ, 1993, ECOLOGY, V74, P1802, DOI 10.2307/1939938; LONGINO J T, 1990, Psyche (Cambridge), V97, P81, DOI 10.1155/1990/36505; Longino John T., 2003, Zootaxa, V151, P1; Longino JT, 2002, ECOLOGY, V83, P689, DOI 10.1890/0012-9658(2002)083[0689:TAFOAT]2.0.CO;2; MACKAY WP, 1989, SOCIOBIOLOGY, V16, P3; MACKAY WP, 1993, SOCIOBIOLOGY, V22, P1; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MAJER JD, 1994, BIOTROPICA, V26, P73, DOI 10.2307/2389112; Majer JD, 1996, J TROP ECOL, V12, P257, DOI 10.1017/S0266467400009445; MAJER JD, 1994, INSECT SOC, V41, P343, DOI 10.1007/BF01240639; Melo A. S., 2004, Community Ecology, V5, P149, DOI 10.1556/ComEc.5.2004.2.1; Mertl AL, 2010, INSECT SOC, V57, P441, DOI 10.1007/s00040-010-0102-5; Mertl AL, 2009, BIOTROPICA, V41, P633, DOI 10.1111/j.1744-7429.2009.00520.x; Mittermeier RA, 2000, NATURE, V405, p254B; Orivel J, 1997, BEHAV ECOL SOCIOBIOL, V40, P87, DOI 10.1007/s002650050319; PEARSON DL, 1971, CONDOR, V73, P46, DOI 10.2307/1366123; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; RISCH S, 1977, AM MIDLAND NATURALIS, V98; ROCKWOOD LL, 1979, BIOTROPICA, V11, P1, DOI 10.2307/2388163; Rodgers DJ, 1998, ECOGRAPHY, V21, P392, DOI 10.1111/j.1600-0587.1998.tb00404.x; Roisin Y, 2006, OECOLOGIA, V149, P301, DOI 10.1007/s00442-006-0449-5; Russell JA, 2009, P NATL ACAD SCI USA, V106, P21236, DOI 10.1073/pnas.0907926106; Sabu TK, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.0101; Samson DA, 1997, BIOTROPICA, V29, P349, DOI 10.1111/j.1744-7429.1997.tb00436.x; Silva RR, 2007, FOREST ECOL MANAG, V240, P61, DOI 10.1016/j.foreco.2006.12.002; SMITH AP, 1973, AM NAT, V107, P671, DOI 10.1086/282866; Tobin JE, 1997, J NEW YORK ENTOMOL S, V105, P105; TOBIN JE, 1995, ECOLOGY DIVERSITY NE; Vantaux A, 2007, INSECT SOC, V54, P95, DOI 10.1007/s00040-007-0914-0; Vasconcelos HL, 2006, BIOTROPICA, V38, P100, DOI 10.1111/j.1744-7429.2006.00113.x; Vasconcelos HL, 2000, J APPL ECOL, V37, P508, DOI 10.1046/j.1365-2664.2000.00512.x; Verhaagh M., 1990, P217; Vieira EM, 2003, J TROP ECOL, V19, P501, DOI 10.1017/S0266467403003559; WATKINS JF, 1985, J KANSAS ENTOMOL SOC, V58, P479; WERNEGREEN J, 2009, ONE NUTR SYMBIOSIS B; Wilkie KTR, 2007, NATURWISSENSCHAFTEN, V94, P725, DOI 10.1007/s00114-007-0250-2; Wilkie KTR, 2009, MYRMECOL NEWS, V12, P139; WILSON E O, 1976, Studia Entomologica, V19, P187; Wilson E.O., 2003, PHEIDOLE NEW WORLD D, V1; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	85	78	82	4	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13146	10.1371/journal.pone.0013146	http://dx.doi.org/10.1371/journal.pone.0013146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957208	gold, Green Published			2022-12-27	WOS:000282359300030
J	Munch, D; Baker, N; Kreibich, CD; Braten, AT; Amdam, GV				Munch, Daniel; Baker, Nicholas; Kreibich, Claus D.; Braten, Anders T.; Amdam, Gro V.			In the Laboratory and during Free-Flight: Old Honey Bees Reveal Learning and Extinction Deficits that Mirror Mammalian Functional Decline	PLOS ONE			English	Article							PROBOSCIS-EXTENSION RESPONSE; APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SPONTANEOUS-RECOVERY; SPATIAL MEMORY; WATER MAZE; LIFE-SPAN; NESTMATE RECOGNITION; SOCIAL-ROLE; ACQUISITION	Loss of brain function is one of the most negative and feared aspects of aging. Studies of invertebrates have taught us much about the physiology of aging and how this progression may be slowed. Yet, how aging affects complex brain functions, e.g., the ability to acquire new memory when previous experience is no longer valid, is an almost exclusive question of studies in humans and mammalian models. In these systems, age related cognitive disorders are assessed through composite paradigms that test different performance tasks in the same individual. Such studies could demonstrate that afflicted individuals show the loss of several and often-diverse memory faculties, and that performance usually varies more between aged individuals, as compared to conspecifics from younger groups. No comparable composite surveying approaches are established yet for invertebrate models in aging research. Here we test whether an insect can share patterns of decline similar to those that are commonly observed during mammalian brain aging. Using honey bees, we combine restrained learning with free-flight assays. We demonstrate that reduced olfactory learning performance correlates with a reduced ability to extinguish the spatial memory of an abandoned nest location ( spatial memory extinction). Adding to this, we show that learning performance is more variable in old honey bees. Taken together, our findings point to generic features of brain aging and provide the prerequisites to model individual aspects of learning dysfunction with insect models.	[Munch, Daniel; Kreibich, Claus D.; Braten, Anders T.; Amdam, Gro V.] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway; [Baker, Nicholas; Amdam, Gro V.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Norwegian University of Life Sciences; Arizona State University; Arizona State University-Tempe	Munch, D (corresponding author), Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, As, Norway.	daniel.munch@umb.no			Research Council of Norway [175413, 180504, 185306, 191699]; U.S. National Science Foundation [0615502]; PEW Foundation	Research Council of Norway(Research Council of Norway); U.S. National Science Foundation(National Science Foundation (NSF)); PEW Foundation	G.V.A. was supported by the Research Council of Norway (# 175413, 180504, 185306 and 191699; http://www.forskningsradet.no), the U.S. National Science Foundation (# 0615502; http://www.nsf.gov), and the PEW Foundation (http://www.pewtrusts.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009740; Amdam GV, 2005, EXP GERONTOL, V40, P939, DOI 10.1016/j.exger.2005.08.004; Behrends A, 2007, EXP GERONTOL, V42, P1146, DOI 10.1016/j.exger.2007.09.003; Bevilaqua Lia R. M., 2008, Neural Plasticity, V2008, P1, DOI 10.1155/2008/595282; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BREED MD, 1992, J CHEM ECOL, V18, P1633, DOI 10.1007/BF00993235; Breed MD, 1998, ANIM BEHAV, V55, P13, DOI 10.1006/anbe.1997.0581; BRIGUI N, 1990, J COMP PSYCHOL, V104, P289, DOI 10.1037/0735-7036.104.3.289; Broughton S, 2009, BIOCHEM J, V418, P1, DOI 10.1042/BJ20082102; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Downs SG, 1999, ANIM BEHAV, V58, P643, DOI 10.1006/anbe.1999.1177; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; EBADI R, 1980, ENVIRON ENTOMOL, V9, P144, DOI 10.1093/ee/9.1.144; Fresquet N, 1999, PHYSIOL BEHAV, V67, P205, DOI 10.1016/S0031-9384(99)00058-X; Giurfa M, 2007, J COMP PHYSIOL A, V193, P801, DOI 10.1007/s00359-007-0235-9; Grotewiel MS, 2005, AGEING RES REV, V4, P372, DOI 10.1016/j.arr.2005.04.001; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Herndon LA, 2002, NATURE, V419, P808, DOI 10.1038/nature01135; Huston JP, 2009, J NEURAL TRANSM, V116, P1029, DOI 10.1007/s00702-009-0210-4; Iliadi KG, 2009, EXP GERONTOL, V44, P546, DOI 10.1016/j.exger.2009.05.008; Kirkwood TBL, 2005, MECH AGEING DEV, V126, P439, DOI 10.1016/j.mad.2004.09.008; Lattal KM, 2003, BEHAV NEUROSCI, V117, P1017, DOI 10.1037/0735-7044.117.5.1017; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Menzel R, 2005, P NATL ACAD SCI USA, V102, P3040, DOI 10.1073/pnas.0408550102; Menzel R, 2001, LEARN MEMORY, V8, P198, DOI 10.1101/lm.40001; Menzel Randolf, 2006, Behav Cogn Neurosci Rev, V5, P24, DOI 10.1177/1534582306289522; Mery F, 2007, EXP GERONTOL, V42, P99, DOI 10.1016/j.exger.2006.06.004; Munch D, 2010, FEBS LETT, V584, P2496, DOI 10.1016/j.febslet.2010.04.007; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Pankiw T, 2003, J COMP PHYSIOL A, V189, P675, DOI 10.1007/s00359-003-0442-y; Pavlov I.P., 1927, CONDITIONED REFLEXES; Piper MDW, 2005, EXP GERONTOL, V40, P857, DOI 10.1016/j.exger.2005.06.013; RAPP PR, 1992, TRENDS NEUROSCI, V15, P340, DOI 10.1016/0166-2236(92)90051-9; ROBINSON GE, 1993, ANIM BEHAV, V46, P311, DOI 10.1006/anbe.1993.1192; Rueppell O, 2007, CURR BIOL, V17, pR274, DOI 10.1016/j.cub.2007.02.015; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Sandoz JC, 2004, LEARN MEMORY, V11, P586, DOI 10.1101/lm.81504; Scheiner R, 2005, LEARN MEMORY, V12, P626, DOI 10.1101/lm.98105; Scheiner R, 2009, J EXP BIOL, V212, P994, DOI 10.1242/jeb.021188; SCHMIDT JO, 1994, J CHEM ECOL, V20; Schubert M, 2002, ANIM BEHAV, V64, P175, DOI 10.1006/anbe.2002.3055; Schulz D, 2007, NEUROBIOL LEARN MEM, V87, P309, DOI 10.1016/j.nlm.2006.09.006; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Stollhoff N, 2005, J NEUROSCI, V25, P4485, DOI 10.1523/JNEUROSCI.0117-05.2005; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Wolschin F, 2009, J EXP BIOL, V212, P4027, DOI 10.1242/jeb.033845; Ylikoski R, 1999, EUR J NEUROL, V6, P645, DOI 10.1046/j.1468-1331.1999.660645.x; Zhang SW, 2006, J EXP BIOL, V209, P4420, DOI 10.1242/jeb.02522; Zhang SW, 2005, P NATL ACAD SCI USA, V102, P5250, DOI 10.1073/pnas.0501440102	54	13	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13504	10.1371/journal.pone.0013504	http://dx.doi.org/10.1371/journal.pone.0013504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976061	Green Published, gold, Green Submitted			2022-12-27	WOS:000283114700023
J	Zavizion, B; Zhao, ZH; Nittayajarn, A; Rieder, RJ				Zavizion, Boris; Zhao, Zhihui; Nittayajarn, Aphakorn; Rieder, Ronald J.			Rapid Microbiological Testing: Monitoring the Development of Bacterial Stress	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; RESPONSES	The ability to respond to adverse environments effectively along with the ability to reproduce are sine qua non conditions for all sustainable cellular forms of life. Given the availability of an appropriate sensing modality, the ubiquity and immediacy of the stress response could form the basis for a new approach for rapid biological testing. We have found that measuring the dielectric permittivity of a cellular suspension, an easily measurable electronic property, is an effective way to monitor the response of bacterial cells to adverse conditions continuously. The dielectric permittivity of susceptible and resistant strains of Escherichia coli and Staphylococcus aureus, treated with gentamicin and vancomycin, were measured directly using differential impedance sensing methods and expressed as the Normalized Impedance Response (NIR). These same strains were also heat-shocked and chemically stressed with Triton X-100 or H2O2. The NIR profiles obtained for antibiotic-treated susceptible organisms showed a strong and continuous decrease in value. In addition, the intensity of the NIR value decrease for susceptible cells varied in proportion to the amount of antibiotic added. Qualitatively similar profiles were found for the chemically treated and heat-shocked bacteria. In contrast, antibiotic-resistant cells showed no change in the NIR values in the presence of the drug to which it is resistant. The data presented here show that changes in the dielectric permittivity of a cell suspension are directly correlated with the development of a stress response as well as bacterial recovery from stressful conditions. The availability of a practical sensing modality capable of monitoring changes in the dielectric properties of stressed cells could have wide applications in areas ranging from the detection of bacterial infections in clinical specimens to antibiotic susceptibility testing and drug discovery.	[Zavizion, Boris; Zhao, Zhihui; Nittayajarn, Aphakorn; Rieder, Ronald J.] BioSense Technol Inc, Woburn, MA USA		Zavizion, B (corresponding author), BioSense Technol Inc, Woburn, MA USA.	rieder@biosensetech.com		Zavizion, Boris/0000-0001-7246-4179	National Institutes of Health [5R44DK075198]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R44DK075198] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding for this work was provided by the National Institutes of Health through grant 5R44DK075198. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bore E, 2007, MICROBIOL-SGM, V153, P2289, DOI 10.1099/mic.0.2007/005942-0; Chang W, 2006, J BACTERIOL, V188, P1648, DOI 10.1128/JB.188.4.1648-1659.2006; COLVIN HJ, 1977, ANTIMICROB AGENTS CH, V12, P61, DOI 10.1128/AAC.12.1.61; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fleury B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-76; Giuliodori AM, 2007, ANN NY ACAD SCI, V1113, P95, DOI 10.1196/annals.1391.008; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Marles-Wright J, 2007, CURR OPIN STRUC BIOL, V17, P755, DOI 10.1016/j.sbi.2007.08.004; Michan C, 1999, J BACTERIOL, V181, P2759; MILIOTIS MD, 1991, J CLIN MICROBIOL, V29, P830, DOI 10.1128/JCM.29.4.830-831.1991; Muthaiyan A, 2008, ANTIMICROB AGENTS CH, V52, P980, DOI 10.1128/AAC.01121-07; Provvedi R, 2009, MICROBIOL-SGM, V155, P1093, DOI 10.1099/mic.0.024802-0; Rieder R, 2008, TRANSFUSION, V48, P2596, DOI 10.1111/j.1537-2995.2008.01880.x; Rieder RJ, 2009, ANTIMICROB AGENTS CH, V53, P4598, DOI 10.1128/AAC.00643-09; Umakoshi H, 1998, BIOTECHNOL PROGR, V14, P909, DOI 10.1021/bp980091s; Viveiros M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000365; Wu JJ, 1997, J CLIN MICROBIOL, V35, P1460, DOI 10.1128/JCM.35.6.1460-1464.1997	17	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13374	10.1371/journal.pone.0013374	http://dx.doi.org/10.1371/journal.pone.0013374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976282	gold, Green Submitted, Green Published			2022-12-27	WOS:000282941000013
J	Goni, F; Prelli, F; Ji, Y; Scholtzova, H; Yang, J; Sun, YJ; Liang, FX; Kascsak, R; Kascsak, R; Mehta, P; Wisniewski, T				Goni, Fernando; Prelli, Frances; Ji, Yong; Scholtzova, Henrieta; Yang, Jing; Sun, Yanjie; Liang, Feng-Xia; Kascsak, Regina; Kascsak, Richard; Mehta, Pankaj; Wisniewski, Thomas			Immunomodulation Targeting Abnormal Protein Conformation Reduces Pathology in a Mouse Model of Alzheimer's Disease	PLOS ONE			English	Article							FAMILIAL BRITISH DEMENTIA; AMYLOID BETA-PROTEIN; TRANSGENIC MICE; PRECURSOR-PROTEIN; PRESENILIN-1 TRANSGENES; FIBRIL FORMATION; PEPTIDE; IMMUNIZATION; OLIGOMERS; VACCINATION	Many neurodegenerative diseases are characterized by the conformational change of normal self-proteins into amyloidogenic, pathological conformers, which share structural properties such as high beta-sheet content and resistance to degradation. The most common is Alzheimer's disease (AD) where the normal soluble amyloid beta (sA beta) peptide is converted into highly toxic oligomeric A beta and fibrillar A beta that deposits as neuritic plaques and congophilic angiopathy. Currently, there is no highly effective treatment for AD, but immunotherapy is emerging as a potential disease modifying intervention. A major problem with most active and passive immunization approaches for AD is that both the normal sA beta and pathogenic forms are equally targeted with the potential of autoimmune inflammation. In order to avoid this pitfall, we have developed a novel immunomodulatory method that specifically targets the pathological conformations, by immunizing with polymerized British amyloidosis (pABri) related peptide which has no sequence homology to A beta or other human proteins. We show that the pA beta ri peptide through conformational mimicry induces a humoral immune response not only to the toxic A beta in APP/PS1 AD transgenic mice but also to paired helical filaments as shown on AD human tissue samples. Treated APP/PS1 mice had a cognitive benefit compared to controls (p<0.0001), associated with a reduction in the amyloid burden (p = 0.0001) and A beta 40/42 levels, as well as reduced A beta oligomer levels. This type of immunomodulation has the potential to be a universal beta-sheet disrupter, which could be useful for the prevention or treatment of a wide range of neurodegenerative diseases.	[Goni, Fernando; Prelli, Frances; Ji, Yong; Scholtzova, Henrieta; Yang, Jing; Sun, Yanjie; Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10016 USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA; [Liang, Feng-Xia] NYU, Sch Med, Image Core Facil, New York, NY USA; [Kascsak, Regina; Kascsak, Richard; Mehta, Pankaj] New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; [Goni, Fernando] Univ Uruguay, Sch Chem, Dept Immunol, Montevideo, Uruguay	New York University; New York University; New York University; New York University; Institute for Basic Research in Developmental Disabilities; Universidad de la Republica, Uruguay	Goni, F (corresponding author), NYU, Sch Med, Dept Neurol, New York, NY 10016 USA.	Thomas.wisniewski@nyumc.org	Wisniewski, Thomas/Q-6525-2019	Wisniewski, Thomas/0000-0002-3379-8966; Prelli, Frances/0000-0002-8744-4151; Liang, Fengxia/0000-0003-0037-4590	National Institutes of Health [AG20245, AG08051, AG15408]; NATIONAL INSTITUTE ON AGING [P30AG008051, R01AG020245, R01AG015408] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants: AG20245, AG08051 and AG15408. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Asuni AA, 2006, EUR J NEUROSCI, V24, P2530, DOI 10.1111/j.1460-9568.2006.05149.x; Dhenain M, 2006, MAGN RESON MED, V55, P687, DOI 10.1002/mrm.20810; Ghiso J, 2000, ANN NY ACAD SCI, V920, P84; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Gilman S, 2005, NEUROLOGY, V64, P1553, DOI 10.1212/01.WNL.0000159740.16984.3C; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Glabe CG, 2008, J BIOL CHEM, V283, P29639, DOI 10.1074/jbc.R800016200; Goni F, 2005, NEUROSCIENCE, V133, P413, DOI 10.1016/j.neuroscience.2005.02.031; Gordon MN, 2002, EXP NEUROL, V173, P183, DOI 10.1006/exnr.2001.7754; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holmes C, 2008, LANCET, V372, P216, DOI 10.1016/S0140-6736(08)61075-2; Ito K, 2009, CURR ALZHEIMER RES, V6, P132, DOI 10.2174/156720509787602889; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Jellinger KA, 2009, J NEURAL TRANSM, V116, P1111, DOI 10.1007/s00702-009-0240-y; Josephs KA, 2008, NEUROLOGY, V70, P1850, DOI 10.1212/01.wnl.0000304041.09418.b1; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Lambert MP, 2009, CNS NEUROL DISORD-DR, V8, P65, DOI 10.2174/187152709787601876; Lee EB, 2006, J BIOL CHEM, V281, P4292, DOI 10.1074/jbc.M511018200; Lublin AL, 2010, MT SINAI J MED, V77, P43, DOI 10.1002/msj.20160; Mamikonyan G, 2007, J BIOL CHEM, V282, P22376, DOI 10.1074/jbc.M700088200; McGowan E, 1999, NEUROBIOL DIS, V6, P231, DOI 10.1006/nbdi.1999.0243; Moretto N, 2007, J BIOL CHEM, V282, P11436, DOI 10.1074/jbc.M609690200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D, 2005, J NEUROPATH EXP NEUR, V64, P743, DOI 10.1097/01.jnen.0000178444.33972.e0; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Rinne JO, 2010, LANCET NEUROL, V9, P363, DOI 10.1016/S1474-4422(10)70043-0; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Rostagno A, 2010, CELL MOL LIFE SCI, V67, P581, DOI 10.1007/s00018-009-0182-4; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Scholtzova H, 2008, J NEUROSCI RES, V86, P2784, DOI 10.1002/jnr.21713; Scholtzova H, 2009, J NEUROSCI, V29, P1846, DOI 10.1523/JNEUROSCI.5715-08.2009; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; Soscia SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009505; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Srinivasan R, 2003, J MOL BIOL, V333, P1003, DOI 10.1016/j.jmb.2003.09.001; TOUMADJE A, 1992, ANAL BIOCHEM, V200, P321, DOI 10.1016/0003-2697(92)90473-K; van der Zee J, 2008, NEUROLOGY, V71, P1191, DOI 10.1212/01.wnl.0000327523.52537.86; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2009, BRAIN PATHOL, V19, P58, DOI 10.1111/j.1750-3639.2008.00164.x; Walsh DM, 2000, BIOCHEMISTRY-US, V39, P10831, DOI 10.1021/bi001048s; Wisniewski T, 2007, REV SCI TECH OIE, V26, P243, DOI 10.20506/rst.26.1.1739; WISNIEWSKI T, 1995, AM J PATHOL, V147, P238; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Wisniewski T, 2010, BRAIN STRUCT FUNCT, V214, P201, DOI 10.1007/s00429-009-0236-2	52	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13391	10.1371/journal.pone.0013391	http://dx.doi.org/10.1371/journal.pone.0013391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967130	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800050
J	Han, JA; Kubota, S; Uchida, H; Stanley, GD; Yao, XY; Shu, DG; Li, Y; Yasui, K				Han, Jian; Kubota, Shin; Uchida, Hiro-omi; Stanley, George D., Jr.; Yao, Xiaoyong; Shu, Degan; Li, Yong; Yasui, Kinya			Tiny Sea Anemone from the Lower Cambrian of China	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; PALEOZOIC CORALS; SOFT-TISSUE; CNIDARIA; EVOLUTION; ORIGINS; EXPRESSION; BIOTA; FOSSILIZATION; BILATERALITY	Background: Abundant fossils from the Ediacaran and Cambrian showing cnidarian grade grossly suggest that cnidarian diversification occurred earlier than that of other eumetazoans. However, fossils of possible soft-bodied polyps are scanty and modern corals are dated back only to the Middle Triassic, although molecular phylogenetic results support the idea that anthozoans represent the first major branch of the Cnidaria. Because of difficulties in taxonomic assignments owing to imperfect preservation of fossil cnidarian candidates, little is known about forms ancestral to those of living groups. Methods and Findings: We have analyzed the soft-bodied polypoid microfossils Eolympia pediculata gen. et sp. nov. from the lowest Cambrian Kuanchuanpu Formation in southern China by scanning electron microscopy and computer-aided microtomography after isolating fossils from sedimentary rocks by acetic acid maceration. The fossils, about a half mm in body size, are preserved with 18 mesenteries including directives bilaterally arranged, 18 tentacles and a stalk-like pedicle. The pedicle suggests a sexual life cycle, while asexual reproduction by transverse fission also is inferred by circumferential grooves on the body column. Conclusions: The features found in the present fossils fall within the morphological spectrum of modern Hexacorallia excluding Ceriantharia, and thus Eolympia pediculata could be a stem member for this group. The fossils also demonstrate that basic features characterizing modern hexacorallians such as bilateral symmetry and the reproductive system have deep roots in the Early Cambrian.	[Han, Jian; Yao, Xiaoyong; Shu, Degan] NW Univ Xian, State Key Lab Continental Dynam, Dept Geol, Early Life Inst, Xian 710069, Shaanxi, Peoples R China; [Kubota, Shin] Kyoto Univ, Seto Marine Biol Lab, Field Sci Educ & Res Ctr, Wakayama, Japan; [Uchida, Hiro-omi] Kushimoto Marine Pk Ctr, Wakayama, Japan; [Stanley, George D., Jr.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA; [Li, Yong] Changan Univ, Key Lab Western Chinas Mineral Resources & Geol E, Sch Earth Sci & Land Resources, Xian, Shaanxi, Peoples R China; [Yasui, Kinya] Hiroshima Univ, Marine Biol Lab, Grad Sch Sci, Hiroshima, Japan	Northwest University Xi'an; Kyoto University; University of Montana System; University of Montana; Chang'an University; Hiroshima University	Han, JA (corresponding author), NW Univ Xian, State Key Lab Continental Dynam, Dept Geol, Early Life Inst, Xian 710069, Shaanxi, Peoples R China.	furaha@sci.hiroshima-u.ac.jp	Han, Jian/AAU-4500-2021	Han, Jian/0000-0002-2134-4078; yao, xiaoyong/0000-0002-9329-8955	National Science Foundation of China [40830208, 40602003, 50702005]; State Key Laboratory of Continental Dynamics, Northwest University, China	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Continental Dynamics, Northwest University, China	Funding was provided by the National Science Foundation of China (http://www.nsfc.gov.cn/) grants 40830208, 40602003, 50702005 to J. Han and D. G. Shu, and by MOST Special Fund from the State Key Laboratory of Continental Dynamics, Northwest University, China (http://sklcd.nwu.edu.cn/) to J. Han and D. G. Shu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball EE, 2007, INTEGR COMP BIOL, V47, P701, DOI 10.1093/icb/icm028; Bengtson S, 2004, SCIENCE, V306; Bengtson S, 1997, SCIENCE, V277, P1645, DOI 10.1126/science.277.5332.1645; Berntson EA, 1999, MOL PHYLOGENET EVOL, V13, P417, DOI 10.1006/mpev.1999.0649; Berntson EA, 2001, MAR BIOL, V138, P235, DOI 10.1007/s002270000457; Briggs DEG, 2005, PALEOBIOLOGY, V31, P94, DOI 10.1666/0094-8373(2005)031[0094:WSSSGA]2.0.CO;2; BRIGGS DEG, 1993, SCIENCE, V259, P1439, DOI 10.1126/science.259.5100.1439; Cappola VA, 2000, J MAR BIOL ASSOC UK, V80, P995, DOI 10.1017/S0025315400003064; CARLGREN O, 1921, DAN INGOLF EXPED, V5, P3; Cartwright P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001121; CHEN CA, 1995, MOL PHYLOGENET EVOL, V4, P175, DOI 10.1006/mpev.1995.1017; Chen J.-y., 1991, P57; Chen JY, 2002, DEV BIOL, V248, P182, DOI 10.1006/dbio.2002.0714; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Daly M, 2003, ZOOL J LINN SOC-LOND, V139, P419, DOI 10.1046/j.1096-3642.2003.00084.x; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; England K.W., 1987, B BR MUS NAT HIS Z, V53, P205; Ezaki Y, 1997, PALAEONTOLOGY, V40, P1; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Fedonkin M.A., 1981, T GEOLOGICHESKIY INS, V342, P1; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; France SC, 1996, MOL MAR BIOL BIOTECH, V5, P15; Gudo M, 2002, LETHAIA, V35, P328, DOI 10.1080/002411602320790643; Hahn G., 1980, Senckenbergiana Lethaea, V60, P449; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; Hicks M, 2006, J PALEONTOL, V80, P609, DOI 10.1666/0022-3360(2006)80[609:ANGOEC]2.0.CO;2; HILL D., 1981, TREATISE INVERTE F S, VI- XL, P1; Hou X. -G., 2004, CAMBRIAN FOSSILS CHE; Hou XG, 2005, LETHAIA, V38, P193, DOI 10.1080/00241160510013295; Hyman L.H., 1940, INVERTEBRATES, V1; Jenkins RJF, 2002, J GEOL SOC LONDON, V159, P645, DOI 10.1144/0016-764901-127; Kayal E, 2008, GENE, V410, P177, DOI 10.1016/j.gene.2007.12.002; Liu AG, 2010, GEOLOGY, V38, P123, DOI 10.1130/G30368.1; Marques AC, 2004, INVERTEBR BIOL, V123, P23; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; MORRIS SC, 1993, PALAEONTOLOGY, V36, P593; NARBONNE GM, 1987, PALAEONTOLOGY, V30, P647; OLIVER JWA, 1996, PALAEONTOLOGY BIOL C, V1, P107; PETERSEN JJ, 1979, J NEMATOL, V11, P105; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Raff EC, 2006, P NATL ACAD SCI USA, V103, P5846, DOI 10.1073/pnas.0601536103; Raff EC, 2008, P NATL ACAD SCI USA, V105, P19360, DOI 10.1073/pnas.0810106105; ROBSON EA, 1971, J EXP BIOL, V55, P611; RUPPERT EE, 2004, INVERTEBRATE ZOOLOGY, P111; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; SCHCHERT P, 1993, Z ZOOLOGISCHE SYSTEM, V31, P161; Schmidt H., 1974, P 2 INT S COR REEFS, P533; Scrutton Colin, 1999, Geology Today, V15, P184, DOI 10.1046/j.1365-2451.1999.1505005.x; SCRUTTON CT, 1991, PALAEONTOLOGY, V34, P179; Scrutton CT, 1997, P YORKS GEOL SOC, V51, P177, DOI 10.1144/pygs.51.3.177; Seilacher Adolf, 2003, Paleontological Research, V7, P43, DOI 10.2517/prpsj.7.43; SHICK J. M., 1991, FUNCTIONAL BIOL SEA; Shu DG, 2006, SCIENCE, V312, P731, DOI 10.1126/science.1124565; Stanley GD, 2003, EARTH-SCI REV, V60, P195, DOI 10.1016/S0012-8252(02)00104-6; Stanley GD, 2001, SCIENCE, V291, P1913, DOI 10.1126/science.1056632; Steiner M, 2004, GEOBIOS-LYON, V37, P259, DOI 10.1016/j.geobios.2003.08.001; Steiner M, 2007, PALAEOGEOGR PALAEOCL, V254, P67, DOI 10.1016/j.palaeo.2007.03.046; Won JH, 2001, CORAL REEFS, V20, P39; Wood R., 1999, REEF EVOLUTION; Xiao SH, 2000, P NATL ACAD SCI USA, V97, P13684, DOI 10.1073/pnas.250491697	61	36	46	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13276	10.1371/journal.pone.0013276	http://dx.doi.org/10.1371/journal.pone.0013276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967244	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800010
J	Magri, C; Sacchetti, E; Traversa, M; Valsecchi, P; Gardella, R; Bonvicini, C; Minelli, A; Gennarelli, M; Barlati, S				Magri, Chiara; Sacchetti, Emilio; Traversa, Michele; Valsecchi, Paolo; Gardella, Rita; Bonvicini, Cristian; Minelli, Alessandra; Gennarelli, Massimo; Barlati, Sergio			New Copy Number Variations in Schizophrenia	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDER; SYNAPTIC PLASTICITY; MENTAL-RETARDATION; CANDIDATE GENE; HUMAN GENOME; ASSOCIATION; POLYMORPHISM; DISRUPTION; DELETIONS; VARIANTS	Genome-wide screenings for copy number variations (CNVs) in patients with schizophrenia have demonstrated the presence of several CNVs that increase the risk of developing the disease and a growing number of large rare CNVs; the contribution of these rare CNVs to schizophrenia remains unknown. Using Affymetrix 6.0 arrays, we undertook a systematic search for CNVs in 172 patients with schizophrenia and 160 healthy controls, all of Italian origin, with the aim of confirming previously identified loci and identifying novel schizophrenia susceptibility genes. We found five patients with a CNV occurring in one of the regions most convincingly implicated as risk factors for schizophrenia: NRXN1 and the 16p13.1 regions were found to be deleted in single patients and 15q11.2 in 2 patients, whereas the 15q13.3 region was duplicated in one patient. Furthermore, we found three distinct patients with CNVs in 2q12.2, 3q29 and 17p12 loci, respectively. These loci were previously reported to be deleted or duplicated in patients with schizophrenia but were never formally associated with the disease. We found 5 large CNVs (>900 kb) in 4q32, 5q14.3, 8q23.3, 11q25 and 17q12 in five different patients that could include some new candidate schizophrenia susceptibility genes. In conclusion, the identification of previously reported CNVs and of new, rare, large CNVs further supports a model of schizophrenia that includes the effect of multiple, rare, highly penetrant variants.	[Magri, Chiara; Traversa, Michele; Gardella, Rita; Gennarelli, Massimo; Barlati, Sergio] Univ Brescia, Sch Med, Dept Biomed Sci & Technol, Div Biol & Genet, Brescia, Italy; [Sacchetti, Emilio; Valsecchi, Paolo] Brescia Spedali Civili, Dept Mental Hlth, Brescia, Italy; [Sacchetti, Emilio; Valsecchi, Paolo] Univ Brescia, Sch Med, Univ Psychiat Unit, Brescia, Italy; [Sacchetti, Emilio; Barlati, Sergio] Univ Brescia, Ctr Behav & Neurodegenerat Disorders, Brescia, Italy; [Sacchetti, Emilio; Barlati, Sergio] EULO, Brescia, Italy; [Bonvicini, Cristian; Minelli, Alessandra; Gennarelli, Massimo] IRCCS San Giovanni di Dio, Genet Unit, Brescia, Italy	University of Brescia; Hospital Spedali Civili Brescia; University of Brescia; University of Brescia; IRCCS Fatebenefratelli	Magri, C (corresponding author), Univ Brescia, Sch Med, Dept Biomed Sci & Technol, Div Biol & Genet, Brescia, Italy.	sacchett@med.unibs.it; barlati@med.unibs.it	Gennarelli, Massimo/B-1377-2010; Bonvicini, Cristian/G-4427-2011; Magri, Chiara/I-4691-2017; Gennarelli, Massimo/AAL-3542-2020; Barlati, Sergio/A-2666-2010; Minelli, Alessandra/ABI-2890-2020	Bonvicini, Cristian/0000-0003-1577-2823; Magri, Chiara/0000-0001-9933-8666; Minelli, Alessandra/0000-0002-9463-7808; SACCHETTI, EMILIO/0000-0003-0700-5173; GENNARELLI, Massimo/0000-0003-4192-945X	Health Authority of the Lombardia Region [153]; Center of Behavioural and Neurodegenerative Disordes; IDET Centre of Excellence	Health Authority of the Lombardia Region; Center of Behavioural and Neurodegenerative Disordes; IDET Centre of Excellence	The study was supported by the Health Authority of the Lombardia Region (Project 153) (www.sanita.regione.lombardia.it) together with grants from the Center of Behavioural and Neurodegenerative Disordes and IDET Centre of Excellence (www.unibs.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon M, 2008, AM J HUM GENET, V82, P150, DOI 10.1016/j.ajhg.2007.09.005; *APS, 2000, DIAGN STAT MAN DIS; Barlati S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-49; Bassett AS, 2010, AM J PSYCHIAT, V167, P899, DOI 10.1176/appi.ajp.2009.09071016; Bonvicini C, 2010, PSYCHIAT GENET, V20, P44, DOI 10.1097/YPG.0b013e3283351167; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; FIRST MB, 1996, STRUCTURAL CLIN INTE; Floris C, 2008, EUR J HUM GENET, V16, P696, DOI 10.1038/ejhg.2008.7; Goto Y, 2010, BIOL PSYCHIAT, V67, P199, DOI 10.1016/j.biopsych.2009.08.026; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; Jeffries AR, 2003, MOL PSYCHIATR, V8, P654, DOI 10.1038/sj.mp.4001382; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2008, HUM MOL GENET, V17, P458, DOI 10.1093/hmg/ddm323; Kirov G, 2010, EXPERT REV NEUROTHER, V10, P25, DOI [10.1586/ern.09.133, 10.1586/ERN.09.133]; Kirov G, 2009, HUM MOL GENET, V18, P1497, DOI 10.1093/hmg/ddp043; Lau WL, 2003, GENOMICS, V82, P412, DOI 10.1016/S0888-7543(03)00149-6; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Masuda T, 2009, BRAIN RES, V1249, P61, DOI 10.1016/j.brainres.2008.10.028; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; NURNBERGER JI, 1994, ARCH GEN PSYCHIAT, V51, P849, DOI 10.1001/archpsyc.1994.03950110009002; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Sacchetti E, 2007, BRAIN BEHAV IMMUN, V21, P450, DOI 10.1016/j.bbi.2006.11.009; Sato J, 2008, J NEURAL TRANSM, V115, P1355, DOI 10.1007/s00702-008-0085-9; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shimizu A, 2003, BIOCHEM BIOPH RES CO, V309, P143, DOI 10.1016/S0006-291X(03)01555-9; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Tam GWC, 2009, BIOL PSYCHIAT, V66, P1005, DOI 10.1016/j.biopsych.2009.07.027; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Wagenstaller J, 2007, AM J HUM GENET, V81, P768, DOI 10.1086/521274; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162; Yamamoto S, 2002, J BIOL CHEM, V277, P27227, DOI 10.1074/jbc.C200296200	37	71	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13422	10.1371/journal.pone.0013422	http://dx.doi.org/10.1371/journal.pone.0013422			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967226	gold, Green Published, Green Submitted			2022-12-27	WOS:000282869800052
J	Smith, MW; Herfort, L; Tyrol, K; Suciu, D; Campbell, V; Crump, BC; Peterson, TD; Zuber, P; Baptista, AM; Simon, HM				Smith, Maria W.; Herfort, Lydie; Tyrol, Kaitlin; Suciu, Dominic; Campbell, Victoria; Crump, Byron C.; Peterson, Tawnya D.; Zuber, Peter; Baptista, Antonio M.; Simon, Holly M.			Seasonal Changes in Bacterial and Archaeal Gene Expression Patterns across Salinity Gradients in the Columbia River Coastal Margin	PLOS ONE			English	Article							CARBON STARVATION GENE; NITRATE AMMONIFICATION; ORGANIC-CARBON; ESTUARY; OCEAN; DNA; BACTERIOPLANKTON; DENITRIFICATION; NITROGEN; BAY	Through their metabolic activities, microbial populations mediate the impact of high gradient regions on ecological function and productivity of the highly dynamic Columbia River coastal margin (CRCM). A 2226-probe oligonucleotide DNA microarray was developed to investigate expression patterns for microbial genes involved in nitrogen and carbon metabolism in the CRCM. Initial experiments with the environmental microarrays were directed toward validation of the platform and yielded high reproducibility in multiple tests. Bioinformatic and experimental validation also indicated that >85% of the microarray probes were specific for their corresponding target genes and for a few homologs within the same microbial family. The validated probe set was used to query gene expression responses by microbial assemblages to environmental variability. Sixty-four samples from the river, estuary, plume, and adjacent ocean were collected in different seasons and analyzed to correlate the measured variability in chemical, physical and biological water parameters to differences in global gene expression profiles. The method produced robust seasonal profiles corresponding to pre-freshet spring (April) and late summer (August). Overall relative gene expression was high in both seasons and was consistent with high microbial abundance measured by total RNA, heterotrophic bacterial production, and chlorophyll a. Both seasonal patterns involved large numbers of genes that were highly expressed relative to background, yet each produced very different gene expression profiles. April patterns revealed high differential gene expression in the coastal margin samples (estuary, plume and adjacent ocean) relative to freshwater, while little differential gene expression was observed along the river-to-ocean transition in August. Microbial gene expression profiles appeared to relate, in part, to seasonal differences in nutrient availability and potential resource competition. Furthermore, our results suggest that highly-active particle-attached microbiota in the Columbia River water column may perform dissimilatory nitrate reduction (both dentrification and DNRA) within anoxic particle microniches.	[Smith, Maria W.; Herfort, Lydie; Tyrol, Kaitlin; Campbell, Victoria; Peterson, Tawnya D.; Zuber, Peter; Baptista, Antonio M.; Simon, Holly M.] Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Ctr Coastal Margin Observat & Predict, Beaverton, OR USA; [Suciu, Dominic] CombiMatrix Corp, Mukilteo, WA USA; [Crump, Byron C.] Univ Maryland, Ctr Environm Sci, Horn Point Lab, Cambridge, MD USA	Oregon Health & Science University; University System of Maryland; University of Maryland Center for Environmental Science	Smith, MW (corresponding author), Oregon Hlth & Sci Univ, Div Environm & Biomol Syst, Ctr Coastal Margin Observat & Predict, Beaverton, OR USA.	simonh@ebs.ogi.edu	Crump, Byron/ABF-3711-2020	Zuber, Peter/0000-0003-1757-7837; Smit, Mariya/0000-0001-7458-4545; Crump, Byron/0000-0001-7062-1273; Baptista, Antonio/0000-0002-7641-5937	National Science Foundation (NSF) [OCE 0424602]	National Science Foundation (NSF)(National Science Foundation (NSF))	The research reported in this article was funded by a grant from the National Science Foundation (NSF grant OCE 0424602); http://www.nsf.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Islas AM, 2006, MAR CHEM, V101, P233, DOI 10.1016/j.marchem.2006.03.005; Allawi HT, 1998, BIOCHEMISTRY-US, V37, P9435, DOI 10.1021/bi9803729; Allawi HT, 1998, BIOCHEMISTRY-US, V37, P2170, DOI 10.1021/bi9724873; Allawi HT, 1998, NUCLEIC ACIDS RES, V26, P2694, DOI 10.1093/nar/26.11.2694; Arhonditsis G, 2003, ENVIRON MANAGE, V31, P603, DOI 10.1007/s00267-002-2891-4; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Barnes C, 1972, COLUMBIA RIVER ESTUA, P71; BAROSS JA, 1994, CHANGES IN FLUXES IN ESTUARIES: IMPLICATIONS FROM SCIENCE TO MANAGEMENT, P459; Bolotin S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-37; BRONK DA, 2002, BIOGEOCHEMISTRY MARI, P153, DOI DOI 10.1016/B978-012323841-2/50007-5; Brown CA, 2009, ESTUAR COAST, V32, P219, DOI 10.1007/s12237-008-9128-6; Bruland KW, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004702; Chawla A, 2008, ESTUAR COAST, V31, P269, DOI 10.1007/s12237-007-9022-7; Colbert D, 2003, ESTUARIES, V26, P1205, DOI 10.1007/BF02803625; CONOMOS TJ, 1972, COLUMBIA RIVER ESTUA, P151; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Crump BC, 2000, FEMS MICROBIOL ECOL, V31, P231, DOI 10.1016/S0168-6496(99)00102-6; Crump BC, 2004, APPL ENVIRON MICROB, V70, P1494, DOI 10.1128/AEM.70.3.1494-1505.2004; Crump BC, 1998, AQUAT MICROB ECOL, V14, P7, DOI 10.3354/ame014007; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dubey AK, 2003, J BACTERIOL, V185, P4450, DOI 10.1128/JB.185.15.4450-4460.2003; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Ghindilis AL, 2009, ELECTROANAL, V21, P1459, DOI 10.1002/elan.200904549; Ghindilis AL, 2007, BIOSENS BIOELECTRON, V22, P1853, DOI 10.1016/j.bios.2006.06.024; GIOVANNONI SJ, 2000, MICROBIAL ECOLOGY OC, P47; GLIBERT PM, 1991, LIMNOL OCEANOGR, V36, P895, DOI 10.4319/lo.1991.36.5.0895; Grant S, 2006, APPL ENVIRON MICROB, V72, P135, DOI 10.1128/AEM.72.1.135-143.2006; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; He SM, 2010, ENVIRON MICROBIOL, V12, P1205, DOI 10.1111/j.1462-2920.2010.02163.x; Hickey BM, 2003, ESTUARIES, V26, P1010, DOI 10.1007/BF02803360; JAY DA, 1990, PROG OCEANOGR, V25, P157, DOI 10.1016/0079-6611(90)90006-N; Jay DA, 1997, ESTUARIES, V20, P262, DOI 10.2307/1352342; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Kan J, 2007, APPL ENVIRON MICROB, V73, P6776, DOI 10.1128/AEM.00541-07; Kudela RM, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004913; Liu Jinsong, 2006, Wuhan University Journal of Natural Sciences, V11, P360, DOI 10.1007/BF02832122; Lodes MJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000924; Lodes MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006229; Lodes MJ, 2006, J CLIN MICROBIOL, V44, P1209, DOI 10.1128/JCM.44.4.1209-1218.2006; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Maurer K, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000034; Michotey V, 1997, MAR ECOL PROG SER, V160, P47, DOI 10.3354/meps160047; Omnes P, 1996, MAR ECOL PROG SER, V141, P275, DOI 10.3354/meps141275; Parro V, 2007, ENVIRON MICROBIOL, V9, P453, DOI 10.1111/j.1462-2920.2006.01162.x; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Prahl FG, 1997, MAR ECOL PROG SER, V160, P173, DOI 10.3354/meps160173; Preston CM, 2009, ENVIRON MICROBIOL, V11, P1168, DOI 10.1111/j.1462-2920.2009.01848.x; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; ROBERTSON LA, 1988, APPL ENVIRON MICROB, V54, P2812, DOI 10.1128/AEM.54.11.2812-2818.1988; ROBERTSON LA, 1995, FEMS MICROBIOL ECOL, V18, P113, DOI 10.1111/j.1574-6941.1995.tb00168.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sala MM, 2008, ENVIRON MICROBIOL, V10, P942, DOI 10.1111/j.1462-2920.2007.01513.x; Schena M., 2003, MICROARRAY ANAL; SCHULTZ JE, 1991, J MOL BIOL, V218, P129, DOI 10.1016/0022-2836(91)90879-B; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SIMENSTAD CA, 1990, PROG OCEANOGR, V25, P1, DOI 10.1016/0079-6611(90)90002-J; Small LF, 2004, ESTUARIES, V27, P999, DOI 10.1007/BF02803426; SMALL LF, 1990, PROG OCEANOGR, V25, P175, DOI 10.1016/0079-6611(90)90007-O; SUGIMURA Y, 1988, MAR CHEM, V24, P105, DOI 10.1016/0304-4203(88)90043-6; Takaya N, 2003, APPL ENVIRON MICROB, V69, P3152, DOI 10.1128/AEM.69.6.3152-3157.2003; Taroncher-Oldenburg G, 2003, APPL ENVIRON MICROB, V69, P1159, DOI 10.1128/AEM.69.2.1159-1171.2003; Teira E, 2008, ENVIRON MICROBIOL, V10, P906, DOI 10.1111/j.1462-2920.2007.01509.x; Tiedje JM, 1988, MICROORGANISMS, V717, P179; Treusch AH, 2009, ISME J, V3, P1148, DOI 10.1038/ismej.2009.60; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; VERARDO DJ, 1990, DEEP-SEA RES, V37, P157, DOI 10.1016/0198-0149(90)90034-S; Zhou JZ, 2002, CURR OPIN BIOTECH, V13, P204, DOI 10.1016/S0958-1669(02)00319-1	70	24	24	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13312	10.1371/journal.pone.0013312	http://dx.doi.org/10.1371/journal.pone.0013312			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967204	gold, Green Submitted, Green Published			2022-12-27	WOS:000282869800017
J	Hiratsuka, T; Matsuzaki, S; Miyata, S; Kinoshita, M; Kakehi, K; Nishida, S; Katayama, T; Tohyama, M				Hiratsuka, Toru; Matsuzaki, Shinsuke; Miyata, Shingo; Kinoshita, Mitsuhiro; Kakehi, Kazuaki; Nishida, Shinji; Katayama, Taiichi; Tohyama, Masaya			Yokukansan Inhibits Neuronal Death during ER Stress by Regulating the Unfolded Protein Response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRADITIONAL JAPANESE MEDICINE; ALZHEIMERS-DISEASE; FERULIC ACID; PSYCHOLOGICAL SYMPTOMS; SIGNALING PATHWAY; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; MESSENGER-RNA; IMMUNOTHERAPY	Background: Recently, several studies have reported Yokukansan (Tsumura TJ-54), a traditional Japanese medicine, as a potential new drug for the treatment of Alzheimer's disease (AD). Endoplasmic reticulum (ER) stress is known to play an important role in the pathogenesis of AD, particularly in neuronal death. Therefore, we examined the effect of Yokukansan on ER stress-induced neurotoxicity and on familial AD-linked presenilin-1 mutation-associated cell death. Methods: We employed the WST-1 assay and monitored morphological changes to evaluate cell viability following Yokukansan treatment or treatment with its components. Western blotting and PCR were used to observe the expression levels of GRP78/BiP, caspase-4 and C/EBP homologous protein. Results: Yokukansan inhibited neuronal death during ER stress, with Cnidii Rhizoma (Senkyu), a component of Yokukansan, being particularly effective. We also showed that Yokukansan and Senkyu affect the unfolded protein response following ER stress and that these drugs inhibit the activation of caspase-4, resulting in the inhibition of ER stress-induced neuronal death. Furthermore, we found that the protective effect of Yokukansan and Senkyu against ER stress could be attributed to the ferulic acid content of these two drugs. Conclusions: Our results indicate that Yokukansan, Senkyu and ferulic acid are protective against ER stress-induced neuronal cell death and may provide a possible new treatment for AD.	[Hiratsuka, Toru; Matsuzaki, Shinsuke; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Hamamatsu Univ Sch Med, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Katayama, Taiichi; Tohyama, Masaya] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka, Japan; [Matsuzaki, Shinsuke; Miyata, Shingo; Tohyama, Masaya] Osaka Univ, Grad Sch Med, Osaka Hamamatsu Joint Res Ctr Child Mental Dev, Suita, Osaka, Japan; [Kinoshita, Mitsuhiro; Kakehi, Kazuaki] Kinki Univ, Sch Pharmaceut Sci, Lab Biopharmaco Informat, Higashiosaka, Osaka 577, Japan; [Nishida, Shinji] Osaka Univ, Grad Sch Med, Dept Kampo Med, Suita, Osaka, Japan	Osaka University; Kanazawa University; Osaka University; Osaka University; Kindai University (Kinki University); Osaka University	Hiratsuka, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Anat & Neurosci, Suita, Osaka, Japan.	s-matsuzaki@anat2.med.osaka-u.ac.jp		Hiratsuka, Toru/0000-0002-5359-2690	Health Labour Sciences Research Grant; Ministry of Education, Science, Sports and Culture; Global COE project	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global COE project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by the Global COE project, by Health Labour Sciences Research Grant, by Grant-in-Aid for Young Scientists(B) and by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid KAKENHI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbel M, 2007, CURR ALZHEIMER RES, V4, P437, DOI 10.2174/156720507781788792; Balasubashini MS, 2004, PHYTOTHER RES, V18, P310, DOI 10.1002/ptr.1440; Brody DL, 2008, ANNU REV NEUROSCI, V31, P175, DOI 10.1146/annurev.neuro.31.060407.125529; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Getsios D, 2007, PHARMACOECONOMICS, V25, P997, DOI 10.2165/00019053-200725120-00003; Giacobini E, 2007, J ALZHEIMERS DIS, V12, P37; Hayashi H, 2005, BIOL PHARM BULL, V28, P744, DOI 10.1248/bpb.28.744; He LM, 2002, BRAIN RES, V939, P65, DOI 10.1016/S0006-8993(02)02549-0; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Hutton M, 2004, NEURON, V43, P293, DOI 10.1016/j.neuron.2004.07.023; IIZUKA S, 2010, NEUROPATHOL IN PRESS; Ikarashi Y, 2009, BIOL PHARM BULL, V32, P1701, DOI 10.1248/bpb.32.1701; JACKSON TR, 1988, BIOCHEM J, V253, P81, DOI 10.1042/bj2530081; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kawabata K, 2000, CANCER LETT, V157, P15, DOI 10.1016/S0304-3835(00)00461-4; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Manabe T, 2003, CELL DEATH DIFFER, V10, P698, DOI 10.1038/sj.cdd.4401221; Matsuzaki S, 2004, J NEUROCHEM, V88, P1345, DOI 10.1111/j.1471-4159.2004.02290.x; McShane R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003154.pub5; Mizukami K, 2009, INT J NEUROPSYCHOPH, V12, P191, DOI 10.1017/S146114570800970X; Monji A, 2009, PROG NEURO-PSYCHOPH, V33, P308, DOI 10.1016/j.pnpbp.2008.12.008; MUKHOPADHYAY A, 1982, AGENTS ACTIONS, V12, P508, DOI 10.1007/BF01965935; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Pereira C, 2004, J MOL NEUROSCI, V23, P97, DOI 10.1385/JMN:23:1-2:097; Picone P, 2009, FREE RADICAL RES, V43, P1133, DOI 10.1080/10715760903214454; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Sato N, 1999, J NEUROCHEM, V72, P2498, DOI 10.1046/j.1471-4159.1999.0722498.x; Sato N, 2001, J BIOL CHEM, V276, P2108, DOI 10.1074/jbc.M006886200; Sekiguchi K, 2009, PHYTOTHER RES, V23, P1175, DOI 10.1002/ptr.2777; Seltzer B, 2007, DRUG AGING, V24, P881, DOI 10.2165/00002512-200724110-00001; Shinno H, 2008, PROG NEURO-PSYCHOPH, V32, P1749, DOI 10.1016/j.pnpbp.2008.06.015; Sidrauski C, 1998, TRENDS CELL BIOL, V8, P245, DOI 10.1016/S0962-8924(98)01267-7; Sigurdsson EM, 2008, J ALZHEIMERS DIS, V15, P157; Solomon B, 2007, CURR OPIN MOL THER, V9, P79; Srinivasan M, 2007, J CLIN BIOCHEM NUTR, V40, P92, DOI 10.3164/jcbn.40.92; Sultana R, 2005, J NEUROCHEM, V92, P749, DOI 10.1111/j.1471-4159.2004.02899.x; Sun XD, 2003, NEUROBIOL DIS, V14, P567, DOI 10.1016/j.nbd.2003.08.007; Tateno M, 2008, PROG NEURO-PSYCHOPH, V32, P1704, DOI 10.1016/j.pnpbp.2008.07.006; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Wang X, 2007, NEUROSCIENCE, V144, P1045, DOI 10.1016/j.neuroscience.2006.10.008; Yan JJ, 2001, BRIT J PHARMACOL, V133, P89, DOI 10.1038/sj.bjp.0704047; Yogeeta SK, 2006, BASIC CLIN PHARMACOL, V98, P467, DOI 10.1111/j.1742-7843.2006.pto_335.x; Yu MS, 2006, APOPTOSIS, V11, P687, DOI 10.1007/s10495-006-5540-1; Yukioka F, 2008, NEUROCHEM INT, V52, P683, DOI 10.1016/j.neuint.2007.08.017	49	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13280	10.1371/journal.pone.0013280	http://dx.doi.org/10.1371/journal.pone.0013280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967273	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300015
J	A, JY; Qian, SX; Wang, GJ; Yan, B; Zhang, SJ; Huang, Q; Ni, LN; Zha, WB; Liu, LS; Cao, B; Hong, M; Wu, HX; Lu, H; Shi, JA; Li, MJ; Li, J				A, Jiye; Qian, Sixuan; Wang, Guangji; Yan, Bei; Zhang, Sujiang; Huang, Qing; Ni, Lingna; Zha, Weibin; Liu, Linsheng; Cao, Bei; Hong, Ming; Wu, Hanxin; Lu, Hua; Shi, Jian; Li, Mengjie; Li, Jianyong			Chronic Myeloid Leukemia Patients Sensitive and Resistant to Imatinib Treatment Show Different Metabolic Responses	PLOS ONE			English	Article							CHROMOSOME-POSITIVE LEUKEMIAS; TYROSINE KINASE INHIBITORS; MOLECULAR RESPONSES; CD34(+) CELLS; CHRONIC-PHASE; METABONOMICS; EXPRESSION; MECHANISMS; SIGNATURE; PATHWAYS	The BCR-ABL tyrosine kinase inhibitor imatinib is highly effective for chronic myeloid leukemia (CML). However, some patients gradually develop resistance to imatinib, resulting in therapeutic failure. Metabonomic and genomic profiling of patients' responses to drug interventions can provide novel information about the in vivo metabolism of low-molecular-weight compounds and extend our insight into the mechanism of drug resistance. Based on a multi-platform of high-throughput metabonomics, SNP array analysis, karyotype and mutation, the metabolic phenotypes and genomic polymorphisms of CML patients and their diverse responses to imatinib were characterized. The untreated CML patients (UCML) showed different metabolic patterns from those of healthy controls, and the discriminatory metabolites suggested the perturbed metabolism of the urea cycle, tricarboxylic acid cycle, lipid metabolism, and amino acid turnover in UCML. After imatinib treatment, patients sensitive to imatinib (SCML) and patients resistant to imatinib (RCML) had similar metabolic phenotypes to those of healthy controls and UCML, respectively. SCML showed a significant metabolic response to imatinib, with marked restoration of the perturbed metabolism. Most of the metabolites characterizing CML were adjusted to normal levels, including the intermediates of the urea cycle and tricarboxylic acid cycle (TCA). In contrast, neither cytogenetic nor metabonomic analysis indicated any positive response to imatinib in RCML. We report for the first time the associated genetic and metabonomic responses of CML patients to imatinib and show that the perturbed in vivo metabolism of UCML is independent of imatinib treatment in resistant patients. Thus, metabonomics can potentially characterize patients' sensitivity or resistance to drug intervention.	[A, Jiye; Wang, Guangji; Yan, Bei; Huang, Qing; Zha, Weibin; Liu, Linsheng; Cao, Bei; Shi, Jian; Li, Mengjie] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China; [Qian, Sixuan; Zhang, Sujiang; Ni, Lingna; Hong, Ming; Wu, Hanxin; Lu, Hua; Li, Jianyong] Nanjing Med Univ, Affiliated Hosp 1, Dept Hematol, Nanjing, Peoples R China	China Pharmaceutical University; Nanjing Medical University	A, JY (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing 210009, Peoples R China.	lijianyonglm@medmail.com.cn	li, mengjie/GRS-3931-2022; Shi, Jian/Y-9055-2019; Shi, Jian/Q-1667-2018; liu, linsheng/AGF-5590-2022	Shi, Jian/0000-0003-2609-0094; Shi, Jian/0000-0003-2609-0094; liu, linsheng/0000-0001-5371-3109; Huang, Qing/0000-0001-6803-8038	National Natural Science Foundation of the People's Republic of China [81070437, 30700461]; National Key New Drug Creation Special Programs [2009ZX09304-001, 2009ZX09502-004]; Jiangsu Province Social Development Foundation [BE2008673]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ200623]; National Science & Technology Pillar Program of China [2008BAI61B01]	National Natural Science Foundation of the People's Republic of China(National Natural Science Foundation of China (NSFC)); National Key New Drug Creation Special Programs; Jiangsu Province Social Development Foundation; Jiangsu Province's Outstanding Medical Academic Leader Program; National Science & Technology Pillar Program of China	This work was supported by the National Natural Science Foundation of the People's Republic of China (No. 81070437,30700461), the National Key New Drug Creation Special Programs (2009ZX09304-001 and 2009ZX09502-004), Jiangsu Province Social Development Foundation (BE2008673), Jiangsu Province's Outstanding Medical Academic Leader Program (LJ200623), and the National Science & Technology Pillar Program of China (Grant No. 2008BAI61B01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Apperley JF, 2007, LANCET ONCOL, V8, P1018, DOI 10.1016/S1470-2045(07)70342-X; Batetta B, 2006, EUR J LIPID SCI TECH, V108, P687, DOI 10.1002/ejlt.200600015; Berman E, 2006, NEW ENGL J MED, V354, P2006, DOI 10.1056/NEJMoa051140; Branford S, 2003, LEUKEMIA, V17, P2401, DOI 10.1038/sj.leu.2403158; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Ellis DI, 2007, PHARMACOGENOMICS, V8, P1243, DOI 10.2217/14622416.8.9.1243; Eriksson L., 2001, MULTI MEGAVARIATE DA; Fan TWM, 2006, DRUG METAB REV, V38, P707, DOI 10.1080/03602530600959599; Franceschino A, 2008, HAEMATOLOGICA, V93, P317, DOI 10.3324/haematol.11680; Gottardi M, 2005, NEW ENGL J MED, V353, P2722, DOI 10.1056/NEJMc052500; Gottschalk S, 2004, CLIN CANCER RES, V10, P6661, DOI 10.1158/1078-0432.CCR-04-0039; Holmes E, 2008, CELL, V134, P714, DOI 10.1016/j.cell.2008.08.026; Hughes T, 2006, BLOOD, V108, P28, DOI 10.1182/blood-2006-01-0092; Johansson B, 2002, ACTA HAEMATOL-BASEL, V107, P76, DOI 10.1159/000046636; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Kantarjian H, 2008, BLOOD, V111, P1774, DOI 10.1182/blood-2007-09-110189; Kantarjian HM, 2003, CANCER-AM CANCER SOC, V97, P1033, DOI 10.1002/cncr.11223; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Kominsky DJ, 2009, CLIN CANCER RES, V15, P3442, DOI 10.1158/1078-0432.CCR-08-3291; KURZROCK R, 1988, NEW ENGL J MED, V319, P990; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; McWeeney SK, 2010, BLOOD, V115, P315, DOI 10.1182/blood-2009-03-210732; Mitelman F., 1995, ISCN INT SYSTEM HUMA; Morvan D, 2007, CANCER RES, V67, P2150, DOI 10.1158/0008-5472.CAN-06-2346; Nicholson JK, 2008, NATURE, V455, P1054, DOI 10.1038/4551054a; Nowak D, 2010, BLOOD, V115, P1049, DOI 10.1182/blood-2009-03-210377; Oksman-Caldentey KM, 2005, CURR OPIN BIOTECH, V16, P174, DOI 10.1016/j.copbio.2005.02.007; Pelicano H, 2006, ONCOGENE, V25, P4633, DOI 10.1038/sj.onc.1209597; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Rowley JD, 2008, SCIENCE, V321, P1302, DOI 10.1126/science.1163791; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; Talpaz M, 2006, NEW ENGL J MED, V354, P2531, DOI 10.1056/NEJMoa055229; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Xu GW, 2001, METH MOL B, V162, P459; Yong ASM, 2006, BLOOD, V107, P205, DOI 10.1182/blood-2005-05-2155; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	44	14	19	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13186	10.1371/journal.pone.0013186	http://dx.doi.org/10.1371/journal.pone.0013186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949032	Green Published, gold, Green Submitted			2022-12-27	WOS:000282676700005
J	Lambard, S; Reichman, S; Berlinicke, C; Niepon, ML; Goureau, O; Sahel, JA; Leveillard, T; Zack, DJ				Lambard, Sophie; Reichman, Sacha; Berlinicke, Cynthia; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.			Expression of Rod-Derived Cone Viability Factor: Dual Role of CRX in Regulating Promoter Activity and Cell-Type Specificity	PLOS ONE			English	Article							THIOREDOXIN-LIKE PROTEIN; HOMEOBOX GENE; IDENTIFICATION; MUTATIONS; LINE; NRL; DYSTROPHY; THERAPY	Background: RdCVF and RdCVF2, encoded by the nucleoredoxin-like genes NXNL1 and NXNL2, are trophic factors with therapeutic potential that are involved in cone photoreceptor survival. Studying how their expression is regulated in the retina has implications for understanding both their activity and the mechanisms determining cell-type specificity within the retina. Methodology/Principal Findings: In order to define and characterize their promoters, a series of luciferase/GFP reporter constructs that contain various fragments of the 5'-upstream region of each gene, both murine and human, were tested in photoreceptor-like and non-photoreceptor cell lines and also in a biologically more relevant mouse retinal explant system. For NXNL1, 5'-deletion analysis identified the human -205/+57 bp and murine -351/+51 bp regions as having promoter activity. Moreover, in the retinal explants these constructs drove expression specifically to photoreceptor cells. For NXNL2, the human -393/+27 bp and murine -195/+70 bp regions were found to be sufficient for promoter activity. However, despite the fact that endogenous NXNL2 expression is photoreceptor-specific within the retina, neither of these DNA sequences nor larger upstream regions demonstrated photoreceptor-specific expression. Further analysis showed that a 79 bp NXNL2 positive regulatory sequence (-393 to 315 bp) combined with a 134 bp inactive minimal NXNL1 promoter fragment (-77 to +57 bp) was able to drive photoreceptor-specific expression, suggesting that the minimal NXNL1 fragment contains latent elements that encode cell-type specificity. Finally, based on bioinformatic analysis that suggested the importance of a CRX binding site within the minimal NXNL1 fragment, we found by mutation analysis that, depending on the context, the CRX site can play a dual role. Conclusions/Significance: The regulation of the Nucleoredoxin-like genes involves a CRX responsive element that can act as both as a positive regulator of promoter activity and as a modulator of cell-type specificity.	[Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] INSERM, Dept Genet, U968, Paris, France; [Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] UPMC Univ Paris 06, INSERM, UMR S 968, Inst Vis, Paris, France; [Lambard, Sophie; Reichman, Sacha; Niepon, Marie-Laure; Goureau, Olivier; Sahel, Jose-Alain; Leveillard, Thierry; Zack, Donald J.] CNRS, UMR 7210, Paris, France; [Berlinicke, Cynthia; Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Dept Neurosci, Baltimore, MD 21205 USA; [Zack, Donald J.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Lambard, S (corresponding author), INSERM, Dept Genet, U968, Paris, France.	thierry.leveillard@inserm.fr	GOUREAU, Olivier/ABH-9547-2020; Léveillard, Thierry/AAR-1804-2020; Reichman, Sacha/R-7581-2017; GOUREAU, Olivier/F-2752-2017; Sahel, Jose-Alain/F-3172-2017	GOUREAU, Olivier/0000-0001-7730-9143; Léveillard, Thierry/0000-0001-5692-8770; Reichman, Sacha/0000-0003-1776-6339; GOUREAU, Olivier/0000-0001-7730-9143; Sahel, Jose-Alain/0000-0002-4831-1153; Zack, Don/0000-0002-7966-1973	Agence Nationale de la Recherche (ANR); Inserm; Conventions Industrielles de Formation par la Recherche (CIFRE); National Institutes of Health (NIH); Foundation Fighting Blindness; European Vision Institute; NATIONAL EYE INSTITUTE [R01EY009769] Funding Source: NIH RePORTER	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Conventions Industrielles de Formation par la Recherche (CIFRE); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); European Vision Institute; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by funds from Agence Nationale de la Recherche (ANR, Chaire d'excellence), Inserm, Conventions Industrielles de Formation par la Recherche (CIFRE), National Institutes of Health (NIH), Foundation Fighting Blindness, and European Vision Institute FP6 programme acronym GENORET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameixa C, 2000, BIOCHEM J, V347, P485, DOI 10.1042/0264-6021:3470485; Chalmel F, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-74; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cronin T, 2010, CELL DEATH DIFFER, V17, P1199, DOI 10.1038/cdd.2010.2; Cronin T, 2007, CURR GENE THER, V7, P121, DOI 10.2174/156652307780363143; Daiger SP, 2007, ARCH OPHTHALMOL-CHIC, V125, P151, DOI 10.1001/archopht.125.2.151; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fridlich R, 2009, MOL CELL PROTEOMICS, V8, P1206, DOI 10.1074/mcp.M800406-MCP200; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Goodwin P, 2008, CURR OPIN OPHTHALMOL, V19, P255, DOI 10.1097/ICU.0b013e3282fc27fc; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; Ikeda T, 2007, BIOCHEM BIOPH RES CO, V357, P383, DOI 10.1016/j.bbrc.2007.03.133; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; Livesey FJ, 2000, CURR BIOL, V10, P301, DOI 10.1016/S0960-9822(00)00379-1; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Pittler SJ, 2004, J BIOL CHEM, V279, P19800, DOI 10.1074/jbc.M401864200; Reichman S, 2010, HUM MOL GENET, V19, P250, DOI 10.1093/hmg/ddp484; Roger J, 2006, DEV BIOL, V298, P527, DOI 10.1016/j.ydbio.2006.07.003; Sahel JA, 2005, CR BIOL, V328, P163, DOI 10.1016/j.crvi.2004.12.007; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wang J, 2007, BIOCHEM BIOPH RES CO, V357, P8, DOI 10.1016/j.bbrc.2007.02.153; Wang QL, 2004, HUM MOL GENET, V13, P1025, DOI 10.1093/hmg/ddh117; Wang XW, 2008, FREE RADICAL BIO MED, V45, P336, DOI 10.1016/j.freeradbiomed.2008.04.028; Wang XW, 2007, FREE RADICAL BIO MED, V42, P247, DOI 10.1016/j.freeradbiomed.2006.10.040; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yoshida T, 2005, NUCLEIC ACIDS RES, V33, P3465, DOI 10.1093/nar/gki653; ZACK DJ, 1991, NEURON, V6, P187, DOI 10.1016/0896-6273(91)90355-4	40	8	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13075	10.1371/journal.pone.0013075	http://dx.doi.org/10.1371/journal.pone.0013075			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660IN	20949100	Green Submitted, Green Published, gold			2022-12-27	WOS:000282633700004
J	Yoong, J; Burger, N; Spreng, C; Sood, N				Yoong, Joanne; Burger, Nicholas; Spreng, Connor; Sood, Neeraj			Private Sector Participation and Health System Performance in Sub-Saharan Africa	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; CARE PROVISION; QUALITY	Background: The role of the private health sector in developing countries remains a much-debated and contentious issue. Critics argue that the high prices charged in the private sector limits the use of health care among the poorest, consequently reducing access and equity in the use of health care. Supporters argue that increased private sector participation might improve access and equity by bringing in much needed resources for health care and by allowing governments to increase focus on underserved populations. However, little empirical exists for or against either side of this debate. Methodology/Principal Findings: We examine the association between private sector participation and self-reported measures of utilization and equity in deliveries and treatment of childhood respiratory disease using regression analysis, across a sample of nationally-representative Demographic and Health Surveys from 34 SSA economies. We also examine the correlation between private sector participation and key background factors (socioeconomic development, business environment and governance) and use multivariate regression to control for potential confounders. Private sector participation is positively associated with greater overall access and reduced disparities between rich and poor as well as urban and rural populations. The positive association between private sector participation and improved health system performance is robust to controlling for confounders including per capita income and maternal education. Private sector participation is positively correlated with measures of socio-economic development and favorable business environment. Conclusions/Significance: Greater participation is associated with favorable intermediate outcomes in terms of access and equity. While these results do not establish a causal link between private sector participation and health system performance, they suggest that there is no deleterious link between private sector participation and health system performance in SSA.	[Yoong, Joanne; Burger, Nicholas] RAND Corp, Arlington, VA USA; [Spreng, Connor] World Bank, Investment Climate Dept, Washington, DC 20433 USA; [Sood, Neeraj] Univ So Calif, Los Angeles, CA USA; [Sood, Neeraj] RAND Corp, Los Angeles, CA USA	RAND Corporation; The World Bank; University of Southern California; RAND Corporation	Yoong, J (corresponding author), RAND Corp, Arlington, VA USA.	nsood@sppd.usc.edu		Yoong, Joanne/0000-0002-0162-9885; Sood, Neeraj/0000-0001-9805-213X	Schaeffer Center for Health Policy and Economics, University of Southern California; RAND Corporation; World Bank Group	Schaeffer Center for Health Policy and Economics, University of Southern California; RAND Corporation; World Bank Group	Sood acknowledges funding from the Schaeffer Center for Health Policy and Economics, University of Southern California. Yoong and Burger acknowledge funding from the RAND Corporation. Spreng acknowledges funding from the World Bank Group. As the authors are employees of RAND and the World Bank, the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this work are those of the authors and not necessarily those of RAND, USC, the World Bank or its affiliate institutions.	[Anonymous], 2007, BUS HLTH AFR PARTN P; Berman PA, 1998, WORLD DEV, V26, P1463, DOI 10.1016/S0305-750X(98)00059-X; Brugha R, 1998, HEALTH POLICY PLANN, V13, P107, DOI 10.1093/heapol/13.2.107; Chakraborty S, 2002, SOC SCI MED, V55, P1579, DOI 10.1016/S0277-9536(01)00292-1; Dahlgren G, 2007, INT J HEALTH SERV, V37, P363, DOI 10.2190/U814-6X80-N787-807J; Das J, 2008, J ECON PERSPECT, V22, P93, DOI 10.1257/jep.22.2.93; Gilson L, 2007, WHO COMM SOC DET HLT; Hanson K, 1998, HEALTH POLICY PLANN, V13, P195, DOI 10.1093/heapol/13.3.195; Hanson K, 2008, PLOS MED, V5, P1528, DOI 10.1371/journal.pmed.0050233; Kakwani N, 1997, J ECONOMETRICS, V77, P87, DOI 10.1016/S0304-4076(96)01807-6; Kamat VR, 2001, SOC SCI MED, V52, P885, DOI 10.1016/S0277-9536(00)00191-X; Mills A, 2002, B WORLD HEALTH ORGAN, V80, P325; PATOUILLARD E, 2007, INT J EQUITY HEALTH, V6, P6; Preker AS, 2003, PRIVATE PARTICIPATIO; Sauerborn R, 2001, INT J QUAL HEALTH C, V13, P281, DOI 10.1093/intqhc/13.4.281; WHO, 2008, PHARMAFORUM 0121; Zwi AB, 2001, BRIT MED J, V323, P463, DOI 10.1136/bmj.323.7311.463	17	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2010	5	10							e13243	10.1371/journal.pone.0013243	http://dx.doi.org/10.1371/journal.pone.0013243			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	660IN	20949054	Green Published, gold, Green Submitted			2022-12-27	WOS:000282633700020
J	Feng, J; Wang, QS; Chiang, A; Chen, BY				Feng, Jing; Wang, Qing-shan; Chiang, Ambrose; Chen, Bao-yuan			The Effects of Sleep Hypoxia on Coagulant Factors and Hepatic Inflammation in Emphysematous Rats	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; QUALITY-OF-LIFE; FACTOR-KAPPA-B; COPD PATIENTS; NOCTURNAL DESATURATION; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; ALVEOLAR HYPOXIA; OXYGEN; HYPERTENSION	Objectives: To develop a sleep hypoxia (SH) in emphysema (SHE) rat model and to explore whether SHE results in more severe hepatic inflammation than emphysema alone and whether the inflammation changes levels of coagulant/anticoagulant factors synthesized in the liver. Methods: Seventy-five rats were put into 5 groups: SH control (SHCtrl), treated with sham smoke exposure (16 weeks) and SH exposure (12.5% O-2, 3 h/d, latter 8 weeks); emphysema control (ECtrl), smoke exposure and sham SH exposure (21% O-2); short SHE (SHEShort), smoke exposure and short SH exposure (1.5 h/d); mild SHE (SHEMild), smoke exposure and mild SH exposure (15% O-2); standard SHE (SHEStand), smoke exposure and SH exposure. Therefore, ECtrl, SHEShort, SHEMild and SHEStand group were among emphysematous groups. Arterial blood gas (ABG) data was obtained during preliminary tests. After exposure, hepatic inflammation (interleukin -6 [IL-6] mRNA and protein, tumor necrosis factor alpha [TNF alpha] mRNA and protein) and liver coagulant/anticoagulant factors (antithrombin [AT], fibrinogen [FIB] and Factor VIII [F VIII]) were evaluated. SPSS 11.5 software was used for statistical analysis. Results: Characteristics of emphysema were obvious in emphysematous groups and ABGs reached SH criteria on hypoxia exposure. Hepatic inflammation parameters and coagulant factors are the lowest in SHCtrl and the highest in SHEStand while AT is the highest in SHCtrl and the lowest in SHEStand. Inflammatory cytokines of liver correlate well with coagulant factors positively and with AT negatively. Conclusions: When SH is combined with emphysema, hepatic inflammation and coagulability enhance each other synergistically and produce a more significant liver-derivative inflammatory and prothrombotic status.	[Feng, Jing; Chen, Bao-yuan] Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China; [Feng, Jing; Chiang, Ambrose] Duke Univ, Med Ctr, Div Pulm & Crit Care Med, Durham, NC USA; [Wang, Qing-shan] Shandong Univ, Inst Toxicol, Jinan 250100, Shandong, Peoples R China	Tianjin Medical University; Duke University; Shandong University	Feng, J (corresponding author), Tianjin Med Univ, Gen Hosp, Resp Dept, Tianjin, Peoples R China.	zyyhxkcby@yahoo.com.cn	Wang, Qingshan/P-4861-2014	Wang, Qingshan/0000-0002-8724-7465	National Natural Science Foundation of China [30800507, 30770934]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Natural Science Foundation of China (No. 30800507, 30770934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, P165; Barnes PJ, 2009, EUR RESPIR J, V33, P1165, DOI 10.1183/09031936.00128008; Barnes PJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000220; Becker HF, 1999, AM J RESP CRIT CARE, V159, P112, DOI 10.1164/ajrccm.159.1.9803037; Bendz B, 2000, LANCET, V356, P1657, DOI 10.1016/S0140-6736(00)03165-2; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P74, DOI 10.1164/rccm.200409-1257OC; Brijker F, 2001, CHEST, V119, P1820, DOI 10.1378/chest.119.6.1820; Casey KR, 2007, CHEST, V131, P1936, DOI 10.1378/chest.06-2334; CELLI BR, 1995, AM J RESP CRIT CARE, V152, pS77; Chao J, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-54; Chaouat A, 2008, EUR RESPIR J, V32, P1371, DOI 10.1183/09031936.00015608; COSIO M, 1978, NEW ENGL J MED, V298, P1277, DOI 10.1056/NEJM197806082982303; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Fabbri LM, 2007, LANCET, V370, P797, DOI 10.1016/S0140-6736(07)61383-X; Feng J, 2009, SLEEP BREATH, V13, P277, DOI 10.1007/s11325-009-0246-6; Feng Jing, 2007, Zhonghua Yi Xue Za Zhi, V87, P774; Feng Jing, 2007, Zhonghua Jiehe He Huxi Zazhi, V30, P202; FLETCHER EC, 1992, CHEST, V101, P649, DOI 10.1378/chest.101.3.649; FLETCHER EC, 1987, CHEST, V92, P604, DOI 10.1378/chest.92.4.604; Fuhrmann V, 2009, INTENS CARE MED, V35, P1397, DOI 10.1007/s00134-009-1508-2; GERTLER JP, 1993, J VASC SURG, V18, P939, DOI 10.1016/0741-5214(93)90548-Z; GERTLER JP, 1991, J VASC SURG, V13, P428, DOI 10.1067/mva.1991.25767; Goldhaber SZ, 2004, AM J CARDIOL, V93, P259, DOI 10.1016/j.amjcard.2003.09.057; Gonzalez NC, 2010, ADV EXP MED BIOL, V662, P27, DOI 10.1007/978-1-4419-1241-1_3; Horner RL, 1997, J NEUROSCI, V17, P7541; Kardos Peter, 2006, MedGenMed, V8, P54; Kim Victor, 2008, Proc Am Thorac Soc, V5, P513, DOI 10.1513/pats.200708-124ET; KOO KW, 1975, AM J MED, V58, P663, DOI 10.1016/0002-9343(75)90502-1; Krachman Samuel, 2008, Proc Am Thorac Soc, V5, P536, DOI 10.1513/pats.200708-134ET; Krachman SL, 2005, CHEST, V128, P3221, DOI 10.1378/chest.128.5.3221; Lee LH, 2005, AM J RESP CRIT CARE, V172, P987, DOI 10.1164/rccm.200501-041OC; Lewis CA, 2009, THORAX, V64, P133, DOI 10.1136/thx.2007.088930; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; Nunes DM, 2009, LUNG, V187, P159, DOI 10.1007/s00408-009-9147-5; O'Donoghue FJ, 2004, J PHYSIOL-LONDON, V559, P663, DOI 10.1113/jphysiol.2004.066084; O'Reilly P, 2007, CURR OPIN PULM MED, V13, P120, DOI 10.1097/MCP.0b013e32802c7cfe; OLDS RJ, 1994, SEMIN THROMB HEMOST, V20, P353, DOI 10.1055/s-2007-1001927; Orem JM, 2005, SLEEP, V28, P801, DOI 10.1093/sleep/28.7.801; Papaioannou AI, 2010, RESP MED, V104, P275, DOI 10.1016/j.rmed.2009.09.016; PDE TM, 2008, J BRAS PNEUMOL, V34, P567; Plywaczewski R, 2000, CHEST, V117, P679, DOI 10.1378/chest.117.3.679; Rota S, 1998, BLOOD, V91, P508, DOI 10.1182/blood.V91.2.508.508_508_515; Sabit R, 2010, CHEST, V138, P47, DOI 10.1378/chest.09-2764; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; Sergi M, 2002, RESPIRATION, V69, P117, DOI 10.1159/000056313; Tapson Victor F, 2005, Proc Am Thorac Soc, V2, P71, DOI 10.1513/pats.200407-038MS; Ten Vadim S, 2002, Curr Opin Crit Care, V8, P242, DOI 10.1097/00075198-200206000-00008; THURLBEC.WM, 1967, THORAX, V22, P483, DOI 10.1136/thx.22.6.483; Tillie-Leblond I, 2006, ANN INTERN MED, V144, P390, DOI 10.7326/0003-4819-144-6-200603210-00005; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Vaidyula VR, 2009, THROMB RES, V124, P259, DOI 10.1016/j.thromres.2008.12.030; van Eeden SF, 2008, RESPIRATION, V75, P224, DOI 10.1159/000111820; Viegi G, 2001, RESPIRATION, V68, P4, DOI 10.1159/000050456; Wagner U, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-12	55	16	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13201	10.1371/journal.pone.0013201	http://dx.doi.org/10.1371/journal.pone.0013201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949089	Green Published, gold			2022-12-27	WOS:000282568400013
J	Pecarevic, M; Danoff-Burg, J; Dunn, RR				Pecarevic, Marko; Danoff-Burg, James; Dunn, Robert R.			Biodiversity on Broadway - Enigmatic Diversity of the Societies of Ants (Formicidae) on the Streets of New York City	PLOS ONE			English	Article							HYMENOPTERA; ECOLOGY; URBANIZATION; HABITAT; FRAGMENTATION; CONSERVATION; COMMUNITIES; ASSEMBLAGES	Each year, a larger proportion of the Earth's surface is urbanized, and a larger proportion of the people on Earth lives in those urban areas. The everyday nature, however, that humans encounter in cities remains poorly understood. Here, we consider perhaps the most urban green habitat, street medians. We sampled ants from forty-four medians along three boulevards in New York City and examined how median properties affect the abundance and species richness of native and introduced ants found on them. Ant species richness varied among streets and increased with area but was independent of the other median attributes measured. Ant assemblages were highly nested, with three numerically dominant species present at all medians and additional species present at a subset of medians. The most common ant species were the introduced Pavement ant (Tetramorium caespitum) and the native Thief ant (Solenopsis molesta) and Cornfield ant (Lasius neoniger). The common introduced species on the medians responded differently to natural and disturbed elements of medians. Tetramorium caespitum was most abundant in small medians, with the greatest edge/area ratio, particularly if those medians had few trees, whereas Nylanderia flavipes was most abundant in the largest medians, particularly if they had more trees. Many of the species encountered in Manhattan were similar to those found in other large North American cities, such that a relatively small subset of ant species probably represent most of the encounters humans have with ants in North America.	[Pecarevic, Marko; Danoff-Burg, James] Columbia Univ, Dept Ecol Evolut & Environm Biol E3B, New York, NY 10027 USA; [Pecarevic, Marko] State Inst Nat Protect, Zagreb, Croatia; [Danoff-Burg, James] Columbia Univ, CEES, New York, NY USA; [Dunn, Robert R.] N Carolina State Univ, Dept Biol, Raleigh, NC 27695 USA; [Dunn, Robert R.] N Carolina State Univ, Keck Behav Biol Ctr, Raleigh, NC 27695 USA	Columbia University; Columbia University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Pecarevic, M (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol E3B, New York, NY 10027 USA.	marko.pecarevic@gmail.com	Dunn, Robert/B-1360-2013	Danoff-Burg, James/0000-0002-0685-6948; Dunn, Robert/0000-0002-6030-4837	United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR); DOE [DE-FG02-08ER64510]; National Science Foundation (NSF); National Aeronautics and Space Administration (NASA) [NNX09AK22G]; Office Of The Director [0809267] Funding Source: National Science Foundation	United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR)(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF)); National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	RRD was supported by a United States Department of Energy (DOE) National Institute for Climatic Change Research (DOE-NICCR) grant, DOE Program for Ecosystem Research (DOE-PER) grant (DE-FG02-08ER64510), a National Science Foundation (NSF) Career grant and a National Aeronautics and Space Administration (NASA) Biodiversity grant (NNX09AK22G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso Leeanne E., 2000, P80; Andersen AN, 2002, J APPL ECOL, V39, P8, DOI 10.1046/j.1365-2664.2002.00704.x; Anderson D. R., 2008, MODEL BASED INFERENC; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; ATMAR W, 1993, OECOLOGIA, V96, P373, DOI 10.1007/BF00317508; ATMAR W, 1995, NESTEDNESS TEMPERATU; Beier P, 1998, CONSERV BIOL, V12, P1241, DOI 10.1046/j.1523-1739.1998.98036.x; Bestelmeyer Brandon T., 2000, P122; BIERREGAARD RO, 1992, BIOSCIENCE, V42, P859, DOI 10.2307/1312085; Bruhl CA, 2003, BIODIVERS CONSERV, V12, P1371, DOI 10.1023/A:1023621609102; BUCZKOWSKI G, 2010, BIOL INVASIONS, P1387; Chawla L., 1998, J ENVIRON EDUC, V4, P369, DOI DOI 10.1080/00958969809599114; Chawla L., 1999, J ENVIRON EDUC, V31, P15, DOI [10.1080/00958969909598628, DOI 10.1080/00958969909598628]; Clarke Kevin M., 2008, Urban Ecosystems, V11, P317, DOI 10.1007/s11252-008-0065-8; Cohn JP, 2005, BIOSCIENCE, V55, P201, DOI 10.1641/0006-3568(2005)055[0201:UW]2.0.CO;2; Collingwood CA, 1997, J ARID ENVIRON, V37, P505, DOI 10.1006/jare.1997.0309; Colwell R.K., 2009, ESTIMATE S STAT ESTI; COPE R, 2006, UNDERSTANDING SPREAD; Crawley M. J, 2002, STAT COMPUTING INTRO; de Bruyn LAL, 1999, AGR ECOSYST ENVIRON, V74, P425, DOI 10.1016/S0167-8809(99)00047-X; Dunn RR, 2010, ANT ECOLOGY, P38; Dunn RR, 2006, CONSERV BIOL, V20, P1814, DOI 10.1111/j.1523-1739.2006.00533.x; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; FRANKIE GW, 1978, ANNU REV ENTOMOL, V23, P367, DOI 10.1146/annurev.en.23.010178.002055; Friedrich R, 2009, ENVIRON ENTOMOL, V38, P600, DOI 10.1603/022.038.0311; Guenard B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011614; HERBERT RA, 1965, AUK, V82, P62; Holldobler B., 1990, pi; Holldobler B, 1994, JOURNEY ANTS; Ivanov K, 2008, P ENTOMOL SOC WASH, V110, P439, DOI 10.4289/07-046.1; Kaspari M, 2000, AM NAT, V155, P280, DOI 10.1086/303313; Klotz J., 2008, URBAN ANTS N AM EURO; KLOTZ JH, 1995, FLA ENTOMOL, V78, P109, DOI 10.2307/3495674; KONDOH M, 1984, Journal of UOEH, V6, P221; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; Lassau SA, 2004, ECOGRAPHY, V27, P157, DOI 10.1111/j.0906-7590.2004.03675.x; Lessard JP, 2009, INSECT SOC, V56, P149, DOI 10.1007/s00040-009-0006-4; Lessard JP, 2005, CAN ENTOMOL, V137, P215, DOI 10.4039/N04-055; Louv R, 2008, LAST CHILD WOODS SAV; MAC ARTHUR ROBERT H., 1967; McIntyre NE, 2000, ANN ENTOMOL SOC AM, V93, P825, DOI 10.1603/0013-8746(2000)093[0825:EOUAAR]2.0.CO;2; McIntyre NE., 2000, URBAN ECOSYST, V4, P5, DOI [10.1023/A:1009540018553, DOI 10.1023/A:1009540018553]; Mehtala J, 2006, TRENDS ECOL EVOL, V21, P116, DOI 10.1016/j.tree.2005.12.001; Menke SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009194; Miller JR, 2002, CONSERV BIOL, V16, P330, DOI 10.1046/j.1523-1739.2002.00420.x; Na Julie P.S., 2001, Tropical Biomedicine, V18, P1; Nelder MP, 2006, J MED ENTOMOL, V43, P1094, DOI 10.1603/0022-2585(2006)43[1094:EOTIAP]2.0.CO;2; Niemela J, 1999, BIODIVERS CONSERV, V8, P119, DOI 10.1023/A:1008817325994; NUHN TP, 1979, AM MIDL NAT, V102, P353, DOI 10.2307/2424662; Pauchard A, 2006, BIOL CONSERV, V127, P272, DOI 10.1016/j.biocon.2005.05.015; Peck SL, 1998, ENVIRON ENTOMOL, V27, P1102, DOI 10.1093/ee/27.5.1102; Pickett STA, 2001, ANNU REV ECOL SYST, V32, P127, DOI 10.1146/annurev.ecolsys.32.081501.114012; PLOWES N, 2008, SELF ORG CONFLICT TE; Plowes RM, 2007, BIOL INVASIONS, V9, P825, DOI 10.1007/s10530-006-9084-7; REBELE F, 1994, GLOBAL ECOL BIOGEOGR, V4, P173, DOI 10.2307/2997649; Sanford MP, 2009, CONSERV BIOL, V23, P131, DOI 10.1111/j.1523-1739.2008.01040.x; *SAS I INC, 1989, JMP 7; Savard JPL, 2000, LANDSCAPE URBAN PLAN, V48, P131, DOI 10.1016/S0169-2046(00)00037-2; Schaefer V., 2003, GREEN LINKS URBAN BI; Schultz Ted R., 2000, P35; SIMBERLOFF D, 1976, ECOLOGY, V57, P629, DOI 10.2307/1936179; Small EC, 2002, J INSECT CONSERV, V6, P233, DOI 10.1023/A:1024491111572; Smith RM, 2006, BIODIVERS CONSERV, V15, P2415, DOI 10.1007/s10531-004-5014-0; Sokal R. R, 1981, BIOMETRY; Suarez AV, 1998, ECOLOGY, V79, P2041, DOI 10.1890/0012-9658(1998)079[2041:EOFAIO]2.0.CO;2; Talbot M, 1934, ECOLOGY, V15, P416, DOI 10.2307/1932358; TERBORGH J, 1977, ECOLOGY, V58, P1007, DOI 10.2307/1936921; Thompson Bill, 2007, Urban Ecosystems, V10, P43, DOI 10.1007/s11252-006-0013-4; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; UN, 2008, WORLD URB PROSP 2007; Weisman A., 2008, WORLD US; WERNER FG, 1994, INSECTS SW IDENTIFY; Whittaker RJ, 1998, ISLAND BIOGEOGRAPHY; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yamaguchi T, 2005, ENTOMOL SCI, V8, P17, DOI 10.1111/j.1479-8298.2005.00096.x	75	43	47	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2010	5	10							e13222	10.1371/journal.pone.0013222	http://dx.doi.org/10.1371/journal.pone.0013222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	658RC	20957156	Green Published, Green Submitted, gold			2022-12-27	WOS:000282506100016
J	Seinen, E; Burgerhof, JGM; Jansen, RC; Sibon, OCM				Seinen, Erwin; Burgerhof, Johannes G. M.; Jansen, Ritsert C.; Sibon, Ody C. M.			RNAi Experiments in D. melanogaster: Solutions to the Overlooked Problem of Off-Targets Shared by Independent dsRNAs	PLOS ONE			English	Article							MESSENGER-RNA; LONG DSRNAS; HUMAN-CELLS; INTERFERENCE; DROSOPHILA; MICRORNAS; NUCLEUS; SCREENS; SIRNA; MIRNA	Background: RNAi technology is widely used to downregulate specific gene products. Investigating the phenotype induced by downregulation of gene products provides essential information about the function of the specific gene of interest. When RNAi is applied in Drosophila melanogaster or Caenorhabditis elegans, often large dsRNAs are used. One of the drawbacks of RNAi technology is that unwanted gene products with sequence similarity to the gene of interest can be down regulated too. To verify the outcome of an RNAi experiment and to avoid these unwanted off-target effects, an additional non-overlapping dsRNA can be used to down-regulate the same gene. However it has never been tested whether this approach is sufficient to reduce the risk of off-targets. Methodology: We created a novel tool to analyse the occurance of off-target effects in Drosophila and we analyzed 99 randomly chosen genes. Principal Findings: Here we show that nearly all genes contain non-overlapping internal sequences that do show overlap in a common off-target gene. Conclusion: Based on our in silico findings, off-target effects should not be ignored and our presented on-line tool enables the identification of two RNA interference constructs, free of overlapping off-targets, from any gene of interest.	[Seinen, Erwin; Sibon, Ody C. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands; [Burgerhof, Johannes G. M.] Univ Groningen, Univ Med Ctr Groningen, Fac Med Sci, Groningen, Netherlands; [Jansen, Ritsert C.] Univ Groningen, Groningen Bioinformat Ctr, Groningen Biomol Sci & Biotechnol Inst, Haren, Netherlands	University of Groningen; University of Groningen; University of Groningen	Seinen, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Radiat & Stress Cell Biol, Groningen, Netherlands.	o.c.m.sibon@med.umcg.nl	Jansen, Ritsert C/C-1160-2013; Burgerhof, Johannes G/B-2455-2013	Jansen, Ritsert C/0000-0003-2977-9110; Burgerhof, Johannes G/0000-0003-3827-9601; Sibon, Ody/0000-0002-6836-6063	Netherlands Organization for Scientific Research (NWO) [971-36-400]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a VIDI grant from the Netherlands Organization for Scientific Research (NWO; 971-36-400) to O.C.M.S. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosher JM, 1999, GENETICS, V153, P1245; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Langlois MA, 2005, J BIOL CHEM, V280, P16949, DOI 10.1074/jbc.M501591200; Lin SL, 2008, FRONT BIOSCI-LANDMRK, V13, P2216, DOI 10.2741/2836; Lin SL, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/26818; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Moffat J, 2007, TRENDS PHARMACOL SCI, V28, P149, DOI 10.1016/j.tips.2007.02.009; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Qiu S, 2005, NUCLEIC ACIDS RES, V33, P1834, DOI 10.1093/nar/gki324; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Saxena S, 2003, J BIOL CHEM, V278, P44312, DOI 10.1074/jbc.M307089200; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Weinberg MS, 2007, NUCLEIC ACIDS RES, V35, P7303, DOI 10.1093/nar/gkm847	25	13	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13119	10.1371/journal.pone.0013119	http://dx.doi.org/10.1371/journal.pone.0013119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957038	Green Submitted, Green Published, gold			2022-12-27	WOS:000282359300017
J	Davis, BM; Jensen, R; Williams, P; O'Shea, P				Davis, Benjamin Michael; Jensen, Rasmus; Williams, Paul; O'Shea, Paul			The Interaction of N-Acylhomoserine Lactone Quorum Sensing Signaling Molecules with Biological Membranes: Implications for Inter-Kingdom Signaling	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA AUTOINDUCER; N-(3-OXODODECANOYL)-L-HOMOSERINE LACTONE; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; PHOSPHOLIPID-MEMBRANES; GENE-EXPRESSION; CELL-ACTIVATION; LIPID RAFTS; IN-VIVO; RECEPTORS	Background: The long chain N-acylhomoserine lactone (AHL) quorum sensing signal molecules released by Pseudomonas aeruginosa have long been known to elicit immunomodulatory effects through a process termed inter-kingdom signaling. However, to date very little is known regarding the exact mechanism of action of these compounds on their eukaryotic targets. Methodology/Principal Findings: The use of the membrane dipole fluorescent sensor di-8-ANEPPS to characterise the interactions of AHL quorum sensing signal molecules, N-(3-oxotetradecanoyl)-L-homoserine lactone (3-oxo-C14-HSL), N-(3-oxododecanoyl) homoserine-L-lactone (3-oxo-C12-HSL) and N-(3-oxodecanoyl) homoserine-L-lactone (3-oxo-C10 HSL) produced by Pseudomonas aeruginosa with model and cellular membranes is reported. The interactions of these AHLs with artificial membranes reveal that each of the compounds is capable of membrane interaction in the micromolar concentration range causing significant modulation of the membrane dipole potential. These interactions fit simple hyperbolic binding models with membrane affinity increasing with acyl chain length. Similar results were obtained with T-lymphocytes providing the evidence that AHLs are capable of direct interaction with the plasma membrane. 3-oxo-C12-HSL interacts with lymphocytes via a cooperative binding model therefore implying the existence of an AHL membrane receptor. The role of cholesterol in the interactions of AHLs with membranes, the significance of modulating cellular dipole potential for receptor conformation and the implications for immune modulation are discussed. Conclusions/Significance: Our observations support previous findings that increasing AHL lipophilicity increases the immunomodulatory activity of these quorum compounds, while providing evidence to suggest membrane interaction plays an important role in quorum sensing and implies a role for membrane microdomains in this process. Finally, our results suggest the existence of a eukaryotic membrane-located system that acts as an AHL receptor.	[Davis, Benjamin Michael; O'Shea, Paul] Univ Nottingham, Inst Biophys Imaging & Opt Sci, Cell Biophys Grp, Nottingham NG7 2RD, England; [Jensen, Rasmus; Williams, Paul] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Davis, BM (corresponding author), Univ Nottingham, Inst Biophys Imaging & Opt Sci, Cell Biophys Grp, Nottingham NG7 2RD, England.	paul.oshea@nottingham.ac.uk	Williams, Paul/A-5629-2011; Williams, Paul/P-5224-2019	Williams, Paul/0000-0002-1920-5036; Davis, Benjamin/0000-0001-6121-1635; O'Shea, paul/0000-0001-9313-8313	Engineering and Physical Sciences Research Council (EPSRC) [C534697]; UK national research council organizations; Medical Research Council (MRC) [G9219778]; MRC [G9219778] Funding Source: UKRI; Medical Research Council [G9219778] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); UK national research council organizations; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors are grateful to the UK national research council organizations, the Engineering and Physical Sciences Research Council (EPSRC) [URL:www.EPSRC.ac.uk] (reference C534697) and the Medical Research Council (MRC) [URL: www.mrc.ac.uk] (reference G9219778) for support for much of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asawakarn T, 2001, J BIOL CHEM, V276, P38457, DOI 10.1074/jbc.M103269200; Balbis A, 2010, J CELL BIOCHEM, V109, P1103, DOI 10.1002/jcb.22505; Bari M, 2005, J BIOL CHEM, V280, P12212, DOI 10.1074/jbc.M411642200; Charlton TS, 2000, ENVIRON MICROBIOL, V2, P530, DOI 10.1046/j.1462-2920.2000.00136.x; CHHABRA SR, 1993, J ANTIBIOT, V46, P441, DOI 10.7164/antibiotics.46.441; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; Cladera J, 1998, BIOPHYS J, V74, P2434, DOI 10.1016/S0006-3495(98)77951-2; Cladera J, 1999, J BIOL CHEM, V274, P29951, DOI 10.1074/jbc.274.42.29951; Clarke RJ, 2001, ADV COLLOID INTERFAC, V89, P263, DOI 10.1016/S0001-8686(00)00061-0; Cooley M, 2008, CHEM BIOL, V15, P1141, DOI 10.1016/j.chembiol.2008.10.010; Demeule M, 2000, FEBS LETT, V466, P219, DOI 10.1016/S0014-5793(00)01087-5; Duggan J, 2008, EUR BIOPHYS J BIOPHY, V37, P1279, DOI 10.1007/s00249-008-0349-1; Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x; Filipp D, 2004, MOL IMMUNOL, V41, P645, DOI 10.1016/j.molimm.2004.04.011; Gardiner SM, 2001, BRIT J PHARMACOL, V133, P1047, DOI 10.1038/sj.bjp.0704174; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; Jahoor A, 2008, J BACTERIOL, V190, P4408, DOI 10.1128/JB.01444-07; Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102; Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594; Kravchenko VV, 2008, SCIENCE, V321, P259, DOI 10.1126/science.1156499; Kravchenko VV, 2006, J BIOL CHEM, V281, P28822, DOI 10.1074/jbc.M606613200; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; Lowery CA, 2009, J AM CHEM SOC, V131, P14473, DOI 10.1021/ja9056079; Luker GD, 2001, J BIOL CHEM, V276, P49053, DOI 10.1074/jbc.M105192200; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; McKeegan KS, 2004, CURR OPIN PHARMACOL, V4, P479, DOI 10.1016/j.coph.2004.07.002; Middleton B, 2002, FEMS MICROBIOL LETT, V207, P1; O'Shea P, 2005, PHILOS T R SOC A, V363, P575, DOI 10.1098/rsta.2004.1509; O'Shea P, 2004, BIOELECTROCHEM P & P, V6, P23; O'Shea P, 2003, BIOCHEM SOC T, V31, P990; Ozer EA, 2005, FEMS MICROBIOL LETT, V253, P29, DOI 10.1016/j.femsle.2005.09.023; Pritchard DI, 2006, INT J MED MICROBIOL, V296, P111, DOI 10.1016/j.ijmm.2006.01.037; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Richardson G, 2007, BIOPHYS J, V92, P4145, DOI 10.1529/biophysj.106.090233; Ritchie AJ, 2007, IMMUNOL CELL BIOL, V85, P596, DOI 10.1038/sj.icb.7100090; Ritchie AJ, 2005, INFECT IMMUN, V73, P1648, DOI 10.1128/IAI.73.3.1648-1655.2005; Ritchie AJ, 2003, INFECT IMMUN, V71, P4421, DOI 10.1128/IAI.71.8.4421-4431.2003; Robert J, 2003, J MED CHEM, V46, P4805, DOI 10.1021/jm030183a; Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036; SEABRA R, 2008, CALCIUM BINDING PROT, V3, P31; Shiner EK, 2006, CELL MICROBIOL, V8, P1601, DOI 10.1111/j.1462-5822.2006.00734.x; Shiner Erin K, 2004, Biol Proced Online, V6, P268, DOI 10.1251/bpo98; Smith RS, 2002, J BACTERIOL, V184, P1132, DOI 10.1128/jb.184.4.1132-1139.2002; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Tateda K, 2003, INFECT IMMUN, V71, P5785, DOI 10.1128/IAI.71.10.5785-5793.2003; Telford G, 1998, INFECT IMMUN, V66, P36, DOI 10.1128/IAI.66.1.36-42.1998; TEPLITSKI M, 2010, PERCEPTION DEGRADATI; Vikstrom E, 2009, EXP CELL RES, V315, P313, DOI 10.1016/j.yexcr.2008.10.044; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Williams P, 2009, CURR OPIN MICROBIOL, V12, P182, DOI 10.1016/j.mib.2009.01.005; Yates EA, 2002, INFECT IMMUN, V70, P5635, DOI 10.1128/IAI.70.10.5635-5646.2002; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257	52	60	63	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13522	10.1371/journal.pone.0013522	http://dx.doi.org/10.1371/journal.pone.0013522			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20975958	Green Published, gold, Green Submitted			2022-12-27	WOS:000283216400026
J	Ramirez-Villegas, J; Khoury, C; Jarvis, A; Debouck, DG; Guarino, L				Ramirez-Villegas, Julian; Khoury, Colin; Jarvis, Andy; Gabriel Debouck, Daniel; Guarino, Luigi			A Gap Analysis Methodology for Collecting Crop Genepools: A Case Study with Phaseolus Beans	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; WILD RELATIVES; CLIMATE-CHANGE; SAMPLE-SIZE; CONSERVATION; DISTRIBUTIONS; PERFORMANCE; DIVERSITY; BIAS; PREDICTION	Background: The wild relatives of crops represent a major source of valuable traits for crop improvement. These resources are threatened by habitat destruction, land use changes, and other factors, requiring their urgent collection and long-term availability for research and breeding from ex situ collections. We propose a method to identify gaps in ex situ collections (i.e. gap analysis) of crop wild relatives as a means to guide efficient and effective collecting activities. Methodology/Principal Findings: The methodology prioritizes among taxa based on a combination of sampling, geographic, and environmental gaps. We apply the gap analysis methodology to wild taxa of the Phaseolus genepool. Of 85 taxa, 48 (56.5%) are assigned high priority for collecting due to lack of, or under-representation, in genebanks, 17 taxa are given medium priority for collecting, 15 low priority, and 5 species are assessed as adequately represented in ex situ collections. Gap "hotspots'', representing priority target areas for collecting, are concentrated in central Mexico, although the narrow endemic nature of a suite of priority species adds a number of specific additional regions to spatial collecting priorities. Conclusions/Significance: Results of the gap analysis method mostly align very well with expert opinion of gaps in ex situ collections, with only a few exceptions. A more detailed prioritization of taxa and geographic areas for collection can be achieved by including in the analysis predictive threat factors, such as climate change or habitat destruction, or by adding additional prioritization filters, such as the degree of relatedness to cultivated species (i.e. ease of use in crop breeding). Furthermore, results for multiple crop genepools may be overlaid, which would allow a global analysis of gaps in ex situ collections of the world's plant genetic resources.	[Ramirez-Villegas, Julian; Jarvis, Andy] Int Ctr Trop Agr CIAT, Decis & Policy Anal Program, Cali, Colombia; [Khoury, Colin; Guarino, Luigi] Global Crop Divers Trust, Rome, Italy; [Jarvis, Andy] Agr & Food Secur CCAFS, Challenge Program Climate Change, Copenhagen, Denmark; [Jarvis, Andy] Reg Off Amer, Cali, Colombia; [Gabriel Debouck, Daniel] Int Ctr Trop Agr CIAT, Genet Resources Unit, Cali, Colombia	Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT	Ramirez-Villegas, J (corresponding author), Int Ctr Trop Agr CIAT, Decis & Policy Anal Program, Cali, Colombia.	j.r.villegas@cgiar.org	Khoury, Colin K./AAA-1864-2020; Ramirez-Villegas, Julian/AAY-8073-2020; Jarvis, Andy/K-5516-2013	Khoury, Colin K./0000-0001-7893-5744; Ramirez-Villegas, Julian/0000-0002-8044-583X; Jarvis, Andy/0000-0001-6543-0798	Grains Research and Development Corporation (GRDC); System-wide Genetic Resources Program (SGRP) of Bioversity International; World Bank	Grains Research and Development Corporation (GRDC)(Grains R&D Corp); System-wide Genetic Resources Program (SGRP) of Bioversity International; World Bank(The World Bank India)	The Grains Research and Development Corporation (GRDC, http://www.grdc.com.au/), provided the initial funding that allowed the development of the methodology, and the gathering of input data. Global Public Goods Phase 2 of the System-wide Genetic Resources Program (SGRP) of Bioversity International (http://www.sgrp.cgiar.org/), provided part of the funding for the final phase of the project. The World Bank (http://www.worldbank.org/), likewise, provided part of the funding for the final phase of the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Gallegos JA, 2007, CROP SCI, V47, pS44, DOI 10.2135/cropsci2007.04.0008IPBS; [Anonymous], 2007, IPCC 4 ASS REP CLIM; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; BURLE ML, 2003, PLANT GENETIC RESOUR, V135, P1; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Munoz LC, 2006, CROP SCI, V46, P1744, DOI 10.2135/cropsci2005-12-0475; Challinor AJ, 2007, AGR ECOSYST ENVIRON, V119, P190, DOI 10.1016/j.agee.2006.07.009; Costa GC, 2010, BIODIVERS CONSERV, V19, P883, DOI 10.1007/s10531-009-9746-8; Debouck D. G., 2000, The Seventh Ministry of Agriculture, Forestry and Fisheries (MAFF), Japan, International Workshop on Genetic Resources, Ibaraki, Japan, 13-15 October, 1999: Part 1, wild legumes., P95; Debouck D.G., 1999, COMMON BEAN IMPROVEM, P25, DOI DOI 10.1007/978-94-015-9211-6_2; Debouck D. G., 1995, EVOLUTION CROP PLANT, P287; DEBOUCK DG, 2009, CAHIERS PHASEOLOGIE; Delgado-Salinas A, 1999, SYST BOT, V24, P438, DOI 10.2307/2419699; Delgado-Salinas Alfonso, 2007, Lundellia, V10, P11; DELGADOSALINAS A, 1985, THESIS U TEXAS AUSTI, P363; Dormann CF, 2007, BASIC APPL ECOL, V8, P387, DOI 10.1016/j.baae.2006.11.001; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fitzpatrick MC, 2009, BIODIVERS CONSERV, V18, P2255, DOI 10.1007/s10531-009-9584-8; Food and Agriculture Organization of the United Nations (FAO), 1997, STAT WORLDS PLANT GE; Freytag G.F., 2002, TAXONOMY DISTRIBUTIO; GARVIN DF, 1994, CROP SCI, V34, P1390, DOI 10.2135/cropsci1994.0011183X003400050045x; Gepts P., 2001, ENCY GENET, P1444; Graham CH, 2008, J APPL ECOL, V45, P239, DOI 10.1111/j.1365-2664.2007.01408.x; Graham CH, 2006, GLOBAL ECOL BIOGEOGR, V15, P578, DOI 10.1111/j.1466-8238.2006.00257.x; Guralnick RP, 2006, PLOS BIOL, V4, P1908, DOI 10.1371/journal.pbio.0040381; Hajjar R, 2007, EUPHYTICA, V156, P1, DOI 10.1007/s10681-007-9363-0; HARLAN J R, 1971, Taxon, V20, P509, DOI 10.2307/1218252; Hawkins B., 2008, PLANTS CLIMATE CHANG; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans R., 2002, ATLAS WILD POTATOES; Hijmans R.J., 2005, DIVAGIS VERSION 5 2; Hijmans RJ, 2001, AM J BOT, V88, P2101, DOI 10.2307/3558435; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Hijmans RJ, 2006, GLOBAL CHANGE BIOL, V12, P2272, DOI 10.1111/j.1365-2486.2006.01256.x; Jarvis A, 2003, CROP SCI, V43, P1100, DOI 10.2135/cropsci2003.1100; JARVIS A, 2005, MOL EVOLUTION PROD B; JARVIS A, 2002, PLANT GENET RES NEWS, V131, P29; Jesus Salcedo C., 2009, Journal of the Botanical Research Institute of Texas, V3, P751; Jimenez-Valverde A, 2008, DIVERS DISTRIB, V14, P885, DOI 10.1111/j.1472-4642.2008.00496.x; Jones PG, 1997, BIODIVERS CONSERV, V6, P947, DOI 10.1023/A:1018311513176; Khoury C, 2010, GENET RESOUR CROP EV, V57, P625, DOI 10.1007/s10722-010-9534-z; KIPENOLT JA, 1992, NEW PHYTOL, V120, P489, DOI 10.1111/j.1469-8137.1992.tb01797.x; Kornegay J., 1991, Common beans: research for crop improvement., P619; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo JM, 2008, GLOBAL ECOL BIOGEOGR, V17, P145, DOI 10.1111/j.1466-8238.2007.00358.x; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Loiselle BA, 2008, J BIOGEOGR, V35, P105, DOI 10.1111/j.1365-2699.2007.01779.x; Maxted N, 2009, 39 FAO UN COMM GEN R; Maxted N, 2008, DIVERS DISTRIB, V14, P1018, DOI 10.1111/j.1472-4642.2008.00512.x; Maxted N, 2006, BIODIVERS CONSERV, V15, P2673, DOI 10.1007/s10531-005-5409-6; McClean P, 2004, LEGUME CROP GENOMICS, P60; Meilleur BA, 2004, BIODIVERS CONSERV, V13, P663, DOI 10.1023/B:BIOC.0000011719.03230.17; Nabhan GP., 1990, SYSTEMATIC ECOGEOGRA, V5; PARTHASARATHY U, 2006, CURRENT SCI, V91; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOGRAPHY, V31, P272, DOI 10.1111/j.0906-7590.2008.5378.x; Prescott-Allen C., 1986, 1 RESOURCE WILD SPEC; Salcedo J, 2006, NOVON, V16, P105, DOI 10.3417/1055-3177(2006)16[105:PNANSL]2.0.CO;2; SCHINKEL C, 1988, PLANT BREEDING, V101, P292, DOI 10.1111/j.1439-0523.1988.tb00301.x; Shellie-Dessert K. C., 1991, Common beans: research for crop improvement., P649; Singh RJ, 2005, GEN RESOUR CHROM ENG, V1, P1; Singh SP, 2001, CROP SCI, V41, P1659, DOI 10.2135/cropsci2001.1659; SMARTT J, 1981, EUPHYTICA, V30, P445, DOI 10.1007/BF00034009; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Termansen M, 2006, ECOL MODEL, V192, P410, DOI 10.1016/j.ecolmodel.2005.07.009; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; *UN FAO, 2009, 2 FAO UN; VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010; Veloz SD, 2009, J BIOGEOGR, V36, P2290, DOI 10.1111/j.1365-2699.2009.02174.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x	75	114	119	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2010	5	10							e13497	10.1371/journal.pone.0013497	http://dx.doi.org/10.1371/journal.pone.0013497			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	667TI	20976009	Green Published, Green Submitted, gold			2022-12-27	WOS:000283216400012
J	Moser, JJ; Fritzler, MJ				Moser, Joanna J.; Fritzler, Marvin J.			The MicroRNA and MessengerRNA Profile of the RNA-Induced Silencing Complex in Human Primary Astrocyte and Astrocytoma Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR-SUPPRESSOR; DOWN-REGULATION; EXPRESSION PROFILES; MIR-34A CONTRIBUTES; GENE-EXPRESSION; GW182; MIRNA; CANCER; APOPTOSIS	Background: GW/P bodies are cytoplasmic ribonucleoprotein-rich foci involved in microRNA (miRNA)-mediated messenger RNA ( mRNA) silencing and degradation. The mRNA regulatory functions within GW/P bodies are mediated by GW182 and its binding partner hAgo2 that bind miRNA in the RNA-induced silencing complex ( RISC). To date there are no published reports of the profile of miRNA and mRNA targeted to the RISC or a comparison of the RISC-specific miRNA/mRNA profile differences in malignant and non-malignant cells. Methodology/Principal Findings: RISC mRNA and miRNA components were profiled by microarray analysis of malignant human U-87 astrocytoma cells and its non-malignant counterpart, primary human astrocytes. Total cell RNA as well as RNA from immunoprecipitated RISC was analyzed. The novel findings were fourfold: ( 1) miRNAs were highly enriched in astrocyte RISC compared to U-87 astrocytoma RISC, ( 2) astrocytoma and primary astrocyte cells each contained unique RISC miRNA profiles as compared to their respective cellular miRNA profiles, ( 3) miR-195, 10b, 29b, 19b, 34a and 455-3p levels were increased and the miR-181b level was decreased in U-87 astrocytoma RISC as compared to astrocyte RISC, and ( 4) the RISC contained decreased levels of mRNAs in primary astrocyte and U-87 astrocytoma cells. Conclusions/Significance: The observation that miR-34a and miR-195 levels were increased in the RISC of U-87 astrocytoma cells suggests an oncogenic role for these miRNAs. Differential regulation of mRNAs by specific miRNAs is evidenced by the observation that three miR34a-targeted mRNAs and two miR-195-targeted mRNAs were downregulated while one miR-195-targeted mRNA was upregulated. Biological pathway analysis of RISC mRNA components suggests that the RISC plays a pivotal role in malignancy and other conditions. This study points to the importance of the RISC and ultimately GW/P body composition and function in miRNA and mRNA deregulation in astrocytoma cells and possibly in other malignancies.	[Moser, Joanna J.; Fritzler, Marvin J.] Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary	Moser, JJ (corresponding author), Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB, Canada.	fritzler@ucalgary.ca		Moser, Joanna J./0000-0001-7145-7284	Canadian Institutes for Health Research [MOP-57674]; Alberta Heritage Foundation for Medical Research	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This research was supported by a grant in aid (#MOP-57674) from the Canadian Institutes for Health Research and an anonymous donor. JJM is supported by a Canadian Institute for Health Research Doctoral Research Award in the Area of Clinical Research and by an Alberta Heritage Foundation for Medical Research Studentship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Ares M, 2005, CELL, V120, P163, DOI 10.1016/j.cell.2005.01.002; Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dijkstra MK, 2009, LEUKEMIA, V23, P625, DOI 10.1038/leu.2008.264; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Eulalio A, 2009, NUCLEIC ACIDS RES, V37, P2974, DOI 10.1093/nar/gkp173; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; Eystathioy T, 2002, MOL BIOL CELL, V13, P1338, DOI 10.1091/mbc.01-11-0544; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallardo E, 2009, CARCINOGENESIS, V30, P1903, DOI 10.1093/carcin/bgp219; Gao XL, 2004, BIOPOLYMERS, V73, P579, DOI 10.1002/bip.20005; Gillies JK, 2007, CELL CYCLE, V6, P2005, DOI 10.4161/cc.6.16.4526; Godlewski J, 2010, MOL CELL, V37, P620, DOI 10.1016/j.molcel.2010.02.018; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Griffiths MR, 2009, J NEUROPATH EXP NEUR, V68, P217, DOI 10.1097/NEN.0b013e3181996688; Guessous F, 2010, CELL CYCLE, V9, P1031, DOI 10.4161/cc.9.6.10987; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Helmuth L, 2001, SCIENCE, V291, P569; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Ikeda K, 2006, J IMMUNOL METHODS, V317, P38, DOI 10.1016/j.jim.2006.09.010; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jakymiw A, 2007, J CELL SCI, V120, P1317, DOI 10.1242/jcs.03429; Jakymiw A, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1959; Lawler S, 2009, J NEURO-ONCOL, V92, P297, DOI 10.1007/s11060-009-9843-2; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Li N, 2009, CANCER LETT, V275, P44, DOI 10.1016/j.canlet.2008.09.035; Li SQ, 2008, J CELL SCI, V121, P4134, DOI 10.1242/jcs.036905; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lian S, 2007, MOL BIOL CELL, V18, P3375, DOI 10.1091/mbc.E07-01-0070; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Moser JJ, 2007, J NEUROSCI RES, V85, P3619, DOI 10.1002/jnr.21439; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; Moser JJ, 2009, NAT PROTOC, V4, P674, DOI 10.1038/nprot.2009.34; Navarro F, 2009, BLOOD, V114, P2181, DOI 10.1182/blood-2009-02-205062; Nunez-Iglesias J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008898; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pauley KM, 2006, EMBO REP, V7, P904, DOI 10.1038/sj.embor.7400783; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Sasayama T, 2009, INT J CANCER, V125, P1407, DOI 10.1002/ijc.24522; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sun F, 2008, FEBS LETT, V582, P1564, DOI 10.1016/j.febslet.2008.03.057; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Vasudevan S, 2008, CELL CYCLE, V7, P1545, DOI 10.4161/cc.7.11.6018; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005878; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Wei JS, 2008, ONCOGENE, V27, P5204, DOI 10.1038/onc.2008.154; Welch C, 2007, ONCOGENE, V26, P5017, DOI 10.1038/sj.onc.1210293; Xu T, 2009, HEPATOLOGY, V50, P113, DOI 10.1002/hep.22919; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Zhu Qi, 2007, V382, P287, DOI 10.1007/978-1-59745-304-2_19	86	21	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13445	10.1371/journal.pone.0013445	http://dx.doi.org/10.1371/journal.pone.0013445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976148	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300020
J	Liao, FL; Wang, L; Yang, LB; Peng, XB; Sun, MX				Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Peng, Xiongbo; Sun, Mengxiang			NtGNL1 Plays an Essential Role in Pollen Tube Tip Growth and Orientation Likely via Regulation of Post-Golgi Trafficking	PLOS ONE			English	Article							LOCALIZED F-ACTIN; GNOM ARF-GEF; BREFELDIN-A; MEMBRANE TRAFFICKING; PLANT-CELLS; PREVACUOLAR COMPARTMENTS; ENDOPLASMIC-RETICULUM; VESICLE TRAFFICKING; AUXIN TRANSPORT; EXCHANGE FACTOR	Background: Tobacco GNOM LIKE 1 (NtGNL1), a new member of the Big/GBF family, is characterized by a sec 7 domain. Thus, we proposed that NtGNL1 may function in regulating pollen tube growth for vesicle trafficking. Methodology/Principal Findings: To test this hypothesis, we used an RNAi technique to down-regulate NtGNL1 expression and found that pollen tube growth and orientation were clearly inhibited. Cytological observations revealed that both timing and behavior of endocytosis was disrupted, and endosome trafficking to prevacuolar compartments (PVC) or multivesicular bodies (MVB) was altered in pollen tube tips. Moreover, NtGNL1 seemed to partially overlap with Golgi bodies, but clearly colocalized with putative late endosome compartments. We also observed that in such pollen tubes, the Golgi apparatus disassembled and fused with the endoplasmic reticulum, indicating abnormal post-Golgi trafficking. During this process, actin organization was also remodeled. Conclusions/Significance: Thus, we revealed that NtGNL1 is essential for pollen tube growth and orientation and it likely functions via stabilizing the structure of the Golgi apparatus and ensuring post-Golgi trafficking.	[Liao, Fanglei; Wang, Lu; Yang, Li-Bo; Peng, Xiongbo; Sun, Mengxiang] Wuhan Univ, Coll Life Sci, Key Lab Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China; [Liao, Fanglei] Zhejiang Normal Univ, Coll Chem & Life Sci, Jinhua, Peoples R China; [Wang, Lu] Chinese Acad Agr Sci, Tobacco Res Inst, Dept Biotechnol, Qingdao, Peoples R China	Wuhan University; Zhejiang Normal University; Chinese Academy of Agricultural Sciences; Tobacco Research Institute, CAAS	Liao, FL (corresponding author), Wuhan Univ, Coll Life Sci, Key Lab Minist Educ Plant Dev Biol, Wuhan 430072, Peoples R China.	mxsun@whu.edu.cn			Ministry of Science and Technology of China [2007CB947600, 2007CB108700]; NSFC [30821064, 31000139]; "111" project	Ministry of Science and Technology of China(Ministry of Science and Technology, China); NSFC(National Natural Science Foundation of China (NSFC)); "111" project(Ministry of Education, China - 111 Project)	This work was supported by the fund of Key Basic Theory Research of Ministry of Science and Technology of China (2007CB947600; 2007CB108700), NSFC (30821064,31000139) and the "111" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders N, 2008, CELL MOL LIFE SCI, V65, P3433, DOI 10.1007/s00018-008-8227-7; Anders N, 2008, PLANT CELL, V20, P142, DOI 10.1105/tpc.107.056515; Baba M, 1997, J CELL BIOL, V139, P1687, DOI 10.1083/jcb.139.7.1687; Bove J, 2008, PLANT PHYSIOL, V147, P1646, DOI 10.1104/pp.108.120212; Campanoni P, 2007, J EXP BOT, V58, P65, DOI 10.1093/jxb/erl059; Cardenas L, 2008, PLANT PHYSIOL, V146, P1611, DOI 10.1104/pp.107.113035; Chen T, 2007, PLANT CELL PHYSIOL, V48, P19, DOI 10.1093/pcp/pcl036; Cheung AY, 1996, TRENDS PLANT SCI, V1, P45, DOI 10.1016/S1360-1385(96)80028-8; Franklin-Tong VE, 2002, CURR OPIN PLANT BIOL, V5, P14, DOI 10.1016/S1369-5266(01)00217-5; Fu Y, 2001, J CELL BIOL, V152, P1019, DOI 10.1083/jcb.152.5.1019; GALWAY ME, 1993, J CELL SCI, V106, P847; Geldner N, 2001, NATURE, V413, P425, DOI 10.1038/35096571; Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5; Geldner N, 2004, DEVELOPMENT, V131, P389, DOI 10.1242/dev.00926; Gu Y, 2003, J EXP BOT, V54, P93, DOI 10.1093/jxb/54.380.93; Hanton SL, 2007, PLANT CELL REP, V26, P1431, DOI 10.1007/s00299-007-0390-z; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Kleine-Vehn J, 2008, CURR BIOL, V18, P526, DOI 10.1016/j.cub.2008.03.021; Lam SK, 2007, TRENDS PLANT SCI, V12, P497, DOI 10.1016/j.tplants.2007.09.001; Lowe SL, 1996, J CELL SCI, V109, P209; MAYER U, 1993, DEVELOPMENT, V117, P149; Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Parton RM, 2003, J CELL SCI, V116, P2707, DOI 10.1242/jcs.00468; Parton RM, 2001, J CELL SCI, V114, P2685; Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967; Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Saint-Jore CM, 2002, PLANT J, V29, P661, DOI 10.1046/j.0960-7412.2002.01252.x; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; Sun MX, 2000, SEX PLANT REPROD, V12, P267; Tanaka H, 2009, CURR BIOL, V19, P391, DOI 10.1016/j.cub.2009.01.057; Teh OK, 2007, NATURE, V448, P493, DOI 10.1038/nature06023; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Tse YC, 2006, PLANT PHYSIOL, V142, P1442, DOI 10.1104/pp.106.090423; TWELL D, 1990, DEVELOPMENT, V109, P705; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang L, 2008, NEW PHYTOL, V179, P81, DOI 10.1111/j.1469-8137.2008.02444.x; Wang QL, 2005, PLANT PHYSIOL, V139, P1692, DOI 10.1104/pp.105.069765; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Xiang Y, 2007, PLANT CELL, V19, P1930, DOI 10.1105/tpc.106.048413; Xu J, 2005, PLANT CELL, V17, P525, DOI 10.1105/tpc.104.028449; Zonia L, 2008, J EXP BOT, V59, P861, DOI 10.1093/jxb/ern007	44	11	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13401	10.1371/journal.pone.0013401	http://dx.doi.org/10.1371/journal.pone.0013401			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976165	Green Submitted, Green Published, gold			2022-12-27	WOS:000283043700007
J	Bornmann, L; Daniel, HD				Bornmann, Lutz; Daniel, Hans-Dieter			Do Author-Suggested Reviewers Rate Submissions More Favorably than Editor-Suggested Reviewers? A Study on Atmospheric Chemistry and Physics	PLOS ONE			English	Article							MODELING APPROACH; QUALITY; SCIENCE; CHOSEN; RECOMMENDATIONS; ARTICLES	Background: Ratings in journal peer review can be affected by sources of bias. The bias variable investigated here was the information on whether authors had suggested a possible reviewer for their manuscript, and whether the editor had taken up that suggestion or had chosen a reviewer that had not been suggested by the authors. Studies have shown that author-suggested reviewers rate manuscripts more favorably than editor-suggested reviewers do. Methodology/Principal Findings: Reviewers' ratings on three evaluation criteria and the reviewers' final publication recommendations were available for 552 manuscripts (in total 1145 reviews) that were submitted to Atmospheric Chemistry and Physics, an interactive open access journal using public peer review (authors' and reviewers' comments are publicly exchanged). Public peer review is supposed to bring a new openness to the reviewing process that will enhance its objectivity. In the statistical analysis the quality of a manuscript was controlled for to prevent favorable reviewers' ratings from being attributable to quality instead of to the bias variable. Conclusions/Significance: Our results agree with those from other studies that editor-suggested reviewers rated manuscripts between 30% and 42% less favorably than author-suggested reviewers. Against this backdrop journal editors should consider either doing without the use of author-suggested reviewers or, if they are used, bringing in more than one editor-suggested reviewer for the review process (so that the review by author-suggested reviewers can be put in perspective).	[Bornmann, Lutz] Max Planck Gesell, Off Res Anal & Foresight, Munich, Germany; [Daniel, Hans-Dieter] ETH, Zurich, Switzerland; [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bornmann, L (corresponding author), Max Planck Gesell, Off Res Anal & Foresight, Munich, Germany.	bornmann@gv.mpg.de	Daniel, Hans-Dieter/A-2419-2013; Bornmann, Lutz/A-3926-2008	Bornmann, Lutz/0000-0003-0810-7091	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study was funded by the Max Planck Society. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Arkes HR, 2003, PSYCHOL SCI, V14, P1, DOI 10.1111/1467-9280.01410; BAILEY CW, 2005, OPEN ACCESS BIBLIO; Bingham CM, 1998, LANCET, V352, P441, DOI 10.1016/S0140-6736(97)11510-0; Bornmann L, 2010, LEARN PUBL, V23, P124, DOI 10.1087/20100207; BORNMANN L, 2010, RES EVALUAT, V19, P81; BORNMANN L, SCIENTOMETR IN PRESS; Bornmann L, 2008, J INFORMETR, V2, P280, DOI 10.1016/j.joi.2008.09.003; Bornmann L, 2009, RES EVALUAT, V18, P262, DOI 10.3152/095820209X477520; Bornmann L, 2009, LEARN PUBL, V22, P117, DOI 10.1087/2009207; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; Budden AE, 2008, TRENDS ECOL EVOL, V23, P480, DOI 10.1016/j.tree.2008.06.004; Cole Stephen., 1991, OUTER CIRCLE WOMEN S, P205; Cook T.D., 2002, EXPT QUASIEXPERIMENT; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; *CYT SOFTW CORP, 2010, STATXACT VERS 9; Earnshaw JJ, 2000, ANN ROY COLL SURG, V82, P133; European Association for Chemical and Molecular Sciences (EuCheMS), 2006, ETH GUID PUBL J REV; Giesler E, 2001, SCIENTIST, V15, P35; Godlee F., 2003, PEER REV HLTH SCI, P91; GOLDSMITH LA, 2005, 5 INT C PEER REV BIO; Grimm D, 2005, SCIENCE, V309, P1974, DOI 10.1126/science.309.5743.1974; Hojat M, 2003, ADV HEALTH SCI EDUC, V8, P75, DOI 10.1023/A:1022670432373; Jayasinghe U. W., 2003, PEER REV ASSESSMENT; Jayasinghe UW, 2003, J R STAT SOC A STAT, V166, P279, DOI 10.1111/1467-985X.00278; Jayasinghe UW, 2001, EDUC EVAL POLICY AN, V23, P343, DOI 10.3102/01623737023004343; KOOP T, 2006, SYSTEMS OPEN 2 STAGE; LABAND DN, 1994, J POLIT ECON, V102, P194, DOI 10.1086/261927; LEE K, 2004, LOOK INSIDE BLACK BO; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; Long J.S., 2006, REGRESSION MODELS CA; Long JS, 1997, REGRESSION MODELS CA; Nichols A, 2007, STATA J, V7, P507, DOI 10.1177/1536867X0700700403; Perlman D., 1987, SCI EXCELLENCE ORIGI, P204; PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183; Poschl U, 2004, LEARN PUBL, V17, P105, DOI 10.1087/095315104322958481; Poschl Ulrich, 2010, LIBER Quarterly, V19, P293; Rabe-Hesketh S., 2008, MULTILEVEL LONGITUDI; RIVARA FP, 2007, J PEDIAT, V151; SCHARSCHMIDT BF, 1994, J CLIN INVEST, V93, P1877, DOI 10.1172/JCI117177; Schroter S, 2006, JAMA-J AM MED ASSOC, V295, P314, DOI 10.1001/jama.295.3.314; Smart Scott, 1996, 5460 NBER; StataCorp, 2021, STATA STAT SOFTWARE; Thorngate W, 2009, JUDGING MERIT, P1; TONKS A, 1995, BRIT MED J, V311, P210, DOI 10.1136/bmj.311.6999.210; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; Wager E, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-13; Weller A, 2002, EDITORIAL PEER REV I; Ziman J, 1996, NATURE, V382, P751, DOI 10.1038/382751a0; 2007, BIF FUTURA, V22, P14	50	20	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2010	5	10							e13345	10.1371/journal.pone.0013345	http://dx.doi.org/10.1371/journal.pone.0013345			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	664DX	20976226	Green Submitted, Green Published, gold			2022-12-27	WOS:000282941000005
J	Dupuis, L; Spreux-Varoquaux, O; Bensimon, G; Jullien, P; Lacomblez, L; Salachas, F; Bruneteau, GL; Pradat, PF; Loeffler, JP; Meininger, V				Dupuis, Luc; Spreux-Varoquaux, Odile; Bensimon, Gilbert; Jullien, Philippe; Lacomblez, Lucette; Salachas, Francois; Bruneteau, Gaelle; Pradat, Pierre-Francois; Loeffler, Jean-Philippe; Meininger, Vincent			Platelet Serotonin Level Predicts Survival in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							VIOLENT SUICIDE ATTEMPTERS; SPINAL-CORD; PROGNOSTIC-FACTORS; DEPRESSION; DISEASE; ALS; TRANSPORTER; FLUOXETINE; EXPRESSION; 5-HT1A	Background: Amyotrophic lateral sclerosis (ALS) is a life-threatening neurodegenerative disease involving upper and lower motor neurons loss. Clinical features are highly variable among patients and there are currently few known disease-modifying factors underlying this heterogeneity. Serotonin is involved in a range of functions altered in ALS, including motor neuron excitability and energy metabolism. However, whether serotoninergic activity represents a disease modifier of ALS natural history remains unknown. Methodology: Platelet and plasma unconjugated concentrations of serotonin and plasma 5-HIAA, the major serotonin metabolite, levels were measured using HPLC with coulometric detection in a cohort of 85 patients with ALS all followed-up until death and compared to a control group of 29 subjects. Principal Findings: Platelet serotonin levels were significantly decreased in ALS patients. Platelet serotonin levels did not correlate with disease duration but were positively correlated with survival of the patients. Univariate Cox model analysis showed a 57% decreased risk of death for patients with platelet serotonin levels in the normal range relative to patients with abnormally low platelet serotonin (p = 0.0195). This protective effect remained significant after adjustment with age, gender or site of onset in multivariate analysis. Plasma unconjugated serotonin and 5-HIAA levels were unchanged in ALS patients compared to controls and did not correlate with clinical parameters. Conclusions/Significance: The positive correlation between platelet serotonin levels and survival strongly suggests that serotonin influences the course of ALS disease.	[Dupuis, Luc; Loeffler, Jean-Philippe] INSERM, U692, Strasbourg, France; [Dupuis, Luc; Loeffler, Jean-Philippe] Univ Strasbourg, Strasbourg, France; [Spreux-Varoquaux, Odile] Fac Med Paris Ile France Ouest, Paris, France; [Spreux-Varoquaux, Odile] Univ Versailles St Quentin En Yvelines, Versailles, France; [Spreux-Varoquaux, Odile; Jullien, Philippe] Ctr Hosp Versailles, Le Chesnay, France; [Bensimon, Gilbert; Lacomblez, Lucette; Meininger, Vincent] Univ Paris 06, Paris, France; [Bensimon, Gilbert] CNRS, UMR 7211, Paris, France; [Bensimon, Gilbert] Hosp Pitie Salpetriere, AP HP, Serv Pharmacol Clin, Paris, France; [Lacomblez, Lucette; Salachas, Francois; Bruneteau, Gaelle; Pradat, Pierre-Francois; Meininger, Vincent] Ctr Referent Malad Rare SLA Hosp Pitie Salpetrier, AP HP, Dept Malad Syst Nerveux, Paris, France; [Lacomblez, Lucette] INSERM, U678, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universite Paris Saclay; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Dupuis, L (corresponding author), INSERM, U692, Strasbourg, France.	ldupuis@unistra.fr	LOEFFLER, Jean-Philippe/AAS-4401-2020; Dupuis, Luc/A-6981-2012	Dupuis, Luc/0000-0002-0902-5824; BRUNETEAU, GAELLE/0000-0002-1905-7985	Amyotrophic Lateral Sclerosis Association [1698]; association pour la recherche sur la sclerose laterale amyotrophique (ARSla); Association Francaise contre les Myopathies (AFM); Teva Pharma; GSK; Trophos; Eisai; Novartis; Janssen-Cilag	Amyotrophic Lateral Sclerosis Association; association pour la recherche sur la sclerose laterale amyotrophique (ARSla); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Teva Pharma(Teva Pharmaceutical Industries); GSK(GlaxoSmithKline); Trophos; Eisai(Eisai Co Ltd); Novartis(Novartis); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Dupuis received research support from the Amyotrophic Lateral Sclerosis Association (Grant 1698, ALSA). Drs. Dupuis, Lacomblez, Pradat and Pr Meininger received support from the association pour la recherche sur la sclerose laterale amyotrophique (ARSla). Drs. Loeffler, Lacomblez and Pradat received research support from the Association Francaise contre les Myopathies (AFM). Pr Meininger received research support from Teva Pharma, GSK and Trophos. Dr. Lacomblez received research support from Trophos, Eisai, GSK, Novartis and Janssen-Cilag. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 1999, BIOL PSYCHIAT, V45, P1066, DOI 10.1016/S0006-3223(98)00160-7; Alvarez JC, 1999, CLIN PHARMACOL THER, V66, P617; Alvarez JC, 1999, PSYCHOPHARMACOLOGY, V143, P97, DOI 10.1007/s002130050924; BERTEL O, 1991, BRAIN RES, V566, P54, DOI 10.1016/0006-8993(91)91680-Y; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Csernansky J G, 1993, Ann Clin Psychiatry, V5, P275, DOI 10.3109/10401239309148828; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Desport JC, 2001, AM J CLIN NUTR, V74, P328; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; FLACHAIRE E, 1990, CLIN CHEM, V36, P2117; Forrest V, 1996, J NEUROL SCI, V139, P83, DOI 10.1016/0022-510X(96)00109-8; FUNALOT B, 2008, AMYOTROPH LATERAL SC, P1; GUICHENEY P, 1988, METHOD FIND EXP CLIN, V10, P253; HECKMAN CJ, 2009, CLIN NEUROPHYSIOL; Hillemacher T, 2004, AMYOTROPH LATERAL SC, V5, P245, DOI 10.1080/14660820410021294; Huey ED, 2006, NEUROLOGY, V66, P17, DOI 10.1212/01.wnl.0000191304.55196.4d; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Landers JE, 2009, P NATL ACAD SCI USA, V106, P9004, DOI 10.1073/pnas.0812937106; LESCH KP, 1993, J NEUROCHEM, V60, P2319, DOI 10.1111/j.1471-4159.1993.tb03522.x; MCDONALD ER, 1994, ARCH NEUROL-CHICAGO, V51, P17, DOI 10.1001/archneur.1994.00540130027010; Muck-Seler D, 2009, PROG NEURO-PSYCHOPH, V33, P1226, DOI 10.1016/j.pnpbp.2009.07.004; OWENS MJ, 1994, CLIN CHEM, V40, P288; Paillisse C, 2005, AMYOTROPH LATERAL SC, V6, P37, DOI 10.1080/14660820510027035; PRADAT PF, 2009, AMYOTROPH LATERAL SC, P1; Radat F, 1996, PSYCHOPHARMACOLOGY, V127, P370, DOI 10.1007/BF02806017; RAMAMOORTHY S, 1993, P NATL ACAD SCI USA, V90, P2542, DOI 10.1073/pnas.90.6.2542; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Sandyk R, 2006, INT J NEUROSCI, V116, P775, DOI 10.1080/00207450600754087; Sneddon J M, 1973, Prog Neurobiol, V1, P151, DOI 10.1016/0301-0082(73)90019-1; SOFIC E, 1991, J NEURAL TRANSM-PARK, V3, P133, DOI 10.1007/BF02260888; Spreux-Varoquaux O, 2001, LIFE SCI, V69, P647, DOI 10.1016/S0024-3205(01)01158-4; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; SUSSMUTH SD, NEUROLOGY, V74, P982; Tecott LH, 2007, CELL METAB, V6, P352, DOI 10.1016/j.cmet.2007.09.012; Turner BJ, 2003, AMYOTROPH LATERAL SC, V4, P171, DOI 10.1080/14660820310009389; Turner MR, 2005, BRAIN, V128, P896, DOI 10.1093/brain/awh428; Yadav VK, 2009, CELL, V138, P976, DOI 10.1016/j.cell.2009.06.051	40	31	32	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13346	10.1371/journal.pone.0013346	http://dx.doi.org/10.1371/journal.pone.0013346			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967129	Green Published, Green Submitted, gold			2022-12-27	WOS:000282869800035
J	Krammer, F; Pontiller, J; Tauer, C; Palmberger, D; Maccani, A; Baumann, M; Grabherr, R				Krammer, Florian; Pontiller, Jens; Tauer, Christopher; Palmberger, Dieter; Maccani, Andreas; Baumann, Martina; Grabherr, Reingard			Evaluation of the Influenza A Replicon for Transient Expression of Recombinant Proteins in Mammalian Cells	PLOS ONE			English	Article							RNA-POLYMERASE-I; MUTATIONAL ANALYSIS; REVERSE GENETICS; VIRUS; GENERATION; PROMOTER; VECTORS; VRNA; DNA; CLONING	Recombinant protein expression in mammalian cells has become a very important technique over the last twenty years. It is mainly used for production of complex proteins for biopharmaceutical applications. Transient recombinant protein expression is a possible strategy to produce high quality material for preclinical trials within days. Viral replicon based expression systems have been established over the years and are ideal for transient protein expression. In this study we describe the evaluation of an influenza A replicon for the expression of recombinant proteins. We investigated transfection and expression levels in HEK-293 cells with EGFP and firefly luciferase as reporter proteins. Furthermore, we studied the influence of different influenza non-coding regions and temperature optima for protein expression as well. Additionally, we exploited the viral replication machinery for the expression of an antiviral protein, the human monoclonal anti-HIV-gp41 antibody 3D6. Finally we could demonstrate that the expression of a single secreted protein, an antibody light chain, by the influenza replicon, resulted in fivefold higher expression levels compared to the usually used CMV promoter based expression. We emphasize that the influenza A replicon system is feasible for high level expression of complex proteins in mammalian cells.	[Krammer, Florian; Pontiller, Jens; Tauer, Christopher; Palmberger, Dieter; Maccani, Andreas; Baumann, Martina; Grabherr, Reingard] Univ Nat Resources & Appl Life Sci, Vienna Inst BioTechnol, Dept Biotechnol, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Krammer, F (corresponding author), Univ Nat Resources & Appl Life Sci, Vienna Inst BioTechnol, Dept Biotechnol, Vienna, Austria.	Reingard.grabherr@boku.ac.at	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Palmberger, Dieter/0000-0002-2086-0396; Grabherr, Reingard/0000-0002-4501-927X; Maccani, Andreas/0000-0002-7564-7410	FWF (Austrian Science Fund) [P17361-B13]	FWF (Austrian Science Fund)(Austrian Science Fund (FWF))	This work was funded by the FWF (Austrian Science Fund, http://www.fwf.ac.at/) project P17361-B13. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Fageeh MB, 2006, BIOTECHNOL BIOENG, V93, P829, DOI 10.1002/bit.20789; Baldi L, 2007, BIOTECHNOL LETT, V29, P677, DOI 10.1007/s10529-006-9297-y; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; HEIX J, 1995, CURR OPIN GENET DEV, V5, P652, DOI 10.1016/0959-437X(95)80035-2; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2000, VIROLOGY, V267, P310, DOI 10.1006/viro.1999.0140; HOSSAIN M, 2010, J CLIN MICROBIOL; Kittel C, 2005, J VIROL, V79, P10672, DOI 10.1128/JVI.79.16.10672-10677.2005; Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035; LUYTJES W, 1989, CELL, V59, P1107, DOI 10.1016/0092-8674(89)90766-6; Massin P, 2005, J VIROL, V79, P13811, DOI 10.1128/JVI.79.21.13811-13816.2005; Molnar MJ, 2004, MOL THER, V10, P447, DOI 10.1016/j.ymthe.2004.06.642; Nakowitsch S, 2006, MOL BIOTECHNOL, V34, P157, DOI 10.1385/MB:34:2:157; NEUMANN G, 1995, J GEN VIROL, V76, P1709, DOI 10.1099/0022-1317-76-7-1709; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ng SSF, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-2; Nishimura K, 2007, J BIOL CHEM, V282, P27383, DOI 10.1074/jbc.M702028200; Ozaki H, 2004, J VIROL, V78, P1851, DOI 10.1128/JVI.78.4.1851-1857.2004; PICCONE ME, 1993, VIRUS RES, V28, P99, DOI 10.1016/0168-1702(93)90129-B; Pontiller J, 2010, MOL BIOTECHNOL, V45, P235, DOI 10.1007/s12033-010-9278-1; Rice Charles M., 1992, Current Opinion in Biotechnology, V3, P523, DOI 10.1016/0958-1669(92)90081-S; RUKER F, 1991, ANN NY ACAD SCI, V646, P212; Schlatter S, 2005, BIOTECHNOL PROGR, V21, P122, DOI 10.1021/bp049780w; Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359; Sereinig S, 2006, CLIN VACCINE IMMUNOL, V13, P898, DOI 10.1128/CVI.00056-06; Spadaccini A, 2010, VACCINE, V28, P1181, DOI 10.1016/j.vaccine.2009.11.037; Varnavski AN, 2000, J VIROL, V74, P4394, DOI 10.1128/JVI.74.9.4394-4403.2000; Wang LY, 2009, VET MICROBIOL, V135, P239, DOI 10.1016/j.vetmic.2008.09.067; Wang ZT, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-102	30	3	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13265	10.1371/journal.pone.0013265	http://dx.doi.org/10.1371/journal.pone.0013265			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20949004	Green Submitted, Green Published, gold			2022-12-27	WOS:000282748100014
J	Bryksin, AV; Matsumura, I				Bryksin, Anton V.; Matsumura, Ichiro			Rational Design of a Plasmid Origin That Replicates Efficiently in Both Gram-Positive and Gram-Negative Bacteria	PLOS ONE			English	Article							CLONING VECTORS; DNA; CONSTRUCTION; PROKARYOTES; PERSISTENCE; EVOLUTION; PROTEINS; SEQUENCE; GROWTH; GENES	Background: Most plasmids replicate only within a particular genus or family. Methodology/Principal Findings: Here we describe an engineered high copy number expression vector, pBAV1K-T5, that produces varying quantities of active reporter proteins in Escherichia coli, Acinetobacter baylyi ADP1, Agrobacterium tumefaciens, (all Gram-negative), Streptococcus pneumoniae, Leifsonia shinshuensis, Peanibacillus sp. S18-36 and Bacillus subtilis (Gram-positive). Conclusions/Significance: Our results demonstrate the efficiency of pBAV1K-T5 replication in different bacterial species, thereby facilitating the study of proteins that don't fold well in E. coli and pathogens not amenable to existing genetic tools.	[Bryksin, Anton V.; Matsumura, Ichiro] Emory Univ, Dept Biochem, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA	Emory University	Bryksin, AV (corresponding author), Emory Univ, Dept Biochem, Ctr Fundamental & Appl Mol Evolut, Atlanta, GA 30322 USA.	imatsum@emory.edu	Matsumura, Ichiro/E-1985-2011		National Institutes of Health [1 R01 GM074264, 1 R01 GM086824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086824, R01GM074264] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the National Institutes of Health grants 1 R01 GM074264 and 1 R01 GM086824 to IM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakvik T, 2009, FEMS MICROBIOL LETT, V296, P149, DOI 10.1111/j.1574-6968.2009.01639.x; Alloing G, 1998, MOL MICROBIOL, V29, P75, DOI 10.1046/j.1365-2958.1998.00904.x; Bosse JT, 2009, APPL ENVIRON MICROB, V75, P6124, DOI 10.1128/AEM.00809-09; BREHM SP, 1973, J BACTERIOL, V115, P1063, DOI 10.1128/JB.115.3.1063-1070.1973; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; Bugrysheva JV, 2005, INFECT IMMUN, V73, P4972, DOI 10.1128/IAI.73.8.4972-4981.2005; BUJARD H, 1987, METHOD ENZYMOL, V155, P416; CANGELOSI GA, 1991, METHOD ENZYMOL, V204, P384; Cheng CH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-102; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Dennis JJ, 2005, CURR OPIN BIOTECH, V16, P291, DOI 10.1016/j.copbio.2005.04.002; GRUSS A, 1989, MICROBIOL REV, V53, P231, DOI 10.1128/MMBR.53.2.231-241.1989; HAMILTON RH, 1971, EXPERIENTIA, V27, P229, DOI 10.1007/BF02145913; HARWOOD CR, 1990, MOL BIOL METHODS BAC, pR35; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Huang HH, 2010, NUCLEIC ACIDS RES, V38, P2577, DOI 10.1093/nar/gkq164; Jun SR, 2010, P NATL ACAD SCI USA, V107, P133, DOI 10.1073/pnas.0913033107; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; KOK J, 1984, APPL ENVIRON MICROB, V48, P726, DOI 10.1128/AEM.48.4.726-731.1984; LEENHOUTS KJ, 1991, PLASMID, V26, P55, DOI 10.1016/0147-619X(91)90036-V; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Moreno C, 2002, MICROBIOL-SGM, V148, P1233, DOI 10.1099/00221287-148-4-1233; OTTOLENGHI E, 1962, J EXP MED, V116, P491, DOI 10.1084/jem.116.4.491; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; Posfai G, 2006, SCIENCE, V312, P1044, DOI 10.1126/science.1126439; Boer DR, 2009, EMBO J, V28, P1666, DOI 10.1038/emboj.2009.125; ROMANOWSKI G, 1993, APPL ENVIRON MICROB, V59, P3438, DOI 10.1128/AEM.59.10.3438-3446.1993; Sambrook J., 2001, MOL CLONING LAB MANU; SATOH K, 2009, PLASMID; SEEGERS JFML, 1995, MOL GEN GENET, V249, P43, DOI 10.1007/BF00290234; Shareck J, 2004, CRIT REV BIOTECHNOL, V24, P155, DOI 10.1080/07388550490904288; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; SHEVCHUK NA, 2007, METHODS EXPRESS SERI, P197; Trevors JT, 1996, ANTON LEEUW INT J G, V70, P1, DOI 10.1007/BF00393564; Vaneechoutte M, 2006, APPL ENVIRON MICROB, V72, P932, DOI 10.1128/AEM.72.1.932-936.2006	39	63	71	5	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2010	5	10							e13244	10.1371/journal.pone.0013244	http://dx.doi.org/10.1371/journal.pone.0013244			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	660WH	20949038	Green Submitted, gold, Green Published			2022-12-27	WOS:000282676700016
J	Gardiner, BS; Smith, DW; Coote, M; Crowston, JG				Gardiner, Bruce S.; Smith, David W.; Coote, Michael; Crowston, Jonathan G.			Computational Modeling of Fluid Flow and Intra-Ocular Pressure following Glaucoma Surgery	PLOS ONE			English	Article							EPISCLERAL VENOUS-PRESSURE; FILTERING BLEBS; INTERSTITIAL FLOW; DRAINAGE DEVICES; AQUEOUS DYNAMICS; MITOMYCIN-C; TRABECULECTOMY	Background: Glaucoma surgery is the most effective means for lowering intraocular pressure by providing a new route for fluid to exit the eye. This new pathway is through the sclera of the eye into sub-conjunctival tissue, where a fluid filled bleb typically forms under the conjunctiva. The long-term success of the procedure relies on the capacity of the sub-conjunctival tissue to absorb the excess fluid presented to it, without generating excessive scar tissue during tissue remodeling that will shut-down fluid flow. The role of inflammatory factors that promote scarring are well researched yet little is known regarding the impact of physical forces on the healing response. Methodology: To help elucidate the interplay of physical factors controlling the distribution and absorption of aqueous humor in sub-conjunctival tissue, and tissue remodeling, we have developed a computational model of fluid production in the eye and removal via the trabecular/uveoscleral pathways and the surgical pathway. This surgical pathway is then linked to a porous media computational model of a fluid bleb positioned within the sub-conjunctival tissue. The computational analysis is centered on typical functioning bleb geometry found in a human eye following glaucoma surgery. A parametric study is conducted of changes in fluid absorption by the sub-conjunctival blood vessels, changes in hydraulic conductivity due to scarring, and changes in bleb size and shape, and eye outflow facility. Conclusions: This study is motivated by the fact that some blebs are known to have 'successful' characteristics that are generally described by clinicians as being low, diffuse and large without the formation of a distinct sub-conjunctival encapsulation. The model predictions are shown to accord with clinical observations in a number of key ways, specifically the variation of intra-ocular pressure with bleb size and shape and the correspondence between sites of predicted maximum interstitial fluid pressure and key features observed in blebs, which gives validity to the model described here. This model should contribute to a more complete explanation of the physical processes behind successful bleb characteristics and provide a new basis for clinically grading blebs.	[Gardiner, Bruce S.; Smith, David W.] Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia; [Coote, Michael; Crowston, Jonathan G.] Univ Melbourne, CERA, Melbourne, Vic, Australia; [Coote, Michael; Crowston, Jonathan G.] Royal Victorian Eye & Ear Hosp, Melbourne, Vic 3002, Australia	University of Western Australia; University of Melbourne; Royal Victorian Eye & Ear Hospital	Gardiner, BS (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Crawley, WA, Australia.	bruce.gardiner@uwa.edu.au	Gardiner, Bruce/C-8593-2012; Smith, David W/H-5856-2014	Smith, David W/0000-0003-4864-0288; Gardiner, Bruce/0000-0001-8770-5908	Australian National Health and Medical Research Council (NHMRC) [529918]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Australian National Health and Medical Research Council (NHMRC Project Grant # 529918) http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuara-Blanco A, 1998, SURV OPHTHALMOL, V43, P93, DOI 10.1016/S0039-6257(98)00025-3; Bill A, 1989, Prog Clin Biol Res, V312, P417; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; Brubaker RF, 2004, EXP EYE RES, V78, P633, DOI 10.1016/j.exer.2003.07.002; Casillan AJ, 2003, J APPL PHYSIOL, V94, P2313, DOI 10.1152/japplphysiol.00047.2002; Chang L, 2000, SURV OPHTHALMOL, V45, P49, DOI 10.1016/S0039-6257(00)00135-1; Ethier CR, 2004, ANNU REV BIOMED ENG, V6, P249, DOI 10.1146/annurev.bioeng.6.040803.140055; Filippopoulos Theodoros, 2009, Int Ophthalmol Clin, V49, P71, DOI 10.1097/IIO.0b013e3181924d55; FUNG YC, 1996, BIOMECHANICS CIRCULA, P214; GUYTON AC, 1966, CIRC RES, V19, P412, DOI 10.1161/01.RES.19.2.412; HARRIS NR, 1993, AM J PHYSIOL-HEART C, V34, pH1623; He PN, 2006, AM J PHYSIOL-HEART C, V291, pH591, DOI 10.1152/ajpheart.01228.2005; Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Kumar S, 2006, ANN BIOMED ENG, V34, P530, DOI 10.1007/s10439-005-9048-6; LEVICK JR, 1987, Q J EXP PHYSIOL CMS, V72, P409, DOI 10.1113/expphysiol.1987.sp003085; Lim KS, 1998, BRIT J OPHTHALMOL, V82, P1083, DOI 10.1136/bjo.82.9.1083; McWhae JA, 1996, CAN J OPHTHALMOL, V31, P187; MELLANDER S, 1994, J PHYSIOL-LONDON, V481, P163, DOI 10.1113/jphysiol.1994.sp020427; *MOLT OPHTH LTD, 2010, MOLTENO3 TECHN INF; MOLTENO ACB, 1969, BRIT J OPHTHALMOL, V53, P606, DOI 10.1136/bjo.53.9.606; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Ng CP, 2006, ANN BIOMED ENG, V34, P446, DOI 10.1007/s10439-005-9067-3; Ng CP, 2003, AM J PHYSIOL-HEART C, V284, pH1771, DOI 10.1152/ajpheart.01008.2002; Nilsson SFE, 1997, EYE, V11, P149, DOI 10.1038/eye.1997.43; Olsen TW, 1998, AM J OPHTHALMOL, V125, P237, DOI 10.1016/S0002-9394(99)80096-8; PALLIKARIS IG, 2005, INVEST OPHTHALMOL, V46; PHELPS CD, 1978, AM J OPHTHALMOL, V85, P35, DOI 10.1016/S0002-9394(14)76662-0; Picht G, 1998, Curr Opin Ophthalmol, V9, P2, DOI 10.1097/00055735-199804000-00002; Sacu S, 2003, J GLAUCOMA, V12, P430, DOI 10.1097/00061198-200310000-00006; Selbach JM, 2005, OPHTHALMOLOGICA, V219, P357, DOI 10.1159/000088378; Singh M, 2007, OPHTHALMOLOGY, V114, P47, DOI 10.1016/j.ophtha.2006.05.078; Sit AJ, 2008, INVEST OPHTH VIS SCI, V49, P1473, DOI 10.1167/iovs.07-1139; Swartz MA, 2007, ANNU REV BIOMED ENG, V9, P229, DOI 10.1146/annurev.bioeng.9.060906.151850; Terzaghi K., 1943, THEORETICAL SOIL MEC; VANBUSKIRK EM, 1982, AM J OPHTHALMOL, V94, P522, DOI 10.1016/0002-9394(82)90248-3; Waite L., 2007, APPL BIOFLUID MECH; Wells AP, 2006, OPHTHALMOLOGY, V113, P77, DOI 10.1016/j.ophtha.2005.06.037; Williams DA, 2007, MICROVASC RES, V73, P48, DOI 10.1016/j.mvr.2006.08.003; Yamamoto T, 1995, OPHTHALMOLOGY, V102, P1770, DOI 10.1016/S0161-6420(95)30795-6; Yamanaka O, 2008, JPN J OPHTHALMOL, V52, P8, DOI 10.1007/s10384-007-0497-3	41	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 4	2010	5	10							e13178	10.1371/journal.pone.0013178	http://dx.doi.org/10.1371/journal.pone.0013178			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	657OZ	20957178	Green Published, Green Submitted, gold			2022-12-27	WOS:000282423300015
J	Baltzer, JL; Thomas, SC				Baltzer, Jennifer L.; Thomas, Sean C.			A Second Dimension to the Leaf Economics Spectrum Predicts Edaphic Habitat Association in a Tropical Forest	PLOS ONE			English	Article							FUNCTIONAL TRAITS; SOIL NUTRIENTS; PHOSPHORUS; NITROGEN; SPECIALIZATION; TREES; PHOTOSYNTHESIS; DISTRIBUTIONS; PHOSPHATE; GROWTH	Background: Strong patterns of habitat association are frequent among tropical forest trees and contribute to the maintenance of biodiversity. The relation of edaphic differentiation to tradeoffs among leaf functional traits is less clear, but may provide insights into mechanisms of habitat partitioning in these species rich assemblages. Methodology/Principal Findings: We quantify the leaf economics spectrum (LES) for 16 tree species within a Bornean forest characterized by highly pronounced habitat specialization. Our findings suggest that the primary axis of trait variation in light-limited, lowland tropical forests was identical to the LES and corresponds with the shade tolerance continuum. There was no separation with respect to edaphic variation along this primary axis of trait variation. However, a second orthogonal axis determined largely by foliar P concentrations resulted in a near-perfect separation of species occupying distinct soil types within the forest. Conclusions/Significance: We suggest that this second axis of leaf trait variation represents a "leaf edaphic habitat spectrum'' related to foliar P and potentially other nutrients closely linked to geological substrate, and may generally occur in plant communities characterized by strong edaphic resource gradients.	[Baltzer, Jennifer L.] Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada; [Baltzer, Jennifer L.; Thomas, Sean C.] Univ Toronto, Fac Forestry, Toronto, ON, Canada	Mount Allison University; University of Toronto	Baltzer, JL (corresponding author), Mt Allison Univ, Dept Biol, Sackville, NB E0A 3C0, Canada.	jbaltzer@mta.ca	THOMAS, Sean C./B-6089-2008	THOMAS, Sean C./0000-0002-0686-2483	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Research was funded by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen S.E., 1974, CHEM ANAL ECOLOGICAL; ASHTON PS, 1964, OXFORD FORESTRY MEMO, V8; Baker TR, 2003, J TROP ECOL, V19, P109, DOI 10.1017/S0266467403003146; Baltzer JL, 2007, J ECOL, V95, P1208, DOI 10.1111/j.1365-2745.2007.01286.x; Baltzer JL, 2005, ECOLOGY, V86, P3063, DOI 10.1890/04-0598; BIELESKI RL, 1973, ANNU REV PLANT PHYS, V24, P225, DOI 10.1146/annurev.pp.24.060173.001301; CALDWELL MM, 1992, OECOLOGIA, V89, P305, DOI 10.1007/BF00317406; Campbell CD, 2006, PLANT CELL ENVIRON, V29, P844, DOI 10.1111/j.1365-3040.2005.01464.x; Chase J.M., 2009, ECOLOGICAL NICHES LI; Clark DB, 1999, ECOLOGY, V80, P2662, DOI 10.1890/0012-9658(1999)080[2662:EFATLS]2.0.CO;2; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; DeWalt SJ, 2006, PLANT ECOL, V186, P203, DOI 10.1007/s11258-006-9123-6; Espeleta JF, 2009, ECOLOGY, V90, P1773, DOI 10.1890/08-0056.1; Fox J. E. D., 1973, KABILI SEPILOK FORES; Gleason SM, 2009, FUNCT ECOL, V23, P1157, DOI 10.1111/j.1365-2435.2009.01575.x; Gusewell S, 2005, PLANT ECOL, V176, P35, DOI 10.1007/s11258-004-0010-8; IMSANDE J, 1994, PLANT PHYSIOL, V105, P3, DOI 10.1104/pp.105.1.3; Jackson RB, 1996, J ECOL, V84, P891, DOI 10.2307/2960560; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kitajima K., 2008, TROPICAL FOREST COMM, P160; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Mirmanto E, 1999, PHILOS T ROY SOC B, V354, P1825, DOI 10.1098/rstb.1999.0524; Nilus, 2004, EFFECT EDAPHIC VARIA; Palmiotto PA, 2004, J ECOL, V92, P609, DOI 10.1111/j.0022-0477.2004.00894.x; Paoli GD, 2006, J TROP ECOL, V22, P397, DOI 10.1017/S0266467406003208; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Paz-Rivera C, 2009, BIOTROPICA, V41, P665, DOI 10.1111/j.1744-7429.2009.00521.x; Phillips OL, 2003, J ECOL, V91, P757, DOI 10.1046/j.1365-2745.2003.00815.x; Poorter L, 2009, NEW PHYTOL, V181, P890, DOI 10.1111/j.1469-8137.2008.02715.x; Poorter L, 2006, ECOLOGY, V87, P1733, DOI 10.1890/0012-9658(2006)87[1733:LTAGPO]2.0.CO;2; Potts MD, 2002, ECOLOGY, V83, P2782, DOI 10.1890/0012-9658(2002)083[2782:HPITRF]2.0.CO;2; RAAIMAKERS D, 1995, OECOLOGIA, V102, P120, DOI 10.1007/BF00333319; Reich PB, 2009, OECOLOGIA, V160, P207, DOI 10.1007/s00442-009-1291-3; RYAN MG, 1995, PLANT CELL ENVIRON, V18, P765, DOI 10.1111/j.1365-3040.1995.tb00579.x; Santiago LS, 2007, FUNCT ECOL, V21, P19, DOI 10.1111/j.1365-2435.2006.01218.x; Santiago LS, 2004, OECOLOGIA, V139, P495, DOI 10.1007/s00442-004-1542-2; Schachtman DP, 1998, PLANT PHYSIOL, V116, P447, DOI 10.1104/pp.116.2.447; SCHUMAN GE, 1973, SOIL SCI SOC AM J, V37, P480, DOI 10.2136/sssaj1973.03615995003700030045x; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; VITOUSEK PM, 1984, ECOLOGY, V65, P285, DOI 10.2307/1939481; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WILLIAMS K, 1989, AM NAT, V133, P198, DOI 10.1086/284910; Wright IJ, 2005, NEW PHYTOL, V166, P485, DOI 10.1111/j.1469-8137.2005.01349.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P411, DOI 10.1111/j.1466-822x.2005.00172.x; Wright IJ, 2001, FUNCT ECOL, V15, P423, DOI 10.1046/j.0269-8463.2001.00542.x; [No title captured]	50	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2010	5	10							e13163	10.1371/journal.pone.0013163	http://dx.doi.org/10.1371/journal.pone.0013163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656TI	20957212	Green Published, Green Submitted, gold			2022-12-27	WOS:000282359300033
J	Shen, Y; Winkler, IG; Barbier, V; Sims, NA; Hendy, J; Levesque, JP				Shen, Yi; Winkler, Ingrid G.; Barbier, Valerie; Sims, Natalie A.; Hendy, Jean; Levesque, Jean-Pierre			Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Regulates Hematopoiesis and Bone Formation In Vivo	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; GROWTH-PROMOTING ACTIVITY; STEM-CELL MOBILIZATION; PROGENITOR CELLS; MATRIX-METALLOPROTEINASE; G-CSF; OSTEOBLASTIC METALLOPROTEINASES; TUMOR-GROWTH; C-KIT	Background: Tissue inhibitor of metalloproteinases-3 (TIMP-3) inhibits matrix metalloproteinases and membrane-bound sheddases. TIMP-3 is associated with the extracellular matrix and is expressed in highly remodeling tissues. TIMP-3 function in the hematopoietic system is unknown. Methodology/Principal Findings: We now report that TIMP-3 is highly expressed in the endosteal region of the bone marrow (BM), particularly by osteoblasts, endothelial and multipotent mesenchymal stromal cells which are all important cellular components of hematopoietic stem cell (HSC) niches, whereas its expression is very low in mature leukocytes and hematopoietic stem and progenitor cells. A possible role of TIMP-3 as an important niche component was further suggested by its down-regulation during granulocyte colony-stimulating factor-induced mobilization. To further investigate TIMP-3 function, mouse HSC were retrovirally transduced with human TIMP-3 and transplanted into lethally irradiated recipients. TIMP-3 overexpression resulted in decreased frequency of B and T lymphocytes and increased frequency of myeloid cells in blood and BM, increased Lineage-negative Sca-1(+)KIT(+) cell proliferation in vivo and in vitro and increased colony-forming cell trafficking to blood and spleen. Finally, over-expression of human TIMP-3 caused a late onset fatal osteosclerosis. Conclusions/Significance: Our results suggest that TIMP-3 regulates HSC proliferation, differentiation and trafficking in vivo, as well as bone and bone turn-over, and that TIMP-3 is expressed by stromal cells forming HSC niches within the BM. Thus, TIMP-3 may be an important HSC niche component regulating both hematopoiesis and bone remodeling.	[Shen, Yi; Winkler, Ingrid G.; Barbier, Valerie; Levesque, Jean-Pierre] Mater Med Res Inst, Hematopoiet Stem Cell Lab, Brisbane, Qld, Australia; [Shen, Yi; Levesque, Jean-Pierre] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Sims, Natalie A.; Hendy, Jean] St Vincents Inst, Fitzroy, Vic, Australia	Mater Research; University of Queensland; St. Vincent's Institute of Medical Research	Shen, Y (corresponding author), Mater Med Res Inst, Hematopoiet Stem Cell Lab, Brisbane, Qld, Australia.	jplevesque@mmri.mater.org.au	Sims, Natalie Ann/A-7192-2012; Levesque, Jean-Pierre/C-5426-2011; Heazlewood, Shen/C-9238-2015; Heazlewood, Shen Y/I-7370-2013; Winkler, Ingrid G/F-3263-2011	Sims, Natalie Ann/0000-0003-1421-8468; Levesque, Jean-Pierre/0000-0002-7299-6025; Heazlewood, Shen Y/0000-0003-1541-0224; Winkler, Ingrid G/0000-0001-6026-3572	National Health and Medical Research Council of Australia [288701, 434515, 488817]; Australian Postgraduate Award; Mater Medical Research Institute; Cancer Council of Queensland	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); Mater Medical Research Institute; Cancer Council of Queensland(Cancer Council Queensland)	This work was supported by project grants (#288701 and #434515 to JPL) and a research fellowship (#488817 to IGW) from the National Health and Medical Research Council of Australia, an Australian Postgraduate Award and Mater Medical Research Institute top-up scholarship (YS), and a senior research fellowship from the Cancer Council of Queensland (JPL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Althoff K, 2000, EUR J BIOCHEM, V267, P2624, DOI 10.1046/j.1432-1327.2000.01278.x; Amour A, 1998, FEBS LETT, V435, P39, DOI 10.1016/S0014-5793(98)01031-X; AnandApte B, 1997, INVEST OPHTH VIS SCI, V38, P817; AnandApte B, 1996, BIOCHEM CELL BIOL, V74, P853, DOI 10.1139/o96-090; APTE SS, 1995, J BIOL CHEM, V270, P14313, DOI 10.1074/jbc.270.24.14313; Askmyr M, 2009, TRENDS ENDOCRIN MET, V20, P303, DOI 10.1016/j.tem.2009.03.004; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; BLAVIER L, 1995, J CELL SCI, V108, P3649; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cruz AC, 2004, J BIOL CHEM, V279, P5612, DOI 10.1074/jbc.M312323200; Engsig MT, 2000, J CELL BIOL, V151, P879, DOI 10.1083/jcb.151.4.879; Garton KJ, 2003, J BIOL CHEM, V278, P37459, DOI 10.1074/jbc.M305877200; GASSON JC, 1985, NATURE, V315, P768, DOI 10.1038/315768a0; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Haviernik P, 2008, BLOOD CELL MOL DIS, V41, P179, DOI 10.1016/j.bcmd.2008.03.005; Hawkes SP, 2000, METH MOL B, V151, P399, DOI 10.1385/1-59259-046-2:399; HAYAKAWA T, 1994, J CELL SCI, V107, P2373; HAYAKAWA T, 1992, FEBS LETT, V298, P29, DOI 10.1016/0014-5793(92)80015-9; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Horiuchi K, 2009, J IMMUNOL, V182, P2093, DOI 10.4049/jimmunol.0802491; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Kamei M, 1999, INVEST OPHTH VIS SCI, V40, pS919; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohler A, 2009, BLOOD, V114, P290, DOI 10.1182/blood-2008-12-195644; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kuiperij HB, 2009, EXP HEMATOL, V37, P641, DOI 10.1016/j.exphem.2009.02.004; Lee MH, 2007, J BIOL CHEM, V282, P6887, DOI 10.1074/jbc.M610490200; Levesque JP, 2002, EXP HEMATOL, V30, P440, DOI 10.1016/S0301-472X(02)00788-9; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Levesque JP, 2003, EXP HEMATOL, V31, P109, DOI 10.1016/S0301-472X(02)01028-7; LEVESQUE JP, 2010, LEUKEMIA IN PRESS; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lundberg P, 2007, J BIOL CHEM, V282, P19082, DOI 10.1074/jbc.M609629200; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Mahmoodi M, 2005, AM J PATHOL, V166, P1733, DOI 10.1016/S0002-9440(10)62483-2; Marquez-Curtis LA, 2001, BRIT J HAEMATOL, V115, P595, DOI 10.1046/j.1365-2141.2001.03160.x; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; NAKAJIMA H, 2010, BLOOD, DOI DOI 10.1182/BL00D-2010-2001-266528; NAKAMURA Y, 2010, BLOOD; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Pelus LM, 2004, BLOOD, V103, P110, DOI 10.1182/blood-2003-04-1115; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Pruijt JFM, 1999, P NATL ACAD SCI USA, V96, P10863, DOI 10.1073/pnas.96.19.10863; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Robbins PB, 1997, J VIROL, V71, P9466, DOI 10.1128/JVI.71.12.9466-9474.1997; Rovida E, 2001, J IMMUNOL, V166, P1583, DOI 10.4049/jimmunol.166.3.1583; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; Schiltz C, 2008, J CELL BIOCHEM, V104, P1803, DOI 10.1002/jcb.21747; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; Sims NA, 2006, AM J PHYSIOL-ENDOC M, V290, pE456, DOI 10.1152/ajpendo.00311.2005; Six E, 2003, P NATL ACAD SCI USA, V100, P7638, DOI 10.1073/pnas.1230693100; Smookler DS, 2006, J IMMUNOL, V176, P721, DOI 10.4049/jimmunol.176.2.721; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; van Pel M, 2006, P NATL ACAD SCI USA, V103, P1469, DOI 10.1073/pnas.0510192103; Villeneuve J, 2009, EXP HEMATOL, V37, P849, DOI 10.1016/j.exphem.2009.03.009; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Winkler I. G., 2010, BLOOD; Winkler IG, 2005, J EXP MED, V201, P1077, DOI 10.1084/jem.20042299; WINKLER IG, 2010, BLOOD, DOI DOI 10.1182/BL00D-2009-2011-253534; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200; Zeng Y, 1998, DEV DYNAM, V211, P228	78	55	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2010	5	9							e13086	10.1371/journal.pone.0013086	http://dx.doi.org/10.1371/journal.pone.0013086			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	656FQ	20941363	gold, Green Published			2022-12-27	WOS:000282312600019
J	Lewis, SJ; Murad, A; Chen, LN; Smith, GD; Donovan, J; Palmer, T; Hamdy, F; Neal, D; Lane, JA; Davis, M; Cox, A; Martin, RM				Lewis, Sarah J.; Murad, Ali; Chen, Lina; Smith, George Davey; Donovan, Jenny; Palmer, Tom; Hamdy, Freddie; Neal, David; Lane, J. Athene; Davis, Michael; Cox, Angela; Martin, Richard M.			Associations between an Obesity Related Genetic Variant (FTO rs9939609) and Prostate Cancer Risk	PLOS ONE			English	Article							BODY-MASS INDEX; MENDELIAN RANDOMIZATION; RADICAL PROSTATECTOMY; WEIGHT CHANGE; MEN; EPIDEMIOLOGY; PSA; METAANALYSIS; POPULATION; DIAGNOSIS	Observational studies suggest that obese men have a lower risk of incident prostate cancer, but an increased risk of advanced and fatal cancers. These observations could be due to confounding, detection bias, or a biological effect of obesity. Genetic studies are less susceptible to confounding than observational epidemiology and can suggest how associations between phenotypes (such as obesity) and diseases arise. To determine whether the associations between obesity and prostate cancer are causal, we conducted a genetic association study of the relationship between a single nucleotide polymorphism known to be associated with obesity (FTO rs9939609) and prostate cancer. Data are from a population-based sample of 1550 screen-detected prostate cancers, 1815 age-and general practice matched controls with unrestricted prostate specific antigen (PSA) values and 1175 low-PSA controls (PSA <0.5 ng/ml). The rs9939609 A allele, which was associated with higher BMI in the sample, was inversely associated with overall (odds ratio (OR) versus all controls = 0.93; 95% confidence interval (CI): 0.85-1.02 p = 0.12 per allele) and low-grade (OR = 0.90; 0.81-0.99 p = 0.03 per allele) prostate cancer risk, but positively associated with high-grade cancer among cases (OR high-versus low-grade cancer = 1.16; 0.99-1.37 p = 0.07 per allele). Although evidence for these effects was weak, they are consistent with observational data based on BMI phenotypes and suggest that the observed association between obesity and prostate cancer is not due to confounding. Further research should confirm these findings, extend them to other BMI-related genetic variants and determine whether they are due to detection bias or obesity-related hormonal changes.	[Lewis, Sarah J.; Murad, Ali; Chen, Lina; Smith, George Davey; Donovan, Jenny; Palmer, Tom; Lane, J. Athene; Davis, Michael; Martin, Richard M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Smith, George Davey; Palmer, Tom; Martin, Richard M.] Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Sch Social & Community Med, Bristol, Avon, England; [Hamdy, Freddie] John Radcliffe Hosp, Nuffield Dept Surg, Oxford OX3 9DU, England; [Neal, David] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Cox, Angela] Univ Sheffield, Inst Canc Studies, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England	University of Bristol; University of Bristol; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield	Lewis, SJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	S.J.Lewis@bristol.ac.uk	FENTON, MIRIAM C/B-6430-2011; Davey Smith, George/A-7407-2013; Palmer, Tom Michael/X-6807-2019	Davey Smith, George/0000-0002-1407-8314; Palmer, Tom Michael/0000-0003-4655-4511; Neal, David/0000-0002-6033-5086; s, hema/0000-0002-3440-9475; Martin, Richard/0000-0002-7992-7719; Hamdy, Freddie/0000-0003-2627-2154; Lewis, Sarah/0000-0003-4311-6890; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Cox, Angela/0000-0002-5138-1099	World Cancer Research Fund UK [2004/18]; UK National Institute for Health Research Health Technology [96/20/06, 96/20/99]; National Institute for Health Research through the Biomedical Research Centre; U.S. Department of Defense [W81XWH-04-1-0280]; Yorkshire Cancer Research; MRC [G0601625]; MRC [G0900871, G0600705] Funding Source: UKRI; Medical Research Council [G0601625, G0600705, G0900871] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242] Funding Source: researchfish	World Cancer Research Fund UK; UK National Institute for Health Research Health Technology; National Institute for Health Research through the Biomedical Research Centre; U.S. Department of Defense(United States Department of Defense); Yorkshire Cancer Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the World Cancer Research Fund UK grant number 2004/18. The Prostate Testing for Cancer and Treatment (ProtecT) study is funded by the UK National Institute for Health Research Health Technology Assessment Programme (projects 96/20/06, 96/20/99). Funding for the ProtecT biorepository in Cambridge is provided by National Institute for Health Research through the Biomedical Research Centre. DNA extraction in ProtecT was also supported by U.S. Department of Defense award W81XWH-04-1-0280 and Yorkshire Cancer Research. TP was supported by MRC Project Grant G0601625. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery KNL, 2008, EUR UROL, V53, P1186, DOI 10.1016/j.eururo.2007.07.040; Baillargeon J, 2005, CANCER-AM CANCER SOC, V103, P1092, DOI 10.1002/cncr.20856; BANEZ LL, 2007, JAMA-J AM MED ASSOC, V98, P2275; Barqawi AB, 2005, UROLOGY, V65, P708, DOI 10.1016/j.urology.2004.10.074; Buschemeyer WC, 2007, EUR UROL, V52, P331, DOI 10.1016/j.eururo.2007.04.069; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chen L, 2009, CANCER EPIDEM BIOMAR, V18, P2874, DOI 10.1158/1055-9965.EPI-09-0544; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Didelez V, 2007, STAT METHODS MED RES, V16, P309, DOI 10.1177/0962280206077743; Donovan J, 2003, Health Technol Assess, V7, P1; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Freedland SJ, 2006, CANCER CAUSE CONTROL, V17, P5, DOI 10.1007/s10552-005-0378-3; Freedland SJ, 2004, J CLIN ONCOL, V22, P446, DOI 10.1200/JCO.2004.04.181; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gong ZH, 2007, CANCER-AM CANCER SOC, V109, P1192, DOI 10.1002/cncr.22534; Gong ZH, 2006, CANCER EPIDEM BIOMAR, V15, P1977, DOI 10.1158/1055-9965.EPI-06-0477; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hsing AW, 2008, CANCER EPIDEM BIOMAR, V17, P2525, DOI 10.1158/1055-9965.EPI-08-0448; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; MacInnis RJ, 2006, CANCER CAUSE CONTROL, V17, P989, DOI 10.1007/s10552-006-0049-z; Millender LE, 2004, INT J RADIAT ONCOL, V59, P6, DOI 10.1016/j.ijrobp.2003.12.027; Minelli C, 2004, AM J EPIDEMIOL, V160, P445, DOI 10.1093/aje/kwh228; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; PIERCE BL, INT J EPIDE IN PRESS; Rodriguez C, 2007, CANCER EPIDEM BIOMAR, V16, P63, DOI 10.1158/1055-9965.EPI-06-0754; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; SMITH GD, GENES NUTR IN PRESS, DOI DOI 10.1007/IS12263-010-0181-Y; Steuber T, 2006, CANCER-AM CANCER SOC, V106, P775, DOI 10.1002/cncr.21632; Stratigopoulos G, 2008, AM J PHYSIOL-REG I, V294, pR1185, DOI 10.1152/ajpregu.00839.2007; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Turner EL, 2011, INT J CANCER, V128, P440, DOI 10.1002/ijc.25360; van Roermund JGH, 2007, WORLD J UROL, V25, P491, DOI 10.1007/s00345-007-0178-3; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Werny DM, 2007, CANCER EPIDEM BIOMAR, V16, P70, DOI 10.1158/1055-9965.EPI-06-0588; Wittekind C, 2002, CANCER-AM CANCER SOC, V94, P2511, DOI 10.1002/cncr.10492; *WORLD CANC FUND A, 2007, GLOB PERSP; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; Zuccolo L, 2008, CANCER EPIDEM BIOMAR, V17, P2325, DOI 10.1158/1055-9965.EPI-08-0342	43	43	46	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13485	10.1371/journal.pone.0013485	http://dx.doi.org/10.1371/journal.pone.0013485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976066	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000283114700015
J	Nankabirwa, J; Cundill, B; Clarke, S; Kabatereine, N; Rosenthal, PJ; Dorsey, G; Brooker, S; Staedke, SG				Nankabirwa, Joaniter; Cundill, Bonnie; Clarke, Sian; Kabatereine, Narcis; Rosenthal, Philip J.; Dorsey, Grant; Brooker, Simon; Staedke, Sarah G.			Efficacy, Safety, and Tolerability of Three Regimens for Prevention of Malaria: A Randomized, Placebo-Controlled Trial in Ugandan Schoolchildren	PLOS ONE			English	Article							UNCOMPLICATED FALCIPARUM-MALARIA; SULFADOXINE-PYRIMETHAMINE; COMBINATION THERAPY; TRIMETHOPRIM-SULFAMETHOXAZOLE; ARTEMETHER-LUMEFANTRINE; CLINICAL-TRIALS; PREGNANT-WOMEN; DOUBLE-BLIND; AMODIAQUINE; CHILDREN	Background: Intermittent preventive treatment (IPT) is a promising malaria control strategy; however, the optimal regimen remains unclear. We conducted a randomized, single-blinded, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of a single course of sulfadoxine-pyrimethamine (SP), amodiaquine + SP (AQ+SP) or dihydroartemisinin-piperaquine (DP) among schoolchildren to inform IPT. Methods: Asymptomatic girls aged 8 to 12 years and boys aged 8 to 14 years enrolled in two primary schools in Tororo, Uganda were randomized to receive one of the study regimens or placebo, regardless of presence of parasitemia at enrollment, and followed for 42 days. The primary outcome was risk of parasitemia at 42 days. Survival analysis was used to assess differences between regimens. Results: Of 780 enrolled participants, 769 (98.6%) completed follow-up and were assigned a treatment outcome. The risk of parasitemia at 42 days varied significantly between DP (11.7% [95% confidence interval (CI): 7.9, 17.1]), AQ+SP (44.3% [37.6, 51.5]), and SP (79.7% [95% CI: 73.6, 85.2], p<0.001). The risk of parasitemia in SP-treated children was no different than in those receiving placebo (84.6% [95% CI: 79.1, 89.3], p = 0.22). No serious adverse events occurred, but AQ+SP was associated with increased risk of vomiting compared to placebo (13.0% [95% CI: 9.1, 18.5] vs. 4.7% [95% CI: 2.5, 8.8], respectively, p = 0.003). Conclusions: DP was the most efficacious and well-tolerated regimen tested, although AQ+SP appears to be a suitable alternative for IPT in schoolchildren. Use of SP for IPT may not be appropriate in areas with high-level SP resistance in Africa.	[Nankabirwa, Joaniter; Rosenthal, Philip J.; Dorsey, Grant; Staedke, Sarah G.] Uganda Malaria Surveillance Project, Kampala, Uganda; [Cundill, Bonnie; Clarke, Sian; Brooker, Simon; Staedke, Sarah G.] London Sch Hyg & Trop Med, London WC1, England; [Kabatereine, Narcis] Uganda Minist Hlth, Vector Control Div, Kampala, Uganda; [Rosenthal, Philip J.; Dorsey, Grant] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA USA; [Brooker, Simon] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth & Epidemiol Grp, Nairobi, Kenya	University of London; London School of Hygiene & Tropical Medicine; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Kenya Medical Research Institute	Nankabirwa, J (corresponding author), Uganda Malaria Surveillance Project, Kampala, Uganda.	sarah.staedke@lshtm.ac.uk	Clarke, Sian/AAF-5805-2019	Cundill, Bonnie/0000-0002-3648-820X	Gates Malaria Partnership; Malaria Capacity Development Consortium (MCDC); Wellcome Trust [081673, 084933]; ACT Consortium	Gates Malaria Partnership; Malaria Capacity Development Consortium (MCDC); Wellcome Trust(Wellcome TrustEuropean Commission); ACT Consortium	The study was funded by the Gates Malaria Partnership, which was supported by a grant from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JN is a PhD student funded by the Malaria Capacity Development Consortium (MCDC), which is supported by a grant from the Bill and Melinda Gates Foundation. SC and SB are supported by the Wellcome Trust through Career Development Fellowships (081673 and 084933). PJR is a Doris Duke Charitable Foundation Distinguished Clinical Scientist. BC is funded by the ACT Consortium, which is supported by a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine.	Aponte JJ, 2009, LANCET, V374, P1533, DOI 10.1016/S0140-6736(09)61258-7; Arinaitwe E, 2009, CLIN INFECT DIS, V49, P1629, DOI 10.1086/647946; Barger B, 2009, TROP MED INT HEALTH, V14, P784, DOI 10.1111/j.1365-3156.2009.02294.x; Bell DJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001578; Brooker S, 2009, MALARIA CONTROL SCH; Brooker S, 2008, T ROY SOC TROP MED H, V102, P304, DOI 10.1016/j.trstmh.2008.01.010; CAMPBELL MJ, 1995, BRIT MED J, V311, P1145, DOI 10.1136/bmj.311.7013.1145; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Cisse B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007164; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; Collett, 2003, MODELLING SURVIVAL D; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Dorsey G, 2002, LANCET, V360, P2031, DOI 10.1016/S0140-6736(02)12021-6; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Fanello CI, 2006, TROP MED INT HEALTH, V11, P589, DOI 10.1111/j.1365-3156.2006.01610.x; Francis D, 2006, J INFECT DIS, V193, P978, DOI 10.1086/500951; Gasasira AF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-177; Gimnig JE, 2006, AM J TROP MED HYG, V74, P738, DOI 10.4269/ajtmh.2006.74.738; Gosling RD, 2010, EXPERT REV ANTI-INFE, V8, P589, DOI [10.1586/eri.10.36, 10.1586/ERI.10.36]; Gosling RD, 2009, LANCET, V374, P1521, DOI 10.1016/S0140-6736(09)60997-1; Greenhouse B, 2006, AM J TROP MED HYG, V75, P836, DOI 10.4269/ajtmh.2006.75.836; Greenwood B, 2006, TROP MED INT HEALTH, V11, P983, DOI 10.1111/j.1365-3156.2006.01657.x; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Kamya Moses R, 2007, PLoS Clin Trials, V2, pe20, DOI 10.1371/journal.pctr.0020020; Lalloo DG, 2006, LANCET INFECT DIS, V6, P780, DOI 10.1016/S1473-3099(06)70655-7; Maiteki-Sebuguzi C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-106; Markham LN, 2007, AM J TROP MED HYG, V77, P14, DOI 10.4269/ajtmh.2007.77.14; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Nsobya SL, 2007, ANTIMICROB AGENTS CH, V51, P3023, DOI 10.1128/AAC.00012-07; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Olliaro P., 2003, COCHRANE DB SYST REV, V2, pCD000016; PHILLIPSHOWARD PA, 1990, J ROY SOC MED, V83, P82, DOI 10.1177/014107689008300208; Pullan RL, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-2; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471; Staedke SG, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-107; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; STURCHLER D, 1993, DRUG SAFETY, V8, P160; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; Tren R, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-305; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; WHO, 2008, GLOB MAL CONTR EL RE; Wongsrichanalai C, 2008, EMERG INFECT DIS, V14, P716, DOI 10.3201/eid1405.071601; World Health Organization (WHO), 2010, WHO POL REC INT PREV; Yeka A, 2005, PLOS MED, V2, P654, DOI 10.1371/journal.pmed.0020190; Zongo I, 2007, LANCET, V369, P491, DOI 10.1016/S0140-6736(07)60236-0	47	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2010	5	10							e13438	10.1371/journal.pone.0013438	http://dx.doi.org/10.1371/journal.pone.0013438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	666KU	20976051	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000283114700005
J	Corbett, HJ; Fernando, GJP; Chen, XF; Frazer, IH; Kendall, MAF				Corbett, Holly J.; Fernando, Germain J. P.; Chen, Xianfeng; Frazer, Ian H.; Kendall, Mark A. F.			Skin Vaccination against Cervical Cancer Associated Human Papillomavirus with a Novel Micro-Projection Array in a Mouse Model	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; EPIDERMAL POWDER IMMUNIZATION; DENDRITIC CELLS; UNSAFE INJECTIONS; IMMUNE-RESPONSES; TYPE-16 L1; INFECTION; VACCINES; IMMUNOGENICITY; CERVARIX(TM)	Background: Better delivery systems are needed for routinely used vaccines, to improve vaccine uptake. Many vaccines contain alum or alum based adjuvants. Here we investigate a novel dry-coated densely-packed micro-projection array skin patch (Nanopatch (TM)) as an alternate delivery system to intramuscular injection for delivering an alum adjuvanted human papillomavirus (HPV) vaccine (Gardasil (R)) commonly used as a prophylactic vaccine against cervical cancer. Methodology/ Principal Findings: Micro-projection arrays dry-coated with vaccine material (Gardasil (R)) delivered to C57BL/6 mouse ear skin released vaccine within 5 minutes. To assess vaccine immunogenicity, doses of corresponding to HPV-16 component of the vaccine between 0.43 +/- 0.084 ng and 300 +/- 120 ng (mean +/- SD) were administered to mice at day 0 and day 14. A dose of 55 +/- 6.0 ng delivered intracutaneously by micro-projection array was sufficient to produce a maximal virus neutralizing serum antibody response at day 28 post vaccination. Neutralizing antibody titres were sustained out to 16 weeks post vaccination, and, for comparable doses of vaccine, somewhat higher titres were observed with intracutaneous patch delivery than with intramuscular delivery with the needle and syringe at this time point. Conclusions/ Significance: Use of dry micro-projection arrays (Nanopatch (TM)) has the potential to overcome the need for a vaccine cold chain for common vaccines currently delivered by needle and syringe, and to reduce risk of needle-stick injury and vaccine avoidance due to the fear of the needle especially among children.	[Corbett, Holly J.; Fernando, Germain J. P.; Chen, Xianfeng; Kendall, Mark A. F.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia; [Frazer, Ian H.; Kendall, Mark A. F.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Woolloongabba, Qld, Australia	University of Queensland; University of Queensland	Corbett, HJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld, Australia.	m.kendall@uq.edu.au	Fernando, Germain JP/C-3733-2009; Chen, Xianfeng/D-1709-2010; Kendall, Mark/M-4122-2017; Chen, Xianfeng/O-3359-2019; Frazer, Ian/A-1137-2007	Fernando, Germain JP/0000-0003-3260-0548; Chen, Xianfeng/0000-0002-3189-2756; Chen, Xianfeng/0000-0002-3189-2756; Frazer, Ian/0000-0002-8002-4680	Cancer Council of Queensland; University of Queensland; National Health and Medical Research Council (Australia) [569726, 456150]; Australian Research Council [DP077464]; Queensland Smart State Scheme; Queensland Government	Cancer Council of Queensland(Cancer Council Queensland); University of Queensland(University of Queensland); National Health and Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Queensland Smart State Scheme; Queensland Government	Cancer Council of Queensland, the University of Queensland, National Health and Medical Research Council (Australia) Grants ID# 569726, ID# 456150, Australian Research Council Grant ID# DP077464 and the Queensland Smart State Scheme funded this research. Professor Mark A. F. Kendall was the recipient of an Australian Research Council Future Fellowship. Professor Ian H. Frazer was the recipient of a Queensland Government Premier's Fellowship. The University of Queensland and Professor Ian H. Frazer derive royalty income from the sale of HPV VLP vaccines. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	[Anonymous], WHO M STAND HPV ASS; BAKER TS, 1991, BIOPHYS J, V60, P1445, DOI 10.1016/S0006-3495(91)82181-6; Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; BREITBURD F, 1995, J VIROL, V69, P3959, DOI 10.1128/JVI.69.6.3959-3963.1995; BUCK CB, 2006, GENERATION HPV PSEUD, P445; Chen XF, 2009, J CONTROL RELEASE, V139, P212, DOI 10.1016/j.jconrel.2009.06.029; Crichton ML, 2010, BIOMATERIALS, V31, P4562, DOI 10.1016/j.biomaterials.2010.02.022; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Einstein MH, 2009, HUM VACCINES, V5, P705, DOI 10.4161/hv.5.10.9518; Fernando GJP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010266; Fieller E., 1940, J ROYAL STAT SOC S, V7, P1, DOI [10.2307/2983630, DOI 10.2307/2983630]; FINCH JT, 1965, J MOL BIOL, V13, P1, DOI 10.1016/S0022-2836(65)80075-4; Ghim S, 2000, EXP MOL PATHOL, V68, P147, DOI 10.1006/exmp.1999.2298; Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8; HAMILTON JG, 1995, J FAM PRACTICE, V41, P169; HILLARD W, 2004, PERSPECT SEX REPRO H, V36, P6; JAN MMW, 1999, J PATHOL, V189, P12; Kendall M. A. F., 2005, WIPO Patent, Patent No. [2005072630, WO 2005/072630]; Kendall M, 2006, VACCINE, V24, P4651, DOI 10.1016/j.vaccine.2005.08.066; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; KIRNBAUER R, 1993, J VIROL, V67, P6929, DOI 10.1128/JVI.67.12.6929-6936.1993; Kundi M, 2007, EXPERT REV VACCINES, V6, P133, DOI 10.1586/14760584.6.2.133; Le Tallec D, 2009, HUM VACCINES, V5, P467, DOI 10.4161/hv.8485; Lenz P, 2001, J IMMUNOL, V166, P5346, DOI 10.4049/jimmunol.166.9.5346; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; Maa YF, 2003, PHARMACEUT RES, V20, P969, DOI 10.1023/A:1024493719236; Maa YF, 2003, J PHARM SCI-US, V92, P319, DOI 10.1002/jps.10294; McCarthy MP, 1998, J VIROL, V72, P32, DOI 10.1128/JVI.72.1.32-41.1998; Miller MA, 1999, B WORLD HEALTH ORGAN, V77, P808; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; MIZUNO K, 1989, Patent No. 0130619; Nir Y, 2003, AM J TROP MED HYG, V68, P341, DOI 10.4269/ajtmh.2003.68.341; Nokleby H, 2006, CURR ALLERGY ASTHM R, V6, P9, DOI 10.1007/s11882-006-0003-x; O'Connor K, 2007, AUST FAM PHYSICIAN, V36, P677; Osorio JE, 2003, IMMUNOL CELL BIOL, V81, P52, DOI 10.1046/j.1440-1711.2003.01134.x; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pastrana DV, 2004, VIROLOGY, V321, P205, DOI 10.1016/j.virol.2003.12.027; PHELPS WC, 1988, CELL, V53, P539, DOI 10.1016/0092-8674(88)90570-3; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHULER G, 1985, J EXP MED, V161, P526, DOI 10.1084/jem.161.3.526; Shank-Retzlaff ML, 2006, HUM VACCINES, V2, P147, DOI 10.4161/hv.2.4.2989; SHINJE G, 1991, INT J CANCER, V49, P285; Simonsen L, 1999, B WORLD HEALTH ORGAN, V77, P789; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; Thones N, 2008, J VIROL, V82, P5472, DOI 10.1128/JVI.02482-07; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; *WHO EXP COMM BIOL, 2006, GUID ASS QUAL SAF EF; Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	53	82	85	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13460	10.1371/journal.pone.0013460	http://dx.doi.org/10.1371/journal.pone.0013460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976136	Green Published, gold			2022-12-27	WOS:000283045300029
J	Lifjeld, JT; Laskemoen, T; Kleven, O; Albrecht, T; Robertson, RJ				Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund; Albrecht, Tomas; Robertson, Raleigh J.			Sperm Length Variation as a Predictor of Extrapair Paternity in Passerine Birds	PLOS ONE			English	Article							POSTCOPULATORY SEXUAL SELECTION; BLUETHROAT LUSCINIA-SVECICA; WARBLER PHYLLOSCOPUS-TROCHILUS; PAIR PATERNITY; TESTES SIZE; INTRASPECIFIC VARIATION; MOLECULAR PHYLOGENY; MATING SYSTEMS; ZEBRA FINCH; COMPETITION	Background: The rate of extrapair paternity is a commonly used index for the risk of sperm competition in birds, but paternity data exist for only a few percent of the approximately 10400 extant species. As paternity analyses require extensive field sampling and costly lab work, species coverage in this field will probably not improve much in the foreseeable future. Recent findings from passerine birds, which constitute the largest avian order (, 5 900 species), suggest that sperm phenotypes carry a signature of sperm competition. Here we examine how well standardized measures of sperm length variation can predict the rate of extrapair paternity in passerine birds. Methodology/Principal Findings: We collected sperm samples from 55 passerine species in Canada and Europe for which extrapair paternity rates were already available from either the same (n = 24) or a different (n = 31) study population. We measured the total length of individual spermatozoa and found that both the coefficient of between-male variation (CVbm) and within-male variation (CVwm) in sperm length were strong predictors of the rate of extrapair paternity, explaining as much as 65% and 58%, respectively, of the variation in extrapair paternity among species. However, only the CVbm predictor was independent of phylogeny, which implies that it can readily be converted into a currency of extrapair paternity without the need for phylogenetic correction. Conclusion/Significance: We propose the CVbm index as an alternative measure to extrapair paternity for passerine birds. Given the ease of sperm extraction from male birds in breeding condition, and a modest number of sampled males required for a robust estimate, this new index holds a great potential for mapping the risk of sperm competition across a wide range of passerine birds.	[Lifjeld, Jan T.; Laskemoen, Terje; Kleven, Oddmund] Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Oslo, Norway; [Albrecht, Tomas] Acad Sci Czech Republic, Dept Populat Biol, Inst Vertebrate Biol, Brno, Czech Republic; [Albrecht, Tomas] Charles Univ Prague, Fac Sci, Dept Zool, Brno, Czech Republic; [Robertson, Raleigh J.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	University of Oslo; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; Charles University Prague; Queens University - Canada	Lifjeld, JT (corresponding author), Univ Oslo, Nat Hist Museum, Natl Ctr Biosystemat, Oslo, Norway.	j.t.lifjeld@nhm.uio.no	Kleven, Oddmund/A-6116-2009; Albrecht, Tomas/A-1130-2011; ASCR, IVB/A-9883-2011; Lifjeld, Jan T/B-1978-2008	Kleven, Oddmund/0000-0003-0267-6795; Lifjeld, Jan T/0000-0002-9172-9985; Albrecht, Tomas/0000-0002-9213-0034	Research Council of Norway [170853/V40, 196554/V40]; Ministry of Education, Youth and Sport of the Czech Republic [0021620828]; Academy of Sciences of the Czech Republic [AV0Z60930519]; Research Centrum Project [LC06073]; National Sciences and Engineering Research Council of Canada	Research Council of Norway(Research Council of Norway); Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Research Centrum Project; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The project was funded by two grants (170853/V40 and 196554/V40) from the Research Council of Norway to JTL, the Ministry of Education, Youth and Sport of the Czech Republic (0021620828), the Academy of Sciences of the Czech Republic (AV0Z60930519) and the Research Centrum Project (LC06073) to TA, and the National Sciences and Engineering Research Council of Canada (operational grant) to RJR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2006, MOL PHYLOGENET EVOL, V38, P381, DOI 10.1016/j.ympev.2005.05.015; Alstrom P, 2008, MOL PHYLOGENET EVOL, V47, P960, DOI 10.1016/j.ympev.2007.12.007; [Anonymous], 2010, R LANG ENV STAT COMP; Arnold KE, 2002, P ROY SOC B-BIOL SCI, V269, P1263, DOI 10.1098/rspb.2002.2013; Birkhead TR, 2010, EMU, V110, P189, DOI 10.1071/MU09086; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; Birkhead TR, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P1; Birkhead TR, 1998, SPERM COMPETITION SE; Breed WG, 2007, J ZOOL, V272, P299, DOI 10.1111/j.1469-7998.2006.00269.x; Briskie JV, 1997, EVOLUTION, V51, P937, DOI 10.1111/j.1558-5646.1997.tb03674.x; Calhim S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000413; Calhim S, 2007, BEHAV ECOL, V18, P271, DOI 10.1093/beheco/arl076; Cornwallis CK, 2010, NATURE, V466, P969, DOI 10.1038/nature09335; Dunn PO, 2001, EVOLUTION, V55, P161; Evans ML, 2009, J FIELD ORNITHOL, V80, P146, DOI 10.1111/j.1557-9263.2009.00216.x; Fitzpatrick JL, 2009, BIOL LETTERS, V5, P320, DOI 10.1098/rsbl.2008.0734; Fossoy F, 2006, BEHAV ECOL SOCIOBIOL, V60, P255, DOI 10.1007/s00265-006-0163-7; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Gill FB, 2005, AUK, V122, P121, DOI 10.1642/0004-8038(2005)122[0121:POTPIS]2.0.CO;2; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Griffith SC, 2010, ANIM BEHAV, V79, P261, DOI 10.1016/j.anbehav.2009.11.031; Griffith SC, 2009, J AVIAN BIOL, V40, P97, DOI 10.1111/j.1600-048X.2009.04562.x; HARCOURT AH, 1991, EVOLUTION, V45, P314, DOI [10.2307/2409666, 10.1111/j.1558-5646.1991.tb04406.x]; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Johnsen A, 2003, OECOLOGIA, V136, P476, DOI 10.1007/s00442-003-1286-4; Jonsson KA, 2006, ZOOL SCR, V35, P149, DOI 10.1111/j.1463-6409.2006.00221.x; Kleven O, 2008, EVOLUTION, V62, P494, DOI 10.1111/j.1558-5646.2007.00287.x; Kleven O, 2009, EVOLUTION, V63, P2466, DOI 10.1111/j.1558-5646.2009.00725.x; Klicka J, 2007, MOL PHYLOGENET EVOL, V45, P1014, DOI 10.1016/j.ympev.2007.07.006; Kvist L, 2005, MOL PHYLOGENET EVOL, V34, P501, DOI 10.1016/j.ympev.2004.11.017; Laskemoen T, 2008, J AVIAN BIOL, V39, P322, DOI 10.1111/j.0908-8857.2008.04178.x; Laskemoen T, 2007, ORNIS FENNICA, V84, P131; Laskemoen T, 2010, BEHAV ECOL SOCIOBIOL, V64, P1473, DOI 10.1007/s00265-010-0962-8; Lifjeld JT, 2007, J AVIAN BIOL, V38, P267, DOI 10.1111/j.2007.0908-8857.04126.x; Lovette IJ, 2010, MOL PHYLOGENET EVOL, V57, P753, DOI 10.1016/j.ympev.2010.07.018; Lupold S, 2009, BEHAV ECOL SOCIOBIOL, V63, P899, DOI 10.1007/s00265-009-0733-6; Lupold S, 2009, P R SOC B, V276, P1175, DOI 10.1098/rspb.2008.1645; Lupold S, 2009, EVOLUTION, V63, P391, DOI 10.1111/j.1558-5646.2008.00571.x; Macedo RH, 2008, AUK, V125, P769, DOI 10.1525/auk.2008.11008; Michalczyk L, 2010, P ROY SOC B-BIOL SCI, V277, P3483, DOI 10.1098/rspb.2010.0514; MOLLER AP, 1995, BEHAV ECOL SOCIOBIOL, V36, P357, DOI 10.1007/BF00167797; Nguembock B, 2009, MOL PHYLOGENET EVOL, V51, P169, DOI 10.1016/j.ympev.2008.10.022; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parapanov RN, 2009, ANIM REPROD SCI, V114, P269, DOI 10.1016/j.anireprosci.2008.09.013; Parker G.A., 1998, SPERM COMPETITION SE, P3, DOI DOI 10.1016/B978-012100543-6/50026-X; PARKER GA, 1990, P ROY SOC B-BIOL SCI, V242, P120, DOI 10.1098/rspb.1990.0114; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Pitcher TE, 2005, J EVOLUTION BIOL, V18, P557, DOI 10.1111/j.1420-9101.2004.00874.x; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Reale D, 2003, EVOLUTION, V57, P597, DOI 10.1111/j.0014-3820.2003.tb01551.x; Salzburger W, 2002, MOL PHYLOGENET EVOL, V24, P19, DOI 10.1016/S1055-7903(02)00265-8; Sangster G, 2010, MOL PHYLOGENET EVOL, V57, P380, DOI 10.1016/j.ympev.2010.07.008; SEUANEZ HN, 1977, NATURE, V270, P345, DOI 10.1038/270345a0; Sheldon FH, 2005, MOL PHYLOGENET EVOL, V35, P254, DOI 10.1016/j.ympev.2004.11.008; Sibley C.G., 1990, PHYLOGENY CLASSIFICA; Simmons LW, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P405, DOI 10.1016/B978-0-12-372568-4.00010-0; Sokal R. R, 1981, BIOMETRY; Treplin S, 2008, CLADISTICS, V24, P328, DOI 10.1111/j.1096-0031.2007.00178.x; Voelker G, 2008, MOL PHYLOGENET EVOL, V49, P377, DOI 10.1016/j.ympev.2008.06.014; Voelker G, 2007, MOL PHYLOGENET EVOL, V42, P422, DOI 10.1016/j.ympev.2006.07.016; White-Cooper H, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P151, DOI 10.1016/B978-0-12-372568-4.00004-5; Zuccon D, 2010, ZOOL SCR, V39, P213, DOI 10.1111/j.1463-6409.2010.00423.x; [No title captured]; [No title captured]	66	70	72	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2010	5	10							e13456	10.1371/journal.pone.0013456	http://dx.doi.org/10.1371/journal.pone.0013456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665ON	20976147	Green Published, Green Submitted, gold			2022-12-27	WOS:000283045300026
J	Lucio, M; Fekete, A; Weigert, C; Wagele, B; Zhao, XJ; Chen, J; Fritsche, A; Haring, HU; Schleicher, ED; Xu, GW; Schmitt-Kopplin, P; Lehmann, R				Lucio, Marianna; Fekete, Agnes; Weigert, Cora; Waegele, Brigitte; Zhao, Xinjie; Chen, Jing; Fritsche, Andreas; Haering, Hans-Ulrich; Schleicher, Erwin D.; Xu, Guowang; Schmitt-Kopplin, Philippe; Lehmann, Rainer			Insulin Sensitivity Is Reflected by Characteristic Metabolic Fingerprints - A Fourier Transform Mass Spectrometric Non-Targeted Metabolomics Approach	PLOS ONE			English	Article							GLUCOSE-TOLERANCE TEST; BIOMARKERS; ACIDS; PROFILES; BLOOD; OBESE	Background: A decline in body insulin sensitivity in apparently healthy individuals indicates a high risk to develop type 2 diabetes. Investigating the metabolic fingerprints of individuals with different whole body insulin sensitivity according to the formula of Matsuda, et al. (ISIMatsuda) by a non-targeted metabolomics approach we aimed a) to figure out an unsuspicious and altered metabolic pattern, b) to estimate a threshold related to these changes based on the ISI, and c) to identify the metabolic pathways responsible for the discrimination of the two patterns. Methodology and Principal Findings: By applying infusion ion cyclotron resonance Fourier transform mass spectrometry, we analyzed plasma of 46 non-diabetic subjects exhibiting high to low insulin sensitivities. The orthogonal partial least square model revealed a cluster of 28 individuals with alterations in their metabolic fingerprints associated with a decline in insulin sensitivity. This group could be separated from 18 subjects with an unsuspicious metabolite pattern. The orthogonal signal correction score scatter plot suggests a threshold of an ISIMatsuda of 15 for the discrimination of these two groups. Of note, a potential subgroup represented by eight individuals (ISIMatsuda value between 8.5 and 15) was identified in different models. This subgroup may indicate a metabolic transition state, since it is already located within the cluster of individuals with declined insulin sensitivity but the metabolic fingerprints still show some similarities with unaffected individuals (ISI > 15). Moreover, the highest number of metabolite intensity differences between unsuspicious and altered metabolic fingerprints was detected in lipid metabolic pathways (arachidonic acid metabolism, metabolism of essential fatty acids and biosynthesis of unsaturated fatty acids), steroid hormone biosyntheses and bile acid metabolism, based on data evaluation using the metabolic annotation interface MassTRIX. Conclusions: Our results suggest that altered metabolite patterns that reflect changes in insulin sensitivity respectively the ISIMatsuda are dominated by lipid-related pathways. Furthermore, a metabolic transition state reflected by heterogeneous metabolite fingerprints may precede severe alterations of metabolism. Our findings offer future prospects for novel insights in the pathogenesis of the pre-diabetic phase.	[Lucio, Marianna; Fekete, Agnes; Schmitt-Kopplin, Philippe] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Ecol Chem, Dept BioGeoChem & Analyt, Neuherberg, Germany; [Weigert, Cora; Schleicher, Erwin D.; Lehmann, Rainer] Univ Hosp Tuebingen, Div Clin Chem & Pathobiochem, Cent Lab, Tubingen, Germany; [Weigert, Cora; Fritsche, Andreas; Haering, Hans-Ulrich; Schleicher, Erwin D.; Lehmann, Rainer] Univ Tubingen, Paul Langerhans Inst Tubingen, Tubingen, Germany; [Waegele, Brigitte] German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Waegele, Brigitte; Xu, Guowang] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Dept Genome Oriented Bioinformat, D-8050 Freising Weihenstephan, Germany; [Zhao, Xinjie; Chen, Jing] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Fritsche, Andreas; Haering, Hans-Ulrich] Univ Hosp Tuebingen, Dept Internal Med 4, Tubingen, Germany; [Schmitt-Kopplin, Philippe] Tech Univ Munich, Dept Chem Tech Anal Res Ctr Weihenstephan Brewing, D-8050 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich	Lucio, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Muenchen, Inst Ecol Chem, Dept BioGeoChem & Analyt, Neuherberg, Germany.	schmitt-kopplin@helmholtz-muenchen.de; Rainer.Lehmann@med.uni-tuebingen.de	Xu, Guowang/L-6910-2014; Fekete, Agnes/C-8048-2019; Lehmann, Rainer/AAF-4281-2019; Schmitt-Kopplin, Philippe/H-6271-2011	Xu, Guowang/0000-0003-4298-3554; Fekete, Agnes/0000-0003-3058-7570; Lehmann, Rainer/0000-0003-1218-6810; Schmitt-Kopplin, Philippe/0000-0003-0824-2664; Lucio, Marianna/0000-0002-5844-0098	Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research; Foundation for Distinguished Young Scholars [20425516]; Foundation from National Natural Science Foundation of China [20675082]; Sino-German Center for Research Promotion (DFG) [GZ 364]; Sino-German Center for Research Promotion (NSFC); National Basic Research Program of China [2006CB503902]; State Ministry of Science & Technology of China [2006BAK02A12]	Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Foundation for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Foundation from National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sino-German Center for Research Promotion (DFG)(German Research Foundation (DFG)); Sino-German Center for Research Promotion (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); State Ministry of Science & Technology of China(Ministry of Science and Technology, China)	This work was supported in part by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research (FKZ 01GI0803-04), a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD eV), the Foundation for Distinguished Young Scholars (No. 20425516), the Foundation from National Natural Science Foundation of China (No. 20675082), the Sino-German Center for Research Promotion (DFG and NSFC, GZ 364), the National Basic Research Program of China (No. 2006CB503902) and National Key Project of Scientific and Technical Supporting Programs (No. 2006BAK02A12) from State Ministry of Science & Technology of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gougeon RD, 2009, P NATL ACAD SCI USA, V106, P9174, DOI 10.1073/pnas.0901100106; Han J, 2008, METABOLOMICS, V4, P128, DOI 10.1007/s11306-008-0104-8; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Huo TG, 2009, J PHARMACEUT BIOMED, V49, P976, DOI 10.1016/j.jpba.2009.01.008; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kernan WN, 2003, STROKE, V34, P1431, DOI 10.1161/01.STR.0000071108.00234.0E; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Matsuda M, 2010, NUTR METAB CARDIOVAS, V20, P79, DOI 10.1016/j.numecd.2009.07.007; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MIHALIK SJ, 2010, OBESITY SILVER SPRIN; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Nixon GF, 2009, BRIT J PHARMACOL, V158, P982, DOI 10.1111/j.1476-5381.2009.00281.x; Ohta D, 2010, CURR OPIN BIOTECH, V21, P35, DOI 10.1016/j.copbio.2010.01.012; Salek RM, 2007, PHYSIOL GENOMICS, V29, P99, DOI 10.1152/physiolgenomics.00194.2006; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Shaham O, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.50; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Suhre K, 2008, NUCLEIC ACIDS RES, V36, pW481, DOI 10.1093/nar/gkn194; TAI ES, 2010, DIABETOLOGIA; Van der Greef J, 2006, PHARMACOGENOMICS, V7, P1087, DOI 10.2217/14622416.7.7.1087; van Doorn M, 2007, BRIT J CLIN PHARMACO, V63, P562, DOI 10.1111/j.1365-2125.2006.02816.x; VANDERVOET H, 1994, CHEMOMETR INTELL LAB, V25, P313, DOI 10.1016/0169-7439(94)85050-X; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Wopereis S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004525; World Health Organization, 2006, DEF DIAGN DIAB MELL, P1; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yuan KL, 2007, J CHROMATOGR B, V850, P236, DOI 10.1016/j.jchromb.2006.11.035; ZHAO X, 2010, METABOLOMICS, P6; Zhao XJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE384, DOI 10.1152/ajpendo.90748.2008	44	58	59	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e13317	10.1371/journal.pone.0013317	http://dx.doi.org/10.1371/journal.pone.0013317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	20976215	Green Published, gold, Green Submitted			2022-12-27	WOS:000283043700002
J	Lau, JY; Oliver, BG; Baraket, M; Beckett, EL; Hansbro, NG; Moir, LM; Wilton, SD; Williams, C; Foster, PS; Hansbro, PM; Black, JL; Burgess, JK				Lau, Justine Y.; Oliver, Brian G.; Baraket, Melissa; Beckett, Emma L.; Hansbro, Nicole G.; Moir, Lyn M.; Wilton, Steve D.; Williams, Carolyn; Foster, Paul S.; Hansbro, Philip M.; Black, Judith L.; Burgess, Janette K.			Fibulin-1 Is Increased in Asthma - A Novel Mediator of Airway Remodeling?	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; GENE-EXPRESSION; MESSENGER-RNA; PROLIFERATION; ROLES; PATHOGENESIS; ASSOCIATION; FIBROBLASTS	Background: The extracellular matrix is a dynamic and complex network of macromolecules responsible for maintaining and influencing cellular functions of the airway. The role of fibronectin, an extracellular matrix protein, is well documented in asthma. However, the expression and function of fibulin-1, a secreted glycoprotein which interacts with fibronectin, has not been reported. Fibulin-1 is widely expressed in basement membranes in many organs including the lung. There are four isoforms in humans (A-D) of which fibulin-1C and 1D predominate. The objective of this study was to study the expression of fibulin-1 in volunteers with and without asthma, and to examine its function in vitro. Methodology/Principal Findings: We used immunohistochemistry and dot-blots to examine fibulin-1 levels in bronchial biopsies, bronchoalveolar lavage fluid and serum. Real-time PCR for fibulin-1C and 1D, and ELISA and western blotting for fibulin-1 were used to study the levels in airway smooth muscle cells. The function of fibulin-1C was determined by assessing its role, using an antisense oligonucleotide, in cell proliferation, migration and wound healing. A murine model of airway hyperresponsiveness (AHR) was used to explore the biological significance of fibulin-1. Levels of fibulin-1 were significantly increased in the serum and bronchoalveolar lavage fluid of 21 asthmatics compared with 11 healthy volunteers. In addition fibulin-1 was increased in asthma derived airway smooth muscle cells and fibulin-1C contributed to the enhanced proliferation and wound repair in these cells. These features were reversed when fibulin-1C was suppressed using an antisense oligomer. In a mouse model of AHR, treatment with an AO inhibited the development of AHR to methacholine. Conclusions: Our data collectively suggest fibulin-1C may be worthy of further investigation as a target for airway remodeling in asthma.	[Lau, Justine Y.; Oliver, Brian G.; Hansbro, Nicole G.; Moir, Lyn M.; Wilton, Steve D.; Williams, Carolyn; Foster, Paul S.; Hansbro, Philip M.; Black, Judith L.; Burgess, Janette K.] Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia; [Lau, Justine Y.; Oliver, Brian G.; Baraket, Melissa; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.] Univ Sydney, Discipline Pharmacol, Sydney, NSW 2006, Australia; [Oliver, Brian G.; Baraket, Melissa; Moir, Lyn M.; Black, Judith L.; Burgess, Janette K.] Woolcock Inst Med Res, Sydney, NSW, Australia; [Beckett, Emma L.; Hansbro, Nicole G.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Beckett, Emma L.; Hansbro, Nicole G.; Foster, Paul S.; Hansbro, Philip M.] Univ Newcastle, Hunter Med Res Inst, Newcastle, NSW 2308, Australia; [Wilton, Steve D.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Perth, WA 6009, Australia; [Wilton, Steve D.; Williams, Carolyn] Univ Western Australia, Lung Inst Western Australia, Perth, WA 6009, Australia; [Wilton, Steve D.; Williams, Carolyn] Univ Western Australia, Ctr Asthma Allergy & Resp Res, Perth, WA 6009, Australia	University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Western Australia; University of Western Australia; University of Western Australia	Lau, JY (corresponding author), Cooperat Res Ctr Asthma & Airways, Sydney, NSW, Australia.	janette.burgess@sydney.edu.au	Beckett, Emma/AAU-8537-2021; Oliver, Brian/E-7939-2010; Black, Judith L/C-6559-2008; Moir, Lyn/A-8967-2011; Burgess, Janette K/A-3597-2010; Foster, Paul/G-5057-2013; Hansbro, Phil/G-7486-2013; Burgess, Janette/M-7117-2019	Beckett, Emma/0000-0002-8888-3789; Oliver, Brian/0000-0002-7122-9262; Hansbro, Phil/0000-0002-4741-3035; Wilton, Steve/0000-0002-9400-893X; , Paul/0000-0002-0827-8299; Burgess, Janette/0000-0001-9868-9966	Cooperative Research Centre for Asthma and Airways; National Health and Medical Research Council, Australia [512301]; Asthma Foundation of NSW; CRC for Asthma and Airways; National Health and Medical Research Council Australia [402835]; NHMRC [571098]	Cooperative Research Centre for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Asthma Foundation of NSW; CRC for Asthma and Airways(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Cooperative Research Centre for Asthma and Airways (http://www.asthma.crc.org.au/), and the National Health and Medical Research Council Project Grant #512301, Australia (http://www.nhmrc.gov.au/). J.Y. Lau was supported by The Asthma Foundation of NSW (http://www.asthmansw.org.au/content.cfm?id=1996), and the CRC for Asthma and Airways. J.K. Burgess is supported by a National Health and Medical Research Council Australia R. Douglas Wright Fellowship #402835 and J.L. Black by an NH&MRC Senior Principal Research Fellowship #571098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA SK, 1989, J CELL BIOL, V109, P863, DOI 10.1083/jcb.109.2.863; Burgess JK, 2003, AM J RESP CRIT CARE, V167, P71, DOI 10.1164/rccm.200205-416OC; Ducros E, 2007, CURR EYE RES, V32, P481, DOI 10.1080/02713680701411269; EBINA M, 1993, AM REV RESPIR DIS, V148, P720, DOI 10.1164/ajrccm/148.3.720; GAILIT J, 1994, CURR OPIN CELL BIOL, V6, P717, DOI 10.1016/0955-0674(94)90099-X; GINA, 2002, GLOB STRAT ASTHM MAN; Hassan M, 2010, J ALLERGY CLIN IMMUN, V125, P1037, DOI 10.1016/j.jaci.2010.02.031; Hergeth SP, 2008, EXP HEMATOL, V36, P1022, DOI 10.1016/j.exphem.2008.03.013; Hesselson D, 2004, CURR BIOL, V14, P2005, DOI 10.1016/j.cub.2004.11.006; Hirst SJ, 2000, AM J RESP CELL MOL, V23, P335, DOI 10.1165/ajrcmb.23.3.3990; HIRST SJ, 1992, AM J RESP CELL MOL, V7, P574, DOI 10.1165/ajrcmb/7.6.574; Holgate ST, 2000, J ALLERGY CLIN IMMUN, V105, P193, DOI 10.1016/S0091-6749(00)90066-6; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; JEFFERY PK, 1992, BRIT MED BULL, V48, P23, DOI 10.1093/oxfordjournals.bmb.a072537; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Johnson PRA, 2006, AM J RESP CRIT CARE, V173, P32, DOI 10.1164/rccm.200406-703OC; Johnson PRA, 2004, J ALLERGY CLIN IMMUN, V113, P690, DOI 10.1016/j.jaci.2003.12.312; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Johnson PRA, 2001, CLIN EXP PHARMACOL P, V28, P233, DOI 10.1046/j.1440-1681.2001.03426.x; Kenyon NJ, 2003, THORAX, V58, P772, DOI 10.1136/thorax.58.9.772; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; LAITINEN LA, 1995, INT ARCH ALLERGY IMM, V107, P215, DOI 10.1159/000236981; Laprise C, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-21; Mitrpant Chalermchai, 2009, Curr Mol Pharmacol, V2, P110; Moll F, 2002, ONCOGENE, V21, P1097, DOI 10.1038/sj.onc.1205171; Parameswaran K, 2004, EUR RESPIR J, V24, P545, DOI 10.1183/09031936.04.00113103; Pupa SM, 2004, ONCOGENE, V23, P2153, DOI 10.1038/sj.onc.1207323; Qing J, 1997, ONCOGENE, V15, P2159, DOI 10.1038/sj.onc.1201385; Redington AE, 1997, AM J RESP CRIT CARE, V156, P642, DOI 10.1164/ajrccm.156.2.9605065; ROARK EF, 1995, J HISTOCHEM CYTOCHEM, V43, P401, DOI 10.1177/43.4.7534784; ROMBERGER DJ, 1992, AM J RESP CELL MOL, V7, P149, DOI 10.1165/ajrcmb/7.2.149; Syed F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-9; Tran H, 1997, J BIOL CHEM, V272, P22600, DOI 10.1074/jbc.272.36.22600; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Twal WO, 2001, J CELL SCI, V114, P4587; Vignola AM, 1997, AM J RESP CRIT CARE, V156, P591, DOI 10.1164/ajrccm.156.2.9609066; Westergren-Thorsson G, 2002, INT J BIOCHEM CELL B, V34, P1256, DOI 10.1016/S1357-2725(02)00058-4; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC; Zimmermann N, 2003, J CLIN INVEST, V111, P1863, DOI 10.1172/JCI200317912	39	42	42	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13360	10.1371/journal.pone.0013360	http://dx.doi.org/10.1371/journal.pone.0013360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967215	Green Published, gold			2022-12-27	WOS:000282869800040
J	Finlay, D; Richardson, RD; Landberg, LK; Howes, AL; Vuori, K				Finlay, Darren; Richardson, Robyn D.; Landberg, Lisa K.; Howes, Amy L.; Vuori, Kristiina			Novel HTS Strategy Identifies TRAIL-Sensitizing Compounds Acting Specifically Through the Caspase-8 Apoptotic Axis	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; DEATH; TUMOR; REEXPRESSION; LINE	Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) is potentially a very important therapeutic as it shows selectivity for inducing apoptosis in cancer cells whilst normal cells are refractory. TRAIL binding to its cognate receptors, Death Receptors-4 and -5, leads to recruitment of caspase-8 and classical activation of downstream effector caspases, leading to apoptosis. As with many drugs however, TRAIL's usefulness is limited by resistance, either innate or acquired. We describe here the development of a novel 384-well high-throughput screening (HTS) strategy for identifying potential TRAIL-sensitizing agents that act solely in a caspase-8 dependent manner. By utilizing a TRAIL resistant cell line lacking caspase-8 (NB7) compared to the same cells reconstituted with the wild-type protein, or with a catalytically inactive point mutant of caspase-8, we are able to identify compounds that act specifically through the caspase-8 axis, rather than through general toxicity. In addition, false positive hits can easily be "weeded out" in this assay due to their activity in cells lacking caspase-8-inducible activity. Screening of the library of pharmacologically active compounds (LOPAC) was performed as both proof-of-concept and to discover potential unknown TRAIL sensitizers whose mechanism is caspase-8 mediated. We identified known TRAIL sensitizers from the library and identified new compounds that appear to sensitize specifically through caspase-8. In sum, we demonstrate proof-of-concept and discovery of novel compounds with a screening strategy optimized for the detection of caspase-8 pathway-specific TRAIL sensitizers. This screen was performed in the 384-well format, but could easily be further miniaturized, allows easy identification of artifactual false positives, and is highly scalable to accommodate diverse libraries.	[Finlay, Darren; Richardson, Robyn D.; Landberg, Lisa K.; Howes, Amy L.; Vuori, Kristiina] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA	Sanford Burnham Prebys Medical Discovery Institute	Finlay, D (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA USA.	kvuori@sanfordburnham.org			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants (to KV) from the National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Booth NL, 2009, CANCER IMMUNOL IMMUN, V58, P1229, DOI 10.1007/s00262-008-0637-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cuello M, 2001, GYNECOL ONCOL, V81, P380, DOI 10.1006/gyno.2001.6194; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Finlay D, 2009, CANCER RES, V69, P5023, DOI 10.1158/0008-5472.CAN-08-3731; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Huang L, 2004, BONE, V34, P971, DOI 10.1016/j.bone.2004.02.005; Jin CY, 2009, ANTI-CANCER DRUG, V20, P713, DOI 10.1097/CAD.0b013e32832e8998; Koehler BC, 2009, WORLD J GASTROENTERO, V15, P5924, DOI 10.3748/wjg.15.5924; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Mellier G, 2010, MOL ASPECTS MED, V31, P93, DOI 10.1016/j.mam.2009.12.002; Moxley KM, 2009, GYNECOL ONCOL, V115, P438, DOI 10.1016/j.ygyno.2009.09.007; Muhlethaler-Mottet A, 2003, ANN NY ACAD SCI, V1010, P195, DOI 10.1196/annals.1299.033; Rokhlin OW, 2002, PROSTATE, V52, P1, DOI 10.1002/pros.10074; Song JH, 2003, BRAIN PATHOL, V13, P539; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Yeo EJ, 2003, J NATL CANCER I, V95, P516, DOI 10.1093/jnci/95.7.516; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang YQ, 2009, CANCER BIOL THER, V8, P917, DOI 10.4161/cbt.8.10.8141	23	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13375	10.1371/journal.pone.0013375	http://dx.doi.org/10.1371/journal.pone.0013375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	662KX	20967281	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300032
J	Liao, QY; Cowling, B; Lam, WT; Ng, MW; Fielding, R				Liao, Qiuyan; Cowling, Benjamin; Lam, Wing Tak; Ng, Man Wai; Fielding, Richard			Situational Awareness and Health Protective Responses to Pandemic Influenza A (H1N1) in Hong Kong: A Cross-Sectional Study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; SELF-EFFICACY; AVIAN INFLUENZA; RISK PERCEPTIONS; PLANNED BEHAVIOR; OUTBREAK; PREDICTORS; PREVENTION; KNOWLEDGE; ATTITUDES	Background: Whether information sources influence health protective behaviours during influenza pandemics or other emerging infectious disease epidemics is uncertain. Methodology: Data from cross-sectional telephone interviews of 1,001 Hong Kong adults in June, 2009 were tested against theory and data-derived hypothesized associations between trust in (formal/informal) information, understanding, self-efficacy, perceived susceptibility and worry, and hand hygiene and social distancing using Structural Equation Modelling with multigroup comparisons. Principal Findings: Trust in formal (government/media) information about influenza was associated with greater reported understanding of A/H1N1 cause (beta = 0.36) and A/H1N1 prevention self-efficacy (beta = 0.25), which in turn were associated with more hand hygiene (beta = 0.19 and beta = 0.23, respectively). Trust in informal (interpersonal) information was negatively associated with perceived personal A/H1N1 susceptibility (beta = -0.21), which was negatively associated with perceived self-efficacy (beta = -0.42) but positively associated with influenza worry (beta = 0.44). Trust in informal information was positively associated with influenza worry (beta = 0.16) which was in turn associated with greater social distancing (beta = 0.36). Multigroup comparisons showed gender differences regarding paths from trust in formal information to understanding of A/H1N1 cause, trust in informal information to understanding of A/H1N1 cause, and understanding of A/H1N1 cause to perceived self-efficacy. Conclusions/Significance: Trust in government/media information was more strongly associated with greater self-efficacy and handwashing, whereas trust in informal information was strongly associated with perceived health threat and avoidance behaviour. Risk communication should consider the effect of gender differences.	[Liao, Qiuyan; Lam, Wing Tak; Fielding, Richard] Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Sch Publ Hlth,Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Cowling, Benjamin; Ng, Man Wai] Univ Hong Kong, Infect Dis Grp, Dept Community Med,Sch Publ Hlth, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Liao, QY (corresponding author), Univ Hong Kong, Hlth Behav Res Grp, Dept Community Med, Sch Publ Hlth,Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China.	fielding@hkusua.hku.hk	Cowling, Benjamin John/C-4263-2009; Lam, Wendy Wing Tak/C-4319-2009	Cowling, Benjamin John/0000-0002-6297-7154; Liao, Qiuyan/0000-0002-1105-6857; Lam, Wendy Wing Tak/0000-0003-2383-0149	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region [PHE-01]; Harvard Center for Communicable Disease Dynamics, United States National Institutes of Health (NIH) [1 U54 GM088558]; Area of Excellence Scheme of the Hong Kong University Grants Committee [AoE/M-12/06]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region; Harvard Center for Communicable Disease Dynamics, United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Area of Excellence Scheme of the Hong Kong University Grants Committee; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Research Fund for the Control of Infectious Disease, Food and Health Bureau, Government of the Hong Kong Special Administrative Region (SAR) (grant number PHE-01), the Harvard Center for Communicable Disease Dynamics from the United States National Institutes of Health (NIH) Models of Infectious Disease Agent Study program (grant number 1 U54 GM088558), and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant number AoE/M-12/06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandura A, 1998, PSYCHOL HEALTH, V13, P623, DOI 10.1080/08870449808407422; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; BEAN B, 1982, J INFECT DIS, V146, P47, DOI 10.1093/infdis/146.1.47; Beier ME, 2003, J PERS SOC PSYCHOL, V84, P439, DOI 10.1037/0022-3514.84.2.439; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; Brahmbhatt M., 2008, SARS TYPE EC EFFECTS; Brewer NT, 2004, ANN BEHAV MED, V27, P125, DOI 10.1207/s15324796abm2702_7; Calman KC, 2002, LANCET, V360, P166, DOI 10.1016/S0140-6736(02)09421-7; *CDCP, 2010, CDC SAYS TAK 3 ACT F; Chapman GB, 2006, HEALTH PSYCHOL, V25, P82, DOI 10.1037/0278-6133.25.1.82; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; *CTR HLTH PROT HON, 2005, PREV AV INFL; *CTR HLTH PROT HON, 2009, HUM SWIN INFL; *ED ENC STATEUNIVE, 2010, HONG KONG HIST BACKG; ENDSLEY MR, 1995, HUM FACTORS, V37, P32, DOI 10.1518/001872095779049543; FISHBEIN M, 1974, PSYCHOL REV, V81, P59, DOI 10.1037/h0035872; FRESCO DM, 2004, COGNITIVE THER RES, V26, P179; GATTUSO SM, 1992, J CONSULT CLIN PSYCH, V60, P133, DOI 10.1037/0022-006X.60.1.133; Godin G, 1996, AM J HEALTH PROMOT, V11, P87, DOI 10.4278/0890-1171-11.2.87; Grayson ML, 2009, CLIN INFECT DIS, V48, P285, DOI 10.1086/595845; Helweg-Larsen M, 2001, PERS SOC PSYCHOL REV, V5, P74, DOI 10.1207/S15327957PSPR0501_5; *HONG KONG CENS ST, 2006, MAIN TABL 2006 POP C; Jerant A, 2008, CHRONIC ILLN, V4, P173, DOI 10.1177/1742395308089057; Kalichman SC, 1996, ANN BEHAV MED, V18, P6, DOI 10.1007/BF02903934; Katz Sara, 2005, BMC Med Educ, V5, P4, DOI 10.1186/1472-6920-5-4; King DK, 2010, DIABETES CARE, V33, P751, DOI 10.2337/dc09-1746; King G, 2001, AM POLIT SCI REV, V95, P49, DOI 10.1017/S0003055401000235; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kraft P, 2005, BRIT J SOC PSYCHOL, V44, P479, DOI 10.1348/014466604X17533; Leppin A, 2009, INT J BEHAV MED, V16, P7, DOI 10.1007/s12529-008-9002-8; Leung GM, 2003, J EPIDEMIOL COMMUN H, V57, P857, DOI 10.1136/jech.57.11.857; LIAO Q, 2010, INT J BEHAV IN PRESS; Liao QY, 2009, J PUBLIC HEALTH-UK, V31, P573, DOI 10.1093/pubmed/fdp043; Liao QY, 2009, RISK ANAL, V29, P416, DOI 10.1111/j.1539-6924.2008.01157.x; Mahler HIM, 1998, ANN BEHAV MED, V20, P39, DOI 10.1007/BF02893808; Munro S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-104; Muthen B., 2010, MPLUS USERS GUIDE; OLIVER J, 2002, NZ J PSYCHOL; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Rhodes RE, 2003, PSYCHOL HEALTH, V18, P79, DOI 10.1080/0887044031000080665; Rubin GJ, 2010, HEALTH TECHNOL ASSES, V14, P183, DOI 10.3310/hta14340-03; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Sekirime W K, 2001, Afr Health Sci, V1, P16; Sessa A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-171; Setbon M, 2010, EUR J PUBLIC HEALTH, V20, P490, DOI 10.1093/eurpub/ckq054; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; Slaughter L, 2005, J BIOMED INFORM, V38, P298, DOI 10.1016/j.jbi.2004.12.006; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Tang CSK, 2005, J AGING HEALTH, V17, P490, DOI 10.1177/0898264305277966; Tang CSK, 2003, AM J PUBLIC HEALTH, V93, P1887, DOI 10.2105/AJPH.93.11.1887; Voeten HACM, 2009, INT J BEHAV MED, V16, P49, DOI 10.1007/s12529-008-9006-4; Weinstein ND, 2007, HEALTH PSYCHOL, V26, P146, DOI 10.1037/0278-6133.26.2.146; World Health Organization, 2009, PAND INFL PREV MIT L; Wu JT, 2010, EMERG INFECT DIS, V16, P538, DOI 10.3201/eid1603.091216	57	101	101	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13350	10.1371/journal.pone.0013350	http://dx.doi.org/10.1371/journal.pone.0013350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	662KX	20967280	gold, Green Submitted, Green Published			2022-12-27	WOS:000282807300028
J	Zalla, T; Daprati, E; Sav, AM; Chaste, P; Nico, D; Leboyer, M				Zalla, Tiziana; Daprati, Elena; Sav, Anca-Maria; Chaste, Pauline; Nico, Daniele; Leboyer, Marion			Memory for Self-Performed Actions in Individuals with Asperger Syndrome	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; HIGH-FUNCTIONING AUTISM; AUTOBIOGRAPHICAL MEMORY; DIAGNOSTIC INTERVIEW; RECOGNITION MEMORY; CHILDRENS MEMORY; FAUX PAS; ADULTS; MIND; RECALL	Memory for action is enhanced if individuals are allowed to perform the corresponding movements, compared to when they simply listen to them (enactment effect). Previous studies have shown that individuals with Autism Spectrum Disorders (ASD) have difficulties with processes involving the self, such as autobiographical memories and self performed actions. The present study aimed at assessing memory for action in Asperger Syndrome (AS). We investigated whether adults with AS would benefit from the enactment effect when recalling a list of previously performed items vs. items that were only visually and verbally experienced through three experimental tasks (Free Recall, Old/New Recognition and Source Memory). The results showed that while performance on Recognition and Source Memory tasks was preserved in individuals with AS, the enactment effect for self-performed actions was not consistently present, as revealed by the lower number of performed actions being recalled on the Free Recall test, as compared to adults with typical development. Subtle difficulties in encoding specific motor and proprioceptive signals during action execution in individuals with AS might affect retrieval of relevant personal episodic information. These disturbances might be associated to an impaired action monitoring system.	[Zalla, Tiziana] Ecole Normale Super, CNRS, Inst Jean Nicod, Paris, France; [Daprati, Elena] Univ Roma Tor Vergata, Dipartimento Neurosci, Rome, Italy; [Daprati, Elena] Univ Roma Tor Vergata, Ctr Biomed Spaziale, Rome, Italy; [Daprati, Elena] IRCCS Fdn Santa Lucia, Dipartimento Fisiol Neuromotoria, Rome, Italy; [Sav, Anca-Maria] Univ Paris 08, Lab EA 2027, Paris, France; [Chaste, Pauline] Hop Robert Debre, F-75019 Paris, France; [Nico, Daniele] Univ Roma La Sapienza, Dipartimento Psicol, Rome, Italy; [Leboyer, Marion] Univ Paris Est Creteil, Henri Mondor Albert Chenevier Hosp, AP HP, Dept Psychiat,Fdn FondaMental,French Natl Sci Fdn, Creteil, France; [Leboyer, Marion] Hop Henri Mondor, INSERM, U 955, IMRB, F-94010 Creteil, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); University of Rome Tor Vergata; University of Rome Tor Vergata; IRCCS Santa Lucia; Universite Paris-VIII; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Sapienza University Rome; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Zalla, T (corresponding author), Ecole Normale Super, CNRS, Inst Jean Nicod, Paris, France.	tiziana.zalla@ens.fr	Leboyer, Marion/AAW-3648-2021; daprati, elena/AAA-2224-2019	Leboyer, Marion/0000-0001-5473-3697; tiziana, zalla/0000-0002-2710-2512	Fondation FondaMental, Fondation Orange; Agence Nationale de la Recherche; Italian Space Agency	Fondation FondaMental, Fondation Orange; Agence Nationale de la Recherche(French National Research Agency (ANR)); Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This research was supported by Fondation FondaMental, Fondation Orange to TZ, and ML, by Agence Nationale de la Recherche (Grant Programme << Neurosciences, Neurologie et Psychiatrie) to TZ and by the Italian Space Agency (DCMC grant) to ED and DN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; [Anonymous], 1983, CANADIAN PSYCHOL; BAKERWARD L, 1990, COGNITIVE DEV, V5, P55, DOI 10.1016/0885-2014(90)90012-I; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; BOUCHER J, 1989, J CHILD PSYCHOL PSYC, V30, P99, DOI 10.1111/j.1469-7610.1989.tb00771.x; Bowler DM, 2004, J AUTISM DEV DISORD, V34, P533, DOI 10.1007/s10803-004-2548-7; Bowler DM, 2000, J ABNORM PSYCHOL, V109, P663, DOI 10.1037//0021-843X.109.4.663; Bowler DM, 2000, J AUTISM DEV DISORD, V30, P305, DOI 10.1023/A:1005552811441; Bowler DM, 1997, NEUROPSYCHOLOGIA, V35, P65, DOI 10.1016/S0028-3932(96)00054-1; CASTIELLO U, 1991, BRAIN, V114, P2639, DOI 10.1093/brain/114.6.2639; Cattaneo L, 2007, P NATL ACAD SCI USA, V104, P17825, DOI 10.1073/pnas.0706273104; Crane L, 2008, J AUTISM DEV DISORD, V38, P498, DOI 10.1007/s10803-007-0420-2; Dahlgren SO, 1996, J CHILD PSYCHOL PSYC, V37, P759, DOI 10.1111/j.1469-7610.1996.tb01469.x; Daprati E, 2005, NEUROPSYCHOLOGIA, V43, P281, DOI 10.1016/j.neuropsychologia.2004.11.014; DONALDSON W, 1992, J EXP PSYCHOL GEN, V121, P275, DOI 10.1037/0096-3445.121.3.275; Engelkamp J., 1998, MEMORY ACTIONS; ERGIS AM, 1995, NEUROPSYCHOLOGIA LAT, V1, P18; Fabbri-Destro M, 2009, EXP BRAIN RES, V192, P521, DOI 10.1007/s00221-008-1578-3; Farrant A, 1998, J AUTISM DEV DISORD, V28, P43, DOI 10.1023/A:1026010919219; Frith U, 1999, MIND LANG, V14, P1; Gillberg C, 2001, AUTISM, V5, P57, DOI 10.1177/1362361301005001006; Hala S, 2005, J AUTISM DEV DISORD, V35, P75, DOI 10.1007/s10803-004-1036-4; Hansson SL, 2005, BRIT J PSYCHIAT, V187, P262, DOI 10.1192/bjp.187.3.262; HAPPE FGE, 1995, CHILD DEV, V66, P843, DOI 10.2307/1131954; HAPPE FGE, 1994, J AUTISM DEV DISORD, V24, P129, DOI 10.1007/BF02172093; Hare DJ, 2007, RES DEV DISABIL, V28, P317, DOI 10.1016/j.ridd.2006.03.003; Hermelin B., 1970, PSYCHOL EXPT AUTISTI; Hill EL, 2002, INFANT CHILD DEV, V11, P159, DOI 10.1002/icd.303; Hughes C, 1996, J AUTISM DEV DISORD, V26, P99, DOI 10.1007/BF02276237; Hulburt R., 1994, PSYCHOL MED, V24, P385; Jeannerod M, 2004, MIND LANG, V19, P113, DOI 10.1111/j.1468-0017.2004.00251.x; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; Lind SE, 2009, J AUTISM DEV DISORD, V39, P1231, DOI 10.1007/s10803-009-0735-2; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Millward C, 2000, J AUTISM DEV DISORD, V30, P15, DOI 10.1023/A:1005455926727; MINSHEW NJ, 1994, J CLIN EXP NEUROPSYC, V16, P261, DOI 10.1080/01688639408402637; O'Shea AG, 2005, DEV NEUROPSYCHOL, V27, P337, DOI 10.1207/s15326942dn2703_3; POWELL SD, 1993, EDUC PSYCHOL, V13, P359, DOI DOI 10.1080/0144341930130312; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Russell J, 1999, Cogn Neuropsychiatry, V4, P303; Russell J, 1998, J AUTISM DEV DISORD, V28, P177, DOI 10.1023/A:1026009203333; TAGERFLUSBERG H, 1991, BRIT J DEV PSYCHOL, V9, P417, DOI 10.1111/j.2044-835X.1991.tb00886.x; Tanweer T, 2010, NEUROPSYCHOLOGIA, V48, P900, DOI 10.1016/j.neuropsychologia.2009.11.007; Toichi M, 2002, AM J PSYCHIAT, V159, P1422, DOI 10.1176/appi.ajp.159.8.1422; Uhlhaas PJ, 2007, BIOL PSYCHIAT, V62, P190, DOI 10.1016/j.biopsych.2007.05.023; WECHSLER D, 1999, ECHELLE CLIN MEMOIRE; *WHO, 1992, ICD10 WHO; Williams D, 2009, J AUTISM DEV DISORD, V39, P251, DOI 10.1007/s10803-008-0619-x; Williams DM, 2009, J AUTISM DEV DISORD, V39, P865, DOI 10.1007/s10803-009-0695-6; WING L, 1981, PSYCHOL MED, V11, P115, DOI 10.1017/S0033291700053332; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Zalla T, 2010, EXP BRAIN RES, V201, P809, DOI 10.1007/s00221-009-2096-7; Zalla T, 2009, J AUTISM DEV DISORD, V39, P373, DOI 10.1007/s10803-008-0634-y	55	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2010	5	10							e13370	10.1371/journal.pone.0013370	http://dx.doi.org/10.1371/journal.pone.0013370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	662KX	20967277	Green Submitted, Green Published, gold			2022-12-27	WOS:000282807300031
J	Veliz, LA; Toro, CA; Vivar, JP; Arias, LA; Villegas, J; Castro, MA; Brauchi, S				Veliz, Luis A.; Toro, Carlos A.; Vivar, Juan P.; Arias, Luis A.; Villegas, Jenifer; Castro, Maite A.; Brauchi, Sebastian			Near-Membrane Dynamics and Capture of TRPM8 Channels within Transient Confinement Domains	PLOS ONE			English	Article							INTERNAL-REFLECTION FLUORESCENCE; KISS-AND-RUN; PLASMA-MEMBRANE; CATION CHANNEL; RECEPTOR TRPM8; CELL-SURFACE; ION CHANNELS; TRAFFICKING; TRANSLOCATION; CHOLESTEROL	Background: The cold and menthol receptor, TRPM8, is a non-selective cation channel expressed in a subset of peripheral neurons that is responsible for neuronal detection of environmental cold stimuli. It was previously shown that members of the transient receptor potential (TRP) family of ion channels are translocated toward the plasma membrane (PM) in response to agonist stimulation. Because the spatial and temporal dynamics of cold receptor cell-surface residence may determine neuronal activity, we hypothesized that the movement of TRPM8 to and from the PM might be a regulated process. Single particle tracking (SPT) is a useful tool for probing the organization and dynamics of protein constituents in the plasma membrane. Methodology/Principal Findings: We used SPT to study the receptor dynamics and describe membrane/near-membrane behavior of particles containing TRPM8-EGFP in transfected HEK-293T and F-11 cells. Cells were imaged using total internal reflection fluorescence (TIRF) microscopy and the 2D and 3D trajectories of TRPM8 molecules were calculated by analyzing mean-square particle displacement against time. Four characteristic types of motion were observed: stationary mode, simple Brownian diffusion, directed motion, and confined diffusion. In the absence of cold or menthol to activate the channel, most TRPM8 particles move in network covering the PM, periodically lingering for 2-8 s in confined microdomains of about 800 nm radius. Removing cholesterol with methyl-beta-cyclodextrin (M beta CD) stabilizes TRPM8 motion in the PM and is correlated with larger TRPM8 current amplitude that results from an increase in the number of available channels without a change in open probability. Conclusions/Significance: These results reveal a novel mechanism for regulating TRPM8 channel activity, and suggest that PM dynamics may play an important role in controlling electrical activity in cold-sensitive neurons.	[Veliz, Luis A.; Toro, Carlos A.; Vivar, Juan P.; Arias, Luis A.; Villegas, Jenifer; Brauchi, Sebastian] Univ Austral Chile, Fac Med, Inst Fisiol, Valdivia, Chile; [Castro, Maite A.] Univ Austral Chile, Fac Ciencias, Inst Bioquim, Valdivia, Chile; [Veliz, Luis A.] Univ Austral Chile, Fac Ciencias Ingn, Inst Ingn Informat, Valdivia, Chile	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Austral de Chile	Veliz, LA (corresponding author), Univ Austral Chile, Fac Med, Inst Fisiol, Campus Isla Teja, Valdivia, Chile.	sbrauchi@docentes.uach.cl	Toro, Carlos A/K-6642-2019; Soriano, Vicente/O-5730-2018; Brauchi, Sebastian E/A-2395-2008	Toro, Carlos A/0000-0002-7355-7534; Soriano, Vicente/0000-0002-4624-5199; Brauchi, Sebastian E/0000-0002-8494-9912	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [11070190, 11070065]; SeedingLabs, MA; PEW Program in Biomedical Sciences	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); SeedingLabs, MA; PEW Program in Biomedical Sciences	This work was funded by the PEW Program in Biomedical Sciences, Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) grants #11070190 and #11070065, and SeedingLabs, MA. C.T. is a Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez O, 2002, ADV PHYSIOL EDUC, V26, P327, DOI 10.1152/advan.00006.2002; AXELROD D, 1984, ANNU REV BIOPHYS BIO, V13, P247, DOI 10.1146/annurev.bb.13.060184.001335; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Brauchi S, 2008, P NATL ACAD SCI USA, V105, P8304, DOI 10.1073/pnas.0800881105; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang YP, 2008, J BIOPHOTONICS, V1, P287, DOI 10.1002/jbio.200810029; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Dong XP, 2008, NATURE, V455, P992, DOI 10.1038/nature07311; Dragoni I, 2006, J BIOL CHEM, V281, P37353, DOI 10.1074/jbc.M607227200; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lambers TT, 2007, MOL CELL BIOL, V27, P1486, DOI 10.1128/MCB.01468-06; Latorre R, 2009, Q REV BIOPHYS, V42, P201, DOI 10.1017/S0033583509990072; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Mattheyses AL, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2161018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Morenilla-Palao C, 2009, J BIOL CHEM, V284, P9215, DOI 10.1074/jbc.M807228200; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Peters KW, 2001, PFLUG ARCH EUR J PHY, V443, pS65, DOI 10.1007/s004240100647; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Ryan TA, 2003, P NATL ACAD SCI USA, V100, P2171, DOI 10.1073/pnas.0530260100; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Schmidt M, 2009, NEURON, V64, P498, DOI 10.1016/j.neuron.2009.09.030; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Stewart AP, 2010, BIOCHEM BIOPH RES CO, V394, P383, DOI 10.1016/j.bbrc.2010.03.027; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Watson RT, 2004, ENDOCR REV, V25, P177, DOI 10.1210/er.2003-0011; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Zhang Q, 2009, SCIENCE, V323, P1448, DOI 10.1126/science.1167373; ZHANG X, 2005, EMBO J, P2424	41	23	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2010	5	10							e13290	10.1371/journal.pone.0013290	http://dx.doi.org/10.1371/journal.pone.0013290			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	661SK	20948964	Green Submitted, gold, Green Published			2022-12-27	WOS:000282748100022
J	Mohd-Padil, H; Tajul-Arifin, K; Mohd-Adnan, A				Mohd-Padil, Hirzahida; Tajul-Arifin, Khairina; Mohd-Adnan, Adura			Characterization of the Functional Domain of beta 2-Microglobulin from the Asian Seabass, Lates calcarifer	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; BETA(2)-MICROGLOBULIN GENE; EXPRESSION; IDENTIFICATION; CHICKEN; CLONING; FISH	Background: beta 2-Microglobulin (beta M-2) is the light chain of major histocompatibility class I (MHC I) that binds non-covalently with the a heavy chain. Both proteins attach to the antigen peptide, presenting a complex to the T cell to be destroyed via the immune mechanism. Methodology/Principal Findings: In this study, a cDNA sequence encoding beta M-2 in the Asian seabass (Lates calcarifer) was identified and analyzed using in silico approaches to predict and characterize its functional domain. The beta M-2 cDNA contains an open reading frame (ORF) of 351 bases with a coding capacity of 116 amino acids. A large portion of the protein consists of the IG constant domain (IGc1), similar to beta M-2 sequences from other species studied thus far. Alignment of the IGc1 domains of beta M-2 from L. calcarifer and other species shows a high degree of overall conservation. Seven amino acids were found to be conserved across taxa whereas conservation between L. calcarifer and other fish species was restricted to 14 amino acids at identical conserved positions. Conclusion/Significance: As the L. calcarifer beta M-2 protein analyzed in this study contains a functional domain similar to that of beta M-2 proteins in other species, it can be postulated that the beta M-2 proteins from L. calcarifer and other organisms are derived from a common ancestor and thus have a similar immune function. Interestingly, fish beta M-2 genes could also be classified according to the ecological habitat of the species, i.e. whether it is from a freshwater, marine or euryhaline environment.	[Mohd-Padil, Hirzahida; Tajul-Arifin, Khairina; Mohd-Adnan, Adura] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia	Universiti Kebangsaan Malaysia	Mohd-Padil, H (corresponding author), Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi 43600, Selangor, Malaysia.	kay.tarifin@gmail.com	Mohd-Padil, Hirzahida/AAK-8082-2020		Ministry of Science, Technology and Innovation (MOSTI), Malaysia [05-02-02-T002]	Ministry of Science, Technology and Innovation (MOSTI), Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	Ministry of Science, Technology and Innovation (MOSTI), Malaysia under the Top-Down program (Project no. 05-02-02-T002). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECKER JW, 1985, P NATL ACAD SCI USA, V82, P4225, DOI 10.1073/pnas.82.12.4225; Benyamini H, 2003, J MOL BIOL, V330, P159, DOI 10.1016/S0022-2836(03)00557-6; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Canavez FC, 1999, AM J PRIMATOL, V48, P225, DOI 10.1002/(SICI)1098-2345(1999)48:3<225::AID-AJP4>3.0.CO;2-4; Canavez FC, 1998, IMMUNOGENETICS, V48, P133, DOI 10.1007/s002510050413; Cannon JP, 2002, NAT IMMUNOL, V3, P1200, DOI 10.1038/ni849; Choi WB, 2006, MOL IMMUNOL, V43, P1565, DOI 10.1016/j.molimm.2005.09.021; Coico R., 2003, IMMUNOLOGY SHORT COU; COLE T, 1989, EUR J BIOCHEM, V186, P35, DOI 10.1111/j.1432-1033.1989.tb15174.x; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; Criscitiello MF, 1998, IMMUNOGENETICS, V48, P339, DOI 10.1007/s002510050441; DANIEL F, 1983, EMBO J, V2, P1061, DOI 10.1002/j.1460-2075.1983.tb01546.x; DIXON B, 1995, DEV COMP IMMUNOL, V19, P109, DOI 10.1016/0145-305X(94)00056-L; Dixon B, 1996, IMMUNOGENETICS, V44, P419, DOI 10.1007/s002510050148; Durbin R., 1998, BIOL SEQUENCE ANAL P; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ELLIS SA, 1993, IMMUNOGENETICS, V38, P383, DOI 10.1007/BF00210486; Felsenstein J, 1996, METHOD ENZYMOL, V266, P418; GASTINEL LN, 1992, P NATL ACAD SCI USA, V89, P638, DOI 10.1073/pnas.89.2.638; GATES FT, 1979, BIOCHEMISTRY-US, V18, P2267, DOI 10.1021/bi00578a021; GROVES ML, 1982, J BIOL CHEM, V257, P2619; GUSSOW D, 1987, J IMMUNOL, V139, P3132; Hansen TH, 1997, ADV IMMUNOL, V64, P105, DOI 10.1016/S0065-2776(08)60888-3; HUI FH, 2006, FISH SHELLFISH IMMMU, V20, P118; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Hurley IA, 2007, P ROY SOC B-BIOL SCI, V274, P489, DOI 10.1098/rspb.2006.3749; Lundqvist ML, 1999, IMMUNOGENETICS, V50, P79, DOI 10.1007/s002510050690; MILLAND J, 1993, IMMUNOGENETICS, V38, P464, DOI 10.1007/BF00184532; Miska KB, 2003, DEV COMP IMMUNOL, V27, P247, DOI 10.1016/S0145-305X(02)00095-2; Naruse K, 2000, GENETICS, V154, P1773; ONO H, 1993, IMMUNOGENETICS, V38, P1, DOI 10.1007/BF00216384; Riegert P, 1996, P NATL ACAD SCI USA, V93, P1243, DOI 10.1073/pnas.93.3.1243; ROBERT DF, 2006, NUCLEIC ACIDS RES, V34, P247; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shum BP, 1996, P NATL ACAD SCI USA, V93, P2779, DOI 10.1073/pnas.93.7.2779; Stewart R, 2005, DEV COMP IMMUNOL, V29, P723, DOI 10.1016/j.dci.2004.12.004; Tallmadge RL, 2003, IMMUNOGENETICS, V54, P725, DOI 10.1007/s00251-002-0514-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan SL, 2008, GENE, V411, P77, DOI 10.1016/j.gene.2008.01.008; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; Vihtelic TS, 2005, MOL VIS, V11, P1083; WELINDER KG, 1991, MOL IMMUNOL, V28, P177, DOI 10.1016/0161-5890(91)90102-P; Western AH, 2003, MOL IMMUNOL, V39, P707, DOI 10.1016/S0161-5890(02)00260-2; WOLFE PB, 1980, MOL IMMUNOL, V17, P1493, DOI 10.1016/0161-5890(80)90175-3; York IA, 2005, J IMMUNOL, V174, P6839, DOI 10.4049/jimmunol.174.11.6839; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	46	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13159	10.1371/journal.pone.0013159	http://dx.doi.org/10.1371/journal.pone.0013159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949082	Green Published, Green Submitted, gold			2022-12-27	WOS:000282568400005
J	Wu, H; Min, JR; Lunin, VV; Antoshenko, T; Dombrovski, L; Zeng, H; Allali-Hassani, A; Campagna-Slater, V; Vedadi, M; Arrowsmith, CH; Plotnikov, AN; Schapira, M				Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu			Structural Biology of Human H3K9 Methyltransferases	PLOS ONE			English	Article							HISTONE LYSINE METHYLTRANSFERASES; PRODUCT SPECIFICITY; PROTEIN METHYLTRANSFERASES; MOLECULAR REPLACEMENT; METHYLATION; DOMAIN; RECOGNITION; MECHANISM; CATALYSIS; CHROMATIN	SET domain methyltransferases deposit methyl marks on specific histone tail lysine residues and play a major role in epigenetic regulation of gene transcription. We solved the structures of the catalytic domains of GLP, G9a, Suv39H2 and PRDM2, four of the eight known human H3K9 methyltransferases in their apo conformation or in complex with the methyl donating cofactor, and peptide substrates. We analyzed the structural determinants for methylation state specificity, and designed a G9a mutant able to tri-methylate H3K9. We show that the I-SET domain acts as a rigid docking platform, while induced-fit of the Post-SET domain is necessary to achieve a catalytically competent conformation. We also propose a model where long-range electrostatics bring enzyme and histone substrate together, while the presence of an arginine upstream of the target lysine is critical for binding and specificity.	[Wu, Hong; Min, Jinrong; Lunin, Vladimir V.; Antoshenko, Tatiana; Dombrovski, Ludmila; Zeng, Hong; Allali-Hassani, Abdellah; Campagna-Slater, Valerie; Vedadi, Masoud; Arrowsmith, Cheryl H.; Plotnikov, Alexander N.; Schapira, Matthieu] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Schapira, Matthieu] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Wu, H (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	alexander.plotnikov@mssm.edu; matthieu.schapira@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by the Structural Genomics Consortium (SGC), a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Collazo E, 2005, ANAL BIOCHEM, V342, P86, DOI 10.1016/j.ab.2005.04.007; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gonzalez ME, 2009, ONCOGENE, V28, P843, DOI 10.1038/onc.2008.433; Grewal SIS, 2003, SCIENCE, V301, P798, DOI 10.1126/science.1086887; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krivtsov AV, 2008, CANCER CELL, V14, P355, DOI 10.1016/j.ccr.2008.10.001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Marmorstein R, 2003, TRENDS BIOCHEM SCI, V28, P59, DOI 10.1016/S0968-0004(03)00007-0; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Qian C, 2006, CELL MOL LIFE SCI, V63, P2755, DOI 10.1007/s00018-006-6274-5; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rathert P, 2008, NAT CHEM BIOL, V4, P344, DOI 10.1038/nchembio.88; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Schneider R, 2002, TRENDS BIOCHEM SCI, V27, P396, DOI 10.1016/S0968-0004(02)02141-2; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Smith BC, 2009, BBA-GENE REGUL MECH, V1789, P45, DOI 10.1016/j.bbagrm.2008.06.005; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Volkel P, 2007, BIOCHIMIE, V89, P1, DOI 10.1016/j.biochi.2006.07.009; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao B, 2003, CURR OPIN STRUC BIOL, V13, P699, DOI 10.1016/j.sbi.2003.10.003; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	206	217	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 11	2010	5	1							e8570	10.1371/journal.pone.0008570	http://dx.doi.org/10.1371/journal.pone.0008570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541YB	20967253	gold, Green Published			2022-12-27	WOS:000273456300003
J	Schaub, M; Martinez, N; Tagmann-Ioset, A; Weisshaupt, N; Maurer, ML; Reichlin, TS; Abadi, F; Zbinden, N; Jenni, L; Arlettaz, R				Schaub, Michael; Martinez, Nicolas; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael			Patches of Bare Ground as a Staple Commodity for Declining Ground-Foraging Insectivorous Farmland Birds	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; AGRICULTURAL INTENSIFICATION; TERRESTRIAL ECOSYSTEMS; PROMOTING BIODIVERSITY; HABITAT STRUCTURE; PREDATION RISK; FOOD RESOURCES; GRASSLAND; MANAGEMENT; LANDSCAPES	Conceived to combat widescale biodiversity erosion in farmland, agri-environment schemes have largely failed to deliver their promises despite massive financial support. While several common species have shown to react positively to existing measures, rare species have continued to decline in most European countries. Of particular concern is the status of insectivorous farmland birds that forage on the ground. We modelled the foraging habitat preferences of four declining insectivorous bird species (hoopoe, wryneck, woodlark, common redstart) inhabiting fruit tree plantations, orchards and vineyards. All species preferred foraging in habitat mosaics consisting of patches of grass and bare ground, with an optimal, species-specific bare ground coverage of 30-70% at the foraging patch scale. In the study areas, birds thrived in intensively cultivated farmland where such ground vegetation mosaics existed. Not promoted by conventional agri-environment schemes until now, patches of bare ground should be implemented throughout grassland in order to prevent further decline of insectivorous farmland birds.	[Schaub, Michael; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Schaub, Michael; Martinez, Nicolas; Reichlin, Thomas S.; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael] Swiss Ornithol Inst, Sempach, Switzerland	University of Bern; Swiss Ornithological Institute	Schaub, M (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	raphael.arlettaz@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Walter, Jens/0000-0003-1754-172X; Schaub, Michael/0000-0003-2745-0557	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	Most funding was provided by the University of Bern and the Swiss Ornithological Institute. Reduced additional funding was provided by the Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles) in the form of an MSc grant to Melanie Maurer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PW, 2005, J APPL ECOL, V42, P932, DOI 10.1111/j.1365-2664.2005.01070.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Birrer S, 2007, J ORNITHOL, V148, pS295, DOI 10.1007/s10336-007-0237-y; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Britschgi A, 2006, BIOL CONSERV, V130, P193, DOI 10.1016/j.biocon.2005.12.013; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Buckingham DL, 2004, IBIS, V146, P163, DOI 10.1111/j.1474-919X.2004.00350.x; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; COUDRAIN V, 2010, J ORNITHOL EARLY; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Davey CM, 2010, IBIS, V152, P459, DOI 10.1111/j.1474-919X.2009.01001.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Devereux CL, 2006, AGR ECOSYST ENVIRON, V117, P57, DOI 10.1016/j.agee.2006.03.007; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Martinez N, 2010, J ORNITHOL, V151, P297, DOI 10.1007/s10336-009-0455-6; Mermod M, 2009, IBIS, V151, P731, DOI 10.1111/j.1474-919X.2009.00956.x; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Royle J. A., 2008, HIERARCHICAL MODELIN; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sierro Antoine, 2009, Nos Oiseaux, V56, P129; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x	41	301	309	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13115	10.1371/journal.pone.0013115	http://dx.doi.org/10.1371/journal.pone.0013115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949083	Green Published, gold			2022-12-27	WOS:000282568400002
J	Bornmann, L; Daniel, HD				Bornmann, Lutz; Daniel, Hans-Dieter			The Usefulness of Peer Review for Selecting Manuscripts for Publication: A Utility Analysis Taking as an Example a High-Impact Journal	PLOS ONE			English	Article							CITATION ANALYSIS; QUALITY; VALIDITY; COUNTS	Background: High predictive validity - that is, a strong association between the outcome of peer review (usually, reviewers' ratings) and the scientific quality of a manuscript submitted to a journal (measured as citations of the later published paper) - does not as a rule suffice to demonstrate the usefulness of peer review for the selection of manuscripts. To assess usefulness, it is important to include in addition the base rate (proportion of submissions that are fundamentally suitable for publication) and the selection rate (the proportion of submissions accepted). Methodology/Principal Findings: Taking the example of the high-impact journal Angewandte Chemie International Edition (AC-IE), we present a general approach for determining the usefulness of peer reviews for the selection of manuscripts for publication. The results of our study show that peer review is useful: 78% of the submissions accepted by AC-IE are correctly accepted for publication when the editor's decision is based on one review, 69% of the submissions are correctly accepted for publication when the editor's decision is based on two reviews, and 65% of the submissions are correctly accepted for publication when the editor's decision is based on three reviews. Conclusions/Significance: The paper points out through what changes in the selection rate, base rate or validity coefficient a higher success rate (utility) in the AC-IE selection process could be achieved.	[Bornmann, Lutz; Daniel, Hans-Dieter] ETH, Zurich, Switzerland; [Daniel, Hans-Dieter] Univ Zurich, Evaluat Off, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Bornmann, L (corresponding author), ETH, Zurich, Switzerland.	bornmann@gess.ethz.ch	Bornmann, Lutz/A-3926-2008; Daniel, Hans-Dieter/A-2419-2013; Leydesdorff, Loet/E-2903-2010	Bornmann, Lutz/0000-0003-0810-7091; de Moya Anegon, Felix/0000-0002-0255-8628; Leydesdorff, Loet/0000-0002-7835-3098	Max Planck Society	Max Planck Society(Max Planck SocietyFoundation CELLEX)	The study, which is also investigating quality assurance of open access journals, is supported by a grant from the Max Planck Society (www.mpg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baskerville RL, 2009, MIS QUART, V33, P647; Bornmann L., 2008, ETHICS SCI ENV POLIT, V2014, DOI [10.3354/esep00084, DOI 10.3354/ESEP00084]; BORNMANN L, J INFORMETR IN PRESS; Bornmann L, 2008, J DOC, V64, P45, DOI 10.1108/00220410810844150; Bornmann L, 2008, ANGEW CHEM INT EDIT, V47, P7173, DOI 10.1002/anie.200800513; Bornmann L, 2008, J AM SOC INF SCI TEC, V59, P1841, DOI 10.1002/asi.20901; Bornmann L, 2007, J INFORMETR, V1, P204, DOI 10.1016/j.joi.2007.01.002; Bornmann L, 2010, LIBR INFORM SCI RES, V32, P5, DOI 10.1016/j.lisr.2009.07.010; Bornmann L, 2009, J INFORMETR, V3, P348, DOI 10.1016/j.joi.2009.05.002; Bornmann L, 2009, LEARN PUBL, V22, P117, DOI 10.1087/2009207; Bornmann L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003480; Cabrera EF, 2001, INT J SELECT ASSESS, V9, P92, DOI 10.1111/1468-2389.00166; Cascio W. F., 1991, COSTING HUMAN RESOUR; Craig ID, 2007, J INFORMETR, V1, P239, DOI 10.1016/j.joi.2007.04.001; Daniel H.D., 1993, GUARDIANS SCI FAIRNE, DOI [10.1002/3527602208, DOI 10.1002/3527602208]; EGGHE L, RES EVALUAT IN PRESS; Grover V, 2009, MIS QUART, V33, pIII; Jefferson T, 2002, JAMA-J AM MED ASSOC, V287, P2786, DOI 10.1001/jama.287.21.2786; LINDSEY D, 1989, SCIENTOMETRICS, V15, P189, DOI 10.1007/BF02017198; MARTIN BR, 1983, RES POLICY, V12, P61, DOI 10.1016/0048-7333(83)90005-7; Neuhaus C, 2009, SCIENTOMETRICS, V78, P219, DOI 10.1007/s11192-007-2007-2; Poschl U, 2004, LEARN PUBL, V17, P105, DOI 10.1087/095315104322958481; Radicchi F, 2008, P NATL ACAD SCI USA, V105, P17268, DOI 10.1073/pnas.0806977105; SCHULTZ DM, SCIENTOMETR IN PRESS; *SENS SCI, 2004, PEER VIEW ACC NEW SC; SMITH LC, 1981, LIBR TRENDS, V30, P83; STEWART JA, 1994, INFORM PROCESS MANAG, V30, P239, DOI 10.1016/0306-4573(94)90067-1; STOSSEL TP, 1985, SCI TECHNOL, V10, P39; Straub D.W., 2008, MIS Q, V32, piii; Straub DW, 2008, MIS QUART, V32, pV; Taylor HC, 1939, J APPL PSYCHOL, V23, P565, DOI 10.1037/h0057079; Thorngate W, 2009, JUDGING MERIT, P1; Van Leeuwen TN, 2007, RES EVALUAT, V16, P93, DOI 10.3152/095820207X227529; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19; vanRaan AFJ, 1996, SCIENTOMETRICS, V36, P397, DOI 10.1007/BF02129602; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039; Vinkler P, 1997, SCIENTOMETRICS, V40, P163, DOI 10.1007/BF02459266	37	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 28	2010	5	6							e11344	10.1371/journal.pone.0011344	http://dx.doi.org/10.1371/journal.pone.0011344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	617DB	20596540	Green Submitted, gold, Green Published			2022-12-27	WOS:000279259900017
J	Truman, JP; Garcia-Barros, M; Kaag, M; Hambardzumyan, D; Stancevic, B; Chan, M; Fuks, Z; Kolesnick, R; Haimovitz-Friedman, A				Truman, Jean-Philip; Garcia-Barros, Monica; Kaag, Matthew; Hambardzumyan, Dolores; Stancevic, Branka; Chan, Michael; Fuks, Zvi; Kolesnick, Richard; Haimovitz-Friedman, Adriana			Endothelial Membrane Remodeling Is Obligate for Anti-Angiogenic Radiosensitization during Tumor Radiosurgery	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; FIBROBLAST-GROWTH-FACTOR; ACID SPHINGOMYELINASE; CERAMIDE SYNTHASE; LNCAP CELLS; MICE; RADIOTHERAPY; RAFTS; NORMALIZATION; INHIBITION	Background: While there is significant interest in combining anti-angiogenesis therapy with conventional anti-cancer treatment, clinical trials have as of yet yielded limited therapeutic gain, mainly because mechanisms of anti-angiogenic therapy remain to a large extent unknown. Currently, anti-angiogenic tumor therapy is conceptualized to either "normalize" dysfunctional tumor vasculature, or to prevent recruitment of circulating endothelial precursors into the tumor. An alternative biology, restricted to delivery of anti-angiogenics immediately prior to single dose radiotherapy (radiosurgery), is provided in the present study. Methodology/Principal Findings: Genetic data indicate an acute wave of ceramide-mediated endothelial apoptosis, initiated by acid sphingomyelinase (ASMase), regulates tumor stem cell response to single dose radiotherapy, obligatory for tumor cure. Here we show VEGF prevented radiation-induced ASMase activation in cultured endothelium, occurring within minutes after radiation exposure, consequently repressing apoptosis, an event reversible with exogenous C(16)-ceramide. Anti-VEGFR2 acts conversely, enhancing ceramide generation and apoptosis. In vivo, MCA/129 fibrosarcoma tumors were implanted in asmase(+/+) mice or asmase(-/-) littermates and irradiated in the presence or absence of anti-VEGFR2 DC101 or anti-VEGF G6-31 antibodies. These anti-angiogenic agents, only if delivered immediately prior to single dose radiotherapy, de-repressed radiation-induced ASMase activation, synergistically increasing the endothelial apoptotic component of tumor response and tumor cure. Anti-angiogenic radiosensitization was abrogated in tumors implanted in asmase(-/-) mice that provide apoptosis-resistant vasculature, or in wild-type littermates pre-treated with anti-ceramide antibody, indicating that ceramide is necessary for this effect. Conclusions/Significance: These studies show that angiogenic factors fail to suppress apoptosis if ceramide remains elevated while anti-angiogenic therapies fail without ceramide elevation, defining a ceramide rheostat that determines outcome of single dose radiotherapy. Understanding the temporal sequencing of anti-angiogenic drugs and radiation enables optimized radiosensitization and design of innovative radiosurgery clinical trials.	[Truman, Jean-Philip; Fuks, Zvi; Haimovitz-Friedman, Adriana] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Garcia-Barros, Monica; Stancevic, Branka; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Kaag, Matthew] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Hambardzumyan, Dolores] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Chan, Michael] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Wake Forest University	Truman, JP (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA.	a-haimovitz-friedman@ski.mskcc.org			National Institutes of Health [R01 CA105125, R01 CA085704]; D.K. Ludwig Fund for Cancer Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); D.K. Ludwig Fund for Cancer Research	This work was supported by National Institutes of Health R01 CA105125 to Adriana Haimovitz-Friedman, NIH R01 CA085704 to Richard Kolesnick, and a gift from the Virginia and D.K. Ludwig Fund for Cancer Research to Zvi Fuks. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bocci G, 2001, MOL HUM REPROD, V7, P771, DOI 10.1093/molehr/7.8.771; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Ferrara N, 1999, CURR TOP MICROBIOL, V237, P1; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Fuks Z, 2005, CANCER CELL, V8, P89, DOI 10.1016/j.ccr.2005.07.014; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garzotto M, 1999, CANCER RES, V59, P5194; Garzotto M, 1998, CANCER RES, V58, P2260; Geng L, 2001, CANCER RES, V61, P2413; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2004, J MOL MED, V82, P357, DOI 10.1007/s00109-004-0539-y; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; HaimovitzFriedman A, 1997, J EXP MED, V186, P1831, DOI 10.1084/jem.186.11.1831; HORINOUCHI K, 1995, NAT GENET, V10, P288, DOI 10.1038/ng0795-288; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; KIM JH, 1986, CANCER RES, V46, P1120; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; Korsisaari N, 2007, P NATL ACAD SCI USA, V104, P10625, DOI 10.1073/pnas.0704213104; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; MCCAMMON R, 2008, INT J RAD ONCOL BIOL; Nix M, 2000, CELL DEATH DIFFER, V7, P413, DOI 10.1038/sj.cdd.4400666; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Sessa C, 2008, NAT CLIN PRACT ONCOL, V5, P378, DOI 10.1038/ncponc1150; Siejka A, 2003, LIFE SCI, V72, P2473, DOI 10.1016/S0024-3205(03)00164-4; Tabas I, 1999, CHEM PHYS LIPIDS, V102, P123, DOI 10.1016/S0009-3084(99)00080-8; UCHIDA K, 1994, AM J PHYSIOL, V266, P81; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Witte L, 1998, CANCER METAST REV, V17, P155, DOI 10.1023/A:1006094117427; Yamada Y, 2008, INT J RADIAT ONCOL, V71, P484, DOI 10.1016/j.ijrobp.2007.11.046; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200	39	94	97	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 19	2010	5	8							e12310	10.1371/journal.pone.0012310	http://dx.doi.org/10.1371/journal.pone.0012310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640TN	20941382	Green Published, gold, Green Submitted			2022-12-27	WOS:000281075500027
J	Hu, CX; Hoene, M; Zhao, XJ; Haring, HU; Schleicher, E; Lehmann, R; Han, XL; Xu, GW; Weigert, C				Hu, Chunxiu; Hoene, Miriam; Zhao, Xinjie; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Han, Xianlin; Xu, Guowang; Weigert, Cora			Lipidomics Analysis Reveals Efficient Storage of Hepatic Triacylglycerides Enriched in Unsaturated Fatty Acids after One Bout of Exercise in Mice	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; POSTPRANDIAL LIPEMIA; ENDURANCE EXERCISE; PROLONGED EXERCISE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SINGLE BOUT; TRIGLYCERIDE SECRETION; INSULIN SENSITIVITY; VLDL-TRIGLYCERIDE	Background: Endurance exercise induces lipolysis, increases circulating concentrations of free fatty acids (FFA) and the uptake and oxidation of fatty acids in the working muscle. Less is known about the regulation of lipid metabolism in the liver during and post-exercise. Methodology/Principal Findings: We performed an ultra fast liquid chromatography-mass spectrometry (UFLC-MS) based lipidomics analysis of liver tissue samples obtained from C57Bl/6J mice immediately after a 60 min treadmill run of moderate intensity, and after 3 h of recovery. The PLS-DA scores plot for 115 quantified lipid molecular species revealed a clear separation of the hepatic lipid profile of sedentary from recovering mice, but not from mice immediately after running. 21 lipid species were considered to be most responsible for the difference in the hepatic lipid profiles, including 17 triacylglycerides (TG), one lysophosphatidylcholine (LPC) and three phosphatidylcholines (PC). TG species were found to be more abundant in the recovery phase, while PC species were decreased. The degree of accumulation of individual TG species correlated well with the amount of theoretical energy stored whereas no increase was found for TG species containing only saturated or one monounsaturated fatty acid. Total liver TG content as assayed by an enzymatic method was increased to 163% in the recovery phase, while it was significantly decreased in skeletal muscle by the exercise bout and remained less in the recovery phase. Results from fasted and refed mice indicate that fasting-induced lipolysis was associated with a pronounced accumulation of hepatic TG, which is reversed by refeeding for 5 h. Thus food intake per se did not elevate hepatic TG. Conclusion: These data indicate that high availability of FFA induced by endurance exercise or fasting resulted in a transient hepatic TG accumulation, while muscle TG content was decreased during exercise presumably due to increased muscle fatty acid oxidation.	[Hu, Chunxiu; Zhao, Xinjie; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Univ Hosp Tuebingen, Div Endocrinol, Dept Internal Med, Tubingen, Germany; [Han, Xianlin] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Paul Langerhans Inst Tuebingen, Tubingen, Germany	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Washington University (WUSTL)	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019; Xu, Guowang/L-6910-2014; Wang, Congrong/HDM-0959-2022	Lehmann, Rainer/0000-0003-1218-6810; Xu, Guowang/0000-0003-4298-3554; Hu, Cheng/0000-0003-4314-2386; Wang, Congrong/0000-0002-8645-1114	Deutsche Forschungsgemeinschaft [WE 4176, GRK 1302/1]; Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research (BMBF); Sino-German Center for Research Promotion [GZ 364]; State Ministry of Science and Technology of China [2006CB503902]; National Natural Science Foundation of China [20835006]; Chinese Academy of Sciences [KSCX1-YW-02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sino-German Center for Research Promotion; State Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to C. W. (WE 4176) and to E. S. (GRK 1302/1), by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research to R. L. and H. U. H. (FKZ 01GI0803-04), by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), the Sino-German Center for Research Promotion to R. L. and G. X. (DFG and NSFC, GZ 364), the 973 Project of the State Ministry of Science and Technology of China to G. X. (No. 2006CB503902), the National Natural Science Foundation of China to G. X. (No. 20835006), and the Knowledge Innovation Program of the Chinese Academy of Sciences to G. X. (KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; ALDRED HE, 1994, METABOLISM, V43, P836, DOI 10.1016/0026-0495(94)90263-1; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; ANNUZZI G, 1987, METABOLISM, V36, P438, DOI 10.1016/0026-0495(87)90040-0; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Borsheim E, 1999, MED SCI SPORT EXER, V31, P522; Burguera B, 2000, AM J PHYSIOL-ENDOC M, V278, pE113, DOI 10.1152/ajpendo.2000.278.1.E113; CHEN ZY, 1992, AM J PHYSIOL, V263, pR233, DOI 10.1152/ajpregu.1992.263.2.R233; CULLINANE E, 1982, METABOLISM, V31, P844, DOI 10.1016/0026-0495(82)90085-3; Eriksson L, 2001, MULTI AND MEGAVARIAT; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; GORSKI J, 1988, EUR J APPL PHYSIOL, V57, P554, DOI 10.1007/BF00418461; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; HOLLOSZY JO, 1964, AM J CARDIOL, V14, P753, DOI 10.1016/0002-9149(64)90004-9; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Magkos F, 2008, J APPL PHYSIOL, V105, P1228, DOI 10.1152/japplphysiol.90761.2008; Magkos F, 2007, AM J PHYSIOL-ENDOC M, V292, pE1568, DOI 10.1152/ajpendo.00636.2006; Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004; MONDON CE, 1984, J APPL PHYSIOL, V57, P1466, DOI 10.1152/jappl.1984.57.5.1466; Nielsen HB, 2007, J APPL PHYSIOL, V103, P1227, DOI 10.1152/japplphysiol.00027.2007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Petridou A, 2005, EUR J APPL PHYSIOL, V94, P84, DOI 10.1007/s00421-004-1294-z; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; SADY SP, 1988, METABOLISM, V37, P568, DOI 10.1016/0026-0495(88)90173-4; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SIMONELLI C, 1978, AM J PHYSIOL, V234, pE221, DOI 10.1152/ajpendo.1978.234.3.E221; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; TRISCARI J, 1980, METABOLISM, V29, P377, DOI 10.1016/0026-0495(80)90013-X; Tsekouras YE, 2008, AM J PHYSIOL-ENDOC M, V295, pE851, DOI 10.1152/ajpendo.90545.2008; Tsekouras YE, 2009, CLIN SCI, V116, P147, DOI 10.1042/CS20080078; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Ziogas GG, 1997, MED SCI SPORT EXER, V29, P986, DOI 10.1097/00005768-199708000-00002	49	71	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13318	10.1371/journal.pone.0013318	http://dx.doi.org/10.1371/journal.pone.0013318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967198	Green Published, gold			2022-12-27	WOS:000282869800021
J	Kiebala, M; Polesskaya, O; Yao, ZQ; Perry, SW; Maggirwar, SB				Kiebala, Michelle; Polesskaya, Oksana; Yao, Zhenqiang; Perry, Seth W.; Maggirwar, Sanjay B.			Nuclear Factor-Kappa B Family Member RelB Inhibits Human Immunodeficiency Virus-1 Tat-Induced Tumor Necrosis Factor-Alpha Production	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 ASSOCIATED DEMENTIA; UP-REGULATES EXPRESSION; TYPE-1 GENE-EXPRESSION; HUMAN FETAL MICROGLIA; TNF-ALPHA; TRANSCRIPTION FACTORS; CHEMOKINE EXPRESSION; RECEPTOR ACTIVATION; NEURONAL INJURY	Human Immunodeficiency Virus-1 (HIV-1)-associated neurocognitive disorder (HAND) is likely neuroinflammatory in origin, believed to be triggered by inflammatory and oxidative stress responses to cytokines and HIV protein gene products such as the HIV transactivator of transcription (Tat). Here we demonstrate increased messenger RNA for nuclear factor- kappa B (NF-kappa B) family member, transcription factor RelB, in the brain of doxycycline-induced Tat transgenic mice, and increased RelB synthesis in Tat-exposed microglial cells. Since genetic ablation of RelB in mice leads to multi-organ inflammation, we hypothesized that Tat-induced, newly synthesized RelB inhibits cytokine production by microglial cells, possibly through the formation of transcriptionally inactive RelB/RelA complexes. Indeed, tumor necrosis factor-alpha (TNF alpha) production in monocytes isolated from RelB deficient mice was significantly higher than in monocytes isolated from RelB expressing controls. Moreover, RelB overexpression in microglial cells inhibited Tat-induced TNF alpha synthesis in a manner that involved transcriptional repression of the TNF alpha promoter, and increased phosphorylation of RelA at serine 276, a prerequisite for increased RelB/RelA protein interactions. The Rel-homology-domain within RelB was necessary for this interaction. Overexpression of RelA itself, in turn, significantly increased TNF alpha promoter activity, an effect that was completely blocked by RelB overexpression. We conclude that RelB regulates TNF alpha cytokine synthesis by competitive interference binding with RelA, which leads to downregulation of TNF alpha production. Moreover, because Tat activates both RelB and TNF alpha in microglia, and because Tat induces inflammatory TNF alpha synthesis via NF-kappa B, we posit that RelB serves as a cryoprotective, anti-inflammatory, counter-regulatory mechanism for pathogenic NF-kappa B activation. These findings identify a novel regulatory pathway for controlling HIV-induced microglial activation and cytokine production that may have important therapeutic implications for the management of HAND.	[Kiebala, Michelle; Polesskaya, Oksana; Maggirwar, Sanjay B.] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA; [Yao, Zhenqiang] Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Rochester, NY 14642 USA; [Perry, Seth W.] Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Neural Dev & Dis, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Kiebala, M (corresponding author), Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, Rochester, NY 14642 USA.	sanjay_maggirwar@urmc.rochester.edu	Polesskaya, Oksana/AAX-9283-2021; Zhu, Yingjie/W-3315-2017	Zhu, Yingjie/0000-0003-1849-6019; Perry, Seth W/0000-0002-1503-6634; Xu, Hongxi/0000-0001-6238-4511	National Institutes of Health [RO1 NS054578, RO1 NS066801, R21 MH084718, T32 AI49105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI049815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH084718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066801, R01NS054578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the following National Institutes of Health grants: RO1 NS054578 and RO1 NS066801 (to SBM); R21 MH084718 (to SWP); T32 AI49105 (to MK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony IC, 2008, INT REV PSYCHIATR, V20, P15, DOI 10.1080/09540260701862037; Archibald SL, 2004, ARCH NEUROL-CHICAGO, V61, P369, DOI 10.1001/archneur.61.3.369; Avison MJ, 2004, J NEUROVIROL, V10, P223, DOI 10.1080/13550280490463532; Beauparlant P, 1996, J VIROL, V70, P5777, DOI 10.1128/JVI.70.9.5777-5785.1996; BIDDISON WE, 2001, CURR PROTOC CELL BIO, pCH2; *BIO RAD LAB I LIF, B BIO RAD LAB I LIF, V2890; Bissel SJ, 2002, AM J PATHOL, V160, P927, DOI 10.1016/S0002-9440(10)64915-2; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Bossi P, 1998, CLIN INFECT DIS, V26, P1072, DOI 10.1086/520301; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; BRAKE DA, 1990, J CELL BIOL, V111, P1275, DOI 10.1083/jcb.111.3.1275; Bren GD, 2001, ONCOGENE, V20, P7722, DOI 10.1038/sj.onc.1204868; CARDENAS V, 2009, J NEUROVIROL, P1; CHANAKYA HN, 1997, BIOENERGY NEWS, V1, P11; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Chen YS, 2009, NEUROIMAGE, V47, P1154, DOI 10.1016/j.neuroimage.2009.04.030; D'Aversa TG, 2004, J NEUROVIROL, V10, P86, DOI 10.1080/13550280490279807; D'Aversa TG, 2002, AM J PATHOL, V160, P559, DOI 10.1016/S0002-9440(10)64875-4; de Jager W, 2003, CLIN DIAGN LAB IMMUN, V10, P133, DOI 10.1128/CDLI.10.1.133-139.2003; Devadas K, 2004, J IMMUNOL, V173, P6735, DOI 10.4049/jimmunol.173.11.6735; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; DOBRZANSKI P, 1993, MOL CELL BIOL, V13, P1572, DOI 10.1128/MCB.13.3.1572; Eugenin EA, 2005, GLIA, V49, P501, DOI 10.1002/glia.20137; Everall IP, 1999, BRAIN PATHOL, V9, P209; EVERALL IP, 1994, ACTA NEUROPATHOL, V88, P538; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; Fusco AJ, 2009, EMBO REP, V10, P152, DOI 10.1038/embor.2008.227; GELBARD HA, 1993, DEV NEUROSCI-BASEL, V15, P417, DOI 10.1159/000111367; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; Ghafouri M, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-28; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GLASS JD, 1995, ANN NEUROL, V38, P755, DOI 10.1002/ana.410380510; Gongvatana A, 2009, J NEUROVIROL, V15, P187, DOI 10.1080/13550280902769756; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Guillemard E, 2004, VIROLOGY, V329, P371, DOI 10.1016/j.virol.2004.08.030; Harhaj E, 1996, VIROLOGY, V216, P284, DOI 10.1006/viro.1996.0062; Hayashi K, 2006, J CEREBR BLOOD F MET, V26, P1052, DOI 10.1038/sj.jcbfm.9600254; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herbein G, 2008, CURR HIV RES, V6, P117, DOI 10.2174/157016208783884985; HOWARD OMZ, 1993, P NATL ACAD SCI USA, V90, P2335, DOI 10.1073/pnas.90.6.2335; Iwata A, 2003, J IMMUNOL, V171, P3136, DOI 10.4049/jimmunol.171.6.3136; Jacque E, 2005, P NATL ACAD SCI USA, V102, P14635, DOI 10.1073/pnas.0507342102; Jeang KT, 1999, J BIOL CHEM, V274, P28837, DOI 10.1074/jbc.274.41.28837; Ju SM, 2009, EXP MOL MED, V41, P86, DOI 10.3858/emm.2009.41.2.011; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2006, CURR HIV RES, V4, P307, DOI 10.2174/157016206777709384; Kaul M, 2009, CURR OPIN NEUROL, V22, P315, DOI 10.1097/WCO.0b013e328329cf3c; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Langford TD, 2002, AIDS, V16, P1019, DOI 10.1097/00002030-200205030-00008; Langford TD, 2003, BRAIN PATHOL, V13, P195; LERNBECHER T, 1994, EMBO J, V13, P4060, DOI 10.1002/j.1460-2075.1994.tb06723.x; Letendre Scott L, 2009, Top HIV Med, V17, P46; Li WX, 2008, J NEUROSCI, V28, P12190, DOI 10.1523/JNEUROSCI.3019-08.2008; Maggirwar SB, 2000, J NEUROCHEM, V74, P527, DOI 10.1046/j.1471-4159.2000.740527.x; Maggirwar SB, 1998, J NEUROSCI, V18, P10356; MAJOR EO, 2009, ANN REV MED; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Masliah E, 2000, AIDS, V14, P69, DOI 10.1097/00002030-200001070-00008; Masliah E, 1997, ANN NEUROL, V42, P963, DOI 10.1002/ana.410420618; Mayne M, 1998, NEUROIMMUNOMODULAT, V5, P184, DOI 10.1159/000026336; McArthur JC, 2003, J NEUROVIROL, V9, P205, DOI 10.1080/13550280390194109; McArthur JC, 2004, J NEUROIMMUNOL, V157, P3, DOI 10.1016/j.jneuroim.2004.08.042; Melrose RJ, 2008, BEHAV BRAIN RES, V188, P337, DOI 10.1016/j.bbr.2007.11.021; MERRILL JE, 1991, FASEB J, V5, P2391, DOI 10.1096/fasebj.5.10.2065887; Minagar A, 2002, J NEUROL SCI, V202, P13, DOI 10.1016/S0022-510X(02)00207-1; MULLEROEHRING EM, 2009, NEUROPSYCHOLOGIA; Nath A, 2000, ANN NEUROL, V47, P186, DOI 10.1002/1531-8249(200002)47:2<186::AID-ANA8>3.3.CO;2-V; Nath A, 1998, PROG NEUROBIOL, V54, P19, DOI 10.1016/S0301-0082(97)00053-1; Nath A, 1999, J BIOL CHEM, V274, P17098, DOI 10.1074/jbc.274.24.17098; Nath A, 2006, CURR OPIN NEUROL, V19, P358, DOI 10.1097/01.wco.0000236614.51592.ca; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; NGUYEN TP, 2009, AM J PATHOL; Nichol KE, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-13; Oberdorfer P, 2009, INT J PEDIAT, V2009, DOI 10.1155/2009/348507; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Perry SW, 1998, J BIOL CHEM, V273, P17660, DOI 10.1074/jbc.273.28.17660; Pfefferbaum A, 2009, AIDS, V23, P1977, DOI 10.1097/QAD.0b013e32832e77fe; Quiterio S, 2003, BIOMED PHARMACOTHER, V57, P49, DOI 10.1016/S0753-3322(02)00332-3; Ranga U, 2004, J VIROL, V78, P2586, DOI 10.1128/JVI.78.5.2586-2590.2004; RESNICK L, 1988, NEUROLOGY, V38, P9, DOI 10.1212/WNL.38.1.9; Rezaie P, 1999, DEV BRAIN RES, V115, P71, DOI 10.1016/S0165-3806(99)00043-7; RUBEN S, 1989, J VIROL, V63, P1; Rumbaugh JA, 2006, CURR PHARM DESIGN, V12, P1023, DOI 10.2174/138161206776055877; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sanchez JF, 2003, MOL CELL BIOL, V23, P4649, DOI 10.1128/MCB.23.13.4649-4662.2003; SCHUTZE S, 1995, IMMUNOBIOLOGY, V193, P193, DOI 10.1016/S0171-2985(11)80543-7; Shatrov VA, 1997, EUR CYTOKINE NETW, V8, P37; Solan NJ, 2002, J BIOL CHEM, V277, P1405, DOI 10.1074/jbc.M109619200; Sui Z, 2007, J IMMUNOL, V178, P3226, DOI 10.4049/jimmunol.178.5.3226; Sui Z, 2006, J IMMUNOL, V177, P702, DOI 10.4049/jimmunol.177.1.702; SWINGLER S, 1994, BIOCHEM BIOPH RES CO, V203, P623, DOI 10.1006/bbrc.1994.2228; TORNATORE C, 1991, J VIROL, V65, P6094, DOI 10.1128/JVI.65.11.6094-6100.1991; Tozzi V, 2007, JAIDS-J ACQ IMM DEF, V45, P174, DOI 10.1097/QAI.0b013e318042e1ee; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Verstrepen L, 2008, CELL MOL LIFE SCI, V65, P2964, DOI 10.1007/s00018-008-8064-8; Weih F, 1997, J IMMUNOL, V158, P5211; WEIH F, 1995, CELL, V80, P331, DOI 10.1016/0092-8674(95)90416-6; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WESTENDORP MO, 1995, EMBO J, V14, P546, DOI 10.1002/j.1460-2075.1995.tb07030.x; WILEY CA, 1991, ANN NEUROL, V29, P651, DOI 10.1002/ana.410290613; Wohlschlaeger J, 2009, CLIN NEUROL NEUROSUR, V111, P422, DOI 10.1016/j.clineuro.2008.12.006; Xia YY, 1999, MOL CELL BIOL, V19, P7688; Xia YY, 1997, AM J PATHOL, V151, P375; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080	109	279	330	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 29	2010	5	7							e11875	10.1371/journal.pone.0011875	http://dx.doi.org/10.1371/journal.pone.0011875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633QY	20686703	Green Published, gold, Green Submitted			2022-12-27	WOS:000280520200037
J	Sato, Y; Poynter, G; Huss, D; Filla, MB; Czirok, A; Rongish, BJ; Little, CD; Fraser, SE; Lansford, R				Sato, Yuki; Poynter, Greg; Huss, David; Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.; Fraser, Scott E.; Lansford, Rusty			Dynamic Analysis of Vascular Morphogenesis Using Transgenic Quail Embryos	PLOS ONE			English	Article							BLOOD-VESSEL FORMATION; LENTIVIRAL VECTORS; CHICK EMBRYO; CELL-MIGRATION; VASCULOGENESIS; MECHANISMS; EXPRESSION; EFFICIENT; EMBRYOGENESIS; ANGIOGENESIS	Background: One of the least understood and most central questions confronting biologists is how initially simple clusters or sheet-like cell collectives can assemble into highly complex three-dimensional functional tissues and organs. Due to the limits of oxygen diffusion, blood vessels are an essential and ubiquitous presence in all amniote tissues and organs. Vasculogenesis, the de novo self-assembly of endothelial cell (EC) precursors into endothelial tubes, is the first step in blood vessel formation [1]. Static imaging and in vitro models are wholly inadequate to capture many aspects of vascular pattern formation in vivo, because vasculogenesis involves dynamic changes of the endothelial cells and of the forming blood vessels, in an embryo that is changing size and shape. Methodology/Principal Findings: We have generated Tie1 transgenic quail lines Tg(tie1:H2B-eYFP) that express H2B-eYFP in all of their endothelial cells which permit investigations into early embryonic vascular morphogenesis with unprecedented clarity and insight. By combining the power of molecular genetics with the elegance of dynamic imaging, we follow the precise patterning of endothelial cells in space and time. We show that during vasculogenesis within the vascular plexus, ECs move independently to form the rudiments of blood vessels, all while collectively moving with gastrulating tissues that flow toward the embryo midline. The aortae are a composite of somatic derived ECs forming its dorsal regions and the splanchnic derived ECs forming its ventral region. The ECs in the dorsal regions of the forming aortae exhibit variable mediolateral motions as they move rostrally; those in more ventral regions show significant lateral-to-medial movement as they course rostrally. Conclusions/Significance: The present results offer a powerful approach to the major challenge of studying the relative role(s) of the mechanical, molecular, and cellular mechanisms of vascular development. In past studies, the advantages of the molecular genetic tools available in mouse were counterbalanced by the limited experimental accessibility needed for imaging and perturbation studies. Avian embryos provide the needed accessibility, but few genetic resources. The creation of transgenic quail with labeled endothelia builds upon the important roles that avian embryos have played in previous studies of vascular development.	[Sato, Yuki; Poynter, Greg; Huss, David; Fraser, Scott E.; Lansford, Rusty] CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA; [Filla, Michael B.; Czirok, Andras; Rongish, Brenda J.; Little, Charles D.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA	California Institute of Technology; University of Kansas; University of Kansas Medical Center	Sato, Y (corresponding author), CALTECH, Beckman Inst, Biol Imaging Ctr, Div Biol, Pasadena, CA 91125 USA.	rusty@caltech.edu	Fraser, Scott/Y-3406-2019; Czirok, Andras/E-4253-2014; Rongish, Brenda/G-7637-2016; Lansford, Rusty/C-6956-2014; Rochel, Natacha/A-5718-2016; Sato, Yoshinori/J-2497-2015	Fraser, Scott/0000-0002-5377-0223; Czirok, Andras/0000-0002-2694-5163; Rongish, Brenda/0000-0002-1559-2876; Lansford, Rusty/0000-0002-2159-3699; Ueno, Takamasa/0000-0003-4852-4236; Poussin-Courmontagne, Pierre/0000-0003-4813-6882; POTIER, Noelle/0000-0002-6381-4365; Rochel, Natacha/0000-0002-3573-5889; Takata, Hiroshi/0000-0003-1457-6919; Nakagata, Naomi/0000-0002-5737-9993; Sato, Yoshinori/0000-0001-8250-6598	National Institutes of Health (NIH) National Center for Research Resources [R21HD047347-01]; NIH National Heart, Lung, and Blood Institute [(R01) HL085694, HL068855, HL87136]; NIH Center of Excellence in Genomic Science [P50 HG004071]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD047347] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085694, R01HL087136, R01HL068855] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004071] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Center of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Grants by the National Institutes of Health (NIH) National Center for Research Resources (R21HD047347-01), NIH National Heart, Lung, and Blood Institute (R01) HL085694 (BJR), HL068855 (CDL), HL87136 (AC), and NIH Center of Excellence in Genomic Science (P50 HG004071) supported the work. Y.S. was a postdoctoral fellow for research abroad of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Blomer U, 1997, J VIROL, V71, P6641; Cleaver O, 1998, DEVELOPMENT, V125, P3905; COFFIN JD, 1991, ANAT REC, V231, P383; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; DE PALMA M, 2003, HUM GENE THER, V14, P1193; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DERUITER MC, 1993, ANAT RECORD, V235, P261, DOI 10.1002/ar.1092350210; DRAKE CJ, 1992, DEV DYNAM, V193, P83, DOI 10.1002/aja.1001930111; Drake CJ, 1997, DEV BIOL, V192, P17, DOI 10.1006/dbio.1997.8751; DRAKE CJ, 1995, P NATL ACAD SCI USA, V92, P7657, DOI 10.1073/pnas.92.17.7657; Eichmann A, 2005, INT J DEV BIOL, V49, P259, DOI 10.1387/ijdb.041941ae; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; GONZALEZCRUSSI F, 1971, AM J ANAT, V130, P441, DOI 10.1002/aja.1001300406; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harvey AJ, 2002, NAT BIOTECHNOL, V20, P396, DOI 10.1038/nbt0402-396; Huss D, 2008, LAB ANIMAL, V37, P513, DOI 10.1038/laban1108-513; Iljin K, 2002, FASEB J, V16, P1764, DOI 10.1096/fj.01-1043com; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kootstra NA, 2003, ANNU REV PHARMACOL, V43, P413, DOI 10.1146/annurev.pharmtox.43.100901.140257; Kulesa PM, 2000, DEVELOPMENT, V127, P1161; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; PARDANAUD L, 1987, CELL DIFFER DEV, V22, P47, DOI 10.1016/0045-6039(87)90412-X; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Perryn ED, 2008, DEV BIOL, V313, P545, DOI 10.1016/j.ydbio.2007.10.036; Pinter E, 1997, AM J PATHOL, V150, P1523; POOLE TJ, 1989, J EXP ZOOL, V251, P224, DOI 10.1002/jez.1402510210; POYNTER G, 2009, COLD SPRING HARBOR P; Pudliszewski M, 2005, INT J DEV BIOL, V49, P355, DOI 10.1387/ijdb.041956mp; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; ROMANOFF A, 1960, HEMATOPOIETIC VASCUL, P571; Rupp PA, 2004, DEVELOPMENT, V131, P2887, DOI 10.1242/dev.01160; Sabin FR, 1920, CONTRIB EMBRYOL, V9, P215; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schmidt A, 2007, CIRC RES, V101, P125, DOI 10.1161/CIRCRESAHA.107.148932; Scott BB, 2005, P NATL ACAD SCI USA, V102, P16443, DOI 10.1073/pnas.0508437102; Sedmera D, 2006, ANAT REC PART A, V288A, P933, DOI 10.1002/ar.a.20383; STALSBERG H, 1969, DEV BIOL, V19, P128, DOI 10.1016/0012-1606(69)90052-9; Trinkaus J.P., 1969, CELLS ORGANS FORCES, Vfirst; Zamir EA, 2005, ANN BIOMED ENG, V33, P854, DOI 10.1007/s10439-005-3037-7; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zeng GF, 2007, BLOOD, V109, P1345, DOI 10.1182/blood-2006-07-037952	50	104	105	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2010	5	9							e12674	10.1371/journal.pone.0012674	http://dx.doi.org/10.1371/journal.pone.0012674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	649ZO	21152046	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000281815700006
